PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zandian, M; Mott, KR; Allen, SJ; Chen, SA; Arditi, M; Ghiasi, H				Zandian, Mandana; Mott, Kevin R.; Allen, Sariah J.; Chen, Shuang; Arditi, Moshe; Ghiasi, Homayon			IL-2 Suppression of IL-12p70 by a Recombinant HSV-1 Expressing IL-2 Induces T-Cell Auto-Reactivity and CNS Demyelination	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS PATIENTS; TRANSCRIPTION FACTOR FOXP3; MYELIN BASIC-PROTEIN; WILD-TYPE VIRUS; DENDRITIC CELLS; IN-VIVO; REGULATORY CELLS	To evaluate the role of cellular infiltrates in CNS demyelination in immunocompetent mice, we have used a model of multiple sclerosis (MS) in which different strains of mice are infected with a recombinant HSV-1 expressing IL-2. Histologic examination of the mice infected with HSV-IL-2 demonstrates that natural killer cells, dendritic cells, B cells, and CD25 (IL-2r alpha) do not play any role in the HSV-IL-2-induced demyelination. T cell depletion, T cell knockout and T cell adoptive transfer experiments suggest that both CD8(+) and CD4(+) T cells contribute to HSV-IL-2-induced CNS demyelination with CD8(+) T cells being the primary inducers. In the adoptive transfer studies, all of the transferred T cells irrespective of their CD25 status at the time of transfer were positive for expression of FoxP3 and depletion of FoxP3 blocked CNS demyelination by HSV-IL-2. The expression levels of IL-12p35 relative to IL-12p40 differed in BM-derived macrophages infected with HSV-IL-2 from those infected with wild-type HSV-1. HSV-IL-2-induced demyelination was blocked by injecting HSV-IL-2-infected mice with IL-12p70 DNA. This study demonstrates that suppression of the IL-12p70 function of macrophages by IL-2 causes T cells to become auto-aggressive. Interruption of this immunoregulatory axis results in demyelination of the optic nerve, the spinal cord and the brain by autoreactive T cells in the HSV-IL-2 mouse model of MS.	[Zandian, Mandana; Mott, Kevin R.; Allen, Sariah J.; Ghiasi, Homayon] Cedars Sinai Med Ctr, Dept Surg, Ctr Neurobiol & Vaccine Dev, Los Angeles, CA 90048 USA; [Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zandian, M (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Ctr Neurobiol & Vaccine Dev, Los Angeles, CA 90048 USA.	ghiasih@cshs.org			National Eye Institute [EY15557]; NATIONAL EYE INSTITUTE [R01EY015557] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by Public Health Service grant EY15557 from the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1987, J VIROL, V61, P1571, DOI 10.1128/JVI.61.5.1571-1576.1987; Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Boman J, 2000, NEUROLOGY, V54, P265, DOI 10.1212/WNL.54.1.265; Boyman O, 2006, EXPERT OPIN BIOL TH, V6, P1323, DOI 10.1517/14712598.6.12.1323; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; CHEN YH, 1995, J IMMUNOL, V155, P910; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cua DJ, 1999, J EXP MED, V189, P1005, DOI 10.1084/jem.189.6.1005; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Friedman JE, 1999, MULT SCLER, V5, P355, DOI 10.1177/135245859900500509; GALLO P, 1988, ANN NEUROL, V24, P795, DOI 10.1002/ana.410240618; GALLO P, 1989, J NEUROL SCI, V92, P9, DOI 10.1016/0022-510X(89)90171-8; Ghiasi H, 2002, J VIROL, V76, P9069, DOI 10.1128/JVI.76.18.9069-9078.2002; GHIASI H, 1995, J VIROL, V69, P334, DOI 10.1128/JVI.69.1.334-340.1995; Ghiasi H, 2000, ANTIVIR RES, V45, P33, DOI 10.1016/S0166-3542(99)00075-3; Ghiasi H, 2002, VIROLOGY, V302, P144, DOI 10.1006/viro.2002.1609; Ghiasi H, 2001, J VIROL, V75, P9029, DOI 10.1128/JVI.75.19.9029-9036.2001; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hemmer B, 2002, CURR OPIN NEUROL, V15, P227, DOI 10.1097/00019052-200206000-00001; Kang BY, 1999, INT J CANCER, V82, P569, DOI 10.1002/(SICI)1097-0215(19990812)82:4<569::AID-IJC16>3.0.CO;2-M; Karp CL, 2001, CURR OPIN NEUROL, V14, P361, DOI 10.1097/00019052-200106000-00016; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohlmann WM, 2004, EXP DERMATOL, V13, P607, DOI 10.1111/j.0906-6705.2004.00195.x; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Kuroda K, 1996, J IMMUNOL, V157, P1422; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; LU CZ, 1993, J NEUROL SCI, V120, P99, DOI 10.1016/0022-510X(93)90032-T; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Martin C, 1997, ACTA NEUROL SCAND, V95, P280, DOI 10.1111/j.1600-0404.1997.tb00210.x; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Mirandola P, 1999, NEUROLOGY, V53, P1367, DOI 10.1212/WNL.53.6.1367-a; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2007, MOL VIS, V13, P1802; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Osorio Y, 2005, EXP NEUROL, V193, P1, DOI 10.1016/j.expneurol.2004.12.004; Osorio Y, 2002, OCUL IMMUNOL INFLAMM, V10, P105, DOI 10.1076/ocii.10.2.105.13982; Peters JH, 1996, IMMUNOL TODAY, V17, P273, DOI 10.1016/0167-5699(96)80544-5; Petitto JM, 2000, NEUROSCI LETT, V285, P66, DOI 10.1016/S0304-3940(00)00996-4; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; PRINEAS JW, 1978, LAB INVEST, V38, P409; Putheti P, 2004, J CLIN IMMUNOL, V24, P155, DOI 10.1023/B:JOCI.0000019780.93817.82; Ramirez MC, 2004, TRENDS MICROBIOL, V12, P204, DOI 10.1016/j.tim.2004.03.008; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; Schwarz T, 1995, RES IMMUNOL, V146, P494, DOI 10.1016/0923-2494(96)83022-7; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tran EH, 1998, J IMMUNOL, V161, P3767; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; TROTTER JL, 1989, ANN NEUROL, V25, P172, DOI 10.1002/ana.410250211; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zandian M, 2009, INVEST OPHTH VIS SCI, V50, P3275, DOI 10.1167/iovs.08-3211; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	74	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16820	10.1371/journal.pone.0016820	http://dx.doi.org/10.1371/journal.pone.0016820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364747	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800016
J	Chen, X; Tolkovsky, AM; Herbert, J				Chen, Xia; Tolkovsky, Aviva M.; Herbert, Joe			Cell Origin and Culture History Determine Successful Integration of Neural Precursor Transplants into the Dentate Gyrus of the Adult Rat	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; PROLIFERATION; ASTROCYTES; GENERATION; LINEAGES; SURVIVAL	The success of transplants of neural tissue into the adult dentate gyrus in generating mature neurons is highly variable. Here we address the roles of the origin of the tissue and its pre-implantation preparation, and show that both are critical. We transplanted neonatal cultured or primary rat cells from either the ventral subventricular zone (vSVZ) or the dentate gyrus (DG) into the adult rat DG. Only primary DG cells robustly generated DG neurons (80% NeuN and Prox1-positive cells at 6 weeks), substantially repaired the damaged DG, and formed glutamatergic projections to the target CA3 region. Cultured DG cells expanded for 7 days showed limited neuronal differentiation after transplantation (10% NeuN and Prox1-positive cells) whereas cultured or primary vSVZ cells failed to make any Prox1-positive DG granular neurons. We found that a specific population of postmitotic young neurons (triple doublecortin/NeuN/Prox1-positive) were particularly abundant in primary DG cells, but were markedly reduced in the cultured DG cells and were absent in the cultured and primary vSVZ cells. Labelling of primary DG cells with the mitotic marker BrdU suggested that postmitotic young neurons are the source of the transplanted mature neurons in-vivo. We conclude that both the origin and pre-transplantation history of donor cells are key factors that determine the outcome of transplantation. These findings may be of therapeutic interest for cell replacement therapy in treating the damaged hippocampus.	[Chen, Xia; Tolkovsky, Aviva M.; Herbert, Joe] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge, England	University of Cambridge	Herbert, J (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge, England.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		John and Lucille van Geest Foundation; Wellcome Trust	John and Lucille van Geest Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the John and Lucille van Geest Foundation and by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Chen K, 2007, CELL TRANSPLANT, V16, P799, DOI 10.3727/000000007783465253; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Gritti A, 2009, J COMP NEUROL, V517, P333, DOI 10.1002/cne.22153; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; LEGENDRE DI, 1994, EXP NEUROL, V125, P247, DOI 10.1006/exnr.1994.1027; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Milosevic A, 2008, MOL CELL NEUROSCI, V39, P324, DOI 10.1016/j.mcn.2008.07.015; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ormerod BK, 2008, PHILOS T R SOC B, V363, P153, DOI 10.1098/rstb.2006.2018; Palmer TD, 1999, J NEUROSCI, V19, P8487; Raedt R, 2009, EPILEPSY RES, V87, P148, DOI 10.1016/j.eplepsyres.2009.08.009; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shetty AK, 1996, PROG NEUROBIOL, V50, P597, DOI 10.1016/S0301-0082(96)00048-2; Shetty AK, 2008, J NEUROSCI RES, V86, P3062, DOI 10.1002/jnr.21764; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Studer L, 2000, J NEUROSCI, V20, P7377; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Villaescusa JC, 2010, EXP NEUROL, V222, P173, DOI 10.1016/j.expneurol.2009.12.028; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhu H, 2007, J NEUROSCI RES, V85, P2783, DOI 10.1002/jnr.21257; Zietlow R, 2005, J ANAT, V207, P227, DOI 10.1111/j.1469-7580.2005.00449.x	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17072	10.1371/journal.pone.0017072	http://dx.doi.org/10.1371/journal.pone.0017072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359219	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700045
J	Katz, SL; Hampton, SE; Izmest'eva, LR; Moore, MV				Katz, Stephen L.; Hampton, Stephanie E.; Izmest'eva, Lyubov R.; Moore, Marianne V.			Influence of Long-Distance Climate Teleconnection on Seasonality of Water Temperature in the World's Largest Lake - Lake Baikal, Siberia	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; ASIAN WINTER MONSOON; ENSO TELECONNECTIONS; SYNOPTIC CONDITIONS; ARCTIC OSCILLATION; DECEMBER 1974; EASTERN ASIA; COLD SURGES; VARIABILITY; PACIFIC	Large-scale climate change is superimposed on interacting patterns of climate variability that fluctuate on numerous temporal and spatial scales-elements of which, such as seasonal timing, may have important impacts on local and regional ecosystem forcing. Lake Baikal in Siberia is not only the world's largest and most biologically diverse lake, but it has exceptionally strong seasonal structure in ecosystem dynamics that may be dramatically affected by fluctuations in seasonal timing. We applied time-frequency analysis to a near-continuous, 58-year record of water temperature from Lake Baikal to examine how seasonality in the lake has fluctuated over the past half century and to infer underlying mechanisms. On decadal scales, the timing of seasonal onset strongly corresponds with deviation in the zonal wind intensity as described by length of day (LOD); on shorter scales, these temperature patterns shift in concert with the El Nino-Southern Oscillation (ENSO). Importantly, the connection between ENSO and Lake Baikal is gated by the cool and warm periods of the Pacific Decadal Oscillation (PDO). Large-scale climatic phenomena affecting Siberia are apparent in Lake Baikal surface water temperature data, dynamics resulting from jet stream and storm track variability in central Asia and across the Northern Hemisphere.	[Katz, Stephen L.] Natl Oceanog & Atmospher Adm, Santa Barbara, CA 93109 USA; [Hampton, Stephanie E.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Izmest'eva, Lyubov R.] Irkutsk State Univ, Sci Res Inst Biol, Irkutsk 664003, Russia; [Moore, Marianne V.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Irkutsk State University; Wellesley College	Katz, SL (corresponding author), Natl Oceanog & Atmospher Adm, Santa Barbara, CA 93109 USA.	steve.katz@noaa.gov		Hampton, Stephanie/0000-0003-2389-4249	National Science Foundation [DEB-0072909, DEB-0528531]; Wellesley College	National Science Foundation(National Science Foundation (NSF)); Wellesley College	The National Center for Ecological Analysis and Synthesis, funded by the National Science Foundation (#DEB-0072909) on the University of California Santa Barbara campus, hosted the Lake Baikal Working Group. Wellesley College and NSF (#DEB-0528531) supported additional translation and technical help. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; Bond NA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018597; BOX GEP, 1971, J R STAT SOC SER A-G, V134, P229, DOI 10.2307/2343873; BOYLE JS, 1986, MON WEATHER REV, V114, P919, DOI 10.1175/1520-0493(1986)114<0919:COTSCI>2.0.CO;2; BOYLE JS, 1986, MON WEATHER REV, V114, P903, DOI 10.1175/1520-0493(1986)114<0903:COTSCI>2.0.CO;2; Branstator G, 2002, J CLIMATE, V15, P1893, DOI 10.1175/1520-0442(2002)015<1893:CTTJSW>2.0.CO;2; Chatfield C., 2016, ANAL TIME SERIES INT; Chen TC, 2004, J CLIMATE, V17, P401, DOI 10.1175/1520-0442(2004)017<0401:IVOTEA>2.0.CO;2; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; del Rio RA, 1999, ANN GEOPHYS-ATM HYDR, V17, P806, DOI 10.1007/s005850050809; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Gershunov A, 1998, B AM METEOROL SOC, V79, P2715, DOI 10.1175/1520-0477(1998)079<2715:IMOET>2.0.CO;2; GONG D, 2001, GEOPHYS RES LETT, V28, P4; Gross RS, 1996, GEOPHYS RES LETT, V23, P3373, DOI 10.1029/96GL03260; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Izmest'eva Lyubov R., 2006, LAKE BAIKAL PLANKTON; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McCabe GJ, 1999, INT J CLIMATOL, V19, P1399, DOI 10.1002/(SICI)1097-0088(19991115)19:13&lt;1399::AID-JOC457&gt;3.0.CO;2-A; McWilliams JC, 1994, CHAOS, V4, P305, DOI 10.1063/1.166010; Moore MV, 2009, BIOSCIENCE, V59, P405, DOI 10.1525/bio.2009.59.5.8; Munk W.H., 1960, ROTATION EARTH; Nakamura H, 2002, J CLIMATE, V15, P1855, DOI 10.1175/1520-0442(2002)015<1855:IADMRO>2.0.CO;2; *NAT RES COUNC PAN, 1998, DEC TO CENT SCAL CLI; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Qian S., 1996, JOINT TIME FREQUENCY; Rogers JC, 2002, CLIM DYNAM, V19, P599, DOI 10.1007/s00382-002-0247-7; Rosen RD, 2000, CLIM DYNAM, V16, P693, DOI 10.1007/s003820000076; SCHEMSKE DW, 1978, ECOLOGY, V59, P351, DOI 10.2307/1936379; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Schwing FB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016535; Seebens H, 2009, GLOBAL CHANGE BIOL, V15, P1394, DOI 10.1111/j.1365-2486.2008.01806.x; Shimaraev M. N., 1994, PHYS LIMNOLOGY LAKE; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Strong C, 2008, J CLIMATE, V21, P584, DOI 10.1175/2007JCLI1723.1; Strong C, 2010, J CLIMATE, V23, P1269, DOI 10.1175/2009JCLI2676.1; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; THOMSON DJ, 1995, SCIENCE, V268, P59, DOI 10.1126/science.268.5207.59; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2; 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI DOI 10.1111/J.1365-2486.2008.01616.X	48	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14688	10.1371/journal.pone.0014688	http://dx.doi.org/10.1371/journal.pone.0014688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359207	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700005
J	Audouard, C; Le Masson, F; Charry, C; Li, ZH; Christians, ES				Audouard, Christophe; Le Masson, Florent; Charry, Colette; Li, Zihai; Christians, Elisabeth S.			Oocyte-Targeted Deletion Reveals That Hsp90b1 Is Needed for the Completion of First Mitosis in Mouse Zygotes	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; ENDOPLASMIC-RETICULUM; MITOTIC PROGRESSION; MAMMALIAN OOCYTES; GENE DISRUPTION; CRE RECOMBINASE; EXPRESSION; EMBRYOS; MICE; CELLS	Background: Hsp90b1 is an endoplasmic reticulum (ER) chaperone (also named Grp94, ERp99, gp96, Targ2, Tra-1, Tra1, Hspc4) (MGI:98817) contributing with Hspa5 (also named Grp78, BIP) (MGI:95835) to protein folding in ER compartment. Besides its high protein expression in mouse oocytes, little is known about Hsp90b1 during the transition from oocyte-to-embryo. Because the constitutive knockout of Hsp90b1 is responsible for peri-implantation embryonic lethality, it was not yet known whether Hsp90b1 is a functionally important maternal factor. Methodology/Findings: To circumvent embryonic lethality, we established an oocyte-specific conditional knockout line taking advantage of the more recently created floxed Hsp90b1 line (Hsp90b1(flox), MGI:3700023) in combination with the transgenic mouse line expressing the cre recombinase under the control of zona pellucida 3 (ZP3) promoter (Zp3-cre, MGI:2176187). Altered expression of Hsp90b1 in growing oocytes provoked a limited, albeit significant reduction of the zona pellucida thickness but no obvious anomalies in follicular growth, meiotic maturation or fertilization. Interestingly, mutant zygotes obtained from oocytes lacking Hsp90b1 were unable to reach the 2-cell stage. They exhibited either a G2/M block or, more frequently an abnormal mitotic spindle leading to developmental arrest. Despite the fact that Hspa5 displayed a similar profile of expression as Hsp90b1, we found that HSPA5 and HSP90B1 did not fully colocalize in zygotes suggesting distinct function for the two chaperones. Consequently, even if HSPA5 was overexpressed in Hsp90b1 mutant embryos, it did not compensate for HSP90B1 deficiency. Finally, further characterization of ER compartment and cytoskeleton revealed a defective organization of the cytoplasmic region surrounding the mutant zygotic spindle. Conclusions: Our findings demonstrate that the maternal contribution of Hsp90b1 is critical for the development of murine zygotes. All together our data indicate that Hsp90b1 is involved in unique and specific aspects of the first mitosis, which brings together the maternal and paternal genomes on a single spindle.	[Audouard, Christophe; Le Masson, Florent; Charry, Colette; Christians, Elisabeth S.] Univ Toulouse 3, Ctr Dev Biol, UPS, UMR 5547, F-31062 Toulouse, France; [Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Div Basic Sci, Charleston, SC 29425 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Medical University of South Carolina	Audouard, C (corresponding author), Univ Toulouse 3, Ctr Dev Biol, UPS, UMR 5547, F-31062 Toulouse, France.	Elisabeth.Christians@cict.fr			Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale et de la Recherche; Universite de Toulouse III; Fondation pour la Recherche Medicale (FRM); National Institutes of Health [R01AI070603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale et de la Recherche; Universite de Toulouse III; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work presented in this paper was supported by the Centre National de la Recherche Scientifique (CNRS), the Ministere de l'Education Nationale et de la Recherche (PhD fellowship to FLM), the Universite de Toulouse III (to FLM and ESC), the Fondation pour la Recherche Medicale (FRM) (to ESC), and National Institutes of Health grant R01AI070603 (to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Bierkamp C, 2010, DEV BIOL, V339, P338, DOI 10.1016/j.ydbio.2009.12.037; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Christians E, 1997, MOL CELL BIOL, V17, P778, DOI 10.1128/MCB.17.2.778; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; FitzHarris G, 2003, MOL BIOL CELL, V14, P288, DOI 10.1091/mbc.E02-07-0431; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Hartshorn C, 2007, GENE REGUL SYST BIO, V1, P365; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Irelan JT, 2007, P NATL ACAD SCI USA, V104, P16940, DOI 10.1073/pnas.0706493104; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lin XQ, 2007, MOL CELL BIOL, V27, P4905, DOI 10.1128/MCB.02396-06; Mao CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010852; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MEZGER V, 1994, DEV BIOL, V165, P627, DOI 10.1006/dbio.1994.1281; MORANGE M, 1984, MOL CELL BIOL, V4, P730, DOI 10.1128/MCB.4.4.730; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; PAVELKA M, 1989, J HISTOCHEM CYTOCHEM, V37, P877, DOI 10.1177/37.6.2542394; Rankin T, 1999, DEVELOPMENT, V126, P3847; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voss AK, 2000, DEVELOPMENT, V127, P1; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Zhang P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-348; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	38	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17109	10.1371/journal.pone.0017109	http://dx.doi.org/10.1371/journal.pone.0017109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358806	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200023
J	Verges, A; Vanderklift, MA; Doropoulos, C; Hyndes, GA				Verges, Adriana; Vanderklift, Mathew A.; Doropoulos, Christopher; Hyndes, Glenn A.			Spatial Patterns in Herbivory on a Coral Reef Are Influenced by Structural Complexity but Not by Algal Traits	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SEA-URCHIN; PHASE-SHIFTS; GRAZING OPTIMIZATION; COMMUNITY STRUCTURE; CHEMICAL DEFENSES; FRINGING-REEF; FISHES; PLANT; HETEROGENEITY	Background: Patterns of herbivory can alter the spatial structure of ecosystems, with important consequences for ecosystem functions and biodiversity. While the factors that drive spatial patterns in herbivory in terrestrial systems are well established, comparatively less is known about what influences the distribution of herbivory in coral reefs. Methodology and Principal Findings: We quantified spatial patterns of macroalgal consumption in a cross-section of Ningaloo Reef (Western Australia). We used a combination of descriptive and experimental approaches to assess the influence of multiple macroalgal traits and structural complexity in establishing the observed spatial patterns in macroalgal herbivory, and to identify potential feedback mechanisms between herbivory and macroalgal nutritional quality. Spatial patterns in macroalgal consumption were best explained by differences in structural complexity among habitats. The biomass of herbivorous fish, and rates of herbivory were always greater in the structurally-complex coral-dominated outer reef and reef flat habitats, which were also characterised by high biomass of herbivorous fish, low cover and biomass of macroalgae and the presence of unpalatable algae species. Macroalgal consumption decreased to undetectable levels within 75 m of structurally-complex reef habitat, and algae were most abundant in the structurally-simple lagoon habitats, which were also characterised by the presence of the most palatable algae species. In contrast to terrestrial ecosystems, herbivory patterns were not influenced by the distribution, productivity or nutritional quality of resources (macroalgae), and we found no evidence of a positive feedback between macroalgal consumption and the nitrogen content of algae. Significance: This study highlights the importance of seascape-scale patterns in structural complexity in determining spatial patterns of macroalgal consumption by fish. Given the importance of herbivory in maintaining the ability of coral reefs to reorganise and retain ecosystem functions following disturbance, structural complexity emerges as a critical feature that is essential for the healthy functioning of these ecosystems.	[Verges, Adriana] Univ New S Wales, Sydney Inst Marine Sci & Evolut, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Verges, Adriana] Univ New S Wales, Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Verges, Adriana; Vanderklift, Mathew A.; Hyndes, Glenn A.] Edith Cowan Univ, Sch Nat Sci, Ctr Marine Ecosyst Res, Joondalup, Australia; [Vanderklift, Mathew A.] CSIRO Wealth Oceans Flagship, Wembley, WA, Australia; [Doropoulos, Christopher] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Doropoulos, Christopher] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Edith Cowan University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland	Verges, A (corresponding author), Univ New S Wales, Sydney Inst Marine Sci & Evolut, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	a.verges@unsw.edu.au	Verges, Adriana/B-8288-2013; Hyndes, G.a./AAB-6619-2019; Vanderklift, Mathew A/B-1003-2008; Doropoulos, Christopher/B-7249-2016	Verges, Adriana/0000-0002-3507-1234; Hyndes, G.a./0000-0002-3525-1665; Vanderklift, Mathew A/0000-0002-5170-7546; Doropoulos, Christopher/0000-0001-8038-2771	Western Australian Marine Science Institute (WAMSI)	Western Australian Marine Science Institute (WAMSI)	Funding: This study was funded by the Western Australian Marine Science Institute (WAMSI) under the Ningaloo Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Alcoverro T, 2005, BOT MAR, V48, P1, DOI 10.1515/BOT.2005.010; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 2008, PERMANOVA PRIMER; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Augustine DJ, 2001, ECOLOGY, V82, P3149, DOI 10.1890/0012-9658(2001)082[3149:EOMGOS]2.0.CO;2; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barile PJ, 2004, J EXP MAR BIOL ECOL, V303, P65, DOI 10.1016/j.jembe.2003.11.004; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bennett S, 2010, CORAL REEFS, V29, P471, DOI 10.1007/s00338-010-0594-5; Bennett S, MAR ECOL PR IN PRESS; Bittick SJ, 2010, MAR BIOL, V157, P317, DOI 10.1007/s00227-009-1319-6; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat J.H., 1991, ECOLOGY FISHES CORAL; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COEN LD, 1989, MAR ECOL PROG SER, V54, P287, DOI 10.3354/meps054287; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; De Mazancourt C, 1998, ECOLOGY, V79, P2242, DOI 10.1890/0012-9658(1998)079[2242:GOANCW]2.0.CO;2; Diaz-Pulido G, 2003, ECOLOGY, V84, P2026, DOI 10.1890/01-3127; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Fong P, 1997, J PHYCOL, V33, P353, DOI 10.1111/j.0022-3646.1997.00353.x; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Gorley RN, 2006, PRIMER V6; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hay M, 1992, HERBIVORES THEIR INT; Hay M.E., 1991, P96; HAY ME, 1981, AM NAT, V118, P520, DOI 10.1086/283845; HAY ME, 1983, OECOLOGIA, V58, P299, DOI 10.1007/BF00385227; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; HAY ME, 1984, OECOLOGIA, V64, P396, DOI 10.1007/BF00379139; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; HUNTLY N, 1988, BIOSCIENCE, V38, P786, DOI 10.2307/1310788; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LEWIS SM, 1985, OECOLOGIA, V65, P370, DOI 10.1007/BF00378911; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; McClanahan TR, 2001, CORAL REEFS, V19, P380, DOI 10.1007/s003380000133; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; McClanahan TR, 1999, ECOSYSTEMS, V2, P511, DOI 10.1007/s100219900099; McCook LJ, 1997, MAR BIOL, V129, P713, DOI 10.1007/s002270050214; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, P NATL ACAD SCI US, V107, P12930; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; PASTOR J, 1993, ECOLOGY, V74, P467, DOI 10.2307/1939308; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; PICKETT STA, 1995, SCIENCE, V269, P331, DOI 10.1126/science.269.5222.331; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; RUSS G, 1984, MAR ECOL PROG SER, V20, P35, DOI 10.3354/meps020035; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; STEINBERG PD, 1990, MAR ECOL PROG SER, V58, P253; Stimson J, 2001, CORAL REEFS, V19, P343, DOI 10.1007/s003380000123; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Valentine JF, 2008, ECOL APPL, V18, P1501, DOI 10.1890/07-1720.1; Van Alstyne KL, 2009, J EXP MAR BIOL ECOL, V379, P85, DOI 10.1016/j.jembe.2009.08.002; Vanderklift MA, 2007, MAR ECOL PROG SER, V340, P235, DOI 10.3354/meps340235; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; VONWESTERNHAGEN H, 1974, AQUACULTURE, V3, P109, DOI 10.1016/0044-8486(74)90106-9; Westera, 2003, EFFECT RECREATIONAL; WILKINSON CR, 1983, MAR ECOL PROG SER, V13, P15, DOI 10.3354/meps013015; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; ZIEMAN JC, 1984, MAR ECOL PROG SER, V15, P151, DOI 10.3354/meps015151	96	71	71	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17115	10.1371/journal.pone.0017115	http://dx.doi.org/10.1371/journal.pone.0017115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347254	Green Published, gold			2022-12-27	WOS:000287364500029
J	Sabatel, C; Malvaux, L; Bovy, N; Deroanne, C; Lambert, V; Gonzalez, MLA; Colige, A; Rakic, JM; Noel, A; Martial, JA; Struman, I				Sabatel, Celine; Malvaux, Ludovic; Bovy, Nicolas; Deroanne, Christophe; Lambert, Vincent; Gonzalez, Maria-Luz Alvarez; Colige, Alain; Rakic, Jean-Marie; Noel, Agnes; Martial, Joseph A.; Struman, Ingrid			MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; VASCULAR INTEGRITY; LUNG-CANCER; OVEREXPRESSION; MIR-21; METASTASIS; INVASION	Background: MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs that regulate gene expression at post-transcriptional level. The recent discovery of the involvement of these RNAs in the control of angiogenesis renders them very attractive in the development of new approaches for restoring the angiogenic balance. Whereas miRNA-21 has been demonstrated to be highly expressed in endothelial cells, the potential function of this miRNA in angiogenesis has never been investigated. Methodology/Principal Findings: We first observed in endothelial cells a negative regulation of miR-21 expression by serum and bFGF, two pro-angiogenic factors. Then using in vitro angiogenic assays, we observed that miR-21 acts as a negative modulator of angiogenesis. miR-21 overexpression reduced endothelial cell proliferation, migration and the ability of these cells to form tubes whereas miR-21 inhibition using a LNA-anti-miR led to opposite effects. Expression of miR-21 in endothelial cells also led to a reduction in the organization of actin into stress fibers, which may explain the decrease in cell migration. Further mechanistic studies showed that miR-21 targets RhoB, as revealed by a decrease in RhoB expression and activity in miR-21 overexpressing cells. RhoB silencing impairs endothelial cell migration and tubulogenesis, thus providing a possible mechanism for miR-21 to inhibit angiogenesis. Finally, the therapeutic potential of miR-21 as an angiogenesis inhibitor was demonstrated in vivo in a mouse model of choroidal neovascularization. Conclusions/Significance: Our results identify miR-21 as a new angiogenesis inhibitor and suggest that inhibition of cell migration and tubulogenesis is mediated through repression of RhoB.	[Sabatel, Celine; Malvaux, Ludovic; Bovy, Nicolas; Martial, Joseph A.; Struman, Ingrid] Univ Liege, GIGA Res, Unit Mol Biol & Genet Engn, Liege, Belgium; [Deroanne, Christophe; Colige, Alain] Univ Liege, GIGA Res, Lab Connect Tissues, Liege, Belgium; [Lambert, Vincent; Gonzalez, Maria-Luz Alvarez; Noel, Agnes] Univ Liege, GIGA Res, Lab Tumor & Dev Biol, Liege, Belgium; [Lambert, Vincent; Rakic, Jean-Marie] Univ Hosp, Dept Ophthalmol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Sabatel, C (corresponding author), Univ Liege, GIGA Res, Unit Mol Biol & Genet Engn, Liege, Belgium.	I.Struman@ulg.ac.be		struman, ingrid/0000-0003-2550-3707; Noel, Agnes/0000-0002-7670-6179	FRIA (Fonds pour la Recherche industrielle et agricole); FNRS (Fond national de la recherche scientifique); Televie; Fonds Leon Fredericq; ULg (Mirage program); FP7-HEALTH-2007-A [201279]; Belgian Science Policy (Brussels, Belgium); Neoangio Program of the Walloon Region	FRIA (Fonds pour la Recherche industrielle et agricole)(Fonds de la Recherche Scientifique - FNRS); FNRS (Fond national de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); Televie; Fonds Leon Fredericq; ULg (Mirage program); FP7-HEALTH-2007-A; Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Neoangio Program of the Walloon Region	This study was supported by the FRIA (Fonds pour la Recherche industrielle et agricole), FNRS (Fond national de la recherche scientifique), Televie, le Fonds Leon Fredericq, ULg (Mirage program), FP7-HEALTH-2007-A, proposal No. 201279 "MICROENVIMET", the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium) and by the Neoangio Program of the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Connolly EC, 2010, MOL CANCER RES, V8, P691, DOI 10.1158/1541-7786.MCR-09-0465; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; GORDON SR, 1982, CELL MOTIL CYTOSKEL, V2, P343, DOI 10.1002/cm.970020404; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lambert V, 2001, FASEB J, V15, P1021, DOI 10.1096/fj.00-0393com; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; MORIYAMA T, 2009, MOL CANC THER; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Noel A, 2007, TRENDS MOL MED, V13, P345, DOI 10.1016/j.molmed.2007.06.005; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Veeranna, 1998, J NEUROSCI, V18, P4008; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang CX, 2010, J CARDIOVASC TRANSL, V3, P235, DOI 10.1007/s12265-010-9164-z; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	49	189	202	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16979	10.1371/journal.pone.0016979	http://dx.doi.org/10.1371/journal.pone.0016979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347332	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000027
J	Reveillaud, J; van Soest, R; Derycke, S; Picton, B; Rigaux, A; Vanreusel, A				Reveillaud, Julie; van Soest, Rob; Derycke, Sofie; Picton, Bernard; Rigaux, Annelien; Vanreusel, Ann			Phylogenetic Relationships among NE Atlantic Plocamionida Topsent (1927) (Porifera, Poecilosclerida): Under-Estimated Diversity in Reef Ecosystems	PLOS ONE			English	Article							BATHYAL CORAL-REEFS; OXIDASE SUBUNIT-I; INTEGRATIVE TAXONOMY; NORTHEAST ATLANTIC; SPONGE; MITOCHONDRIAL; DEEP; DNA; DEMOSPONGIAE; BANK	Background: Small and cryptic sponges associated with cold-water coral reefs are particularly numerous and challenging to identify, but their ecological and biochemical importance is likely to compete with megabenthic specimens. Methodology/Principal Findings: Here we use a combination of the standard M1M6 and I3M11 partitions of the COI fragment, partial rDNA 28S sequences and morphology to delineate small encrusting Plocamionida species. In total, 46 specimens were retrieved from seven shallow to deep-water coral locations, crossing 3,000 km along the European margins. Our work provides evidence that the Plocamionida ambigua f. tylotata and f. grandichelata can be considered valid species, whereas Plocamionida ambigua f. tornata corresponds to the species P. ambigua. Within the monophyletic group of Plocamionida, P. microcionides is shown as really divergent from the other taxa, and four putative new Plocamionida species are suggested. Conclusions/Significance: This study shows that the use of molecular and morphological information in an integrative approach is a powerful tool for the identification of sponge species, and suggests that an under-estimated biodiversity of sponges occurs in cold-water coral reefs.	[Reveillaud, Julie; Derycke, Sofie; Rigaux, Annelien; Vanreusel, Ann] Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium; [Reveillaud, Julie; Derycke, Sofie; Rigaux, Annelien; Vanreusel, Ann] Ctr Mol Phylogeny & Evolut, CeMoFE, Ghent, Belgium; [van Soest, Rob] Univ Amsterdam ZMA, Zool Museum, Amsterdam, Netherlands; [Picton, Bernard] Natl Museums No Ireland, Dept Nat Sci, Holywood, North Ireland	Ghent University	Reveillaud, J (corresponding author), Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium.	julie.reveillaud@ugent.be	Picton, Bernard/K-2482-2019	Picton, Bernard/0000-0002-1500-2215	European Community Research Infrastructure Action; European Community [FP7/2007-2013, 226354]; Ghent University; European Science Foundation [813.03.006/855.01.040]; Netherlands Organisation for Scientific Research [814.01.005/835.20.024]	European Community Research Infrastructure Action(European Commission); European Community(European Commission); Ghent University(Ghent University); European Science Foundation(European Science Foundation (ESF)European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The support of a SYNTHESYS Grant financed by European Community Research Infrastructure Action under the FP6 "Structuring the European Research Area" Program to visit to the Zoological Museum in Amsterdam (JR) is acknowledged. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project, grant 517 agreement no 226354. JR had a Special Research Fund (BOF) from Ghent University. The study benefited from funding by the EUROMARGIN Programme of the European Science Foundation (Moundforce 2004 Project, 813.03.006/855.01.040) and the Netherlands Organisation for Scientific Research (BIOSYS project 814.01.005/835.20.024) to support sponge material collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alander H., 1942, THESIS U LUND H STRU, P1; Barthel D., 1991, P387; Blanquer A, 2007, MOL PHYLOGENET EVOL, V45, P392, DOI 10.1016/j.ympev.2007.03.004; Boury-Esnault Nicole, 1994, Memoires du Museum National d'Histoire Naturelle, V160, P1; Bowerbank JS., 1866, MONOGRAPH BRIT SPONG, VII; BRONDSTED HV, 1932, ZOOLOGY FAROES, V1, P1; Carter H.J., 1876, ANN MAGAZINE NATURAL, V18, P458, DOI DOI 10.1080/00222937608682035; Carter H.J, 1876, ANN MAGAZINE NATURAL, V18, p[105, 307], DOI [10.1080/00222937608682078, DOI 10.1080/00222937608682035]; Carter H.J., 1876, ANN MAGAZINE NATURAL, V18, P307, DOI DOI 10.1080/00222937608682035; Carter HJ, 1876, J NAT HIST, V18, P226, DOI [10.1080/00222937608682035, DOI 10.1080/00222937608682035]; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Faulkner DJ, 2000, NAT PROD REP, V17, P1, DOI 10.1039/a909113k; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Hilario A, 2010, DEEP-SEA RES PT I, V57, P143, DOI 10.1016/j.dsr.2009.10.004; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; NYLANDER JAA, 2002, MRMODELTEST V 1 0 PR; Picton BE, 2007, J MAR BIOL ASSOC UK, V87, P1441, DOI 10.1017/S0025315407058122; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROT C, 2006, BMC EVOLUTIONARY BIO; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; STEPHENS J, 1921, SCI INVESTIGATIONS F, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Topsent E., 1928, Resultats des Campagnes Scientifiques Albert I de Monaco Fasc, V74, P1; Vacelet J., 1969, Memoires du Museum Nationale d'Histoire Naturelle Paris (Ser A), V59, P145; van Soest RWM, 2007, CONTRIB ZOOL, V76, P121, DOI 10.1163/18759866-07602005; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004	49	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16533	10.1371/journal.pone.0016533	http://dx.doi.org/10.1371/journal.pone.0016533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347368	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700019
J	Hudson, JJR; Bednarova, K; Kozakova, L; Liao, CY; Guerineau, M; Colnaghi, R; Vidot, S; Marek, J; Bathula, SR; Lehmann, AR; Palecek, J				Hudson, Jessica J. R.; Bednarova, Katerina; Kozakova, Lucie; Liao, Chunyan; Guerineau, Marc; Colnaghi, Rita; Vidot, Susanne; Marek, Jaromir; Bathula, Sreenivas R.; Lehmann, Alan R.; Palecek, Jan			Interactions between the Nse3 and Nse4 Components of the SMC5-6 Complex Identify Evolutionarily Conserved Interactions between MAGE and EID Families	PLOS ONE			English	Article							DNA-REPAIR; STATISTICAL-MODEL; SUMO LIGASE; PROTEIN; GENE; ROLES; IDENTIFICATION; RECOMBINATION; INHIBITOR	Background: The SMC5-6 protein complex is involved in the cellular response to DNA damage. It is composed of 6-8 polypeptides, of which Nse1, Nse3 and Nse4 form a tight sub-complex. MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and Nse4 is related to the EID (E1A-like inhibitor of differentiation) family of transcriptional repressors. Methodology/Principal Findings: Using site-directed mutagenesis, protein-protein interaction analyses and molecular modelling, we have identified a conserved hydrophobic surface on the C-terminal domain of Nse3 that interacts with Nse4 and identified residues in its N-terminal domain that are essential for interaction with Nse1. We show that these interactions are conserved in the human orthologs. Furthermore, interaction of MAGEG1, the mammalian ortholog of Nse3, with NSE4b, one of the mammalian orthologs of Nse4, results in transcriptional co-activation of the nuclear receptor, steroidogenic factor 1 (SF1). In an examination of the evolutionary conservation of the Nse3-Nse4 interactions, we find that several MAGE proteins can interact with at least one of the NSE4/EID proteins. Conclusions/Significance: We have found that, despite the evolutionary diversification of the MAGE family, the characteristic hydrophobic surface shared by all MAGE proteins from yeast to humans mediates its binding to NSE4/EID proteins. Our work provides new insights into the interactions, evolution and functions of the enigmatic MAGE proteins.	[Hudson, Jessica J. R.; Liao, Chunyan; Colnaghi, Rita; Vidot, Susanne; Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Bednarova, Katerina; Kozakova, Lucie; Marek, Jaromir; Palecek, Jan] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Bathula, Sreenivas R.] Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic	University of Sussex; Masaryk University Brno; Masaryk University Brno	Hudson, JJR (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	a.r.lehmann@sussex.ac.uk; jpalecek@sci.muni.cz	Zabrady, Katerina/D-9232-2012; Bathula, Sreenivas Reddy/D-9493-2012; Palecek, Jan/D-6864-2012; Marek, Jaromir/D-8825-2012; Bozděchová, Lucie/D-9149-2012; Guerineau, Marc/AAR-1167-2021	Zabrady, Katerina/0000-0003-1946-0851; Palecek, Jan/0000-0002-6223-5169; Bozděchová, Lucie/0000-0002-7113-4343; Guerineau, Marc/0000-0002-0546-3106; Marek, Jaromir/0000-0002-8881-2040	Grant Agency of the Czech Academy of Sciences [IAA501630902]; Grant Agency of the Czech Republic [204/08/H054]; MRC; Medical Research Council [G0801130B, G0901011, G0501450] Funding Source: researchfish; MRC [G0501450, G0901011] Funding Source: UKRI	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants to J.P. from the Grant Agency of the Czech Academy of Sciences (IAA501630902, http://www.gaav.cz/en/) and Institutional support was provided by Czech Ministry of Education, Youth and Sports (MSM0021622415, http://www.msmt.cz/eu-presidency-2009/events). M.G. was supported from Grant Agency of the Czech Republic (204/08/H054, http://www.gacr.cz/international.htm). Work from the ARL lab was funded by an MRC Programme Grant. The authors are grateful to the METACentrum (super) computing facilities at Masaryk University for access under the research intent MSM6383917201. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bavner A, 2005, NUCLEIC ACIDS RES, V33, P3561, DOI 10.1093/nar/gki667; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Caballero OL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012773; Chomez P, 2001, CANCER RES, V61, P5544; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, MOL BIOL CELL, V19, P4099, DOI 10.1091/mbc.E08-02-0226; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Wang XH, 2010, EMBO J, V29, P1389, DOI 10.1038/emboj.2010.34; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17270	10.1371/journal.pone.0017270	http://dx.doi.org/10.1371/journal.pone.0017270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364888	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100039
J	Menon, S; Beningo, KA				Menon, Shalini; Beningo, Karen A.			Cancer Cell Invasion Is Enhanced by Applied Mechanical Stimulation	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; TUMOR-CELL; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; FIBRONECTIN; INVADOPODIA; INTEGRIN; METASTASIS; STROMA; FIBROBLASTS	Metastatic cells migrate from the site of the primary tumor, through the stroma, into the blood and lymphatic vessels, finally colonizing various other tissues to form secondary tumors. Numerous studies have been done to identify the stimuli that drive the metastatic cascade. This has led to the identification of multiple biochemical signals that promote metastasis. However, information on the role of mechanical factors in cancer metastasis has been limited to the affect of compliance. Interestingly, the tumor microenvironment is rich in many cell types including highly contractile cells that are responsible for extensive remodeling and production of the dense extracellular matrix surrounding the cancerous tissue. We hypothesize that the mechanical forces produced by remodeling activities of cells in the tumor microenvironment contribute to the invasion efficiency of metastatic cells. We have discovered a significant difference in the extent of invasion in mechanically stimulated verses non-stimulated cell culture environments. Furthermore, this mechanically enhanced invasion is dependent upon substrate protein composition, and influenced by topography. Finally, we have found that the protein cofilin is needed to sense the mechanical stimuli that enhances invasion. We conclude that other types of mechanical signals in the tumor microenvironment, besides the rigidity, can enhance the invasive abilities of cancer cells in vitro. We further propose that in vivo, non-cancerous cells located within the tumor micro-environment may be capable of providing the necessary mechanical stimulus during the remodeling of the extracellular matrix surrounding the tumor.	[Menon, Shalini; Beningo, Karen A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Menon, S (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	beningo@wayne.edu	; Gullberg, Donald/H-2495-2016	Menon, Shalini/0000-0001-8952-9004; Gullberg, Donald/0000-0002-7245-4437	Wayne State University	Wayne State University	Financial support was provided by a Wayne State University Faculty Research Grant to KAB and a Wayne State University Graduate Research Award and Enhancement Funds to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Beningo KA, 2002, METHOD CELL BIOL, V69, P325, DOI 10.1016/S0091-679X(02)69021-1; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BOUSQUET PF, 1990, CANCER RES, V50, P1431; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Busco G, 2010, FASEB J; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Craig DH, 2009, CELL CYCLE, V8, P828, DOI 10.4161/cc.8.6.7940; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dugina V, 2001, J CELL SCI, V114, P3285; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Follonier L, 2008, J CELL SCI, V121, P3305, DOI 10.1242/jcs.024521; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kutcher ME, 2007, AM J PATHOL, V171, P693, DOI 10.2353/ajpath.2007.070102; Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wrobel LK, 2002, CELL MOTIL CYTOSKEL, V52, P82, DOI 10.1002/cm.10034; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49	72	55	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17277	10.1371/journal.pone.0017277	http://dx.doi.org/10.1371/journal.pone.0017277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359145	Green Submitted, gold, Green Published			2022-12-27	WOS:000287482300045
J	Wozniak, KL; Hardison, SE; Kolls, JK; Wormley, FL				Wozniak, Karen L.; Hardison, Sarah E.; Kolls, Jay K.; Wormley, Floyd L., Jr.			Role of IL-17A on Resolution of Pulmonary C-neoformans Infection	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE INFECTION; CLASSICAL MACROPHAGE ACTIVATION; IL-17-PRODUCING T-CELLS; CRYPTOCOCCUS-NEOFORMANS; HOST-DEFENSE; IMMUNE-RESPONSE; NEUTROPHIL RECRUITMENT; INFLAMMATORY RESPONSE; VIRULENCE FACTOR; TH17 CELLS	The current studies evaluated the role of interleukin (IL)-17A in the induction of protective immunity against pulmonary cryptococcosis in mice. Protection against pulmonary infection with C. neoformans strain H99 gamma was associated with increased IL-17A production. Signaling through the IFN-gamma receptor (R) was required for increased IL-17A production, however, a Th17-type cytokine profile was not observed. Neutrophils were found to be the predominant leukocytic source of IL-17A, rather than T cells, suggesting that the IL-17A produced was not part of a T cell-mediated Th17-type immune response. Depletion of IL-17A in mice during pulmonary infection with C. neoformans strain H99 gamma resulted in an initial increase in pulmonary fungal burden, but had no effect on cryptococcal burden at later time points. Also, depletion of IL-17A did not affect the local production of other cytokines. IL-17RA(-/-) mice infected with C. neoformans strain H99 gamma survived the primary infection as well as a secondary challenge with wild-type cryptococci. However, dissemination of the wild-type strain to the brain was noted in the surviving IL-17RA(-/-) mice. Altogether, our results suggested that IL-17A may be important for optimal protective immune responsiveness during pulmonary C. neoformans infection, but protective Th1-type immune responses are sufficient for protection against cryptococcal infection.	[Wozniak, Karen L.; Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Wozniak, Karen L.; Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wozniak, KL (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	Karen.Wozniak@utsa.edu	Hardison, Sarah E./AAC-7510-2019; Hardison, Sarah/ABB-1606-2021; Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Wozniak, Karen/0000-0003-1798-2146	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [RO1 AI071752-03, RO1 HL079142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079142, R01HL061271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071752] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant RO1 AI071752-03 (F.L.W. Jr.) and RO1 HL079142 (J.K.K.) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) http://www.niaid.nih.gov. This content is solely the responsibility of the authors and does not reflect the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BLASI E, 1994, INFECT IMMUN, V62, P3189, DOI 10.1128/IAI.62.8.3189-3196.1994; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hardison SE, 2010, INFECT IMMUN, V78, P5341, DOI 10.1128/IAI.00845-10; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; HILL JO, 1991, J EXP MED, V173, P755, DOI 10.1084/jem.173.3.755; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; HUFFNAGLE GB, 1994, J LEUKOCYTE BIOL, V55, P35, DOI 10.1002/jlb.55.1.35; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Kish DD, 2009, J IMMUNOL, V182, P5949, DOI 10.4049/jimmunol.0802830; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LEVITZ SM, 1991, REV INFECT DIS, V13, P1163; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; MODY CH, 1990, J IMMUNOL, V144, P1472; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Singh N, 1997, CLIN TRANSPLANT, V11, P66; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; Smith E, 2008, J IMMUNOL, V181, P1357, DOI 10.4049/jimmunol.181.2.1357; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Voelz K, 2009, INFECT IMMUN; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	54	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17204	10.1371/journal.pone.0017204	http://dx.doi.org/10.1371/journal.pone.0017204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359196	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482300038
J	Riemer, J; Hansen, HG; Appenzeller-Herzog, C; Johansson, L; Ellgaard, L				Riemer, Jan; Hansen, Henning G.; Appenzeller-Herzog, Christian; Johansson, Linda; Ellgaard, Lars			Identification of the PDI-Family Member ERp90 as an Interaction Partner of ERFAD	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; BINDING SITE; REDUCTION; OXIDATION; MECHANISM	In the endoplasmic reticulum (ER), members of the protein disulfide isomerase (PDI) family perform critical functions during protein maturation. Herein, we identify the previously uncharacterized PDI-family member ERp90. In cultured human cells, we find ERp90 to be a soluble ER-luminal glycoprotein that comprises five potential thioredoxin (Trx)-like domains. Mature ERp90 contains 10 cysteine residues, of which at least some form intramolecular disulfides. While none of the Trx domains contain a canonical Cys-Xaa-Xaa-Cys active-site motif, other conserved cysteines could endow the protein with redox activity. Importantly, we show that ERp90 co-immunoprecipitates with ERFAD, a flavoprotein involved in ER-associated degradation (ERAD), through what is most likely a direct interaction. We propose that the function of ERp90 is related to substrate recruitment or delivery to the ERAD retrotranslocation machinery by ERFAD.	[Riemer, Jan; Hansen, Henning G.; Appenzeller-Herzog, Christian; Johansson, Linda; Ellgaard, Lars] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Riemer, J (corresponding author), Univ Kaiserslautern, Dept Cell Biol, Kaiserslautern, Germany.	lellgaard@bio.ku.dk	Appenzeller-Herzog, Christian/A-2894-2014; Riemer, Jan/B-3340-2012; Riemer, Jan/AAC-1072-2021; Ellgaard, Lars/I-9034-2014	Appenzeller-Herzog, Christian/0000-0001-7430-294X; Ellgaard, Lars/0000-0002-7018-0137; Riemer, Jan/0000-0002-7574-8457; Hansen, Henning Gram/0000-0002-2832-730X	Novo Nordisk Foundation; Lundbeckfonden; Augustinusfonden; Danish Natural Science Research Council; Novartis Stiftung	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeckfonden(Lundbeckfonden); Augustinusfonden; Danish Natural Science Research Council(Danish Natural Science Research Council); Novartis Stiftung	Funding was obtained from the Novo Nordisk Foundation, Lundbeckfonden, Augustinusfonden, the Danish Natural Science Research Council and the Novartis Stiftung. J.R. was a fellow of the Boehringer Ingelheim Fonds and is a recipient of an EMBO long-term fellowship. C.A.-H. was a fellow of the Swiss National Science Foundation and is a recipient of an Ambizione research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Hagiwara M, MOL CELL IN PRESS; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Raghava GPS, 2002, CASP5A132; Riemer J, 2009, P NATL ACAD SCI USA, V106, P14831, DOI 10.1073/pnas.0900742106; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shim S, 2010, CELL MOL LIFE SCI; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	27	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17037	10.1371/journal.pone.0017037	http://dx.doi.org/10.1371/journal.pone.0017037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359175	Green Published, gold			2022-12-27	WOS:000287392700037
J	Kwee, RM; Hofman, PAM; Gronenschild, EHBM; van Oostenbrugge, RJ; Mess, WH; ter Berg, JWM; Franke, CL; Korten, AGGC; Meems, BJ; van Engelshoven, JMA; Wildberger, JE; Kooi, ME				Kwee, Robert M.; Hofman, Paul A. M.; Gronenschild, Ed H. B. M.; van Oostenbrugge, Robert J.; Mess, Werner H.; ter Berg, Johannes W. M.; Franke, Cees L.; Korten, Arthur G. G. C.; Meems, Be J.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline			Association between Carotid Plaque Characteristics and Cerebral White Matter Lesions: One-Year Follow-Up Study by MRI	PLOS ONE			English	Article							ELDERLY-PEOPLE; HYPERINTENSITIES; POPULATION; STROKE; RISK; ATHEROSCLEROSIS; ENDARTERECTOMY; LEUKOARAIOSIS; PROGRESSION; INFARCTS	Objective: To prospectively assess the relation between carotid plaque characteristics and the development of new cerebral white matter lesions (WMLs) at MRI. Methods: Fifty TIA/stroke patients with ipsilateral 30-69% carotid stenosis underwent MRI of the plaque at baseline. Total plaque volume and markers of vulnerability to thromboembolism (lipid-rich necrotic core [LRNC] volume, fibrous cap [FC] status, and presence of intraplaque hemorrhage [IPH]) were assessed. All patients also underwent brain MRI at baseline and after one year. Ipsilateral cerebral WMLs were quantified with a semiautomatic method. Results: Mean WML volume significantly increased over a one-year period (6.52 vs. 6.97 mm(3), P = 0.005). WML volume at baseline and WML progression did not significantly differ (P>0.05) between patients with 30-49% and patients with 50-69% stenosis. There was a significant correlation between total plaque volume and baseline ipsilateral WML volume (Spearman rho = 0.393, P = 0.005). There was no significant correlation between total plaque volume and ipsilateral WML progression. There were no significant associations between LRNC volume and WML volume at baseline and WML progression. WML volume at baseline and WML progression did not significantly differ between patients with a thick and intact FC and patients with a thin and/or ruptured FC. WML volume at baseline and WML progression also did not significantly differ between patients with and without IPH. Conclusion: The results of this study indicate that carotid plaque burden is significantly associated with WML severity, but that there is no causal relationship between carotid plaque vulnerability and the occurrence of WMLs.	[Kwee, Robert M.; Hofman, Paul A. M.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Kwee, Robert M.; van Oostenbrugge, Robert J.; Mess, Werner H.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.] Maastricht Univ Med Ctr, Dept Psychiat, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.] Maastricht Univ Med Ctr, Dept Neuropsychol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Mess, Werner H.] Maastricht Univ Med Ctr, Dept Clin Neurophysiol, Maastricht, Netherlands; [ter Berg, Johannes W. M.] Orbis Med Ctr, Dept Neurol, Sittard, Netherlands; [Franke, Cees L.] Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; [Korten, Arthur G. G. C.] Laurentius Hosp, Dept Neurol, Roermond, Netherlands; [Meems, Be J.] Vie Curi Med Ctr, Dept Neurol, Venlo, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Orbis Medical Center; Atrium Medical Center; VieCuri Medical Center	Kwee, RM (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	eline.kooi@mumc.nl	Mess, Werner/AAB-9527-2020; Kooi, M. Eline/D-3848-2016	Kooi, M. Eline/0000-0001-7562-5724; Wildberger, Joachim/0000-0002-4810-6854	Dutch Heart Foundation [2006B061]	Dutch Heart Foundation(Netherlands Heart Foundation)	This study was supported by Dutch Heart Foundation grant 2006B061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; [Anonymous], DEF DIAGN DIAB MELL; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Fujita S, 2005, INT PSYCHOGERIATR, V17, P689, DOI 10.1017/S104161020500164X; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Henskens LH, 2009, J HYPERTENS, V27, P1446, DOI 10.1097/HJH.0b013e32832b5204; Inzitari Domenico, 2009, BMJ, V339, pb2477, DOI 10.1136/bmj.b2477; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Kwee RM, 2009, STROKE, V40, P3718, DOI 10.1161/STROKEAHA.109.564088; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Moustafa RR, 2010, STROKE, V41, P1410, DOI 10.1161/STROKEAHA.110.580415; Ouhlous M, 2005, AM J NEURORADIOL, V26, P1044; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Patterson AJ, 2009, EUR J VASC ENDOVASC, V38, P149, DOI 10.1016/j.ejvs.2009.04.005; Pico F, 2002, CEREBROVASC DIS, V14, P109, DOI 10.1159/000064741; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17070	10.1371/journal.pone.0017070	http://dx.doi.org/10.1371/journal.pone.0017070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347225	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200017
J	Itzhar, N; Dessen, P; Toujani, S; Auger, N; Preudhomme, C; Richon, C; Lazar, V; Saada, V; Bennaceur, A; Bourhis, JH; de Botton, S; Bernheim, A				Itzhar, Nathalie; Dessen, Philippe; Toujani, Saloua; Auger, Nathalie; Preudhomme, Claude; Richon, Catherine; Lazar, Vladimir; Saada, Veronique; Bennaceur, Anelyse; Bourhis, Jean Henri; de Botton, Stephane; Bernheim, Alain			Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BONE-MARROW-CELLS; ACUTE MYELOGENOUS LEUKEMIA; OLIGONUCLEOTIDE ARRAY-CGH; COPY NUMBER ALTERATIONS; HUMAN GENOME; HOX GENES; MYELODYSPLASTIC SYNDROMES; HEMATOPOIETIC-CELLS; AML1 GENE	Therapy-related acute leukemia (t-AML), is a severe complication of cytotoxic therapy used for primary cancer treatment. The outcome of these patients is poor, compared to people who develop de novo acute leukemia (p-AML). Cytogenetic abnormalities in t-AML are similar to those found in p-AML but present more frequent unfavorable karyotypes depending on the inducting agent. Losses of chromosome 5 or 7 are observed after alkylating agents while balanced translocations are found after topoisomerase II inhibitors. This study compared t-AML to p-AML using high resolution array CGH in order to find copy number abnormalities (CNA) at a higher resolution than conventional cytogenetics. More CNAs were observed in 30 t-AML than in 36 p-AML: 104 CNAs were observed with 63 losses and 41 gains (mean number 3.46 per case) in t-AML, while in p-AML, 69 CNAs were observed with 32 losses and 37 gains (mean number of 1.9 per case). In primary leukemia with a previously "normal'' karyotype, 18% exhibited a previously undetected CNA, whereas in the (few) t-AML with a normal karyotype, the rate was 50%. Several minimal critical regions (MCRs) were found in t-AML and p-AML. No common MCRs were found in the two groups. In t-AML a 40kb deleted MCR pointed to RUNX1 on 21q22, a gene coding for a transcription factor implicated in frequent rearrangements in leukemia and in familial thrombocytopenia. In de novo AML, a 1Mb MCR harboring ERG and ETS2 was observed from patients with complex aCGH profiles. High resolution cytogenomics obtained by aCGH and similar techniques already published allowed us to characterize numerous non random chromosome abnormalities. This work supports the hypothesis that they can be classified into several categories: abnormalities common to all AML; those more frequently found in t-AML and those specifically found in p-AML.	[Itzhar, Nathalie; Dessen, Philippe; Toujani, Saloua; Auger, Nathalie; Bernheim, Alain] Inst Gustave Roussy, Inst Sante & Reherche Med U985, Villejuif, France; [Itzhar, Nathalie; Dessen, Philippe; Toujani, Saloua; Auger, Nathalie; Bernheim, Alain] Univ Paris 11, Orsay, France; [Dessen, Philippe; Richon, Catherine; Lazar, Vladimir] Inst Gustave Roussy, Funct Genom Unit, Villejuif, France; [Preudhomme, Claude] Ctr Hosp Reg Univ Lille, Dept Hematol, Ctr Biol Pathol, Lille, France; [Saada, Veronique; Bennaceur, Anelyse; Bourhis, Jean Henri; de Botton, Stephane] Inst Gustave Roussy, Dept Hematol, Villejuif, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Universite de Lille - ISITE; CHU Lille; UNICANCER; Gustave Roussy	Itzhar, N (corresponding author), Inst Gustave Roussy, Inst Sante & Reherche Med U985, Villejuif, France.	bernheim@igr.fr	Lazar, Vladimir/AAV-2087-2020; Preudhomme, Claude/T-8553-2018; Lazar, Vladimir/AAQ-2086-2020	Preudhomme, Claude/0000-0002-1267-9546; bennaceur griscelli, annelise/0000-0002-3557-4499; RICHON, Catherine/0000-0002-3556-3941; Veronique, SAADA/0000-0001-8021-9050; DE BOTTON, stephane/0000-0002-8126-4942	IGR Taxe Apprentissage	IGR Taxe Apprentissage	IGR Taxe Apprentissage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P1301, DOI 10.3324/haematol.2009.005744; Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P213, DOI 10.3324/haematol.13024; Baldus CD, 2008, SEMIN ONCOL, V35, P356, DOI 10.1053/j.seminoncol.2008.04.006; Beri-Dexheimer M, 2008, EUR J HUM GENET, V16, P1014, DOI 10.1038/ejhg.2008.89; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Christiansen DH, 2004, BLOOD, V104, P1474, DOI 10.1182/blood-2004-02-0754; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding Y, 2009, BLOOD, V114, P5201, DOI 10.1182/blood-2009-06-223982; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dupret C, 2005, LEUKEMIA, V19, P2337, DOI 10.1038/sj.leu.2403981; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Evers C, 2007, GENE CHROMOSOME CANC, V46, P1119, DOI 10.1002/gcc.20498; Farra C, 2004, CANCER GENET CYTOGEN, V155, P138, DOI 10.1016/j.cancergencyto.2004.03.016; Ferch U, 2009, J EXP MED, V206, P2313, DOI 10.1084/jem.20091167; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fortier JM, 2010, LEUKEMIA, V24, P950, DOI 10.1038/leu.2010.61; Gao MY, 2009, J MOL HISTOL, V40, P227, DOI 10.1007/s10735-009-9234-1; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grozdanov PN, 2009, RNA, V15, P1188, DOI 10.1261/rna.1532109; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Huret JL, ATLAS GENET CYTOGENE; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Leone G, 2007, HAEMATOLOGICA, V92, P1389, DOI 10.3324/haematol.11034; Lin CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-72; Liu WC, 2003, MOL CELL BIOL, V23, P4083, DOI 10.1128/MCB.23.12.4083-4093.2003; Lui WO, 2008, CANCER RES, V68, P7156, DOI 10.1158/0008-5472.CAN-08-1085; Monnier J, 2008, FEBS J, V275, P4014, DOI 10.1111/j.1742-4658.2008.06559.x; Mrozek K, 2008, SEMIN ONCOL, V35, P365, DOI 10.1053/j.seminoncol.2008.04.007; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Panagopoulos L, 2004, GENE CHROMOSOME CANC, V40, P218, DOI 10.1002/gcc.20037; Parkin B, 2010, BLOOD; Parkin B, 2010, CLIN CANCER RES, V16, P4135, DOI 10.1158/1078-0432.CCR-09-2639; Paulsson K, 2006, LEUKEMIA, V20, P840, DOI 10.1038/sj.leu.2404145; Pedersen-Bjergaard J, 2008, LEUKEMIA, V22, P240, DOI 10.1038/sj.leu.2405078; Pedersen-Bjergaard Jens, 2007, Hematology Am Soc Hematol Educ Program, P392; Peterson LF, 2007, BLOOD, V110, P799, DOI 10.1182/blood-2006-11-019265; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Preudhomme C, 2009, BLOOD, V113, P5583, DOI 10.1182/blood-2008-07-168260; Quentmeier H, 2004, LEUKEMIA LYMPHOMA, V45, P567, DOI 10.1080/10428190310001609942; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roumier C, 2003, BLOOD, V101, P1277, DOI 10.1182/blood-2002-05-1474; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; SANTORO A, 1992, CANCER GENET CYTOGEN, V58, P71, DOI 10.1016/0165-4608(92)90137-W; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schmetzer HM, 2000, ACTA HAEMATOL-BASEL, V103, P125, DOI 10.1159/000041035; Schoch C, 2002, GENE CHROMOSOME CANC, V35, P20, DOI 10.1002/gcc.10088; Skjelbred CF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-228; Sreeja Leelakumari, 2008, J Exp Ther Oncol, V7, P73; Stankiewicz MJ, 2009, BLOOD, V113, P3337, DOI 10.1182/blood-2008-08-174813; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Stockwin LH, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-22; Storlazzi CT, 2006, HUM MOL GENET, V15, P933, DOI 10.1093/hmg/ddl010; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Suzen HS, 2007, ONCOL RES, V16, P423; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Toujani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007089; Tyybakinoja A, 2007, LEUKEMIA, V21, P571, DOI 10.1038/sj.leu.2404543; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yamazaki T, 2007, BIOCHEM BIOPH RES CO, V362, P971, DOI 10.1016/j.bbrc.2007.08.082; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	77	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16623	10.1371/journal.pone.0016623	http://dx.doi.org/10.1371/journal.pone.0016623			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339820	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600015
J	Sanchez, DH; Pieckenstain, FL; Szymanski, J; Erban, A; Bromke, M; Hannah, MA; Kraemer, U; Kopka, J; Udvardi, MK				Sanchez, Diego H.; Pieckenstain, Fernando L.; Szymanski, Jedrzey; Erban, Alexander; Bromke, Mariusz; Hannah, Matthew A.; Kraemer, Ute; Kopka, Joachim; Udvardi, Michael K.			Comparative Functional Genomics of Salt Stress in Related Model and Cultivated Plants Identifies and Overcomes Limitations to Translational Genomics	PLOS ONE			English	Article							LEGUME LOTUS-JAPONICUS; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; METABOLIC-RESPONSES; SALINITY TOLERANCE; GAS-CHROMATOGRAPHY; GENETICS; ASPARAGINE; MECHANISMS; TRANSPORT	One of the objectives of plant translational genomics is to use knowledge and genes discovered in model species to improve crops. However, the value of translational genomics to plant breeding, especially for complex traits like abiotic stress tolerance, remains uncertain. Using comparative genomics (ionomics, transcriptomics and metabolomics) we analyzed the responses to salinity of three model and three cultivated species of the legume genus Lotus. At physiological and ionomic levels, models responded to salinity in a similar way to crop species, and changes in the concentration of shoot Cl(-) correlated well with tolerance. Metabolic changes were partially conserved, but divergence was observed amongst the genotypes. Transcriptome analysis showed that about 60% of expressed genes were responsive to salt treatment in one or more species, but less than 1% was responsive in all. Therefore, genotype-specific transcriptional and metabolic changes overshadowed conserved responses to salinity and represent an impediment to simple translational genomics. However, 'triangulation' from multiple genotypes enabled the identification of conserved and tolerant-specific responses that may provide durable tolerance across species.	[Sanchez, Diego H.; Szymanski, Jedrzey; Erban, Alexander; Bromke, Mariusz; Hannah, Matthew A.; Kopka, Joachim] Max Planck Inst Mol Plant Physiol MPIMP, Potsdam, Germany; [Kraemer, Ute] Ruhr Univ Bochum, Dept Plant Physiol, Bochum, Germany; [Udvardi, Michael K.] Samuel Roberts Noble Fdn Inc, Ardmore, OK USA; [Pieckenstain, Fernando L.] Inst Tecnol Chascomus IIB Intech, Chascomus, Argentina	Max Planck Society; Ruhr University Bochum; Noble Research Institute	Sanchez, DH (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	mudvardi@noble.org	Kraemer, Ute/C-5025-2008; Bromke, Mariusz A./AAZ-4519-2020; Udvardi, Michael/GPX-4653-2022	Kraemer, Ute/0000-0001-7870-4508; Bromke, Mariusz A./0000-0002-0806-6608; Udvardi, Michael/0000-0001-9850-0828; Kopka, Joachim/0000-0001-9675-4883; Hannah, Matthew/0000-0002-4889-490X; Sanchez, Diego H./0000-0002-4234-1124; Szymanski, Jedrzej/0000-0003-1086-0920; Pieckenstain, Fernando Luis/0000-0001-6234-7147	European LOTASSA project (Lotus Adaptation and Sustainability in South America) [INCO-CT-2005-517617]	European LOTASSA project (Lotus Adaptation and Sustainability in South America)	This work was conducted within the framework of the European LOTASSA project (Lotus Adaptation and Sustainability in South America, INCO-CT-2005-517617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Allwood JW, 2009, METABOLOMICS, V5, P479, DOI 10.1007/s11306-009-0169-z; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cuartero J, 2006, J EXP BOT, V57, P1045, DOI 10.1093/jxb/erj102; Degtjareva GV, 2006, CAN J BOT, V84, P813, DOI 10.1139/B06-035; Desbrosses GG, 2005, PLANT PHYSIOL, V137, P1302, DOI 10.1104/pp.104.054957; DIAZ P, 2010, NEW PHYTOL; Diaz P, 2005, LOTUS JAPONICUS HANDBOOK, P25, DOI 10.1007/1-4020-3735-X_2; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Foolad MR, 2004, PLANT CELL TISS ORG, V76, P101, DOI 10.1023/B:TICU.0000007308.47608.88; Gondo T, 2007, GENOME, V50, P627, DOI 10.1139/G07-040; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Grattan S. R., 1999, HDB PLANT CROP STRES, P203; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Ishikawa T, 2006, PHYSIOL PLANTARUM, V126, P343, DOI 10.1111/j.1399-3054.2006.00640.x; Kawaguchi M, 2005, DNA RES, V12, P69, DOI 10.1093/dnares/12.1.69; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Marquez AJ, 2005, J EXP BOT, V56, P1741, DOI 10.1093/jxb/eri171; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Moller IS, 2007, TRENDS PLANT SCI, V12, P534, DOI 10.1016/j.tplants.2007.09.009; Monforte AJ, 1997, THEOR APPL GENET, V95, P706, DOI 10.1007/s001220050616; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Salentijn EMJ, 2007, MOL BREEDING, V20, P1, DOI 10.1007/s11032-006-9069-3; Sanchez DH, 2005, PLANT SCI, V168, P541, DOI 10.1016/j.plantsci.2004.09.025; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sanchez DH, 2008, PLANT SIGNAL BEHAV, V3, P598, DOI 10.4161/psb.3.8.6347; Sanchez DH, 2010, PLANT CELL ENVIRON, V33, P468, DOI 10.1111/j.1365-3040.2009.02047.x; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; SIECIECHOWICZ KA, 1988, PHYTOCHEMISTRY, V27, P663, DOI 10.1016/0031-9422(88)84071-8; Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Udvardi MK, 2005, TRENDS PLANT SCI, V10, P222, DOI 10.1016/j.tplants.2005.03.008; Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3; Walia H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-398; Waterhouse RN, 1996, PLANT MOL BIOL, V30, P883, DOI 10.1007/BF00020801; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Yamaguchi K, 2006, FEBS LETT, V580, P6783, DOI 10.1016/j.febslet.2006.10.078; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005	52	83	84	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17094	10.1371/journal.pone.0017094	http://dx.doi.org/10.1371/journal.pone.0017094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347266	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600038
J	Pandeeti, EVP; Pitchika, GK; Jotshi, J; Nilegaonkar, SS; Kanekar, PP; Siddavattam, D				Pandeeti, Emmanuel Vijay Paul; Pitchika, Gopi Krishna; Jotshi, Jyotsna; Nilegaonkar, Smita S.; Kanekar, Pradnya P.; Siddavattam, Dayananda			Enzymatic Depilation of Animal Hide: Identification of Elastase (LasB) from Pseudomonas aeruginosa MCM B-327 as a Depilating Protease	PLOS ONE			English	Article							ALKALINE PROTEASE; EXTRACELLULAR PROTEINS; ESCHERICHIA-COLI; KERATINASE; EXPRESSION; PURIFICATION; ACTIVATION; CLONING; OPTIMIZATION; MUTAGENESIS	Conventional leather processing involving depilation of animal hide by lime and sulphide treatment generates considerable amounts of chemical waste causing severe environmental pollution. Enzymatic depilation is an environmentally friendly process and has been considered to be a viable alternative to the chemical depilation process. We isolated an extracellular protease from Pseudomonas aeruginosa strain MCM B-327 with high depilation activity using buffalo hide as a substrate. This 33 kDa protease generated a peptide mass fingerprint and de novo sequence that matched perfectly with LasB (elastase), of Pseudomonas aeruginosa. In support of this data a lasB mutant of MCM B-327 strain lacked depilatory activity and failed to produce LasB. LasB heterologously over-produced and purified from Escherichia coli also exhibited high depilating activity. Moreover, reintroduction of the lasB gene to the P. aeruginosa lasB mutant via a knock-in strategy also successfully restored depilation activity thus confirming the role of LasB as the depilating enzyme.	[Pandeeti, Emmanuel Vijay Paul; Pitchika, Gopi Krishna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India; [Jotshi, Jyotsna; Nilegaonkar, Smita S.; Kanekar, Pradnya P.] MACS Agharkar Res Inst, Microbial Sci Div, Pune, Maharashtra, India	University of Hyderabad; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Pandeeti, EVP (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	sdsl@uohyd.ernet.in		Pandeeti, Emmanuel/0000-0001-8244-7401	CSIR-NMITLI, New Delhi [5/258/13A/2005-NMITLI]	CSIR-NMITLI, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by CSIR-NMITLI, New Delhi through the grant 5/258/13A/2005-NMITLI to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbu P, 2005, ENZYME MICROB TECH, V36, P639, DOI 10.1016/j.enzmictec.2004.07.019; Anderson RM, 1999, J BACTERIOL, V181, P6264, DOI 10.1128/JB.181.20.6264-6270.1999; Bayoudh A, 2000, J IND MICROBIOL BIOT, V24, P291, DOI 10.1038/sj.jim.2900822; Brandelli A, 2008, FOOD BIOPROCESS TECH, V1, P105, DOI 10.1007/s11947-007-0025-y; Braun P, 2000, MICROBIOL-UK, V146, P2565, DOI 10.1099/00221287-146-10-2565; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Friedrich J, 2005, ENZYME MICROB TECH, V36, P455, DOI 10.1016/j.enzmictec.2004.09.015; Germann H.P., 1999, P 25 IULTCS C CHENN; Giongo JL, 2007, WORLD J MICROB BIOT, V23, P375, DOI 10.1007/s11274-006-9234-1; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauser AR, 1998, INFECT IMMUN, V66, P1413, DOI 10.1128/IAI.66.4.1413-1420.1998; HOLDER IA, 1989, INFECT IMMUN, V57, P3345, DOI 10.1128/IAI.57.11.3345-3348.1989; Kanekar PP, 2002, BIORESOURCE TECHNOL, V85, P87, DOI 10.1016/S0960-8524(02)00018-4; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lin HH, 2009, J AGR FOOD CHEM, V57, P5321, DOI 10.1021/jf900417t; Lin HH, 2009, J AGR FOOD CHEM, V57, P3506, DOI 10.1021/jf803752j; Lin XJ, 2009, PROTEIN EXPRES PURIF, V63, P69, DOI 10.1016/j.pep.2007.12.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDVIK J, 2000, USRAS921201151 UN NA; Macedo AJ, 2005, APPL ENVIRON MICROB, V71, P594, DOI 10.1128/AEM.71.1.594-596.2005; Marsal A, 1999, J SOC LEATH TECH CH, V83, P310; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Mukhopadhyay R. P., 1993, Indian Journal of Experimental Biology, V31, P557; Najafi MF, 2006, ENZYME MICROB TECH, V39, P1433, DOI 10.1016/j.enzmictec.2006.03.031; Nilegaonkar SS, 2007, BIORESOURCE TECHNOL, V98, P1238, DOI 10.1016/j.biortech.2006.05.003; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; Nouwens AS, 2002, PROTEOMICS, V2, P1325, DOI 10.1002/1615-9861(200209)2:9<1325::AID-PROT1325>3.0.CO;2-4; Pandeeti EVP, 2009, LETT APPL MICROBIOL, V48, P566, DOI 10.1111/j.1472-765X.2009.02564.x; PANDEY JP, 2009, MOL BIOL REP, V34, P13; Puvanakrishnan R., 1988, ENZYMES DEHAIRING; Ramasami T, 1999, J SOC LEATH TECH CH, V83, P39; RAMASAMI T, 1998, BACKGROUND INFORMATI, P183; RUST L, 1996, J BACTERIOL, V179, P557; Sambrook J., 2002, MOL CLONING LAB MANU; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Sharma R, 2010, BIOTECHNOL LETT, V32, P1863, DOI 10.1007/s10529-010-0361-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YATES JR, 1968, AUST J BIOL SCI, V21, P361, DOI 10.1071/BI9680361; Yates JR, 1972, J SOC LEATHER TRADES, V56, P158; Zambare VP, 2007, WORLD J MICROB BIOT, V23, P1569, DOI 10.1007/s11274-007-9402-y; ZAMBARE VP, 2010, NEW BIOTECH IN PRESS	48	12	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16742	10.1371/journal.pone.0016742	http://dx.doi.org/10.1371/journal.pone.0016742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347249	gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500004
J	Khattar, SK; Kumar, S; Xiao, S; Collins, PL; Samal, SK				Khattar, Sunil K.; Kumar, Sachin; Xiao, Sa; Collins, Peter L.; Samal, Siba K.			Experimental Infection of Mice with Avian Paramyxovirus Serotypes 1 to 9	PLOS ONE			English	Article							NEWCASTLE-DISEASE-VIRUS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; COMPLETE GENOME SEQUENCE; COMPLETE NUCLEOTIDE-SEQUENCE; VACCINE VECTOR; COMPLETE REGRESSION; FUSION PROTEIN; GREAT-BRITAIN; CLEAVAGE SITE; VIRULENCE	The nine serotypes of avian paramyxoviruses (APMVs) are frequently isolated from domestic and wild birds worldwide. APMV-1, also called Newcastle disease virus, was shown to be attenuated in non-avian species and is being developed as a potential vector for human vaccines. In the present study, we extended this evaluation to the other eight serotypes by evaluating infection in BALB/c mice. Mice were inoculated intranasally with a prototype strain of each of the nine serotypes and monitored for clinical disease, gross pathology, histopathology, virus replication and viral antigen distribution, and seroconversion. On the basis of multiple criteria, each of the APMV serotypes except serotype 5 was found to replicate in mice. Five of the serotypes produced clinical disease and significant weight loss in the following order of severity: 1, 2>6, 9>7. However, disease was short-lived. The other serotypes produced no evident clinical disease. Replication of all of the APMVs except APMV-5 in the nasal turbinates and lungs was confirmed by the recovery of infectious virus and by substantial expression of viral antigen in the epithelial lining detected by immunohistochemistry. Trace levels of infectious APMV-4 and -9 were detected in the brain of some animals; otherwise, no virus was detected in the brain, small intestine, kidney, or spleen. Histologically, infection with the APMVs resulted in lung lesions consistent with broncho-interstitial pneumonia of varying severity that were completely resolved at 14 days post infection. All of the mice infected with the APMVs except APMV-5 produced serotype-specific HI serum antibodies, confirming a lack of replication of APMV-5. Taken together, these results demonstrate that all APMV serotypes except APMV-5 are capable of replicating in mice with minimal disease and pathology.	[Khattar, Sunil K.; Kumar, Sachin; Xiao, Sa; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Khattar, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			NIAID [N01A060009]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID contract no. N01A060009 (85% support) and NIAID, NIH Intramural Research Program (15% support). The views expressed herein do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 1997, VET REC, V140, P20, DOI 10.1136/vr.140.1.20; ALEXANDER DJ, 1982, VET REC, V111, P571; ALEXANDER DJ, 1983, AVIAN PATHOL, V12, P469, DOI 10.1080/03079458308436192; Alexander DJ, 2009, MANUAL DIAGNOSTIC TE; ALEXANDER DJ, 2003, AVIAN PARAMYXOVIRUSE; BANKOWSKI RA, 1981, AVIAN DIS, V25, P517, DOI 10.2307/1589944; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Capua I, 2004, VET REC, V155, P156; Carnero E, 2009, J VIROL, V83, P584, DOI 10.1128/JVI.01443-08; Chang PC, 2001, J GEN VIROL, V82, P2157, DOI 10.1099/0022-1317-82-9-2157; de Leeuw O, 1999, J GEN VIROL, V80, P131, DOI 10.1099/0022-1317-80-1-131; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; Dortmans JCFM, 2010, J VIROL, V84, P10113, DOI 10.1128/JVI.00097-10; Elankumaran S, 2010, J VIROL, V84, P3835, DOI 10.1128/JVI.01553-09; Estevez C, 2007, VIRUS RES, V129, P182, DOI 10.1016/j.virusres.2007.07.008; GOUGH RE, 1984, VET REC, V115, P653, DOI 10.1136/vr.115.25-26.653; Huang ZH, 2004, J VIROL, V78, P10054, DOI 10.1128/JVI.78.18.10054-10063.2004; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; Jeon WJ, 2008, VIRUS GENES, V37, P342, DOI 10.1007/s11262-008-0267-4; Khattar SK, 2010, VACCINE, V28, P3159, DOI 10.1016/j.vaccine.2010.02.051; Kortekaas J, 2010, VACCINE, V28, P4394, DOI 10.1016/j.vaccine.2010.04.048; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Kumar S, 2008, VIRUS RES, V137, P189, DOI 10.1016/j.virusres.2008.07.012; Kumar S, 2010, VET RES, V41, DOI 10.1051/vetres/2010042; Kumar S, 2010, VIRUS RES, V149, P78, DOI 10.1016/j.virusres.2009.12.015; LIPKIND MA, 1979, VET REC, V105, P577; LORENCE RM, 1988, J NATL CANCER I, V80, P1305, DOI 10.1093/jnci/80.16.1305; LORENCE RM, 1994, JNCI-J NATL CANCER I, V86, P1228, DOI 10.1093/jnci/86.16.1228; LORENCE RM, 1994, CANCER RES, V54, P6017; MALDONADO A, 1995, J WILDLIFE DIS, V31, P66, DOI 10.7589/0090-3558-31.1.66; Martinez-Sobrido L, 2006, J VIROL, V80, P1130, DOI 10.1128/JVI.80.3.1130-1139.2006; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Miller PJ, 2009, VIROLOGY, V391, P64, DOI 10.1016/j.virol.2009.05.033; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; Nayak B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006509; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Romer-Oberdorfer A, 2008, VACCINE, V26, P2307, DOI 10.1016/j.vaccine.2008.02.061; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; RUSSELL PH, 1989, J GEN VIROL, V70, P315, DOI 10.1099/0022-1317-70-2-315; Saif YM, 1997, AVIAN DIS, V41, P326, DOI 10.2307/1592185; Samuel AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009269; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; Schirrmacher Volker, 2009, V542, P565, DOI 10.1007/978-1-59745-561-9_30; SHORTRIDGE KF, 1980, J GEN VIROL, V49, P255, DOI 10.1099/0022-1317-49-2-255; STALLKNECHT DE, 1991, J WILDLIFE DIS, V27, P123, DOI 10.7589/0090-3558-27.1.123; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Subbiah M, 2010, AVIAN DIS, V54, P1050, DOI 10.1637/9380-041910-Reg.1; Subbiah M, 2010, VIRUS RES, V152, P85, DOI 10.1016/j.virusres.2010.06.009; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; TUMOVA B, 1979, RES VET SCI, V27, P135, DOI 10.1016/S0034-5288(18)32817-0; Vigil A, 2008, MOL THER, V16, P1883, DOI 10.1038/mt.2008.181; Vigil A, 2007, CANCER RES, V67, P8285, DOI 10.1158/0008-5472.CAN-07-1025; Warke A, 2008, AVIAN PATHOL, V37, P429, DOI 10.1080/03079450802216645; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003; Zamarin D, 2009, GENE THER, V16, P796, DOI 10.1038/gt.2009.14	59	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16776	10.1371/journal.pone.0016776	http://dx.doi.org/10.1371/journal.pone.0016776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347313	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000017
J	Mihali, TK; Carmichael, WW; Neilan, BA				Mihali, Troco K.; Carmichael, Wayne W.; Neilan, Brett A.			A Putative Gene Cluster from a Lyngbya wollei Bloom that Encodes Paralytic Shellfish Toxin Biosynthesis	PLOS ONE			English	Article							CYANOBACTERIUM CYLINDROSPERMOPSIS-RACIBORSKII; DINOFLAGELLATE GYMNODINIUM-CATENATUM; POISONING TOXINS; 1ST EVIDENCE; SAXITOXIN; IDENTIFICATION; AUSTRALIA; TOXICITY; PROTEINS; WATERS	Saxitoxin and its analogs cause the paralytic shellfish-poisoning syndrome, adversely affecting human health and coastal shellfish industries worldwide. Here we report the isolation, sequencing, annotation, and predicted pathway of the saxitoxin biosynthetic gene cluster in the cyanobacterium Lyngbya wollei. The gene cluster spans 36 kb and encodes enzymes for the biosynthesis and export of the toxins. The Lyngbya wollei saxitoxin gene cluster differs from previously identified saxitoxin clusters as it contains genes that are unique to this cluster, whereby the carbamoyltransferase is truncated and replaced by an acyltransferase, explaining the unique toxin profile presented by Lyngbya wollei. These findings will enable the creation of toxin probes, for water monitoring purposes, as well as proof-of-concept for the combinatorial biosynthesis of these natural occurring alkaloids for the production of novel, biologically active compounds.	[Mihali, Troco K.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Carmichael, Wayne W.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	University of New South Wales Sydney; University System of Ohio; Wright State University Dayton; University of New South Wales Sydney	Mihali, TK (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	b.neilan@unsw.edu.au	Neilan, Brett A/I-5767-2012	Neilan, Brett A/0000-0001-6113-772X	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council. BAN is a fellow of the Australian Research Council. The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA O, 1994, TOXICON, V32, P175, DOI 10.1016/0041-0101(94)90106-6; Arakawa O, 1995, TOXICON, V33, P1577, DOI 10.1016/0041-0101(95)00106-9; BAKER PD, 1994, AUST J MAR FRESH RES, V45, P773; Beltran EC, 2000, APPL ENVIRON MICROB, V66, P4468, DOI 10.1128/AEM.66.10.4468-4474.2000; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Hallegraeff G. M., 1995, MANUAL HARMFUL MARIN, V33, P1; HARADA T, 1982, AGR BIOL CHEM TOKYO, V46, P1861, DOI 10.1080/00021369.1982.10865327; Hawkins PR, 1997, TOXICON, V35, P341, DOI 10.1016/S0041-0101(96)00185-7; HUMPAGE AR, 1994, AUST J MAR FRESH RES, V45, P761, DOI 10.1071/MF9940761; Kao C., 1986, TETRODOTOXIN SAXITOX; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2007, J PHYCOL, V43, P497, DOI 10.1111/j.1529-8817.2007.00351.x; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Messineo V, 2010, ENVIRON TOXICOL, V25, P18, DOI 10.1002/tox.20469; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Moffitt MC, 2004, APPL ENVIRON MICROB, V70, P6353, DOI 10.1128/AEM.70.11.6353-6362.2004; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Negri A, 2003, CHEM RES TOXICOL, V16, P1029, DOI 10.1021/tx034037j; Neilan BA, 2003, MOL ECOL, V12, P133, DOI 10.1046/j.1365-294X.2003.01709.x; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P2286, DOI 10.1128/AEM.61.6.2286-2291.1995; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; OSHIMA Y, 1987, TOXICON, V25, P1105, DOI 10.1016/0041-0101(87)90267-4; OSHIMA Y, 1995, J AOAC INT, V78, P528; Pomati F, 2004, MICROBIOL-SGM, V150, P455, DOI 10.1099/mic.0.26350-0; Pomati F, 2000, J PHYCOL, V36, P553, DOI 10.1046/j.1529-8817.2000.99181.x; Seifert M, 2007, HARMFUL ALGAE, V6, P73, DOI 10.1016/j.hal.2006.07.001; SHIMIZU Y, 1993, CHEM REV, V93, P1685, DOI 10.1021/cr00021a002; SPEZIALE BJ, 1992, J PHYCOL, V28, P613; St-Pierre B, 1998, PLANT J, V14, P703, DOI 10.1046/j.1365-313x.1998.00174.x; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; SU Z, 2004, J PHARM EXPT THERAPE, V308; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Velzeboer RMA, 2000, PHYCOLOGIA, V39, P395, DOI 10.2216/i0031-8884-39-5-395.1; Wang JX, 2003, J GEN PHYSIOL, V121, P583, DOI 10.1085/jgp.200308812; Zaman L, 1998, TOXICON, V36, P627, DOI 10.1016/S0041-0101(97)00086-X	43	73	77	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14657	10.1371/journal.pone.0014657	http://dx.doi.org/10.1371/journal.pone.0014657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347365	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000002
J	MacIntyre, DA; Sanchis, DM; Jimenez, B; Moreno, R; Stojkovic, M; Pineda-Lucena, A				MacIntyre, David A.; Melguizo Sanchis, Dario; Jimenez, Beatriz; Moreno, Ruben; Stojkovic, Miodrag; Pineda-Lucena, Antonio			Characterisation of Human Embryonic Stem Cells Conditioning Media by H-1-Nuclear Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							PROLONGED UNDIFFERENTIATED GROWTH; HUMAN-DIPLOID FIBROBLASTS; HUMAN FEEDERS; HUMAN BLASTOCYSTS; CULTURE-MEDIA; HUMAN-SERUM; IN-VITRO; URINE; LINES; METABONOMICS	Background: Cell culture media conditioned by human foreskin fibroblasts (HFFs) provide a complex supplement of protein and metabolic factors that support in vitro proliferation of human embryonic stem cells (hESCs). However, the conditioning process is variable with different media batches often exhibiting differing capacities to maintain hESCs in culture. While recent studies have examined the protein complement of conditioned culture media, detailed information regarding the metabolic component of this media is lacking. Methodology/Principal Findings: Using a H-1-Nuclear Magnetic Resonance (H-1-NMR) metabonomics approach, 32 metabolites and small compounds were identified and quantified in media conditioned by passage 11 HFFs (CMp11). A number of metabolites were secreted by HFFs with significantly higher concentration of lactate, alanine, and formate detected in CMp11 compared to non-conditioned media. In contrast, levels of tryptophan, folate and niacinamide were depleted in CMp11 indicating the utilisation of these metabolites by HFFs. Multivariate statistical analysis of the H-1-NMR data revealed marked age-related differences in the metabolic profile of CMp11 collected from HFFs every 24 h over 72 h. Additionally, the metabolic profile of CMp11 was altered following freezing at -20 degrees C for 2 weeks. CM derived from passage 18 HFFs (CMp18) was found to be ineffective at supporting hESCs in an undifferentiated state beyond 5 days culture. Multivariate statistical comparison of CMp11 and CMp18 metabolic profiles enabled rapid and clear discrimination between the two media with CMp18 containing lower concentrations of lactate and alanine as well as higher concentrations of glucose and glutamine. Conclusions/Significance: H-1-NMR-based metabonomics offers a rapid and accurate method of characterising hESC conditioning media and is a valuable tool for monitoring, controlling and optimising hESC culture media preparation.	[MacIntyre, David A.; Jimenez, Beatriz; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain; [Melguizo Sanchis, Dario; Moreno, Ruben; Stojkovic, Miodrag] Ctr Invest Principe Felipe, Cellular Reprogramming Lab, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center	MacIntyre, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod Dev Biol, Hammersmith Hosp Campus, London, England.	apineda@cipf.es	MacIntyre, David A/D-9267-2012; Pineda-Lucena, Antonio/B-1320-2014	Pineda-Lucena, Antonio/0000-0002-3532-8781; Stojkovic, Miodrag/0000-0001-7526-6573; MacIntyre, David/0000-0002-4186-5567; Melguizo Sanchis, Dario/0000-0002-5728-4345	Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII) [CD2006/00133]	Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III)	DAM is a Marie Curie International Incoming Fellow (PIIF-GA-2008-221484). BJ is supported by a Fondo de Investigacion Sanitario from Instituto de Salud Carlos III (ISCIII) Sara Borrell grant (CD2006/00133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; ANTHONY ML, 1994, MOL PHARMACOL, V46, P199; BALES JR, 1984, CLIN CHEM, V30, P426; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; Cobo F, 2005, APPL MICROBIOL BIOT, V68, P456, DOI 10.1007/s00253-005-0062-2; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Jimenez B, 2010, J PROTEOME RES, V9, P5180, DOI 10.1021/pr100486e; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kettapeh-Wold S., 1999, INTRO MULTI MEGAVARI, P213; Lamers RJAN, 2003, J NUTR, V133, P3080, DOI 10.1093/jn/133.10.3080; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Miccheli AT, 2006, BBA-GEN SUBJECTS, V1760, P1723, DOI 10.1016/j.bbagen.2006.09.009; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; NICHOLSON JK, 1983, BIOCHEM J, V211, P605, DOI 10.1042/bj2110605; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; PINE L, 1989, CAN J MICROBIOL, V35, P245, DOI 10.1139/m89-037; Prowse ABJ, 2007, J PROTEOME RES, V6, P3796, DOI 10.1021/pr0702262; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; SAUDE E, 2007, METABOLOMICS, V3, P1573; Seagle C, 2008, TISSUE ENG PART C-ME, V14, P107, DOI 10.1089/ten.tec.2007.0401; Shufaro Y, 2004, BEST PRACT RES CL OB, V18, P909, DOI 10.1016/j.bpobgyn.2004.07.002; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Teahan O, 2006, ANAL CHEM, V78, P4307, DOI 10.1021/ac051972y; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRITSCH GL, 1962, EXP CELL RES, V28, P360, DOI 10.1016/0014-4827(62)90290-2; Willker W., 1996, J MAGN RESON ANAL, V2, P21; Wilson ID, 2005, J PROTEOME RES, V4, P591, DOI 10.1021/pr049769r; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; ZIELKE HR, 1976, P NATL ACAD SCI USA, V73, P4110, DOI 10.1073/pnas.73.11.4110; ZIELKE HR, 1980, J CELL PHYSIOL, V104, P433, DOI 10.1002/jcp.1041040316	47	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16732	10.1371/journal.pone.0016732	http://dx.doi.org/10.1371/journal.pone.0016732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347425	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700030
J	Wang, FY; Tong, RJ; Shi, ZY; Xu, XF; He, XH				Wang, Fa Yuan; Tong, Rui Jian; Shi, Zhao Yong; Xu, Xiao Feng; He, Xin Hua			Inoculations with Arbuscular Mycorrhizal Fungi Increase Vegetable Yields and Decrease Phoxim Concentrations in Carrot and Green Onion and Their Soils	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE-RESIDUES; POLYCYCLIC AROMATIC-HYDROCARBONS; MICROBIAL COMMUNITY STRUCTURE; PHOSPHATASE-ACTIVITY; NONIONIC SURFACTANT; SPIKED SOIL; DISSIPATION; RHIZOSPHERE; GROWTH; CHINA	Background: As one of the most widely used organophosphate insecticides in vegetable production, phoxim (C12H15N2O3PS) is often found as residues in crops and soils and thus poses a potential threat to public health and environment. Arbuscular mycorrhizal (AM) fungi may make a contribution to the decrease of organophosphate residues in crops and/or the degradation in soils, but such effects remain unknown. Methodology/Principal Findings: A greenhouse pot experiment studied the influence of AM fungi and phoxim application on the growth of carrot and green onion, and phoxim concentrations in the two vegetables and their soil media. Treatments included three AM fungal inoculations with Glomus intraradices BEG 141, G. mosseae BEG 167, and a nonmycorrhizal control, and four phoxim application rates (0, 200, 400, 800 mg l(-1), while 400 mg l(-1) rate is the recommended dose in the vegetable production system). Carrot and green onion were grown in a greenhouse for 130 d and 150 d. Phoxim solution (100 ml) was poured into each pot around the roots 14d before plant harvest. Results showed that mycorrhizal colonization was higher than 70%, and phoxim application inhibited AM colonization on carrot but not on green onion. Compared with the nonmycorrhizal controls, both shoot and root fresh weights of these two vegetables were significantly increased by AM inoculations irrespective of phoxim application rates. Phoxim concentrations in shoots, roots and soils were increased with the increase of phoxim application rate, but significantly decreased by the AM inoculations. Soil phosphatase activity was enhanced by both AM inocula, but not affected by phoxim application rate. In general, G. intraradices BEG 141 had more pronounced effects than G. mosseae BEG 167 on the increase of fresh weight production in both carrot and green onion, and the decrease of phoxim concentrations in plants and soils. Conclusions/Significance: Our results indicate a promising potential of AM fungi for enhancing vegetable production and reducing organophosphorus pesticide residues in plant tissues and their growth media, as well as for the phytoremediation of organophosphorus pesticide-contaminated soils.	[Wang, Fa Yuan; Shi, Zhao Yong; Xu, Xiao Feng] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Tong, Rui Jian] Luoyang Normal Univ, Dept Life Sci, Luoyang, Peoples R China; [He, Xin Hua] Edith Cowan Univ, Sch Nat Resources, Ctr Ecosyst Management, Joondalup, Australia; [He, Xin Hua] Univ Western Australia, State Ctr Excellence Ecohydrol, Crawley, Australia; [He, Xin Hua] Univ Western Australia, Sch Plant Biol, Crawley, Australia	Henan University of Science & Technology; Luoyang Normal University; Edith Cowan University; University of Western Australia; University of Western Australia	Wang, FY (corresponding author), Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China.	wfy1975@163.com	He, Xinhua/B-8047-2015; Wang, F./U-8471-2018	He, Xinhua/0000-0002-5570-3454; Wang, F./0000-0003-1345-256X	National Natural Science Foundation of China [40801120, 40971150]; China Postdoctoral Science Foundation [20080440373, 200902095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the National Natural Science Foundation of China (grant numbers 40801120, 40971150) (http://www.nsfc.gov.cn/Portal0/default106.htm) and China Postdoctoral Science Foundation funded project (grant numbers 20080440373, 200902095) (http://www.chinapostdoctor.org.cn/new_english/main_en.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; Bai YH, 2006, FOOD CHEM, V98, P240, DOI 10.1016/j.foodchem.2005.05.070; Cabello MN, 1997, FEMS MICROBIOL ECOL, V22, P233, DOI 10.1016/S0168-6496(96)00094-3; Cairney JWG, 1999, ENVIRON POLLUT, V106, P169, DOI 10.1016/S0269-7491(99)00081-0; Chen C, 2009, FOOD ADDIT CONTAM A, V26, P340, DOI 10.1080/02652030802524516; Criquet S, 2000, BIOTECHNOL LETT, V22, P1733, DOI 10.1023/A:1005604719909; FAO, PEST RES FOOD 1983; Feng G, 2003, APPL SOIL ECOL, V22, P139, DOI 10.1016/S0929-1393(02)00133-6; Franco-Ramirez A, 2007, J BASIC MICROB, V47, P378, DOI 10.1002/jobm.200610293; *GEN ADM QUAL SUP, 2003, 145522003 GBT GEN AD; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Arroyo S, 2007, TOXICOL IN VITRO, V21, P950, DOI 10.1016/j.tiv.2007.01.027; HABTE M, 1988, BIOL FERT SOILS, V5, P313, DOI 10.1007/BF00262138; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Huang HL, 2007, ENVIRON POLLUT, V146, P452, DOI 10.1016/j.envpol.2006.07.001; Huang HL, 2009, SOIL BIOL BIOCHEM, V41, P726, DOI 10.1016/j.soilbio.2009.01.009; International Programme on Chemical Safety, 2010, WHO REC CLASS PEST H; Isoda Hiroko, 2005, Environ Sci, V12, P9; JIANG JD, 2004, CHINESE J APPL ECOL, V15, P1459; Jin F, 2010, J PESTIC SCI, V35, P138, DOI 10.1584/jpestics.G10-15; Joner EJ, 2000, MYCOL RES, V104, P81, DOI 10.1017/S0953756299001240; Joner EJ, 2001, MYCORRHIZA, V10, P155, DOI 10.1007/s005720000071; Joner EJ, 2003, ENVIRON SCI TECHNOL, V37, P2371, DOI 10.1021/es020196y; Joner EJ, 2001, ENVIRON SCI TECHNOL, V35, P2773, DOI 10.1021/es000288s; Joner Erik Jautris, 2003, Agronomie (Paris), V23, P495, DOI 10.1051/agro:2003021; Koide RT, 2000, NEW PHYTOL, V148, P511, DOI 10.1046/j.1469-8137.2000.00776.x; Kojima T, 1998, BIOL FERT SOILS, V26, P331, DOI 10.1007/s003740050384; [李芳 Li Fang], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P104; LU ZR, 1984, ACTA U MED NANJING, V4, P29; Marin M, 2002, AGR FOOD SCI FINLAND, V11, P245, DOI 10.23986/afsci.5728; Menendez A, 1999, Int Microbiol, V2, P43; *MIN AGR CHIN, 2008, 7612008 NYT MIN AGR; NEMEC S, 1985, PLANT SOIL, V85, P543; *PAN PEST, PAN PEST DAT; Pattinson GS, 1997, MYCORRHIZA, V7, P155, DOI 10.1007/s005720050175; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Shen Yu-jia, 2007, Huanjing Kexue, V28, P2833; SREENIVASA MN, 1989, PLANT SOIL, V119, P127, DOI 10.1007/BF02370276; Sun J, 2000, Wei Sheng Yan Jiu, V29, P65; Sun XinGui, 2003, CHINESE J FOOD HYGIE, V15, P536; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; TARAFDAR JC, 1994, SOIL BIOL BIOCHEM, V26, P387, DOI 10.1016/0038-0717(94)90288-7; VEERASWAMY J, 1993, AGR ECOSYST ENVIRON, V43, P337, DOI 10.1016/0167-8809(93)90096-8; Wang J, 1999, CRIT REV PLANT SCI, V18, P403, DOI 10.1016/S0735-2689(99)00374-3; Wang LG, 2008, B ENVIRON CONTAM TOX, V81, P377, DOI 10.1007/s00128-008-9498-2; Whipps JM, 2004, CAN J BOT, V82, P1198, DOI [10.1139/b04-082, 10.1139/B04-082]; White JC, 2006, J HAZARD MATER, V137, P1750, DOI 10.1016/j.jhazmat.2006.05.012; WU JZ, 2006, CHIN J IND MED, V19, P94; Wu NY, 2008, SCI TOTAL ENVIRON, V394, P230, DOI 10.1016/j.scitotenv.2008.02.003; Wu NY, 2008, ENVIRON POLLUT, V151, P569, DOI 10.1016/j.envpol.2007.04.005; ZHAN N, 2000, J HYG RES, V29, P4; [张瑞福 Zhang Ruifu], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P411; ZHENG J, 1999, ANHUI J PREVENT MED, V5, P33	53	22	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16949	10.1371/journal.pone.0016949	http://dx.doi.org/10.1371/journal.pone.0016949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347374	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700055
J	Burghardt, TP				Burghardt, Thomas P.			Single Molecule Fluorescence Image Patterns Linked to Dipole Orientation and Axial Position: Application to Myosin Cross-Bridges in Muscle Fibers	PLOS ONE			English	Article							LEVER-ARM ORIENTATION; LOCALIZATION ANALYSIS; MICROSCOPY; EMISSION; FIELD; GFP; DIFFRACTION	Background: Photoactivatable fluorescent probes developed specifically for single molecule detection extend advantages of single molecule imaging to high probe density regions of cells and tissues. They perform in the native biomolecule environment and have been used to detect both probe position and orientation. Methods and Findings: Fluorescence emission from a single photoactivated probe captured in an oil immersion, high numerical aperture objective, produces a spatial pattern on the detector that is a linear combination of 6 independent and distinct spatial basis patterns with weighting coefficients specifying emission dipole orientation. Basis patterns are tabulated for single photoactivated probes labeling myosin cross-bridges in a permeabilized muscle fiber undergoing total internal reflection illumination. Emitter proximity to the glass/aqueous interface at the coverslip implies the dipole near-field and dipole power normalization are significant affecters of the basis patterns. Other characteristics of the basis patterns are contributed by field polarization rotation with transmission through the microscope optics and refraction by the filter set. Pattern recognition utilized the generalized linear model, maximum likelihood fitting, for Poisson distributed uncertainties. This fitting method is more appropriate for treating low signal level photon counting data than x 2 minimization. Conclusions: Results indicate that emission dipole orientation is measurable from the intensity image except for the ambiguity under dipole inversion. The advantage over an alternative method comparing two measured polarized emission intensities using an analyzing polarizer is that information in the intensity spatial distribution provides more constraints on fitted parameters and a single image provides all the information needed. Axial distance dependence in the emission pattern is also exploited to measure relative probe position near focus. Single molecule images from axial scanning fitted simultaneously boost orientation and axial resolution in simulation.	[Burghardt, Thomas P.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Burghardt, Thomas P.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Burghardt, TP (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	burghardt@mayo.edu			United States National Instutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR049277]; National Heart Lung Blood Institute (NHLBI) [R01HL095572]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049277] Funding Source: NIH RePORTER	United States National Instutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart Lung Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was supported by United States National Instutes of Health: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grant R01AR049277, National Heart Lung Blood Institute (NHLBI) grant R01HL095572, and by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Axelrod D, 2006, NAT REV MOL CELL BIO, V7, P944, DOI 10.1038/nrm2062; Bartko AP, 1999, J PHYS CHEM B, V103, P3053, DOI 10.1021/jp9846330; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Bohmer M, 2003, J OPT SOC AM B, V20, P554, DOI 10.1364/JOSAB.20.000554; BORN M, 1975, PRINCIPLES OPTICS, pCH10; Burghardt TP, 2007, BIOPHYS J, V93, P2226, DOI 10.1529/biophysj.107.107433; Burghardt Thomas P, 2010, Biophys Rev, V2, P159, DOI 10.1007/s12551-010-0038-z; Burghardt TP, 2009, BIOCHEMISTRY-US, V48, P754, DOI 10.1021/bi8017703; BURGHARDT TP, 1984, OPT ENG, V23, P62, DOI 10.1117/12.7973254; HELLEN EH, 1987, J OPT SOC AM B, V4, P337, DOI 10.1364/JOSAB.4.000337; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Lieb MA, 2004, J OPT SOC AM B, V21, P1210, DOI 10.1364/JOSAB.21.001210; Mattheyses AL, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2052867; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Stoneking MR, 1997, REV SCI INSTRUM, V68, P914, DOI 10.1063/1.1147768; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X	22	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16772	10.1371/journal.pone.0016772	http://dx.doi.org/10.1371/journal.pone.0016772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347442	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600024
J	Uschakov, A; Grivel, J; Cvetkovic-Lopes, V; Bayer, L; Bernheim, L; Jones, BE; Muhlethaler, M; Serafin, M				Uschakov, Aaron; Grivel, Jeremy; Cvetkovic-Lopes, Vesna; Bayer, Laurence; Bernheim, Laurent; Jones, Barbara E.; Muehlethaler, Michel; Serafin, Mauro			Sleep-Deprivation Regulates alpha-2 Adrenergic Responses of Rat Hypocretin/Orexin Neurons	PLOS ONE			English	Article							OREXIN NEURONS; RGS PROTEINS; WAKEFULNESS; CHANNELS; CATECHOLAMINES; NORADRENALINE; TRAFFICKING; NARCOLEPSY; RECEPTORS; COMPLEX	We recently demonstrated, in rat brain slices, that the usual excitation by noradrenaline (NA) of hypocretin/orexin (hcrt/orx) neurons was changed to an inhibition following sleep deprivation (SD). Here we describe that in control condition (CC), i.e. following 2 hours of natural sleep in the morning, the alpha(2)-adrenergic receptor (alpha(2)-AR) agonist, clonidine, had no effect on hcrt/orx neurons, whereas following 2 hours of SD (SDC), it hyperpolarized the neurons by activating G-protein-gated inwardly rectifying potassium (GIRK) channels. Since concentrations of clonidine up to a thousand times (100 mu M) higher than those effective in SDC (100 nM), were completely ineffective in CC, a change in the availability of G-proteins is unlikely to explain the difference between the two conditions. To test whether the absence of effect of clonidine in CC could be due to a down-regulation of GIRK channels, we applied baclofen, a GABA(B) agonist known to also activate GIRK channels, and found that it hyperpolarized hcrt/orx neurons in that condition. Moreover, baclofen occluded the response to clonidine in SDC, indicating that absence of effect of clonidine in CC could not be attributed to down-regulation of GIRK channels. We finally tested whether alpha(2)-ARs were still available at the membrane in CC and found that clonidine could reduce calcium currents, indicating that alpha(2)-ARs associated with calcium channels remain available in that condition. Taken together, these results suggest that a pool of alpha(2)-ARs associated with GIRK channels is normally down-regulated (or desensitized) in hcrt/orx neurons to only become available for their inhibition following sleep deprivation.	[Uschakov, Aaron; Grivel, Jeremy; Cvetkovic-Lopes, Vesna; Bayer, Laurence; Bernheim, Laurent; Muehlethaler, Michel; Serafin, Mauro] Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland; [Jones, Barbara E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	University of Geneva; McGill University	Uschakov, A (corresponding author), Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland.	mauro.serafin@unige.ch	Jones, Barbara E/A-8033-2017		Swiss Fonds National [31003A-113996]	Swiss Fonds National	Swiss Fonds National 31003A-113996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; ALFOLDI P, 1990, AM J PHYSIOL, V258, pR634, DOI 10.1152/ajpregu.1990.258.3.R634; Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; Bayer L, 2005, NEUROSCIENCE, V130, P807, DOI 10.1016/j.neuroscience.2004.10.032; BERNHEIM L, 1991, NEURON, V6, P859, DOI 10.1016/0896-6273(91)90226-P; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Eggermann E, 2003, J NEUROSCI, V23, P1557; Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005; HANK PJ, 2008, EUROPEAN J NEUROSCIE, V27, P2433; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Jones BE, 2005, HYPOCRETINS: INTEGRATORS OF PHYSIOLOGICAL FUNCTIONS, P289; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Lomazzi M, 2008, TRENDS PHARMACOL SCI, V29, P544, DOI 10.1016/j.tips.2008.07.011; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Peyron C, 1998, J NEUROSCI, V18, P9996; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saunders C, 1999, PHARMACOL THERAPEUT, V84, P193, DOI 10.1016/S0163-7258(99)00032-7; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; TONONI G, 1994, BRAIN RES BULL, V35, P589, DOI 10.1016/0361-9230(94)90173-2; VEA V, 2004, EUR J NEURO IN PRESS; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yamanaka A, 2006, J NEUROPHYSIOL, V96, P284, DOI 10.1152/jn.01361.2005; Zeitzer JM, 2006, TRENDS PHARMACOL SCI, V27, P368, DOI 10.1016/j.tips.2006.05.006	33	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16672	10.1371/journal.pone.0016672	http://dx.doi.org/10.1371/journal.pone.0016672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347440	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600014
J	Erdman, LK; Dhabangi, A; Musoke, C; Conroy, AL; Hawkes, M; Higgins, S; Rajwans, N; Wolofsky, KT; Streiner, DL; Liles, WC; Cserti-Gazdewich, CM; Kain, KC				Erdman, Laura K.; Dhabangi, Aggrey; Musoke, Charles; Conroy, Andrea L.; Hawkes, Michael; Higgins, Sarah; Rajwans, Nimerta; Wolofsky, Kayla T.; Streiner, David L.; Liles, W. Conrad; Cserti-Gazdewich, Christine M.; Kain, Kevin C.			Combinations of Host Biomarkers Predict Mortality among Ugandan Children with Severe Malaria: A Retrospective Case-Control Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL MALARIA; NITRIC-OXIDE; NEUROLOGICAL SEQUELAE; AFRICAN CHILDREN; DISEASE SEVERITY; FACTOR-ALPHA; ANEMIA	Background: Severe malaria is a leading cause of childhood mortality in Africa. However, at presentation, it is difficult to predict which children with severe malaria are at greatest risk of death. Dysregulated host inflammatory responses and endothelial activation play central roles in severe malaria pathogenesis. We hypothesized that biomarkers of these processes would accurately predict outcome among children with severe malaria. Methodology/Findings: Plasma was obtained from children with uncomplicated malaria (n = 53), cerebral malaria (n = 44) and severe malarial anemia (n = 59) at time of presentation to hospital in Kampala, Uganda. Levels of angiopoietin-2, von Willebrand Factor (vWF), vWF propeptide, soluble P-selectin, soluble intercellular adhesion molecule-1 (ICAM-1), soluble endoglin, soluble FMS-like tyrosine kinase-1 (Flt-1), soluble Tie-2, C-reactive protein, procalcitonin, 10 kDa interferon gamma-induced protein (IP-10), and soluble triggering receptor expressed on myeloid cells-1 (TREM-1) were determined by ELISA. Receiver operating characteristic (ROC) curve analysis was used to assess predictive accuracy of individual biomarkers. Six biomarkers (angiopoietin-2, soluble ICAM-1, soluble Flt-1, procalcitonin, IP-10, soluble TREM-1) discriminated well between children who survived severe malaria infection and those who subsequently died (area under ROC curve > 0.7). Combinational approaches were applied in an attempt to improve accuracy. A biomarker score was developed based on dichotomization and summation of the six biomarkers, resulting in 95.7% (95% CI: 78.1-99.9) sensitivity and 88.8% (79.7-94.7) specificity for predicting death. Similar predictive accuracy was achieved with models comprised of 3 biomarkers. Classification tree analysis generated a 3-marker model with 100% sensitivity and 92.5% specificity (cross-validated misclassification rate: 15.4%, standard error 4.9%). Conclusions: We identified novel host biomarkers of pediatric severe and fatal malaria (soluble TREM-1 and soluble Flt-1) and generated simple biomarker combinations that accurately predicted death in an African pediatric population. While requiring validation in further studies, these results suggest the utility of combinatorial biomarker strategies as prognostic tests for severe malaria.	[Erdman, Laura K.; Conroy, Andrea L.; Hawkes, Michael; Higgins, Sarah; Rajwans, Nimerta; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, SA Rotman Labs,McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada; [Dhabangi, Aggrey; Musoke, Charles] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Wolofsky, Kayla T.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1L7, Canada; [Liles, W. Conrad; Kain, Kevin C.] Toronto Gen Hosp, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON M5G 1L7, Canada; [Cserti-Gazdewich, Christine M.] Univ Toronto, Lab Med Program Transfus Med, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Makerere University; University of Queensland; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Erdman, LK (corresponding author), Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, SA Rotman Labs,McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/AAA-8356-2020; Conroy, Andrea/ABC-5715-2020; Streiner, David/E-6563-2011; Cserti-Gazdewich, Christine/AAK-7413-2021; , Michael/AAP-3049-2020; Erdman, Laura/ABB-6936-2021	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Streiner, David/0000-0003-0610-6271; Erdman, Laura/0000-0001-8142-825X; Cserti-Gazdewich, Christine/0000-0002-5297-6406; Kain, Kevin/0000-0001-6068-1272; Hawkes, Michael/0000-0002-4122-0937	Canadian Institutes of Health Research [CIHR CTP-79842, CIHR MOP-13721]; Defense Advanced Research Projects Agency; Genome Canada through the Ontario Genomics Institute; CIHR Canada Research Chairs; International Society of Blood Transfusion (ISBT) Foundation; National Blood Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Genome Canada through the Ontario Genomics Institute(Genome Canada); CIHR Canada Research Chairs(Canada Research ChairsCanadian Institutes of Health Research (CIHR)); International Society of Blood Transfusion (ISBT) Foundation; National Blood Foundation	This study was funded in part by a Canadian Institutes of Health Research (CIHR CTP-79842) Team Grant in Malaria (KCK), CIHR MOP-13721 (KCK), a Defense Advanced Research Projects Agency grant (KCK), Genome Canada through the Ontario Genomics Institute (KCK), CIHR Canada Research Chairs (KCK, WCL), CIHR MD/PhD studentship (LKE), the International Society of Blood Transfusion (ISBT) Foundation (CMC-G), the National Blood Foundation (CMC-G), and a kind donation from Mr. Kim Kirkwood. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2009, J INFECT DIS, V199, P263, DOI 10.1086/595735; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Chimma P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000631; Chiwakata CB, 2001, J INFECT DIS, V183, P1161, DOI 10.1086/319283; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Deininger MH, 2003, J NEUROIMMUNOL, V142, P101, DOI 10.1016/S0165-5728(03)00250-9; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dietmann A, 2009, J INFECT DIS, V200, P1842, DOI 10.1086/648476; Faille D, 2009, THROMB HAEMOSTASIS, V102, P1093, DOI 10.1160/TH09-05-0337; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gomei Y, 2010, EXP HEMATOL, V38, P82, DOI 10.1016/j.exphem.2009.11.007; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Gyan B, 2002, ACTA TROP, V83, P133, DOI 10.1016/S0001-706X(02)00109-2; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; *MIN HLTH UG, 2006, NAT POL MAL TREATM; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Raj DSC, 2009, SEMIN ARTHRITIS RHEU, V38, P382, DOI 10.1016/j.semarthrit.2008.01.006; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Shapiro NI, 2008, SHOCK, V29, P452, DOI 10.1097/SHK.0b013e31815072c1; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Tchinda VHM, 2007, ACTA TROP, V102, P20, DOI 10.1016/j.actatropica.2007.02.011; Turner GDH, 1998, AM J PATHOL, V152, P1477; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vinueza CA, 2000, J REPROD MED, V45, P332; *WHO, 2009, WORLD MAL REP; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819	54	107	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17440	10.1371/journal.pone.0017440	http://dx.doi.org/10.1371/journal.pone.0017440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364762	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100062
J	Trainor, BC; Pride, MC; Landeros, RV; Knoblauch, NW; Takahashi, EY; Silva, AL; Crean, KK				Trainor, Brian C.; Pride, Michael C.; Landeros, Rosalina Villalon; Knoblauch, Nicholas W.; Takahashi, Elizabeth Y.; Silva, Andrea L.; Crean, Katie K.			Sex Differences in Social Interaction Behavior Following Social Defeat Stress in the Monogamous California Mouse (Peromyscus californicus)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CONDITIONED DEFEAT; DOPAMINE RELEASE; LIFE EVENTS; DEPRESSION; MICE; AGGRESSION; RECEPTORS; FEMALE; PHOTOPERIOD	Stressful life experiences are known to be a precipitating factor for many mental disorders. The social defeat model induces behavioral responses in rodents (e.g. reduced social interaction) that are similar to behavioral patterns associated with mood disorders. The model has contributed to the discovery of novel mechanisms regulating behavioral responses to stress, but its utility has been largely limited to males. This is disadvantageous because most mood disorders have a higher incidence in women versus men. Male and female California mice (Peromyscus californicus) aggressively defend territories, which allowed us to observe the effects of social defeat in both sexes. In two experiments, mice were exposed to three social defeat or control episodes. Mice were then behaviorally phenotyped, and indirect markers of brain activity and corticosterone responses to a novel social stimulus were assessed. Sex differences in behavioral responses to social stress were long lasting (4 wks). Social defeat reduced social interaction responses in females but not males. In females, social defeat induced an increase in the number of phosphorylated CREB positive cells in the nucleus accumbens shell after exposure to a novel social stimulus. This effect of defeat was not observed in males. The effects of defeat in females were limited to social contexts, as there were no differences in exploratory behavior in the open field or light-dark box test. These data suggest that California mice could be a useful model for studying sex differences in behavioral responses to stress, particularly in neurobiological mechanisms that are involved with the regulation of social behavior.	[Trainor, Brian C.; Pride, Michael C.; Landeros, Rosalina Villalon; Knoblauch, Nicholas W.; Takahashi, Elizabeth Y.; Silva, Andrea L.; Crean, Katie K.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis	Trainor, BC (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	bctrainor@ucdavis.edu	Trainor, Brian C./L-3618-2016	Trainor, Brian C./0000-0002-4627-5478; Villalon Landeros, Rosalina/0000-0001-5022-5935; Knoblauch, Nicholas/0000-0002-2890-6520	National Institutes of Health [R21 MH090392]; UC Davis; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant R21 MH090392 and a UC Davis Academic Senate Grant to BCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Cooper MA, 2005, BEHAV NEUROSCI, V119, P1042, DOI 10.1037/0735-7044.119.4.1042; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; Davis ES, 2003, HORM BEHAV, V44, P185, DOI 10.1016/S0018-506X(03)00128-4; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Dudman JT, 2003, J NEUROCHEM, V87, P922, DOI 10.1046/j.1471-4159.2003.02067.x; Ferris MJ, 2007, INT J DEV NEUROSCI, V25, P445, DOI 10.1016/j.ijdevneu.2007.08.009; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Fuxjager MJ, 2009, HORM BEHAV, V56, P214, DOI 10.1016/j.yhbeh.2009.04.009; Glasper ER, 2005, BRAIN BEHAV IMMUN, V19, P61, DOI 10.1016/j.bbi.2004.03.002; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Huhman KL, 2003, HORM BEHAV, V44, P293, DOI 10.1016/j.yhbeh.2003.05.001; Huhman KL, 2005, BIOL AGGRESSION, P295; Jasnow AM, 2004, BEHAV NEUROSCI, V118, P1052, DOI 10.1037/0735-7044.118.5.1052; Jasnow AM, 2001, BRAIN RES, V920, P142, DOI 10.1016/S0006-8993(01)03054-2; KAHN MW, 1961, J GENET PSYCHOL, V98, P211, DOI 10.1080/00221325.1961.10534371; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kercmar J, 2011, BEHAV BRAIN RES, V216, P647, DOI 10.1016/j.bbr.2010.09.007; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kudryavtseva NN, 2002, BEHAV BRAIN RES, V133, P83, DOI 10.1016/S0166-4328(01)00443-0; KUDRYAVTSEVA NN, 1991, PHARMACOL BIOCHEM BE, V38, P315, DOI 10.1016/0091-3057(91)90284-9; Lim MM, 2005, J COMP NEUROL, V487, P75, DOI 10.1002/cne.20532; Markham CM, 2008, LEARN MEMORY, V15, P6, DOI 10.1101/lm.768208; Meerlo, 1996, Stress, V1, P21; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nazarian A, 2009, PSYCHOPHARMACOLOGY, V203, P641, DOI 10.1007/s00213-008-1411-5; NELSON RJ, 1995, PHYSIOL BEHAV, V57, P1175, DOI 10.1016/0031-9384(94)00380-N; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Overli O, 2004, HORM BEHAV, V45, P324, DOI 10.1016/j.yhbeh.2004.01.001; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; POTEGAL M, 1993, BEHAV NEURAL BIOL, V60, P93, DOI 10.1016/0163-1047(93)90159-F; Prendergast BJ, 2001, Q REV BIOL, V76, P293, DOI 10.1086/393989; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; SACHAR EJ, 1973, ARCH GEN PSYCHIAT, V28, P19; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schneier FR, 2000, AM J PSYCHIAT, V157, P457, DOI 10.1176/appi.ajp.157.3.457; Schneier FR, 2009, DEPRESS ANXIETY, V26, P411, DOI 10.1002/da.20543; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silva AL, 2010, BEHAV BRAIN RES, V208, P528, DOI 10.1016/j.bbr.2009.12.038; STEINMAN MQ, 2011, EUR J NEURO IN PRESS; Szego EM, 2006, J NEUROSCI, V26, P4104, DOI 10.1523/JNEUROSCI.0222-06.2006; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tiihonen J, 1997, AM J PSYCHIAT, V154, P239; Trainor BC, 2010, NEUROSCIENCE, V165, P325, DOI 10.1016/j.neuroscience.2009.10.050; Trainor BC, 2004, HORM BEHAV, V45, P115, DOI 10.1016/j.yhbeh.2003.09.006; Trainor BC, 2008, HORM BEHAV, V53, P192, DOI 10.1016/j.yhbeh.2007.09.016; Trainor BC, 2006, GEN COMP ENDOCR, V148, P252, DOI 10.1016/j.ygcen.2006.03.006; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; van Kampen Marja, 2002, Stress, V5, P37; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3	76	104	104	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17405	10.1371/journal.pone.0017405	http://dx.doi.org/10.1371/journal.pone.0017405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364768	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100055
J	Cattaneo, M; Lotti, LV; Martino, S; Alessio, M; Conti, A; Bachi, A; Mariani-Costantini, R; Biunno, I				Cattaneo, Monica; Lotti, Lavinia Vittoria; Martino, Simone; Alessio, Massimo; Conti, Antonio; Bachi, Angela; Mariani-Costantini, Renato; Biunno, Ida			Secretion of Novel SEL1L Endogenous Variants Is Promoted by ER Stress/UPR via Endosomes and Shed Vesicles in Human Cancer Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; UBIQUITIN-PROTEASOME PATHWAY; DISULFIDE BOND FORMATION; QUALITY-CONTROL; IN-VITRO; HELICOBACTER-PYLORI; MISFOLDED PROTEINS; MASS-SPECTROMETRY; TUMOR PROGRESSION	We describe here two novel endogenous variants of the human endoplasmic reticulum (ER) cargo receptor SEL1LA, designated p38 and p28. Biochemical and RNA interference studies in tumorigenic and non-tumorigenic cells indicate that p38 and p28 are N-terminal, ER-anchorless and more stable relative to the canonical transmembrane SEL1LA. P38 is expressed and constitutively secreted, with increase after ER stress, in the KMS11 myeloma line and in the breast cancer lines MCF7 and SKBr3, but not in the non-tumorigenic breast epithelial MCF10A line. P28 is detected only in the poorly differentiated SKBr3 cell line, where it is secreted after ER stress. Consistently with the presence of p38 and p28 in culture media, morphological studies of SKBr3 and KMS11 cells detect N-terminal SEL1L immunolabeling in secretory/degradative compartments and extracellularly-released membrane vesicles. Our findings suggest that the two new SEL1L variants are engaged in endosomal trafficking and secretion via vesicles, which could contribute to relieve ER stress in tumorigenic cells. P38 and p28 could therefore be relevant as diagnostic markers and/or therapeutic targets in cancer.	[Cattaneo, Monica; Biunno, Ida] CNR, Inst Biomed Technol, Milan, Italy; [Lotti, Lavinia Vittoria; Martino, Simone] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; [Alessio, Massimo; Conti, Antonio; Bachi, Angela] Ist Sci San Raffaele, I-20132 Milan, Italy; [Mariani-Costantini, Renato] Univ G DAnnunzio, Dept Oncol & Expt Med, Chieti, Italy; [Mariani-Costantini, Renato] Univ G dAnnunzio, Aging Res Ctr CeSI, Chieti, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Cattaneo, M (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ida.biunno@itb.cnr.it	Mariani-Costantini, Renato/B-6637-2012; Conti, Antonio/AAN-7161-2020; Alessio, Massimo/L-4518-2019; bachi, angela/B-3527-2015; Alessio, Massimo/K-7028-2014	Mariani-Costantini, Renato/0000-0002-4440-1848; Conti, Antonio/0000-0001-9150-5271; bachi, angela/0000-0003-4842-6556; /0000-0002-1866-5866; , IDA_2/0000-0002-1068-4763; Alessio, Massimo/0000-0002-4133-3472	Ministero Universita e Ricerca (MIUR) [MIUR-FIRB nRBIP064CRT]; MAPLOMBARDIA [7/193]; MIUR from the University La Sapienza; G. d'Annunzio University; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Ministero Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); MAPLOMBARDIA; MIUR from the University La Sapienza; G. d'Annunzio University; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from MIUR-FIRB nRBIP064CRT Ministero Universita e Ricerca (MIUR), and MAPLOMBARDIA, Grant 7/193 ar 3 to IB, MIUR 60% grants from the University La Sapienza to LVL, MIUR 60% grants 2008-2010 from G. d'Annunzio University to RMC, and by a 2009 grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to RMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Barberis MCP, 2006, HISTOPATHOLOGY, V48, P614, DOI 10.1111/j.1365-2559.2005.02274.x; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Boutros R, 2003, J MOL BIOL, V332, P675, DOI 10.1016/S0022-2836(03)00944-6; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BYRNE JA, 1995, CANCER RES, V55, P2896; Byrne JA, 1996, GENOMICS, V35, P523, DOI 10.1006/geno.1996.0393; Cattaneo M, 2003, ONCOGENE, V22, P6359, DOI 10.1038/sj.onc.1206665; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cattaneo M, 2009, J BIOL CHEM, V284, P11405, DOI 10.1074/jbc.M805408200; Chan P, 2006, PROTEOMICS, V6, P3494, DOI 10.1002/pmic.200500534; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chignard N, 2006, GASTROENTEROLOGY, V130, P2010, DOI 10.1053/j.gastro.2006.02.058; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dees E Claire, 2006, Future Oncol, V2, P121, DOI 10.2217/14796694.2.1.121; Deml L, 2005, INFECT IMMUN, V73, P4732, DOI 10.1128/IAI.73.8.4732-4742.2005; Deng XT, 2007, CANCER INFORM, V3, P183; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Ferrero S, 2006, HUM PATHOL, V37, P505, DOI 10.1016/j.humpath.2005.12.012; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Granelli P, 2004, CLIN CANCER RES, V10, P5857, DOI 10.1158/1078-0432.CCR-04-0075; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lewis JD, 2007, MOL CANCER RES, V5, P133, DOI 10.1158/1541-7786.MCR-06-0245; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Orlandi R, 2002, CANCER RES, V62, P567; Orlandi R, 2002, INT J BIOL MARKER, V17, P104, DOI 10.1177/172460080201700205; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Proux-Gillardeaux V, 2003, BIOCHEM J, V370, P213, DOI 10.1042/BJ20021309; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott Melissa D, 2003, Methods Mol Biol, V232, P67; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SOULE HD, 1990, CANCER RES, V50, P6075; Spiess C, 1997, J BIOL CHEM, V272, P22125, DOI 10.1074/jbc.272.35.22125; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Thomas DDH, 2010, AM J PHYSIOL-CELL PH, V298, pC725, DOI 10.1152/ajpcell.00455.2009; Tiacci E, 2005, BLOOD, V105, P2812, DOI 10.1182/blood-2004-07-2630; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wilson SHD, 2001, GENOMICS, V76, P81, DOI 10.1006/geno.2001.6610; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	83	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17206	10.1371/journal.pone.0017206	http://dx.doi.org/10.1371/journal.pone.0017206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359144	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482300039
J	Egger, M; Jurets, A; Wallner, M; Briza, P; Ruzek, S; Hainzl, S; Pichler, U; Kitzmuller, C; Bohle, B; Huber, CG; Ferreira, F				Egger, Matthias; Juerets, Alexander; Wallner, Michael; Briza, Peter; Ruzek, Silke; Hainzl, Stefan; Pichler, Ulrike; Kitzmueller, Claudia; Bohle, Barbara; Huber, Christian G.; Ferreira, Fatima			Assessing Protein Immunogenicity with a Dendritic Cell Line-Derived Endolysosomal Degradome	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; ANTIGEN PRESENTATION; LYSOSOMAL PROTEOLYSIS; IMMUNE-RESPONSE; IN-VIVO; IMMUNOTHERAPY; PROTEASES; EPITOPES; VACCINES; ISOFORMS	Background: The growing number of novel candidate molecules for the treatment of allergic diseases imposed a dramatic increase in the demand for animal experiments to select immunogenic vaccines, a pre-requisite for efficacy. Because no in vitro methods to predict the immunogenicity of a protein are currently available, we developed an in vitro assay that exploits the link between a protein's immunogenicity and its susceptibility to endolysosomal proteolysis. Methodology: We compared protein composition and proteolytic activity of endolysosomal fractions isolated from murine bone marrow-and human blood-derived dendritic cells, and from the dendritic cell line JAWS II. Three groups of structurally related antigen variants differing in their ability to elicit immune responses in vivo (Bet v 1.0101 and Bet v 1.0401, RNases A and S, holo-and apo-HRP) were subjected to in vitro simulated endolysosomal degradation. Kinetics and patterns of generated proteolytic peptides were evaluated by gel electrophoresis and mass spectrometry. Results: Antigens displaying weak capacity of T cell priming in vivo were highly susceptible to endolysosomal proteases in vitro. As proteolytic composition, activity, and specificity of endolysosomal fractions derived from human and murine dendritic cells were comparable, the JAWS II cell line could be used as a substitute for freshly isolated human or murine cells in in vitro degradation assays. Conclusions: Endolysosomal fractions prepared from the JAWS II cell line provide a reliable tool for in vitro estimation of protein immunogenicity. The rapid and simple assay described here is very useful to study the immunogenic properties of a protein, and can help to replace, reduce, and refine animal experiments in allergy research and vaccine development in general.	[Egger, Matthias; Wallner, Michael; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, Dept Mol Biol, A-5020 Salzburg, Austria; [Juerets, Alexander; Briza, Peter; Pichler, Ulrike] Salzburg Univ, Dept Mol Biol, Div Allergy & Immunol, A-5020 Salzburg, Austria; [Ruzek, Silke; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria; [Hainzl, Stefan] Paracelsus Private Med Univ Salzburg, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Kitzmueller, Claudia; Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Dept Pathophysiol & Allergy Res, Vienna, Austria	Salzburg University; Salzburg University; Salzburg University; Paracelsus Private Medical University; Medical University of Vienna	Egger, M (corresponding author), Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, Dept Mol Biol, A-5020 Salzburg, Austria.	matthias.egger@sbg.ac.at	Jürets, Alexander/K-3469-2019; Briza, Peter/D-7309-2012; Wallner, Michael/L-5437-2015; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Huber, Christian G./E-5445-2011	Briza, Peter/0000-0002-4941-6782; Wallner, Michael/0000-0001-6568-7892; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Huber, Christian G./0000-0001-8358-1880; Egger, Matthias/0000-0001-7462-5132; Kitzmuller, Claudia/0000-0002-3829-8020; Bohle, Barbara/0000-0002-5105-7985	Christian-Doppler Research Association (CDG); Austrian Science Funds, FWF [L688]; Biomay AG; Land Salzburg; Austrian Science Fund (FWF) [L 688] Funding Source: researchfish	Christian-Doppler Research Association (CDG); Austrian Science Funds, FWF(Austrian Science Fund (FWF)); Biomay AG; Land Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: This work was supported by the Christian-Doppler Research Association (CDG; www.cdg.ac.at), the Austrian Science Funds (www.fwf.ac.at; FWF Project L688), Biomay AG (www.biomay.com), and Land Salzburg (www.salzburg.gv.at). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratin M, 2002, J PEPT SCI, V8, P327, DOI 10.1002/psc.391; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014; Carra JH, 2003, CLIN IMMUNOL, V108, P60, DOI 10.1016/S1521-6616(03)00058-5; Colbert JD, 2009, EUR J IMMUNOL, V39, P2955, DOI 10.1002/eji.200939650; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; EGGER M, 2009, FRONT BIOSCI, P77; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; FERREIRA FD, 1993, J BIOL CHEM, V268, P19574; Gonzalez PA, 2005, P NATL ACAD SCI USA, V102, P4824, DOI 10.1073/pnas.0500922102; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Linhart B, 2002, FASEB J, V16, P1301, DOI 10.1096/fj.01-1012fje; Lippolis JD, 2002, J IMMUNOL, V169, P5089, DOI 10.4049/jimmunol.169.9.5089; Lutzner N, 2008, J BIOL CHEM, V283, P36185, DOI 10.1074/jbc.M806500200; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; Mutschlechner S, 2009, CLIN EXP ALLERGY, V39, P1635, DOI 10.1111/j.1365-2222.2009.03317.x; Mutschlechner S, 2010, J ALLERGY CLIN IMMUN, V125, P711, DOI 10.1016/j.jaci.2009.10.052; PAUL WE, NAT REV IMMUNOL, V10, P225; Rolland JM, 2009, PHARMACOL THERAPEUT, V121, P273, DOI 10.1016/j.pharmthera.2008.11.007; Saarelainen S, 2002, INT IMMUNOL, V14, P401, DOI 10.1093/intimm/14.4.401; Scheiblhofer S, 2007, MOL IMMUNOL, V44, P1879, DOI 10.1016/j.molimm.2006.09.023; SLUTTER B, J CONTROL RELEASE, V143, P207; SMOLE U, 2010, IMMUNOBIOLOGY; Tan HY, 2007, BIOTECHNIQUES, V42, P474, DOI 10.2144/000112402; Thalhamer T, 2010, J ALLERGY CLIN IMMUN, V125, P926, DOI 10.1016/j.jaci.2010.01.031; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; VIDARD L, 1992, J IMMUNOL, V149, P498; Wagner S, 2008, J ALLERGY CLIN IMMUN, V121, P246, DOI 10.1016/j.jaci.2007.08.006; Wallner M, 2007, CURR OPIN MOL THER, V9, P160; Wallner M, 2007, J ALLERGY CLIN IMMUN, V120, P374, DOI 10.1016/j.jaci.2007.05.021; Wallner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008457; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	37	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17278	10.1371/journal.pone.0017278	http://dx.doi.org/10.1371/journal.pone.0017278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359181	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700066
J	Hosoda, K; Suzuki, S; Yamauchi, Y; Shiroguchi, Y; Kashiwagi, A; Ono, N; Mori, K; Yomo, T				Hosoda, Kazufumi; Suzuki, Shingo; Yamauchi, Yoshinori; Shiroguchi, Yasunori; Kashiwagi, Akiko; Ono, Naoaki; Mori, Kotaro; Yomo, Tetsuya			Cooperative Adaptation to Establishment of a Synthetic Bacterial Mutualism	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; PHENOTYPIC PLASTICITY; INITIAL-STAGE; EVOLUTION; CONFLICT; COMPETITION; GENES	To understand how two organisms that have not previously been in contact can establish mutualism, it is first necessary to examine temporal changes in their phenotypes during the establishment of mutualism. Instead of tracing back the history of known, well-established, natural mutualisms, we experimentally simulated the development of mutualism using two genetically-engineered auxotrophic strains of Escherichia coli, which mimic two organisms that have never met before but later establish mutualism. In the development of this synthetic mutualism, one strain, approximately 10 hours after meeting the partner strain, started oversupplying a metabolite essential for the partner's growth, eventually leading to the successive growth of both strains. This cooperative phenotype adaptively appeared only after encountering the partner strain but before the growth of the strain itself. By transcriptome analysis, we found that the cooperative phenotype of the strain was not accompanied by the local activation of the biosynthesis and transport of the oversupplied metabolite but rather by the global activation of anabolic metabolism. This study demonstrates that an organism has the potential to adapt its phenotype after the first encounter with another organism to establish mutualism before its extinction. As diverse organisms inevitably encounter each other in nature, this potential would play an important role in the establishment of a nascent mutualism in nature.	[Hosoda, Kazufumi; Suzuki, Shingo; Shiroguchi, Yasunori; Ono, Naoaki; Yomo, Tetsuya] Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan; [Yamauchi, Yoshinori; Mori, Kotaro] Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka, Japan; [Kashiwagi, Akiko] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Suita, Osaka, Japan	Osaka University; Osaka University; Hirosaki University; Japan Science & Technology Agency (JST)	Hosoda, K (corresponding author), Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Shingo/O-3651-2014	Suzuki, Shingo/0000-0003-1332-3194; ONO, Naoaki/0000-0002-7722-055X	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by both the "Global Centers of Excellence Program" and the "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" of the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bar-Yam Y, 2009, SCIENCE, V323, P1016, DOI 10.1126/science.1163225; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Begon M., 1996, ECOLOGY; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; BUCHSBAUM RALPH, 1934, SCIENCE, V80, P408, DOI 10.1126/science.80.2079.408; Cashel M., 1996, E COLI SALMONELLA CE, V2; Chuang JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.57; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong G, 2003, NATURE, V424, P16, DOI 10.1038/424016b; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Hosoda K, 2008, P BIONETICS 2008 ICS, P1; Hu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010619; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; Kashiwagi A, 2009, METAB ENG, V11, P56, DOI 10.1016/j.ymben.2008.08.002; Katsuyama C, 2009, J THEOR BIOL, V256, P644, DOI 10.1016/j.jtbi.2008.10.024; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; May R., 2007, THEORETICAL ECOLOGY, V3rd; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Reaka-Kudla M. L., 1997, BIODIVERSITY; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Ross-Gillespie A, 2009, EVOLUTION, V63, P2315, DOI 10.1111/j.1558-5646.2009.00723.x; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Shimada M, 2010, POPUL ECOL, V52, P5, DOI 10.1007/s10144-009-0187-8; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Song H, 2009, NAT CHEM BIOL, V5, P929, DOI 10.1038/nchembio.244; Suzuki Takao, 2006, Biophysics (Nagoya-shi), V2, P63, DOI 10.2142/biophysics.2.63; Todoriki M, 2002, BIOSYSTEMS, V65, P105, DOI 10.1016/S0303-2647(02)00006-0; TSUCHIYA HM, 1972, J BACTERIOL, V110, P1147, DOI 10.1128/JB.110.3.1147-1153.1972; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; WADDINGTON CH, 1952, NATURE, V169, P278, DOI 10.1038/169278a0; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West-Eberhard Mary Jane, 2003, pi; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yamada A, 2008, BIOSYSTEMS, V92, P1, DOI 10.1016/j.biosystems.2007.10.004	61	54	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17105	10.1371/journal.pone.0017105	http://dx.doi.org/10.1371/journal.pone.0017105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359225	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700049
J	Ricci, G; Astolfi, A; Remondini, D; Cipriani, F; Formica, S; Dondi, A; Pession, A				Ricci, Giampaolo; Astolfi, Annalisa; Remondini, Daniel; Cipriani, Francesca; Formica, Serena; Dondi, Arianna; Pession, Andrea			Pooled Genome-Wide Analysis to Identify Novel Risk Loci for Pediatric Allergic Asthma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SUSCEPTIBILITY GENES; SMOOTH-MUSCLE; ASSOCIATION; RECEPTORS; DNA; IDENTIFICATION; ANAPHYLATOXIN; MACROPHAGES; ABILITY	Background: Genome-wide association studies of pooled DNA samples were shown to be a valuable tool to identify candidate SNPs associated to a phenotype. No such study was up to now applied to childhood allergic asthma, even if the very high complexity of asthma genetics is an appropriate field to explore the potential of pooled GWAS approach. Methodology/Principal Findings: We performed a pooled GWAS and individual genotyping in 269 children with allergic respiratory diseases comparing allergic children with and without asthma. We used a modular approach to identify the most significant loci associated with asthma by combining silhouette statistics and physical distance method with cluster-adapted thresholding. We found 97% concordance between pooled GWAS and individual genotyping, with 36 out of 37 top-scoring SNPs significant at individual genotyping level. The most significant SNP is located inside the coding sequence of C5, an already identified asthma susceptibility gene, while the other loci regulate functions that are relevant to bronchial physiopathology, as immune-or inflammation-mediated mechanisms and airway smooth muscle contraction. Integration with gene expression data showed that almost half of the putative susceptibility genes are differentially expressed in experimental asthma mouse models. Conclusion/Significance: Combined silhouette statistics and cluster-adapted physical distance threshold analysis of pooled GWAS data is an efficient method to identify candidate SNP associated to asthma development in an allergic pediatric population.	[Ricci, Giampaolo; Cipriani, Francesca; Formica, Serena; Dondi, Arianna; Pession, Andrea] Univ Bologna, Pediat Unit, Dept Gynecol Obstet & Pediat Sci, Bologna, Italy; [Astolfi, Annalisa; Formica, Serena; Pession, Andrea] Univ Bologna, Interdept Ctr Canc Res G Prodi, Bologna, Italy; [Remondini, Daniel] Univ Bologna, Dept Phys, I-40126 Bologna, Italy; [Remondini, Daniel] Univ Bologna, Interdept Ctr L Galvani, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; University of Bologna	Ricci, G (corresponding author), Univ Bologna, Pediat Unit, Dept Gynecol Obstet & Pediat Sci, Bologna, Italy.	giampaolo.ricci@unibo.it	Astolfi, Annalisa/K-3034-2016; Remondini, Daniel/ABA-9971-2020; Pession, Andrea/O-3200-2013; Dondi, Arianna/E-4269-2012	Astolfi, Annalisa/0000-0002-2732-0747; Pession, Andrea/0000-0002-0379-9562; Dondi, Arianna/0000-0002-7516-243X; Remondini, Daniel/0000-0003-3185-7456	Fondazione del Monte di Bologna e Ravenna; Vanini-Cavagnino; University of Bologna; UniBO Strategic grant	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Vanini-Cavagnino; University of Bologna; UniBO Strategic grant	This study was supported by the "Fondazione del Monte di Bologna e Ravenna." S.F. is supported by the "Vanini-Cavagnino" grant, F.C. is supported by a grant from the University of Bologna, D. R. is supported by the UniBO Strategic grant "p53 and Non-Neoplastic Pathologies." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Antonicelli L, 2007, CLIN EXP ALLERGY, V37, P954, DOI 10.1111/j.1365-2222.2007.02729.x; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; Bosse Y, 2009, HUM GENET, V125, P305, DOI 10.1007/s00439-009-0626-9; Bostrom MA, 2010, HUM GENET, V128, P195, DOI 10.1007/s00439-010-0842-3; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Butcher LM, 2004, BEHAV GENET, V34, P549, DOI 10.1023/B:BEGE.0000038493.26202.d3; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Comabella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003490; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Docherty SJ, 2010, GENES BRAIN BEHAV, V9, P234, DOI 10.1111/j.1601-183X.2009.00553.x; Docherty SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-214; Drineas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011892; Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502905200; Fietta AM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2067; Gorlov IP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006511; Harris J, 2006, INT J EXP PATHOL, V87, P29, DOI 10.1111/j.0959-9673.2006.00450.x; Hasegawa K, 2004, HUM GENET, V115, P295, DOI 10.1007/s00439-004-1157-z; Hosur V, 2009, J NEUROCHEM, V111, P848, DOI 10.1111/j.1471-4159.2009.06373.x; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Lachance C, 2007, FEMS IMMUNOL MED MIC, V51, P422, DOI 10.1111/j.1574-695X.2007.00317.x; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lambrecht BN, 2006, J CLIN INVEST, V116, P628, DOI 10.1172/JCI27876; Lovmar L, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-35; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Medina I, 2009, NUCLEIC ACIDS RES, V37, pW340, DOI 10.1093/nar/gkp481; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Mullershausen F, 2006, MOL PHARMACOL, V69, P1969, DOI 10.1124/mol.105.020909; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1889, DOI 10.1111/j.1365-2222.2009.03366.x; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sebastiani P, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-6; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Sestini Piersante, 2005, Epidemiol Prev, V29, P24; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Viding E, 2010, J CHILD PSYCHOL PSYC, V51, P780, DOI 10.1111/j.1469-7610.2010.02236.x; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Weiss ST, 2009, CURR OPIN GENET DEV, V19, P279, DOI 10.1016/j.gde.2009.05.001; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	48	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16912	10.1371/journal.pone.0016912	http://dx.doi.org/10.1371/journal.pone.0016912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359210	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700030
J	Mukherjee, S; Machado, FS; Huang, HA; Oz, HS; Jelicks, LA; Prado, CM; Koba, W; Fine, EJ; Zhao, DZ; Factor, SM; Collado, JE; Weiss, LM; Tanowitz, HB; Ashton, AW				Mukherjee, Shankar; Machado, Fabiana S.; Huang, Huang; Oz, Helieh S.; Jelicks, Linda A.; Prado, Cibele M.; Koba, Wade; Fine, Eugene J.; Zhao, Dazhi; Factor, Stephen M.; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.; Ashton, Anthony W.			Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NITRIC-OXIDE SYNTHASE; HEART-DISEASE; INDUCIBLE CYCLOOXYGENASE; LYMPHOCYTE-PROLIFERATION; PGE(2) INVOLVEMENT; ACUTE-PHASE; BRUCEI; MICROCIRCULATION; ENDOTHELIN-1	Chagas disease, caused by infection with Trypanosoma cruzi, is an important cause of cardiovascular disease. It is increasingly clear that parasite-derived prostaglandins potently modulate host response and disease progression. Here, we report that treatment of experimental T. cruzi infection (Brazil strain) beginning 5 days post infection (dpi) with aspirin (ASA) increased mortality (2-fold) and parasitemia (12-fold). However, there were no differences regarding histopathology or cardiac structure or function. Delayed treatment with ASA (20 mg/kg) beginning 60 dpi did not increase parasitemia or mortality but improved ejection fraction. ASA treatment diminished the profile of parasite-and host-derived circulating prostaglandins in infected mice. To distinguish the effects of ASA on the parasite and host bio-synthetic pathways we infected cyclooxygenase-1 (COX-1) null mice with the Brazil-strain of T. cruzi. Infected COX-1 null mice displayed a reduction in circulating levels of thromboxane (TX)A(2) and prostaglandin (PG)F-2 alpha. Parasitemia was increased in COX-1 null mice compared with parasitemia and mortality in ASA-treated infected mice indicating the effects of ASA on mortality potentially had little to do with inhibition of prostaglandin metabolism. Expression of SOCS-2 was enhanced, and TRAF6 and TNF alpha reduced, in the spleens of infected ASA-treated mice. Ablation of the initial innate response to infection may cause the increased mortality in ASA-treated mice as the host likely succumbs more quickly without the initiation of the "cytokine storm'' during acute infection. We conclude that ASA, through both COX inhibition and other "off-target'' effects, modulates the progression of acute and chronic Chagas disease. Thus, eicosanoids present during acute infection may act as immunomodulators aiding the transition to and maintenance of the chronic phase of the disease. A deeper understanding of the mechanism of ASA action may provide clues to the differences between host response in the acute and chronic T. cruzi infection.	[Mukherjee, Shankar; Huang, Huang; Prado, Cibele M.; Zhao, Dazhi; Factor, Stephen M.; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.; Ashton, Anthony W.] Albert Einstein Coll Med, Dept Pathol, Div Parasitol, New York, NY USA; [Machado, Fabiana S.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Oz, Helieh S.] Univ Kentucky, Med Ctr, Ctr Oral Hlth Res, Lexington, KY USA; [Jelicks, Linda A.; Koba, Wade; Fine, Eugene J.] Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA; [Jelicks, Linda A.; Koba, Wade; Fine, Eugene J.] Albert Einstein Coll Med, M Donald Blaufox Lab Mol Imaging Physiol & Biophy, New York, NY USA; [Prado, Cibele M.; Zhao, Dazhi; Collado, J. Elias; Weiss, Louis M.; Tanowitz, Herbert B.] Albert Einstein Coll Med, Dept Med, Div Infect Dis, New York, NY USA; [Prado, Cibele M.] Univ Sao Paulo, Dept Pathol, BR-14049 Ribeirao Preto, Brazil; [Ashton, Anthony W.] Univ Sydney, Kolling Inst Med Res, Div Perinatal Res, Sydney, NSW 2006, Australia	Yeshiva University; Universidade Federal de Minas Gerais; University of Kentucky; Yeshiva University; Yeshiva University; Yeshiva University; Universidade de Sao Paulo; University of Sydney; Kolling Institute of Medical Research	Mukherjee, S (corresponding author), Albert Einstein Coll Med, Dept Pathol, Div Parasitol, New York, NY USA.	herbert.tanowitz@einstein.yu.edu	Jelicks, Linda/L-9740-2019; Prado, Cibele M/P-5773-2016; Oliveira, Claudia DL/G-8618-2011	Jelicks, Linda/0000-0002-6438-1792; Prado, Cibele M/0000-0003-4321-0879; Simao Machado, Fabiana/0000-0001-9272-5209	United States National Institutes of Health [AI-76248]; National Health and Medical Research Council of Australia [512154, 402847]; American Heart Association [0735252N]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [576200/2008-5, 473670/2008-9]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [14916]; Fogarty International [D43TW007129]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076248] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States National Institutes of Health (HBT [AI-76248]) and the National Health and Medical Research Council of Australia (AWA [512154]). The work was also supported by a Career Development Award from the American Heart Association (SM [0735252N]), the National Health and Medical Research Council of Australia (AWA [402847]), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (FSM [576200/2008-5, 473670/2008-9]), and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (FSM [14916]). CMP was supported by a Fogarty International Training Grant (HBT [D43TW007129]). The funding bodies indicated had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla GK, 2008, EXP PARASITOL, V118, P514, DOI 10.1016/j.exppara.2007.11.003; Ashton AW, 2007, J EXP MED, V204, P929, DOI 10.1084/jem.20062432; Cardoni RL, 2004, MEDIAT INFLAMM, V13, P235, DOI 10.1080/09637480400003022; CELENTANO AM, 1995, PROSTAGLANDINS, V49, P141, DOI 10.1016/0090-6980(95)00002-R; Chandra M, 2002, INT J PARASITOL, V32, P207, DOI 10.1016/S0020-7519(01)00320-4; FACTOR SM, 1985, AM J TROP MED HYG, V34, P246, DOI 10.4269/ajtmh.1985.34.246; FIEDLER VB, 1988, PHARMACOTHERAPY, V8, P158; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Huang H, 1997, CARDIOVASC PATHOL, V6, P161, DOI 10.1016/S1054-8807(96)00094-4; Huang H, 1999, J MOL CELL CARDIOL, V31, P75, DOI 10.1006/jmcc.1998.0848; Hyland KV, 2006, TRENDS PARASITOL, V22, P101, DOI 10.1016/j.pt.2006.01.001; Jelicks LA, 1999, AM J TROP MED HYG, V61, P207, DOI 10.4269/ajtmh.1999.61.207; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kabututu Z, 2003, INT J PARASITOL, V33, P219, DOI 10.1016/S0020-7519(02)00253-9; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Machado FS, 2009, ADV EXP MED BIOL, V666, P78; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Michelin MA, 2005, EXP PARASITOL, V111, P71, DOI 10.1016/j.exppara.2005.05.001; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; OPPERDOES FR, 1982, MOL BIOCHEM PARASIT, V5, P309, DOI 10.1016/0166-6851(82)90038-X; Paiva CN, 2007, EUR J IMMUNOL, V37, P1355, DOI 10.1002/eji.200636705; Parente L, 2003, BIOCHEM PHARMACOL, V65, P153, DOI 10.1016/S0006-2952(02)01422-3; Petkova SB, 2001, INT J PARASITOL, V31, P499, DOI 10.1016/S0020-7519(01)00168-0; Petkova SB, 2000, CARDIOVASC PATHOL, V9, P257, DOI 10.1016/S1054-8807(00)00045-4; Pinge P, 1999, CELL IMMUNOL, V193, P90, DOI 10.1006/cimm.1999.1463; Prado CM, 2009, AM J TROP MED HYG, V81, P900, DOI 10.4269/ajtmh.2009.09-0338; Ramakrishnan R, 2001, INT IMMUNOPHARMACOL, V1, P2035, DOI 10.1016/S1567-5769(01)00132-1; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; SAGE L, 1981, TROPENMED PARASITOL, V32, P215; Santovito D, 2009, CURR OPIN LIPIDOL, V20, P402, DOI 10.1097/MOL.0b013e32832fa22c; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smith WL, 1997, THROMB HAEMOSTASIS, V78, P627; Smith WL, 1997, ADV EXP MED BIOL, V400, P189; SterinBorda L, 1996, CLIN IMMUNOL IMMUNOP, V81, P122, DOI 10.1006/clin.1996.0167; TANOWITZ HB, 1992, CLIN MICROBIOL REV, V5, P400, DOI 10.1128/CMR.5.4.400-419.1992; Tanowitz HB, 2005, INFECT IMMUN, V73, P2496, DOI 10.1128/IAI.73.4.2496-2503.2005; Tanowitz HB, 1996, J PARASITOL, V82, P124, DOI 10.2307/3284127; TANOWITZ HB, 1990, AM J TROP MED HYG, V43, P274, DOI 10.4269/ajtmh.1990.43.274; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Tatakihara VLH, 2008, FEMS IMMUNOL MED MIC, V52, P47, DOI 10.1111/j.1574-695X.2007.00340.x; Zordoky BNM, 2008, CURR DRUG METAB, V9, P122	46	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16959	10.1371/journal.pone.0016959	http://dx.doi.org/10.1371/journal.pone.0016959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347238	Green Published, gold			2022-12-27	WOS:000287369200012
J	Peden, MC; Min, J; Meyers, C; Lukowski, Z; Li, QH; Boye, SL; Levine, M; Hauswirth, WW; Ratnakaram, R; Dawson, W; Smith, WC; Sherwood, MB				Peden, Marc C.; Min, Jeff; Meyers, Craig; Lukowski, Zachary; Li, Qiuhong; Boye, Sanford L.; Levine, Monica; Hauswirth, William W.; Ratnakaram, Ramakrishna; Dawson, William; Smith, Wesley C.; Sherwood, Mark B.			Ab-Externo AAV-Mediated Gene Delivery to the Suprachoroidal Space Using a 250 Micron Flexible Microcatheter	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; THERAPY	Background: The current method of delivering gene replacement to the posterior segment of the eye involves a three-port pars plana vitrectomy followed by injection of the agent through a 37-gauge cannula, which is potentially wrought with retinal complications. In this paper we investigate the safety and efficacy of delivering adeno-associated viral (AAV) vector to the suprachoroidal space using an ab externo approach that utilizes an illuminated microcatheter. Methods: 6 New Zealand White rabbits and 2 Dutch Belted rabbits were used to evaluate the ab externo delivery method. sc-AAV5-smCBA-hGFP vector was delivered into the suprachoroidal space using an illuminated iTrackTM 250A microcatheter. Six weeks after surgery, the rabbits were sacrificed and their eyes evaluated for AAV transfection using immunofluorescent antibody staining of GFP. Results: Immunostaining of sectioned and whole-mounted eyes demonstrated robust transfection in all treated eyes, with no fluorescence in untreated control eyes. Transfection occurred diffusely and involved both the choroid and the retina. No apparent adverse effects caused by either the viral vector or the procedure itself could be seen either clinically or histologically. Conclusions: The ab externo method of delivery using a microcatheter was successful in safely and effectively delivering a gene therapy agent to the suprachoroidal space. This method presents a less invasive alternative to the current method of virally vectored gene delivery.	[Peden, Marc C.; Min, Jeff; Meyers, Craig; Lukowski, Zachary; Li, Qiuhong; Boye, Sanford L.; Levine, Monica; Hauswirth, William W.; Ratnakaram, Ramakrishna; Dawson, William; Smith, Wesley C.; Sherwood, Mark B.] Univ Florida, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Peden, MC (corresponding author), Univ Florida, Gainesville, FL 32610 USA.	sherwood@ufl.edu; sherwood@ufl.edu		hauswirth, william/0000-0002-3244-4947; Min, Jeff/0000-0003-4633-6792	Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY021721] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This study was funded in part by an unrestricted departmental grant from Research to Prevent Blindness. This financial supporter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Lewis RA, 2007, J CATARACT REFR SURG, V33, P1217, DOI 10.1016/j.jcrs.2007.03.051; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P1994; Olsen TW, 2006, AM J OPHTHALMOL, V142, P777, DOI 10.1016/j.ajo.2006.05.045; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	11	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17140	10.1371/journal.pone.0017140	http://dx.doi.org/10.1371/journal.pone.0017140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347253	Green Published, Green Submitted, gold			2022-12-27	WOS:000287364500034
J	Simpfendorfer, CA; Yeiser, BG; Wiley, TR; Poulakis, GR; Stevens, PW; Heupel, MR				Simpfendorfer, Colin A.; Yeiser, Beau G.; Wiley, Tonya R.; Poulakis, Gregg R.; Stevens, Philip W.; Heupel, Michelle R.			Environmental Influences on the Spatial Ecology of Juvenile Smalltooth Sawfish (Pristis pectinata): Results from Acoustic Monitoring	PLOS ONE			English	Article							SHARKS CARCHARHINUS-LEUCAS; RAYS RHINOPTERA-BONASUS; MOVEMENT PATTERNS; FLORIDA ESTUARY; BULL SHARKS; SUMMER NURSERY; BEHAVIORAL THERMOREGULATION; TRIAKIS-SEMIFASCIATA; WESTERN ATLANTIC; SALINITY CHANGE	To aid recovery efforts of smalltooth sawfish (Pristis pectinata) populations in U.S. waters a research project was developed to assess how changes in environmental conditions within estuarine areas affected the presence, movements, and activity space of this endangered species. Forty juvenile P. pectinata were fitted with acoustic tags and monitored within the lower 27 km of the Caloosahatchee River estuary, Florida, between 2005 and 2007. Sawfish were monitored within the study site from 1 to 473 days, and the number of consecutive days present ranged from 1 to 125. Residency index values for individuals varied considerably, with annual means highest in 2005 (0.95) and lowest in 2007 (0.73) when several P. pectinata moved upriver beyond detection range during drier conditions. Mean daily activity space was 1.42 km of river distance. The distance between 30-minute centers of activity was typically <0.1 km, suggesting limited movement over short time scales. Salinity electivity analysis demonstrated an affinity for salinities between 18 and at least 24 psu, suggesting movements are likely made in part, to remain within this range. Thus, freshwater flow from Lake Okeechobee (and its effect on salinity) affects the location of individuals within the estuary, although it remains unclear whether or not these movements are threatening recovery.	[Simpfendorfer, Colin A.; Yeiser, Beau G.; Wiley, Tonya R.; Heupel, Michelle R.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [Poulakis, Gregg R.; Stevens, Philip W.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Charlotte Harbor Field Lab, Port Charlotte, FL USA	Mote Marine Laboratory & Aquarium; Florida Fish & Wildlife Conservation Commission	Simpfendorfer, CA (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Fishing & Fisheries Res Ctr, Townsville, Qld 4811, Australia.	colin.simpfendorfer@jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011; Wiley, Tonya/AAO-7329-2020	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332	NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration; Disney Wildlife Conservation Fund; Florida Fish and Wildlife Conservation Commission	NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration(National Geographic Society); Disney Wildlife Conservation Fund; Florida Fish and Wildlife Conservation Commission	Financial support was provided by NOAA Fisheries Office of Protected Resources, South Florida Water Management District, National Fish and Wildlife Foundation, National Geographic Committee for Research and Exploration, The Disney Wildlife Conservation Fund, and the Florida Fish and Wildlife Conservation Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Collins AB, 2008, ESTUAR COAST, V31, P1174, DOI 10.1007/s12237-008-9100-5; Compagno Leonard J. V., 1995, Journal of Aquariculture and Aquatic Sciences, V7, P62; Doering PH, 1988, 9802 CHARL HARB NAT, P229; Dowd WW, 2010, J EXP BIOL, V213, P210, DOI 10.1242/jeb.031781; Grubbs R. Dean, 2007, V50, P63; Grubbs R. Dean, 2007, V50, P87; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Heupel Michelle R., 2007, V50, P265; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2001, ELECT TAGGING TRACKI; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; Matern SA, 2000, ENVIRON BIOL FISH, V58, P173, DOI 10.1023/A:1007625212099; NMFS, 2009, REC PLAN SMALLT SAWF; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; Poulakis Gregg R., 2004, Florida Scientist, V67, P27; Seitz Jason C., 2002, Florida Scientist, V65, P256; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P371, DOI 10.1023/A:1007675111597; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2004, CRC MAR BIOL SER, P553; Simpfendorfer CA, 2010, BIOL CONSERV, V143, P1460, DOI 10.1016/j.biocon.2010.03.021; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Sklar FH, 1998, ENVIRON MANAGE, V22, P547, DOI 10.1007/s002679900127; Thorburn D. C., 2006, BIOL ECOLOGY TROPHIC, P135; Thorburn DC, 2007, ZOOTAXA, P27; THORSON TB, 1974, COPEIA, P560; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Whitty JM, 2009, MAR FRESHWATER RES, V60, P306, DOI 10.1071/MF08169; Wiley TR, ENDANGERED IN PRESS; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	35	62	62	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16918	10.1371/journal.pone.0016918	http://dx.doi.org/10.1371/journal.pone.0016918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347294	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287364500012
J	To, AWM; Ribe, EM; Chuang, TT; Schroeder, JE; Lovestone, S				To, Alvina W. M.; Ribe, Elena M.; Chuang, Tsu Tshen; Schroeder, Joern E.; Lovestone, Simon			The epsilon 3 and epsilon 4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; APOLIPOPROTEIN-E GENOTYPE; AMYLOID PRECURSOR PROTEIN; ALZHEIMER-LIKE CHANGES; TRANSGENIC MICE; DIABETES-MELLITUS; INTRANASAL INSULIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; BEHAVIORAL DEFICITS	Background: Impaired insulin signalling is increasingly thought to contribute to Alzheimer's disease (AD). The epsilon 4 isoform of the APOE gene is the greatest genetic risk factor for sporadic, late onset AD, and is also associated with risk for type 2 diabetes mellitus (T2DM). Neuropathological studies reported the highest number of AD lesions in brain tissue of epsilon 4 diabetic patients. However other studies assessing AD pathology amongst the diabetic population have produced conflicting reports and have failed to show an increase in AD-related pathology in diabetic brain. The thiazolidinediones (TZDs), peroxisome proliferator-activated receptor gamma agonists, are peripheral insulin sensitisers used to treat T2DM. The TZD, pioglitazone, improved memory and cognitive functions in mild to moderate AD patients. Since it is not yet clear how apoE isoforms influence the development of T2DM and its progression to AD, we investigated amyloid beta and tau pathology in APOE knockout mice, carrying human APOE epsilon 3 or epsilon 4 transgenes after diet-induced insulin resistance with and without pioglitazone treatment. Methods: Male APOE knockout, APOE epsilon 3-transgenic and APOE epsilon 4-transgenic mice, together with background strain C57BL6 mice were kept on a high fat diet (HFD) or low fat diet (LFD) for 32 weeks, or were all fed HFD for 32 weeks and during the final 3 weeks animals were treated with pioglitazone or vehicle. Results: All HFD animals developed hyperglycaemia with elevated plasma insulin. Tau phosphorylation was reduced at 3 epitopes (Ser396, Ser202/Thr205 and Thr231) in all HFD, compared to LFD, animals independent of APOE genotype. The introduction of pioglitazone to HFD animals led to a significant reduction in tau phosphorylation at the Ser202/Thr205 epitope in APOE epsilon 3 animals only. We found no changes in APP processing however the levels of soluble amyloid beta 40 was reduced in APOE knockout animals treated with pioglitazone.	[To, Alvina W. M.; Ribe, Elena M.; Lovestone, Simon] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Chuang, Tsu Tshen] GlaxoSmithKline, Stem Cell DPU, Cambridge, MA USA; [Schroeder, Joern E.] GlaxoSmithKline, Neurosci CEDD, Harlow, Essex, England	University of London; King's College London; GlaxoSmithKline; GlaxoSmithKline	To, AWM (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	Simon.lovestone@kcl.ac.uk		Lovestone, Simon/0000-0003-0473-4565; Ribe, Elena/0000-0003-2854-2576	Biotechnology and Biological Sciences Research Council (BBSRC) [PAAPALA]; GlaxoSmithKline [PAAPALA]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline)	All work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) CASE award scheme jointly with GlaxoSmithKline (website http://www.bbsrc.ac.uk/). Grant number: PAAPALA. The BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JE Schroeder and TT Chuang are employees of GlaxoSmithKline and were involved with the study design, data collection and analysis and decision to publish.	Alafuzoff I, 2009, NEUROPATH APPL NEURO, V35, P60, DOI 10.1111/j.1365-2990.2008.00948.x; ARBONESMAINAR JM, 2010, FASEB J; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Arvanitakis Z, 2006, J NUTR HEALTH AGING, V10, P287; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bodles AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1100, DOI 10.1152/ajpendo.00187.2006; Bolten CW, 2007, GENE REGUL SYST BIO, V1, P73; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Camacho IE, 2004, J NEUROSCI, V24, P10908, DOI 10.1523/JNEUROSCI.3987-04.2004; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chung SH, 2009, BMB REP, V42, P467, DOI 10.5483/BMBRep.2009.42.8.467; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cole AR, 2007, NEUROSCI BIOBEHAV R, V31, P1046, DOI 10.1016/j.neubiorev.2007.04.004; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; d'Abramo C, 2005, BIOCHEM J, V391, P693, DOI 10.1042/BJ20050560; d'Abramo C, 2006, J NEUROCHEM, V98, P1068, DOI 10.1111/j.1471-4159.2006.03931.x; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; GENIS I, 1995, NEUROSCI LETT, V199, P5, DOI 10.1016/0304-3940(95)12007-Q; Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Heitner J, 1997, NEUROLOGY, V49, P1306, DOI 10.1212/WNL.49.5.1306; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hoe HS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-18; HOYER S, 1991, ANN NY ACAD SCI, V640, P53; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; JOLIVALT CG, 2009, EXP NEUROL; JULIEN C, 2008, NEUROBIOL AGING; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kobayashi M, 2003, NEUROREPORT, V14, P699, DOI 10.1097/00001756-200304150-00008; KOHJIMA M, 2010, ENDOCRINOLOGY; Kummer MP, 2008, PPAR RES, V2008, DOI 10.1155/2008/403896; Kypreos KE, 2009, FEBS J, V276, P5720, DOI 10.1111/j.1742-4658.2009.07301.x; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Ljungberg MC, 2002, NEUROREPORT, V13, P867, DOI 10.1097/00001756-200205070-00026; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Moroz N, 2008, J ALZHEIMERS DIS, V15, P29; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; SATO T, 2009, NEUROBIOL AGING; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200; Watson GS, 2005, AM J GERIAT PSYCHIAT, V13, P950, DOI 10.1176/appi.ajgp.13.11.950; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Yan Q, 2003, J NEUROSCI, V23, P7504; Zhou Jie, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P272	80	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16991	10.1371/journal.pone.0016991	http://dx.doi.org/10.1371/journal.pone.0016991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347323	Green Submitted, Green Published, gold			2022-12-27	WOS:000287363000028
J	Zhao, XG; Cao, MD; Liu, JJ; Zhu, HZ; Nelson, DR; Liu, C				Zhao, Xiangxuan; Cao, Mengde; Liu, Joy J.; Zhu, Haizhen; Nelson, David R.; Liu, Chen			Reactive Oxygen Species Is Essential for Cycloheximide to Sensitize Lexatumumab-Induced Apoptosis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; TUMOR-NECROSIS-FACTOR; PROSTATE EPITHELIAL-CELLS; ALPHA-MEDIATED APOPTOSIS; KAPPA-B ACTIVATION; COLON-CANCER CELLS; LIGAND TRAIL; AGONISTIC ANTIBODY; SURVIVIN LEVELS; UP-REGULATION	This study aims to investigate apoptosis induced by lexatumumab (Lexa) in hepatocellular carcinoma (HCC) cells. We assessed the sensitivity of HCC cell lines and normal human hepatocytes to Lexa and explored the sensitization of HCC cells to Lexa-induced apoptosis by cycloheximide (CHX). Our data indicated that CHX sensitized HCC cell lines to Lexa-induced apoptosis, whereas treatment using solely CHX or Lexa was ineffective. The sequential treatment of CHX followed by Lexa dramatically induced caspase-dependent apoptosis in HCC cells and had synergistically increased intracellular rates of reactive oxygen species (ROS). Additionally, when ROS production was blocked by N-acetyl-L-cysteine (NAC), HCC cells were protected against Lexa and CHX combination treatment-induced apoptosis. ROS generation induced by combination treatment of Lexa and CHX triggered pro-apoptotic protein Bax oligomerization, conformation change, and translocation to mitochondria, which resulted in the release of cytochrome c and subsequent cell death. Furthermore, HSP90 was involved in mediating Lexa and CHX combination treatment-induced ROS increase and apoptotic death. More importantly, we observed that combination treatment of Lexa and CHX did not cause apoptotic toxicity in normal human primary hepatocytes. These results suggest that Lexa and CHX combination treatment merits investigation for the development of therapies for patients with HCC.	[Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Immunol, Gainesville, FL USA; [Zhao, Xiangxuan; Liu, Joy J.; Zhu, Haizhen; Liu, Chen] Univ Florida, Coll Med, Dept Lab Med, Gainesville, FL USA; [Cao, Mengde; Nelson, David R.] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhao, XG (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA.	liu@pathology.ufl.edu			National Institutes of Health [R01CA133086]; University of Florida; NATIONAL CANCER INSTITUTE [R01CA133086, K24CA139570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the National Institutes of Health: R01CA133086 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; Brooks AD, 2005, CANCER IMMUNOL IMMUN, V54, P499, DOI 10.1007/s00262-004-0595-8; Camidge DR, 2010, CLIN CANCER RES, V16, P1256, DOI 10.1158/1078-0432.CCR-09-1267; Chaudhari AA, 2007, ONCOL REP, V18, P71; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; DEL MMS, 2001, BIOCHEMISTRY-US, V40, P9983; Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4; Dieterle A, 2009, INT J CANCER, V125, P932, DOI 10.1002/ijc.24374; Forero-Torres A, 2010, CANCER BIOTHER RADIO, V25, P13, DOI 10.1089/cbr.2009.0673; Gao F, 2010, J ZHEJIANG UNIV-SC B, V11, P608, DOI 10.1631/jzus.B1001007; Gong J, 2006, MOL CANCER THER, V5, P2991, DOI 10.1158/1535-7163.MCT-06-0188; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; He Song-qing, 2003, Zhonghua Zhongliu Zazhi, V25, P116; He Songqing, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P51; Hernandez A, 2001, J GASTROINTEST SURG, V5, P56, DOI 10.1016/S1091-255X(01)80014-7; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; Koornstra JJ, 2003, J PATHOL, V200, P327, DOI 10.1002/path.1364; Lee SH, 2010, MOL IMMUNOL, V47, P816, DOI 10.1016/j.molimm.2009.09.041; Lin TT, 2011, CARCINOGENESIS, V32, P154, DOI 10.1093/carcin/bgq234; Lirdprapamongkol K, 2010, IN VIVO, V24, P501; Liu DH, 2007, ACTA PHARMACOL SIN, V28, P1907, DOI 10.1111/j.1745-7254.2007.00702.x; Lu ML, 2008, CLIN CANCER RES, V14, P3168, DOI 10.1158/1078-0432.CCR-07-4362; Luster TA, 2009, MOL CANCER THER, V8, P292, DOI 10.1158/1535-7163.MCT-08-0918; Ma YL, 2006, MOL CANCER THER, V5, P170, DOI 10.1158/1535-7163.MCT-05-0129; Maddipatla S, 2007, CLIN CANCER RES, V13, P4556, DOI 10.1158/1078-0432.CCR-07-0680; Mahalingam D, 2009, BRIT J CANCER, V100, P1415, DOI 10.1038/sj.bjc.6605021; Menoret E, 2006, BLOOD, V108, P1346, DOI 10.1182/blood-2005-12-007971; Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785; Mori E, 2004, CELL DEATH DIFFER, V11, P203, DOI 10.1038/sj.cdd.4401331; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nesterov A, 2002, ONCOGENE, V21, P1135, DOI 10.1038/sj.onc.1205151; Patsos HA, 2010, INT J ONCOL, V37, P187, DOI 10.3892/ijo_00000666; Perotti C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2193; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Seol DW, 2001, CANCER RES, V61, P1138; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Smith MR, 2007, CLIN CANCER RES, V13, p5528S, DOI 10.1158/1078-0432.CCR-07-0982; Su CC, 2006, ANTICANCER RES, V26, P4379; Sundararajan R, 2001, J VIROL, V75, P7506, DOI 10.1128/JVI.75.16.7506-7516.2001; Sung ES, 2009, MOL CANCER THER, V8, P2276, DOI 10.1158/1535-7163.MCT-09-0235; TAKENAGA K, 1984, INT J CANCER, V34, P83, DOI 10.1002/ijc.2910340115; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yamaguchi H, 2002, CANCER RES, V62, P466; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Zhang L, 2007, CANCER LETT, V251, P146, DOI 10.1016/j.canlet.2006.11.013; Zhao C, 2004, CELL SIGNAL, V16, P313, DOI 10.1016/j.cellsig.2003.08.005	59	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16966	10.1371/journal.pone.0016966	http://dx.doi.org/10.1371/journal.pone.0016966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347335	Green Submitted, gold, Green Published			2022-12-27	WOS:000287363000026
J	Kasai, A; Bai, SL; Li, TZ; Harada, T				Kasai, Atsushi; Bai, Songling; Li, Tianzhong; Harada, Takeo			Graft-Transmitted siRNA Signal from the Root Induces Visual Manifestation of Endogenous Post-Transcriptional Gene Silencing in the Scion	PLOS ONE			English	Article							RNA; MOVEMENT; PHLOEM; PLANTS; EXPRESSION; SPREAD	In plants, post-transcriptional gene silencing (PTGS) spreads systemically, being transmitted from the silenced stock to the scion expressing the corresponding transgene. It has been reported that a graft-transmitted siRNA signal can also induce PTGS of an endogenous gene, but this was done by top-grafting using silenced stock. In the present study involving grafting of Nicotiana benthamiana, we found that PTGS of an endogenous gene, glutamate-1-semialdehyde aminotransferase (GSA), which acts as a visible marker of RNAi via inhibition of chlorophyll synthesis, was manifested along the veins of newly developed leaves in the wild-type scion by the siRNA signal synthesized only in companion cells of the rootstock.	[Kasai, Atsushi; Bai, Songling; Harada, Takeo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Li, Tianzhong] China Agr Univ, Lab Fruit Cell & Mol Breeding, Beijing 100094, Peoples R China	Hirosaki University; China Agricultural University	Kasai, A (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.	tharada@cc.hirosaki-u.ac.jp	Bai, Songling/X-9850-2019	Bai, Songling/0000-0002-8103-3095	Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan;  [22380003]	Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan; 	This work was supported by the Program for Promotion of Basic Activities for Innovative Bioscience (PROBRAIN) in Japan, a Grant-in-Aid for Scientific Research in Japan (22380003) and a Grant for Hirosaki University Institutional Research. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Crete P, 2001, PLANT J, V28, P493, DOI 10.1046/j.1365-313X.2001.01171.x; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Harada T, 2010, SCI HORTIC-AMSTERDAM, V125, P545, DOI 10.1016/j.scienta.2010.05.013; Hedtke B, 2007, PLANT MOL BIOL, V64, P733, DOI 10.1007/s11103-007-9194-3; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; HOFGEN R, 1994, P NATL ACAD SCI USA, V91, P1726, DOI 10.1073/pnas.91.5.1726; Kanehira A, 2010, TREE GENET GENOMES, V6, P635, DOI 10.1007/s11295-010-0279-9; Kasai A., 2010, Open Plant Science Journal, V4, P1, DOI 10.2174/1874294701004010001; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; Kragler F, 2010, PLANT SCI, V178, P99, DOI 10.1016/j.plantsci.2009.12.006; Lin SI, 2008, PLANT PHYSIOL, V147, P732, DOI 10.1104/pp.108.116269; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Matsuda Y, 2002, PROTOPLASMA, V220, P51, DOI 10.1007/s00709-002-0027-6; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oparka KJ, 1999, PLANT CELL, V11, P739, DOI 10.1105/tpc.11.4.739; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; SJOLUND RD, 1997, PLANT CELL, V11, P739; Stadler R, 1996, BOT ACTA, V109, P299, DOI 10.1111/j.1438-8677.1996.tb00577.x; Suarez-Lopez P, 2005, INT J DEV BIOL, V49, P761, DOI 10.1387/ijdb.052002ps; Tournier B, 2006, PLANT J, V47, P383, DOI 10.1111/j.1365-313X.2006.02796.x; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Xu HY, 2010, TREE GENET GENOMES, V6, P1013, DOI 10.1007/s11295-010-0309-7	33	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16895	10.1371/journal.pone.0016895	http://dx.doi.org/10.1371/journal.pone.0016895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347381	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700052
J	Malcom, JW				Malcom, Jacob W.			Smaller, Scale-Free Gene Networks Increase Quantitative Trait Heritability and Result in Faster Population Recovery	PLOS ONE			English	Article							RAPID EVOLUTION; PREVENT EXTINCTION; NATURAL-SELECTION; DUPLICATIONS; CONVERGENCE; EPISTASIS; ARCHITECTURE; ADAPTATION; DYNAMICS	One of the goals of biology is to bridge levels of organization. Recent technological advances are enabling us to span from genetic sequence to traits, and then from traits to ecological dynamics. The quantitative genetics parameter heritability describes how quickly a trait can evolve, and in turn describes how quickly a population can recover from an environmental change. Here I propose that we can link the details of the genetic architecture of a quantitative trait-i.e., the number of underlying genes and their relationships in a network-to population recovery rates by way of heritability. I test this hypothesis using a set of agent-based models in which individuals possess one of two network topologies or a linear genotype-phenotype map, 16-256 genes underlying the trait, and a variety of mutation and recombination rates and degrees of environmental change. I find that the network architectures introduce extensive directional epistasis that systematically hides and reveals additive genetic variance and affects heritability: network size, topology, and recombination explain 81% of the variance in average heritability in a stable environment. Network size and topology, the width of the fitness function, pre-change additive variance, and certain interactions account for similar to 75% of the variance in population recovery times after a sudden environmental change. These results suggest that not only the amount of additive variance, but importantly the number of loci across which it is distributed, is important in regulating the rate at which a trait can evolve and populations can recover. Taken in conjunction with previous research focused on differences in degree of network connectivity, these results provide a set of theoretical expectations and testable hypotheses for biologists working to span levels of organization from the genotype to the phenotype, and from the phenotype to the environment.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu	/AAD-1873-2020	/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amoutzias GD, 2004, EMBO REP, V5, P274, DOI 10.1038/sj.embor.7400096; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; B³rger R., 2000, MATH THEORY SELECTIO; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barton N. H., 2007, EVOLUTION; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Cowperthwaite MC, 2007, ANNU REV ECOL EVOL S, V38, P203, DOI 10.1146/annurev.ecolsys.38.091206.095507; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Edwards Alexis C, 2009, BMC Biol, V7, P29, DOI 10.1186/1741-7007-7-29; Falconer D. S., 1996, INTRO QUANTITATIVE G; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I., 1999, METAPOPULATION ECOLO; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hermisson J, 2003, AM NAT, V161, P708, DOI 10.1086/374204; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; KIMBRELL T, 2010, EVOLUTIONARY ECOLOGY; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Naciri-Graven Y, 2003, EVOLUTION, V57, P706, DOI 10.1111/j.0014-3820.2003.tb00284.x; Ohno S., 1970, EVOLUTION GENE DUPLI; Platts Adrian E., 2009, P227, DOI 10.1007/978-1-59745-440-7_13; R Core Team, 2020, R LANG ENV STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Roff Derek A., 1992; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Stearns SC, 2003, AM NAT, V161, P171, DOI 10.1086/367983; Stumpf MPH, 2007, TRENDS ECOL EVOL, V22, P366, DOI 10.1016/j.tree.2007.04.004; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Wagner A, 1996, BIOL CYBERN, V74, P557, DOI 10.1007/BF00209427; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; Wilenski U., 1999, NETLOGO; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Yee TW, 2008, R NEWS, V8, P28; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Zhou Q, 2008, J GENET GENOMICS, V35, P639, DOI 10.1016/S1673-8527(08)60085-5	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14645	10.1371/journal.pone.0014645	http://dx.doi.org/10.1371/journal.pone.0014645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347400	Green Submitted, Green Published, gold			2022-12-27	WOS:000287361700001
J	Ninove, L; Nougairede, A; Gazin, C; Thirion, L; Delogu, I; Zandotti, C; Charrel, RN; De Lamballerie, X				Ninove, Laetitia; Nougairede, Antoine; Gazin, Celine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier			RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests	PLOS ONE			English	Article							REAL-TIME PCR; QUANTITATIVE PCR; INFLUENZA-VIRUS; ASSAY; QUANTIFICATION; SPECIMENS; STEP	Real-time PCR techniques are now commonly used for the detection of viral genomes in various human specimens and require for validation both external and internal controls (ECs and ICs). In particular, ICs added to clinical samples are necessary to monitor the extraction, reverse transcription, and amplification steps in order to detect false-negative results resulting from PCR-inhibition or errors in the technical procedure. Here, we performed a large scale evaluation of the use of bacteriophages as ICs in routine molecular diagnosis. This allowed to propose simple standardized procedures (i) to design specific ECs for both DNA and RNA viruses and (ii) to use T4 (DNA) or MS2 (RNA) phages as ICs in routine diagnosis. Various technical formats for using phages as ICs were optimised and validated. Subsequently, T4 and MS2 ICs were evaluated in routine real-time PCR or RT-PCR virological diagnostic tests, using a series of 8,950 clinical samples (representing 36 distinct specimen types) sent to our laboratory for the detection of a variety of DNA and RNA viruses. The frequency of inefficient detection of ICs was analyzed according to the nature of the sample. Inhibitors of enzymatic reactions were detected at high frequency in specific sample types such as heparinized blood and bone marrow (>70%), broncho-alveolar liquid (41%) and stools (36%). The use of T4 and MS2 phages as ICs proved to be cost-effective, flexible and adaptable to various technical procedures of real-time PCR detection in virology. It represents a valuable strategy for enhancing the quality of routine molecular diagnosis in laboratories that use in-house designed diagnostic systems, which can conveniently be associated to the use of specific synthetic ECs. The high rate of inhibitors observed in a variety of specimen types should stimulate the elaboration of improved technical protocols for the extraction and amplification of nucleic acids.	[Ninove, Laetitia; Nougairede, Antoine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Univ Aix Marseille 2, UMR190, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Thirion, Laurence; Delogu, Ilenia; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Inst Rech Dev, Marseille, France; [Ninove, Laetitia; Nougairede, Antoine; Gazin, Celine; Zandotti, Christine; Charrel, Remi N.; De Lamballerie, Xavier] Assistance Publ Hop Marseille, Marseille, France; [De Lamballerie, Xavier] EHESP Sch Publ Hlth, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Ninove, L (corresponding author), Univ Aix Marseille 2, UMR190, Marseille, France.	xavier.de-lamballerie@univmed.fr		Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital system; Universite de la Mediterranee	AP-HM Public Hospital system; Universite de la Mediterranee	This study has been funded by AP-HM Public Hospital system and by Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study is based on results obtained in the virological diagnosis of patients in the AP-HM Public Hospital.	Aberham C, 2001, J VIROL METHODS, V92, P183, DOI 10.1016/S0166-0934(00)00292-5; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Dreier J, 2006, J CLIN MICROBIOL, V44, P2714, DOI 10.1128/JCM.00443-06; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gerriets JE, 2008, J MOL DIAGN, V10, P28, DOI 10.2353/jmoldx.2008.070028; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Kessler HH, 2000, J CLIN MICROBIOL, V38, P2638, DOI 10.1128/JCM.38.7.2638-2642.2000; Lallemand F, 2000, J CLIN MICROBIOL, V38, P1404, DOI 10.1128/JCM.38.4.1404-1408.2000; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Locatelli G, 2000, J CLIN MICROBIOL, V38, P4042, DOI 10.1128/JCM.38.11.4042-4048.2000; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Perez-Ruiz M, 2007, J CLIN VIROL, V39, P276, DOI 10.1016/j.jcv.2007.05.003; Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Watkins-Riedel T, 2002, DIAGN MICR INFEC DIS, V42, P99, DOI 10.1016/S0732-8893(01)00330-3; Whiley DM, 2001, J CLIN MICROBIOL, V39, P4357, DOI 10.1128/JCM.39.12.4357-4361.2001; Yu XF, 2008, J CLIN MICROBIOL, V46, P837, DOI 10.1128/JCM.01904-07	22	93	96	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16142	10.1371/journal.pone.0016142	http://dx.doi.org/10.1371/journal.pone.0016142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347398	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700012
J	Gregory, R; Darby, AC; Irving, H; Coulibaly, MB; Hughes, M; Koekemoer, LL; Coetzee, M; Ranson, H; Hemingway, J; Hall, N; Wondji, CS				Gregory, Richard; Darby, Alistair C.; Irving, Helen; Coulibaly, Mamadou B.; Hughes, Margaret; Koekemoer, Lizette L.; Coetzee, Maureen; Ranson, Hilary; Hemingway, Janet; Hall, Neil; Wondji, Charles S.			A De Novo Expression Profiling of Anopheles funestus, Malaria Vector in Africa, Using 454 Pyrosequencing	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; MICROARRAY	Background: Anopheles funestus is one of the major malaria vectors in Africa and yet there are few genomic tools available for this species compared to An. gambiae. To start to close this knowledge gap, we sequenced the An. funestus transcriptome using cDNA libraries developed from a pyrethroid resistant laboratory strain and a pyrethroid susceptible field strain from Mali. Results: Using a pool of life stages (pupae, larvae, adults: females and males) for each strain, 454 sequencing generated 375,619 reads (average length of 182 bp). De novo assembly generated 18,103 contigs with average length of 253 bp. The average depth of coverage of these contigs was 8.3. In total 20.8% of all reads were novel when compared to reference databases. The sequencing of the field strain generated 204,758 reads compared to 170,861 from the insecticide resistant laboratory strain. The contigs most differentially represented in the resistant strain belong to the P450 gene family and cuticular genes which correlates with previous studies implicating both of these gene families in pyrethroid resistance. qPCR carried out on six contigs indicates that these ESTs could be suitable for gene expression studies such as microarray. 31,000 sites were estimated to contain Single Nucleotide Polymorphisms (SNPs) and analysis of SNPs from 20 contigs suggested that most of these SNPs are likely to be true SNPs. Gene conservation analysis confirmed the close phylogenetic relationship between An. funestus and An. gambiae. Conclusion: This study represents a significant advance for the genetics and genomics of An. funestus since it provides an extensive set of both Expressed Sequence Tags (ESTs) and SNPs which can be readily adopted for the design of new genomic tools such as microarray or SNP platforms.	[Gregory, Richard; Darby, Alistair C.; Hughes, Margaret; Hall, Neil] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Irving, Helen; Ranson, Hilary; Hemingway, Janet; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Coulibaly, Mamadou B.] Malaria Res & Training Ctr, Bamako, Mali; [Koekemoer, Lizette L.; Coetzee, Maureen] Univ Witwatersrand, Div Virol & Communicable Dis Surveillance, Johannesburg, South Africa; [Koekemoer, Lizette L.; Coetzee, Maureen] NICD, Johannesburg, South Africa	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institute for Communicable Diseases (NICD)	Gregory, R (corresponding author), Univ Liverpool, Sch Biol Sci, Cornwall House, Liverpool L69 3BX, Merseyside, England.	c.s.wondji@liverpool.ac.uk	Hall, Neil/A-8717-2013; Coetzee, Maureen/AAI-1413-2020; Coulibaly, Mamadou/AAE-7006-2019; Darby, Alistair/I-6485-2012; Wondji, Charles/AAG-1510-2020; Coetzee, Maureen/AAW-4739-2020	Hall, Neil/0000-0002-7995-3810; Coetzee, Maureen/0000-0003-2019-866X; Darby, Alistair/0000-0002-3786-6209; Hemingway, Janet/0000-0002-3200-7173; Wondji, Charles S./0000-0003-0791-3673; Hall, Neil/0000-0003-2808-0009; Koekemoer, Lizette/0000-0003-4236-6345; Ranson, Hilary/0000-0003-2332-8247	National Institute of Health (NIH) [IU01 A1058271-01]; Wellcome Trust [083515/Z/07/Z]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Institute of Health (NIH) grant IU01 A1058271-01 and by a Wellcome Trust Research Career Development Fellowship (083515/Z/07/Z) to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; AWOLOLA TS, 2008, T R SOC TROP MED HYG; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morlais I, 2003, INSECT MOL BIOL, V12, P631, DOI 10.1046/j.1365-2583.2003.00449.x; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-5; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574	16	46	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17418	10.1371/journal.pone.0017418	http://dx.doi.org/10.1371/journal.pone.0017418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364769	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287764100060
J	Meng, LS; He, XJ; Zhu, WH; Yang, XD; Jiang, CS; Sun, QZ; Asim, RMB; Zhang, SM; Xue, QA; Xie, XF; Lu, SM				Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Zhang, Simeng; Xue, Qian; Xie, Xinfang; Lu, Shemin			TLR3 and TLR7 Modulate IgE Production in Antigen Induced Pulmonary Inflammation via Influencing IL-4 Expression in Immune Organs	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; EXPERIMENTAL ASTHMA; RESPONSE MODIFIER; EPITHELIAL-CELLS; DENDRITIC CELLS; NITRIC-OXIDE; IMIQUIMOD; DISEASE	Background: Toll-like receptors (TLRs) as pattern recognition receptors, participate in both innate and adaptive immune responses, and seem to play an important role in the pathogenesis of asthma. This study aimed to identify key TLRs involved in antigen induced pulmonary inflammation (AIPI), a rat model for asthma, and to explore the role of TLRs in the disease development. Methods and Findings: E3 rats were sensitized with ovalbumin (OVA)/alum intraperitoneally and intranasally challenged with OVA to induce AIPI model. TLR1-9 and cytokine mRNA expression in spleen, lung and mediastinal lymph node (mLN) tissues were screened by quantitative real-time polymerase chain reaction. TLR7 expression was found to be significantly down-regulated in spleen while TLR3 and TLR8 expression was up-regulated in mLN of AIPI rats. Furthermore, imiquimod (a ligand of TLR7) and TLR3 specific short-hairpin RNA plasmid for RNA interference were administrated, respectively, in vivo to AIPI rats to observe their effects on the disease by assessing various asthmatic parameters. The numbers of total cells, eosinophils, macrophages and lymphocytes were counted according to differential morphology in bronchoalveolar lavage fluid. Serum IgE and OVA specific IgG(1) concentration was detected by enzyme-linked immunosorbent assay. The results showed that both TLR7 ligand treatment and TLR3 RNAi in vivo decreased serum IgE level and interleukin-4 mRNA expression. Conclusion/Significance: TLR3 in mLN and TLR7 in spleen both systemically modulate disease development in AIPI rats via altering serum IgE concentration relevant to Th2 responses. And these findings may provide an important clue for further research in the asthma pathogenesis and suggest a new remedy for asthma treatment.	[Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Zhang, Simeng; Xue, Qian; Xie, Xinfang; Lu, Shemin] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Meng, Liesu; He, Xiaojing; Zhu, Wenhua; Yang, Xudong; Jiang, Congshan; Sun, Qingzhu; Asim, Raza M. B.; Lu, Shemin] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Meng, LS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China.	shemin.lu@gmail.com	Lu, Shemin/AAI-6479-2021; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Zhu, Wenhua/0000-0002-2820-2427; Lu, Shemin/0000-0001-8250-850X; Jiang, Congshan/0000-0002-7457-6243	National Natural Science Foundation of China [30630058, 30801027, 81070030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30630058, 30801027 and 81070030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bian T, 2006, CHINESE MED J-PEKING, V119, P640, DOI 10.1097/00029330-200604020-00005; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Curtis Jeffrey L, 2005, Proc Am Thorac Soc, V2, P412, DOI 10.1513/pats.200507-070JS; Du Q, 2009, CLIN EXP PHARMACOL P, V36, P43, DOI 10.1111/j.1440-1681.2008.05027.x; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Frotscher B, 2002, J INVEST DERMATOL, V119, P1059, DOI 10.1046/j.1523-1747.2002.19531.x; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Hoffjan S, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-34; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kumar RK, 2002, AM J RESP CELL MOL, V27, P267, DOI 10.1165/rcmb.F248; [龙静雯 LONG Jing-wen], 2009, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V30, P550; Long JW, 2009, ACTA PHARMACOL SIN, V30, P965, DOI 10.1038/aps.2009.61; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Nishitsuji M, 2004, EXP LUNG RES, V30, P723, DOI 10.1080/01902140490517827; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Quarcoo D, 2004, CLIN EXP ALLERGY, V34, P1314, DOI 10.1111/j.1365-2222.2004.02023.x; Raza Asim M.B., 2010, SWISS MED WEEKLY, V140, DOI DOI 10.4414/SMW.2010.13128; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Sel S, 2007, J IMMUNOL, V178, P7805, DOI 10.4049/jimmunol.178.12.7805; Shahzad M, 2009, PULM PHARMACOL THER, V22, P37, DOI 10.1016/j.pupt.2008.11.006; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Torres R, 2005, ARCH BRONCONEUMOL, V41, P141, DOI 10.1016/S0300-2896(05)70605-0; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang XF, 2008, INT J CHEM REACT ENG, V6; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC; Yang IA, 2004, GENES IMMUN, V5, P41, DOI 10.1038/sj.gene.6364037; Yang XD, 2010, J ASTHMA, V47, P135, DOI 10.3109/02770900903483808; Zhang XD, 2004, J ALLERGY CLIN IMMUN, V113, P320, DOI 10.1016/j.jaci.2003.11.047	46	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17252	10.1371/journal.pone.0017252	http://dx.doi.org/10.1371/journal.pone.0017252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364926	gold, Green Submitted, Green Published			2022-12-27	WOS:000287764100035
J	Sekar, N; Shah, NK; Abbas, SS; Kakkar, M				Sekar, Nitin; Shah, Naman K.; Abbas, Syed Shahid; Kakkar, Manish		Roadmap Combat Zoonoses India RCZ	Research Options for Controlling Zoonotic Disease in India, 2010-2015	PLOS ONE			English	Article							HEALTH	Background: Zoonotic infections pose a significant public health challenge for low- and middle-income countries and have traditionally been a neglected area of research. The Roadmap to Combat Zoonoses in India (RCZI) initiative conducted an exercise to systematically identify and prioritize research options needed to control zoonoses in India. Methods and Findings: Priority setting methods developed by the Child Health and Nutrition Research Initiative were adapted for the diversity of sectors, disciplines, diseases and populations relevant for zoonoses in India. A multidisciplinary group of experts identified priority zoonotic diseases and knowledge gaps and proposed research options to address key knowledge gaps within the next five years. Each option was scored using predefined criteria by another group of experts. The scores were weighted using relative ranks among the criteria based upon the feedback of a larger reference group. We categorized each research option by type of research, disease targeted, factorials, and level of collaboration required. We analysed the research options by tabulating them along these categories. Seventeen experts generated four universal research themes and 103 specific research options, the majority of which required a high to medium level of collaboration across sectors. Research options designated as pertaining to 'social, political and economic' factorials predominated and scored higher than options focussing on ecological, genetic and biological, or environmental factors. Research options related to 'health policy and systems' scored highest while those related to 'research for development of new interventions' scored the lowest. Conclusions: We methodically identified research themes and specific research options incorporating perspectives of a diverse group of stakeholders. These outputs reflect the diverse nature of challenges posed by zoonoses and should be acceptable across diseases, disciplines, and sectors. The identified research options capture the need for 'actionable research' for advancing the prevention and control of zoonoses in India.	[Sekar, Nitin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Abbas, Syed Shahid; Kakkar, Manish] Publ Hlth Fdn India, New Delhi, India; [Shah, Naman K.] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	Princeton University; Public Health Foundation of India; University of North Carolina; University of North Carolina Chapel Hill	Sekar, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	manish.kakkar@phfi.org	Abbas, Syed Shahid/A-4806-2012	Abbas, Syed Shahid/0000-0003-1964-5303	WHO India [SE/09/202227]; NIH [GM008719, 5-T32-AI070114-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	WHO India(World Health Organization); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WHO India provided the funding for the overall study under APW No. SE/09/202227, NKS is supported by NIH Medical Scientist Training Program grant GM008719 and Infectious Disease Epidemiology Training Program grant 5-T32-AI070114-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L.A., 2001, RISK AM HLTH HLTH CA; *CHILD HLTH NUTR R, 2006, NEW APPR SYST PRIOR; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Forman S, 2008, REV SCI TECH OIE, V27, P581, DOI 10.20506/rst.27.2.1814; GEERING WA, 1995, EXOTIC DIS ANIMALS, P301; Harit AK, 2006, INDIAN J MED RES, V123, P553; Ichhpujani R. L., 2004, Journal of Communicable Diseases, V36, P199; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; MANTUR BG, 2008, BRUCELLOSIS INDIA RE, P539; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PRASAD HK, TUBERCULOSIS EDINBUR, V85, P421; *PUBL HLTH FDN IND, 2008, BRAINST M NEW DELH 1; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Thappa DM, 2001, INT J DERMATOL, V40, P216, DOI 10.1046/j.1365-4362.2001.01174.x; Thornton P.K., 2002, MAPPING POVERTY LIVE; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Traub RJ, 2005, TRENDS PARASITOL, V21, P42, DOI 10.1016/j.pt.2004.10.011; *UN, 2008, CONTR ONE WORLD ONE; *WHO, 2010, WHO ZOON; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	21	40	41	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17120	10.1371/journal.pone.0017120	http://dx.doi.org/10.1371/journal.pone.0017120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364879	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287764100030
J	Kroon, AA; Wang, JX; Kavanagh, B; Huang, Z; Kuliszewski, M; van Goudoever, JB; Post, M				Kroon, Andreas A.; Wang, Jinxia; Kavanagh, Brian; Huang, Zhen; Kuliszewski, Maciej; van Goudoever, Johannes B.; Post, Martin			Prolonged Mechanical Ventilation Induces Cell Cycle Arrest in Newborn Rat Lung	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; P27(KIP1); DISEASE; SIMILARITIES; INHIBITOR; COMPLEXES; APOPTOSIS; PATHWAYS; MEDIATOR	Rationale: The molecular mechanism(s) by which mechanical ventilation disrupts alveolar development, a hallmark of bronchopulmonary dysplasia, is unknown. Objective: To determine the effect of 24 h of mechanical ventilation on lung cell cycle regulators, cell proliferation and alveolar formation in newborn rats. Methods: Seven-day old rats were ventilated with room air for 8, 12 and 24 h using relatively moderate tidal volumes (8.5 mL. kg(-1)). Measurement and Main Results: Ventilation for 24 h (h) decreased the number of elastin-positive secondary crests and increased the mean linear intercept, indicating arrest of alveolar development. Proliferation (assessed by BrdU incorporation) was halved after 12 h of ventilation and completely arrested after 24 h. Cyclin D1 and E1 mRNA and protein levels were decreased after 8-24 h of ventilation, while that of p27(Kip1) was significantly increased. Mechanical ventilation for 24 h also increased levels of p57(Kip2), decreased that of p16(INK4a), while the levels of p21(Waf/Cip1) and p15(INK4b) were unchanged. Increased p27(Kip1) expression coincided with reduced phosphorylation of p27(Kip1) at Thr(157), Thr(187) and Thr(198) (p<0.05), thereby promoting its nuclear localization. Similar -but more rapid-changes in cell cycle regulators were noted when 7-day rats were ventilated with high tidal volume (40 mL.kg(-1)) and when fetal lung epithelial cells were subjected to a continuous (17% elongation) cyclic stretch. Conclusion: This is the first demonstration that prolonged (24 h) of mechanical ventilation causes cell cycle arrest in newborn rat lungs; the arrest occurs in G(1) and is caused by increased expression and nuclear localization of Cdk inhibitor proteins (p27(Kip)1, p57(Kip2)) from the Kip family.	[Kroon, Andreas A.; Wang, Jinxia; Kavanagh, Brian; Huang, Zhen; Kuliszewski, Maciej; Post, Martin] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Post, Martin] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Kavanagh, Brian; Post, Martin] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Kavanagh, Brian] Univ Toronto, Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Kavanagh, Brian] Univ Toronto, Hosp Sick Children, Dept Anesthesia, Toronto, ON M5G 1X8, Canada; [Kroon, Andreas A.; van Goudoever, Johannes B.] Erasmus MC Sophia, Dept Pediat, Rotterdam, Netherlands; [van Goudoever, Johannes B.] Emmas Childrens Hosp, Dept Pediat, Amsterdam Med Ctr, Amsterdam, Netherlands; [van Goudoever, Johannes B.] Free Univ Amsterdam Hosp, Dept Pediat, NL-1081 HV Amsterdam, Netherlands	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Kroon, AA (corresponding author), Hosp Sick Children, Res Inst, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	martin.post@sickkids.ca	van Goudoever, Johannes Bernard/Y-4520-2018	van Goudoever, Johannes (Hans)/0000-0003-3960-1703	Canadian Institute of Health Research [MOP-15272]; Canadian Foundation for Innovation; Sophia Children's Hospital	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Sophia Children's Hospital	The study was supported by operating grants (MOP-15272) from the Canadian Institute of Health Research and the Sophia Children's Hospital Fund (SSWO) and infrastructure grants (CCURE, CSCCD) from the Canadian Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burri P.H., 1999, LUNG DEV, P122; CANIGGIA I, 1991, AM J PHYSIOL, V261, pL424, DOI 10.1152/ajplung.1991.261.6.L424; Clement A, 2001, AM J RESP CRIT CARE, V164, pS81, DOI 10.1164/ajrccm.164.supplement_2.2106069; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Copland IB, 2006, AM J PHYSIOL-LUNG C, V291, pL487, DOI 10.1152/ajplung.00510.2005; Corroyer S, 1996, J BIOL CHEM, V271, P25117, DOI 10.1074/jbc.271.41.25117; Cutz E, 2008, NEW ENGL J MED, V358, P743, DOI 10.1056/NEJMc073362; Das KC, 2004, ANTIOXID REDOX SIGN, V6, P117, DOI 10.1089/152308604771978426; De Paepe ME, 1999, AM J RESP CELL MOL, V21, P65, DOI 10.1165/ajrcmb.21.1.3511; DUNNILL M. S., 1964, THORAX, V19, P443, DOI 10.1136/thx.19.5.443; Edwards YS, 1999, FEBS LETT, V448, P127, DOI 10.1016/S0014-5793(99)00357-9; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Helt CE, 2004, AM J PHYSIOL-LUNG C, V286, pL506, DOI 10.1152/ajplung.00243.2003; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; KAUFFMAN SL, 1974, ANAT RECORD, V180, P63, DOI 10.1002/ar.1091800108; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Kroon AA, 2010, PEDIATR RES, V68, P63, DOI 10.1203/00006450-201011001-00120; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Maniscalco WM, 2005, PEDIATR RES, V58, P549, DOI 10.1203/01.pdr.0000176923.79584.f7; McAdams RM, 2006, AM J PHYSIOL-LUNG C, V291, pL166, DOI 10.1152/ajplung.00160.2005; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; McGrath SA, 1998, AM J RESP CELL MOL, V18, P179, DOI 10.1165/ajrcmb.18.2.2964m; Mokres LM, 2010, AM J PHYSIOL-LUNG C, V298, pL23, DOI 10.1152/ajplung.00251.2009; Nardo L, 2000, EXP LUNG RES, V26, P105, DOI 10.1080/019021400269907; Ngiam N, 2010, AM J RESP CRIT CARE, V181, P947, DOI 10.1164/rccm.200908-1297OC; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Rancourt RC, 2001, AM J PHYSIOL-LUNG C, V280, pL617, DOI 10.1152/ajplung.2001.280.4.L617; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Roth-Kleiner M, 2007, PEDIATR RES, V61, P191, DOI 10.1203/01.pdr.0000252437.51779.21; Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Staversky RJ, 2006, FREE RADICAL BIO MED, V41, P601, DOI 10.1016/j.freeradbiomed.2006.04.029; Susaki E, 2007, CELL CYCLE, V6, P3015, DOI 10.4161/cc.6.24.5087; Susaki E, 2009, CELL CYCLE, V8, P2497, DOI 10.4161/cc.8.16.9330; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Xu J, 1998, AM J PHYSIOL-LUNG C, V275, pL545, DOI 10.1152/ajplung.1998.275.3.L545; Yi M, 2004, AM J RESP CRIT CARE, V170, P1188, DOI 10.1164/rccm.200402-215OC	49	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16910	10.1371/journal.pone.0016910	http://dx.doi.org/10.1371/journal.pone.0016910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359218	Green Published, gold			2022-12-27	WOS:000287392700029
J	Longo, MS; O'Neill, MJ; O'Neill, RJ				Longo, Mark S.; O'Neill, Michael J.; O'Neill, Rachel J.			Abundant Human DNA Contamination Identified in Non-Primate Genome Databases	PLOS ONE			English	Article							ERRORS; BLAST	During routine screens of the NCBI databases using human repetitive elements we discovered an unlikely level of nucleotide identity across a broad range of phyla. To ascertain whether databases containing DNA sequences, genome assemblies and trace archive reads were contaminated with human sequences, we performed an in depth search for sequences of human origin in non-human species. Using a primate specific SINE, AluY, we screened 2,749 non-primate public databases from NCBI, Ensembl, JGI, and UCSC and have found 492 to be contaminated with human sequence. These represent species ranging from bacteria (B. cereus) to plants (Z. mays) to fish (D. rerio) with examples found from most phyla. The identification of such extensive contamination of human sequence across databases and sequence types warrants caution among the sequencing community in future sequencing efforts, such as human re-sequencing. We discuss issues this may raise as well as present data that gives insight as to how this may be occurring.	[Longo, Mark S.; O'Neill, Michael J.; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Longo, MS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	rachel.oneill@uconn.edu	Puigbò, Pere/A-2214-2008		NSF	NSF(National Science Foundation (NSF))	This work was funded by the NSF (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Katz TJ, 2006, SCIENCE, V313, P1236; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kyrpides NC, 1998, SCIENCE, V281, P1457; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu GE, 2009, GENOME RES, V19, P876, DOI 10.1101/gr.083972.108; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rutty GN, 2003, INT J LEGAL MED, V117, P170, DOI 10.1007/s00414-002-0348-14; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	13	68	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16410	10.1371/journal.pone.0016410	http://dx.doi.org/10.1371/journal.pone.0016410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358816	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700018
J	Riau, AK; Wong, TT; Finger, SN; Chaurasia, SS; Hou, AH; Chen, SL; Yu, SJ; Tong, L				Riau, Andri K.; Wong, Tina T.; Finger, Sharon N.; Chaurasia, Shyam S.; Hou, Ai Hua; Chen, Silin; Yu, Shang Juan; Tong, Louis			Aberrant DNA Methylation of Matrix Remodeling and Cell Adhesion Related Genes in Pterygium	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DIFFERENTIALLY EXPRESSED GENES; BASE-SPECIFIC CLEAVAGE; TISSUE TRANSGLUTAMINASE; CYTOSINE METHYLATION; CANCER-CELLS; LUNG-CANCER; EPIGENETIC REGULATION; EXTRACELLULAR-MATRIX; CORNEAL EPITHELIUM	Background: Pterygium is a common ocular surface disease characterized by abnormal epithelial and fibrovascular proliferation, invasion, and matrix remodeling. This lesion, which migrates from the periphery to the center of the cornea, impairs vision and causes considerable irritation. The mechanism of pterygium formation remains ambiguous, and current treatment is solely surgical excision, with a significant risk of recurrence after surgery. Here, we investigate the role of methylation in DNA sequences that regulate matrix remodeling and cell adhesion in pterygium formation. Methodology/Principal Findings: Pterygium and uninvolved conjunctiva samples were obtained from the same eye of patients undergoing surgery. The EpiTYPER Sequenom technology, based on differential base cleavage and bisulfite sequencing was used to evaluate the extent of methylation of 29 matrix and adhesion related genes. In pterygium, three CpG sites at -268, -32 and -29 bp upstream of transglutaminase 2 (TGM-2) transcription initiation were significantly hypermethylated (p < 0.05), whereas hypomethylation was detected at CpGs +484 and +602 bp downstream of matrix metalloproteinase 2 (MMP-2) transcription start site, and -809, -762, -631 and -629 bp upstream of the CD24 transcription start site. RT-qPCR, western blot and immunofluorescent staining showed that transcript and protein expression were reduced for TGM-2 and increased for MMP-2 and CD24. Inhibition of methylation in cultured conjunctival epithelial cells increased these transcripts. Conclusions/Significance: We found regions of aberrant DNA methylation which were consistent with alteration of TGM-2, MMP-2, and CD24 transcript and protein expression, and that inhibition of methylation in cultured cells can increase the expression of these genes. Since these genes were related to cell adhesion and matrix remodeling, dysregulation may lead to fibroblastic and neovascular changes and pterygium formation. These results have implications for the prognostication of pterygium in clinical practice, for example, detection of epigenetic changes may have a role in predicting post surgical recurrence of aggressive lesions.	[Riau, Andri K.; Wong, Tina T.; Finger, Sharon N.; Chaurasia, Shyam S.; Hou, Ai Hua; Chen, Silin; Yu, Shang Juan; Tong, Louis] Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Lab, Singapore, Singapore; [Wong, Tina T.; Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tina T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Wong, Tina T.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Riau, AK (corresponding author), Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Lab, Singapore, Singapore.	Louistong@hotmail.com	Chaurasia, Shyam/AAB-4709-2019; Riau, Andri/P-9693-2019	Chaurasia, Shyam/0000-0001-8725-676X; Riau, Andri/0000-0002-5105-0484; Tong, Louis/0000-0002-3986-6552	National Medical Research Council of Singapore (NMRC-IBG) [R677/27/2009, CSA/013/2009]; National Research Foundation of Singapore [NMRC/TCR/002-SERI/2008]	National Medical Research Council of Singapore (NMRC-IBG)(National Medical Research Council, Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore)	National Medical Research Council of Singapore (NMRC-IBG, R677/27/2009 and CSA/013/2009) and National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR/002-SERI/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Blanco D, 2007, NEOPLASIA, V9, P840, DOI 10.1593/neo.07517; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Chui J, 2007, INVEST OPHTH VIS SCI, V48, P4482, DOI 10.1167/iovs.07-0123; Coroneo M T, 1999, Curr Opin Ophthalmol, V10, P282, DOI 10.1097/00055735-199908000-00011; Cullinan A, 2008, PHARMACOGENOMICS, V9, P1211, DOI 10.2217/14622416.9.9.1211; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Di Girolamo N, 2001, INVEST OPHTH VIS SCI, V42, P1963; Di Girolamo N, 2006, INVEST OPHTH VIS SCI, V47, P2430, DOI 10.1167/iovs.05-1130; DUSHKU N, 1994, CURR EYE RES, V13, P473, DOI 10.3109/02713689408999878; Dushku N, 2001, ARCH OPHTHALMOL-CHIC, V119, P695, DOI 10.1001/archopht.119.5.695; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Henniker AJ, 2001, J BIOL REG HOMEOS AG, V15, P182; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Igarashi J, 2008, BIOCHEM BIOPH RES CO, V376, P658, DOI 10.1016/j.bbrc.2008.09.044; Ikehata H, 2007, PHOTOCHEM PHOTOBIOL, V83, P196, DOI 10.1562/2006-02-28-IR-822; John-Aryankalayil M, 2006, MOL VIS, V12, P55; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kato N, 2007, INVEST OPHTH VIS SCI, V48, P1511, DOI 10.1167/iovs.06-1060; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lu S, 1997, P NATL ACAD SCI USA, V94, P4692, DOI 10.1073/pnas.94.9.4692; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; MORAN DJ, 1984, BRIT J OPHTHALMOL, V68, P343, DOI 10.1136/bjo.68.5.343; Nestl A, 2001, CANCER RES, V61, P1569; Pedersen MW, 2001, BRIT J CANCER, V85, P1211, DOI 10.1054/bjoc.2001.2053; Perra MT, 2006, MOL VIS, V12, P1136; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Re FB, 2002, J IMMUNOL, V169, P2264, DOI 10.4049/jimmunol.169.5.2264; Riau AK, 2009, MOL VIS, V15, P335; Saleem M, 2009, CARCINOGENESIS, V30, P808, DOI 10.1093/carcin/bgp044; Sathyanarayana UG, 2007, CANCER LETT, V245, P112, DOI 10.1016/j.canlet.2005.12.042; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Song F, 2009, GENOMICS, V93, P130, DOI 10.1016/j.ygeno.2008.09.003; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Tan DTH, 2000, BRIT J OPHTHALMOL, V84, P212, DOI 10.1136/bjo.84.2.212; Tomita T, 2000, CANCER LETT, V156, P83, DOI 10.1016/S0304-3835(00)00446-8; Tong L, 2008, CORNEA, V27, P693, DOI 10.1097/QAI.0b013e31815e4041; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Tong L, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-14; Touhami A, 2005, BRIT J OPHTHALMOL, V89, P269, DOI 10.1136/bjo.2004.050633; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; van den Boom Dirk, 2009, V507, P207, DOI 10.1007/978-1-59745-522-0_16; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang GP, 1999, NUCLEIC ACIDS RES, V27, P1517, DOI 10.1093/nar/27.6.1517; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Ye HQQ, 1998, INVEST OPHTH VIS SCI, V39, P913; Zhang W, 2004, CURR EYE RES, V28, P37, DOI 10.1076/ceyr.28.1.37.23493	61	38	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14687	10.1371/journal.pone.0014687	http://dx.doi.org/10.1371/journal.pone.0014687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359202	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700004
J	Ho, JQ; Asagiri, M; Hoffmann, A; Ghosh, G				Ho, Jessica Q.; Asagiri, Masataka; Hoffmann, Alexander; Ghosh, Gourisankar			NF-kappa B Potentiates Caspase Independent Hydrogen Peroxide Induced Cell Death	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; TNF-ALPHA; ACTIVATION; APOPTOSIS; TRANSCRIPTION; PATHWAY; SURVIVAL; KINASE	Background: The pro-survival activity of NF-kappa B in response to a variety of stimuli has been extensively characterized. Although there have been a few reports addressing the pro-cell death role of NF-kappa B, the precise mechanism of NF-kappa B's procell death function still remains elusive. Methodology/Principal Findings: In the present study, we investigated the role of NF-kappa B in cell death induced by chronic insult with hydrogen peroxide (H2O2). Here, we show that NF-kappa B promotes H2O2 induced caspase independent but PARP dependent fibroblast cell death. The pro-death activity of NF-kappa B is due to the DNA binding activity of RelA, which is induced through IKK-mediated I kappa B alpha degradation. NF-kappa B dependent pro-survival genes, Bcl-2 and XIAP, were significantly repressed, while NF-kappa B dependent pro-death genes, TNF alpha and Fas Ligand, were induced in response to H2O2. Conclusions/Significance: We discovered an unexpected function of NF-kappa B, in that it potentiates chronic H2O2 exposure induced cell death, and suggest that NF-kappa B mediates cell death through the repression of pro-survival genes and induction of pro-death genes. Since unremitting exposure of tissues to H2O2 and other reactive oxygen species can lead to several degenerative disorders and diseases, our results have important implications for the use of NF-kappa B inhibitors in therapeutic drug design.	[Ho, Jessica Q.; Asagiri, Masataka; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ho, JQ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	gghosh@ucsd.edu			National Institutes of Health [GM071862, GM085490]; Ruth L. Kirschstein National Research Service [NIH/NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085490, P01GM071862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM071862 and GM085490. JQH is supported by the Ruth L. Kirschstein National Research Service Award NIH/NCI T32 CA009523. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Gardner AM, 1997, FREE RADICAL BIO MED, V22, P73, DOI 10.1016/S0891-5849(96)00235-3; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gloire G, 2006, ONCOGENE, V25, P5485, DOI 10.1038/sj.onc.1209542; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lin KI, 1998, J CELL BIOL, V141, P1479, DOI 10.1083/jcb.141.7.1479; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Takahashi A, 2002, EXP LUNG RES, V28, P275, DOI 10.1080/01902140252964366; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wang YJ, 2004, J IMMUNOL, V173, P6820, DOI 10.4049/jimmunol.173.11.6820; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Xiao J, 2010, BIOL PHARM BULL, V33, P444, DOI 10.1248/bpb.33.444; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	50	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16815	10.1371/journal.pone.0016815	http://dx.doi.org/10.1371/journal.pone.0016815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347231	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200007
J	Espinosa, N; Marino, J; de Labra, C; Cudeiro, J				Espinosa, Nelson; Marino, Jorge; de Labra, Carmen; Cudeiro, Javier			Cortical Modulation of the Transient Visual Response at Thalamic Level: A TMS Study	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; RECEPTIVE-FIELD ORGANIZATION; RETINAL GANGLION-CELLS; CATS STRIATE CORTEX; SPATIAL SUMMATION; X-CELLS; SPATIOTEMPORAL ORGANIZATION; RELAY CELLS; LGN BURSTS	The transient visual response of feline dorsal lateral geniculate nucleus (dLGN) cells was studied under control conditions and during the application of repetitive transcranial magnetic stimulation at 1 Hz (rTMS@1Hz) on the primary visual cortex (V1). The results show that rTMS@1Hz modulates the firing mode of Y cells, inducing an increase in burst spikes and a decrease in tonic firing. On the other hand, rTMS@1Hz modifies the spatiotemporal characteristics of receptive fields of X cells, inducing a delay and a decrease of the peak response, and a change of the surround/center amplitude ratio of RF profiles. These results indicate that V1 controls the activity of the visual thalamus in a different way in the X and Y pathways, and that this feedback control is consistent with functional roles associated with each cell type.	[Espinosa, Nelson] Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain; Univ A Coruna, Biomed Inst Coruna INIBIC, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Espinosa, N (corresponding author), Univ A Coruna, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain.	jcud@udc.es	de Labra, Carmen/C-9992-2017	de Labra, Carmen/0000-0002-5306-0475; Cudeiro, Javier/0000-0002-6597-6077; , Gerontology Research Group/0000-0001-7207-9481	MICINN, Spain [BFU2009-08169]; Xunta de Galicia (Conselleria de Educacion) [2007/000140-0]	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Conselleria de Educacion)(Xunta de Galicia)	The work was supported by grants BFU2009-08169-MICINN, Spain and Xunta de Galicia (Conselleria de Educacion-2007/000140-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alitto HJ, 2005, J NEUROSCI, V25, P514, DOI 10.1523/JNEUROSCI.3369-04.2005; Aydin-Abidin S, 2006, J PHYSIOL-LONDON, V574, P443, DOI 10.1113/jphysiol.2006.108464; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P525, DOI 10.1113/jphysiol.1984.sp015515; Briggs F, 2009, NEURON, V62, P135, DOI 10.1016/j.neuron.2009.02.024; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; de Labra C, 2007, CEREB CORTEX, V17, P1376, DOI 10.1093/cercor/bhl048; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; FUKUDA Y, 1976, BRAIN RES, V113, P188, DOI 10.1016/0006-8993(76)90018-4; FUNKE K, 1995, J PHYSIOL-LONDON, V485, P715, DOI 10.1113/jphysiol.1995.sp020764; Funke K, 1996, NEUROREPORT, V7, P2130, DOI 10.1097/00001756-199609020-00013; Funke K, 1997, PROG NEUROBIOL, V53, P67, DOI 10.1016/S0301-0082(97)00032-4; GEISERT EE, 1981, BRAIN RES, V208, P409, DOI 10.1016/0006-8993(81)90568-0; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Grieve KL, 2009, BRAIN RES, V1273, P48, DOI 10.1016/j.brainres.2009.03.053; Grubb MS, 2005, J NEUROPHYSIOL, V93, P3224, DOI 10.1152/jn.00445.2004; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KALIL RE, 1970, J NEUROPHYSIOL, V33, P459, DOI 10.1152/jn.1970.33.3.459; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; LINDSTROM S, 1990, J PHYSIOL-LONDON, V429, P259, DOI 10.1113/jphysiol.1990.sp018255; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; MCCLURKIN JW, 1984, J PHYSIOL-LONDON, V348, P135, DOI 10.1113/jphysiol.1984.sp015103; Mix A, 2010, EUR J NEUROSCI, V32, P1575, DOI 10.1111/j.1460-9568.2010.07425.x; Moliadze V, 2003, J PHYSIOL-LONDON, V553, P665, DOI 10.1113/jphysiol.2003.050153; MONTERO VM, 1985, EXP BRAIN RES, V60, P603; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1996, J NEUROSCI, V16, P1180; Murphy PC, 2000, J NEUROSCI, V20, P845, DOI 10.1523/JNEUROSCI.20-02-00845.2000; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; PALMER LA, 1991, NEURAL BASIS VISUAL, P246; Pasley BN, 2009, NEURON, V62, P291, DOI 10.1016/j.neuron.2009.03.012; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Rivadulla C, 2003, J PHYSIOL-LONDON, V553, P601, DOI 10.1113/jphysiol.2003.048561; Rivadulla C, 2002, J NEUROSCI, V22, P2956, DOI 10.1523/JNEUROSCI.22-07-02956.2002; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sack AT, 2006, CURR OPIN NEUROBIOL, V16, P593, DOI 10.1016/j.conb.2006.06.016; SHAPLEY R, 1975, NATURE, V256, P411, DOI 10.1038/256411a0; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; SINGER W, 1977, PHYSIOL REV, V57, P386, DOI 10.1152/physrev.1977.57.3.386; Smith GD, 2002, J NEUROSCI, V22, P10242; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Waleszczyk WJ, 2005, EXP NEUROL, V196, P54, DOI 10.1016/j.expneurol.2005.07.006; Wang W, 2006, NAT NEUROSCI, V9, P1330, DOI 10.1038/nn1768; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Wassermann EM, 1996, LANCET, V347, P825, DOI 10.1016/S0140-6736(96)90898-3; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360	63	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17041	10.1371/journal.pone.0017041	http://dx.doi.org/10.1371/journal.pone.0017041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347322	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000033
J	Rocca, MA; Valsasina, P; Pagani, E; Bianchi-Marzoli, S; Milesi, J; Falini, A; Comi, G; Filippi, M				Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Bianchi-Marzoli, Stefania; Milesi, Jacopo; Falini, Andrea; Comi, Giancarlo; Filippi, Massimo			Extra-Visual Functional and Structural Connection Abnormalities in Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; RESTING-STATE NETWORKS; BEHAVIORAL-DEVELOPMENT; ENERGY-METABOLISM; GREY-MATTER; BRAIN; CORTEX; MUTATION; BASES	We assessed abnormalities within the principal brain resting state networks (RSNs) in patients with Leber's hereditary optic neuropathy (LHON) to define whether functional abnormalities in this disease are limited to the visual system or, conversely, tend to be more diffuse. We also defined the structural substrates of fMRI changes using a connectivity-based analysis of diffusion tensor (DT) MRI data. Neuro-ophthalmologic assessment, DT MRI and RS fMRI data were acquired from 13 LHON patients and 13 healthy controls. RS fMRI data were analyzed using independent component analysis and SPM5. A DT MRI connectivity-based parcellation analysis was performed using the primary visual and auditory cortices, bilaterally, as seed regions. Compared to controls, LHON patients had a significant increase of RS fluctuations in the primary visual and auditory cortices, bilaterally. They also showed decreased RS fluctuations in the right lateral occipital cortex and right temporal occipital fusiform cortex. Abnormalities of RS fluctuations were correlated significantly with retinal damage and disease duration. The DT MRI connectivity-based parcellation identified a higher number of clusters in the right auditory cortex in LHON vs. controls. Differences of cluster-centroid profiles were found between the two groups for all the four seeds analyzed. For three of these areas, a correspondence was found between abnormalities of functional and structural connectivities. These results suggest that functional and structural abnormalities extend beyond the visual network in LHON patients. Such abnormalities also involve the auditory network, thus corroborating the notion of a cross-modal plasticity between these sensory modalities in patients with severe visual deficits.	[Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Filippi, Massimo] Inst Sci, Neuroimaging Res Unit, Milan, Italy; [Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Bianchi-Marzoli, Stefania; Milesi, Jacopo; Falini, Andrea; Comi, Giancarlo; Filippi, Massimo] Univ Osped San Raffaele, Milan, Italy; [Rocca, Maria A.; Valsasina, Paola; Pagani, Elisabetta; Comi, Giancarlo; Filippi, Massimo] Inst Sci, Dept Neurosci, Dept Neurol, Inst Expt Neurol, Milan, Italy; [Bianchi-Marzoli, Stefania; Milesi, Jacopo] Inst Sci, Dept Ophthalmol, Milan, Italy; [Falini, Andrea] Inst Sci, Dept Neuroradiol, Milan, Italy	Vita-Salute San Raffaele University	Rocca, MA (corresponding author), Inst Sci, Neuroimaging Res Unit, Milan, Italy.	m.filippi@hsr.it	Filippi, Massimo/K-1755-2018; Valsasina, Paola/K-5820-2016; Rocca, Maria Assunta/K-1619-2018	Filippi, Massimo/0000-0002-5485-0479; Valsasina, Paola/0000-0001-5390-2655; Rocca, Maria Assunta/0000-0003-2358-4320; falini, andrea/0000-0002-1461-8755; Pagani, Elisabetta/0000-0002-1850-1175				Abu-Amero KK, 2010, BRIT J OPHTHALMOL, V94, P256, DOI 10.1136/bjo.2009.165571; Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364; BARCELLA V, 2010, HUM BRAIN MAPP; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Ciccarelli O, 2005, HUM BRAIN MAPP, V25, P308, DOI 10.1002/hbm.20101; CORTELLI P, 1991, NEUROLOGY, V41, P1211, DOI 10.1212/WNL.41.8.1211; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DeVolder AG, 1997, BRAIN RES, V750, P235, DOI 10.1016/S0006-8993(96)01352-2; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Herschkowitz N, 2000, BRAIN DEV-JPN, V22, P411, DOI 10.1016/S0387-7604(00)00185-6; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Inglese M, 2001, J NEUROL NEUROSUR PS, V70, P444, DOI 10.1136/jnnp.70.4.444; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kitajima M, 1997, AM J NEURORADIOL, V18, P1291; Leclerc C, 2000, NEUROREPORT, V11, P545, DOI 10.1097/00001756-200002280-00024; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Mendola JD, 2005, HUM BRAIN MAPP, V25, P222, DOI 10.1002/hbm.20109; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160; Perrin M, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/368406; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Rocca MA, 2009, HUM BRAIN MAPP, V30, P276, DOI 10.1002/hbm.20504; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; von dem Hagen EAH, 2005, EUR J NEUROSCI, V22, P2475, DOI 10.1111/j.1460-9568.2005.04433.x; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17081	10.1371/journal.pone.0017081	http://dx.doi.org/10.1371/journal.pone.0017081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347331	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000036
J	Banerjee, A; Rao, DN				Banerjee, Arun; Rao, Desirazu N.			Functional Analysis of an Acid Adaptive DNA Adenine Methyltransferase from Helicobacter pylori 26695	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; RESTRICTION-MODIFICATION SYSTEM; CATALYTIC-PROPERTIES; METHYLATION; IDENTIFICATION; MECHANISM; BINDING; MOTIFS; GENES; PURIFICATION	HP0593 DNA-(N-6-adenine)-methyltransferase (HP0593 MTase) is a member of a Type III restriction-modification system in Helicobacter pylori strain 26695. HP0593 MTase has been cloned, overexpressed and purified heterologously in Escherichia coli. The recognition sequence of the purified MTase was determined as 5'-GCAG-3' and the site of methylation was found to be adenine. The activity of HP0593 MTase was found to be optimal at pH 5.5. This is a unique property in context of natural adaptation of H. pylori in its acidic niche. Dot-blot assay using antibodies that react specifically with DNA containing m6A modification confirmed that HP0593 MTase is an adenine-specific MTase. HP0593 MTase occurred as both monomer and dimer in solution as determined by gel-filtration chromatography and chemical-crosslinking studies. The nonlinear dependence of methylation activity on enzyme concentration indicated that more than one molecule of enzyme was required for its activity. Analysis of initial velocity with AdoMet as a substrate showed that two molecules of AdoMet bind to HP0593 MTase, which is the first example in case of Type III MTases. Interestingly, metal ion cofactors such as Co2+, Mn2+, and also Mg2+ stimulated the HP0593 MTase activity. Preincubation and isotope partitioning analyses clearly indicated that HP0593 MTase-DNA complex is catalytically competent, and suggested that DNA binds to the MTase first followed by AdoMet. HP0593 MTase shows a distributive mechanism of methylation on DNA having more than one recognition site. Considering the occurrence of GCAG sequence in the potential promoter regions of physiologically important genes in H. pylori, our results provide impetus for exploring the role of this DNA MTase in the cellular processes of H. pylori.	[Banerjee, Arun; Rao, Desirazu N.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Banerjee, A (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	dnrao@biochem.iisc.ernet.in			Department of Biotechnology, New Delhi, India [BT/PR10407/BRB/10/604/2008]; CSIR; DST	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	The project was funded by Department of Biotechnology, New Delhi, India, grant number BT/PR10407/BRB/10/604/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Genomic DNA of H. pylori 26695 strain and antibodies against N<SUP>6</SUP>-methyladenine were kindly provided by New England Biolabs, USA. Arathi is thanked for technical assistance. Sreelatha is acknowledged for help with BIACORE experiments. Ruchika Sharma, Dr. Shivakumara B and Ritesh Kumar are acknowledged for critical reading of the manuscript and critical discussion. AB thanks CSIR for a Senior Research Fellowship. DNR acknowledges DST for the J.C.Bose Fellowship.	Adams GM, 1997, BIOCHEMISTRY-US, V36, P8284, DOI 10.1021/bi961885n; AHAMD I, 1994, J MOL BIOL, V242, P378, DOI 10.1006/jmbi.1994.1588; AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; BALGANESH TS, 1987, EMBO J, V6, P3543, DOI 10.1002/j.1460-2075.1987.tb02681.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; BERGERAT A, 1991, P NATL ACAD SCI USA, V88, P6394, DOI 10.1073/pnas.88.15.6394; Bhattacharya SK, 1999, J BIOL CHEM, V274, P14743, DOI 10.1074/jbc.274.21.14743; Bheemanaik S, 2003, J BIOL CHEM, V278, P7863, DOI 10.1074/jbc.M211458200; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Bheemanaik S, 2006, BIOL CHEM, V387, P515, DOI 10.1515/BC.2006.067; Bist P, 2003, J BIOL CHEM, V278, P41837, DOI 10.1074/jbc.M307053200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpenter MA, 2008, NUCLEIC ACIDS RES, V36, P5417, DOI 10.1093/nar/gkn528; Chan SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009071; Chang KC, 2001, BIOCHEM BIOPH RES CO, V288, P961, DOI 10.1006/bbrc.2001.5877; DELACAMPA AG, 1987, J MOL BIOL, V196, P457, DOI 10.1016/0022-2836(87)90024-6; Didier W., 2006, NATURE REV, V4, P183; DIEKMANN S, 1987, EMBO J, V6, P4213, DOI 10.1002/j.1460-2075.1987.tb02769.x; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; ENGEL JD, 1978, J BIOL CHEM, V253, P927; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Joseph N, 2004, DNA REPAIR, V3, P1561, DOI 10.1016/j.dnarep.2004.06.014; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; MADHUSOODANAN UK, 2010, CRIT REV BIOCHEM MOL, V39, P1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mruk I, 2003, MICROBIOL-SGM, V149, P3331, DOI 10.1099/mic.0.26562-0; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Piekarowicz A, 1999, J MOL BIOL, V293, P1055, DOI 10.1006/jmbi.1999.3198; Polaczek P, 1998, MOL GEN GENET, V258, P488, DOI 10.1007/s004380050759; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; ROSE IA, 1980, ADV ENZYMOL RELAT AR, V64, P47; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Saha S, 1998, BIOL CHEM, V379, P511, DOI 10.1515/bchm.1998.379.4-5.511; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHERZER E, 1987, J BIOL CHEM, V262, P15225; Segel IH., 1993, ENZYME KINETICS BEHA; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; Thomas CB, 2006, NUCLEIC ACIDS RES, V34, P806, DOI 10.1093/nar/gkj486; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vitkute J, 2001, J BACTERIOL, V183, P443, DOI 10.1128/JB.183.2.443-450.2001; Watanabe M, 2006, APPL ENVIRON MICROB, V72, P5367, DOI 10.1128/AEM.00433-06; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539; WU JC, 1987, J BIOL CHEM, V262, P4778; Zinoviev VV, 2004, MOL BIOL+, V38, P737, DOI 10.1023/B:MBIL.0000043943.07792.80	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16810	10.1371/journal.pone.0016810	http://dx.doi.org/10.1371/journal.pone.0016810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347417	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000287361700036
J	Chen, DS; Barry, AE; Leliwa-Sytek, A; Smith, TA; Peterson, I; Brown, SM; Migot-Nabias, F; Deloron, P; Kortok, MM; Marsh, K; Daily, JP; Ndiaye, D; Sarr, O; Mboup, S; Day, KP				Chen, Donald S.; Barry, Alyssa E.; Leliwa-Sytek, Aleksandra; Smith, Terry-Ann; Peterson, Ingrid; Brown, Stuart M.; Migot-Nabias, Florence; Deloron, Philippe; Kortok, Moses M.; Marsh, Kevin; Daily, Johanna P.; Ndiaye, Daouda; Sarr, Ousmane; Mboup, Souleymane; Day, Karen P.			A Molecular Epidemiological Study of var Gene Diversity to Characterize the Reservoir of Plasmodium falciparum in Humans in Africa	PLOS ONE			English	Article							SICKLE-CELL TRAIT; MALARIA TRANSMISSION; MICROSATELLITE MARKERS; HAPTOGLOBIN GENOTYPE; POPULATION; DENSITY; NUMBER; REPERTOIRE; PATTERNS; KILIFI	Background: The reservoir of Plasmodium infection in humans has traditionally been defined by blood slide positivity. This study was designed to characterize the local reservoir of infection in relation to the diverse var genes that encode the major surface antigen of Plasmodium falciparum blood stages and underlie the parasite's ability to establish chronic infection and transmit from human to mosquito. Methodology/Principal Findings: We investigated the molecular epidemiology of the var multigene family at local sites in Gabon, Senegal and Kenya which differ in parasite prevalence and transmission intensity. 1839 distinct var gene types were defined by sequencing DBL alpha domains in the three sites. Only 76 (4.1%) var types were found in more than one population indicating spatial heterogeneity in var types across the African continent. The majority of var types appeared only once in the population sample. Non-parametric statistical estimators predict in each population at minimum five to seven thousand distinct var types. Similar diversity of var types was seen in sites with different parasite prevalences. Conclusions/Significance: Var population genomics provides new insights into the epidemiology of P. falciparum in Africa where malaria has never been conquered. In particular, we have described the extensive reservoir of infection in local African sites and discovered a unique var population structure that can facilitate superinfection through minimal overlap in var repertoires among parasite genomes. Our findings show that var typing as a molecular surveillance system defines the extent of genetic complexity in the reservoir of infection to complement measures of malaria prevalence. The observed small scale spatial diversity of var genes suggests that var genetics could greatly inform current malaria mapping approaches and predict complex malaria population dynamics due to the import of var types to areas where no widespread pre-existing immunity in the population exists.	[Chen, Donald S.; Barry, Alyssa E.; Leliwa-Sytek, Aleksandra; Smith, Terry-Ann; Peterson, Ingrid; Day, Karen P.] NYU, Sch Med, Dept Med Parasitol, New York, NY 10012 USA; [Chen, Donald S.] NYU, Sch Med, Dept Med, New York, NY USA; [Barry, Alyssa E.; Day, Karen P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Barry, Alyssa E.] Ctr Populat Hlth, Burnet Inst, Melbourne, Vic, Australia; [Barry, Alyssa E.] Monash Univ, Dept Med, Cent & Eastern Clin Sch, Clayton, Vic 3800, Australia; [Brown, Stuart M.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Migot-Nabias, Florence; Deloron, Philippe] Univ Paris 05, Inst Rech Dev, Fac Pharm, Paris, France; [Kortok, Moses M.; Marsh, Kevin] Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Daily, Johanna P.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Daily, Johanna P.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ndiaye, Daouda; Sarr, Ousmane; Mboup, Souleymane] Cheikh Anta Diop Univ, Fac Med & Pharm, Dakar, Senegal	New York University; New York University; University of Oxford; Burnet Institute; Monash University; New York University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Kenya Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University Cheikh Anta Diop Dakar	Chen, DS (corresponding author), NYU, Sch Med, Dept Med Parasitol, New York, NY 10012 USA.	Karen.day@nyumc.org	Deloron, Philippe/G-6305-2010; Day, Karen/F-3697-2015	Deloron, Philippe/0000-0003-4705-2484; Day, Karen/0000-0002-6115-6135; Migot-Nabias, Florence/0000-0001-9982-594X; Barry, Alyssa/0000-0002-1189-2310	NIH/Fogarty International [TW001503]; Bill and Melinda Gates Foundation/Broad Institute; European Union [IC18-CT98-0359]; Wellcome Trust [041354]; NIH/National Institute of General Medical Sciences [GM061351-07]; NIH/National Institute of Allergy and Infectious Disease [R01 AI084156]; NIH [F32AI071765]; Victorian Endowment for Science Knowledge and Innovation; National Health and Medical Research Council, Australia; FOGARTY INTERNATIONAL CENTER [D43TW001503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI071765, R01AI084156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061351] Funding Source: NIH RePORTER	NIH/Fogarty International(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill and Melinda Gates Foundation/Broad Institute(Bill & Melinda Gates Foundation); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Endowment for Science Knowledge and Innovation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge NIH/Fogarty International TW001503: "Training in Malaria Pathogenesis and Diversity in Africa", Bill and Melinda Gates Foundation/Broad Institute: "P. falciparum Genetic Diversity" and ExxonMobil-HSPH Program on Malaria for support of the Senegal field sample collection. Isolates were collected in Gabon thanks to the European Union INCO Programme (contract no. IC18-CT98-0359). This work was supported by Wellcome Trust Programme grant No. 041354 awarded to KPD, NIH/National Institute of General Medical Sciences grant GM061351-07, and NIH/National Institute of Allergy and Infectious Disease grant R01 AI084156. DSC was supported by a NIH Ruth L. Kirschstein National Research Service Award (F32AI071765). AEB was supported by an Innovation Fellowship from the Victorian Endowment for Science Knowledge and Innovation and a Howard Florey Centenary Fellowship from the National Health and Medical Research Council, Australia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2006, MOL BIOCHEM PARASIT, V150, P157, DOI 10.1016/j.molbiopara.2006.07.007; Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Aubouy A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-12; Aubouy A, 2003, ANTIMICROB AGENTS CH, V47, P231, DOI 10.1128/AAC.47.1.231-237.2003; BABIKER HA, 1994, PARASITOLOGY, V109, P413, DOI 10.1017/S0031182000080665; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; BURKOT TR, 1988, AM J TROP MED HYG, V39, P135, DOI 10.4269/ajtmh.1988.39.135; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2009, PROGRAM SPADE SPECIE; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Direction de la Prevision et de la Statistique/Ministere de l'Economie et des finances, 2004, PROJ POP SEN ISS REC; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; EARLE WC, 1962, WHOMAL333; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; FELGER I, 1993, EXP PARASITOL, V77, P372, DOI 10.1006/expr.1993.1094; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Fowler EV, 2002, MOL BIOCHEM PARASIT, V120, P117, DOI 10.1016/S0166-6851(01)00443-1; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerin PJ, 2009, CURR OPIN INFECT DIS, V22, P593, DOI 10.1097/QCO.0b013e328332c4a7; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; *I BRAS GEOGR EST, 2004, CENS MUN PORT VELH 2; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; MACDONALD G, 1964, B WORLD HEALTH ORGAN, V31, P365; *MARA, 2004, POP RISK MAL; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Mu J., 2005, PLOS BIOL, V3, pe335; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Ndiaye D, 2006, ACTA TROP, V99, P106, DOI 10.1016/j.actatropica.2006.07.002; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; *PLASM WRIT GROUP, 2008, COMPR SEQ PROP PLASM; Sallenave-Sales S, 2000, PARASITOL RES, V86, P692, DOI 10.1007/PL00008554; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Smith T, 1999, T ROY SOC TROP MED H, V93, pS53, DOI 10.1016/S0035-9203(99)90328-0; Staalsoe T, 2002, J INFECT DIS, V186, P719, DOI 10.1086/342390; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250	66	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							10.1371	10.1371/journal.pone.0016629	http://dx.doi.org/10.1371/journal.pone.0016629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347415	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700023
J	Hawlitschek, O; Porch, N; Hendrich, L; Balke, M				Hawlitschek, Oliver; Porch, Nick; Hendrich, Lars; Balke, Michael			Ecological Niche Modelling and nDNA Sequencing Support a New, Morphologically Cryptic Beetle Species Unveiled by DNA Barcoding	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; POTENTIAL DISTRIBUTION; DIVING BEETLES; ARID ZONE; CONSERVATISM; EVOLUTION; DISTRIBUTIONS; COLEOPTERA; SPECIATION; GENUS	Background: DNA sequencing techniques used to estimate biodiversity, such as DNA barcoding, may reveal cryptic species. However, disagreements between barcoding and morphological data have already led to controversy. Species delimitation should therefore not be based on mtDNA alone. Here, we explore the use of nDNA and bioclimatic modelling in a new species of aquatic beetle revealed by mtDNA sequence data. Methodology/Principal Findings: The aquatic beetle fauna of Australia is characterised by high degrees of endemism, including local radiations such as the genus Antiporus. Antiporus femoralis was previously considered to exist in two disjunct, but morphologically indistinguishable populations in south-western and south-eastern Australia. We constructed a phylogeny of Antiporus and detected a deep split between these populations. Diagnostic characters from the highly variable nuclear protein encoding arginine kinase gene confirmed the presence of two isolated populations. We then used ecological niche modelling to examine the climatic niche characteristics of the two populations. All results support the status of the two populations as distinct species. We describe the south-western species as Antiporus occidentalis sp.n. Conclusion/Significance: In addition to nDNA sequence data and extended use of mitochondrial sequences, ecological niche modelling has great potential for delineating morphologically cryptic species.	[Hawlitschek, Oliver; Hendrich, Lars; Balke, Michael] Zool State Collect, Dept Entomol, Munich, Germany; [Porch, Nick] Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Balke, Michael] Univ Munich, GeoBioCtr, Munich, Germany	Deakin University; University of Munich	Hawlitschek, O (corresponding author), Zool State Collect, Dept Entomol, Munich, Germany.	Coleoptera-ZSM@zsm.mwn.de		Hawlitschek, Oliver/0000-0001-8010-4157	German Research Foundation (DFG) [HE5729/1-1, BA2152/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work, as well as ongoing research on the Australian predaceous water beetle fauna was supported by grants from the German Research Foundation (DFG) to Lars Hendrich (HE5729/1-1) and Michael Balke (BA2152/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; ANDERSSON L, 1990, TAXON, V39, P375, DOI 10.2307/1223084; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Balke M, 2007, MOL PHYLOGENET EVOL, V42, P505, DOI 10.1016/j.ympev.2006.07.019; Balke M, 2009, P ROY SOC B-BIOL SCI, V276, P2359, DOI 10.1098/rspb.2009.0015; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; BRANCUCCI M, 1984, AQUAT INSECT, V6, P149, DOI 10.1080/01650428409361178; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Buffington Matthew, 2008, American Entomologist, V54, P222; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Chefaoui RM, 2005, BIOL CONSERV, V122, P327, DOI 10.1016/j.biocon.2004.08.005; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Frakes LA, 1987, FAUNA AUSTR A, P1; GOLOBOFF P, 2000, TNT TREE ANAL USING; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HABEL JC, 2010, GLOBAL CHAN IN PRESS; HABEL JC, 2010, BIOL J LINN IN PRESS; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hendrich L., 2004, Koleopterologische Rundschau, V74, P75; Hendrich L., 2001, Linzer Biologische Beitraege, V33, P299; HENDRICH L, 2010, PLOS ONE UNPUB; Hendrich Lars, 2009, Zootaxa, V2288, P1; Hendrich Lars, 2010, Zootaxa, V2338, P35; Hendrich L, 2009, ZOOTAXA, P49, DOI 10.11646/zootaxa.2134.1.4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Johnson NK, 2002, MOL ECOL, V11, P2065, DOI 10.1046/j.1365-294X.2002.01588.x; KEMP EM, 1981, ECOLOGICAL BIOGEOGRA, V1, P31; Knapp S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010502; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Lobo JM, 2006, DIVERS DISTRIB, V12, P179, DOI 10.1111/j.1366-9516.2005.00214.x; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mayr E., 1942, P1; Miller K.B., 2003, Latissimus, V17, P1; Miller M. A., 2010, CIPRES PORTALS; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murienne J, 2009, BIOL J LINN SOC, V97, P177, DOI 10.1111/j.1095-8312.2008.01184.x; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; PAGE RDM, 2010, NATURE P; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Porch N, 2010, QUATERNARY SCI REV, V29, P633, DOI 10.1016/j.quascirev.2009.10.014; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; RODDER D, 2010, SYSTEMATICS CLIMATE; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2010, PAC SCI, V64, P11, DOI 10.2984/64.1.011; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Watts C. H. S., 1997, Records of the South Australian Museum (Adelaide), V30, P35; Watts C. H. S., 2000, Records of the South Australian Museum (Adelaide), V33, P17; Watts C.H.S., 1978, AUSTR J ZOOLOGY S, V57, P1, DOI DOI 10.1071/AJZS057; WATTS CHS, 2004, T ROY SOC S AUS, V130, P123; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Williams W.D., 1987, P156; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	101	45	46	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16662	10.1371/journal.pone.0016662	http://dx.doi.org/10.1371/journal.pone.0016662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347370	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700027
J	Wang, M; Yuan, J; Li, TG; Liu, Y; Wu, JB; Di, BA; Chen, X; Xu, XH; Lu, EJ; Li, KB; Liu, YH; Wu, YJ; Chen, XF; He, P; Wang, YL; Liu, JH				Wang, Ming; Yuan, Jun; Li, Tiegang; Liu, Yang; Wu, Jibin; Di, Biao; Chen, Xi; Xu, Xinhong; Lu, Enjie; Li, Kuibiao; Liu, Yanhui; Wu, Yejian; Chen, Xiongfei; He, Peng; Wang, Yulin; Liu, Jianhua			Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China	PLOS ONE			English	Article							RESPONSES; CHILDREN; ADULTS	Background: To evaluate the risk of the recurrence and the efficiency of the vaccination, we followed-up antibody responses in patients with the 2009 pandemic H1N1 influenza and persons who received the pandemic H1N1 vaccine in Guangzhou China. Methods: We collected serum samples from 129 patients and 86 vaccinated persons at day 0, 15, 30, 180 after the disease onset or the vaccination, respectively. Antibody titers in these serum samples were determined by haemagglutination inhibition (HI) assay using a local isolated virus strain A/Guangdong Liwan/SWL1538/2009(H1N1). Results: HI antibody positive rate of the patients increased significantly from 0% to 60% at day 15 (chi(2)=78, P<0.001) and 100% at day 30 (chi(2)=23, P<0.001), but decreased significantly to 52% at day 180 (chi(2)=38, P<0.001), while that of vaccinated subjects increased from 0% to 78% at day 15 (chi(2)=110, P<0.001) and 81% at day 30 (chi(2)=0.32, P=0.57), but decreased significantly to 34% at day 180 (chi(2)=39, P<0.001). Geometric mean titers (GMT) of HI antibodies in positive samples from the patients did not change significantly between day 15 and day 30 (T=0.92, P=0.36), but it decreased significantly from 80 at day 30 to 52 at day 180 (T=4.5, P<0.001). GMT of vaccinated persons increased significantly from 100 at day 15 to 193 at day 30 (T=4.5, P<0.001), but deceased significantly to 74 at day 180 (T=5.1, P<0.001). Compared to the patients, the vaccinated subjects showed lower seroconversion rate (chi(2)=11, P<0.001; chi(2)=5.9, P=0.015), but higher GMT (T=6.0, P<0.001; T=3.6, P=0.001) at day 30 and day 180, respectively. Conclusion: Vaccination of 2009 influenza A (H1N1) was effective. However, about half or more recovered patients and vaccinated persons might have lost sufficient immunity against the recurrence of the viral infection after half a year. Vaccination or re-vaccination may be necessary for prevention of the recurrence.	[Wang, Ming; Yuan, Jun; Li, Tiegang; Liu, Yang; Wu, Jibin; Di, Biao; Chen, Xi; Xu, Xinhong; Lu, Enjie; Li, Kuibiao; Liu, Yanhui; Wu, Yejian; Chen, Xiongfei; He, Peng; Wang, Yulin; Liu, Jianhua] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Wang, M (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	wangming@gzcdc.org.cn			Ministry of Science and Technology of the People's Republic of China [2009ZX10004-306]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This study was funded by the Ministry of Science and Technology of the People's Republic of China (grant 2009ZX10004-306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; KILBOURNE ED, 1976, J INFECT DIS, V134, P384, DOI 10.1093/infdis/134.4.384; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; *WHO, 2010, FOC H1N1 NOW POSTP P; *WHO, 2010, DIR GEN STAT FOLL 7; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	14	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16809	10.1371/journal.pone.0016809	http://dx.doi.org/10.1371/journal.pone.0016809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347418	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700035
J	Worringham, C; Rojek, A; Stewart, I				Worringham, Charles; Rojek, Amanda; Stewart, Ian			Development and Feasibility of a Smartphone, ECG and GPS Based System for Remotely Monitoring Exercise in Cardiac Rehabilitation	PLOS ONE			English	Article							ATTENDANCE; ADHERENCE; OUTCOMES; SURGERY; SPEED; COST	Background: Despite its efficacy and cost-effectiveness, exercise-based cardiac rehabilitation is undertaken by less than one-third of clinically eligible cardiac patients in every country for which data is available. Reasons for non-participation include the unavailability of hospital-based rehabilitation programs, or excessive travel time and distance. For this reason, there have been calls for the development of more flexible alternatives. Methodology and Principal Findings: We developed a system to enable walking-based cardiac rehabilitation in which the patient's single-lead ECG, heart rate, GPS-based speed and location are transmitted by a programmed smartphone to a secure server for real-time monitoring by a qualified exercise scientist. The feasibility of this approach was evaluated in 134 remotely-monitored exercise assessment and exercise sessions in cardiac patients unable to undertake hospital-based rehabilitation. Completion rates, rates of technical problems, detection of ECG changes, pre- and post-intervention six minute walk test (6 MWT), cardiac depression and Quality of Life (QOL) were key measures. The system was rated as easy and quick to use. It allowed participants to complete six weeks of exercise-based rehabilitation near their homes, worksites, or when travelling. The majority of sessions were completed without any technical problems, although periodic signal loss in areas of poor coverage was an occasional limitation. Several exercise and post-exercise ECG changes were detected. Participants showed improvements comparable to those reported for hospital-based programs, walking significantly further on the post-intervention 6 MWT, 637 m (95% CI: 565-726), than on the pre- test, 524 m (95% CI: 420-655), and reporting significantly reduced levels of cardiac depression and significantly improved physical health-related QOL. Conclusions and Significance: The system provided a feasible and very flexible alternative form of supervised cardiac rehabilitation for those unable to access hospital-based programs, with the potential to address a well-recognised deficiency in health care provision in many countries. Future research should assess its longer-term efficacy, cost-effectiveness and safety in larger samples representing the spectrum of cardiac morbidity and severity.	[Worringham, Charles; Rojek, Amanda; Stewart, Ian] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT)	Worringham, C (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	c.worringham@qut.edu.au	Stewart, Ian B/I-9927-2012	Stewart, Ian/0000-0003-1741-718X; Rojek, Amanda/0000-0002-3948-0756	Australian Research Council [LP0562608]	Australian Research Council(Australian Research Council)	This work was supported by a Linkage Grant LP0562608 from the Australian Research Council awarded to Queensland University of Technology and Alive Technologies, Pty Ltd. Funding agency URL: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Bethell H, 2009, HEART, V95, P271, DOI 10.1136/hrt.2007.134338; Briffa TG, 2005, MED J AUSTRALIA, V183, P450, DOI 10.5694/j.1326-5377.2005.tb07121.x; Carlson J J, 2001, J Cardiopulm Rehabil, V21, P363, DOI 10.1097/00008483-200111000-00004; Carlson JJ, 2000, AM J CARDIOL, V86, P17, DOI 10.1016/S0002-9149(00)00822-5; Collins L, 2001, Aust Health Rev, V24, P51; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Dollard Joanne, 2004, Eur J Cardiovasc Nurs, V3, P27, DOI 10.1016/j.ejcnurse.2003.10.002; Dunlay SM, 2009, AM HEART J, V158, P852, DOI 10.1016/j.ahj.2009.08.010; Fiorina C, 2007, EUR J CARDIO-THORAC, V32, P724, DOI 10.1016/j.ejcts.2007.08.013; FLETCHER GF, 1984, CHEST, V86, P198, DOI 10.1378/chest.86.2.198; GRALL SK, 2000, CLIN EXERC PHYSL, V2, P133; Hare DL, 1996, J PSYCHOSOM RES, V40, P379, DOI 10.1016/0022-3999(95)00612-5; Higgins RO, 2008, MED J AUSTRALIA, V188, P712, DOI 10.5694/j.1326-5377.2008.tb01852.x; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Le Faucheur A, 2008, CIRCULATION, V117, P897, DOI 10.1161/CIRCULATIONAHA.107.725994; Papadakis S, 2005, EUR J CARDIOV PREV R, V12, P513; Pavy B, 2006, ARCH INTERN MED, V166, P2329, DOI 10.1001/archinte.166.21.2329; Scalvini S, 2009, J TELEMED TELECARE, V15, P297, DOI 10.1258/jtt.2009.090208; Scott IA, 2003, MED J AUSTRALIA, V179, P341, DOI 10.5694/j.1326-5377.2003.tb05588.x; SHAW DK, 1995, AM J CARDIOL, V76, P1069, DOI 10.1016/S0002-9149(99)80300-2; SQUIRES RW, 1991, AM J CARDIOL, V67, P962, DOI 10.1016/0002-9149(91)90168-K; Sundararajan V, 2004, MED J AUSTRALIA, V180, P268, DOI 10.5694/j.1326-5377.2004.tb05923.x; Thompson DR, 2009, HEART, V95, P1897, DOI 10.1136/hrt.2009.173732; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Wenger NK, 2008, J AM COLL CARDIOL, V51, P1619, DOI 10.1016/j.jacc.2008.01.030; 2005, MMWR MORB MORTAL WKL, V57, P89	29	124	130	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14669	10.1371/journal.pone.0014669	http://dx.doi.org/10.1371/journal.pone.0014669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347403	Green Published, gold			2022-12-27	WOS:000287361700003
J	Paximadis, M; Minevich, G; Winchester, R; Schramm, DB; Gray, GE; Sherman, GG; Coovadia, AH; Kuhn, L; Tiemessen, CT				Paximadis, Maria; Minevich, Gregory; Winchester, Robert; Schramm, Diana B.; Gray, Glenda E.; Sherman, Gayle G.; Coovadia, Ashraf H.; Kuhn, Louise; Tiemessen, Caroline T.			KIR-HLA and Maternal-Infant HIV-1 Transmission in Sub-Saharan Africa	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR GENES; VIRUS TYPE-1 INFECTION; CLASS-I; DISEASE PROGRESSION; ALLELES; KIR3DL1; RESPONSES; ABSENCE; PROPORTION	Numerous studies have suggested a role for natural killer (NK) cells in attenuation of HIV-1 disease progression via recognition by killer-cell immunoglobulin-like receptors (KIRs) of specific HLA class I molecules. The role of KIR and HLA class I has not been addressed in the context of maternal-infant HIV-1 transmission. KIR and HLA class I B and C genes from 224 HIV-1-infected mothers and 222 infants (72 infected and 150 uninfected) from South Africa were characterized. Although a number of significant associations were determined in both the total group and in the nevirapine (NVP) exposed group, the most significant findings involved KIR2DL2 and KIR2DL3 and HLA-C. KIR2DL2/KIR2DL3 was underrepresented in intrapartum (IP)-transmitting mothers compared to non-transmitting (NT) mothers (P = 0.008) and remained significant (P = 0.036) after correction for maternal viral load (MVL). Homozygosity for KIR2DL3 alone and in combination with HLA-C allotype heterozygosity (C1C2) was elevated in IP-transmitting mothers compared to NT mothers (P = 0.034 and P = 0.01 respectively), and after MVL correction (P = 0.033 and P = 0.027, respectively). In infants, KIR2DL3 in combination with its HLA-C1 ligand (C1) as well as homozygosity for KIR2DL3 with C1C2, were both found to be underrepresented in infected infants compared to exposed uninfected infants in the total group (P = 0.06 and P = 0.038, respectively) and in the sub-group of infants whose mothers received NVP (P = 0.007 and P = 0.03, respectively). These associations were stronger post MVL adjustment (total group: P = 0.02 and P = 0.009, respectively; NVP group: P = 0.004 and P = 0.02, respectively). Upon stratification according to low and high MVL, all significant associations fell within the low MVL group, suggesting that with low viral load, the effects of genotype can be more easily detected. In conclusion this study has identified a number of significant associations that suggest an important role for NK cells in maternal-to-infant HIV-1 transmission.	[Paximadis, Maria; Schramm, Diana B.; Tiemessen, Caroline T.] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa; [Minevich, Gregory; Winchester, Robert] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Gray, Glenda E.] Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, Soweto, South Africa; [Sherman, Gayle G.] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, Johannesburg, South Africa; [Sherman, Gayle G.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Coovadia, Ashraf H.] Univ Witwatersrand, Empilweni Clin, Coronat Women & Children Hosp, Enhancing Childhood HIV Outcomes ECHO, Johannesburg, South Africa; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Tiemessen, Caroline T.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); Columbia University; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Columbia University; Columbia University; University of Witwatersrand	Paximadis, M (corresponding author), Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa.	paxim@nicd.ac.za		Minevich, Gregory/0000-0002-7115-4416; Tiemessen, Caroline/0000-0002-0991-1690	NICHD [42402]; Wellcome Trust; Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042402] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from NICHD 42402, the Wellcome Trust and Elizabeth Glaser Pediatric AIDS Foundation. Caroline T. Tiemessen is a Wellcome Trust International Senior Research Fellow (076352/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Boulet S, 2008, AIDS, V22, P1487, DOI 10.1097/QAD.0b013e3282ffde7e; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gumperz JE, 1997, J IMMUNOL, V158, P5237; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MIDDLETON D, TISSUE ANTIGENS, V61, P403; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MULLER CA, 1989, IMMUNOGENETICS, V30, P200, DOI 10.1007/BF02421207; Schramm DB, 2006, JAIDS-J ACQ IMM DEF, V42, P545, DOI 10.1097/01.qai.0000225009.30698.ce; Stratov I, 2008, J VIROL, V82, P5450, DOI 10.1128/JVI.01952-07; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Tiemessen CT, 2010, J INFECT DIS, V202, P1444, DOI 10.1086/656535; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; UITENBROEK DG, 1997, SISA BINOMIAL SOUTHA; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	34	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16541	10.1371/journal.pone.0016541	http://dx.doi.org/10.1371/journal.pone.0016541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346814	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600009
J	Zaher, H; Pol, D; Carvalho, AB; Nascimento, PM; Riccomini, C; Larson, P; Juarez-Valieri, R; Pires-Domingues, R; da Silva, NJ; Campos, DD				Zaher, Hussam; Pol, Diego; Carvalho, Alberto B.; Nascimento, Paulo M.; Riccomini, Claudio; Larson, Peter; Juarez-Valieri, Ruben; Pires-Domingues, Ricardo; da Silva, Nelson Jorge, Jr.; Campos, Diogenes de Almeida			A Complete Skull of an Early Cretaceous Sauropod and the Evolution of Advanced Titanosaurians	PLOS ONE			English	Article							DINOSAURS; REDESCRIPTION; DIVERSITY; LAMINAE; LINK	Advanced titanosaurian sauropods, such as nemegtosaurids and saltasaurids, were diverse and one of the most important groups of herbivores in the terrestrial biotas of the Late Cretaceous. However, little is known about their rise and diversification prior to the Late Cretaceous. Furthermore, the evolution of their highly-modified skull anatomy has been largely hindered by the scarcity of well-preserved cranial remains. A new sauropod dinosaur from the Early Cretaceous of Brazil represents the earliest advanced titanosaurian known to date, demonstrating that the initial diversification of advanced titanosaurians was well under way at least 30 million years before their known radiation in the latest Cretaceous. The new taxon also preserves the most complete skull among titanosaurians, further revealing that their low and elongated diplodocid-like skull morphology appeared much earlier than previously thought.	[Zaher, Hussam; Carvalho, Alberto B.; Nascimento, Paulo M.; Pires-Domingues, Ricardo] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Riccomini, Claudio; Pires-Domingues, Ricardo] Univ Sao Paulo, Inst Geosci, Sao Paulo, Brazil; [Larson, Peter] Black Hills Inst Geol Res, Hill City, SD USA; [Larson, Peter] Univ Manchester, Manchester, Lancs, England; [Juarez-Valieri, Ruben] Museo Patagon Ciencias Nat, Gen Roca, Rio Negro, Argentina; [da Silva, Nelson Jorge, Jr.] Pontificia Univ Catolica Goias, Dept Biol, Goiania, Go, Brazil; [Campos, Diogenes de Almeida] Museu Ciencias Terra, Dept Nacl Prod Mineral, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; University of Manchester; Pontificia Universidade Catolica de Goias	Zaher, H (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	hzaher@usp.br	da Silva, Nelson Jorge/AAV-1811-2021; Zaher, Hussam/D-4000-2012; Riccomini, Claudio/G-1764-2010; Pol, Diego/A-8007-2008; Silva, Nelson Jorge/Z-3842-2019; Zaher, Hussam/ABC-1701-2021	Zaher, Hussam/0000-0002-6994-489X; Riccomini, Claudio/0000-0002-7249-5706; Pol, Diego/0000-0002-9690-7517; Silva, Nelson Jorge/0000-0001-5517-3791; Zaher, Hussam/0000-0002-6994-489X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by a grant from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP to H. Zaher (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Arai M., 1995, ATAS 14 CONGRESSO BR, P2; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Campos J.E.G., REV BRAS GEOCIENC, V27, P269, DOI [10.25249/0375-7536.1997269282, DOI 10.25249/0375-7536.1997269282]; Carvalho I.S., 1994, STRATIGRAPHIC RANGE; CODDINGTON J, 1994, CLADISTICS, V10, P415; do Carmo D.A., 2004, RBP, V7, P139; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Riccomini C., 2005, MESOZOIC CENOZOIC AL, P31, DOI [10.2138/am.2007.485, DOI 10.2138/AM.2007.485]; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado Leonardo, 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P69; Salgado Leonardo, 1997, Ameghiniana, V34, P3; SANTOS VF, 1994, GAIA, V10, P5; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Suteethorn S, 2009, GEOL SOC SPEC PUBL, V315, P189, DOI 10.1144/SP315.14; TURNER S, 1994, EARTH PLANET SC LETT, V121, P333, DOI 10.1016/0012-821X(94)90076-0; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; WILSON J., 2006, ACT 3 JORN DIN ENT B, P169; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691	34	104	107	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16663	10.1371/journal.pone.0016663	http://dx.doi.org/10.1371/journal.pone.0016663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326881	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037100011
J	Brunnschweiler, JM; Baensch, H				Brunnschweiler, Juerg M.; Baensch, Harald			Seasonal and Long-Term Changes in Relative Abundance of Bull Sharks from a Tourist Shark Feeding Site in Fiji	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; SICKLEFIN LEMON SHARKS; REEF-MARINE-RESERVE; CARCHARHINUS-LEUCAS; CARCHARODON-CARCHARIAS; NEGAPRION-ACUTIDENS; MOVEMENT PATTERNS; FRENCH-POLYNESIA; SOUTH-PACIFIC; BEHAVIOR	Shark tourism has become increasingly popular, but remains controversial because of major concerns originating from the need of tour operators to use bait or chum to reliably attract sharks. We used direct underwater sampling to document changes in bull shark Carcharhinus leucas relative abundance at the Shark Reef Marine Reserve, a shark feeding site in Fiji, and the reproductive cycle of the species in Fijian waters. Between 2003 and 2009, the total number of C. leucas counted on each day ranged from 0 to 40. Whereas the number of C. leucas counted at the feeding site increased over the years, shark numbers decreased over the course of a calendar year with fewest animals counted in November. Externally visible reproductive status information indicates that the species' seasonal departure from the feeding site may be related to reproductive activity.	[Brunnschweiler, Juerg M.] Swiss Fed Inst Technol, Zurich, Switzerland; [Baensch, Harald] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Nebraska System	Brunnschweiler, JM (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	juerg@gluecklich.net	Brunnschweiler, Juerg/A-2110-2008	Brunnschweiler, Juerg/0000-0002-9901-3279	Save Our Seas Foundation; Shark Foundation Switzerland	Save Our Seas Foundation; Shark Foundation Switzerland	This work was funded through grants to JMB from the Save Our Seas Foundation (http://saveourseas.com/) and the Shark Foundation Switzerland (http://www.shark.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2006, CYBIUM, V30, P133; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Buray N, 2009, CYBIUM, V33, P21; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carrier JC, 2004, CRC MAR BIOL SER, P269; Castro ALF, 2005, ENVIRON BIOL FISH, V72, P213, DOI 10.1007/s10641-004-1479-7; Cater C., 2008, NEW FRONTIERS MARINE, DOI 10.1016/B978-0-08-045357-6.50006-1; Catlin J, 2010, INT J TOUR RES, V12, P134, DOI 10.1002/jtr.742; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Colonello JH, 2007, ICES J MAR SCI, V64, P131, DOI 10.1093/icesjms/fsl004; Cruz-Martinez A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P367; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Dicken ML, 2009, AFR J MAR SCI, V31, P227, DOI 10.2989/AJMS.2009.31.2.10.882; Dobson J., 2006, Tourism in Marine Environments, V3, P15, DOI 10.3727/154427306779380275; Dobson J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P49, DOI 10.1079/9781845933456.0049; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; MYRBERG AA, 1974, COPEIA, P358; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Porcher IF, 2005, MAR BIOL, V146, P1207, DOI 10.1007/s00227-004-1518-0; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; SNELSON FF, 1984, B MAR SCI, V34, P71; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	36	48	49	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16597	10.1371/journal.pone.0016597	http://dx.doi.org/10.1371/journal.pone.0016597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21346792	Green Published, Green Submitted, gold			2022-12-27	WOS:000286663900079
J	Koo, MS; Manca, C; Yang, G; O'Brien, P; Sung, N; Tsenova, L; Subbian, S; Fallows, D; Muller, G; Ehrt, S; Kaplan, G				Koo, Mi-Sun; Manca, Claudia; Yang, Guibin; O'Brien, Paul; Sung, Nackmoon; Tsenova, Liana; Subbian, Selvakumar; Fallows, Dorothy; Muller, George; Ehrt, Sabine; Kaplan, Gilla			Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice	PLOS ONE			English	Article							MICROBIAL ENUMERATION TECHNIQUE; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; MOUSE TISSUES; IN-VITRO; PULMONARY TUBERCULOSIS; TUBERCLE BACILLI; CONTROLLED-TRIAL; CYCLIC-AMP; T-CELLS	Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the leading infectious disease causes of morbidity and mortality worldwide. Though current antibiotic regimens can cure the disease, treatment requires at least six months of drug therapy. One reason for the long duration of therapy is that the currently available TB drugs were selected for their ability to kill replicating organisms and are less effective against subpopulations of non-replicating persistent bacilli. Evidence from in vitro models of Mtb growth and mouse infection studies suggests that host immunity may provide some of the environmental cues that drive Mtb towards non-replicating persistence. We hypothesized that selective modulation of the host immune response to modify the environmental pressure on the bacilli may result in better bacterial clearance during TB treatment. For this proof of principal study, we compared bacillary clearance from the lungs of Mtb-infected mice treated with the anti-TB drug isoniazid (INH) in the presence and absence of an immunomodulatory phosphodiesterase 4 inhibitor (PDE4i), CC-3052. The effects of CC-3052 on host global gene expression, induction of cytokines, and T cell activation in the lungs of infected mice were evaluated. We show that CC-3052 modulates the innate immune response without causing generalized immune suppression. Immune modulation combined with INH treatment improved bacillary clearance and resulted in smaller granulomas and less lung pathology, compared to treatment with INH alone. This novel strategy of combining anti-TB drugs with an immune modulating molecule, if applied appropriately to patients, may shorten the duration of TB treatment and improve clinical outcome.	[Koo, Mi-Sun; Manca, Claudia; Yang, Guibin; O'Brien, Paul; Sung, Nackmoon; Tsenova, Liana; Subbian, Selvakumar; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Muller, George] Celgene Corp, San Diego, CA USA; [Sung, Nackmoon] Natl Masan Hosp, Clin Res Ctr, Masan, Gyeongsangnam, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; Bristol-Myers Squibb; Celgene Corporation	Koo, MS (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA.	kaplangi@umdnj.edu	Ehrt, Sabine/AAU-6449-2020	Subbian, Selvakumar/0000-0003-2021-8632	Bill and Melinda Gates Foundation; The Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); The Heiser Program for Research in Leprosy and Tuberculosis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Bill and Melinda Gates Foundation. NS was funded by The Heiser Program for Research in Leprosy and Tuberculosis. The funders had no role in study design and data collection as well as decision to publish. However, GM is an employee of Celgene and GK is on the board of Celgene, and Celgene approved the decision to publish and reviewed the manuscript before publication.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Bartek IL, 2009, TUBERCULOSIS, V89, P310, DOI 10.1016/j.tube.2009.06.001; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Bilaceroglu S, 1999, INT J TUBERC LUNG D, V3, P47; BLOOM BR, 1994, IMMUNOBIOLOGY, V191, P526, DOI 10.1016/S0171-2985(11)80459-6; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Caruso AM, 1999, J IMMUNOL, V162, P5407; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Corral LG, 1999, J IMMUNOL, V163, P380; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GONZALEZJUARRER.M, 2009, CELL, V40, P398; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guckian M, 2000, CLIN EXP IMMUNOL, V121, P472, DOI 10.1046/j.1365-2249.2000.01332.x; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; HORNE NW, 1960, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.5215.1751; Jain S. K., 2008, MICROBE, V3, P285, DOI [DOI 10.1128/MICROBE.3.285.1, DOI 10.1128/MICR0BE.3.285.1]; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Manca C, 1999, J IMMUNOL, V162, P6740; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Marriott JB, 2002, CLIN EXP IMMUNOL, V130, P75, DOI 10.1046/j.1365-2249.2002.01954.x; Marriott JB, 1998, J IMMUNOL, V161, P4236; Mayanja-Kizza H, 2005, J INFECT DIS, V191, P856, DOI 10.1086/427995; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Mootoo Amanda, 2009, Inflammation & Allergy Drug Targets, V8, P53; MUTHUSWAMY P, 1995, CHEST, V107, P1621, DOI 10.1378/chest.107.6.1621; Nathan C., 2004, TUBERCULOSIS, V84, P215; NUSSLER AK, 1994, J BIOL CHEM, V269, P1257; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Thorn CF, 2002, AMYLOID, V9, P229, DOI 10.3109/13506120209114098; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351, DOI 10.1164/ajrccm.157.2.9708012; TSENOVA L, 1997, J AM BIOL SAFETY ASS, V2, P20; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wallis RS, 2004, AIDS, V18, P257, DOI 10.1097/00002030-200401230-00015; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; WHO, 2010, GLOB TUB CONTR SHORT	56	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17091	10.1371/journal.pone.0017091	http://dx.doi.org/10.1371/journal.pone.0017091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364878	Green Submitted, gold, Green Published			2022-12-27	WOS:000287764100027
J	Smith, CS; Epstein, JH; Breed, AC; Plowright, RK; Olival, KJ; de Jong, C; Daszak, P; Field, HE				Smith, Craig S.; Epstein, Jonathan H.; Breed, Andrew C.; Plowright, Raina K.; Olival, Kevin J.; de Jong, Carol; Daszak, Peter; Field, Hume E.			Satellite Telemetry and Long-Range Bat Movements	PLOS ONE			English	Article							HEADED FLYING-FOXES; PTEROPUS-POLIOCEPHALUS; NIPAH VIRUS; PTEROPODIDAE; CHIROPTERA; ALECTO	Background: Understanding the long-distance movement of bats has direct relevance to studies of population dynamics, ecology, disease emergence, and conservation. Methodology/Principal Findings: We developed and trialed several collar and platform terminal transmitter (PTT) combinations on both free-living and captive fruit bats (Family Pteropodidae: Genus Pteropus). We examined transmitter weight, size, profile and comfort as key determinants of maximized transmitter activity. We then tested the importance of bat-related variables (species size/weight, roosting habitat and behavior) and environmental variables (day-length, rainfall pattern) in determining optimal collar/PTT configuration. We compared battery-and solar-powered PTT performance in various field situations, and found the latter more successful in maintaining voltage on species that roosted higher in the tree canopy, and at lower density, than those that roost more densely and lower in trees. Finally, we trialed transmitter accuracy, and found that actual distance errors and Argos location class error estimates were in broad agreement. Conclusions/Significance: We conclude that no single collar or transmitter design is optimal for all bat species, and that species size/weight, species ecology and study objectives are key design considerations. Our study provides a strategy for collar and platform choice that will be applicable to a larger number of bat species as transmitter size and weight continue to decrease in the future.	[Smith, Craig S.; de Jong, Carol; Field, Hume E.] Biosecur Queensland, Econ Dev & Innovat, Dept Employment, Biosecur Sci Lab, Coopers Plains, Qld, Australia; [Epstein, Jonathan H.; Olival, Kevin J.; Daszak, Peter] EcoHlth Alliance, New York, NY USA; [Breed, Andrew C.] Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Surrey, England; [Plowright, Raina K.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	Queensland Department of Agriculture & Fisheries; EcoHealth Alliance; Veterinary Laboratories Agency; University of California System; University of California Davis	Smith, CS (corresponding author), Biosecur Queensland, Econ Dev & Innovat, Dept Employment, Biosecur Sci Lab, Coopers Plains, Qld, Australia.	hume.field@deedi.qld.gov.au	daszak, peter/U-4588-2017; Breed, Andrew C/A-5682-2011	daszak, peter/0000-0002-2046-5695; Breed, Andrew C/0000-0002-3439-9510; Olival, Kevin/0000-0003-3211-1875	John E. Fogarty International Center [R01 TW005869]; Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was core-funded by an NSF/NIH Ecology of Infectious Diseases award (R01 TW005869) from the John E. Fogarty International Center (http://www.fic.nih.gov/) awarded to Peter Daszak, and partially funded by the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Diseases (http://www.abcrc.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ARGOS TOOLS SUPPORT; [Anonymous], 2010, TELNET PROTOCOL; [Anonymous], 2010, CSL COLLECTE LOCALIS; Bander R, 1991, RADIO LOCATION TELEM; Breed AC, 2010, ECO HLTH IN PRESS; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Daszak P, 2006, DIS ECOLOGY COMMUNIT; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Hall L.S., 2000, FLYING FOXES FRUIT B; Heard DJ, 1996, J ZOO WILDLIFE MED, V27, P44; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Jonsson NN, 2004, VET REC, V154, P664, DOI 10.1136/vr.154.21.664; Judas J, 2006, IBIS, V148, P343, DOI 10.1111/j.1474-919X.2006.00546.x; Mackenzie JS, 2003, J APPL MICROBIOL, V94, p59S; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Mickleburg S., 1992, OLD WORLD FRUIT BATS; Olival Kevin J., 2006, P319; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1046/j.1442-9993.2001.01072.x; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; USGS, 1998, OP CRAN WATCH; Vardon MJ, 2001, J ZOOL, V253, P523, DOI 10.1017/S0952836901000486; Williams NSG, 2006, AUSTRAL ECOL, V31, P190, DOI 10.1111/j.1442-9993.2006.01590.x	29	44	45	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14696	10.1371/journal.pone.0014696	http://dx.doi.org/10.1371/journal.pone.0014696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358823	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700009
J	Dovas, A; Gligorijevic, B; Chen, XM; Entenberg, D; Condeelis, J; Cox, D				Dovas, Athanassios; Gligorijevic, Bojana; Chen, Xiaoming; Entenberg, David; Condeelis, John; Cox, Dianne			Visualization of Actin Polymerization in Invasive Structures of Macrophages and Carcinoma Cells Using Photoconvertible beta-Actin-Dendra2 Fusion Proteins	PLOS ONE			English	Article							BARBED ENDS; N-WASP; PODOSOMES; ARGINYLATION; COFILIN; NUCLEATION; CORTACTIN	Actin polymerization controls a range of cellular processes, from intracellular trafficking to cell motility and invasion. Generation and elongation of free barbed ends defines the regions of actively polymerizing actin in cells and, consequently, is of importance in the understanding of the mechanisms through which actin dynamics are regulated. Herein we present a method that does not involve cell permeabilization and provides direct visualization of growing barbed ends using photoswitchable beta-actin - Dendra2 constructs expressed in murine macrophage and rat mammary adenocarcinoma cell lines. The method exploits the ability of photoconverted (red) G-actin species to become incorporated into pre-existing (green) actin filaments, visualized in two distinct wavelengths using TIRF microscopy. In growing actin filaments, photoconverted (red) monomers are added to the barbed end while only green monomers are recycled from the pointed end. We demonstrate that incorporation of actin into intact podosomes of macrophages occurs constitutively and is amenable to inhibition by cytochalasin D indicating barbed end incorporation. Additionally, actin polymerization does not occur in quiescent invadopodial precursors of carcinoma cells suggesting that the filaments are capped and following epidermal growth factor stimulation actin incorporation occurs in a single but extended peak. Finally, we show that Dendra2 fused to either the N- or the C-terminus of beta-actin profoundly affects its localization and incorporation in distinct F-actin structures in carcinoma cells, thus influencing the ability of monomers to be photoconverted. These data support the use of photoswitchable actin-Dendra2 constructs as powerful tools in the visualization of free barbed ends in living cells.	[Dovas, Athanassios; Gligorijevic, Bojana; Entenberg, David; Condeelis, John] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Dovas, A (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA.	dianne.cox@einstein.yu.edu	gligorijevic, bojana/AAV-9687-2020; Entenberg, David/AAT-2722-2020	Entenberg, David/0000-0003-0422-7264; gligorijevic, bojana/0000-0001-9071-7467; Cox, Dianne/0000-0002-0591-9767	NIH [GM07828, CA150344, CA100324]; Revson; NATIONAL CANCER INSTITUTE [R01CA150344, P01CA100324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Revson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (GM07828 to DC and CA150344 to JC, CA100324 to DE), and a postdoctoral fellowship from Revson to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Ballestrem C, 1998, J CELL SCI, V111, P1649; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Campbell JJ, 2007, MICROSC RES TECHNIQ, V70, P1034, DOI 10.1002/jemt.20513; Chan AY, 1998, J CELL SCI, V111, P199; Condeelis J, 2005, BIOL CELL, V97, P97; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kashina AS, 2006, TRENDS CELL BIOL, V16, P610, DOI 10.1016/j.tcb.2006.10.001; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; NERI A, 1982, J NATL CANCER I, V68, P507; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Saha S, 2010, MOL BIOL CELL, V21, P1350, DOI 10.1091/mbc.E09-09-0829; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16485	10.1371/journal.pone.0016485	http://dx.doi.org/10.1371/journal.pone.0016485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339827	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600013
J	Lizundia, R; Newman, C; Buesching, CD; Ngugi, D; Blake, D; Sin, YW; Macdonald, DW; Wilson, A; McKeever, D				Lizundia, Regina; Newman, Chris; Buesching, Christina D.; Ngugi, Daniel; Blake, Damer; Sin, Yung Wa; Macdonald, David W.; Wilson, Alan; McKeever, Declan			Evidence for a Role of the Host-Specific Flea (Paraceras melis) in the Transmission of Trypanosoma (Megatrypanum) pestanai to the European Badger	PLOS ONE			English	Article							MELES-MELES; CLETHRIONOMYS-GLAREOLUS; EURASIAN BADGER; RIBOSOMAL-RNA; RAT FLEA; PARASITES; ECTOPARASITES; TESTOSTERONE; COCCIDIOSIS; MORPHOLOGY	We investigated the epidemiology of Trypanosoma pestanai infection in European badgers (Meles meles) from Wytham Woods (Oxfordshire, UK) to determine prevalence rates and to identify the arthropod vector responsible for transmission. A total of 245 badger blood samples was collected during September and November 2009 and examined by PCR using primers derived from the 18S rRNA of T. pestanai. The parasite was detected in blood from 31% of individuals tested. T. pestanai was isolated from primary cultures of Wytham badger peripheral blood mononuclear cells and propagated continually in vitro. This population was compared with cultures of two geographically distinct isolates of the parasite by amplified fragment length polymorphism (AFLP) and PCR analysis of 18S rDNA and ITS1 sequences. High levels of genotypic polymorphism were observed between the isolates. PCR analysis of badger fleas (Paraceras melis) collected from infected individuals at Wytham indicated the presence of T. pestanai and this was confirmed by examination of dissected specimens. Wet smears and Giemsa-stained preparations from dissected fleas revealed large numbers of trypanosome-like forms in the hindgut, some of which were undergoing binary fission. We conclude that P. melis is the primary vector of T. pestanai in European badgers.	[Lizundia, Regina; Ngugi, Daniel; Blake, Damer; Wilson, Alan; McKeever, Declan] Univ London Royal Vet Coll, Hatfield, Herts, England; [Newman, Chris; Buesching, Christina D.; Sin, Yung Wa; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Abingdon, Oxon, England	University of London; University of London Royal Veterinary College; University of Oxford	Lizundia, R (corresponding author), Univ London Royal Vet Coll, Hatfield, Herts, England.	dmckeever@rvc.ac.uk		Blake, Damer/0000-0003-1077-2306; Sin, Simon Yung Wa/0000-0003-2484-2897	Peoples' Trust for Endangered Species	Peoples' Trust for Endangered Species	The fieldwork was supported by a grant to DWM from the Peoples' Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MA, 2000, PARASITOLOGY, V120, P255, DOI 10.1017/S0031182099005491; Bettencourt A, 1905, ARCH I R BACTERIAL, V1, P73; Blake DP, 2003, PARASITOL RES, V90, P473, DOI 10.1007/s00436-003-0890-x; BOSE R, 1993, J EUKARYOT MICROBIOL, V40, P788, DOI 10.1111/j.1550-7408.1993.tb04475.x; BRABIN L, 1992, ADV PARASIT, V31, P1, DOI 10.1016/S0065-308X(08)60020-2; Butler JM, 1996, ANIM BEHAV, V52, P621, DOI 10.1006/anbe.1996.0203; Cox R, 1999, J INSECT BEHAV, V12, P245, DOI 10.1023/A:1020923001987; Filipin MD, 2010, RES VET SCI, V89, P98, DOI 10.1016/j.rvsc.2010.01.016; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2005, MOL ECOL, V14, P3167, DOI 10.1111/j.1365-294X.2005.02602.x; Hamilton PB, 2005, INT J PARASITOL, V35, P431, DOI 10.1016/j.ijpara.2004.12.005; Hoare C. A., 1923, Parasitology Cambridge, V15, P365, DOI 10.1017/S0031182000014888; Hoare CA, 1972, TRYPANOSOMES MAMMALS, P3; KRUUK H, 1978, J ZOOL, V184, P1; Kruuk H, 1978, ECOLOGY SOCIOBIOLOGY, V4, P14; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; Macdonald DW, 1999, J ZOOL, V247, P65, DOI 10.1111/j.1469-7998.1999.tb00193.x; McCarthy G, 2009, VET CLIN PATH, V38, P381, DOI 10.1111/j.1939-165X.2009.00127.x; Minchin EA, 1911, BRIT MED J, V1911, P1309; MOHAMED HA, 1987, J PARASITOL, V73, P1050, DOI 10.2307/3282534; Molyneux D.H., 1976, P285; MOLYNEUX DH, 1969, ANN TROP MED PARASIT, V63, P229, DOI 10.1080/00034983.1969.11686624; MOLYNEUX DH, 1969, PARASITOLOGY, V59, P843, DOI 10.1017/S0031182000070360; Neal E., 1996, BADGERS; Newman C, 2001, PARASITOLOGY, V123, P133, DOI 10.1017/S0031182001008265; Noyes HA, 2002, PARASITOLOGY, V124, P185, DOI 10.1017/S0031182001001019; Olsson M, 2000, P ROY SOC B-BIOL SCI, V267, P2339, DOI 10.1098/rspb.2000.1289; PEIRCE M A, 1974, International Journal for Parasitology, V4, P439, DOI 10.1016/0020-7519(74)90055-1; RIOUX J. A., 1966, ANN PARASITOL HUM COMP, V41, P281; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 1999, INT J PARASITOL, V29, P749, DOI 10.1016/S0020-7519(99)00016-8; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Stewart PD, 1999, ANIM BEHAV, V57, P153, DOI 10.1006/anbe.1998.0935; Strickland C, 1911, BRIT MED J, V1911, P1049, DOI 10.1136/bmj.1.2627.1049; Thekisoe OMM, 2007, PARASITOLOGY, V134, P967, DOI 10.1017/S0031182007002375; Thornton PD, 2005, VET ANAESTH ANALG, V32, P40, DOI 10.1111/j.1467-2995.2004.00163.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEINSTEIN Y, 1984, J IMMUNOL, V132, P656	39	23	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16977	10.1371/journal.pone.0016977	http://dx.doi.org/10.1371/journal.pone.0016977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340028	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600028
J	Rodrigo, G; Elena, SF				Rodrigo, Guillermo; Elena, Santiago F.			Structural Discrimination of Robustness in Transcriptional Feedforward Loops for Pattern Formation	PLOS ONE			English	Article							FOLD-CHANGE DETECTION; NETWORK MOTIFS; GENE; NOISE; DESIGN; CHEMOTAXIS; ADAPTATION; MECHANISMS; EXPRESSION; STABILITY	Signaling pathways are interconnected to regulatory circuits for sensing the environment and expressing the appropriate genetic profile. In particular, gradients of diffusing molecules (morphogens) determine cell fate at a given position, dictating development and spatial organization. The feedforward loop (FFL) circuit is among the simplest genetic architectures able to generate one-stripe patterns by operating as an amplitude detection device, where high output levels are achieved at intermediate input ones. Here, using a heuristic optimization-based approach, we dissected the design space containing all possible topologies and parameter values of the FFL circuits. We explored the ability of being sensitive or adaptive to variations in the critical morphogen level where cell fate is switched. We found four different solutions for precision, corresponding to the four incoherent architectures, but remarkably only one mode for adaptiveness, the incoherent type 4 (I4-FFL). We further carried out a theoretical study to unveil the design principle for such structural discrimination, finding that the synergistic action and cooperative binding on the downstream promoter are instrumental to achieve absolute adaptive responses. Subsequently, we analyzed the robustness of these optimal circuits against perturbations in the kinetic parameters and molecular noise, which has allowed us to depict a scenario where adaptiveness, parameter sensitivity and noise tolerance are different, correlated facets of the robustness of the I4-FFL circuit. Strikingly, we showed a strong correlation between the input (environment-related) and the intrinsic (mutation-related) susceptibilities. Finally, we discussed the evolution of incoherent regulations in terms of multifunctionality and robustness.	[Rodrigo, Guillermo; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Rodrigo, G (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	guirodta@ibmcp.upv.es	Elena, Santiago F./A-4191-2011; Rodrigo, Guillermo/K-9207-2014	Elena, Santiago F./0000-0001-8249-5593; Rodrigo, Guillermo/0000-0002-1871-9617	Spanish Ministerio de Ciencia e Innovacion [BFU-2009-06993]; Generalitat Valenciana [BFPI-2007-160]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion grant BFU-2009-06993. GR is the recipient of a graduate fellowship from the Generalitat Valenciana (BFPI-2007-160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Entus Robert, 2007, Syst Synth Biol, V1, P119, DOI 10.1007/s11693-007-9008-6; Ghosh B, 2005, PHYS BIOL, V2, P36, DOI 10.1088/1478-3967/2/1/005; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Macia J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-84; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papatsenko D, 2005, P NATL ACAD SCI USA, V102, P4966, DOI 10.1073/pnas.0409414102; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Rodrigo G, 2007, BIOINFORMATICS, V23, P1857, DOI 10.1093/bioinformatics/btm237; Rodrigo G, 2010, BIOCHIMIE, V92, P746, DOI 10.1016/j.biochi.2010.04.003; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Sontag ED, 2010, IET SYST BIOL, V4, P39, DOI 10.1049/iet-syb.2008.0171; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wagner A., 2005, ROBUSTNESS EVOLVABIL; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	42	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16904	10.1371/journal.pone.0016904	http://dx.doi.org/10.1371/journal.pone.0016904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340024	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600023
J	Stawarczyk, D; Majerus, S; Maquet, P; D'Argembeau, A				Stawarczyk, David; Majerus, Steve; Maquet, Pierre; D'Argembeau, Arnaud			Neural Correlates of Ongoing Conscious Experience: Both Task-Unrelatedness and Stimulus-Independence Are Related to Default Network Activity	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; LEFT INTRAPARIETAL SULCUS; STREAM-OF-CONSCIOUSNESS; SHORT-TERM-MEMORY; WORKING-MEMORY; WANDERING MINDS; BRAIN ACTIVITY; RESTING STATE; AUTOBIOGRAPHICAL MEMORY; SUBJECTIVE EXPERIENCE	The default mode network (DMN) is a set of brain regions that consistently shows higher activity at rest compared to tasks requiring sustained focused attention toward externally presented stimuli. The cognitive processes that the DMN possibly underlies remain a matter of debate. It has alternately been proposed that DMN activity reflects unfocused attention toward external stimuli or the occurrence of internally generated thoughts. The present study aimed at clarifying this issue by investigating the neural correlates of the various kinds of conscious experiences that can occur during task performance. Four classes of conscious experiences (i.e., being fully focused on the task, distractions by irrelevant sensations/perceptions, interfering thoughts related to the appraisal of the task, and mind-wandering) that varied along two dimensions ("task-relatedness" and "stimulus-dependency") were sampled using thought-probes while the participants performed a go/no-go task. Analyses performed on the intervals preceding each probe according to the reported subjective experience revealed that both dimensions are relevant to explain activity in several regions of the DMN, namely the medial prefrontal cortex, posterior cingulate cortex/precuneus, and posterior inferior parietal lobe. Notably, an additive effect of the two dimensions was demonstrated for midline DMN regions. On the other hand, lateral temporal regions (also part of the DMN) were specifically related to stimulus-independent reports. These results suggest that midline DMN regions underlie cognitive processes that are active during both internal thoughts and external unfocused attention. They also strengthen the view that the DMN can be fractionated into different subcomponents and reveal the necessity to consider both the stimulus-dependent and the task-related dimensions of conscious experiences when studying the possible functional roles of the DMN.	[Stawarczyk, David; Majerus, Steve; D'Argembeau, Arnaud] Univ Liege, Dept Cognit Sci, Liege, Belgium; [Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of Liege; University of Liege	Stawarczyk, D (corresponding author), Univ Liege, Dept Cognit Sci, Liege, Belgium.	d.stawarczyk@ulg.ac.be	Majerus, Steve/D-4678-2009	Majerus, Steve/0000-0002-8206-8097; D'Argembeau, Arnaud/0000-0003-3618-9768; , Pierre/0000-0003-3106-3357	National Fund for Scientific Research (Belgium)	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are supported by the National Fund for Scientific Research (Belgium; http://www2.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Benoit RG, 2010, NEUROIMAGE, V50, P1340, DOI 10.1016/j.neuroimage.2009.12.091; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Christoff K, NEUROSCIENC IN PRESS; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cunningham S., 2000, J MENTAL IMAG, V24, P61; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; D'Argembeau A, 2010, SOC NEUROSCI-UK, V5, P187, DOI 10.1080/17470910903233562; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dumontheil I, 2010, Q J EXP PSYCHOL, V63, P1740, DOI 10.1080/17470210903538114; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Forster S, 2008, J EXP PSYCHOL-APPL, V14, P73, DOI 10.1037/1076-898X.14.1.73; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; GIAMBRA LM, 1995, CONSCIOUS COGN, V4, P1, DOI 10.1006/ccog.1995.1001; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Gold S. R., 1985, IMAGIN COGN PERS, V5, P117; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; KLINGER E, 1980, J PERS SOC PSYCHOL, V39, P1222, DOI 10.1037/h0077724; Klinger E., 2009, HDB IMAGINATION MENT, P225, DOI DOI 10.4324/9780203809846.CH15; Lustig C, 2001, EUR J COGN PSYCHOL, V13, P107, DOI 10.1080/09541440042000241; Lutz A, 2003, J CONSCIOUSNESS STUD, V10, P31; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mason MF, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1141078; Matthews G, 1999, HDB COPING THEORY RE, P333; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schmitz TW, 2007, NEUROSCI BIOBEHAV R, V31, P585, DOI 10.1016/j.neubiorev.2006.12.003; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; SINGER JL, 1993, CIBA F SYMP, V174, P100; Singer JL, 1998, EMPIRICAL PERSPECTIV, P141; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2008, BRAIN COGNITION, V66, P50, DOI 10.1016/j.bandc.2007.05.004; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stawarczyk D, ACTA PSYCHO IN PRESS; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TEASDALE JD, 1993, EUR J COGN PSYCHOL, V5, P417, DOI 10.1080/09541449308520128; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Unsworth N, 2010, INTELLIGENCE, V38, P111, DOI 10.1016/j.intell.2009.08.002; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Walther S, 2010, NEUROREPORT, V21, P191, DOI 10.1097/WNR.0b013e328335640f; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	95	200	203	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16997	10.1371/journal.pone.0016997	http://dx.doi.org/10.1371/journal.pone.0016997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721PR	21347270	Green Published, gold			2022-12-27	WOS:000287367600030
J	Wang, PY; Pai, LM				Wang, Pei-Yu; Pai, Li-Mei			D-Cbl Binding to Drk Leads to Dose-Dependent Down-Regulation of EGFR Signaling and Increases Receptor-Ligand Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-COATED PITS; TYROSINE KINASE; C-CBL; RING FINGER; V-CBL; DROSOPHILA OOGENESIS; NEGATIVE REGULATOR; IN-VIVO; PROTEIN	Proper control of Epidermal Growth Factor Receptor (EGFR) signaling is critical for normal development and regulated cell behaviors. Abnormal EGFR signaling is associated with tumorigenic process of various cancers. Complicated feedback networks control EGFR signaling through ligand production, and internalization-mediated destruction of ligand-receptor complexes. Previously, we found that two isoforms of D-Cbl, D-CblS and D-CblL, regulate EGFR signaling through distinct mechanisms. While D-CblL plays a crucial role in dose-dependent down-regulation of EGFR signaling, D-CblS acts in normal restriction of EGFR signaling and does not display dosage effect. Here, we determined the underlying molecular mechanism, and found that Drk facilitates the dose-dependent regulation of EGFR signaling through binding to the proline-rich motif of D-CblL, PR. Furthermore, the RING finger domain of D-CblL is essential for promoting endocytosis of the ligand-receptor complex. Interestingly, a fusion protein of the two essential domains of D-CblL, RING-PR, is sufficient to down-regulate EGFR signal in a dose-dependent manner by promoting internalization of the ligand, Gurken. Besides, RING-SH2(Drk), a fusion protein of the RING finger domain of D-Cbl and the SH2 domain of Drk, also effectively down-regulates EGFR signaling in Drosophila follicle cells, and suppresses the effects of constitutively activated EGFR. The RING-SH2(Drk) suppresses EGFR signaling by promoting the endosomal trafficking of ligand-receptor complexes, suggesting that Drk plays a negative role in EGFR signaling by enhancing receptor endocytosis through cooperating with the RING domain of D-Cbl. Interfering the recruitment of signal transducer, Drk, to the receptor by the RING-SH2(Drk) might further reduces EGFR signaling. The fusion proteins we developed may provide alternative strategies for therapy of cancers caused by hyper-activation of EGFR signaling.	[Wang, Pei-Yu; Pai, Li-Mei] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Pai, Li-Mei] Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan; [Pai, Li-Mei] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wang, PY (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	pai@mail.cgu.edu.tw		Pai, Li-Mei/0000-0002-1417-6432	Chang-Gung Memorial Hospital [CMRPD 180111]; National Science Council of Republic of China [NSC97-2311-B-182-001-MY3]; Ministry of Education, Taiwan, ROC [EMRPD180121]	Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC(Ministry of Education, Taiwan)	This work was supported by grants from Chang-Gung Memorial Hospital (CMRPD 180111 to Li-Mei Pai), the National Science Council of Republic of China (NSC97-2311-B-182-001-MY3 to Li-Mei Pai) (http://web1.nsc.gov.tw/), and the Ministry of Education, Taiwan, ROC (EMRPD180121 to Li-Mei Pai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Berg CA, 2005, TRENDS GENET, V21, P346, DOI 10.1016/j.tig.2005.04.010; CASTRILLON DH, 1993, GENETICS, V135, P489; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Chang WL, 2008, DEVELOPMENT, V135, P1923, DOI 10.1242/dev.017103; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Donovan JA, 1996, J BIOL CHEM, V271, P26369, DOI 10.1074/jbc.271.42.26369; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hime GR, 2001, MECH DEVELOP, V102, P235, DOI 10.1016/S0925-4773(01)00292-1; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Pai LM, 2006, MECH DEVELOP, V123, P450, DOI 10.1016/j.mod.2006.04.001; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Reich A, 1999, DEVELOPMENT, V126, P4139; Robertson H, 2000, ONCOGENE, V19, P3299, DOI 10.1038/sj.onc.1203624; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Wang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001447; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17097	10.1371/journal.pone.0017097	http://dx.doi.org/10.1371/journal.pone.0017097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340027	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600039
J	Peh, KSH; Sonke, B; Lloyd, J; Quesada, CA; Lewis, SL				Peh, Kelvin S. -H.; Sonke, Bonaventure; Lloyd, Jon; Quesada, Carlos A.; Lewis, Simon L.			Soil Does Not Explain Monodominance in a Central African Tropical Forest	PLOS ONE			English	Article							RAIN-FOREST; RESERVE	Background: Soil characteristics have been hypothesised as one of the possible mechanisms leading to monodominance of Gilbertiodendron dewerei in some areas of Central Africa where higher-diversity forest would be expected. However, the differences in soil characteristics between the G. dewevrei-dominated forest and its adjacent mixed forest are still poorly understood. Here we present the soil characteristics of the G. dewevrei forest and quantify whether soil physical and chemical properties in this monodominant forest are significantly different from the adjacent mixed forest. Methodology/Principal Findings: We sampled top soil (0-5, 5-10, 10-20, 20-30 cm) and subsoil (150-200 cm) using an augur in 661 ha areas of intact central Africa forest in SE Cameroon, three independent patches of G. dewevrei-dominated forest and three adjacent areas (450-800 m apart), all chosen to be topographically homogeneous. Analysis - subjected to Bonferroni correction procedure - revealed no significant differences between the monodominant and mixed forests in terms of soil texture, median particle size, bulk density, pH, carbon (C) content, nitrogen (N) content, C: N ratio, C: total NaOH-extractable P ratio and concentrations of labile phosphorous (P), inorganic NaOH-extractable P, total NaOH-extractable P, aluminium, barium, calcium, copper, iron, magnesium, manganese, molybdenum, nickel, potassium, selenium, silicon, sodium and zinc. Prior to Bonferroni correction procedure, there was a significant lower level of silicon concentration found in the monodominant than mixed forest deep soil; and a significant lower level of nickel concentration in the monodominant than mixed forest top soil. Nevertheless, these were likely to be the results of multiple tests of significance. Conclusions/Significance: Our results do not provide clear evidence of soil mediation for the location of monodominant forests in relation to adjacent mixed forests. It is also likely that G. dewevrei does not influence soil chemistry in the monodominant forests.	[Peh, Kelvin S. -H.; Lloyd, Jon; Quesada, Carlos A.; Lewis, Simon L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Peh, Kelvin S. -H.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Sonke, Bonaventure] Univ Yaounde I, Plant Systemat & Ecol Lab, Higher Teachers Training Coll, Yaounde, Cameroon; [Lloyd, Jon] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia	University of Leeds; University of Cambridge; University of Yaounde I; University of Queensland	Peh, KSH (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	kelvin.peh@gmail.com	Lloyd, Jonathan J/F-8893-2010; Peh, Kelvin/C-3408-2013	Lloyd, Jonathan J/0000-0002-5458-9960; Peh, Kelvin/0000-0002-2921-1341; Lewis, Simon/0000-0002-8066-6851	Marie Curie EST Fellowship; Royal Society	Marie Curie EST Fellowship(European Commission); Royal Society(Royal Society of London)	The sources of funding are Marie Curie EST Fellowship and Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brady N.C., 1999, NATURE PROPERTIES SO; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Cherry S, 1998, WILDLIFE SOC B, V26, P947; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Conway D., 1992, COMP SOIL PARAMETERS; DECKERS JF, 2003, EVOLUTION TROPICAL S; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; Hart TB, 1985, THESIS MICHIGAN STAT; Henkel TW, 2003, J TROP ECOL, V19, P417, DOI 10.1017/S0266467403003468; *IUSS, 2006, WORLD SOIL RES REP, V103; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P159; Martijena NE, 1998, J BIOGEOGR, V25, P707, DOI 10.1046/j.1365-2699.1998.2540707.x; MCGINLEY M, 2008, ENCY EARTH UN ENV PR; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nascimento MT, 1997, GLOBAL ECOL BIOGEOGR, V6, P387, DOI 10.2307/2997339; Newbery DM, 1997, ECOL MONOGR, V67, P367, DOI 10.1890/0012-9615(1997)067[0367:PDIALA]2.0.CO;2; Peh K.S-H., 2011, J VEGETATIO IN PRESS; PEH KSH, 2011, J ECOLOGY IN PRESS; PLEYSIER JL, 1980, SOIL SCI, V129, P205, DOI 10.1097/00010694-198004000-00002; Powers JS, 2004, J TROP ECOL, V20, P587, DOI 10.1017/S0266467404001877; QUESADA CA, 2009, THESIS U LEEDS LEEDS; Rhoades CC, 1997, AGROFOREST SYST, V39, P31, DOI 10.1023/A:1005995201216; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards P.W., 1996, TROPICAL RAIN FOREST, VSecond edition; SONKE B, 2004, THESIS U LIBRE BRUXE; Tilman D., 1982, Monographs in Population Biology, pi; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; VANREEEUWIJK LP, 2002, PROCEDURES SOIL ANAL; Whitney KD, 1998, J TROP ECOL, V14, P351, DOI 10.1017/S0266467498000273; WILME L, 2002, RESERVE FAUNE DJA; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	34	38	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16996	10.1371/journal.pone.0016996	http://dx.doi.org/10.1371/journal.pone.0016996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347320	gold, Green Published, Green Accepted			2022-12-27	WOS:000287363000030
J	Wanke, D; Hohenstatt, ML; Dynowski, M; Bloss, U; Hecker, A; Elgass, K; Hummel, S; Hahn, A; Caesar, K; Schleifenbaum, F; Harter, K; Berendzen, KW				Wanke, Dierk; Hohenstatt, Mareike L.; Dynowski, Marek; Bloss, Ulrich; Hecker, Andreas; Elgass, Kirstin; Hummel, Sabine; Hahn, Achim; Caesar, Katharina; Schleifenbaum, Frank; Harter, Klaus; Berendzen, Kenneth W.			Alanine Zipper-Like Coiled-Coil Domains Are Necessary for Homotypic Dimerization of Plant GAGA-Factors in the Nucleus and Nucleolus	PLOS ONE			English	Article							PROTEIN INTERACTIONS; DNA-BINDING; TRANSCRIPTION; PROMOTER; TROPOMYOSIN; ACTIVATION; MECHANISMS; PREDICTION; SEQUENCES; TRANSPORT	GAGA-motif binding proteins control transcriptional activation or repression of homeotic genes. Interestingly, there are no sequence similarities between animal and plant proteins. Plant BBR/BPC-proteins can be classified into two distinct groups: Previous studies have elaborated on group I members only and so little is known about group II proteins. Here, we focused on the initial characterization of AtBPC6, a group II protein from Arabidopsis thaliana. Comparison of orthologous BBR/BPC sequences disclosed two conserved signatures besides the DNA binding domain. A first peptide signature is essential and sufficient to target AtBPC6-GFP to the nucleus and nucleolus. A second domain is predicted to form a zipper-like coiled-coil structure. This novel type of domain is similar to Leucine zippers, but contains invariant alanine residues with a heptad spacing of 7 amino acids. By yeast-2-hybrid and BiFC-assays we could show that this Alanine zipper domain is essential for homotypic dimerization of group II proteins in vivo. Interhelical salt bridges and charge-stabilized hydrogen bonds between acidic and basic residues of the two monomers are predicted to form an interaction domain, which does not follow the classical knobs-into-holes zipper model. FRET-FLIM analysis of GFP/RFP-hybrid fusion proteins validates the formation of parallel dimers in planta. Sequence comparison uncovered that this type of domain is not restricted to BBR/BPC proteins, but is found in all kingdoms.	[Wanke, Dierk; Hohenstatt, Mareike L.; Dynowski, Marek; Bloss, Ulrich; Hecker, Andreas; Elgass, Kirstin; Hummel, Sabine; Hahn, Achim; Caesar, Katharina; Schleifenbaum, Frank; Harter, Klaus; Berendzen, Kenneth W.] Univ Tubingen, Ctr Plant Mol Biol ZMBP Plant Physiol, Tubingen, Germany	Eberhard Karls University of Tubingen	Wanke, D (corresponding author), Univ Tubingen, Ctr Plant Mol Biol ZMBP Plant Physiol, Tubingen, Germany.	dierk.wanke@zmbp.uni-tuebingen.de	Wanke, Dierk/AAA-8529-2019	Berendzen, Kenneth/0000-0001-9870-6164	Deutsche Forschungsgemeinschaft (DFG) [(Ha2146/9-2]; Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wurttemberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wurttemberg	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG) to KH (Ha2146/9-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like thank all the group members at the ZMBP-Plant Physiology for their constant support, advice and critical discussion on the manuscript; special thanks to Friederike Ladwig, Sebastien Peter and Anne Mohrholz for contributing ideas to the present version of the manuscript. We would like to acknowledge bwGrid, member of the German D-Grid initiative, founded by the Ministry for Education and Research and the Ministry for Science, Research and Arts Baden-Wurttemberg, for providing the computational resources (http://www.bw-grid.de).	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berendzen K, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-4; Berendzen KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-522; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Brown JH, 2010, PROTEIN SCI, V19, P1366, DOI 10.1002/pro.415; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunin-Horkawicz S, 2010, J STRUCT BIOL, V170, P226, DOI 10.1016/j.jsb.2010.01.023; Elgass K, 2010, ANAL BIOANAL CHEM, V398, P1919, DOI 10.1007/s00216-010-4127-4; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fujioka M, 2008, DEVELOPMENT, V135, P4131, DOI 10.1242/dev.024554; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GERNERT KM, 1995, PROTEIN SCI, V4, P2252, DOI 10.1002/pro.5560041102; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Horak J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-77; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kooiker M, 2005, PLANT CELL, V17, P722, DOI 10.1105/tpc.104.030130; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lehmann M, 2004, TRENDS GENET, V20, P15, DOI 10.1016/j.tig.2003.11.005; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Liu J, 2002, J BIOL CHEM, V277, P48708, DOI 10.1074/jbc.M208773200; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mahmoudi T, 2002, EMBO J, V21, P1775, DOI 10.1093/emboj/21.7.1775; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; Meister RJ, 2004, PLANT J, V37, P426, DOI 10.1046/j.1365-313X.2003.01971.x; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Noiges R, 2006, BBA-MOL CELL RES, V1763, P1011, DOI 10.1016/j.bbamcr.2006.08.029; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Paponov IA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-126; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Petrascheck M, 2005, NUCLEIC ACIDS RES, V33, P3743, DOI 10.1093/nar/gki689; Reiser L, 2000, PLANT MOL BIOL, V42, P151, DOI 10.1023/A:1006384122567; Roig C, 2004, GENETICS, V167, P439, DOI 10.1534/genetics.167.1.439; Rusanov AL, 2010, J BIOPHOTONICS, V3, P774, DOI 10.1002/jbio.201000065; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sangwan I, 2002, PLANT PHYSIOL, V129, P1788, DOI 10.1104/pp.002618; Santi L, 2003, PLANT J, V34, P813, DOI 10.1046/j.1365-313X.2003.01767.x; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Schweinsberg S, 2004, GENETICS, V168, P1371, DOI 10.1534/genetics.104.029561; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; Solan A, 2002, J MOL BIOL, V317, P601, DOI 10.1006/jmbi.2002.5427; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Tsiantis M, 2003, NAT REV GENET, V4, P169, DOI 10.1038/nrg1002; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Vaquero A, 2008, BBA-GENE REGUL MECH, V1779, P312, DOI 10.1016/j.bbagrm.2008.02.005; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Voss TC, 2005, BIOTECHNIQUES, V38, P413, DOI 10.2144/05383RV01; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wanke Dierk, 2009, V479, P291, DOI 10.1007/978-1-59745-289-2_19; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yaguchi S, 2003, J BIOL CHEM, V278, P29760, DOI 10.1074/jbc.M301441200; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x	76	35	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16070	10.1371/journal.pone.0016070	http://dx.doi.org/10.1371/journal.pone.0016070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347358	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000005
J	Cha, DH; Linn, CE; Teal, PEA; Zhang, AJ; Roelofs, WL; Loeb, GM				Cha, Dong H.; Linn, Charles E., Jr.; Teal, Peter E. A.; Zhang, Aijun; Roelofs, Wendell L.; Loeb, Gregory M.			Eavesdropping on Plant Volatiles by a Specialist Moth: Significance of Ratio and Concentration	PLOS ONE			English	Article							GREEN LEAF VOLATILES; HOST LOCATION; RESPONSES; IDENTIFICATION; HERBIVORY; INSECT; DISCRIMINATION; LEPIDOPTERA; EMISSIONS; ECOLOGY	We investigated the role that the ratio and concentration of ubiquitous plant volatiles play in providing host specificity for the diet specialist grape berry moth Paralobesia viteana (Clemens) in the process of locating its primary host plant Vitis sp. In the first flight tunnel experiment, using a previously identified attractive blend with seven common but essential components ("optimized blend''), we found that doubling the amount of six compounds singly [(E)- & (Z)-linalool oxides, nonanal, decanal, beta-caryophyllene, or germacrene-D], while keeping the concentration of other compounds constant, significantly reduced female attraction (average 76% full and 59% partial upwind flight reduction) to the synthetic blends. However, doubling (E)-4,8-dimethyl 1,3,7-nonatriene had no effect on female response. In the second experiment, we manipulated the volatile profile more naturally by exposing clonal grapevines to Japanese beetle feeding. In the flight tunnel, foliar damage significantly reduced female landing on grape shoots by 72% and full upwind flight by 24%. The reduction was associated with two changes: (1) more than a two-fold increase in total amount of the seven essential volatile compounds, and (2) changes in their relative ratios. Compared to the optimized blend, synthetic blends mimicking the volatile ratio emitted by damaged grapevines resulted in an average of 87% and 32% reduction in full and partial upwind orientation, respectively, and the level of reduction was similar at both high and low doses. Taken together, these results demonstrate that the specificity of a ubiquitous volatile blend is determined, in part, by the ratio of key volatile compounds for this diet specialist. However, P. viteana was also able to accommodate significant variation in the ratio of some compounds as well as the concentration of the overall mixture. Such plasticity may be critical for phytophagous insects to successfully eavesdrop on variable host plant volatile signals.	[Cha, Dong H.; Linn, Charles E., Jr.; Roelofs, Wendell L.; Loeb, Gregory M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Teal, Peter E. A.] ARS, Chem Res Unit, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Zhang, Aijun] ARS, Invas Insect Biocontrol & Behav Lab, Inst Plant Sci, USDA, Beltsville, MD USA	Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cha, DH (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	gme1@cornell.edu	Cha, Dong H/A-3977-2013		USDA NRI [2005-35302-16154]	USDA NRI(United States Department of Agriculture (USDA))	This work was partially supported by USDA NRI grant #2005-35302-16154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Cha DH, 2010, FOREST ECOL MANAG, V259, P1930, DOI 10.1016/j.foreco.2010.02.004; Chamberlain K, 2006, J CHEM ECOL, V32, P565, DOI 10.1007/s10886-005-9016-5; D'Alessandro M, 2009, J CHEM ECOL, V35, P999, DOI 10.1007/s10886-009-9692-7; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Hilker M., 2007, BEHAV ECOLOGY INSECT, P92, DOI DOI 10.1007/S00359-004-0576-6; Hillier NK, 2006, J COMP PHYSIOL A, V192, P199, DOI 10.1007/s00359-005-0061-x; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Linn C, 2003, P NATL ACAD SCI USA, V100, P11490, DOI 10.1073/pnas.1635049100; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; Loughrin JH, 1997, PHYTOCHEMISTRY, V45, P919, DOI 10.1016/S0031-9422(97)00076-9; Najar-Rodriguez AJ, 2010, J EXP BIOL, V213, P3388, DOI 10.1242/jeb.046284; Nojima S, 2003, J CHEM ECOL, V29, P321, DOI 10.1023/A:1022677827233; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Penuelas J, 2004, TRENDS ECOL EVOL, V19, P402, DOI 10.1016/j.tree.2004.06.002; Pichersky E, 2006, TRENDS PLANT SCI, V11, P421, DOI 10.1016/j.tplants.2006.07.007; PIEMENTEL D, 2004, ENCY PLANT CROP SCI, V1, P407; Pinero JC, 2007, ENTOMOL EXP APPL, V125, P185, DOI 10.1111/j.1570-7458.2007.00614.x; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; *SAS I, 2009, SAS STAT 9 2 US GUID, DOI DOI 10.1007/S10886-008-9474-7; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SCHOONHOVEN LM, 1998, INSECT PLANT BIOL; Tasin M, 2006, NATURWISSENSCHAFTEN, V93, P141, DOI 10.1007/s00114-005-0077-7; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; van Dam NM, 2008, PLANT BIOLOGY, V10, P29, DOI 10.1055/s-2007-964961; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Webster B, 2010, PHYTOCHEMISTRY, V71, P81, DOI 10.1016/j.phytochem.2009.09.029; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6	45	61	61	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17033	10.1371/journal.pone.0017033	http://dx.doi.org/10.1371/journal.pone.0017033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347337	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700065
J	Nada, RM; Maal, TJJ; Breuning, KH; Berge, SJ; Mostafa, YA; Kuijpers-Jagtman, AM				Nada, Rania M.; Maal, Thomas J. J.; Breuning, K. Hero; Berge, Stefaan J.; Mostafa, Yehya A.; Kuijpers-Jagtman, Anne Marie			Accuracy and Reproducibility of Voxel Based Superimposition of Cone Beam Computed Tomography Models on the Anterior Cranial Base and the Zygomatic Arches	PLOS ONE			English	Article							ORTHOGNATHIC SURGERY PATIENTS; 3-DIMENSIONAL ANALYSIS	Superimposition of serial Cone Beam Computed Tomography (CBCT) scans has become a valuable tool for three dimensional (3D) assessment of treatment effects and stability. Voxel based image registration is a newly developed semi-automated technique for superimposition and comparison of two CBCT scans. The accuracy and reproducibility of CBCT superimposition on the anterior cranial base or the zygomatic arches using voxel based image registration was tested in this study. 16 pairs of 3D CBCT models were constructed from pre and post treatment CBCT scans of 16 adult dysgnathic patients. Each pair was registered on the anterior cranial base three times and on the left zygomatic arch twice. Following each superimposition, the mean absolute distances between the 2 models were calculated at 4 regions: anterior cranial base, forehead, left and right zygomatic arches. The mean distances between the models ranged from 0.2 to 0.37 mm (SD 0.08-0.16) for the anterior cranial base registration and from 0.2 to 0.45 mm (SD 0.09-0.27) for the zygomatic arch registration. The mean differences between the two registration zones ranged between 0.12 to 0.19 mm at the 4 regions. Voxel based image registration on both zones could be considered as an accurate and a reproducible method for CBCT superimposition. The left zygomatic arch could be used as a stable structure for the superimposition of smaller field of view CBCT scans where the anterior cranial base is not visible.	[Nada, Rania M.; Breuning, K. Hero; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Oral Biol, NL-6525 ED Nijmegen, Netherlands; [Nada, Rania M.; Maal, Thomas J. J.; Breuning, K. Hero; Berge, Stefaan J.; Kuijpers-Jagtman, Anne Marie] Radboud Univ Nijmegen, Med Ctr, 3D Facial Imaging Res Grp Nijmegen Bruges, NL-6525 ED Nijmegen, Netherlands; [Maal, Thomas J. J.; Berge, Stefaan J.] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Nada, Rania M.; Mostafa, Yehya A.] Cairo Univ, Dept Orthodont, Fac Oral & Dent Med, Cairo, Egypt	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Egyptian Knowledge Bank (EKB); Cairo University	Nada, RM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Oral Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Kuijpers-Jagtman, Anne Marie/A-9413-2008; Berge, Stefaan/AAP-3708-2020; Maal, Thomas JJ/L-4497-2015; Bergé, S.J./H-8011-2014; Breuning, K.H./L-4228-2015	Kuijpers-Jagtman, Anne Marie/0000-0001-8172-0090; Maal, Thomas JJ/0000-0002-1702-4733; 	Dutch Technology Foundation [STW 10315]; Netherlands Ministry of Foreign Affairs; Netherlands Organization for International Cooperation in Higher Education (Nuffic) [NFP-PhD: CF 2916/2006]	Dutch Technology Foundation(Technologiestichting STW); Netherlands Ministry of Foreign Affairs; Netherlands Organization for International Cooperation in Higher Education (Nuffic)	This work was supported by a grant from the Dutch Technology Foundation (STW 10315). R. Nada was funded by the Netherlands Fellowship Program PhD studies, Netherlands Ministry of Foreign Affairs and Netherlands Organization for International Cooperation in Higher Education (Nuffic), grant number: NFP-PhD: CF 2916/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cevidanes LHS, 2005, DENTOMAXILLOFAC RAD, V34, P369, DOI 10.1259/dmfr/17102411; Cevidanes LHC, 2009, AM J ORTHOD DENTOFAC, V136, P94, DOI 10.1016/j.ajodo.2009.01.018; Cevidanes LHS, 2007, AM J ORTHOD DENTOFAC, V131, P44, DOI 10.1016/j.ajodo.2005.03.029; Cevidanes LHS, 2006, AM J ORTHOD DENTOFAC, V129, P611, DOI 10.1016/j.ajodo.2005.12.008; Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P460, DOI 10.1016/j.ajodo.2009.04.016; Hajeer Mohammad Y, 2002, Int J Adult Orthodon Orthognath Surg, V17, P318; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; Ludlow JB, 2006, DENTOMAXILLOFAC RAD, V35, P219, DOI 10.1259/dmfr/14340323; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Okano T, 2009, DENTOMAXILLOFAC RAD, V38, P79, DOI 10.1259/dmfr/14769929; Palomo JM, 2008, ORAL SURG ORAL MED O, V105, P773, DOI 10.1016/j.tripleo.2007.12.019; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Swennen GRJ, 2009, J CRANIOFAC SURG, V20, P297, DOI 10.1097/SCS.0b013e3181996803; Terajima M, 2008, AM J ORTHOD DENTOFAC, V134, P100, DOI 10.1016/j.ajodo.2006.06.027	14	101	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16520	10.1371/journal.pone.0016520	http://dx.doi.org/10.1371/journal.pone.0016520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347419	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700018
J	Prots, I; Skapenko, A; Lipsky, PE; Schulze-Koops, H				Prots, Iryna; Skapenko, Alla; Lipsky, Peter E.; Schulze-Koops, Hendrik			Analysis of the Transcriptional Program of Developing Induced Regulatory T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TGF-BETA; RETINOIC-ACID; CUTTING EDGE; FOXP3 EXPRESSION; GENE-EXPRESSION; INDUCTION; DIFFERENTIATION; TREG; COMMITMENT	CD25+ regulatory T cells develop in the thymus (nTregs), but may also be generated in the periphery upon stimulation of naive CD4 T cells under appropriate conditions (iTregs). To gain insight into the mechanisms governing iTreg development, we performed longitudinal transcriptional profiling of CD25+ T cells during their differentiation from uncommitted naive CD4 T cells. Microarray analysis of mRNA from CD25+ iTregs early after stimulation revealed expression of genes involved in cell cycle progression and T cell activation, which largely overlapped with genes expressed in CD25+ effector T cells (Teffs) used as a control. Whereas expression of these genes remained elevated in Teffs, it declined gradually in developing iTregs, resulting in a more quiescent phenotype in mature iTregs. A similar pattern of kinetics was observed for biological processes and for intracellular pathways over-represented within the expressed genes. A maximum dichotomy of transcriptional activity between iTregs and Teffs was reached at late stages of their maturation. Of interest, members of the FoxO and FoxM1 transcription factor family pathways exhibited a reciprocal expression pattern in iTregs and Teffs, suggesting a role of these transcription factors in determining T cell fate.	[Prots, Iryna; Skapenko, Alla; Schulze-Koops, Hendrik] Univ Munich, Med Poliklin, Div Rheumatol, D-8000 Munich, Germany; [Lipsky, Peter E.] Natl Inst Arthrit & Musculoskeletal & Skin, NIH, Bethesda, MD USA	University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Prots, I (corresponding author), Univ Munich, Med Poliklin, Div Rheumatol, Pettenkoferstr 8A, D-8000 Munich, Germany.	alla.skapenko@med.uni-muenchen.de	Prots, Iryna/O-7982-2018	Prots, Iryna/0000-0001-9561-0909	Deutsche Forschungsgemeinschaft [Schu786/8-1, Schu786/2-5, SK59/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp; Grants Schu786/8-1, Schu786/2-5, and SK59/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2006, EUR J IMMUNOL, V36, P1360, DOI 10.1002/eji.200636171; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Golshayan D, 2007, BLOOD, V109, P827, DOI 10.1182/blood-2006-05-025460; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jaeckel E, 2006, SEMIN IMMUNOL, V18, P89, DOI 10.1016/j.smim.2006.01.011; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Pillai V, 2007, IMMUNOL LETT, V114, P9, DOI 10.1016/j.imlet.2007.08.012; ROSENBERG SA, 1979, J IMMUNOL, V122, P926; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Skapenko A, 2001, J IMMUNOL, V166, P4283, DOI 10.4049/jimmunol.166.7.4283; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	60	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16913	10.1371/journal.pone.0016913	http://dx.doi.org/10.1371/journal.pone.0016913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347372	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700053
J	Reneerkens, J; Grond, K; Schekkerman, H; Tulp, I; Piersma, T				Reneerkens, Jeroen; Grond, Kirsten; Schekkerman, Hans; Tulp, Ingrid; Piersma, Theunis			Do Uniparental Sanderlings Calidris alba Increase Egg Heat Input to Compensate for Low Nest Attentiveness?	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; INCUBATION SCHEDULES; WOOD DUCKS; DEMANDS; TEMPERATURE; GROWTH; BIRDS; SHOREBIRDS; INVESTMENT; ATTENDANCE	Birds breeding in cold environments regularly have to interrupt incubation to forage, causing a trade-off between two mutually exclusive behaviours. Earlier studies showed that uniparental Arctic sandpipers overall spend less time incubating their eggs than biparental species, but interspecific differences in size and ecology were potential confounding factors. This study reports on a within-species comparison of breeding schedules and metal egg temperatures in uni- and biparental sanderlings (Calidris alba) in Northeast Greenland in relation to ambient temperature. We recorded incubation schedules with nest temperature loggers in 34 sanderling clutches (13 uniparentals, 21 biparentals). The temperature of a metal egg placed within the clutch of 17 incubating birds (6 uniparentals, 9 biparentals) was measured as an indicator of the heat put into eggs. Recess frequency, recess duration and total recess time were higher in uniparentals than in biparentals and positively correlated with ambient temperatures in uniparentals only. Uniparental sanderlings maintained significantly higher metal egg temperatures during incubation than biparentals (1.4 degrees C difference on average). Our results suggest that uniparental sanderlings compensate for the lower nest attendance, which may prolong the duration of the incubation period and negatively affect the condition of the hatchlings, by maintaining a higher heat flux into the eggs.	[Reneerkens, Jeroen; Grond, Kirsten; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Schekkerman, Hans] Dutch Ctr Field Ornithol, SOVON, Nijmegen, Netherlands; [Tulp, Ingrid] Inst Marine Resources & Ecosyst Studies, Ijmuiden, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands	University of Groningen; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Reneerkens, J (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	J.W.H.Reneerkens@rug.nl	Reneerkens, Jeroen/J-3880-2015; Grond, Kirsten/J-9862-2019; Piersma, Theunis/D-1871-2012	Reneerkens, Jeroen/0000-0003-0674-8143; Grond, Kirsten/0000-0001-6197-7139; Piersma, Theunis/0000-0001-9668-466X; Schekkerman, Hans/0000-0003-3127-4832	Netherlands Organization for Scientific Research (NWO) [851.40.072]; Schure-Beijerinck-Popping Fund	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Schure-Beijerinck-Popping Fund	This work was supported by an International Polar Year grant (851.40.072) by the Netherlands Organization for Scientific Research (NWO) to T. Piersma and J. Reneerkens, and by a research grant by the Schure-Beijerinck-Popping Fund (http://www.knaw.nl/cfdata/funding/funding_detail.cfm?orgid = 103) to I. Tulp and H. Schekkerman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; BOSQUE C, 1995, AM NAT, V145, P234, DOI 10.1086/285738; CAREY C, 2001, AVIAN INCUBATION BEH, P238; Cresswell W, 2003, BEHAV ECOL, V14, P97, DOI 10.1093/beheco/14.1.97; Cresswell W, 2004, BEHAV ECOL, V15, P498, DOI 10.1093/beheco/arh042; D'Alba L, 2009, J THERM BIOL, V34, P93, DOI 10.1016/j.jtherbio.2008.11.005; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; DEEMING DC, 2001, AVIAN INCUBATION BEH, P63; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hainsworth FR, 1998, J AVIAN BIOL, V29, P113, DOI 10.2307/3677188; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hepp GR, 2005, J AVIAN BIOL, V36, P523; Jongbloed Frank, 2006, Limosa, V79, P63; KALAS JA, 1986, ARDEA, V74, P185; Klaassen M, 2003, AVIAN MIGRATION, P237; KOMEDA S, 1983, AUK, V100, P48, DOI 10.1093/auk/100.1.48; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; LOFALDLI L, 1985, HOLARCTIC ECOL, V8, P107; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; MEHLUM F, 1991, FAUNA NOR C, V1, P33; Meltofte H, 2008, ADV ECOL RES, V40, P101, DOI 10.1016/S0065-2504(07)00005-0; Meltofte Hans, 2007, Meddelelser om Gronland Bioscience, V59, P1; NORTON DW, 1972, CONDOR, V74, P164, DOI 10.2307/1366280; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; PARMELEE D F, 1970, Living Bird, V9, P97; PARMELEE DF, 1973, IBIS, V115, P218, DOI 10.1111/j.1474-919X.1973.tb02638.x; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; PIENKOWSKI M W, 1976, British Birds, V69, P165; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T, 1996, HDB BIRDS WORLD, V3, P444; Piersma Theunis, 2006, Wader Study Group Bulletin, V109, P83; Pulliainen E, 1997, ARDEA, V85, P67; Rasbash J, 2004, USERS GUIDE MLWIN; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Reid JM, 2002, OX ORN SER, V13, P314; Reneerkens Jeroen, 2009, Wader Study Group Bulletin, V116, P2; Reneerkens Jeroen, 2005, Wader Study Group Bulletin, V106, P12; Romanoff A. L., 1949, AVIAN EGG; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; SCHMIDT NM, 2010, BIOBASIS CONCEPTUAL; Smith PA, 2010, OECOLOGIA, V163, P613, DOI 10.1007/s00442-010-1644-y; THIBAULT M, 1995, CAN J ZOOL, V73, P879, DOI 10.1139/z95-103; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tinbergen JM, 2002, OX ORN SER, V13, P299; Tombre IM, 1996, J ANIM ECOL, V65, P325, DOI 10.2307/5878; Tomkovich P.S., 2001, Ornitologiya, V29, P125; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; TULP I, 2007, THESIS U GRONINGEN; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; VLECK CM, 1980, AM ZOOL, V20, P405; WARD D, 1990, AUK, V107, P10; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Williams Joseph B., 1996, P375; Yasue M, 2008, J ETHOL, V26, P99, DOI 10.1007/s10164-007-0034-3; [No title captured]	61	34	35	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16834	10.1371/journal.pone.0016834	http://dx.doi.org/10.1371/journal.pone.0016834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347377	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700041
J	Hu, JZ; Nudelman, G; Shimoni, Y; Kumar, M; Ding, YM; Lopez, C; Hayot, F; Wetmur, JG; Sealfon, SC				Hu, Jianzhong; Nudelman, German; Shimoni, Yishai; Kumar, Madhu; Ding, Yaomei; Lopez, Carolina; Hayot, Fernand; Wetmur, James G.; Sealfon, Stuart C.			Role of Cell-to-Cell Variability in Activating a Positive Feedback Antiviral Response in Human Dendritic Cells	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNE-RESPONSE; VIRAL-INFECTION; MATURATION; RNA; BIFURCATION; DYNAMICS; PROMOTER; VIRUSES; NOISE	In the first few hours following Newcastle disease viral infection of human monocyte-derived dendritic cells, the induction of IFNB1 is extremely low and the secreted type I interferon response is below the limits of ELISA assay. However, many interferon-induced genes are activated at this time, for example DDX58 (RIGI), which in response to viral RNA induces IFNB1. We investigated whether the early induction of IFNBI in only a small percentage of infected cells leads to low level IFN secretion that then induces IFN-responsive genes in all cells. We developed an agent-based mathematical model to explore the IFNBI and DDX58 temporal dynamics. Simulations showed that a small number of early responder cells provide a mechanism for efficient and controlled activation of the DDX58-IFNBI positive feedback loop. The model predicted distributions of single cell responses that were confirmed by single cell mRNA measurements. The results suggest that large cell-to-cell variation plays an important role in the early innate immune response, and that the variability is essential for the efficient activation of the IFNB1 based feedback loop.	[Hu, Jianzhong; Kumar, Madhu; Ding, Yaomei; Lopez, Carolina; Wetmur, James G.; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Nudelman, German; Shimoni, Yishai; Hayot, Fernand; Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Nudelman, German; Shimoni, Yishai; Hayot, Fernand; Wetmur, James G.] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hu, JZ (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	james.wetmur@mssm.edu	Lopez, Carolina/A-8887-2008; Hu, Jianzhong/ABE-4311-2020; Hu, Jianzhong/P-6305-2014	Lopez, Carolina/0000-0002-7669-6572; Hu, Jianzhong/0000-0001-8546-5111; Hu, Jianzhong/0000-0001-8546-5111; SEALFON, Stuart/0000-0001-5791-1217	National Institute of Allergy and Infectious Diseases [HHSN266200500021C, U19 AI06231]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract HHSN266200500021C and grant U19 AI06231 from the National Institute of Allergy and Infectious Diseases. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin A, 1998, GENETICS, V149, P1633; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Coppey M, 2007, BIOPHYS J, V93, P1917, DOI 10.1529/biophysj.107.109736; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hu J, 2009, BIOPHYS J, V97, P1984, DOI 10.1016/j.bpj.2009.05.067; Hu JZ, 2007, NUCLEIC ACIDS RES, V35, P5232, DOI 10.1093/nar/gkm557; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lopez CB, 2006, J VIROL, V80, P3128, DOI 10.1128/JVI.80.7.3128-3134.2006; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Pascal V, 2006, IMMUNOL REV, V214, P9, DOI 10.1111/j.1600-065X.2006.00452.x; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Phipps-Yonas H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000193; Qiao L, 2010, BIOPHYS J, V98, P505, DOI 10.1016/j.bpj.2009.10.049; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Shimoni Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005363; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16614	10.1371/journal.pone.0016614	http://dx.doi.org/10.1371/journal.pone.0016614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347441	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600010
J	Pfafferott, K; Gaudieri, S; Ulsenheimer, A; James, I; Heeg, M; Nolan, D; John, M; Rauch, A; Mallal, S; Lucas, A; Klenerman, P; Diepolder, HM; Lucas, M				Pfafferott, Katja; Gaudieri, Silvana; Ulsenheimer, Axel; James, Ian; Heeg, Malte; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Klenerman, Paul; Diepolder, Helmut M.; Lucas, Michaela			Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity	PLOS ONE			English	Article							HEPATITIS-C VIRUS; T-CELL RESPONSE; IMMUNE-RESPONSES; IMMUNOLOGICAL DETERMINANTS; SEQUENCE DIVERSITY; SOURCE OUTBREAK; HIV-1 GAG; CLEARANCE; ESCAPE; PERSISTENCE	Cellular immune responses during acute Hepatitis C virus (HCV) and HIV infection are a known correlate of infection outcome. Viral adaptation to these responses via mutation(s) within CD8+ T-cell epitopes allows these viruses to subvert host immune control. This study examined HCV evolution in 21 HCV genotype 1-infected subjects to characterise the level of viral adaptation during acute and early HCV infection. Of the total mutations observed 25% were within described CD8+ T-cell epitopes or at viral adaptation sites. Most mutations were maintained into the chronic phase of HCV infection (75%). The lack of reversion of adaptations and high proportion of silent substitutions suggests that HCV has structural and functional limitations that constrain evolution. These results were compared to the pattern of viral evolution observed in 98 subjects during a similar phase in HIV infection from a previous study. In contrast to HCV, evolution during acute HIV infection is marked by high levels of amino acid change relative to silent substitutions, including a higher proportion of adaptations, likely reflecting strong and continued CD8+ T-cell pressure combined with greater plasticity of the virus. Understanding viral escape dynamics for these two viruses is important for effective T cell vaccine design.	[Pfafferott, Katja; Gaudieri, Silvana; James, Ian; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Lucas, Michaela] Murdoch Univ, Inst Immunol & Infect Dis, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; [Pfafferott, Katja; Gaudieri, Silvana; James, Ian; Nolan, David; John, Mina; Rauch, Andri; Mallal, Simon; Lucas, Andrew; Lucas, Michaela] Royal Perth Hosp, Perth, WA, Australia; [Gaudieri, Silvana] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Gaudieri, Silvana] Univ Western Australia, Ctr Forens Sci, Perth, WA 6009, Australia; [Ulsenheimer, Axel; Heeg, Malte; Diepolder, Helmut M.] Univ Munich, Dept Med 2, Munich, Germany; [Ulsenheimer, Axel; Heeg, Malte; Diepolder, Helmut M.] Univ Munich, Inst Immunol, D-8000 Munich, Germany; [Rauch, Andri] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Klenerman, Paul] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Munich; University of Munich; University of Bern; University Hospital of Bern; University of Bern; University of Oxford	Pfafferott, K (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia.	michaela.lucas@health.wa.gov.au	Mallal, Simon Alexander/HDM-9561-2022; Rauch, Andri/E-9948-2017	Mallal, Simon Alexander/0000-0002-7036-1309; Rauch, Andri/0000-0001-5297-6062; , Silvana/0000-0001-6873-0198; klenerman, paul/0000-0003-4307-9161; Lucas, Michaela/0000-0001-8881-9990; Lucas, Andrew Douglas/0000-0003-2899-1806	National Health and Medical Research Council of Australia [334603, 384702]; Roche; Swiss National Science Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research described in this manuscript has been funded by the National Health and Medical Research Council of Australia (Grant numbers 334603 and 384702) and a Pillar Award from Roche. A. R. was supported by a Grant for Prospective Researchers from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Barnes E, 2004, EUR J IMMUNOL, V34, P1570, DOI 10.1002/eji.200424898; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; *FRAHM NLCABC, 2008, HIV MOL IMMUNOLOGY, P3; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Gerlach JT, 1999, GASTROENTEROLOGY, V117, P933, DOI 10.1016/S0016-5085(99)70353-7; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; GRAUR D, 1985, J MOL EVOL, V21, P221, DOI 10.1007/BF02102356; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timm J, 2007, WORLD J GASTROENTERO, V13, P4808, DOI 10.3748/wjg.v13.i36.4808; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16797	10.1371/journal.pone.0016797	http://dx.doi.org/10.1371/journal.pone.0016797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347433	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600029
J	Brito, JC; Martinez-Freiria, F; Sierra, P; Sillero, N; Tarroso, P				Brito, Jose C.; Martinez-Freiria, Fernando; Sierra, Pablo; Sillero, Neftali; Tarroso, Pedro			Crocodiles in the Sahara Desert: An Update of Distribution, Habitats and Population Status for Conservation Planning in Mauritania	PLOS ONE			English	Article							CROCODYLUS-NILOTICUS; CLIMATE; QUATERNARY; MODELS; NORTH; FLORA	Background: Relict populations of Crocodylus niloticus persist in Chad, Egypt and Mauritania. Although crocodiles were widespread throughout the Sahara until the early 20(th) century, increased aridity combined with human persecution led to local extinction. Knowledge on distribution, occupied habitats, population size and prey availability is scarce in most populations. This study evaluates the status of Saharan crocodiles and provides new data for Mauritania to assist conservation planning. Methodology/Principal Findings: A series of surveys in Mauritania detected crocodile presence in 78 localities dispersed across 10 river basins and most tended to be isolated within river basins. Permanent gueltas and seasonal tamourts were the most common occupied habitats. Crocodile encounters ranged from one to more than 20 individuals, but in most localities less than five crocodiles were observed. Larger numbers were observed after the rainy season and during night sampling. Crocodiles were found dead in between water points along dry river-beds suggesting the occurrence of dispersal. Conclusion/Significance: Research priorities in Chad and Egypt should focus on quantifying population size and pressures exerted on habitats. The present study increased in by 35% the number of known crocodile localities in Mauritania. Gueltas are crucial for the persistence of mountain populations. Oscillations in water availability throughout the year and the small dimensions of gueltas affect biological traits, including activity and body size. Studies are needed to understand adaptation traits of desert populations. Molecular analyses are needed to quantify genetic variability, population sub-structuring and effective population size, and detect the occurrence of gene flow. Monitoring is needed to detect demographical and genetical trends in completely isolated populations. Crocodiles are apparently vulnerable during dispersal events. Awareness campaigns focusing on the vulnerability and relict value of crocodiles should be implemented. Classification of Mauritanian mountains as protected areas should be prioritised.	[Brito, Jose C.; Martinez-Freiria, Fernando; Tarroso, Pedro] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Inst Ciencias Agr Vaira, Vairao, Portugal; [Sillero, Neftali] Univ Porto, CICGE, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Brito, JC (corresponding author), Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Inst Ciencias Agr Vaira, Vairao, Portugal.	jcbrito@mail.icav.up.pt	Brito, José C./A-7831-2010; Tarroso, Pedro/I-3023-2012; Sillero, Neftali/C-1803-2008; Martínez-Freiría, Fernando/L-7075-2013	Brito, José C./0000-0001-5444-8132; Tarroso, Pedro/0000-0002-2694-1170; Sillero, Neftali/0000-0002-3490-3780; Martínez-Freiría, Fernando/0000-0003-2311-8960	National Geographic Society [8412-08]; Fundacao para a Ciencia e Tecnologia [PTDC/BIA-BEC/099934/2008]	National Geographic Society(National Geographic Society); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported in part by the National Geographic Society (8412-08) and by the Fundacao para a Ciencia e Tecnologia (PTDC/BIA-BEC/099934/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL F, 1928, B COMITE ETUDES HIST, V21, P346; Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Baha El Din S., 2006, GUIDE REPTILES AMPHI; Behra O., 1994, CROCODILE SPECIALIST, V13, P4; BERNEZAT JL, 2002, IMMIDIR TASSILI OUBL; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Bons J, 1996, ANFIBIOS REPTILES MA; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; BRITO JC, 2005, FROGLOG, V71, P3; Brito JC, 2010, MAMMALIA, V74, P449, DOI 10.1515/MAMM.2010.055; Brooks N, 2004, DROUGHT AFRICAN SAHE; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; CLARK JD, 1971, GEOGR J, V137, P455; Cooper A, 2006, J ARID ENVIRON, V67, P116, DOI 10.1016/j.jaridenv.2006.02.003; de Smet K, 1998, HYDROBIOLOGIA, V391, P81, DOI 10.1023/A:1003592123079; DEODATUS F, 2004, CROCODILE SPECIALIST, V23, P5; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Dumont H.J., 1982, Palaeoecology of Africa and the Surrounding Islands, V14, P1; ESRI, 2006, ARCMAP 9 2; Fabre J., 2005, TERVUREN AFRICAN GEO, V108; FUCHS G, 1989, AFR ARCHAEOL REV, V7, P127; Fuchs K. H., 1974, STUTTGARTER BEITRA A, V266, P1; Gautier EF, 1926, GEOGR REV, V16, P378, DOI 10.2307/208708; *GLC, 2003, GLOB LAND COV YEAR 2; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Hancock GR, 2006, EARTH SURF PROC LAND, V31, P1394, DOI 10.1002/esp.1335; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holl AFC, 2009, CR GEOSCI, V341, P703, DOI 10.1016/j.crte.2009.04.005; Holmes JA, 2008, SCIENCE, V320, P752, DOI 10.1126/science.1158105; HUBERT H, 1920, B COMITE ETUDES HIST, V26, P401; JOLEAUD L, 1933, B SOC ZOOLOGIQUE FRA, V58, P397; KIRSCHJUNG KP, 2007, CONSERVATION UTILISA, P109; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Lavauden L., 1926, VERTEBRES SAHARA; Le Houerou HN, 1997, J ARID ENVIRON, V37, P619, DOI 10.1006/jare.1997.0315; LEBERRE M, 1989, FAUNE SAHARA AMPHIBI; Leblanc MJ, 2006, PALAEOGEOGR PALAEOCL, V230, P230, DOI 10.1016/j.palaeo.2005.07.016; LLUCH P, 2006, CROCODILES, P104; Lluch Pascal, 2004, Bulletin de la Societe Herpetologique de France, V111-112, P5; Mateo J. A., 2004, AMPHIBIANS REPTILES, DOI 10.1643/0045-8511(2007)2007[772:TAAROT]2.0.CO;2; MCINTOSH SK, 1986, J AFR HIST, V27, P413, DOI 10.1017/S0021853700023252; Monod T., 1964, Bull Inst fr Afr noire, V26A, P1393; Monod T., 1937, MEHAREES EXPLORATION; MONOD T, 1950, MEMOIRES I FONDAMENT, V8, P1; MONTEIL V, 1951, NOTES DOCUMENTS I HA, V8; Munch Z, 2007, HYDROGEOL J, V15, P19, DOI 10.1007/s10040-006-0125-1; MUNIER P, 1952, ETUDES MAURITANIENNE, V3, P1; *NAT RES COUNC, 1981, ENV DEGR MAUR BOARD; NICKEL H, 2003, OKOLOGISCHE UNTERSUC, P89; Padial J. M., 2006, Graellsia, V62, P159; PADIAL JM, 2011, AMPHIBIAN CONSERVATI; Paeth H, 2007, CLIMATIC CHANGE, V83, P401, DOI 10.1007/s10584-006-9235-y; Petit-Maire N, 1983, AFR ARCHAEOL REV, V1, P105; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; ROBERTY G, 1958, B IFAN, V20, P869; ROGNON P, 1967, ANN ASSOC AM GEOGR, V57, P115, DOI 10.1111/j.1467-8306.1967.tb00594.x; *SAH CONS FUND, 2007, SANDSCRIPT, V2, P4; SANDFORD KS, 1960, GEOGR J, V126, P27; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; SEURAT LG, 1925, B SOC HIST NATURELLE, V16, P153; Shine T, 2001, ORYX, V35, P260, DOI 10.1046/j.1365-3008.2001.00187.x; Shirley M.H., 2008, CROCODILE SPECIALIST, V27, P17; STAUDINGER P, 1928, SITZ BER GES NATURF, V4, P141; TELLERI JL, 2008, LAC GABOU RESEAU HYD; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Thesiger W, 1939, GEOGR J, V94, P433, DOI 10.2307/1787293; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; Trutnau L., 2006, CROCODILIANS THEIR N; TUBIANA J, 1995, COURRIER NATURE, V153, P26; VILLIERS A, 1958, INITIATIONS AFRICAIN, V25, P1; Ward D, 2009, BIO HABIT, P1; WENDORF F, 1987, AFR ARCHAEOL REV, V5, P49; [No title captured]	77	41	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14734	10.1371/journal.pone.0014734	http://dx.doi.org/10.1371/journal.pone.0014734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364897	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100005
J	Harper, MA; Chen, ZG; Toy, T; Machado, IMP; Nelson, SF; Liao, JC; Lee, CJ				Harper, Marc A.; Chen, Zugen; Toy, Traci; Machado, Iara M. P.; Nelson, Stanley F.; Liao, James C.; Lee, Christopher J.			Phenotype Sequencing: Identifying the Genes That Cause a Phenotype Directly from Pooled Sequencing of Independent Mutants	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; NEXT-GENERATION; GENOME; POPULATIONS	Random mutagenesis and phenotype screening provide a powerful method for dissecting microbial functions, but their results can be laborious to analyze experimentally. Each mutant strain may contain 50-100 random mutations, necessitating extensive functional experiments to determine which one causes the selected phenotype. To solve this problem, we propose a "Phenotype Sequencing'' approach in which genes causing the phenotype can be identified directly from sequencing of multiple independent mutants. We developed a new computational analysis method showing that 1. causal genes can be identified with high probability from even a modest number of mutant genomes; 2. costs can be cut many-fold compared with a conventional genome sequencing approach via an optimized strategy of library-pooling (multiple strains per library) and tag-pooling (multiple tagged libraries per sequencing lane). We have performed extensive validation experiments on a set of E. coli mutants with increased isobutanol biofuel tolerance. We generated a range of sequencing experiments varying from 3 to 32 mutant strains, with pooling on 1 to 3 sequencing lanes. Our statistical analysis of these data (4099 mutations from 32 mutant genomes) successfully identified 3 genes (acrB, marC, acrA) that have been independently validated as causing this experimental phenotype. It must be emphasized that our approach reduces mutant sequencing costs enormously. Whereas a conventional genome sequencing experiment would have cost $7,200 in reagents alone, our Phenotype Sequencing design yielded the same information value for only $1200. In fact, our smallest experiments reliably identified acrB and marC at a cost of only $110-$340.	[Harper, Marc A.; Machado, Iara M. P.; Liao, James C.; Lee, Christopher J.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90024 USA; [Chen, Zugen; Toy, Traci; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Machado, Iara M. P.; Liao, James C.] Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90024 USA; [Lee, Christopher J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Christopher J.] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Lee, Christopher J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harper, MA (corresponding author), Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90024 USA.	leec@chem.ucla.edu	Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Liao, James/0000-0002-4580-7276	Office of Science (BER), United States Department of Energy [DE-FC02-02ER63421]	Office of Science (BER), United States Department of Energy(United States Department of Energy (DOE))	Funding: This research was supported by the Office of Science (BER), United States Department of Energy, Cooperative Agreement No. DE-FC02-02ER63421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATSUMI S, 2011, MOL SYS BIO IN PRESS; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Cridland JM, 2010, GENOME BIOL EVOL, V2, P83, DOI 10.1093/gbe/evq001; Hanai T, 2007, APPL ENVIRON MICROB, V73, P7814, DOI 10.1128/AEM.01140-07; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Jones E., 2001, SCIPY OPEN SOURCE SC; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; LEE C, 2009, SCIPY, V8, P82; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; MILLER JH, 1972, EXPT MOL GENETICS, P143; Ohnishi J, 2008, MUTAT RES-GEN TOX EN, V649, P239, DOI 10.1016/j.mrgentox.2007.10.003; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103	29	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16517	10.1371/journal.pone.0016517	http://dx.doi.org/10.1371/journal.pone.0016517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364744	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800008
J	Monson, NL; Cravens, P; Hussain, R; Harp, CT; Cummings, M; Martin, MD; Ben, LH; Do, J; Lyons, JA; Lovette-Racke, A; Cross, AH; Racke, MK; Stuve, O; Shlomchik, M; Eagar, TN				Monson, Nancy L.; Cravens, Petra; Hussain, Rehana; Harp, Christopher T.; Cummings, Matthew; Martin, Maria de Pilar; Ben, Li-Hong; Do, Julie; Lyons, Jeri-Anne; Lovette-Racke, Amy; Cross, Anne H.; Racke, Michael K.; Stueve, Olaf; Shlomchik, Mark; Eagar, Todd N.			Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; B-CELLS; INDUCTION; DEPLETION; PROTEIN; TOLERANCE; CTLA-4; IL-10; MICE; EAE	Recent clinical trials have established B cell depletion by the anti-CD20 chimeric antibody Rituximab as a beneficial therapy for patients with relapsing-remitting multiple sclerosis (MS). The impact of Rituximab on T cell responses remains largely unexplored. In the experimental autoimmune encephalomyelitis (EAE) model of MS in mice that express human CD20, Rituximab administration rapidly depleted peripheral B cells and strongly reduced EAE severity. B cell depletion was also associated with diminished Delayed Type Hypersensitivity (DTH) and a reduction in T cell proliferation and IL-17 production during recall immune response experiments. While Rituximab is not considered a broad immunosuppressant, our results indicate a role for B cells as a therapeutic cellular target in regulating encephalitogenic T cell responses in specific tissues.	[Monson, Nancy L.; Cravens, Petra; Hussain, Rehana; Harp, Christopher T.; Cummings, Matthew; Martin, Maria de Pilar; Ben, Li-Hong; Do, Julie; Stueve, Olaf; Eagar, Todd N.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Monson, Nancy L.; Eagar, Todd N.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Lyons, Jeri-Anne] Univ Wisconsin, Milwaukee, WI 53201 USA; [Lovette-Racke, Amy] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cross, Anne H.] Washington Univ, Dept Neurol, St Louis, MO USA; [Racke, Michael K.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Stueve, Olaf] VA N Texas Hlth Care Syst, Neurol Sect, Med Serv, Dallas, TX USA; [Shlomchik, Mark] Yale Univ, Sch Med, Lab Med & Immunobiol, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Milwaukee; University System of Ohio; Ohio State University; Washington University (WUSTL); University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; Yale University	Monson, NL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	Todd.eagar@utsouthwestern.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Cross, Anne/0000-0003-0829-7569	University of Texas Southwestern Medical Center Department of Neurology; National Multiple Sclerosis Society [PP1122, RG3267]; Howson Funds	University of Texas Southwestern Medical Center Department of Neurology; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Howson Funds	This work was supported by funds provided by the University of Texas Southwestern Medical Center Department of Neurology. This work was supported by grants from the National Multiple Sclerosis Society to NLM (PP1122 and RG3267) and Howson Funds to NLM. The funders had no role in study desing, data collection, analysis, decision to publish or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Bauman TM, 2004, FRONT BIOSCI-LANDMRK, V9, P2302, DOI 10.2741/1398; Martin MD, 2007, FRONT BIOSCI-LANDMRK, V12, P2735, DOI 10.2741/2268; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Eagar TN, 2004, J IMMUNOL, V172, P7442, DOI 10.4049/jimmunol.172.12.7442; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; EINFELD DA, 1988, EMBO J, V7, P711, DOI 10.1002/j.1460-2075.1988.tb02867.x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Grillo-Lopez AJ, 2002, SEMIN ONCOL, V29, P105, DOI 10.1053/sonc.2002.30145; Harp CT, 2010, EUR J IMMUNOL, V40, P2942, DOI 10.1002/eji.201040516; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; HERRMANN P, 1988, IMMUNOBIOLOGY, V177, P382, DOI 10.1016/S0171-2985(88)80006-8; LEDBETTER JA, 1986, HUM IMMUNOL, V15, P30, DOI 10.1016/0198-8859(86)90315-0; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Menge T, 2008, DRUGS, V68, P2445, DOI 10.2165/0003495-200868170-00004; PRESS OW, 1987, BLOOD, V69, P584; Saville MW, 2003, BLOOD, V102, P408, DOI 10.1182/blood-2003-03-1005; STUVE O, 2005, ARCH NEUROL IN PRESS; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; 2008, FDA MEDWATCH INFORM	23	62	63	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17103	10.1371/journal.pone.0017103	http://dx.doi.org/10.1371/journal.pone.0017103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359213	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700048
J	Zhang, FY; Chen, LQ; Qin, JG; Zhao, WH; Wu, P; Yu, N; Ma, LB				Zhang, Fengying; Chen, Liqiao; Qin, Jianguang; Zhao, Weihong; Wu, Ping; Yu, Na; Ma, Lingbo			cDNA Cloning and Expression Analysis of Gustavus Gene in the Oriental River Prawn Macrobrachium nipponense	PLOS ONE			English	Article							SOCS-BOX MOTIF; SPRY-DOMAIN; STRUCTURAL BASIS; GERM PLASM; PROTEIN; RECOGNITION; INTERACTS; ELEGANS; FAMILY; SPSB2	The gustavus gene is required for localizing pole plasm and specifying germ cells. Research on gustavus gene expression will advance our understanding of the biological function of gustavus in animals. A cDNA encoding gustavus protein was identified and termed MnGus in the oriental river prawn Macrobrachium nipponense. Bioinformatic analyses showed that this gene encoded a protein of 262 amino acids and the protein belongs to the Spsb1 family. Real-time quantitative PCR analyses revealed that the expression level of MnGus in prawn embryos was slightly higher at the cleavage stage than at the blastula stage, and reached the maximum level during the zoea stage of embryos. The minimum level of MnGus expression occurred during the perinucleolus stage in the ovary, while the maximum was at the oil globule stage, and then the level of MnGus expression gradually decreased with the advancement of ovarian development. The expression level of MnGus in muscle was much higher than that in other tissues in mature prawn. The gustavus cDNA sequence was firstly cloned from the oriental river prawn and the pattern of gene expression was described during oocyte maturation, embryonic development, and in other tissues. The differential expression patterns of MnGus in the embryo, ovary and other somatic tissues suggest that the gustavus gene performs multiple physiological functions in the oriental river prawn.	[Zhang, Fengying; Chen, Liqiao; Zhao, Weihong; Wu, Ping; Yu, Na] E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China; [Zhang, Fengying; Ma, Lingbo] Chinese Acad Fishery Sci, E China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Qin, Jianguang] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	East China Normal University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Flinders University South Australia	Zhang, FY (corresponding author), E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China.	lqchen@bio.ecnu.edu.cn		Chen, Liqiao/0000-0003-0138-7828; Qin, Jianguang/0000-0003-2448-8058	Shanghai Committee of Science and Technology, China [08DZ1906401, 10JC1404100]; National Natural Science Foundation of China [30771670]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200802690012]; National Basic Research Program (973 Program) [2009CB118702]; Shanghai Agriculture Science and Technology Key Grant [2-1]; National Key Technology RD Program [2006BAD01A13]; E-Institute of Shanghai Municipal Education Commission [E03009]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program (973 Program)(National Basic Research Program of China); Shanghai Agriculture Science and Technology Key Grant; National Key Technology RD Program(National Key Technology R&D Program); E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	Funding: This study was supported by the Shanghai Committee of Science and Technology, China (08DZ1906401, 10JC1404100), the National Natural Science Foundation of China (No. 30771670), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 200802690012), the National Basic Research Program (973 Program, No. 2009CB118702), the Shanghai Agriculture Science and Technology Key Grant (No. 2-1, 2009), and the National Key Technology R&D Program (No. 2006BAD01A13) and partially by the E-Institute of Shanghai Municipal Education Commission (No. E03009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EDDY EM, 1975, INT REV CYTOL, V43, P229; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Gao X.G., 2006, BIOTECHNOL B S, P438, DOI DOI 10.3969/J.ISSN.1002-5464.2006.Z1.097; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kleiber ML, 2009, GENOMICS, V93, P358, DOI 10.1016/j.ygeno.2008.11.011; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kugler JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009048; Li JZ, 2009, BIOCHEM GENET, V47, P179, DOI 10.1007/s10528-008-9215-1; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MAHOWALD AP, 1992, SCIENCE, V255, P1216, DOI 10.1126/science.1372132; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Meeratana P, 2007, AQUACULTURE, V270, P249, DOI 10.1016/j.aquaculture.2007.03.009; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pelegri F, 1999, CURR BIOL, V9, P1431, DOI 10.1016/S0960-9822(00)80112-8; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STROME S, 1992, NATURE, V358, P368; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Xing Y, 2006, REPRODUCTION, V131, P905, DOI 10.1530/rep.1.01046; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; [赵艳民 ZHAO Yanmin], 2006, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P75	33	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17170	10.1371/journal.pone.0017170	http://dx.doi.org/10.1371/journal.pone.0017170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359189	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700057
J	Lewellyn, EB; Loeb, DD				Lewellyn, Eric B.; Loeb, Daniel D.			Serine Phosphoacceptor Sites within the Core Protein of Hepatitis B Virus Contribute to Genome Replication Pleiotropically	PLOS ONE			English	Article							STRAND DNA-SYNTHESIS; HEPADNAVIRUS REVERSE TRANSCRIPTION; ARGININE-RICH DOMAIN; CIS-ACTING SEQUENCES; RNA ENCAPSIDATION; VIRAL-DNA; PREGENOME ENCAPSIDATION; STEM-LOOP; PHOSPHORYLATION; SIGNAL	The core protein of hepatitis B virus can be phosphorylated at serines 155, 162, and 170. The contribution of these serine residues to DNA synthesis was investigated. Core protein mutants were generated in which each serine was replaced with either alanine or aspartate. Aspartates can mimic constitutively phosphorylated serines while alanines can mimic constitutively dephosphorylated serines. The ability of these mutants to carry out each step of DNA synthesis was determined. Alanine substitutions decreased the efficiency of minus-strand DNA elongation, primer translocation, circularization, and plus-strand DNA elongation. Aspartate substitutions also reduced the efficiency of these steps, but the magnitude of the reduction was less. Our findings suggest that phosphorylated serines are required for multiple steps during DNA synthesis. It has been proposed that generation of mature DNA requires serine dephosphorylation. Our results suggest that completion of rcDNA synthesis requires phosphorylated serines.	[Lewellyn, Eric B.; Loeb, Daniel D.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lewellyn, EB (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	loeb@oncology.wisc.edu			NIH [R01 AI060018, P01 CA022443, T32 CA009135]; NATIONAL CANCER INSTITUTE [P01CA022443, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI060018, P01 CA022443, and T32 CA009135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2008, VIROLOGY, V379, P30, DOI 10.1016/j.virol.2008.06.021; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Basagoudanavar SH, 2007, J VIROL, V81, P1641, DOI 10.1128/JVI.01671-06; BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; CHIANG PW, 1992, VIROLOGY, V186, P701, DOI 10.1016/0042-6822(92)90037-P; Chua PK, 2010, J VIROL, V84, P2340, DOI 10.1128/JVI.01666-09; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; DELIUS H, 1983, J VIROL, V47, P337, DOI 10.1128/JVI.47.2.337-343.1983; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; GERLICH WH, 1980, CELL, V21, P801, DOI 10.1016/0092-8674(80)90443-2; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Jiang T, 2009, BIOPHYS J, V96, P3065, DOI 10.1016/j.bpj.2009.01.009; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 1998, J VIROL, V72, P9116; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; LEHMANN EL, 1975, BLOCKED COMP 2 TREAT, P120; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Lewellyn EB, 2007, J VIROL, V81, P6207, DOI 10.1128/JVI.00210-07; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Liu N, 2004, J VIROL, V78, P642, DOI 10.1128/JVI.78.2.642-649.2004; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Perlman DH, 2005, P NATL ACAD SCI USA, V102, P9020, DOI 10.1073/pnas.0502138102; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; PUGH J, 1989, J VIROL, V63, P1371, DOI 10.1128/JVI.63.3.1371-1376.1989; Rieger A, 1996, J VIROL, V70, P585, DOI 10.1128/JVI.70.1.585-589.1996; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; TAVIS JE, 1994, J VIROL, V68, P3536, DOI 10.1128/JVI.68.6.3536-3543.1994; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; *WHO, 2008, 204 WHO; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	41	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17202	10.1371/journal.pone.0017202	http://dx.doi.org/10.1371/journal.pone.0017202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358805	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200028
J	Jin, M; Wu, ZZ; Chen, L; Jaimes, J; Collins, D; Walters, ET; O'Neil, RG				Jin, Min; Wu, Zizhen; Chen, Ling; Jaimes, Jose; Collins, Diana; Walters, Edgar T.; O'Neil, Roger G.			Determinants of TRPV4 Activity following Selective Activation by Small Molecule Agonist GSK1016790A	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; HEAT-EVOKED ACTIVATION; CALCIUM-ENTRY; PROTEIN; DOMAIN; MECHANISM; INSERTION	TRPV4 (Transient Receptor Potential Vanilloid 4) channels are activated by a wide range of stimuli, including hypotonic stress, non-noxious heat and mechanical stress and some small molecule agonists (e.g. phorbol ester 4 alpha-PDD). GSK1016790A (GSK101) is a recently discovered specific small molecule agonist of TRPV4. Its effects on physical determinants of TRPV4 activity were evaluated in HeLa cells transiently transfected with TRPV4 (HeLa-TRPV4). GSK101 (10 nM) causes a TRPV4 specific Ca2+ influx in HeLa-TRPV4 cells, but not in control transfected cells, which can be inhibited by ruthenium red and Ca2+-free medium more significantly at the early stage of the activation rather than the late stage, reflecting apparent partial desensitization. Western blot analysis showed that GSK101 activation did not induce an increase in TRPV4 expression at the plasma membrane, but caused an immediate and sustained downregulation of TRPV4 on the plasma membrane in HeLa-TRPV4 cells. Patch clamp analysis also revealed an early partial desensitization of the channel which was Ca2+-independent. FRET analysis of TRPV4 subunit assembly demonstrated that the GSK101-induced TRPV4 channel activation/desensitization was not due to alterations in homotetrameric channel formation on the plasma membrane. It is concluded that GSK101 specifically activates TRPV4 channels, leading to a rapid partial desensitization and downregulation of the channel expression on the plasma membrane. TRPV4 subunit assembly appears to occur during trafficking from the ER/Golgi to the plasma membrane and is not altered by agonist stimulation.	[Jin, Min; Wu, Zizhen; Chen, Ling; Jaimes, Jose; Collins, Diana; Walters, Edgar T.; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Jin, M (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX USA.	roger.g.oneil@uth.tmc.edu		Walters, Edgar/0000-0003-0718-102X	National Institutes of Health [R01 DK70950, R21 DE018522]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was received from National Institutes of Health R01 DK70950 and NIH R21 DE018522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gadzikowska Maria, 2002, Acta Pol Pharm, V59, P149; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gordon-Shaag A, 2008, CHANNELS, V2, P125, DOI 10.4161/chan.2.2.6026; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Shukla AK, 2010, J BIOL CHEM; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	47	63	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16713	10.1371/journal.pone.0016713	http://dx.doi.org/10.1371/journal.pone.0016713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339821	Green Submitted, Green Published, gold			2022-12-27	WOS:000287367600016
J	Mittempergher, L; de Ronde, JJ; Nieuwland, M; Kerkhoven, RM; Simon, I; Rutgers, EJT; Wessels, LFA; Van't Veer, LJ				Mittempergher, Lorenza; de Ronde, Jorma J.; Nieuwland, Marja; Kerkhoven, Ron M.; Simon, Iris; Rutgers, Emiel J. Th; Wessels, Lodewyk F. A.; Van't Veer, Laura J.			Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue Are Largely Comparable to Fresh Frozen Matched Tissue	PLOS ONE			English	Article							MAMMALIAN-CELLS; BEAD ARRAYS; DASL ASSAY; RNA; MICROARRAY; SAMPLES; TUMORS; OPTIMIZATION; SIGNATURE	Background and Methods: Formalin Fixed Paraffin Embedded (FFPE) samples represent a valuable resource for cancer research. However, the discovery and development of new cancer biomarkers often requires fresh frozen (FF) samples. Recently, the Whole Genome (WG) DASL (cDNA-mediated Annealing, Selection, extension and Ligation) assay was specifically developed to profile FFPE tissue. However, a thorough comparison of data generated from FFPE RNA and Fresh Frozen (FF) RNA using this platform is lacking. To this end we profiled, in duplicate, 20 FFPE tissues and 20 matched FF tissues and evaluated the concordance of the DASL results from FFPE and matched FF material. Methodology and Principal Findings: We show that after proper normalization, all FFPE and FF pairs exhibit a high level of similarity (Pearson correlation >0.7), significantly larger than the similarity between non-paired samples. Interestingly, the probes showing the highest correlation had a higher percentage G/C content and were enriched for cell cycle genes. Predictions of gene expression signatures developed on frozen material (Intrinsic subtype, Genomic Grade Index, 70 gene signature) showed a high level of concordance between FFPE and FF matched pairs. Interestingly, predictions based on a 60 gene DASL list (best match with the 70 gene signature) showed very high concordance with the MammaPrint (R) results. Conclusions and Significance: We demonstrate that data generated from FFPE material with the DASL assay, if properly processed, are comparable to data extracted from the FF counterpart. Specifically, gene expression profiles for a known set of prognostic genes for a specific disease are highly comparable between two conditions. This opens up the possibility of using both FFPE and FF material in gene expressions analyses, leading to a vast increase in the potential resources available for cancer research.	[Mittempergher, Lorenza; de Ronde, Jorma J.; Rutgers, Emiel J. Th; Wessels, Lodewyk F. A.; Van't Veer, Laura J.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Nieuwland, Marja; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, Amsterdam, Netherlands; [Simon, Iris; Van't Veer, Laura J.] Agendia BV, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Agendia	Mittempergher, L (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.vt.veer@nki.nl	Rutgers, Emiel J T/C-5934-2015	Mittempergher, Lorenza/0000-0003-3425-3965	Top Institute Pharma (TI PHARMA) [T3-108-1]	Top Institute Pharma (TI PHARMA)	Funding: This work was supported by the Top Institute Pharma (TI PHARMA) (project T3-108-1). Two co-authors (LVV, IS) are employed by Agendia BV. Therefore the funder Agendia had a role in study design, analysis, decision to publish and preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Armitage P, 2001, STAT METHODS MED RES, P288; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Desmedt C, 2008, EUR J CANCER, V44, P2714, DOI 10.1016/j.ejca.2008.09.011; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hannemann J, 2006, BRIT J CANCER, V95, P1334, DOI 10.1038/sj.bjc.6603449; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kok M, 2009, BREAST CANCER RES TR, V113, P275, DOI 10.1007/s10549-008-9939-y; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2004, NEW ENGL J MED, V350, P1814, DOI 10.1056/NEJMp048059; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Ton CC, 2010, BREAST CANC RES TREA; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Waddell N, 2010, J PATHOL, V221, P452, DOI 10.1002/path.2728; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xiang CC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng053	37	103	104	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17163	10.1371/journal.pone.0017163	http://dx.doi.org/10.1371/journal.pone.0017163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347257	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500035
J	Aknin, LB; Sandstrom, GM; Dunn, EW; Norton, MI				Aknin, Lara B.; Sandstrom, Gillian M.; Dunn, Elizabeth W.; Norton, Michael I.			It's the Recipient That Counts: Spending Money on Strong Social Ties Leads to Greater Happiness than Spending on Weak Social Ties	PLOS ONE			English	Article							NETWORK	Previous research has shown that spending money on others (prosocial spending) increases happiness. But, do the happiness gains depend on who the money is spent on? Sociologists have distinguished between strong ties with close friends and family and weak ties-relationships characterized by less frequent contact, lower emotional intensity, and limited intimacy. We randomly assigned participants to reflect on a time when they spent money on either a strong social tie or a weak social tie. Participants reported higher levels of positive affect after recalling a time they spent on a strong tie versus a weak tie. The level of intimacy in the relationship was more important than the type of relationship; there was no significant difference in positive affect after recalling spending money on a family member instead of a friend. These results add to the growing literature examining the factors that moderate the link between prosocial behaviour and happiness.	[Aknin, Lara B.; Sandstrom, Gillian M.; Dunn, Elizabeth W.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Norton, Michael I.] Harvard Univ, Sch Business, Mkt Unit, Boston, MA 02163 USA	University of British Columbia; Harvard University	Aknin, LB (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	laknin@psych.ubc.ca		Sandstrom, Gillian/0000-0002-0549-9600	Social Sciences and Humanities Research Council of Canada [410-2008-2509]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This project was supported by the Social Sciences and Humanities Research Council of Canada (grant number: 410-2008-2509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dal Bo P, 2005, AM ECON REV, V95, P1591; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Dunn EW, 2010, J HEALTH PSYCHOL, V15, P627, DOI 10.1177/1359105309356366; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hill AL, 2010, P ROY SOC B-BIOL SCI, V277, P3827, DOI 10.1098/rspb.2010.1217; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Boven L, 2003, J PERS SOC PSYCHOL, V85, P1193, DOI 10.1037/0022-3514.85.6.1193; VanLear CA, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P91, DOI 10.1017/CBO9780511606632.007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zauberman G, 2009, J CONSUM RES, V35, P715, DOI 10.1086/592943	14	65	67	19	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17018	10.1371/journal.pone.0017018	http://dx.doi.org/10.1371/journal.pone.0017018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NZ	21347326	Green Published, gold, Green Accepted			2022-12-27	WOS:000287363000032
J	Gilbert, MR; Douris, N; Tongjai, S; Green, CB				Gilbert, Misty R.; Douris, Nicholas; Tongjai, Siripong; Green, Carla B.			Nocturnin Expression Is Induced by Fasting in the White Adipose Tissue of Restricted Fed Mice	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ARNT-LIKE PROTEIN-1; CIRCADIAN CLOCK; REGULATED GENE; ENERGY-BALANCE; LIPOLYSIS; LIVER; FAT; PHOSPHORYLATION; TRANSCRIPTION	The relationship between circadian clocks and metabolism is intimate and complex and a number of recent studies have begun to reveal previously unknown effects of food and its temporal availability on the clock and the rhythmic transcriptome of peripheral tissues. Nocturnin, a circadian deadenylase, is expressed rhythmically in a wide variety of tissues, but we report here that Nocturnin expression is arrhythmic in epididymal white adipose tissue (eWAT) of mice housed in 12: 12 LD with ad libitum access to food. However, Nocturnin expression becomes rhythmic in eWAT of mice placed on restricted feeding. We show here that Nocturnin's rhythmic expression pattern is not dependent upon feeding, nor is it acutely induced by feeding in the liver or eWAT of ad libitum fed mice. However, Nocturnin is acutely induced by the absence of the expected meal in eWAT of restricted fed mice. A rise in cAMP levels also induces Nocturnin expression, suggesting that Nocturnin's induction in eWAT by fasting is likely mediated through the same pathways that activate lipolysis. Therefore, this suggests that Nocturnin plays a role in linking nutrient sensing by the circadian clock to lipid mobilization in the adipocytes.	[Gilbert, Misty R.; Douris, Nicholas; Tongjai, Siripong; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Virginia	Gilbert, MR (corresponding author), Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA.	Carla.Green@utsouthwestern.edu		Tongjai, Siripong/0000-0001-6451-675X	National Institutes of Health [R01 GM076626, R01 MH090247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH090247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institutes of Health R01 GM076626 and R01 MH090247 to CBG (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BELFRAGE P, 1980, FEBS LETT, V111, P120, DOI 10.1016/0014-5793(80)80775-7; BOLINDER J, 1983, J CLIN ENDOCR METAB, V57, P455, DOI 10.1210/jcem-57-3-455; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; GALITZKY J, 1995, FUND CLIN PHARMACOL, V9, P324, DOI 10.1111/j.1472-8206.1995.tb00506.x; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Gimble JM, 2009, OBES REV, V10, P46, DOI 10.1111/j.1467-789X.2009.00661.x; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Gronke S, 2009, GENETICS, V183, P219, DOI 10.1534/genetics.109.105601; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; KAWAMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P732, DOI 10.1073/pnas.78.2.732; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu XR, 2002, MOL CELL BIOL, V22, P7501, DOI 10.1128/MCB.22.21.7501-7511.2002; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; STRALFORS P, 1983, J BIOL CHEM, V258, P5146; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	40	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17051	10.1371/journal.pone.0017051	http://dx.doi.org/10.1371/journal.pone.0017051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347334	Green Submitted, Green Published, gold			2022-12-27	WOS:000287363000035
J	Nausch, N; Midzi, N; Mduluza, T; Maizels, RM; Mutapi, F				Nausch, Norman; Midzi, Nicholas; Mduluza, Takafira; Maizels, Rick M.; Mutapi, Francisca			Regulatory and Activated T Cells in Human Schistosoma haematobium Infections	PLOS ONE			English	Article							INTERLEUKIN-5 PRODUCTION; HELMINTH INFECTION; MANSONI INFECTION; IMMUNE REGULATION; RESPONSES; IMMUNOPATHOLOGY; FOXP3; DISEASE; CD4(+); TH2	Acquired immunity against helminths is characterised by a complex interplay between the effector Th1 and Th2 immune responses and it slowly manifests with age as a result of cumulative exposure to parasite antigens. Data from experimental models suggest that immunity is also influenced by regulatory T cells (Treg), but as yet studies on Treg in human schistosome infections are limited. This study investigated the relationship between schistosome infection intensity and the two cell populations regulatory T cells (Treg: CD4(+(dim))CD(25+(high))FOXP(3+)CD127(low)), and activated (Tact: CD4(+)CD25(+)FOXP3(-)) T cells in Zimbabweans exposed to Schistosoma haematobium parasites. Participants were partitioned into two age groups, young children (8-13 years) in whom schistosome infection levels were rising to peak and older people (14+ years) with declining infection levels. The relationship between Tact proportions and schistosome infection intensity remained unchanged with age. However Treg proportions rose significantly with increasing infection in the younger age group. In contrast Treg were negatively correlated to infection intensity in the older age group. The relative proportions of regulatory T cells differ significantly between young individuals in whom high infection is associated with an enhanced regulatory phenotype and older infected patients in whom the regulatory response is attenuated. This may influence or reflect different stages of the development of protective schistosome acquired immunity and immunopathogenesis.	[Nausch, Norman; Maizels, Rick M.; Mutapi, Francisca] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Midzi, Nicholas] Natl Inst Hlth Res, Harare, Zimbabwe; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Edinburgh; University of Zimbabwe	Nausch, N (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Ashworth Labs, Edinburgh, Midlothian, Scotland.	nnausch@staffmail.ed.ac.uk	Nausch, Norman/L-9276-2013; Nausch, Norman/M-4526-2019	Nausch, Norman/0000-0002-9704-2148; Nausch, Norman/0000-0002-9704-2148; Mutapi, Francisca/0000-0002-2537-3466	Wellcome Trust UK [WT082028MA]; Medical Research Council UK [G81/538]; Cunningham Trust; Carnegie Trust for the Universities of Scotland	Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cunningham Trust; Carnegie Trust for the Universities of Scotland	This work was supported by Wellcome Trust UK (Grant no WT082028MA), http://www.wellcome.ac.uk/; Medical Research Council UK (Grant no G81/538), www.mrc.ac.uk; Cunningham Trust; and Carnegie Trust for the Universities of Scotland, http://www.carnegie-trust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; Babu S, 2006, J IMMUNOL, V176, P3248, DOI 10.4049/jimmunol.176.5.3248; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Black CL, 2010, J INFECT DIS, V202, P399, DOI 10.1086/653828; Capron A, 1999, MICROBES INFECT, V1, P485, DOI 10.1016/S1286-4579(99)80086-0; Capron A, 2004, CLIN REV ALLERG IMMU, V26, P25, DOI 10.1385/CRIAI:26:1:25; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Correa-Oliveira R, 1998, BRAZ J MED BIOL RES, V31, P171, DOI 10.1590/S0100-879X1998000100024; Everts B, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000667; Faal N, 2006, PLOS MED, V3, P1292, DOI 10.1371/journal.pmed.0030266; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hoffmann KF, 2002, ADV PARASIT, V52, P265, DOI 10.1016/S0065-308X(02)52014-5; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; KING CH, 1989, J INFECT DIS, V160, P686, DOI 10.1093/infdis/160.4.686; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Layland LE, 2007, EUR J IMMUNOL, V37, P2174, DOI 10.1002/eji.200737063; Layland LE, 2010, J IMMUNOL, V184, P713, DOI 10.4049/jimmunol.0901435; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; McKinley L, 2006, J IMMUNOL, V177, P6215, DOI 10.4049/jimmunol.177.9.6215; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; MDULUZA M, 2007, GATEWAY BIOMEDICAL R; Mduluza T, 2003, IMMUNOL LETT, V88, P249, DOI 10.1016/S0165-2478(03)00088-9; Medhat A, 1998, J INFECT DIS, V178, P512, DOI 10.1086/515630; MEVIN MD, 1982, LAB PROCEDURES DIAGN; Midzi N, 2008, T ROY SOC TROP MED H, V102, P1039, DOI 10.1016/j.trstmh.2008.05.024; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; MOTT KE, 1983, B SOC PATHOL EXOT, V76, P101; Mouk EMO, 2009, AM J TROP MED HYG, V80, P475, DOI 10.4269/ajtmh.2009.80.475; Mutapi F, 1998, J INFECT DIS, V178, P289, DOI 10.1086/517456; Mutapi F, 2002, LANCET INFECT DIS, V2, P219, DOI 10.1016/S1473-3099(02)00240-2; Mutapi F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-96; NDHLOVU P, 1992, 1992 NATL SCHISTOSOM; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Rausch S, 2008, INFECT IMMUN, V76, P1908, DOI 10.1128/IAI.01233-07; Reilly L, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-158; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Scott JT, 2000, PARASITE IMMUNOL, V22, P341, DOI 10.1046/j.1365-3024.2000.00311.x; Sokal R.R., 2012, BIOMETRY; Stothard JR, 2002, T ROY SOC TROP MED H, V96, P507, DOI 10.1016/S0035-9203(02)90421-9; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taylor JJ, 2006, J IMMUNOL, V176, P5839, DOI 10.4049/jimmunol.176.10.5839; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Teixeira-Carvalho A, 2008, ACTA TROP, V108, P139, DOI 10.1016/j.actatropica.2008.04.010; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Watanabe K, 2009, PARASITE IMMUNOL, V31, P440, DOI 10.1111/j.1365-3024.2009.01127.x; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; WOOLHOUSE MEJ, 1991, NATURE, V351, P757, DOI 10.1038/351757a0; World Health Organization, 2002, PREV CONTR SCHIST SO; Wynn TA, 2000, PARASITOL TODAY, V16, P497, DOI 10.1016/S0169-4758(00)01788-9; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	63	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16860	10.1371/journal.pone.0016860	http://dx.doi.org/10.1371/journal.pone.0016860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347311	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000020
J	Cavina-Pratesi, C; Kuhn, G; Ietswaart, M; Milner, AD				Cavina-Pratesi, Cristiana; Kuhn, Gustav; Ietswaart, Magdalena; Milner, A. David			The Magic Grasp: Motor Expertise in Deception	PLOS ONE			English	Article							VISUAL CONTROL; HANDEDNESS; BRAIN; BODY	Background: Most of us are poor at faking actions. Kinematic studies have shown that when pretending to pick up imagined objects (pantomimed actions), we move and shape our hands quite differently from when grasping real ones. These differences between real and pantomimed actions have been linked to separate brain pathways specialized for different kinds of visuomotor guidance. Yet professional magicians regularly use pantomimed actions to deceive audiences. Methodology and Principal Findings: In this study, we tested whether, despite their skill, magicians might still show kinematic differences between grasping actions made toward real versus imagined objects. We found that their pantomimed actions in fact closely resembled real grasps when the object was visible (but displaced) (Experiment 1), but failed to do so when the object was absent (Experiment 2). Conclusions and Significance: We suggest that although the occipito-parietal visuomotor system in the dorsal stream is designed to guide goal-directed actions, prolonged practice may enable it to calibrate actions based on visual inputs displaced from the action.	[Cavina-Pratesi, Cristiana; Milner, A. David] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Kuhn, Gustav] Brunel Univ, Dept Psychol, Uxbridge UB8 3PH, Middx, England; [Ietswaart, Magdalena] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Durham University; Brunel University; Northumbria University	Cavina-Pratesi, C (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	cristiana.cavina-pratesi@durham.ac.uk	Kuhn, Gustav/A-9155-2013	Kuhn, Gustav/0000-0003-2888-914X; Ietswaart, Magdalena/0000-0003-4576-9393	Medical Research Council [G0401090]; MRC [G0401090] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council (G0401090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Gonzalez CLR, 2008, NEUROPSYCHOLOGIA, V46, P624, DOI 10.1016/j.neuropsychologia.2007.09.006; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Iriki A, 1996, NEUROREPORT, V7, P2325; JEANNEROD M, 1986, NEUROPSYCHOLOGIA, V24, P41, DOI 10.1016/0028-3932(86)90042-4; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Kuhn G, 2008, TRENDS COGN SCI, V12, P349, DOI 10.1016/j.tics.2008.05.008; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Rizzolatti G, 2003, EXP BRAIN RES, V153, P146, DOI 10.1007/s00221-003-1588-0; RUNESON S, 1983, J EXP PSYCHOL GEN, V112, P585, DOI 10.1037/0096-3445.112.4.585; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170	17	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16568	10.1371/journal.pone.0016568	http://dx.doi.org/10.1371/journal.pone.0016568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347416	Green Accepted, Green Published, gold			2022-12-27	WOS:000287361700021
J	Horner, JR; Goodwin, MB; Myhrvold, N				Horner, John R.; Goodwin, Mark B.; Myhrvold, Nathan			Dinosaur Census Reveals Abundant Tyrannosaurus and Rare Ontogenetic Stages in the Upper Cretaceous Hell Creek Formation (Maastrichtian), Montana, USA	PLOS ONE			English	Article							GROWTH DYNAMICS; PREDATOR	Background: A dinosaur census recorded during the Hell Creek Project (1999-2009) incorporates multiple lines of evidence from geography, taphohistory, stratigraphy, phylogeny and ontogeny to investigate the relative abundance of large dinosaurs preserved in the Upper Cretaceous Hell Creek Formation of northeastern Montana, USA. Overall, the dinosaur skeletal assemblages in the Hell Creek Formation (excluding lag-influenced records) consist primarily of subadult or small adult size individuals. Small juveniles and large adults are both extremely rare, whereas subadult individuals are relatively common. We propose that mature individuals of at least some dinosaur taxa either lived in a separate geographic locale analogous to younger individuals inhabiting an upland environment where sedimentation rates were relatively less, or these taxa experienced high mortality before reaching terminal size where late stage and often extreme cranial morphology is expressed. Methodology/Principal Findings: Tyrannosaurus skeletons are as abundant as Edmontosaurus, an herbivore, in the upper Hell Creek Formation and nearly twice as common in the lower third of the formation. Smaller, predatory dinosaurs (e. g., Troodon and dromaeosaurids) are primarily represented by teeth found in microvertebrate localities and their skeletons or identifiable lag specimens were conspicuously absent. This relative abundance suggests Tyrannosaurus was not a typical predator and likely benefited from much wider food choice opportunities than exclusively live prey and/or specific taxa. Tyrannosaurus adults may not have competed with Tyrannosaurus juveniles if the potential for selecting carrion increased with size during ontogeny. Conclusions/Significance: Triceratops is the most common dinosaur and isolated skulls contribute to a significant portion of this census. Associated specimens of Triceratops consisting of both cranial and postcranial elements remain relatively rare. This rarity may be explained by a historical collecting bias influenced by facies and taphonomic factors. The limited discovery of postcranial elements may also depend on how extensive a fossil quarry is expanded after a skull is collected.	[Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Goodwin, Mark B.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Myhrvold, Nathan] Intellectual Ventures, Bellevue, WA USA	Montana State University System; Montana State University Bozeman; University of California System; University of California Berkeley; Intellectual Ventures	Horner, JR (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	jhorner@montana.edu		Myhrvold, Nathan/0000-0003-3994-5143; Goodwin, Mark/0000-0001-7127-439X	Intellectual Ventures; Windway Foundation; Smithsonian Institution; University of California Museum of Paleontology	Intellectual Ventures; Windway Foundation; Smithsonian Institution(Smithsonian Institution); University of California Museum of Paleontology	This work was supported with funding by the following individuals: James Kinsey, Catherine B. Reynolds, and Homer Hickam. Intellectual Ventures, the Windway Foundation, and the Smithsonian Institution provided additional funding. The University of California Museum of Paleontology provided funding to MBG. NM is the founder and CEO of Intellectual Ventures and contributed to the study design. Homer Hickham participated as a Hell Creek Project volunteer in the field in Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; Brown B, 1907, B AM MUS NAT HIST, V23, P823; CARPENTER K, 1982, Contributions to Geology University of Wyoming, V20, P123; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CLOSS G, 1993, ECOLOGY, V74, P238, DOI 10.2307/1939518; Dodson P., 1983, Mosasaur, V1, P89; DODSON P, 1987, OCCASIONAL PAPER TYR, V3, P70; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; Farlow James O., 1994, Historical Biology, V7, P159; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; FOWLER DW, 2009, CINCINNATI MUSEUM CT, V3; Goodwin Mark B., 2010, P551; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; Holtz T.R., 2008, TYRANNOSAURUS REX TY, P371; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; MARSH OC, 1891, AM J SCI 3, V42, P265, DOI DOI 10.2475/AJS.S3-42.249.265; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Mills M. G. L., 2003, KALAHARI HYENAS COMP; Paul G.S., 2008, TYRANNOSAURUS REX, P307; Pearson DA, 2002, GEOL S AM S, P145; Russell DA, 2002, GEOL S AM S, P169; RUSSELL DA, 1977, NATURAL HIST SERIES, V4; Ruxton GD, 2003, P ROY SOC B-BIOL SCI, V270, P731, DOI 10.1098/rspb.2002.2279; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; SCANNELLA JB, 2009, J VERTEBRATE PALEONT, V29, P128; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; SHEEHAN PM, 1991, SCIENCE, V254, P835, DOI 10.1126/science.11536489; SINCLAIR ARE, 1995, SERENGETI, V2; STERNBERG CM, 1955, ANN REPT NAT MUS CAN, V136, P120; White PD, 1998, PALAIOS, V13, P41, DOI 10.2307/3515280; Wilson JB, 1996, OECOLOGIA, V106, P272, DOI 10.1007/BF00328608	41	76	79	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16574	10.1371/journal.pone.0016574	http://dx.doi.org/10.1371/journal.pone.0016574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347420	gold, Green Submitted, Green Published			2022-12-27	WOS:000287361700022
J	Murthy, AK; Chaganty, BKR; Troutman, T; Guentzel, MN; Yu, JJ; Ali, SK; Lauriano, CM; Chambers, JP; Klose, KE; Arulanandam, BP				Murthy, Ashlesh K.; Chaganty, Bharat K. R.; Troutman, Ty; Guentzel, M. Neal; Yu, Jieh-Juen; Ali, Syed Khalid; Lauriano, Crystal M.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.			Mannose-Containing Oligosaccharides of Non-Specific Human Secretory Immunoglobulin A Mediate Inhibition of Vibrio cholerae Biofilm Formation	PLOS ONE			English	Article							HUMAN-IGA ANTIBODIES; O1 EL-TOR; ESCHERICHIA-COLI; MUCOSAL SURFACES; PROTECTION; COMPONENT; IMMUNITY; EXPRESSION; MICE; IMMUNIZATION	The role of antigen-specific secretory IgA (SIgA) has been studied extensively, whereas there is a limited body of evidence regarding the contribution of non-specific SIgA to innate immune defenses against invading pathogens. In this study, we evaluated the effects of non-specific SIgA against infection with Vibrio cholerae O139 strain MO10 and biofilm formation. Seven day old infant mice deficient in IgA (IgA(-/-) mice) displayed significantly greater intestinal MO10 burden at 24 hr post-challenge when compared to IgA(+/+) pups. Importantly, cross-fostering of IgA(-/-) pups with IgA(+/+) nursing dams reversed the greater susceptibility to MO10 infection, suggesting a role for non-specific SIgA in protection against the infection. Since biofilm formation is associated with virulence of MO10, we further examined the role of human non-specific SIgA on this virulence phenotype of the pathogen. Human non-specific SIgA, in a dose-dependent fashion, significantly reduced the biofilm formation by MO10 without affecting the viability of the bacterium. Such an inhibitory effect was not induced by human serum IgA, IgG, or IgM, suggesting a role for the oligosaccharide-rich secretory component (SC) of SIgA. This was supported by the demonstration that SIgA treated with endoglycosidase H, to cleave the high-mannose containing terminal chitobiose residues, did not induce a reduction in biofilm formation by MO10. Furthermore, the addition of free mannose per se, across a wide dose range, induced significant reduction in MO10 biofilm formation. Collectively, these results suggest that mannose containing oligosacchardies within human non-specific secretory IgA can alter important virulence phenotypes of Vibrio cholerae such as biofilm formation, without affecting viability of the microorganism. Such effects may contribute significantly to innate immune defenses against invading pathogens in vivo in the gastrointestinal tract.	[Murthy, Ashlesh K.; Chaganty, Bharat K. R.; Troutman, Ty; Guentzel, M. Neal; Yu, Jieh-Juen; Ali, Syed Khalid; Lauriano, Crystal M.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.] S Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX USA		Murthy, AK (corresponding author), S Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX USA.	Bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014	Troutman, Ty/0000-0001-8925-8080; Chaganty, Bharat Kumar Reddy/0000-0003-3281-6218	National Institutes of Health [AR048973, GM01894]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR048973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This project was funded National Institutes of Health Grants AR048973 and GM01894. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; CAMARA LM, 1995, ADV EXP MED BIOL, V371, P673; CLARK JA, 1983, AM J CLIN PATHOL, V80, P210, DOI 10.1093/ajcp/80.2.210; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Corthesy B, 2010, FUTURE MICROBIOL, V5, P817, DOI 10.2217/FMB.10.39; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Dallas SD, 1998, J MED MICROBIOL, V47, P879, DOI 10.1099/00222615-47-10-879; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; EUBANKS ER, 1977, INFECT IMMUN, V15, P533, DOI 10.1128/IAI.15.2.533-538.1977; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Flajnik MF, 2010, NAT IMMUNOL, V11, P777, DOI 10.1038/ni0910-777; GIUGLIANO LG, 1995, J MED MICROBIOL, V42, P3, DOI 10.1099/00222615-42-1-3; GUENTZEL MN, 1977, INFECT IMMUN, V15, P539, DOI 10.1128/IAI.15.2.539-548.1977; GUENTZEL MN, 1974, INFECT IMMUN, V10, P167, DOI 10.1128/IAI.10.1.167-172.1974; GUENTZEL MN, 1975, INFECT IMMUN, V11, P890, DOI 10.1128/IAI.11.5.890-897.1975; GUENTZEL MN, 1981, SCAN ELECTRON MICROS, P115; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hsiao A, 2006, P NATL ACAD SCI USA, V103, P14542, DOI 10.1073/pnas.0604650103; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; LAMM ME, 1992, ADV EXP MED BIOL, V327, P91; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; Mestecky J, 1999, GUT, V44, P2, DOI 10.1136/gut.44.1.2; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Murthy AK, 2006, J GASTROEN HEPATOL, V21, P1372, DOI 10.1111/j.1440-1746.2006.04312.x; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NIKOLOVA EB, 1994, SCAND J IMMUNOL, V39, P275, DOI 10.1111/j.1365-3083.1994.tb03371.x; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; RUSSELL MW, 1989, EUR J IMMUNOL, V19, P2243, DOI 10.1002/eji.1830191210; TOMANA M, 1972, J IMMUNOL, V108, P1631; VANDERHEIJDEN PJ, 1987, IMMUNOLOGY, V62, P551; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	43	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16847	10.1371/journal.pone.0016847	http://dx.doi.org/10.1371/journal.pone.0016847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347387	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700044
J	Po, JYT; Subramanian, SV				Po, June Y. T.; Subramanian, S. V.			Mortality Burden and Socioeconomic Status in India	PLOS ONE			English	Article							SOCIAL-CLASS; CASTE; GENDER; HEALTH; BIAS	Background: The dimensions along which mortality is patterned in India remains unclear. We examined the specific contribution of social castes, household income, assets, and monthly per capita consumption to mortality differentials in India. Methods and Findings: Cross-sectional data on 217 363 individuals from 41 554 households from the 2004-2005 India Human Development Survey was analyzed using multiple logistic regressions. Mortality differentials across social castes were attenuated after adjusting for household economic factors such as income and assets. Individuals living in the lowest income and assets quintiles had an increased risk of mortality with odds ratio (OR) of 1.66 (95% CI = 1.23-2.24) in the bottom income quintile and OR of 2.94 (95% CI = 1.66-5.22) in the bottom asset quintile. Counter-intuitively, individuals living in households with lowest monthly consumption per capita had significantly lower probability of death (OR = 0.27, 95% CI = 0.20-0.38). Conclusions: Mortality burden in India is largely patterned on economic dimensions as opposed to caste dimensions, though caste may play an important role in predicting economic opportunities.	[Po, June Y. T.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Po, JYT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu		Po, June Yee Tsun/0000-0001-6124-8235	National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. However, S. V. Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADARI S, 1991, Genus, V47, P89; BETEILLE A, 1992, BACKWARD CLASSES CON; Fabricant SJ, 1999, INT J HEALTH PLAN M, V14, P179; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Kaplan GA, 1996, INT J HEALTH SERV, V26, P507, DOI 10.2190/4CUU-7B3G-G4XR-0K0B; Kurian NJ, 2007, INDIAN J MED RES, V126, P374; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; Mohan VR, 2009, T ROY SOC TROP MED H, V103, P801, DOI 10.1016/j.trstmh.2009.04.014; Murthi M, 1995, POPUL DEV REV, V21, P745, DOI 10.2307/2137773; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Rajna P N, 1998, Asia Pac Popul J, V13, P27; Singh RB, 2005, ACTA CARDIOL, V60, P611, DOI 10.2143/AC.60.6.2004933; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P294, DOI 10.1097/EDE.0b013e3181632c75; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Van de Poel E, 2009, ETHNIC HEALTH, V14, P271, DOI 10.1080/13557850802609931; Vanneman R., 2009, INDIA HUMAN DEV SURV	19	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16844	10.1371/journal.pone.0016844	http://dx.doi.org/10.1371/journal.pone.0016844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347373	Green Published, Green Accepted, gold			2022-12-27	WOS:000287361700042
J	Uno, Y; Uehara, S; Kohara, S; Iwasaki, K; Nagata, R; Fukuzaki, K; Utoh, M; Murayama, N; Yamazaki, H				Uno, Yasuhiro; Uehara, Shotaro; Kohara, Sakae; Iwasaki, Kazuhide; Nagata, Ryoichi; Fukuzaki, Koichiro; Utoh, Masahiro; Murayama, Norie; Yamazaki, Hiroshi			Newly Identified CYP2C93 Is a Functional Enzyme in Rhesus Monkey, but Not in Cynomolgus Monkey	PLOS ONE			English	Article							MACACA-FASCICULARIS; ESCHERICHIA-COLI; CYTOCHROME-P450; CYP3A5; LIVER; EXPRESSION; VARIANTS; CLONING; HYDROXYLATION; TOLBUTAMIDE	Cynomolgus monkey and rhesus monkey are used in drug metabolism studies due to their evolutionary closeness and physiological resemblance to human. In cynomolgus monkey, we previously identified cytochrome P450 (P450 or CYP) 2C76 that does not have a human ortholog and is partly responsible for species differences in drug metabolism between cynomolgus monkey and human. In this study, we report characterization of CYP2C93 cDNA newly identified in cynomolgus monkey and rhesus monkey. The CYP2C93 cDNA contained an open reading frame of 490 amino acids approximately 84-86% identical to human CYP2Cs. CYP2C93 was located in the genomic region, which corresponded to the intergenic region in the human genome, indicating that CYP2C93 does not correspond to any human genes. CYP2C93 mRNA was expressed predominantly in the liver among 10 tissues analyzed. The CYP2C93 proteins heterologously expressed in Escherichia coli metabolized human CYP2C substrates, diclofenac, flurbiprofen, paclitaxel, S-mephenytoin, and tolbutamide. In addition to a normal transcript (SV1), an aberrantly spliced transcript (SV2) lacking exon 2 was identified, which did not give rise to a functional protein due to frameshift and a premature termination codon. Mini gene assay revealed that the genetic variant IVS2-1G>T at the splice site of intron 1, at least partly, accounted for the exon-2 skipping; therefore, this genotype would influence CYP2C93-mediated drug metabolism. SV1 was expressed in 6 of 11 rhesus monkeys and 1 of 8 cynomolgus monkeys, but the SV1 in the cynomolgus monkey was nonfunctional due to a rare null genotype (c.102T>del). These results suggest that CYP2C93 can play roles as a drug-metabolizing enzyme in rhesus monkeys (not in cynomolgus monkeys), although its relative contribution to drug metabolism has yet to be validated.	[Uno, Yasuhiro; Uehara, Shotaro; Kohara, Sakae; Nagata, Ryoichi; Fukuzaki, Koichiro; Utoh, Masahiro] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan; [Iwasaki, Kazuhide] Shin Nippon Biomed Labs Ltd, Business Dev Dept, Osaka, Japan; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan	Shin Nippon Biomedical Laboratories Ltd.; Shin Nippon Biomedical Laboratories Ltd.; Showa Pharmaceutical University	Uno, Y (corresponding author), Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan.	uno-yasuhiro@snbl.co.jp	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Uehara, Shotaro/0000-0002-1359-8828; Uno, Yasuhiro/0000-0001-9040-1681	Shin Nippon Biomedical Laboratories, Ltd.	Shin Nippon Biomedical Laboratories, Ltd.	The funder, Shin Nippon Biomedical Laboratories, Ltd., had no role in study design, data collection and analysis, or preparation of the manuscript, but approved the decision to publish.	Chen WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-82; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; GOTOH O, 1992, J BIOL CHEM, V267, P83; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Inoue K, 1997, PHARMACOGENETICS, V7, P103, DOI 10.1097/00008571-199704000-00003; Iwata H, 1998, BIOCHEM PHARMACOL, V55, P1315, DOI 10.1016/S0006-2952(97)00643-6; KOMORI M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P141, DOI 10.1016/0167-4781(92)90113-E; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lin YS, 2002, MOL PHARMACOL, V62, P162, DOI 10.1124/mol.62.1.162; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Matsunaga Tamihide, 2002, Drug Metab Pharmacokinet, V17, P117, DOI 10.2133/dmpk.17.117; Mitsuda M, 2006, J BIOCHEM, V139, P865, DOI 10.1093/jb/mvj093; Narimatsu S, 2006, BIOCHEM PHARMACOL, V72, P1738, DOI 10.1016/j.bcp.2006.08.025; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; SHARER JE, 1995, DRUG METAB DISPOS, V23, P1231; Tang CY, 2007, BIOCHEM PHARMACOL, V73, P880, DOI 10.1016/j.bcp.2006.11.016; Uno Y, 2007, XENOBIOTICA, V37, P30, DOI 10.1080/00498250600968275; UNO Y, 2009, J VET MED S IN PRESS; Uno Y, 2008, FEBS LETT, V582, P351, DOI 10.1016/j.febslet.2007.12.031; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Uno Y, 2010, CURR DRUG METAB, V11, P142, DOI 10.2174/138920010791110854; Uno Y, 2010, J VET MED SCI, V72, P225, DOI 10.1292/jvms.09-0341; Uno Y, 2010, DRUG METAB DISPOS, V38, P209, DOI 10.1124/dmd.109.029710; Uno Y, 2009, DRUG METAB DISPOS, V37, P14, DOI 10.1124/dmd.108.023622; Yamazaki H, 1998, BIOCHEM PHARMACOL, V56, P243, DOI 10.1016/S0006-2952(98)00133-6; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578	27	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16923	10.1371/journal.pone.0016923	http://dx.doi.org/10.1371/journal.pone.0016923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347438	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600034
J	Moss, R; McCaw, JM; McVernon, J				Moss, Robert; McCaw, James M.; McVernon, Jodie			Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic	PLOS ONE			English	Article							SWINE FLU EPIDEMIC; PANDEMIC INFLUENZA; DRUG-RESISTANCE; CONTAINMENT PLAN; GENERAL-PRACTICE; H1N1 2009; AUSTRALIA; TRANSMISSION; POPULATION; HOUSEHOLD	Background: Many countries have amassed antiviral stockpiles for pandemic preparedness. Despite extensive trial data and modelling studies, it remains unclear how to make optimal use of antiviral stockpiles within the constraints of healthcare infrastructure. Modelling studies informed recommendations for liberal antiviral distribution in the pandemic phase, primarily to prevent infection, but failed to account for logistical constraints clearly evident during the 2009 H1N1 outbreaks. Here we identify optimal delivery strategies for antiviral interventions accounting for logistical constraints, and so determine how to improve a strategy's impact. Methods and Findings: We extend an existing SEIR model to incorporate finite diagnostic and antiviral distribution capacities. We evaluate the impact of using different diagnostic strategies to decide to whom antivirals are delivered. We then determine what additional capacity is required to achieve optimal impact. We identify the importance of sensitive and specific case ascertainment in the early phase of a pandemic response, when the proportion of false-positive presentations may be high. Once a substantial percentage of ILI presentations are caused by the pandemic strain, identification of cases for treatment on syndromic grounds alone results in a greater potential impact than a laboratory-dependent strategy. Our findings reinforce the need for a decentralised system capable of providing timely prophylaxis. Conclusions: We address specific real-world issues that must be considered in order to improve pandemic preparedness policy in a practical and methodologically sound way. Provision of antivirals on the scale proposed for an effective response is infeasible using traditional public health outbreak management and contact tracing approaches. The results indicate to change the transmission dynamics of an influenza epidemic with an antiviral intervention, a decentralised system is required for contact identification and prophylaxis delivery, utilising a range of existing services and infrastructure in a "whole of society" response.	[Moss, Robert] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Moss, R (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	rgmoss@unimelb.edu.au	Moss, Rob/R-4767-2018	Moss, Rob/0000-0002-4568-2012; McVernon, Jodie/0000-0001-9774-1961; McCaw, James/0000-0002-2452-3098	National Health and Medical Research Council (NHMRC) [358425, 410224, 566635]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding support was provided by the National Health and Medical Research Council (NHMRC) through Capacity Building (Grant 358425), Urgent Research (Grant 410224) and Career Development Award Schemes (J. McVernon, Grant 566635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2007, WHO GEN TECH REP; *AUSTR POST, 2009, 200809 AUSTR POST; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Catton MG, 2009, MED J AUSTRALIA, V191, P288, DOI 10.5694/j.1326-5377.2009.tb02789.x; Collins N, 2006, MED J AUSTRALIA, V185, pS66; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; DOHA, 2008, AUSTR HLTH MAN PLAN; Eastwood K, 2009, RURAL REMOTE HEALTH, V9; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Foo H, 2009, J CLIN VIROL, V46, P384, DOI 10.1016/j.jcv.2009.09.019; Franco-Paredes Carlos, 2009, J Immune Based Ther Vaccines, V7, P2, DOI 10.1186/1476-8518-7-2; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grayson ML, 2009, MED J AUSTRALIA, V191, P150, DOI 10.5694/j.1326-5377.2009.tb02724.x; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; HANCOCK K, 2009, N ENGL J MED; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Kamigaki T, 2009, PLOS CURR INFLUENZA; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; KELLY HA, 2010, MED J AUSTRALIA, V192, P1; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kmietowicz Z, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2932; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Lipsitch M, 2009, N ENGL J MED; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lokuge B, 2006, MED J AUSTRALIA, V184, P16, DOI 10.5694/j.1326-5377.2006.tb00089.x; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; McBryde E, 2009, EURO SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; McCaw JM, 2009, MED J AUSTRALIA, V191, P136, DOI 10.5694/j.1326-5377.2009.tb02720.x; McCaw JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002362; McVernon J, 2010, AUST NZ J PUBL HEAL, V34, P113, DOI 10.1111/j.1753-6405.2010.00493.x; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MILLER E, 2010, LANCET; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Shortridge KF, 2006, LANCET, V367, P1374, DOI 10.1016/S0140-6736(06)68512-7; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033; THORN F, 2009, VICTORIA GOVT GAZETT, pS175; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Yang Y, 2009, BIOSTATISTICS, V10, P390, DOI 10.1093/biostatistics/kxn045	63	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14505	10.1371/journal.pone.0014505	http://dx.doi.org/10.1371/journal.pone.0014505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21346794	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000001
J	Li, Y; Guo, YQ; Wang, JX; Hou, W; Chang, MN; Liao, DP; Wu, RL				Li, Yao; Guo, Yunqian; Wang, Jianxin; Hou, Wei; Chang, Myron N.; Liao, Duanping; Wu, Rongling			A Statistical Design for Testing Transgenerational Genomic Imprinting in Natural Human Populations	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; BODY-COMPOSITION; TRAIT; GENE; RESOLUTION; BLOCKS; GROWTH; MODEL	Genomic imprinting is a phenomenon in which the same allele is expressed differently, depending on its parental origin. Such a phenomenon, also called the parent-of-origin effect, has been recognized to play a pivotal role in embryological development and pathogenesis in many species. Here we propose a statistical design for detecting imprinted loci that control quantitative traits based on a random set of three-generation families from a natural population in humans. This design provides a pathway for characterizing the effects of imprinted genes on a complex trait or disease at different generations and testing transgenerational changes of imprinted effects. The design is integrated with population and cytogenetic principles of gene segregation and transmission from a previous generation to next. The implementation of the EM algorithm within the design framework leads to the estimation of genetic parameters that define imprinted effects. A simulation study is used to investigate the statistical properties of the model and validate its utilization. This new design, coupled with increasingly used genome-wide association studies, should have an immediate implication for studying the genetic architecture of complex traits in humans.	[Li, Yao; Guo, Yunqian; Wang, Jianxin; Wu, Rongling] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Li, Yao] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA; [Hou, Wei; Chang, Myron N.] Univ Florida, Dept Biostat, Gainesville, FL USA; [Liao, Duanping; Wu, Rongling] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Beijing Forestry University; West Virginia University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Li, Y (corresponding author), Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China.	rwu@bjfu.edu.cn	Guo, Yunqian/L-4716-2013; hou, wei/GWM-4800-2022		National Natural Science Foundation of China [30900854]; Beijing Forestry University [Blx2w8003]; Changjiang Scholars Award; "One-thousand Person Plan'' Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Forestry University; Changjiang Scholars Award; "One-thousand Person Plan'' Award	This work is supported by the Changjiang Scholars Award, "One-thousand Person Plan'' Award, National Natural Science Foundation of China (Grant No. 30900854) and Beijing Forestry University Young Scientist Fund (Grant No. Blx2w8003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Chan EY, 2005, MUTAT RES-FUND MOL M, V573, P13, DOI 10.1016/j.mrfmmm.2005.01.004; Cheng Y, 2009, METHODS MOL BIOL, V573, P189, DOI 10.1007/978-1-60761-247-6_11; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; CHURCHILL GA, 1994, GENETICS, V138, P963; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li Q, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1419; Li YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003131; Liu T, 2007, GENOMICS, V90, P276, DOI 10.1016/j.ygeno.2007.04.004; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tal O, 2010, GENETICS, V184, P1037, DOI 10.1534/genetics.109.112466; Wang CG, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-13; Wang CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011396; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; WILKINSON LS, 2007, NAT REV NEUROSCI, V4, P1; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Wu R, 2008, STAT COMPUTATIONAL P; Wu R., 2007, STAT GENETICS QUANTI; Wu S, 2007, CURR GENOMICS, V8, P343, DOI 10.2174/138920207782446179; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	45	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16858	10.1371/journal.pone.0016858	http://dx.doi.org/10.1371/journal.pone.0016858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364891	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100011
J	Ravindranath, SP; Henne, KL; Thompson, DK; Irudayaraj, J				Ravindranath, Sandeep P.; Henne, Kristene L.; Thompson, Dorothea K.; Irudayaraj, Joseph			Surface-Enhanced Raman Imaging of Intracellular Bioreduction of Chromate in Shewanella oneidensis	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; GOLD NANOPARTICLES; ESCHERICHIA-COLI; HEAVY-METALS; REDUCTION; MR-1; SCATTERING; GENOME; CHROMIUM; GROWTH	This proposed research aims to use novel nanoparticle sensors and spectroscopic tools constituting surface-enhanced Raman spectroscopy (SERS) and Fluorescence Lifetime imaging (FLIM) to study intracellular chemical activities within single bioremediating microorganism. The grand challenge is to develop a mechanistic understanding of chromate reduction and localization by the remediating bacterium Shewanella oneidensis MR-1 by chemical and lifetime imaging. MR-1 has attracted wide interest from the research community because of its potential in reducing multiple chemical and metallic electron acceptors. While several biomolecular approaches to decode microbial reduction mechanisms exist, there is a considerable gap in the availability of sensor platforms to advance research from population-based studies to the single cell level. This study is one of the first attempts to incorporate SERS imaging to address this gap. First, we demonstrate that chromate-decorated nanoparticles can be taken up by cells using TEM and Fluorescence Lifetime imaging to confirm the internalization of gold nanoprobes. Second, we demonstrate the utility of a Raman chemical imaging platform to monitor chromate reduction and localization within single cells. Distinctive differences in Raman signatures of Cr(VI) and Cr(III) enabled their spatial identification within single cells from the Raman images. A comprehensive evaluation of toxicity and cellular interference experiments conducted revealed the inert nature of these probes and that they are non-toxic. Our results strongly suggest the existence of internal reductive machinery and that reduction occurs at specific sites within cells instead of at disperse reductive sites throughout the cell as previously reported. While chromate-decorated gold nanosensors used in this study provide an improved means for the tracking of specific chromate interactions within the cell and on the cell surface, we expect our single cell imaging tools to be extended to monitor the interaction of other toxic metal species.	[Ravindranath, Sandeep P.; Irudayaraj, Joseph] Purdue Univ, Birck Nanotechnol Ctr, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Henne, Kristene L.] Argonne Natl Lab, Chicago, IL USA; [Thompson, Dorothea K.] Univ Tennessee, Dept Biol Sci, Knoxville, TN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Ravindranath, SP (corresponding author), Purdue Univ, Birck Nanotechnol Ctr, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.	josephi@purdue.edu		Irudayaraj, Joseph/0000-0002-0630-1520; Thompson, Dorothea K./0000-0002-6017-8359	National Institutes of Health-National Institute of Environmental Health Sciences [R01 ES017066-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017066] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this research was provided by National Institutes of Health-National Institute of Environmental Health Sciences R01 ES017066-02 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x; Ackerley DF, 2004, APPL ENVIRON MICROB, V70, P873, DOI 10.1128/AEM.70.2.873-882.2004; *AG TOX SUBST DIS, 2008, 7440473 CAS AG TOX S; Ambushe AA, 2009, J ANAL ATOM SPECTROM, V24, P502, DOI 10.1039/b819962k; Asatiani NV, 2004, CURR MICROBIOL, V49, P321, DOI 10.1007/s00284-004-4351-2; Bochenkov V. E., 2007, RUSS CHEM REV, V76, P1084, DOI [DOI 10.1070/RC2007v076n11ABEH003735, DOI 10.1070/RC2007V076N11ABEH003735]; Bombach P, 2010, APPL MICROBIOL BIOT, V86, P839, DOI 10.1007/s00253-010-2461-2; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; CERVANTES C, 1992, PLASMID, V27, P65, DOI 10.1016/0147-619X(92)90007-W; Chourey K, 2006, APPL ENVIRON MICROB, V72, P6331, DOI 10.1128/AEM.00813-06; Ding M, 2002, MOL CELL BIOCHEM, V234, P293, DOI 10.1023/A:1015975218920; Efrima S, 2009, J RAMAN SPECTROSC, V40, P277, DOI 10.1002/jrs.2121; ERICLE R, 2009, PRINCIPLES SURFACE E; Frazier ME, 2003, SCIENCE, V300, P290, DOI 10.1126/science.1084566; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; GERSTEN J, 1980, J CHEM PHYS, V73, P3023, DOI 10.1063/1.440560; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; IARC, 1990, IARC MON EV CARC RIS, V49, P49; JAMES BR, 1994, J ENVIRON QUAL, V23, P227, DOI 10.2134/jeq1994.00472425002300020002x; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Jarvis RM, 2008, ANAL CHEM, V80, P6741, DOI 10.1021/ac800838v; Katz S.A., 1994, BIOL ENV CHEM CHROMI, Vfirst; Kneipp K, 2002, APPL SPECTROSC, V56, P150, DOI 10.1366/0003702021954557; LEV AD, 2007, RUSSIAN CHEM REV; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Middleton SS, 2003, BIOTECHNOL BIOENG, V83, P627, DOI 10.1002/bit.10725; MURRAY CA, 1981, PHYS REV LETT, V46, P57, DOI 10.1103/PhysRevLett.46.57; Nakatsu CH, 2005, APPL ENVIRON MICROB, V71, P7679, DOI 10.1128/AEM.71.12.7679-7689.2005; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; OHTAKE H, 1987, J BACTERIOL, V169, P3853, DOI 10.1128/jb.169.8.3853-3856.1987; Park CH, 2000, APPL ENVIRON MICROB, V66, P1788, DOI 10.1128/AEM.66.5.1788-1795.2000; Rojas-Chapana JA, 2004, NANO LETT, V4, P985, DOI 10.1021/nl049699n; Smith WL, 2000, J APPL MICROBIOL, V88, P983, DOI 10.1046/j.1365-2672.2000.01066.x; Sun L, 2009, BIOPHYS J, V96, P4709, DOI 10.1016/j.bpj.2009.03.021; Tian ZQ, 2007, CHEM COMMUN, P3514, DOI 10.1039/b616986d; Tiedje JM, 2002, NAT BIOTECHNOL, V20, P1093, DOI 10.1038/nbt1102-1093; *US EPA, 2007, TREATMENT TECHNOLOGI, P2; Valls M, 2002, FEMS MICROBIOL REV, V26, P327, DOI 10.1111/j.1574-6976.2002.tb00618.x; Viamajala S, 2003, BIOTECHNOL BIOENG, V83, P790, DOI 10.1002/bit.10724; Viamajala S, 2002, BIOTECHNOL BIOENG, V78, P770, DOI 10.1002/bit.10261; Viamajala S, 2002, BIOTECHNOL PROGR, V18, P290, DOI 10.1021/bp0202968; WANG PC, 1990, J BACTERIOL, V172, P1670, DOI 10.1128/jb.172.3.1670-1672.1990; Williams Darryl N, 2006, J Nanobiotechnology, V4, P3, DOI 10.1186/1477-3155-4-3	46	26	26	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16634	10.1371/journal.pone.0016634	http://dx.doi.org/10.1371/journal.pone.0016634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364911	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100007
J	Zanotti-Fregonara, P; Liow, JS; Fujita, M; Dusch, E; Zoghbi, SS; Luong, E; Boellaard, R; Pike, VW; Comtat, C; Innis, RB				Zanotti-Fregonara, Paolo; Liow, Jeih-San; Fujita, Masahiro; Dusch, Elodie; Zoghbi, Sami S.; Luong, Elise; Boellaard, Ronald; Pike, Victor W.; Comtat, Claude; Innis, Robert B.			Image-Derived Input Function for Human Brain Using High Resolution PET Imaging with [C-11](R)-rolipram and [C-11]PBR28	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL METABOLIC-RATE; NONINVASIVE QUANTIFICATION; DYNAMIC PET; RECEPTORS; QUANTITATION; RADIOLIGAND	Background: The aim of this study was to test seven previously published image-input methods in state-of-the-art high resolution PET brain images. Images were obtained with a High Resolution Research Tomograph plus a resolution-recovery reconstruction algorithm using two different radioligands with different radiometabolite fractions. Three of the methods required arterial blood samples to scale the image-input, and four were blood-free methods. Methods: All seven methods were tested on twelve scans with [C-11](R)-rolipram, which has a low radiometabolite fraction, and on nineteen scans with [C-11]PBR28 (high radiometabolite fraction). Logan V-T values for both blood and image inputs were calculated using the metabolite-corrected input functions. The agreement of image-derived Logan V-T values with the reference blood-derived Logan V-T values was quantified using a scoring system. Using the image input methods that gave the most accurate results with Logan analysis, we also performed kinetic modelling with a two-tissue compartment model. Results: For both radioligands the highest scores were obtained with two blood-based methods, while the blood-free methods generally performed poorly. All methods gave higher scores with [C-11](R)-rolipram, which has a lower metabolite fraction. Compartment modeling gave less reliable results, especially for the estimation of individual rate constants. Conclusion: Our study shows that: 1) Image input methods that are validated for a specific tracer and a specific machine may not perform equally well in a different setting; 2) despite the use of high resolution PET images, blood samples are still necessary to obtain a reliable image input function; 3) the accuracy of image input may also vary between radioligands depending on the magnitude of the radiometabolite fraction: the higher the metabolite fraction of a given tracer (e. g., [C-11]PBR28), the more difficult it is to obtain a reliable image-derived input function; and 4) in association with image inputs, graphical analyses should be preferred over compartmental modelling.	[Zanotti-Fregonara, Paolo; Liow, Jeih-San; Fujita, Masahiro; Zoghbi, Sami S.; Luong, Elise; Pike, Victor W.; Innis, Robert B.] NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA; [Dusch, Elodie; Comtat, Claude] CEA SHFJ, Orsay, France; [Boellaard, Ronald] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med, Amsterdam, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); CEA; UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Zanotti-Fregonara, P (corresponding author), NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA.	innisr@mail.nih.gov	Pike, Victor/AAJ-4139-2020	Fujita, Masahiro/0000-0001-7078-6844; Boellaard, Ronald/0000-0002-0313-5686	National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services (IRP-NIMH-NIH); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002852, ZIAMH002793, ZIAMH002795] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services (IRP-NIMH-NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services (IRP-NIMH-NIH) (PZ-F, J-SL, MF, SSZ, EL, VWP, RBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes H, 2009, EUR J NUCL MED MOL I; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; BODVARSSON B, 2007, NMF POSITRON EMISSIO; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; BROWN AK, 2007, ALCOHOLISM CLIN EXP, V31, P1; Brown AK, 2008, J NUCL MED, V49, P2042, DOI 10.2967/jnumed.108.056291; Carson RE, 2004, J NUCL MED, V45, p105P; Chen K, 2007, PHYS MED BIOL, V52, P7055, DOI 10.1088/0031-9155/52/23/019; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; COMTAT C, 1999, IEEE NUCL SCI S 24 3, V3; Croteau E, 2010, EUR J NUCL MED MOL I, V37, P1539, DOI 10.1007/s00259-010-1443-z; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Dusch E, 2009, IEEE NUCL SCI CONF R, P2770, DOI 10.1109/NSSMIC.2009.5401956; Everett BA, 2009, J NUCL MED, V50, P1742, DOI 10.2967/jnumed.109.063206; Fujita M, 2005, NEUROIMAGE, V26, P1201, DOI 10.1016/j.neuroimage.2005.03.017; Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011; Kimura Y, 2004, NUCL MED BIOL, V31, P975, DOI 10.1016/j.nucmedbio.2004.06.005; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Litton JE, 1997, J COMPUT ASSIST TOMO, V21, P907, DOI 10.1097/00004728-199711000-00012; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Mourik JEM, 2010, J CEREBR BLOOD F MET, V30, P381, DOI 10.1038/jcbfm.2009.225; Mourik JEM, 2009, EUR J NUCL MED MOL I, V36, P463, DOI 10.1007/s00259-008-0986-8; Mourik JEM, 2008, NEUROIMAGE, V43, P676, DOI 10.1016/j.neuroimage.2008.07.035; Naganawa M, 2005, IEEE T BIO-MED ENG, V52, P201, DOI 10.1109/TBME.2004.840193; Naganawa M, 2005, NEUROIMAGE, V26, P885, DOI 10.1016/j.neuroimage.2005.02.025; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Parker BJ, 2005, IEEE T NUCL SCI, V52, P79, DOI 10.1109/TNS.2004.843133; Rousset OG, 1998, J NUCL MED, V39, P904; Su KH, 2005, NUCL MED COMMUN, V26, P995, DOI 10.1097/01.mnm.0000184999.81203.5c; Terry GE, 2010, J NUCL MED, V51, P112, DOI 10.2967/jnumed.109.067074; Terry GE, 2009, NEUROIMAGE, V48, P362, DOI 10.1016/j.neuroimage.2009.06.059; Zanotti-Fregonara P, 2007, EUR J NUCL MED MOL I, V34, pS144; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93; Zanotti-Fregonara P, 2009, J NUCL MED, V50, P461, DOI 10.2967/jnumed.108.059642; ZANOTTIFREGONAR.P, 2010, NEUROIMAGE; Zoghbi SS, 2006, J NUCL MED, V47, P520; ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290; [No title captured], DOI DOI 10.1109/NSSMIC.2008.4774188	38	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17056	10.1371/journal.pone.0017056	http://dx.doi.org/10.1371/journal.pone.0017056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364880	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100024
J	Purcell, O; di Bernardo, M; Grierson, CS; Savery, NJ				Purcell, Oliver; di Bernardo, Mario; Grierson, Claire S.; Savery, Nigel J.			A Multi-Functional Synthetic Gene Network: A Frequency Multiplier, Oscillator and Switch	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAMMALIAN OSCILLATOR; TOGGLE SWITCH; CELLS; EXPRESSION; PROTEINS; BEHAVIOR; BIOLOGY; PATTERN	We present the design and analysis of a synthetic gene network that performs frequency multiplication. It takes oscillatory transcription factor concentrations, such as those produced from the currently available genetic oscillators, as an input, and produces oscillations with half the input frequency as an output. Analysis of the bifurcation structure also reveals novel, programmable multi-functionality; in addition to functioning as a frequency multiplier, the network is able to function as a switch or an oscillator, depending on the temporal nature of the input. Multi-functionality is often observed in neuronal networks, where it is suggested to allow for the efficient coordination of different responses. This network represents a significant theoretical addition that extends the capabilities of synthetic gene networks.	[Purcell, Oliver; di Bernardo, Mario] Univ Bristol, Bristol Ctr Complex Sci, Dept Engn Math, Bristol, Avon, England; [di Bernardo, Mario] Univ Naples Federico 2, Dept Syst & Comp Engn, Naples, Italy; [Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Savery, Nigel J.] Univ Bristol, Sch Biochem, Bristol, Avon, England	University of Bristol; University of Naples Federico II; University of Bristol; University of Bristol	Purcell, O (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Dept Engn Math, Bristol, Avon, England.	enoep@bristol.ac.uk	di Bernardo, Mario/I-2805-2012; di Bernardo, Mario/AAL-9311-2021	di Bernardo, Mario/0000-0002-2171-4745; Savery, Nigel/0000-0002-0803-4075	Engineering and Physical Sciences Research Council (EPSRC)	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was provided by the Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Deiters A, 2009, CURR OPIN CHEM BIOL, V13, P678, DOI 10.1016/j.cbpa.2009.09.026; DOEDEL E, 2007, AUTO 07 SOFTWARE CON; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Getting P.A., 1985, P3; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Giesecke AV, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100053; Gommans WM, 2005, J MOL BIOL, V354, P507, DOI 10.1016/j.jmb.2005.06.082; Guantes R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012314; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Neupert J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn545; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Soffe SR, 1997, J COMP PHYSIOL A, V180, P711, DOI 10.1007/s003590050085; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tigges M, 2010, NUCLEIC ACIDS RES, V38, P2702, DOI 10.1093/nar/gkq121; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457	35	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16140	10.1371/journal.pone.0016140	http://dx.doi.org/10.1371/journal.pone.0016140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359152	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482300015
J	Kristiansson, E; Fick, J; Janzon, A; Grabic, R; Rutgersson, C; Weijdegard, B; Soderstrom, H; Larsson, DGJ				Kristiansson, Erik; Fick, Jerker; Janzon, Anders; Grabic, Roman; Rutgersson, Carolin; Weijdegard, Birgitta; Soderstrom, Hanna; Larsson, D. G. Joakim			Pyrosequencing of Antibiotic-Contaminated River Sediments Reveals High Levels of Resistance and Gene Transfer Elements	PLOS ONE			English	Article							QUINOLONE RESISTANCE; AQUATIC ENVIRONMENT; BACTERIA; DATABASE; WATER; IDENTIFICATION; METAGENOMICS; MECHANISMS; EMERGENCE; INTEGRONS	The high and sometimes inappropriate use of antibiotics has accelerated the development of antibiotic resistance, creating a major challenge for the sustainable treatment of infections world-wide. Bacterial communities often respond to antibiotic selection pressure by acquiring resistance genes, i.e. mobile genetic elements that can be shared horizontally between species. Environmental microbial communities maintain diverse collections of resistance genes, which can be mobilized into pathogenic bacteria. Recently, exceptional environmental releases of antibiotics have been documented, but the effects on the promotion of resistance genes and the potential for horizontal gene transfer have yet received limited attention. In this study, we have used culture-independent shotgun metagenomics to investigate microbial communities in river sediments exposed to waste water from the production of antibiotics in India. Our analysis identified very high levels of several classes of resistance genes as well as elements for horizontal gene transfer, including integrons, transposons and plasmids. In addition, two abundant previously uncharacterized resistance plasmids were identified. The results suggest that antibiotic contamination plays a role in the promotion of resistance genes and their mobilization from environmental microbes to other species and eventually to human pathogens. The entire life-cycle of antibiotic substances, both before, under and after usage, should therefore be considered to fully evaluate their role in the promotion of resistance.	[Kristiansson, Erik; Janzon, Anders; Rutgersson, Carolin; Weijdegard, Birgitta; Larsson, D. G. Joakim] Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Kristiansson, Erik] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden; [Fick, Jerker; Grabic, Roman; Soderstrom, Hanna] Umea Univ, Dept Chem, Umea, Sweden	University of Gothenburg; Chalmers University of Technology; Umea University	Kristiansson, E (corresponding author), Univ Gothenburg, Dept Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	joakim.larsson@fysiologi.gu.se	Grabic, Roman/AAF-5412-2021; Larsson, D.G. Joakim/E-5243-2011; Berglund Fick, Jerker/HDO-5788-2022; Grabic, Roman/B-1289-2013	Grabic, Roman/0000-0002-0935-2075; Larsson, D.G. Joakim/0000-0002-5496-0328; Grabic, Roman/0000-0002-0935-2075; Soderstrom, Hanna/0000-0003-1341-7879; Fick, Jerker/0000-0002-3949-7371	Swedish Research Council (VR); Swedish International Development Cooperation Agency (SIDA); Swedish Society for Medical Research (SSMF); Swedish Research Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS); Swedish Foundation for Strategic Environmental Research (MISTRA); Adlerbertska Research Foundation; Helge Ax:son Johnsons Research Foundation	Swedish Research Council (VR)(Swedish Research Council); Swedish International Development Cooperation Agency (SIDA); Swedish Society for Medical Research (SSMF); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research); Adlerbertska Research Foundation; Helge Ax:son Johnsons Research Foundation	The research was funded by the Swedish Research Council (VR, www.vr.se), the Swedish International Development Cooperation Agency (SIDA, www.sida.se), the Swedish Society for Medical Research (SSMF, www.ssmf.se), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, www.formas.se), the Swedish Foundation for Strategic Environmental Research (MISTRA, www.mistra.org), Adlerbertska Research Foundation (http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen) and Helge Ax:son Johnsons Research Foundation (http://www.haxsonj.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Allen HK, 2010, NAT REV MICROBIOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Dudoit S, 2008, SPRINGER SER STAT, P1; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hooper SD, 2010, BIOINFORMATICS, V26, P295, DOI 10.1093/bioinformatics/btp687; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Rodriguez-Martinez JM, 2008, J ANTIMICROB CHEMOTH, V61, P1240, DOI 10.1093/jac/dkn115; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; Xia RR, 2010, ANTIMICROB AGENTS CH, V54, P3471, DOI 10.1128/AAC.01668-09; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y	55	358	377	3	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17038	10.1371/journal.pone.0017038	http://dx.doi.org/10.1371/journal.pone.0017038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359229	Green Published, gold			2022-12-27	WOS:000287392700038
J	Silver, AC; Williams, D; Faucher, J; Horneman, AJ; Gogarten, JP; Graf, J				Silver, Adam C.; Williams, David; Faucher, Joshua; Horneman, Amy J.; Gogarten, J. Peter; Graf, Joerg			Complex Evolutionary History of the Aeromonas veronii Group Revealed by Host Interaction and DNA Sequence Data	PLOS ONE			English	Article							III SECRETION SYSTEM; SALMONICIDA SUBSP SALMONICIDA; HORIZONTAL GENE-TRANSFER; ET-AL. 1990; GALLERIA-MELLONELLA; MEDICINAL LEECH; DETECTING RECOMBINATION; PHYLOGENETIC ANALYSIS; PHENOTYPIC DATA; MODEL SYSTEM	Aeromonas veronii biovar sobria, Aeromonas veronii biovar veronii, and Aeromonas allosaccharophila are a closely related group of organisms, the Aeromonas veronii Group, that inhabit a wide range of host animals as a symbiont or pathogen. In this study, the ability of various strains to colonize the medicinal leech as a model for beneficial symbiosis and to kill wax worm larvae as a model for virulence was determined. Isolates cultured from the leech out-competed other strains in the leech model, while most strains were virulent in the wax worms. Three housekeeping genes, recA, dnaJ and gyrB, the gene encoding chitinase, chiA, and four loci associated with the type three secretion system, ascV, ascFG, aexT, and aexU were sequenced. The phylogenetic reconstruction failed to produce one consensus tree that was compatible with most of the individual genes. The Approximately Unbiased test and the Genetic Algorithm for Recombination Detection both provided further support for differing evolutionary histories among this group of genes. Two contrasting tests detected recombination within aexU, ascFG, ascV, dnaJ, and gyrB but not in aexT or chiA. Quartet decomposition analysis indicated a complex recent evolutionary history for these strains with a high frequency of horizontal gene transfer between several but not among all strains. In this study we demonstrate that at least for some strains, horizontal gene transfer occurs at a sufficient frequency to blur the signal from vertically inherited genes, despite strains being adapted to distinct niches. Simply increasing the number of genes included in the analysis is unlikely to overcome this challenge in organisms that occupy multiple niches and can exchange DNA between strains specialized to different niches. Instead, the detection of genes critical in the adaptation to specific niches may help to reveal the physiological specialization of these strains.	[Silver, Adam C.; Williams, David; Faucher, Joshua; Gogarten, J. Peter; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Horneman, Amy J.] VA Maryland Hlth Care Syst, Pathol Serv, Baltimore, MD USA; [Horneman, Amy J.] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA; [Horneman, Amy J.] VA Maryland Hlth Care Syst, Lab Med Serv, Baltimore, MD USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore	Silver, AC (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA.	joerg.graf@uconn.edu	Graf, Joerg/ABI-2447-2020	Graf, Joerg/0000-0001-5320-2712; Gogarten, Johann Peter/0000-0001-6459-6518; Williams, David/0000-0002-6925-7408	NSF [MCB 0448052, DEB 0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by the NSF CAREER grant MCB 0448052 to JG and NSF Grant DEB 0830024 to JPG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Braun M, 2002, J BACTERIOL, V184, P1851, DOI 10.1128/JB.184.7.1851-1858.2002; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003; Carnahan AM, 2001, THESIS U MARYLAND CO, P1; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Darwin C, 1859, ORIGIN SPECIES MEANS; deChalain TMB, 1996, J RECONSTR MICROSURG, V12, P165, DOI 10.1055/s-2007-1006471; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESTEVE C, 1995, J APPL BACTERIOL, V78, P555, DOI 10.1111/j.1365-2672.1995.tb03099.x; Farfan M, 2010, SYST APPL MICROBIOL, V33, P427, DOI 10.1016/j.syapm.2010.09.005; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Graf J, 1999, INFECT IMMUN, V67, P1; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grunewald S, 2007, MOL BIOL EVOL, V24, P532, DOI 10.1093/molbev/msl180; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; HANNINEN ML, 1995, J MED MICROBIOL, V42, P26, DOI 10.1099/00222615-42-1-26; HASEGAWA M, 1989, EVOLUTION, V43, P672, DOI 10.1111/j.1558-5646.1989.tb04264.x; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Huys G, 2002, INT J SYST EVOL MICR, V52, P1969, DOI [10.1099/ijs.0.01996-0, 10.1099/00207713-52-6-1969]; Huys G, 2001, SYST APPL MICROBIOL, V24, P177, DOI 10.1078/0723-2020-00038; IHAKA R, 1996, J COMPUT GRAPH STAT, V5, P99; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JANDA JM, 1991, FEMS MICROBIOL LETT, V90, P29; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; MARTINEZMURCIA AJ, 1992, FEMS MICROBIOL LETT, V91, P199; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nhung PH, 2007, INT J SYST EVOL MICR, V57, P1232, DOI 10.1099/ijs.0.64957-0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; REED LJ, 1938, AM J HYG, V27, P93; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Retchless AC, 2010, P NATL ACAD SCI USA, V107, P11453, DOI 10.1073/pnas.1001291107; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rio RVM, 2007, MICROBIOL-SGM, V153, P1897, DOI 10.1099/mic.0.2006/003020-0; Rio RVM, 2009, APPL ENVIRON MICROB, V75, P6890, DOI 10.1128/AEM.01129-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saavedra MJ, 2007, ANTON LEEUW INT J G, V91, P159, DOI 10.1007/s10482-006-9107-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sepe A, 2008, LETT APPL MICROBIOL, V46, P439, DOI 10.1111/j.1472-765X.2008.02339.x; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sierra JC, 2007, MICROB PATHOGENESIS, V43, P147, DOI 10.1016/j.micpath.2007.05.003; Silver AC, 2007, J BACTERIOL, V189, P6763, DOI 10.1128/JB.00685-07; Silver AC, 2007, P NATL ACAD SCI USA, V104, P9481, DOI 10.1073/pnas.0700286104; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; SNEATH PHA, 1993, INT J SYST BACTERIOL, V43, P626, DOI 10.1099/00207713-43-3-626; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; SUGITA H, 1995, APPL ENVIRON MICROB, V61, P4128, DOI 10.1128/AEM.61.11.4128-4130.1995; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032; Zhaxybayeva Olga, 2009, V532, P195, DOI 10.1007/978-1-60327-853-9_11	74	52	55	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16751	10.1371/journal.pone.0016751	http://dx.doi.org/10.1371/journal.pone.0016751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359176	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700023
J	Tarimo, EAM; Thorson, A; Kohi, TW; Bakari, M; Mhalu, F; Kulane, A				Tarimo, Edith A. M.; Thorson, Anna; Kohi, Thecla W.; Bakari, Muhammad; Mhalu, Fred; Kulane, Asli			Reasons for Declining to Enoll in a Phase I and II HIV Vaccine Trial after Randomization among Eligible Volunteers in Dar es Salaam, Tanzania	PLOS ONE			English	Article							RECRUITMENT; BARRIERS; WOMEN; WILLINGNESS; PARTICIPATE; ACHIEVE; FUTURE; RISK	Background: Recruitment, enrollment and retention of volunteers in an HIV vaccine trial is important in the efforts to ultimately develop a vaccine that can prevent new HIV infections. Following recruitment, some randomized individuals decline to be enrolled in an HIV vaccine trial. The reasons for such a decision are not well known. This article describes why individuals who were randomized in a phase I and II HIV vaccine trial in Dar es Salaam, Tanzania declined to be enrolled. Methods: Face-to-face interviews were conducted with 14 individuals (7 men and 7 women). Repeated readings of the 14 interview transcripts to look for reasons for declining to enroll in the trial were performed. Data was analyzed using the content analysis approach. Results: Informants expressed fear of the outcome of an experimental HIV vaccine in their lives. Unlike women, some men were concerned over the effect of the vaccine on their reproduction intentions. Women were concerned about the unknown effects of the vaccine in their bodies. Also, to a large extent, informants faced resistance from significant others such as fiancees, parents, relatives, and friends. Women were influenced by their potential intimate sexual partners; men were forbidden by their parents, and mothers had the most influential opinion. Conclusions: Fear of the negative outcome of an experimental vaccine and resistance from significant others are the main reasons for declining to enroll in the HIV vaccine trial among eligible volunteers after randomization. The resistance from the significant others provides valuable guidance for designing future trials in Tanzania; for example, expanding the HIV vaccine trial education to the general population from the onset of the trial design.	[Tarimo, Edith A. M.; Thorson, Anna; Kulane, Asli] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden; [Tarimo, Edith A. M.; Kohi, Thecla W.] Muhimbili Univ Hlth & Allied Sci, Dept Nursing Management, Dar Es Salaam, Tanzania; [Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Mhalu, Fred] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania	Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Tarimo, EAM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden.	etarimo54@yahoo.co.uk		Kulane, Asli/0000-0002-5823-7559; Thorson, Anna/0000-0002-8703-6561	Swedish International Agency for Development Cooperation (SIDA)	Swedish International Agency for Development Cooperation (SIDA)	The study was supported with funding from the Swedish International Agency for Development Cooperation (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airhihenbuwa CO., 2007, HEALING OUR DIFFEREN; [Anonymous], 2007, QUALITATIVE METHODOL; Brown-Peterside P, 2000, J URBAN HEALTH, V77, P425, DOI 10.1007/BF02386751; Brown-Peterside P, 2001, AM J PUBLIC HEALTH, V91, P1377, DOI 10.2105/AJPH.91.9.1377; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; de Bruyn G, 2005, JAIDS-J ACQ IMM DEF, V39, P499, DOI 10.1097/01.qai.0000148532.12329.df; Esparza J, 2002, VACCINE, V20, P1897, DOI 10.1016/S0264-410X(02)00062-2; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; *INT AIDS VACC IN, 2009, DAT AIDS VACC CAND C; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009; Mills E, 2006, PLOS MED, V3, P308, DOI 10.1371/journal.pmed.0030094; Mills E, 2004, AIDS, V18, P2235, DOI 10.1097/00002030-200411190-00003; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2004, AIDS PATIENT CARE ST, V18, P691, DOI 10.1089/apc.2004.18.691; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rudy ET, 2005, AIDS EDUC PREV, V17, P253, DOI 10.1521/aeap.17.4.253.66529; Ruzagira E, 2009, TROP MED INT HEALTH, V14, P196, DOI 10.1111/j.1365-3156.2008.02200.x; *SAAVI, 2009, HIV VACC INF LIN 080; Tarimo EAM, 2009, GLOBAL HLTH ACTION, V2, DOI [10.3402/gha.v3402:3400.1953, DOI 10.3402/GHA.V3402:3400.1953]; Tarimo EAM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-292; Unaids, 2008, SUBS AFR AIDS EP UPD; *UNAIDS, 2009, AIDS EP UPD	25	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14619	10.1371/journal.pone.0014619	http://dx.doi.org/10.1371/journal.pone.0014619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721YC	21358826	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700002
J	Abou-Jaoude, W; Chaves, M; Gouze, JL				Abou-Jaoude, Wassim; Chaves, Madalena; Gouze, Jean-Luc			A Theoretical Exploration of Birhythmicity in the p53-Mdm2 Network	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; PIECEWISE-LINEAR MODELS; QUALITATIVE SIMULATION; ESCHERICHIA-COLI; FEEDBACK LOOP; P53; MDM2; OSCILLATIONS; DYNAMICS; SYSTEMS	Experimental observations performed in the p53-Mdm2 network, one of the key protein modules involved in the control of proliferation of abnormal cells in mammals, revealed the existence of two frequencies of oscillations of p53 and Mdm2 in irradiated cells depending on the irradiation dose. These observations raised the question of the existence of birhythmicity, i.e. the coexistence of two oscillatory regimes for the same external conditions, in the p53-Mdm2 network which would be at the origin of these two distinct frequencies. A theoretical answer has been recently suggested by Ouattara, Abou-Jaoude and Kaufman who proposed a 3-dimensional differential model showing birhythmicity to reproduce the two frequencies experimentally observed. The aim of this work is to analyze the mechanisms at the origin of the birhythmic behavior through a theoretical analysis of this differential model. To do so, we reduced this model, in a first step, into a 3-dimensional piecewise linear differential model where the Hill functions have been approximated by step functions, and, in a second step, into a 2-dimensional piecewise linear differential model by setting one autonomous variable as a constant in each domain of the phase space. We find that two features related to the phase space structure of the system are at the origin of the birhythmic behavior: the existence of two embedded cycles in the transition graph of the reduced models; the presence of a bypass in the orbit of the large amplitude oscillatory regime of low frequency. Based on this analysis, an experimental strategy is proposed to test the existence of birhythmicity in the p53-Mdm2 network. From a methodological point of view, this approach greatly facilitates the computational analysis of complex oscillatory behavior and could represent a valuable tool to explore mathematical models of biological rhythms showing sufficiently steep nonlinearities.	[Abou-Jaoude, Wassim; Chaves, Madalena; Gouze, Jean-Luc] INRIA Sophia Antipolis, COMORE Project Team, Sophia Antipolis, France		Abou-Jaoude, W (corresponding author), INRIA Sophia Antipolis, COMORE Project Team, Sophia Antipolis, France.	wabou@sophia.inria.fr	Chaves, Madalena/D-1182-2014	Chaves, Madalena/0000-0003-0647-9254; Gouze, Jean-Luc/0000-0001-7156-7934	INRIA-INSERM initiative action ColAge; INRIA	INRIA-INSERM initiative action ColAge; INRIA	This work was supported in part by the INRIA-INSERM initiative action ColAge. The authors thank INRIA for funding the post-doctoral stay of WAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abou-Jaoude W, 2009, J THEOR BIOL, V258, P561, DOI 10.1016/j.jtbi.2009.02.005; ALAMGIR M, 1983, J AM CHEM SOC, V105, P2500, DOI 10.1021/ja00346a080; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; CITRI O, 1988, J PHYS CHEM-US, V92, P1865, DOI 10.1021/j100318a034; Dayarian A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000256; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; DECROLY O, 1982, P NATL ACAD SCI-BIOL, V79, P6917, DOI 10.1073/pnas.79.22.6917; Edwards R, 2000, PHYSICA D, V146, P165, DOI 10.1016/S0167-2789(00)00130-5; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GLASS L, 1978, J MATH BIOL, V6, P207, DOI 10.1007/BF02547797; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hirsch MW, 1988, NONLINEARITY, V1, P51, DOI 10.1088/0951-7715/1/1/003; Hirsch MW, 2003, LECT NOTES CONTROL I, V294; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Omholt SW, 1998, J THEOR BIOL, V195, P339, DOI 10.1006/jtbi.1998.0800; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Snoussi E, 1989, DYNAMICS STABILITY S, V4, P189; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Strogatz H, 1994, NONLINEAR DYNAMICS C, P498; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; ZHU HR, 1994, J DIFFER EQUATIONS, V110, P143, DOI 10.1006/jdeq.1994.1063	42	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17075	10.1371/journal.pone.0017075	http://dx.doi.org/10.1371/journal.pone.0017075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340030	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600034
J	McCoy, M; Campbell, I; Stone, P; Fedorchuk, C; Wijayawardana, S; Easley, K				McCoy, Matthew; Campbell, Ismay; Stone, Pamela; Fedorchuk, Curtis; Wijayawardana, Sameera; Easley, Kirk			Intra-Examiner and Inter-Examiner Reproducibility of Paraspinal Thermography	PLOS ONE			English	Article							INTRAEXAMINER RELIABILITY; CORRELATION-COEFFICIENT; INTEREXAMINER	Objective: The objective of this study was to evaluate the intra-examiner and inter-examiner reproducibility of paraspinal thermography using an infrared scanner. Materials and Methods: The thermal functions of a commercially available infrared scanner (Insight Subluxation Station (R)) were evaluated for clinical reliability. Two practicing clinicians conducted the measures on 100 subjects. Intra class correlation coefficients (ICCs) and concordance correlation coefficients (CCCs) were calculated from the collected data. Results: Mean bilateral paraspinal skin temperature was 89.78 degrees F and ranged from 88.77 degrees F to 91.43 degrees F. Intra class correlation coefficients (ICCs) for agreement and consistency ranged from 0.959 to 0.976. Concordance correlation coefficients (CCCs) ranged from 0.783 to 0.859 with tight confidence intervals indicating robust estimates of these quantities. Conclusion: This study revealed excellent intra-examiner and inter-examiner reproducibility of paraspinal thermography using a commercially available unit.	[McCoy, Matthew] Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA; [Wijayawardana, Sameera; Easley, Kirk] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	Emory University	McCoy, M (corresponding author), Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA.	matthewmccoy@comcast.net	Easley, Kirk A/K-6910-2015	Easley, Kirk A/0000-0003-4419-2617				BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BRAND NE, 1982, J MANIP PHYSIOL THER, V5, P113; DeBoer KF, 1985, RES FORUM, V2, P4; DUFF SA, 1976, CHIROPRACTIC CLIN RE, pR6; EBRALL PS, 1994, CHIROPR J AUSTR, V24, P139; Guyton AC, 1986, TXB MED PHYSL; Haber M, 2005, J DATA SCI, V3, P69; HART J, 2000, J VERTEBRAL SUBLUXAT, V3, P1; HART JF, 2001, J CHIROPRACTIC ED, V15, P30; Hart John, 2007, J Can Chiropr Assoc, V51, P175; KEATING JC, 1990, J MANIP PHYSIOL THER, V13, P463; Kyneur JS, 1991, CHIROPR J AUST, V21, P82; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MILLER JL, 1967, INT REV CHIROPRA APR, P39; OWENS E, 2000, J CHIROPRACTIC ED, V14, P44; Owens EF, 2004, J MANIP PHYSIOL THER, V27, P155, DOI 10.1016/j.jmpt.2003.12.019; OWENS EF, 2000, CHIROPR RES J, V7, P65; Palmer BJ, 1951, CHIROPRACTIC CLIN CO, VXXV; PERDEW W, 1976, DIG CHIRO EC     MAY, P60; PLAUGHER G, 1991, J MANIP PHYSIOL THER, V14, P361; PLAUGHER G, 1992, J MANIP PHYSIOL THER, V15, P368; RADEMACHER WJ, 1994, CHIROPR TECH, V6, P84; SCHRAM SB, 1982, J MANIP PHYSIOL THER, V5, P5; SENZON SA, 2000, J VERTEBRAL SUBLUXAT, V4, P17; SPECTOR B, 1981, J MANIP PHYSIOL THER, V4, P30; STEWART MS, 1989, J MANIP PHYSIOL THER, V12, P345; UEMATSU E, 1988, J NEUROSURG, V69, P552	27	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16535	10.1371/journal.pone.0016535	http://dx.doi.org/10.1371/journal.pone.0016535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347290	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500002
J	Ribeiro, D; Ellwanger, K; Glagow, D; Theofilopoulos, S; Corsini, NS; Martin-Villalba, A; Niehrs, C; Arenas, E				Ribeiro, Diogo; Ellwanger, Kristina; Glagow, Desiree; Theofilopoulos, Spyridon; Corsini, Nina S.; Martin-Villalba, Ana; Niehrs, Christof; Arenas, Ernest			Dkk1 Regulates Ventral Midbrain Dopaminergic Differentiation and Morphogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; WNT/BETA-CATENIN; HEAD INDUCTION; INHIBITOR DICKKOPF-1; INT-1 PROTOONCOGENE; BETA-CATENIN/TCF; PRECHORDAL PLATE; LIMB DEVELOPMENT; MOUSE; EXPRESSION	Dickkopf1 (Dkk1) is a Wnt/beta-catenin inhibitor that participates in many processes during embryonic development. One of its roles during embryogenesis is to induce head formation, since Dkk1-null mice lack head structures anterior to midbrain. The Wnt/beta-catenin pathway is also known to regulate different aspects of ventral midbrain (VM) dopaminergic (DA) neuron development and, in vitro, Dkk1-mediated inhibition of the Wnt/beta-catenin pathway improves the DA differentiation in mouse embryonic stem cells (mESC). However, the in vivo function of Dkk1 on the development of midbrain DA neurons remains to be elucidated. Here we examined Dkk1(+/-) embryos and found that Dkk1 is required for the differentiation of DA precursors/neuroblasts into DA neurons at E13.5. This deficit persisted until E17.5, when a defect in the number and distribution of VM DA neurons was detected. Furthermore, analysis of the few Dkk1(-/-) embryos that survived until E17.5 revealed a more severe loss of midbrain DA neurons and morphogenesis defects. Our results thus show that Dkk1 is required for midbrain DA differentiation and morphogenesis.	[Ribeiro, Diogo; Theofilopoulos, Spyridon; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Sect, Stockholm, Sweden; [Ellwanger, Kristina; Niehrs, Christof] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany; [Glagow, Desiree; Corsini, Nina S.; Martin-Villalba, Ana] German Canc Res Ctr, Div Mol Neurobiol, D-6900 Heidelberg, Germany	Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Ribeiro, D (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Sect, Stockholm, Sweden.	ernest.arenas@ki.se	Arenas, Ernest/AAO-5231-2020; Theofilopoulos, Spyridon/B-2075-2015; Seib, Desiree/AAF-2801-2021; Theofilopoulos, Spyridon/E-1508-2011	Arenas, Ernest/0000-0003-0197-6577; Theofilopoulos, Spyridon/0000-0003-1986-0943; Seib, Desiree/0000-0001-9953-8270; Martin-Villalba, Ana/0000-0002-9405-8910; Corsini, Nina/0000-0001-6731-3544; Ribeiro, Diogo/0000-0003-4400-8752	Swedish Foundation for Strategic Research (INGVAR and CEDB); Swedish Research Council [VR2008:2811]; Norwegian Research Council; Karolinska Institutet; Portuguese Government [SFRH/BD/24585/2005]	Swedish Foundation for Strategic Research (INGVAR and CEDB)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Karolinska Institutet(Karolinska Institutet); Portuguese Government(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Swedish Foundation for Strategic Research (INGVAR and CEDB), Swedish Research Council (VR2008:2811 and DBRM), Norwegian Research Council, and Karolinska Institutet to EA, and DR was supported by the Foundation for Science and Technology from the Portuguese Government (SFRH/BD/24585/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barrantes ID, 2003, GENE DEV, V17, P2239, DOI 10.1101/gad.269103; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castelo-Branco G, 2010, DEV DYNAM, V239, P211, DOI 10.1002/dvdy.22094; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CONLON RA, 1993, GUIDE TECHNIQUES MOU, P373; Gaulden J, 2008, HUM MOL GENET, V17, pR60, DOI 10.1093/hmg/ddn119; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Grotewold L, 1999, MECH DEVELOP, V89, P151, DOI 10.1016/S0925-4773(99)00194-X; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kazanskaya O, 2000, DEVELOPMENT, V127, P4981; Kong XB, 2009, IN VITRO CELL DEV-AN, V45, P185, DOI 10.1007/s11626-008-9157-2; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; LIEVEN O, 2010, DEV BIOL; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402	47	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e15786	10.1371/journal.pone.0015786	http://dx.doi.org/10.1371/journal.pone.0015786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347250	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500001
J	Dale, JJ; Stankus, AM; Burns, MS; Meyer, CG				Dale, Jonathan J.; Stankus, Austin M.; Burns, Michael S.; Meyer, Carl G.			The Shark Assemblage at French Frigate Shoals Atoll, Hawai'i: Species Composition, Abundance and Habitat Use	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; ESTIMATING POPULATION-SIZE; VISUAL-CENSUS; GALEOCERDO-CUVIER; REEF SHARKS; CARCHARHINUS GALAPAGENSIS; ANNOTATED CHECKLIST; MOVEMENT PATTERNS; CLOSED POPULATION; CLIPPERTON ATOLL	Empirical data on the abundance and habitat preferences of coral reef top predators are needed to evaluate their ecological impacts and guide management decisions. We used longline surveys to quantify the shark assemblage at French Frigate Shoals (FFS) atoll from May to August 2009. Fishing effort consisted of 189 longline sets totaling 6,862 hook hours of soak time. A total of 221 sharks from 7 species were captured, among which Galapagos (Carcharhinus galapagensis, 36.2%), gray reef (Carcharhinus amblyrhynchos, 25.8%) and tiger (Galeocerdo cuvier, 20.4%) sharks were numerically dominant. A lack of blacktip reef sharks (Carcharhinus melanopterus) distinguished the FFS shark assemblage from those at many other atolls in the Indo-Pacific. Compared to prior underwater visual survey estimates, longline methods more accurately represented species abundance and composition for the majority of shark species. Sharks were significantly less abundant in the shallow lagoon than adjacent habitats. Recaptures of Galapagos sharks provided the first empirical estimate of population size for any Galapagos shark population. The overall recapture rate was 5.4%. Multiple closed population models were evaluated, with Chao M-h ranking best in model performance and yielding a population estimate of 668 sharks with 95% confidence intervals ranging from 289-1720. Low shark abundance in the shallow lagoon habitats suggests removal of a small number of sharks from the immediate vicinity of lagoonal islets may reduce short-term predation on endangered monk seal (Monachus schauinslandi) pups, but considerable fishing effort would be required to catch even a small number of sharks. Additional data on long-term movements and habitat use of sharks at FFS are required to better assess the likely ecological impacts of shark culling.	[Dale, Jonathan J.; Stankus, Austin M.; Burns, Michael S.; Meyer, Carl G.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Dale, Jonathan J.; Stankus, Austin M.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Dale, JJ (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA.	jjdale@hawaii.edu			National Marine Sanctuary Program [MOA 2005-008/6882]; Protected Species Division of the National Marine Fisheries Service	National Marine Sanctuary Program; Protected Species Division of the National Marine Fisheries Service	This study was funded by an award to Hawaii Institute of Marine Biology from the National Marine Sanctuary Program (MOA 2005-008/6882). Additional funding was provided by the Protected Species Division of the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 1997, REV BIOL TROP, V45, P813; [Anonymous], 1978, USERS MANUAL PROGRAM; [Anonymous], 1991, USERS GUIDE INTERACT; BROCK RE, 1979, MAR BIOL, V54, P281, DOI 10.1007/BF00395790; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Compagno L.J.V., 2005, SHARKS WORLD; Connell SD, 1998, AUST J ECOL, V23, P579, DOI 10.1111/j.1442-9993.1998.tb00768.x; DECROSTA MA, 1984, UNIHISEAGRANTMR8401, P75; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; GRIGG RW, 1994, MAR ECOL PROG SER, V103, P25, DOI 10.3354/meps103025; Guillemette M, 2001, J APPL ECOL, V38, P1, DOI 10.1046/j.1365-2664.2001.00564.x; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holzwarth Stephani R., 2006, Atoll Research Bulletin, P257; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lobel Phillip S., 2004, Pacific Science, V58, P65, DOI 10.1353/psc.2004.0007; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Papastamatiou YP, 2009, J FISH BIOL, V75, P647, DOI 10.1111/j.1095-8649.2009.02329.x; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; RANDALL JE, 1985, PAC SCI, V39, P24; Randall John E., 1993, Pacific Science, V47, P356; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Robertson DR, 1996, CORAL REEFS, V15, P121, DOI 10.1007/s003380050032; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sims DW, 2001, MAR BIOL, V139, P1165; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; TAYLOR LR, 1994, SHARKS HAWAII; Wetherbee BM, 1996, ENVIRON BIOL FISH, V45, P299, DOI 10.1007/BF00003099; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; ZIPPIN CALVIN, 1958, JOUR WILDLIFE MANAGEMENT, V22, P82, DOI 10.2307/3797301	49	20	20	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16962	10.1371/journal.pone.0016962	http://dx.doi.org/10.1371/journal.pone.0016962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347321	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000025
J	Dunstan, A; Bradshaw, CJA; Marshall, J				Dunstan, Andrew; Bradshaw, Corey J. A.; Marshall, Justin			Nautilus at Risk - Estimating Population Size and Demography of Nautilus pompilius	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; LIVING NAUTILUS; CHAMBERED NAUTILUS; ADMIRALTY ISLANDS; GROWTH; CEPHALOPODA; FIJI; MACROMPHALUS; SHELL; PALAU	The low fecundity, late maturity, long gestation and long life span of Nautilus suggest that this species is vulnerable to over-exploitation. Demand from the ornamental shell trade has contributed to their rapid decline in localized populations. More data from wild populations are needed to design management plans which ensure Nautilus persistence. We used a variety of techniques including capture-mark-recapture, baited remote underwater video systems, ultrasonic telemetry and remotely operated vehicles to estimate population size, growth rates, distribution and demographic characteristics of an unexploited Nautilus pompilius population at Osprey Reef (Coral Sea, Australia). We estimated a small and dispersed population of between 844 and 4467 individuals (14.6-77.4 km(-2)) dominated by males (83: 17 male: female) and comprised of few juveniles (<10%). These results provide the first Nautilid population and density estimates which are essential elements for long-term management of populations via sustainable catch models. Results from baited remote underwater video systems provide confidence for their more widespread use to assess efficiently the size and density of exploited and unexploited Nautilus populations worldwide.	[Dunstan, Andrew] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] S Australian Res & Dev Inst, Henley Beach, SA, Australia; [Marshall, Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Adelaide; University of Adelaide; University of Queensland	Dunstan, A (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com	Bradshaw, Corey J.A./A-1311-2008	Bradshaw, Corey J.A./0000-0002-5328-7741; Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; University of Western Australia; Australian Research Council [ID LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); University of Western Australia; Australian Research Council(Australian Research Council)	Funding for this work came from Undersea Explorer, University of Queensland, University of Western Australia and from an Australian Research Council Linkage Project: Project ID LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 1990, J CEPHALOPOD BIOL, V2, P1; Beaman, 2010, 3DGBR HIGH RESOLUTIO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARLSON BA, 1979, PAC SCI, V33, P118; Collins D., 2010, NAUTILUS BIOL PALEOB, P421; DEANGELIS P, 2010, 8 INT S CEPH PRES DI; Del Norte-Campos A.G.C., 2005, PHUKET MAR BIO CEN R, V66, P299; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; Hanlon RT, 1996, CEPHALOPOD BEHAV; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; HEWITT R, 2010, NAUTILUS BIOL PALEOB, P435; KANIE Y, 1979, Venus the Japanese Journal of Malacology, V38, P129; KANIE Y, 1980, PALEOBIOLOGY, V6, P44, DOI 10.1017/S0094837300012483; Landman N.H., 2010, NAUTILUS BIOL PALEOB, P401, DOI DOI 10.1007/978-90-481-3299-7_28; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; ODOR RK, 1993, NATURE, V362, P626, DOI 10.1038/362626a0; OKUBO S, 1995, VELIGER, V38, P192; Saunders W. B., 2010, NAUTILUS BIOL PALEOB; SAUNDERS WB, 1987, NAUTILUS, V101, P93; SAUNDERS WB, 1990, NATL GEOGR RES, V6, P504; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; SAUNDERS WB, 1978, PALEOBIOLOGY, V4, P349, DOI 10.1017/S0094837300006047; Saunders WB, 2010, NAUTILUS BIOL PALEOB, V6, P137; SCHWARZ CJ, JOLLYSEBER MODEL MOD, P195; Sinclair B, 2007, REV FISH BIOL FISHER, V17, P223, DOI 10.1007/s11160-006-9030-x; Strugnell JM, 2007, REV FISH BIOL FISHER, V17, P337, DOI 10.1007/s11160-007-9043-0; Swan A.R.H., 2010, NAUTILUS BIOL PALEOB, P85, DOI [DOI 10.1007/978-90-481-3299-7_6, 10.1007/978-90-481-3299-7_6]; TANABE K, 1990, MALACOLOGIA, V31, P297; WARD P, 1980, LETHAIA, V13, P182, DOI 10.1111/j.1502-3931.1980.tb01050.x; WARD P, 1977, PALEOBIOLOGY, V3, P377, DOI 10.1017/S0094837300005534; WARD P, 1981, PALEOBIOLOGY, V7, P481, DOI 10.1017/S0094837300025537; WARD P, 1983, CEPHALOPOD LIFE CYCL, P137; Ward P. D., 1987, NATURAL HIST NAUTILU; WARD PD, 1980, VELIGER, V22, P259; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZANN LP, 1984, VELIGER, V27, P19	43	38	39	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16716	10.1371/journal.pone.0016716	http://dx.doi.org/10.1371/journal.pone.0016716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347360	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000013
J	Gaebel, R; Furlani, D; Sorg, H; Polchow, B; Frank, J; Bieback, K; Wang, WW; Klopsch, C; Ong, LL; Li, WZ; Ma, N; Steinhoff, G				Gaebel, Ralf; Furlani, Dario; Sorg, Heiko; Polchow, Bianca; Frank, Johannes; Bieback, Karen; Wang, Weiwei; Klopsch, Christian; Ong, Lee-Lee; Li, Wenzhong; Ma, Nan; Steinhoff, Gustav			Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration	PLOS ONE			English	Article							HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD; SKELETAL MYOBLAST TRANSPLANTATION; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE; STROMAL CELLS; CARDIOMYOCYTE TRANSPLANTATION; PROGENITOR CELLS; GENE DELIVERY; SCAR TISSUE	The possible different therapeutic efficacy of human mesenchymal stem cells (hMSC) derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the treatment of myocardial infarction (MI) remains unexplored. This study was to assess the regenerative potential of hMSC from different origins and to evaluate the role of CD105 in cardiac regeneration. Male SCID mice underwent LAD-ligation and received the respective cell type (400,000/per animal) intramyocardially. Six weeks post infarction, cardiac catheterization showed significant preservation of left ventricular functions in BM and CD105(+)-CB treated groups compared to CB and nontreated MI group (MI-C). Cell survival analyzed by quantitative real time PCR for human GAPDH and capillary density measured by immunostaining showed consistent results. Furthermore, cardiac remodeling can be significantly attenuated by BM-hMSC compared to MI-C. Under hypoxic conditions in vitro, remarkably increased extracellular acidification and apoptosis has been detected from CB-hMSC compared to BM and CD105 purified CB-derived hMSC. Our findings suggests that hMSC originating from different sources showed a different healing performance in cardiac regeneration and CD105(+) hMSC exhibited a favorable survival pattern in infarcted hearts, which translates into a more robust preservation of cardiac function.	[Gaebel, Ralf; Furlani, Dario; Sorg, Heiko; Polchow, Bianca; Frank, Johannes; Wang, Weiwei; Klopsch, Christian; Ong, Lee-Lee; Li, Wenzhong; Ma, Nan; Steinhoff, Gustav] Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany; [Bieback, Karen] German Red Cross Blood Serv Baden Wurttemberg Hes, Inst Transfus Med & Immunol, Mannheim, Germany	University of Rostock	Gaebel, R (corresponding author), Univ Rostock, Dept Cardiac Surg, Reference & Translat Ctr Cardiac Stem Cell Therap, Rostock, Germany.	wenzhong.li@med.uni-rostock.de; nan.ma@med.uni-rostock.de	ma, nan/AAF-6968-2020; Steinhoff, Gustav/AAB-1848-2020; Ma, Nan/L-1282-2013; Li, Wenzhong/I-2882-2014	ma, nan/0000-0003-4006-1003; Ma, Nan/0000-0003-4006-1003; Sorg, Heiko/0000-0001-6827-0857	Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio [37]; German Federal Ministry of Education and Research [0313191]; German Helmholtz Association; Mecklenburg-Vorpommern; German Federal Ministry of Education and Research; German Research Foundation [0402710]; Forderkennzeichen A (Ministry of Education (Germany, Berlin) [0312138]; Ministry of Economy (Mecklenburg-West Pommerania, Schwerin [V220-630-08-TFMV-F/S-035]; Marie Curie International Research Staff Exchange Scheme [IRSES, FP7-PEOPLE-2009-IRSES]; Reference and Translation Center for Cardiac Stem Cell Therapy (RTC)	Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Helmholtz Association(Helmholtz Association); Mecklenburg-Vorpommern; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Forderkennzeichen A (Ministry of Education (Germany, Berlin); Ministry of Economy (Mecklenburg-West Pommerania, Schwerin; Marie Curie International Research Staff Exchange Scheme(European Commission); Reference and Translation Center for Cardiac Stem Cell Therapy (RTC)	This work was supported by Standardization for Regenerative Therapy - Mesenchymal Stem Cells (START-MSC); Sonderforschungsbereich/Transregio 37 (B5, B2 and A4); German Federal Ministry of Education and Research, BioChancePlus program (0313191); The German Helmholtz Association, Mecklenburg-Vorpommern, German Federal Ministry of Education and Research, German Research Foundation (Nachwuchsgruppe Regenerative Medizin Regulation der Stammzellmigration 0402710); Forderkennzeichen 0312138 A (Ministry of Education (Germany, Berlin)); V220-630-08-TFMV-F/S-035 (Ministry of Economy (Mecklenburg-West Pommerania, Schwerin)); Marie Curie International Research Staff Exchange Scheme (IRSES, FP7-PEOPLE-2009-IRSES); the Reference and Translation Center for Cardiac Stem Cell Therapy (RTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bieback K, 2008, BIO-MED MATER ENG, V18, pS71; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Furlani D, 2009, CELL TRANSPLANT, V18, P319, DOI 10.3727/096368909788534906; Goodwin HS, 2001, BIOL BLOOD MARROW TR, V7, P581, DOI 10.1053/bbmt.2001.v7.pm11760145; Hao JM, 1999, J MOL CELL CARDIOL, V31, P667, DOI 10.1006/jmcc.1998.0902; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jia ZQ, 1997, TRANSPLANT P, V29, P2093, DOI 10.1016/S0041-1345(97)00247-9; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882; Li RK, 1996, ANN THORAC SURG, V62, P654; Li RK, 2001, ANN THORAC SURG, V72, P1957, DOI 10.1016/S0003-4975(01)03216-7; Li WZ, 2008, J GENE MED, V10, P897, DOI 10.1002/jgm.1208; Li WZ, 2007, J MAGN MAGN MATER, V311, P336, DOI 10.1016/j.jmmm.2006.11.201; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Ma N, 2006, CARDIOVASC RES, V71, P158, DOI 10.1016/j.cardiores.2006.03.020; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Nesselmann Catharina, 2010, Ther Adv Cardiovasc Dis, V4, P27, DOI 10.1177/1753944709353338; Nishida S, 1999, J BONE MINER METAB, V17, P171, DOI 10.1007/s007740050081; Ong LL, 2010, TISSUE ENG PART C-ME, V16, P1069, DOI [10.1089/ten.tec.2009.0641, 10.1089/ten.TEC.2009.0641]; OU L, 2010, J CELL MOL MED; Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; SCHALLMOSER K, HAEMATOLOGICA, V95, P867; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Thedinga E, 2007, TOXICOL APPL PHARM, V220, P33, DOI 10.1016/j.taap.2006.12.027; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Van de Kerkhof PCM, 1998, ACTA DERM-VENEREOL, V78, P19; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; WAGNER W, TISSUE ENG B, V16, P445; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang BQ, 2002, AM J PHYSIOL-HEART C, V282, pH1685, DOI 10.1152/ajpheart.00266.2001; WANG W, 2010, J CELL MOL MED; Wang WW, 2010, J CELL MOL MED, V14, P392, DOI 10.1111/j.1582-4934.2008.00624.x; Wang WW, 2009, INT J ARTIF ORGANS, V32, P141, DOI 10.1177/039139880903200304; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	61	104	109	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e15652	10.1371/journal.pone.0015652	http://dx.doi.org/10.1371/journal.pone.0015652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347366	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000004
J	Allam, US; Krishna, MG; Lahiri, A; Joy, O; Chakravortty, D				Allam, Uday Shankar; Krishna, M. Gopala; Lahiri, Amit; Joy, Omana; Chakravortty, Dipshikha			Salmonella enterica Serovar Typhimurium Lacking hfq Gene Confers Protective Immunity against Murine Typhoid	PLOS ONE			English	Article							ADENINE METHYLASE MUTANTS; LIVE ATTENUATED BACTERIA; III SECRETION SYSTEM; RNA CHAPERONE HFQ; PATHOGENICITY ISLAND-2; ESCHERICHIA-COLI; DENDRITIC CELLS; ORAL CHALLENGE; IFN-GAMMA; T-CELLS	Salmonella enterica is an important enteric pathogen and its various serovars are involved in causing both systemic and intestinal diseases in humans and domestic animals. The emergence of multidrug-resistant strains of Salmonella leading to increased morbidity and mortality has further complicated its management. Live attenuated vaccines have been proven superior over killed or subunit vaccines due to their ability to induce protective immunity. Of the various strategies used for the generation of live attenuated vaccine strains, focus has gradually shifted towards manipulation of virulence regulator genes. Hfq is a RNA chaperon which mediates the binding of small RNAs to the mRNA and assists in post-transcriptional gene regulation in bacteria. In this study, we evaluated the efficacy of the Salmonella Typhimurium Dhfq strain as a candidate for live oral vaccine in murine model of typhoid fever. Salmonella hfq deletion mutant is highly attenuated in cell culture and animal model implying a significant role of Hfq in bacterial virulence. Oral immunization with the Salmonella hfq deletion mutant efficiently protects mice against subsequent oral challenge with virulent strain of Salmonella Typhimurium. Moreover, protection was induced upon both multiple as well as single dose of immunizations. The vaccine strain appears to be safe for use in pregnant mice and the protection is mediated by the increase in the number of CD4(+) T lymphocytes upon vaccination. The levels of serum IgG and secretory-IgA in intestinal washes specific to lipopolysaccharide and outer membrane protein were significantly increased upon vaccination. Furthermore, hfq deletion mutant showed enhanced antigen presentation by dendritic cells compared to the wild type strain. Taken together, the studies in murine immunization model suggest that the Salmonella hfq deletion mutant can be a novel live oral vaccine candidate.	[Allam, Uday Shankar] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Allam, US (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Allam, Uday/HDN-4342-2022; Mannala, Gopala Krishna/ABF-2325-2020; Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009	Allam, Uday/0000-0003-4641-3903; LAHIRI, AMIT/0000-0003-0307-3478; Chakravortty, Dipshikha/0000-0002-7838-5145	Indian Institute of Science, Bangalore, India; Department of Biotechnology [DBT 197, DBT 172]; DST-FIST (Department of Science and Technology); U.G.C.	Indian Institute of Science, Bangalore, India; Department of Biotechnology; DST-FIST (Department of Science and Technology)(Department of Science & Technology (India)); U.G.C.(University Grants Commission, India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172) to D. C. Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST-FIST (Department of Science and Technology-Infrastructure support grant) and UGC (University Grant Commission-special assistance) is acknowledged. U.S.A. acknowledges U.G.C. for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chan K, 2003, J BACTERIOL, V185, P553, DOI 10.1128/JB.185.2.553-563.2003; CHAO Y, 2010, CURR OPIN MICROBIOL; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cheminay C, 2008, INT J MED MICROBIOL, V298, P87, DOI 10.1016/j.ijmm.2007.08.006; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeRoeck D, 2007, NEW ENGL J MED, V357, P1069, DOI 10.1056/NEJMp078144; Dueger EL, 2001, INFECT IMMUN, V69, P7950, DOI 10.1128/IAI.69.12.7950-7954.2001; Eckmann L, 1996, J IMMUNOL, V156, P2894; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Hamid N, 2008, CLIN VACCINE IMMUNOL, V15, P1461, DOI 10.1128/CVI.00093-08; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Karem KL, 1996, VACCINE, V14, P1495, DOI 10.1016/S0264-410X(96)00118-1; KEITEL WA, 1994, VACCINE, V12, P195, DOI 10.1016/0264-410X(94)90194-5; Khan SA, 2003, VACCINE, V21, P538, DOI 10.1016/S0264-410X(02)00410-3; Kirkpatrick BD, 2006, VACCINE, V24, P116, DOI 10.1016/j.vaccine.2005.08.008; Kotton CN, 2006, VACCINE, V24, P6216, DOI 10.1016/j.vaccine.2006.05.094; Krishnan L, 1996, J IMMUNOL, V156, P644; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Matsui H, 2003, INFECT IMMUN, V71, P30, DOI 10.1128/IAI.71.1.30-39.2003; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Nagarajan AG, 2009, VACCINE, V27, P2804, DOI 10.1016/j.vaccine.2009.02.092; Nagy G, 2004, INFECT IMMUN, V72, P4297, DOI 10.1128/IAI.72.7.4297-4301.2004; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Negi VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009139; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; OBRIEN AD, 1981, J IMMUNOL, V126, P1368; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Peters SE, 2010, INFECT IMMUN, V78, P326, DOI 10.1128/IAI.00768-09; Pie S, 1997, INFECT IMMUN, V65, P4509, DOI 10.1128/IAI.65.11.4509-4514.1997; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Sagi SSK, 2006, VACCINE, V24, P7135, DOI 10.1016/j.vaccine.2006.06.056; Secundino I, 2006, IMMUNOLOGY, V117, P59, DOI 10.1111/j.1365-2567.2005.02263.x; Singh SP, 1996, MICROB PATHOGENESIS, V21, P249, DOI 10.1006/mpat.1996.0059; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Srinivasan A, 2009, J IMMUNOL, V182, P7838, DOI 10.4049/jimmunol.0900382; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Viret JF, 1999, INFECT IMMUN, V67, P3680, DOI 10.1128/IAI.67.7.3680-3685.1999; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	64	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16667	10.1371/journal.pone.0016667	http://dx.doi.org/10.1371/journal.pone.0016667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347426	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000287361700028
J	Liu, BJ; Wang, P; Wang, ZJ; Zhang, W				Liu, Bianjiang; Wang, Peng; Wang, Zengjun; Zhang, Wei			The Use of Anti-VDAC2 Antibody for the Combined Assessment of Human Sperm Acrosome Integrity and Ionophore A23187-Induced Acrosome Reaction	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; MITOCHONDRIAL OUTER-MEMBRANE; HUMAN SPERMATOZOA; VDAC ISOFORMS; LOCALIZATION; EXPRESSION; BINDING; PORIN; FLUX; CAPACITATION	Voltage-dependent anion channel (VDAC) is mainly located in the mitochondrial outer membrane and participates in many biological processes. In mammals, three VDAC subtypes (VDAC1, 2 and 3) have been identified. Although VDAC has been extensively studied in various tissues and cells, there is little knowledge about the distribution and function of VDAC in male mammalian reproductive system. Several studies have demonstrated that VDAC exists in mammalian spermatozoa and is implicated in spermatogenesis, sperm maturation, motility and fertilization. However, there is no knowledge about the respective localization and function of three VDAC subtypes in human spermatozoa. In this study, we focused on the presence of VDAC2 in human spermatozoa and its possible role in the acrosomal integrity and acrosome reaction using specific anti-VDAC2 monoclonal antibody for the first time. The results exhibited that native VDAC2 existed in the membrane components of human spermatozoa. The co-incubation of spermatozoa with anti-VDAC2 antibody did not affect the acrosomal integrity and acrosome reaction, but inhibited ionophore A23187-induced intracellular Ca(2+) increase. Our study suggested that VDAC2 was located in the acrosomal membrane or plasma membrane of human spermatozoa, and played putative roles in sperm functions through mediating Ca(2+) transmembrane transport.	[Liu, Bianjiang; Wang, Peng; Wang, Zengjun; Zhang, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Lab Reprod Med, Nanjing, Peoples R China	Nanjing Medical University	Liu, BJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Lab Reprod Med, Nanjing, Peoples R China.	zengjunwang@njmu.edu.cn; zhangwei@njmu.edu.cn			National Natural Science Foundation of China [30872575]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from National Natural Science Foundation of China (No.: 30872575). URL: http://www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1993, J ANDROL, V14, P132; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; DEPINTO V, 1985, BIOCHIM BIOPHYS ACTA, V813, P230; DOHERTY CM, 1995, J ANDROL, V16, P36; DOMINGUEZ L, 1995, INT J ANDROL, V18, P203, DOI 10.1111/j.1365-2605.1995.tb00411.x; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hinsch KD, 2004, J BIOL CHEM, V279, P15281, DOI 10.1074/jbc.M313433200; Hinsch KD, 2001, BBA-GENE STRUCT EXPR, V1518, P329, DOI 10.1016/S0167-4781(01)00199-3; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Israelson A, 2007, CELL CALCIUM, V41, P235, DOI 10.1016/j.ceca.2006.06.005; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Krasznai Z, 2006, CELL MOTIL CYTOSKEL, V63, P66, DOI 10.1002/cm.20108; LINDEN M, 1984, BIOCHIM BIOPHYS ACTA, V770, P93, DOI 10.1016/0005-2736(84)90077-4; Liu BJ, 2010, BIOCHEM BIOPH RES CO, V397, P633, DOI 10.1016/j.bbrc.2010.06.025; Liu BJ, 2009, BIOCHEM BIOPH RES CO, V378, P366, DOI 10.1016/j.bbrc.2008.10.177; Liu DY, 1996, HUM REPROD, V11, P551, DOI 10.1093/HUMREP/11.3.551; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; Triphan X, 2008, PFLUG ARCH EUR J PHY, V455, P677, DOI 10.1007/s00424-007-0316-1; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Wang ZJ, 2007, BIOL REPROD, V77, P476, DOI 10.1095/biolreprod.107.060194; World Health Organization, 1999, WHO LAB MAN EX HUM S; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P149, DOI 10.1073/pnas.0135565100; Young C, 2009, FERTIL STERIL, V91, P2230, DOI 10.1016/j.fertnstert.2008.05.021; Yu WH, 1996, J BIOENERG BIOMEMBR, V28, P93, DOI 10.1007/BF02110638; Zhang J, 2010, HUM REPROD, V25, P29, DOI 10.1093/humrep/dep356	45	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16985	10.1371/journal.pone.0016985	http://dx.doi.org/10.1371/journal.pone.0016985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347391	Green Submitted, gold, Green Published			2022-12-27	WOS:000287361700062
J	Zhang, FL; Shi, YP; Wang, LL; Sriram, S				Zhang, Fanglin; Shi, Yaping; Wang, Lily; Sriram, Subramaniam			Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MEDICAL PROGRESS; CYCLE ARREST; TRICHOSTATIN; ACETYLATION; DISCOVERY; PATHWAY	Background: Histone deacetylase 3 (HDAC3) belongs to a family of proteins which plays an important role in protein acetylation, chromatin remodeling and transcription of genes, including those that are involved in cell proliferation and cell death. While increased expression of HDAC3 is seen in neoplastic cells, the role of HDAC3 in T cells and their role in autoimmune disease is not known. Methodology/Principal Findings: Applying Affymetrix GeneChip Human Gene 1.0 ST Array and the mixed effects model for gene set analysis, we compared gene expression profiles between multiple sclerosis (MS) patients and healthy controls (HC). Within the Apoptosis_GO gene set, the constitutive expression level of HDAC3 in peripheral blood mononuclear cell (PBMC) was significantly increased in MS patients when compared to controls. Following addition of trichostatin A (TSA), an inhibitor of HDAC3, we examined the expression of p53 by flow cytometry and p53 targeted genes by real time RT-PCR in MS and HC. Culture of PBMC with TSA resulted in increased expression of p53 in HC but not in MS patients. TSA treated T cells from MS patients also showed reduced sensitivity to apoptosis when compared to HC, which was independent of activation of p53 targeted pro-apoptotic genes. Conclusion/Significance: MS patients, when compared to controls, show an increased expression of HDAC3 and relative resistance to TSA induced apoptosis in T cells. Increased expression of HDAC3 in PBMC of MS patients may render putative autoreactive lymphocytes resistance to apoptosis and thereby contribute to autoimmunity.	[Zhang, Fanglin; Sriram, Subramaniam] Vanderbilt Univ Sch Med, Multiple Sclerosis Res Ctr, Dept Neurol, Nashville, TN 37203 USA; [Shi, Yaping; Wang, Lily] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Zhang, FL (corresponding author), Vanderbilt Univ Sch Med, Multiple Sclerosis Res Ctr, Dept Neurol, Nashville, TN 37203 USA.	Subramaniam.sriram@vanderbilt.edu	Zhang, Fang/HHN-2153-2022		National Multiple Sclerosis Society	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	National Multiple Sclerosis Society. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO PV, BLOOD; ALAMDARI N, AM J PHYSL REGUL INT, V299, pR509; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BIRAN A, INT J CANC; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Cecconi D, 2009, PROTEOMICS, V9, P1952, DOI 10.1002/pmic.200701089; CHEN S, P NATL ACAD SCI US, V107, P11032; Chen XF, 2009, CANCER BIOTHER RADIO, V24, P689, DOI 10.1089/cbr.2009.0629; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deng XQ, 2005, ANN NEUROL, V58, P577, DOI 10.1002/ana.20600; Di Gennaro E, 2009, CANCER BIOL THER, V8, P782, DOI 10.4161/cbt.8.9.8118; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MINAMIYA Y, TUMOUR BIOL; MORENO DA, 2003, BR J HAEMATOL; Munro KM, 2009, NEUROSIGNALS, V17, P311, DOI 10.1159/000231897; Murphy ME, 2004, CELL CYCLE, V3, P836; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Park H, 2008, INT J MOL MED, V22, P605, DOI 10.3892/ijmm_00000062; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Satoh J, 2007, NEUROSCI LETT, V422, P30, DOI 10.1016/j.neulet.2007.05.056; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000115; Wang L, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1484; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	54	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16795	10.1371/journal.pone.0016795	http://dx.doi.org/10.1371/journal.pone.0016795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346816	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600028
J	Feenders, G; Bateson, M				Feenders, Gesa; Bateson, Melissa			Hand-Rearing Reduces Fear of Humans in European Starlings, Sturnus vulgaris	PLOS ONE			English	Article							WINGED AMAZON PARROTS; PSYCHOLOGICAL STRESS; MESSENGER-RNA; RESPONSES; CHICKENS; RECOVERY; BEHAVIOR; ALTERS; RATS; EXPRESSION	Pending changes in European legislation ban the use of wild-caught animals in research. This change is partly justified on the assumption that captive-breeding (or hand-rearing) increases welfare of captive animals because these practices result in animals with reduced fear of humans. However, there are few actual data on the long-term behavioural effects of captive-breeding in non-domestic species, and these are urgently needed in order to understand the welfare and scientific consequences of adopting this practice. We compared the response of hand-reared and wild-caught starlings to the presence of a human in the laboratory. During human presence, all birds increased their general locomotor activity but the wild-caught birds moved away from the human and were less active than the hand-reared birds. After the human departed, the wild-caught birds were slower to decrease their activity back towards baseline levels, and showed a dramatic increase in time at the periphery of the cage compared with the hand-reared birds. We interpret these data as showing evidence of a greater fear response in wild-caught birds with initial withdrawal followed by a subsequent rebound of prolonged attempts to escape the cage. We found no effects of environmental enrichment. However, birds in cages on low shelves were less active than birds on upper shelves, and showed a greater increase in the time spent at the periphery of their cages after the human departed, perhaps indicating that the lower cages were more stressful. In demonstrating reduced fear of humans in hand-reared birds, our results support one of the proposed welfare benefits of this practice, but without further data on the possible welfare costs of hand-rearing, it is not yet possible to reach a general conclusion about its net welfare impact. However, our results confirm a clear scientific impact of both hand-rearing and cage position at the behavioural level.	[Feenders, Gesa; Bateson, Melissa] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Feenders, G (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Gesa.Feenders@newcastle.ac.uk	Bateson, Melissa/B-1874-2008; Bateson, Melissa/AAE-7075-2022	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191	Biotechnology and Biological Sciences Research Council [BB/05623/1]; Biotechnology and Biological Sciences Research Council [BB/F015623/1] Funding Source: researchfish; BBSRC [BB/F015623/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council, grant number BB/05623/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER DN, 1991, PSYCHOSOM MED, V53, P313, DOI 10.1097/00006842-199105000-00005; Aengus WL, 1999, ZOO BIOL, V18, P177; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Bateson M, 2007, ANIM WELFARE, V16, P33; BATESON M, 2010, ILAR J IN PRESS; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; Brilot BO, 2009, ANIM BEHAV, V78, P801, DOI 10.1016/j.anbehav.2009.07.022; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; *CEU, 2010, DIR EUR PARL COUNC P; Collette JC, 2000, APPL ANIM BEHAV SCI, V66, P335, DOI 10.1016/S0168-1591(99)00098-2; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Dickens M, 2009, J NEUROENDOCRINOL, V21, P832, DOI 10.1111/j.1365-2826.2009.01908.x; FAWC, 1993, 2 FAWC; Feare C.J., 1984, STARLING; Garcia A, 2000, NEUROENDOCRINOLOGY, V72, P114, DOI 10.1159/000054578; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Gold SA, 2004, BIOL PSYCHOL, V67, P261, DOI 10.1016/j.biopsycho.2003.12.001; HAWKINS P, 2003, COUNC EUR CONV ETS12; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Latham NR, 2008, APPL ANIM BEHAV SCI, V110, P84, DOI 10.1016/j.applanim.2007.03.026; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Maddocks SA, 2002, J AVIAN BIOL, V33, P103, DOI 10.1034/j.1600-048X.2002.330117.x; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Newman JA, 1997, ECOLOGY, V78, P1312; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Schmid R, 2006, APPL ANIM BEHAV SCI, V98, P293, DOI 10.1016/j.applanim.2005.09.002; SUAREZ SD, 1982, J COMP PHYSIOL PSYCH, V96, P432, DOI 10.1037/h0077886; Zar JH., 1999, BIOSTAT ANAL; Zulkifli I, 2002, APPL ANIM BEHAV SCI, V79, P103, DOI 10.1016/S0168-1591(02)00135-1; [No title captured]	39	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17466	10.1371/journal.pone.0017466	http://dx.doi.org/10.1371/journal.pone.0017466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364770	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100064
J	Langer, K; Dian, C; Rybin, V; Muller, CW; Petosa, C				Langer, Karla; Dian, Cyril; Rybin, Vladimir; Mueller, Christoph W.; Petosa, Carlo			Insights into the Function of the CRM1 Cofactor RanBP3 from the Structure of Its Ran-Binding Domain	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; GUANINE-NUCLEOTIDE EXCHANGE; PROTEIN; LOCALIZATION; TRANSPORT; RECEPTOR; COMPLEX; LINKS	Proteins bearing a leucine-rich nuclear export signal (NES) are exported from the nucleus by the transport factor CRM1, which forms a cooperative ternary complex with the NES-bearing cargo and with the small GTPase Ran. CRM1-mediated export is regulated by RanBP3, a Ran-interacting nuclear protein. Unlike the related proteins RanBP1 and RanBP2, which promote disassembly of the export complex in the cytosol, RanBP3 acts as a CRM1 cofactor, enhancing NES export by stabilizing the export complex in the nucleus. RanBP3 also alters the cargo selectivity of CRM1, promoting recognition of the NES of HIV-1 Rev and of other cargos while deterring recognition of the import adaptor protein Snurportin1. Here we report the crystal structure of the Ran-binding domain (RBD) from RanBP3 and compare it to RBD structures from RanBP1 and RanBP2 in complex with Ran and CRM1. Differences among these structures suggest why RanBP3 binds Ran with unusually low affinity, how RanBP3 modulates the cargo selectivity of CRM1, and why RanBP3 promotes assembly rather than disassembly of the export complex. The comparison of RBD structures thus provides an insight into the functional diversity of Ran-binding proteins.	[Langer, Karla; Rybin, Vladimir; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Dian, Cyril; Petosa, Carlo] Univ Grenoble 1, CNRS, Commissariat Energie Atom & Energies Alternat, Inst Biol Struct Jean Pierre Ebel,UMR 5075, Grenoble, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Langer, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	cmueller@embl.de; carlo.petosa@ibs.fr	Müller, Christoph W/I-7420-2012; Dian, Cyril/I-4285-2012	Müller, Christoph W/0000-0003-2176-8337; Dian, Cyril/0000-0002-6349-3901; Petosa, Carlo/0000-0002-9975-1167	Rhone-Alpes Region; ANRS/Fondation de France; CNRS; ANR	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); ANRS/Fondation de France(ANRSFondation de FranceFrench National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	KL was supported by a CIBLE pre-doctoral fellowship from the Rhone-Alpes Region. CP acknowledges support from the ANRS/Fondation de France (AIJC program), CNRS (ATIP program), and ANR (program blanc, NucExp grant). URLs: http://www.rhonealpes.fr, http://www.anrs.fr, http://www.cnrs.fr, http://www.fondationdefrance.org, http://www.agence- nationale-recherche.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Engelsma D, 2008, MOL BIOL CELL, V19, P2544, DOI 10.1091/mbc.E08-01-0009; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Floer M, 1999, J BIOL CHEM, V274, P16279, DOI 10.1074/jbc.274.23.16279; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Geyer JP, 2005, J MOL BIOL, V348, P711, DOI 10.1016/j.jmb.2005.02.033; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Koyama M, 2010, EMBO J, V29, P2002, DOI 10.1038/emboj.2010.89; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Mueller L, 1998, FEBS LETT, V427, P330, DOI 10.1016/S0014-5793(98)00459-1; Nemergut ME, 2002, J BIOL CHEM, V277, P17385, DOI 10.1074/jbc.c100620200; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Welch K, 1999, MOL CELL BIOL, V19, P8400; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17011	10.1371/journal.pone.0017011	http://dx.doi.org/10.1371/journal.pone.0017011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364925	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100018
J	Trivigno, C; Haerry, TE				Trivigno, Catherine; Haerry, Theodor E.			The Drosophila Mitochondrial Translation Elongation Factor G1 Contains a Nuclear Localization Signal and Inhibits Growth and DPP Signaling	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; 2ND CHROMOSOME; MUTATIONS; MELANOGASTER; PROTEIN; EFG1	Mutations in the human mitochondrial elongation factor G1 (EF-G1) are recessive lethal and cause death shortly after birth. We have isolated mutations in iconoclast (ico), which encodes the highly conserved Drosophila orthologue of EF-G1. We find that EF-G1 is essential during fly development, but its function is not required in every tissue. In contrast to null mutations, missense mutations exhibit stronger, possibly neomorphic phenotypes that lead to premature death during embryogenesis. Our experiments show that EF-G1 contains a secondary C-terminal nuclear localization signal. Expression of missense mutant forms of EF-G1 can accumulate in the nucleus and cause growth and patterning defects and animal lethality. We find that transgenes that encode mutant human EF-G1 proteins can rescue ico mutants, indicating that the underlying problem of the human disease is not just the loss of enzymatic activity. Our results are consistent with a model where EF-G1 acts as a retrograde signal from mitochondria to the nucleus to slow down cell proliferation if mitochondrial energy output is low.	[Trivigno, Catherine; Haerry, Theodor E.] Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA; [Trivigno, Catherine] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Trivigno, C (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	thaerry@gmail.com			National Institutes of Health [1 R15 GM071394-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM071394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health 1 R15 GM071394-01 to TEH (from 2004-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Becker T, 2009, CURR OPIN CELL BIOL, V21, P484, DOI 10.1016/j.ceb.2009.04.002; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Newsome TP, 2000, DEVELOPMENT, V127, P851; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; RAFTERY LA, 1995, GENETICS, V139, P241; TIONG SYK, 1990, GENETICS, V124, P889; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559	20	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16799	10.1371/journal.pone.0016799	http://dx.doi.org/10.1371/journal.pone.0016799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364917	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100010
J	Bonnet, M; Gagnidze, L; Githui, W; Guerin, PJ; Bonte, L; Varaine, F; Ramsay, A				Bonnet, Maryline; Gagnidze, Laramie; Githui, Willie; Guerin, Philippe Jean; Bonte, Laurence; Varaine, Francis; Ramsay, Andrew			Performance of LED-Based Fluorescence Microscopy to Diagnose Tuberculosis in a Peripheral Health Centre in Nairobi	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; SPUTUM; OPPORTUNITY; OPTIMIZE; BACILLI	Background: Sputum microscopy is the only tuberculosis (TB) diagnostic available at peripheral levels of care in resource limited countries. Its sensitivity is low, particularly in high HIV prevalence settings. Fluorescence microscopy (FM) can improve performance of microscopy and with the new light emitting diode (LED) technologies could be appropriate for peripheral settings. The study aimed to compare the performance of LED-FM versus Ziehl-Neelsen (ZN) microscopy and to assess feasibility of LED-FM at a low level of care in a high HIV prevalence country. Methods: A prospective study was conducted in an urban health clinic in Nairobi, Kenya. Three sputum specimens were collected over 2 days from suspected TB patients. Each sample was processed with Auramine O and ZN methods and a 4(th) specimen was collected for TB culture reference standard. Auramine smears were read using the same microscope, equipped with the FluoLED (TM) fluorescence illuminator. Inter-reader agreement, reading time and technicians' acceptability assessed feasibility. Results: 497 patients were included and 1394 specimens were collected. The detection yields of LED-FM and ZN microscopy were 20.3% and 20.6% (p = 0.64), respectively. Sensitivity was 73.2% for LED-FM and 72% for ZN microscopy, p = 0.32. It was 96.7% and 95.9% for specificity, p = 0.53. Inter-reader agreement was high (kappa = 0.9). Mean reading time was three times faster than ZN microscopy with very good acceptance by technicians. Conclusions: Although it did not increase sensitivity, the faster reading time combined with very good acceptance and ease of use supports the introduction of LED-FM at the peripheral laboratory level of high TB and HIV burden countries.	[Bonnet, Maryline; Gagnidze, Laramie; Guerin, Philippe Jean] Epicentre, Paris, France; [Githui, Willie] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya; [Bonte, Laurence; Varaine, Francis] Med Sans Frontieres, Paris, France; [Ramsay, Andrew] WHO, WHO Special Programme Res & Training Trop Dis, World Bank, UNICEF,UNDP, CH-1211 Geneva, Switzerland	Kenya Medical Research Institute; Doctors Without Borders; The World Bank; World Health Organization	Bonnet, M (corresponding author), Epicentre, Paris, France.	maryline.bonnet@geneva.msf.org	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963				Affolabi D, 2010, INT J TUBERC LUNG D, V14, P160; Albert H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015206; Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; BENNEDSEN J, 1966, SCAND J RESPIR DIS, V47, P114; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Cambanis A, 2007, INT J TUBERC LUNG D, V11, P40; CATTAMANCHI A, 2010, AJRCCM IN PRESS; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kuhn Walter, 2010, Open Microbiol J, V4, P30, DOI 10.2174/1874285801004010030; Mabaera B, 2007, INT J TUBERC LUNG D, V11, P959; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, INT J TUBERC LUNG D, V13, P613; Ramsay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007760; *STOP TB PARTN, 2008, NEW LAB DIAGN TOOLS; *STOP TB PARTN RET, 2008, NEW LAB DIAGN TOOLS; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; World Health Organization, 2006, STOP TB STRATEGY BUI	28	28	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17214	10.1371/journal.pone.0017214	http://dx.doi.org/10.1371/journal.pone.0017214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364757	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800034
J	Castoria, G; D'Amato, L; Ciociola, A; Giovannelli, P; Giraldi, T; Sepe, L; Paolella, G; Barone, MV; Migliaccio, A; Auricchio, F				Castoria, Gabriella; D'Amato, Loredana; Ciociola, Alessandra; Giovannelli, Pia; Giraldi, Tiziana; Sepe, Leandra; Paolella, Giovanni; Barone, Maria Vittoria; Migliaccio, Antimo; Auricchio, Ferdinando			Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROGESTERONE-RECEPTOR; FILAMIN-A; INTEGRATING SIGNALS; ESTRADIOL-RECEPTOR; DNA-SYNTHESIS; CROSS-TALK; ESTROGEN; ACTIVATION; SRC	Background: Androgen receptor (AR) controls male morphogenesis, gametogenesis and prostate growth as well as development of prostate cancer. These findings support a role for AR in cell migration and invasiveness. However, the molecular mechanism involved in AR-mediated cell migration still remains elusive. Methodology/Principal Findings: Mouse embryo NIH3T3 fibroblasts and highly metastatic human fibrosarcoma HT1080 cells harbor low levels of transcriptionally incompetent AR. We now report that, through extra nuclear action, AR triggers migration of both cell types upon stimulation with physiological concentrations of the androgen R1881. We analyzed the initial events leading to androgen-induced cell migration and observed that challenging NIH3T3 cells with 10 nM R1881 rapidly induces interaction of AR with filamin A (FlnA) at cytoskeleton. AR/FlnA complex recruits integrin beta 1, thus activating its dependent cascade. Silencing of AR, FlnA and integrin beta 1 shows that this ternary complex controls focal adhesion kinase (FAK), paxillin and Rac, thereby driving cell migration. FAK-null fibroblasts migrate poorly and Rac inhibition by EHT impairs motility of androgen-treated NIH3T3 cells. Interestingly, FAK and Rac activation by androgens are independent of each other. Findings in human fibrosarcoma HT1080 cells strengthen the role of Rac in androgen signaling. The Rac inhibitor significantly impairs androgen-induced migration in these cells. A mutant AR, deleted of the sequence interacting with FlnA, fails to mediate FAK activation and paxillin tyrosine phosphorylation in androgen-stimulated cells, further reinforcing the role of AR/FlnA interaction in androgen-mediated motility. Conclusions/Significance: The present report, for the first time, indicates that the extra nuclear AR/FlnA/integrin beta 1 complex is the key by which androgen activates signaling leading to cell migration. Assembly of this ternary complex may control organ development and prostate cancer metastasis.	[Castoria, Gabriella; D'Amato, Loredana; Ciociola, Alessandra; Giovannelli, Pia; Giraldi, Tiziana; Migliaccio, Antimo; Auricchio, Ferdinando] Univ Naples Federico II, Dipartimento Patol Gen, Naples, Italy; [Barone, Maria Vittoria] Univ Naples Federico II, European Lab Invest Food Induced Dis, Dipartimento Pediat, Naples, Italy; [Sepe, Leandra; Paolella, Giovanni] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Castoria, G (corresponding author), Univ Naples Federico II, Dipartimento Patol Gen, Naples, Italy.	antimo.migliaccio@unina2.it	Giovannelli, Pia/J-7931-2019; Migliaccio, Antimo/AAB-3376-2019; Castoria, Gabriella/I-3349-2019	Castoria, Gabriella/0000-0002-0576-4494; Migliaccio, Antimo/0000-0002-4197-2055; BARONE, Maria Vittoria/0000-0001-6190-4917; Giovannelli, Pia/0000-0002-2488-917X	Italian Association for Cancer Research (A.I.R.C.) [IG 5389]	Italian Association for Cancer Research (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro)	Funding: This work was supported by the Italian Association for Cancer Research (A.I.R.C., Grant No. IG 5389). P. G. was supported by a fellowship from A.I.R.C. (ITALY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1999, DEVELOPMENT, V126, P1655; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Boonyaratanakornkit V, MOL CELL, V8, P269; Bulens F, 1997, J BIOL CHEM, V272, P663; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cantarella C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S12; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHAUDHURI PK, 1980, CANCER RES, V40, P861; Chauhan S, 2004, J BIOL CHEM, V279, P937, DOI 10.1074/jbc.M311325200; Cheng HL, 2000, J BIOL CHEM, V275, P27197; Chuang KH, 2009, J EXP MED, V206, P1181, DOI 10.1084/jem.20082521; Cunha GR, 2008, DIFFERENTIATION, V76, P578, DOI 10.1111/j.1432-0436.2008.00290.x; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fu XD, 2010, ENDOCR-RELAT CANCER, V17, P431, DOI 10.1677/ERC-09-0258; Fu XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002790; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giretti MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002238; Hatzoglou A, 2005, J CLIN ENDOCR METAB, V90, P893, DOI 10.1210/jc.2004-0801; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Papakonstanti EA, 2003, MOL ENDOCRINOL, V17, P870, DOI 10.1210/me.2002-0253; Planas-Silva MD, 2006, BIOCHEM BIOPH RES CO, V341, P73, DOI 10.1016/j.bbrc.2005.12.164; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vallejo G, 2005, MOL ENDOCRINOL, V19, P3023, DOI 10.1210/me.2005-0016; Varricchio L, 2007, MOL CANCER RES, V5, P1213, DOI 10.1158/1541-7786.MCR-07-0150; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhao Z, 2009, P NATL ACAD SCI USA, V106, P7221, DOI 10.1073/pnas.0812597106; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	57	76	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17218	10.1371/journal.pone.0017218	http://dx.doi.org/10.1371/journal.pone.0017218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359179	Green Submitted, gold, Green Published			2022-12-27	WOS:000287392700062
J	Morello, E; Saussereau, E; Maura, D; Huerre, M; Touqui, L; Debarbieux, L				Morello, Eric; Saussereau, Emilie; Maura, Damien; Huerre, Michel; Touqui, Lhousseine; Debarbieux, Laurent			Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention	PLOS ONE			English	Article							RESISTANCE; VIRUSES; ISOLATE; HOST	Multidrug-resistant bacteria are the cause of an increasing number of deadly pulmonary infections. Because there is currently a paucity of novel antibiotics, phage therapy-the use of specific viruses that infect bacteria-is now more frequently being considered as a potential treatment for bacterial infections. Using a mouse lung-infection model caused by a multidrug resistant Pseudomonas aeruginosa mucoid strain isolated from a cystic fibrosis patient, we evaluated bacteriophage treatments. New bacteriophages were isolated from environmental samples and characterized. Bacteria and bacteriophages were applied intranasally to the immunocompetent mice. Survival was monitored and bronchoalveolar fluids were analysed. Quantification of bacteria, bacteriophages, pro-inflammatory and cytotoxicity markers, as well as histology and immunohistochemistry analyses were performed. A curative treatment (one single dose) administrated 2 h after the onset of the infection allowed over 95% survival. A four-day preventive treatment (one single dose) resulted in a 100% survival. All of the parameters measured correlated with the efficacy of both curative and preventive bacteriophage treatments. We also showed that in vitro optimization of a bacteriophage towards a clinical strain improved both its efficacy on in vivo treatments and its host range on a panel of 20 P. aeruginosa cystic fibrosis strains. This work provides an incentive to develop clinical studies on pulmonary bacteriophage therapy to combat multidrug-resistant lung infections.	[Morello, Eric; Saussereau, Emilie; Maura, Damien; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Huerre, Michel] Inst Pasteur, Dept Infect & Epidemiol, Histotechnol & Pathol Unit, Paris, France; [Touqui, Lhousseine] Inst Pasteur, Dept Infect & Epidemiol, Innate Host Def & Inflammat Unit, Paris, France; [Touqui, Lhousseine] INSERM, U874, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Morello, E (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	laurent.debarbieux@pasteur.fr	MORELLO, Eric/P-8087-2016	MORELLO, Eric/0000-0002-2009-4919; Debarbieux, Laurent/0000-0001-6875-5758	Institut Pasteur PTR [255]; Vaincre la Mucoviscidose [IC0704]	Institut Pasteur PTR; Vaincre la Mucoviscidose	Funding was provided by Institut Pasteur PTR N<SUP>o</SUP>255, Vaincre la Mucoviscidose grant IC0704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Boulanger Pascale, 2009, V502, P227, DOI 10.1007/978-1-60327-565-1_13; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Clark Jason R, 2004, Expert Rev Vaccines, V3, P463, DOI 10.1586/14760584.3.4.463; Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; DelicAttree I, 1996, MICROBIOL-UK, V142, P2785, DOI 10.1099/13500872-142-10-2785; DIF F, 2010, EUR ESP J; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Gorski A, 2009, CURR OPIN INVEST DR, V10, P766; Gould IM, 2008, INT J ANTIMICROB AG, V32, pS2, DOI 10.1016/j.ijantimicag.2008.06.016; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Knezevic P, 2008, J MICROBIOL METH, V74, P114, DOI 10.1016/j.mimet.2008.03.005; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kurzepa A, 2009, CLIN EXP MED, V9, P93, DOI 10.1007/s10238-008-0027-8; Kutateladze M, 2008, MED MALADIES INFECT, V38, P426, DOI 10.1016/j.medmal.2008.06.023; KUTATELADZE M, 2010, TRENDS BIOTECHNOL; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Miedzybrodzki R, 2005, VIRUS RES, V110, P1, DOI 10.1016/j.virusres.2005.01.009; Nordmann P, 2007, CURR OPIN MICROBIOL, V10, P436, DOI 10.1016/j.mib.2007.07.004; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Ventura GMD, 2009, J IMMUNOL, V183, P670, DOI 10.4049/jimmunol.0801497; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x	34	175	187	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16963	10.1371/journal.pone.0016963	http://dx.doi.org/10.1371/journal.pone.0016963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347240	Green Published, gold			2022-12-27	WOS:000287369200013
J	Gupta, R; Nalla, AK; Gogineni, VR; Chetty, C; Bhoopathi, P; Klopfenstein, JD; Tsung, AJ; Mohanam, S; Rao, JS				Gupta, Reshu; Nalla, Arun Kumar; Gogineni, Venkateswara Rao; Chetty, Chandramu; Bhoopathi, Praveen; Klopfenstein, Jeffrey D.; Tsung, Andrew J.; Mohanam, Sanjeeva; Rao, Jasti S.			uPAR/Cathepsin B Overexpression Reverse Angiogenesis by Rescuing FAK Phosphorylation in uPAR/Cathepsin B Down Regulated Meningioma	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; UROKINASE RECEPTOR; CELL INVASION; HEPATOCELLULAR-CARCINOMA; PLASMINOGEN-ACTIVATOR; SIGNALING PATHWAYS; DUCTAL CARCINOMA; GENE-EXPRESSION; PROTEIN-KINASE; TUMOR-GROWTH	Background: Meningiomas are the most commonly occurring intracranial tumors and account for approximately 15-20% of central nervous system tumors. Surgery and radiation therapy is a common treatment for brain tumors, however, patients whose tumors recur after such treatments have limited therapeutic options. Earlier studies have reported important roles of uPA, uPAR and cathepsin B in tumor progression. Methodology/Principal Findings: In the present study, we examined the therapeutic significance of RNAi-mediated simultaneous down regulation of these proteolytic networks using two bicistronic siRNA constructs, pUC (uPAR/cathepsin B) and pU2 (uPA/uPAR) either alone or in combination with radiation in two different meningioma cell lines. Transfection of meningioma cells with pUC and pU2 significantly reduced angiogenesis as compared to control treatment both in vitro and in vivo nude mice model. This effect is mediated by inhibiting angiogenic molecules (Ang-1, Ang-2 and VEGF). Expression of focal adhesion kinase (FAK) is elevated in malignant meningioma, yet the role of intrinsic FAK activity in promoting tumor progression remains undefined. We found that pUC treatment reduced FAK phosphorylation at Y925 more efficiently compared to pU2 treatment. In immunoprecipitation assay, we found pronounced reduction of FAK (Y925) interaction with Grb2 in meningioma cells transfected with pUC with and without irradiation. Transient over-expression of uPAR and cathepsin B by full length uPAR/cathepsin B (FLpU/C) in pUC transfected meningioma cells promoted vascular phenotype, rescued expression of Ang-1, Ang-2, VEGF, FAK (Y925) and Grb2 both in vitro and in vivo mice model. Conclusion/Significance: These studies provide the first direct proof that bicistronic siRNA construct for uPAR and cathepsin B (pUC) reduces Y925-FAK activity and this inhibition is rescued by overexpression of both uPAR and cathepsin B which clearly demonstrates that pUC could thus be a potential therapeutic approach as an anti-angiogenic agent in meningioma.	[Gupta, Reshu; Nalla, Arun Kumar; Gogineni, Venkateswara Rao; Chetty, Chandramu; Bhoopathi, Praveen; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Klopfenstein, Jeffrey D.; Tsung, Andrew J.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Gupta, R (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu	Nalla, Arun Kumar/D-1457-2012		National Institute of Neurological Disorders and Stroke (NINDS) [NS61835]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061835] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This research was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS), NS61835 (to J.S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberis L, 2000, J BIOL CHEM, V275, P36532, DOI 10.1074/jbc.M002487200; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bouterfa H, 1999, J NEURO-ONCOL, V44, P23, DOI 10.1023/A:1006331416283; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gond CS, 2007, INT J ONCOL, V31, P19; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Graham FL, 1991, METHOD MOL BIOL, P109; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hecker TP, 2003, FRONT BIOSCI-LANDMRK, V8, pS705, DOI 10.2741/1115; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kunigal S, 2008, CLIN CANCER RES, V14, P3617, DOI 10.1158/1078-0432.CCR-07-2060; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lee JS, 2001, ANAL QUANT CYTOL, V23, P161; LEUNIG M, 1992, CANCER RES, V52, P6553; Lightfoot HM, 2004, BREAST CANCER RES TR, V88, P109, DOI 10.1007/s10549-004-1022-8; Louis DN, 2000, PATHOLOGY GENETICS T, P176; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; RAO NK, 1995, J CLIN INVEST, V96, P465, DOI 10.1172/JCI118057; Recher C, 2004, CANCER RES, V64, P3191, DOI 10.1158/0008-5472.CAN-03-3005; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; SCHMITT M, 1992, BIOL CHEM H-S, V373, P611, DOI 10.1515/bchm3.1992.373.2.611; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Speake WJ, 2005, EJSO-EUR J SURG ONC, V31, P869, DOI 10.1016/j.ejso.2005.05.016; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17123	10.1371/journal.pone.0017123	http://dx.doi.org/10.1371/journal.pone.0017123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347260	gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500031
J	Biot, FV; Valade, E; Garnotel, E; Chevalier, J; Villard, C; Thibault, FM; Vidal, DR; Pages, JM				Biot, Fabrice V.; Valade, Eric; Garnotel, Eric; Chevalier, Jacqueline; Villard, Claude; Thibault, Francois M.; Vidal, Dominique R.; Pages, Jean-Marie			Involvement of the Efflux Pumps in Chloramphenicol Selected Strains of Burkholderia thailandensis: Proteomic and Mechanistic Evidence	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ENTEROBACTER-AEROGENES; ANTIBIOTIC SUSCEPTIBILITY; PSEUDOMONAS-PSEUDOMALLEI; MEMBRANE-PERMEABILITY; OUTER-MEMBRANE; ACTIVE EFFLUX; MAR MUTANTS; DRUG EFFLUX; BPEAB-OPRB	Burkholderia is a bacterial genus comprising several pathogenic species, including two species highly pathogenic for humans, B. pseudomallei and B. mallei. B. thailandensis is a weakly pathogenic species closely related to both B. pseudomallei and B. mallei. It is used as a study model. These bacteria are able to exhibit multiple resistance mechanisms towards various families of antibiotics. By sequentially plating B. thailandensis wild type strains on chloramphenicol we obtained several resistant variants. This chloramphenicol-induced resistance was associated with resistance against structurally unrelated antibiotics including quinolones and tetracyclines. We functionally and proteomically demonstrate that this multidrug resistance phenotype, identified in chloramphenicol-resistant variants, is associated with the overexpression of two different efflux pumps. These efflux pumps are able to expel antibiotics from several families, including chloramphenicol, quinolones, tetracyclines, trimethoprim and some beta-lactams, and present a partial susceptibility to efflux pump inhibitors. It is thus possible that Burkholderia species can develop such adaptive resistance mechanisms in response to antibiotic pressure resulting in emergence of multidrug resistant strains. Antibiotics known to easily induce overexpression of these efflux pumps should be used with discernment in the treatment of Burkholderia infections.	[Biot, Fabrice V.; Valade, Eric; Garnotel, Eric; Chevalier, Jacqueline; Thibault, Francois M.; Vidal, Dominique R.; Pages, Jean-Marie] Univ Mediterrane, IFR88, Fac Med & Pharm, UMR MD 1, Marseille, France; [Biot, Fabrice V.; Valade, Eric; Thibault, Francois M.; Vidal, Dominique R.] Inst Rech Biomed Armees, CRSSA, Unite Bacteriol, UMR MD 1, La Tronche, France; [Garnotel, Eric] Hop Instruct Armees Laveran, Marseille, France; [Villard, Claude] Univ Mediterrane, Fac Pharm, INSERM UMR 911 CRO2, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Biot, FV (corresponding author), Univ Mediterrane, IFR88, Fac Med & Pharm, UMR MD 1, Marseille, France.	evalade@crssa.net	PAGES, jean-marie/F-2555-2013	PAGES, jean-marie/0000-0001-7092-7977; BIOT, Fabrice/0000-0002-3632-2146; Villard, claude/0000-0002-6600-0762	Ministry of Defense [23e]; Universite de la Mediterranee	Ministry of Defense; Universite de la Mediterranee	This study was supported by the Ministry of Defense (Grant 23e) and by the Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornet C, 2003, BIOCHEM BIOPH RES CO, V301, P985, DOI 10.1016/S0006-291X(03)00074-3; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Chan YY, 2004, ANTIMICROB AGENTS CH, V48, P1128, DOI 10.1128/AAC.48.4.1128-1135.2004; Chaowagul W, 2005, ANTIMICROB AGENTS CH, V49, P4020, DOI 10.1128/AAC.49.10.4020-4025.2005; Chevalier J, 2004, ANTIMICROB AGENTS CH, V48, P1043, DOI 10.1128/AAC.48.3.1043-1046.2004; Chevalier J, 2010, INT J ANTIMICROB AG, V36, P164, DOI 10.1016/j.ijantimicag.2010.03.027; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Ghisalberti D, 2005, BIOCHEM BIOPH RES CO, V328, P1113, DOI 10.1016/j.bbrc.2005.01.069; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar Ayush, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS145, DOI 10.1016/S0035-9203(08)70032-4; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; Mamelli L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006443; MCMURRY LM, 1994, ANTIMICROB AGENTS CH, V38, P542, DOI 10.1128/AAC.38.3.542; MIMA T, 2010, J ANTIMICROB CH 1021; Mima T, 2010, ANTIMICROB AGENTS CH, V54, P3113, DOI 10.1128/AAC.01803-09; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Ong C, 2004, GENOME RES, V14, P2295, DOI 10.1101/gr.1608904; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Yoshihara E, 2009, FEMS MICROBIOL LETT, V299, P200, DOI 10.1111/j.1574-6968.2009.01752.x; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	39	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16892	10.1371/journal.pone.0016892	http://dx.doi.org/10.1371/journal.pone.0016892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347382	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700051
J	Graveland, H; Wagenaar, JA; Bergs, K; Heesterbeek, H; Heederik, D				Graveland, Haitske; Wagenaar, Jaap A.; Bergs, Kelly; Heesterbeek, Hans; Heederik, Dick			Persistence of Livestock Associated MRSA CC398 in Humans Is Dependent on Intensity of Animal Contact	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; NASAL CARRIAGE; RISK-FACTORS; COLONIZATION; DURATION; EPIDEMIOLOGY; INFECTION; ORIGIN; ST398	Introduction: The presence of Livestock Associated MRSA (LA-MRSA) in humans is associated with intensity of animal contact. It is unknown whether the presence of LA-MRSA is a result of carriage or retention of MRSA-contaminated dust. We conducted a longitudinal study among 155 veal farmers in which repeated nasal and throat swabs were taken for MRSA detection. Periods with and without animal exposure were covered. Methods: Randomly, 51 veal calf farms were visited from June - December 2008. Participants were asked to fill in questionnaires (n = 155) to identify potential risk factors for MRSA colonisation. Nasal and throat swabs were repeatedly taken from each participant for approximately 2 months. Swabs were analysed for MRSA and MSSA by selective bacteriological culturing. Spa-types of the isolates were identified and a ST398 specific PCR was performed. Data were analyzed using generalized estimation equations (GEE) to allow for correlated observations within individuals. Results: Mean MRSA prevalence was 38% in farmers and 16% in family members. Presence of MRSA in farmers was strongly related to duration of animal contact and was strongly reduced in periods with absence of animal contact (258%). Family members, especially children, were more often carriers when the farmer was a carrier (OR = 2, P<0.05). Only 7% (n = 11) of the participants appeared to be persistent carriers. A large heterogeneity in spa-types was detected, however 92.7% belonged to LA-MRSA CC398. A surprisingly high fraction of the spa-types (7.3%) did not belong to CC398. Conclusion: The presence of LA-MRSA in farmers is strongly animal-exposure related. The rapidly decreasing MRSA prevalence during absence of animal contact suggests that LA-MRSA is a poor persistent colonizer in most humans. These results are of relevance for MRSA control strategies.	[Graveland, Haitske; Bergs, Kelly; Heederik, Dick] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Graveland, Haitske; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Graveland, Haitske; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Heederik, Dick] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Graveland, H (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	h.graveland@uu.nl		Heederik, Dick/0000-0002-4550-1437; Heesterbeek, Hans/0000-0001-8537-6418	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality	Dutch Product Boards for Livestock, Meat and Eggs; Dutch Ministry of Agriculture, Nature and Food Quality	The study was supported by the Dutch Product Boards for Livestock, Meat and Eggs and the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; EHRENKRANTZ NJ, 1964, NEW ENGL J MED, V271, P225, DOI 10.1056/NEJM196407302710503; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Hamscher G, 2003, ENVIRON HEALTH PERSP, V111, P1590, DOI 10.1289/ehp.6288; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; MacKinnon MM, 2000, J HOSP INFECT, V46, P216, DOI [10.1053/jhin.2000.0807, 10.1016/S0195-6701(00)90807-7]; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Portengen L, 2005, J ALLERGY CLIN IMMUN, V115, P797, DOI 10.1016/j.jaci.2004.11.046; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; SANFORD MD, 1994, CLIN INFECT DIS, V19, P1123, DOI 10.1093/clinids/19.6.1123; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van den Broek IVF, 2008, EPIDEMIOL INFECT, V24, P1; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen MML, 2009, J HOSP INFECT, V72, P299, DOI 10.1016/j.jhin.2009.05.006; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Trijp MJCA, 2007, INFECT CONT HOSP EP, V28, P970, DOI 10.1086/519210; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Wertheim HFL, 2005, CRIT CARE, V9, P257, DOI 10.1186/cc3720; Wilson RD, 2004, ANAESTH INTENS CARE, V32, P202, DOI 10.1177/0310057X0403200207	35	143	144	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16830	10.1371/journal.pone.0016830	http://dx.doi.org/10.1371/journal.pone.0016830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347386	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700039
J	Kiialainen, A; Karlberg, O; Ahlford, A; Sigurdsson, S; Lindblad-Toh, K; Syvanen, AC				Kiialainen, Anna; Karlberg, Olof; Ahlford, Annika; Sigurdsson, Snaevar; Lindblad-Toh, Kerstin; Syvanen, Ann-Christine			Performance of Microarray and Liquid Based Capture Methods for Target Enrichment for Massively Parallel Sequencing and SNP Discovery	PLOS ONE			English	Article							GENOMIC SELECTION; MUTATIONS; GENE; AMPLIFICATION; HYBRIDIZATION	Targeted sequencing is a cost-efficient way to obtain answers to biological questions in many projects, but the choice of the enrichment method to use can be difficult. In this study we compared two hybridization methods for target enrichment for massively parallel sequencing and single nucleotide polymorphism (SNP) discovery, namely Nimblegen sequence capture arrays and the SureSelect liquid-based hybrid capture system. We prepared sequencing libraries from three HapMap samples using both methods, sequenced the libraries on the Illumina Genome Analyzer, mapped the sequencing reads back to the genome, and called variants in the sequences. 74-75% of the sequence reads originated from the targeted region in the SureSelect libraries and 41-67% in the Nimblegen libraries. We could sequence up to 99.9% and 99.5% of the regions targeted by capture probes from the SureSelect libraries and from the Nimblegen libraries, respectively. The Nimblegen probes covered 0.6 Mb more of the original 3.1 Mb target region than the SureSelect probes. In each sample, we called more SNPs and detected more novel SNPs from the libraries that were prepared using the Nimblegen method. Thus the Nimblegen method gave better results when judged by the number of SNPs called, but this came at the cost of more over-sampling.	[Kiialainen, Anna; Karlberg, Olof; Ahlford, Annika; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sigurdsson, Snaevar; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Sigurdsson, Snaevar; Lindblad-Toh, Kerstin] Harvard & Massachusetts Inst Technol MIT, Broad Inst, Cambridge, MA USA	Uppsala University; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kiialainen, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	anna.kiialainen@medsci.uu.se		Sigurdsson, Snaevar/0000-0003-4860-6311	European Community [FP7/2007-2013, HEALTH-F4-2007-201413]; Nordic Centre of Excellence in Disease Genetics; Nordic Sequencing Infrastructure; Swedish Research Council for Science and Technology [2009-5594]; Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation	European Community(European Commission); Nordic Centre of Excellence in Disease Genetics; Nordic Sequencing Infrastructure; Swedish Research Council for Science and Technology(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation	This research was supported through funds from The European Community's Seventh Framework Programme [FP7/2007-2013, ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413] (AK, A-CS); the Nordic Centre of Excellence in Disease Genetics (AK); The Nordic Sequencing Infrastructure (KL-T, A-CS); The Swedish Research Council for Science and Technology [2009-5594] (A-CS); the Knut and Alice Wallenberg Foundation (A-CS); and the Swedish Cancer Foundation (A-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET; Dahl F, 2007, P NATL ACAD SCI USA, V104, P9387, DOI 10.1073/pnas.0702165104; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fredriksson S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm078; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herman DS, 2009, NAT METHODS, V6, P507, DOI 10.1038/nmeth.1343; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; JOHANSSON H, 2010, NUCL ACIDS RES; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; LOVETT M, 2001, CURR PROTOC HUM GENE, pCH6; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; SUMMERER D, 2010, GENOMICS; TEER JK, 2010, GENOME RES; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	41	17	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16486	10.1371/journal.pone.0016486	http://dx.doi.org/10.1371/journal.pone.0016486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347407	gold, Green Published			2022-12-27	WOS:000287361700017
J	Liew, SH; Sarraj, MA; Drummond, AE; Findlay, JK				Liew, Seng H.; Sarraj, Mai A.; Drummond, Ann E.; Findlay, Jock K.			Estrogen-Dependent Gene Expression in the Mouse Ovary	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; DEFICIENT ARKO MICE; GRANULOSA-CELLS; TARGETED DISRUPTION; RECEPTOR-BETA; RODENT OVARY; PHENOTYPE; OOCYTE; TESTIS; DIFFERENTIATION	Estrogen (E) plays a pivotal role in regulating the female reproductive system, particularly the ovary. However, the number and type of ovarian genes influenced by estrogen remain to be fully elucidated. In this study, we have utilized wild-type (WT) and aromatase knockout (ArKO; estrogen free) mouse ovaries as an in vivo model to profile estrogen dependent genes. RNA from each individual ovary (n = 3) was analyzed by a microarray-based screen using Illumina Sentrix Mouse WG-6 BeadChip (45,281 transcripts). Comparative analysis (GeneSpring) showed differential expression profiles of 450 genes influenced by E, with 291 genes up-regulated and 159 down-regulated by 2-fold or greater in the ArKO ovary compared to WT. Genes previously reported to be E regulated in ArKO ovaries were confirmed, in addition to novel genes not previously reported to be expressed or regulated by E in the ovary. Of genes involved in 5 diverse functional processes (hormonal processes, reproduction, sex differentiation and determination, apoptosis and cellular processes) 78 had estrogen-responsive elements (ERE). These analyses define the transcriptome regulated by E in the mouse ovary. Further analysis and investigation will increase our knowledge pertaining to how E influences follicular development and other ovarian functions.	[Liew, Seng H.; Sarraj, Mai A.; Drummond, Ann E.; Findlay, Jock K.] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Liew, Seng H.; Findlay, Jock K.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Liew, SH (corresponding author), Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	Jason.liew@princehenrys.org	Liew, Seng/G-8432-2011	Liew, Seng Hii/0000-0001-5514-9871; Sarraj, Mai/0000-0001-9891-8159; Drummond, Ann/0000-0002-2183-6013	National Health and Medical Research Council of Australia [Regkeys 494802, 441101]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The financial support of the National Health and Medical Research Council of Australia (Regkeys 494802 and 441101) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3605, DOI 10.1093/nar/gkg517; BRANNSTROM M, 1993, BIOL REPROD, V48, P277, DOI 10.1095/biolreprod48.2.277; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Britt KL, 2002, FASEB J, V16, P1389, DOI 10.1096/fj.01-0992com; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Britt KL, 2004, ENDOCRINOLOGY, V145, P3950, DOI 10.1210/en.2003-1628; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Charpentier AH, 2000, CANCER RES, V60, P5977; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; Constam DB, 2000, GENE DEV, V14, P1146; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Drake JM, 2003, APOPTOSIS, V8, P389, DOI 10.1023/A:1024181203729; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; LIEW SH, 2010, MOL CELL ENDOCRINOL; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Praz V, 2002, NUCLEIC ACIDS RES, V30, P322, DOI 10.1093/nar/30.1.322; Ren Y, 2009, MOL ENDOCRINOL, V23, P711, DOI 10.1210/me.2008-0391; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Russell MC, 2007, BIOL REPROD, V77, P226, DOI 10.1095/biolreprod.106.053629; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wang C, 2009, J LIPID RES, V50, P2164, DOI 10.1194/jlr.M800533-JLR200; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311; WU TCJ, 1992, MOL REPROD DEV, V33, P407, DOI 10.1002/mrd.1080330406; Zachos NC, 2002, BIOL REPROD, V67, P1148, DOI 10.1095/biolreprod67.4.1148; Zhang H, 2009, MOL REPROD DEV, V76, P514, DOI 10.1002/mrd.20973	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14672	10.1371/journal.pone.0014672	http://dx.doi.org/10.1371/journal.pone.0014672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347412	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700006
J	Salmela, E; Lappalainen, T; Liu, JJ; Sistonen, P; Andersen, PM; Schreiber, S; Savontaus, ML; Czene, K; Lahermo, P; Hall, P; Kere, J				Salmela, Elina; Lappalainen, Tuuli; Liu, Jianjun; Sistonen, Pertti; Andersen, Peter M.; Schreiber, Stefan; Savontaus, Marja-Liisa; Czene, Kamila; Lahermo, Paivi; Hall, Per; Kere, Juha			Swedish Population Substructure Revealed by Genome-Wide Single Nucleotide Polymorphism Data	PLOS ONE			English	Article							PATTERNS; ASSOCIATION; SWEDEN; LIBRARY; PACKAGE; COMMON; LOCI	The use of genome-wide single nucleotide polymorphism (SNP) data has recently proven useful in the study of human population structure. We have studied the internal genetic structure of the Swedish population using more than 350,000 SNPs from 1525 Swedes from all over the country genotyped on the Illumina HumanHap550 array. We have also compared them to 3212 worldwide reference samples, including Finns, northern Germans, British and Russians, based on the more than 29,000 SNPs that overlap between the Illumina and Affymetrix 250K Sty arrays. The Swedes - especially southern Swedes - were genetically close to the Germans and British, while their genetic distance to Finns was substantially longer. The overall structure within Sweden appeared clinal, and the substructure in the southern and middle parts was subtle. In contrast, the northern part of Sweden, Norrland, exhibited pronounced genetic differences both within the area and relative to the rest of the country. These distinctive genetic features of Norrland probably result mainly from isolation by distance and genetic drift caused by low population density. The internal structure within Sweden (F-ST = 0.0005 between provinces) was stronger than that in many Central European populations, although smaller than what has been observed for instance in Finland; importantly, it is of the magnitude that may hamper association studies with a moderate number of markers if cases and controls are not properly matched geographically. Overall, our results underline the potential of genome-wide data in analyzing substructure in populations that might otherwise appear relatively homogeneous, such as the Swedes.	[Salmela, Elina; Lappalainen, Tuuli; Lahermo, Paivi] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Salmela, Elina; Lappalainen, Tuuli; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salmela, Elina; Lappalainen, Tuuli; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Lappalainen, Tuuli] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Sistonen, Pertti] Finnish Red Cross Blood Transfus Serv, Helsinki, Finland; [Andersen, Peter M.] Umea Univ, Dept Neurol, Umea Univ Hosp, S-90187 Umea, Sweden; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Dept Gen Internal Med, Kiel, Germany; [Savontaus, Marja-Liisa] Univ Turku, Dept Med Genet, Turku, Finland; [Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kere, Juha] Karolinska Univ Hosp, Clin Res Ctr, Huddinge, Sweden	University of Helsinki; University of Helsinki; University of Geneva; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Umea University; University of Kiel; University of Turku; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Salmela, E (corresponding author), Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland.	juha.kere@ki.se	Liu, Jianjun/AAK-4989-2020; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Lappalainen, Tuuli/AAE-6532-2020	Liu, Jianjun/0000-0002-3255-3019; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Lappalainen, Tuuli/0000-0002-7746-8109; Czene, Kamila/0000-0002-3233-5695; Salmela, Elina/0000-0003-1326-4462	Sigrid Juselius Foundation; Emil Aaltonen foundation; Academy of Finland; Research Foundation of the University of Helsinki; Swedish Research Council; National Genome Research Network through the German Ministry of Education and Science; popgen biobank through the German Ministry of Education and Science; DFG; National Institutes of Health [R01 CA104021-05]; Agency for Science, Technology and Research (A*STAR); Wellcome Trust [076113]; NATIONAL CANCER INSTITUTE [R01CA104021] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen foundation; Academy of Finland(Academy of Finland); Research Foundation of the University of Helsinki; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Genome Research Network through the German Ministry of Education and Science; popgen biobank through the German Ministry of Education and Science; DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sigrid Juselius Foundation (http://www.sigridjuselius.fi) (ES, TL, JK), Emil Aaltonen foundation (http://www.emilaaltonen.fi) (TL, PL), Academy of Finland (http://www.aka.fi/fi/A/) (TL, JK), Research Foundation of the University of Helsinki (http://www.helsinki.fi/tiedesaatio/index.htm) (TL), Swedish Research Council (http://www.vr.se) (JK), National Genome Research Network (NGFN; http://www.ngfn.de) and the popgen biobank (http://www.popgen.de), both through the German Ministry of Education and Science (SS), DFG excellence cluster "inflammation at interfaces" (SS), National Institutes of Health (http://www.nih.gov) grant number R01 CA104021-05 (KC, PH), Agency for Science, Technology and Research (A*STAR) (JL, KC, PH). Funding for the WTCCC project was provided by the Wellcome Trust (http://www.wellcome.ac.uk/) under award 076113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Einarsdottir E, 2007, HEREDITAS, V144, P171, DOI 10.1111/j.2007.0018-0661.02007.x; Einarsdottir K, 2006, PLOS MED, V3, P895, DOI 10.1371/journal.pmed.0030168; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINDKVIST T, 2003, CAMBRIDGE HIST SCAND; LINDQVIST H, 2006, HIST SWEDEN; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Myhre Bjorn, 2003, CAMBRIDGE HIST SCAND, P60; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P274, DOI 10.1038/nature07566; Nychka D., 2007, FIELDS TOOLS SPATIAL; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Pitkanen K., 2007, SUOMEN VAESTO, P41; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; SIIRIAINEN A, 2003, CAMBRIDGE HIST SCAND; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; VIRTARANTAKNOWLES K, 1991, HUM HERED, V41, P248, DOI 10.1159/000154009	41	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16747	10.1371/journal.pone.0016747	http://dx.doi.org/10.1371/journal.pone.0016747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347369	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700031
J	Kiparissides, A; Koutinas, M; Moss, T; Newman, J; Pistikopoulos, EN; Mantalaris, A				Kiparissides, Alexandros; Koutinas, Michalis; Moss, Toby; Newman, John; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios			Modelling the Delta1/Notch1 Pathway: In Search of the Mediator(s) of Neural Stem Cell Differentiation	PLOS ONE			English	Article							PROMOTES NEURONAL DIFFERENTIATION; FEEDBACK LOOP; OSCILLATORY EXPRESSION; NEGATIVE REGULATION; LATERAL INHIBITION; NERVOUS-SYSTEM; TIME DELAYS; P19 CELLS; NOTCH; HES1	The Notch1 signalling pathway has been shown to control neural stem cell fate through lateral inhibition of mash1, a key promoter of neuronal differentiation. Interaction between the Delta1 ligand of a differentiating cell and the Notch1 protein of a neighbouring cell results in cleavage of the trans-membrane protein, releasing the intracellular domain (NICD) leading to the up regulation of hes1. Hes1 homodimerisation leads to down regulation of mash1. Most mathematical models currently represent this pathway up to the formation of the HES1 dimer. Herein, we present a detailed model ranging from the cleavage of the NICD and how this signal propagates through the Delta1/Notch1 pathway to repress the expression of the proneural genes. Consistent with the current literature, we assume that cells at the self renewal state are represented by a stable limit cycle and through in silico experimentation we conclude that a drastic change in the main pathway is required in order for the transition from self-renewal to differentiation to take place. Specifically, a model analysis based approach is utilised in order to generate hypotheses regarding potential mediators of this change. Through this process of model based hypotheses generation and testing, the degradation rates of Hes1 and Mash1 mRNA and the dissociation constant of Mash1-E47 heterodimers are identified as the most potent mediators of the transition towards neural differentiation.	[Kiparissides, Alexandros; Koutinas, Michalis; Moss, Toby; Newman, John; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Biol Syst Engn Lab, Ctr Proc Syst Engn, London SW7 2AZ, England	Imperial College London	Kiparissides, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Biol Syst Engn Lab, Ctr Proc Syst Engn, London SW7 2AZ, England.	a.mantalaris@imperial.ac.uk	Koutinas, Michalis/D-9515-2016; Kiparissides, Alexandros/N-4970-2014; Kiparissides, Alexandros/ABH-5729-2020	Koutinas, Michalis/0000-0002-5371-4280; Kiparissides, Alexandros/0000-0003-2923-2481; Kiparissides, Alexandros/0000-0003-2923-2481; Pistikopoulos, Stratos/0000-0001-6220-818X	European Union [029104]	European Union(European Commission)	This work was supported by the European Union with the following projects: a) PROBACTYS (FP6 - NEST-PATHFINDER EU call on Synthetic Biology, Project Number 029104), b) PSYSMO (BBSRC - ERA-NET program on the Systems Biology of Microorganisms) and c) TARPOL (FP7 EU - KBBE Coordination Action for SynBio in Environmental Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bae SK, 2000, DEVELOPMENT, V127, P2933; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BRATLEY P, 1988, ACM T MATH SOFTWARE, V14, P88, DOI 10.1145/42288.214372; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cossins J, 2002, DEVELOPMENT, V129, P2195; Dai JP, 2010, J CELL BIOCHEM, V110, P1457, DOI 10.1002/jcb.22703; Eun B, 2010, BRAIN RES, V1313, P1, DOI 10.1016/j.brainres.2009.11.078; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; FOX BL, 1986, ACM T MATH SOFTWARE, V12, P362, DOI 10.1145/22721.356187; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Jensen MH, 2003, FEBS LETT, V541, P176, DOI 10.1016/S0014-5793(03)00279-5; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kato H, 1997, DEVELOPMENT, V124, P4133; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kocis L, 1997, ACM T MATH SOFTWARE, V23, P266, DOI 10.1145/264029.264064; KONTORAVDI C, 2010, COMPUTERS C IN PRESS; Koutinas M, 2010, ENVIRON MICROBIOL, V12, P1705, DOI 10.1111/j.1462-2920.2010.02245.x; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Lam MC, 2009, THESIS IMPERIAL COLL; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Momiji H, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021930; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; MOROKOFF WJ, 1993, SIAM J NUMER ANAL, V30, P1558, DOI 10.1137/0730081; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Sobol I.M., 1967, USSR COMP MATH MATH, V7, P86, DOI [DOI 10.1016/0041-5553(67)90144-9, 10.1016/0041-5553(67)90144-9]; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Veflingstad SR, 2005, PHYSICA D, V207, P254, DOI 10.1016/j.physd.2005.06.006; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zeiser S, 2007, J COMPUT BIOL, V14, P984, DOI 10.1089/cmb.2007.0029	51	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14668	10.1371/journal.pone.0014668	http://dx.doi.org/10.1371/journal.pone.0014668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346804	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600004
J	Wong, CM; Wong, CCL; Ng, YL; Au, SLK; Ko, FCF; Ng, IOL				Wong, Chun-Ming; Wong, Carmen Chak-Lui; Ng, Yeung-Lam; Au, Sandy Leung-Kuen; Ko, Frankie Chi-Fat; Ng, Irene Oi-Lin			Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery	PLOS ONE			English	Article							HUMAN CANCER-CELLS; TUMOR-SUPPRESSOR GENES; DE-NOVO METHYLATION; IN-VIVO ACTIVITY; HISTONE H3; HEPATOCELLULAR-CARCINOMA; EPIGENETIC THERAPY; NEUROSPORA-CRASSA; HUMAN-DISEASE; CPG ISLANDS	DNA methylation and histone modifications are two major epigenetic events regulating gene expression and chromatin structure, and their alterations are linked to human carcinogenesis. DNA methylation plays an important role in tumor suppressor gene inactivation, and can be revised by DNA methylation inhibitors. The reversible nature of DNA methylation forms the basis of epigenetic cancer therapy. However, it has been reported that DNA re-methylation and gene re-silencing could occur after removal of demethylation treatment and this may significantly hamper the therapeutic value of DNA methylation inhibitors. In this study we have provided detailed evidence demonstrating that mammalian cells possess a bona fide DNA methylation recovery system. We have also shown that DNA methylation recovery was mediated by the major human DNA methyltransferase, DNMT1. In addition, we found that H3K9-tri-methylation and H3K27-tri-methylation were closely associated with this DNA methylation recovery. These persistent transcriptional repressive histone modifications may have a crucial role in regulating DNMT1-mediated DNA methylation recovery. Our findings may have important implications towards a better understanding of epigenetic regulation and future development of epigenetic therapeutic intervention.	[Wong, Chun-Ming] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Pathol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CM (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	iolng@hku.hk	WONG, Chun-Ming/A-6739-2009; Ko, Frankie Chi Fat/C-4759-2009; Wong, Carmen Chak Lui/C-4660-2009	WONG, Chun-Ming/0000-0002-2497-7858; Ko, Frankie Chi Fat/0000-0002-0393-9668; Wong, Carmen Chak Lui/0000-0001-5866-4705; Ng, Irene Oi-lin/0000-0001-7532-2029	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRG/09]; Michael and Betty Kadoorie Cancer Genetics Research Program	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Michael and Betty Kadoorie Cancer Genetics Research Program	The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09) and Michael and Betty Kadoorie Cancer Genetics Research Program 2004. I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CM, 1999, MOL CELL BIOL, V19, P6690; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Fahrner JA, 2002, CANCER RES, V62, P7213; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Isham CR, 2007, BLOOD, V109, P2579, DOI 10.1182/blood-2006-07-027326; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; ISSA JP, 2005, NAT REV DRUG DISCO S, pS6, DOI DOI 10.1038/NRD1726; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagey JD, 2010, MOL CANCER RES, V8, P1048, DOI 10.1158/1541-7786.MCR-10-0189; Liu ZF, 2006, RAPID COMMUN MASS SP, V20, P1117, DOI 10.1002/rcm.2423; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rudek MA, 2005, J CLIN ONCOL, V23, P3906, DOI 10.1200/JCO.2005.07.450; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Si J, 2010, CANCER RES, V70, P6968, DOI 10.1158/0008-5472.CAN-09-4474; SPADA F, 2002, CANCER RES, V62, P7213; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Velicescu M, 2002, CANCER RES, V62, P2378; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong CCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002779; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Wong CM, 2003, CANCER RES, V63, P7646; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	46	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16702	10.1371/journal.pone.0016702	http://dx.doi.org/10.1371/journal.pone.0016702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347439	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600020
J	Gad, GF; Mohamed, HA; Ashour, HM				Gad, Gamal F.; Mohamed, Heba A.; Ashour, Hossam M.			Aminoglycoside Resistance Rates, Phenotypes, and Mechanisms of Gram-Negative Bacteria from Infected Patients in Upper Egypt	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTICS; COMBINATION; PREVALENCE; THERAPY; MEXXY; MONOTHERAPY; ENZYMES	With the re-emergence of older antibiotics as valuable choices for treatment of serious infections, we studied the aminoglycoside resistance of Gram-negative bacteria isolated from patients with ear, urinary tract, skin, and gastrointestinal tract infections at Minia university hospital in Egypt. Escherichia coli (mainly from urinary tract and gastrointestinal tract infections) was the most prevalent isolate (28.57%), followed by Pseudomonas aeruginosa (25.7%) (mainly from ear discharge and skin infections). Isolates exhibited maximal resistance against streptomycin (83.4%), and minimal resistance against amikacin (17.7%) and intermediate degrees of resistance against neomycin, kanamycin, gentamicin, and tobramycin. Resistance to older aminoglycosides was higher than newer aminoglycoides. The most common aminoglycoside resistance phenotype was that of streptomycin resistance, present as a single phenotype or in combination, followed by kanamycin-neomycin as determined by interpretative reading. The resistant Pseudomonas aeruginosa strains were capable of producing aminoglycoside-modifying enzymes and using efflux as mechanisms of resistance. Using checkerboard titration method, the most frequently-observed outcome in combinations of aminoglycosides with beta-lactams or quinolones was synergism. The most effective combination was amikacin with ciprofloxacin (100% Synergism), whereas the least effective combination was gentamicin with amoxicillin (53.3% Synergistic, 26.7% additive, and 20% indifferent FIC indices). Whereas the studied combinations were additive and indifferent against few of the tested strains, antagonism was never observed. The high resistance rates to aminoglycosides exhibited by Gram-negative bacteria in this study could be attributed to the selective pressure of aminoglycoside usage which could be controlled by successful implementation of infection control measures.	[Gad, Gamal F.; Mohamed, Heba A.] Menia Univ, Dept Microbiol & Immunol, Fac Pharm, Al Minya, Egypt; [Ashour, Hossam M.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [Ashour, Hossam M.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA	Egyptian Knowledge Bank (EKB); Minia University; Egyptian Knowledge Bank (EKB); Cairo University; Wayne State University	Gad, GF (corresponding author), Menia Univ, Dept Microbiol & Immunol, Fac Pharm, Al Minya, Egypt.	hossam@wayne.edu		Ashour, Hossam/0000-0002-1256-7368				Abd-El-Haleem D, 2003, J ENVIRON MONITOR, V5, P865, DOI 10.1039/b307476e; Beauchamp D, 2007, ADV DRUG DELIVER REV, V59, P896, DOI 10.1016/j.addr.2006.07.028; BENVENISTE R, 1971, FEBS LETT, V14, P293, DOI 10.1016/0014-5793(71)80282-X; Cirioni O, 2007, PEPTIDES, V28, P747, DOI 10.1016/j.peptides.2007.01.001; Clinical and Laboratory Standards Institute (CLSI), 2007, M100S15 CLSI; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Drusano GL, 2007, CLIN INFECT DIS, V45, P753, DOI 10.1086/520991; Falagas ME, 2008, EXPERT REV ANTI-INFE, V6, P593, DOI 10.1586/14787210.6.5.593; Falagas ME, 2007, CURR OPIN CRIT CARE, V13, P592, DOI 10.1097/MCC.0b013e32827851d7; FOSSE T, 1983, PATHOL BIOL, V31, P483; Freundlich M, 2007, J ANTIMICROB CHEMOTH, V60, P1115, DOI 10.1093/jac/dkm354; Gad GF, 2008, J UROLOGY, V180, P176, DOI 10.1016/j.juro.2008.03.081; Gad GF, 2007, J ANTIMICROB CHEMOTH, V60, P1010, DOI 10.1093/jac/dkm348; GIAMARELLOU H, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90490-0; Goldin AB, 2007, PEDIATRICS, V119, P905, DOI 10.1542/peds.2006-2040; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1371, DOI 10.1128/AAC.47.4.1371-1375.2003; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Leibovici L, 2007, J ANTIMICROB CHEMOTH, V60, P911, DOI 10.1093/jac/dkm377; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V48, P87, DOI 10.1093/jac/48.suppl_1.87; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lorian V., 2005, ANTIBIOTICS LAB MED; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Neonakis I, 2003, INT J ANTIMICROB AG, V22, P526, DOI 10.1016/S0924-8579(03)00152-3; Over U, 2001, CLIN MICROBIOL INFEC, V7, P470, DOI 10.1046/j.1198-743x.2001.00284.x; Paul M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003344.pub2; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Schmitz FJ, 1999, EUR J CLIN MICROBIOL, V18, P414, DOI 10.1007/s100960050310; Shahid M, 2005, INDIAN J MED RES, V122, P324; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Tsai Tung-Yuan, 2007, Journal of Microbiology Immunology and Infection, V40, P481; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004	36	37	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17224	10.1371/journal.pone.0017224	http://dx.doi.org/10.1371/journal.pone.0017224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359143	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300041
J	Caetano, C; Klier, S; de Bruin, RAM				Caetano, Catia; Klier, Steffi; de Bruin, Robertus A. M.			Phosphorylation of the MBF Repressor Yox1p by the DNA Replication Checkpoint Keeps the G1/S Cell-Cycle Transcriptional Program Active	PLOS ONE			English	Article							FISSION YEAST	Background: In fission yeast Schizosaccharomyces pombe G1/S cell-cycle regulated transcription depends upon MBF. A negative feedback loop involving Nrm1p and Yox1p bound to MBF leads to transcriptional repression as cells exit G1 phase. However, activation of the DNA replication checkpoint response during S phase results in persistent expression of MBF-dependent genes. Methodology/Principal Findings: This report shows that Yox1p binding to MBF is Nrm1-dependent and that Yox1p and Nrm1p require each other to bind and repress MBF targets. In response to DNA replication stress both Yox1p and Nrm1p dissociate from MBF at promoters leading to de-repression of MBF targets. Inactivation of Yox1p is an essential part of the checkpoint response. Cds1p (human Chk2p) checkpoint protein kinase-dependent phosphorylation of Yox1p promotes its dissociation from the MBF transcription factor. We establish that phosphorylation of Yox1p at Ser114, Thr115 is required for maximal checkpoint-dependent activation of the G1/S cell-cycle transcriptional program. Conclusions/Significance: This study shows that checkpoint-dependent phosphorylation of Yox1p at Ser114, Thr115 results in de-repression of the MBF transcriptional program. The remodeling of the cell cycle transcriptional program by the DNA replication checkpoint is likely to comprise an important mechanism for the avoidance of genomic instability.	[Caetano, Catia; Klier, Steffi; de Bruin, Robertus A. M.] UCL, MRC Lab Mol Cell Biol, London, England	MRC Laboratory Molecular Biology; University of London; University College London	Caetano, C (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.	r.debruin@ucl.ac.uk			MRC	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the MRC (http://www.mrc.ac.uk/index.htm). R.A.M. de Bruin is a recipient of an MRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; AYTE J, 1995, MOL CELL BIOL, V15, P2589; Baum B, 1997, EMBO J, V16, P4676, DOI 10.1093/emboj/16.15.4676; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; CALIGIURI M, 1993, CELL, V72, P607, DOI 10.1016/0092-8674(93)90079-6; Chu Z, 2009, MOL CELLULAR BIOL; Chu ZQ, 2007, MOL BIOL CELL, V18, P1756, DOI 10.1091/mbc.E06-10-0928; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; Dutta C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006944; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; NAKASHIMA N, 1995, EMBO J, V14, P4794, DOI 10.1002/j.1460-2075.1995.tb00161.x; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Rhind N, 2000, J CELL SCI, V113, P3889; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Tahara S, 1998, MOL BIOL CELL, V9, P1577, DOI 10.1091/mbc.9.6.1577; TANAKA K, 1992, EMBO J, V11, P4923, DOI 10.1002/j.1460-2075.1992.tb05599.x; Whitehall S, 1999, MOL BIOL CELL, V10, P3705, DOI 10.1091/mbc.10.11.3705; Zhu Y, 1997, EMBO J, V16, P1023, DOI 10.1093/emboj/16.5.1023	34	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17211	10.1371/journal.pone.0017211	http://dx.doi.org/10.1371/journal.pone.0017211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359180	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700060
J	Lehmann, LE; Hauser, S; Malinka, T; Klaschik, S; Weber, SU; Schewe, JC; Stuber, F; Book, M				Lehmann, Lutz E.; Hauser, Stefan; Malinka, Thomas; Klaschik, Sven; Weber, Stefan U.; Schewe, Jens-Christian; Stueber, Frank; Book, Malte			Rapid Qualitative Urinary Tract Infection Pathogen Identification by SeptiFast (R) Real-Time PCR	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SALMONELLA SPP.; DIAGNOSIS; BACTERIAL; ASSAY; DIFFERENTIATION; QUANTIFICATION; SUSCEPTIBILITY; THERAPY	Background: Urinary tract infections (UTI) are frequent in outpatients. Fast pathogen identification is mandatory for shortening the time of discomfort and preventing serious complications. Urine culture needs up to 48 hours until pathogen identification. Consequently, the initial antibiotic regimen is empirical. Aim: To evaluate the feasibility of qualitative urine pathogen identification by a commercially available real-time PCR blood pathogen test (SeptiFast (R)) and to compare the results with dipslide and microbiological culture. Design of study: Pilot study with prospectively collected urine samples. Setting: University hospital. Methods: 82 prospectively collected urine samples from 81 patients with suspected UTI were included. Dipslide urine culture was followed by microbiological pathogen identification in dipslide positive samples. In parallel, qualitative DNA based pathogen identification (SeptiFast (R)) was performed in all samples. Results: 61 samples were SeptiFast (R) positive, whereas 67 samples were dipslide culture positive. The inter-methodological concordance of positive and negative findings in the gram+, gram-and fungi sector was 371/410 (90%), 477/492 (97%) and 238/246 (97%), respectively. Sensitivity and specificity of the SeptiFast (R) test for the detection of an infection was 0.82 and 0.60, respectively. SeptiFast (R) pathogen identifications were available at least 43 hours prior to culture results. Conclusion: The SeptiFast (R) platform identified bacterial DNA in urine specimens considerably faster compared to conventional culture. For UTI diagnosis sensitivity and specificity is limited by its present qualitative setup which does not allow pathogen quantification. Future quantitative assays may hold promise for PCR based UTI pathogen identification as a supplementation of conventional culture methods.	[Lehmann, Lutz E.; Stueber, Frank; Book, Malte] Univ Bern, Inselspital, Univ Dept Anaesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Hauser, Stefan] Univ Hosp Bonn, Clin & Policlin Urol, Bonn, Germany; [Malinka, Thomas] Kantonsspital Aarau AG, Dept Surg, Aarau, Switzerland; [Klaschik, Sven; Weber, Stefan U.; Schewe, Jens-Christian] Univ Hosp Bonn, Univ Dept Anaesthesiol & Intens Care Med, Bonn, Germany	University of Bern; University Hospital of Bern; University of Bonn; Kantonsspital Aarau AG (KSA); University of Bonn	Lehmann, LE (corresponding author), Univ Bern, Inselspital, Univ Dept Anaesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	malte.book@dkf.unibe.ch	Weber, Stefan U/J-8879-2017	Weber, Stefan U/0000-0001-7964-0411; Malinka, Thomas/0000-0002-5860-5710				Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; Botezatu I, 2000, CLIN CHEM, V46, P1078; Chen FH, 2004, PEDIAT ALLERG IMM-UK, V15, P210, DOI 10.1111/j.1399-3038.2004.00131.x; Cheng CM, 2008, J FOOD PROTECT, V71, P2436, DOI 10.4315/0362-028X-71.12.2436; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Elhanan G, 1997, J INFECTION, V35, P283, DOI 10.1016/S0163-4453(97)93194-7; Grude N, 2001, CLIN MICROBIOL INFEC, V7, P543, DOI 10.1046/j.1198-743x.2001.00306.x; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Hinata Nobuyuki, 2004, Mol Diagn, V8, P179, DOI 10.2165/00066982-200408030-00006; Kahlmeter G, 2003, INT J ANTIMICROB AG, V22, pS49, DOI 10.1016/S0924-8579(03)00229-2; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; KASS EH, 1957, ARCH INTERN MED, V100, P709, DOI 10.1001/archinte.1957.00260110025004; Kouri T., 2000, SCAND J CLIN LAB I S, V231, P1, DOI DOI 10.1080/00365513.2000.12056993; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Le Gal F, 2005, J CLIN MICROBIOL, V43, P2363, DOI 10.1128/JCM.43.5.2363-2369.2005; Lee SH, 2009, J VET SCI, V10, P43, DOI 10.4142/jvs.2009.10.1.43; Lehmann LE, 2009, BJU INT; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Maes N, 2002, J CLIN MICROBIOL, V40, P1514, DOI 10.1128/JCM.40.4.1514-1517.2002; Omiccioli E, 2009, FOOD MICROBIOL, V26, P615, DOI 10.1016/j.fm.2009.04.008; Palmqvist E, 2008, SCAND J CLIN LAB INV, V68, P312, DOI 10.1080/00365510701759703; Schabereiter-Gurtner C, 2008, CLIN MICROBIOL INFEC, V14, P480, DOI 10.1111/j.1469-0691.2008.01962.x; Shigemura K, 2005, CLIN EXP MED, V4, P196, DOI 10.1007/s10238-004-0056-x; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Vromen M, 1999, J ANTIMICROB CHEMOTH, V44, P113, DOI 10.1093/jac/44.1.113; Weber G, 1997, EUR J CLIN MICROBIOL, V16, P834, DOI 10.1007/BF01700414; Yang G, 2009, CLIN MICROBIOL INFEC	29	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17146	10.1371/journal.pone.0017146	http://dx.doi.org/10.1371/journal.pone.0017146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359187	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700055
J	Makani, J; Cox, SE; Soka, D; Komba, AN; Oruo, J; Mwamtemi, H; Magesa, P; Rwezaula, S; Meda, E; Mgaya, J; Lowe, B; Muturi, D; Roberts, DJ; Williams, TN; Pallangyo, K; Kitundu, J; Fegan, G; Kirkham, FJ; Marsh, K; Newton, CR				Makani, Julie; Cox, Sharon E.; Soka, Deogratius; Komba, Albert N.; Oruo, Julie; Mwamtemi, Hadija; Magesa, Pius; Rwezaula, Stella; Meda, Elineema; Mgaya, Josephine; Lowe, Brett; Muturi, David; Roberts, David J.; Williams, Thomas N.; Pallangyo, Kisali; Kitundu, Jesse; Fegan, Gregory; Kirkham, Fenella J.; Marsh, Kevin; Newton, Charles R.			Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania	PLOS ONE			English	Article							PNEUMOCOCCAL PROPHYLAXIS; BLOOD-TRANSFUSION; NATURAL-HISTORY; DISEASE; CHILDREN; SURVIVAL; DEATH; DISORDERS; MORBIDITY; JAMAICA	Background: The World Health Organization has declared Sickle Cell Anemia (SCA) a public health priority. There are 300,000 births/year, over 75% in Africa, with estimates suggesting that 6 million Africans will be living with SCA if average survival reaches half the African norm. Countries such as United States of America and United Kingdom have reduced SCA mortality from 3 to 0.13 per 100 person years of observation (PYO), with interventions such as newborn screening, prevention of infections and comprehensive care, but implementation of interventions in African countries has been hindered by lack of locally appropriate information. The objective of this study was to determine the incidence and factors associated with death from SCA in Dar-es-Salaam. Methods and Findings: A hospital-based cohort study was conducted, with prospective surveillance of 1,725 SCA patients recruited from 2004 to 2009, with 209 (12%) lost to follow up, while 86 died. The mortality rate was 1.9 (95% CI 1.5, 2.9) per 100 PYO, highest under 5-years old [7.3 (4.8-11.0)], adjusting for dates of birth and study enrollment. Independent risk factors, at enrollment to the cohort, predicting death were low hemoglobin (<5 g/dL) [3.8 (1.8-8.2); p = 0.001] and high total bilirubin (>= 102 mu mol/L) [1.7 (1.0-2.9); p = 0.044] as determined by logistic regression. Conclusions: Mortality in SCA in Africa is high, with the most vulnerable period being under 5-years old. This is most likely an underestimate, as this was a hospital cohort and may not have captured SCA individuals with severe disease who died in early childhood, those with mild disease who are undiagnosed or do not utilize services at health facilities. Prompt and effective treatment for anemia in SCA is recommended as it is likely to improve survival. Further research is required to determine the etiology, pathophysiology and the most appropriate strategies for management of anemia in SCA.	[Makani, Julie; Cox, Sharon E.; Soka, Deogratius; Komba, Albert N.; Oruo, Julie; Mwamtemi, Hadija; Magesa, Pius; Rwezaula, Stella; Meda, Elineema; Mgaya, Josephine; Pallangyo, Kisali; Kitundu, Jesse; Newton, Charles R.] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania; [Makani, Julie; Lowe, Brett; Roberts, David J.; Williams, Thomas N.; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Oxford, England; [Cox, Sharon E.; Fegan, Gregory; Newton, Charles R.] London Sch Hyg & Trop Med, MRC, Int Nutr Grp, London WC1, England; [Lowe, Brett; Muturi, David; Williams, Thomas N.; Fegan, Gregory; Marsh, Kevin; Newton, Charles R.] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Roberts, David J.] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Oxford OX3 9DU, England; [Williams, Thomas N.] INDEPTH Network Demog Surveillance Sites, Accra, Ghana; [Kirkham, Fenella J.; Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England	Muhimbili University of Health & Allied Sciences; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; NHS Blood & Transplant (NHSBT); University of Oxford; INDEPTH Network; University of London; University College London	Makani, J (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania.	jmakani@muhas.ac.tz	Kirkham, Fenella/C-2442-2009; Newton, Charles RJC/B-7578-2014; Makani, Julie/N-9370-2013; Makani, Julie/E-8525-2017; Fegan, Greg W/O-8079-2018; Newton, Charles/V-7872-2019; Cox, Sharon E/ABA-7986-2020	Kirkham, Fenella/0000-0002-2443-7958; Newton, Charles RJC/0000-0002-6999-5507; Makani, Julie/0000-0002-4801-6250; Makani, Julie/0000-0002-4801-6250; Fegan, Greg W/0000-0002-2663-2765; Newton, Charles/0000-0002-6999-5507; Cox, Sharon E/0000-0002-9908-2936	Wellcome Trust, UK [JKM 072064, 080025, 084538]; Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast)	Wellcome Trust, UK(Wellcome Trust); Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast)	This work was supported by the Wellcome Trust, UK (JKM 072064; Project grant 080025; Strategic award 084538) and Kenya Medical Research Institute (KEMRI) - Centre for Geographic Medicine Research (Coast). CRN is funded by the Wellcome Trust. DJR is supported by a programme grant from the National Institutes of Health Research to NHS Blood and Transplant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christianson A., 2006, GLOBAL REPORT BIRTH; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; de Montalembert M, 2008, ARCH DIS CHILD, V93, P715; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Ikefuna A N, 2007, Niger J Clin Pract, V10, P24; Juwah AI, 2004, ARCH DIS CHILD, V89, P572, DOI 10.1136/adc.2003.037374; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kizito ME, 2007, ARCH DIS CHILD, V92, P21, DOI 10.1136/adc.2005.088807; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEIKIN SL, 1989, PEDIATRICS, V84, P500; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; National Malaria Control Programme, 2006, NAT GUID MAL DIAGN T; OBARO S, 2009, ARCH DIS CHILD; Odunvbun ME, 2008, PUBLIC HEALTH, V122, P1111, DOI 10.1016/j.puhe.2008.01.008; Olabode J O, 2006, West Afr J Med, V25, P284; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS D, 1990, SEMIN HEMATOL, V27, P360; POWARS DR, 1975, SEMIN HEMATOL, V12, P267; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Rahimy MC, 2009, J CLIN PATHOL, V62, P46, DOI 10.1136/jcp.2008.059113; RWEZAULA S, 2010, NEONATAL SCREENING H; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Telfer P, 2007, HAEMATOLOGICA, V92, P905, DOI 10.3324/haematol.10937; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; Tshilolo LM, 2007, INDIAN J PEDIATR, V74, P735, DOI 10.1007/s12098-007-0129-4; VICHINSKY EP, 1991, SEMIN HEMATOL, V28, P220; Wahl S, 2009, CURR OPIN PEDIATR, V21, P15, DOI 10.1097/MOP.0b013e328321882e; Weatherall D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P663; *WHO, 2006, WHO MARCH DIM M GEN; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5; WILLIAMS TN, 2009, LANCET; Yanni E, 2009, J PEDIATR-US, V154, P541, DOI 10.1016/j.jpeds.2008.09.052; 2008, ANAL INFORM MANAGEME	36	171	175	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14699	10.1371/journal.pone.0014699	http://dx.doi.org/10.1371/journal.pone.0014699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358818	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287392700012
J	Seidl, CI; Ryan, K				Seidl, Christine I.; Ryan, Kevin			Circular Single-Stranded Synthetic DNA Delivery Vectors for MicroRNA	PLOS ONE			English	Article							RNA-POLYMERASE; ROLLING TRANSCRIPTION; DROSHA-DGCR8 COMPLEX; MAMMALIAN-CELLS; CATALYTIC RNAS; SHRNAS; OLIGONUCLEOTIDES; INTERFERENCE; RECOGNITION; EXPRESSION	Single-stranded (ss) circular oligodeoxynucleotides were previously found to undergo rolling circle transcription (RCT) by phage and bacterial RNA polymerases (RNAPs) into tandemly repetitive RNA multimers. Here, we redesign them to encode minimal primary miRNA mimics, with the long term aim of intracellular transcription followed by RNA processing and maturation via endogenous pathways. We describe an improved method for circularizing ss synthetic DNA for RCT by using a recently described thermostable RNA ligase, which does not require a splint oligonucleotide to juxtapose the ligating ends. In vitro transcription of four templates demonstrates that the secondary structure inherent in miRNA-encoding vectors does not impair their RCT by RNAPs previously shown to carry out RCT. A typical primary-miRNA rolling circle transcript was accurately processed by a human Drosha immunoprecipitate, indicating that if human RNAPs prove to be capable of RCT, the resulting transcripts should enter the endogenous miRNA processing pathway in human cells. Circular oligonucleotides are therefore candidate vectors for small RNA delivery in human cells, which express RNAPs related to those tested here.	[Seidl, Christine I.; Ryan, Kevin] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Ryan, Kevin] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Seidl, CI (corresponding author), CUNY City Coll, Dept Chem, New York, NY 10031 USA.	kr107@sci.ccny.cuny.edu	Ryan, Kevin/K-6527-2012	Ryan, Kevin/0000-0001-5304-2026	National Institutes of Health [1R21GM073944, 5SC1GM083754]; City College of New York Science Division; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM073944, SC1GM083754] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City College of New York Science Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health (http:/www.nih.gov/; 1R21GM073944 and 5SC1GM083754 to K.R.), and the City College of New York Science Division. Additional infrastructure support was provided by the National Institutes of Health RCMI Grant G12 RR03060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondal T, 2005, NUCLEIC ACIDS RES, V33, P135, DOI 10.1093/nar/gki149; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; DAUBENDIEK SL, 1995, J AM CHEM SOC, V117, P7818, DOI 10.1021/ja00134a032; Daubendiek SL, 1997, NAT BIOTECHNOL, V15, P273, DOI 10.1038/nbt0397-273; Diegelman AM, 1999, CHEM BIOL, V6, P569, DOI 10.1016/S1074-5521(99)80089-1; Diegelman AM, 1998, NUCLEIC ACIDS RES, V26, P3235, DOI 10.1093/nar/26.13.3235; DIEGELMAN AM, 2000, PROTOCOLS NUCL ACID; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Ohmichi T, 2002, P NATL ACAD SCI USA, V99, P54, DOI 10.1073/pnas.012589099; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Sambrook J, 2001, MOL CLONING LAB MANU; Seyhan AA, 2006, OLIGONUCLEOTIDES, V16, P353, DOI 10.1089/oli.2006.16.353; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	14	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16925	10.1371/journal.pone.0016925	http://dx.doi.org/10.1371/journal.pone.0016925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359172	Green Published, gold			2022-12-27	WOS:000287392700032
J	Opitz, D; Maier, B				Opitz, Dirk; Maier, Berenike			Rapid Cytoskeletal Response of Epithelial Cells to Force Generation by Type IV Pili	PLOS ONE			English	Article							CORTICAL PLAQUE-FORMATION; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIAE; ENDOTHELIAL-CELLS; DYNAMICS; MOTILITY; ACTIN; MECHANOTRANSDUCTION; PHOSPHORYLATION; CYTOPROTECTION	Many bacterial pathogens interfere with cellular functions including phagocytosis and barrier integrity. The human pathogen Neissieria gonorrhoeae generates grappling hooks for adhesion, spreading, and induction of signal cascades that lead to formation cortical plaques containing f-actin and ezrin. It is unclear whether high mechanical forces generated by type IV pili (T4P) are a direct signal that leads to cytoskeletal rearrangements and at which time scale the cytoskeletal response occurs. Here we used laser tweezers to mimic type IV pilus mediated force generation by T4P-coated beads on the order of 100pN. We found that actin-EGFP and ezrin-EGFP accumulated below pilus-coated beads when force was applied. Within 2 min, accumulation significantly exceeded controls without force or without pili, demonstrating that T4P-generated force rapidly induces accumulation of plaque proteins. This finding adds mechanical force to the many strategies by which bacteria modulate the host cell cytoskeleton.	[Opitz, Dirk; Maier, Berenike] Univ Munster, Inst Mol Zellbiol, Munster, Germany	University of Munster	Opitz, D (corresponding author), Univ Munster, Inst Mol Zellbiol, Munster, Germany.	maierb@uni-muenster.de	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927; Giannakakou, Paraskevi/0000-0001-7378-262X	Deutsche Forschungsgemeinschaft [SFB 629, A12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft through SFB 629, A12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Ayala P, 2005, CELL MICROBIOL, V7, P1736, DOI 10.1111/j.1462-5822.2005.00586.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Brinton C., 1978, USES PILI GONORRHEA; Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eugene E, 2002, J CELL SCI, V115, P1231; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Glogauer M, 1997, J CELL SCI, V110, P11; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; HOLZ C, PHYS REV LETT, V104; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17088	10.1371/journal.pone.0017088	http://dx.doi.org/10.1371/journal.pone.0017088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340023	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600037
J	Shah, I; Houck, K; Judson, RS; Kavlock, RJ; Martin, MT; Reif, DM; Wambaugh, J; Dix, DJ				Shah, Imran; Houck, Keith; Judson, Richard S.; Kavlock, Robert J.; Martin, Matthew T.; Reif, David M.; Wambaugh, John; Dix, David J.			Using Nuclear Receptor Activity to Stratify Hepatocarcinogens	PLOS ONE			English	Article							PREGNANE-X RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; THROUGHPUT SCREENING ASSAYS; PEROXISOME PROLIFERATOR; PYRETHROID PESTICIDES; AGONISTIC ACTIVITY; CLUSTER-ANALYSIS; CELL-LINE; INDUCTION; TOXICITY	Background: Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that control a range of cellular processes. Persistent stimulation of some NR is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. Here we report on a systematic analysis of new in vitro human NR activity data on 309 environmental chemicals in relationship to their liver cancer-related chronic outcomes in rodents. Results: The effects of 309 environmental chemicals on human constitutive androstane receptors (CAR/NR1I3), pregnane X receptor (PXR/NR1I2), aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptors (PPAR/NR1C), liver X receptors (LXR/NR1H), retinoic X receptors (RXR/NR2B) and steroid receptors (SR/NR3) were determined using in vitro data. Hepatic histopathology, observed in rodents after two years of chronic treatment for 171 of the 309 chemicals, was summarized by a cancer lesion progression grade. Chemicals that caused proliferative liver lesions in both rat and mouse were generally more active for the human receptors, relative to the compounds that only affected one rodent species, and these changes were significant for PPAR (p < 0.001), PXR (p < 0.01) and CAR (p < 0.05). Though most chemicals exhibited receptor promiscuity, multivariate analysis clustered them into relatively few NR activity combinations. The human NR activity pattern of chemicals weakly associated with the severity of rodent liver cancer lesion progression (p < 0.05). Conclusions: The rodent carcinogens had higher in vitro potency for human NR relative to non-carcinogens. Structurally diverse chemicals with similar NR promiscuity patterns weakly associated with the severity of rodent liver cancer progression. While these results do not prove the role of NR activation in human liver cancer, they do have implications for nuclear receptor chemical biology and provide insights into putative toxicity pathways. More importantly, these findings suggest the utility of in vitro assays for stratifying environmental contaminants based on a combination of human bioactivity and rodent toxicity.	[Shah, Imran; Houck, Keith; Judson, Richard S.; Kavlock, Robert J.; Martin, Matthew T.; Reif, David M.; Wambaugh, John; Dix, David J.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Shah, I (corresponding author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	shah.imran@epa.gov	Houck, Keith/G-8654-2014; Shah, Syed I/B-8275-2011; Martin, Matthew/A-1982-2013; Wambaugh, John/AAM-4487-2020	Houck, Keith/0000-0002-0055-2249; Martin, Matthew/0000-0002-8096-9908; Wambaugh, John/0000-0002-4024-534X; Shah, Imran/0000-0003-0808-0140; Reif, David/0000-0001-7815-6767; Judson, Richard/0000-0002-2348-9633				ABDELLATIF AG, 1991, TOXICOL APPL PHARM, V111, P530, DOI 10.1016/0041-008X(91)90257-F; Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P1; Benjamini Y, 1995, CONTROLLING FALSE DI, DOI [10.1176/ajp.156.6, DOI 10.1176/AJP.156.6]; Boronat S, 2007, FEBS J, V274, P3327, DOI 10.1111/j.1742-4658.2007.05867.x; BUTLER EG, 1988, TOXICOL APPL PHARM, V93, P72, DOI 10.1016/0041-008X(88)90026-9; Chen HY, 2002, J TOXICOL ENV HEAL A, V65, P1419, DOI 10.1080/00984100290071243; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Doe JE, 2006, CRIT REV TOXICOL, V36, P37, DOI 10.1080/10408440500534370; Dubois M, 1996, ECOTOX ENVIRON SAFE, V34, P205, DOI 10.1006/eesa.1996.0065; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023; Goetz AK, 2009, TOXICOLOGICAL SCI OF; Goetz AK, 2009, TOXICOL APPL PHARM, V238, P80, DOI 10.1016/j.taap.2009.04.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Judson R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-241; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; Lemaire G, 2006, TOXICOL SCI, V91, P501, DOI 10.1093/toxsci/kfj173; Lobenhofer EK, 2006, TOXICOL PATHOL, V34, P921, DOI 10.1080/01926230601072319; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Martinasso G, 2006, J TOXICOL ENV HEAL A, V69, P353, DOI 10.1080/15287390500227522; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Oliver JD, 2002, PHARMACOL TOXICOL, V91, P1, DOI 10.1034/j.1600-0773.2002.910101.x; Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204; Parsons L., 2004, SIGKDD EXPLOR NEWSL, V6, P90, DOI DOI 10.1145/1007730.1007731; Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Scassellati-Sfozolini G., 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P11; Scollon EJ, 2009, DRUG METAB DISPOS, V37, P221, DOI 10.1124/dmd.108.022343; Sergent T, 2009, TOXICOL LETT, V184, P159, DOI 10.1016/j.toxlet.2008.11.009; Takeuchi S, 2008, CHEMOSPHERE, V74, P155, DOI 10.1016/j.chemosphere.2008.08.015; Takeuchi S, 2006, TOXICOL APPL PHARM, V217, P235, DOI 10.1016/j.taap.2006.08.011; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Washington Teresa, 2004, Int J Environ Res Public Health, V1, P12, DOI 10.3390/ijerph2004010012; Whitfield GK, 1999, J CELLULAR BIOCH, V75; Zhu ZR, 2004, J BIOMOL SCREEN, V9, P533, DOI 10.1177/1087057104264902	47	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14584	10.1371/journal.pone.0014584	http://dx.doi.org/10.1371/journal.pone.0014584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339822	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600001
J	Wang, B; Howel, P; Bruheim, S; Ju, JF; Owen, LB; Fodstad, O; Xi, YG				Wang, Bin; Howel, Paul; Bruheim, Skjalg; Ju, Jingfang; Owen, Laurie B.; Fodstad, Oystein; Xi, Yaguang			Systematic Evaluation of Three microRNA Profiling Platforms: Microarray, Beads Array, and Quantitative Real-Time PCR Array	PLOS ONE			English	Article							GENERATION SEQUENCING TECHNOLOGIES; DIFFERENTIALLY-EXPRESSED GENES; NORMALIZATION METHODS; REDUCED EXPRESSION; RT-PCR; CANCER; TARGETS; QUANTIFICATION; REVEALS; MODEL	Background: A number of gene-profiling methodologies have been applied to microRNA research. The diversity of the platforms and analytical methods makes the comparison and integration of cross-platform microRNA profiling data challenging. In this study, we systematically analyze three representative microRNA profiling platforms: Locked Nucleic Acid (LNA) microarray, beads array, and TaqMan quantitative real-time PCR Low Density Array (TLDA). Methodology/Principal Findings: The microRNA profiles of 40 human osteosarcoma xenograft samples were generated by LNA array, beads array, and TLDA. Results show that each of the three platforms perform similarly regarding intra-platform reproducibility or reproducibility of data within one platform while LNA array and TLDA had the best inter-platform reproducibility or reproducibility of data across platforms. The endogenous controls/probes contained in each platform have been observed for their stability under different treatments/environments; those included in TLDA have the best performance with minimal coefficients of variation. Importantly, we identify that the proper selection of normalization methods is critical for improving the inter-platform reproducibility, which is evidenced by the application of two non-linear normalization methods (loess and quantile) that substantially elevated the sensitivity and specificity of the statistical data assessment. Conclusions: Each platform is relatively stable in terms of its own microRNA profiling intra-reproducibility; however, the inter-platform reproducibility among different platforms is low. More microRNA specific normalization methods are in demand for cross-platform microRNA microarray data integration and comparison, which will improve the reproducibility and consistency between platforms.	[Wang, Bin] Univ S Alabama, Dept Math & Stat, Coll Arts & Sci, Mobile, AL 36688 USA; [Howel, Paul; Owen, Laurie B.; Xi, Yaguang] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA; [Bruheim, Skjalg; Fodstad, Oystein] Univ Hosp, Rikshosp, Norwegian Radium Hosp, Inst Canc Res,Dept Tumor Biol, Oslo, Norway; [Ju, Jingfang] SUNY Stony Brook, Sch Med, Dept Pathol, Stony Brook, NY 11794 USA	University of South Alabama; University of South Alabama; University of Oslo; National Hospital Norway; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, B (corresponding author), Univ S Alabama, Dept Math & Stat, Coll Arts & Sci, Mobile, AL 36688 USA.	xi@usouthal.edu		Wang, Bin/0000-0002-3689-6932; Ju, Jingfang/0000-0002-4821-7458; Xi, Yaguang/0000-0003-3681-9352				Abruzzo LV, 2005, BIOTECHNIQUES, V38, P785, DOI 10.2144/05385MT01; Auer Herbert, 2009, V509, P35, DOI 10.1007/978-1-59745-372-1_3; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruheim S, 2009, CLIN CANCER RES, V15, P7161, DOI 10.1158/1078-0432.CCR-08-2816; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Dudoit S, 2002, STAT SINICA, V12, P111; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mascellani N, 2008, MINERVA BIOTECNOL, V20, P23; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Wang B, 2010, BIOINFORMATICS, V26, P228, DOI 10.1093/bioinformatics/btp655; Werner T., 2010, BRIEF BIOINFORM; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257	39	73	77	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17167	10.1371/journal.pone.0017167	http://dx.doi.org/10.1371/journal.pone.0017167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347261	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500036
J	Ahmad, N; Boutron, I; Dechartres, A; Durieux, P; Ravaud, P				Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Durieux, Pierre; Ravaud, Philippe			Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SYSTEMATIC REVIEWS; COCHRANE REVIEWS; MEDICAL JOURNALS; GLOBAL BURDEN; HEALTH; DISEASE; METAANALYSES; ACHIEVE; QUALITY	Background: The challenge for evidence-based healthcare is to reduce mortality and the burden of diseases. This study aimed to compare where research is conducted to where research is needed for 2 public health priorities: tobacco consumption and HIV infection. Methods: We identified randomized controlled trials (RCTs) included in Cochrane systematic reviews published between 1997 and 2007 and registered ongoing RCTs identified in January 2009 through the World Health Organization's International Clinical Trials Registry Platform (WHO-ICTRP) evaluating interventions aimed at reducing or stopping tobacco use and treating or preventing HIV infection. We used the WHO and World Bank reports to classify the countries by income level, as well as map the global burden of disease and mortality attributable to tobacco use and HIV infection to the countries where the trials performed. Results: We evaluated 740 RCTs included in systematic reviews and 346 ongoing RCTs. For tobacco use, 4% of RCTs included in systematic reviews and 2% of ongoing trials were performed in low-and middle-income countries, even though these countries represented 70% of the mortality related to tobacco use. For HIV infection, 31% of RCTs included in systematic reviews and 33% of ongoing trials were performed in low-and middle-income countries, even though these countries represented 99% of the mortality related to HIV infection. Conclusions: Our results highlight an important underrepresentation of low-and middle-income countries in currently available evidence (RCTs included in systematic reviews) and awaiting evidence (registered ongoing RCTs) for reducing or stopping tobacco use and treating or preventing HIV infection.	[Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] INSERM, U738, Paris, France; [Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ahmad, Nizar; Boutron, Isabelle; Dechartres, Agnes; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Durieux, Pierre; Ravaud, Philippe] APHP, INSERM, HAS, Ctr Med Fondee Preuves,EHESP, Paris, France; [Durieux, Pierre] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ahmad, N (corresponding author), INSERM, U738, Paris, France.	nizar.ahmad@htd.aphp.fr	ravaud, philippe/C-1694-2009	Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France; Institut National du Cancer (INCA), France	Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France; Institut National du Cancer (INCA), France(Institut National du Cancer (INCA) France)	This work was supported by a grant "Recherche sur la Recherche" from the "Delegation Interregionale a la Recherche Clinique (DIRC), Ile de France" and a grant from the Institut National du Cancer (INCA), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto ML, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4846; Buekens P, 2004, JAMA-J AM MED ASSOC, V291, P2639, DOI 10.1001/jama.291.21.2639; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Chinnock P, 2005, PLOS MED, V2, P367, DOI 10.1371/journal.pmed.0020107; Daar AS, 2009, SCIENCE, V324, P1642, DOI 10.1126/science.324_1642; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Harris E, 2000, BRIT MED J, V321, P817, DOI 10.1136/bmj.321.7264.817; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Jadad AR, 2000, BRIT MED J, V320, P537, DOI 10.1136/bmj.320.7234.537; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, REP GLOB HIV AIDS EP; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; LOUIS J, 10 90 REP HLTH RES 2; MCDEVITT TM, WP98 US CENS BUR; McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; *ONU, 2005, POP DIV WORLD POP PR; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Sheriff RJS, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-69; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; [UNAIDS WHO], AIDS EP UPD DEC 2007; VOLMINK J, 2007, COCHRANE DB SYST REV, V24; WHO, WORLD HLTH STAT REP; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2002, STAT MED, V21, P2859, DOI 10.1002/sim.1290	37	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16878	10.1371/journal.pone.0016878	http://dx.doi.org/10.1371/journal.pone.0016878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347383	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700048
J	Chan, J; Ko, FCF; Yeung, YS; Ng, IOL; Yam, JWP				Chan, Jenny; Ko, Frankie Chi Fat; Yeung, Yin-Shan; Ng, Irene Oi-Lin; Yam, Judy Wai Ping			Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma	PLOS ONE			English	Article							ACTIN STRESS FIBERS; PROTEIN-KINASE; EXPRESSION INCREASES; DEPENDENT REGULATION; BETA-CATENIN; CANCER; ILK; AKT; ACTIVATION; TUMOR	Background: Integrin-linked kinase (ILK) was first discovered as an integrin beta 1-subunit binding protein. It localizes at the focal adhesions and is involved in cytoskeleton remodeling. ILK overexpression and its dysregulated signaling cascades have been reported in many human cancers. Aberrant expression of ILK influenced a wide range of signaling pathways and cellular functions. Although ILK has been well characterized in many malignancies, its role in hepatocellular carcinoma (HCC) is still largely unknown. Methodology/Principal Findings: Quantitative PCR analysis was used to examine ILK mRNA expression in HCC clinical samples. It was shown that ILK was overexpressed in 36.9% (21/57) of HCC tissues when compared to the corresponding non-tumorous livers. The overall ILK expression level was significantly higher in tumorous tissues (P = 0.004), with a significant stepwise increase in expression level along tumor progression from tumor stage I to IV (P = 0.045). ILK knockdown stable clones were established in two HCC cell lines, BEL7402 and HLE, and were subjected to different functional assays. Knockdown of ILK significantly suppressed HCC cell growth, motility and invasion in vitro and inhibited tumorigenicity in vivo. Western blot analysis revealed a reduced phosphorylated-Akt (pAkt) at Serine-473 expression in ILK knockdown stable clones when compared to control clones. Conclusion/Significance: This study provides evidence about the clinical relevance of ILK in hepatocarcinogenesis. ILK was found to be progressively elevated along HCC progression. Here our findings also provide the first validation about the oncogenic capacity of ILK in vivo by suppressing its expression in HCC cells. The oncogenic role of ILK is implicated to be mediated by Akt pathway.	[Chan, Jenny; Ko, Frankie Chi Fat; Yeung, Yin-Shan; Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ko, Frankie Chi Fat; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin; Yam, Judy Wai Ping] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, Liver Canc & Hepatitis Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, J (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	judyyam@pathology.hku.hk	Ko, Frankie Chi Fat/C-4759-2009; Yam, Judy Wai Ping/C-4454-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029	University of Hong Kong; Hong Kong Research Grants Council [HKU7798/07M]; Outstanding Young Researcher Award	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Outstanding Young Researcher Award	This work was supported by The University of Hong Kong Seed Funding Programme for Basic Research, Hong Kong Research Grants Council (HKU7798/07M), and Outstanding Young Researcher Award (to J.W.P. Yam). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Ahmed N, 2003, J PATHOL, V201, P229, DOI 10.1002/path.1441; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Chung DH, 1998, VIRCHOWS ARCH, V433, P113, DOI 10.1007/s004280050225; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fukui K, 2006, J CANCER RES CLIN, V132, P627, DOI 10.1007/s00432-006-0107-7; Graff JR, 2001, CLIN CANCER RES, V7, P1987; Haase M, 2008, J HISTOCHEM CYTOCHEM, V56, P819, DOI 10.1369/jhc.2008.951095; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1997, GENOMICS, V42, P177, DOI 10.1006/geno.1997.4719; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Intaraprasong P, 2007, ANTICANCER RES, V27, P4371; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Ko FCF, 2010, LIVER INT, V30, P139, DOI 10.1111/j.1478-3231.2009.02133.x; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peroukides S, 2008, ONCOL REP, V20, P1337, DOI 10.3892/or_00000149; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Roxburgh P, 2008, ADV THER, V25, P1089, DOI 10.1007/s12325-008-0113-z; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Wang DS, 2007, J GASTROEN HEPATOL, V22, P1916, DOI 10.1111/j.1440-1746.2006.04534.x; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yam JWP, 2006, HEPATOLOGY, V44, P881, DOI 10.1002/hep.21339; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561	35	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16984	10.1371/journal.pone.0016984	http://dx.doi.org/10.1371/journal.pone.0016984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347395	Green Submitted, gold, Green Published			2022-12-27	WOS:000287361700061
J	Torrent, M; Andreu, D; Nogues, VM; Boix, E				Torrent, Marc; Andreu, David; Nogues, Victoria M.; Boix, Ester			Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model	PLOS ONE			English	Article							COMPUTER-AIDED-DESIGN; SELECTIVE CYTOTOXICITY; QSAR DESCRIPTORS; HOST-DEFENSE; MEMBRANES; AGGREGATION; TEMPORINS; MELITTIN; POTENT; PORES	The increasing rate in antibiotic-resistant bacterial strains has become an imperative health issue. Thus, pharmaceutical industries have focussed their efforts to find new potent, non-toxic compounds to treat bacterial infections. Antimicrobial peptides (AMPs) are promising candidates in the fight against antibiotic-resistant pathogens due to their low toxicity, broad range of activity and unspecific mechanism of action. In this context, bioinformatics' strategies can inspire the design of new peptide leads with enhanced activity. Here, we describe an artificial neural network approach, based on the AMP's physicochemical characteristics, that is able not only to identify active peptides but also to assess its antimicrobial potency. The physicochemical properties considered are directly derived from the peptide sequence and comprise a complete set of parameters that accurately describe AMPs. Most interesting, the results obtained dovetail with a model for the AMP's mechanism of action that takes into account new concepts such as peptide aggregation. Moreover, this classification system displays high accuracy and is well correlated with the experimentally reported data. All together, these results suggest that the physicochemical properties of AMPs determine its action. In addition, we conclude that sequence derived parameters are enough to characterize antimicrobial peptides.	[Torrent, Marc; Nogues, Victoria M.; Boix, Ester] Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain; [Torrent, Marc; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Torrent, M (corresponding author), Univ Autonoma Barcelona, Biosci Fac, Dept Biochem & Mol Biol, Cerdanyola Del Valles, Spain.	marc.torrent@uab.cat	Boix, Ester/B-9038-2012; Nogues, M. Victoria/H-6100-2015; Andreu, David/I-4359-2014; Burgas, Marc Torrent/A-5171-2010	Boix, Ester/0000-0003-1790-2142; Nogues, M. Victoria/0000-0002-7104-0961; Andreu, David/0000-0002-6317-6666; Burgas, Marc Torrent/0000-0001-6567-3474	Alianza Cuatro Universidades (Spain); European Union [HEALTH-F3-2008-223414]; Spanish Ministry of Science and Innovation [BIO2008-04487-CO3-02, BFU2009-09371]; Generalitat de Catalunya [SGR2009-494, SGR2009-795]	Alianza Cuatro Universidades (Spain); European Union(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	M.T. is the recipient of a postdoctoral grant from Alianza Cuatro Universidades (Spain). Work supported by the European Union (HEALTH-F3-2008-223414), the Spanish Ministry of Science and Innovation (BIO2008-04487-CO3-02, BFU2009-09371) and the Generalitat de Catalunya (SGR2009-494, SGR2009-795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Andres E, 2004, J INTERN MED, V255, P519, DOI 10.1046/j.1365-2796.2003.01278.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; BROWN LR, 1980, BIOCHIM BIOPHYS ACTA, V622, P231, DOI 10.1016/0005-2795(80)90034-3; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cherkasov A, 2004, MOLECULES, V9, P1034, DOI 10.3390/91201034; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Feder R, 2000, J BIOL CHEM, V275, P4230, DOI 10.1074/jbc.275.6.4230; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x; Gorr SU, 2008, PEPTIDES, V29, P2118, DOI 10.1016/j.peptides.2008.09.019; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; He K, 1996, BIOPHYS J, V70, P2659, DOI 10.1016/S0006-3495(96)79835-1; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kustanovich I, 2002, J BIOL CHEM, V277, P16941, DOI 10.1074/jbc.M111071200; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Mangoni ML, 2007, J PEPT SCI, V13, P603, DOI 10.1002/psc.853; NGUYEN LT, 2010, PLOS ONE, V2; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Oyston PCF, 2009, J MED MICROBIOL, V58, P977, DOI 10.1099/jmm.0.011122-0; Poole Keith, 2003, Curr Opin Investig Drugs, V4, P128; Rosenfeld Y, 2006, J BIOL CHEM, V281, P28565, DOI 10.1074/jbc.M606031200; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Taboureau O, 2010, METHODS MOL BIOL, V618, P77, DOI 10.1007/978-1-60761-594-1_6; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2010, FEBS J, V277, P1713, DOI 10.1111/j.1742-4658.2010.07595.x; Torrent M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-373	38	129	134	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16968	10.1371/journal.pone.0016968	http://dx.doi.org/10.1371/journal.pone.0016968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347392	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700059
J	Yang, XL; Wang, Y; Guo, W; Xie, Y; Xie, Q; Fan, LJ; Zhou, XP				Yang, Xiuling; Wang, Yu; Guo, Wei; Xie, Yan; Xie, Qi; Fan, Longjiang; Zhou, Xueping			Characterization of Small Interfering RNAs Derived from the Geminivirus/Betasatellite Complex Using Deep Sequencing	PLOS ONE			English	Article							DICER-LIKE PROTEINS; SIRNA BIOGENESIS; VIRUS; DNA; ARABIDOPSIS; PLANT; PATHWAY; GEMINIVIRUSES; FUNCTIONALITY; ACCUMULATION	Background: Small RNA (sRNA)-guided RNA silencing is a critical antiviral defense mechanism employed by a variety of eukaryotic organisms. Although the induction of RNA silencing by bipartite and monopartite begomoviruses has been described in plants, the nature of begomovirus/betasatellite complexes remains undefined. Methodology/Principal Findings: Solanum lycopersicum plant leaves systemically infected with Tomato yellow leaf curl China virus (TYLCCNV) alone or together with its associated betasatellite (TYLCCNB), and Nicotiana benthamiana plant leaves systemically infected with TYLCCNV alone, or together with TYLCCNB or with mutant TYLCCNB were harvested for RNA extraction; sRNA cDNA libraries were then constructed and submitted to Solexa-based deep sequencing. Both sense and anti-sense TYLCCNV and TYLCCNB-derived sRNAs (V-sRNAs and S-sRNAs) accumulated preferentially as 22 nucleotide species in infected S. lycopersicum and N. benthamiana plants. High resolution mapping of V-sRNAs and S-sRNAs revealed heterogeneous distribution of V-sRNA and S-sRNA sequences across the TYLCCNV and TYLCCNB genomes. In TYLCCNV-infected S. lycopersicum or N. benthamiana and TYLCCNV and beta C1-mutant TYLCCNB co-infected N. benthamiana plants, the primary TYLCCNV targets were AV2 and the 5' terminus of AV1. In TYLCCNV and betasatellite-infected plants, the number of V-sRNAs targeting this region decreased and the production of V-sRNAs increased corresponding to the overlapping regions of AC2 and AC3, as well as the 3' terminal of AC1. beta C1 is the primary determinant mediating symptom induction and also the primary silencing target of the TYLCCNB genome even in its mutated form. Conclusions/Significance: We report the first high-resolution sRNA map for a monopartite begomovirus and its associated betasatellite using Solexa-based deep sequencing. Our results suggest that viral transcript might act as RDR substrates resulting in dsRNA and secondary siRNA production. In addition, the betasatellite affected the amount of V-sRNAs detected in S. lycopersicum and N. benthamiana plants.	[Yang, Xiuling; Guo, Wei; Xie, Yan; Zhou, Xueping] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yu; Fan, Longjiang] Zhejiang Univ, Inst Crop Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Qi] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yang, XL (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zzhou@zju.edu.cn	Xie, Qi/P-1464-2016; Guo, Wei/J-9488-2015	Xie, Qi/0000-0002-8262-9093; Guo, Wei/0000-0002-6411-6227; Yang, Xiuling/0000-0002-7355-5643; Wang, Yu/0000-0002-2819-4551; Fan, Longjiang/0000-0003-4846-0500	National Natural Science Foundation of China [30530520]; National Key Basic Research and Development Program of China [2006CB101903]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z413]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This research was financially supported by the National Natural Science Foundation of China (Grant No. 30530520), the National Key Basic Research and Development Program of China (2006CB101903) and the National High Technology Research and Development Program of China (863 Program) (Grant No. 2007AA10Z413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Aragao FJL, 2009, NAT BIOTECHNOL, V27, P1086, DOI 10.1038/nbt1209-1086; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bisaro DM, 2006, VIROLOGY, V344, P158, DOI 10.1016/j.virol.2005.09.041; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Cui XF, 2004, J VIROL, V78, P13966, DOI 10.1128/JVI.78.24.13966-13974.2004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; GERMAN M, 2010, MOL PLANT PATHOL, V11, P347; Guo W, 2008, APPL ENVIRON MICROB, V74, P1909, DOI 10.1128/AEM.02461-07; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Jeske H, 2001, EMBO J, V20, P6158, DOI 10.1093/emboj/20.21.6158; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Pilartz M, 2003, J VIROL, V77, P10808, DOI 10.1128/JVI.77.20.10808-10818.2003; PILARTZ M, 1992, VIROLOGY, V189, P800, DOI 10.1016/0042-6822(92)90610-2; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2010, BBA-GENE REGUL MECH, V1799, P337, DOI 10.1016/j.bbagrm.2010.01.004; Ribeiro SG, 2007, J VIROL, V81, P1563, DOI 10.1128/JVI.01238-06; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; Sharma P, 2008, J GEN PLANT PATHOL, V74, P189, DOI 10.1007/s10327-008-0085-5; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xie Y, 2002, CHINESE SCI BULL, V47, P197, DOI 10.1360/02tb9047; Xie ZX, 2008, BBA-GENE REGUL MECH, V1779, P720, DOI 10.1016/j.bbagrm.2008.02.009; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	54	61	62	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16928	10.1371/journal.pone.0016928	http://dx.doi.org/10.1371/journal.pone.0016928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347388	Green Published, gold			2022-12-27	WOS:000287361700054
J	Wu, BL; Blanchard-Letort, A; Liu, Y; Zhou, GH; Wang, XF; Elena, SF				Wu, Beilei; Blanchard-Letort, Alexandra; Liu, Yan; Zhou, Guanghe; Wang, Xifeng; Elena, Santiago F.			Dynamics of Molecular Evolution and Phylogeography of Barley yellow dwarf virus-PAV	PLOS ONE			English	Article							PLANT RNA VIRUSES; RECOMBINATION; SEQUENCES; DNA; PHYLOGENIES; HYPOTHESIS; PHENOTYPES; ALIGNMENT; SEROTYPE; RATES	Barley yellow dwarf virus (BYDV) species PAV occurs frequently in irrigated wheat fields worldwide and can be efficiently transmitted by aphids. Isolates of BYDV-PAV from different countries show great divergence both in genomic sequences and pathogenicity. Despite its economical importance, the genetic structure of natural BYDV-PAV populations, as well as of the mechanisms maintaining its high diversity, remain poorly explored. In this study, we investigate the dynamics of BYDV-PAV genome evolution utilizing time-structured data sets of complete genomic sequences from 58 isolates from different hosts obtained worldwide. First, we observed that BYDV-PAV exhibits a high frequency of homologous recombination. Second, our analysis revealed that BYDV-PAV genome evolves under purifying selection and at a substitution rate similar to other RNA viruses (3.158x10(-4) nucleotide substitutions/site/year). Phylogeography analyses show that the diversification of BYDV-PAV can be explained by local geographic adaptation as well as by host-driven adaptation. These results increase our understanding of the diversity, molecular evolutionary characteristics and epidemiological properties of an economically important plant RNA virus.	[Wu, Beilei; Liu, Yan; Zhou, Guanghe; Wang, Xifeng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Blanchard-Letort, Alexandra; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Wu, BL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	xfwang@ippcaas.cn; sfelena@ibmcp.upv.es	Elena, Santiago F./A-4191-2011; Blanchard, Alexandra/AAM-5138-2020; Wang, Xifeng/A-6476-2016	Elena, Santiago F./0000-0001-8249-5593; Wang, Xifeng/0000-0002-4982-8947	Chinese National Key Basic Research Program (973 program) [2006CB100203]; Chinese Nature Science Foundation [30871622]; Spanish Ministry of Science and Innovation [BFU2009-06993]; Generalitat Valenciana [PROMETEO2010/019]	Chinese National Key Basic Research Program (973 program)(National Basic Research Program of China); Chinese Nature Science Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Chinese National Key Basic Research Program (973 program No. 2006CB100203) and by the Chinese Nature Science Foundation grant number 30871622. Work in Valencia was supported by the Spanish Ministry of Science and Innovation grant BFU2009-06993 and by Generalitat Valenciana grant PROMETEO2010/019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulila M, 2011, BIOCHIMIE, V93, P242, DOI 10.1016/j.biochi.2010.09.017; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chay CA, 1996, PHYTOPATHOLOGY, V86, P370, DOI 10.1094/Phyto-86-370; Codoner FM, 2008, J GEN VIROL, V89, P1739, DOI 10.1099/vir.0.2008/000166-0; D'Arcy CJ., 2005, VIRUS TAXONOMY 8 REP, P891; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Du ZQ, 2007, J PLANT PATHOL, V89, P251; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2008, HEREDITY, V100, P478, DOI 10.1038/sj.hdy.6801088; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; GAUNT BS, 2002, NEW PHYTOL, V154, P15; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Liu F, 2007, ARCH VIROL, V152, P1365, DOI 10.1007/s00705-007-0947-8; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mastari J, 1998, PHYTOPATHOLOGY, V88, P818, DOI 10.1094/PHYTO.1998.88.8.818; Mayo MA, 1996, ADV VIRUS RES, V46, P413, DOI 10.1016/S0065-3527(08)60077-9; MILLER MA, 1997, ANNU REV PHYTOPATHOL, V35, P167; Miller WA, 2002, MOL PLANT PATHOL, V3, P177, DOI 10.1046/j.1364-3703.2002.00112.x; OSWALD JOHN W., 1951, PLANT DIS REPORTER, V35, P471; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROCHOW WF, 1969, PHYTOPATHOLOGY, V59, P1580; ROCHOW WF, 1971, PLANT DIS REP, V55, P874; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SLATKIN M, 1989, GENETICS, V123, P603; TAJIMA F, 1989, GENETICS, V123, P585; van Regenmortel MHV, 2000, ARCH VIROL, V145, P2227, DOI 10.1007/s007050070053; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhou G., 1987, SCI AGR SINICA, V20, P7	40	52	58	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16896	10.1371/journal.pone.0016896	http://dx.doi.org/10.1371/journal.pone.0016896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326861	Green Published, gold			2022-12-27	WOS:000287037000031
J	Hedlund, M; Nagaeva, O; Kargl, D; Baranov, V; Mincheva-Nilsson, L				Hedlund, Malin; Nagaeva, Olga; Kargl, Dominic; Baranov, Vladimir; Mincheva-Nilsson, Lucia			Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; MHC CLASS-I; PROSTATE-CANCER; DOWN-REGULATION; NK CELLS; EXPRESSION; LEUKEMIA; RECEPTOR; IMMUNORECEPTOR; CYTOTOXICITY	Immune evasion from NK surveillance related to inadequate NK-cell function has been suggested as an explanation of the high incidence of relapse and fatal outcome of many blood malignancies. In this report we have used Jurkat and Raji cell lines as a model for studies of the NKG2D receptor-ligand system in T-and B cell leukemia/lymphoma. Using real-time quantitative RT-PCR and immunoflow cytometry we show that Jurkat and Raji cells constitutively express mRNA and protein for the stress-inducible NKG2D ligands MICA/B and ULBP1 and 2, and up-regulate the expression in a cell-line specific and stress-specific manner. Furthermore, we revealed by electron microscopy, immunoflow cytometry and western blot that these ligands were expressed and secreted on exosomes, nanometer-sized microvesicles of endosomal origin. Acting as a decoy, the NKG2D ligand-bearing exosomes downregulate the in vitro NKG2D receptor-mediated cytotoxicity and thus impair NK-cell function. Interestingly, thermal and oxidative stress enhanced the exosome secretion generating more soluble NKG2D ligands that aggravated the impairment of the cytotoxic response. Taken together, our results might partly explain the clinically observed NK-cell dysfunction in patients suffering from leukemia/lymphoma. The adverse effect of thermal and oxidative stress, enhancing the release of immunosuppressive exosomes, should be considered when cytostatic and hyperthermal anti-cancer therapies are designed.	[Hedlund, Malin; Nagaeva, Olga; Kargl, Dominic; Baranov, Vladimir; Mincheva-Nilsson, Lucia] Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden	Umea University	Hedlund, M (corresponding author), Umea Univ, Dept Clin Microbiol, Div Clin Immunol, Umea, Sweden.	lucia.mincheva-nilsson@climi.umu.se		Kargl, Dominic/0000-0001-7206-1708	Swedish National Cancer Research Foundation Cancerfonden [CAN 2010/495]; research foundations Cancerforskningsfonden I Norrland [AMP 08-587]; Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University	Swedish National Cancer Research Foundation Cancerfonden; research foundations Cancerforskningsfonden I Norrland; Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University	This work was supported by the Swedish National Cancer Research Foundation Cancerfonden (CAN 2010/495), and the research foundations Cancerforskningsfonden I Norrland (AMP 08-587), Centrala ALF medel and Spjutspetsanslag, Vasterbottens Lans Landsting and Insamlingsstiftelsen at the Medical Faculty, Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Coudert JD, 2006, SEMIN CANCER BIOL, V16, P333, DOI 10.1016/j.semcancer.2006.07.008; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; GONZALES C, 2006, CURR TOP MICROBIOL I, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayashi T, 2006, CANCER RES, V66, P563, DOI 10.1158/0008-5472.CAN-05-2776; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Koga T, 2005, BIOCHEM BIOPH RES CO, V337, P1319, DOI 10.1016/j.bbrc.2005.09.184; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Wodnar-Filipowicz A, 2006, SWISS MED WKLY, V136, P359; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438	36	237	244	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16899	10.1371/journal.pone.0016899	http://dx.doi.org/10.1371/journal.pone.0016899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364924	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100014
J	De Biasio, A; Sanchez, R; Prieto, J; Villate, M; Campos-Olivas, R; Blanco, FJ				De Biasio, Alfredo; Sanchez, Ricardo; Prieto, Jesus; Villate, Maider; Campos-Olivas, Ramon; Blanco, Francisco J.			Reduced Stability and Increased Dynamics in the Human Proliferating Cell Nuclear Antigen (PCNA) Relative to the Yeast Homolog	PLOS ONE			English	Article							BACKBONE ASSIGNMENT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; DNA-REPLICATION; SLIDING CLAMP; PROTEIN; BETA; DENATURATION; ASSOCIATION	Proliferating Cell Nuclear Antigen (PCNA) is an essential factor for DNA replication and repair. PCNA forms a toroidal, ring shaped structure of 90 kDa by the symmetric association of three identical monomers. The ring encircles the DNA and acts as a platform where polymerases and other proteins dock to carry out different DNA metabolic processes. The amino acid sequence of human PCNA is 35% identical to the yeast homolog, and the two proteins have the same 3D crystal structure. In this report, we give evidence that the budding yeast (sc) and human (h) PCNAs have highly similar structures in solution but differ substantially in their stability and dynamics. hPCNA is less resistant to chemical and thermal denaturation and displays lower cooperativity of unfolding as compared to scPCNA. Solvent exchange rates measurements show that the slowest exchanging backbone amides are at the beta-sheet, in the structure core, and not at the helices, which line the central channel. However, all the backbone amides of hPCNA exchange fast, becoming undetectable within hours, while the signals from the core amides of scPCNA persist for longer times. The high dynamics of the alpha-helices, which face the DNA in the PCNA-loaded form, is likely to have functional implications for the sliding of the PCNA ring on the DNA since a large hole with a flexible wall facilitates the establishment of protein-DNA interactions that are transient and easily broken. The increased dynamics of hPCNA relative to scPCNA may allow it to acquire multiple induced conformations upon binding to its substrates enlarging its binding diversity. A	[De Biasio, Alfredo; Sanchez, Ricardo; Villate, Maider; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, Derio, Spain; [Prieto, Jesus; Campos-Olivas, Ramon] CNIO, Struct & Computat Biol Programme, Madrid, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	CIC bioGUNE; Centro Nacional de Investigaciones Oncologicas (CNIO); Basque Foundation for Science	De Biasio, A (corresponding author), CIC BioGUNE, Struct Biol Unit, Derio, Spain.	fblanco@cicbiogune.es	Blanco, Francisco J/D-4401-2009; Campos-Olivas, Ramón/L-9173-2014; Sánchez, Ricardo/AAB-1516-2019; cancer, biogune/H-7276-2012	Blanco, Francisco J/0000-0003-2545-4319; Campos-Olivas, Ramón/0000-0002-5743-2221; De Biasio, Alfredo/0000-0003-2139-2958	spanish Ministerio de Ciencia e Innovacion [CTQ2008-03115/BQU]; Comunidad Autonoma de Madrid [P-BIO-0214-2006]	spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid)	Funding: This work was funded by Grant CTQ2008-03115/BQU from the spanish Ministerio de Ciencia e Innovacion (www.micinn.es) and Grant BIPEDD-CM (P-BIO-0214-2006) from the Comunidad Autonoma de Madrid (www.madrid.rg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHM G, 1994, INT J PEPT PROT RES, V43, P97; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Campos-Olivas R, 2007, J BIOMOL NMR, V38, P167, DOI 10.1007/s10858-006-9084-z; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Choe SE, 1998, BIOCHEMISTRY-US, V37, P14508, DOI 10.1021/bi980889k; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Dempsey CE, 2001, PROG NUCL MAG RES SP, V39, P135, DOI 10.1016/S0079-6565(01)00032-2; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guidry JJ, 2000, PROTEIN SCI, V9, P2109, DOI 10.1110/ps.9.11.2109; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Hlinkova V, 2008, ACTA CRYSTALLOGR D, V64, P941, DOI 10.1107/S0907444908021665; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kontopidis G, 2006, CHEM BIOL, V13, P201, DOI 10.1016/j.chembiol.2005.11.011; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2005, J BIOL CHEM, V280, P13888, DOI 10.1074/jbc.M500304200; Pace C N, 1986, Methods Enzymol, V131, P266; Pantoja-Uceda D, 2008, BIOCHEMISTRY-US, V47, P7066, DOI 10.1021/bi800403m; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sanchez R, 2007, BIOMOL NMR ASSIGN, V1, P245, DOI 10.1007/s12104-007-9068-2; Schurtenberger P, 1998, J MOL BIOL, V275, P123, DOI 10.1006/jmbi.1997.1435; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; ZHANG YZ, 2007, THESIS U PENNSYLVANI	44	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16600	10.1371/journal.pone.0016600	http://dx.doi.org/10.1371/journal.pone.0016600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364740	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800011
J	Leren, TP; Berge, KE				Leren, Trond P.; Berge, Knut Erik			Subjects with Molecularly Defined Familial Hypercholesterolemia or Familial Defective apoB-100 Are Not Being Adequately Treated	PLOS ONE			English	Article							HEART-DISEASE; CHOLESTEROL; DIAGNOSIS; CRITERIA; EXTENT	Objectives: To study whether subjects with a molecular genetic diagnosis of familial hypercholesterolemia (FH) or familial defective apoB-100 (FDB) are being adequately treated. Design: A questionnaire regarding medical history was sent to 2611 subjects who had been provided with a molecular genetic diagnosis of FH or FDB, and a blood sample was obtained for lipid measurements. Results: 956 (36.6%) of the 2611 subjects participated. The mean age for starting lipid-lowering therapy was 33.4 (+/- 12.1) years. Among those below 18 years of age, only 20.4% were on lipid-lowering drugs, whereas 89.1% of those aged 18 and above were on lipid-lowering drugs. The mean levels of total serum cholesterol and LDL-cholesterol were 5.7 (+/- 1.5) mmol/l and 3.9 (+/- 1.3) mmol/l, respectively. Among those who were on lipid-lowering drugs, 29.0% and 12.2% had levels of LDL cholesterol below 3.0 mmol/l and 2.6 mmol/l, respectively. Only 47.3% of the 956 subjects were considered as being adequately treated largely due to a failure to titrate their drug regimens. From the use of cholesterol-years score, lipid-lowering therapy must start before the age of 20 in order to prevent the subjects from contracting premature coronary heart disease. Conclusion: The majority of FH/FDB subjects are being diagnosed late in life and are not being adequately treated. In order to prevent them from contracting premature coronary heart disease, it is key that levels of LDL cholesterol are normalized from a young age and that sufficient doses of lipid-lowering drugs are being used.	[Leren, Trond P.; Berge, Knut Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Med Genet Lab,Dept Med Genet, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Leren, TP (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Med Genet Lab,Dept Med Genet, N-0027 Oslo, Norway.	trond.leren@rikshospitalet.no			Extrastiftelsen Helse og Hehabilitering	Extrastiftelsen Helse og Hehabilitering	Funding: This study was funded by Extrastiftelsen Helse og Hehabilitering. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, BMJ, V303, P893; Calonge N, 2007, PEDIATRICS, V120, pE215, DOI 10.1542/peds.2006-1812; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Defesche J., 2000, LIPIDS VASCULAR DIS, V6, P65; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; HEIBERG A, 1976, CLIN GENET, V9, P203; HOEG JM, 1994, ARTERIOSCLER THROMB, V14, P1066, DOI 10.1161/01.ATV.14.7.1066; HUIGEN R, 2008, EXPERT REV CARDIOVAS, V6, P567; KOIVISTO UM, 1993, J LIPID RES, V34, P269; LAW M, 1995, EUR J CLIN NUTR, V49, P223; Leren TP, 2004, CLIN GENET, V66, P483, DOI 10.1111/j.1399-0004.2004.00320.x; Leren TP, 2008, COMMUNITY GENET, V11, P26, DOI 10.1159/000111637; Leren TP, 2009, CLIN LIPIDOL, V4, P303, DOI 10.2217/CLP.09.24; MAARLE MCV, 2002, BRIT MED J, V324, P1367; Marks D, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4290, DOI 10.3310/HTA4290]; Mousavi SA, 2009, J INTERN MED, V266, P507, DOI 10.1111/j.1365-2796.2009.02167.x; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Nozue T, 2006, J ATHEROSCLER THROMB, V13, P323, DOI 10.5551/jat.13.323; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Rallidis L, 1998, HEART, V80, P583, DOI 10.1136/hrt.80.6.583; Sidhu P S, 1996, J Cardiovasc Risk, V3, P61, DOI 10.1097/00043798-199602000-00009; SLACK J, 1969, LANCET, V2, P1380; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; Tonstad S, 1998, EUR J CLIN INVEST, V28, P971; Umans-Eckenhausen MAW, 2003, ARCH INTERN MED, V163, P65, DOI 10.1001/archinte.163.1.65; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Vuorio A, 2010, COCHRANE DB SYST REV, V7; Wierzbicki Anthony S, 2008, BMJ, V337, pa1095, DOI 10.1136/bmj.a1095; Williams RR, 1996, GENETIC APPROACHES TO NONCOMMUNICABLE DISEASES, P35; WILLIAMS RR, 1990, ARCH INTERN MED, V150, P582, DOI 10.1001/archinte.150.3.582; Wonderling David, 2004, Semin Vasc Med, V4, P97; [No title captured]	33	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16721	10.1371/journal.pone.0016721	http://dx.doi.org/10.1371/journal.pone.0016721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364743	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800014
J	Cao, Y; Staropoli, JF; Biswas, S; Espinola, JA; MacDonald, ME; Lee, JM; Cotman, SL				Cao, Yi; Staropoli, John F.; Biswas, Sunita; Espinola, Janice A.; MacDonald, Marcy E.; Lee, Jong-Min; Cotman, Susan L.			Distinct Early Molecular Responses to Mutations Causing vLINCL and JNCL Presage ATP Synthase Subunit C Accumulation in Cerebellar Cells	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; LINK BATTEN-DISEASE; LYSOSOMAL STORAGE; CLN3 PROTEIN; EXPRESSION; PATHWAYS; DEATH; MICE; NCLF	Variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), caused by CLN6 mutation, and juvenile neuronal ceroid lipofuscinosis (JNCL), caused by CLN3 mutation, share clinical and pathological features, including lysosomal accumulation of mitochondrial ATP synthase subunit c, but the unrelated CLN6 and CLN3 genes may initiate disease via similar or distinct cellular processes. To gain insight into the NCL pathways, we established murine wild-type and CbCln6(nclf/nclf) cerebellar cells and compared them to wild-type and CbCln3(Delta ex7/8/Delta ex7/8) cerebellar cells. CbCln6(nclf/nclf) cells and CbCln3(Delta ex7/8/Delta ex7/8) cells both displayed abnormally elongated mitochondria and reduced cellular ATP levels and, as cells aged to confluence, exhibited accumulation of subunit c protein in Lamp 1-positive organelles. However, at sub-confluence, endoplasmic reticulum PDI immunostain was decreased only in CbCln6(nclf/nclf) cells, while fluid-phase endocytosis and LysoTracker (R) labeled vesicles were decreased in both CbCln6(nclf/nclf) and CbCln3(Delta ex7/8/Delta ex7/8) cells, though only the latter cells exhibited abnormal vesicle subcellular distribution. Furthermore, unbiased gene expression analyses revealed only partial overlap in the cerebellar cell genes and pathways that were altered by the Cln3(Delta ex7/8) and Cln6(nclf) mutations. Thus, these data support the hypothesis that CLN6 and CLN3 mutations trigger distinct processes that converge on a shared pathway, which is responsible for proper subunit c protein turnover and neuronal cell survival.	[Cao, Yi; Staropoli, John F.; Biswas, Sunita; Espinola, Janice A.; MacDonald, Marcy E.; Lee, Jong-Min; Cotman, Susan L.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Cao, Y (corresponding author), Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA.	cotman@helix.mgh.harvard.edu			Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke, National Institutes of Health [NS33648]; National Tay-Sachs and Allied Diseases Association; Massachusetts Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center; Dubai-Harvard Foundation for Medical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033648] Funding Source: NIH RePORTER	Batten Disease Support and Research Association; National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Tay-Sachs and Allied Diseases Association; Massachusetts Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center; Dubai-Harvard Foundation for Medical Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Batten Disease Support and Research Association (www.bdsra.org; Postdoctoral Fellowships to Y.C. and S.B., Grant to S.L.C.), by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (www.ninds.nih.gov; NS33648, to M.E.M.), the National Tay-Sachs and Allied Diseases Association (www.ntsad.org; to S.L.C.), the Massachusetts Alzheimer's Disease Research Center and Harvard NeuroDiscovery Center Pilot Study Grants Program (madrc.mgh.harvard.edu; to S.L.C.) and the Dubai-Harvard Foundation for Medical Research (www.dhfmr.hms.harvard.edu; to S.L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Blaveri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012596; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; HALL NA, 1987, CLIN CHIM ACTA, V170, P323, DOI 10.1016/0009-8981(87)90143-4; Haltia M, 2006, BBA-MOL BASIS DIS, V1762, P850, DOI 10.1016/j.bbadis.2006.06.010; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Kyttala A, 2006, BBA-MOL BASIS DIS, V1762, P920, DOI 10.1016/j.bbadis.2006.05.007; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Lyly A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-83; MARTIN JJ, 1991, DEV NEUROSCI-BASEL, V13, P331, DOI 10.1159/000112182; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narayan SB, 2006, ANN NEUROL, V60, P570, DOI 10.1002/ana.20975; Nijssen PCG, 2003, BRAIN PATHOL, V13, P574; PALMER DN, 1989, ADV EXP MED BIOL, V266, P211; PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428; Pearce DA, 1999, NAT GENET, V22, P55, DOI 10.1038/8861; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Persaud-Sawin DA, 2005, APOPTOSIS, V10, P973, DOI 10.1007/s10495-005-0733-6; Persaud-Sawin DANW, 2002, HUM MOL GENET, V11, P2129, DOI 10.1093/hmg/11.18.2129; Persaud-Sawin DA, 2007, PEDIATR RES, V61, P146, DOI 10.1203/pdr.0b013e31802d8a4a; Puranam KL, 1999, MOL GENET METAB, V66, P294, DOI 10.1006/mgme.1999.2834; Savukoski M, 1998, NAT GENET, V19, P286, DOI 10.1038/975; Siintola E, 2006, BBA-MOL BASIS DIS, V1762, P857, DOI 10.1016/j.bbadis.2006.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Vella F, 2002, IUBMB LIFE, V54, P89, DOI 10.1080/15216540214307; Vesa J, 2002, MOL BIOL CELL, V13, P2410, DOI 10.1091/mbc.E02-01-0031; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Williams RE, 2006, BBA-MOL BASIS DIS, V1762, P865, DOI 10.1016/j.bbadis.2006.07.001; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27	57	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17118	10.1371/journal.pone.0017118	http://dx.doi.org/10.1371/journal.pone.0017118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359198	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300030
J	Cesar, L; Suarez, SV; Adi, J; Adi, N; Vazquez-Padron, R; Yu, H; Ma, Q; Goldschmidt-Clermont, PJ; Agatston, A; Kurlansky, P; Webster, KA				Cesar, Liliana; Suarez, Samuel Vasallo; Adi, Jennipher; Adi, Nikhil; Vazquez-Padron, Roberto; Yu, Hong; Ma, Qi; Goldschmidt-Clermont, Pascal J.; Agatston, Arthur; Kurlansky, Paul; Webster, Keith A.			An Essential Role for Diet in Exercise-Mediated Protection against Dyslipidemia, Inflammation and Atherosclerosis in ApoE-/- Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; SEDENTARY OCCUPATIONS; METABOLIC SYNDROME; DISEASE; INTERVENTION; CARBOHYDRATE	Background: Diet and exercise promote cardiovascular health but their relative contributions to atherosclerosis are not fully known. The transition from a sedentary to active lifestyle requires increased caloric intake to achieve energy balance. Using atherosclerosis-prone ApoE-null mice we sought to determine whether the benefits of exercise for arterial disease are dependent on the food source of the additional calories. Methods and Results: Mice were fed a high-fat diet (HF) for 4.5 months to initiate atherosclerosis after which time half were continued on HF while the other half were switched to a high protein/fish oil diet (HP). Half of each group underwent voluntary running. Food intake, running distance, body weight, lipids, inflammation markers, and atherosclerotic plaque were quantified. Two-way ANOVA tests were used to assess differences and interactions between groups. Exercised mice ran approximately 6-km per day with no difference between groups. Both groups increased food intake during exercise and there was a significant main effect of exercise F((1,44) = 9.86, p<0.01) without interaction. Diet or exercise produced significant independent effects on body weight (diet: F(1,52) = 6.85, p = 0.012; exercise: F(1,52) = 9.52, p<0.01) with no significant interaction. The combination of HP diet and exercise produced a greater decrease in total cholesterol (F(1, 46) = 7.9, p<0.01) and LDL (F(1, 46) = 7.33, p<0.01) with a large effect on the size of the interaction. HP diet and exercise independently reduced TGL and VLDL (p<0.05 and 0.001 respectively). Interleukin 6 and C-reactive protein were highest in the HF-sedentary group and were significantly reduced by exercise only in this group. Plaque accumulation in the aortic arch, a marker of cardiovascular events was reduced by the HP diet and the effect was significantly potentiated by exercise only in this group resulting in significant plaque regression (F1, 49 = 4.77, p<0.05). Conclusion: In this model exercise is beneficial to combat dyslipidemia and protect from atherosclerosis only when combined with diet.	[Cesar, Liliana; Suarez, Samuel Vasallo; Adi, Jennipher; Adi, Nikhil; Vazquez-Padron, Roberto; Yu, Hong; Ma, Qi; Goldschmidt-Clermont, Pascal J.; Webster, Keith A.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Cesar, Liliana; Suarez, Samuel Vasallo; Adi, Jennipher; Adi, Nikhil; Vazquez-Padron, Roberto; Yu, Hong; Ma, Qi; Goldschmidt-Clermont, Pascal J.; Webster, Keith A.] Univ Miami, Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA; [Kurlansky, Paul] Florida Heart Res Inst, Miami Beach, FL USA; [Kurlansky, Paul] Agatston Res Inst, Miami Beach, FL USA	University of Miami; University of Miami	Cesar, L (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kwebster@med.miami.edu	Ma, Qi/B-6569-2012	Webster, Keith A/0000-0002-6431-3642	National Institutes of Health [HL092499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: The work was supported by grant # HL092499 (KAW) from the National Institutes of Health. KAW holds a Distinguished Chair in Vascular Biology from the Walter G. Ross Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu B, 2006, Niger J Med, V15, P190; Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Batsis JA, 2007, CLIN PHARMACOL THER, V82, P509, DOI 10.1038/sj.clpt.6100355; Bayturan O, 2010, ARCH INTERN MED, V170, P478, DOI 10.1001/archinternmed.2009.551; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Blasi C, 2008, ATHEROSCLEROSIS, V201, P17, DOI 10.1016/j.atherosclerosis.2008.05.025; Cardenas GA, 2008, REV CARDIOVASC MED, V9, P239; Caulin-Glaser Teresa, 2005, J Cardiopulm Rehabil, V25, P332, DOI 10.1097/00008483-200511000-00003; Cuffe M, 2006, CLIN CARDIOL, V29, P4; Di Tullio MR, 2009, CIRCULATION, V119, P2376, DOI 10.1161/CIRCULATIONAHA.108.811935; Foley Susan M, 2005, Medsurg Nurs, V14, P43; Fontana L, 2008, EUR J CARDIOV PREV R, V15, P3, DOI 10.1097/HJR.0b013e3282f17bd4; Genest J, 2006, CAN J CARDIOL, V22, P863, DOI 10.1016/S0828-282X(06)70305-1; Gielen Stephan, 2003, Am Heart J, V145, pE3; Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Jolliffe JA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001800; Kim YJ, 2008, PFLUG ARCH EUR J PHY, V455, P1081, DOI 10.1007/s00424-007-0356-6; Kraus WE, 2009, OBESITY, V17, pS21, DOI 10.1038/oby.2009.384; Lakka TA, 2005, HANDB EXP PHARM, V170, P137; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lippincott MF, 2008, AM J CARDIOL, V102, P820, DOI 10.1016/j.amjcard.2008.05.020; Lippincott MF, 2008, AM J CARDIOL, V102, P348, DOI 10.1016/j.amjcard.2008.03.069; Milani RV, 2004, J AM COLL CARDIOL, V43, P1056, DOI 10.1016/j.jacc.2003.10.041; Morgan LM, 2009, PUBLIC HEALTH NUTR, V12, P799, DOI 10.1017/S1368980008003236; Muchiteni Tshaka, 2009, Curr Cardiol Rep, V11, P476; Nesto Richard W, 2005, Am J Cardiovasc Drugs, V5, P379, DOI 10.2165/00129784-200505060-00005; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pynn M, 2004, CIRCULATION, V109, P386, DOI 10.1161/01.CIR.0000109500.03050.7C; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Ribeiro F, 2010, INT J CARDIOL, V141, P214, DOI 10.1016/j.ijcard.2009.09.548; Rice Terry W, 2006, Vasc Endovascular Surg, V40, P312, DOI 10.1177/1538574406291835; Shimada K, 2007, CIRC J, V71, P1147, DOI 10.1253/circj.71.1147; Soderlund A, 2009, PERSPECT PUBLIC HEAL, V129, P132, DOI 10.1177/1757913908094805; Stanner S, 2009, BR J COMMUNITY NURS, V14, P210; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Walther C, 2008, EUR J CARDIOV PREV R, V15, P107, DOI 10.1097/HJR.0b013e3282f29aa6; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17263	10.1371/journal.pone.0017263	http://dx.doi.org/10.1371/journal.pone.0017263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359188	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700065
J	Dumanis, SB; Cha, HJ; Song, JM; Trotter, JH; Spitzer, M; Lee, JY; Weeber, EJ; Turner, RS; Pak, DTS; Rebeck, GW; Hoe, HS				Dumanis, Sonya B.; Cha, Hyun-Jung; Song, Jung Min; Trotter, Justin H.; Spitzer, Matthew; Lee, Ji-Yun; Weeber, Edwin J.; Turner, R. Scott; Pak, Daniel T. S.; Rebeck, G. William; Hoe, Hyang-Sook			ApoE Receptor 2 Regulates Synapse and Dendritic Spine Formation	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; AMPA RECEPTORS; LIPOPROTEIN RECEPTORS; NEURONAL MIGRATION; NEURITE OUTGROWTH; PYRAMIDAL NEURONS; F-SPONDIN; PLASTICITY; REELIN; EXPRESSION	Background: Apolipoprotein E receptor 2 (ApoEr2) is a postsynaptic protein involved in long-term potentiation (LTP), learning, and memory through unknown mechanisms. We examined the biological effects of ApoEr2 on synapse and dendritic spine formation-processes critical for learning and memory. Methodology/Principal Findings: In a heterologous co-culture synapse assay, overexpression of ApoEr2 in COS7 cells significantly increased colocalization with synaptophysin in primary hippocampal neurons, suggesting that ApoEr2 promotes interaction with presynaptic structures. In primary neuronal cultures, overexpression of ApoEr2 increased dendritic spine density. Consistent with our in vitro findings, ApoEr2 knockout mice had decreased dendritic spine density in cortical layers II/III at 1 month of age. We also tested whether the interaction between ApoEr2 and its cytoplasmic adaptor proteins, specifically X11 alpha and PSD-95, affected synapse and dendritic spine formation. X11 alpha decreased cell surface levels of ApoEr2 along with synapse and dendritic spine density. In contrast, PSD-95 increased cell surface levels of ApoEr2 as well as synapse and dendritic spine density. Conclusions/Significance: These results suggest that ApoEr2 plays important roles in structure and function of CNS synapses and dendritic spines, and that these roles are modulated by cytoplasmic adaptor proteins X11 alpha and PSD-95.	[Dumanis, Sonya B.; Cha, Hyun-Jung; Song, Jung Min; Spitzer, Matthew; Rebeck, G. William; Hoe, Hyang-Sook] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Lee, Ji-Yun; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA; [Cha, Hyun-Jung; Song, Jung Min; Spitzer, Matthew; Turner, R. Scott; Hoe, Hyang-Sook] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Trotter, Justin H.; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA	Georgetown University; Georgetown University; Georgetown University; State University System of Florida; University of South Florida	Dumanis, SB (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	hh69@georgetown.edu	Rebeck, George William/J-2192-2012; Lee, Ji-Yun/F-8127-2013; Trotter, Justin H/I-6458-2012; Weeber, Edwin J/A-5396-2012; Turner, Raymond Scott/G-2263-2011	Rebeck, George William/0000-0001-6276-248X; Turner, Raymond Scott/0000-0001-7534-2935; Lee, Ji-Yun/0000-0002-4053-6577; Spitzer, Matthew/0000-0002-5291-3819; Dumanis, Sonya/0000-0002-3345-9497	National Institutes of Health (NIH) [AG032330 (HSH), AG032330-02S1(HSH), AG034253(HSH), P01 AG030128 (GWR), NS048085 (DTSP), AG026478 (RST)]; National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG034253, R03AG032330, P01AG030128, R01AG026478] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by grants from the National Institutes of Health (NIH) AG032330 (HSH), AG032330-02S1(HSH), AG034253(HSH), P01 AG030128 (GWR), NS048085 (DTSP), and AG026478 (RST), and from the National Science Foundation Graduate Research Fellowship (SBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Clatworthy AE, 1999, NEUROSCIENCE, V90, P903, DOI 10.1016/S0306-4522(98)00489-8; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; HOE HS, 2009, J BIOL CHEM; HOE HS, 2008, MOL NEUROBIOL; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Okamoto M, 2000, EUR J NEUROSCI, V12, P3067, DOI 10.1046/j.1460-9568.2000.00200.x; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	45	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17203	10.1371/journal.pone.0017203	http://dx.doi.org/10.1371/journal.pone.0017203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347244	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200029
J	Hubisz, MJ; Lin, MF; Kellis, M; Siepel, A				Hubisz, Melissa J.; Lin, Michael F.; Kellis, Manolis; Siepel, Adam			Error and Error Mitigation in Low-Coverage Genome Assemblies	PLOS ONE			English	Article							DNA-SEQUENCES; FUNCTIONAL ELEMENTS; MAMMALIAN GENOMES; ACCURACY; IDENTIFICATION; MOUSE; ALIGNMENTS; 1-PERCENT; SELECTION; REGIONS	The recent release of twenty-two new genome sequences has dramatically increased the data available for mammalian comparative genomics, but twenty of these new sequences are currently limited to similar to 2x coverage. Here we examine the extent of sequencing error in these 2x assemblies, and its potential impact in downstream analyses. By comparing 2x assemblies with high-quality sequences from the ENCODE regions, we estimate the rate of sequencing error to be 1-4 errors per kilobase. While this error rate is fairly modest, sequencing error can still have surprising effects. For example, an apparent lineage-specific insertion in a coding region is more likely to reflect sequencing error than a true biological event, and the length distribution of coding indels is strongly distorted by error. We find that most errors are contributed by a small fraction of bases with low quality scores, in particular, by the ends of reads in regions of single-read coverage in the assembly. We explore several approaches for automatic sequencing error mitigation (SEM), making use of the localized nature of sequencing error, the fact that it is well predicted by quality scores, and information about errors that comes from comparisons across species. Our automatic methods for error mitigation cannot replace the need for additional sequencing, but they do allow substantial fractions of errors to be masked or eliminated at the cost of modest amounts of overcorrection, and they can reduce the impact of error in downstream phylogenomic analyses. Our error-mitigated alignments are available for download.	[Hubisz, Melissa J.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Lin, Michael F.; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02139 USA; [Lin, Michael F.; Kellis, Manolis] Harvard Univ, Cambridge, MA 02138 USA; [Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Siepel, Adam] Cornell Univ, Cornell Ctr Comparat & Populat Genom, Ithaca, NY USA	Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Cornell University	Hubisz, MJ (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	acs4@cornell.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Siepel, Adam/0000-0002-3557-7219; Hubisz, Melissa/0000-0002-9561-6830	NSF [DBI-0644111, DBI-0644282]; NIH [U54 HG004555-01]; David and Lucile Packard Fellowship for Science and Engineering; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555, R01HG004037] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship for Science and Engineering(The David & Lucile Packard Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NSF Faculty Early Career Development grants DBI-0644111 (AS) and DBI-0644282 (MK, MFL), NIH grant U54 HG004555-01 (MK, MFL), and a David and Lucile Packard Fellowship for Science and Engineering (AS, MJH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bishop C. M, 2006, PATTERN RECOGNITION; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; CHURCHILL GA, 1992, GENOMICS, V14, P89, DOI 10.1016/S0888-7543(05)80288-5; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gajer P, 2004, NUCLEIC ACIDS RES, V32, P562, DOI 10.1093/nar/gkh216; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; KRAWETZ SA, 1989, NUCLEIC ACIDS RES, V17, P3951, DOI 10.1093/nar/17.10.3951; LANDER E S, 1988, Genomics, V2, P231; LAWRENCE CB, 1994, NUCLEIC ACIDS RES, V22, P1272, DOI 10.1093/nar/22.7.1272; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li M, 2004, NUCLEIC ACIDS RES, V32, P5183, DOI 10.1093/nar/gkh850; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mallick S, 2009, GENOME RES, V19, P922, DOI 10.1101/gr.086512.108; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; POSFAI J, 1992, P NATL ACAD SCI USA, V89, P4698, DOI 10.1073/pnas.89.10.4698; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; STATES DJ, 1991, P NATL ACAD SCI USA, V88, P5518, DOI 10.1073/pnas.88.13.5518; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zinck JM, 2004, MOL ECOL NOTES, V4, P239, DOI 10.1111/j.1471-8286.2004.00629.x	42	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17034	10.1371/journal.pone.0017034	http://dx.doi.org/10.1371/journal.pone.0017034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340033	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287367600031
J	Krissak, R; Mistretta, CA; Henzler, T; Chatzikonstantinou, A; Scharf, J; Schoenberg, SO; Fink, C				Krissak, Radko; Mistretta, Charles A.; Henzler, Thomas; Chatzikonstantinou, Anastasios; Scharf, Johann; Schoenberg, Stefan O.; Fink, Christian			Noise Reduction and Image Quality Improvement of Low Dose and Ultra Low Dose Brain Perfusion CT by HYPR-LR Processing	PLOS ONE			English	Article							DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; ACUTE STROKE; RECONSTRUCTION; ANGIOGRAPHY; PERFORMANCE	Purpose: To evaluate image quality and signal characteristics of brain perfusion CT (BPCT) obtained by low-dose (LD) and ultra-low-dose (ULD) protocols with and without post-processing by highly constrained back-projection (HYPR)-local reconstruction (LR) technique. Methods and Materials: Simultaneous BPCTs were acquired in 8 patients on a dual-source-CT by applying LD (80 kV, 200 mAs, 14 x 1.2 mm) on tube A and ULD (80 kV, 30 mAs, 14 x 1.2 mm) on tube B. Image data from both tubes was reconstructed with identical parameters and post-processed using the HYPR-LR. Correlation coefficients between mean and maximum (MAX) attenuation values within corresponding ROIs, area under attenuation curve (AUC), and signal to noise ratio (SNR) of brain parenchyma were assessed. Subjective image quality was assessed on a 5-point scale by two blinded observers (1:excellent, 5: non-diagnostic). Results: Radiation dose of ULD was more than six times lower compared to LD. SNR was improved by HYPR: ULD vs. ULD+HYPR: 1.9 +/- 0.3 vs. 8.4 +/- 1.7, LD vs. LD+HYPR: 5.0 +/- 0.7 vs. 13.4 +/- 2.4 (both p<0.0001). There was a good correlation between the original datasets and the HYPR-LR post-processed datasets: r = 0.848 for ULD and ULD+HYPR and r = 0.933 for LD and LD+HYPR (p < 0.0001 for both). The mean values of the HYPR-LR post-processed ULD dataset correlated better with the standard LD dataset (r = 0.672) than unprocessed ULD (r = 0.542), but both correlations were significant (p < 0.0001). There was no significant difference in AUC or MAX. Image quality was rated excellent (1.3) in LD+HYPR and non-diagnostic (5.0) in ULD. LD and ULD+HYPR images had moderate image quality (3.3 and 2.7). Conclusion: SNR and image quality of ULD-BPCT can be improved to a level similar to LD-BPCT when using HYPR-LR without distorting attenuation measurements. This can be used to substantially reduce radiation dose. Alternatively, LD images can be improved by HYPR-LR to higher diagnostic quality.	[Krissak, Radko; Henzler, Thomas; Schoenberg, Stefan O.; Fink, Christian] Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Heidelberg, Germany; [Mistretta, Charles A.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Chatzikonstantinou, Anastasios] Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Neurol, Heidelberg, Germany; [Scharf, Johann] Univ Heidelberg, Dept Neuroradiol, Univ Med Ctr Mannheim, Med Fac Mannheim, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Wisconsin System; University of Wisconsin Madison; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Krissak, R (corresponding author), Univ Heidelberg, Med Fac Mannheim, Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Heidelberg, Germany.	radko.krissak@umm.de			Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz) [StSch 4543]	Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz)	Funding: This work was supported in part (R.K., S.O.S., C.F.) by a research grant from the Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz; StSch 4543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barfett JJ, 2010, INVEST RADIOL, V45, P370, DOI 10.1097/RLI.0b013e3181e1939d; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cohnen M, 2006, AM J NEURORADIOL, V27, P1741; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Imanishi Y, 2005, EUR RADIOL, V15, P41, DOI 10.1007/s00330-004-2459-1; Johnson KM, 2008, MAGN RESON MED, V59, P456, DOI 10.1002/mrm.21505; Koenig M, 1998, RADIOLOGY, V209, P85, DOI 10.1148/radiology.209.1.9769817; Konig M, 2003, EUR J RADIOL, V45, pS11, DOI 10.1016/S0720-048X(02)00359-5; Liu X, 2009, RADIOLOGY, V253, P98, DOI [10.1148/radiol.2531081677, 10.1148/radiol.2531081677/-/DC1]; McCollough CH, 2008, MED PHYS, V35, P764, DOI 10.1118/1.2826559; McCollough CH, 2007, RADIOLOGY, V243, P775, DOI 10.1148/radiol.2433061165; Mistretta CA, 2006, MAGN RESON MED, V55, P30, DOI 10.1002/mrm.20772; Morhard D, 2010, INVEST RADIOL, V45, P363, DOI 10.1097/RLI.0b013e3181e1956f; Nabavi DG, 1999, RADIOLOGY, V213, P141, DOI 10.1148/radiology.213.1.r99oc03141; Supanich M, 2009, PHYS MED BIOL, V54, P4575, DOI 10.1088/0031-9155/54/14/013; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Youn SW, 2008, AM J ROENTGENOL, V191, pW120, DOI 10.2214/AJR.07.2519	20	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17098	10.1371/journal.pone.0017098	http://dx.doi.org/10.1371/journal.pone.0017098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347259	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500027
J	Baine, MJ; Chakraborty, S; Smith, LM; Mallya, K; Sasson, AR; Brand, RE; Batra, SK				Baine, Michael J.; Chakraborty, Subhankar; Smith, Lynette M.; Mallya, Kavita; Sasson, Aaron R.; Brand, Randall E.; Batra, Surinder K.			Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic Utility	PLOS ONE			English	Article							EXPRESSION PROFILES; MOLECULAR MARKERS; SUPPRESSOR-CELLS; BREAST-CANCER; CARCINOMA; BIOMARKERS; CA19-9; MOUSE	Background: It is well known that many malignancies, including pancreatic cancer (PC), possess the ability to evade the immune system by indirectly downregulating the mononuclear cell machinery necessary to launch an effective immune response. This knowledge, in conjunction with the fact that the trancriptome of peripheral blood mononuclear cells has been shown to be altered in the context of many diseases, including renal cell carcinoma, lead us to study if any such alteration in gene expression exists in PC as it may have diagnostic utility. Methods and Findings: PBMC samples from 26 PC patients and 33 matched healthy controls were analyzed by whole genome cDNA microarray. Three hundred eighty-three genes were found to be significantly different between PC and healthy controls, with 65 having at least a 1.5 fold change in expression. Pathway analysis revealed that many of these genes fell into pathways responsible for hematopoietic differentiation, cytokine signaling, and natural killer (NK) cell and CD8+ T-cell cytotoxic response. Unsupervised hierarchical clustering analysis identified an eight-gene predictor set, consisting of SSBP2, Ube2b-rs1, CA5B, F5, TBC1D8, ANXA3, ARG1, and ADAMTS20, that could distinguish PC patients from healthy controls with an accuracy of 79% in a blinded subset of samples from treatment naive patients, giving a sensitivity of 83% and a specificity of 75%. Conclusions: In summary, we report the first in-depth comparison of global gene expression profiles of PBMCs between PC patients and healthy controls. We have also identified a gene predictor set that can potentially be developed further for use in diagnostic algorithms in PC. Future directions of this research should include analysis of PBMC expression profiles in patients with chronic pancreatitis as well as increasing the number of early-stage patients to assess the utility of PBMCs in the early diagnosis of PC.	[Baine, Michael J.; Batra, Surinder K.] Univ Nebraska Med Ctr Omaha, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Chakraborty, Subhankar; Mallya, Kavita; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Smith, Lynette M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Sasson, Aaron R.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Brand, Randall E.] Univ Pittsburgh, Sch Med, Div Gastroenterol, Pittsburgh, PA USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Baine, MJ (corresponding author), Univ Nebraska Med Ctr Omaha, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	sbatra@unmc.edu			National Institutes of Health [RO1 CA131944, RO1 CA78590, RO1 CA 133774, EDRN UO1 CA 111294, SPORE P50 CA127297]; National Center for Research Resources, NIH [P20 RR016469]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA131944, P50CA127297, R01CA133774, R01CA078590] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (RO1 CA131944, RO1 CA78590, RO1 CA 133774, EDRN UO1 CA 111294, and SPORE P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The UNMC Microarray Core Facility receives partial support from the INBRE Program of the National Center for Research Resources, NIH grant number P20 RR016469.	American Cancer Society, 2022, CANC FACTS FIGURES 2; [Anonymous], 1999, ANTICANCER RES, V19, P2811; Bluth M, 2008, ARCH SURG-CHICAGO, V143, P227, DOI 10.1001/archsurg.2007.73; Brandt R, 2004, PANCREATOLOGY, V4, P587, DOI 10.1159/000082241; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; CHAKRABORTY S, 2010, BIOCHIM BIOPHYS ACTA, V1815, P44; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; DiMagno EP, 1999, GASTROENTEROLOGY, V117, P1464, DOI 10.1016/S0016-5085(99)70298-2; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Goggins M, 2005, J CLIN ONCOL, V23, P4524, DOI 10.1200/JCO.2005.19.711; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Huang H, 2010, AM J GASTROENTEROL, V105, P1661, DOI 10.1038/ajg.2010.32; Liang JJ, 2009, INT J CLIN EXP PATHO, V2, P1; Mikuriya K, 2007, INT J ONCOL, V30, P849; *NAT CANC I, 1975, SURV EP END RES CANC; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; PLESKOW DK, 1989, ANN INTERN MED, V110, P704, DOI 10.7326/0003-4819-110-9-704; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Simon R, 2007, CANCER INFORM, V3, P11; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Talmadge JE, 2007, CLIN CANCER RES, V13, P5243, DOI 10.1158/1078-0432.CCR-07-0182; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Twine NC, 2003, CANCER RES, V63, P6069; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x	32	85	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17014	10.1371/journal.pone.0017014	http://dx.doi.org/10.1371/journal.pone.0017014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347333	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000287363000031
J	Haapkyla, J; Unsworth, RKF; Flavell, M; Bourne, DG; Schaffelke, B; Willis, BL				Haapkylae, Jessica; Unsworth, Richard K. F.; Flavell, Mike; Bourne, David G.; Schaffelke, Britta; Willis, Bette L.			Seasonal Rainfall and Runoff Promote Coral Disease on an Inshore Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BLACK BAND DISEASE; SPATIAL VARIABILITY; NUTRIENT ENRICHMENT; ORGANIC-CARBON; TERRESTRIAL; ECOLOGY; SEDIMENTS; RATES; TEMPERATURE	Background: Declining water quality coupled with the effects of climate change are rapidly increasing coral diseases on reefs worldwide, although links between coral diseases and environmental parameters remain poorly understood. This is the first study to document a correlation between coral disease and water quality on an inshore reef. Methodology/Principal Findings: The temporal dynamics of the coral disease atramentous necrosis (AN) was investigated over two years within inshore populations of Montipora aequituberculata in the central Great Barrier Reef, in relation to rainfall, salinity, temperature, water column chlorophyll a, suspended solids, sedimentation, dissolved organic carbon, and particulate nitrogen, phosphorus and organic carbon. Overall, mean AN prevalence was 10-fold greater during summer wet seasons than winter dry seasons. A 2.5-fold greater mean disease abundance was detected during the summer of 2009 (44 +/- SE 6.7 diseased colonies per 25 m(2)), when rainfall was 1.6-fold greater than in the summer of 2008. Two water quality parameters explained 67% of the variance in monthly disease prevalence in a Partial Least Squares regression analysis; disease abundance was negatively correlated with salinity (R2 = -0.6) but positively correlated with water column particulate organic carbon concentration (R2 = 0.32). Seasonal temperature patterns were also positively correlated with disease abundance, but explained only a small portion of the variance. Conclusions/Significance: The results suggest that rainfall and associated runoff may facilitate seasonal disease outbreaks, potentially by reducing host fitness or by increasing pathogen virulence due to higher availability of nutrients and organic matter. In the future, rainfall and seawater temperatures are likely to increase due to climate change which may lead to decreased health of inshore reefs.	[Haapkylae, Jessica; Flavell, Mike; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Haapkylae, Jessica; Bourne, David G.; Schaffelke, Britta] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Unsworth, Richard K. F.] Univ Glamorgan, Biol Sci Res Unit, Pontypridd CF37 1DL, M Glam, Wales	James Cook University; Australian Institute of Marine Science; University of South Wales	Haapkyla, J (corresponding author), James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Jessica.Haapkyla@jcu.edu.au	Bourne, David G/B-5073-2008; Unsworth, Richard K.F./C-1266-2009	Bourne, David G/0000-0002-1492-8710; Unsworth, Richard K.F./0000-0003-0036-9724	Australian Research Council; Australian Institute of Marine Science at James Cook University (AIMS@JCU)	Australian Research Council(Australian Research Council); Australian Institute of Marine Science at James Cook University (AIMS@JCU)	This work was supported by an Australian Research Council Grant and Australian Institute of Marine Science at James Cook University (AIMS@JCU) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2005, MAR POLLUT BULL, V51, P239, DOI 10.1016/j.marpolbul.2004.10.033; Anthony SL, 2008, DIS AQUAT ORGAN, V81, P255, DOI 10.3354/dao01962; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; BRUCKNER AW, 2002, PRIORITIES EFFECTIVE; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chartrand KM, 2009, MAR BIOL, V156, P1691, DOI 10.1007/s00227-009-1204-3; Clarke K. R., 1994, CHANGE MARINE COMMUN, P172; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DEATH G, 2008, RES PUBLICATION GREA, V89; DeVantier LM, 1997, WORKSHOP SERIES GREA, V22, P65; DEVLIN M, 2001, RES PUBLICATION GREA, V68; Devlin M, 2009, MAR FRESHWATER RES, V60, P1109, DOI 10.1071/MF08343; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Farnsworth EJ, 1998, GLOBAL ECOL BIOGEOGR, V7, P15, DOI 10.2307/2997694; Furnas M, 2005, MAR POLLUT BULL, V51, P253, DOI 10.1016/j.marpolbul.2004.11.010; Furnas M., 2003, CATCHMENT CORALS TER; Furnas M.J., 1995, RES PUBLICATION GREA; HAAPKYLA J, 2010, CORAL REEFS; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, AM NAT, V164, pS1, DOI 10.1086/424611; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson PTJ, 2010, ECOL APPL, V20, P16, DOI 10.1890/08-0633.1; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Kim Kiho, 2002, P813; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; KING B, 2002, 44 CRC REEF RES CTR; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; LONERGAN C, 2006, THESIS J COOK U TOWN; Maughan M., 2008, P WAT 2008 INC 31 HY, P1912; McCallum H, 2003, ECOL LETT, V6, P1062, DOI 10.1046/j.1461-0248.2003.00545.x; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; *REEF RAINF RES CT, 2010, REEF RESC MAR MON PR; ROGERS CS, 1983, MAR POLLUT BULL, V14, P378, DOI 10.1016/0025-326X(83)90602-1; ROY KJ, 1971, PAC SCI, V25, P234; SATO Y, 2009, P ROY SOC LOND B BIO, V27, P2795, DOI DOI 10.1098/RSPB.2009.0481; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; SCHAFFELKE B, 2007, WATER QUALITY ECOSYS; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Trenberth KE, 1998, CLIMATIC CHANGE, V39, P667, DOI 10.1023/A:1005319109110; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Veron JEN, 2008, CORAL REEFS, V27, P459, DOI 10.1007/s00338-008-0381-8; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Walsh KJE, 2000, J CLIMATE, V13, P3029, DOI 10.1175/1520-0442(2000)013<3029:TCIINA>2.0.CO;2; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P49	77	116	116	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16893	10.1371/journal.pone.0016893	http://dx.doi.org/10.1371/journal.pone.0016893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347317	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287363000022
J	Morris, GAJ; Edwards, DRV; Hill, PC; Wejse, C; Bisseye, C; Olesen, R; Edwards, TL; Gilbert, JR; Myers, JL; Stryjewski, ME; Abbate, E; Estevan, R; Hamilton, CD; Tacconelli, A; Novelli, G; Brunetti, E; Aaby, P; Sodemann, M; Ostergaard, L; Adegbola, R; Williams, SM; Scott, WK; Sirugo, G				Morris, Gerard A. J.; Edwards, Digna R. Velez; Hill, Philip C.; Wejse, Christian; Bisseye, Cyrille; Olesen, Rikke; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Stryjewski, Martin E.; Abbate, Eduardo; Estevan, Rosa; Hamilton, Carol D.; Tacconelli, Alessandra; Novelli, Giuseppe; Brunetti, Ercole; Aaby, Peter; Sodemann, Morten; Ostergaard, Lars; Adegbola, Richard; Williams, Scott M.; Scott, William K.; Sirugo, Giorgio			Interleukin 12B (IL12B) Genetic Variation and Pulmonary Tuberculosis: A Study of Cohorts from The Gambia, Guinea-Bissau, United States and Argentina	PLOS ONE			English	Article							D-RECEPTOR POLYMORPHISMS; IFN-GAMMA; LINKAGE DISEQUILIBRIUM; WEST-AFRICA; SUSCEPTIBILITY; ASSOCIATION; INFECTION; VARIANTS; COMPLEX; DEFICIENCY	We examined whether polymorphisms in interleukin-12B (IL12B) associate with susceptibility to pulmonary tuberculosis (PTB) in two West African populations (from The Gambia and Guinea-Bissau) and in two independent populations from North and South America. Nine polymorphisms (seven SNPs, one insertion/deletion, one microsatellite) were analyzed in 321 PTB cases and 346 controls from Guinea-Bissau and 280 PTB cases and 286 controls from The Gambia. For replication we studied 281 case and 179 control African-American samples and 221 cases and 144 controls of European ancestry from the US and Argentina. First-stage single locus analyses revealed signals of association at IL12B 3' UTR SNP rs3212227 (unadjusted allelic p = 0.04; additive genotypic p = 0.05, OR = 0.78, 95% CI [0.61-0.99]) in Guinea-Bissau and rs11574790 (unadjusted allelic p = 0.05; additive genotypic p = 0.05, OR = 0.76, 95% CI [0.58-1.00]) in The Gambia. Association of rs3212227 was then replicated in African-Americans (rs3212227 allelic p = 0.002; additive genotypic p = 0.05, OR = 0.78, 95% CI [0.61-1.00]); most importantly, in the African-American cohort, multiple significant signals of association (seven of the nine polymorphisms tested) were detected throughout the gene. These data suggest that genetic variation in IL12B, a highly relevant candidate gene, is a risk factor for PTB in populations of African ancestry, although further studies will be required to confirm this association and identify the precise mechanism underlying it.	[Morris, Gerard A. J.; Hill, Philip C.; Bisseye, Cyrille; Adegbola, Richard] MRC Labs, Fajara, Gambia; [Edwards, Digna R. Velez; Edwards, Todd L.; Tacconelli, Alessandra; Brunetti, Ercole; Sirugo, Giorgio] Osped San Pietro FBF, Unita Genet Med, Rome, Italy; [Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Scott, William K.] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Coral Gables, FL 33124 USA; [Edwards, Digna R. Velez; Edwards, Todd L.; Gilbert, John R.; Myers, Jamie L.; Scott, William K.] Univ Miami, Hussman Inst Human Gen, Coral Gables, FL 33124 USA; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Christchurch, New Zealand; [Wejse, Christian; Olesen, Rikke; Ostergaard, Lars] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark; [Wejse, Christian; Aaby, Peter] Danish Epidemiol Sci Ctr, Bandim Hlth Project, Bissau, Guinea Bissau; [Wejse, Christian; Aaby, Peter] Statens Serum Inst, Bissau, Guinea Bissau; [Stryjewski, Martin E.] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Div Infect Dis, Dept Med, Buenos Aires, DF, Argentina; [Abbate, Eduardo; Estevan, Rosa] Hosp FJ Muniz, Dept Med, Buenos Aires, DF, Argentina; [Hamilton, Carol D.] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Hamilton, Carol D.] Duke Univ, Med Ctr, Durham, NC USA; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dipartimento Biopatol & Diagnost Immagini, Rome, Italy; [Sodemann, Morten] Univ So Denmark, Odense, Denmark; [Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	MRC Laboratory Molecular Biology; University of Miami; University of Miami; University of Otago; Aarhus University; Aarhus University; Statens Serum Institut; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Buenos Aires; Duke University; University of Rome Tor Vergata; University of Southern Denmark; Vanderbilt University	Morris, GAJ (corresponding author), MRC Labs, Fajara, Gambia.	BScott@med.miami.edu; sirugo.giorgio@fbfrm.it	Bisseye, C./AFO-0118-2022; Bisseye, Cyrille/AGP-8782-2022; Sirugo, Giorgio/N-9056-2019; Edwards, Todd/B-9750-2012; Wejse, Christian/C-8468-2014; Novelli, Giuseppe/GQB-3329-2022; Sirugo, Giorgio/L-1628-2016; Velez Edwards, Digna/C-1090-2012; Novelli, Giuseppe/A-5195-2013; Williams, Scott/B-9491-2012; Ostergaard, Lars/AAA-3020-2020; Williams, Scott/Q-4812-2019; Novelli, Giuseppe/T-8822-2019	Bisseye, Cyrille/0000-0002-6888-6317; Wejse, Christian/0000-0002-2534-2942; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Ostergaard, Lars/0000-0003-2459-0511; Williams, Scott/0000-0002-4835-9544; Scott, William/0000-0001-9336-6404; Stryjewski, Martin/0000-0002-4986-6564; Sodemann, Morten/0000-0001-8992-2500; Aaby, Peter/0000-0001-8331-1389; Ostergaard, Lars/0000-0002-7619-605X; Olesen, Rikke/0000-0002-5157-080X	Medical Research Council [G0000690]; Danish Medical Research Council; Danish Society of Respiratory Medicine; Danish Council of Development Research; U.S. National Institutes of Health [HL068534]; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068534] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Society of Respiratory Medicine; Danish Council of Development Research; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Medical Research Council award G0000690 to GS, by Grants from the Danish Medical Research Council, the Danish Society of Respiratory Medicine, the Danish Council of Development Research to RO, CW, MS and LO and by the U.S. National Institutes of Health grant HL068534 to WKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Anand SP, 2007, INDIAN J MED RES, V126, P135; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergholdt R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010454; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freidin MB, 2006, INT J IMMUNOGENET, V33, P231, DOI 10.1111/j.1744-313X.2006.00591.x; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Frucht DM, 1996, J IMMUNOL, V157, P411; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Ha SJ, 2006, INFECT IMMUN, V74, P4954, DOI 10.1128/IAI.01781-05; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; LEWONTIN RC, 1964, GENETICS, V49, P49; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma X, 2003, J INFECT DIS, V188, P1116, DOI 10.1086/378674; Marquet S, 2008, HUM MOL GENET, V17, P2190, DOI 10.1093/hmg/ddn118; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Selvaraj P, 2003, CURR SCI INDIA, V84, P1564; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Tso HW, 2004, J INFECT DIS, V190, P913, DOI 10.1086/422693; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wright G W, 1969, J Air Pollut Control Assoc, V19, P681; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	49	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16656	10.1371/journal.pone.0016656	http://dx.doi.org/10.1371/journal.pone.0016656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21339808	Green Submitted, gold, Green Published			2022-12-27	WOS:000287361700024
J	Marengo, B; De Ciucis, C; Ricciarelli, R; Passalacqua, M; Nitti, M; Zingg, JM; Marinari, UM; Pronzato, MA; Domenicotti, C				Marengo, Barbara; De Ciucis, Chiara; Ricciarelli, Roberta; Passalacqua, Mario; Nitti, Mariapaola; Zingg, Jean-Marc; Marinari, Umberto M.; Pronzato, Maria A.; Domenicotti, Cinzia			PKC delta Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage	PLOS ONE			English	Article							PROTEIN-KINASE-C; GLUTATHIONE DEPLETION; NADPH OXIDASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; ACTIVATION; GROWTH; PHOSPHORYLATION; INHIBITION; ROTTLERIN	Neuroblastoma is a type of pediatric cancer. The sensitivity of neuroblastoma (NB) cancer cells to chemotherapy and radiation is inhibited by the presence of antioxidants, such as glutathione (GSH), which is crucial in counteracting the endogenous production of reactive oxygen species (ROS). We have previously demonstrated that cells depleted of GSH undergo apoptosis via oxidative stress and Protein kinase C (PKC) delta activation. In the present study, we transfected PKC delta in NB cells resistant to oxidative death induced by L-buthionine-S, R-sulfoximine (BSO), a GSH-depleting agent. Cell responses, in terms of ROS production, apoptosis and DNA damage were evaluated. Moreover, PKC delta activation was monitored by analyzing the phosphorylation status of threonine 505 residue, carrying out PKC activity assay and investigating the subcellular localization of the kinase. The cell responses obtained in BSO-resistant cells were also compared with those obtained in BSO-sensitive cells subjected to the same experimental protocol. Our results demonstrate, for the first time, that PKC delta induces DNA oxidation and ROS overproduction leading to apoptosis of BSO-resistant NB cells and potentiates the cytotoxic effects induced by BSO in sensitive cells. Moreover, PKC delta overexpression enhances the sensitivity of NB cells to etoposide, a well-characterised drug, commonly used in neuroblastoma therapy. Altogether our data provide evidence of a pro-oxidant role of PKC delta that might be exploited to design new therapeutic strategies aimed at selective killing of cancer cells and overcoming drug resistance. However, it becomes evident that a more detailed understanding of ROS-mediated signaling in cancer cells is necessary for the development of redox-modulated therapeutic approaches.	[Marengo, Barbara] Giannina Gaslini Inst, Genoa, Italy; [De Ciucis, Chiara; Ricciarelli, Roberta; Nitti, Mariapaola; Marinari, Umberto M.; Pronzato, Maria A.; Domenicotti, Cinzia] Univ Genoa, Gen Pathol Sect, Dept Expt Med, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Biochem Sect, Dept Expt Med, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa	Marengo, B (corresponding author), Giannina Gaslini Inst, Genoa, Italy.	Cinzia.Domenicotti@unige.it	Marengo, Barbara/U-3934-2019; Ricciarelli, Roberta/AAE-8063-2019; Domenicotti, Cinzia/C-7786-2011; Passalacqua, Mario/W-1973-2019; Zingg, Jean-Marc/H-6960-2019; Nitti, Mariapaola/ABB-1067-2020	Passalacqua, Mario/0000-0003-2779-6259; Ricciarelli, Roberta/0000-0002-2053-2501	Italian Ministry of Universities [20077S9A32_002, 2008N9N9KL_002]; Genoa University; FONDAZIONE CARIGE	Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Genoa University; FONDAZIONE CARIGE(Fondazione Carige)	This work was supported by grants from the Italian Ministry of Universities (PRIN n<SUP>o</SUP> 20077S9A32_002 and 2008N9N9KL_002), Genoa University and FONDAZIONE CARIGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cacace AM, 1996, ONCOGENE, V13, P2517; Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day TW, 2009, MOL PHARMACOL, V76, P632, DOI 10.1124/mol.109.054999; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Domenicotti C, 2003, FREE RADICAL BIO MED, V35, P504, DOI 10.1016/S0891-5849(03)00332-0; Ellerby LM, 2000, METHOD ENZYMOL, V322, P413; Emoto Y, 1996, BLOOD, V87, P1990; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Fulda S, 2003, CANCER LETT, V197, P131, DOI 10.1016/S0304-3835(03)00091-0; Gokce G, 2009, BIOCHEMISTRY-US, V48, P4980, DOI 10.1021/bi900030z; GOPALAKRISHNA R, 1987, FEBS LETT, V225, P233, DOI 10.1016/0014-5793(87)81164-X; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Heit I, 2001, ONCOGENE, V20, P5143, DOI 10.1038/sj.onc.1204657; Herrlich P, 2000, BIOCHEM PHARMACOL, V59, P35, DOI 10.1016/S0006-2952(99)00298-1; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Hsieh HL, 2007, CELL SIGNAL, V19, P330, DOI 10.1016/j.cellsig.2006.07.006; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Kambhampati S, 2003, J BIOL CHEM, V278, P32544, DOI 10.1074/jbc.M301523200; Karlsson J, 2004, CLIN CANCER RES, V10, P3179, DOI 10.1158/1078-0432.CCR-03-0309; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; Marengo B, 2005, CANCER LETT, V228, P111, DOI 10.1016/j.canlet.2005.01.046; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nitti M, 2007, NEUROSCI LETT, V416, P261, DOI 10.1016/j.neulet.2007.02.013; Nitti M, 2010, CELL SIGNAL, V22, P828, DOI 10.1016/j.cellsig.2010.01.007; Perletti GP, 1999, ONCOGENE, V18, P1251, DOI 10.1038/sj.onc.1202408; PESSINO A, 1995, BIOCHEM J, V312, P549, DOI 10.1042/bj3120549; Puhakka A, 2002, MUTAT RES-GEN TOX EN, V514, P7, DOI 10.1016/S1383-5718(01)00322-9; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Simon T, 2007, J CANCER RES CLIN, V133, P653, DOI 10.1007/s00432-007-0216-y; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; de Tudela MVP, 2010, J NEUROCHEM, V113, P819, DOI 10.1111/j.1471-4159.2010.06648.x; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	54	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14661	10.1371/journal.pone.0014661	http://dx.doi.org/10.1371/journal.pone.0014661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326872	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037100003
J	Bialleck, KA; Schaal, HP; Kranz, TA; Fell, J; Elger, CE; Axmacher, N				Bialleck, Katharina A.; Schaal, Hans-Peter; Kranz, Thorsten A.; Fell, Juergen; Elger, Christian E.; Axmacher, Nikolai			Ventromedial Prefrontal Cortex Activation Is Associated with Memory Formation for Predictable Rewards	PLOS ONE			English	Article							EVENT-RELATED FMRI; ORBITOFRONTAL CORTEX; RECOGNITION MEMORY; DOPAMINE NEURONS; NEURAL RESPONSES; RECOLLECTION; ANTICIPATION; HIPPOCAMPUS; BRAIN; DISSOCIATION	During reinforcement learning, dopamine release shifts from the moment of reward consumption to the time point when the reward can be predicted. Previous studies provide consistent evidence that reward-predicting cues enhance long-term memory (LTM) formation of these items via dopaminergic projections to the ventral striatum. However, it is less clear whether memory for items that do not precede a reward but are directly associated with reward consumption is also facilitated. Here, we investigated this question in an fMRI paradigm in which LTM for reward-predicting and neutral cues was compared to LTM for items presented during consumption of reliably predictable as compared to less predictable rewards. We observed activation of the ventral striatum and enhanced memory formation during reward anticipation. During processing of less predictable as compared to reliably predictable rewards, the ventral striatum was activated as well, but items associated with less predictable outcomes were remembered worse than items associated with reliably predictable outcomes. Processing of reliably predictable rewards activated the ventromedial prefrontal cortex (vmPFC), and vmPFC BOLD responses were associated with successful memory formation of these items. Taken together, these findings show that consumption of reliably predictable rewards facilitates LTM formation and is associated with activation of the vmPFC.	[Bialleck, Katharina A.; Schaal, Hans-Peter; Kranz, Thorsten A.; Fell, Juergen; Elger, Christian E.; Axmacher, Nikolai] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany; [Elger, Christian E.; Axmacher, Nikolai] Life & Brain Ctr Acad Res, Bonn, Germany	University of Bonn	Bialleck, KA (corresponding author), Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany.	nikolai.axmacher@ukb.uni-bonn.de		Axmacher, Nikolai/0000-0002-0475-6492				Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; BUNZECK N, 2010, HUM BRAIN MAPP; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Delgado MR, 2005, NEUROIMAGE, V24, P862, DOI 10.1016/j.neuroimage.2004.10.002; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Frey S, 2002, NEURON, V36, P171, DOI 10.1016/S0896-6273(02)00901-7; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Ranganath C, 2005, HIPPOCAMPUS, V15, P997, DOI 10.1002/hipo.20141; SABATINELLI D, 2010, NEUROIMAGE; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsukiura T, 2008, NEUROPSYCHOLOGIA, V46, P2310, DOI 10.1016/j.neuropsychologia.2008.03.013; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Yonelinas AP, 1996, CONSCIOUS COGN, V5, P418, DOI 10.1006/ccog.1996.0026	34	16	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16695	10.1371/journal.pone.0016695	http://dx.doi.org/10.1371/journal.pone.0016695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326612	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000017
J	Nolan, T; Petris, E; Muller, HM; Cronin, A; Catteruccia, F; Crisanti, A				Nolan, Tony; Petris, Elisa; Mueller, Hans-Michael; Cronin, Ann; Catteruccia, Flaminia; Crisanti, Andrea			Analysis of Two Novel Midgut-Specific Promoters Driving Transgene Expression in Anopheles stephensi Mosquitoes	PLOS ONE			English	Article							GERMLINE TRANSFORMATION; MALARIA VECTOR; TRANSPOSABLE ELEMENT; PLASMODIUM-BERGHEI; VITELLOGENIN GENE; GAMBIAE; TRANSMISSION; PROTEIN; GUT	Background: Tissue-specific promoters controlling the expression of transgenes in Anopheles mosquitoes represent a valuable tool both for studying the interaction between these malaria vectors and the Plasmodium parasites they transmit and for novel malaria control strategies based on developing Plasmodium-refractory mosquitoes by expressing anti-parasitic genes. With this aim we have studied the promoter regions of two genes from the most important malaria vector, Anopheles gambiae, whose expression is strongly induced upon blood feeding. Results: We analysed the A. gambiae Antryp1 and G12 genes, which we have shown to be midgut-specific and maximally expressed at 24 hours post-bloodmeal (PBM). Antryp1, required for bloodmeal digestion, encodes one member of a family of 7 trypsin genes. The G12 gene, of unknown function, was previously identified in our laboratory in a screen for genes induced in response to a bloodmeal. We fused 1.1 kb of the upstream regions containing the putative promoter of these genes to reporter genes and transformed these into the Indian malaria vector A. stephensi to see if we could recapitulate the expression pattern of the endogenous genes. Both the Antryp1 and G12 upstream regions were able to drive female-predominant, midgut-specific expression in transgenic mosquitoes. Expression of the Antryp1-driven reporter in transgenic A. stephensi lines was low, undetectable by northern blot analysis, and failed to fully match the induction kinetics of the endogenous Antryp1 gene in A. gambiae. This incomplete conservation of expression suggests either subtle differences in the transcriptional machinery between A. stephensi and A. gambiae or that the upstream region chosen lacked all the control elements. In contrast, the G12 upstream region was able to faithfully reproduce the expression profile of the endogenous A. gambiae gene, showing female midgut specificity in the adult mosquito and massive induction PBM, peaking at 24 hours. Conclusions: Our studies on two putative blood-meal induced, midgut-specific promoters validate the use of G12 upstream regulatory regions to drive targeted transgene expression coinciding spatially and temporally with pre-sporogonic stages of Plasmodium parasites in the mosquito, offering the possibility of manipulating vector competence or performing functional studies on vector-parasite interactions.	[Nolan, Tony; Petris, Elisa; Cronin, Ann; Catteruccia, Flaminia; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Catteruccia, Flaminia] Univ Perugia, I-06100 Perugia, Italy; [Mueller, Hans-Michael] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany	Imperial College London; University of Perugia; Ruprecht Karls University Heidelberg	Nolan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	f.catteruccia@imperial.ac.uk; acrs@imperial.ac.uk	Nolan, Tony/I-4925-2012	Nolan, Tony/0000-0002-2982-8333; Muller, Hans-Michael/0000-0002-2384-7285; Crisanti, Andrea/0000-0002-2406-4426; Catteruccia, Flaminia/0000-0003-3295-6683	Wellcome Trust; BBSRC; European Community [242095]; Fondazione Cenci Bolognetti; BBSRC [BB/E021794/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021794/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Community(European Commission); Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by grants from the Wellcome Trust, BBSRC and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N<SUP>o</SUP> 242095. FC received a bursary from the Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; [Anonymous], 2009, WORLD MAL REP 2009; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Chen XG, 2007, AM J TROP MED HYG, V76, P1118, DOI 10.4269/ajtmh.2007.76.1118; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giannoni F, 2001, J BIOL CHEM, V276, P700, DOI 10.1074/jbc.M005540200; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Klinakis AG, 2000, INSECT MOL BIOL, V9, P269, DOI 10.1046/j.1365-2583.2000.00183.x; Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; MULLER HM, 1993, EMBO J, V12, P2891, DOI 10.1002/j.1460-2075.1993.tb05951.x; Nirmala X, 2006, INSECT BIOCHEM MOLEC, V36, P694, DOI 10.1016/j.ibmb.2006.05.011; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; SINDEN RE, 1987, PROC R SOC SER B-BIO, V230, P443, DOI 10.1098/rspb.1987.0028; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Skavdis G, 1996, EMBO J, V15, P344, DOI 10.1002/j.1460-2075.1996.tb00364.x; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Vernick KD, 1995, EXP PARASITOL, V81, P436, DOI 10.1006/expr.1995.1136; Yoshida S, 2006, INSECT MOL BIOL, V15, P403, DOI 10.1111/j.1365-2583.2006.00645.x; Yoshida S, 1999, MOL BIOCHEM PARASIT, V104, P195, DOI 10.1016/S0166-6851(99)00158-9; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	32	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16471	10.1371/journal.pone.0016471	http://dx.doi.org/10.1371/journal.pone.0016471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326609	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037000012
J	Castells-Roca, L; Garcia-Martinez, J; Moreno, J; Herrero, E; Belli, G; Perez-Ortin, JE				Castells-Roca, Laia; Garcia-Martinez, Jose; Moreno, Joaquin; Herrero, Enrique; Belli, Gemma; Perez-Ortin, Jose E.			Heat Shock Response in Yeast Involves Changes in Both Transcription Rates and mRNA Stabilities	PLOS ONE			English	Article							GENE-EXPRESSION; STRESS RESPONSES; ACTIVATION; REVEALS; SYSTEM; CELLS	We have analyzed the heat stress response in the yeast Saccharomyces cerevisiae by determining mRNA levels and transcription rates for the whole transcriptome after a shift from 25 degrees C to 37 degrees C. Using an established mathematical algorithm, theoretical mRNA decay rates have also been calculated from the experimental data. We have verified the mathematical predictions for selected genes by determining their mRNA decay rates at different times during heat stress response using the regulatable tetO promoter. This study indicates that the yeast response to heat shock is not only due to changes in transcription rates, but also to changes in the mRNA stabilities. mRNA stability is affected in 62% of the yeast genes and it is particularly important in shaping the mRNA profile of the genes belonging to the environmental stress response. In most cases, changes in transcription rates and mRNA stabilities are homodirectional for both parameters, although some interesting cases of antagonist behavior are found. The statistical analysis of gene targets and sequence motifs within the clusters of genes with similar behaviors shows that both transcriptional and post-transcriptional regulons apparently contribute to the general heat stress response by means of transcriptional factors and RNA binding proteins.	[Castells-Roca, Laia; Herrero, Enrique; Belli, Gemma] Univ Lleida, Dept Ciencies Med Basiques, Lleida, Catalunya, Spain; [Castells-Roca, Laia; Herrero, Enrique; Belli, Gemma] Univ Lleida, IRBLleida, Lleida, Catalunya, Spain; [Moreno, Joaquin; Perez-Ortin, Jose E.] Univ Valencia, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Valencia, Spain; [Garcia-Martinez, Jose] Univ Valencia, Secc Chips DNA Serv Cent Suport Invest Expt, Valencia, Spain	Universitat de Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Valencia; University of Valencia	Castells-Roca, L (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Lleida, Catalunya, Spain.	gemma.belli@cmb.udl.cat; jose.e.perez@uv.es	Herrero, Enrique/B-5592-2009; Pérez-Ortín, José E./K-8582-2014; Garcia-Martinez, Jose/X-4995-2019; belli, gemma/A-7424-2011; Castells Roca, Laia/C-4444-2011; Garcia-Martinez, Jose/F-6790-2016; Bellí, Gemma/AAD-5325-2019; Castells-Roca, Laia/I-1227-2015	Herrero, Enrique/0000-0002-6763-111X; Pérez-Ortín, José E./0000-0002-1992-513X; Garcia-Martinez, Jose/0000-0001-5866-5994; belli, gemma/0000-0002-4161-3204; Garcia-Martinez, Jose/0000-0001-5866-5994; Bellí, Gemma/0000-0002-4161-3204; Castells-Roca, Laia/0000-0002-4604-9999	MICINN [BFU2007-62703, CSD 2007-0020, BFU2007-67575-CO3-01/BMC]; Generalitat de Catalunya [SGR2 009-196]; Generalitat Valenciana [ACOMP/2009/368]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants BFU2007-62703 and CSD 2007-0020 (MICINN) and SGR2 009-196 (Generalitat de Catalunya) to E.H., and BFU2007-67575-CO3-01/BMC (MICINN) ACOMP/2009/368 (Generalitat Valenciana) to J.E.P.-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, BIOPHYS J, V89, pL61, DOI 10.1529/biophysj.105.074195; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayles B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009908; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kim TS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r75; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Mejia YX, 2008, J MOL BIOL, V382, P628, DOI 10.1016/j.jmb.2008.06.079; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Perez-Ortin Jose E., 2007, Briefings in Functional Genomics & Proteomics, V6, P282, DOI 10.1093/bfgp/elm029; Riezman H, 2004, CELL CYCLE, V3, P61; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trott A, 2003, TOP CURR GENET, V1, P71; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Yamamoto A, 2007, EUKARYOT CELL, V6, P1373, DOI 10.1128/EC.00098-07; Yamamoto N, 2008, EUKARYOT CELL, V7, P783, DOI 10.1128/EC.00029-08	41	70	72	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17272	10.1371/journal.pone.0017272	http://dx.doi.org/10.1371/journal.pone.0017272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364882	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100040
J	Guo, YC; Bao, YH; Wang, H; Hu, XX; Zhao, ZH; Li, N; Zhao, YF				Guo, Yongchen; Bao, Yonghua; Wang, Hui; Hu, Xiaoxiang; Zhao, Zhihui; Li, Ning; Zhao, Yaofeng			A Preliminary Analysis of the Immunoglobulin Genes in the African Elephant (Loxodonta africana)	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; ORNITHORHYNCHUS-ANATINUS PLATYPUS; TOXOPLASMA-GONDII ANTIBODIES; CONSTANT-REGION GENES; HORSE SICKNESS VIRUS; AMINO-ACID-SEQUENCES; HUMAN GERMLINE GENES; HUMAN-IGG SUBCLASSES; LIGHT-CHAIN; ASIAN ELEPHANTS	The genomic organization of the IgH (Immunoglobulin heavy chain), Ig kappa (Immunoglobulin kappa chain), and Ig lambda (Immunoglobulin lambda chain) loci in the African elephant (Loxodonta africana) was annotated using available genome data. The elephant IgH locus on scaffold 57 spans over 2,974 kb, and consists of at least 112 V-H gene segments, 87 D-H gene segments (the largest number in mammals examined so far), six J(H) gene segments, a single mu, a delta remnant, and eight gamma genes (alpha and epsilon genes are missing, most likely due to sequence gaps). The Ig kappa locus, found on three scaffolds (202, 50 and 86), contains a total of 153 V-kappa gene segments, three J(kappa) segments, and a single C-kappa gene. Two different transcriptional orientations were determined for these V-kappa gene segments. In contrast, the Ig lambda locus on scaffold 68 includes 15 V-lambda gene segments, all with the same transcriptional polarity as the downstream J(lambda)-C-lambda cluster. These data suggest that the elephant immunoglobulin gene repertoire is highly diverse and complex. Our results provide insights into the immunoglobulin genes in a placental mammal that is evolutionarily distant from humans, mice, and domestic animals.	[Guo, Yongchen; Hu, Xiaoxiang; Li, Ning; Zhao, Yaofeng] China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China; [Bao, Yonghua; Wang, Hui] Xinxiang Med Univ, Dept Basic Immunol, Xinxiang, Peoples R China; [Zhao, Zhihui] Jilin Univ, Coll Anim Sci & Vet Med, Div Agr, Changchun 130023, Peoples R China; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China	China Agricultural University; Xinxiang Medical University; Jilin University; Qingdao Agricultural University	Guo, YC (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China.	baoyonghua2005@yahoo.com.cn; yaofengzhao@cau.edu.cn		Wang, Hui/0000-0002-2454-3814	National Science Fund for Distinguished Young Scholars [30725029]; Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program) [2010CB945300]; University of China	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China); University of China	This research was supported by the National Science Fund for Distinguished Young Scholars (30725029), the Taishan Scholar Foundation of Shandong Province, the National Basic Research Program of China (973 Program-2010CB945300) and Program for New Century Excellent Talents in University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Almagro JC, 2006, MOL IMMUNOL, V43, P1836, DOI 10.1016/j.molimm.2005.10.017; Almagro JC, 1996, IMMUNOGENETICS, V43, P92; Bao YH, 2010, VET IMMUNOL IMMUNOP, V137, P64, DOI 10.1016/j.vetimm.2010.04.011; BECK OE, 1981, CLIN EXP IMMUNOL, V43, P626; BELL RG, 1974, IMMUNOLOGY, V27, P1103; BELL RG, 1977, IMMUNOLOGY, V33, P917; Belov K, 2003, COMP BIOCHEM PHYS A, V136, P811, DOI 10.1016/S1095-6433(03)00165-X; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; Bhat MN, 1997, J WILDLIFE DIS, V33, P919, DOI 10.7589/0090-3558-33.4.919; BINEPAL VS, 1992, VET MICROBIOL, V31, P19, DOI 10.1016/0378-1135(92)90137-I; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; BUTLER JE, 1994, VET IMMUNOL IMMUNOP, V43, P5, DOI 10.1016/0165-2427(94)90114-7; Charlton KA, 2000, J IMMUNOL, V164, P6221, DOI 10.4049/jimmunol.164.12.6221; Chevillard C, 2002, J IMMUNOL, V168, P5659, DOI 10.4049/jimmunol.168.11.5659; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; Dangolla A, 2006, VET PARASITOL, V137, P172, DOI 10.1016/j.vetpar.2005.11.028; DAVIES FG, 1977, VET REC, V100, P291, DOI 10.1136/vr.100.14.291; EDELMAN GM, 1969, ANNU REV BIOCHEM, V38, P415, DOI 10.1146/annurev.bi.38.070169.002215; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; FORMENTY P, 1994, REV SCI TECH OIE, V13, P737, DOI 10.20506/rst.13.3.798; FRIPPIAT JP, 1995, HUM MOL GENET, V4, P983; Gambon-Deza F, 2009, MOL IMMUNOL, V46, P2515, DOI 10.1016/j.molimm.2009.05.025; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAINO M, 1994, J BIOL CHEM, V269, P2619; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hendricks J, 2010, IMMUNOGENETICS, V62, P479, DOI 10.1007/s00251-010-0448-x; Honjo T., 2003, MOL BIOL B CELLS; Hove T, 1999, J PARASITOL, V85, P372, DOI 10.2307/3285650; HOWELL P G, 1973, Onderstepoort Journal of Veterinary Research, V40, P41; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; Kawasaki K, 2001, EUR J IMMUNOL, V31, P1017, DOI 10.1002/1521-4141(200104)31:4<1017::AID-IMMU1017>3.3.CO;2-V; KELLY PJ, 1993, COMP IMMUNOL MICROB, V16, P299, DOI 10.1016/0147-9571(93)90159-3; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; King DP, 1998, COMP BIOCHEM PHYS B, V121, P363, DOI 10.1016/S0305-0491(98)10118-9; Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731; Kirschbaum T, 1998, EUR J IMMUNOL, V28, P1458, DOI 10.1002/(SICI)1521-4141(199805)28:05&lt;1458::AID-IMMU1458&gt;3.0.CO;2-5; KNIGHT KL, 1985, J IMMUNOL, V134, P1245; KNIGHT KL, 1994, ADV IMMUNOL, V56, P179, DOI 10.1016/S0065-2776(08)60452-6; KNIGHT KL, 1988, J IMMUNOL, V140, P3654; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P100, DOI 10.1159/000049189; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Lucier MR, 1998, J IMMUNOL, V161, P5438; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; MARQUEZ MEI, 1995, COMP BIOCHEM PHYS B, V112, P569, DOI 10.1016/0305-0491(95)00101-8; METZLER AE, 1990, J WILDLIFE DIS, V26, P41, DOI 10.7589/0090-3558-26.1.41; Mikota SK, 2001, J ZOO WILDLIFE MED, V32, P1, DOI 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Oni O, 2006, VET REC, V159, P420, DOI 10.1136/vr.159.13.420; OTA T, 1994, MOL BIOL EVOL, V11, P469; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; PECH M, 1985, J MOL BIOL, V183, P291, DOI 10.1016/0022-2836(85)90001-4; PORTER RR, 1967, BIOCHEM J, V105, P417, DOI 10.1042/bj1050417; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; REYNAUD CA, 1991, EUR J IMMUNOL, V21, P2661, DOI 10.1002/eji.1830211104; RIEMANN H P, 1975, Journal of Wildlife Diseases, V11, P529; Roux KH, 1997, J IMMUNOL, V159, P3372; ROUX KH, 1998, P NATL ACAD SCI, V95; Schrenzel MD, 1997, IMMUNOGENETICS, V45, P386, DOI 10.1007/s002510050220; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; SHIMIZU A, 1982, CELL, V28, P499, DOI 10.1016/0092-8674(82)90204-5; SIEBENLIST U, 1981, NATURE, V294, P631, DOI 10.1038/294631a0; Sinclair MC, 1997, J IMMUNOL, V159, P3883; SUN J, 1994, J IMMUNOL, V153, P5618; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tang L, 2001, VET IMMUNOL IMMUNOP, V80, P259, DOI 10.1016/S0165-2427(01)00318-X; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Thomas RK, 2004, LANCET ONCOL, V5, P11, DOI 10.1016/S1470-2045(03)01319-6; Tuntasuvan D, 2001, J PARASITOL, V87, P229, DOI 10.1645/0022-3395(2001)087[0229:SOTGIE]2.0.CO;2; TURNBULL PCB, 1991, VET REC, V128, P399, DOI 10.1136/vr.128.17.399; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VARGASMADRAZO E, 1995, J MOL BIOL, V246, P74, DOI 10.1006/jmbi.1994.0067; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Wagner B, 2002, IMMUNOGENETICS, V54, P353, DOI 10.1007/s00251-002-0458-4; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Zhang YA, 2003, VET IMMUNOL IMMUNOP, V95, P81, DOI 10.1016/S0165-2427(03)00105-3; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200; Zhao ZH, 2007, DEV COMP IMMUNOL, V31, P1034, DOI 10.1016/j.dci.2007.01.002	88	35	46	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16889	10.1371/journal.pone.0016889	http://dx.doi.org/10.1371/journal.pone.0016889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364892	gold, Green Submitted, Green Published			2022-12-27	WOS:000287764100013
J	Kuo, CH; Chen, HC; Chung, FT; Lo, YL; Lee, KY; Wang, CW; Kuo, WH; Yen, TC; Kuo, HP				Kuo, Chih-Hsi; Chen, Hao-Cheng; Chung, Fu-Tsai; Lo, Yu-Lun; Lee, Kang-Yun; Wang, Chih-Wei; Kuo, Wen-Han; Yen, Tzu-Chen; Kuo, Han-Pin			Diagnostic Value of EBUS-TBNA for Lung Cancer with Non-Enlarged Lymph Nodes: A Study in a Tuberculosis-Endemic Country	PLOS ONE			English	Article							TRANSBRONCHIAL NEEDLE ASPIRATION; POSITRON-EMISSION-TOMOGRAPHY; ENDOBRONCHIAL ULTRASOUND; FDG-PET; F-18-FDG PET; STAGE; EFFICACY; ADULTS; SCAN	Background: In tuberculosis (TB)-endemic areas, contrast-enhanced computed tomography (CT) and positron emission tomography (PET) findings of lung cancer patients with non-enlarged lymph nodes are frequently discrepant. Endobronchial ultrasound-guided transbronchial aspiration (EBUS-TBNA) enables real-time nodal sampling, and thereby improves nodal diagnosis accuracy. This study aimed to compare the accuracy of nodal diagnosis by using EBUS-TBNA, and PET. Methods: We studied 43 lung cancer patients with CT-defined non-enlarged mediastinal and hilar lymph nodes and examined 78 lymph nodes using EBUS-TBNA. Results: The sensitivity, specificity, positive predictive value, and negative predictive value of EBUS-TBNA were 80.6%, 100%, 100%, and 85.7%, respectively. PET had low specificity (18.9%) and a low positive predictive value (44.4%). The diagnostic accuracy of EBUS-TBNA was higher than that of PET (91% vs. 47.4%; p < 0.001). Compared to CT-based nodal assessment, PET yielded a positive diagnostic impact in 36.9% nodes, a negative diagnostic impact in 46.2% nodes, and no diagnostic impact in 16.9% nodes. Patients with lymph nodes showing negative PET diagnostic impact had a high incidence of previous pulmonary TB. Multivariate analysis indicated that detection of hilar nodes on PET was an independent predictor of negative diagnostic impact of PET. Conclusion: In a TB-endemic area with a condition of CT-defined non-enlarged lymph node, the negative diagnostic impact of PET limits its clinical usefulness for nodal staging; therefore, EBUS-TBNA, which facilitates direct diagnosis, is preferred.	[Kuo, Chih-Hsi; Chen, Hao-Cheng; Chung, Fu-Tsai; Lo, Yu-Lun; Lee, Kang-Yun; Kuo, Han-Pin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan; [Wang, Chih-Wei] Chang Gung Mem Hosp, Dept Pathol, Taipei 10591, Taiwan; [Kuo, Wen-Han; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Taipei 10591, Taiwan; [Kuo, Wen-Han; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Kuo, CH (corresponding author), Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Dept Thorac Med, Taipei, Taiwan.	q8828@ms11.hinet.net			Chang Gung Medical Research Program [CMRPG391211]	Chang Gung Medical Research Program	This study was supported by the Chang Gung Medical Research Program (CMRPG391211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet SM, 1998, SEMIN NUCL MED, V28, P352; Bowerman RJ, 2004, INT J TUBERC LUNG D, V8, P1228; Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330; Cerfolio RJ, 2010, ANN THORAC SURG, V90, P427, DOI 10.1016/j.athoracsur.2010.04.062; Doddoli C, 2005, EUR J CARDIO-THORAC, V27, P680, DOI 10.1016/j.ejcts.2004.12.035; Gajra A, 2003, J CLIN ONCOL, V21, P1029, DOI 10.1200/JCO.2003.07.010; GawneCain ML, 1996, CLIN RADIOL, V51, P263, DOI 10.1016/S0009-9260(96)80343-6; Guhlmann A, 1997, THORAX, V52, P438, DOI 10.1136/thx.52.5.438; Gupta NC, 2000, CHEST, V117, P773, DOI 10.1378/chest.117.3.773; Herth FJF, 2006, EUR RESPIR J, V28, P910, DOI 10.1183/09031936.06.00124905; Herth FJF, 2006, THORAX, V61, P795, DOI 10.1136/thx.2005.047829; Herth FJF, 2008, J CLIN ONCOL, V26, P3346, DOI 10.1200/JCO.2007.14.9229; Hetth FJF, 2008, CHEST, V133, P887, DOI 10.1378/chest.07-2535; Keller SM, 2000, ANN THORAC SURG, V70, P358, DOI 10.1016/S0003-4975(00)01673-8; Kim YK, 2007, CANCER-AM CANCER SOC, V109, P1068, DOI 10.1002/cncr.22518; Konishi J, 2003, RESPIRATION, V70, P500, DOI 10.1159/000074207; Kramer H, 2003, ANN SURG, V238, P180, DOI 10.1097/01.SLA.0000081086.37779.1a; Kubota K, 2001, EUR J NUCL MED, V28, P696, DOI 10.1007/s002590100537; Lee HS, 2008, CHEST, V134, P368, DOI 10.1378/chest.07-2105; Matthies A, 2002, J NUCL MED, V43, P871; Nishiyama Y, 2008, ANN NUCL MED, V22, P245, DOI 10.1007/s12149-007-0103-2; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Roberts PF, 2000, ANN THORAC SURG, V70, P1154, DOI 10.1016/S0003-4975(00)01769-0; Schrevens L, 2004, ONCOLOGIST, V9, P633, DOI 10.1634/theoncologist.9-6-633; Takamochi K, 2005, LUNG CANCER, V47, P235, DOI 10.1016/j.lungcan.2004.08.004; Takamochi K, 2000, J THORAC CARDIOV SUR, V119, P1135, DOI 10.1067/mtc.2000.105830; Turkmen C, 2007, CLIN NUCL MED, V32, P607, DOI 10.1097/RLU.0b013e3180a1ac87; Vansteenkiste JF, 1997, CHEST, V112, P1480, DOI 10.1378/chest.112.6.1480; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540; Yasufuku K, 2005, LUNG CANCER, V50, P347, DOI 10.1016/j.lungcan.2005.07.013; Yasufuku K, 2004, CHEST, V126, P122, DOI 10.1378/chest.126.1.122; Yeh YP, 2005, T ROY SOC TROP MED H, V99, P509, DOI 10.1016/j.trstmh.2005.03.001; Yen RF, 2008, EUR J NUCL MED MOL I, V35, P1305, DOI 10.1007/s00259-008-0733-1	33	22	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16877	10.1371/journal.pone.0016877	http://dx.doi.org/10.1371/journal.pone.0016877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364919	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100012
J	Ou, WB; Yi, TF; Kim, JM; Khorana, HG				Ou, Wen-bin; Yi, Tingfang; Kim, Jong-Myoung; Khorana, H. Gobind			The Roles of Transmembrane Domain Helix-III during Rhodopsin Photoactivation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CYSTEINE SUBSTITUTION MUTANTS; METARHODOPSIN-II; TRANSDUCIN ACTIVATION; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; RETINITIS-PIGMENTOSA; TERTIARY STRUCTURE; LIGHT-ACTIVATION; GLYCINE 121	Background: Rhodopsin, the prototypic member of G protein-coupled receptors (GPCRs), undergoes isomerization of 11-cis-retinal to all-trans-retinal upon photoactivation. Although the basic mechanism by which rhodopsin is activated is well understood, the roles of whole transmembrane (TM) helix-III during rhodopsin photoactivation in detail are not completely clear. Principal Findings: We herein use single-cysteine mutagenesis technique to investigate conformational changes in TM helices of rhodopsin upon photoactivation. Specifically, we study changes in accessibility and reactivity of cysteine residues introduced into the TM helix-III of rhodopsin. Twenty-eight single-cysteine mutants of rhodopsin (P107C-R135C) were prepared after substitution of all natural cysteine residues (C140/C167/C185/C222/C264/C316) by alanine. The cysteine mutants were expressed in COS-1 cells and rhodopsin was purified after regeneration with 11-cis-retinal. Cysteine accessibility in these mutants was monitored by reaction with 4,4'-dithiodipyridine (4-PDS) in the dark and after illumination. Most of the mutants except for T108C, G109C, E113C, I133C, and R135C showed no reaction in the dark. Wide variation in reactivity was observed among cysteines at different positions in the sequence 108-135 after photoactivation. In particular, cysteines at position 115, 119, 121, 129, 131, 132, and 135, facing 11-cis-retinal, reacted with 4-PDS faster than neighboring amino acids. The different reaction rates of mutants with 4-PDS after photoactivation suggest that the amino acids in different positions in helix-III are exposed to aqueous environment to varying degrees. Significance: Accessibility data indicate that an aqueous/hydrophobic boundary in helix-III is near G109 and I133. The lack of reactivity in the dark and the accessibility of cysteine after photoactivation indicate an increase of water/4-PDS accessibility for certain cysteine-mutants at Helix-III during formation of Meta II. We conclude that photoactivation resulted in water-accessible at the chromophore-facing residues of Helix-III.	[Ou, Wen-bin; Kim, Jong-Myoung; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA USA; [Yi, Tingfang] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Ou, WB (corresponding author), Tsinghua Univ Jiaxing, Yangtze Delta Reg Inst, Jiaxing, Zhejiang, Peoples R China.	ouwb75@gmail.com; Khorana@mit.edu	Ou, Wen-Bin/J-1142-2019	, Wenbin/0000-0002-6311-9442	National Institutes of Health [GM28289]; National Eye Institute [EY11716]; National Science Foundation [EIA-0225609]; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028289, R37GM028289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM28289, National Eye Institute Grant EY11716, and National Science Foundation Grant EIA-0225609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Andres A, 2003, BIOCHEM BIOPH RES CO, V303, P294, DOI 10.1016/S0006-291X(03)00328-0; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Cai KW, 1997, P NATL ACAD SCI USA, V94, P14267, DOI 10.1073/pnas.94.26.14267; Choi G, 2002, BIOCHEMISTRY-US, V41, P7318, DOI 10.1021/bi025507w; Ernst OP, 2002, CHEMBIOCHEM, V3, P968, DOI 10.1002/1439-7633(20021004)3:10<968::AID-CBIC968>3.0.CO;2-Q; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; *GPCRDB, INF SYST G PROT COUP; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Klein-Seetharaman J, 1999, BIOCHEMISTRY-US, V38, P7938, DOI 10.1021/bi990013t; Klein-Seetharaman J, 1999, P NATL ACAD SCI USA, V96, P13744, DOI 10.1073/pnas.96.24.13744; Klein-Seetharaman J, 2002, CHEMBIOCHEM, V3, P981, DOI 10.1002/1439-7633(20021004)3:10<981::AID-CBIC981>3.0.CO;2-9; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Madathil S, 2009, J BIOL CHEM, V284, P28801, DOI 10.1074/jbc.M109.002030; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; MIN KC, 1993, J BIOL CHEM, V268, P9400; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P8804, DOI 10.1021/bi00027a032; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Yang K, 1996, BIOCHEMISTRY-US, V35, P12464, DOI 10.1021/bi960848t; Yeagle PL, 2001, BIOCHEMISTRY-US, V40, P11932, DOI 10.1021/bi015543f	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17398	10.1371/journal.pone.0017398	http://dx.doi.org/10.1371/journal.pone.0017398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364764	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100053
J	Xue, B; Sukumaran, S; Nie, J; Jusko, WJ; DuBois, DC; Almon, RR				Xue, Bai; Sukumaran, Siddharth; Nie, Jing; Jusko, William J.; DuBois, Debra C.; Almon, Richard R.			Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; GENE-EXPRESSION; CIRCADIAN VARIATIONS; DISEASE; OBESITY; LEPTIN; LIVER; GLUCOCORTICOIDS; ADIPONECTIN; DISRUPTION	Type 2 diabetes (T2DM) is a heterogeneous group of diseases that is progressive and involves multiple tissues. Goto-Kakizaki (GK) rats are a polygenic model with elevated blood glucose, peripheral insulin resistance, a non-obese phenotype, and exhibit many degenerative changes observed in human T2DM. As part of a systems analysis of disease progression in this animal model, this study characterized the contribution of adipose tissue to pathophysiology of the disease. We sacrificed subgroups of GK rats and appropriate controls at 4, 8, 12, 16 and 20 weeks of age and carried out a gene array analysis of white adipose tissue. We expanded our physiological analysis of the animals that accompanied our initial gene array study on the livers from these animals. The expanded analysis included adipose tissue weights, HbA1c, additional hormonal profiles, lipid profiles, differential blood cell counts, and food consumption. HbA1c progressively increased in the GK animals. Altered corticosterone, leptin, and adiponectin profiles were also documented in GK animals. Gene array analysis identified 412 genes that were differentially expressed in adipose tissue of GKs relative to controls. The GK animals exhibited an age-specific failure to accumulate body fat despite their relatively higher calorie consumption which was well supported by the altered expression of genes involved in adipogenesis and lipogenesis in the white adipose tissue of these animals, including Fasn, Acly, Kklf9, and Stat3. Systemic inflammation was reflected by chronically elevated white blood cell counts. Furthermore, chronic inflammation in adipose tissue was evident from the differential expression of genes involved in inflammatory responses and activation of natural immunity, including two interferon regulated genes, Ifit and Iipg, as well as MHC class II genes. This study demonstrates an age specific failure to accumulate adipose tissue in the GK rat and the presence of chronic inflammation in adipose tissue from these animals.	[Xue, Bai; Sukumaran, Siddharth; Nie, Jing; DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Jusko, William J.; DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Jusko, William J.; Almon, Richard R.] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xue, B (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	almon@buffalo.edu	Jusko, William J/G-4885-2015; Sukumaran, Siddharth/I-6911-2012		National Institute of General Medical Sciences, NIH [GM 24211]; UB-Pfizer Strategic Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024211, R37GM024211] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UB-Pfizer Strategic Alliance; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institute of General Medical Sciences, NIH (GM 24211) and the UB-Pfizer Strategic Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Almon RR, 2005, J ENDOCRINOL, V184, P219, DOI 10.1677/joe.1.05953; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bach AG, 2010, ENDOCRINOLOGY, V151, P2483, DOI 10.1210/en.2009-1299; Bahtiyar Gul, 2004, Curr Diab Rep, V4, P194, DOI 10.1007/s11892-004-0023-7; Barbu A, 2009, MOL CELL ENDOCRINOL, V299, P163, DOI 10.1016/j.mce.2008.11.019; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; BOMALASKI JS, 1989, J IMMUNOL, V142, P3957; Brunetti P, 2007, INT J CLIN PRACT, V61, P3, DOI 10.1111/j.1742-1241.2007.01359.x; Buren J, 2008, ARCH BIOCHEM BIOPHYS, V474, P91, DOI 10.1016/j.abb.2008.02.034; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Ettinger RA, 2006, J IMMUNOL, V176, P1988, DOI 10.4049/jimmunol.176.3.1988; Ettinger RA, 2004, IMMUNOGENETICS, V56, P585, DOI 10.1007/s00251-004-0725-7; Fife KL, 2008, J PHARMACOL EXP THER, V327, P707, DOI 10.1124/jpet.108.142398; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Gale SM, 2004, J NUTR, V134, P295, DOI 10.1093/jn/134.2.295; Goto Y, 1988, Adv Exp Med Biol, V246, P29; GREENWOOD MR, 1974, J LIPID RES, V15, P474; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hackl H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r108; Halleux CM, 2001, BIOCHEM BIOPH RES CO, V288, P1102, DOI 10.1006/bbrc.2001.5904; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hazra A, 2008, PHARM RES-DORDR, V25, P769, DOI 10.1007/s11095-007-9371-8; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Knobler H, 2003, AM J GASTROENTEROL, V98, P2751, DOI 10.1016/j.amjgastroenterol.2003.06.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Maekawa F, 2006, J NEUROENDOCRINOL, V18, P748, DOI 10.1111/j.1365-2826.2006.01470.x; MCNEELY M, 2004, CLIN DIABETES, V22, P42; Mealey BL, 2008, COMPEND CONTIN ED DE, V29, P410; Mealey BL, 2008, COMPEND CONTIN ED DE, V29, P412; Mealey Brian L, 2008, Compend Contin Educ Dent, V29, P402; Mofredj A, 2002, DIGEST DIS SCI, V47, P1649, DOI 10.1023/A:1015852110353; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Plachot C, 2001, HISTOCHEM CELL BIOL, V116, P131; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Tiengo A, 2008, DIABETES METAB, V34, P447, DOI 10.1016/j.diabet.2008.08.001; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; YUAN JH, 1993, TOXICOL APPL PHARM, V119, P131, DOI 10.1006/taap.1993.1052; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	59	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17386	10.1371/journal.pone.0017386	http://dx.doi.org/10.1371/journal.pone.0017386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364767	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100050
J	Kalia, LV; Kalia, SK; Chau, H; Lozano, AM; Hyman, BT; McLean, PJ				Kalia, Lorraine V.; Kalia, Suneil K.; Chau, Hien; Lozano, Andres M.; Hyman, Bradley T.; McLean, Pamela J.			Ubiquitinylation of alpha-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DEPENDENT E3 LIGASE; PARKINSONS-DISEASE; LEWY BODIES; MOLECULAR CHAPERONES; NUCLEOTIDE EXCHANGE; COCHAPERONE BAG2; QUALITY-CONTROL; CELL-DEATH; DEGRADATION	Parkinson's disease (PD) is a common neurodegenerative condition in which abnormalities in protein homeostasis, or proteostasis, may lead to accumulation of the protein alpha-synuclein (alpha-syn). Mutations within or multiplications of the gene encoding alpha-syn are known to cause genetic forms of PD and polymorphisms in the gene are recently established risk factors for idiopathic PD. alpha-syn is a major component of Lewy bodies, the intracellular proteinaceous inclusions which are pathological hallmarks of most forms of PD. Recent evidence demonstrates that alpha-syn can self associate into soluble oligomeric species and implicates these alpha-syn oligomers in cell death. We have previously shown that carboxyl terminus of Hsp70-interacting protein (CHIP), a co-chaperone molecule with E3 ubiquitin ligase activity, may reduce the levels of toxic alpha-syn oligomers. Here we demonstrate that alpha-syn is ubiquitinylated by CHIP both in vitro and in cells. We find that the products from ubiquitinylation by CHIP include both monoubiquitinylated and polyubiquitinylated forms of alpha-syn. We also demonstrate that CHIP and alpha-syn exist within a protein complex with the co-chaperone bcl-2-associated athanogene 5 (BAG5) in brain. The interaction of CHIP with BAG5 is mediated by Hsp70 which binds to the tetratricopeptide repeat domain of CHIP and the BAG domains of BAG5. The Hsp70-mediated association of BAG5 with CHIP results in inhibition of CHIP E3 ubiquitin ligase activity and subsequently reduces alpha-syn ubiquitinylation. Furthermore, we use a luciferase-based protein-fragment complementation assay of alpha-syn oligomerization to investigate regulation of alpha-syn oligomers by CHIP in living cells. We demonstrate that BAG5 mitigates the ability of CHIP to reduce alpha-syn oligomerization and that non-ubiquitinylated alpha-syn has an increased propensity for oligomerization. Thus, our results identify CHIP as an E3 ubiquitin ligase of alpha-syn and suggest a novel function for BAG5 as a modulator of CHIP E3 ubiquitin ligase activity with implications for CHIP-mediated regulation of alpha-syn oligomerization.	[Kalia, Lorraine V.; Kalia, Suneil K.; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Kalia, Lorraine V.] Univ Toronto, Div Neurol, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Kalia, Suneil K.; Lozano, Andres M.] Univ Toronto, Div Neurosurg, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Kalia, Lorraine V.; Kalia, Suneil K.; Chau, Hien; Lozano, Andres M.] Univ Toronto, Div Brain Imaging & Behav Syst Neurosci, Toronto Western Res Inst, Univ Hlth Network, Toronto, ON, Canada	Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kalia, LV (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	lorraine.kalia@utoronto.ca	Lozano, Andres M/A-5058-2012	Kalia, Lorraine/0000-0002-9384-1305; Lozano, Andres M./0000-0001-8257-3694; Kalia, Suneil/0000-0003-2054-1915; McLean, Pamela/0000-0003-4870-5715	NIH/NINDS [NS 063963]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS grant NS 063963 and research grants from the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Briknarova K, 2002, J BIOL CHEM, V277, P31172, DOI 10.1074/jbc.M202792200; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	62	103	108	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14695	10.1371/journal.pone.0014695	http://dx.doi.org/10.1371/journal.pone.0014695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358815	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700008
J	Wang, LX; Million, M; Rivier, J; Rivier, C; Craft, N; Stenzel-Poore, MP; Tache, Y				Wang, Lixin; Million, Mulugeta; Rivier, Jean; Rivier, Catherine; Craft, Noah; Stenzel-Poore, Mary P.; Tache, Yvette			CRF Receptor Antagonist Astressin-B Reverses and Prevents Alopecia in CRF Over-Expressing Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HAIR-GROWTH; TRANSGENIC MICE; DIFFERENTIAL EXPRESSION; CUTANEOUS EXPRESSION; STRESS-RESPONSE; MOUSE MODELS; HPA AXIS; SKIN; UROCORTIN	Corticotropin-releasing factor (CRF) signaling pathways are involved in the stress response, and there is growing evidence supporting hair growth inhibition of murine hair follicle in vivo upon stress exposure. We investigated whether the blockade of CRF receptors influences the development of hair loss in CRF over-expressing (OE)-mice that display phenotypes of Cushing's syndrome and chronic stress, including alopecia. The non-selective CRF receptors antagonist, astressin-B (5 mu g/mouse) injected peripherally once a day for 5 days in 4-9 months old CRF-OE alopecic mice induced pigmentation and hair re-growth that was largely retained for over 4 months. In young CRF-OE mice, astressin-B prevented the development of alopecia that occurred in saline-treated mice. Histological examination indicated that alopecic CRF-OE mice had hair follicle atrophy and that astressin-B revived the hair follicle from the telogen to anagen phase. However, astressin-B did not show any effect on the elevated plasma corticosterone levels and the increased weights of adrenal glands and visceral fat in CRF-OE mice. The selective CRF2 receptor antagonist, astressin(2)-B had moderate effect on pigmentation, but not on hair regrowth. The commercial drug for alopecia, minoxidil only showed partial effect on hair re-growth. These data support the existence of a key molecular switching mechanism triggered by blocking peripheral CRF receptors with an antagonist to reset hair growth in a mouse model of alopecia associated with chronic stress.	[Wang, Lixin; Million, Mulugeta; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Div Digest Dis,Dept Med,CURE, Los Angeles, CA 90095 USA; [Wang, Lixin; Million, Mulugeta; Tache, Yvette] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Rivier, Jean; Rivier, Catherine] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, San Diego, CA 92138 USA; [Craft, Noah] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Dermatol,Dept Med,Los Angeles Biomed Res Inst, Torrance, CA USA; [Craft, Noah] Univ Calif Los Angeles, David Geffen Sch Med, Harbor UCLA Med Ctr, Div Infect Dis,Dept Med,Los Angeles Biomed Res In, Torrance, CA USA; [Stenzel-Poore, Mary P.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University	Wang, LX (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, Div Digest Dis,Dept Med,CURE, Los Angeles, CA 90095 USA.	milllionmulugeta@mednet.ucla.edu			Department of Veterans Affairs; NIH [R01 DK-57238, R21 DK-068155, RO1 DK-078676, R01 DK-33061, P50 DK-64539, DK PO1-26741]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033061, R21DK068155, R01DK078676, R01DK057238, P01DK026741, P50DK064539] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Career Scientist Award, Department of Veterans Affairs (Y. Tache); and the following NIH grants: R01 DK-57238 (Y. Tache); R21 DK-068155 and RO1 DK-078676 (M. Million); R01 DK-33061 (Y. Tache, M. Million); P50 DK-64539 (Y. Tache, M. Million); DK PO1-26741 (J. Rivier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Botchkarev VA, 2003, AM J PATHOL, V162, P709, DOI 10.1016/S0002-9440(10)63866-7; Chen C, 2006, CURR MED CHEM, V13, P1261, DOI 10.2174/092986706776873014; Coste SC, 2001, PEPTIDES, V22, P733, DOI 10.1016/S0196-9781(01)00386-2; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; Goebel M, 2010, NEUROSCI LETT; Harrison S, 2009, CLEV CLIN J MED, V76, P361, DOI 10.3949/ccjm.76a.08080; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Kauser S, 2006, FASEB J, V20, P882, DOI 10.1096/fj.05-5257com; Martinez V, 2002, J PHARMACOL EXP THER, V301, P611, DOI 10.1124/jpet.301.2.611; Messenger AG, 2004, BRIT J DERMATOL, V150, P186, DOI 10.1111/j.1365-2133.2004.05785.x; Million M, 2007, AM J PHYSIOL-REG I, V292, pR1429, DOI 10.1152/ajpregu.00626.2006; Paus R, 2010, PIGMENT CELL MELANOM; Peters EMJ, 2006, EXP DERMATOL, V15, P1, DOI 10.1111/j.0906-6705.2005.00372.x; Porter RM, 2003, J ANAT, V202, P125, DOI 10.1046/j.1469-7580.2003.00140.x; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rivier JE, 1999, J MED CHEM, V42, P3175, DOI 10.1021/jm9902133; Roloff B, 1998, FASEB J, V12, P287, DOI 10.1096/fasebj.12.3.287; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shirai A, 2001, J DERMATOL SCI, V25, P213, DOI 10.1016/S0923-1811(00)00147-X; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 1996, FEBS LETT, V399, P175, DOI 10.1016/S0014-5793(96)01315-4; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Slominski AT, 1999, ANN NY ACAD SCI, V885, P287; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Stengel A, 2009, ENDOCRINOLOGY, V150, P153, DOI 10.1210/en.2008-0723; StenzelPoore MP, 1996, ANN NY ACAD SCI, V780, P36, DOI 10.1111/j.1749-6632.1996.tb15110.x; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; Tobin DJ, 2005, MOL CELL ENDOCRINOL, V243, P1, DOI 10.1016/j.mce.2005.09.001; Turnbull AV, 1999, ENDOCRINOLOGY, V140, P1013, DOI 10.1210/en.140.2.1013; Vegesna V, 2002, ENDOCRINOLOGY, V143, P4389, DOI 10.1210/en.2002-220118; Wang LX, 2001, AM J PHYSIOL-REG I, V281, pR1401, DOI 10.1152/ajpregu.2001.281.5.R1401; Wood GA, 2005, EXP DERMATOL, V14, P373; Zhang XQ, 2009, J INVEST DERMATOL, V129, P1527, DOI 10.1038/jid.2008.371	38	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16377	10.1371/journal.pone.0016377	http://dx.doi.org/10.1371/journal.pone.0016377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359208	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700017
J	Homolka, D; Ivanek, R; Forejt, J; Jansa, P				Homolka, David; Ivanek, Robert; Forejt, Jiri; Jansa, Petr			Differential Expression of Non-Coding RNAs and Continuous Evolution of the X Chromosome in Testicular Transcriptome of Two Mouse Species	PLOS ONE			English	Article							HYBRID STERILITY; HUMAN GENOME; GENE; INACTIVATION; TESTIS; MICE; SPERMATOGENESIS; DROSOPHILA; CELLS; IDENTIFICATION	Background: Tight regulation of testicular gene expression is a prerequisite for male reproductive success, while differentiation of gene activity in spermatogenesis is important during speciation. Thus, comparison of testicular transcriptomes between closely related species can reveal unique regulatory patterns and shed light on evolutionary constraints separating the species. Methodology/Principal Findings: Here, we compared testicular transcriptomes of two closely related mouse species, Mus musculus and Mus spretus, which diverged more than one million years ago. We analyzed testicular expression using tiling arrays overlapping Chromosomes 2, X, Y and mitochondrial genome. An excess of differentially regulated non-coding RNAs was found on Chromosome 2 including the intronic antisense RNAs, intergenic RNAs and premature forms of Piwi-interacting RNAs (piRNAs). Moreover, striking difference was found in the expression of X-linked G6pdx gene, the parental gene of the autosomal retrogene G6pd2. Conclusions/Significance: The prevalence of non-coding RNAs among differentially expressed transcripts indicates their role in species-specific regulation of spermatogenesis. The postmeiotic expression of G6pdx in Mus spretus points towards the continuous evolution of X-chromosome silencing and provides an example of expression change accompanying the out-of-the X-chromosomal retroposition.	[Homolka, David; Ivanek, Robert; Forejt, Jiri; Jansa, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Mouse Mol Genet, Ctr Appl Genom, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Homolka, D (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Mouse Mol Genet, Ctr Appl Genom, Prague, Czech Republic.	pjansa@img.cas.cz	Jansa, Petr/B-8153-2019; Jansa, Petr/G-6360-2014; Forejt, Jiri/AAF-5276-2019; Forejt, Jiri/G-7719-2012; Ivanek, Robert/A-8852-2008	Jansa, Petr/0000-0002-1406-1707; Forejt, Jiri/0000-0002-2793-3623; Forejt, Jiri/0000-0002-2793-3623; Ivanek, Robert/0000-0002-8403-056X	Czech Science Foundation (GACR) [301/07/1383]; Ministry of Education, Youth and Sports of the Czech Republic [IM6837805002, AV0Z5052514]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Science Foundation (GACR), Grant 301/07/1383 and nos. IM6837805002 and AV0Z5052514 from the Ministry of Education, Youth and Sports of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bradley J, 2004, NAT GENET, V36, P872, DOI 10.1038/ng1390; Chan WY, 2006, GENOMICS, V87, P681, DOI 10.1016/j.ygeno.2005.12.006; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Homolka D, 2007, GENOME RES, V17, P1431, DOI 10.1101/gr.6520107; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Mahler KL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-626; Marcon E, 2008, CHROMOSOME RES, V16, P243, DOI 10.1007/s10577-007-1190-6; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Yan W, 2009, EPIGENETICS, P4; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17198	10.1371/journal.pone.0017198	http://dx.doi.org/10.1371/journal.pone.0017198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347268	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600041
J	Ishikita, H				Ishikita, Hiroshi			Proton-Binding Sites of Acid-Sensing Ion Channel 1	PLOS ONE			English	Article							TRANSPORTER PROTEIN AMTB; ELECTROSTATIC MODELS; ENVIRONMENT; DYNAMICS; PORE	Acid-sensing ion channels (ASICs) are proton-gated cation channels that exist throughout the mammalian central and peripheral nervous systems. ASIC1 is the most abundant of all the ASICs and is likely to modulate synaptic transmission. Identifying the proton-binding sites of ASCI1 is required to elucidate its pH-sensing mechanism. By using the crystal structure of ASIC1, the protonation states of each titratable site of ASIC1 were calculated by solving the Poisson-Boltzmann equation under conditions wherein the protonation states of all these sites are simultaneously in equilibrium. Four acidic-acidic residue pairs-Asp238-Asp350, Glu220-Asp408, Glu239-Asp346, and Glu80-Glu417-were found to be highly protonated. In particular, the Glu80-Glu417 pair in the inner pore was completely protonated and possessed 2 H(+), implying its possible importance as a proton-binding site. The pK(a) of Glu239, which forms a pair with a possible pH-sensing site Asp346, differs among each homo-trimer subunit due to the different H-bond pattern of Thr237 in the different protein conformations of the subunits. His74 possessed a pK(a) of similar to 6-7. Conservation of His74 in the proton-sensitive ASIC3 that lacks a residue corresponding to Asp346 may suggest its possible pH-sensing role in proton-sensitive ASICs.	[Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	hiro@cp.kyoto-u.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150	JST PRESTO program; Ministry of Education, Science, Sport and Culture of Japan [21770163]; MEXT; Takeda Science Foundation	JST PRESTO program; Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JST PRESTO program, Grant-in-Aid for Science Research from the Ministry of Education, Science, Sport and Culture of Japan (21770163), Special Coordination Fund for Promoting Science and Technology of MEXT, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Ishikita H, 2005, P NATL ACAD SCI USA, V102, P16215, DOI 10.1073/pnas.0503826102; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P14772, DOI 10.1021/bi051099v; Ishikita H, 2005, FEBS LETT, V579, P3190, DOI 10.1016/j.febslet.2005.05.004; Ishikita H, 2007, FEBS LETT, V581, P4293, DOI 10.1016/j.febslet.2007.07.085; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16920	10.1371/journal.pone.0016920	http://dx.doi.org/10.1371/journal.pone.0016920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340031	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600025
J	Lu, F; Xue, W; Tian, C; Wang, GC; Niu, JF; Pan, GH; Hu, SN				Lue, Fang; Xue, Wei; Tian, Chao; Wang, Guangce; Niu, Jiangfeng; Pan, Guanghua; Hu, Songnian			The Bryopsis hypnoides Plastid Genome: Multimeric Forms and Complete Nucleotide Sequence	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; GREEN-ALGA; CHLOROPLAST GENOME; CATALYTIC INTRONS; GENE-TRANSFER; SEA SLUGS; ARCHITECTURE; REVEALS; CHLOROPHYTA; LAMOUROUX	Background: Bryopsis hypnoides Lamouroux is a siphonous green alga, and its extruded protoplasm can aggregate spontaneously in seawater and develop into mature individuals. The chloroplast of B. hypnoides is the biggest organelle in the cell and shows strong autonomy. To better understand this organelle, we sequenced and analyzed the chloroplast genome of this green alga. Principal Findings: A total of 111 functional genes, including 69 potential protein-coding genes, 5 ribosomal RNA genes, and 37 tRNA genes were identified. The genome size (153,429 bp), arrangement, and inverted-repeat (IR)-lacking structure of the B. hypnoides chloroplast DNA (cpDNA) closely resembles that of Chlorella vulgaris. Furthermore, our cytogenomic investigations using pulsed-field gel electrophoresis (PFGE) and southern blotting methods showed that the B. hypnoides cpDNA had multimeric forms, including monomer, dimer, trimer, tetramer, and even higher multimers, which is similar to the higher order organization observed previously for higher plant cpDNA. The relative amounts of the four multimeric cpDNA forms were estimated to be about 1, 1/2, 1/4, and 1/8 based on molecular hybridization analysis. Phylogenetic analyses based on a concatenated alignment of chloroplast protein sequences suggested that B. hypnoides is sister to all Chlorophyceae and this placement received moderate support. Conclusion: All of the results suggest that the autonomy of the chloroplasts of B. hypnoides has little to do with the size and gene content of the cpDNA, and the IR-lacking structure of the chloroplasts indirectly demonstrated that the multimeric molecules might result from the random cleavage and fusion of replication intermediates instead of recombinational events.	[Lue, Fang; Tian, Chao; Wang, Guangce; Niu, Jiangfeng] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xue, Wei] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China; [Lue, Fang; Xue, Wei; Hu, Songnian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin University Science & Technology	Lu, F (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	gcwang@qdio.ac.cn	NIU, Jiangfeng/GWM-7257-2022; tian, chao/GYD-3462-2022; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [30970302, 40806063, 30830015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (30970302, 40806063, and 30830015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; BACKERT S, 1995, CURR GENET, V28, P390, DOI 10.1007/BF00326439; Belanger AS, 2006, MOL GENET GENOMICS, V276, P464, DOI 10.1007/s00438-006-0156-2; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; BURR F A, 1970, Phycologia, V9, P17, DOI 10.2216/i0031-8884-9-1-17.1; de Cambiaire JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-213; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; DENG XW, 1989, P NATL ACAD SCI USA, V86, P4156, DOI 10.1073/pnas.86.11.4156; Friedl T, 2002, EUR J PHYCOL, V37, P373, DOI 10.1017/S0967026202003712; Glockner G, 2000, J MOL EVOL, V51, P382; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Karyn D, 1998, PLANT MOL BIOL REP, V16, P219; Kim GH, 2001, J CELL SCI, V114, P2009; KOLODNER R, 1975, BIOCHIM BIOPHYS ACTA, V402, P372, DOI 10.1016/0005-2787(75)90273-7; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Lee RE, 1999, PHYCOLOGY; Lehman RL, 1997, J PHYCOL, V33, P1055, DOI 10.1111/j.0022-3646.1997.01055.x; Lemieux C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-2; Li D, 2009, RUSS J PLANT PHYSL+, V56, P110, DOI 10.1134/S1021443709010166; Lilly JW, 2001, PLANT CELL, V13, P245, DOI 10.1105/tpc.13.2.245; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MANHART JR, 1989, MOL GEN GENET, V216, P417, DOI 10.1007/BF00334385; MARIN A, 1992, MAR BIOL, V112, P677, DOI 10.1007/BF00346186; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; SALGANIK RI, 1991, ELECTRON MICROSC REV, V4, P221, DOI 10.1016/0892-0354(91)90004-V; Sambrook J, 2001, MOL CLONING LAB MANU; Simpson CL, 2002, PLANT PHYSIOL, V129, P957, DOI 10.1104/pp.010908; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian C, 2005, ACTA OCEANOL SIN, V24, P150; TRENCH RK, 1969, J CELL BIOL, V42, P404, DOI 10.1083/jcb.42.2.404; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wang GC, 2006, J INTEGR PLANT BIOL, V48, P190, DOI 10.1111/j.1744-7909.2006.00190.x; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Ye NH, 2005, J INTEGR PLANT BIOL, V47, P856, DOI 10.1111/j.1744-7909.2005.00050.x	61	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14663	10.1371/journal.pone.0014663	http://dx.doi.org/10.1371/journal.pone.0014663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339817	Green Published, gold			2022-12-27	WOS:000287367600003
J	Martiniova, L; Lu, J; Chiang, J; Bernardo, M; Lonser, R; Zhuang, ZP; Pacak, K				Martiniova, Lucia; Lu, Jie; Chiang, Jeffrey; Bernardo, Marcelino; Lonser, Russell; Zhuang, Zhengping; Pacak, Karel			Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy	PLOS ONE			English	Article							POLO-LIKE KINASE-1; DNA-DAMAGE; CANCER-CHEMOTHERAPY; PHEOCHROMOCYTOMA; INHIBITION; CYCLE; PARAGANGLIOMA; TEMOZOLOMIDE; DACARBAZINE; CYCLOPHOSPHAMIDE	Background: The failure of cytotoxic cancer regimens to cure the most drug-resistant, well-differentiated solid tumors has attributed to the heterogeneity of cell types that differ in their capacities for growth, differentiation, and metastases. We investigated the effect of LB1, a small molecule inhibitor of serine/threonine protein phosphatase 2A (PP2A), on its ability to inhibit a low growth fraction and highly drug-resistant solid neuroendocrine tumor, such as metastatic pheochromocytoma (PHEO). Subsequently, we evaluated the increased efficacy of chemotherapy combined with LB1. Methodology/Principal Findings: The effect of LB1 and temozolomide (TMZ), a standard chemotherapeutic agent that alone only transiently suppressed the growth and regression of metastatic PHEO, was evaluated in vitro on a single PHEO cell line and in vivo on mouse model of metastatic PHEO. In the present study, we show that metastatic PHEO, for which there is currently no cure, can be eliminated by combining LB1, thereby inhibiting PP2A, with TMZ. This new treatment approach resulted in long term, disease-free survival of up to 40% of animals bearing multiple intrahepatic metastases, a disease state that the majority of patients die from. Inhibition of PP2A was associated with prevention of G1/S phase arrest by p53 and of mitotic arrest mediated by polo-like kinase 1 (Plk-1). Conclusions/Significance: The elimination of DNA damage-induced defense mechanisms, through transient pharmacologic inhibition of PP2A, is proposed as a new approach for enhancing the efficacy of non-specific cancer chemotherapy regimens against a broad spectrum of low growth fraction tumors very commonly resistant to cytotoxic drugs.	[Martiniova, Lucia; Pacak, Karel] NICHHD, Reprod & Adult Endocrinol Program, NIH, Bethesda, MD 20892 USA; [Lu, Jie; Lonser, Russell; Zhuang, Zhengping] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD USA; [Chiang, Jeffrey] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Bernardo, Marcelino] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Bernardo, Marcelino] NCI, Lab Anim Sci Program, SAIC Frederick, Frederick, MD 21701 USA; [Martiniova, Lucia] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Slovak Academy of Sciences	Martiniova, L (corresponding author), NICHHD, Reprod & Adult Endocrinol Program, NIH, Bethesda, MD 20892 USA.	zhuangp@ninds.nih.gov; karel@mail.nih.gov			National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Neurological Disorders and Stroke (NINDS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Programs of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, and the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Bravo EL, 2009, HORM METAB RES, V41, P703, DOI 10.1055/s-0029-1224135; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Darzynkiewicz Z, 2009, EUR J PHARMACOL, V625, P143, DOI 10.1016/j.ejphar.2009.05.032; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Huang H, 2008, CANCER-AM CANCER SOC, V113, P2020, DOI 10.1002/cncr.23812; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; KOVACH JS, 2008, Patent No. 2008097561; Kulke MH, 2006, J CLIN ONCOL, V24, P401, DOI 10.1200/JCO.2005.03.6046; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARTINIOVA L, 2010, ENDOCR RELAT CA 1122; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mougey AM, 2007, HOSP PHYS, V43, P12; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Nomura K, 2009, J CLIN ENDOCR METAB, V94, P2850, DOI 10.1210/jc.2008-2697; PACAK K, 1995, ENDOCRINOLOGY, V136, P4814, DOI 10.1210/en.136.11.4814; PARDEE AB, 1975, P NATL ACAD SCI USA, V72, P4994, DOI 10.1073/pnas.72.12.4994; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Tischler AS, 2008, ENDOCR PATHOL, V19, P207, DOI 10.1007/s12022-008-9047-x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhuang ZP, 2009, CELL CYCLE, V8, P3303, DOI 10.4161/cc.8.20.9689	36	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14678	10.1371/journal.pone.0014678	http://dx.doi.org/10.1371/journal.pone.0014678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339823	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600007
J	Wu, GG; Sun, Y; Qu, W; Huang, Y; Lu, L; Li, L; Shao, WL				Wu, Guogan; Sun, Yu; Qu, Wei; Huang, Ying; Lu, Ling; Li, Lun; Shao, Weilan			Application of GFAT as a Novel Selection Marker to Mediate Gene Expression	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; SELECTABLE MARKER; GLUCOSAMINE SYNTHETASE; MOLECULAR-CLONING; YEAST; AMIDOTRANSFERASE; TRANSFORMATION; PURIFICATION; DISRUPTION	The enzyme glutamine: fructose-6-phosphate aminotransferase (GFAT), also known as glucosamine synthase (GlmS), catalyzes the formation of glucosamine-6-phosphate from fructose-6-phosphate and is the first and rate-limiting enzyme of the hexosamine biosynthetic pathway. For the first time, the GFAT gene was proven to possess a function as an effective selection marker for genetically modified (GM) microorganisms. This was shown by construction and analysis of two GFAT deficient strains, E. coli Delta glmS and S. pombe Delta gfa1, and the ability of the GFAT encoding gene to mediate plasmid selection. The gfa1 gene of the fission yeast Schizosaccharomyces pombe was deleted by KanMX6-mediated gene disruption and the Cre-loxP marker removal system, and the glmS gene of Escherichia coli was deleted by using lambda-Red mediated recombinase system. Both E. coli Delta glmS and S. pombe Delta gfa1 could not grow normally in the media without addition of glucosamine. However, the deficiency was complemented by transforming the plasmids that expressed GFAT genes. The xylanase encoding gene, xynA2 from Thermomyces lanuginosus was successfully expressed and secreted by using GFAT as selection marker in S. pombe. Optimal glucosamine concentration for E. coli Delta glmS and S. pombe Delta gfa1 growth was determined respectively. These findings provide an effective technique for the construction of GM bacteria without an antibiotic resistant marker, and the construction of GM yeasts to be applied to complex media.	[Wu, Guogan; Sun, Yu; Qu, Wei; Shao, Weilan] Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Peoples R China; [Wu, Guogan; Huang, Ying; Lu, Ling; Shao, Weilan] Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Peoples R China; [Wu, Guogan; Huang, Ying; Lu, Ling; Shao, Weilan] Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China; [Li, Lun] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia	Nanjing Normal University; Nanjing Normal University; Nanjing Normal University; University of Sydney	Wu, GG (corresponding author), Nanjing Normal Univ, Res Ctr Biotechnol & Biomass Energy, Nanjing, Peoples R China.	lun.li@sydney.edu.au; weilanshao@gmail.com	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022	Shao, Weilan/0000-0001-8067-3755; Sun, Yu/0000-0003-1389-9855	National Natural Science Foundation of China [30370034, 30970062]; University Natural Science Foundation of Jiangsu, China [09KJA180003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Natural Science Foundation of Jiangsu, China	This work was supported by the National Natural Science Foundation of China (30370034, 30970062) (URL: http://www.nsfc.gov.cn/Portal0/default124.htm), and the key Project from University Natural Science Foundation of Jiangsu, China (09KJA180003) (http://www.ec.js.edu.cn/html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; ARTHUR FJR, 2004, MICROBIOLOGY, V150, P3315; BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DUTKAMALEN S, 1988, BIOCHIMIE, V70, P287, DOI 10.1016/0300-9084(88)90073-9; ERKWALL K, 1991, NUCLEIC ACIDS RES, V19, P1150; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hoffman RL, 2006, CURR GENET, V49, P414, DOI 10.1007/s00294-006-0065-2; Iwaki T, 2004, BIOSCI BIOTECH BIOCH, V68, P545, DOI 10.1271/bbb.68.545; Kjaerulff S, 2005, BIOCHEM BIOPH RES CO, V336, P974, DOI 10.1016/j.bbrc.2005.08.195; Luo CP, 2009, PROTEIN J, V28, P34, DOI 10.1007/s10930-009-9163-6; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; Pei J, 2008, APPL MICROBIOL BIOT, V78, P115, DOI 10.1007/s00253-007-1295-z; RATLEDGE C, 2001, GENETIC ENG YEASTS F, P95; RATLEDGE C, 2001, PUBLIC PERCEPTION BI, P1; Sambrook J, 1989, MOL COLONING; Smith RJ, 1996, J BACTERIOL, V178, P2320, DOI 10.1128/jb.178.8.2320-2327.1996; WATZELE G, 1989, J BIOL CHEM, V264, P8753; Wu HW, 2010, BIOTECHNOL LETT, V32, P795, DOI 10.1007/s10529-010-0223-y; Yin E, 2008, WORLD J MICROB BIOT, V24, P275, DOI 10.1007/s11274-007-9469-5	27	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17082	10.1371/journal.pone.0017082	http://dx.doi.org/10.1371/journal.pone.0017082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340036	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600036
J	Flanagan, KA; Webb, W; Stowers, L				Flanagan, Kelly A.; Webb, William; Stowers, Lisa			Analysis of Male Pheromones That Accelerate Female Reproductive Organ Development	PLOS ONE			English	Article							MALE-MOUSE URINE; VOMERONASAL ORGAN; HOUSE MOUSE; SEXUAL-MATURATION; SYNTHETIC CHEMOSIGNALS; PUBERTY ACCELERATION; INDUCED OVULATION; PREPUTIAL GLAND; MALE AGGRESSION; MUS-MUSCULUS	Male odors can influence a female's reproductive physiology. In the mouse, the odor of male urine results in an early onset of female puberty. Several volatile and protein pheromones have previously been reported to each account for this bioactivity. Here we bioassay inbred BALB/cJ females to study pheromone-accelerated uterine growth, a developmental hallmark of puberty. We evaluate the response of wild-type and mutant mice lacking a specialized sensory transduction channel, TrpC2, and find TrpC2 function to be necessary for pheromone-mediated uterine growth. We analyze the relative effectiveness of pheromones previously identified to accelerate puberty through direct bioassay and find none to significantly accelerate uterine growth in BALB/cJ females. Complementary to this analysis, we have devised a strategy of partial purification of the uterine growth bioactivity from male urine and applied it to purify bioactivity from three different laboratory strains. The biochemical characteristics of the active fraction of all three strains are inconsistent with that of previously known pheromones. When directly analyzed, we are unable to detect previously known pheromones in urine fractions that generate uterine growth. Our analysis indicates that pheromones emitted by males to advance female puberty remain to be identified.	[Flanagan, Kelly A.; Webb, William; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Flanagan, KA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	stowers@scripps.edu	Stowers, Lisa/K-6137-2015	Stowers, Lisa/0000-0002-4403-1269	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [2R01DC006885, 1R01CD009413]; Skaggs Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Skaggs Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The submitted work was funded by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders 2R01DC006885 and 1R01CD009413 and the Skaggs Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Bimova B, 2009, BEHAV PROCESS, V80, P20, DOI 10.1016/j.beproc.2008.08.004; BRONSON FH, 1973, BIOL REPROD, V9, P449, DOI 10.1093/biolreprod/9.5.449; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLISSOLD PM, 1984, BIOCHEM GENET, V22, P379, DOI 10.1007/BF00484236; CLISSOLD PM, 1982, GENE, V18, P211, DOI 10.1016/0378-1119(82)90158-5; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; DRICKAMER LC, 1981, DEV PSYCHOBIOL, V14, P487, DOI 10.1002/dev.420140511; DRICKAMER LC, 1976, J REPROD FERTIL, V46, P369, DOI 10.1530/jrf.0.0460369; DRICKAMER LC, 1986, PHYSIOL BEHAV, V37, P741, DOI 10.1016/0031-9384(86)90179-4; GAGNAIRE F, 1989, J APPL TOXICOL, V9, P301, DOI 10.1002/jat.2550090504; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; JEMIOLO B, 1992, PHYSIOL BEHAV, V52, P521, DOI 10.1016/0031-9384(92)90341-X; JEMIOLO B, 1991, PHYSIOL BEHAV, V50, P1119, DOI 10.1016/0031-9384(91)90570-E; KANEKO N, 1980, BIOL REPROD, V22, P873, DOI 10.1095/biolreprod22.4.873; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Koyama S, 2004, HORM BEHAV, V46, P303, DOI 10.1016/j.yhbeh.2004.03.002; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LOMAS DE, 1982, J REPROD FERTIL, V66, P101, DOI 10.1530/jrf.0.0660101; Ma WD, 1999, CHEM SENSES, V24, P289, DOI 10.1093/chemse/24.3.289; Matsumoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P223, DOI 10.1271/bbb.90756; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; NISHIMURA K, 1989, J EXP ZOOL, V251, P300, DOI 10.1002/jez.1402510306; NISHIMURA K, 1979, OKAYAMA DAIGAKU  FEB, P23; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; PANDEY SD, 1988, ACTA PHYSIOL HUNG, V72, P165; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; PRICE MA, 1992, J EXP ZOOL, V264, P42, DOI 10.1002/jez.1402640107; Ramm SA, 2008, P ROY SOC B-BIOL SCI, V275, P1727, DOI 10.1098/rspb.2008.0302; Rekwot PI, 2001, ANIM REPROD SCI, V65, P157, DOI 10.1016/S0378-4320(00)00223-2; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rock F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000429; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Sharrow SD, 2002, PROTEIN SCI, V11, P2247, DOI 10.1110/ps.0204202; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; VANDENBERGH JG, 1969, ENDOCRINOLOGY, V84, P658, DOI 10.1210/endo-84-3-658; VANDENBERGH JG, 1972, J REPROD FERTIL, V28, P397, DOI 10.1530/jrf.0.0280397; VANDENBERGH JG, 1976, BIOL REPROD, V15, P260, DOI 10.1095/biolreprod15.2.260; VANDENBERGH JG, 1975, J REPROD FERTIL, V43, P515, DOI 10.1530/jrf.0.0430515; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; ZARROW MX, 1971, BIOL REPROD, V4, P52, DOI 10.1093/biolreprod/4.1.52; ZARROW MX, 1973, J REPROD FERTIL, V35, P81, DOI 10.1530/jrf.0.0350081; Zhang JX, 2007, CHEM SENSES, V32, P293, DOI 10.1093/chemse/bjl058	61	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16660	10.1371/journal.pone.0016660	http://dx.doi.org/10.1371/journal.pone.0016660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347429	gold, Green Published			2022-12-27	WOS:000287077600013
J	Eaton, HE; Desrochers, G; Drory, SB; Metcalf, J; Angers, A; Brunetti, CR				Eaton, Heather E.; Desrochers, Guillaume; Drory, Samuel B.; Metcalf, Julie; Angers, Annie; Brunetti, Craig R.			SIMPLE/LITAF Expression Induces the Translocation of the Ubiquitin Ligase Itch towards the Lysosomal Compartments	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; EPIDERMAL-GROWTH-FACTOR; PROLINE-RICH LIGAND; TNF-ALPHA FACTOR; TRANSCRIPTION FACTOR; PROTEIN LIGASE; IDENTIFICATION; DEGRADATION; NEUROPATHY; DOMAIN	LITAF is a small cellular protein with an unknown function. The C-terminus of LITAF contains a highly conserved domain termed the SIMPLE-like domain (SLD), while the N-terminus contains two PPXY motifs that mediate protein-protein interactions with WW-domain containing proteins. LITAF also harbors two endosome/lysosome targeting sequences at its C-terminus, but there has been conflicting reports regarding its intracellular localization. Here, we demonstrate that LITAF is localized to the late endosome/lysosomal compartment in a variety of cell lines. We also show that Itch, a WW-domain containing protein, and LITAF strongly interact and that this interaction depends on the two PPXY motifs in the N-terminus of LITAF. Interestingly, co-expression of LITAF with Itch induces major changes in Itch intracellular localization, bringing Itch from the trans-Golgi network to lysosomes. We show that this re-localization is dependent upon the interaction with the PPXY sequences of LITAF, since disruption of these binding motifs completely abrogates Itch re-localization.	[Eaton, Heather E.; Metcalf, Julie; Brunetti, Craig R.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Desrochers, Guillaume; Drory, Samuel B.; Angers, Annie] Univ Montreal, Dept Sci Biol, Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada	Trent University; Universite de Montreal	Eaton, HE (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	craigbrunetti@trentu.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X; Drory, Samuel/0000-0001-9502-2023	Natural Science and Engineering Research Council (NSERC) of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by Discovery Grants (Natural Science and Engineering Research Council (NSERC) of Canada) to A. A. and C. R. B. H. E. E. is the recipient of a NSERC postgraduate scholarship. S. B. D. was the recipient of a NSERC undergraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Azakir BA, 2009, CELL SIGNAL, V21, P1326, DOI 10.1016/j.cellsig.2009.03.020; Bennett CL, 2004, ANN NEUROL, V55, P713, DOI 10.1002/ana.20094; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Huang YZ, 2007, INFLAMM BOWEL DIS, V13, P120, DOI 10.1002/ibd.20010; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Kroeger Karen M, 2004, Methods Mol Biol, V259, P323; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Meggouh F, 2005, ANN NEUROL, V57, P589, DOI 10.1002/ana.20434; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100	34	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16873	10.1371/journal.pone.0016873	http://dx.doi.org/10.1371/journal.pone.0016873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326863	gold, Green Submitted, Green Published			2022-12-27	WOS:000287037000029
J	Stember, JN; Andersen, O				Stember, Joseph N.; Andersen, Olaf			A One-Dimensional Continuum Elastic Model for Membrane-Embedded Gramicidin Dimer Dissociation	PLOS ONE			English	Article							CHANNEL FUNCTION; PROTEIN FUNCTION; LIPID-BILAYERS; MECHANISM; ENERGETICS; DRUG	Membrane elastic properties, which are subject to alteration by compounds such as cholesterol, lipid metabolites and other amphiphiles, as well as pharmaceuticals, can have important effects on membrane proteins. A useful tool for measuring some of these effects is the gramicidin A channels, which are formed by transmembrane dimerization of non-conducting subunits that reside in each bilayer leaflet. The length of the conducting channels is less than the bilayer thickness, meaning that channel formation is associated with a local bilayer deformation. Electrophysiological studies have shown that the dimer becomes increasingly destabilized as the hydrophobic mismatch between the channel and the host bilayer increases. That is, the bilayer imposes a disjoining force on the channel, which grows larger with increasing hydrophobic mismatch. The energetic analysis of the channel-bilayer coupling is usually pursued assuming that each subunit, as well as the subunit-subunit interface, is rigid. Here we relax the latter assumption and explore how the bilayer junction responds to changes in this disjoining force using a simple one-dimensional energetic model, which reproduces key features of the bilayer regulation of gramicidin channel lifetimes.	[Stember, Joseph N.; Andersen, Olaf] Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA	Cornell University	Stember, JN (corresponding author), Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA.	js1569@nyumc.org	Stember, Joseph/AAK-9356-2020	Stember, Joseph/0000-0003-3169-9590	National Institutes of Health [GM021342, DA012923, DA012408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, P01DA012923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants GM021342, DA012923 and DA012408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2006, BIOPHYS J, V90, P3447, DOI 10.1529/biophysj.105.077073; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; ANDERSEN O, METH ENZYMOL, V171, P62; ANDERSEN O, METHODS MOL BIOL, V400; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Andersen OS, 2008, J GEN PHYSIOL, V131, P395, DOI 10.1085/jgp.200810012; Artigas P, 2006, MOL PHARMACOL, V70, P2015, DOI 10.1124/mol.106.026070; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; BUSATH D, 1998, BIOPHYS J, V53, P689; Dzikovski BG, 2004, BIOPHYS J, V87, P3504, DOI 10.1529/biophysj.104.044305; Eisenberg D., 1979, PHYS CHEM APPL LIFE; Evans E, 1995, FALK SYMP, V80, P59; Galbraith TP, 1998, FARADAY DISCUSS, V111, P159; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; HELFRICH P, 1990, BIOPHYS J, V57, P1075, DOI 10.1016/S0006-3495(90)82625-4; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Miloshevsky GV, 2006, STRUCTURE, V14, P1241, DOI 10.1016/j.str.2006.06.007; Miloshevsky GV, 2004, BIOPHYS J, V86, P92, DOI 10.1016/S0006-3495(04)74087-4; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Seddon AM, 2009, CHEM SOC REV, V38, P2509, DOI 10.1039/b813853m; Zhelev DV, 1998, BIOPHYS J, V75, P321, DOI 10.1016/S0006-3495(98)77516-2	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e15563	10.1371/journal.pone.0015563	http://dx.doi.org/10.1371/journal.pone.0015563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326605	Green Submitted, Green Published, gold			2022-12-27	WOS:000287037000007
J	Wichard, JD; ter Laak, A; Krause, G; Heinrich, N; Kuhne, R; Kleinau, G				Wichard, Joerg D.; ter Laak, Antonius; Krause, Gerd; Heinrich, Nikolaus; Kuehne, Ronald; Kleinau, Gunnar			Chemogenomic Analysis of G-Protein Coupled Receptors and Their Ligands Deciphers Locks and Keys Governing Diverse Aspects of Signalling	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; 2ND EXTRACELLULAR LOOP; MELANOCORTIN-4 RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR DETERMINANTS; PHYLOGENETIC ANALYSIS; MUTUAL INFORMATION; RHODOPSIN FAMILY; AMINO-ACID; BINDING	Understanding the molecular mechanism of signalling in the important super-family of G-protein-coupled receptors (GPCRs) is causally related to questions of how and where these receptors can be activated or inhibited. In this context, it is of great interest to unravel the common molecular features of GPCRs as well as those related to an active or inactive state or to subtype specific G-protein coupling. In our underlying chemogenomics study, we analyse for the first time the statistical link between the properties of G-protein-coupled receptors and GPCR ligands. The technique of mutual information (MI) is able to reveal statistical inter-dependence between variations in amino acid residues on the one hand and variations in ligand molecular descriptors on the other. Although this MI analysis uses novel information that differs from the results of known site-directed mutagenesis studies or published GPCR crystal structures, the method is capable of identifying the well-known common ligand binding region of GPCRs between the upper part of the seven transmembrane helices and the second extracellular loop. The analysis shows amino acid positions that are sensitive to either stimulating (agonistic) or inhibitory (antagonistic) ligand effects or both. It appears that amino acid positions for antagonistic and agonistic effects are both concentrated around the extracellular region, but selective agonistic effects are cumulated between transmembrane helices (TMHs) 2, 3, and ECL2, while selective residues for antagonistic effects are located at the top of helices 5 and 6. Above all, the MI analysis provides detailed indications about amino acids located in the transmembrane region of these receptors that determine G-protein signalling pathway preferences.	[Wichard, Joerg D.; Krause, Gerd; Kuehne, Ronald; Kleinau, Gunnar] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Wichard, Joerg D.; ter Laak, Antonius; Heinrich, Nikolaus] Bayer Schering Pharma, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals	Wichard, JD (corresponding author), Leibniz Inst Mol Pharmacol, Berlin, Germany.	kuehne@fmp-berlin.de	Kleinau, Gunnar/GPX-6330-2022	ter Laak, Antonius/0000-0003-1820-002X				Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; BALAKIN K, 2005, DRUG DISCOV TODAY, V3, P397; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Bhattacharya S, 2010, J COMPUT AID MOL DES, V24, P659, DOI 10.1007/s10822-010-9364-2; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans PD, 1995, PROG BRAIN RES, V106, P259; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Hall LH, 2000, J CHEM INF COMP SCI, V40, P784, DOI 10.1021/ci990140w; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hogan K, 2006, J MED CHEM, V49, P911, DOI 10.1021/jm050780s; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Huang J, 2008, BIOCHEM BIOPH RES CO, V371, P610, DOI 10.1016/j.bbrc.2008.03.135; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; KUBINYI H, 2004, CHEMOGENOMICS DRUG D; Kuhn B, 1999, BIOCHEMISTRY-US, V38, P12490, DOI 10.1021/bi990755m; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lehmann N, 2007, J MOL BIOL, V366, P1129, DOI 10.1016/j.jmb.2006.11.098; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; LOWELL L, 1991, J CHEM INF COMP SCI, V31, P76; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nickolls SA, 2003, J PHARMACOL EXP THER, V304, P1217, DOI 10.1124/jpet.102.044974; Okuno Y, 2008, NUCLEIC ACIDS RES, V36, pD907, DOI 10.1093/nar/gkm948; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pogozheva ID, 2005, BIOCHEMISTRY-US, V44, P11329, DOI 10.1021/bi0501840; RAYMOND JR, 1995, AM J PHYSIOL-RENAL, V269, pF141, DOI 10.1152/ajprenal.1995.269.2.F141; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Runyon SP, 2008, J MED CHEM, V51, P6808, DOI 10.1021/jm800771x; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schoneberg T, 2007, TRENDS PHARMACOL SCI, V28, P117, DOI 10.1016/j.tips.2007.01.001; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Sun Y, 2007, MOL BIOSYST, V3, P849, DOI 10.1039/b706343a; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tarnow P, 2008, OBESITY FACTS, V1, P155, DOI 10.1159/000138251; Todeschini R., 2008, HDB MOL DESCRIPTORS; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; van der Horst E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-316; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; van Koppen CJ, 2008, N-S ARCH PHARMACOL, V378, P503, DOI 10.1007/s00210-008-0318-3; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954, DOI 10.1124/mol.58.5.954; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Westkaemper R B, 1994, NIDA Res Monogr, V146, P263; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Yang Y, 2000, BIOCHEMISTRY-US, V39, P14900, DOI 10.1021/bi001684q; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	98	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16811	10.1371/journal.pone.0016811	http://dx.doi.org/10.1371/journal.pone.0016811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326864	Green Submitted, Green Published, gold			2022-12-27	WOS:000287037000023
J	Sacchi, O; Rossi, ML; Canella, R; Fesce, R				Sacchi, Oscar; Rossi, Maria Lisa; Canella, Rita; Fesce, Riccardo			Changes in Cationic Selectivity of the Nicotinic Channel at the Rat Ganglionic Synapse: A Role for Chloride Ions?	PLOS ONE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; SYMPATHETIC NEURON; ACETYLCHOLINE-RECEPTORS; VOLTAGE-CLAMP; INTRACELLULAR SODIUM; AUTONOMIC GANGLIA; CELLS; SUBUNIT; PHOSPHORYLATION; ALPHA-7	The permeability of the nicotinic channel (nAChR) at the ganglionic synapse has been examined, in the intact rat superior cervical ganglion in vitro, by fitting the Goldman current equation to the synaptic current (EPSC) I-V relationship. Subsynaptic nAChRs, activated by neurally-released acetylcholine (ACh), were thus analyzed in an intact environment as natively expressed by the mature sympathetic neuron. Postsynaptic neuron hyperpolarization (from -40 to -90 mV) resulted in a change of the synaptic potassium/sodium permeability ratio (P-K/P-Na) from 1.40 to 0.92, corresponding to a reversible shift of the apparent acetylcholine equilibrium potential, E-ACh, by about +10 mV. The effect was accompanied by a decrease of the peak synaptic conductance (g(syn)) and of the EPSC decay time constant. Reduction of [Cl-](o) to 18 mM resulted in a change of P-K/P-Na from 1.57 (control) to 2.26, associated with a reversible shift of EACh by about -10 mV. Application of 200 nM alpha BgTx evoked P-K/P-Na and g(syn) modifications similar to those observed in reduced [Cl-](o). The two treatments were overlapping and complementary, as if the same site/mechanism were involved. The difference current before and after chloride reduction or toxin application exhibited a strongly positive equilibrium potential, which could not be explained by the block of a calcium component of the EPSC. Observations under current-clamp conditions suggest that the driving force modification of the EPSC due to P-K/P-Na changes represent an additional powerful integrative mechanism of neuron behavior. A possible role for chloride ions is suggested: the nAChR selectivity was actually reduced by increased chloride gradient (membrane hyperpolarization), while it was increased, moving towards a channel preferentially permeable for potassium, when the chloride gradient was reduced.	[Sacchi, Oscar; Rossi, Maria Lisa; Canella, Rita] Univ Ferrara, Sect Physiol & Biophys, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Fesce, Riccardo] Insubria Univ, DBSF, Varese, Italy; [Fesce, Riccardo] Insubria Univ, Ctr Neurosci, Varese, Italy	University of Ferrara; University of Insubria; University of Insubria	Sacchi, O (corresponding author), Univ Ferrara, Sect Physiol & Biophys, Dept Biol & Evolut, I-44100 Ferrara, Italy.	sho@unife.it	Rossi, Maria Lisa/D-4251-2011	Rossi, Maria Lisa/0000-0002-9057-7422; fesce, riccardo/0000-0001-9473-896X	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [2006050200-002, 2006050200-003]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This paper was supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca within the national research project PRIN 2006 (2006050200-002 O.S. and 2006050200-003 R.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAVAREZLEEFMAN.FJ, 1988, J PHYSL, V406, P225; BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; BELLUZZI O, 1991, PROG BIOPHYS MOL BIO, V55, P1, DOI 10.1016/0079-6107(91)90009-H; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P91, DOI 10.1113/jphysiol.1985.sp015542; BELLUZZI O, 1985, J PHYSIOL-LONDON, V358, P109, DOI 10.1113/jphysiol.1985.sp015543; CHRISTOFFERSEN GRJ, 1975, COMP BIOCHEM PHYS A, V52, P317, DOI 10.1016/S0300-9629(75)80094-6; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Cuevas J, 2000, J PHYSIOL-LONDON, V525, P735, DOI 10.1111/j.1469-7793.2000.t01-1-00735.x; DeKoninck P, 1995, J NEUROSCI, V15, P7966; DERKACH VA, 1983, J PHYSIOL-LONDON, V336, P511, DOI 10.1113/jphysiol.1983.sp014595; DUN N, 1976, NEUROPHARMACOLOGY, V15, P211, DOI 10.1016/0028-3908(76)90066-6; FORSTER I, 1995, P ROY SOC B-BIOL SCI, V260, P139, DOI 10.1098/rspb.1995.0071; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Gotti C, 2000, BEHAV BRAIN RES, V113, P183, DOI 10.1016/S0166-4328(00)00212-6; Gotti C, 1998, BRIT J PHARMACOL, V124, P1197, DOI 10.1038/sj.bjp.0701957; Henderson P, 1907, Z PHYS CHEM-STOCH VE, V59, P118; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Knopfel T, 1998, EUR J NEUROSCI, V10, P1926, DOI 10.1046/j.1460-9568.1998.00195.x; KOKETSU K, 1969, FED PROC, V28, P101; KUBA K, 1979, PFLUG ARCH EUR J PHY, V378, P205, DOI 10.1007/BF00592737; MACDERMOTT AB, 1980, J GEN PHYSIOL, V75, P39, DOI 10.1085/jgp.75.1.39; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; MIDDLETON P, 1986, P NATL ACAD SCI USA, V83, P4967, DOI 10.1073/pnas.83.13.4967; OBATA K, 1974, BRAIN RES, V73, P71, DOI 10.1016/0006-8993(74)91008-7; Paradiso K, 1998, J NEUROSCI, V18, P9227; Pitt SJ, 2008, J NEUROSCI, V28, P11454, DOI 10.1523/JNEUROSCI.3890-08.2008; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; RANG HP, 1981, J PHYSIOL-LONDON, V311, P23, DOI 10.1113/jphysiol.1981.sp013571; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Sacchi O, 2008, NEUROSCIENCE, V154, P1360, DOI 10.1016/j.neuroscience.2008.04.058; Sacchi O, 1999, J NEUROPHYSIOL, V82, P1662, DOI 10.1152/jn.1999.82.4.1662; Sacchi O, 1998, J NEUROPHYSIOL, V79, P727, DOI 10.1152/jn.1998.79.2.727; Sacchi O, 2000, J NEUROPHYSIOL, V83, P3254, DOI 10.1152/jn.2000.83.6.3254; Sacchi O, 1998, J NEUROSCI METH, V80, P171, DOI 10.1016/S0165-0270(97)00199-4; SELYANKO AA, 1979, J AUTONOM NERV SYST, V1, P127, DOI 10.1016/0165-1838(79)90011-0; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Skok VI, 2002, AUTON NEUROSCI-BASIC, V97, P1, DOI 10.1016/S1566-0702(01)00386-1; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Tsubokawa H, 1999, J PHYSIOL-LONDON, V517, P135, DOI 10.1111/j.1469-7793.1999.0135z.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voitenko S V, 2000, Neurosci Behav Physiol, V30, P19, DOI 10.1007/BF02461388; Yu CR, 1998, J PHYSIOL-LONDON, V509, P651, DOI 10.1111/j.1469-7793.1998.651bm.x	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17318	10.1371/journal.pone.0017318	http://dx.doi.org/10.1371/journal.pone.0017318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364885	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100045
J	Shirdel, EA; Xie, W; Mak, TW; Jurisica, I				Shirdel, Elize A.; Xie, Wing; Mak, Tak W.; Jurisica, Igor			NAViGaTing the Micronome - Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; PROTEIN-SYNTHESIS; GENOME BROWSER; BINDING-SITES; TARGETS; IDENTIFICATION; EXPRESSION; SEQUENCES; GENES	Background: MicroRNAs are a class of small RNAs known to regulate gene expression at the transcript level, the protein level, or both. Since microRNA binding is sequence-based but possibly structure-specific, work in this area has resulted in multiple databases storing predicted microRNA: target relationships computed using diverse algorithms. We integrate prediction databases, compare predictions to in vitro data, and use cross-database predictions to model the microRNA: transcript interactome - referred to as the micronome - to study microRNA involvement in well-known signalling pathways as well as associations with disease. We make this data freely available with a flexible user interface as our microRNA Data Integration Portal - mirDIP (http://ophid.utoronto.ca/mirDIP). Results: mirDIP integrates prediction databases to elucidate accurate microRNA: target relationships. Using NAViGaTOR to produce interaction networks implicating microRNAs in literature-based, KEGG-based and Reactome-based pathways, we find these signalling pathway networks have significantly more microRNA involvement compared to chance (p < 0.05), suggesting microRNAs co-target many genes in a given pathway. Further examination of the micronome shows two distinct classes of microRNAs; universe microRNAs, which are involved in many signalling pathways; and intra-pathway microRNAs, which target multiple genes within one signalling pathway. We find universe microRNAs to have more targets (p < 0.0001), to be more studied (p < 0.0002), and to have higher degree in the KEGG cancer pathway (p < 0.0001), compared to intra-pathway microRNAs. Conclusions: Our pathway-based analysis of mirDIP data suggests microRNAs are involved in intra-pathway signalling. We identify two distinct classes of microRNAs, suggesting a hierarchical organization of microRNAs co-targeting genes both within and between pathways, and implying differential involvement of universe and intra-pathway microRNAs at the disease level.	[Shirdel, Elize A.; Mak, Tak W.; Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Shirdel, Elize A.; Xie, Wing; Jurisica, Igor] Campbell Family Inst Canc Res, Toronto, ON, Canada; [Mak, Tak W.] Princess Margaret Hosp Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Shirdel, EA (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	juris@ai.utoronto.ca			Canada Foundation for Innovation [12301, 203383]; Canada Research Chair Program; CIHR [202370]; Natural Science and Engineering Research Council of Canada [104105]; IBM; Ontario Ministry of Health and Long Term Care (OMOHLTC); CIHR Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair Program(Canada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); IBM(International Business Machines (IBM)); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); CIHR Canada(Canadian Institutes of Health Research (CIHR))	The authors gratefully acknowledge funding from the Canada Foundation for Innovation Grants #12301 and #203383, the Canada Research Chair Program, CIHR Catalyst Grant #202370, the Natural Science and Engineering Research Council of Canada Grant #104105, the CIHR Canada Graduate Scholarship Program, and IBM. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; [Anonymous], ONL MEND INH MAN OMI; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blankenberg D, 2007, GENOME RES, V17, P960, DOI 10.1101/gr.5578007; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; CAREY V, RBGL INTERFACE BOOST; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; GENTLEMAN R, FALCON S GRAPH PACKA; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HORVITZ HR, 1980, GENETICS, V96, P435; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Joshi-Tope G, 2003, COLD SPRING HARB SYM, V68, P237, DOI 10.1101/sqb.2003.68.237; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Schneider R, 1996, NUCLEIC ACIDS RES, V24, P201, DOI 10.1093/nar/24.1.201; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; TEAM RDC, 2005, R LANGUAGE ENV STAT; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; WATERMAN MS, 1987, J MOL BIOL, V197, P723, DOI 10.1016/0022-2836(87)90478-5; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	96	172	175	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17429	10.1371/journal.pone.0017429	http://dx.doi.org/10.1371/journal.pone.0017429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364759	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100061
J	Xiao, L; Shang, HC; Wang, JY; Hu, J; Xiong, J				Xiao Lu; Shang Hongcai; Wang Jiaying; Hu Jing; Xiong Jun			Assessing the Quality of Reports about Randomized Controlled Trials of Acupuncture Treatment on Mild Cognitive Impairment	PLOS ONE			English	Article							CONSORT STATEMENT	Objective: To evaluate the reports' qualities which are about randomized controlled trials (RCTs) of acupuncture treatment on Mild Cognitive Impairment (MIC). Methods: Nine databases including the Cochrane Central Register of Controlled Trials (CENTRAL, 2010), PUBMED (1984-5/2010), EMbase (1984-5/2010), MEDLINE (1984-5/2010), CINAL (1984-5/2010), China National Knowledge Infrastructure (CNKI, 1980-5/2010), China Biomedicine Database disc (CBMdisc, 1980-5/2010), VIP (a full text issues database of China, 1989-5/2010) were searched systematically. Hand search for further references was conducted. Language was limited to Chinese and English. We identified 14 RCTs that used acupuncture as an intervention and assessed the quality of these reports against the Consolidated Standards for Reporting of Trials (CONSORT) statement and Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA). Results: In regard to the items in the CONSORT statement, 13(92.86%) RCTs described baseline demographic and clinical characteristics in each group. 7 (50.0%) mentioned the method of generating the random sequence, only 2 (14.3%) RCTs had adequate allocation concealment. No RCTs used blinding. RCTs reported the sample size calculation. In regard to the items in STRICTA, 10 (71.43%) mentioned the depths of insertion, 6 (42.86%) reported acupuncture response, 11 (78.57%) mentioned the technique of acupuncture, 12 (85.71%) recorded the time, and only 3 (21.43%) RCTs reported the numbers of needles inserted. No RCTs reported the background of the acupuncture practitioners and professional title of practitioners. Conclusion: The reporting quality of RCTs of acupuncture for mild cognitive impairment was moderate to low. The CONSORT statement and STRICTA should be used to standardize the reporting of RCTs of acupuncture in future.	[Xiao Lu; Shang Hongcai; Wang Jiaying] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Xiao Lu; Shang Hongcai] MOE Virtual Res Ctr Evidence Based Med, Chengdu, Peoples R China; [Wang Jiaying] Evidence Based Med Ctr Tianjin, Tianjin, Peoples R China; [Hu Jing] Peking Univ, Beijing 100871, Peoples R China; [Xiong Jun] Jiang Xi Hosp Tradit Chinese Med, Dept Acupuncture, Nanchang, Jiangxi, Peoples R China	Tianjin University of Traditional Chinese Medicine; Peking University	Shang, HC (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China.	shanghongcai@foxmail.com	shang, hongcai/H-1257-2014		New Century Excellent Talent Project Grant [2009613]	New Century Excellent Talent Project Grant	New Century Excellent Talent Project Grant (No 2009613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; CHEN SJ, 2009, CHINESE J TRADITIONA; CHEN SJ, 2008, J EMERGENCY TRADITIO; FENG CQ, 2009, LIN J TRADITIONAL CH, V29; Gmdman M, 1996, NEUROLOGY, V46, pA403; HE X, 2008, J PRACTICAL TRADITIO; HOU XB, 2010, WORLD J INTEGRATED T; HOU XB, 2009, BRAIN FUNCTIONAL MAG; LIU J, 2009, SHANGHAI J ACUPUNTUR; MACPHERSON H, 2001, COMPLEMENT THER MED, P216; MACPHERSON H, 2001, COMPLEMENT THER MED, V8, P85; MACPHERSON H, 2001, COMPLEMENT THER MED, V20, P22; MacPherson Hugh, 2002, Acupunct Med, V20, P22; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; SU ZW, 2006, LIAONING J TRADITION; SUN YZ, 2007, CHINESE J TRADITIONA; SUN YZ, 2009, J CLIN ACUPUNTURE MO; WANG Y, 2006, J BAOTOU MED COLL, P355; YU T, 2007, SHAANXI J TRADITIONA; ZHANG XL, 2006, CHINESE J EVIDENCE B, V6; ZHOU XP, 2008, GUANGXI J TRADITIONA; ZHOU XP, 2008, SHANGHAI J ACUPUNTUR; 2009, J ALTERNATIVE COMPLE	24	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16922	10.1371/journal.pone.0016922	http://dx.doi.org/10.1371/journal.pone.0016922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364920	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100015
J	Weber, E; Engler, C; Gruetzner, R; Werner, S; Marillonnet, S				Weber, Ernst; Engler, Carola; Gruetzner, Ramona; Werner, Stefan; Marillonnet, Sylvestre			A Modular Cloning System for Standardized Assembly of Multigene Constructs	PLOS ONE			English	Article							BIOSYNTHETIC-PATHWAY; FUNCTIONAL-ANALYSIS; DNA; DESIGN; VECTOR	The field of synthetic biology promises to revolutionize biotechnology through the design of organisms with novel phenotypes useful for medicine, agriculture and industry. However, a limiting factor is the ability of current methods to assemble complex DNA molecules encoding multiple genetic elements in various predefined arrangements. We present here a hierarchical modular cloning system that allows the creation at will and with high efficiency of any eukaryotic multigene construct, starting from libraries of defined and validated basic modules containing regulatory and coding sequences. This system is based on the ability of type IIS restriction enzymes to assemble multiple DNA fragments in a defined linear order. We constructed a 33 kb DNA molecule containing 11 transcription units made from 44 individual basic modules in only three successive cloning steps. This modular cloning (MoClo) system can be readily automated and will be extremely useful for applications such as gene stacking and metabolic engineering.	[Weber, Ernst; Engler, Carola; Gruetzner, Ramona; Werner, Stefan; Marillonnet, Sylvestre] Icon Genet GmbH, Halle, Germany	ICON plc	Weber, E (corresponding author), Icon Genet GmbH, Halle, Germany.	marillonnet@icongenetics.de		Werner, Stefan/0000-0002-4932-1441	Icon Genetics GmbH	Icon Genetics GmbH	Funding: This work was funded by Icon Genetics GmbH. No external grants were used to support this research. As all authors are employed by the funder, the funder played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; Cai YZ, 2010, NUCLEIC ACIDS RES, V38, P2637, DOI 10.1093/nar/gkq086; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Itaya M, 2008, NAT METHODS, V5, P41, DOI 10.1038/NMETH1143; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Knight T., 2003, IDEMPOTENT VECTOR DE; Laubinger S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r112; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; Sleight SC, 2010, NUCLEIC ACIDS RES, V38, P2624, DOI 10.1093/nar/gkq179; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	21	541	642	9	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16765	10.1371/journal.pone.0016765	http://dx.doi.org/10.1371/journal.pone.0016765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364738	Green Published, gold			2022-12-27	WOS:000287482800015
J	Yan, A; Avraham, T; Zampell, JC; Aschen, SZ; Mehrara, BJ				Yan, Alan; Avraham, Tomer; Zampell, Jamie C.; Aschen, Seth Z.; Mehrara, Babak J.			Mechanisms of Lymphatic Regeneration after Tissue Transfer	PLOS ONE			English	Article							BREAST-CANCER; INTERSTITIAL FLOW; FLAP TRANSFER; WOUND REPAIR; NODE BIOPSY; LYMPHEDEMA; LYMPHANGIOGENESIS; DISSECTION; SKIN; MACROPHAGES	Introduction: Lymphedema is the chronic swelling of an extremity that occurs commonly after lymph node resection for cancer treatment. Recent studies have demonstrated that transfer of healthy tissues can be used as a means of bypassing damaged lymphatics and ameliorating lymphedema. The purpose of these studies was to investigate the mechanisms that regulate lymphatic regeneration after tissue transfer. Methods: Nude mice (recipients) underwent 2-mm tail skin excisions that were either left open or repaired with full-thickness skin grafts harvested from donor transgenic mice that expressed green fluorescent protein in all tissues or from LYVE-1 knockout mice. Lymphatic regeneration, expression of VEGF-C, macrophage infiltration, and potential for skin grafting to bypass damaged lymphatics were assessed. Results: Skin grafts healed rapidly and restored lymphatic flow. Lymphatic regeneration occurred beginning at the peripheral edges of the graft, primarily from ingrowth of new lymphatic vessels originating from the recipient mouse. In addition, donor lymphatic vessels appeared to spontaneously re-anastomose with recipient vessels. Patterns of VEGF-C expression and macrophage infiltration were temporally and spatially associated with lymphatic regeneration. When compared to mice treated with excision only, there was a 4-fold decrease in tail volumes, 2.5-fold increase in lymphatic transport by lymphoscintigraphy, 40% decrease in dermal thickness, and 54% decrease in scar index in skin-grafted animals, indicating that tissue transfer could bypass damaged lymphatics and promote rapid lymphatic regeneration. Conclusions: Our studies suggest that lymphatic regeneration after tissue transfer occurs by ingrowth of lymphatic vessels and spontaneous re-connection of existing lymphatics. This process is temporally and spatially associated with VEGF-C expression and macrophage infiltration. Finally, tissue transfer can be used to bypass damaged lymphatics and promote rapid lymphatic regeneration.	[Yan, Alan; Avraham, Tomer; Zampell, Jamie C.; Aschen, Seth Z.; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Yan, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org			Breast Cancer Alliance; Plastic Surgery Education Foundation [136866]; NIH [CA0095001]	Breast Cancer Alliance; Plastic Surgery Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Breast Cancer Alliance (BJM), the Plastic Surgery Education Foundation Research Fellowship Grant #136866 (TA), and the NIH T-32 Surgical Oncology Training Grant #CA0095001 (JCZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2008, J CLIN ONCOL, V26, P5689, DOI 10.1200/JCO.2008.16.4731; Anthony JP, 1997, J RECONSTR MICROSURG, V13, P327, DOI 10.1055/s-2007-1006411; Armer JM, 2004, LYMPHOLOGY, V37, P73; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Beesley V, 2007, CANCER, V109, P2607, DOI 10.1002/cncr.22684; Boardman KC, 2003, CIRC RES, V92, P801, DOI 10.1161/01.RES.0000065621.69843.49; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; Classen DA, 2005, J RECONSTR MICROSURG, V21, P93, DOI 10.1055/s-2005-864841; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Goldman J, 2007, AM J PHYSIOL-HEART C, V292, pH2176, DOI 10.1152/ajpheart.01011.2006; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Hinrichs CS, 2004, J SURG ONCOL, V85, P187, DOI 10.1002/jso.20020; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5220, DOI 10.1200/JCO.2008.16.3766; McLaughlin SA, 2008, J CLIN ONCOL, V26, P5213, DOI 10.1200/JCO.2008.16.3725; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Rockson Stanley G, 2006, Curr Treat Options Cardiovasc Med, V8, P129, DOI 10.1007/s11936-006-0005-y; Rutkowski JM, 2006, AM J PHYSIOL-HEART C, V291, pH1402, DOI 10.1152/ajpheart.00038.2006; Saaristo A, 2004, FASEB J, V18, P1707, DOI 10.1096/fj.04-1592fje; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Slavin SA, 1999, ANN SURG, V229, P421, DOI 10.1097/00000658-199903000-00017; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689	28	74	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17201	10.1371/journal.pone.0017201	http://dx.doi.org/10.1371/journal.pone.0017201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359148	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482300037
J	Dekleva, M; Dufour, V; de Vries, H; Spruijt, BM; Sterck, EHM				Dekleva, Marusha; Dufour, Valerie; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.			Chimpanzees (Pan troglodytes) Fail a What-Where-When Task but Find Rewards by Using a Location-Based Association Strategy	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; GORILLA-GORILLA-GORILLA; MENTAL TIME-TRAVEL; SPATIAL MEMORY; FUTURE; EVOLUTION; MATRICES; ELEMENTS; OBJECTS; RECALL	Recollecting the what-where-when of an episode, or episodic-like memory, has been established in corvids and rodents. In humans, a linkage between remembering the past and imagining the future has been recognised. While chimpanzees can plan for the future, their episodic-like memory has hardly been investigated. We tested chimpanzees (Pan troglodytes) with an adapted food-caching paradigm. They observed the baiting of two locations amongst four and chose one after a given delay (15 min, 1 h or 5 h). We used two combinations of food types, a preferred and a less preferred food that disappeared at different rates. The subjects had to base their choices on the time elapsed since baiting, and on their memory of which food was where. They could recover either their preferred food or the one that remained present. All animals failed to obtain the preferred or present foods above chance levels. They were like-wise unsuccessful at choosing baited cups above chance levels. The subjects, thus, failed to use any feature of the baiting events to guide their choices. Nonetheless, their choices were not random, but the result of a developed location-based association strategy. Choices in the second half of the study correlated with the rewards obtained at each location in the first half of the study, independent from the choices made for each location in the first half of the study. This simple location-based strategy yielded a fair amount of food. The animals' failure to remember the what-where-when in the presented set-up may be due to the complexity of the task, rather than an inability to form episodic-like memories, as they even failed to remember what was where after 15 minutes.	[Dekleva, Marusha; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Utrecht, Netherlands; [Dufour, Valerie] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dekleva, M (corresponding author), Univ Utrecht, Utrecht, Netherlands.	marusha.dekleva@gmail.com	Spruijt, Berry/C-2122-2011; Sterck, Elisabeth/C-1063-2011; de Vries, Han/B-9359-2011	Sterck, Elisabeth/0000-0003-1101-6027; 	NWO [09245126]	NWO(Netherlands Organization for Scientific Research (NWO))	The source of funding was NWO, Vidi grant 09245126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb SJ, 2006, LEARN BEHAV, V34, P124, DOI 10.3758/BF03193188; Babb SJ, 2006, CURR BIOL, V16, P1317, DOI 10.1016/j.cub.2006.05.025; Beran MJ, 2004, ANIM COGN, V7, P86, DOI 10.1007/s10071-003-0191-x; Bird LR, 2003, J COMP PSYCHOL, V117, P176, DOI 10.1037/0735-7036.117.2.176; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Clayton NS, 2001, J EXP PSYCHOL-ANIM B, V27, P17, DOI 10.1037//0097-7403.27.1.17; Crystal JD, 2009, BEHAV PROCESS, V80, P269, DOI 10.1016/j.beproc.2008.09.009; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; Dere E, 2006, NEUROSCI BIOBEHAV R, V30, P1206, DOI 10.1016/j.neubiorev.2006.09.005; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; Dufour V, 2008, BEHAV PROCESS, V79, P19, DOI 10.1016/j.beproc.2008.04.003; Eacott MJ, 2010, NEUROPSYCHOLOGIA, V48, P2273, DOI 10.1016/j.neuropsychologia.2009.11.002; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Feeney MC, 2009, ANIM COGN, V12, P767, DOI 10.1007/s10071-009-0236-x; Ferkin MH, 2008, ANIM COGN, V11, P147, DOI 10.1007/s10071-007-0101-8; Hampton RR, 2005, LEARN MOTIV, V36, P245, DOI 10.1016/j.lmot.2005.02.004; Hampton RR, 2004, CURR OPIN NEUROBIOL, V14, P192, DOI 10.1016/j.conb.2004.03.006; Kart-Teke E, 2006, NEUROBIOL LEARN MEM, V85, P173, DOI 10.1016/j.nlm.2005.10.002; Martin-Ordas G, 2010, ANIM COGN, V13, P331, DOI 10.1007/s10071-009-0282-4; Menzel CR, 1999, J COMP PSYCHOL, V113, P426, DOI 10.1037/0735-7036.113.4.426; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Schwartz BL, 2005, LEARN MOTIV, V36, P226, DOI 10.1016/j.lmot.2005.02.012; Schwartz BL, 2004, ANIM COGN, V7, P93, DOI 10.1007/s10071-003-0194-7; Schwartz BL, 2002, ANIM COGN, V5, P85, DOI 10.1007/s10071-002-0132-0; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Vargha-Khadem F, 2001, PHILOS T R SOC B, V356, P1435, DOI 10.1098/rstb.2001.0951; Zinkivskay A, 2009, ANIM COGN, V12, P119, DOI 10.1007/s10071-008-0176-x	41	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16593	10.1371/journal.pone.0016593	http://dx.doi.org/10.1371/journal.pone.0016593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359204	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700020
J	Gilroy, KL; Austin, CA				Gilroy, Kathryn L.; Austin, Caroline A.			The Impact of the C-Terminal Domain on the Interaction of Human DNA Topoisomerase II alpha and beta with DNA	PLOS ONE			English	Article							POSITIVELY SUPERCOILED DNA; BIMODAL RECOGNITION; STRUCTURAL BASIS; CLEAVAGE; BINDING; MECHANISM; RESISTANCE; INHIBITION; EXPRESSION; MUTATIONS	Background: Type II DNA topoisomerases are essential, ubiquitous enzymes that act to relieve topological problems arising in DNA from normal cellular activity. Their mechanism of action involves the ATP-dependent transport of one DNA duplex through a transient break in a second DNA duplex; metal ions are essential for strand passage. Humans have two isoforms, topoisomerase II alpha and topoisomerase II beta, that have distinct roles in the cell. The C-terminal domain has been linked to isoform specific differences in activity and DNA interaction. Methodology/Principal Findings: We have investigated the role of the C-terminal domain in the binding of human topoisomerase II alpha and topoisomerase II beta to DNA in fluorescence anisotropy assays using full length and C-terminally truncated enzymes. We find that the C-terminal domain of topoisomerase II beta but not topoisomerase II alpha affects the binding of the enzyme to the DNA. The presence of metal ions has no effect on DNA binding. Additionally, we have examined strand passage of the full length and truncated enzymes in the presence of a number of supporting metal ions and find that there is no difference in relative decatenation between isoforms. We find that calcium and manganese, in addition to magnesium, can support strand passage by the human topoisomerase II enzymes. Conclusions/Significance: The C-terminal domain of topoisomerase II beta, but not that of topoisomerase II alpha, alters the enzyme's K-D for DNA binding. This is consistent with previous data and may be related to the differential modes of action of the two isoforms in vivo. We also show strand passage with different supporting metal ions for human topoisomerase II alpha or topoisomerase II beta, either full length or C-terminally truncated. They all show the same preferences, whereby Mg > Ca > Mn.	[Gilroy, Kathryn L.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Gilroy, KL (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland.	caroline.austin@ncl.ac.uk		Austin, Caroline/0000-0002-1921-5947; Gilroy, Kathryn/0000-0003-4607-194X	Newcastle University	Newcastle University	Funded by a studentship to Kathryn Gilroy from Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Baldwin EL, 2004, BIOCHEMISTRY-US, V43, P728, DOI 10.1021/bi035472f; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Bist P, 2003, J BIOL CHEM, V278, P41837, DOI 10.1074/jbc.M307053200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; Grishin NV, 2000, NUCLEIC ACIDS RES, V28, P2229, DOI 10.1093/nar/28.11.2229; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Leontiou C, 2004, MOL PHARMACOL, V66, P430; Leontiou C, 2003, FEBS LETT, V554, P206, DOI 10.1016/S0014-5793(03)01172-4; Leontiou C, 2007, MOL PHARMACOL, V71, P1006, DOI 10.1124/mol.106.032953; Li W, 1997, J BIOL CHEM, V272, P31190, DOI 10.1074/jbc.272.49.31190; McClendon AK, 2006, BIOCHEMISTRY-US, V45, P11674, DOI 10.1021/bi0520838; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; McNamara S, 2008, MOL CELL BIOL, V28, P2066, DOI 10.1128/MCB.01576-07; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; Morant-Lhomel A, 2006, BIOCHIMIE, V88, P253, DOI 10.1016/j.biochi.2005.08.003; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P6402, DOI 10.1021/bi00394a015; ROCA J, 1993, J BIOL CHEM, V268, P14250; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Timsit Y, 1998, J MOL BIOL, V284, P1289, DOI 10.1006/jmbi.1998.2281; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1993, CANCER RES, V53, P3591; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b; West KL, 1999, NUCLEIC ACIDS RES, V27, P984, DOI 10.1093/nar/27.4.984; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14693	10.1371/journal.pone.0014693	http://dx.doi.org/10.1371/journal.pone.0014693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358820	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000287392700007
J	Samuel, MS; Lourenco, FC; Olson, MF				Samuel, Michael S.; Lourenco, Filipe C.; Olson, Michael F.			K-Ras Mediated Murine Epidermal Tumorigenesis Is Dependent upon and Associated with Elevated Rac1 Activity	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; SMALL-MOLECULE INHIBITORS; RHO-GTPASES; CANCER; PROGRESSION; KINASES; COMPLEX	A common goal for potential cancer therapies is the identification of differences in protein expression or activity that would allow for the selective targeting of tumor vs. normal cells. The Ras proto-oncogene family (K-Ras, H-Ras and N-Ras) are amongst the most frequently mutated genes in human cancers. As a result, there has been substantial effort dedicated to determining which pathways are activated by Ras signaling and, more importantly, which of these contribute to cancer. Although the most widely studied Ras-regulated signaling pathway is the Raf/mitogen-activated protein kinase cascade, previous research in model systems has revealed that the Rac1 GTP-binding protein is also required for Ras-induced biological responses. However, what have been lacking are rigorous in vivo Rac1 target validation data and a clear demonstration that in Ras-driven hyperplastic lesions, Rac1 activity is increased. Using a combination of genetically-modified mouse models that allow for the tissue-selective activation or deletion of signaling molecules and an activation-state sensitive Rac1 antibody that detects GTP-bound Rac1, we found that Rac1 contributes to K-Ras induced epidermal papilloma initiation and growth and that Rac1 activity is elevated by oncogenic K-Ras in vivo. Previously, it was not practical to assess Rac1 activation status in the most commonly used format for clinical tumor specimens, formalin-fixed paraffin embedded (FFPE) tissues samples. However, this study clearly demonstrates that Rac1 is essential for K-Ras driven epithelial cell hyperproliferation and that Rac1 activity is elevated in tissues expressing mutant oncogenic K-Ras, while also characterizing the activation-state specific Rac1-GTP antibody as a probe to examine Rac1 activation status in FFPE samples. Our findings will facilitate further research on the status of Rac1 activity in human tumors and will help to define the tumor types of the patient population that could potentially benefit from therapies targeting Rac activation or downstream effector signaling pathways.	[Samuel, Michael S.; Lourenco, Filipe C.; Olson, Michael F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Samuel, MS (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	M.Samuel@beatson.gla.ac.uk; m.olson@beatson.gla.ac.uk	Olson, Michael F/A-3240-2011; Olson, Michael/ABA-4240-2021; Lourenco, Filipe/G-9254-2011; Samuel, Michael/D-2706-2011	Olson, Michael/0000-0003-3428-3507; Lourenco, Filipe/0000-0002-9655-2488; Samuel, Michael/0000-0001-7880-6379	Cancer Research UK; Think Pink breast cancer group	Cancer Research UK(Cancer Research UK); Think Pink breast cancer group	This study was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All work was carried out under a project license, and in accord with guidelines, from the Home Office. We acknowledge the support of the Think Pink breast cancer group who funded purchase of the NDP slide scanner and the assistance of Clare Orange in image analysis. Thanks to David Tuveson (Cambridge Research Institute) for LSL-K-Ras<SUP>G12D</SUP> mice. Thanks also to Laura Machesky and Owen Sansom (Beatson Institute for Cancer Research) for access to mouse strains in their collections.	BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012	27	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17143	10.1371/journal.pone.0017143	http://dx.doi.org/10.1371/journal.pone.0017143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358804	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000287369200025
J	Weiss, M; Sykorova, Z; Garnica, S; Riess, K; Martos, F; Krause, C; Oberwinkler, F; Bauer, R; Redecker, D				Weiss, Michael; Sykorova, Zuzana; Garnica, Sigisfredo; Riess, Kai; Martos, Florent; Krause, Cornelia; Oberwinkler, Franz; Bauer, Robert; Redecker, Dirk			Sebacinales Everywhere: Previously Overlooked Ubiquitous Fungal Endophytes	PLOS ONE			English	Article							NEOTTIA-NIDUS-AVIS; PIRIFORMOSPORA-INDICA; MYCORRHIZAL ASSOCIATIONS; DNA-SEQUENCES; CELL-DEATH; RESISTANCE; ERICACEAE; COMMON; PLANT; MYCOBIONTS	Inconspicuous basidiomycetes from the order Sebacinales are known to be involved in a puzzling variety of mutualistic plant-fungal symbioses (mycorrhizae), which presumably involve transport of mineral nutrients. Recently a few members of this fungal order not fitting this definition and commonly referred to as 'endophytes' have raised considerable interest by their ability to enhance plant growth and to increase resistance of their host plants against abiotic stress factors and fungal pathogens. Using DNA-based detection and electron microscopy, we show that Sebacinales are not only extremely versatile in their mycorrhizal associations, but are also almost universally present as symptomless endophytes. They occurred in field specimens of bryophytes, pteridophytes and all families of herbaceous angiosperms we investigated, including liverworts, wheat, maize, and the non-mycorrhizal model plant Arabidopsis thaliana. They were present in all habitats we studied on four continents. We even detected these fungi in herbarium specimens originating from pioneering field trips to North Africa in the 1830s/40s. No geographical or host patterns were detected. Our data suggest that the multitude of mycorrhizal interactions in Sebacinales may have arisen from an ancestral endophytic habit by specialization. Considering their proven beneficial influence on plant growth and their ubiquity, endophytic Sebacinales may be a previously unrecognized universal hidden force in plant ecosystems.	[Weiss, Michael; Garnica, Sigisfredo; Riess, Kai; Krause, Cornelia; Oberwinkler, Franz; Bauer, Robert] Univ Tubingen, Inst Evolut & Okol, Tubingen, Germany; [Sykorova, Zuzana; Redecker, Dirk] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Martos, Florent] Univ La Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Denis, France	Eberhard Karls University of Tubingen; University of Basel; University of La Reunion	Weiss, M (corresponding author), Univ Tubingen, Inst Evolut & Okol, Tubingen, Germany.	michael.weiss@uni-tuebingen.de	Krause, Cornelia/P-6049-2014; Weiß, Michael/F-6206-2012; Kolaříková, Zuzana/C-3558-2009; Sigisfredo, Garnica/P-6506-2014; Florent, Martos/B-5151-2014; Riess, Kai/B-5491-2015	Krause, Cornelia/0000-0002-7886-3629; Weiß, Michael/0000-0002-4869-9186; Florent, Martos/0000-0003-1213-5466; Riess, Kai/0000-0002-8804-0175; Kolarikova, Zuzana/0000-0002-3693-2657				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barazani O, 2005, OECOLOGIA, V146, P234, DOI 10.1007/s00442-005-0193-2; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; CULLINGS K, 1994, J EVOLUTION BIOL, V7, P501, DOI 10.1046/j.1420-9101.1994.7040501.x; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Druege U, 2007, SCI HORTIC-AMSTERDAM, V112, P422, DOI 10.1016/j.scienta.2007.01.018; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Glen M, 2002, MYCORRHIZA, V12, P243, DOI 10.1007/s00572-002-0180-y; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kottke I, 2003, MYCOL RES, V107, P957, DOI 10.1017/S0953756203008141; McKendrick SL, 2002, NEW PHYTOL, V154, P233, DOI 10.1046/j.1469-8137.2002.00372.x; Neubert K, 2006, APPL ENVIRON MICROB, V72, P1118, DOI 10.1128/AEM.72.2.1118-1128.2006; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P465, DOI 10.1111/j.1399-3054.2004.00424.x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Schafer P, 2007, FEMS MICROBIOL LETT, V275, P1, DOI 10.1111/j.1574-6968.2007.00848.x; Selosse MA, 2002, MOL ECOL, V11, P1831, DOI 10.1046/j.1365-294X.2002.01553.x; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Selosse MA, 2009, MYCOL RES, V113, P1062, DOI 10.1016/j.mycres.2009.07.004; Setaro S, 2006, NEW PHYTOL, V169, P355, DOI 10.1111/j.1469-8137.2005.01583.x; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Urban A, 2003, MYCOL RES, V107, P3, DOI 10.1017/S0953756202007116; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Varma A., 2001, MYCOTA, VIX, P125; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WARCUP JH, 1988, NEW PHYTOL, V110, P227, DOI 10.1111/j.1469-8137.1988.tb00256.x; Weiss M, 1998, CAN J BOT, V76, P1170, DOI 10.1139/cjb-76-7-1170; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	43	139	145	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16793	10.1371/journal.pone.0016793	http://dx.doi.org/10.1371/journal.pone.0016793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347229	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200006
J	Yang, JL; Wang, LL; Zhang, HA; Qiu, LM; Wang, H; Song, LS				Yang, Jialong; Wang, Lingling; Zhang, Huan; Qiu, Limei; Wang, Hao; Song, Linsheng			C-Type Lectin in Chlamys farreri (CfLec-1) Mediating Immune Recognition and Opsonization	PLOS ONE			English	Article							SHRIMP FENNEROPENAEUS-CHINENSIS; HORNWORM MANDUCA-SEXTA; BOMBYX-MORI; CELLULAR ENCAPSULATION; COMPLEMENT ACTIVATION; MONOCLONAL-ANTIBODY; INNATE IMMUNITY; HEMOCYTES; RECEPTORS; PROTEIN	Background: C-type lectins are a superfamily of Ca(2+) dependent carbohydrate-recognition proteins that play significant diverse roles in nonself-recognition and clearance of invaders. Though they are well characterized in vertebrates, the study of the potential function and mechanism of C-type lectins in invertebrate immunity is still in its infancy. Methodology: A C-type lectin (CfLec-1) from scallop Chlamys farreri, a dominant cultured mollusk species in China, was selected to investigate its mRNA expression, localization and the possible functions in innate immunity in the present study. After scallop was stimulated by three typical PAMPs, the mRNA expression of CfLec-1 in hemocytes was poles apart. It was significantly up-regulated (p < 0.01) after scallops were stimulated by LPS or beta-glucan, but significantly down-regulated (p < 0.01) after PGN stimulation. The binding ability of recombinant CfLec-1 (designated as rCfLec-1) towards eight PAMPs was investigated subsequently by PAMPs microarray, which revealed rCfLec-1 could bind LPS, PGN and mannan in vitro, indicating CfLec-1 served as a PRR involved in the pathogen recognition. Immunofluorescence assay with polyclonal antibody specific for CfLec-1 revealed that CfLec-1 was mainly located in the mantle and gill of the scallop. CfLec-1 could bind to the surface of scallop hemocytes and recruited hemocytes to enhance their encapsulation in vitro, and this process could be specifically blocked by anti-rCfLec-1 antibody. Meanwhile, rCfLec-1 could also enhance the phagocytic activity of scallop hemocytes against Escherichia coli. Conclusions: The results clearly suggested that CfLec-1 in C. farreri not only served as a PRR involved in the PAMPs recognition, but also functioned as an opsonin participating in the clearance of invaders. It is therefore suspected that CfLec-1 could be an attachment-molecule to nonself-agents acting as an alternative to immunoglobulin in vertebrates.	[Yang, Jialong; Wang, Lingling; Zhang, Huan; Qiu, Limei; Wang, Hao; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yang, Jialong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, JL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China [2010CB126404]; NSFC [41006096, 40806064, 30730070, 30925028]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2010CB126404), http://www.973.gov.cn/; and grants (Nos. 41006096, 40806064 and 30730070,30925028) from NSFC, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; FRENETTE PS, 1995, P NATL ACAD SCI USA, V92, P7450, DOI 10.1073/pnas.92.16.7450; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lin YB, 2007, DEV COMP IMMUNOL, V31, P1073, DOI 10.1016/j.dci.2007.02.001; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P301, DOI 10.1016/j.dci.2005.05.006; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Loukas A, 1999, CURR BIOL, V9, P825, DOI 10.1016/S0960-9822(99)80366-2; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Ohta M, 2006, DEV COMP IMMUNOL, V30, P867, DOI 10.1016/j.dci.2005.12.005; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tian YY, 2009, DEV COMP IMMUNOL, V33, P772, DOI 10.1016/j.dci.2009.01.002; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang N, 2008, DEV COMP IMMUNOL, V32, P1034, DOI 10.1016/j.dci.2008.02.001; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Yan PS, 2002, METHODS, V27, P162, DOI 10.1016/S1046-2023(02)00070-1; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 2001, ADV EXP MED BIOL, V484, P191; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zennadi R, 2006, BLOOD, V108, p361A; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P707, DOI 10.1016/j.fsi.2009.02.017; Zhang H, 2009, DEV COMP IMMUNOL, V33, P780, DOI 10.1016/j.dci.2009.01.003; Zheng PL, 2008, FISH SHELLFISH IMMUN, V24, P286, DOI 10.1016/j.fsi.2007.11.014; Zucchetti I, 2008, DIFFERENTIATION, V76, P267, DOI 10.1111/j.1432-0436.2007.00214.x	59	89	98	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17089	10.1371/journal.pone.0017089	http://dx.doi.org/10.1371/journal.pone.0017089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347232	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200021
J	Mudroch, A; Richter, U; Joger, U; Kosma, R; Ide, O; Maga, A				Mudroch, Alexander; Richter, Ute; Joger, Ulrich; Kosma, Ralf; Ide, Oumarou; Maga, Abdoulaye			Didactyl Tracks of Paravian Theropods (Maniraptora) from the ?Middle Jurassic of Africa	PLOS ONE			English	Article							IULLEMMEDEN BASIN; LONG FEATHERS; DINOSAUR; EVOLUTION; ARCHAEOPTERYX; CHINA; BIRDS; OXFORDSHIRE; SEDIMENTARY; FOOTPRINTS	Background: A new dinosaur tracksite from ?Middle Jurassic sediments of the Irhazer Group on the plains of Agadez (Rep. Niger, northwest Africa) revealed extraordinarily well preserved didactyl tracks of a digitigrade bipedal trackmaker. The distinct morphology of the pes imprints indicates a theropod trackmaker from a paravian maniraptoran closely related to birds. Methodology/Principal Findings: The early age and the morphological traits of the tracks allow for description of the new ichnotaxon Paravipus didactyloides. A total of 120 tracks are assigned to 5 individual trackways. The 'medium-sized' tracks with an average footprint length of 27.5 cm and footprint width of 23.1 cm are deeply imprinted into the track bearing sandstone. Conclusions/Significance: A comparison with other didactyl tracks gives new insights into the foot morphology of advanced maniraptoran theropods and contributes to knowledge of their evolutionary history. The new ichnotaxon takes an important position in the ichnological fossil record of Gondwana and the mid-Jurassic biota worldwide, because it is among the earliest known records of paravian maniraptorans and of didactyl theropod tracks from Africa.	[Mudroch, Alexander; Richter, Ute] Initiat Independent Palaeobiologists, Hannover, Germany; [Joger, Ulrich; Kosma, Ralf] Staatliches Nat Hist Museum Braunschweig, Braunschweig, Germany; [Ide, Oumarou; Maga, Abdoulaye] Univ Abdou Moumouni, Inst Rech Sci Humaines, Niamey, Niger		Mudroch, A (corresponding author), Initiat Independent Palaeobiologists, Hannover, Germany.	mudroch@iipd.de		Maga, Abdoulaye/0000-0002-4684-217X	Volkswagen Financial Services	Volkswagen Financial Services	Field trips were sponsored by Volkswagen Financial Services. No other funding took place. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AAK, 2004, LETHAIA, V37, P467, DOI 10.1080/00241160410002162; Axsmith BJ, 2008, PALAEONTOL ELECTRON, V11; Buffetaut E, 2005, B SOC GEOL FR, V176, P467, DOI 10.2113/176.5.467; Bumby AJ, 2005, J AFR EARTH SCI, V43, P1, DOI 10.1016/j.jafrearsci.2005.07.016; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Catuneanu O, 2005, J AFR EARTH SCI, V43, pVII, DOI 10.1016/j.jafrearsci.2005.09.001; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Cleal CJ, 2003, PALAEONTOLOGY, V46, P739, DOI 10.1111/1475-4983.00319; Colbert E. H., 1969, American Museum Novitates, VNo. 2380, P1; Day JJ, 2004, PALAEONTOLOGY, V47, P319, DOI 10.1111/j.0031-0239.2004.00366.x; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Ferrusquia-Villafranca Ismael, 2007, Contributions in Science (Los Angeles), P1; Flynn John J., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P476; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; HALLAM A, 1993, PHILOS T ROY SOC B, V341, P287, DOI 10.1098/rstb.1993.0114; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ishigaki S, 2010, HIST BIOL, V22, P100, DOI 10.1080/08912961003789867; Kim JY, 2008, PALAEOGEOGR PALAEOCL, V262, P72, DOI 10.1016/j.palaeo.2008.02.003; Lapparent A. F. de, 1960, Memoires de la Societe Geologique de France Paleontologie, V88A, P1; LEFRANC JP, 1990, J AFR EARTH SCI, V10, P27, DOI 10.1016/0899-5362(90)90047-I; Li Daqing, 2006, Journal of the Paleontological Society of Korea, V22, P29; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P572, DOI 10.1007/s00114-003-0477-5; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Lockley Martin G., 2004, Ichnos, V11, P285, DOI 10.1080/10420940490428742; LOCKLEY MG, 1992, PHILOS T ROY SOC B, V336, P113, DOI 10.1098/rstb.1992.0051; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Marty D, 2009, ICHNOS, V16, P127, DOI 10.1080/10420940802471027; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Mayr G, 2007, AUK, V124, P1450, DOI 10.1642/0004-8038(2007)124[1450:TFOART]2.0.CO;2; McLoughlin S, 2009, GFF, V131, P113, DOI 10.1080/11035890902857846; Meyer CA, 2005, 3 SWISS GEOSC M ZUR, P59; Meyer CA, 2002, 7 EUR WORKSH VERT PA; MOODY RTJ, 1991, CRETACEOUS RES, V12, P137, DOI 10.1016/S0195-6671(05)80021-7; Moser M, 2006, PALAEONTOL Z, V80, P34, DOI 10.1007/BF02988396; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Pole M, 2009, GFF, V131, P105, DOI 10.1080/11035890902808948; Rauhut O. W. M., 2001, Journal of Vertebrate Paleontology, V21, p91A; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W. M., 2008, Rev. Asoc. Geol. Argent., V63, P557; Rauhut OWM, 2009, PALAEOGEOGR PALAEOCL, V271, P259, DOI 10.1016/j.palaeo.2008.10.019; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rees PM, 2004, J GEOL, V112, P643, DOI 10.1086/424577; Rees PM, 2000, WARM CLIMATES EARTH, P297, DOI [DOI 10.1017/CB09780511564512.011, 10.1017/CBO9780511564512.011]; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Roach Brian T., 2007, Bulletin of the Peabody Museum of Natural History, V48, P103, DOI 10.3374/0079-032X(2007)48[103:AROCPH]2.0.CO;2; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; SCOTESE C. R., 2001, ATLAS EARTH HIST, V1; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; Smith ND, 2008, P ROY SOC B-BIOL SCI, V275, P2085, DOI 10.1098/rspb.2008.0504; Thorn V, 2005, PALAEONTOLOGY, V48, P1021, DOI 10.1111/j.1475-4983.2005.00490.x; THULBORN R A, 1984, Memoirs of the Queensland Museum, V21, P413; THULBORN RA, 1982, PALAEOGEOGR PALAEOCL, V38, P227, DOI 10.1016/0031-0182(82)90005-0; THULBORN RA, 1984, ALCHERINGA, V8, P243, DOI 10.1080/03115518408618947; Thulborn RA., 1990, DINOSAUR TRACKS; Turner S, 2009, GFF, V131, P49, DOI 10.1080/11035890902924877; Volkheimer Wolfgang, 2008, Rev. Asoc. Geol. Argent., V63, P549; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Witmer LM, 2009, NATURE, V461, P601, DOI 10.1038/461601a; Xing Li-da, 2009, Acta Palaeontologica Sinica, V48, P662; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhen Shuonan, 1995, Memoirs of Beijing Natural History Museum, V54, P105	80	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14642	10.1371/journal.pone.0014642	http://dx.doi.org/10.1371/journal.pone.0014642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339816	Green Submitted, gold, Green Published			2022-12-27	WOS:000287367600002
J	Wang, YB; Skilton, RJ; Cutcliffe, LT; Andrews, E; Clarke, IN; Marsh, P				Wang, Yibing; Skilton, Rachel J.; Cutcliffe, Lesley T.; Andrews, Emma; Clarke, Ian N.; Marsh, Pete			Evaluation of a High Resolution Genotyping Method for Chlamydia trachomatis Using Routine Clinical Samples	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; SEQUENCE-ANALYSIS; GENOME SEQUENCE; EPIDEMIOLOGY; INFECTIONS; STRAINS; PCR; IDENTIFICATION; WOMEN	Background: Genital chlamydia infection is the most commonly diagnosed sexually transmitted infection in the UK. C. trachomatis genital infections are usually caused by strains which fall into two pathovars: lymphogranuloma venereum (LGV) and the genitourinary genotypes D-K. Although these genotypes can be discriminated by outer membrane protein gene (ompA) sequencing or multi-locus sequence typing (MLST), neither protocol affords the high-resolution genotyping required for local epidemiology and accurate contact-tracing. Principal Findings: We evaluated variable number tandem repeat (VNTR) and ompA sequencing (now called multi-locus VNTR analysis and ompA or "MLVA-ompA'') to study local epidemiology in Southampton over a period of six months. One hundred and fifty seven endocervical swabs that tested positive for C. trachomatis from both the Southampton genitourinary medicine (GUM) clinic and local GP surgeries were tested by COBAS Taqman 48 (Roche) PCR for the presence of C. trachomatis. Samples tested as positive by the commercial NAATs test were genotyped, where possible, by a MLVA-ompA sequencing technique. Attempts were made to isolate C. trachomatis from all 157 samples in cell culture, and 68 (43%) were successfully recovered by repeatable passage in culture. Of the 157 samples, 93 (i.e. 59%) were fully genotyped by MLVA-ompA. Only one mixed infection (E & D) in a single sample was confirmed. There were two distinct D genotypes for the ompA gene. Most frequent ompA genotypes were D, E and F, comprising 20%, 41% and 16% of the type-able samples respectively. Within all genotypes we detected numerous MLVA sub-types. Conclusions: Amongst the common genotypes, there are a significant number of defined MLVA sub-types, which may reflect particular background demographics including age group, geography, high-risk sexual behavior, and sexual networks.	[Wang, Yibing; Skilton, Rachel J.; Cutcliffe, Lesley T.; Clarke, Ian N.] Univ Southampton, Sch Med, Southampton, Hants, England; [Andrews, Emma; Marsh, Pete] Southampton Gen Hosp, Hlth Protect Agcy, Reg Microbiol Network Southampton Lab, Southampton SO9 4XY, Hants, England	University of Southampton; Health Protection Agency; University of Southampton	Wang, YB (corresponding author), Univ Southampton, Sch Med, Southampton, Hants, England.	Peter.Marsh@suht.swest.nhs.uk		Clarke, Ian/0000-0002-4938-1620	MRC Sexual Health; HIV Research Strategy Committee [G0601640]; MRC [G0601640] Funding Source: UKRI; Medical Research Council [G0601640] Funding Source: researchfish	MRC Sexual Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HIV Research Strategy Committee; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC Sexual Health and HIV Research Strategy Committee G0601640 to INC and PM. All views expressed are those of the authors and not necessarily those of the MRC nor Health Departments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 1999, AM J PUBLIC HEALTH, V89, P825, DOI 10.2105/AJPH.89.6.825; Beni BT, 2010, J MED MICROBIOL, V59, P1023, DOI 10.1099/jmm.0.016717-0; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Brunelle BW, 2006, INFECT IMMUN, V74, P578, DOI 10.1128/IAI.74.1.578-585.2006; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Chernesky Max A, 2005, Can J Infect Dis Med Microbiol, V16, P39; Choudhury B, 2006, LANCET, V368, P139, DOI 10.1016/S0140-6736(06)69003-X; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jalal H, 2007, INT J STD AIDS, V18, P617, DOI 10.1258/095646207781568501; Jalal H, 2007, J CLIN MICROBIOL, V45, P2649, DOI 10.1128/JCM.00451-07; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; LAN J, 1994, J CLIN MICROBIOL, V32, P528, DOI 10.1128/JCM.32.2.528-530.1994; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Petrovay F, 2009, J MED MICROBIOL, V58, P760, DOI 10.1099/jmm.0.008607-0; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; WENTWORTH BB, 1973, ANTIMICROB AGENTS CH, V3, P698, DOI 10.1128/AAC.3.6.698	27	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16971	10.1371/journal.pone.0016971	http://dx.doi.org/10.1371/journal.pone.0016971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347295	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500016
J	Mathis, JM; Bhatia, S; Khandelwal, A; Kovesdi, I; Lokitz, SJ; Odaka, Y; Takalkar, AM; Terry, T; Curiel, DT				Mathis, J. Michael; Bhatia, Shilpa; Khandelwal, Alok; Kovesdi, Imre; Lokitz, Stephen J.; Odaka, Yoshi; Takalkar, Amol M.; Terry, Tracee; Curiel, David T.			Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT Imaging	PLOS ONE			English	Article							TYPE-1 THYMIDINE KINASE; BICISTRONIC ADENOVIRUS; REPORTER GENE; TUMOR-CELLS; IN-VIVO; BINDING; VIRUS; EXPRESSION; DOMAINS; CANCER	As the limits of existing treatments for cancer are recognized, clearly novel therapies must be considered for successful treatment; cancer therapy using adenovirus vectors is a promising strategy. However tracking the biodistribution of adenovirus vectors in vivo is limited to invasive procedures such as biopsies, which are error prone, non-quantitative, and do not give a full representation of the pharmacokinetics involved. Current non-invasive imaging strategies using reporter gene expression have been applied to analyze adenoviral vectors. The major drawback to approaches that tag viruses with reporter genes is that these systems require initial viral infection and subsequent cellular expression of a reporter gene to allow non-invasive imaging. As an alternative to conventional vector detection techniques, we developed a specific genetic labeling system whereby an adenoviral vector incorporates a fusion between capsid protein IX and human metallothionein. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional metallothionein (MT) as a component of their capsid surface. We demonstrate the feasibility of (99m)Tc binding in vitro to the pIX-MT fusion on the capsid of adenovirus virions using a simple transchelation reaction. SPECT imaging of a mouse after administration of a (99m)Tc-radiolabeled virus showed clear localization of radioactivity to the liver. This result strongly supports imaging using pIX-MT, visualizing the normal biodistribution of Ad primarily to the liver upon injection into mice. The ability we have developed to view real-time biodistribution in their physiological milieu represents a significant tool to study adenovirus biology in vivo.	[Mathis, J. Michael; Bhatia, Shilpa; Odaka, Yoshi; Terry, Tracee] LSU Hlth Sci Ctr, Dept Cellular Biol, Gene Therapy Program, Shreveport, LA USA; [Mathis, J. Michael; Bhatia, Shilpa; Odaka, Yoshi; Terry, Tracee] LSU Hlth Sci Ctr, Dept Anat, Gene Therapy Program, Shreveport, LA USA; [Khandelwal, Alok; Lokitz, Stephen J.; Takalkar, Amol M.] Biomed Res Fdn NW Louisiana, Shreveport, LA USA; [Kovesdi, Imre] VectorLogics Inc, Birmingham, AL USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Washington University (WUSTL)	Mathis, JM (corresponding author), LSU Hlth Sci Ctr, Dept Cellular Biol, Gene Therapy Program, Shreveport, LA USA.	jmathi@lsuhsc.edu	Odaka, Yoshinobu/AAY-6918-2021; Mathis, J. Michael/J-1379-2018	Odaka, Yoshinobu/0000-0003-3966-5475; Kovesdi, Imre/0000-0002-0322-3969; Mathis, J. Michael/0000-0001-5528-5195	NIH [2R42CA114921, 5R01CA121187-03, 5R01-CA111569]; Louisiana Gene Therapy Research Consortium; Feist-Weiller Cancer Center; NATIONAL CANCER INSTITUTE [R01CA154697, R42CA114921, R01CA111569, R01CA121187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Gene Therapy Research Consortium; Feist-Weiller Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by NIH grants 2R42CA114921, 5R01CA121187-03 and 5R01-CA111569, and funding from the Louisiana Gene Therapy Research Consortium and the Feist-Weiller Cancer Center. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imre Kovesdi is Chief Executive Officer of VectorLogics, Inc; he contributed to the preparation of the manuscript and interpretation of the data. No other funding was provided by VectorLogics.	Akalu A, 1999, J VIROL, V73, P6182, DOI 10.1128/JVI.73.7.6182-6187.1999; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BOULANGER P, 1979, J GEN VIROL, V44, P783, DOI 10.1099/0022-1317-44-3-783; Bult W, 2009, Q J NUCL MED MOL IM, V53, P325; DAS C, 1992, P NATL ACAD SCI USA, V89, P9749, DOI 10.1073/pnas.89.20.9749; de Vrij J, 2008, GENE THER, V15, P978, DOI 10.1038/gt.2008.26; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; Fabry CMS, 2009, J VIROL, V83, P1135, DOI 10.1128/JVI.01808-08; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Gkialas I, 2008, J BUON, V13, P177; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Haviv YS, 2002, MOL CANCER THER, V1, P321; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hedley SJ, 2006, CANCER IMMUNOL IMMUN, V55, P1412, DOI 10.1007/s00262-006-0158-2; Ibrahim SM, 2008, WORLD J GASTROENTERO, V14, P1664, DOI 10.3748/wjg.14.1664; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kuruppu D, 2007, CURR CANCER DRUG TAR, V7, P175, DOI 10.2174/156800907780058871; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Liang Q, 2002, GENE THER, V9, P1659, DOI 10.1038/sj.gt.3301899; Luo D, 1996, J BIOCHEM-TOKYO, V120, P229; Maheshwari G, 2004, J VIROL METHODS, V118, P141, DOI 10.1016/j.jviromet.2004.02.003; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; Matthews K, 2009, CLIN CANCER RES, V15, P4131, DOI 10.1158/1078-0432.CCR-08-3354; Matthews QL, 2006, MOL IMAGING, V5, P510, DOI 10.2310/7290.2006.00029; MERRON A, 2007, GENE THER; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; MONTASER A, 1992, P SOC EXP BIOL MED, V200, P321, DOI 10.3181/00379727-200-43437; Morelock M M, 1987, Experientia Suppl, V52, P247; NIELSON KB, 1985, J BIOL CHEM, V260, P5342; Noureddini SC, 2005, MOL PHARMACEUT, V2, P341, DOI 10.1021/mp050045c; PAIK CH, 1985, INT J NUCL MED BIOL, V12, P3, DOI 10.1016/0047-0740(85)90004-X; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Rosa-Calatrava M, 2001, J VIROL, V75, P7131, DOI 10.1128/JVI.75.15.7131-7141.2001; SANO T, 1992, P NATL ACAD SCI USA, V89, P1534, DOI 10.1073/pnas.89.5.1534; SAWYER JR, 1992, P NATL ACAD SCI USA, V89, P9754, DOI 10.1073/pnas.89.20.9754; Tolcher AW, 2006, J CLIN ONCOL, V24, P2052, DOI 10.1200/JCO.2005.03.6756; Vellinga J, 2007, GENE THER, V14, P664, DOI 10.1038/sj.gt.3302908; Vellinga J, 2005, J VIROL, V79, P3206, DOI 10.1128/JVI.79.5.3206-3210.2005; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; VIRZI F, 1995, BIOCONJUGATE CHEM, V6, P139, DOI 10.1021/bc00031a018; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Whitfield RJ, 2009, J CHROMATOGR A, V1216, P2725, DOI 10.1016/j.chroma.2008.11.010; Yang M, 2000, P NATL ACAD SCI USA, V97, P12278, DOI 10.1073/pnas.97.22.12278; Zinn KR, 2002, RADIOLOGY, V223, P417, DOI 10.1148/radiol.2232010501; J GENE MED CLIN TRIA	48	7	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16792	10.1371/journal.pone.0016792	http://dx.doi.org/10.1371/journal.pone.0016792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347423	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700034
J	Radicchi, F				Radicchi, Filippo			Who Is the Best Player Ever? A Complex Network Analysis of the History of Professional Tennis	PLOS ONE			English	Article							HEAVY TAILS	We considered all matches played by professional tennis players between 1968 and2010, and, on the basis of this data set, constructed a directed and weighted network of contacts. The resulting graph showed complex features, typical of many real networked systems studied in literature. We developed a diffusion algorithm and applied it to the tennis contact network in order to rank professional players. Jimmy Connors was identified as the best player in the history of tennis according to our ranking procedure. We performed a complete analysis by determining the best players on specific playing surfaces as well as the best ones in each of the years covered by the data set. The results of our technique were compared to those of two other well established methods. In general, we observed that our ranking method performed better: it had a higher predictive power and did not require the arbitrary introduction of external criteria for the correct assessment of the quality of players. The present work provides novel evidence of the utility of tools and methods of network theory in real applications.	Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University	Radicchi, F (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	f.radicchi@gmail.com	Avendaño Arosemena, Antonio/F-6673-2011; Radicchi, Filippo/B-4407-2009	Radicchi, Filippo/0000-0002-8352-1287				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Ben-Naim E, 2007, J KOREAN PHYS SOC, V50, P124, DOI 10.3938/jkps.50.124; Ben-Naim E, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30005; Bergstrom CT, 2008, NEUROLOGY, V71, P1850, DOI 10.1212/01.wnl.0000338904.37585.66; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onody RN, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.037103; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Petersen AM, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50010; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026118; Saavedra S, 2010, PHYSICA A, V389, P1131, DOI 10.1016/j.physa.2009.10.038; Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5; Skinner B, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1217; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; West J, 2010, J AM SOC INF SCI TEC, V61, P1800, DOI 10.1002/asi.21374; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107	32	79	79	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17249	10.1371/journal.pone.0017249	http://dx.doi.org/10.1371/journal.pone.0017249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21339809	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700067
J	Crellin, PK; Brammananth, R; Coppel, RL				Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.			Decaprenylphosphoryl-beta-D-Ribose 2 '-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis	PLOS ONE			English	Article							CELL-WALL; TUBERCULOSIS; MUTAGENESIS; ARABINAN; RESISTANCE; EXCHANGE; LAYERS	Background: The unique cell wall of bacteria of the suborder Corynebacterineae is essential for the growth and survival of significant human pathogens including Mycobacterium tuberculosis and Mycobacterium leprae. Drug resistance in mycobacteria is an increasingly common development, making identification of new antimicrobials a priority. Recent studies have revealed potent anti-mycobacterial compounds, the benzothiazinones and dinitrobenzamides, active against DprE1, a subunit of decaprenylphosphoribose 29 epimerase which forms decaprenylphosphoryl arabinose, the arabinose donor for mycobacterial cell wall biosynthesis. Despite the exploitation of Mycobacterium smegmatis in the identification of DprE1 as the target of these new antimicrobials and its use in the exploration of mechanisms of resistance, the essentiality of DprE1 in this species has never been examined. Indeed, direct experimental evidence of the essentiality of DprE1 has not been obtained in any species of mycobacterium. Methodology/Principal Findings: In this study we constructed a conditional gene knockout strain targeting the ortholog of dprE1 in M. smegmatis, MSMEG_6382. Disruption of the chromosomal copy of MSMEG_6382 was only possible in the presence of a plasmid-encoded copy of MSMEG_6382. Curing of this "rescue'' plasmid from the bacterial population resulted in a cessation of growth, demonstrating gene essentiality. Conclusions/Significance: This study provides the first direct experimental evidence for the essentiality of DprE1 in mycobacteria. The essentiality of DprE1 in M. smegmatis, combined with its conservation in all sequenced mycobacterial genomes, suggests that decaprenylphosphoryl arabinose synthesis is essential in all mycobacteria. Our findings indicate a lack of redundancy in decaprenylphosphoryl arabinose synthesis in M. smegmatis, despite the relatively large coding capacity of this species, and suggest that no alternative arabinose donors for cell wall biosynthesis exist. Overall, this study further validates DprE1 as a promising target for new anti-mycobacterial drugs.	[Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University	Crellin, PK (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Dept Microbiol, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Crellin, Paul K/0000-0002-2017-4935	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council of Australia	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERBERG RJ, 1995, BIOTECHNIQUES, V18, P217; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; GUILHOT C, 1992, FEMS MICROBIOL LETT, V98, P181; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarov V, 2006, J ANTIMICROB CHEMOTH, V57, P1134, DOI 10.1093/jac/dkl095; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; *WHO, 2009, WHO REP 2009 GLOB TU; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	25	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16869	10.1371/journal.pone.0016869	http://dx.doi.org/10.1371/journal.pone.0016869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346818	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600032
J	Lurie, G; Gaudet, MM; Spurdle, AB; Carney, ME; Wilkens, LR; Yang, HP; Weiss, NS; Webb, PM; Thompson, PJ; Terada, K; Setiawan, VW; Rebbeck, TR; Prescott, J; Orlow, I; O'Mara, T; Olson, SH; Narod, SA; Matsuno, RK; Lissowska, J; Liang, XL; Levine, DA; Le Marchand, L; Kolonel, LN; Henderson, BE; Garcia-Closas, M; Doherty, JA; De Vivo, I; Chen, C; Brinton, LA; Akbari, MR; Goodman, MT				Lurie, Galina; Gaudet, Mia M.; Spurdle, Amanda B.; Carney, Michael E.; Wilkens, Lynne R.; Yang, Hannah P.; Weiss, Noel S.; Webb, Penelope M.; Thompson, Pamela J.; Terada, Keith; Setiawan, Veronica Wendy; Rebbeck, Timothy R.; Prescott, Jennifer; Orlow, Irene; O'Mara, Tracy; Olson, Sara H.; Narod, Steven A.; Matsuno, Rayna K.; Lissowska, Jolanta; Liang, Xiaolin; Levine, Douglas A.; Le Marchand, Loic; Kolonel, Laurence N.; Henderson, Brian E.; Garcia-Closas, Montserrat; Doherty, Jennifer Anne; De Vivo, Immaculata; Chen, Chu; Brinton, Louise A.; Akbari, Mohammad R.; Goodman, Marc T.		Epidemiology Endometrial Canc	The Obesity-Associated Polymorphisms FTO rs9939609 and MC4R rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women	PLOS ONE			English	Article							GENE-EXPRESSION; FAT MASS; ENDOGENOUS HORMONES; ENERGY-INTAKE; FOOD-INTAKE; VARIANT; CHILDHOOD; INSULIN	Overweight and obesity are strongly associated with endometrial cancer. Several independent genome-wide association studies recently identified two common polymorphisms, FTO rs9939609 and MC4R rs17782313, that are linked to increased body weight and obesity. We examined the association of FTO rs9939609 and MC4R rs17782313 with endometrial cancer risk in a pooled analysis of nine case-control studies within the Epidemiology of Endometrial Cancer Consortium (E2C2). This analysis included 3601 non-Hispanic white women with histologically-confirmed endometrial carcinoma and 5275 frequency-matched controls. Unconditional logistic regression models were used to assess the relation of FTO rs9939609 and MC4R rs17782313 genotypes to the risk of endometrial cancer. Among control women, both the FTO rs9939609 A and MC4R rs17782313 C alleles were associated with a 16% increased risk of being overweight (p = 0.001 and p = 0.004, respectively). In case-control analyses, carriers of the FTO rs9939609 AA genotype were at increased risk of endometrial carcinoma compared to women with the TT genotype [ odds ratio (OR) = 1.17; 95% confidence interval (CI): 1.03-1.32, p = 0.01]. However, this association was no longer apparent after adjusting for body mass index (BMI), suggesting mediation of the gene-disease effect through body weight. The MC4R rs17782313 polymorphism was not related to endometrial cancer risk (per allele OR = 0.98; 95% CI: 0.91-1.06; p = 0.68). FTO rs9939609 is a susceptibility marker for white non-Hispanic women at higher risk of endometrial cancer. Although FTO rs9939609 alone might have limited clinical or public health significance for identifying women at high risk for endometrial cancer beyond that of excess body weight, further investigation of obesity-related genetic markers might help to identify the pathways that influence endometrial carcinogenesis.	[Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Matsuno, Rayna K.; Le Marchand, Loic; Kolonel, Laurence N.; Goodman, Marc T.] Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA; [Gaudet, Mia M.] Amer Canc Soc Inc, Epidemiol Res Program, Atlanta, GA USA; [Spurdle, Amanda B.; Webb, Penelope M.; O'Mara, Tracy] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Spurdle, Amanda B.; Webb, Penelope M.; O'Mara, Tracy] PO Royal Brisbane Hosp, Brisbane, Qld, Australia; [Carney, Michael E.; Terada, Keith] Univ Hawaii, Dept Obstet & Gynecol, John A Burns Sch Med, Honolulu, HI 96813 USA; [Yang, Hannah P.; Garcia-Closas, Montserrat; Brinton, Louise A.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Weiss, Noel S.; Chen, Chu] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Weiss, Noel S.; Doherty, Jennifer Anne; Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Setiawan, Veronica Wendy; Henderson, Brian E.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Rebbeck, Timothy R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Abramson Canc Ctr, Philadelphia, PA USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Prescott, Jennifer; De Vivo, Immaculata] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA; [Orlow, Irene; Olson, Sara H.; Liang, Xiaolin] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [O'Mara, Tracy] Queensland Univ Technol, Hormone Dependent Canc Grp, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Narod, Steven A.; Akbari, Mohammad R.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Matsuno, Rayna K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Chen, Chu] Univ Washington, Dept Otolaryngol Head & Neck Surg, Sch Med, Seattle, WA 98195 USA	Cancer Research Center of Hawaii; University of Hawaii System; American Cancer Society; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Southern California; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Queensland University of Technology (QUT); University of Toronto; University Toronto Affiliates; Womens College Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Lurie, G (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Canc Epidemiol Program, Honolulu, HI 96813 USA.	glurie@crch.hawaii.edu	Ursin, Giske/U-6637-2017; Berrino, Franco/AAC-2364-2020; Weiderpass, Elisabete/AAP-2747-2021; Krogh, Vittorio/K-2628-2016; Brinton, Louise A/G-7486-2015; Webb, Penelope/D-5736-2013; Garcia-Closas, Montserrat/AAZ-6930-2021; Rebbeck, Timothy/GLU-8348-2022; Spurdle, Amanda B/A-4978-2011; Weiderpass, Elisabete/M-4029-2016; Garcia-Closas, Montserrat/F-3871-2015; O'Mara, Tracy/M-7508-2016; Bandera, Elisa V/M-4169-2014; Narod, Steven A/AAA-6112-2022; Lissowska, Jolanta/AAH-3252-2020	Ursin, Giske/0000-0002-0835-9507; Berrino, Franco/0000-0002-4858-1866; Weiderpass, Elisabete/0000-0003-2237-0128; Krogh, Vittorio/0000-0003-0122-8624; Brinton, Louise A/0000-0003-3853-8562; Webb, Penelope/0000-0003-0733-5930; Garcia-Closas, Montserrat/0000-0003-1033-2650; Rebbeck, Timothy/0000-0002-4799-1900; Spurdle, Amanda B/0000-0003-1337-7897; Weiderpass, Elisabete/0000-0003-2237-0128; Garcia-Closas, Montserrat/0000-0003-1033-2650; O'Mara, Tracy/0000-0002-5436-3232; Bandera, Elisa V/0000-0002-8789-2755; Lissowska, Jolanta/0000-0003-2695-5799; Sacerdote, Carlotta/0000-0002-8008-5096; Orlow, Irene/0000-0001-6234-6961; McCullough, Marjorie/0000-0003-3025-6341; La Vecchia, Carlo/0000-0003-1441-897X; De Vivo, Immaculata/0000-0002-7185-7402; Friberg, Emilie/0000-0001-7874-4243; Setiawan, Veronica/0000-0001-9239-5692; Olson, Sara/0000-0003-0182-2754; Levine, Douglas/0000-0003-1038-8232; van den Brandt, Piet/0000-0001-8781-8099; Goodman, Marc/0000-0002-4839-3021	Australian National Endometrial Cancer Study [339435, 4196615, 403031, 457636]; Estrogen; Diet; Genetics; Endometrial Cancer study, NJ, USA [NIH R01CA38918]; Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA [NIH R35 CA 39779, R01 CA 75977, R03 CA 80636, N01 HD 23166, K05 CA 92002, R01 CA 105212, R01 CA87538]; Fred Hutchinson Cancer Research Center; Hawaii Endometrial Cancer Study, Hawaii, USA [NIH P01CA33619, R01CA58598, N01CN67001, N01 PC35137]; Nurses' Health Study [NIH CAO82838, CA134958]; Polish Endometrial Cancer Study of the NCI; Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study [NIH CA63464, CA54281]; Women's Insights and Shared Experiences, PA, USA [NIH P01-CA77596]; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010126] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	Australian National Endometrial Cancer Study; Estrogen; Diet; Genetics; Endometrial Cancer study, NJ, USA; Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA; Fred Hutchinson Cancer Research Center; Hawaii Endometrial Cancer Study, Hawaii, USA; Nurses' Health Study; Polish Endometrial Cancer Study of the NCI; Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study(Canadian Institutes of Health Research (CIHR)); Women's Insights and Shared Experiences, PA, USA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Australian National Endometrial Cancer Study (NHMRC ID #339435, TCCQ ID #4196615, TCCT IDs #403031 and #457636), Estrogen, Diet, Genetics, and Endometrial Cancer study, NJ, USA (NIH R01CA38918), Fred Hutchinson Cancer Research Center Case-Control Study, WA, USA (NIH R35 CA 39779, R01 CA 75977, R03 CA 80636, N01 HD 23166, K05 CA 92002, R01 CA 105212, R01 CA87538 and funds from the Fred Hutchinson Cancer Research Center), Hawaii Endometrial Cancer Study, Hawaii, USA (NIH P01CA33619, R01CA58598, N01CN67001, N01 PC35137), Nurses' Health Study (NIH CAO82838, CA134958), Polish Endometrial Cancer Study (Intramural Program of the NCI), Toronto Case-Control Endometrial Cancer Study (Canadian Institute of Health Research, CIHR), Multiethnic Cohort Study (NIH CA63464, CA54281), Women's Insights and Shared Experiences, PA, USA (NIH P01-CA77596, Dr. Mia Gaudet (American Cancer Society, Atlanta, GA, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, Dr. Mia Gaudet is employed by the American Cancer Society (since October 4th 2010). Dr Gaudet contributed the data for the Polish Endometrial Cancer Study that was funded by the National Cancer Institute. Her current employment by the American Cancer Society does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akhmedkhanov A, 2001, ANN NY ACAD SCI, V943, P296, DOI 10.1111/j.1749-6632.2001.tb03811.x; Altekruse SF, 2010, SEER CANC STAT REV 1; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; BULUN SE, 1994, J STEROID BIOCHEM, V49, P319, DOI 10.1016/0960-0760(94)90274-7; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Dina C, 2008, CURR OPIN CLIN NUTR, V11, P378, DOI 10.1097/MCO.0b013e328303e5e6; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Olson SH, 2009, CANCER CAUSE CONTROL, V20, P491, DOI 10.1007/s10552-008-9290-y; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SIITERI PK, 1978, CANCER RES, V38, P4360; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0	33	47	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16756	10.1371/journal.pone.0016756	http://dx.doi.org/10.1371/journal.pone.0016756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347432	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600021
J	Artal, P; Benito, A; Perez, GM; Alcon, E; De Casas, A; Pujol, J; Marin, JM				Artal, Pablo; Benito, Antonio; Perez, Guillermo M.; Alcon, Encarna; De Casas, Alvaro; Pujol, Jaume; Marin, Jose M.			An Objective Scatter Index Based on Double-Pass Retinal Images of a Point Source to Classify Cataracts	PLOS ONE			English	Article							CLASSIFICATION-SYSTEM; OPTICAL-PERFORMANCE; LIGHT-SCATTERING; HUMAN EYE; QUALITY; AGE; STRAYLIGHT; LENS; ABERRATIONS; SENSOR	Purpose: To propose a new objective scatter index (OSI) based in the analysis of double-pass images of a point source to rank and classify cataract patients. This classification scheme is compared with a current subjective system. Methods: We selected a population including a group of normal young eyes as control and patients diagnosed with cataract (grades NO2, NO3 and NO4) according to the Lens Opacities Classification System (LOCS III). For each eye, we recorded double-pass retinal images of a point source. In each patient, we determined an objective scatter index (OSI) as the ratio of the intensity at an eccentric location in the image and the central part. This index provides information on the relevant forward scatter affecting vision. Since the double-pass retinal images are affected by both ocular aberrations and intraocular scattering, an analysis was performed to show the ranges of contributions of aberrations to the OSI. Results: We used the OSI values to classify each eye according to the degree of scatter. The young normal eyes of the control group had OSI values below 1, while the OSI for subjects in LOCS grade II were around 1 to 2. The use of the objective index showed some of the weakness of subjective classification schemes. In particular, several subjects initially classified independently as grade NO2 or NO3 had similar OSI values, and in some cases even higher than subjects classified as grade NO4. A new classification scheme based in OSI is proposed. Conclusions: We introduced an objective index based in the analysis of double-pass retinal images to classify cataract patients. The method is robust and fully based in objective measurements; i.e., not depending on subjective decisions. This procedure could be used in combination with standard current methods to improve cataract patient surgery scheduling.	[Artal, Pablo; Benito, Antonio; Perez, Guillermo M.; Alcon, Encarna] Univ Murcia, Lab Opt, Murcia, Spain; [De Casas, Alvaro; Marin, Jose M.] Hosp Univ Virgen Arrixaca, Murcia, Spain; [Pujol, Jaume] Univ Politecn Cataluna, Ctr Desenvolupament Sensors Instrumentacio & Sist, E-08028 Barcelona, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Universitat Politecnica de Catalunya	Artal, P (corresponding author), Univ Murcia, Lab Opt, Murcia, Spain.	pablo@um.es	Artal, Pablo/AAG-4485-2020; Perez, Guillermo M/C-1363-2010; Artal, Pablo/AGV-7547-2022; Artal, Pablo/D-7423-2012	Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591; Artal, Pablo/0000-0003-1284-6591; Benito, Antonio/0000-0002-9419-4859; Pujol, Jaume/0000-0003-0811-9244; Marin Sanchez, Jose Maria/0000-0002-0092-8429	"Ministerio de Educacion y Ciencia," Spain [FIS2007-64765]; "Fundacion Seneca," Murcia, Spain [04524/GERM/06]	"Ministerio de Educacion y Ciencia," Spain(Spanish Government); "Fundacion Seneca," Murcia, Spain(Fundacion Seneca)	This work has been supported by "Ministerio de Educacion y Ciencia," Spain (grant FIS2007-64765) and "Fundacion Seneca," Murcia, Spain (grant 04524/GERM/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCON E, 2007, ARVO M, V48, P3821; ALLEN MJ, 1967, AMER J OPT ARCH AM A, V44, P717; Artal P, 2002, J OPT SOC AM A, V19, P137, DOI 10.1364/JOSAA.19.000137; ARTAL P, 1990, J OPT SOC AM A, V7, P1374, DOI 10.1364/JOSAA.7.001374; ARTAL P, 1993, J OPT SOC AM A, V10, P1656, DOI 10.1364/JOSAA.10.001656; ARTAL P, 1995, OPT ENG, V34, P772, DOI 10.1117/12.191818; ARTAL P, 1995, J OPT SOC AM A, V12, P2358, DOI 10.1364/JOSAA.12.002358; Artal P, 2000, J REFRACT SURG, V16, pS560; BAILEY IL, 1991, OPTOMETRY VISION SCI, V68, P911, DOI 10.1097/00006324-199112000-00001; BENITO A, 2007, ARVO M, V48, P3822; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Datiles MB, 2002, EXP EYE RES, V74, P93, DOI 10.1006/exer.2001.1106; de Wit GC, 2006, J CATARACT REFR SURG, V32, P294, DOI 10.1016/j.jcrs.2006.01.048; DEWAARD PWT, 1992, INVEST OPHTH VIS SCI, V33, P618; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Duncan DD, 1997, J OPT SOC AM A, V14, P1197, DOI 10.1364/JOSAA.14.001197; Franssen L, 2006, INVEST OPHTH VIS SCI, V47, P768, DOI 10.1167/iovs.05-0690; Guirao A, 1999, INVEST OPHTH VIS SCI, V40, P203; HOLLADAY JT, 1987, J CATARACT REFR SURG, V13, P67, DOI 10.1016/S0886-3350(87)80016-0; PAULSSON LE, 1980, INVEST OPHTH VIS SCI, V19, P401; Perez GM, 2009, J VISION, V9, DOI 10.1167/9.3.19; Prieto PM, 2000, J OPT SOC AM A, V17, P1388, DOI 10.1364/JOSAA.17.001388; SANTAMARIA J, 1987, J OPT SOC AM A, V4, P1109, DOI 10.1364/JOSAA.4.001109; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P896, DOI 10.1001/archopht.1994.01090190044020; Van den Berg TJTP, 2007, AM J OPHTHALMOL, V144, P358, DOI 10.1016/j.ajo.2007.05.037; VANDENBERG TJTP, 1992, APPL OPTICS, V31, P3694, DOI 10.1364/AO.31.003694; VIVINO MA, 1993, EYE, V7, P791, DOI 10.1038/eye.1993.186; WESTHEIMER G, 1994, INVEST OPHTH VIS SCI, V35, P2652; WESTHEIMER G, 1995, J OPT SOC AM A, V12, P1417, DOI 10.1364/JOSAA.12.001417	29	163	174	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16823	10.1371/journal.pone.0016823	http://dx.doi.org/10.1371/journal.pone.0016823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326868	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037000025
J	Juncker-Jensen, A; Lund, LR				Juncker-Jensen, Anna; Lund, Leif R.			Phenotypic Overlap between MMP-13 and the Plasminogen Activation System during Wound Healing in Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; MATRIX METALLOPROTEINASES; COLLAGENASE-3; EXPRESSION; CANCER; ANGIOGENESIS; DEGRADATION; INVASION; CONTRACTION; INHIBITOR	Background: Proteolytic degradation of extracellular matrix is a crucial step in the healing of incisional skin wounds. Thus, healing of skin wounds is delayed by either plasminogen-deficiency or by treatment with the broad-spectrum metalloproteinase (MP) inhibitor Galardin alone, while the two perturbations combined completely prevent wound healing. Both urokinase-type plasminogen activator and several matrix metallo proteinases (MMPs), such as MMP-3, -9 and -13, are expressed in the leading-edge keratinocytes of skin wounds, which may account for this phenotypic overlap between these classes of proteases. Methodology: To further test that hypothesis we generated Mmp13;Plau and Mmp13;Plg double-deficient mice in a cross between Mmp13- and Plau-deficient mice as well as Mmp13- and Plg-deficient mice. These mice were examined for normal physiology in a large cohort study and in a well-characterized skin wound healing model, in which we made incisional 20 mm-long full-thickness skin wounds. Principal Findings: While mice that are deficient in Mmp13 have a mean healing time indistinguishable to wild-type mice, wound healing in both Plau- and Plg-deficient mice is significantly delayed. Histological analysis of healed wounds revealed a significant increase in keratin 10/14 immunoreactive layers of kerationcytes in the skin surface in Mmp13; Plau double-deficient mice. Furthermore, we observe, by immunohistological analysis, an aberrant angiogenic pattern during wound healing induced by Plau-deficiency, which has not previously been described. Conclusions: We demonstrate a phenotypic overlap, defined as an additional delay in wound healing in the double-deficient mice compared to the individual single-deficient mice, between MMP-13 and the plasminogen activation system in the process of wound healing, but not during gestation and in postnatal development. Thus, a dual targeting of uPA and MMP-13 might be a possible future strategy in designing therapies aimed at tissue repair or other pathological processes, such as cancer invasion, where proteolytic degradation is a hallmark.	[Juncker-Jensen, Anna; Lund, Leif R.] Rigshosp, Finsen Lab, Copenhagen Bioctr, DK-2100 Copenhagen, Denmark; [Lund, Leif R.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Juncker-Jensen, A (corresponding author), Rigshosp, Finsen Lab, Copenhagen Bioctr, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	lrlund@sund.ku.dk			European Union [201279]; MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus" Foundation; Danish Cancer Society; Danish Cancer Research Foundation; "Agnes og Poul Friis" Foundation; Soren og Helene Hempels Legat; Lundbeck Foundation; Desiree og Niels Ydes Fond	European Union(European Commission); MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus" Foundation; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; "Agnes og Poul Friis" Foundation; Soren og Helene Hempels Legat; Lundbeck Foundation(Lundbeckfonden); Desiree og Niels Ydes Fond	This work is supported by grants from the European Union Grant 201279, MICROENVIMET, Aage Bangs Foundation, "Grosserer Alfred Nielsen og Hustrus" Foundation, Danish Cancer Society, the Danish Cancer Research Foundation, "Agnes og Poul Friis" Foundation, "Soren og Helene Hempels Legat", Lundbeck Foundation, and "Desiree og Niels Ydes Fond". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affara Nesrine I., 2009, V539, P1, DOI 10.1007/978-1-60327-003-8_1; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Almholt Kasper, 2008, P203, DOI 10.1007/978-0-387-69057-5_11; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Frossing S, 2010, EXP DERMATOL, V19, pE234, DOI 10.1111/j.1600-0625.2009.01062.x; Goscinski MA, 2008, ONCOLOGY-BASEL, V75, P49, DOI 10.1159/000151741; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HALD A, 2010, DIS MODEL MECH; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hiller O, 2000, J BIOL CHEM, V275, P33008, DOI 10.1074/jbc.M001836200; Johansson N, 1997, AM J PATHOL, V151, P499; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Lund LR, 1996, DEVELOPMENT, V122, P181; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mingers AM, 1997, SEMIN THROMB HEMOST, V23, P259, DOI 10.1055/s-2007-996099; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Netzel-Arnett S, 2002, J BIOL CHEM, V277, P45154, DOI 10.1074/jbc.M206354200; Nielsen BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002959; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rakic JM, 2003, CELL MOL LIFE SCI, V60, P463, DOI 10.1007/s000180300039; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Romer J, 2001, J INVEST DERMATOL, V116, P353, DOI 10.1046/j.1523-1747.2001.01241.x; ROMER J, 1991, J INVEST DERMATOL, V97, P803, DOI 10.1111/1523-1747.ep12486833; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tkachuk VA, 2009, CAN J PHYSIOL PHARM, V87, P231, DOI 10.1139/Y08-113; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; Wahlgren J, 2003, J ORAL PATHOL MED, V32, P100, DOI 10.1034/j.1600-0714.2003.00075.x; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	58	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16954	10.1371/journal.pone.0016954	http://dx.doi.org/10.1371/journal.pone.0016954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326869	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037000032
J	Chakraborty, C; Agoramoorthy, G; Hsu, MJ				Chakraborty, Chiranjib; Agoramoorthy, Govindasamy; Hsu, Minna J.			Exploring the Evolutionary Relationship of Insulin Receptor Substrate Family Using Computational Biology	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; O-GLYCOSYLATION; PROTEIN GLYCOSYLATION; IRS PROTEINS; INFORMATION; DOMAIN; CONSERVATION; CONSURF; SYSTEM	Insulin receptor substrate (IRS) harbors proteins such as IRS1, IRS2, IRS3, IRS4, IRS5 and IRS6. These key proteins act as vital downstream regulators in the insulin signaling pathway. However, little is known about the evolutionary relationship among the IRS family members. This study explores the potential to depict the evolutionary relationship among the IRS family using bioinformatics, algorithm analysis and mathematical models.	[Chakraborty, Chiranjib] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Agoramoorthy, Govindasamy] Tajen Univ, Coll Environm & Hlth Sci, Yanpu, Taiwan; [Hsu, Minna J.] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Vellore Institute of Technology; National Sun Yat Sen University	Hsu, MJ (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hsumin@mail.nsysu.edu.tw	Chakraborty, Chiranjib/J-4847-2013	Chakraborty, Chiranjib/0000-0002-3958-239X; Hsu, Minna J/0000-0001-7681-3532; Agoramoorthy, Govindasamy/0000-0002-8936-6978				ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Anand S, 2010, FEBS LETT, V584, P3170, DOI 10.1016/j.febslet.2010.06.004; ANGELA MV, 1998, MOL ENDOCRINOL, V12, P688; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Balakrishnan S, 2010, INDIAN J BIOTECHNOL, V9, P24; Branden C., 1999, INTRO PROTEIN STRUCT; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Chakraborty C, 2006, CURR PROTEIN PEPT SC, V7, P113, DOI 10.2174/138920306776359759; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Alessandris C, 2004, FASEB J, V18, P959, DOI 10.1096/fj.03-0725fje; Deo N., 1974, GRAPH THEORY APPL EN; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hounsell EF, 1996, GLYCOCONJUGATE J, V13, P19, DOI 10.1007/BF01049675; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kirnarsky L, 1998, BIOCHEMISTRY-US, V37, P12811, DOI 10.1021/bi981034a; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; MITTAL R, 1994, MICROELECTRON RELIAB, V34, P1301, DOI 10.1016/0026-2714(94)90143-0; Park SY, 2008, NAT STRUCT MOL BIOL, V15, P224, DOI 10.1038/nsmb0308-224; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Vainshtein I, 2001, J BIOL CHEM, V276, P8073, DOI 10.1074/jbc.M008436200; Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0	41	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16580	10.1371/journal.pone.0016580	http://dx.doi.org/10.1371/journal.pone.0016580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364910	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100006
J	Zhang, ZJ; Tan, QR; Tong, Y; Wang, XY; Wang, HH; Ho, LM; Wong, HK; Feng, YB; Wang, D; Ng, R; McAlonan, GM; Wang, CY; Wong, VT				Zhang, Zhang-Jin; Tan, Qing-Rong; Tong, Yao; Wang, Xue-Yi; Wang, Huai-Hai; Ho, Lai-Ming; Wong, Hei Kiu; Feng, Yi-Bin; Wang, Di; Ng, Roger; McAlonan, Grainne M.; Wang, Chuan-Yue; Wong, Vivian Taam			An Epidemiological Study of Concomitant Use of Chinese Medicine and Antipsychotics in Schizophrenic Patients: Implication for Herb-Drug Interaction	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; UNITED-STATES; PREVALENCE; ASSOCIATION; PHENELZINE; SUBTYPES; WOMEN	Background: Herb-drug interactions are an important issue in drug safety and clinical practice. The aim of this epidemiological study was to characterize associations of clinical outcomes with concomitant herbal and antipsychotic use in patients with schizophrenia. Methods and Findings: In this retrospective, cross-sectional study, 1795 patients with schizophrenia who were randomly selected from 17 psychiatric hospitals in China were interviewed face-to-face using a structured questionnaire. Association analyses were conducted to examine correlates between Chinese medicine (CM) use and demographic, clinical variables, antipsychotic medication mode, and clinical outcomes. The prevalence of concomitant CM and antipsychotic treatment was 36.4% [95% confidence interval (95% CI) 34.2%-38.6%]. Patients using concomitant CM had a significantly greater chance of improved outcomes than non-CM use (61.1% vs. 34.3%, OR = 3.44, 95% CI 2.80-4.24). However, a small but significant number of patients treated concomitantly with CM had a greater risk of developing worse outcomes (7.2% vs. 4.4%, OR = 2.06, 95% CI 2.06-4.83). Significant predictors for concomitant CM treatment-associated outcomes were residence in urban areas, paranoid psychosis, and exceeding 3 months of CM use. Herbal medicine regimens containing Radix Bupleuri, Fructus Gardenia, Fructus Schisandrae, Radix Rehmanniae, Akebia Caulis, and Semen Plantaginis in concomitant use with quetiapine, clozapine, and olanzepine were associated with nearly 60% of the risk of adverse outcomes. Conclusions: Concomitant herbal and antipsychotic treatment could produce either beneficial or adverse clinical effects in schizophrenic population. Potential herb-drug pharmacokinetic interactions need to be further evaluated.	[Zhang, Zhang-Jin; Tong, Yao; Wong, Hei Kiu; Feng, Yi-Bin; Wang, Di] Univ Hong Kong, Sch Chinese Med, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Zhang-Jin; Tan, Qing-Rong; Wang, Huai-Hai] Fourth Mil Med Univ, Dept Psychiat, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Wang, Xue-Yi] Hebei Med Univ, Mental Hlth Ctr, Shijiazhuang, Hebei, Peoples R China; [Ho, Lai-Ming] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Ng, Roger] Kowloon Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [McAlonan, Grainne M.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Wang, Chuan-Yue] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Wong, Vivian Taam] Hosp Author, Chinese Med Sect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Air Force Military Medical University; Hebei Medical University; University of Hong Kong; University of Hong Kong; Capital Medical University	Zhang, ZJ (corresponding author), Univ Hong Kong, Sch Chinese Med, Fac Med, Hong Kong, Hong Kong, Peoples R China.	zhangzj@hku.hk; tanqingr@fmmu.edu.cn	zhang, zhang/GQZ-6804-2022; zhang, zheng/HCH-9684-2022; Wang, Chuan-Yue/C-9369-2015; McAlonan, Grainne/G-1541-2011	Wang, Chuan-Yue/0000-0001-6549-3713; McAlonan, Grainne/0000-0002-4466-2343; ho, lm/0000-0002-2709-927X	University of Hong Kong; Hospital Authority of Hong Kong	University of Hong Kong(University of Hong Kong); Hospital Authority of Hong Kong	Funding: This study was supported by the intramural research fund of the University of Hong Kong and Hospital Authority of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnis CI, 2004, AM J KIDNEY DIS, V44, P1, DOI 10.1053/j.ajkd.2004.02.009; BERSANI G, 1989, J PSYCHIAT RES, V23, P213, DOI 10.1016/0022-3956(89)90026-5; Chen Z, 2008, J ALTERN COMPLEM MED, V14, P1049, DOI 10.1089/acm.2008.0039; Csernansky JG, 2002, CNS DRUGS, V16, P473, DOI 10.2165/00023210-200216070-00004; DEAHL M, 1989, MOVEMENT DISORD, V4, P330, DOI 10.1002/mds.870040406; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2004, PHARMACOEPIDEM DR S, V13, P767, DOI 10.1002/pds.1014; Ernst E, 2002, TRENDS PHARMACOL SCI, V23, P136, DOI 10.1016/S0165-6147(00)01972-6; Fanous Ayman H, 2008, Curr Psychiatry Rep, V10, P164, DOI 10.1007/s11920-008-0028-z; Feng YB, 2009, BASIC CLIN TOXICOLOG; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jablensky A, 2006, MOL PSYCHIATR, V11, P815, DOI 10.1038/sj.mp.4001857; JONES BD, 1987, J CLIN PSYCHOPHARM, V7, P201, DOI 10.1097/00004714-198706000-00030; Ma K, 2008, AIDS BEHAV, V12, P637, DOI 10.1007/s10461-007-9245-4; Maciocia G., 1994, PRACTICE CHINESE MED, P342; Peterson Erica, 2008, S D Med, V61, P173; Przekop P, 2009, AM J PSYCHIAT, V166, P832, DOI 10.1176/appi.ajp.2009.08121759; SHADER RI, 1985, J CLIN PSYCHOPHARM, V5, P65, DOI 10.1097/00004714-198504000-00001; Sheehan JJ, 2010, CURR DRUG METAB, V11, P516, DOI 10.2174/138920010791636202; Tanaka A, 2001, INTERNAL MED, V40, P296, DOI 10.2169/internalmedicine.40.296; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Wang B, 2009, CURR MED CHEM, V16, P4066, DOI 10.2174/092986709789378198; World Health Organization, 1992, ICD 10 CLAS MENT BEH; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xiang YT, 2007, PHARMACOPSYCHIATRY, V40, P47, DOI 10.1055/s-2007-970062; Xiang YT, 2008, SCHIZOPHR RES, V102, P270, DOI 10.1016/j.schres.2008.04.009; Yang XX, 2006, CURR PHARM DESIGN, V12, P4649, DOI 10.2174/138161206779010440; Yuan HN, 2008, J CLIN PSYCHOPHARM, V28, P264, DOI 10.1097/JCP.0b013e318172473c; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; Zalewski C, 1998, SCHIZOPHRENIA BULL, V24, P127, DOI 10.1093/oxfordjournals.schbul.a033305; Zhang ZJ, 2007, J PSYCHIATR RES, V41, P828, DOI 10.1016/j.jpsychires.2006.08.002; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Zhang ZJ, 2010, CLIN TRIALS PSYCHOPH, V21, P311	36	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17239	10.1371/journal.pone.0017239	http://dx.doi.org/10.1371/journal.pone.0017239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359185	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700064
J	Chipperfield, JD; Dytham, C; Hovestadt, T				Chipperfield, Joseph D.; Dytham, Calvin; Hovestadt, Thomas			An Updated Algorithm for the Generation of Neutral Landscapes by Spectral Synthesis	PLOS ONE			English	Article							FRACTAL LANDSCAPES; STRUCTURED LANDSCAPES; MODELS; CONNECTIVITY; ENVIRONMENTS; HETEROGENEITY; RESPONSES; EVOLUTION; DYNAMICS; PATTERNS	Background: Patterns that arise from an ecological process can be driven as much from the landscape over which the process is run as it is by some intrinsic properties of the process itself. The disentanglement of these effects is aided if it possible to run models of the process over artificial landscapes with controllable spatial properties. A number of different methods for the generation of so-called 'neutral landscapes' have been developed to provide just such a tool. Of these methods, a particular class that simulate fractional Brownian motion have shown particular promise. The existing methods of simulating fractional Brownian motion suffer from a number of problems however: they are often not easily generalisable to an arbitrary number of dimensions and produce outputs that can exhibit some undesirable artefacts. Methodology: We describe here an updated algorithm for the generation of neutral landscapes by fractional Brownian motion that do not display such undesirable properties. Using Monte Carlo simulation we assess the anisotropic properties of landscapes generated using the new algorithm described in this paper and compare it against a popular benchmark algorithm. Conclusion/Significance: The results show that the existing algorithm creates landscapes with values strongly correlated in the diagonal direction and that the new algorithm presented here corrects this artefact. A number of extensions of the algorithm described here are also highlighted: we describe how the algorithm can be employed to generate landscapes that display different properties in different dimensions and how they can be combined with an environmental gradient to produce landscapes that combine environmental variation at the local and macro scales.	[Chipperfield, Joseph D.; Hovestadt, Thomas] Univ Wurzburg, Field Stn Fabrikschleichach, Rauhenebrach, Germany; [Chipperfield, Joseph D.; Dytham, Calvin] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Hovestadt, Thomas] Museum Natl Hist Nat, Brunoy, France	University of Wurzburg; University of York - UK; Museum National d'Histoire Naturelle (MNHN)	Chipperfield, JD (corresponding author), Univ Wurzburg, Field Stn Fabrikschleichach, Rauhenebrach, Germany.	j.chipperfield@biozentrum.uni-wuerzburg.de	; Chipperfield, Joseph/A-8280-2018	Dytham, Calvin/0000-0002-4111-9484; Chipperfield, Joseph/0000-0003-3314-0846; Hovestadt, Thomas/0000-0001-7368-6013	NERC/UKPopNet [NER/S/R/2005/13941]; DFG [1374, HO 2051/2-1]	NERC/UKPopNet(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DFG(German Research Foundation (DFG))	This research was supported by a NERC/UKPopNet studentship (NER/S/R/2005/13941 - http://bioltfws1.york.ac.uk/UKPopNet/studentships/jchipperfield) and by the DFG Priority Program 1374 'Infrastructure-Biodiversity-Exploratories' (HO 2051/2-1 http://www.biodiversity-exploratories.de/Projects/contributing-projects/modeling-remote-sensing/beam). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascompte J, 2002, AM NAT, V159, P128, DOI 10.1086/324793; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Dey S, 2006, J THEOR BIOL, V238, P78, DOI 10.1016/j.jtbi.2005.05.013; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; FORNEY KA, 1989, CONSERV BIOL, V3, P45, DOI 10.1111/j.1523-1739.1989.tb00223.x; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Gardner RH, 1999, LANDSCAPE ECOLOGICAL ANALYSIS: ISSUES AND APPLICATIONS, P280; GARDNER RH, 1991, QUANTITATIVE METHODS, P289; Gardner RH, 2007, LANDSCAPE ECOL, V22, P15, DOI 10.1007/s10980-006-9011-4; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I., 2002, METAPOPULATION ECOLO; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; LAVOREL S, 1993, OIKOS, V67, P521, DOI 10.2307/3545364; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; MANDELBROT BB, 1982, COMMUN ACM, V25, P581; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Moloney KA, 1996, ECOLOGY, V77, P375, DOI 10.2307/2265616; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; NOSS RF, 1991, LANDSCAPE LINKAGES AND BIODIVERSITY, P27; ODEN NL, 1986, SYST ZOOL, V35, P608, DOI 10.2307/2413120; ONEILL RV, 1992, LANDSCAPE ECOL, V7, P55, DOI 10.1007/BF02573957; PALMER MW, 1992, AM NAT, V139, P375, DOI 10.1086/285332; Peitgen H.-O., 1988, SCI FRACTAL IMAGES; PRESS WH, 2007, NUMERICAL RECIPIES; Shima JS, 2010, ECOLOGY, V91, P1215, DOI 10.1890/08-2058.1; Travis JMJ, 2004, OIKOS, V104, P410; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; With KA, 1999, ECOLOGY, V80, P1340, DOI 10.1890/0012-9658(1999)080[1340:MRTPSI]2.0.CO;2	35	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17040	10.1371/journal.pone.0017040	http://dx.doi.org/10.1371/journal.pone.0017040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347228	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200015
J	Graham, AC; Carr, KD; Sieve, AN; Indramohan, M; Break, TJ; Berg, RE				Graham, Amy C.; Carr, Karen D.; Sieve, Amy N.; Indramohan, Mohanalaxmi; Break, Timothy J.; Berg, Rance E.			IL-22 Production Is Regulated by IL-23 During Listeria monocytogenes Infection but Is Not Required for Bacterial Clearance or Tissue Protection	PLOS ONE			English	Article							INNATE IMMUNE PROTECTION; MUCOSAL HOST-DEFENSE; T-CELLS; ADAPTIVE IMMUNITY; TH17 CELLS; MICE; INTERLEUKIN-22; IL-12; ROLES; INFLAMMATION	Listeria monocytogenes (LM) is a gram-positive bacterium that is a common contaminant of processed meats and dairy products. In humans, ingestion of LM can result in intracellular infection of the spleen and liver, which can ultimately lead to septicemia, meningitis, and spontaneous abortion. Interleukin (IL)-23 is a cytokine that regulates innate and adaptive immune responses by inducing the production of IL-17A, IL-17F, and IL-22. We have recently demonstrated that the IL-23/IL-17 axis is required for optimal recruitment of neutrophils to the liver, but not the spleen, during LM infection. Furthermore, these cytokines are required for the clearance of LM during systemic infection. In other infectious models, IL-22 induces the secretion of anti-microbial peptides and protects tissues from damage by preventing apoptosis. However, the role of IL-22 has not been thoroughly investigated during LM infection. In the present study, we show that LM induces the production of IL-22 in vivo. Interestingly, IL-23 is required for the production of IL-22 during primary, but not secondary, LM infection. Our findings suggest that IL-22 is not required for clearance of LM during primary or secondary infection, using both systemic and mucosal models of infection. IL-22 is also not required for the protection of LM infected spleens and livers from organ damage. Collectively, these data indicate that IL-22 produced during LM infection must play a role other than clearance of LM or protection of tissues from pathogen- or immune-mediated damage.	[Graham, Amy C.; Carr, Karen D.; Sieve, Amy N.; Indramohan, Mohanalaxmi; Break, Timothy J.; Berg, Rance E.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center	Graham, AC (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA.	Rance.Berg@unthsc.edu		Break, Timothy/0000-0001-5987-7817	National Institutes of Health (NIH) [AI064592, AI072946]; Texas Norman Hackerman Advanced Research Program Grant [000130-002502007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI064592, F32AI072946] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI064592 and a Texas Norman Hackerman Advanced Research Program Grant #000130-002502007 (to R.E.B.). A.N.S. was supported by NIH AI072946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Ghilardi N, 2007, SEMIN IMMUNOL, V19, P383, DOI 10.1016/j.smim.2007.10.016; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Henry CJ, 2008, J IMMUNOL, V181, P8576, DOI 10.4049/jimmunol.181.12.8576; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manohar M, 2001, INFECT IMMUN, V69, P3542, DOI 10.1128/IAI.69.6.3542-3549.2001; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Merrick JC, 1997, AM J PATHOL, V151, P785; Misse D, 2007, J IMMUNOL, V178, P407, DOI 10.4049/jimmunol.178.1.407; Miura T, 2000, FEMS IMMUNOL MED MIC, V28, P335, DOI 10.1111/j.1574-695X.2000.tb01495.x; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang W, 2008, MUCOSAL IMMUNOL, V1, P335, DOI 10.1038/mi.2008.26; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PINE L, 1990, INFECT IMMUN, V58, P2940, DOI 10.1128/IAI.58.9.2940-2945.1990; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	43	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17171	10.1371/journal.pone.0017171	http://dx.doi.org/10.1371/journal.pone.0017171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347242	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200026
J	Wang, DV; Tsien, JZ				Wang, Dong V.; Tsien, Joe Z.			Convergent Processing of Both Positive and Negative Motivational Signals by the VTA Dopamine Neuronal Populations	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; LATERAL HABENULA; PREFRONTAL CORTEX; REWARD; ENCODE; DIFFERENTIATE; ADDICTION; BEHAVIOR; PATTERN	Dopamine neurons in the ventral tegmental area (VTA) have been traditionally studied for their roles in reward-related motivation or drug addiction. Here we study how the VTA dopamine neuron population may process fearful and negative experiences as well as reward information in freely behaving mice. Using multi-tetrode recording, we find that up to 89% of the putative dopamine neurons in the VTA exhibit significant activation in response to the conditioned tone that predict food reward, while the same dopamine neuron population also respond to the fearful experiences such as free fall and shake events. The majority of these VTA putative dopamine neurons exhibit suppression and offset-rebound excitation, whereas similar to 25% of the recorded putative dopamine neurons show excitation by the fearful events. Importantly, VTA putative dopamine neurons exhibit parametric encoding properties: their firing change durations are proportional to the fearful event durations. In addition, we demonstrate that the contextual information is crucial for these neurons to respectively elicit positive or negative motivational responses by the same conditioned tone. Taken together, our findings suggest that VTA dopamine neurons may employ the convergent encoding strategy for processing both positive and negative experiences, intimately integrating with cues and environmental context.	[Wang, Dong V.] E China Normal Univ, Key Lab MOE & STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wang, DV (corresponding author), E China Normal Univ, Key Lab MOE & STCSM, Shanghai Inst Brain Funct Genom, Shanghai 200062, Peoples R China.	jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG025918, R01AG034663] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Cools R, 2007, NEUROPSYCHOPHARMACOL, V32, P180, DOI 10.1038/sj.npp.1301153; DEPAULIS A, 1992, EXP BRAIN RES, V90, P307; DIANA M, 1993, P NATL ACAD SCI USA, V90, P7966, DOI 10.1073/pnas.90.17.7966; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Frank MJ, 2009, J MOL CELL BIOL, V1, P15, DOI 10.1093/jmcb/mjp010; GRACE AA, 1984, J NEUROSCI, V4, P2877; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Joshua M, 2009, NEURON, V62, P695, DOI 10.1016/j.neuron.2009.04.026; Karreman M, 1996, J NEUROCHEM, V66, P589; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Komendantov AO, 2002, J NEUROPHYSIOL, V87, P1526, DOI 10.1152/jn.00255.2001; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2001, J NEUROSCI, V21, P1757; Levita L, 2002, BEHAV BRAIN RES, V137, P115, DOI 10.1016/S0166-4328(02)00287-5; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	52	78	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17047	10.1371/journal.pone.0017047	http://dx.doi.org/10.1371/journal.pone.0017047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347237	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200016
J	Hilario, A; Capa, M; Dahlgren, TG; Halanych, KM; Little, CTS; Thornhill, DJ; Verna, C; Glover, AG				Hilario, Ana; Capa, Maria; Dahlgren, Thomas G.; Halanych, Kenneth M.; Little, Crispin T. S.; Thornhill, Daniel J.; Verna, Caroline; Glover, Adrian G.			New Perspectives on the Ecology and Evolution of Siboglinid Tubeworms	PLOS ONE			English	Review							VENT TUBE WORM; RIFTIA-PACHYPTILA JONES; SPERM-WHALE CARCASSES; OLIGOBRACHIA-MASHIKOI; MOLECULAR PHYLOGENY; HYDROTHERMAL VENTS; VESTIMENTIFERAN TUBEWORMS; BACTERIAL ENDOSYMBIONTS; OSEDAX-MUCOFLORIS; SEDIMENT ADJACENT		[Hilario, Ana] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Hilario, Ana] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Capa, Maria] Australian Museum, Sydney, NSW 2000, Australia; [Dahlgren, Thomas G.] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Little, Crispin T. S.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Thornhill, Daniel J.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Verna, Caroline] Max Planck Inst Marine Microbiol, Symbiosis Grp, Bremen, Germany; [Glover, Adrian G.] Nat Hist Museum, Dept Zool, London SW7 5BD, England	Universidade de Aveiro; Universidade de Aveiro; Australian Museum; University of Gothenburg; Auburn University System; Auburn University; University of Leeds; Bowdoin College; Max Planck Society; Natural History Museum London	Hilario, A (corresponding author), Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal.	a.glover@nhm.ac.uk	Balears, Universitat de les Illes/K-5821-2015; Hilário, Ana/C-1260-2008; Verna, Caroline/L-6506-2013; Dahlgren, Thomas/X-6610-2019; Halanych, Ken M/A-9480-2009	Balears, Universitat de les Illes/0000-0002-5063-7961; Hilário, Ana/0000-0001-8287-1528; Verna, Caroline/0000-0002-9037-6014; Dahlgren, Thomas/0000-0001-6854-2031; Halanych, Ken M/0000-0002-8658-9674; Little, Crispin/0000-0002-1917-4460	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/22383/2005]; Systematics Association; Natural Environment Research Council [NE/D000483/1] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Systematics Association; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A. Hilario is supported by a grant (SFRH/BPD/22383/2005) from Fundacao para a Ciencia e Tecnologia (FCT) and A. Glover by a SynTax grant from the Systematics Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGOKE OLUWAFEYISOLA S., 1967, J PALEONTOL, V41, P1090; Aida M, 2008, MICROBES ENVIRON, V23, P81, DOI 10.1264/jsme2.23.81; Andersen AC, 2002, CAN J ZOOL, V80, P320, DOI 10.1139/Z02-005; ARP AJ, 1981, SCIENCE, V213, P342, DOI 10.1126/science.213.4505.342; ARP AJ, 1983, SCIENCE, V219, P295, DOI 10.1126/science.219.4582.295; ARP AJ, 1987, J EXP BIOL, V128, P139; ARP AJ, 1990, RESP PHYSIOL, V80, P323, DOI 10.1016/0034-5687(90)90092-D; BAKKE T, 1974, SARSIA, P57; BAYER FM, 1962, SCIENCE, V137, P670, DOI 10.1126/science.137.3531.670; Black MB, 1997, MAR BIOL, V130, P141, DOI 10.1007/s002270050233; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; BRATTSTROM H, 1959, NATURE, V183, P1458, DOI 10.1038/1831458a0; Bright M, 2005, SYMBIOSIS, V38, P1; BRUNET PCJ, 1958, NATURE, V182, P1689, DOI 10.1038/1821689a0; BUCKLIN A, 1988, DEEP-SEA RES, V35, P1759, DOI 10.1016/0198-0149(88)90048-9; CARLISLE DB, 1964, BIOCHEM J, V90, pC1, DOI 10.1042/bj0900001C; CARY C, 1989, MAR BIOL, V100, P411, DOI 10.1007/BF00391157; CARY SC, 1993, P NATL ACAD SCI USA, V90, P5695, DOI 10.1073/pnas.90.12.5695; Caullery M, 1914, CR HEBD ACAD SCI, V158, P2014; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Chao LSL, 2007, MAR ECOL-EVOL PERSP, V28, P72, DOI 10.1111/j.1439-0485.2007.00151.x; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; CHILDRESS JJ, 1993, NATURE, V362, P147, DOI 10.1038/362147a0; COOK TL, 1995, SCIENCE, V267, P1975, DOI 10.1126/science.267.5206.1975; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; De Beer G., 1955, Nature London, V176, P888, DOI 10.1038/176888a0; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; ENDOW K, 1990, MAR ECOL PROG SER, V64, P309, DOI 10.3354/meps064309; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; Feldman RA, 1997, MOL MAR BIOL BIOTECH, V6, P268; Feldman RA, 1998, BIOL BULL, V194, P116, DOI 10.2307/1543041; FISHER CR, 1990, REV AQUAT SCI, V2, P399; FLUGEL H, 1977, NATURE, V269, P800, DOI 10.1038/269800a0; Gardiner SL, 1993, VESTIMENTIFERA ONYCH, P371; GEORGE JD, 1973, J MAR BIOL ASSOC UK, V53, P403, DOI 10.1017/S0025315400022359; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; Haas A, 2009, DEEP-SEA RES PT I, V56, P283, DOI 10.1016/j.dsr.2008.08.007; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Halanych KM, 2002, INTEGR COMP BIOL, V42, P678, DOI 10.1093/icb/42.3.678; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; Harmer TL, 2008, APPL ENVIRON MICROB, V74, P3895, DOI 10.1128/AEM.02470-07; HARTMAN OLGA, 1954, SYSTEMATIC ZOOL, V3, P183, DOI 10.2307/2411385; HENTSCHEL U, 1993, NATURE, V366, P338, DOI 10.1038/366338a0; Higgs ND, 2010, CAH BIOL MAR, V51, P401; Hilario A, 2005, BIOL BULL-US, V208, P20, DOI 10.2307/3593097; Hilario A, 2010, DEEP-SEA RES PT I, V57, P143, DOI 10.1016/j.dsr.2009.10.004; Hilario A, 2008, SCI MAR, V72, P361; Himmler T, 2008, PALAEOGEOGR PALAEOCL, V257, P185, DOI 10.1016/j.palaeo.2007.09.018; Hurtado LA, 2002, CAH BIOL MAR, V43, P377; Ivanov A. V., 1955, Systematic Zoology, V4, P177, DOI 10.2307/2411671; IVANOV AV, 1991, DOKL AKAD NAUK SSSR+, V319, P505; IVANOV AV, 1975, ZH OBSHCH BIOL, V36, P643; Ivanov AV, 1963, POGONOPHORA CARLISLE; Jones M., 1985, B BIOL SOC WASH, V6, P117; JONES ML, 1988, P BIOL SOC WASH, V101, P423; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; Julian D, 1999, J EXP BIOL, V202, P2245; Kiel S, 2010, P NATL ACAD SCI USA, V107, P8656, DOI 10.1073/pnas.1002014107; Kiel S, 2009, ACTA PALAEONTOL POL, V54, P443, DOI 10.4202/app.2009.0022; Kimura H, 2003, MAR BIOTECHNOL, V5, P261, DOI 10.1007/s10126-002-0073-2; KIRKEGAARD JB, 1958, NATURE, V181, P1086, DOI 10.1038/1811086a0; KOJIMA S, 1993, J MOL EVOL, V37, P66; Kojima S, 1998, MOL PHYLOGENET EVOL, V9, P255, DOI 10.1006/mpev.1997.0472; Kojima S, 1997, MAR BIOL, V127, P507, DOI 10.1007/s002270050039; KORC M, 1981, SCIENCE, V213, P351, DOI 10.1126/science.6166044; Kubota N, 2007, MICROBES ENVIRONMENT, V22, P136, DOI 10.1264/jsme2.22.136; LITTLE C, 1968, NATURE, V218, P873, DOI 10.1038/218873a0; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Little CTS, 2004, J PALEONTOL, V78, P542, DOI 10.1666/0022-3360(2004)078<0542:EJHVCF>2.0.CO;2; Little CTS, 1999, GEOLOGY, V27, P1027, DOI 10.1130/0091-7613(1999)027<1027:LCHVCF>2.3.CO;2; Little CTS, 1999, PALAEONTOLOGY, V42, P1043, DOI 10.1111/1475-4983.00110; Livanov NA, 1967, BIOL ZBL, V86, P177; Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x; MANTON SM, 1958, NATURE, V181, P748, DOI 10.1038/181748a0; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; MCINTYRE AD, 1963, NATURE, V197, P616, DOI 10.1038/197616a0; McMullin ER, 2003, SYMBIOSIS, V34, P1; Meunier C, 2010, COMP BIOCHEM PHYS A, V155, P41, DOI 10.1016/j.cbpa.2009.09.010; Millikan DS, 1999, APPL ENVIRON MICROB, V65, P3129; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P2815, DOI 10.1099/ijs.0.65826-0; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P866, DOI 10.1099/ijs.0.65509-0; Morris SC, 2008, ACTA PALAEONTOL POL, V53, P135; Nelson K, 2000, SYMBIOSIS, V28, P1; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; ORGHIDAN T N, 1985, Travaux du Museum d'Histoire Naturelle "Grigore Antipa", V27, P343; Peckmann J, 2005, PALAEOGEOGR PALAEOCL, V227, P242, DOI 10.1016/j.palaeo.2005.04.021; Pleijel F, 2009, CR BIOL, V332, P140, DOI 10.1016/j.crvi.2008.10.007; POULSEN VALDEMAR, 1963, BIOL MEDD KONGELIGE DANSKE VIDENSKAB SELSKAB, V23, P1; POWELL MA, 1983, SCIENCE, V219, P297, DOI 10.1126/science.219.4582.297; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; Rouse GW, 2007, ZOOTAXA, P245, DOI 10.11646/zootaxa.1668.1.13; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Rousset V, 2004, CLADISTICS, V20, P518, DOI 10.1111/j.1096-0031.2004.00039.x; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; SCHMALJOHANN R, 1990, MAR ECOL PROG SER, V61, P119, DOI 10.3354/meps061119; SCHMALJOHANN R, 1991, MAR ECOL PROG SER, V76, P143, DOI 10.3354/meps076143; Schulze A, 2003, HYDROBIOLOGIA, V496, P199, DOI 10.1023/A:1026192715095; Shank TM, 2007, MAR ECOL-EVOL PERSP, V28, P25, DOI 10.1111/j.1439-0485.2007.00146.x; Shillito Bruce, 1995, Geological Society Special Publication, V87, P295, DOI 10.1144/GSL.SP.1995.087.01.22; Skovsted CB, 2006, J PALEONTOL, V80, P1087, DOI 10.1666/0022-3360(2006)80[1087:SSFFTU]2.0.CO;2; SOUTHWARD A J, 1981, Kieler Meeresforschungen, P445; SOUTHWARD AJ, 1968, NATURE, V218, P875, DOI 10.1038/218875a0; SOUTHWARD AJ, 1980, J MAR BIOL ASSOC UK, V60, P1005, DOI 10.1017/S0025315400042053; SOUTHWARD AJ, 1958, NATURE, V181, P1607, DOI 10.1038/1811607a0; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; Southward E.C., 1993, POGONOPHORA MICROSCO, P327; Southward EC, 2005, HYDROBIOLOGIA, V535, P227, DOI 10.1007/s10750-004-4401-6; SOUTHWARD EC, 1988, J MAR BIOL ASSOC UK, V68, P465, DOI 10.1017/S0025315400043344; Southward EC, 1999, HYDROBIOLOGIA, V402, P185, DOI 10.1023/A:1003796626851; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; TERWILLIGER RC, 1987, AM ZOOL, V27, pA32; Thornhill DJ, 2008, BIOL BULL-US, V214, P135, DOI 10.2307/25066670; Thornhill Daniel J., 2008, Communicative & Integrative Biology, V1, P163; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; USCHAKOW P., 1933, ZOOL ANZ, V104, P205; Verna C, 2010, ENVIRON MICROBIOL, V12, P2355, DOI 10.1111/j.1462-2920.2010.02299.x; Vinn O, 2009, EST J EARTH SCI, V58, P286, DOI 10.3176/earth.2009.4.07; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; WEBB M, 1971, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V9, P169; WEBB MICHAEL, 1964, SARSIA, V15, P57; WIGLEY RL, 1963, SCIENCE, V141, P358, DOI 10.1126/science.141.3578.358; WITTENBERG JB, 1981, SCIENCE, V213, P344, DOI 10.1126/science.213.4505.344; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0; YOUNG CM, 1999, AQUATIC LIFE CYCLE S, P1; Yuasa HJ, 1996, BBA-PROTEIN STRUCT M, V1296, P235, DOI 10.1016/0167-4838(96)00081-7; Zal F, 1996, J BIOL CHEM, V271, P8869, DOI 10.1074/jbc.271.15.8869; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	143	83	98	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16309	10.1371/journal.pone.0016309	http://dx.doi.org/10.1371/journal.pone.0016309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339826	Green Published, gold			2022-12-27	WOS:000287367600012
J	Wilson, AL				Wilson, Anne L.		IPTc Taskforce	A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intermittent Preventive Treatment of Malaria in Children (IPTc)	PLOS ONE			English	Review							CHILDHOOD MORTALITY	Background: Intermittent preventive treatment of malaria in children less than five years of age (IPTc) has been investigated as a measure to control the burden of malaria in the Sahel and sub-Sahelian areas of Africa where malaria transmission is markedly seasonal. Methods and Findings: IPTc studies were identified using a systematic literature search. Meta-analysis was used to assess the protective efficacy of IPTc against clinical episodes of falciparum malaria. The impact of IPTc on all-cause mortality, hospital admissions, severe malaria and the prevalence of parasitaemia and anaemia was investigated. Three aspects of safety were also assessed: adverse reactions to study drugs, development of drug resistance and loss of immunity to malaria. Twelve IPTc studies were identified: seven controlled and five non-controlled trials. Controlled studies demonstrated protective efficacies against clinical malaria of between 31% and 93% and meta-analysis gave an overall protective efficacy of monthly administered IPTc of 82% (95% CI 75%-87%) during the malaria transmission season. Pooling results from twelve studies demonstrated a protective effect of IPTc against all-cause mortality of 57% (95% CI 24%-76%) during the malaria transmission season. No serious adverse events attributable to the drugs used for IPTc were observed in any of the studies. Data from three studies that followed children during the malaria transmission season in the year following IPTc administration showed evidence of a slight increase in the incidence of clinical malaria compared to children who had not received IPTc. Conclusions: IPTc is a safe method of malaria control that has the potential to avert a significant proportion of clinical malaria episodes in areas with markedly seasonal malaria transmission and also appears to have a substantial protective effect against all-cause mortality. These findings indicate that IPTc is a potentially valuable tool that can contribute to the control of malaria in areas with markedly seasonal transmission.	[Wilson, Anne L.; IPTc Taskforce] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Wilson, AL (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	Anne.wilson@lshtm.ac.uk	Agyemang, Samuel/H-8377-2014; Conteh, Lesong/ABE-9550-2020	Conteh, Lesong/0000-0002-0719-3672; Bojang, Kalifa/0000-0001-7506-0938; Owusu-Agyei, Seth/0000-0002-0807-1781; Wilson, Anne/0000-0001-7387-353X	Bill & Melinda Gates Foundation [OPP51371]; MRC [MC_UP_A900_1118] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant to the London School of Hygiene & Tropical Medicine from the Bill & Melinda Gates Foundation (Grant number: OPP51371). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Bojang KA, 2011, PLOS MED IN PRESS; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Cairns M, 2010, ANTIMICROB AGENTS CH, V54, P1265, DOI 10.1128/AAC.01161-09; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, PILOT STUDY RO UNPUB; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012223; Dicko A, 2011, PLOS MED IN PRESS; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; GREENWOOD BM, 1988, LANCET, V1, P1121; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; International Conference on Harmonisation, 2004, ICH HARM TRIP GUID C; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kirkwood BR, 2003, ESSENTIAL MED STAT; Konate AT, 2011, PLOS MED IN PRESS; Kweku M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007256; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Meremikwu MM, 2008, COCHRANE DATABASE SY, V2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Olliaro P, 2003, COCHRANE DATABASE SY, P2; Ramroth H, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1909; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; World Health Organization (WHO), 2010, WHO POL REC INT PREV	34	103	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16976	10.1371/journal.pone.0016976	http://dx.doi.org/10.1371/journal.pone.0016976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340029	gold, Green Published, Green Accepted			2022-12-27	WOS:000287367600027
J	Rosa, DS; Ribeiro, SP; Almeida, RR; Mairena, EC; Postol, E; Kalil, J; Cunha-Neto, E				Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Almeida, Rafael Ribeiro; Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio			A DNA Vaccine Encoding Multiple HIV CD4 Epitopes Elicits Vigorous Polyfunctional, Long-Lived CD4(+) and CD8(+) T Cell Responses	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PROTECTIVE IMMUNITY; ELITE CONTROLLERS; RHESUS-MONKEYS; CENTRAL MEMORY; INFECTION; CHALLENGE; STEP; PREDICTION; CORRELATE	T-cell based vaccines against HIV have the goal of limiting both transmission and disease progression by inducing broad and functionally relevant T cell responses. Moreover, polyfunctional and long-lived specific memory T cells have been associated to vaccine-induced protection. CD4(+) T cells are important for the generation and maintenance of functional CD8(+) cytotoxic T cells. We have recently developed a DNA vaccine encoding 18 conserved multiple HLA-DR-binding HIV-1 CD4 epitopes (HIVBr18), capable of eliciting broad CD4(+) T cell responses in multiple HLA class II transgenic mice. Here, we evaluated the breadth and functional profile of HIVBr18-induced immune responses in BALB/c mice. Immunized mice displayed high-magnitude, broad CD4(+)/CD8(+) T cell responses, and 8/18 vaccine-encoded peptides were recognized. In addition, HIVBr18 immunization was able to induce polyfunctional CD4(+) and CD8(+) T cells that proliferate and produce any two cytokines (IFN gamma/TNF alpha, IFN gamma/IL-2 or TNF alpha/IL-2) simultaneously in response to HIV-1 peptides. For CD4(+) T cells exclusively, we also detected cells that proliferate and produce all three tested cytokines simultaneously (IFN gamma/TNF alpha/IL-2). The vaccine also generated long-lived central and effector memory CD4(+) T cells, a desirable feature for T-cell based vaccines. By virtue of inducing broad, polyfunctional and long-lived T cell responses against conserved CD4(+) T cell epitopes, combined administration of this vaccine concept may provide sustained help for CD8(+) T cells and antibody responses-elicited by other HIV immunogens.	[Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Almeida, Rafael Ribeiro; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Dept Med,Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil; [Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Mairena, Eliane Conti; Postol, Edilberto; Kalil, Jorge; Cunha-Neto, Edecio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Rosa, Daniela Santoro] Fed Univ Sao Paulo UNIFESP, Div Immunol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Rosa, DS (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Dept Med,Lab Clin Immunol & Allergy LIM60, Sao Paulo, Brazil.	edecunha@gmail.com	KALIL, JORGE/C-8029-2012; Almeida, Rafael Ribeiro/F-8014-2014; Rosa, Daniela S/D-2190-2012; Cunha-Neto, Edecio/B-4157-2009	KALIL, JORGE/0000-0001-8415-4274; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Rosa, Daniela S/0000-0003-4536-891X; Cunha-Neto, Edecio/0000-0002-3699-3345	Brazilian National Research Council (CNPq); Sao Paulo State Research Funding Agency (FAPESP); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	This research was supported by the Brazilian National Research Council (CNPq), Sao Paulo State Research Funding Agency (FAPESP), International Centre of Genetic Engineering and Biotechnology (ICGEB) and by the Brazilian Ministry of Health (Brazil). D. S. Rosa, S. P. Ribeiro and R. R. Almeida are recipients of a Sao Paulo State Research Funding Agency (FAPESP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; ATHERTON ND, 1989, CLIN CHEM, V35, P975; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; FERRE AL, 2010, J VIROL; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pancre V, 2007, VACCINE, V25, P5927, DOI 10.1016/j.vaccine.2007.05.038; Pike R, 2009, J VIROL, V83, P11211, DOI 10.1128/JVI.01225-09; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; von Gegerfelt A, 2010, J IMMUNOL, V185, P3348, DOI 10.4049/jimmunol.1000572; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Yamamoto T, 2009, J VIROL, V83, P5514, DOI 10.1128/JVI.00145-09; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW180, DOI 10.1093/nar/gki479	56	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16921	10.1371/journal.pone.0016921	http://dx.doi.org/10.1371/journal.pone.0016921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347287	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500013
J	Perdikis, D; Huys, R; Jirsa, V				Perdikis, Dionysios; Huys, Raoul; Jirsa, Viktor			Complex Processes from Dynamical Architectures with Time-Scale Hierarchy	PLOS ONE			English	Article							MOTOR PROGRAMS; RHYTHMICAL MOVEMENTS; ARM MOVEMENTS; DISCRETE; PERCEPTION; SUPERPOSITION; COORDINATION; RECOGNITION; PRIMITIVES; EXCITATOR	The idea that complex motor, perceptual, and cognitive behaviors are composed of smaller units, which are somehow brought into a meaningful relation, permeates the biological and life sciences. However, no principled framework defining the constituent elementary processes has been developed to this date. Consequently, functional configurations (or architectures) relating elementary processes and external influences are mostly piecemeal formulations suitable to particular instances only. Here, we develop a general dynamical framework for distinct functional architectures characterized by the time-scale separation of their constituents and evaluate their efficiency. Thereto, we build on the (phase) flow of a system, which prescribes the temporal evolution of its state variables. The phase flow topology allows for the unambiguous classification of qualitatively distinct processes, which we consider to represent the functional units or modes within the dynamical architecture. Using the example of a composite movement we illustrate how different architectures can be characterized by their degree of time scale separation between the internal elements of the architecture (i.e. the functional modes) and external interventions. We reveal a tradeoff of the interactions between internal and external influences, which offers a theoretical justification for the efficient composition of complex processes out of non-trivial elementary processes or functional modes.	[Perdikis, Dionysios; Huys, Raoul; Jirsa, Viktor] Univ Mediterranean, Inst Sci Mouvement UMR6233, Theoret Neurosci Grp, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Perdikis, D (corresponding author), Univ Mediterranean, Inst Sci Mouvement UMR6233, Theoret Neurosci Grp, Marseille, France.	dionysios.perdikis@etumel.univmed.fr	Jirsa, Viktor/M-4630-2016	Jirsa, Viktor/0000-0002-8251-8860; Perdikis, Dionysios/0000-0003-0103-7094	Codebox research; James S. McDonnell Foundation	Codebox research; James S. McDonnell Foundation	Codebox research and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER WL, 1989, J SOC BIOL STRUCT, V12, P1, DOI 10.1016/0140-1750(89)90015-8; Beek PJ, 1996, J EXP PSYCHOL HUMAN, V22, P1077; BEEK PJ, 1988, TOOLS CONSTRUCTING D, V7, P301; Bernstein N, 1967, COORDINATION REGULAT; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; BROCKETT RW, 1988, COMPUTER CONTROL MOV, P534; Buchanan JJ, 2003, EXP BRAIN RES, V150, P473, DOI 10.1007/s00221-003-1471-z; BULLOCK D, 1993, BIOL CYBERN, V70, P15, DOI 10.1007/BF00202562; Casati R, 2009, PHILOS PSYCHOL, V22, P77, DOI 10.1080/09515080802703711; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; DAFFERTSHOFER A, 1994, PATTERN RECOGN, V27, P1697, DOI 10.1016/0031-3203(94)90087-6; DEGALLIER S, 2006, MOVEMENT GENERATION; DITZINGER T, 2011, NONLINEAR DYNAMICS H, V328; Egerstedt M, 2003, SPRINGER TRAC ADV RO, V4, P75; FELDMAN AG, 1980, NEUROSCIENCE, V5, P81, DOI 10.1016/0306-4522(80)90073-1; FELDMAN AG, 1980, NEUROSCIENCE, V5, P91, DOI 10.1016/0306-4522(80)90074-3; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Fink PW, 2009, J MOTOR BEHAV, V41, P147, DOI 10.3200/JMBR.41.2.147-157; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000081; GISZTER SF, 1993, J NEUROSCI, V13, P467; Haken H, 2004, SYNERGETIC COMPUTERS, V2nd ed.; Hock HS, 2010, STUD COMPUT INTELL, V328, P151; Horridge A., 2009, WHAT DOES HON SEE; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Huys R, 2010, NEUROSCI LETT, V472, P24, DOI 10.1016/j.neulet.2010.01.047; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; KAY BA, 1991, J EXP PSYCHOL HUMAN, V17, P183, DOI 10.1037/0096-1523.17.1.183; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Klippel A, 2009, SPAT COGN COMPUT, V9, P233, DOI 10.1080/13875860903039172; KUGLER PN, 1980, CONCEPT COORDINATIVE, V1, P3; Latash M., 1993, CONTROL HUMAN MOVEME; Marr D., 2010, VISION; McLeod P, 2001, SYNTHESE, V129, P173, DOI 10.1023/A:1013003423323; Mehta TR, 2008, AUTOMATICA, V44, P1912, DOI 10.1016/j.automatica.2007.11.024; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mitra S, 1998, HUM MOVEMENT SCI, V17, P17, DOI 10.1016/S0167-9457(97)00023-7; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nakanishi J, 2004, ROBOT AUTON SYST, V47, P79, DOI 10.1016/j.robot.2004.03.003; Palmer F. R, 1976, SEMANTICS NEW OUTLIN; PILLAI AS, 2008, STRUCTURED FLOWS MAN; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; POLIT A, 1978, SCIENCE, V201, P1235, DOI 10.1126/science.99813; POLIT A, 1979, J NEUROPHYSIOL, V42, P183, DOI 10.1152/jn.1979.42.1.183; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Schaal S, 2003, PHILOS T R SOC B, V358, P537, DOI 10.1098/rstb.2002.1258; SCHAAL S, 2000, NONLINEAR DYNAMICAL; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2005, MOTOR CONTROL LEARNI; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; Seneff S, 2005, SPEECH COMMUN, V46, P204, DOI 10.1016/j.specom.2005.03.005; Shannon C.E., 1963, MATH THEORY COMMUNIC; SHEVCHENKO M, 2009, IMAGE VISION COMPUTI; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Tuller B, 2008, NEW IDEAS PSYCHOL, V26, P208, DOI 10.1016/j.newideapsych.2007.07.002; van Mourik AM, 2006, BIOL CYBERN, V94, P233, DOI 10.1007/s00422-005-0041-9; Verwey WB, 2003, J MOTOR BEHAV, V35, P171, DOI 10.1080/00222890309602131; Wang B, 2007, P NATL ACAD SCI USA, V104, P21014, DOI 10.1073/pnas.0709664104; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; WING AM, 1973, PERCEPT PSYCHOPHYS, V14, P5, DOI 10.3758/BF03198607; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	75	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16589	10.1371/journal.pone.0016589	http://dx.doi.org/10.1371/journal.pone.0016589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347363	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000010
J	Scharf, SH; Liebl, C; Binder, EB; Schmidt, MV; Muller, MB				Scharf, Sebastian H.; Liebl, Claudia; Binder, Elisabeth B.; Schmidt, Mathias V.; Mueller, Marianne B.			Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; GLUCOCORTICOID-RECEPTOR; TREATMENT RESPONSE; POSTNATAL ONTOGENY; CHILDHOOD TRAUMA; STRESS; POLYMORPHISMS; DEPRESSION; RISK; ASSOCIATION	Background: Chronic stress has been found to be a major risk factor for various human pathologies. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which is tightly regulated via, among others, the glucocorticoid receptor (GR). The activity of the GR is modulated by a variety of proteins, including the co-chaperone FK506 binding protein 51 (FKBP5). Although FKBP5 has been associated with risk for affective disorders and has been implicated in GR sensitivity, previous studies focused mainly on peripheral blood, while information about basal distribution and induction in the central nervous system are sparse. Methodology/Principal Findings: In the present study, we describe the basal expression pattern of Fkbp5 mRNA in the brain of adult male mice and show the induction of Fkbp5 mRNA via dexamethasone treatment or different stress paradigms. We could show that Fkbp5 is often, but not exclusively, expressed in regions also known for GR expression, for example the hippocampus. Furthermore, we were able to induce Fkbp5 expression via dexamethasone in the CA1 and DG subregions of the hippocampus, the paraventricular nucleus (PVN) and the central amygdala (CeA). Increase of Fkbp5 mRNA was also found after restrained stress and 24 hours of food deprivation in the PVN and the CeA, while in the hippocampus only food deprivation caused an increase in Fkbp5 mRNA. Conclusions/Significance: Interestingly, regions with a low basal expression showed higher increase in Fkbp5 mRNA following induction than regions with high basal expression, supporting the hypothesis that GR sensitivity is, at least partly, mediated via Fkbp5. In addition, this also supports the use of Fkbp5 gene expression as a marker for GR sensitivity. In summary, we were able to give an overview of the basal expression of fkbp5 mRNA as well as to extend the findings of induction of Fkbp5 and its regulatory influence on GR sensitivity from peripheral blood to the brain.	[Scharf, Sebastian H.; Liebl, Claudia; Mueller, Marianne B.] Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany; [Binder, Elisabeth B.] Max Planck Inst Psychiat, Res Grp Mol Genet Affect Disorders, Munich, Germany; [Schmidt, Mathias V.] Max Planck Inst Psychiat, Res Grp Neurobiol Stress, D-80804 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Scharf, SH (corresponding author), Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany.	sscharf@mpipsykl.mpg.de	Binder, Elisabeth B/K-8905-2014; Müller, Marianne B./AAL-8911-2021	Müller, Marianne B./0000-0002-0269-6131; Scharf, Sebastian/0000-0002-9129-4723; Schmidt, Mathias/0000-0002-3788-2268	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The present study was funded by the Max Planck Society. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Brent D, 2010, AM J PSYCHIAT, V167, P190, DOI 10.1176/appi.ajp.2009.09040576; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Checkley S, 1996, BRIT MED BULL, V52, P597; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Elenkov IJ, 2000, ANN NY ACAD SCI, V917, P94; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; JUSTER RP, 2009, NEUROSCIENC IN PRESS; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; LAVEBRATT C, 2010, J AFFECTIVE IN PRESS; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; Navailles S, 2010, DEV NEUROSCI-BASEL, V32, P139, DOI 10.1159/000293989; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Pahwa P, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-84; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Tyrka AR, 2009, BIOL PSYCHIAT, V66, P681, DOI 10.1016/j.biopsych.2009.05.012; VANEEKELEN JAM, 1991, DEV BRAIN RES, V61, P33, DOI 10.1016/0165-3806(91)90111-U; Vermeer H, 2004, EUR J ENDOCRINOL, V150, P41, DOI 10.1530/eje.0.1500041; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wang JL, 2005, PSYCHOL MED, V35, P865, DOI 10.1017/S0033291704003241; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Yao M, 2008, J COMP NEUROL, V508, P967, DOI 10.1002/cne.21716; Zobel A, 2010, INT J NEUROPSYCHOPH, V13, P649, DOI 10.1017/S1461145709991155; Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949	46	147	148	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16883	10.1371/journal.pone.0016883	http://dx.doi.org/10.1371/journal.pone.0016883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347384	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700050
J	Foti, NJ; Hughes, JM; Rockmore, DN				Foti, Nicholas J.; Hughes, James M.; Rockmore, Daniel N.			Nonparametric Sparsification of Complex Multiscale Networks	PLOS ONE			English	Article							ALGORITHM; BACKBONE	Many real-world networks tend to be very dense. Particular examples of interest arise in the construction of networks that represent pairwise similarities between objects. In these cases, the networks under consideration are weighted, generally with positive weights between any two nodes. Visualization and analysis of such networks, especially when the number of nodes is large, can pose significant challenges which are often met by reducing the edge set. Any effective "sparsification" must retain and reflect the important structure in the network. A common method is to simply apply a hard threshold, keeping only those edges whose weight exceeds some predetermined value. A more principled approach is to extract the multiscale "backbone" of a network by retaining statistically significant edges through hypothesis testing on a specific null model, or by appropriately transforming the original weight matrix before applying some sort of threshold. Unfortunately, approaches such as these can fail to capture multiscale structure in which there can be small but locally statistically significant similarity between nodes. In this paper, we introduce a new method for backbone extraction that does not rely on any particular null model, but instead uses the empirical distribution of similarity weight to determine and then retain statistically significant edges. We show that our method adapts to the heterogeneity of local edge weight distributions in several paradigmatic real world networks, and in doing so retains their multiscale structure with relatively insignificant additional computational costs. We anticipate that this simple approach will be of great use in the analysis of massive, highly connected weighted networks.	[Foti, Nicholas J.; Hughes, James M.; Rockmore, Daniel N.] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Rockmore, Daniel N.] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Rockmore, Daniel N.] Santa Fe Inst, Santa Fe, NM 87501 USA	Dartmouth College; Dartmouth College; The Santa Fe Institute	Foti, NJ (corresponding author), Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA.	rockmore@cs.dartmouth.edu						Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cormen Thomas H., 2009, INTRO ALGORITHMS; Hastie T., 2009, UNSUPERVISED LEARNIN; Hughes JM, 2010, P NATL ACAD SCI USA, V107, P1279, DOI 10.1073/pnas.0910530107; Knight PA, 2008, SIAM J MATRIX ANAL A, V30, P261, DOI 10.1137/060659624; Leibon G, 2008, P NATL ACAD SCI USA, V105, P20589, DOI 10.1073/pnas.0802806106; Leskovec J., 2007, P 24 INT C MACHINE L, P497, DOI [http://doi.acm.org/10.1145/1273496.1273559, DOI 10.1145/1273496.1273559]; Leskovec J., 2010, P 19 INT C WORLD WID, P641, DOI [10.1145/1772690.1772756, DOI 10.1145/1772690.1772756]; Newman M., 2010, NETWORKS; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Royden H. L., 1988, REAL ANAL; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Slater P. B., 2010, MULTISCALE NETWORK R; Slater PB, 2009, P NATL ACAD SCI USA, V106, pE66, DOI 10.1073/pnas.0904725106; SLATER PB, 1976, IEEE T SYST MAN CYB, V6, P321, DOI 10.1109/TSMC.1976.5408783; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	20	49	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16431	10.1371/journal.pone.0016431	http://dx.doi.org/10.1371/journal.pone.0016431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346815	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600007
J	Staples, GO; Shi, XF; Zaia, J				Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph			Glycomics Analysis of Mammalian Heparan Sulfates Modified by the Human Extracellular Sulfatase HSulf2	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; IN-VIVO; PROTEOGLYCANS; BINDING; QSULF1; SULF2; 6-O-ENDOSULFATASES; OLIGOSACCHARIDES; ENDOSULFATASE; 6-O-SULFATION	Background: The Sulfs are a family of endosulfatases that selectively modify the 6O-sulfation state of cell-surface heparan sulfate (HS) molecules. Sulfs serve as modulators of cell-signaling events because the changes they induce alter the cell surface co-receptor functions of HS chains. A variety of studies have been aimed at understanding how Sulfs modify HS structure, and many of these studies utilize Sulf knockout cell lines as the source for the HS used in the experiments. However, genetic manipulation of Sulfs has been shown to alter the expression levels of HS biosynthetic enzymes, and in these cases an assessment of the fine structural changes induced solely by Sulf enzymatic activity is not possible. Therefore, the present work aims to extend the understanding of substrate specificities of HSulf2 using in vitro experiments to compare HSulf2 activities on HS from different organ tissues. Methodology/Principal Findings: To further the understanding of Sulf enzymatic activity, we conducted in vitro experiments where a variety of mammalian HS substrates were modified by recombinant human Sulf2 (HSulf2). Subsequent to treatment with HSulf2, the HS samples were exhaustively depolymerized and analyzed using size-exclusion liquid chromatography-mass spectrometry (SEC-LC/MS). We found that HSulf2 activity was highly dependent on the structural features of the HS substrate. Additionally, we characterized, for the first time, the activity of HSulf2 on the non-reducing end (NRE) of HS chains. The results indicate that the action pattern of HSulf2 at the NRE is different compared to internally within the HS chain. Conclusions/Significance: The results of the present study indicate that the activity of Sulfs is dependent on the unique structural features of the HS populations that they edit. The activity of HSulf2 at HS NREs implicates the Sulfs as key regulators of this region of the chains, and concomitantly, the protein-binding events that occur there.	[Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Staples, GO (corresponding author), Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA.	jzaia@bu.edu	Shi, Xiaofeng/B-8700-2011; Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701; Staples, Gregory/0000-0003-2616-4380	NIH [P41RR10888, R01HL098950]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grants P41RR10888 and R01HL098950 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANN REV CELL DEV BIO; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Mochizuki H, 2008, J BIOL CHEM, V283, P31237, DOI 10.1074/jbc.M801586200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2010, BIOCHEMISTRY-US, V49, P3743, DOI 10.1021/bi100135d; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Sundaram M, 2003, P NATL ACAD SCI USA, V100, P651, DOI 10.1073/pnas.252643299; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	47	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16689	10.1371/journal.pone.0016689	http://dx.doi.org/10.1371/journal.pone.0016689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347431	gold, Green Published, Green Submitted			2022-12-27	WOS:000287077600018
J	Martin, FM; Xu, XL; von Lohneysen, K; Gilmartin, TJ; Friedman, JS				Martin, Florent M.; Xu, Xiuling; von Loehneysen, Katharina; Gilmartin, Timothy J.; Friedman, Jeffrey S.			SOD2 Deficient Erythroid Cells Up-Regulate Transferrin Receptor and Down-Regulate Mitochondrial Biogenesis and Metabolism	PLOS ONE			English	Article							LINKED SIDEROBLASTIC ANEMIA; MISSENSE MUTATION; DNA MUTATIONS; GENE-ONTOLOGY; PROTEIN CIA1; EXPRESSION; MYOPATHY; PATIENT; RNA; ERYTHROPOIESIS	Background: Mice irradiated and reconstituted with hematopoietic cells lacking manganese superoxide dismutase (SOD2) show a persistent hemolytic anemia similar to human sideroblastic anemia (SA), including characteristic intra-mitochondrial iron deposition. SA is primarily an acquired, clonal marrow disorder occurring in individuals over 60 years of age with uncertain etiology. Methodology/Principal Findings: To define early events in the pathogenesis of this murine model of SA, we compared erythroid differentiation of Sod2(-/-) and normal bone marrow cells using flow cytometry and gene expression profiling of erythroblasts. The predominant transcriptional differences observed include widespread down-regulation of mitochondrial metabolic pathways and mitochondrial biogenesis. Multiple nuclear encoded subunits of complexes I-IV of the electron transport chain, ATP synthase (complex V), TCA cycle and mitochondrial ribosomal proteins were coordinately downregulated in Sod2(-/-) erythroblasts. Despite iron accumulation within mitochondria, we found increased expression of transferrin receptor, Tfrc, at both the transcript and protein level in SOD2 deficient cells, suggesting deregulation of iron delivery. Interestingly, there was decreased expression of ABCb7, the gene responsible for X-linked hereditary SA with ataxia, a component required for iron-sulfur cluster biogenesis. Conclusions/Significance: These results indicate that in erythroblasts, mitochondrial oxidative stress reduces expression of multiple nuclear genes encoding components of the respiratory chain, TCA cycle and mitochondrial protein synthesis. An additional target of particular relevance for SA is iron: sulfur cluster biosynthesis. By decreasing transcription of components of cluster synthesis machinery, both iron utilization and regulation of iron uptake are impacted, contributing to the sideroblastic phenotype.	[Martin, Florent M.; Xu, Xiuling; von Loehneysen, Katharina; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Gilmartin, Timothy J.] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Martin, FM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	friedman@scripps.edu			NIH, NIDDK [R21DK075063, R01DK062473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062473] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Sources of support for this work were NIH grants R21DK075063 and R01DK062473 from the NIDDK. The website for the NIDDK is http://www2.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the this manuscript.	Alcindor T, 2002, BRIT J HAEMATOL, V116, P733, DOI 10.1046/j.0007-1048.2002.03378.x; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; BECK EA, 1967, ACTA HAEMATOL-BASEL, V38, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMANN AK, 2009, PEDIAT BLOOD CANC; Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5; Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217; Martin FM, 2005, EXP HEMATOL, V33, P1493, DOI 10.1016/j.exphem.2005.08.009; MARTIN FM, 2008, BRIT J HAEM IN PRESS; MAY A, 1994, BAILLIERE CLIN HAEM, V7, P851, DOI 10.1016/S0950-3536(05)80128-3; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SHARP RA, 1990, BRIT J CLIN PRACT, V44, P706; Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N; YUNIS AA, 1980, CLIN HAEMATOL, V9, P607; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16894	10.1371/journal.pone.0016894	http://dx.doi.org/10.1371/journal.pone.0016894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326867	Green Submitted, Green Published, gold			2022-12-27	WOS:000287037000030
J	Kayser, MS; Lee, AC; Hruska, M; Dalva, MB				Kayser, Matthew S.; Lee, Anderson C.; Hruska, Martin; Dalva, Matthew B.			Preferential Control of Basal Dendritic Protrusions by EphB2	PLOS ONE			English	Article							EXCITATORY SYNAPSE FORMATION; RECEPTOR TYROSINE KINASES; PYRAMIDAL NEURONS; SPINE MORPHOGENESIS; MODULATION; EXPRESSION; MORPHOLOGY; EPHRINS; BRAIN; GENE	The flow of information between neurons in many neural circuits is controlled by a highly specialized site of cell-cell contact known as a synapse. A number of molecules have been identified that are involved in central nervous system synapse development, but knowledge is limited regarding whether these cues direct organization of specific synapse types or on particular regions of individual neurons. Glutamate is the primary excitatory neurotransmitter in the brain, and the majority of glutamatergic synapses occur on mushroom-shaped protrusions called dendritic spines. Changes in the morphology of these structures are associated with long-lasting modulation of synaptic strength thought to underlie learning and memory, and can be abnormal in neuropsychiatric disease. Here, we use rat cortical slice cultures to examine how a previously-described synaptogenic molecule, the EphB2 receptor tyrosine kinase, regulates dendritic protrusion morphology in specific regions of the dendritic arbor in cortical pyramidal neurons. We find that alterations in EphB2 signaling can bidirectionally control protrusion length, and knockdown of EphB2 expression levels reduces the number of dendritic spines and filopodia. Expression of wild-type or dominant negative EphB2 reveals that EphB2 preferentially regulates dendritic protrusion structure in basal dendrites. Our findings suggest that EphB2 may act to specify synapse formation in a particular subcellular region of cortical pyramidal neurons.	[Kayser, Matthew S.; Lee, Anderson C.; Hruska, Martin; Dalva, Matthew B.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Kayser, MS (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	dalva@mail.med.upenn.edu		Kayser, Matthew/0000-0003-2359-4967; Dalva, Matthew/0000-0002-7737-8787	Dana Foundation;  [RO1-DA022727];  [RO1-MH086425]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022727] Funding Source: NIH RePORTER	Dana Foundation; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RO1-DA022727, RO1-MH086425 and the Dana Foundation to Dr. Dalva supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic SD, 2010, J NEUROSCI RES, V88, P2991, DOI 10.1002/jnr.22444; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; McAllister A. Kimberley, 2004, V245, P197; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104	30	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17417	10.1371/journal.pone.0017417	http://dx.doi.org/10.1371/journal.pone.0017417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364901	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100059
J	Yu, L; Jiang, XH; Zhou, Z; Tsang, LL; Yu, MK; Chung, YW; Zhang, XH; Wang, AM; Tang, H; Chan, HC				Yu, Li; Jiang, Xiao Hua; Zhou, Zhen; Tsang, Lai Ling; Yu, Mei Kuen; Chung, Yiu Wa; Zhang, Xiao Hu; Wang, Ai Mei; Tang, Hao; Chan, Hsiao Chang			A Protective Mechanism against Antibiotic-Induced Ototoxicity: Role of Prestin	PLOS ONE			English	Article							OUTER HAIR-CELLS; MOTOR PROTEIN; GENTAMICIN OTOTOXICITY; AMINOGLYCOSIDE ANTIBIOTICS; INDUCED APOPTOSIS; DEATH; ACTIVATION; CHANNELS	Hearing loss or ototoxicity is one of the major side effects associated with the use of the antibiotics, particularly aminoglycosides (AGs), which are the most commonly used antibiotics worldwide. However, the molecular and cellular events involved in the antibiotic-induced ototoxicity remains unclear. In the present study, we test the possibility that prestin, the motor protein specifically expressed in the basolateral membrane of outer hair cells (OHCs) in the cochlea with electromotility responsible for sound amplification, may be involved in the process of AG-induced apoptosis in OHCs. Our results from both mice model and cultured cell line indicate a previously unexpected role of prestin, in mediating antibiotic-induced apoptosis, the effect of which is associated with its anion-transporting capacity. The observed down-regulation of prestin mRNA prior to detectable apoptosis in OHCs and hearing loss in the antibiotic-treated mice is interesting, which may serve as a protective mechanism against hearing loss induced by AGs in the early stage.	[Yu, Li; Jiang, Xiao Hua; Zhou, Zhen; Tsang, Lai Ling; Yu, Mei Kuen; Chung, Yiu Wa; Zhang, Xiao Hu; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cells Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Yu, Li; Tang, Hao] China Med Univ, Dept Physiol, Shenyang, Liao Ning, Peoples R China; [Yu, Li; Wang, Ai Mei] Liao Ning Med Univ, Dept Physiol, Jin Zhou, Liao Ning, Peoples R China	Chinese University of Hong Kong; China Medical University	Yu, L (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cells Biol Res Ctr, Shatin, Hong Kong, Peoples R China.	tanghaocn2003@yahoo.com.cn; hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; jiang, cynthia xiaohua/F-7580-2017	jiang, cynthia xiaohua/0000-0002-7372-4961	Chinese University of Hong Kong; Liao Ning Education Office [L2010267]; Morningside Foundation	Chinese University of Hong Kong(Chinese University of Hong Kong); Liao Ning Education Office; Morningside Foundation	The work was supported by the Focused Investment Scheme on Major Areas of the Chinese University of Hong Kong and by the Liao Ning Education Office (No. L2010267) and the Morningside Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashkin KA, 2006, HEARING RES, V218, P20, DOI 10.1016/j.heares.2006.04.001; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Chen Y, 2007, HEARING RES, V226, P178, DOI 10.1016/j.heares.2006.05.008; CLERICI WJ, 1995, HEARING RES, V84, P30, DOI 10.1016/0378-5955(95)00010-2; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Fischel-Ghodsian N, 2005, PHARMACOGENOMICS, V6, P27, DOI 10.1517/14622416.6.1.27; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Forge A, 2000, HEARING RES, V139, P97, DOI 10.1016/S0378-5955(99)00177-X; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Guthrie OW, 2008, TOXICOLOGY, V249, P91, DOI 10.1016/j.tox.2008.04.015; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Imaizumi Y, 2002, MOL PHARMACOL, V62, P836, DOI 10.1124/mol.62.4.836; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lepple-Wienhues A, 1998, J CELL BIOL, V141, P281, DOI 10.1083/jcb.141.1.281; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; McLarnon SJ, 2002, BIOCHEM BIOPH RES CO, V297, P71, DOI 10.1016/S0006-291X(02)02133-2; Nakagawa T, 1998, EUR ARCH OTO-RHINO-L, V255, P127, DOI 10.1007/s004050050027; Nakagawa T, 1997, EUR ARCH OTO-RHINO-L, V254, P9, DOI 10.1007/BF02630749; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D., 2006, NOVART FDN SYMP, V273, P261; Oliver D., 2006, NOVART FDN SYMP, V273, P253; Oliver Dominik, 2006, Novartis Found Symp, V273, P244; POULSEN KA, AM J PHYSL CELL PHYS, V298, pC14; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; RYBAK LP, 1985, AM J OTOL, V6, P482; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Sha SH, 2001, HEARING RES, V155, P1, DOI 10.1016/S0378-5955(01)00224-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855	33	17	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17322	10.1371/journal.pone.0017322	http://dx.doi.org/10.1371/journal.pone.0017322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364896	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100047
J	Franke, A; Niederfellner, GJ; Klein, C; Burtscher, H				Franke, Andreas; Niederfellner, Gerhard J.; Klein, Christian; Burtscher, Helmut			Antibodies against CD20 or B-Cell Receptor Induce Similar Transcription Patterns in Human Lymphoma Cell Lines	PLOS ONE			English	Article							FC-GAMMA-RIIB; TYROSINE KINASE SYK; BCR CROSS-TALK; ANTIGEN-RECEPTOR; MEDIATED APOPTOSIS; ANTI-CD20 ANTIBODY; ACTIVATION; EXPRESSION; RITUXIMAB; ENGAGEMENT	Background: CD20 is a cell surface protein exclusively expressed on B cells. It is a clinically validated target for Non-Hodgkin's lymphomas (NHL) and autoimmune diseases. The B cell receptor (BCR) plays an important role for development and proliferation of pre-B and B cells. Physical interaction of CD20 with BCR and components of the BCR signaling cascade has been reported but the consequences are not fully understood. Methodology: In this study we employed antibodies against CD20 and against the BCR to trigger the respective signaling. These antibodies induced very similar expression patterns of up-and down-regulated genes in NHL cell lines indicating that CD20 may play a role in BCR signaling and vice versa. Two of the genes that were rapidly and transiently induced by both stimuli are CCL3 and CCL4. 4 hours after stimulation the concentration of these chemokines in culture medium reaches a maximum. Spleen tyrosine kinase Syk is a cytoplasmic tyrosine kinase and a key component of BCR signaling. Both siRNA mediated silencing of Syk and inhibition by selective small molecule inhibitors impaired CCL3/CCL4 protein induction after treatment with either anti-CD20 or anti-BCR antibodies. Conclusion: Our results suggest that treatment with anti-CD20 antibodies triggers at least partially a BCR activation-like response in NHL cell lines.	[Franke, Andreas; Niederfellner, Gerhard J.; Klein, Christian; Burtscher, Helmut] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Klein, Christian] Roche Glycart AG, Pharma Res & Early Dev, Schlieren, Switzerland	Roche Holding; Roche Holding	Franke, A (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany.	helmut.burtscher@roche.com	Klein, Christian/G-1336-2010	Klein, Christian/0000-0001-7594-7280	Roche	Roche(Roche Holding)	Funding: The authors' salaries as well as all material and equipment were paid by Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle A, 2009, MOL IMMUNOL, V46, P1727, DOI 10.1016/j.molimm.2009.02.003; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Caballero A, 2006, EUR J IMMUNOL, V36, P3131, DOI 10.1002/eji.200636447; Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; CHAOUCHI N, 1995, J IMMUNOL, V154, P3096; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; Cittera E, 2005, CANCER IMMUNOL IMMUN, V54, P273, DOI 10.1007/s00262-004-0599-4; Cittera E, 2007, J IMMUNOL, V178, P6616, DOI 10.4049/jimmunol.178.10.6616; Crowley JE, 2009, BLOOD, V113, P1464, DOI 10.1182/blood-2008-02-138651; Dong HY, 2002, LEUKEMIA LYMPHOMA, V43, P1855, DOI 10.1080/1042819021000006385; Eeva J, 2004, APOPTOSIS, V9, P525, DOI 10.1023/B:APPT.0000038032.22343.de; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Glynne R, 2000, IMMUNOL REV, V176, P216; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Isnardi I, 2006, IMMUNOL LETT, V104, P156, DOI 10.1016/j.imlet.2005.11.027; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lai JYQ, 2003, BIOORG MED CHEM LETT, V13, P3111, DOI 10.1016/S0960-894X(03)00658-9; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Mathas S, 2000, CANCER RES, V60, P7170; Mayumi M, 1995, CRIT REV IMMUNOL, V15, P255, DOI 10.1615/CritRevImmunol.v15.i3-4.40; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Mimori K, 2003, LEUKEMIA, V17, P1164, DOI 10.1038/sj.leu.2402936; Mizuno T, 2005, J IMMUNOL, V174, P6062, DOI 10.4049/jimmunol.174.10.6062; Mizuno T, 2005, J IMMUNOL, V174, P3369, DOI 10.4049/jimmunol.174.6.3369; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Murn J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-323; Niederer HA, 2010, ANN NY ACAD SCI, V1183, P69, DOI 10.1111/j.1749-6632.2009.05132.x; Pedersen IM, 2002, BLOOD, V99, P1314, DOI 10.1182/blood.V99.4.1314; Perosa F, 2010, J INTERN MED, V267, P260, DOI 10.1111/j.1365-2796.2009.02207.x; Petrie RJ, 2002, J IMMUNOL, V169, P2886, DOI 10.4049/jimmunol.169.6.2886; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Rankin CT, 2006, BLOOD, V108, P2384, DOI 10.1182/blood-2006-05-020602; Saito Y, 2008, IMMUNOLOGY, V125, P570, DOI 10.1111/j.1365-2567.2008.02872.x; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shan DM, 2000, CANCER IMMUNOL IMMUN, V48, P673, DOI 10.1007/s002620050016; Su GH, 1997, EMBO J, V16, P7118, DOI 10.1093/emboj/16.23.7118; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; WALDSCHMIDT TJ, 1992, ADV EXP MED BIOL, V323, P149; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Young RM, 2008, FUTURE ONCOL, V4, P591, DOI 10.2217/14796694.4.5.591; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618	47	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16596	10.1371/journal.pone.0016596	http://dx.doi.org/10.1371/journal.pone.0016596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364752	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800010
J	Moore, TV; Clay, BS; Ferreira, CM; Williams, JW; Rogozinska, M; Cannon, JL; Shilling, RA; Marzo, AL; Sperling, AI				Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Rogozinska, Magdalena; Cannon, Judy L.; Shilling, Rebecca A.; Marzo, Amanda L.; Sperling, Anne I.			Protective Effector Memory CD4 T Cells Depend on ICOS for Survival	PLOS ONE			English	Article							SCHISTOSOMA-MANSONI EGGS; INFLUENZA-VIRUS INFECTION; EARLY IL-4 PRODUCTION; ATOPIC ASTHMA; AIRWAY-HYPERRESPONSIVENESS; ANTIGEN; RESPONSES; NAIVE; LYMPHOCYTES; GENERATION	Memory CD4 T cells play a vital role in protection against re-infection by pathogens as diverse as helminthes or influenza viruses. Inducible costimulator (ICOS) is highly expressed on memory CD4 T cells and has been shown to augment proliferation and survival of activated CD4 T cells. However, the role of ICOS costimulation on the development and maintenance of memory CD4 T cells remains controversial. Herein, we describe a significant defect in the number of effector memory (EM) phenotype cells in ICOS-/- and ICOSL-/- mice that becomes progressively more dramatic as the mice age. This decrease was not due to a defect in the homeostatic proliferation of EM phenotype CD4 T cells in ICOS-/- or ICOSL-/- mice. To determine whether ICOS regulated the development or survival of EM CD4 T cells, we utilized an adoptive transfer model. We found no defect in development of EM CD4 T cells, but long-term survival of ICOS-/- EM CD4 T cells was significantly compromised compared to wild-type cells. The defect in survival was specific to EM cells as the central memory (CM) ICOS-/- CD4 T cells persisted as well as wild type cells. To determine the physiological consequences of a specific defect in EM CD4 T cells, wild-type and ICOS-/- mice were infected with influenza virus. ICOS-/- mice developed significantly fewer influenza-specific EM CD4 T cells and were more susceptible to re-infection than wild-type mice. Collectively, our findings demonstrate a role for ICOS costimulation in the maintenance of EM but not CM CD4 T cells.	[Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Shilling, Rebecca A.; Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Moore, Tamson V.; Clay, Bryan S.; Ferreira, Caroline M.; Williams, Jesse W.; Cannon, Judy L.; Shilling, Rebecca A.; Sperling, Anne I.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Rogozinska, Magdalena; Marzo, Amanda L.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA	University of Chicago; University of Chicago; Rush University	Moore, TV (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	asperlin@uchicago.edu	Ferreira, Caroline M/D-3949-2012; Sperling, Anne/ACZ-2351-2022	Cannon, Judy/0000-0003-0069-8106; Williams, Jesse/0000-0003-3815-0891; Marzo, amanda/0000-0002-5839-0430; Sperling, Anne I./0000-0002-4265-9212	NIH [R01 AI67697]; Blowitz-Ridgeway Foundation;  [5T32AI07090];  [P01-AI56352]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI059105, U19AI095230, T32AI007090, R01AI067697, P01AI056352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blowitz-Ridgeway Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by NIH Grant R01 AI67697 and a grant from the Blowitz-Ridgeway Foundation. Support for BSC and TVM was provided by 5T32AI07090 and a supplement to P01-AI56352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2001, J IMMUNOL, V166, P926, DOI 10.4049/jimmunol.166.2.926; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; Barefoot BE, 2009, CLIN VACCINE IMMUNOL, V16, P488, DOI 10.1128/CVI.00451-08; Bjorkdahl O, 2003, IMMUNOLOGY, V110, P170, DOI 10.1046/j.1365-2567.2003.01727.x; BOUWER HGA, 1994, J NEUROIMMUNOL, V54, P87; Bradley LM, 2000, IMMUNOL RES, V21, P149, DOI 10.1385/IR:21:2-3:149; Burmeister Y, 2008, J IMMUNOL, V180, P774, DOI 10.4049/jimmunol.180.2.774; BUSSE WW, 1995, AM J RESP CRIT CARE, V152, P388, DOI 10.1164/ajrccm.152.1.7599853; CELLS IN, SFDS; Claesson MH, 1999, J IMMUNOL, V162, P3702; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Elliott David E., 1996, Methods (Orlando), V9, P255, DOI 10.1006/meth.1996.0032; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hengel RL, 2003, J IMMUNOL, V170, P28, DOI 10.4049/jimmunol.170.1.28; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Humphreys IR, 2006, EUR J IMMUNOL, V36, P2928, DOI 10.1002/eji.200636155; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lara-Marquez ML, 2001, CLIN EXP ALLERGY, V31, P1232, DOI 10.1046/j.1365-2222.2001.01146.x; Linton PJ, 1997, IMMUNOL REV, V160, P9, DOI 10.1111/j.1600-065X.1997.tb01023.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mahajan S, 2007, EUR J IMMUNOL, V37, P1796, DOI 10.1002/eji.200636661; Mendez A, 2002, VACCINE, V20, P3702, DOI 10.1016/S0264-410X(02)00376-6; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Metwali Ahmed, 1996, Methods (Orlando), V9, P305, DOI 10.1006/meth.1996.0035; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; MOUNTFORD AP, 1992, IMMUNOLOGY, V75, P250; Nakagome K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-46; Palmer DR, 2002, EUR J IMMUNOL, V32, P652, DOI 10.1002/1521-4141(200203)32:3<652::AID-IMMU652>3.0.CO;2-9; PAULOS CM, SCI TRANSL MED, V2; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; ROBINSON DS, 1993, THORAX, V48, P26, DOI 10.1136/thx.48.1.26; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SABIN EA, 1995, J IMMUNOL, V155, P4844; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; Salek-Ardakani S, 2006, VACCINE, V24, P872, DOI 10.1016/j.vaccine.2005.07.108; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Soroosh P, 2007, J IMMUNOL, V179, P5014, DOI 10.4049/jimmunol.179.8.5014; Sporici RA, 2001, CLIN IMMUNOL, V100, P277, DOI 10.1006/clim.2001.5074; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takahashi N, 2009, J IMMUNOL, V182, P5515, DOI 10.4049/jimmunol.0803256; Tang AL, 2006, AM J TRANSPLANT, V6, P1275, DOI 10.1111/j.1600-6143.2006.01317.x; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; VELLA AT, 1992, J IMMUNOL, V148, P2283; VELLA AT, 1992, J IMMUNOL, V149, P1714; WATANABE M, 2005, INT IMMUNOL; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhong WM, 2001, J IMMUNOL, V167, P1379, DOI 10.4049/jimmunol.167.3.1379	65	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16529	10.1371/journal.pone.0016529	http://dx.doi.org/10.1371/journal.pone.0016529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364749	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800009
J	Owen, K; Charlton-Robb, K; Thompson, R				Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross			Resolving the Trophic Relations of Cryptic Species: An Example Using Stable Isotope Analysis of Dolphin Teeth	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WHALES ORCINUS-ORCA; TURSIOPS-TRUNCATUS; MARINE MAMMALS; COMMON DOLPHIN; DIET; NITROGEN; CARBON; POPULATIONS; DELTA-N-15	Understanding the foraging ecology and diet of animals can play a crucial role in conservation of a species. This is particularly true where species are cryptic and coexist in environments where observing feeding behaviour directly is difficult. Here we present the first information on the foraging ecology of a recently identified species of dolphin (Southern Australian bottlenose dolphin (SABD)) and comparisons to the common bottlenose dolphin (CBD) in Victoria, Australia, using stable isotope analysis of teeth. Stable isotope signatures differed significantly between SABD and CBD for both delta C-13 (-14.4 parts per thousand vs. -15.5 parts per thousand respectively) and delta N-15 (15.9 parts per thousand vs. 15.0 parts per thousand respectively), suggesting that the two species forage in different areas and consume different prey. This finding supports genetic and morphological data indicating that SABD are distinct from CBD. In Victoria, the SABD is divided into two distinct populations, one in the large drowned river system of Port Phillip Bay and the other in a series of coastal lakes and lagoons called the Gippsland Lakes. Within the SABD species, population differences were apparent. The Port Phillip Bay population displayed a significantly higher delta N-15 than the Gippsland Lakes population (17.0 parts per thousand vs. 15.5 parts per thousand), suggesting that the Port Phillip Bay population may feed at a higher trophic level a result which is supported by analysis of local food chains. Important future work is required to further understand the foraging ecology and diet of this newly described, endemic, and potentially endangered species of dolphin.	[Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross] Monash Univ, Australian Ctr Biodivers, Clayton, Vic 3800, Australia; [Owen, Kylie; Charlton-Robb, Kate; Thompson, Ross] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Charlton-Robb, Kate] Monash Univ, CESAR, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Owen, K (corresponding author), Monash Univ, Australian Ctr Biodivers, Clayton, Vic 3800, Australia.	kylie.owen3@optusnet.com	Thompson, Ross/D-7996-2013; Owen, Kylie/K-9400-2015	Thompson, Ross/0000-0002-5287-2455; Owen, Kylie/0000-0002-8986-482X; Robb, Kate/0000-0002-7038-3612	Holsworth Wildlife Research Endowment [MU-3900655]	Holsworth Wildlife Research Endowment	Funding: This research was supported by the Holsworth Wildlife Research Endowment (www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/) (MU-3900655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I, 1977, ECOL MONOGR, V47, P151, DOI 10.2307/1942615; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Barros NB, 1998, J MAMMAL, V79, P1045, DOI 10.2307/1383114; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Carabel S, 2006, J EXP MAR BIOL ECOL, V336, P254, DOI 10.1016/j.jembe.2006.06.001; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Charlton Kate, 2006, Journal of Cetacean Research and Management, V8, P173; Chiaradia A, 2010, ICES J MAR SCI, V67, P1710, DOI 10.1093/icesjms/fsq067; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DICKMAN CR, 1988, J MAMMAL, V69, P108, DOI 10.2307/1381753; EVANS K, 2007, S A M MAR MAMM AG FA, P10; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Grellier K, 2006, CAN J FISH AQUAT SCI, V63, P1982, DOI 10.1139/F06-092; HALE P, 2002, INTERACTIONS DOLPHIN; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 2004, MAR MAMMAL SCI, V20, P621, DOI 10.1111/j.1748-7692.2004.tb01183.x; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; HOELZEL AR, 1991, HEREDITY, V66, P191, DOI 10.1038/hdy.1991.24; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Knoff A, 2008, MAR MAMMAL SCI, V24, P128, DOI 10.1111/j.1748-7692.2007.00174.x; Kurle CM, 2007, MAR ECOL PROG SER, V342, P303, DOI 10.3354/meps342303; Lesage V, 2001, MAR ECOL PROG SER, V210, P203, DOI 10.3354/meps210203; Lusseau SM, 2006, MAR ECOL PROG SER, V321, P283, DOI 10.3354/meps321283; Mcilwee AP, 1998, FUNCT ECOL, V12, P223, DOI 10.1046/j.1365-2435.1998.00181.x; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Moeller LM, 2008, MOL PHYLOGENET EVOL, V49, P674, DOI 10.1016/j.ympev.2008.08.011; Moller LM, 2001, MAR MAMMAL SCI, V17, P249, DOI 10.1111/j.1748-7692.2001.tb01269.x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; POORE G, 1982, MAR FRESHWATER RES, V33, P901; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2018, R LANG ENV STAT COMP; Real J, 1996, J WILDLIFE MANAGE, V60, P632, DOI 10.2307/3802082; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Tollit DJ, 1997, CAN J FISH AQUAT SCI, V54, P105, DOI 10.1139/cjfas-54-1-105; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Walker JL, 1999, MAR MAMMAL SCI, V15, P314, DOI 10.1111/j.1748-7692.1999.tb00804.x; WEBB PW, 1990, T AM FISH SOC, V119, P629, DOI 10.1577/1548-8659(1990)119<0629:LITBOL>2.3.CO;2; WILLIAMS MJ, 1981, J EXP MAR BIOL ECOL, V52, P103, DOI 10.1016/0022-0981(81)90174-X; Yonezaki Shiroh, 2003, Mammal Study, V28, P97, DOI 10.3106/mammalstudy.28.97	56	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16457	10.1371/journal.pone.0016457	http://dx.doi.org/10.1371/journal.pone.0016457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364748	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800007
J	Lin, KY; Tai, CI; Hsu, JC; Li, CF; Fang, CL; Lai, HC; Hseu, YC; Lin, YF; Uen, YH				Lin, Kai-Yuan; Tai, Chein; Hsu, Jung-Chin; Li, Chien-Feng; Fang, Chia-Lang; Lai, Hsi-Chin; Hseu, You-Cheng; Lin, Yi-Feng; Uen, Yih-Huei			Overexpression of Nuclear Protein Kinase CK2 alpha Catalytic Subunit (CK2 alpha) as a Poor Prognosticator in Human Colorectal Cancer	PLOS ONE			English	Article							INDUCED APOPTOSIS; CASEIN KINASE-2; TUMOR-CELLS; MATRIX; EXPRESSION; ASSOCIATION; INHIBITION; DISRUPTION; MECHANISM; MARKER	Background: Colorectal cancer (CRC) is one of the most common malignancies but the current therapeutic approaches for advanced CRC are less efficient. Thus, novel therapeutic approaches are badly needed. The purpose of this study is to investigate the involvement of nuclear protein kinase CK2 alpha subunit (CK2 alpha) in tumor progression, and in the prognosis of human CRC. Methodology/Principal Findings: Expression levels of nuclear CK2 alpha were analyzed in 245 colorectal tissues from patients with CRC by immunohistochemistry, quantitative real-time PCR and Western blot. We correlated the expression levels with clinicopathologic parameters and prognosis in human CRC patients. Overexpression of nuclear V was significantly correlated with depth of invasion, nodal status, American Joint Committee on Cancer (AJCC) staging, degree of differentiation, and perineural invasion. Patients with high expression levels of nuclear CK2 alpha had a significantly poorer overall survival rate compared with patients with low expression levels of nuclear CK2 alpha. In multi-variate Cox regression analysis, overexpression of nuclear CK2 alpha was proven to be an independent prognostic marker for CRC. In addition, DLD-1 human colon cancer cells were employed as a cellular model to study the role of CK2 alpha on cell growth, and the expression of CK2 alpha in DLD-1 cells was inhibited by using siRNA technology. The data indicated that CK2 alpha-specific siRNA treatment resulted in growth inhibition. Conclusions/Significance: Taken together, overexpression of nuclear CK2 alpha can be a useful marker for predicting the outcome of patients with CRC.	[Lin, Kai-Yuan; Hsu, Jung-Chin; Uen, Yih-Huei] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan; [Tai, Chein; Lai, Hsi-Chin] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Municipal Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Lin, Yi-Feng; Uen, Yih-Huei] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Uen, Yih-Huei] So Taiwan Univ, Dept Elect Engn, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; Chi Mei Hospital; Southern Taiwan University of Science & Technology	Lin, KY (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	d970712@mail.chimei.org.tw			Department of Health, Taiwan [DOH98-TD-I-111-TM006]	Department of Health, Taiwan	This work was supported by a grant (DOH98-TD-I-111-TM006) from the Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Ahmed K, 1999, CRIT REV EUKAR GENE, V9, P329, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.170; Arevalo MA, 2006, MOL BIOL CELL, V17, P3369, DOI 10.1091/mbc.E05-12-1144; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; Ferlay J, 2004, IARC CANC BASE; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Guerra B, 2001, INT J ONCOL, V19, P1117; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Kwon KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-203; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Lin KY, 2008, J SURG ONCOL, V97, P538, DOI 10.1002/jso.20997; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Ravi R, 2002, CANCER RES, V62, P4180; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Tawfic S, 1996, J CELL BIOCHEM, V62, P165, DOI 10.1002/(SICI)1097-4644(199608)62:2<165::AID-JCB4>3.0.CO;2-Q; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Wang CG, 2010, WORLD J GASTROENTERO, V16, P2421, DOI 10.3748/wjg.v16.i19.2421; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang X, 2009, J ANDROL, V30, P259, DOI 10.2164/jandrol.108.006494; Washington MK, 2008, ARCH PATHOL LAB MED, V132, P1600, DOI 10.1043/1543-2165(2008)132[1600:CCSIIP]2.0.CO;2; Yonemura Y, 1999, CLIN CANCER RES, V5, P1823; Zhang P, 1998, J CELL BIOCHEM, V69, P211, DOI 10.1002/(SICI)1097-4644(19980501)69:2<211::AID-JCB11>3.3.CO;2-H	45	70	73	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17193	10.1371/journal.pone.0017193	http://dx.doi.org/10.1371/journal.pone.0017193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359197	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482300036
J	Brischoux, F; Gartner, GEA; Garland, T; Bonnet, X				Brischoux, Francois; Gartner, Gabriel E. A.; Garland, Theodore, Jr.; Bonnet, Xavier			Is Aquatic Life Correlated with an Increased Hematocrit in Snakes?	PLOS ONE			English	Article							SEA-SNAKE; PELAMIS-PLATURUS; REPTILES; METABOLISM; LIZARDS; ECTOTHERMY; ESTUARINE; TOLERANCE; EVOLUTION; ENDURANCE	Background: Physiological adaptations that allow air-breathing vertebrates to remain underwater for long periods mainly involve modifications of the respiratory system, essentially through increased oxygen reserves. Physiological constraints on dive duration tend to be less critical for ectotherms than for endotherms because the former have lower mass-specific metabolic rates. Moreover, comparative studies between marine and terrestrial ectotherms have yet to show overall distinct physiological differences specifically associated with oxygen reserves. Methodology/Principal Findings: We used phylogenetically informed statistical models to test if habitat affects hematocrit (an indicator of blood oxygen stores) in snakes, a lineage that varies widely in habitat use. Our results indicate that both phylogenetic position (clade) and especially habitat are significant predictors of hematocrit. Our analysis also confirms the peculiar respiratory physiology of the marine Acrochordus granulatus. Conclusion/Significance: Contrary to previous findings, marine snakes have significantly-albeit slightly-elevated hematocrit, which should facilitate increased aerobic dive times. Longer dives could have consequences for foraging, mate searching, and predation risks. Alternatively, but not exclusively, increased Hct in marine species might also help to fuel other oxygen-demanding physiological adaptations, such as those involved in osmoregulation.	[Brischoux, Francois; Bonnet, Xavier] Ctr Etud Biol Chize CNRS, F-79360 Villiers En Bois, France; [Gartner, Gabriel E. A.; Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Riverside	Brischoux, F (corresponding author), Ctr Etud Biol Chize CNRS, F-79360 Villiers En Bois, France.	francois.brischoux@gmail.com		Bonnet, Xavier/0000-0001-6150-8199; Garland, Theodore/0000-0002-7916-3552	CNRS; US NSF [DEB-0416085]	CNRS(Centre National de la Recherche Scientifique (CNRS)); US NSF(National Science Foundation (NSF))	Funding was provided by the CNRS and US NSF grant DEB-0416085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio C, 2006, AM NAT, V167, P728, DOI 10.1086/503386; BELKIN DA, 1963, SCIENCE, V139, P492, DOI 10.1126/science.139.3554.492; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; Boyd IL, 1997, TRENDS ECOL EVOL, V12, P213, DOI 10.1016/S0169-5347(97)01054-9; Brischoux F, 2008, J EVOLUTION BIOL, V21, P324, DOI 10.1111/j.1420-9101.2007.01438.x; Brischoux F, 2011, J MORPHOL IN PRESS; Brischoux F, 2007, P 11 ANN M HLTH SCI; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; DAWSON WR, 1977, EVOLUTION, V31, P891, DOI 10.1111/j.1558-5646.1977.tb01083.x; de Queiroz A, 2006, AM NAT, V167, P684, DOI 10.1086/503118; DUNSON WA, 1980, COPEIA, P268; DUNSON WA, 1989, B MAR SCI, V44, P229; Garland T, 1999, ANIM BEHAV, V58, P77, DOI 10.1006/anbe.1999.1132; GARLAND T, 1987, AM J PHYSIOL, V252, pR439, DOI 10.1152/ajpregu.1987.252.3.R439; GARLAND T, 1987, EVOLUTION, V41, P1404, DOI 10.1111/j.1558-5646.1987.tb02478.x; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GRAHAM JB, 1974, RESP PHYSIOL, V21, P1, DOI 10.1016/0034-5687(74)90002-4; Heatwole H, 1975, BIOL SEA SNAKES, P289; Heatwole H, 1993, FAMILY HYDROPHIIDAE, V2, P310; HEATWOLE H, 1999, AUSTR NATURAL HIST S; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LILLYWHITE HB, 1989, SCIENCE, V245, P293, DOI 10.1126/science.2749262; LILLYWHITE HB, 1988, J HERPETOL, V22, P434, DOI 10.2307/1564338; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; MILLIGAN LP, 1985, J NUTR, V115, P1374, DOI 10.1093/jn/115.10.1374; Murphy J. C., 2007, HOMALOPSID SNAKES EV; POUGH FH, 1977, J COMP PHYSIOL, V116, P337, DOI 10.1007/BF00689041; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; RUBINOFF I, 1986, MAR BIOL, V91, P181, DOI 10.1007/BF00569434; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; SEYMOUR RS, 1976, AUST J ZOOL, V24, P313, DOI 10.1071/ZO9760313; Seymour RS, 1982, BIOL REPTILIA, P1; SHELTON G, 1982, J EXP BIOL, V100, P245; Shine R, 1993, FAUNA FLORA AUSTR, V2, P322; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; WOJTASZEK JS, 1991, COMP BIOCHEM PHYS A, V100, P805, DOI 10.1016/0300-9629(91)90296-O	41	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17077	10.1371/journal.pone.0017077	http://dx.doi.org/10.1371/journal.pone.0017077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359216	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700046
J	Lanini, S; D'Arezzo, S; Puro, V; Martini, L; Imperi, F; Piselli, P; Montanaro, M; Paoletti, S; Visca, P; Ippolito, G				Lanini, Simone; D'Arezzo, Silvia; Puro, Vincenzo; Martini, Lorena; Imperi, Francesco; Piselli, Pierluca; Montanaro, Marco; Paoletti, Simonetta; Visca, Paolo; Ippolito, Giuseppe			Molecular Epidemiology of a Pseudomonas aeruginosa Hospital Outbreak Driven by a Contaminated Disinfectant-Soap Dispenser	PLOS ONE			English	Article							INFECTIONS; RISK; UNIT	Background and Objective: Pseudomonas aeruginosa infection represents a main cause of morbidity and mortality among immunocompromised patients. This study describes a fatal epidemic of P. aeruginosa that occurred in a hematology unit in Italy. Methods: Retrospective cohort study, prospective surveillance, auditing, extensive testing on healthcare workers and environmental investigation were performed to define the dynamics and potential causes of transmission. RAPD, macrorestriction analyses and sequence typing were used to define relationships between P. aeruginosa isolates. Results: Eighteen cases of infection were identified in the different phases of the investigation. Of these, five constitute a significant molecular cluster of infection. A P. aeruginosa strain with the same genetic fingerprint and sequence type (ST175) as clinical isolates strain was also isolated from a heavily contaminated triclosan soap dispenser. Discussion and Conclusions: Our results are consistent with the hypothesis that patients became indirectly infected, e. g., during central venous catheter handling through contaminated items, and that the triclosan soap dispenser acted as a common continuous source of P. aeruginosa infection. Since P. aeruginosa is intrinsically unsusceptible to triclosan, the use of triclosan-based disinfectant formulations should be avoided in those healthcare settings hosting patients at high risk of P. aeruginosa infection.	[Lanini, Simone; D'Arezzo, Silvia; Puro, Vincenzo; Martini, Lorena; Piselli, Pierluca; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Imperi, Francesco; Visca, Paolo] Univ Roma Tre, Dept Biol, Rome, Italy; [Montanaro, Marco; Paoletti, Simonetta] UOC Ematol Azienda Unita Sanit Locale Viterbo, Viterbo, Italy	IRCCS Lazzaro Spallanzani; Roma Tre University	Lanini, S (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.	simone.lanini@inmi.it	Piselli, Pierluca/K-5337-2016; Ippolito, Giuseppe/J-7207-2017; D'Arezzo, Silvia/B-5324-2017; Visca, Paolo/G-8977-2014; Imperi, Francesco/AAA-3671-2021; Lanini, Simone/C-7523-2012	Piselli, Pierluca/0000-0002-7342-0263; D'Arezzo, Silvia/0000-0002-7783-6194; Lanini, Simone/0000-0002-6743-4001; puro, vincenzo/0000-0003-0291-4490; Visca, Paolo/0000-0002-6128-7039; Ippolito, Giuseppe/0000-0002-1076-2979	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by grants from the Italian Ministry of Health ('Ricerca Corrente 2006 IRCCS Lazzaro Spallanzani'). The Italian Ministry of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-43; Aktas E, 2010, INFECT CONT HOSP EP, V31, P1199, DOI 10.1086/657077; [Anonymous], WORLDWIDE DATABASE N; Aumeran C, 2007, J HOSP INFECT, V65, P47, DOI 10.1016/j.jhin.2006.08.009; Buffet-Bataillon S, 2009, J HOSP INFECT, V72, P17, DOI 10.1016/j.jhin.2009.01.010; Clinical and Laboratory Standards Institute, 2007, METH DIL ANT SUSC TE, P1; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DiazGranados CA, 2009, INFECT CONT HOSP EP, V30, P550, DOI 10.1086/597235; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Fanci R, 2009, BONE MARROW TRANSPL, V43, P335, DOI 10.1038/bmt.2008.319; Hakki M, 2007, BONE MARROW TRANSPL, V39, P687, DOI 10.1038/sj.bmt.1705653; Iversen BG, 2007, CLIN INFECT DIS, V44, P794, DOI 10.1086/511644; Koburger T, 2010, J ANTIMICROB CHEMOTH, V65, P1712, DOI 10.1093/jac/dkq212; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; McCann S, 2004, BONE MARROW TRANSPL, V33, P519, DOI 10.1038/sj.bmt.1704380; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Orsi GB, 2006, SCAND J INFECT DIS, V38, P1085, DOI 10.1080/00365540600794402; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Shimono Nobuyuki, 2008, Journal of Infection and Chemotherapy, V14, P418, DOI 10.1007/s10156-008-0645-9; Speert DP, 2002, AM J RESP CRIT CARE, V166, P988, DOI 10.1164/rccm.2203011; Stone SP, 2007, J ANTIMICROB CHEMOTH, V59, P833, DOI 10.1093/jac/dkm055; Sturmer T, 2000, J CLIN EPIDEMIOL, V53, P57, DOI 10.1016/S0895-4356(99)00137-7; Sung LL, 2000, J CLIN MICROBIOL, V38, P1127, DOI 10.1128/JCM.38.3.1127-1130.2000; Takahashi H, 2004, INFECT CONT HOSP EP, V25, P156, DOI 10.1086/502367; Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vianelli N, 2006, HAEMATOL-HEMATOL J, V91, P983; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07; World Health Organization, 2009, WHO GHID HAND HYG HL	31	68	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17064	10.1371/journal.pone.0017064	http://dx.doi.org/10.1371/journal.pone.0017064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359222	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700042
J	Morency, E; Anguish, L; Coonrod, S				Morency, Eric; Anguish, Lynne; Coonrod, Scott			Subcellular Localization of Cytoplasmic Lattice-Associated Proteins Is Dependent upon Fixation and Processing Procedures	PLOS ONE			English	Article							MATERNAL-EFFECT GENE; EMBRYONIC-DEVELOPMENT; FILIA; CELL	We and others have recently demonstrated by immuno-EM and mutation analysis that two oocyte-restricted maternal effect genes, PADI6 and MATER, localize, in part, to the oocyte cytoplasmic lattices (CPLs). During these ongoing studies, however, we found that the localization of these factors by confocal immunofluorescence (IF) analysis can vary dramatically depending upon how the oocytes and embryos are processed, with the localization pattern sometimes appearing more uniformly cytoplasmic while at other times appearing to be primarily cortical. We set out to better understand this differential staining pattern by testing a range of IF protocol parameters, changing mainly time and temperature conditions of the primary antibody solution incubation, as well as fixation methods. We found by confocal IF whole mount analysis that PADI6 and MATER localization in germinal vesicle stage oocytes is mainly cytoplasmic when the oocytes are fixed and then incubated with primary antibodies at room temperature for 1 hour, while the localization of these factors is largely limited to the cortex when the oocytes are fixed and incubated in primary antibody at 4 degrees C overnight. We then probed sections of fixed/embedded ovaries and isolated two-cell embryos with specific antibodies and found that, under these conditions, PADI6 and MATER were again primarily cytoplasmically localized, although the staining for these factors is slightly more cortical at the two-cell stage. Taken together, our results suggest that the localization of CPL-associated proteins by confocal IF is particularly affected by processing conditions. Further, based on our current observations, it appears that PADI6 and MATER are primarily distributed throughout the cytoplasm as opposed to the oocyte subcortex.	[Morency, Eric; Anguish, Lynne; Coonrod, Scott] Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA	Cornell University	Morency, E (corresponding author), Cornell Univ, Coll Vet Med, James A Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	sac269@cornell.edu			NICHD [RO1 38353]; NIH [1 T32 HD052471-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038353] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: This work was supported by NICHD grant RO1 38353 to S.C. and NIH Reproductive Sciences and Genomics Training Grant 1 T32 HD052471-01A1 to E.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; HOPWOOD D, 1985, HISTOCHEM J, V17, P389, DOI 10.1007/BF01003203; Kim B, 2010, PLOS ONE, V5; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Tashiro F, 2010, GENES CELLS, V15, P813, DOI 10.1111/j.1365-2443.2010.01420.x; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; VISHWANATH R, 1986, GAMETE RES, V15, P361, DOI 10.1002/mrd.1120150408; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yu JY, 2002, BIOL REPROD, V67, P1093, DOI 10.1095/biolreprod67.4.1093; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	14	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17226	10.1371/journal.pone.0017226	http://dx.doi.org/10.1371/journal.pone.0017226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359190	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700063
J	Song, ST; Zhan, ZC; Long, ZY; Zhang, JC; Yao, L				Song, Sutao; Zhan, Zhichao; Long, Zhiying; Zhang, Jiacai; Yao, Li			Comparative Study of SVM Methods Combined with Voxel Selection for Object Category Classification on fMRI Data	PLOS ONE			English	Article							PATTERNS; REPRESENTATIONS; STATES; TASKS	Background: Support vector machine (SVM) has been widely used as accurate and reliable method to decipher brain patterns from functional MRI (fMRI) data. Previous studies have not found a clear benefit for non-linear (polynomial kernel) SVM versus linear one. Here, a more effective non-linear SVM using radial basis function (RBF) kernel is compared with linear SVM. Different from traditional studies which focused either merely on the evaluation of different types of SVM or the voxel selection methods, we aimed to investigate the overall performance of linear and RBF SVM for fMRI classification together with voxel selection schemes on classification accuracy and time-consuming. Methodology/Principal Findings: Six different voxel selection methods were employed to decide which voxels of fMRI data would be included in SVM classifiers with linear and RBF kernels in classifying 4-category objects. Then the overall performances of voxel selection and classification methods were compared. Results showed that: (1) Voxel selection had an important impact on the classification accuracy of the classifiers: in a relative low dimensional feature space, RBF SVM outperformed linear SVM significantly; in a relative high dimensional space, linear SVM performed better than its counterpart; (2) Considering the classification accuracy and time-consuming holistically, linear SVM with relative more voxels as features and RBF SVM with small set of voxels (after PCA) could achieve the better accuracy and cost shorter time. Conclusions/Significance: The present work provides the first empirical result of linear and RBF SVM in classification of fMRI data, combined with voxel selection methods. Based on the findings, if only classification accuracy was concerned, RBF SVM with appropriate small voxels and linear SVM with relative more voxels were two suggested solutions; if users concerned more about the computational time, RBF SVM with relative small set of voxels when part of the principal components were kept as features was a better choice.	[Song, Sutao; Zhan, Zhichao; Long, Zhiying; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Jiacai; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhang, JC (corresponding author), Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China.	jiacai.zhang@bnu.edu.cn		song, sutao/0000-0002-0803-7882	Nature Science Foundation of China (NSFC) [90820019, 60931003, 60905063, 60805040]	Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding: This work was funded in part by Major Research Plan of the Nature Science Foundation of China (NSFC) under Grant Number 90820019, Key Programs of the Nature Science Foundation of China (NSFC) with Project Number 60931003, and two other General Program (60905063, 60805040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni F, 2000, IEEE T REHABIL ENG, V8, P186, DOI 10.1109/86.847810; Bj rnsdotter M, 2010, NEUROIMAGE IN PRESS; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HSU CW, 2009, PRACTICAL GUIDE SUPP; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; LIN SL, 1993, MED BIOL ENG COMPUT, V31, P421, DOI 10.1007/BF02446699; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Penny WD, 2000, IEEE T REHABIL ENG, V8, P214, DOI 10.1109/86.847820; Pereira F, 2010, NEUROIMAGE IN PRESS; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401	30	87	88	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17191	10.1371/journal.pone.0017191	http://dx.doi.org/10.1371/journal.pone.0017191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359184	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700058
J	Quakkelaar, ED; Redeker, A; Haddad, EK; Harari, A; McCaughey, SM; Duhen, T; Filali-Mouhim, A; Goulet, JP; Loof, NM; Ossendorp, F; Perdiguero, B; Heinen, P; Gomez, CE; Kibler, KV; Koelle, DM; Sekaly, RP; Sallusto, F; Lanzavecchia, A; Pantaleo, G; Esteban, M; Tartaglia, J; Jacobs, BL; Melief, CJM				Quakkelaar, Esther D.; Redeker, Anke; Haddad, Elias K.; Harari, Alexandre; McCaughey, Stella Mayo; Duhen, Thomas; Filali-Mouhim, Abdelali; Goulet, Jean-Philippe; Loof, Nikki M.; Ossendorp, Ferry; Perdiguero, Beatriz; Heinen, Paul; Gomez, Carmen E.; Kibler, Karen V.; Koelle, David M.; Sekaly, Rafick P.; Sallusto, Federica; Lanzavecchia, Antonio; Pantaleo, Giuseppe; Esteban, Mariano; Tartaglia, Jim; Jacobs, Bertram L.; Melief, Cornelis J. M.			Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CELLULAR IMMUNE-RESPONSES; PHASE-I TRIAL; VACCINIA VIRUS; DENDRITIC CELLS; IMMUNOGENICITY; CANDIDATES; GENE; VACCINATION; MVA	Attenuated poxviruses are safe and capable of expressing foreign antigens. Poxviruses are applied in veterinary vaccination and explored as candidate vaccines for humans. However, poxviruses express multiple genes encoding proteins that interfere with components of the innate and adaptive immune response. This manuscript describes two strategies aimed to improve the immunogenicity of the highly attenuated, host-range restricted poxvirus NYVAC: deletion of the viral gene encoding type-I interferon-binding protein and development of attenuated replication-competent NYVAC. We evaluated these newly generated NYVAC mutants, encoding HIV-1 env, gag, pol and nef, for their ability to stimulate HIV-specific CD8 T-cell responses in vitro from blood mononuclear cells of HIV-infected subjects. The new vectors were evaluated and compared to the parental NYVAC vector in dendritic cells (DCs), RNA expression arrays, HIV gag expression and cross-presentation assays in vitro. Deletion of type-I interferon-binding protein enhanced expression of interferon and interferon-induced genes in DCs, and increased maturation of infected DCs. Restoration of replication competence induced activation of pathways involving antigen processing and presentation. Also, replication-competent NYVAC showed increased Gag expression in infected cells, permitting enhanced cross-presentation to HIV-specific CD8 T cells and proliferation of HIV-specific memory CD8 T-cells in vitro. The recombinant NYVAC combining both modifications induced interferon-induced genes and genes involved in antigen processing and presentation, as well as increased Gag expression. This combined replication-competent NYVAC is a promising candidate for the next generation of HIV vaccines.	[Quakkelaar, Esther D.; Redeker, Anke; Loof, Nikki M.; Ossendorp, Ferry; Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Haddad, Elias K.; Filali-Mouhim, Abdelali; Goulet, Jean-Philippe; Sekaly, Rafick P.] CR CHUM, Immunol Lab, Montreal, PQ, Canada; [Harari, Alexandre; Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] Swiss Vaccine Res Inst, Lausanne, Switzerland; [McCaughey, Stella Mayo; Koelle, David M.] Univ Washington, Dept Med, Seattle, WA USA; [Duhen, Thomas; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Perdiguero, Beatriz; Heinen, Paul; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Kibler, Karen V.; Jacobs, Bertram L.] Arizona State Univ, Tempe, AZ USA; [Tartaglia, Jim] Sanofi Pasteur, Swiftwater, PA USA; [Melief, Cornelis J. M.] ISA Pharmaceut B V, Bilthoven, Netherlands; [Koelle, David M.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Montreal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle; Universita della Svizzera Italiana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Arizona State University; Arizona State University-Tempe; Sanofi-Aventis; Fred Hutchinson Cancer Center	Quakkelaar, ED (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	c.melief@lumc.nl	Koelle, David/Q-6529-2016; Gomez, Carmen Elena/K-1940-2014; Esteban, Mariano/ABG-5375-2020; Redeker, Anke/A-1953-2019; Pantaleo, Giuseppe/K-6163-2016; Perdiguero, Beatriz/K-6587-2017	Koelle, David/0000-0003-1255-9023; Gomez, Carmen Elena/0000-0002-5414-7935; Esteban, Mariano/0000-0003-0846-2827; Redeker, Anke/0000-0002-5832-6332; Perdiguero, Beatriz/0000-0001-6276-7766; Harari, Alexandre/0000-0002-1055-2090	Bill and Melinda Gates Foundation; Sanofi Pasteur; ISA Pharmaceuticals	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sanofi Pasteur; ISA Pharmaceuticals	This study was conducted as part of the Poxvirus T cell Vaccine Discovery Consortium (PTVDC) as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill and Melinda Gates Foundation. JT and CJMM are employees of Sanofi Pasteur and ISA Pharmaceuticals, respectively, and as such, Sanofi Pasteur and ISA Pharmaceuticals are considered by PLoS ONE to have funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1995, J VIROL, V69, P4633; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bins AD, 2007, J IMMUNOL, V179, P2126, DOI 10.4049/jimmunol.179.4.2126; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; ESPMARK JA, 1978, TISSUE ANTIGENS, V11, P279, DOI 10.1111/j.1399-0039.1978.tb01259.x; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Hel Z, 2002, VIROLOGY, V304, P125, DOI 10.1006/viro.2002.1722; Jackson SS, 2005, J VIROL, V79, P6554, DOI 10.1128/JVI.79.10.6554-6559.2005; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Jing LC, 2009, J IMMUNOL METHODS, V347, P36, DOI 10.1016/j.jim.2009.05.011; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; PERKUS ME, 1995, J LEUKOCYTE BIOL, V58, P1; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUTTER G, 1994, J VIROL, V68, P4109, DOI 10.1128/JVI.68.7.4109-4116.1994; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; TARTAGLIA J, 1994, DEV BIOL STAND, V82, P125; Terajima M, 2008, HUM IMMUNOL, V69, P815, DOI 10.1016/j.humimm.2008.09.009; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	61	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16819	10.1371/journal.pone.0016819	http://dx.doi.org/10.1371/journal.pone.0016819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347234	Green Published, gold			2022-12-27	WOS:000287369200009
J	Wiley, AS				Wiley, Andrea S.			Milk Intake and Total Dairy Consumption: Associations with Early Menarche in NHANES 1999-2004	PLOS ONE			English	Article							BODY-MASS INDEX; GROWTH-FACTOR-I; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ADOLESCENT GIRLS; SECULAR TRENDS; IGF-I; PUBERTAL MATURATION; INTERVENTION TRIAL; PRESCHOOL-CHILDREN	Background: Several components of dairy products have been linked to earlier menarche. Methods/Findings: This study assessed whether positive associations exist between childhood milk consumption and age at menarche or the likelihood of early menarche (< 12 yrs) in a U.S. sample. Data derive from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Two samples were utilized: 2657 women age 20-49 yrs and 1008 girls age 9-12 yrs. In regression analysis, a weak negative relationship was found between frequency of milk consumption at 512 yrs and age at menarche (daily milk intake beta = -0.32, P < 0.10; "sometimes/variable milk intake'' beta = -0.38, P < 0.06, each compared to intake rarely/never). Cox regression yielded no greater risk of early menarche among those who drank milk "sometimes/varied'' or daily vs. never/rarely (HR: 1.20, P < 0.42, HR: 1.25, P < 0.23, respectively). Among the 9-12 yr olds, Cox regression indicated that neither total dairy kcal, calcium and protein, nor daily milk intake in the past 30 days contributed to early menarche. Girls in the middle tertile of milk intake had a marginally lower risk of early menarche than those in the highest tertile (HR: 0.6, P < 0.06). Those in the lowest tertiles of dairy fat intake had a greater risk of early menarche than those in the highest (HR: 1.5, P < 0.05, HR: 1.6, P < 0.07, lowest and middle tertile, respectively), while those with the lowest calcium intake had a lower risk of early menarche (HR: 0.6, P < 0.05) than those in the highest tertile. These relationships remained after adjusting for overweight or overweight and height percentile; both increased the risk of earlier menarche. Blacks were more likely than Whites to reach menarche early (HR: 1.7, P < 0.03), but not after controlling for overweight. Conclusions: There is some evidence that greater milk intake is associated with an increased risk of early menarche, or a lower age at menarche.	Indiana Univ, Dept Anthropol, Program Human Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Wiley, AS (corresponding author), Indiana Univ, Dept Anthropol, Program Human Biol, Bloomington, IN 47405 USA.	wileya@Indiana.edu						Adair LS, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e59; Allsworth JE, 2005, ANN EPIDEMIOL, V15, P438, DOI 10.1016/j.annepidem.2004.12.010; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Beja-Pereira A, 2003, NAT GENET, V35, P311, DOI 10.1038/ng1263; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; BILEZIKIAN JP, 1994, JAMA-J AM MED ASSOC, V272, P1942, DOI 10.1001/jama.1994.03520240070044; Bini V, 2000, EUR J CLIN NUTR, V54, P214, DOI 10.1038/sj.ejcn.1600922; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; Bratberg GH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-54; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; CAMPANA WM, 1995, HDB MILK COMPOSITION, P476; [Center for Disease Control National Center for Health Statistics], 2007, NAT HLTH NURT EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), 2006, NATL HLTH NUTR EXAMI; Chang SH, 2000, ARCH PEDIAT ADOL MED, V154, P880, DOI 10.1001/archpedi.154.9.880; Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P44, DOI 10.1210/jc.2004-1043; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P861, DOI 10.1093/oxfordjournals.aje.a114723; CRAMER DW, 1995, MATURITAS, V22, P79, DOI 10.1016/0378-5122(95)00928-E; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Demerath EW, 2004, AM J CLIN NUTR, V80, P441, DOI 10.1093/ajcn/80.2.441; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Dunger DB, 2006, MOL CELL ENDOCRINOL, V254, P140, DOI 10.1016/j.mce.2006.04.003; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; ELLISON PT, 1994, ANNU REV ANTHROPOL, V23, P255, DOI 10.1146/annurev.an.23.100194.001351; Eveleth PB, 1990, WORLDWIDE VARIATION; Fall CHD, 2000, CLIN ENDOCRINOL, V53, P69, DOI 10.1046/j.1365-2265.2000.01047.x; Fiorito LM, 2006, J AM DIET ASSOC, V106, P1851, DOI 10.1016/j.jada.2006.08.003; FREDERICK L, 1992, J AM DIET ASSOC, V92, P299; FRIEDENREICH CM, 1992, EPIDEMIOL REV, V14, P177, DOI 10.1093/oxfordjournals.epirev.a036086; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; Geronimus AT, 1999, SOC SCI MED, V49, P1623, DOI 10.1016/S0277-9536(99)00246-4; Gunther ALB, 2010, J NUTR, V140, P565, DOI 10.3945/jn.109.114934; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hoppe C, 2004, EUR J CLIN NUTR, V58, P1211, DOI 10.1038/sj.ejcn.1601948; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Jensen RG, 1995, HDB MILK COMPOSITION, P428; JUSKEVICH JC, 1990, SCIENCE, V249, P875, DOI 10.1126/science.2203142; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P2534, DOI 10.1210/jc.80.8.2534; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Kalkwarf HJ, 2003, AM J CLIN NUTR, V77, P257, DOI 10.1093/ajcn/77.1.257; Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; KAPRIO J, 1995, HUM BIOL, V67, P739; Kerver JM, 2010, AM J CLIN NUTR, V91, P643, DOI 10.3945/ajcn.2009.28205; KHAN AD, 1995, J NUTR, V125, pS1090; Koo MM, 2002, PUBLIC HEALTH NUTR, V5, P353, DOI 10.1079/PHN2002261; KULIN HE, 1982, AM J CLIN NUTR, V36, P527, DOI 10.1093/ajcn/36.3.527; Legro RS, 2000, J CLIN ENDOCR METAB, V85, P1021, DOI 10.1210/jc.85.3.1021; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64, DOI 10.1093/oxfordjournals.aje.a116936; Maclure M, 1991, AM J CLIN NUTR, P54; MARLOWE TJ, 1958, J ANIM SCI, V17, P706, DOI 10.2527/jas1958.173706x; MOISAN J, 1990, CANCER CAUSE CONTROL, V1, P149, DOI 10.1007/BF00053166; Novotny R, 2004, J NUTR, V134, P1905, DOI 10.1093/jn/134.8.1905; Ong KK, 2006, MOL CELL ENDOCRINOL, V254, P8, DOI 10.1016/j.mce.2006.04.018; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Patton, 2004, MILK ITS REMARKABLE, DOI 10.4324/9781315124513; PERRON M, 1985, J AM DIET ASSOC, V85, P573; Petridou E, 1996, INT J CANCER, V68, P193, DOI 10.1002/(SICI)1097-0215(19961009)68:2<193::AID-IJC9>3.0.CO;2-T; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; REYNOLDS WL, 1978, J ANIM SCI, V47, P584, DOI 10.2527/jas1978.473584x; Rich-Edwards JW, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-28; Rockett HRH, 2003, CURR OPIN CLIN NUTR, V6, P557, DOI 10.1097/00075197-200309000-00009; Rogers I, 2006, PUBLIC HEALTH NUTR, V9, P359, DOI 10.1079/PHN2006853; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; SANCHEZ A, 1981, MED HYPOTHESES, V7, P1339, DOI 10.1016/0306-9877(81)90124-9; Serdula MK, 2001, ANNU REV NUTR, V21, P475, DOI 10.1146/annurev.nutr.21.1.475; Silva ID, 2002, INT J EPIDEMIOL, V31, P405, DOI 10.1093/intjepid/31.2.405; STATACorp Inc, 2008, STATA 10; Tam CS, 2006, J CLIN ENDOCR METAB, V91, P4369, DOI 10.1210/jc.2006-0953; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Vicini J, 2008, J AM DIET ASSOC, V108, P1198, DOI 10.1016/j.jada.2008.04.021; Vink EE, 2010, OBESITY, V18, P1247, DOI 10.1038/oby.2009.366; Wattigney Wendy A., 1999, Ethnicity and Disease, V9, P181; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748; Wiley AS, 2010, AM J HUM BIOL, V22, P517, DOI 10.1002/ajhb.21042; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Wiley AS, 2005, AM J HUM BIOL, V17, P425, DOI 10.1002/ajhb.20411; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; Zarow R, 2008, AM J HUM BIOL, V20, P146, DOI 10.1002/ajhb.20701; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	88	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14685	10.1371/journal.pone.0014685	http://dx.doi.org/10.1371/journal.pone.0014685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347271	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600009
J	Duzdevich, D; Li, JL; Whang, J; Takahashi, H; Takeyasu, K; Dryden, DTF; Morton, AJ; Edwardson, JM				Duzdevich, Daniel; Li, Jinliang; Whang, Jhoon; Takahashi, Hirohide; Takeyasu, Kunio; Dryden, David T. F.; Morton, A. Jennifer; Edwardson, J. Michael			Unusual Structures Are Present in DNA Fragments Containing Super-Long Huntingtin CAG Repeats	PLOS ONE			English	Article							III RESTRICTION ENZYMES; ATOMIC-FORCE MICROSCOPY; HUMAN GENETIC-DISEASE; AGE-OF-ONSET; TRIPLET REPEAT; MUTANT HUNTINGTIN; MYOTONIC-DYSTROPHY; DYNAMIC MUTATIONS; TRANSGENIC MICE; INSTABILITY	Background: In the R6/2 mouse model of Huntington's disease (HD), expansion of the CAG trinucleotide repeat length beyond about 300 repeats induces a novel phenotype associated with a reduction in transcription of the transgene. Methodology/Principal Findings: We analysed the structure of polymerase chain reaction (PCR)-generated DNA containing up to 585 CAG repeats using atomic force microscopy (AFM). As the number of CAG repeats increased, an increasing proportion of the DNA molecules exhibited unusual structural features, including convolutions and multiple protrusions. At least some of these features are hairpin loops, as judged by cross-sectional analysis and sensitivity to cleavage by mung bean nuclease. Single-molecule force measurements showed that the convoluted DNA was very resistant to untangling. In vitro replication by PCR was markedly reduced, and TseI restriction enzyme digestion was also hindered by the abnormal DNA structures. However, significantly, the DNA gained sensitivity to cleavage by the Type III restriction-modification enzyme, EcoP15I. Conclusions/Significance: "Super-long'' CAG repeats are found in a number of neurological diseases and may also appear through CAG repeat instability. We suggest that unusual DNA structures associated with super-long CAG repeats decrease transcriptional efficiency in vitro. We also raise the possibility that if these structures occur in vivo, they may play a role in the aetiology of CAG repeat diseases such as HD.	[Duzdevich, Daniel; Morton, A. Jennifer; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Li, Jinliang; Whang, Jhoon] Laragen Inc, Culver City, CA USA; [Takahashi, Hirohide; Takeyasu, Kunio] Kyoto Univ, Lab Plasma Membrane & Nucl Signaling, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan; [Dryden, David T. F.] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland	University of Cambridge; Kyoto University; University of Edinburgh	Duzdevich, D (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ajm41@cam.ac.uk; jme1000@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346; Duzdevich, Daniel/0000-0002-8225-6071; Takahashi, Hirohide/0000-0002-2553-8806	CHDI Foundation, Inc.; BBSRC Japan; JSPS; Cambridge European Trust; Emmanuel College, Cambridge	CHDI Foundation, Inc.; BBSRC Japan(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cambridge European Trust; Emmanuel College, Cambridge	Funding: This work was supported by CHDI Foundation, Inc. (AJM), a BBSRC Japan Partnering Award (JME), a JSPS Japan-UK Bilateral Joint Project Award (KT), and a JSPS Grant-in-Aid for Basic Research (KT). DD received funding from the Cambridge European Trust. HT holds a Grant-in-Aid Fellowship from the JSPS. DTFD gratefully acknowledges the award of a Derek Brewer Visiting Fellowship at Emmanuel College, Cambridge, during the tenure of which this paper was written. JL and JW are employees of Laragen, Inc., and contributed reagents for the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 1996, FEBS LETT, V390, P161, DOI 10.1016/0014-5793(96)00651-5; Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Baldi P, 1999, BIOINFORMATICS, V15, P918, DOI 10.1093/bioinformatics/15.11.918; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bochtler M, 2006, EMBO J, V25, P2219, DOI 10.1038/sj.emboj.7601096; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chastain PD, 1998, J MOL BIOL, V275, P405, DOI 10.1006/jmbi.1997.1502; Crampton N, 2007, EMBO J, V26, P3815, DOI 10.1038/sj.emboj.7601807; Dixon KT, 2003, GENE EXPRESSION, V11, P221, DOI 10.3727/000000003783992234; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Janscak P, 1999, EMBO J, V18, P2638, DOI 10.1093/emboj/18.9.2638; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kienberger F, 2005, J MOL BIOL, V347, P597, DOI 10.1016/j.jmb.2005.01.042; Kono Y, 1999, INTERNAL MED, V38, P407, DOI 10.2169/internalmedicine.38.407; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Li JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-71; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Milunsky JM, 2003, CLIN GENET, V64, P70, DOI 10.1034/j.1399-0004.2003.00108.x; Moncke-Buchner E, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf082; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; MUTTER GL, 1995, NUCLEIC ACIDS RES, V23, P1411; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P6269, DOI 10.1093/nar/gkp679; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Norremolle A, 2004, AM J MED GENET A, V130A, P154, DOI 10.1002/ajmg.a.30128; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Poirier J, 1999, HUM MUTAT, V13, P328, DOI 10.1002/(SICI)1098-1004(1999)13:4<328::AID-HUMU10>3.0.CO;2-J; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Reddy YVR, 2000, J MOL BIOL, V298, P597, DOI 10.1006/jmbi.2000.3673; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Sinden RR, 2002, J BIOSCIENCES, V27, P53, DOI 10.1007/BF02703683; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Wang YH, 2007, FRONT BIOSCI-LANDMRK, V12, P4731, DOI 10.2741/2422; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056	52	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17119	10.1371/journal.pone.0017119	http://dx.doi.org/10.1371/journal.pone.0017119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347256	gold, Green Submitted, Green Published			2022-12-27	WOS:000287364500030
J	Ragert, P; Nierhaus, T; Cohen, LG; Villringer, A				Ragert, Patrick; Nierhaus, Till; Cohen, Leonardo G.; Villringer, Arno			Interhemispheric Interactions between the Human Primary Somatosensory Cortices	PLOS ONE			English	Article							POSTERIOR CORPUS-CALLOSUM; MOTOR CORTEX; MEDIAN NERVE; CONNECTIONS; STIMULATION; INFORMATION; MODULATION; PLASTICITY; FIELDS; INPUT	In the somatosensory domain it is still unclear at which processing stage information reaches the opposite hemispheres. Due to dense transcallosal connections, the secondary somatosensory cortex (S2) has been proposed to be the key candidate for interhemispheric information transfer. However, recent animal studies showed that the primary somatosensory cortex (S1) might as well account for interhemispheric information transfer. Using paired median nerve somatosensory evoked potential recordings in humans we tested the hypothesis that interhemispheric inhibitory interactions in the somatosensory system occur already in an early cortical processing stage such as S1. Conditioning right S1 by electrical median nerve (MN) stimulation of the left MN (CS) resulted in a significant reduction of the N20 response in the target (left) S1 relative to a test stimulus (TS) to the right MN alone when the interstimulus interval between CS and TS was between 20 and 25 ms. No such changes were observed for later cortical components such as the N20/P25, N30, P40 and N60 amplitude. Additionally, the subcortically generated P14 response in left S1 was also not affected. These results document the existence of interhemispheric inhibitory interactions between S1 in human subjects in the critical time interval of 20-25 ms after median nerve stimulation.	[Ragert, Patrick; Nierhaus, Till; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Cohen, Leonardo G.] NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; [Nierhaus, Till; Villringer, Arno] Charite, Dept Neurol, Berlin, Germany; [Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany	Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ragert, P (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	ragert@cbs.mpg.de	Nierhaus, Till/ABG-8386-2020	Nierhaus, Till/0000-0003-0906-592X; Villringer, Arno/0000-0003-2604-2404	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002978, ZIANS003030] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Blankenburg F, 2008, J NEUROSCI, V28, P13202, DOI 10.1523/JNEUROSCI.3043-08.2008; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Fabri M, 2005, COGNITIVE BRAIN RES, V24, P73, DOI 10.1016/j.cogbrainres.2004.12.003; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; GOLDRING S, 1970, ELECTROEN CLIN NEURO, V29, P537, DOI 10.1016/0013-4694(70)90096-9; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Hoechstetter K, 2001, NEUROIMAGE, V14, P759, DOI 10.1006/nimg.2001.0855; Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; JONES EG, 1980, NEUROSCI LETT, V19, P167, DOI 10.1016/0304-3940(80)90189-5; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Lee EK, 1998, J CLIN NEUROPHYSIOL, V15, P227, DOI 10.1097/00004691-199805000-00006; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2656, DOI 10.1016/j.clinph.2007.08.027; MANZONI T, 1989, EXP BRAIN RES, V76, P251; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PICARD N, 1990, BRAIN RES, V536, P97, DOI 10.1016/0006-8993(90)90013-2; PIDOUX B, 1979, ELECTROEN CLIN NEURO, V46, P715, DOI 10.1016/0013-4694(79)90111-1; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Sonoo M, 1996, EVOKED POTENTIAL, V100, P319, DOI 10.1016/0168-5597(96)95035-2; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; Stancak A, 2002, BRAIN RES, V936, P47, DOI 10.1016/S0006-8993(02)02502-7; Voller B, 2006, ANN NEUROL, V59, P385, DOI 10.1002/ana.20689; Werhahn KJ, 2002, NAT NEUROSCI, V5, P936, DOI 10.1038/nn917; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954	29	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16150	10.1371/journal.pone.0016150	http://dx.doi.org/10.1371/journal.pone.0016150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347308	Green Published, gold			2022-12-27	WOS:000287363000006
J	Arun, P; Aleti, V; Parikh, K; Manne, V; Chilukuri, N				Arun, Peethambaran; Aleti, Vineela; Parikh, Kalpana; Manne, Veeraswamy; Chilukuri, Nageswararao			Senescence Marker Protein 30 (SMP30) Expression in Eukaryotic Cells: Existence of Multiple Species and Membrane Localization	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; DIISOPROPYL PHOSPHOROFLUORIDATE; ENDOGENOUS REGUCALCIN; SOLUBLE FRACTION; RAT; LIVER; KINASE; MICE; PURIFICATION; DEFICIENCY	Senescence marker protein (SMP30), also known as regucalcin, is a 34 kDa cytosolic marker protein of aging which plays an important role in intracellular Ca2+ homeostasis, ascorbic acid biosynthesis, oxidative stress, and detoxification of chemical warfare nerve agents. In our goal to investigate the activity of SMP30 for the detoxification of nerve agents, we have produced a recombinant adenovirus expressing human SMP30 as a fusion protein with a hemaglutinin tag (Ad-SMP30-HA). Ad-SMP30-HA transduced the expression of SMP30-HA and two additional forms of SMP30 with molecular sizes similar to 28 kDa and 24 kDa in HEK-293A and C3A liver cells in a dose and time-dependent manner. Intravenous administration of Ad-SMP30-HA in mice results in the expression of all the three forms of SMP30 in the liver and diaphragm. LC-MS/MS results confirmed that the lower molecular weight 28 kDa and 24 kDa proteins are related to the 34 kDa SMP30. The 28 kDa and 24 kDa SMP30 forms were also detected in normal rat liver and mice injected with Ad-SMP30-HA suggesting that SMP30 does exist in multiple forms under physiological conditions. Time course experiments in both cell lines suggest that the 28 kDa and 24 kDa SMP30 forms are likely generated from the 34 kDa SMP30. Interestingly, the 28 kDa and 24 kDa SMP30 forms appeared initially in the cytosol and shifted to the particulate fraction. Studies using small molecule inhibitors of proteolytic pathways revealed the potential involvement of beta and gamma-secretases but not calpains, lysosomal proteases, proteasome and caspases. This is the first report describing the existence of multiple forms of SMP30, their preferential distribution to membranes and their generation through proteolysis possibly mediated by secretase enzymes.	[Arun, Peethambaran; Aleti, Vineela; Parikh, Kalpana; Manne, Veeraswamy; Chilukuri, Nageswararao] Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Arun, P (corresponding author), Walter Reed Army Inst Res, Dept Mol Pharmacol, Div Biochem, Silver Spring, MD 20910 USA.	nageswararao.chilukuri@us.army.mil	manne, veeraswamy/B-1954-2010	manne, veeraswamy/0000-0002-1179-5529	Defense Threat Reduction Agency (DTRA) [D0024_07_WR_C]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	The work is supported by funds from Defense Threat Reduction Agency (DTRA, Project # D0024_07_WR_C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter T, 2006, INT J MOL MED, V18, P171; Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4; Boyiri T, 2009, INT J ONCOL, V35, P559, DOI 10.3892/ijo_00000367; Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U; Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841; Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3; Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158; Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028; Leparc GG, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm989; LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274; Misawa H, 2000, INT J MOL MED, V5, P283; Nakagawa T, 2008, INT J MOL MED, V21, P605; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Omura M, 1999, J CELL BIOCHEM, V75, P437, DOI 10.1002/(SICI)1097-4644(19991201)75:3<437::AID-JCB9>3.3.CO;2-N; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A; Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560; Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Szokalska A, 2009, CANCER RES, V69, P4235, DOI 10.1158/0008-5472.CAN-08-3439; Tsurusaki Y, 2001, BIOL PHARM BULL, V24, P958, DOI 10.1248/bpb.24.958; Tsurusaki Y, 2000, INT J MOL MED, V6, P655; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Wu Y, 2007, J BIOL CHEM, V282, P4841, DOI 10.1074/jbc.M607156200; Yamaguchi M, 2002, INT J MOL MED, V10, P377; Yamaguchi M, 2005, INT J MOL MED, V15, P371; YAMAGUCHI M, 1978, CHEM PHARM BULL, V26, P1915; Yamaguchi M, 2004, INT J MOL MED, V14, P647; Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359; YAMAGUCHI M, 1981, CHEM PHARM BULL, V29, P567; Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5; Yates Jr, 2000, METH MOL B, V146, P17, DOI 10.1385/1-59259-045-4:17	45	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16545	10.1371/journal.pone.0016545	http://dx.doi.org/10.1371/journal.pone.0016545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347421	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700020
J	Hausberger, M; Muller, C; Lunel, C				Hausberger, Martine; Muller, Christine; Lunel, Christophe			Does Work Affect Personality? A Study in Horses	PLOS ONE			English	Article							HEART-RATE; TEMPERAMENT; RESPONSES; TRAITS; STRESS; TESTS	It has been repeatedly hypothesized that job characteristics are related to changes in personality in humans, but often personality models still omit effects of life experience. Demonstrating reciprocal relationships between personality and work remains a challenge though, as in humans, many other influential factors may interfere. This study investigates this relationship by comparing the emotional reactivity of horses that differed only by their type of work. Horses are remarkable animal models to investigate this question as they share with humans working activities and their potential difficulties, such as "interpersonal" conflicts or "suppressed emotions". An earlier study showed that different types of work could be associated with different chronic behavioural disorders. Here, we hypothesised that type of work would affect horses' personality. Therefore over one hundred adult horses, differing only by their work characteristics were presented standardised behavioural tests. Subjects lived under the same conditions (same housing, same food), were of the same sex (geldings), and mostly one of two breeds, and had not been genetically selected for their current type of work. This is to our knowledge the first time that a direct relationship between type of work and personality traits has been investigated. Our results show that horses from different types of work differ not as much in their overall emotional levels as in the ways they express emotions (i.e. behavioural profile). Extremes were dressage horses, which presented the highest excitation components, and voltige horses, which were the quietest. The horses' type of work was decided by the stall managers, mostly on their jumping abilities, but unconscious choice based on individual behavioural characteristics cannot be totally excluded. Further research would require manipulating type of work. Our results nevertheless agree with reports on humans and suggest that more attention should be given to work characteristics when evaluating personalities.	[Hausberger, Martine; Muller, Christine; Lunel, Christophe] Univ Rennes 1, Unite Mixte Rech CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Hausberger, M (corresponding author), Univ Rennes 1, Unite Mixte Rech CNRS, UMR Ethol Anim & Humaine 6552, Campus Beaulieu, Rennes, France.	martine.hausberger@univ-rennes1.fr			French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the French Ministry of Research (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson MK, 1999, APPL ANIM BEHAV SCI, V63, P11, DOI 10.1016/S0168-1591(98)00237-8; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CLEMENT F, 1995, CR ACAD SCI III-VIE, V318, P859; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Costa PT., 1999, HDB PERSONALITY THEO, V2, P51, DOI DOI 10.1007/978-1-4615-0763-5_; FISKE JC, 1979, J ANIM SCI, V49, P583, DOI 10.2527/jas1979.492583x; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; JONES RB, 1989, PSYCHOL REC, V39, P397, DOI 10.1007/BF03395891; KILEYWORTHINGTON M, 1976, BEHAVIOUR, V56, P69, DOI 10.1163/156853976X00307; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; LeScolan N, 1997, BEHAV PROCESS, V41, P257, DOI 10.1016/S0376-6357(97)00052-1; LESIMPLE C, 2010, APPL ANIMAL IN PRESS; Lloyd AS, 2008, APPL ANIM BEHAV SCI, V112, P369, DOI 10.1016/j.applanim.2007.08.010; Lloyd AS, 2007, APPL ANIM BEHAV SCI, V105, P205, DOI 10.1016/j.applanim.2006.05.017; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Morris PH, 2002, PERS INDIV DIFFER, V33, P67, DOI 10.1016/S0191-8869(01)00136-2; O'Brien A, 2008, ANXIETY STRESS COPIN, V21, P55, DOI 10.1080/10615800701529504; Roberts BW, 2000, J RES PERS, V34, P26, DOI 10.1006/jrpe.1999.2259; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Visser EK, 2003, EQUINE VET J, V35, P176, DOI 10.2746/042516403776114108; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; WARING GH, 1983, NOYES PUBL; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5	32	29	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14659	10.1371/journal.pone.0014659	http://dx.doi.org/10.1371/journal.pone.0014659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347405	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700002
J	Jurjut, OF; Nikolic, D; Singer, W; Yu, S; Havenith, MN; Muresan, RC				Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf; Yu, Shan; Havenith, Martha N.; Muresan, Raul C.			Timescales of Multineuronal Activity Patterns Reflect Temporal Structure of Visual Stimuli	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; POPULATION CODE; CORTEX; INFORMATION; RESPONSES; DYNAMICS; SPACE; SYNCHRONIZATION; INTEGRATION; ACTIVATION	The investigation of distributed coding across multiple neurons in the cortex remains to this date a challenge. Our current understanding of collective encoding of information and the relevant timescales is still limited. Most results are restricted to disparate timescales, focused on either very fast, e.g., spike-synchrony, or slow timescales, e. g., firing rate. Here, we investigated systematically multineuronal activity patterns evolving on different timescales, spanning the whole range from spike-synchrony to mean firing rate. Using multi-electrode recordings from cat visual cortex, we show that cortical responses can be described as trajectories in a high-dimensional pattern space. Patterns evolve on a continuum of coexisting timescales that strongly relate to the temporal properties of stimuli. Timescales consistent with the time constants of neuronal membranes and fast synaptic transmission (5-20 ms) play a particularly salient role in encoding a large amount of stimulus-related information. Thus, to faithfully encode the properties of visual stimuli the brain engages multiple neurons into activity patterns evolving on multiple timescales.	[Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf; Yu, Shan; Havenith, Martha N.; Muresan, Raul C.] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Jurjut, Ovidiu F.; Muresan, Raul C.] Romanian Inst Sci & Technol, Dept Expt & Theoret Neurosci, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania; [Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf] Frankfurt Inst Adv Studies FIAS, Dept Neurosci, Frankfurt, Germany	Max Planck Society; Romanian Institute of Science & Technology	Jurjut, OF (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany.	muresan@coneural.org	Yu, Shan/S-3123-2017; Nikolic, Danko/GZG-9635-2022; Havenith, Martha N./R-7855-2017; Muresan, Raul C/A-4650-2011; Singer, Wolf/D-6874-2012	Nikolic, Danko/0000-0002-9317-8494; Havenith, Martha N./0000-0002-2329-7500; Muresan, Raul C/0000-0001-7854-3775; yu, shan/0000-0002-4385-6306	CNCSIS/UEFISCSU [TE-11/2010, 23/28.07.2010]; Max Planck-Coneural Partner Group; DFG [NI 708/2-1]	CNCSIS/UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); Max Planck-Coneural Partner Group; DFG(German Research Foundation (DFG))	This work was supported by a CNCSIS/UEFISCSU grant (TE-11/2010 contract no. 23/28.07.2010), a Max Planck-Coneural Partner Group, and a DFG grant (NI 708/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Adrian E.D., 1928, BASIS SENSATION ACTI; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Baker SN, 2000, NEURAL COMPUT, V12, P2597, DOI 10.1162/089976600300014863; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; Desbordes G, 2008, PLOS BIOL, V6, P2672, DOI 10.1371/journal.pbio.0060324; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng WJ, 2010, NEUROREPORT, V21, P680, DOI 10.1097/WNR.0b013e32833ae9d1; Freeman W. J., 1994, NEURAL NETWORKS NEUR, P185; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Goaillard JM, 2006, PHYSIOLOGY, V21, P197, DOI 10.1152/physiol.00063.2005; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Haeusler S, 2007, CEREB CORTEX, V17, P149, DOI 10.1093/cercor/bhj132; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnson DH, 2004, J COMPUT NEUROSCI, V16, P69, DOI 10.1023/B:JCNS.0000004842.04535.7c; Jurjut OF, 2009, J NEUROPHYSIOL, V102, P3766, DOI 10.1152/jn.00758.2009; KASPER EM, 1994, J COMP NEUROL, V339, P475, DOI 10.1002/cne.903390403; Kleppe IC, 1999, BIOPHYS J, V77, P1418, DOI 10.1016/S0006-3495(99)76990-0; Kohonen T, 1999, KOHONEN MAPS, P171, DOI 10.1016/B978-044450270-4/50013-9; Kohonen T., 2001, SPRINGER SERIES INFO; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Li WC, 2006, J NEUROSCI, V26, P4026, DOI 10.1523/JNEUROSCI.4727-05.2006; LINDE Y, 1980, IEEE T COMMUN, V28, P84, DOI 10.1109/TCOM.1980.1094577; Maldonado PE, 2007, NEUROSCIENCE, V144, P1536, DOI 10.1016/j.neuroscience.2006.11.021; Maldonado P, 2008, J NEUROPHYSIOL, V100, P1523, DOI 10.1152/jn.00076.2008; Muresan RC, 2007, J NEUROPHYSIOL, V97, P1911, DOI 10.1152/jn.01043.2006; Nikolic D., 2007, ADV NEURAL INFORM PR, V19, P1041, DOI [10.7551/mitpress/7503.003.0135, DOI 10.7551/MITPRESS/7503.003.0135]; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; PETERSSON M, 2010, THESIS STOCKHOLM; Pipa G, 2008, J COMPUT NEUROSCI, V25, P64, DOI 10.1007/s10827-007-0065-3; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; RADONS G, 1994, BIOL CYBERN, V71, P359, DOI 10.1007/BF00239623; Reinagel P, 2002, J NEUROSCI, V22, P6837; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Rudolph M, 2003, J COMPUT NEUROSCI, V14, P239, DOI 10.1023/A:1023245625896; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seo H, 2009, NATURE, V461, P50, DOI 10.1038/461050a; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Silberberg G, 2008, CURR OPIN NEUROBIOL, V18, P332, DOI 10.1016/j.conb.2008.08.009; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	69	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16758	10.1371/journal.pone.0016758	http://dx.doi.org/10.1371/journal.pone.0016758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346812	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600022
J	Zhang, YKJ; Guo, GL; Klaassen, CD				Zhang, Yu-Kun Jennifer; Guo, Grace L.; Klaassen, Curtis D.			Diurnal Variations of Mouse Plasma and Hepatic Bile Acid Concentrations as well as Expression of Biosynthetic Enzymes and Transporters	PLOS ONE			English	Article							ENTEROHEPATIC CIRCULATORY-SYSTEM; ORGANIC SOLUTE TRANSPORTER; PREGNANE-X-RECEPTOR; ALPHA-OST-BETA; CIRCADIAN DISTRIBUTION; LIGANDS; METABOLISM; LIVER; ASBT; GENE	Background: Diurnal fluctuation of bile acid (BA) concentrations in the enterohepatic system of mammals has been known for a long time. Recently, BAs have been recognized as signaling molecules beyond their well-established roles in dietary lipid absorption and cholesterol homeostasis. Methods and Results: The current study depicted diurnal variations of individual BAs detected by ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) in serum and livers collected from C57BL/6 mice fed a regular chow or a chow containing cholestyramine (resin). Circadian rhythms of mRNA of vital BA-related nuclear receptors, enzymes, and transporters in livers and ilea were determined in control-and resin-fed mice, as well as in farnesoid X receptor (FXR) null mice. The circadian profiles of BAs showed enhanced bacterial dehydroxylation during the fasting phase and efficient hepatic reconjugation of BAs in the fed phase. The resin removed more than 90% of BAs with beta-hydroxy groups, such as muricholic acids and ursodeoxycholic acid, from serum and livers, but did not exert as significant influence on CA and CDCA in both compartments. Both resin-fed and FXR-null mouse models indicate that BAs regulate their own biosynthesis through the FXR-regulated ileal fibroblast growth factor 15. BA flux also influences the daily mRNA levels of multiple BA transporters. Conclusion: BA concentration and composition exhibit circadian variations in mouse liver and serum, which influences the circadian rhythms of BA metabolizing genes in liver and ileum. The diurnal variations of BAs appear to serve as a signal that coordinates daily nutrient metabolism in mammals.	[Zhang, Yu-Kun Jennifer; Guo, Grace L.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Zhang, YKJ (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu			National Institutes of Health [DK-081461, ES-009716, ES-009649, ES-013714, RR-021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343, R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009716, R01ES009649, R01ES013714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported by National Institutes of Health grants DK-081461, ES-009716, ES-009649, ES-013714, and RR-021940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; BOTHAM KM, 1983, EUR J BIOCHEM, V134, P191, DOI 10.1111/j.1432-1033.1983.tb07550.x; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cheng XG, 2006, DRUG METAB DISPOS, V34, P1863, DOI 10.1124/dmd.106.010520; Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014; Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Frankenberg T, 2006, AM J PHYSIOL-GASTR L, V290, pG912, DOI 10.1152/ajpgi.00479.2005; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; HO KJ, 1976, J LIPID RES, V17, P600; HO KJ, 1976, AM J PHYSIOL, V230, P1331, DOI 10.1152/ajplegacy.1976.230.5.1331; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Li H, 2005, AM J PHYSIOL-GASTR L, V288, pG60, DOI 10.1152/ajpgi.00170.2004; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Maher JM, 2005, DRUG METAB DISPOS, V33, P956, DOI 10.1124/dmd.105.003798; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Mottino AD, 2000, J PHARMACOL EXP THER, V293, P717; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; SCHALM SW, 1978, GUT, V19, P1006, DOI 10.1136/gut.19.11.1006; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Tanaka Y, 2009, TOXICOL SCI, V108, P247, DOI 10.1093/toxsci/kfp020; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; ZIBOH VA, 1961, J BIOL CHEM, V236, P387	38	68	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16683	10.1371/journal.pone.0016683	http://dx.doi.org/10.1371/journal.pone.0016683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346810	gold, Green Published, Green Submitted			2022-12-27	WOS:000287077600016
J	Pillai, DR; Heidemann, RM; Kumar, P; Shanbhag, N; Lanz, T; Dittmar, MS; Sandner, B; Beier, CP; Weidner, N; Greenlee, MW; Schuierer, G; Bogdahn, U; Schlachetzki, F				Pillai, Deepu R.; Heidemann, Robin M.; Kumar, Praveen; Shanbhag, Nagesh; Lanz, Titus; Dittmar, Michael S.; Sandner, Beatrice; Beier, Christoph P.; Weidner, Norbert; Greenlee, Mark W.; Schuierer, Gerhard; Bogdahn, Ulrich; Schlachetzki, Felix			Comprehensive Small Animal Imaging Strategies on a Clinical 3 T Dedicated Head MR-Scanner; Adapted Methods and Sequence Protocols in CNS Pathologies	PLOS ONE			English	Article							RAT SPINAL-CORD; MIDDLE CEREBRAL-ARTERY; BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; PARTIALLY PARALLEL ACQUISITIONS; MAGNETIC-RESONANCE MICROSCOPY; IN-VIVO; MOUSE-BRAIN; EDEMA FORMATION; WHITE-MATTER	Background: Small animal models of human diseases are an indispensable aspect of pre-clinical research. Being dynamic, most pathologies demand extensive longitudinal monitoring to understand disease mechanisms, drug efficacy and side effects. These considerations often demand the concomitant development of monitoring systems with sufficient temporal and spatial resolution. Methodology and Results: This study attempts to configure and optimize a clinical 3 Tesla magnetic resonance scanner to facilitate imaging of small animal central nervous system pathologies. The hardware of the scanner was complemented by a custom-built, 4-channel phased array coil system. Extensive modification of standard sequence protocols was carried out based on tissue relaxometric calculations. Proton density differences between the gray and white matter of the rodent spinal cord along with transverse relaxation due to magnetic susceptibility differences at the cortex and striatum of both rats and mice demonstrated statistically significant differences. The employed parallel imaging reconstruction algorithms had distinct properties dependent on the sequence type and in the presence of the contrast agent. The attempt to morphologically phenotype a normal healthy rat brain in multiple planes delineated a number of anatomical regions, and all the clinically relevant sequels following acute cerebral ischemia could be adequately characterized. Changes in blood-brain-barrier permeability following ischemia-reperfusion were also apparent at a later time. Typical characteristics of intracerebral haemorrhage at acute and chronic stages were also visualized up to one month. Two models of rodent spinal cord injury were adequately characterized and closely mimicked the results of histological studies. In the employed rodent animal handling system a mouse model of glioblastoma was also studied with unequivocal results. Conclusions: The implemented customizations including extensive sequence protocol modifications resulted in images of high diagnostic quality. These results prove that lack of dedicated animal scanners shouldn't discourage conventional small animal imaging studies.	[Pillai, Deepu R.; Kumar, Praveen; Shanbhag, Nagesh; Sandner, Beatrice; Beier, Christoph P.; Weidner, Norbert; Bogdahn, Ulrich; Schlachetzki, Felix] Univ Regensburg, Dept Neurol, Med Ctr, Regensburg, Germany; [Pillai, Deepu R.] Univ Wurzburg, Dept Genet & Neurobiol, Biozentrum, Wurzburg, Germany; [Heidemann, Robin M.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Heidemann, Robin M.] Siemens Healthcare Sector, Erlangen, Germany; [Kumar, Praveen; Beier, Christoph P.] Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany; [Lanz, Titus] RAPID Biomed GmbH, Wurzburg, Germany; [Dittmar, Michael S.] Univ Regensburg, Dept Anaesthesiol, Med Ctr, Regensburg, Germany; [Weidner, Norbert] Heidelberg Univ, Inst Paraplegia, Heidelberg, Germany; [Greenlee, Mark W.] Univ Regensburg, Inst Expt Psychol, Regensburg, Germany; [Schuierer, Gerhard] Univ Regensburg, Ctr Neuroradiol, Med Ctr, Regensburg, Germany; [Schuierer, Gerhard] Bezirksklinikum Regensburg, Regensburg, Germany	University of Regensburg; University of Wurzburg; Max Planck Society; Siemens AG; Siemens Germany; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg; Ruprecht Karls University Heidelberg; University of Regensburg; University of Regensburg; University of Regensburg	Pillai, DR (corresponding author), Univ Regensburg, Dept Neurol, Med Ctr, Regensburg, Germany.	felix.schlachetzki@klinik.uni-regensburg.de	Beier, Christoph Patrick/ABF-8791-2021; Greenlee, Mark/M-6414-2018	Beier, Christoph Patrick/0000-0001-8268-1492; Greenlee, Mark/0000-0003-2305-9286; Kumar, Praveen/0000-0002-6330-7355; Shanbhag, Nagesh/0000-0002-5304-8783; Heidemann, Robin/0000-0001-7556-7405; Dittmar, Michael S./0000-0002-8687-5830	Bayerische Forschungsstiftung; Bavarian State Ministry of Sciences, Research and Arts; Siemens Healthcare Sector, Erlangen, Germany; RAPID Biomedical GmbH, Wurzburg-Rimpar, Germany	Bayerische Forschungsstiftung; Bavarian State Ministry of Sciences, Research and Arts; Siemens Healthcare Sector, Erlangen, Germany; RAPID Biomedical GmbH, Wurzburg-Rimpar, Germany	Dr. Pillai was supported by Bayerische Forschungsstiftung "Bayern Brain 3T" project and Bavarian State Ministry of Sciences, Research and Arts,"ForNeuroCell." Dr. Heidemann was supported by Siemens Healthcare Sector, Erlangen, Germany. Dr. Lanz was supported by RAPID Biomedical GmbH, Wurzburg-Rimpar, Germany. P. Kumar was supported by Bayerische Forschungsstiftung graduate student stipend. B. Sandner was supported by Bavarian State Ministry of Sciences, Research and Arts,"ForNeuroCell." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2004, NEUROIMAGE, V22, P381, DOI 10.1016/j.neuroimage.2003.12.046; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; BANDETTINI PA, 1994, NMR BIOMED, V7, P12, DOI 10.1002/nbm.1940070104; Behr VC, 2004, MAGN RESON MATER PHY, V17, P353, DOI 10.1007/s10334-004-0057-5; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Bhagat YA, 2007, AM J NEURORADIOL, V28, P293; Bilgen M, 2001, MAGN RESON MED, V46, P1250, DOI 10.1002/mrm.1325; Bilgen M, 2000, MAGN RESON MED, V43, P594, DOI 10.1002/(SICI)1522-2594(200004)43:4<594::AID-MRM15>3.0.CO;2-1; Blaimer Martin, 2004, Top Magn Reson Imaging, V15, P223, DOI 10.1097/01.rmr.0000136558.09801.dd; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BRANTZAWADZKI M, 1984, RADIOLOGY, V152, P71, DOI 10.1148/radiology.152.1.6729138; Brockmann MA, 2006, BRAIN RES, V1068, P138, DOI 10.1016/j.brainres.2005.10.098; Brockmann MA, 2007, METHODS, V43, P79, DOI 10.1016/j.ymeth.2007.07.001; Calamante F, 1999, MAGN RESON MED, V41, P479, DOI 10.1002/(SICI)1522-2594(199903)41:3<479::AID-MRM9>3.0.CO;2-2; Chen F, 2007, METHODS, V43, P12, DOI 10.1016/j.ymeth.2007.03.007; Christoforidis GA, 2004, AM J NEURORADIOL, V25, P756; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Di X, 1997, STROKE, V28, P2244, DOI 10.1161/01.STR.28.11.2244; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Ding GL, 2005, J CEREBR BLOOD F MET, V25, P87, DOI 10.1038/sj.jcbfm.9600010; Essig Marco, 2006, Eur Radiol, V16 Suppl 7, pM3, DOI 10.1007/s10406-006-0190-5; Fenyes DA, 1999, MAGNET RESON MED, V42, P300, DOI 10.1002/(SICI)1522-2594(199908)42:2<300::AID-MRM12>3.0.CO;2-9; Fenyes DA, 1998, MAGN RESON IMAGING, V16, P1249, DOI 10.1016/S0730-725X(98)00093-9; Fenyes DA, 1999, MAGN RESON IMAGING, V17, P717, DOI 10.1016/S0730-725X(98)00220-3; FORD JC, 1994, MAGNET RESON MED, V31, P218, DOI 10.1002/mrm.1910310216; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guzman R, 2000, J NEUROSCI METH, V97, P77, DOI 10.1016/S0165-0270(00)00172-2; Heiland S, 1998, NEURORADIOLOGY, V40, P216, DOI 10.1007/s002340050570; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hoehn M, 2001, J MAGN RESON IMAGING, V14, P491, DOI 10.1002/jmri.1213; HOULT DI, 1986, MAGNET RESON MED, V3, P730, DOI 10.1002/mrm.1910030509; Hulet SW, 1999, J NEUROCHEM, V72, P868, DOI 10.1046/j.1471-4159.1999.720868.x; Johnson GA, 2002, J MAGN RESON IMAGING, V16, P423, DOI 10.1002/jmri.10175; Kim T, 2008, MAGN RESON MED, V60, P1518, DOI 10.1002/mrm.21766; Koshibu K, 2004, NEUROIMAGE, V22, P1636, DOI 10.1016/j.neuroimage.2004.03.051; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Linn J, 2007, METHODS, V43, P2, DOI 10.1016/j.ymeth.2007.03.008; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mogatadakala KV, 2008, MAGN RESON MED, V60, P1498, DOI 10.1002/mrm.21777; Morton DW, 2001, RADIOLOGY, V218, P598, DOI 10.1148/radiology.218.2.r01fe30598; Nakamura T, 2003, BRAIN RES, V981, P108, DOI 10.1016/S0006-8993(03)02991-3; Narayana P, 1999, MAGN RESON MED, V41, P315, DOI 10.1002/(SICI)1522-2594(199902)41:2<315::AID-MRM15>3.0.CO;2-B; Narayana P, 1999, MAGN RESON IMAGING, V17, P623, DOI 10.1016/S0730-725X(98)00194-5; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rad A M, 2008, Open Magn Reson Rev, V1, P60, DOI 10.2174/1874769800801010060; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Rudin M, 1999, NMR BIOMED, V12, P69, DOI 10.1002/(SICI)1099-1492(199904)12:2<69::AID-NBM548>3.0.CO;2-D; SAHIN B, 2001, IMAGE ANAL STEREOL, V20, P9; Schenck JF, 2004, NMR BIOMED, V17, P433, DOI 10.1002/nbm.922; Schepkin VD, 2010, MAGN RESON IMAGING, V28, P400, DOI 10.1016/j.mri.2009.10.002; Silver X, 2001, MAGN RESON MED, V46, P1216, DOI 10.1002/mrm.1319; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; VILLRINGER A, 1988, MAGNET RESON MED, V6, P164, DOI 10.1002/mrm.1910060205; Vroemen M, 2006, AM J NEURORADIOL, V27, P598; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Yang QX, 2004, MAGNET RESON MED, V52, P1418, DOI 10.1002/mrm.20303; Yung AC, 2007, MAGN RESON IMAGING, V25, P1215, DOI 10.1016/j.mri.2007.01.006; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608; Zhao WD, 2005, J CANCER RES CLIN, V131, P597, DOI 10.1007/s00432-005-0684-x; Zhuo JC, 2006, RADIOGRAPHICS, V26, P275, DOI 10.1148/rg.261055134	69	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16091	10.1371/journal.pone.0016091	http://dx.doi.org/10.1371/journal.pone.0016091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326876	gold, Green Published			2022-12-27	WOS:000287037100006
J	Sneddon, I; McKeown, G; McRorie, M; Vukicevic, T				Sneddon, Ian; McKeown, Gary; McRorie, Margaret; Vukicevic, Tijana			Cross-Cultural Patterns in Dynamic Ratings of Positive and Negative Natural Emotional Behaviour	PLOS ONE			English	Article							FACIAL EXPRESSIONS; RECOGNITION; PERCEPTION; JAPANESE; FACE; JUDGMENTS; DISPLAYS	Background: Studies of cross-cultural variations in the perception of emotion have typically compared rates of recognition of static posed stimulus photographs. That research has provided evidence for universality in the recognition of a range of emotions but also for some systematic cross-cultural variation in the interpretation of emotional expression. However, questions remain about how widely such findings can be generalised to real life emotional situations. The present study provides the first evidence that the previously reported interplay between universal and cultural influences extends to ratings of natural, dynamic emotional stimuli. Methodology/Principal Findings: Participants from Northern Ireland, Serbia, Guatemala and Peru used a computer based tool to continuously rate the strength of positive and negative emotion being displayed in twelve short video sequences by people from the United Kingdom engaged in emotional conversations. Generalized additive mixed models were developed to assess the differences in perception of emotion between countries and sexes. Our results indicate that the temporal pattern of ratings is similar across cultures for a range of emotions and social contexts. However, there are systematic differences in intensity ratings between the countries, with participants from Northern Ireland making the most extreme ratings in the majority of the clips. Conclusions/Significance: The results indicate that there is strong agreement across cultures in the valence and patterns of ratings of natural emotional situations but that participants from different cultures show systematic variation in the intensity with which they rate emotion. Results are discussed in terms of both 'in-group advantage' and 'display rules' approaches. This study indicates that examples of natural spontaneous emotional behaviour can be used to study cross-cultural variations in the perception of emotion.	[Sneddon, Ian; McKeown, Gary; McRorie, Margaret; Vukicevic, Tijana] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Sneddon, I (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland.	I.Sneddon@qub.ac.uk	McKeown, Gary/B-3098-2010	McKeown, Gary/0000-0002-7517-641X				[Anonymous], 2000, ISCA TUT RES WORKSH; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Buck R., 1984, COMMUNICATION EMOTIO; Conway CA, 2007, HORM BEHAV, V51, P202, DOI 10.1016/j.yhbeh.2006.10.002; Conway CA, 2008, SOC NEUROSCI, V3, P89, DOI 10.1080/17470910701676145; Coull BA, 2001, BIOMETRICS, V57, P539, DOI 10.1111/j.0006-341X.2001.00539.x; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 2006, PROG BRAIN RES, V155, P37, DOI 10.1016/S0079-6123(06)55003-4; Douglas-Cowie E, 2003, SPEECH COMMUN, V40, P33, DOI 10.1016/S0167-6393(02)00070-5; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Elfenbein HA, 2003, J CROSS CULT PSYCHOL, V34, P92, DOI 10.1177/0022022102239157; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hofstede G, 1984, CULTURES CONSEQUENCE; HOLM S, 1979, SCAND J STAT, V6, P65; Izard C.E., 1971, FACE EMOTION; Keltner D, 2003, SER AFFECTIVE SCI, P415; MATSUMOTO D, 1992, J CROSS CULT PSYCHOL, V23, P72, DOI 10.1177/0022022192231005; MATSUMOTO D, 1989, J CROSS CULT PSYCHOL, V20, P92, DOI 10.1177/0022022189201006; MATSUMOTO D, 1989, MOTIV EMOTION, V13, P143, DOI 10.1007/BF00992959; Matsumoto D, 2009, UNDERSTANDING CULTURE: THEORY, RESEARCH, AND APPLICATION, P271; Naab PJ, 2007, EMOTION, V7, P736, DOI 10.1037/1528-3542.7.4.736; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Schimmack U, 1996, J CROSS CULT PSYCHOL, V27, P37, DOI 10.1177/0022022196271003; Walls TD., 2006, MODELS INTENSIVE LON, P3; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	31	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e14679	10.1371/journal.pone.0014679	http://dx.doi.org/10.1371/journal.pone.0014679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723CC	21364739	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800001
J	O'Reilly, LP; Watkins, SC; Smithgall, TE				O'Reilly, Linda P.; Watkins, Simon C.; Smithgall, Thomas E.			An Unexpected Role for the Clock Protein Timeless in Developmental Apoptosis	PLOS ONE			English	Article							SRC FAMILY KINASE; TYROSINE KINASE; MAMMALIAN TIMELESS; CRYSTAL-STRUCTURE; CIRCADIAN CLOCK; HNRNP K; DIFFERENTIATION; ACTIVATION; CELLS; HCK	Background: Programmed cell death is critical not only in adult tissue homeostasis but for embryogenesis as well. One of the earliest steps in development, formation of the proamniotic cavity, involves coordinated apoptosis of embryonic cells. Recent work from our group demonstrated that c-Src protein-tyrosine kinase activity triggers differentiation of mouse embryonic stem (mES) cells to primitive ectoderm-like cells. In this report, we identified Timeless (Tim), the mammalian ortholog of a Drosophila circadian rhythm protein, as a binding partner and substrate for c-Src and probed its role in the differentiation of mES cells. Methodology/Principal Findings: To determine whether Tim is involved in ES cell differentiation, Tim protein levels were stably suppressed using shRNA. Tim-defective ES cell lines were then tested for embryoid body (EB) formation, which models early mammalian development. Remarkably, confocal microscopy revealed that EBs formed from the Tim-knockdown ES cells failed to cavitate. Cells retained within the centers of the failed cavities strongly expressed the pluripotency marker Oct4, suggesting that further development is arrested without Tim. Immunoblots revealed reduced basal Caspase activity in the Tim-defective EBs compared to wild-type controls. Furthermore, EBs formed from Tim-knockdown cells demonstrated resistance to staurosporine-induced apoptosis, consistent with a link between Tim and programmed cell death during cavitation. Conclusions/Significance: Our data demonstrate a novel function for the clock protein Tim during a key stage of early development. Specifically, EBs formed from ES cells lacking Tim showed reduced caspase activity and failed to cavitate. As a consequence, further development was halted, and the cells present in the failed cavity remained pluripotent. These findings reveal a new function for Tim in the coordination of ES cell differentiation, and raise the intriguing possibility that circadian rhythms and early development may be intimately linked.	[O'Reilly, Linda P.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Reilly, LP (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [GM077629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health grant GM077629 (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Anneren C, 2008, CLIN SCI, V115, P43, DOI 10.1042/CS20070388; Araki T, 2003, NEPHRON EXP NEPHROL, V93, P117, DOI 10.1159/000069552; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Denham M, 2006, STEM CELLS, V24, P918, DOI 10.1634/stemcells.2005-0151; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eckert JJ, 2004, REPRODUCTION, V127, P653, DOI 10.1530/rep.1.00150; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Pene-Dumitrescu T, 2010, J BIOL CHEM, V285, P21446, DOI 10.1074/jbc.M109.090043; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	41	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17157	10.1371/journal.pone.0017157	http://dx.doi.org/10.1371/journal.pone.0017157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359199	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300032
J	Llandres, AL; Rodriguez-Girones, MA				Llandres, Ana L.; Rodriguez-Girones, Miguel A.			Spider Movement, UV Reflectance and Size, but Not Spider Crypsis, Affect the Response of Honeybees to Australian Crab Spiders	PLOS ONE			English	Article							WAIT PREDATOR; PREY; CHOICE; INFLORESCENCES; VISITATION; COLORATION	According to the crypsis hypothesis, the ability of female crab spiders to change body colour and match the colour of flowers has been selected because flower visitors are less likely to detect spiders that match the colour of the flowers used as hunting platform. However, recent findings suggest that spider crypsis plays a minor role in predator detection and some studies even showed that pollinators can become attracted to flowers harbouring Australian crab spider when the UV contrast between spider and flower increases. Here we studied the response of Apis mellifera honeybees to the presence of white or yellow Thomisus spectabilis Australian crab spiders sitting on Bidens alba inflorescences and also the response of honeybees to crab spiders that we made easily detectable painting blue their forelimbs or abdomen. To account for the visual systems of crab spider's prey, we measured the reflectance properties of the spiders and inflorescences used for the experiments. We found that honeybees did not respond to the degree of matching between spiders and inflorescences (either chromatic or achromatic contrast): they responded similarly to white and yellow spiders, to control and painted spiders. However spider UV reflection, spider size and spider movement determined honeybee behaviour: the probability that honeybees landed on spider-harbouring inflorescences was greatest when the spiders were large and had high UV reflectance or when spiders were small and reflected little UV, and honeybees were more likely to reject inflorescences if spiders moved as the bee approached the inflorescence. Our study suggests that only the large, but not the small Australian crab spiders deceive their preys by reflecting UV light, and highlights the importance of other cues that elicited an anti-predator response in honeybees.	[Llandres, Ana L.; Rodriguez-Girones, Miguel A.] Estn Expt Zonas Aridas CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Llandres, AL (corresponding author), Estn Expt Zonas Aridas CSIC, Dept Funct & Evolutionary Ecol, Almeria, Spain.	allandres@eeza.csic.es	Rodriguez-Girones, Miguel A/H-1859-2015	Rodriguez-Girones, Miguel A/0000-0002-5619-9819	Spanish Ministry of Science and Technology [CGL2007-63223]; CSIC [PIE 2006 3 OI 073, I3P-BPD2005]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	Funding: This work was supported by the Spanish Ministry of Science and Technology (project CGL2007-63223 to MARG) and CSIC (project PIE 2006 3 OI 073 to MARG and studentship I3P-BPD2005 to ALL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; Brechbuhl R, 2010, BASIC APPL ECOL, V11, P76, DOI 10.1016/j.baae.2009.07.001; Brechbuhl R, 2010, P ROY SOC B-BIOL SCI, V277, P739, DOI 10.1098/rspb.2009.1632; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Clark RW, 2004, ETHOLOGY, V110, P471, DOI 10.1111/j.1439-0310.2004.00982.x; Cott H. B, 1957, ADAPTIVE COLORATION; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; ERSON RA, 1981, OECOLOGIA, V49, P67; Gabritscbevsky E, 1927, J EXP ZOOL, V47, P251, DOI 10.1002/jez.1400470207; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Hatle JD, 2001, ENVIRON ENTOMOL, V30, P51, DOI 10.1603/0046-225X-30.1.51; Heiling AM, 2005, J EXP BIOL, V208, P3925, DOI 10.1242/jeb.01861; Heiling AM, 2005, J EXP BIOL, V208, P1785, DOI 10.1242/jeb.01585; Heiling AM, 2004, P ROY SOC B-BIOL SCI, V271, pS196, DOI 10.1098/rsbl.2003.0138; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Herberstein ME, 2009, EVOL ECOL, V23, P621, DOI 10.1007/s10682-008-9260-6; Higginson AD, 2007, ENTOMOL GEN, V29, P165; Hopkins, 1886, ILLUSTRATED AUSTRALA; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Llandres AL, 2011, ECOL ENTOMOL, V36, P72, DOI 10.1111/j.1365-2311.2010.01246.x; Metcalfe NB, 1997, J ANIM ECOL, V66, P866, DOI 10.2307/6002; Morse D. H., 2007, PREDATOR FLOWER LIFE; MORSE DH, 1986, AM MIDL NAT, V116, P341, DOI 10.2307/2425742; Nelson XJ, 2010, ANIM BEHAV, V79, P555, DOI 10.1016/j.anbehav.2009.12.011; OLIVE CW, 1982, ECOLOGY, V63, P912, DOI 10.2307/1937231; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; Shafir S, 1998, BEHAV ECOL, V9, P74, DOI 10.1093/beheco/9.1.74; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Weigel Gertrud, 1941, ZEITSCHR VERGLEICH PHYSIOL, V29, P195; Yong TH, 2003, ANN ENTOMOL SOC AM, V96, P643, DOI 10.1603/0013-8746(2003)096[0643:NBAPAB]2.0.CO;2	39	27	28	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17136	10.1371/journal.pone.0017136	http://dx.doi.org/10.1371/journal.pone.0017136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359183	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700053
J	Caputo, B; Santolamazza, F; Vicente, JL; Nwakanma, DC; Jawara, M; Palsson, K; Jaenson, T; White, BJ; Mancini, E; Petrarca, V; Conway, DJ; Besansky, NJ; Pinto, J; della Torre, A				Caputo, Beniamino; Santolamazza, Federica; Vicente, Jose L.; Nwakanma, Davis C.; Jawara, Musa; Palsson, Katinka; Jaenson, Thomas; White, Bradley J.; Mancini, Emiliano; Petrarca, Vincenzo; Conway, David J.; Besansky, Nora J.; Pinto, Joao; della Torre, Alessandra			The "Far-West'' of Anopheles gambiae Molecular Forms	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENOMIC DIVERGENCE; GENE-FLOW; COMPLEX; SPECIATION; DIFFERENTIATION; IDENTIFICATION; HYBRIDIZATION; CULICIDAE; SELECTION	The main Afrotropical malaria vector, Anopheles gambiae sensu stricto, is undergoing a process of sympatric ecological diversification leading to at least two incipient species (the M and S molecular forms) showing heterogeneous levels of divergence across the genome. The physically unlinked centromeric regions on all three chromosomes of these closely related taxa contain fixed nucleotide differences which have been found in nearly complete linkage disequilibrium in geographic areas of no or low M-S hybridization. Assays diagnostic for SNP and structural differences between M and S forms in the three centromeric regions were applied in samples from the western extreme of their range of sympatry, the only area where high frequencies of putative M/S hybrids have been reported. The results reveal a level of admixture not observed in the rest of the range. In particular, we found: i) heterozygous genotypes at each marker, although at frequencies lower than expected under panmixia; ii) virtually all possible genotypic combinations between markers on different chromosomes, although genetic association was nevertheless detected; iii) discordant M and S genotypes at two X-linked markers near the centromere, suggestive of introgression and inter-locus recombination. These results could be indicative either of a secondary contact zone between M and S, or of the maintenance of ancestral polymorphisms. This issue and the perspectives opened by these results in the study of the M and S incipient speciation process are discussed.	[Caputo, Beniamino; Santolamazza, Federica; Mancini, Emiliano; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Vicente, Jose L.; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, UEI Malaria & UEI Entomol Med, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Nwakanma, Davis C.; Jawara, Musa; Conway, David J.] MRC Labs, Banjul, Gambia; [Palsson, Katinka; Jaenson, Thomas] Uppsala Univ, Dept Systemat Biol, Med Entomol Unit, Uppsala, Sweden; [White, Bradley J.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; MRC Laboratory Molecular Biology; Uppsala University; University of Notre Dame; Fondazione Cenci Bolognetti; Sapienza University Rome	Caputo, B (corresponding author), Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	ale.dellatorre@uniroma1.it	Vicente, José/I-2126-2012; J., Pinto/H-6177-2019; Caputo, Beniamino/I-2880-2015; Mancini, Emiliano/G-4771-2012; Pinto, Joao/C-2208-2012	J., Pinto/0000-0001-8572-7708; Caputo, Beniamino/0000-0002-5650-8773; Pinto, Joao/0000-0001-8572-7708; Santolamazza, Federica/0000-0001-5029-6733; Nwakanma, Davis/0000-0002-6706-6069; Conway, David/0000-0002-8711-3037; MANCINI, Emiliano/0000-0002-7988-4544	Medical Research Council of the UK; UNICEF/UNDP/World Bank/WHO [A50239]; I Faculty of Medicine of Universita "La Sapienza"; Universita "La Sapienza"; National Institutes of Health [R01-AI063508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UNICEF/UNDP/World Bank/WHO(World Health Organization); I Faculty of Medicine of Universita "La Sapienza"; Universita "La Sapienza"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Field collections and laboratory analysis in The Gambia was supported by the Medical Research Council of the UK, with helpful facilitation from the Gambian National Malaria Control Programme. Laboratory analysis of Guinean samples received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR, A50239). BC was partially supported by I Faculty of Medicine of Universita "La Sapienza". The work was supported by Universita "La Sapienza" (Progetti di Ricerca Universitari - 2009) and by R01-AI063508 grant to NJB from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Rauscher JT, 2002, MOL ECOL, V11, P2691, DOI 10.1046/j.1365-294X.2002.01640.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Santolamazza F, 2004, AM J TROP MED HYG, V70, P604, DOI 10.4269/ajtmh.2004.70.604; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	39	54	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16415	10.1371/journal.pone.0016415	http://dx.doi.org/10.1371/journal.pone.0016415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347223	gold, Green Published, Green Submitted			2022-12-27	WOS:000287369200003
J	Cavenaugh, JS; Awi, D; Mendy, M; Hill, AVS; Whittle, H; McConkey, SJ				Cavenaugh, James S.; Awi, Dorka; Mendy, Maimuna; Hill, Adrian V. S.; Whittle, Hilton; McConkey, Samuel J.			Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; BOOST IMMUNIZATION STRATEGIES; HEPATOCELLULAR-CARCINOMA; ENHANCED IMMUNOGENICITY; PROTECTIVE EFFICACY; LAMIVUDINE TREATMENT; VACCINATION REGIMEN; LYMPHOCYTE RESPONSE; VIRAL-HEPATITIS; IMMUNE-RESPONSE	Background: Chronic HBV infects 350 million people causing cancer and liver failure. We aimed to assess the safety and efficacy of plasmid DNA (pSG2.HBs) vaccine, followed by recombinant modified vaccinia virus Ankara (MVA.HBs), encoding the surface antigen of HBV as therapy for chronic HBV. A secondary goal was to characterize the immune responses. Methods: Firstly 32 HBV e antigen negative (eAg(-)) participants were randomly assigned to one of four groups: to receive vaccines alone, lamivudine (3TC) alone, both, or neither. Later 16 eAg(+) volunteers in two groups received either 3TC alone or both 3TC and vaccines. Finally, 12 eAg(-) and 12 eAg+ subjects were enrolled into higher-dose treatment groups. Healthy but chronically HBV-infected males between the ages of 15-25 who lived in the western part of The Gambia were eligible. Participants in some groups received 1 mg or 2 mg of pSG2.HBs intramuscularly twice followed by 5x10(7) pfu or 1.5x10(8) pfu of MVA.HBs intradermally at 3-weekly intervals with or without concomitant 3TC for 11-14 weeks. Intradermal rabies vaccine was administered to a negative control group. Safety was assessed clinically and biochemically. The primary measure of efficacy was a quantitative PCR assay of plasma HBV. Immunity was assessed by IFN-gamma ELISpot and intracellular cytokine staining. Results: Mild local and systemic adverse events were observed following the vaccines. A small shiny scar was observed in some cases after MVA.HBs. There were no significant changes in AST or ALT.HBeAg was lost in one participant in the higher-dose group. As expected, the 3TC therapy reduced viraemia levels during therapy, but the prime-boost vaccine regimen did not reduce the viraemia. The immune responses were variable. The majority of IFN-gamma was made by antigen non-specific CD16(+) cells (both CD3(+) and CD3(-)). Conclusions: The vaccines were well tolerated but did not control HBV infection.	[Cavenaugh, James S.; Awi, Dorka; Mendy, Maimuna; Whittle, Hilton; McConkey, Samuel J.] MRC Labs, Banjul, Gambia; [Cavenaugh, James S.; Hill, Adrian V. S.; McConkey, Samuel J.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Cavenaugh, James S.] Univ Rochester, Sch Med & Dent, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA; [Awi, Dorka] Univ Port Harcourt, Inst Maternal & Child Hlth, Post Harcourt, Nigeria; [Mendy, Maimuna] Int Agcy Res Canc, F-69372 Lyon, France; [Hill, Adrian V. S.] Wellcome Trust Ctr Human Genet, Oxford, England; [McConkey, Samuel J.] Royal Coll Surgeons Ireland, Dept Int Hlth & Trop Med, Dublin 2, Ireland	MRC Laboratory Molecular Biology; University of Oxford; University of Rochester; University of Port Harcourt; World Health Organization; International Agency for Research on Cancer (IARC); University of Oxford; Wellcome Centre for Human Genetics; Royal College of Surgeons - Ireland	Cavenaugh, JS (corresponding author), Royal Coll Surgeons Ireland, Dept Int Hlth & Trop Med, Dublin 2, Ireland.	smcconkey@rcsi.ie	Mendy, Maimuna/ABD-5038-2021; McConkey, Samuel/E-7307-2012	McConkey, Samuel/0000-0001-9085-7793	Wellcome Trust, United Kingdom [060288]; National Institutes of Health [2T32 ES007271]; Medical Research Council [MC_U190081996] Funding Source: researchfish; MRC [MC_U190081996] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007271] Funding Source: NIH RePORTER	Wellcome Trust, United Kingdom(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the Wellcome Trust, United Kingdom, Project Grant Award Number 060288. Medical Research Council Laboratories, The Gambia, contributed to the costs of the project including equipment and infrastructure. Oxxon Therapeutics (Oxford, UK and Boston, USA) provided the vaccines, lamivudine and some reagents and paid for external monitoring and auditing. Oxxon Therapeutics did not influence the composition of this paper. James Cavenaugh was further supported by National Institutes of Health Training Grant 2T32 ES007271 during subsequent write-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza L, 2007, VIROLOGY, V368, P41, DOI 10.1016/j.virol.2007.06.030; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; Bertoletti A, 2000, CURR OPIN IMMUNOL, V12, P403, DOI 10.1016/S0952-7915(00)00108-4; Boni C, 2004, J HEPATOL, V40, P1053, DOI 10.1016/j.jhep.2004.04.011; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Boni C, 2003, J HEPATOL, V39, P595, DOI 10.1016/S0168-8278(03)00292-7; CAVEN TH, 2006, IGE PRODUCTION REGUL; Cavenaugh JS, 2007, CYTOM PART B-CLIN CY, V72B, P49, DOI 10.1002/cyto.b.20146; Cavenaugh JS, 2003, PHARMACEUT RES, V20, P591, DOI 10.1023/A:1023242631413; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Couillin I, 1999, J INFECT DIS, V180, P15, DOI 10.1086/314828; Dahmen A, 2002, J MED VIROL, V66, P452, DOI 10.1002/jmv.2165; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dumpis U, 2001, J HEPATOL, V35, P99, DOI 10.1016/S0168-8278(01)00064-2; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Gilbert SC, 1999, BIOL CHEM, V380, P299, DOI 10.1515/BC.1999.041; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hilleman MR, 2003, VACCINE, V21, P4626, DOI 10.1016/S0264-410X(03)00529-2; Horiike N, 2005, J CLIN VIROL, V32, P156, DOI 10.1016/j.jcv.2004.07.004; Jung MC, 2002, VACCINE, V20, P3598, DOI 10.1016/S0264-410X(02)00309-2; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Mancini-Bourgine M, 2006, VACCINE, V24, P4482, DOI 10.1016/j.vaccine.2005.08.013; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; McShane H, 2001, INFECT IMMUN, V69, P681, DOI 10.1128/IAI.69.2.681-686.2001; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Mendy ME, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-49; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Nakajima A, 2005, JPN J INFECT DIS, V58, P244; Nassal M, 1999, INTERVIROLOGY, V42, P100, DOI 10.1159/000024970; Pan Calvin Q, 2005, Int J Med Sci, V2, P36; Pancholi P, 2001, HEPATOLOGY, V33, P448, DOI 10.1053/jhep.2001.21594; Pol S, 2001, J HEPATOL, V34, P917, DOI 10.1016/S0168-8278(01)00028-9; Rapicetta M, 2002, J MED VIROL, V67, P454, DOI 10.1002/jmv.10096; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Smith Kendall A, 2007, PLoS Clin Trials, V2, pe5, DOI 10.1371/journal.pctr.0020005; Srivastava IK, 2003, ANN INTERN MED, V138, P550, DOI 10.7326/0003-4819-138-7-200304010-00011; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; van der Sande MAB, 2006, J INFECT DIS, V193, P1528, DOI 10.1086/503433; Vandepapeliere P, 2007, VACCINE, V25, P8585, DOI 10.1016/j.vaccine.2007.09.072; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6; Wieland SF, 2005, P NATL ACAD SCI USA, V102, P9913, DOI 10.1073/pnas.0504273102; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Yalcin K, 2003, J CLIN GASTROENTEROL, V37, P330, DOI 10.1097/00004836-200310000-00012; YOSHIHIRO F, 2005, WORLD J GASTROENTERO, V11, P3772; 2002, BD FASTIMMUNE CFC HD	78	52	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e14626	10.1371/journal.pone.0014626	http://dx.doi.org/10.1371/journal.pone.0014626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347224	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200001
J	Pereira, CF; Ellenberg, PC; Jones, KL; Fernandez, TL; Smyth, RP; Hawkes, DJ; Hijnen, M; Vivet-Boudou, V; Marquet, R; Johnson, I; Mak, J				Pereira, Candida F.; Ellenberg, Paula C.; Jones, Kate L.; Fernandez, Tara L.; Smyth, Redmond P.; Hawkes, David J.; Hijnen, Marcel; Vivet-Boudou, Valerie; Marquet, Roland; Johnson, Iain; Mak, Johnson			Labeling of Multiple HIV-1 Proteins with the Biarsenical-Tetracysteine System	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LIVING CELLS; REVERSE-TRANSCRIPTASE; ELECTRON-MICROSCOPY; LIVE CELLS; IN-VIVO; VISUALIZATION; INFECTION; BINDING; FLUORESCENCE	Due to its small size and versatility, the biarsenical-tetracysteine system is an attractive way to label viral proteins for live cell imaging. This study describes the genetic labeling of the human immunodeficiency virus type 1 (HIV-1) structural proteins (matrix, capsid and nucleocapsid), enzymes (protease, reverse transcriptase, RNAse H and integrase) and envelope glycoprotein 120 with a tetracysteine tag in the context of a full-length virus. We measure the impact of these modifications on the natural virus infection and, most importantly, present the first infectious HIV-1 construct containing a fluorescently-labeled nucleocapsid protein. Furthermore, due to the high background levels normally associated with the labeling of tetracysteine-tagged proteins we have also optimized a metabolic labeling system that produces infectious virus containing the natural envelope glycoproteins and specifically labeled tetracysteine-tagged proteins that can easily be detected after virus infection of T-lymphocytes. This approach can be adapted to other viral systems for the visualization of the interplay between virus and host cell during infection.	[Pereira, Candida F.; Ellenberg, Paula C.; Jones, Kate L.; Fernandez, Tara L.; Smyth, Redmond P.; Hawkes, David J.; Hijnen, Marcel; Mak, Johnson] Ctr Virol, Burnet Inst, Melbourne, Vic, Australia; [Pereira, Candida F.; Ellenberg, Paula C.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Hijnen, Marcel; Mak, Johnson] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Mak, Johnson] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Smyth, Redmond P.; Vivet-Boudou, Valerie; Marquet, Roland] Univ Strasbourg, CNRS, IBMC, Architecture & React ARN, Strasbourg, France; [Johnson, Iain] Life Technologies Corp, Eugene, OR USA	Burnet Institute; Monash University; Monash University; Monash University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Thermo Fisher Scientific	Pereira, CF (corresponding author), Ctr Virol, Burnet Inst, Melbourne, Vic, Australia.	mak@burnet.edu.au	Smyth, Redmond/AAP-1637-2020; mak, johnson/H-4605-2014; mak, johnson/S-2457-2019; Ellenberg, paula/AAW-5460-2021	mak, johnson/0000-0002-5229-5707; mak, johnson/0000-0002-5229-5707; Ellenberg, Paula/0000-0002-7622-9106; Smyth, Redmond/0000-0002-1580-0671; Hawkes, David/0000-0002-3882-801X; Marquet, Roland/0000-0002-4209-3976	National Health and Medical Research Council of Australia; Pfizer; European Commission; Portuguese Foundation for Science and Technology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); European Commission(European CommissionEuropean Commission Joint Research Centre); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by grants from the National Health and Medical Research Council of Australia (C.F.P. and J.M.), Pfizer Fellowship (J.M.), the European Social Fund of the European Commission (C.F.P.) and the Portuguese Foundation for Science and Technology (C.F.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Campbell EM, 2008, TRENDS MICROBIOL, V16, P580, DOI 10.1016/j.tim.2008.09.006; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Das SC, 2009, J VIROL, V83, P2611, DOI 10.1128/JVI.01668-08; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Hill MK, 2001, J VIROL, V75, P6835, DOI 10.1128/JVI.75.15.6835-6840.2001; Lanman J, 2008, J STRUCT BIOL, V161, P439, DOI 10.1016/j.jsb.2007.09.009; Li Y, 2010, J VIROL, V84, P7204, DOI 10.1128/JVI.00203-10; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mire CE, 2009, J VIROL, V83, P12139, DOI 10.1128/JVI.00955-09; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137	31	74	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17016	10.1371/journal.pone.0017016	http://dx.doi.org/10.1371/journal.pone.0017016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347302	Green Published, gold			2022-12-27	WOS:000287364500022
J	Thorslund, SE; Edgren, T; Pettersson, J; Nordfelth, R; Sellin, ME; Ivanova, E; Francis, MS; Isaksson, EL; Wolf-Watz, H; Fallman, M				Thorslund, Sara E.; Edgren, Tomas; Pettersson, Jonas; Nordfelth, Roland; Sellin, Mikael E.; Ivanova, Ekaterina; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria			The RACK1 Signaling Scaffold Protein Selectively Interacts with Yersinia pseudotuberculosis Virulence Function	PLOS ONE			English	Article							III SECRETION SYSTEM; MOUSE PERITONEAL-MACROPHAGES; HOST-CELL MEMBRANES; PSEUDOMONAS-AERUGINOSA; PORE FORMATION; GAP ACTIVITY; KINASE-C; DEPENDENT TRANSLOCATION; SHIGELLA-FLEXNERI; OUTER PROTEINS	Many Gram-negative bacteria use type III secretion systems to translocate effector proteins into host cells. These effectors interfere with cellular functions in a highly regulated manner resulting in effects that are beneficial for the bacteria. The pathogen Yersinia can resist phagocytosis by eukaryotic cells by translocating Yop effectors into the target cell cytoplasm. This is called antiphagocytosis, and constitutes an important virulence feature of this pathogen since it allows survival in immune cell rich lymphoid organs. We show here that the virulence protein YopK has a role in orchestrating effector translocation necessary for productive antiphagocytosis. We present data showing that YopK influences Yop effector translocation by modulating the ratio of the pore-forming proteins YopB and YopD in the target cell membrane. Further, we show that YopK that can interact with the translocators, is exposed inside target cells and binds to the eukaryotic signaling protein RACK1. This protein is engaged upon Y. pseudotuberculosis-mediated beta 1-integrin activation and localizes to phagocytic cups. Cells with downregulated RACK1 levels are protected from antiphagocytosis. This resistance is not due to altered levels of translocated antiphagocytic effectors, and cells with reduced levels of RACK1 are still sensitive to the later occurring cytotoxic effect caused by the Yop effectors. Further, a yopK mutant unable to bind RACK1 shows an avirulent phenotype during mouse infection, suggesting that RACK1 targeting by YopK is a requirement for virulence. Together, our data imply that the local event of Yersinia-mediated antiphagocytosis involves a step where YopK, by binding RACK1, ensures an immediate specific spatial delivery of antiphagocytic effectors leading to productive inhibition of phagocytosis.	[Thorslund, Sara E.; Edgren, Tomas; Pettersson, Jonas; Nordfelth, Roland; Sellin, Mikael E.; Ivanova, Ekaterina; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria] Umea Univ, Dept Mol Biol, Umea, Sweden; [Thorslund, Sara E.; Edgren, Tomas; Nordfelth, Roland; Francis, Matthew S.; Isaksson, Elin L.; Wolf-Watz, Hans; Fallman, Maria] Umea Univ, UCMR, Umea, Sweden	Umea University; Umea University	Thorslund, SE (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	maria.fallman@molbiol.umu.se		Sellin, Mikael/0000-0002-8355-0803; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council VR-M [521-2008-2603, K2008-58X-11222-14-3]; J. C. Kempes Memorial Fund	Swedish Research Council VR-M(Swedish Research Council); J. C. Kempes Memorial Fund	This work was supported by grants from the Swedish Research Council VR-M (521-2008-2603, H.W-W; K2008-58X-11222-14-3, M. F; http://www.vr.se), and S. E. T. acknowledges financial support from the J. C. Kempes Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aili M, 2006, CELL MICROBIOL, V8, P1020, DOI 10.1111/j.1462-5822.2005.00684.x; Aili M, 2003, MICROB PATHOGENESIS, V34, P297, DOI 10.1016/S0882-4010(03)00063-9; AILI M, 2008, INT J MED MICROBIOL, P183; Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; BERGMAN T, 1994, J BACTERIOL, V176, P2619, DOI 10.1128/JB.176.9.2619-2626.1994; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOLIN I, 1982, INFECT IMMUN, V37, P506; BOLIN I, 1984, INFECT IMMUN, V43, P72; BOLIN I, 1988, MOL MICROBIOL, V2, P237, DOI 10.1111/j.1365-2958.1988.tb00025.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Buensuceso CS, 2001, J CELL SCI, V114, P1691; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Fallman M, 2002, INT J MED MICROBIOL, V291, P501; FALLMAN M, 1995, INFECT IMMUN, V63, P3117; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; Goosney DL, 1999, INFECT IMMUN, V67, P490, DOI 10.1128/IAI.67.2.490-495.1999; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Guinet F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001688; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; Gustavsson A, 2002, J CELL SCI, V115, P2669; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; HANSKI C, 1989, INFECT IMMUN, V57, P673, DOI 10.1128/IAI.57.3.673-678.1989; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; HOLMSTROM A, 1995, INFECT IMMUN, V63, P2269; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Isberg RR, 2001, J CELL SCI, V114, P21; James P, 1996, GENETICS, V144, P1425; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MULDER B, 1989, INFECT IMMUN, V57, P2534, DOI 10.1128/IAI.57.8.2534-2541.1989; Nordfelth R, 2001, INFECT IMMUN, V69, P3516, DOI 10.1128/IAI.69.5.3516-3518.2001; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Quitard S, 2006, CELL MICROBIOL, V8, P972, DOI 10.1111/j.1462-5822.2005.00680.x; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Sundin C, 2001, CELL MICROBIOL, V3, P237, DOI 10.1046/j.1462-5822.2001.00108.x; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2002, METHOD ENZYMOL, V358, P345; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11	77	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16784	10.1371/journal.pone.0016784	http://dx.doi.org/10.1371/journal.pone.0016784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347310	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000018
J	Chun, CZ; Remadevi, I; Schupp, MO; Samant, GV; Pramanik, K; Wilkinson, GA; Ramchandran, R				Chun, Chang Zoon; Remadevi, Indu; Schupp, Marcus-Oliver; Samant, Ganesh Vinayak; Pramanik, Kallal; Wilkinson, George Albert; Ramchandran, Ramani			Fli(+) etsrp(+) Hemato-Vascular Progenitor Cells Proliferate at the Lateral Plate Mesoderm during Vasculogenesis in Zebrafish	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; FACTOR VEGF; AORTIC ENDOTHELIUM; SIGNALING PATHWAY; SONIC-HEDGEHOG; DORSAL AORTA; DANIO-RERIO; CYCLIN D1; NOTCH	Background: Vasculogenesis, the de novo formation of blood vessels from precursor cells is critical for a developing embryo. However, the signals and events that dictate the formation of primary axial vessels remain poorly understood. Methodology/Principal Findings: In this study, we use ets-related protein-1 (etsrp), which is essential for vascular development, to analyze the early stages of vasculogenesis in zebrafish. We found etsrp(+) cells of the head, trunk and tail follow distinct developmental sequences. Using a combination of genetic, molecular and chemical approaches, we demonstrate that fli(+) etsrp(+) hemato-vascular progenitors (FEVPs) are proliferating at the lateral plate mesoderm (LPM). The Shh-VEGF-Notch-Hey2 signaling pathway controls the proliferation process, and experimental modulation of single components of this pathway alters etsrp(+) cell numbers at the LPM. Conclusions/Significance: This study for the first time defines factors controlling proliferation, and cell numbers of premigratory FEVPs in zebrafish.	[Chun, Chang Zoon; Remadevi, Indu; Schupp, Marcus-Oliver; Samant, Ganesh Vinayak; Pramanik, Kallal; Wilkinson, George Albert; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Translat & Biomed Res Ctr, CRI Dev Vasc Biol Program, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Chun, CZ (corresponding author), Med Coll Wisconsin, Dept Pediat, Translat & Biomed Res Ctr, CRI Dev Vasc Biol Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cchun@mcw.edu; rramchan@mcw.edu			Advancing Healthier Wisconsin grant; American Heart Association; Children's Research Institute; Children's Hospital of Wisconsin; National Institutes of Health [HL090712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090712] Funding Source: NIH RePORTER	Advancing Healthier Wisconsin grant; American Heart Association(American Heart Association); Children's Research Institute; Children's Hospital of Wisconsin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	C.Z.C is partly supported by funds from an Advancing Healthier Wisconsin grant awarded to R. R. G. V. S was supported by a post-doctoral award from the American Heart Association. This work was also supported with start-up funds from Children's Research Institute, Children's Hospital of Wisconsin, and a National Institutes of Health grant HL090712 to R. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; BRODY TB, 2008, STUDY AIDS DEV PATHW; BRODY TB, 2009, STUDY AIDS DEV PATHW; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Campbell WA, 2002, BIOCHEMISTRY-US, V41, P3372, DOI 10.1021/bi015810h; Chun CZ, 2009, BLOOD, V113, P1192, DOI 10.1182/blood-2008-06-162156; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Eriksson J, 2000, J MORPHOL, V244, P167, DOI 10.1002/(SICI)1097-4687(200006)244:3<167::AID-JMOR2>3.0.CO;2-J; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Go MJ, 1998, DEVELOPMENT, V125, P2031; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jia H, 2007, P NATL ACAD SCI USA, V104, P14008, DOI 10.1073/pnas.0702240104; Jonsson JI, 2001, EUR J IMMUNOL, V31, P3240, DOI 10.1002/1521-4141(200111)31:11<3240::AID-IMMU3240>3.0.CO;2-E; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Latimer AJ, 2006, DEV BIOL, V298, P392, DOI 10.1016/j.ydbio.2006.05.039; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lee CY, 2009, CURR BIOL, V19, P1616, DOI 10.1016/j.cub.2009.07.073; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Salanga MC, 2010, DEV DYNAM, V239, P1178, DOI 10.1002/dvdy.22277; Scheer N, 2001, DEVELOPMENT, V128, P1099; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Weinstein BM, 2002, COLD SPRING HARB SYM, V67, P155, DOI 10.1101/sqb.2002.67.155; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Yarden A, 1995, BBA-GENE STRUCT EXPR, V1264, P257, DOI 10.1016/0167-4781(95)00175-1; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zovein AC, 2006, P NATL ACAD SCI USA, V103, P12959, DOI 10.1073/pnas.0606018103	56	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14732	10.1371/journal.pone.0014732	http://dx.doi.org/10.1371/journal.pone.0014732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364913	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100003
J	Kim, SG; Kim, JS; Chung, CK				Kim, Seung-Goo; Kim, June Sic; Chung, Chun Kee			The Effect of Conditional Probability of Chord Progression on Brain Response: An MEG Study	PLOS ONE			English	Article							CHILDREN PROCESSING MUSIC; MISMATCH NEGATIVITY MMN; LANGUAGE IMPAIRMENT; GENDER-DIFFERENCES; STIMULUS DEVIANCE; AUDITORY-CORTEX; MEMORY; SYNTAX; ERP; POTENTIALS	Background: Recent electrophysiological and neuroimaging studies have explored how and where musical syntax in Western music is processed in the human brain. An inappropriate chord progression elicits an event-related potential (ERP) component called an early right anterior negativity (ERAN) or simply an early anterior negativity (EAN) in an early stage of processing the musical syntax. Though the possible underlying mechanism of the EAN is assumed to be probabilistic learning, the effect of the probability of chord progressions on the EAN response has not been previously explored explicitly. Methodology/Principal Findings: In the present study, the empirical conditional probabilities in a Western music corpus were employed as an approximation of the frequencies in previous exposure of participants. Three types of chord progression were presented to musicians and non-musicians in order to examine the correlation between the probability of chord progression and the neuromagnetic response using magnetoencephalography (MEG). Chord progressions were found to elicit early responses in a negatively correlating fashion with the conditional probability. Observed EANm (as a magnetic counterpart of the EAN component) responses were consistent with the previously reported EAN responses in terms of latency and location. The effect of conditional probability interacted with the effect of musical training. In addition, the neural response also correlated with the behavioral measures in the non-musicians. Conclusions/Significance: Our study is the first to reveal the correlation between the probability of chord progression and the corresponding neuromagnetic response. The current results suggest that the physiological response is a reflection of the probabilistic representations of the musical syntax. Moreover, the results indicate that the probabilistic representation is related to the musical training as well as the sensitivity of an individual.	[Kim, Seung-Goo; Chung, Chun Kee] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, MEG Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, SG (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	chungc@snu.ac.kr	Kim, June Sic/F-8069-2013; Kim, Seung-Goo/T-5683-2019; Chung, Chun Kee/J-5650-2012; Kim, Seung-Goo/T-5779-2019	Kim, Seung-Goo/0000-0003-0558-8547; Chung, Chun Kee/0000-0003-3485-2327; 	Korean government (MEST) [KRF-2007-313-H00006, 2010-0000861]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. KRF-2007-313-H00006 and 2010-0000861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Casey BJ, 2001, HUM BRAIN MAPP, V13, P26, DOI 10.1002/hbm.1022; CHUNG MK, COMPUTATIONAL NEUROA; Desai R, 2005, NEUROIMAGE, V26, P1019, DOI 10.1016/j.neuroimage.2005.03.024; FOOTE A, 2005, MODERN HARMONY ITS T; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Huron D.B., 2006, SWEET ANTICIPATION M; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Jentschke S, 2008, J COGNITIVE NEUROSCI, V20, P1940, DOI 10.1162/jocn.2008.20135; Jentschke S, 2005, ANN NY ACAD SCI, V1060, P231, DOI 10.1196/annals.1360.016; Jentschke S, 2009, NEUROIMAGE, V47, P735, DOI 10.1016/j.neuroimage.2009.04.090; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P683, DOI 10.1162/jocn.2003.15.5.683; Koelsch S, 2003, NEUROREPORT, V14, P709, DOI 10.1097/00001756-200304150-00010; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2008, BRAIN RES, V1212, P55, DOI 10.1016/j.brainres.2007.10.078; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Koelsch S, 2010, J COGNITIVE NEUROSCI, V22, P2251, DOI 10.1162/jocn.2009.21338; Koelsch S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002650; Koelsch S, 2009, PSYCHOPHYSIOLOGY, V46, P179, DOI 10.1111/j.1469-8986.2008.00752.x; Koelsch S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002631; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Kuriki S, 2006, J NEUROSCI, V26, P4046, DOI 10.1523/JNEUROSCI.3907-05.2006; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; Loui P, 2005, COGNITIVE BRAIN RES, V25, P678, DOI 10.1016/j.cogbrainres.2005.08.019; Loui P, 2008, MUSIC SCI, V12, P207, DOI 10.1177/102986490801200202; Loui P, 2009, J NEUROSCI, V29, P454, DOI 10.1523/JNEUROSCI.4503-08.2009; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Pearce MT, 2010, NEUROIMAGE, V50, P302, DOI 10.1016/j.neuroimage.2009.12.019; Pearce MT, 2004, J NEW MUSIC RES, V33, P367, DOI 10.1080/0929821052000343840; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; ROHRMEIER M, 2008, ICMPC 10 SAPP JAP; ROHRMEIER M, 2007, SOUND MUS COMP C LEF; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; SAMMLER D, 2010, CORTEX; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; SCHERG M, 1990, FUNDAMENTALS DIPOLE; Soeta Y, 2006, HEARING RES, V220, P106, DOI 10.1016/j.heares.2006.07.006; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Temperley D., 2007, MUSIC PROBABILITY; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101	57	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17337	10.1371/journal.pone.0017337	http://dx.doi.org/10.1371/journal.pone.0017337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726YS	21364895	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100048
J	Vieira, AC; Reid, B; Cao, L; Mannis, MJ; Schwab, IR; Zhao, M				Vieira, Ana Carolina; Reid, Brian; Cao, Lin; Mannis, Mark J.; Schwab, Ivan R.; Zhao, Min			Ionic Components of Electric Current at Rat Corneal Wounds	PLOS ONE			English	Article							EPITHELIAL-CELLS; ASCORBIC-ACID; CHLORIDE TRANSPORT; IN-VITRO; FIELDS; MIGRATION; STIMULATION; SODIUM; RABBIT; CHANNELS	Background: Endogenous electric fields and currents occur naturally at wounds and are a strong signal guiding cell migration into the wound to promote healing. Many cells involved in wound healing respond to small physiological electric fields in vitro. It has long been assumed that wound electric fields are produced by passive ion leakage from damaged tissue. Could these fields be actively maintained and regulated as an active wound response? What are the molecular, ionic and cellular mechanisms underlying the wound electric currents? Methodology/Principal Findings: Using rat cornea wounds as a model, we measured the dynamic timecourses of individual ion fluxes with ion-selective probes. We also examined chloride channel expression before and after wounding. After wounding, Ca2+ efflux increased steadily whereas K+ showed an initial large efflux which rapidly decreased. Surprisingly, Na+ flux at wounds was inward. A most significant observation was a persistent large influx of Cl-, which had a time course similar to the net wound electric currents we have measured previously. Fixation of the tissues abolished ion fluxes. Pharmacological agents which stimulate ion transport significantly increased flux of Cl-, Na+ and K+. Injury to the cornea caused significant changes in distribution and expression of Cl- channel CLC2. Conclusions/Significance: These data suggest that the outward electric currents occurring naturally at corneal wounds are carried mainly by a large influx of chloride ions, and in part by effluxes of calcium and potassium ions. Ca2+ and Cl- fluxes appear to be mainly actively regulated, while K+ flux appears to be largely due to leakage. The dynamic changes of electric currents and specific ion fluxes after wounding suggest that electrical signaling is an active response to injury and offers potential novel approaches to modulate wound healing, for example eye-drops targeting ion transport to aid in the challenging management of non-healing corneal ulcers.	[Vieira, Ana Carolina; Mannis, Mark J.; Schwab, Ivan R.; Zhao, Min] Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA; [Vieira, Ana Carolina] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Reid, Brian; Cao, Lin; Zhao, Min] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA	University of California System; University of California Davis; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Davis	Vieira, AC (corresponding author), Univ Calif Davis, Dept Ophthalmol, Davis, CA 95616 USA.	brireid@ucdavis.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	National Institutes of Health National Eye Institute [1R01EY019101]; Wellcome Trust [068012]; Research to Prevent Blindness, Inc.; NSFC [30628026]; UC Davis Dermatology Department; California Institute of Regenerative Medicine [RB1-01417]; NSF [MCB-0951199]; NATIONAL EYE INSTITUTE [R01EY019101] Funding Source: NIH RePORTER	National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NSFC(National Natural Science Foundation of China (NSFC)); UC Davis Dermatology Department; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health National Eye Institute grant 1R01EY019101 (to MZ and BR). The authors thank the Wellcome Trust for continuous support (068012). This work was also supported in part by Research to Prevent Blindness, Inc., an NSFC grant (30628026), and UC Davis Dermatology Department developmental fund. MZ is also supported by grants from the California Institute of Regenerative Medicine RB1-01417, NSF MCB-0951199. The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; BONANNO JA, 1991, OPTOMETRY VISION SCI, V68, P682, DOI 10.1097/00006324-199109000-00002; Brubaker RF, 2000, INVEST OPHTH VIS SCI, V41, P1681; BUCK MG, 1975, BIOCHIM BIOPHYS ACTA, V389, P251, DOI 10.1016/0005-2736(75)90319-3; Candia OA, 2004, EXP EYE RES, V78, P527, DOI 10.1016/j.exer.2003.08.015; CANDIA OA, 1973, EXP EYE RES, V15, P375, DOI 10.1016/0014-4835(73)90153-X; Cao L, 2010, EXP EYE RES, V90, P771, DOI 10.1016/j.exer.2010.03.013; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Connon CJ, 2006, CELL TISSUE RES, V323, P177, DOI 10.1007/s00441-005-0059-2; Connon CJ, 2004, J HISTOCHEM CYTOCHEM, V52, P415, DOI 10.1177/002215540405200313; DONN A, 1959, ARCH OPHTHALMOL-CHIC, V62, P741, DOI 10.1001/archopht.1959.04220050003001; DONN A, 1959, ARCH OPHTHALMOL-CHIC, V62, P748, DOI 10.1001/archopht.1959.04220050010002; Du Bois-Reymond E., 1860, UNTERSUCHUNGEN THIER; Du Bois-Reymond EH, 1843, FISCHE; EPSTEIN FH, 1985, ANN NY ACAD SCI, V456, P187, DOI 10.1111/j.1749-6632.1985.tb14864.x; Farboud B, 2000, EXP EYE RES, V70, P667, DOI 10.1006/exer.2000.0830; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HANNA C, 1966, AM J OPHTHALMOL, V61, P55, DOI 10.1016/0002-9394(66)90747-1; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Huttenlocher A, 2007, NEW ENGL J MED, V356, P303, DOI 10.1056/NEJMcibr066496; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KLYCE SD, 1985, CURR EYE RES, V4, P323, DOI 10.3109/02713688509025145; KLYCE SD, 1975, AM J PHYSIOL, V228, P1446, DOI 10.1152/ajplegacy.1975.228.5.1446; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; KUWABARA T, 1976, INVEST OPHTH VISUAL, V15, P4; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; MCGAHAN MC, 1982, BIOCHIM BIOPHYS ACTA, V689, P385, DOI 10.1016/0005-2736(82)90273-5; Mukerjee E V, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4326; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Nuccitelli R, 2008, WOUND REPAIR REGEN, V16, P432, DOI 10.1111/j.1524-475X.2008.00389.x; Ojingwa JC, 2003, J INVEST DERMATOL, V121, P1, DOI 10.1046/j.1523-1747.2003.12454.x; PATEL N, 1982, J NEUROSCI, V2, P483; PETROUTSOS G, 1984, OPHTHALMIC RES, V16, P185, DOI 10.1159/000265322; Piccolino M, 1998, BRAIN RES BULL, V46, P381, DOI 10.1016/S0361-9230(98)00026-4; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Reid B, 2010, CORNEA IN PRESS; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Reid B, 2011, JOVE-J VIS EXP, DOI 10.3791/2358; REISS GR, 1986, ARCH OPHTHALMOL-CHIC, V104, P753; REUSS L, 1989, PHYSIOL REV, V69, P503, DOI 10.1152/physrev.1989.69.2.503; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Smith PJS, 1999, MICROSC RES TECHNIQ, V46, P398, DOI 10.1002/(SICI)1097-0029(19990915)46:6<398::AID-JEMT8>3.0.CO;2-H; SMITH PJS, 1995, NATURE, V378, P645, DOI 10.1038/378645a0; SOONG HK, 1990, INVEST OPHTH VIS SCI, V31, P2278; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; STUMP RF, 1983, J CELL BIOL, V97, P1226, DOI 10.1083/jcb.97.4.1226; TANELIAN DL, 1992, INVEST OPHTH VIS SCI, V33, P3024; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; VANDERHEYDEN C, 1975, EXP EYE RES, V20, P89, DOI 10.1016/0014-4835(75)90111-6; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; ZADUNAISKY JA, 1973, EXP EYE RES, V15, P577, DOI 10.1016/0014-4835(73)90069-9; ZADUNAISKY JA, 1966, AM J PHYSIOL, V211, P506, DOI 10.1152/ajplegacy.1966.211.2.506; ZADUNAISKY JA, 1971, AM J PHYSIOL, V221, P1837, DOI 10.1152/ajplegacy.1971.221.6.1837; Zhao M, 1997, CURR EYE RES, V16, P973, DOI 10.1076/ceyr.16.10.973.9014; Zhao M, 1996, INVEST OPHTH VIS SCI, V37, P2548; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	66	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17411	10.1371/journal.pone.0017411	http://dx.doi.org/10.1371/journal.pone.0017411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364900	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100057
J	Kim, HK; Choi, IJ; Kim, CG; Kim, HS; Oshima, A; Michalowski, A; Green, JE				Kim, Hark Kyun; Choi, Il Ju; Kim, Chan Gyoo; Kim, Hee Sung; Oshima, Akira; Michalowski, Aleksandra; Green, Jeffrey E.			A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; C-MYC; BREAST-CANCER; RESISTANCE; SENSITIVITY; DNA; CARCINOMAS; THERAPY; ADENOCARCINOMA; 5-FU/CISPLATIN	Background: We initiated a prospective trial to identify transcriptional alterations associated with acquired chemotherapy resistance from pre- and post-biopsy samples from the same patient and uncover potential molecular pathways involved in treatment failure to help guide therapeutic alternatives. Methodology/Principal Findings: A prospective, high-throughput transcriptional profiling study was performed using endoscopic biopsy samples from 123 metastatic gastric cancer patients prior to cisplatin and fluorouracil (CF) combination chemotherapy. 22 patients who initially responded to CF were re-biopsied after they developed resistance to CF. An acquired chemotherapy resistance signature was identified by analyzing the gene expression profiles from the matched pre-and post-CF treated samples. The acquired resistance signature was able to segregate a separate cohort of 101 newly-diagnosed gastric cancer patients according to the time to progression after CF. Hierarchical clustering using a 633-gene acquired resistance signature (feature selection at P<0.01) separated the 101 pretreatment patient samples into two groups with significantly different times to progression (2.5 vs. 4.7 months). This 633-gene signature included the upregulation of AKT1, EIF4B, and RPS6 (mTOR pathway), DNA repair and drug metabolism genes, and was enriched for genes overexpressed in embryonic stem cell signatures. A 72-gene acquired resistance signature (a subset of the 633 gene signature also identified in ES cell-related gene sets) was an independent predictor for time to progression (adjusted P = 0.011) and survival (adjusted P = 0.034) of these 101 patients. Conclusion/Significance: This signature may offer new insights into identifying new targets and therapies required to overcome the acquired resistance of gastric cancer to CF.	[Kim, Hark Kyun; Oshima, Akira; Michalowski, Aleksandra; Green, Jeffrey E.] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Kim, Hark Kyun; Choi, Il Ju; Kim, Chan Gyoo; Kim, Hee Sung] Natl Canc Ctr, Goyang, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Korea (NCC)	Kim, HK (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	jegreen@nih.gov		Kim, Chan Gyoo/0000-0002-1651-2559	National Institutes of Health, Center for Cancer Research, National Cancer Institute; Korean National Cancer Center through the Ministry of Education, Science and Technology [0910570]; Ministry of Education, Science and Technology [2010K001121]	National Institutes of Health, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korean National Cancer Center through the Ministry of Education, Science and Technology; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Funding: This work was supported in part by the National Institutes of Health Intramural Program, Center for Cancer Research, National Cancer Institute; by the Korean National Cancer Center Grant 0910570 and by the Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Ban N, 1996, CANCER RES, V56, P3577; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biroccio A, 2004, NEOPLASIA, V6, P195, DOI 10.1593/neo.03370; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83; CHU G, 1990, P NATL ACAD SCI USA, V87, P3324, DOI 10.1073/pnas.87.9.3324; Costantino E, 2009, CANCER LETT, V279, P39, DOI 10.1016/j.canlet.2009.01.018; Costello RT, 2000, CANCER RES, V60, P4403; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Ghayad SE, 2008, CANCER SCI, V99, P1992, DOI 10.1111/j.1349-7006.2008.00955.x; Guo QM, 2000, CANCER RES, V60, P5922; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang CY, 2007, CLIN CANCER RES, V13, P5825, DOI 10.1158/1078-0432.CCR-07-1037; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Kang Y, 2006, J CLIN ONCOL, V24, p183S; Kim HK, 2004, BIOCHEM BIOPH RES CO, V316, P781, DOI 10.1016/j.bbrc.2004.02.109; KIM HK, PHARMACOGEN IN PRESS; Knapp DC, 2003, ANTI-CANCER DRUG, V14, P39, DOI 10.1097/00001813-200301000-00006; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Lee SC, 2009, PHARMACOGENET GENOM, V19, P833, DOI 10.1097/FPC.0b013e328330a39f; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nishimura T, 1998, CHEM-BIOL INTERACT, V112, P187, DOI 10.1016/S0009-2797(97)00161-0; Riedel RF, 2008, MOL CANCER THER, V7, P3141, DOI 10.1158/1535-7163.MCT-08-0642; Rylova SN, 2002, CANCER RES, V62, P801; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Simon R, 2007, CANCER INFORM, V3, P11; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu CJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-25; Xie XK, 2006, CANCER INVEST, V24, P1, DOI 10.1080/07357900500449520; Xu XJ, 2008, BIOINFORMATICS, V24, P137, DOI 10.1093/bioinformatics/btm541; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	47	101	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16694	10.1371/journal.pone.0016694	http://dx.doi.org/10.1371/journal.pone.0016694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364753	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800012
J	Castillo, KD; Ries, JB; Weiss, JM				Castillo, Karl D.; Ries, Justin B.; Weiss, Jack M.			Declining Coral Skeletal Extension for Forereef Colonies of Siderastrea siderea on the Mesoamerican Barrier Reef System, Southern Belize	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; MARINE ECOLOGY; CLIMATE-CHANGE; GROWTH-RATES; ENVIRONMENTAL CONTROLS; PORITES-LUTEA; BACK REEF; PATTERNS; SUSCEPTIBILITY; CALCIFICATION	Background: Natural and anthropogenic stressors are predicted to have increasingly negative impacts on coral reefs. Understanding how these environmental stressors have impacted coral skeletal growth should improve our ability to predict how they may affect coral reefs in the future. We investigated century-scale variations in skeletal extension for the slow-growing massive scleractinian coral Siderastrea siderea inhabiting the forereef, backreef, and nearshore reefs of the Mesoamerican Barrier Reef System (MBRS) in the western Caribbean Sea. Methodology/Principal Findings: Thirteen S. siderea cores were extracted, slabbed, and X-rayed. Annual skeletal extension was estimated from adjacent low-and high-density growth bands. Since the early 1900s, forereef S. siderea colonies have shifted from exhibiting the fastest to the slowest average annual skeletal extension, while values for backreef and nearshore colonies have remained relatively constant. The rates of change in annual skeletal extension were -0.020+/-0.005, 0.011+/-0.006, and -0.008+/-0.006 mm yr(-1) per year [mean+/-SE] for forereef, backreef, and nearshore colonies respectively. These values for forereef and nearshore S. siderea were significantly lower by 0.031+/-0.008 and by 0.019+/-0.009 mm yr(-1) per year, respectively, than for backreef colonies. However, only forereef S. siderea exhibited a statistically significant decline in annual skeletal extension over the last century. Conclusions/Significance: Our results suggest that forereef S. siderea colonies are more susceptible to environmental stress than backreef and nearshore counterparts, which may have historically been exposed to higher natural baseline stressors. Alternatively, sediment plumes, nutrients, and pollution originating from watersheds of Guatemala and Honduras may disproportionately impact the forereef environment of the MBRS. We are presently reconstructing the history of environmental stressors that have impacted the MBRS to constrain the cause(s) of the observed reductions in coral skeletal growth. This should improve our ability to predict and potentially mitigate the effects of future environmental stressors on coral reef ecosystems.	[Castillo, Karl D.; Ries, Justin B.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Weiss, Jack M.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Castillo, KD (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	karl_castillo@unc.edu	Ries, Justin B/B-8391-2017	Ries, Justin B/0000-0001-8427-206X	Carolina Postdoctoral Program for Faculty Diversity; National Science Foundation (NSF) [1031995]; University of North Carolina (UNC)	Carolina Postdoctoral Program for Faculty Diversity; National Science Foundation (NSF)(National Science Foundation (NSF)); University of North Carolina (UNC)	This work was supported by funding from the Carolina Postdoctoral Program for Faculty Diversity (to Castillo), National Science Foundation (NSF) award #1031995 (to JBR), and a University of North Carolina (UNC) Faculty Development Grant (to JBR). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Atkinson MJ, 1995, CORAL REEFS, V14, P215, DOI 10.1007/BF00334344; Balding DJ, 2004, APPL LONGITUDINAL AN; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2006, HYDROLOGIC MODELING; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carilli JE, 2008, NATURE P; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carricart-Ganivet JP, 2004, J EXP MAR BIOL ECOL, V302, P249, DOI 10.1016/j.jembe.2003.10.015; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DODGE RE, 1977, J MAR RES, V35, P715; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Fritts H. C., 1976, TREE RINGS CLIMATE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Guzman HM, 2008, AMBIO, V37, P342, DOI 10.1579/07-A-372.1; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Guzman HM, 1998, MAR ECOL PROG SER, V166, P109, DOI 10.3354/meps166109; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Helmle K. P., 2002, EUR M INT SOC REEF S; Heyman WD, 1999, ENVIRON MANAGE, V24, P229, DOI 10.1007/s002679900229; HIGHSMITH RC, 1979, J EXP MAR BIOL ECOL, V37, P105, DOI 10.1016/0022-0981(79)90089-3; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUSTON M, 1985, CORAL REEFS, V4, P19, DOI 10.1007/BF00302200; IPCC W, 2007, CLIM CHANG 2007 PHYS; Kerr RA, 2010, SCIENCE, V328, P1500, DOI 10.1126/science.328.5985.1500; Koltes Karen H., 2009, Smithsonian Contributions to the Marine Sciences, P379; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Lugo-Fernandez A, 1998, CONT SHELF RES, V18, P1099, DOI 10.1016/S0278-4343(97)00020-4; McCook LJ, 1996, MAR ECOL PROG SER, V139, P179, DOI 10.3354/meps139179; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Nie BF, 1997, SCI CHINA SER D, V40, P173, DOI 10.1007/BF02878376; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; R Core Team, 2020, R LANG ENV STAT COMP; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smith LW, 2007, J EXP MAR BIOL ECOL, V341, P282, DOI 10.1016/j.jembe.2006.10.053; Steven Andrew D.L., 1997, P867; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; TOMASCIK T, 1991, MAR ECOL PROG SER, V77, P261, DOI 10.3354/meps077261; Torres JL, 2002, CARIBB J SCI, V38, P222; Veron J.E.N., 2000, CORALS WORLD, V1-3; Weis VM, 2010, MOL ECOL, V19, P1515, DOI 10.1111/j.1365-294X.2010.04575.x; Wolanski E, 2005, ESTUAR COAST SHELF S, V65, P153, DOI 10.1016/j.ecss.2005.06.003; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053; Zuur Alain F., 2009, P1	67	33	34	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14615	10.1371/journal.pone.0014615	http://dx.doi.org/10.1371/journal.pone.0014615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359203	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700001
J	Luton, D; Alberti, C; Vuillard, E; Ducarme, G; Oury, JF; Guibourdenche, J				Luton, Dominique; Alberti, Corinne; Vuillard, Edith; Ducarme, Guillaume; Oury, Jean Francois; Guibourdenche, Jean			Iodine Deficiency in Northern Paris Area: Impact on Fetal Thyroid Mensuration	PLOS ONE			English	Article							PREGNANCY; SUPPLEMENTATION; MANAGEMENT; CHILD; AGE	Introduction: Iodine is essential for normal fetal and neonatal development. We studied the prevalence and impact on fetal thyroid development of iodine deficiency in pregnant women in the northern part of the Paris conurbation. Materials and Methods: 110 patients underwent several determinations of urinary iodine excretion (UIE) and of serum FT4, FT3, and TSH. Fetal thyroid gland size was assessed using ultrasonography. Results: We found evidence of widespread iodine deficiency (mean UIE, 49.8 mu g/L [standard deviation, 2.11]). Iodine deficiency did not correlate significantly with maternal thyroid parameters but showed a significant negative correlation with fetal thyroid gland size (rho = 0.25, P = 0.02). Conclusion: Iodine deficiency during pregnancy is still a problem in our geographical area and affects the fetal thyroid gland. Clinical Trials.gov NCT00162539	[Luton, Dominique; Ducarme, Guillaume] Univ Paris 07, Hop Beaujon, AP HP, GHU Nord,Serv Gynecol Obstet, Clichy, France; [Vuillard, Edith; Oury, Jean Francois] Univ Paris 07, Hop Robert Debre, AP HP, GHU Nord,Serv Gynecol Obstet, Paris, France; [Guibourdenche, Jean] Univ Paris 05, Hop Cochin Port Royal, AP HP, GHU Ouest,Serv Biochim Hormonol, Paris, France; [Alberti, Corinne] Univ Paris 07, INSERM, Hop Robert Debre, AP HP,Unite Epidemiol Clin,CIE 5, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Luton, D (corresponding author), Univ Paris 07, Hop Beaujon, AP HP, GHU Nord,Serv Gynecol Obstet, Clichy, France.	dluton@free.fr	, DUCARME/I-1248-2019	, DUCARME/0000-0002-2549-353X	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris [CRC 04-106]	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris	The project was funded by Development and Clinical Research Department Ile de France (CRC 04-106) of Assistance Publique - Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2007, J CLIN ENDOCR METAB, V92, pS1, DOI 10.1210/jc.2007-0141; [Anonymous], 2007, ASS IOD DEF DIS MON; Barrere X, 2000, CLIN ENDOCRINOL, V52, P273, DOI 10.1046/j.1365-2265.2000.00939.x; Caron P, 1997, THYROID, V7, P749, DOI 10.1089/thy.1997.7.749; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; Fister P, 2011, INT J GYNECOL OBSTET, V112, P52, DOI 10.1016/j.ijgo.2010.07.029; GLINOER D, 1995, J CLIN ENDOCR METAB, V80, P258, DOI 10.1210/jc.80.1.258; GLORIEUX J, 1983, J PEDIATR-US, V102, P19, DOI 10.1016/S0022-3476(83)80279-0; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Huel C, 2009, ULTRASOUND OBST GYN, V33, P412, DOI 10.1002/uog.6315; Luton D, 2005, J CLIN ENDOCR METAB, V90, P6093, DOI 10.1210/jc.2004-2555; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; Pedraza P, 1997, J CLIN INVEST, V99, P2701; Ranzini AC, 2001, J ULTRAS MED, V20, P613; Rendl J, 1997, J LIQ CHROMATOGR R T, V20, P1445, DOI 10.1080/10826079708010987; Vitti P, 2003, LANCET, V361, P1226, DOI 10.1016/S0140-6736(03)12935-2; Volumenie JL, 2000, PRENATAL DIAG, V20, P799, DOI 10.1002/1097-0223(200010)20:10<799::AID-PD925>3.0.CO;2-V; Zimmermann MB, 2009, AM J CLIN NUTR, V89, p668S, DOI 10.3945/ajcn.2008.26811C	18	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14707	10.1371/journal.pone.0014707	http://dx.doi.org/10.1371/journal.pone.0014707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359193	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700014
J	Mercier, E; Droit, A; Li, LP; Robertson, G; Zhang, XK; Gottardo, R				Mercier, Eloi; Droit, Arnaud; Li, Leping; Robertson, Gordon; Zhang, Xuekui; Gottardo, Raphael			An Integrated Pipeline for the Genome-Wide Analysis of Transcription Factor Binding Sites from ChIP-Seq	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; BREAST-CANCER; EM ALGORITHM; DNA; MOTIFS; IDENTIFICATION; ASSOCIATION; ACTIVATION; DISCOVERY; ALIGNMENT	ChIP-Seq has become the standard method for genome-wide profiling DNA association of transcription factors. To simplify analyzing and interpreting ChIP-Seq data, which typically involves using multiple applications, we describe an integrated, open source, R-based analysis pipeline. The pipeline addresses data input, peak detection, sequence and motif analysis, visualization, and data export, and can readily be extended via other R and Bioconductor packages. Using a standard multicore computer, it can be used with datasets consisting of tens of thousands of enriched regions. We demonstrate its effectiveness on published human ChIP-Seq datasets for FOXA1, ER, CTCF and STAT1, where it detected co-occurring motifs that were consistent with the literature but not detected by other methods. Our pipeline provides the first complete set of Bioconductor tools for sequence and motif analysis of ChIP-Seq and ChIP-chip data.	[Mercier, Eloi; Droit, Arnaud] Inst Rech Clin Montreal, Computat Biol Unit, Montreal, PQ H2W 1R7, Canada; [Droit, Arnaud] Univ Laval, Dept Mol Med, Fac Med Endocrinol & Genom, Ctr Rech,CHUQ CRCHUQ, Quebec City, PQ, Canada; [Li, Leping] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Robertson, Gordon] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Zhang, Xuekui] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Laval University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); British Columbia Cancer Agency; University of British Columbia; Fred Hutchinson Cancer Center	Mercier, E (corresponding author), Inst Rech Clin Montreal, Computat Biol Unit, Montreal, PQ H2W 1R7, Canada.	rgottard@fhcrc.org	Zhang, Xuekui/C-5105-2015; Li, Leping/F-6497-2019; Gottardo, Raphael/HCH-3169-2022; Droit, Arnaud/AGZ-6283-2022	Zhang, Xuekui/0000-0003-4728-2343; Li, Leping/0000-0003-4208-0259; Droit, Arnaud/0000-0001-7922-790X; Gottardo, Raphael/0000-0002-3867-0232	National Institutes of Health (NIH) [R01-HG005692]; NIH, National Institute of Environmental Health Sciences [ES101765-05]; Network of Applied Genetic Medicine (RMGA); Genome Canada; Genome British Columbia; Heart and Stroke Foundation of BC/Yukon; British Columbia Knowledge Development Fund; Juvenile Diabetes Research Foundation; Vancouver Foundation; BC Cancer Foundation; Michael Smith Foundation for Health Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101765, Z01ES101765] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Network of Applied Genetic Medicine (RMGA); Genome Canada(Genome Canada); Genome British Columbia; Heart and Stroke Foundation of BC/Yukon; British Columbia Knowledge Development Fund; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Vancouver Foundation; BC Cancer Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Raphael Gottardo was supported by National Institutes of Health (NIH) grant no. R01-HG005692; Leping Li was supported in part by Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ES101765-05); Arnaud Droit was supported by The Network of Applied Genetic Medicine (RMGA); and Gordon Robertson was supported by the MORGEN (Dissecting Gene Expression Networks in Mammalian Organogenesis) project, which was funded by Genome Canada, Genome British Columbia, the Heart and Stroke Foundation of BC/Yukon, the British Columbia Knowledge Development Fund, the Juvenile Diabetes Research Foundation, the Vancouver Foundation, the BC Cancer Foundation, and the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Boeva V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq217; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cicatiello L, 2004, J MOL ENDOCRINOL, V32, P719, DOI 10.1677/jme.0.0320719; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Droit A, 2010, BIOINFORMATICS, V26, P678, DOI 10.1093/bioinformatics/btq023; Durinck S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-2; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Johnson DC, 2008, BLOOD, V112, P4924, DOI 10.1182/blood-2008-02-140434; Keles S, 2008, NUCLEIC ACIDS RES, V36, P3171, DOI 10.1093/nar/gkn057; Knaus J, 2009, R J, V1, P54; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LP, 2009, J COMPUT BIOL, V16, P317, DOI 10.1089/cmb.2008.16TT; Liu J, 1994, AM STAT ASS, V89, P8; Liu X, 2001, Pac Symp Biocomput, P127; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Milde-Langosch K, 2008, BREAST CANCER RES TR, V107, P337, DOI 10.1007/s10549-007-9559-y; Nagarajan N, 2005, BIOINFORMATICS, V21, pI311, DOI 10.1093/bioinformatics/bti1044; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Parkhill J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-402; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; SCHIEMANN WP, 1994, J BIOL CHEM, V269, P6376; SCHWARZSCHILD MA, 1991, J NEUROCHEM, V56, P400, DOI 10.1111/j.1471-4159.1991.tb08165.x; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Su Gang, 2006, In Silico Biology, V6, P307; Szalkowski AM, 2010, BRIEFINGS BIOINFORMA; Valouev A, 2008, NAT METHODS; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; ZHANG X, 2010, BIOMETRICS; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	70	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16432	10.1371/journal.pone.0016432	http://dx.doi.org/10.1371/journal.pone.0016432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358819	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700019
J	Gan, LH; Chen, SJ; Zhong, J; Wang, X; Lam, EKY; Liu, X; Zhang, JB; Zhou, TH; Yu, J; Si, JM; Wang, LJ; Jin, HC				Gan, Lihong; Chen, Shujie; Zhong, Jing; Wang, Xian; Lam, Emily K. Y.; Liu, Xin; Zhang, Jianbin; Zhou, Tianhua; Yu, Jun; Si, Jianmin; Wang, Liangjing; Jin, Hongchuan			ZIC1 Is Downregulated through Promoter Hypermethylation, and Functions as a Tumor Suppressor Gene in Colorectal Cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; IDENTIFICATION; EXPRESSION; PROTEIN; FAMILY; JNK; ANGIOPOIETIN-2; METHYLATION; CARCINOMA; HEDGEHOG	The transcription factor, Zinc finger of the cerebellum (ZIC1), plays a crucial role in vertebrate development. Recently, ZIC1 has also been found to participate in the progression of human cancers, including medulloblastomas, endometrial cancers, and mesenchymal neoplasms. However, the function of ZIC1 in colon cancer progression has not been defined. In this study, we demonstrate ZIC1 to be silenced or significantly downregulated in colon cancer cell lines. These effects were reversed by demethylation treatment with 5-aza-2'-deoxycytidine (Aza). ZIC1 expression is also significantly downregulated in primary colorectal cancer tissues relative to adjacent non-tumor tissues (p = 0.0001). Furthermore, methylation of ZIC1 gene promoter is frequently detected in primary tumor tissues (85%, 34/40), but not in adjacent non-tumor tissues. Ectopic expression of ZIC1 suppresses cell proliferation and induces apoptosis, which is associated with MAPK and PI3K/Akt pathways, as well as the Bcl-xl/Bad/Caspase3 cascade. To identify target candidates of ZIC1, we employed cDNA microarray and found that 337 genes are downregulated and 95 genes upregulated by ectopic expression of ZIC1, which were verified by 10 selected gene expressions by qRT-PCR. Taken together, our results suggest that ZIC1 may potentially function as a tumor suppressor gene, which is downregulated through promoter hypermethylation in colorectal cancers.	[Gan, Lihong; Zhong, Jing; Wang, Liangjing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Shujie; Si, Jianmin] Zhejiang Univ, Sir Run Run Shaw Hosp, Inst Clin, Lab Digest Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xian; Jin, Hongchuan] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Key Lab Biotherapy Zheijang Prov,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Lam, Emily K. Y.; Liu, Xin; Zhang, Jianbin; Yu, Jun] Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Zhou, Tianhua] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Tianhua] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Chinese University of Hong Kong; Prince of Wales Hospital; Zhejiang University; Zhejiang University	Wang, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	Wanglj76@hotmail.com	Yu, Jun/D-8569-2015; zhou, tianhua/K-4908-2013; Jin, Hongchuan/C-3686-2009	Yu, Jun/0000-0001-5008-2153; zhou, tianhua/0000-0002-1791-2124; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Scientific Foundation of China [30900676]; Natural Scientific Foundation of Zhejiang Province of China [Y206280]; Department of Science and Technology of Zhejiang Province of China [2009C03012-3]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Zhejiang Province of China; Department of Science and Technology of Zhejiang Province of China	The study was supported by the National Natural Scientific Foundation of China (30900676), the Natural Scientific Foundation of Zhejiang Province of China (Y206280), and the Department of Science and Technology of Zhejiang Province of China (2009C03012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Etoh T, 2001, CANCER RES, V61, P2145; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; HERMAN JG, 1995, CANCER RES, V55, P4525; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khor TO, 2004, CANCER LETT, V210, P139, DOI 10.1016/j.canlet.2004.01.017; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Maurus D, 2009, GENE DEV, V23, P1461, DOI 10.1101/gad.517009; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Merzdorf CS, 2006, INT J DEV BIOL, V50, P611, DOI 10.1387/ijdb.052110cm; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Vasaturo F, 2000, BREAST CANCER RES TR, V61, P69, DOI 10.1023/A:1006462323260; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; YU J, 2010, ONCOGENE        0830; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	39	47	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16916	10.1371/journal.pone.0016916	http://dx.doi.org/10.1371/journal.pone.0016916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347233	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200011
J	Pandey, RK; Bhatt, KH; Dahiya, Y; Sodhi, A				Pandey, Rajeev Kumar; Bhatt, Kunal H.; Dahiya, Yogesh; Sodhi, Ajit			Mycobacterium indicus pranii Supernatant Induces Apoptotic Cell Death in Mouse Peritoneal Macrophages In Vitro	PLOS ONE			English	Article							KINASE-C-DELTA; PROTEIN-KINASE; MURINE MACROPHAGES; VACCINE; TUBERCULOSIS; RELEASE; GROWTH; PKC	Mycobacterium indicus pranii (MIP), also known as Mw, is a saprophytic, non-pathogenic strain of Mycobacterium and is commercially available as a heat-killed vaccine for leprosy and recently tuberculosis (TB) as part of MDT. In this study we provide evidence that cell-free supernatant collected from original MIP suspension induces rapid and enhanced apoptosis in mouse peritoneal macrophages in vitro. It is demonstrated that the MIP cell-free supernatant induced apoptosis is mitochondria-mediated and caspase independent and involves mitochondrial translocation of Bax and subsequent release of AIF and cytochrome c from the mitochondria. Experiments with pharmacological inhibitors suggest a possible role of PKC in mitochondria-mediated apoptosis of macrophages.	[Pandey, Rajeev Kumar; Bhatt, Kunal H.; Dahiya, Yogesh; Sodhi, Ajit] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Pandey, RK (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	ajit.sodhi@lycos.com	Bhatt, Kunal/ABA-3012-2020	Bhatt, Kunal/0000-0003-3401-5035; Pandey, Rajeev/0000-0002-7883-1854	Department of Biotechnology, Government of India, New Delhi [BT/PR7877/Med/14/1158/2006]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Funding: Funded by Department of Biotechnology, Government of India, New Delhi, Project No. BT/PR7877/Med/14/1158/2006. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Aliprantis AO, 2001, INFECT IMMUN, V69, P6248, DOI 10.1128/IAI.69.10.6248-6255.2001; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Chaudhuri Prabir, 2003, J Indian Med Assoc, V101, P559; Ciaramella A, 2000, CELL DEATH DIFFER, V7, P1270, DOI 10.1038/sj.cdd.4400761; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gronberg A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013839; Gupta S, 2008, J EUR ACAD DERMATOL, V22, P1089, DOI 10.1111/j.1468-3083.2008.02719.x; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; HINGLEYWILSON SM, 2000, MOD ASP IMMUNOBIOL, V1, P96; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kharkar Rajendra, 2002, J Indian Med Assoc, V100, P578; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel Naresh, 2002, J Indian Med Assoc, V100, P191; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Roberts DL, 2001, J CELL BIOL, V153, P221, DOI 10.1083/jcb.153.1.221; Rojas M, 1997, J IMMUNOL, V159, P1352; Saini V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006263; Sharma P, 2005, LEPROSY REV, V76, P127; SINGH IG, 1992, INFECT IMMUN, V60, P257, DOI 10.1128/IAI.60.1.257-263.1992; SINGH IG, 1991, VACCINE, V9, P10, DOI 10.1016/0264-410X(91)90309-T; SODHI A, 1986, INT J IMMUNOPHARMACO, V8, P701, DOI 10.1016/0192-0561(86)90005-6; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Talwar G P, 1999, Int Rev Immunol, V18, P229, DOI 10.3109/08830189909043027; TALWAR GP, 1990, VACCINE, V8, P121, DOI 10.1016/0264-410X(90)90134-8; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YADAVA A, 1991, SCAND J IMMUNOL, V34, P23, DOI 10.1111/j.1365-3083.1991.tb01517.x; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17093	10.1371/journal.pone.0017093	http://dx.doi.org/10.1371/journal.pone.0017093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347304	Green Submitted, Green Published, gold			2022-12-27	WOS:000287364500026
J	Bhavaraju, K; Lakhani, PR; Dorsam, RT; Jin, JG; Hitchcock, IS; Sanjay, A; Kunapuli, SP				Bhavaraju, Kamala; Lakhani, Parth R.; Dorsam, Robert T.; Jin, Jianguo; Hitchcock, Ian S.; Sanjay, Archana; Kunapuli, Satya P.			G(12/13) Signaling Pathways Substitute for Integrin alpha IIb beta 3-Signaling for Thromboxane Generation in Platelets	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISM; PROTEIN-KINASE; SHAPE CHANGE; RECEPTOR; ACTIVATION; INHIBITOR; ROLES; ALPHA(IIB)BETA(3)	Background: We have previously shown that ADP-induced TXA(2) generation requires signaling from alpha IIb beta 3 integrin in platelets. Here we observed that, unlike ADP, protease-activated receptor (PAR)-mediated TXA(2) generation occurs independently of alpha IIb beta 3. PAR agonists, but not ADP, activate G(12/13) signaling pathways. Hence, we evaluated the role of these pathways in TXA(2) generation. Principal Findings: Inhibition of ADP-induced thromboxane generation by fibrinogen receptor antagonist SC57101 was rescued by co-stimulation of G(12/13) pathways with YFLLRNP. This observation suggested an existence of a common signaling effector downstream of integrins and G(12/13) pathways. Hence, we evaluated role of three potential tyrosine kinases; c-Src, Syk and FAK (Focal Adhesion Kinase) that are known to be activated by integrins. c-Src and Syk kinase did not play a role in ADP-induced functional responses in platelets. Selective activation of G(12/13) pathways resulted in the activation of FAK, in the absence of integrin signaling. Interestingly, alpha IIb beta 3-mediated FAK activation occurred in a Src family kinase (SFK)-independent manner whereas G(12/13) pathway caused FAK activation in a SFK and RhoA-dependent manner. A FAK selective inhibitor TAE-226, blocked TXA(2) generation. However, in comparison to WT mice, Pf4-Cre/Fak-Floxed mice did not show any difference in platelet TXA(2) generation. Conclusions: Therefore, we conclude that differential activation of FAK occurs downstream of Integrins and G(12/13) pathways. However, the common effector molecule, possibly a tyrosine kinase downstream of integrins and G(12/13) pathways contributing to TXA(2) generation in platelets remains elusive.	[Bhavaraju, Kamala; Lakhani, Parth R.; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19122 USA; [Dorsam, Robert T.; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA; [Bhavaraju, Kamala; Dorsam, Robert T.; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Hitchcock, Ian S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sanjay, Archana] Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Bhavaraju, K (corresponding author), Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19122 USA.	spk@temple.edu		Hitchcock, Ian/0000-0001-7170-6703	National Institutes of Health [HL81322, HL80444, HL60683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080444, R01HL060683, R01HL081322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by HL81322, HL80444 and HL60683 from National Institutes of Health to SPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Freedman JE, 2005, CIRCULATION, V112, P2725, DOI 10.1161/CIRCULATIONAHA.104.494468; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GONG H, 2003, SCIENCE, V327, P340; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Jones ML, 2009, BIOCHEM BIOPH RES CO, V389, P198, DOI 10.1016/j.bbrc.2009.08.132; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; LAGES B, 1988, BRIT J HAEMATOL, V68, P53, DOI 10.1111/j.1365-2141.1988.tb04179.x; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; MALMSTEN C, 1977, BRIT J HAEMATOL, V35, P511, DOI 10.1111/j.1365-2141.1977.tb00617.x; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, SEMIN THROMB HEMOST, V30, P411, DOI 10.1055/s-2004-833476; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Wonerow P, 2003, J BIOL CHEM, V278, P37520, DOI 10.1074/jbc.M305077200	47	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16586	10.1371/journal.pone.0016586	http://dx.doi.org/10.1371/journal.pone.0016586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347357	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000009
J	Finkbeiner, M; Friedman, J				Finkbeiner, Matthew; Friedman, Jason			The Flexibility of Nonconsciously Deployed Cognitive Processes: Evidence from Masked Congruence Priming	PLOS ONE			English	Article							SEMANTIC CATEGORIZATION; MOTOR ACTIVATION; VISUAL-CORTEX; PRIMES; REPETITION; MECHANISMS; IDENTIFICATION; INTERFERENCE; INFERENCES; ATTENTION	Background: It is well accepted in the subliminal priming literature that task-level properties modulate nonconscious processes. For example, in tasks with a limited number of targets, subliminal priming effects are limited to primes that are physically similar to the targets. In contrast, when a large number of targets are used, subliminal priming effects are observed for primes that share a semantic (but not necessarily physical) relationship with the target. Findings such as these have led researchers to conclude that task-level properties can direct nonconscious processes to be deployed exclusively over central (semantic) or peripheral (physically specified) representations. Principal Findings: We find distinct patterns of masked priming for "novel" and "repeated" primes within a single task context. Novel primes never appear as targets and thus are not seen consciously in the experiment. Repeated primes do appear as targets, thereby lending themselves to the establishment of peripheral stimulus-response mappings. If the source of the masked priming effect were exclusively central or peripheral, then both novel and repeated primes should yield similar patterns of priming. In contrast, we find that both novel and repeated primes produce robust, yet distinct, patterns of priming. Conclusions: Our findings indicate that nonconsciously elicited cognitive processes can be flexibly deployed over both central and peripheral representations within a single task context. While we agree that task-level properties can influence nonconscious processes, our findings sharply constrain the extent of this influence. Specifically, our findings are inconsistent with extant accounts which hold that the influence of task-level properties is strong enough to restrict the deployment of nonconsciously elicited cognitive processes to a single type of representation (i.e. central or peripheral).	[Finkbeiner, Matthew; Friedman, Jason] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Finkbeiner, M (corresponding author), Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia.	matthew.finkbeiner@mq.edu.au	Friedman, Jason/B-4690-2008	Friedman, Jason/0000-0001-8845-5082	Australian Research Council [DP0880806]	Australian Research Council(Australian Research Council)	Our research has been supported by the Australian Research Council (DP0880806). The ARC (http://www.arc.gov.au/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RL, 2002, PSYCHON B REV, V9, P100, DOI 10.3758/BF03196262; Ansorge U, 2005, J EXP PSYCHOL HUMAN, V31, P762, DOI 10.1037/0096-1523.31.4.762; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Damian MF, 2001, J EXP PSYCHOL HUMAN, V27, P154, DOI 10.1037/0096-1523.27.1.154; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dehaene S, 2006, NEURON, V52, P397, DOI 10.1016/j.neuron.2006.10.018; Ferrand L, 1998, PERCEPT PSYCHOPHYS, V60, P263, DOI 10.3758/BF03206035; Finkbeiner M, 2004, J MEM LANG, V51, P1, DOI 10.1016/j.jml.2004.01.004; Finkbeiner M, 2008, J EXP PSYCHOL HUMAN, V34, P894, DOI 10.1037/0096-1523.34.4.894; Finkbeiner M, 2008, TRENDS COGN SCI, V12, P59, DOI 10.1016/j.tics.2007.11.003; Finkbeiner M, 2008, VIS COGN, V16, P11, DOI 10.1080/13506280701203838; Finkbeiner M, 2006, COGN NEUROPSYCHOL, V23, P1083, DOI 10.1080/02643290600665778; Finkbeiner M, 2006, CORTEX, V42, P790, DOI 10.1016/S0010-9452(08)70419-2; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Friedman J, 2010, ASCS09, P98, DOI DOI 10.5096/ASCS200916; GRAINGER J, 1991, J MEM LANG, V30, P370, DOI 10.1016/0749-596X(91)90042-I; Henson RN, 2008, NEUROIMAGE, V40, P884, DOI 10.1016/j.neuroimage.2007.12.003; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiesel A., 2006, ADV COGN PSYCHOL, V2, P37, DOI [10.2478/v10053-008-0043-y, DOI 10.2478/V10053-008-0043-Y, https://doi.org/10.2478/v10053-008-0043-y]; Kiesel Andrea, 2008, Adv Cogn Psychol, V3, P307, DOI 10.2478/v10053-008-0032-1; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Kouider S, 2007, CEREB CORTEX, V17, P2019, DOI 10.1093/cercor/bhl110; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kouider S, 2010, NEUROIMAGE, V49, P922, DOI 10.1016/j.neuroimage.2009.08.043; Kunde W, 2003, COGNITION, V88, P223, DOI 10.1016/S0010-0277(03)00023-4; Lachter J, 2004, PSYCHOL REV, V111, P880, DOI 10.1037/0033-295x.111.4.880; Leuthold H, 1998, PSYCHOL SCI, V9, P263, DOI 10.1111/1467-9280.00053; Marzouki Y, 2007, ACTA PSYCHOL, V126, P34, DOI 10.1016/j.actpsy.2006.11.002; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Naccache L, 2001, COGNITION, V80, P215, DOI 10.1016/S0010-0277(00)00139-6; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Neumann O, 1998, PSYCHOL RUNDSCH, V49, P185; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; Pohl C, 2010, J EXP PSYCHOL HUMAN, V36, P268, DOI 10.1037/a0015793; Qiao E, 2010, NEUROIMAGE, V49, P1786, DOI 10.1016/j.neuroimage.2009.09.034; Reynvoet B, 2005, J EXP PSYCHOL LEARN, V31, P991, DOI 10.1037/0278-7393.31.5.991; Rohrer B, 2006, BIOL CYBERN, V94, P409, DOI 10.1007/s00422-006-0055-y; Song JH, 2008, VISION RES, V48, P853, DOI 10.1016/j.visres.2007.12.015; Song JH, 2008, COGNITION, V106, P994, DOI 10.1016/j.cognition.2007.03.014; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; TURVEY MT, 1973, PSYCHOL REV, V80, P1, DOI 10.1037/h0033872; Van den Bussche E, 2007, EXP PSYCHOL, V54, P225, DOI 10.1027/1618-3169.54.3.225; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Van Opstal F, 2005, COGNITION, V97, P89, DOI 10.1016/j.cognition.2004.12.011; Van Opstal F, 2005, COGNITION, V97, P107, DOI 10.1016/j.cognition.2005.04.005	56	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17095	10.1371/journal.pone.0017095	http://dx.doi.org/10.1371/journal.pone.0017095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NZ	21347336	Green Submitted, Green Published, gold			2022-12-27	WOS:000287363000038
J	Lamers, SL; Poon, AFY; McGrath, MS				Lamers, Susanna L.; Poon, Art F. Y.; McGrath, Michael S.			HIV-1 Nef Protein Structures Associated with Brain Infection and Dementia Pathogenesis	PLOS ONE			English	Article							VIRUS TYPE-1 NEF; I DOWN-REGULATION; ACTIVATION; EXPRESSION; ASTROCYTES; MOTIF; SRC; SUPPRESSION; TRAFFICKING; MECHANISMS	The difference between regional rates of HIV-associated dementia (HAD) in patients infected with different subtypes of HIV suggests that genetic determinants exist within HIV that influence the ability of the virus to replicate in the central nervous system (in Uganda, Africa, subtype D HAD rate is 89%, while subtype A HAD rate is 24%). HIV-1 nef is a multifunctional protein with known toxic effects in the brain compartment. The goal of the current study was to identify if specific three-dimensional nef structures may be linked to patients who developed HAD. HIV-1 nef structures were computationally derived for consensus brain and non-brain sequences from a panel of patients infected with subtype B who died due to varied disease pathologies and consensus subtype A and subtype D sequences from Uganda. Site directed mutation analysis identified signatures in brain structures that appear to change binding potentials and could affect folding conformations of brain-associated structures. Despite the large sequence variation between HIV subtypes, structural alignments confirmed that viral structures derived from patients with HAD were more similar to subtype D structures than to structures derived from patient sequences without HAD. Furthermore, structures derived from brain sequences of patients with HAD were more similar to subtype D structures than they were to their own non-brain structures. The potential finding of a brain-specific nef structure indicates that HAD may result from genetic alterations that alter the folding or binding potential of the protein.	[Lamers, Susanna L.] NYU, Polytech Inst, New York, NY 10012 USA; [Lamers, Susanna L.] BioInfoExperts, Thibodaux, LA USA; [McGrath, Michael S.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [McGrath, Michael S.] AIDS & Canc Specimen Resource W Coast ACSR, San Francisco, CA USA	New York University; New York University Tandon School of Engineering; University of California System; University of California San Francisco	Lamers, SL (corresponding author), NYU, Polytech Inst, New York, NY 10012 USA.	MMcGrath@php.ucsf.edu	Poon, Art/W-9811-2019	Poon, Art/0000-0003-3779-154X	National Institutes of Health (NIH) [U01-CA066529-16, U19-MH081835-04]; Canadian Institutes of Health Research (CIHR) [200802HFE]; NATIONAL CANCER INSTITUTE [U01CA066529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project was funded by grants National Institutes of Health (NIH) U01-CA066529-16 and NIH U19-MH081835-04. The Canadian Institutes of Health Research (CIHR) Fellowships Award in HIV/AIDS Research (200802HFE) provided additional funding for Art F. Y. Poon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian K, 2007, VIROLOGY, V358, P119, DOI 10.1016/j.virol.2006.07.053; Banisadr Ghazal, 2005, Current Drug Targets - Inflammation and Allergy, V4, P387, DOI 10.2174/1568010054022097; BERGONZINI V, 2009, J NEUROVIROL, P1; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Dai L, 2010, J VIROL, V84, P8327, DOI 10.1128/JVI.00741-10; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Foster JL, 2006, CELL, V125, P1034, DOI 10.1016/j.cell.2006.06.005; GARRY RF, 1991, AIDS, V5, P1381, DOI 10.1097/00002030-199111000-00017; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Johannes L, 2003, TRAFFIC, V4, P323, DOI 10.1034/j.1600-0854.2003.00089.x; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Kramer-Hammerle S, 2005, GENE, V358, P31, DOI 10.1016/j.gene.2005.05.011; Lamers SL, 2010, J NEUROVIROL, V16, P230, DOI 10.3109/13550281003735709; Lamers SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005065; Lehmann MH, 2006, EXP CELL RES, V312, P3659, DOI 10.1016/j.yexcr.2006.08.008; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lim WA, 1996, STRUCTURE, V4, P657; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Liner KJ, 2007, J NEUROVIROL, V13, P291, DOI 10.1080/13550280701422383; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marusic C, 2009, TRANSGENIC RES, V18, P499, DOI 10.1007/s11248-009-9244-5; Masliah E, 1996, CRIT REV NEUROBIOL, V10, P57, DOI 10.1615/CritRevNeurobiol.v10.i1.30; Olivieri KC, 2010, AIDS RES HUM RETROV, V26, P495, DOI 10.1089/aid.2009.0257; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Sacktor N, 2009, NEUROLOGY, V72, P165, DOI 10.1212/01.wnl.0000339042.96109.86; Sacktor NC, 2005, AIDS, V19, P1367; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Thomas ER, 2007, AIDS RES HUM RETROV, V23, P575, DOI 10.1089/aid.2006.0246; Thompson KA, 2003, J NEUROVIROL, V9, P442, DOI 10.1080/13550280390218715; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; van de Bovenkamp M, 2002, EUR J CLIN INVEST, V32, P619, DOI 10.1046/j.1365-2362.2002.01029.x; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zhao L, 2009, SCI CHINA SER C, V52, P651, DOI 10.1007/s11427-009-0085-5; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	54	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16659	10.1371/journal.pone.0016659	http://dx.doi.org/10.1371/journal.pone.0016659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347424	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700026
J	McGinnis, EM; Keil, A				McGinnis, E. Menton; Keil, Andreas			Selective Processing of Multiple Features in the Human Brain: Effects of Feature Type and Salience	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FEATURE-BASED ATTENTION; HEMISPHERIC-DIFFERENCES; VISUAL-ATTENTION; COLOR; CORTEX; CONJUNCTIONS; MECHANISMS; LOCATION; STIMULI	Identifying targets in a stream of items at a given constant spatial location relies on selection of aspects such as color, shape, or texture. Such attended (target) features of a stimulus elicit a negative-going event-related brain potential (ERP), termed Selection Negativity (SN), which has been used as an index of selective feature processing. In two experiments, participants viewed a series of Gabor patches in which targets were defined as a specific combination of color, orientation, and shape. Distracters were composed of different combinations of color, orientation, and shape of the target stimulus. This design allows comparisons of items with and without specific target features. Consistent with previous ERP research, SN deflections extended between 160-300 ms. Data from the subsequent P3 component (300-450 ms post-stimulus) were also examined, and were regarded as an index of target processing. In Experiment A, predominant effects of target color on SN and P3 amplitudes were found, along with smaller ERP differences in response to variations of orientation and shape. Manipulating color to be less salient while enhancing the saliency of the orientation of the Gabor patch (Experiment B) led to delayed color selection and enhanced orientation selection. Topographical analyses suggested that the location of SN on the scalp reliably varies with the nature of the to-be-attended feature. No interference of non-target features on the SN was observed. These results suggest that target feature selection operates by means of electrocortical facilitation of feature-specific sensory processes, and that selective electrocortical facilitation is more effective when stimulus saliency is heightened.	[McGinnis, E. Menton; Keil, Andreas] Univ Florida, NIMH, Ctr Study Emot & Attent, Gainesville, FL 32610 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); State University System of Florida; University of Florida	McGinnis, EM (corresponding author), Univ Florida, NIMH, Ctr Study Emot & Attent, Gainesville, FL 32610 USA.	mmcginnis@ufl.edu	Keil, Andreas/F-9427-2011	Keil, Andreas/0000-0002-4064-1924; Deweese, Menton/0000-0001-7361-3826	National Institute of Mental Health [P50-MH072850, R21 MH082702, R01 MH084392]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084932, R21MH082702, P50MH072850] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by National Institute of Mental Health grants P50-MH072850 and R21 MH082702 to P.J. Lang, by National Institute of Mental Health grant R01 MH084392 to A. Keil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINE CJ, 1984, ANN NY ACAD SCI, V425, P154, DOI 10.1111/j.1749-6632.1984.tb23525.x; Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark VP, 1997, HUM BRAIN MAPP, V5, P293, DOI 10.1002/(SICI)1097-0193(1997)5:4<293::AID-HBM15>3.0.CO;2-F; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1992, ROCKY MT J MATH, V22, P837, DOI 10.1216/rmjm/1181072699; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; GARNER WR, 1987, PERCEPT PSYCHOPHYS, V41, P202, DOI 10.3758/BF03208219; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Harter M. R., 1984, VARIETIES ATTENTION, P293; HARTER MR, 1978, ELECTROEN CLIN NEURO, V45, P628, DOI 10.1016/0013-4694(78)90163-3; HARTER MR, 1980, ELECTROEN CLIN NEURO, V49, P461, DOI 10.1016/0013-4694(80)90389-2; HARTER MR, 1982, NEUROPSYCHOLOGIA, V20, P421, DOI 10.1016/0028-3932(82)90041-0; HILLYARD SA, 1993, CURR OPIN NEUROBIOL, V3, P217, DOI 10.1016/0959-4388(93)90213-I; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Junghofer M, 1997, BRAIN TOPOGR, V9, P203, DOI 10.1007/BF01190389; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Keil A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-23; Keil A, 2010, BRAIN RES, V1313, P172, DOI 10.1016/j.brainres.2009.12.006; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; McMains SA, 2007, J NEUROPHYSIOL, V98, P2110, DOI 10.1152/jn.00538.2007; Muller MM, 2004, J COGNITIVE NEUROSCI, V16, P503, DOI 10.1162/089892904322926827; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Stoppel CM, 2007, BRAIN RES, V1181, P51, DOI 10.1016/j.brainres.2007.07.019; Theeuwes J., 1995, CONVERGING OPERATION, P297; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Treisman A., 1993, ATTENTION SELECTION; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P89, DOI 10.1111/j.1469-8986.1989.tb03137.x; WIJERS AA, 1989, BIOL PSYCHOL, V29, P213, DOI 10.1016/0301-0511(89)90021-5; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P529, DOI 10.1111/j.1469-8986.1989.tb00706.x; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8	44	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16824	10.1371/journal.pone.0016824	http://dx.doi.org/10.1371/journal.pone.0016824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347379	gold, Green Submitted, Green Published			2022-12-27	WOS:000287361700037
J	Price, MHH; Proboszcz, SL; Routledge, RD; Gottesfeld, AS; Orr, C; Reynolds, JD				Price, Michael H. H.; Proboszcz, Stan L.; Routledge, Rick D.; Gottesfeld, Allen S.; Orr, Craig; Reynolds, John D.			Sea Louse Infection of Juvenile Sockeye Salmon in Relation to Marine Salmon Farms on Canada's West Coast	PLOS ONE			English	Article							LICE LEPEOPHTHEIRUS-SALMONIS; BRITISH-COLUMBIA; BROUGHTON ARCHIPELAGO; ONCORHYNCHUS-GORBUSCHA; DEVELOPMENTAL-STAGES; ATLANTIC SALMON; FRASER-RIVER; INFESTATION; SURVIVAL; DISEASE	Background: Pathogens are growing threats to wildlife. The rapid growth of marine salmon farms over the past two decades has increased host abundance for pathogenic sea lice in coastal waters, and wild juvenile salmon swimming past farms are frequently infected with lice. Here we report the first investigation of the potential role of salmon farms in transmitting sea lice to juvenile sockeye salmon (Oncorhynchus nerka). Methodology/Principal Findings: We used genetic analyses to determine the origin of sockeye from Canada's two most important salmon rivers, the Fraser and Skeena; Fraser sockeye migrate through a region with salmon farms, and Skeena sockeye do not. We compared lice levels between Fraser and Skeena juvenile sockeye, and within the salmon farm region we compared lice levels on wild fish either before or after migration past farms. We matched the latter data on wild juveniles with sea lice data concurrently gathered on farms. Fraser River sockeye migrating through a region with salmon farms hosted an order of magnitude more sea lice than Skeena River populations, where there are no farms. Lice abundances on juvenile sockeye in the salmon farm region were substantially higher downstream of farms than upstream of farms for the two common species of lice: Caligus clemensi and Lepeophtheirus salmonis, and changes in their proportions between two years matched changes on the fish farms. Mixed-effects models show that position relative to salmon farms best explained C. clemensi abundance on sockeye, while migration year combined with position relative to salmon farms and temperature was one of two top models to explain L. salmonis abundance. Conclusions/Significance: This is the first study to demonstrate a potential role of salmon farms in sea lice transmission to juvenile sockeye salmon during their critical early marine migration. Moreover, it demonstrates a major migration corridor past farms for sockeye that originated in the Fraser River, a complex of populations that are the subject of conservation concern.	[Price, Michael H. H.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Price, Michael H. H.] Raincoast Conservat Fdn, Sidney, BC, Canada; [Proboszcz, Stan L.; Orr, Craig] Watershed Watch Salmon Soc, Coquitlam, BC, Canada; [Routledge, Rick D.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [Gottesfeld, Allen S.] Skeena Fisheries Commiss, Hazelton, BC, Canada; [Reynolds, John D.] Simon Fraser Univ, Dept Biol, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University; Simon Fraser University	Price, MHH (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	pricem@uvic.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Coastal Alliance for Aquaculture Reform; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation; Patrick Hodgson Family Foundation; Ritchie Foundation; Sandler Family Foundation; SOS Marine Conservation Foundation; Tom Buell Endowment Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)	Coastal Alliance for Aquaculture Reform; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Patrick Hodgson Family Foundation; Ritchie Foundation; Sandler Family Foundation; SOS Marine Conservation Foundation; Tom Buell Endowment Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was funded by: The Coastal Alliance for Aquaculture Reform (www.farmedanddangerous.org), David and Lucile Packard Foundation (www.packard.org), Gordon and Betty Moore Foundation (www.moore.org), Patrick Hodgson Family Foundation, Ritchie Foundation, Sandler Family Foundation, SOS Marine Conservation Foundation (www.saveoursalmon.ca), Tom Buell Endowment Fund, a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to RD Routledge and JD Reynolds (www.nserc-crsng.gc.ca), and an NSERC Industrial Postgraduate Scholarship to MHH Price. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beacham TD, 2005, N AM J FISH MANAGE, V25, P763, DOI 10.1577/M04-080.1; Beacham TD, 2004, T AM FISH SOC, V133, P1117, DOI 10.1577/T04-001.1; Beamish R, 2009, AQUACULTURE, V297, P31, DOI 10.1016/j.aquaculture.2009.09.001; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Bjorn P. A., 1997, Nordic Journal of Freshwater Research, P60; *BRIT COL MIN AGR, 2008, FISH HLTH PROGR ANN; *BRIT COL MIN AGR, 2007, FISH HLTH PROGR ANN; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; *COH COMM, 2010, COMM INQ DECL SOCK S; Connors BM, 2010, J APPL ECOL, V47, P1372, DOI 10.1111/j.1365-2664.2010.01889.x; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Finstad B, 2007, AQUACULTURE, V273, P374, DOI 10.1016/j.aquaculture.2007.10.019; Ford JS, 2008, PLOS BIOL, V6, P411, DOI 10.1371/journal.pbio.0060033; FRASER NL, 2009, CONS BIOL, V23, P599; Gottesfeld AS, 2009, J FISH DIS, V32, P45, DOI 10.1111/j.1365-2761.2008.01003.x; Groot C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P53; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; Holst JC, 2000, FISH RES, V48, P87, DOI 10.1016/S0165-7836(00)00116-8; *INT UN CONS NAT, 2008, PAC SOCK SALM ONC NE; JESSUP DA, 1991, WILDLIFE PRODUCTION, P438; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; KABATA Z, 1972, J FISH RES BOARD CAN, V29, P1571, DOI 10.1139/f72-245; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; KRKOSEK M, 2010, ECOL APPL IN PRESS; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Krkosek M, 2011, CAN J FISH AQUAT SCI, V68, P17, DOI 10.1139/F10-137; Krkosek M, 2010, FRONT ECOL ENVIRON, V8, P201, DOI 10.1890/080097; Krkosek M, 2009, P ROY SOC B-BIOL SCI, V276, P2819, DOI 10.1098/rspb.2009.0317; *LEG ASS BRIT COL, 2007, SPEC COMM SUST AQ FI; Macdonald DW, 2006, BIOL CONSERV, V131, P143, DOI 10.1016/j.biocon.2006.05.007; *MAR HARV CORP, 2008, SUST REP; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Morton A, 2008, N AM J FISH MANAGE, V28, P523, DOI 10.1577/M07-042.1; Morton Alexandra, 2005, Alaska Fishery Research Bulletin, V11, P146; Murray AG, 2005, PREV VET MED, V67, P223, DOI 10.1016/j.prevetmed.2004.10.012; Murray AG, 2009, PREV VET MED, V88, P167, DOI 10.1016/j.prevetmed.2008.09.006; NESE L, 1993, DIS AQUAT ORGAN, V16, P79, DOI 10.3354/dao016079; NYLUND A, 1994, DIS AQUAT ORGAN, V19, P95, DOI 10.3354/dao019095; Orr C, 2007, N AM J FISH MANAGE, V27, P187, DOI 10.1577/M06-043.1; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; PARKER RR, 1964, J FISH RES BOARD CAN, V21, P873, DOI 10.1139/f64-085; Pella J, 2001, FISH B-NOAA, V99, P151; Penston MJ, 2008, DIS AQUAT ORGAN, V81, P109, DOI 10.3354/dao01946; Peterman R.M., 2010, SYNTH EV WORKSH DECL; Pike AW, 2000, ADV PARASIT, V44, P233; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Price MHH, 2010, CAN J FISH AQUAT SCI, V67, P1925, DOI 10.1139/F10-105; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Thirgood S, 2009, J APPL ECOL, V46, P454, DOI 10.1111/j.1365-2664.2009.01629.x; THOMSON RE, 1981, CAN SPEC PUB FISH AQ, V56; Tully O, 1999, PARASITOLOGY, V119, P41, DOI 10.1017/S003118209900445X; Webster SJ, 2007, CAN J FISH AQUAT SCI, V64, P672, DOI 10.1139/F07-043; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; [No title captured]; 2009, ADAPTING CHANGE MANA	65	34	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16851	10.1371/journal.pone.0016851	http://dx.doi.org/10.1371/journal.pone.0016851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347456	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700045
J	Tiang, JM; Butcher, NJ; Cullinane, C; Humbert, PO; Minchin, RF				Tiang, Jacky M.; Butcher, Neville J.; Cullinane, Carleen; Humbert, Patrick O.; Minchin, Rodney F.			RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition	PLOS ONE			English	Article							ACETYLTRANSFERASE TYPE-I; N-ACETYLTRANSFERASE; CANCER CELLS; PROGNOSTIC-SIGNIFICANCE; TUMOR PROGRESSION; PROSTATE-CANCER; BREAST-CANCER; GENE; METABOLISM; CARCINOMA	Arylamine N-acetyltransferase-1 (NAT1) is an enzyme that catalyzes the biotransformation of arylamine and hydrazine substrates. It also has a role in the catabolism of the folate metabolite p-aminobenzoyl glutamate. Recent bioinformatics studies have correlated NAT1 expression with various cancer subtypes. However, a direct role for NAT1 in cell biology has not been established. In this study, we have knocked down NAT1 in the colon adenocarcinoma cell-line HT-29 and found a marked change in cell morphology that was accompanied by an increase in cell-cell contact growth inhibition and a loss of cell viability at confluence. NAT1 knock-down also led to attenuation in anchorage independent growth in soft agar. Loss of NAT1 led to the up-regulation of E-cadherin mRNA and protein levels. This change in E-cadherin was not attributed to RNAi off-target effects and was also observed in the prostate cancer cell-line 22Rv1. In vivo, NAT1 knock-down cells grew with a longer doubling time compared to cells stably transfected with a scrambled RNAi or to parental HT-29 cells. This study has shown that NAT1 affects cell growth and morphology. In addition, it suggests that NAT1 may be a novel drug target for cancer therapeutics.	[Tiang, Jacky M.; Butcher, Neville J.; Minchin, Rodney F.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Cullinane, Carleen; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Queensland; Peter Maccallum Cancer Center	Tiang, JM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	n.butcher@uq.edu.au	Humbert, Patrick O/L-4264-2016	Humbert, Patrick O/0000-0002-1366-6691; Cullinane, Carleen/0000-0001-5833-6605; Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	National Health and Medical Research Foundation, Australia [NHMRC 569695]	National Health and Medical Research Foundation, Australia	This work was supported by National Health and Medical Research Foundation, Australia (NHMRC 569695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, MOL CANCER RES, V1, P826; Bieche I, 2004, BREAST CANCER RES, V6, pR252, DOI 10.1186/bcr784; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher N. J., 2002, Pharmacogenomics Journal, V2, P30, DOI 10.1038/sj.tpj.6500053; Butcher NJ, 2007, CANCER RES, V67, P85, DOI 10.1158/0008-5472.CAN-06-2635; Butcher NJ, 2004, J BIOL CHEM, V279, P22131, DOI 10.1074/jbc.M312858200; Butcher NJ, 2003, BIOCHEM J, V376, P441, DOI 10.1042/BJ20030650; Butcher NJ, 2000, MOL PHARMACOL, V57, P468, DOI 10.1124/mol.57.3.468; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cao W, 2005, PHARMACOGENOMICS J, V5, P255, DOI 10.1038/sj.tpj.6500319; Castillon N, 2002, LAB INVEST, V82, P989, DOI 10.1097/01.LAB.0000022221.88025.43; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gout S, 2004, EXP CELL RES, V299, P498, DOI 10.1016/j.yexcr.2004.06.008; Gustafson CE, 1996, CANCER RES, V56, P5238; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawcroft G, 2007, ONCOGENE, V26, P3006, DOI 10.1038/sj.onc.1210113; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Howard EW, 2008, MINI-REV MED CHEM, V8, P496, DOI 10.2174/138955708784223521; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Mell LK, 2004, CLIN CANCER RES, V10, P5546, DOI 10.1158/1078-0432.CCR-0943-03; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Motti ML, 2005, CARCINOGENESIS, V26, P1021, DOI 10.1093/carcin/bgi050; NAGASAWA H, 1995, CANCER RES, V55, P1842; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Nelson Peter J, 2002, Kidney Int, V61, pS99; OKA H, 1993, CANCER RES, V53, P1696; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sugamori KS, 2003, MOL PHARMACOL, V64, P170, DOI 10.1124/mol.64.1.170; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200	39	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17031	10.1371/journal.pone.0017031	http://dx.doi.org/10.1371/journal.pone.0017031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347396	Green Published, gold			2022-12-27	WOS:000287361700064
J	Xu, X; Wang, X; Xiao, ZT; Li, Y; Wang, YH				Xu, Xue; Wang, Xia; Xiao, Zhengtao; Li, Yan; Wang, Yonghua			Two TPX2-Dependent Switches Control the Activity of Aurora A	PLOS ONE			English	Article							AMBER FORCE-FIELD; DYNAMICS SIMULATION; MOLECULAR-DYNAMICS; A ACTIVATION; KINASE; PROTEIN; CANCER; TPX2; CRYSTALLOGRAPHY; CENTROSOME	Aurora A is an important oncogenic kinase for mitotic spindle assembly and a potentially attractive target for human cancers. Its activation could be regulated by ATP cycle and its activator TPX2. To understand the activation mechanism of Aurora A, a series of 20 ns molecular dynamics (MD) simulations were performed on both the wild-type kinase and its mutants. Analyzing the three dynamic trajectories (Aurora A-ATP, Aurora A-ADP, and Aurora A-ADP-TPX2) at the residue level, for the first time we find two TPX2-dependent switches, i.e., switch-1 (Lys-143) and switch-2 (Arg-180), which are tightly associated with Aurora A activation. In the absence of TPX2, Lys-143 exhibits a "closed'' state, and becomes hydrogen-bonded to ADP. Once TPX2 binding occurs, switch-1 is forced to "open'' the binding site, thus pulling ADP away from Aurora A. Without facilitation of TPX2, switch-2 exits in an "open'' conformation which accompanies the outward-flipping movement of P.Thr288 (in an inactive conformation), leading to the crucial phosphothreonine exposed and accessible for deactivation. However, with the binding of TPX2, switch-2 is forced to undergo a "closed'' movement, thus capturing P.Thr288 into a buried position and locking its active conformation. Analysis of two Aurora A (K143A and R180A) mutants for the two switches further verifies their functionality and reliability in controlling Aurora activity. Our systems therefore suggest two switches determining Aurora A activation, which are important for the development of aurora kinase inhibitors.	[Xu, Xue; Wang, Xia; Xiao, Zhengtao; Wang, Yonghua] NW A&F Univ, Ctr Bioinformat, Yangling, Peoples R China; [Li, Yan] Dalian Univ Technol, Sch Chem Engn, Dalian, Peoples R China; [Li, Yan] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Peoples R China	Northwest A&F University - China; Dalian University of Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Wang, YH (corresponding author), NW A&F Univ, Ctr Bioinformat, Yangling, Peoples R China.	dcpwyh@163.com	Xiao, Zhengtao/AAD-3052-2019; , Paulin/U-9063-2019; WANG, XIA/S-3431-2018	Xiao, Zhengtao/0000-0002-5535-5381; , Paulin/0000-0001-6045-3712; WANG, XIA/0000-0003-1960-4157	National Natural Science Foundation of China [10801025]; Northwest A F University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A F University	This work is financially supported by the National Natural Science Foundation of China (Grant No. 10801025) and also the Fund of Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Goodsell D. S., 1996, OUR MOL NATURE BODYS; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lu BZ, 2005, PROTEIN SCI, V14, P159, DOI 10.1110/ps.04894605; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	28	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16757	10.1371/journal.pone.0016757	http://dx.doi.org/10.1371/journal.pone.0016757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347367	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700032
J	Ma, GZM; Stankovich, J; Kilpatrick, TJ; Binder, MD; Field, J				Ma, Gerry Z. M.; Stankovich, Jim; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith		Australia New Zealand Multiple Scl	Polymorphisms in the Receptor Tyrosine Kinase MERTK Gene Are Associated with Multiple Sclerosis Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CUPRIZONE-INDUCED DEMYELINATION; APOPTOTIC CELLS; PROTEIN-S; TAM RECEPTORS; T-CELLS; GAS6; REPLICATION; LOCI; MICE	Multiple sclerosis (MS) is a debilitating, chronic demyelinating disease of the central nervous system affecting over 2 million people worldwide. The TAM family of receptor tyrosine kinases (TYRO3, AXL and MERTK) have been implicated as important players during demyelination in both animal models of MS and in the human disease. We therefore conducted an association study to identify single nucleotide polymorphisms (SNPs) within genes encoding the TAM receptors and their ligands associated with MS. Analysis of genotype data from a genome-wide association study which consisted of 1618 MS cases and 3413 healthy controls conducted by the Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) revealed several SNPs within the MERTK gene (Chromosome 2q14.1, Accession Number NG_011607.1) that showed suggestive association with MS. We therefore interrogated 28 SNPs in MERTK in an independent replication cohort of 1140 MS cases and 1140 healthy controls. We found 12 SNPs that replicated, with 7 SNPs showing p-values of less than 10 25 when the discovery and replication cohorts were combined. All 12 replicated SNPs were in strong linkage disequilibrium with each other. In combination, these data suggest the MERTK gene is a novel risk gene for MS susceptibility.	[Ma, Gerry Z. M.; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith] Univ Melbourne, Florey Neurosci Inst, Multiple Sclerosis Div, Melbourne, Vic, Australia; [Ma, Gerry Z. M.; Kilpatrick, Trevor J.; Binder, Michele D.; Field, Judith] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Stankovich, Jim] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Tasmania; Menzies Institute for Medical Research	Ma, GZM (corresponding author), Univ Melbourne, Florey Neurosci Inst, Multiple Sclerosis Div, Melbourne, Vic, Australia.	judith.field@florey.edu.au	Kermode, Allan/G-3568-2019; MOSCATO, PABLO ALBERTO/G-7668-2013; Browning, Brian L/A-1178-2010; Brown, Matthew A/E-5749-2010; Scott, Rodney/B-2827-2013; Slee, Mark/J-4731-2015	Kermode, Allan/0000-0002-4476-4016; Browning, Brian L/0000-0001-6454-6633; Brown, Matthew A/0000-0003-0538-8211; Moscato, Pablo/0000-0003-2570-5966; Binder, Michele/0000-0002-4494-6717; Scott, Rodney/0000-0001-7724-3404; Stankovich, Jim/0000-0001-9344-7749; Foote, Simon/0000-0002-9142-2107; Lechner-Scott, Jeannette/0000-0002-3850-447X; Field, Judith/0000-0002-7089-0999; Butzkueven, Helmut/0000-0003-3940-8727; Griffiths, Lyn/0000-0002-6774-5475; Slee, Mark/0000-0003-4323-2453; Kilpatrick, Trevor/0000-0003-3999-085X	Perpetual Trustees Australia Ltd [387]; Australian Research Council [LP0776744]; Australian Postgraduate Award; Multiple Sclerosis Research Australia Fellowship; Department of Innovation, Industry and Regional Development, Victoria, Australia; Perpetual Trustees Australia Ltd	Perpetual Trustees Australia Ltd; Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Multiple Sclerosis Research Australia Fellowship; Department of Innovation, Industry and Regional Development, Victoria, Australia; Perpetual Trustees Australia Ltd	This work was supported by a grant from Perpetual Trustees Australia Ltd (Grant number 387) and the Australian Research Council (Linkage Project Grant Number LP0776744). G.Z.M.M is supported by an Australian Postgraduate Award. J.F. is supported by a Multiple Sclerosis Research Australia Fellowship. The Florey Neuroscience Institutes is supported by funding provided from the Operational Infrastructure Scheme of the Department of Innovation, Industry and Regional Development, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: This work was funded by Perpetual Trustees Australia Ltd. This does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Shao WH, 2008, J IMMUNOL, V180, P7728, DOI 10.4049/jimmunol.180.11.7728; SHAO WH, 2010, J AUTOIMMUN; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wallet MA, 2009, P NATL ACAD SCI USA, V106, P4810, DOI 10.1073/pnas.0900683106; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7	38	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16964	10.1371/journal.pone.0016964	http://dx.doi.org/10.1371/journal.pone.0016964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347448	Green Published, gold			2022-12-27	WOS:000287077600037
J	Nakazawa, T				Nakazawa, Takefumi			Alternative Stable States Generated by Ontogenetic Niche Shift in the Presence of Multiple Resource Use	PLOS ONE			English	Article							TROPHIC CASCADES; REGIME SHIFTS; SIZE; PREY; ECOSYSTEMS; DYNAMICS; PREDATION	It has been suggested that when juveniles and adults use different resources or habitats, alternative stable states (ASS) may exist in systems coupled by an ontogenetic niche shift. However, mainly the simplest system, i.e., the one-consumer-two-resource system, has been studied previously, and little is known about the development of ASS existing in more complex systems. Here, I theoretically investigated the development of ASS caused by an ontogenetic niche shift in the presence of multiple resource use. I considered three independent scenarios; (i) additional resources, (ii) multiple habitats, and (iii) interstage resource sharing. The model analyses illustrate that relative balance between the total resource availability in the juvenile and adult habitats is crucial for the development of ASS. This balance is determined by factors such as local habitat productivity, subsidy inputs, colonization area, and foraging mobility. Furthermore, it is also shown that interstage resource sharing generally suppresses ASS. These results suggest that the anthropogenic impacts of habitat modifications (e.g., fragmentation and destruction) or interaction modifications (e.g., changes in ontogeny and foraging behavior) propagate through space and may cause or prevent regime shifts in the regional community structure.	[Nakazawa, Takefumi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Nakazawa, Takefumi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	Kyoto University; National Taiwan University	Nakazawa, T (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	take.nkzw@gmail.com			Japan Society for the Promotion of Science Research Fellowship for Young Scientists [2103033]; Excellent Young Researchers	Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Excellent Young Researchers	This research was supported by a Japan Society for the Promotion of Science Research Fellowship for Young Scientists (2103033) and Excellent Young Researchers Overseas Visit Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2009, ECOL LETT, V12, P462, DOI 10.1111/j.1461-0248.2009.01282.x; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; de Roos AM, 2002, ECOL MONOGR, V72, P271, DOI 10.1890/0012-9615(2002)072[0271:ONSAFB]2.0.CO;2; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; NAKAZAWA T, THEOR ECOL IN PRESS; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Takimoto G, 2003, AM NAT, V162, P93, DOI 10.1086/375540; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435	28	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14667	10.1371/journal.pone.0014667	http://dx.doi.org/10.1371/journal.pone.0014667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346805	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600003
J	Steibel, JP; Bates, RO; Rosa, GJM; Tempelman, RJ; Rilington, VD; Ragavendran, A; Raney, NE; Ramos, AM; Cardoso, FF; Edwards, DB; Ernst, CW				Steibel, Juan Pedro; Bates, Ronald O.; Rosa, Guilherme J. M.; Tempelman, Robert J.; Rilington, Valencia D.; Ragavendran, Ashok; Raney, Nancy E.; Ramos, Antonio Marcos; Cardoso, Fernando F.; Edwards, David B.; Ernst, Catherine W.			Genome-Wide Linkage Analysis of Global Gene Expression in Loin Muscle Tissue Identifies Candidate Genes in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PIETRAIN RESOURCE POPULATION; MEAT QUALITY TRAITS; MICROARRAY EXPERIMENTS; COMPLEX; PROTEIN; OXIDOREDUCTASE; REDUCTASE; DESIGN; ERP18	Background: Nearly 6,000 QTL have been reported for 588 different traits in pigs, more than in any other livestock species. However, this effort has translated into only a few confirmed causative variants. A powerful strategy for revealing candidate genes involves expression QTL (eQTL) mapping, where the mRNA abundance of a set of transcripts is used as the response variable for a QTL scan. Methodology/Principal Findings: We utilized a whole genome expression microarray and an F-2 pig resource population to conduct a global eQTL analysis in loin muscle tissue, and compared results to previously inferred phenotypic QTL (pQTL) from the same experimental cross. We found 62 unique eQTL (FDR <10%) and identified 3 gene networks enriched with genes subject to genetic control involved in lipid metabolism, DNA replication, and cell cycle regulation. We observed strong evidence of local regulation (40 out of 59 eQTL with known genomic position) and compared these eQTL to pQTL to help identify potential candidate genes. Among the interesting associations, we found aldo-keto reductase 7A2 (AKR7A2) and thioredoxin domain containing 12 (TXNDC12) eQTL that are part of a network associated with lipid metabolism and in turn overlap with pQTL regions for marbling, % intramuscular fat (% fat) and loin muscle area on Sus scrofa (SSC) chromosome 6. Additionally, we report 13 genomic regions with overlapping eQTL and pQTL involving 14 local eQTL. Conclusions/Significance: Results of this analysis provide novel candidate genes for important complex pig phenotypes.	[Steibel, Juan Pedro; Bates, Ronald O.; Tempelman, Robert J.; Rilington, Valencia D.; Ragavendran, Ashok; Raney, Nancy E.; Ramos, Antonio Marcos; Cardoso, Fernando F.; Edwards, David B.; Ernst, Catherine W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Steibel, Juan Pedro] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Rosa, Guilherme J. M.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Cardoso, Fernando F.] Embrapa So Reg Anim Husb, Planaltina, RS, Brazil	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Steibel, JP (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	ernstc@msu.edu	Cardoso, Fernando/I-6585-2012; Rosa, Guilherme J. M. J. M./G-3862-2011; Tempelman, R. J./J-9566-2019	Rosa, Guilherme J. M. J. M./0000-0001-9172-6461; Tempelman, Robert/0000-0002-7833-6730; Ramos, Marcos/0000-0003-3450-0970; Cardoso, Fernando/0000-0002-4145-1049	USDA National Institute of Food and Agriculture [2004-35604-14580]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by National Research Initiative Competitive Grant no. 2004-35604-14580 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from the US Swine Genome Coordinator for synthesis of oligonucleotides for the Pigoligoarray, and from the US National Animal Genome Research Program Bioinformatics Coordinator for server access is greatly appreciated.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Bueno JSS, 2006, GENETICS, V174, P945, DOI 10.1534/genetics.106.057281; Cardoso FF, 2008, GENETICS, V180, P1679, DOI 10.1534/genetics.108.090969; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Cogburn LA, 2003, POULTRY SCI, V82, P939, DOI 10.1093/ps/82.6.939; de Koning DJ, 2007, POULTRY SCI, V86, P1501, DOI 10.1093/ps/86.7.1501; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Edwards DB, 2008, J ANIM SCI, V86, P254, DOI 10.2527/jas.2006-626; Edwards DB, 2008, J ANIM SCI, V86, P241, DOI 10.2527/jas.2006-625; GERRARD DE, 2003, TISSUE STRUCTURE ORG, P26; Haley C, 2006, ANIM GENET, V37, P10, DOI 10.1111/j.1365-2052.2006.01470.x; HALEY CS, 1994, GENETICS, V136, P1195; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kadarmideen HN, 2006, MAMM GENOME, V17, P548, DOI 10.1007/s00335-005-0169-x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Lucca-Junior W, 2009, BRAZ J MED BIOL RES, V42, P164, DOI 10.1590/S0100-879X2009000200003; National Research Council, 1998, NUTR REQ SWIN, Vtenth; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Picklo MJ, 2001, BRAIN RES, V916, P229, DOI 10.1016/S0006-8993(01)02897-9; PONSUKSILI S, 2010, HEREDITY; Ponsuksili S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-572; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Rosa GJM, 2005, COMP FUNCT GENOM, V6, P123, DOI 10.1002/cfg.464; ROSSI ML, DNA REPAIR AMST, V9, P331; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Rowe ML, 2009, BIOCHEMISTRY-US, V48, P4596, DOI 10.1021/bi9003342; Satyanarayana A, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-9; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Watanabe TK, 1996, CYTOGENET CELL GENET, V73, P153, DOI 10.1159/000134329; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	40	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16766	10.1371/journal.pone.0016766	http://dx.doi.org/10.1371/journal.pone.0016766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346809	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600023
J	Whiteley, MH; Bell, JS; Rothman, DA				Whiteley, Mary H.; Bell, Jerold S.; Rothman, Debby A.			Novel Allelic Variants in the Canine Cyclooxgenase-2 (Cox-2) Promoter Are Associated with Renal Dysplasia in Dogs	PLOS ONE			English	Article							SHIH-TZU DOGS; JUVENILE NEPHROPATHY; INCOMPLETE PENETRANCE; POSTNATAL-DEVELOPMENT; FAMILIAL NEPHROPATHY; GENE; CYCLOOXYGENASE-2; DISEASE; MICE; TRANSCRIPTION	Renal dysplasia (RD) in dogs is a complex disease with a highly variable phenotype and mode of inheritance that does not follow a simple Mendelian pattern. Cox-2 (Cyclooxgenase-2) deficient mice have renal abnormalities and a pathology that has striking similarities to RD in dogs suggesting to us that mutations in the Cox-2 gene could be the cause of RD in dogs. Our data supports this hypothesis. Sequencing of the canine Cox-2 gene was done from clinically affected and normal dogs. Although no changes were detected in the Cox-2 coding region, small insertions and deletions of GC boxes just upstream of the ATG translation start site were found. These sequences are putative SP1 transcription factor binding sites that may represent important cis-acting DNA regulatory elements that govern the expression of Cox-2. A pedigree study of a family of Lhasa apsos revealed an important statistical correlation of these mutant alleles with the disease. We examined an additional 22 clinical cases from various breeds. Regardless of the breed or severity of disease, all of these had one or two copies of the Cox-2 allelic variants. We suggest that the unusual inheritance pattern of RD is due to these alleles, either by changing the pattern of expression of Cox-2 or making Cox-2 levels susceptible to influences of other genes or environmental factors that play an unknown but important role in the development of RD in dogs.	[Whiteley, Mary H.] DOGenes Inc, Peterborough, ON, Canada; [Bell, Jerold S.] Tufts Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA; [Rothman, Debby A.] Amer Lhasa Apso Club, Conifer, CO USA		Whiteley, MH (corresponding author), DOGenes Inc, Peterborough, ON, Canada.	info@dogenes.com			ASCT (American Shih tzu club); ALAC (American Lhasa Apso Club); AMSC (American Miniature Schnauzer Club); DOGenes Inc.	ASCT (American Shih tzu club); ALAC (American Lhasa Apso Club); AMSC (American Miniature Schnauzer Club); DOGenes Inc.	This research was funded in part by the ASCT (American Shih tzu club), ALAC (American Lhasa Apso Club), and the AMSC (American Miniature Schnauzer Club). The remainder of the funding was a capital expense of DOGenes Inc. Because one of the authors is employed by the funder, the funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham LA, 2003, AUST VET J, V81, P336, DOI 10.1111/j.1751-0813.2003.tb11507.x; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; BOOTH K, 1990, VET REC, V127, P596; Bovee KC, 2003, P 28 WORLD C WORLD S; Davidson AG, 2007, J VET INTERN MED, V21, P394, DOI 10.1892/0891-6640(2007)21[394:GCOARH]2.0.CO;2; de Vooght KMK, 2009, CLIN CHEM, V55, P698, DOI 10.1373/clinchem.2008.120931; DeWitt D L, 1993, Am J Med, V95, p40S, DOI 10.1016/0002-9343(93)90396-7; DIBARTOLA SP, 1983, J AM VET MED ASSOC, V183, P693; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; EPSTEIN DJ, 2009, BRIEF FUNCT GENOMIC; HOPPE A, 1990, J SMALL ANIM PRACT, V31, P83, DOI 10.1111/j.1748-5827.1990.tb00728.x; Hoppe A, 2000, J SMALL ANIM PRACT, V41, P422, DOI 10.1111/j.1748-5827.2000.tb03237.x; HORSTER M, 1971, J CLIN INVEST, V50, P779, DOI 10.1172/JCI106549; JONASSON M, 2009, VETERINARPROGRAMMET, V25; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KERLIN RL, 1995, VET PATHOL, V32, P327, DOI 10.1177/030098589503200319; Khan KNM, 2001, VET PATHOL, V38, P116, DOI 10.1354/vp.38-1-116; Kim SH, 2005, ALLERGY, V60, P760, DOI 10.1111/j.1398-9995.2005.00780.x; KLEINMAN LI, 1973, J PHYSIOL-LONDON, V228, P91, DOI 10.1113/jphysiol.1973.sp010074; Komhoff M, 2000, KIDNEY INT, V57, P414; KRUGER JM, 1995, CONGENITAL HEREDITAR; Lobetti RG, 1996, J SMALL ANIM PRACT, V37, P552, DOI 10.1111/j.1748-5827.1996.tb02319.x; LUCKE VM, 1980, J SMALL ANIM PRACT, V21, P169, DOI 10.1111/j.1748-5827.1980.tb01229.x; MANDERINO DM, 1984, MOD VET PRACT, V65, P633; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORTON LD, 1990, VET PATHOL, V6, P455; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; NASH AS, 1988, VET REC, V123, P654; NASH AS, 1989, J SMALL ANIM PRACT, V30, P178, DOI 10.1111/j.1748-5827.1989.tb01529.x; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Neill PG, 1993, FEBS LETT, V330, P156; OBRIEN TD, 1982, J AM VET MED ASSOC, V180, P658; Olenick CL, 1999, CAN VET J, V40, P425; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Peeters D, 2000, AUST VET J, V78, P162, DOI 10.1111/j.1751-0813.2000.tb10584.x; PICUT CA, 1987, VET PATHOL, V24, P156, DOI 10.1177/030098588702400209; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROBINSON WF, 1985, AUST VET J, V62, P109, DOI 10.1111/j.1751-0813.1985.tb07253.x; Roels S, 1997, J SMALL ANIM PRACT, V38, P115, DOI 10.1111/j.1748-5827.1997.tb03331.x; Schulze C, 1998, VET QUART, V20, P146, DOI 10.1080/01652176.1998.9694861; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; SIMMONS DL, 1992, PROSTAGLANDINS LEUKO, P67; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stanfield KM, 2003, BIRTH DEFECTS RES A, V67, P54, DOI 10.1002/bdra.10032; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; VILAFRANCA M, 1994, VET PATHOL, V3, P375; Wang SY, 2008, MUTAT RES-FUND MOL M, V638, P26, DOI 10.1016/j.mrfmmm.2007.08.011; ZENZIEGREGORY B, 1992, J BIOL CHEM, V267, P2823; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; Zhang MZ, 1997, AM J PHYSIOL-RENAL, V273, pF994, DOI 10.1152/ajprenal.1997.273.6.F994	51	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16684	10.1371/journal.pone.0016684	http://dx.doi.org/10.1371/journal.pone.0016684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346820	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600017
J	Erauso, G; Lakhal, F; Bidault-Toffin, A; Le Chevalier, P; Bouloc, P; Paillard, C; Jacq, A				Erauso, Gael; Lakhal, Fatma; Bidault-Toffin, Adeline; Le Chevalier, Patrick; Bouloc, Philippe; Paillard, Christine; Jacq, Annick			Evidence for the Role of Horizontal Transfer in Generating pVT1, a Large Mosaic Conjugative Plasmid from the Clam Pathogen, Vibrio tapetis	PLOS ONE			English	Article							BROWN RING DISEASE; RUDITAPES-PHILIPPINARUM; VIRULENCE PLASMID; SHIGELLA-FLEXNERI; COMPLETE SEQUENCE; GENETIC ELEMENTS; CAUSATIVE AGENT; MANILA CLAM; IRON UPTAKE; HOST-RANGE	The marine bacterium Vibrio tapetis is the causative agent of the brown ring disease, which affects the clam Ruditapes philippinarum and causes heavy economic losses in North of Europe and in Eastern Asia. Further characterization of V. tapetis isolates showed that all the investigated strains harbored at least one large plasmid. We determined the sequence of the 82,266 bp plasmid pVT1 from the CECT4600(T) reference strain and analyzed its genetic content. pVT1 is a mosaic plasmid closely related to several conjugative plasmids isolated from Vibrio vulnificus strains and was shown to be itself conjugative in Vibrios. In addition, it contains DNA regions that have similarity with several other plasmids from marine bacteria (Vibrio sp., Shewanella sp., Listonella anguillarum and Photobacterium profundum). pVT1 contains a number of mobile elements, including twelve Insertion Sequences or inactivated IS genes and an RS1 phage element related to the CTXphi phage of V. cholerae. The genetic organization of pVT1 underscores an important role of horizontal gene transfer through conjugative plasmid shuffling and transposition events in the acquisition of new genetic resources and in generating the pVT1 modular organization. In addition, pVT1 presents a copy number of 9, relatively high for a conjugative plasmid, and appears to belong to a new type of replicon, which may be specific to Vibrionaceae and Shewanelleacae.	[Le Chevalier, Patrick] Univ Bretagne Occidentale, Lab Univ Biodiversite & Ecol Microbienne, Quimper, France; [Lakhal, Fatma; Bouloc, Philippe; Jacq, Annick] Univ Paris 11, CNRS, Inst Genet & Microbiol,UMR 8621, IFR115, F-91405 Orsay, France; [Erauso, Gael; Bidault-Toffin, Adeline; Paillard, Christine] Univ Bretagne Occidentale, CNRS, Inst Univ Europeen Mer, Lab Sci Environm Marin,UMR 6539, Plouzane, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Erauso, G (corresponding author), Univ Aix Marseille 2, Lab Microbiol & Biotechnol Environm Chauds, IRD,UMR D180, ESIL Case 925, Marseille, France.	annick.jacq@u-psud.fr	Jacq, Annick/H-3896-2012; Bouloc, Philippe/ABA-5732-2021	Jacq, Annick/0000-0002-8526-5942; Bouloc, Philippe/0000-0003-4601-3387; Paillard, Christine/0000-0002-3812-0724	Groupement d'Interet Scientifique; Institut de Genomique Marine; Agence Nationale pour la Recherche [ANR-06-MIME-016-01]; Agence Universitaire de la Francophonie (AUF)	Groupement d'Interet Scientifique; Institut de Genomique Marine; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Agence Universitaire de la Francophonie (AUF)	This work was supported in part by the Groupement d'Interet Scientifique, "Institut de Genomique Marine" and by a grant ANR-06-MIME-016-01 from Agence Nationale pour la Recherche. Additional funding was from state funding to the host institutions. Fatma Lakhal received a fellowship from the Agence Universitaire de la Francophonie (AUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BENES V, 1993, GENE, V130, P151, DOI 10.1016/0378-1119(93)90360-F; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Borrego JJ, 1996, INT J SYST BACTERIOL, V46, P480, DOI 10.1099/00207713-46-2-480; Borrego JJ, 1996, AQUAT LIVING RESOUR, V9, P125, DOI 10.1051/alr:1996016; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bugge DA, 2007, FISH SHELLFISH IMMUN, V23, P188, DOI 10.1016/j.fsi.2006.10.006; Castro D, 1997, APPL ENVIRON MICROB, V63, P1449, DOI 10.1128/AEM.63.4.1449-1452.1997; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; CROSA JH, 1980, NATURE, V284, P566, DOI 10.1038/284566a0; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Faruque SA, 2002, INFECT IMMUN, V70, P163, DOI 10.1128/IAI.70.1.163-170.2002; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; GUNN JS, 1995, J BACTERIOL, V177, P5040, DOI 10.1128/jb.177.17.5040-5047.1995; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Jensen S, 2003, DIS AQUAT ORGAN, V53, P25, DOI 10.3354/dao053025; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kwong SM, 1998, FEMS MICROBIOL LETT, V158, P159, DOI 10.1111/j.1574-6968.1998.tb12815.x; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Le Chevalier P, 2003, J BASIC MICROB, V43, P414, DOI 10.1002/jobm.200310241; Leblond P, 1996, MOL MICROBIOL, V19, P261, DOI 10.1046/j.1365-2958.1996.366894.x; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; LEROUX F, 2010, NUCL ACIDS RES  1004; LEROUX F, 2010, ENV MICROBIOL   0906; LOPEZ JR, 2010, RES VET SCI; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; PAILLARD C, 1990, CR ACAD SCI III-VIE, V310, P15; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Paillard C, 2008, DIS AQUAT ORGAN, V81, P153, DOI 10.3354/dao01950; Pan L, 2010, J MICROBIOL BIOTECHN, V20, P1163, DOI 10.4014/jmb.1003.03007; Park KI, 2006, AQUACULTURE, V255, P610, DOI 10.1016/j.aquaculture.2005.12.011; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Reid HI, 2003, AQUACULTURE, V221, P65, DOI 10.1016/S0044-8486(03)00060-7; Reynaud Y, 2008, APPL ENVIRON MICROB, V74, P3038, DOI 10.1128/AEM.02680-07; Sambrook J, 2001, MOL CLONING LAB MANU; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SORUM H, 1992, ANTIMICROB AGENTS CH, V36, P611, DOI 10.1128/AAC.36.3.611; Stork M, 2002, PLASMID, V48, P222, DOI 10.1016/S0147-619X(02)00111-7; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson FL, 2010, MOL MICROBIOL, V77, P1065, DOI 10.1111/j.1365-2958.2010.07286.x; Travers MA, 2009, J CELL BIOCHEM, V106, P152, DOI 10.1002/jcb.21990; Valiente E, 2008, FISH SHELLFISH IMMUN, V24, P134, DOI 10.1016/j.fsi.2007.10.007; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; WALTER MA, 1983, J BACTERIOL, V156, P880, DOI 10.1128/JB.156.2.880-887.1983; Zhang RF, 2007, J MICROBIOL, V45, P193; Zhang RF, 2009, MAR BIOTECHNOL, V11, P456, DOI 10.1007/s10126-008-9160-3	62	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16759	10.1371/journal.pone.0016759	http://dx.doi.org/10.1371/journal.pone.0016759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326607	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037000018
J	Tsai, FJ; Lee, YC; Chang, JS; Huang, LM; Huang, FY; Chiu, NC; Chen, MR; Chi, H; Lee, YJ; Chang, LC; Liu, YM; Wang, HH; Chen, CH; Chen, YT; Wu, JY				Tsai, Fuu-Jen; Lee, Yi-Ching; Chang, Jeng-Sheng; Huang, Li-Min; Huang, Fu-Yuan; Chiu, Nan-Chang; Chen, Ming-Ren; Chi, Hsin; Lee, Yann-Jinn; Chang, Li-Ching; Liu, Yi-Min; Wang, Hsiang-Hua; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn			Identification of Novel Susceptibility Loci for Kawasaki Disease in a Han Chinese Population by a Genome-Wide Association Study	PLOS ONE			English	Article							CORONARY-ARTERY ANEURYSMS; TUMOR-NECROSIS-FACTOR; EPIDEMIOLOGIC FEATURES; AMINOPEPTIDASE; POLYMORPHISM; RECEPTOR; TAIWAN; GENE; INTERLEUKIN-6; PROTEIN	Kawasaki disease (KD) is an acute systemic vasculitis syndrome that primarily affects infants and young children. Its etiology is unknown; however, epidemiological findings suggest that genetic predisposition underlies disease susceptibility. Taiwan has the third-highest incidence of KD in the world, after Japan and Korea. To investigate novel mechanisms that might predispose individuals to KD, we conducted a genome-wide association study (GWAS) in 250 KD patients and 446 controls in a Han Chinese population residing in Taiwan, and further validated our findings in an independent Han Chinese cohort of 208 cases and 366 controls. The most strongly associated single-nucleotide polymorphisms (SNPs) detected in the joint analysis corresponded to three novel loci. Among these KD-associated SNPs three were close to the COPB2 (coatomer protein complex beta-2 subunit) gene: rs1873668 (p=9.52x10(-5)), rs4243399 (p=9.93x10(-5)), and rs16849083 (p=9.93x10(-5)). We also identified a SNP in the intronic region of the ERAP1 (endoplasmic reticulum amino peptidase 1) gene (rs149481, p(best)=4.61x10(-5)). Six SNPs (rs17113284, rs8005468, rs10129255, rs2007467, rs10150241, and rs12590667) clustered in an area containing immunoglobulin heavy chain variable regions genes, with p(best)-values between 2.08x10(-5) and 8.93x10(-6), were also identified. This is the first KD GWAS performed in a Han Chinese population. The novel KD candidates we identified have been implicated in T cell receptor signaling, regulation of proinflammatory cytokines, as well as antibody-mediated immune responses. These findings may lead to a better understanding of the underlying molecular pathogenesis of KD.	[Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Genet Med Res & Pediat, Taichung, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Lee, Yi-Ching; Chang, Li-Ching; Liu, Yi-Min; Wang, Hsiang-Hua; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Yi-Ching; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Natl Genotyping Ctr, Taipei 115, Taiwan; [Lee, Yi-Ching] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chang, Jeng-Sheng] China Med Univ & Hosp, Dept Pediat, Div Cardiol, Taichung, Taiwan; [Huang, Li-Min] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Fu-Yuan; Chiu, Nan-Chang; Chen, Ming-Ren; Chi, Hsin; Lee, Yann-Jinn] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Chen, Chien-Hsiun] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Wu, Jer-Yuarn] China Med Univ, Chinese Med Sci, Grad Inst, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; National Taiwan University Hospital; Mackay Memorial Hospital; China Medical University Taiwan; Duke University; China Medical University Taiwan	Tsai, FJ (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	chen0010@ibms.sinica.edu.tw; jywu@ibms.sinica.edu.tw	Wu, Jer-Yuarn/S-7010-2018; Chen, Chien Hsiun/Q-3826-2018; Tsai, Fuu-Jen/J-4140-2015; Lee, Yi-Ching/AAE-6900-2022	Lee, Yi-Ching/0000-0002-7734-5619; HUANG, LI-MIN/0000-0002-9291-260X	National Science Council, Taiwan [NSC99-3112-B-001-022, NSC 98-2314-B-039-004-MY2]; National Genotyping Center [NSC99-3112-B-001-023]; Academia Sinica Genomic Medicine Multicenter Study, Taiwan [5202401129-3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Genotyping Center; Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan)	This study was supported by National Research Program for Genomic Medicine, National Science Council, Taiwan (National Clinical Core, NSC99-3112-B-001-022; and National Genotyping Center, NSC99-3112-B-001-023); Academia Sinica Genomic Medicine Multicenter Study, Taiwan (5202401129-3); National Science Council, Taiwan (NSC 98-2314-B-039-004-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Chang LY, 2004, PEDIATRICS, V114, pE678, DOI 10.1542/peds.2004-0726; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cheung YF, 2008, PEDIATRICS, V122, pE608, DOI 10.1542/peds.2008-0646; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; KATO S, 1978, PEDIATRICS, V61, P252; Kim S, 2005, CURR OPIN PEDIATR, V17, P695, DOI 10.1097/01.mop.0000187190.97166.83; LIN CY, 1992, J PEDIATR-US, V121, P924, DOI 10.1016/S0022-3476(05)80343-9; Lin YJ, 2009, ARTHRITIS RHEUM-US, V60, P604, DOI 10.1002/art.24261; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; PARK YW, 2010, PEDIAT INT; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Rowley AH, 2004, J INFECT DIS, V190, P856, DOI 10.1086/422648; Rowley AH, 1997, J IMMUNOL, V159, P5946; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Wu SF, 2004, PEDIATR CARDIOL, V25, P529, DOI 10.1007/s00246-003-0662-5; Yanagawa H, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e33; Yanagawa H, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e65	30	80	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16853	10.1371/journal.pone.0016853	http://dx.doi.org/10.1371/journal.pone.0016853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326860	gold, Green Published			2022-12-27	WOS:000287037000027
J	Chicha, L; Feki, A; Boni, A; Irion, O; Hovatta, O; Jaconi, M				Chicha, Laurie; Feki, Anis; Boni, Alessandro; Irion, Olivier; Hovatta, Outi; Jaconi, Marisa			Human Pluripotent Stem Cells Differentiated in Fully Defined Medium Generate Hematopoietic CD34(+) and CD34(-) Progenitors with Distinct Characteristics	PLOS ONE			English	Article							HUMAN FIBROBLASTS; GROWTH-FACTOR; FLT3 LIGAND; IMMUNOGENICITY; EXPANSION; ANEMIA; LINES	Background: Differentiation of pluripotent stem cells in vitro provides a powerful means to investigate early developmental fates, including hematopoiesis. In particular, the use of a fully defined medium (FDM) would avoid biases induced by unidentified factors contained in serum, and would also allow key molecular mediators involved in such a process to be identified. Our goal was to induce in vitro, the differentiation of human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) into morphologically and phenotypically mature leukocytes and erythrocytes, in the complete absence of serum and feeder cells. Methodology/Principal Findings: ESC and iPSC were sequentially induced in liquid cultures for 4 days with bone morphogenic protein-4, and for 4 days with FLT3-ligand, stem cell factor, thrombopoietin and vascular endothelium growth factor. Cell differentiation status was investigated by both mRNA expression and FACS expression profiles. Cells were further sorted and assayed for their hematopoietic properties in colony-forming unit (CFU) assays. In liquid cultures, cells progressively down-modulated Oct-4 expression while a sizeable cell fraction expressed CD34 de novo. SCL/Tal1 and Runx1 transcripts were exclusively detected in CD34(+) cells. In clonal assays, both ESC and iPSC-derived cells generated CFU, albeit with a 150-fold lower efficacy than cord blood (CB) CD34(+) cells. ESC-derived CD34(+) cells generated myeloid and fully hemoglobinized erythroid cells whereas CD34(-) cells almost exclusively generated small erythroid colonies. Both ESC and iPSC-derived erythroid cells expressed embryonic and fetal globins but were unable to synthesize adult beta-globin in contrast with CB cells, suggesting that they had differentiated from primitive rather than from definitive hematopoietic progenitors. Conclusions/Significance: Short-term, animal protein-free culture conditions are sufficient to sustain the differentiation of human ESC and iPSC into primitive hematopoietic progenitors, which, in turn, produce more mature blood cell types. However, additional factors have yet to be identified to allow their differentiation into definitive erythroid cultures.	[Chicha, Laurie; Boni, Alessandro; Jaconi, Marisa] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Feki, Anis; Irion, Olivier; Hovatta, Outi] Univ Hosp Geneva, Dept Gynecol & Obstet, Stem Cell Res Lab, Geneva, Switzerland; [Hovatta, Outi] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	University of Geneva; University of Geneva; Karolinska Institutet	Chicha, L (corresponding author), Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland.	marisa.jaconi@unige.ch	Jaconi, Marisa EE/J-4392-2013	Jaconi, Marisa/0000-0002-2004-8226; Feki, Anis/0000-0002-9817-9445	European Molecular Biology Organization [ALTF-363-2006]; Roche Research Foundation; Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation; Swiss National Science Foundation [310031-110002]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation; Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by European Molecular Biology Organization (LC, grant #ALTF-363-2006), the Roche Research Foundation (LC, MJ), the Dinu Lipatti-Dr. Henri Dubois-Ferriere Leukemia Foundation (LC) and the Swiss National Science Foundation (MJ, grant #310031-110002). Reagents such as Flt3-ligand and SCF have been kindly donated by Amgen, while VEGF and bFGF have been kindly provided by NCI Biological Resources branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Drukker M, 2006, METHOD ENZYMOL, V420, P391, DOI 10.1016/S0076-6879(06)20019-3; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Galic Z, 2006, P NATL ACAD SCI USA, V103, P11742, DOI 10.1073/pnas.0604244103; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Imreh MP, 2004, STEM CELLS DEV, V13, P337, DOI 10.1089/1547328041797534; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lu M, 2009, EXP HEMATOL, V37, P924, DOI 10.1016/j.exphem.2009.05.007; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; LYMAN SD, 1995, BLOOD, V86, P4091, DOI 10.1182/blood.V86.11.4091.bloodjournal86114091; McKinney-Freeman SL, 2007, CURR OPIN HEMATOL, V14, P343, DOI 10.1097/MOH.0b013e3281900edd; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Piacibello W, 1998, LEUKEMIA, V12, P718, DOI 10.1038/sj.leu.2401003; Piacibello W, 1998, Stem Cells, V16 Suppl 2, P243; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Senju S, 2007, STEM CELLS, V25, P2720, DOI 10.1634/stemcells.2007-0321; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UNGER C, 2009, HUM REPROD; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4	30	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14733	10.1371/journal.pone.0014733	http://dx.doi.org/10.1371/journal.pone.0014733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364915	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100004
J	Putila, J; Remick, SC; Guo, NL				Putila, Joseph; Remick, Scot C.; Guo, Nancy Lan			Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study	PLOS ONE			English	Article							K-RAS ONCOGENE; GENE-EXPRESSION; TUMOR VOLUME; RADIATION-THERAPY; PREDICT SURVIVAL; CELL; ADENOCARCINOMA; STAGE; VALIDATION; MODEL	Background: In the treatment of lung cancer, an accurate estimation of patient clinical outcome is essential for choosing an appropriate course of therapy. It is important to develop a prognostic stratification model which combines clinical, pathological and demographic factors for individualized clinical decision making. Methodology/Principal Findings: A total of 234,412 patients diagnosed with adenocarcinomas or squamous cell carcinomas of the lung or bronchus between 1988 and 2006 were retrieved from the SEER database to construct a prognostic model. A model was developed by estimating a Cox proportional hazards model on 500 bootstrapped samples. Two models, one using stage alone and another comprehensive model using additional covariates, were constructed. The comprehensive model consistently outperformed the model using stage alone in prognostic stratification and on Harrell's C, Nagelkerke's R(2), and Brier Scores in the whole patient population as well as in specific treatment modalities. Specifically, the comprehensive model generated different prognostic groups with distinct post-operative survival (log-rank P < 0.001) within surgical stage IA and IB patients in Kaplan-Meier analyses. Two additional patient cohorts (n = 1,991) were used as an external validation, with the comprehensive model again outperforming the model using stage alone with regards to prognostic stratification and the three evaluated metrics. Conclusion/Significance: These results demonstrate the feasibility of constructing a precise prognostic model combining multiple clinical, pathologic, and demographic factors. The comprehensive model significantly improves individualized prognosis upon AJCC tumor staging and is robust across a range of treatment modalities, the spectrum of patient risk, and in novel patient cohorts.	[Putila, Joseph; Remick, Scot C.; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Putila, Joseph; Guo, Nancy Lan] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Remick, Scot C.] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Putila, J (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			NIH NLM [R01LM009500]; NCRR [P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM009500, R01LM009500] Funding Source: NIH RePORTER	NIH NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by NIH NLM R01LM009500 (PI: Guo) and NCRR P20RR16440 and Supplement (PD: Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America Joint Committee on Cancer, 2010, AJCC CANC STAG MAN; Ball D, 2002, INT J RADIAT ONCOL, V54, P1007, DOI 10.1016/S0360-3016(02)03046-8; Basaki K, 2006, INT J RADIAT ONCOL, V64, P449, DOI 10.1016/j.ijrobp.2005.07.967; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birim O, 2006, J THORAC CARDIOV SUR, V132, P491, DOI 10.1016/j.jtcvs.2006.04.010; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Brown JS, 1996, THORAX, V51, P564, DOI 10.1136/thx.51.6.564; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Dehing-Oberije C, 2010, INT J RAD ONCOL BIOL; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; Firat S, 2002, INT J RADIAT ONCOL, V54, P357, DOI 10.1016/S0360-3016(02)02939-5; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; HORIO Y, 1993, CANCER RES, V53, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; OROURKE MA, 1987, JAMA-J AM MED ASSOC, V258, P921, DOI 10.1001/jama.258.7.921; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Solan Merrill J, 2003, Semin Surg Oncol, V21, P64, DOI 10.1002/ssu.10023; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Surveillance Epidemiology and End Results (SEER) Program, 1969, SEER STAT DAT INC SE; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Werner-Wasik M, 2008, INT J RADIAT ONCOL, V70, P385, DOI 10.1016/j.ijrobp.2007.06.034	38	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17493	10.1371/journal.pone.0017493	http://dx.doi.org/10.1371/journal.pone.0017493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364765	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100067
J	Pflugfelder, A; Eigentler, TK; Keim, U; Weide, B; Leiter, U; Ikenberg, K; Berneburg, M; Garbe, C				Pflugfelder, Annette; Eigentler, Thomas K.; Keim, Ulrike; Weide, Benjamin; Leiter, Ulrike; Ikenberg, Kristian; Berneburg, Mark; Garbe, Claus			Effectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma	PLOS ONE			English	Article							PHASE-II; ADVANCED-CARCINOMA; PLUS CARBOPLATIN; OVARIAN-CANCER; TRIAL; COMBINATION; CHEMOTHERAPY; THERAPY	Background: Patients with metastatic melanoma have a very unfavorable prognosis with few therapeutic options. Based on previous promising experiences within a clinical trial involving carboplatin and paclitaxel a series of advanced metastatic melanoma patients were treated with this combination. Methods: Data of all patients with cutaneous metastatic melanoma treated with carboplatin and paclitaxel (CP) at our institution between October 2005 and December 2007 were retrospectively evaluated. For all patients a once-every-3-weeks dose-intensified regimen was used. Overall and progression free survival were calculated using the method of Kaplan and Meier. Tumour response was evaluated according to RECIST criteria. Results: 61 patients with cutaneous metastatic melanoma were treated with CP. 20 patients (85% M1c) received CP as first-line treatment, 41 patients (90.2% M1c) had received at least one prior systemic therapy for metastatic disease. Main toxicities were myelosuppression, fatigue and peripheral neuropathy. Partial responses were noted in 4.9% of patients, stable disease in 23% of patients. No complete response was observed. Median progression free survival was 10 weeks. Median overall survival was 31 weeks. Response, progression-free and overall survival were equivalent in first-and second-line patients. 60 patients of 61 died after a median follow up of 7 months. Median overall survival differed for patients with controlled disease (PR+SD) (49 weeks) compared to patients with progressive disease (18 weeks). Conclusions: Among patients with metastatic melanoma a subgroup achieved disease control under CP therapy which may be associated with a survival benefit. This potential advantage has to be weighed against considerable toxicity. Since response rates and survival were not improved in previously untreated patients compared to pretreated patients, CP should thus not be applied as first-line treatment.	[Pflugfelder, Annette; Eigentler, Thomas K.; Keim, Ulrike; Weide, Benjamin; Leiter, Ulrike; Ikenberg, Kristian; Berneburg, Mark; Garbe, Claus] Univ Tubingen Hosp, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pflugfelder, A (corresponding author), Univ Tubingen Hosp, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany.	annette.pflugfelder@med.uni-tuebingen.de	Eigentler, Thomas/K-8570-2015; Pflugfelder, Annette/Q-2659-2016; Garbe, Claus/ABH-2128-2021; Keim, Ulrike/C-4938-2017; Weide, Benjamin/N-3698-2013	Eigentler, Thomas/0000-0003-0019-2770; Garbe, Claus/0000-0001-8530-780X; Keim, Ulrike/0000-0001-7236-0548; Leiter, Ulrike/0000-0002-8019-1577	University Hospital Tuebingen	University Hospital Tuebingen	The work was funded by the University Hospital Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias A, 2004, J CLIN ONCOL, V22, P2150, DOI 10.1200/JCO.2004.09.043; Belani CP, 2008, J CLIN ONCOL, V26, P468, DOI 10.1200/JCO.2007.13.1912; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; Einzig A I, 1991, Cancer Treat Res, V58, P89; Flaherty KT, 2008, CLIN CANCER RES, V14, P4836, DOI 10.1158/1078-0432.CCR-07-4123; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Hodi FS, 2002, AM J CLIN ONCOL-CANC, V25, P283, DOI 10.1097/00000421-200206000-00016; Johnson DH, 1996, J CLIN ONCOL, V14, P2054, DOI 10.1200/JCO.1996.14.7.2054; Kaplan EL, 2009, J AM STAT ASSOC, V53, P457; Lee CW, 2005, GYNECOL ONCOL, V99, P393, DOI 10.1016/j.ygyno.2005.06.028; Parmar MKB, 2002, LANCET, V360, P505; Perez DG, 2009, CANCER-AM CANCER SOC, V115, P119, DOI 10.1002/cncr.23987; Rao RD, 2006, CANCER, V106, P375, DOI 10.1002/cncr.21611; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vaughn DJ, 2002, CANCER-AM CANCER SOC, V95, P1022, DOI 10.1002/cncr.10782; Zamagni C, 1998, AM J CLIN ONCOL-CANC, V21, P491, DOI 10.1097/00000421-199810000-00015; Zimpfer-Rechner C, 2003, MELANOMA RES, V13, P531, DOI 10.1097/00008390-200310000-00012	20	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16882	10.1371/journal.pone.0016882	http://dx.doi.org/10.1371/journal.pone.0016882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359173	gold, Green Submitted, Green Published			2022-12-27	WOS:000287392700027
J	Marshall, L; Kirov, R; Brade, J; Molle, M; Born, J				Marshall, Lisa; Kirov, Roumen; Brade, Julian; Moelle, Matthias; Born, Jan			Transcranial Electrical Currents to Probe EEG Brain Rhythms and Memory Consolidation during Sleep in Humans	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LEARNING-DEPENDENT CHANGES; DIRECT-CURRENT STIMULATION; LATE NOCTURNAL SLEEP; REM-SLEEP; SLOW OSCILLATIONS; DECLARATIVE MEMORY; THETA-OSCILLATIONS; PROCEDURAL MEMORY; EMOTIONAL MEMORY	Previously the application of a weak electric anodal current oscillating with a frequency of the sleep slow oscillation (similar to 0.75 Hz) during non-rapid eye movement sleep (NonREM) sleep boosted endogenous slow oscillation activity and enhanced sleep-associated memory consolidation. The slow oscillations occurring during NonREM sleep and theta oscillations present during REM sleep have been considered of critical relevance for memory formation. Here transcranial direct current stimulation (tDCS) oscillating at 5 Hz, i.e., within the theta frequency range (theta-tDCS) is applied during NonREM and REM sleep. Theta-tDCS during NonREM sleep produced a global decrease in slow oscillatory activity conjoint with a local reduction of frontal slow EEG spindle power (8-12 Hz) and a decrement in consolidation of declarative memory, underlining the relevance of these cortical oscillations for sleep-dependent memory consolidation. In contrast, during REM sleep theta-tDCS appears to increase global gamma (25-45 Hz) activity, indicating a clear brain state-dependency of theta-tDCS. More generally, results demonstrate the suitability of oscillating-tDCS as a tool to analyze functions of endogenous EEG rhythms and underlying endogenous electric fields as well as the interactions between EEG rhythms of different frequencies.	[Marshall, Lisa; Kirov, Roumen; Brade, Julian; Moelle, Matthias; Born, Jan] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Kirov, Roumen] Bulgarian Acad Sci, Inst Neurobiol, Sofia, Bulgaria; [Born, Jan] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany	University of Lubeck; Bulgarian Academy of Sciences; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Marshall, L (corresponding author), Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany.	marshall@kfg.uni-luebeck.de	Sanguansri, Luz/B-6630-2011; Born, Jan/K-2596-2016	Sanguansri, Luz/0000-0003-1908-7604; Born, Jan/0000-0002-1847-6248; , Lisa/0000-0002-3976-1822	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bergmann TO, 2009, J NEUROPHYSIOL, V102, P2303, DOI 10.1152/jn.00437.2009; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantero JL, 2003, J NEUROSCI, V23, P10897; De Gennaro L, 2000, BEHAV BRAIN RES, V116, P55, DOI 10.1016/S0166-4328(00)00247-3; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Debus G., 1978, EIGENSCHAFTSWORTERLI; Dickson CT, 2010, BEHAV BRAIN RES, V214, P35, DOI 10.1016/j.bbr.2010.04.002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Doran S. M., 2003, SLEEP RES ONLINE, V5, P133; Ferri R, 2000, CLIN NEUROPHYSIOL, V111, P1258, DOI 10.1016/S1388-2457(00)00303-5; Finelli LA, 2000, J SLEEP RES, V9, P161, DOI 10.1046/j.1365-2869.2000.00191.x; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Fogel SM, 2009, BRAIN RES BULL, V79, P445, DOI 10.1016/j.brainresbull.2009.03.002; Francis JT, 2003, J NEUROSCI, V23, P7255; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gais S, 2002, J NEUROSCI, V22, P6830; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, pR9, DOI 10.1016/0166-4328(95)90032-2; Gross DW, 1999, NEUROSCIENCE, V94, P1005, DOI 10.1016/S0306-4522(99)00343-7; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Ko GYP, 2009, J NEUROCHEM, V110, P1150, DOI 10.1111/j.1471-4159.2009.06223.x; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Lutzenberger W, 1987, SAFETY ASSESSMENT NM, P36; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Marzano C, 2010, J SLEEP RES, V19, P260, DOI 10.1111/j.1365-2869.2009.00776.x; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rechtschaffen A, 1968, NIH PUBL, V204; Ribeiro S, 2004, LEARN MEMORY, V11, P686, DOI 10.1101/lm.75604; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; Tucker MA, 2009, J SLEEP RES, V18, P304, DOI 10.1111/j.1365-2869.2009.00740.x; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D., 1997, TECHNICAL MANUAL WEC; Weiss SA, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00015; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	65	120	124	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16905	10.1371/journal.pone.0016905	http://dx.doi.org/10.1371/journal.pone.0016905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340034	gold, Green Submitted, Green Published			2022-12-27	WOS:000287367600024
J	Conover, MS; Mishra, M; Deora, R				Conover, Matt S.; Mishra, Meenu; Deora, Rajendar			Extracellular DNA Is Essential for Maintaining Bordetella Biofilm Integrity on Abiotic Surfaces and in the Upper Respiratory Tract of Mice	PLOS ONE			English	Article							PERTUSSIS INFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL BIOFILMS; BPS POLYSACCHARIDE; YOUNG INFANTS; IN-VITRO; BRONCHISEPTICA; EPIDEMIOLOGY; PATHOGENESIS; RELEASE	Bacteria form complex and highly elaborate surface adherent communities known as biofilms which are held together by a self-produced extracellular matrix. We have previously shown that by adopting a biofilm mode of existence in vivo, the Gram negative bacterial pathogens Bordetella bronchiseptica and Bordetella pertussis are able to efficiently colonize and persist in the mammalian respiratory tract. In general, the bacterial biofilm matrix includes polysaccharides, proteins and extracellular DNA (eDNA). In this report, we investigated the function of DNA in Bordetella biofilm development. We show that DNA is a significant component of Bordetella biofilm matrix. Addition of DNase I at the initiation of biofilm growth inhibited biofilm formation. Treatment of pre-established mature biofilms formed under both static and flow conditions with DNase I led to a disruption of the biofilm biomass. We next investigated whether eDNA played a role in biofilms formed in the mouse respiratory tract. DNase I treatment of nasal biofilms caused considerable dissolution of the biofilm biomass. In conclusion, these results suggest that eDNA is a crucial structural matrix component of both in vitro and in vivo formed Bordetella biofilms. This is the first evidence for the ability of DNase I to disrupt bacterial biofilms formed on host organs.	[Conover, Matt S.; Deora, Rajendar] Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC 27106 USA; [Mishra, Meenu; Deora, Rajendar] Wake Forest Univ Hlth Sci, Dept Microbiol & Immunol, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Conover, MS (corresponding author), Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC 27106 USA.	rdeora@wfubmc.edu			National Institutes of Health [1R01AI075081, T32 AI07401]; United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2006-35604-16874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081, T32AI007401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the laboratory of R.D. is supported by funds from the National Institutes of Health grant no. 1R01AI075081 and the National Research Initiative grant no. 2006-35604-16874 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture, Microbial Functional Genomics Program. M.S.C. is supported by a National Institutes of Health predoctoral training grant, T32 AI07401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BEMIS DA, 1992, VET CLIN N AM-SMALL, V22, P1173, DOI 10.1016/S0195-5616(92)50308-4; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLEMMING HC, 2007, J BACTERIOL; Fry NK, 2004, J MED MICROBIOL, V53, P519, DOI 10.1099/jmm.0.45624-0; Bass JIF, 2010, J IMMUNOL, V184, P6386, DOI 10.4049/jimmunol.0901640; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Gregory DS, 2006, AM FAM PHYSICIAN, V74, P420; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lasa I, 2006, INT MICROBIOL, V9, P21; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; MOOI FR, INFECT GENET EVOL, V10, P36; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Raymond J, 2007, CLIN MICROBIOL INFEC, V13, P172, DOI 10.1111/j.1469-0691.2006.01616.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Sakurai K, 2005, CHEM COMMUN, P4383, DOI 10.1039/b506673p; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; TUOMANEN E, 1989, J BIOL CHEM, V264, P11093; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WILSON R, 1991, INFECT IMMUN, V59, P337, DOI 10.1128/IAI.59.1.337-345.1991; Yeh SH, 2006, DRUGS, V66, P731, DOI 10.2165/00003495-200666060-00001	57	75	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16861	10.1371/journal.pone.0016861	http://dx.doi.org/10.1371/journal.pone.0016861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347299	Green Submitted, Green Published, gold			2022-12-27	WOS:000287364500011
J	Subramaniam, D; Ramalingam, S; Linehan, DC; Dieckgraefe, BK; Postier, RG; Houchen, CW; Jensen, RA; Anant, S				Subramaniam, Dharmalingam; Ramalingam, Satish; Linehan, David C.; Dieckgraefe, Brian K.; Postier, Russell G.; Houchen, Courtney W.; Jensen, Roy A.; Anant, Shrikant			RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells	PLOS ONE			English	Article							I CLINICAL-TRIAL; MESSENGER-RNA; CYCLOOXYGENASE-2 EXPRESSION; MYOTONIC-DYSTROPHY; CARCINOMA-CELLS; INHIBITION; APOPTOSIS; GROWTH; GEMCITABINE; THERAPY	Background: Curcumin inhibits the growth of pancreatic cancer tumor xenografts in nude mice; however, the mechanism of action is not well understood. It is becoming increasingly clear that RNA binding proteins regulate posttranscriptional gene expression and play a critical role in RNA stability and translation. Here, we have determined that curcumin modulates the expression of RNA binding protein CUGBP2 to inhibit pancreatic cancer growth. Methodology/Principal Findings: In this study, we show that curcumin treated tumor xenografts have a significant reduction in tumor volume and angiogenesis. Curcumin inhibited the proliferation, while inducing G2-M arrest and apoptosis resulting in mitotic catastrophe of various pancreatic cancer cells. This was further confirmed by increased phosphorylation of checkpoint kinase 2 (Chk2) protein coupled with higher levels of nuclear cyclin B1 and Cdc-2. Curcumin increased the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) mRNA, but protein levels were lower. Furthermore, curcumin increased the expression of RNA binding proteins CUGBP2/CELF2 and TIA-1. CUGBP2 binding to COX-2 and VEGF mRNA was also enhanced, thereby increasing mRNA stability, the half-life changing from 30 min to 8 h. On the other hand, silencer-mediated knockdown of CUGBP2 partially restored the expression of COX-2 and VEGF even with curcumin treatment. COX-2 and VEGF mRNA levels were reduced to control levels, while proteins levels were higher. Conclusion/Significance: Curcumin inhibits pancreatic tumor growth through mitotic catastrophe by increasing the expression of RNA binding protein CUGBP2, thereby inhibiting the translation of COX-2 and VEGF mRNA. These data suggest that translation inhibition is a novel mechanism of action for curcumin during the therapeutic intervention of pancreatic cancers.	[Subramaniam, Dharmalingam; Ramalingam, Satish; Anant, Shrikant] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Linehan, David C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Dieckgraefe, Brian K.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Postier, Russell G.] Univ Oklahoma, Hlth Sci Ctr, Dept Surg, Oklahoma City, OK USA; [Houchen, Courtney W.; Anant, Shrikant] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Jensen, Roy A.] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Jensen, Roy A.; Anant, Shrikant] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Subramaniam, D (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	dsubramaniam@kumc.edu; sanant@kumc.edu	Anant, Shrikant/AAF-8020-2020; Ramalingam, Satish/H-1577-2018; Jensen, Roy A/B-9739-2011	Ramalingam, Satish/0000-0002-3076-279X; Jensen, Roy A/0000-0003-4430-2281	NIH [DK062265, CA109269, CA135559]; NATIONAL CANCER INSTITUTE [R01CA135559, R01CA109269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH grants DK062265, CA109269 and CA135559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, BIOCHEM SOC SYMP, V70, P233, DOI 10.1042/bss0700233; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Duffy JP, 2003, CURR OPIN GASTROEN, V19, P458, DOI 10.1097/00001574-200309000-00004; Esclatine A, 2004, J VIROL, V78, P8582, DOI 10.1128/JVI.78.16.8582-8592.2004; Gerecht PSD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-69; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Grau R, 2004, CANCER RES, V64, P5162, DOI 10.1158/0008-5472.CAN-04-0849; Jee SH, 1998, J INVEST DERMATOL, V111, P656, DOI 10.1046/j.1523-1747.1998.00352.x; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Kanai M, 2010, CANC CHEMOTHER PHARM; Kawamori T, 1999, CANCER RES, V59, P597; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Krecicki T, 2004, J LARYNGOL OTOL, V118, P676; Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lev-Ari S, 2005, CLIN CANCER RES, V11, P6738, DOI 10.1158/1078-0432.CCR-05-0171; Lev-Ari S, 2007, CANCER INVEST, V25, P411, DOI 10.1080/07357900701359577; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mehta K, 1997, ANTI-CANCER DRUG, V8, P470, DOI 10.1097/00001813-199706000-00010; Molina MA, 1999, CANCER RES, V59, P4356; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Mukhopadhyay D, 2003, ANN NY ACAD SCI, V1010, P504, DOI 10.1196/annals.1299.093; Nieto J, 2008, ONCOLOGIST, V13, P562, DOI 10.1634/theoncologist.2007-0181; Ramalingam S, 2008, AM J PHYSIOL-GASTR L, V294, pG971, DOI 10.1152/ajpgi.00540.2007; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Singletary K, 1998, CARCINOGENESIS, V19, P1039, DOI 10.1093/carcin/19.6.1039; Stan SD, 2010, NAT REV GASTRO HEPAT, V7, P347, DOI 10.1038/nrgastro.2010.61; Subramaniam D, 2008, AM J PHYSIOL-GASTR L, V294, pG1025, DOI 10.1152/ajpgi.00602.2007; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Swamy MV, 2008, NUTR CANCER, V60, P81, DOI 10.1080/01635580802416703; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	48	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16958	10.1371/journal.pone.0016958	http://dx.doi.org/10.1371/journal.pone.0016958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347286	gold, Green Published			2022-12-27	WOS:000287364500015
J	Kauwe, JSK; Cruchaga, C; Karch, CM; Sadler, B; Lee, M; Mayo, K; Latu, W; Su'a, M; Fagan, AM; Holtzman, DM; Morris, JC; Goate, AM				Kauwe, John S. K.; Cruchaga, Carlos; Karch, Celeste M.; Sadler, Brooke; Lee, Mo; Mayo, Kevin; Latu, Wayne; Su'a, Manti; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.		Alzheimer's Dis Neuroimaging Initi	Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMYLOID-BETA; IDENTIFIES VARIANTS; IN-VIVO; SUSCEPTIBILITY; APOE; DEPOSITION; REVEALS; LOCI	Recent genome-wide association studies of Alzheimer's disease (AD) have identified variants in BIN1, CLU, CR1 and PICALM that show replicable association with risk for disease. We have thoroughly sampled common variation in these genes, genotyping 355 variants in over 600 individuals for whom measurements of two AD biomarkers, cerebrospinal fluid (CSF) 42 amino acid amyloid beta fragments (A beta(42)) and tau phosphorylated at threonine 181 (ptau(181)), have been obtained. Association analyses were performed to determine whether variants in BIN1, CLU, CR1 or PICALM are associated with changes in the CSF levels of these biomarkers. Despite adequate power to detect effects as small as a 1.05 fold difference, we have failed to detect evidence for association between SNPs in these genes and CSF A beta(42) or ptau(181) levels in our sample. Our results suggest that these variants do not affect risk via a mechanism that results in a strong additive effect on CSF levels of A beta(42) or ptau(181).	[Kauwe, John S. K.; Lee, Mo; Latu, Wayne; Su'a, Manti] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Cruchaga, Carlos; Karch, Celeste M.; Sadler, Brooke; Mayo, Kevin; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cruchaga, Carlos; Karch, Celeste M.; Mayo, Kevin; Fagan, Anne M.; Holtzman, David M.; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Cruchaga, Carlos; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA	Brigham Young University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	kauwe@byu.edu	Juengling, Freimut D/L-8071-2016; MOSCATO, PABLO ALBERTO/G-7668-2013; Scharre, Douglas W/E-4030-2011; Obisesan, Thomas O/D-4184-2011; Payoux, Pierre/AGU-9727-2022; Kauwe, John/AAC-6646-2021; Morris, John C/A-1686-2012; Cruchaga, Carlos/ABF-4065-2020; Kauwe, John/B-2034-2009; Strittmatter, Stephen/F-5739-2011; Yushkevich, Paul A/O-6115-2014; Myers, Amanda J/B-1796-2010; Gaser, Christian/F-5103-2010	Juengling, Freimut D/0000-0002-2538-3074; Payoux, Pierre/0000-0002-1374-1620; Kauwe, John/0000-0001-8641-2468; Cruchaga, Carlos/0000-0002-0276-2899; Kauwe, John/0000-0001-8641-2468; Strittmatter, Stephen/0000-0001-8188-3092; Yushkevich, Paul A/0000-0001-8543-4016; Myers, Amanda J/0000-0002-3100-9396; Whitcher, Brandon/0000-0002-6452-2399; Mueller, Notger/0000-0002-5483-6423; Browndyke, Jeffrey/0000-0002-8573-7073; Lemaitre, Herve/0000-0002-5952-076X; Goate, Alison/0000-0002-0576-2472; Hampel, Harald/0000-0003-0894-8982; Gaser, Christian/0000-0002-9940-099X; Karch, Celeste/0000-0002-6854-5547; Looi, Jeffrey/0000-0003-3351-6911	AstraZeneca; National Institutes of Health [AG16208, P01AG03991, P50AG05681, P01AG026276, AG23185, AG05136]; Barnes-Jewish Hospital Foundation; Ford Foundation; Department of Veterans Affairs; Fundacion Alfonso Martin Escudero; National Institute on Aging [U01 AG024904]; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005136, P01AG026276, R01AG016208, U01AG024904, U19AG010483, R01AG023185, P50AG005681] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Hospital Foundation; Ford Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); Fundacion Alfonso Martin Escudero; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from AstraZeneca, National Institutes of Health (AG16208, P01AG03991, P50AG05681, P01AG026276, AG23185, AG05136), the Barnes-Jewish Hospital Foundation, Ford Foundation, the Department of Veterans Affairs, and an anonymous foundation. CC has a fellowship from Fundacion Alfonso Martin Escudero. Data collection and sharing for Alzheimer's Disease Neuroimaging Initiative (ADNI) (Principal Investigator Michael Weiner; National Institutes of Health grant U01 AG024904) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Pfizer, Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., AstraZeneca AB, Novartis, Alzheimer's Association, Eisai Global Clinical Development, Elan Corporation, Forest Laboratories, and the Institute for the Study of Aging, with participation from the United States Food and Drug Administration. Industry partnerships are coordinated through the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Jozsi M, 2002, J IMMUNOL, V168, P2782, DOI 10.4049/jimmunol.168.6.2782; JUN G, 2010, METAANALYSIS CONFIRM; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kauwe JSK, 2009, NEUROGENETICS, V10, P13, DOI 10.1007/s10048-008-0150-4; KAUWE JS, 2010, J ALZHEIMERS DIS; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199	27	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15918	10.1371/journal.pone.0015918	http://dx.doi.org/10.1371/journal.pone.0015918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347408	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700011
J	Ghanta, KS; Li, DQ; Eswaran, J; Kumar, R				Ghanta, Krishna Sumanth; Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh			Gene Profiling of Mta1 Identifies Novel Gene Targets and Functions	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; BREAST-CANCER; DNA-DAMAGE; ESTROGEN-RECEPTOR; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSION; MAMMARY ADENOCARCINOMA; NUCLEAR RECEPTORS; CELL-LINES; COREGULATORS	Background: Metastasis-associated protein 1 (MTA1), a master dual co-regulatory protein is found to be an integral part of NuRD (Nucleosome Remodeling and Histone Deacetylation) complex, which has indispensable transcriptional regulatory functions via histone deacetylation and chromatin remodeling. Emerging literature establishes MTA1 to be a valid DNA-damage responsive protein with a significant role in maintaining the optimum DNA-repair activity in mammalian cells exposed to genotoxic stress. This DNA-damage responsive function of MTA1 was reported to be a P53-dependent and independent function. Here, we investigate the influence of P53 on gene regulation function of Mta1 to identify novel gene targets and functions of Mta1. Methods: Gene expression analysis was performed on five different mouse embryonic fibroblasts (MEFs) samples (i) the Mta1 wild type, (ii) Mta1 knock out (iii) Mta1 knock out in which Mta1 was reintroduced (iv) P53 knock out (v) P53 knock out in which Mta1 was over expressed using Affymetrix Mouse Exon 1.0 ST arrays. Further Hierarchical Clustering, Gene Ontology analysis with GO terms satisfying corrected p-value, 0.1, and the Ingenuity Pathway Analysis were performed. Finally, RT-qPCR was carried out on selective candidate genes. Significance/Conclusion: This study represents a complete genome wide screen for possible target genes of a coregulator, Mta1. The comparative gene profiling of Mta1 wild type, Mta1 knockout and Mta1 re-expression in the Mta1 knockout conditions define "bona fide'' Mta1 target genes. Further extensive analyses of the data highlights the influence of P53 on Mta1 gene regulation. In the presence of P53 majority of the genes regulated by Mta1 are related to inflammatory and antimicrobial responses whereas in the absence of P53 the predominant target genes are involved in cancer signaling. Thus, the presented data emphasizes the known functions of Mta1 and serves as a rich resource which could help us identify novel Mta1 functions.	[Ghanta, Krishna Sumanth; Eswaran, Jeyanthy; Kumar, Rakesh] George Washington Univ, Med Ctr, McCormick Genom & Prote Ctr, Washington, DC 20037 USA; [Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Ghanta, KS (corresponding author), George Washington Univ, Med Ctr, McCormick Genom & Prote Ctr, Washington, DC 20037 USA.	bcmjxe@gwumc.edu	Ghanta, Krishna S./M-1307-2019; Kumar, Rakesh/ABD-1065-2020	Ghanta, Krishna S./0000-0001-7502-3141; Kumar, Rakesh/0000-0001-7664-0803; Eswaran, Jeyanthy/0000-0003-0260-9517	National Institutes of Health [CA90970]; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grant CA90970 to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2006, J VIROL METHODS, V133, P41, DOI 10.1016/j.jviromet.2005.10.016; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Benest AV, 2009, NATURE, V458, P41, DOI 10.1038/458041a; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dobrzycka KM, 2003, ENDOCR-RELAT CANCER, V10, P517, DOI 10.1677/erc.0.0100517; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; HARPER JW, 1993, CELL, V75, P805; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2010, CELL CYCLE, V9, P2071, DOI 10.4161/cc.9.11.11735; Li DQ, 2010, J BIOL CHEM, V285, P19802, DOI 10.1074/jbc.M109.085258; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Martini PGV, 2003, J STEROID BIOCHEM, V85, P117, DOI 10.1016/S0960-0760(03)00207-3; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; McMasters KM, 1996, ONCOGENE, V13, P1731; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Monaco C, 1997, GENOMICS, V46, P217, DOI 10.1006/geno.1997.5036; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; TOH Y, 1995, GENE, V159, P97, DOI 10.1016/0378-1119(94)00410-T; TOH Y, 1994, J BIOL CHEM, V269, P22958; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102	51	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17135	10.1371/journal.pone.0017135	http://dx.doi.org/10.1371/journal.pone.0017135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364872	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100031
J	Park, J; Kerner, A; Burns, MA; Lin, XXN				Park, Jihyang; Kerner, Alissa; Burns, Mark A.; Lin, Xiaoxia Nina			Microdroplet-Enabled Highly Parallel Co-Cultivation of Microbial Communities	PLOS ONE			English	Article							DIVERSITY; BACTERIA; CULTURE; CHIP; MICROORGANISMS; COMMUNICATION; ENCAPSULATION; CULTIVATION; GENERATION; GENOMES	Microbial interactions in natural microbiota are, in many cases, crucial for the sustenance of the communities, but the precise nature of these interactions remain largely unknown because of the inherent complexity and difficulties in laboratory cultivation. Conventional pure culture-oriented cultivation does not account for these interactions mediated by small molecules, which severely limits its utility in cultivating and studying "unculturable'' microorganisms from synergistic communities. In this study, we developed a simple microfluidic device for highly parallel co-cultivation of symbiotic microbial communities and demonstrated its effectiveness in discovering synergistic interactions among microbes. Using aqueous micro-droplets dispersed in a continuous oil phase, the device could readily encapsulate and co-cultivate subsets of a community. A large number of droplets, up to,1,400 in a 10 mmx5 mm chamber, were generated with a frequency of 500 droplets/sec. A synthetic model system consisting of cross-feeding E. coli mutants was used to mimic compositions of symbionts and other microbes in natural microbial communities. Our device was able to detect a pair-wise symbiotic relationship when one partner accounted for as low as 1% of the total population or each symbiont was about 3% of the artificial community.	[Park, Jihyang; Burns, Mark A.; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Kerner, Alissa; Burns, Mark A.; Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Park, J (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu			Elizabeth C. Crosby Research Award; NIH [1R01EB006789, 1R21HG005077]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	Elizabeth C. Crosby Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by an Elizabeth C. Crosby Research Award received by XNL, an NIH grant (1R01EB006789) received by MAB, and an NIH grant (1R21HG005077) received by XNL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; Denou E, 2009, DNA CELL BIOL, V28, P413, DOI 10.1089/dna.2009.0873; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Ferrari BC, 2008, NAT PROTOC, V3, P1261, DOI 10.1038/nprot.2008.102; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grodrian A, 2004, BIOSENS BIOELECTRON, V19, P1421, DOI 10.1016/j.bios.2003.12.021; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hayashi A, 2007, J BIOSCI BIOENG, V103, P358, DOI 10.1263/jbb.103.358; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Inoue I, 2001, LAB CHIP, V1, P50, DOI 10.1039/b103931h; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Liu WS, 2009, LAB CHIP, V9, P2153, DOI 10.1039/b904958d; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Martin K, 2003, LAB CHIP, V3, P202, DOI 10.1039/b301258c; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Schink B, 2002, ANTON LEEUW INT J G, V81, P257, DOI 10.1023/A:1020579004534; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; TIEDJE JM, 1994, ASM NEWS, V60, P524; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van der Heijen MGA, 2008, ECOL LETT, V11, P651, DOI 10.1111/j.1461-0248.2008.01199.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	41	112	119	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17019	10.1371/journal.pone.0017019	http://dx.doi.org/10.1371/journal.pone.0017019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364881	gold, Green Submitted, Green Published			2022-12-27	WOS:000287764100020
J	Tran, TNN; Aboudharam, G; Gardeisen, A; Davoust, B; Bocquet-Appel, JP; Flaudrops, C; Belghazi, M; Raoult, D; Drancourt, M				Tran, Thi-Nguyen-Ny; Aboudharam, Gerard; Gardeisen, Armelle; Davoust, Bernard; Bocquet-Appel, Jean-Pierre; Flaudrops, Christophe; Belghazi, Maya; Raoult, Didier; Drancourt, Michel			Classification of Ancient Mammal Individuals Using Dental Pulp MALDI-TOF MS Peptide Profiling	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; SPECIES IDENTIFICATION; TYRANNOSAURUS-REX; MOLECULAR-IDENTIFICATION; SEQUENCES; PROTEINS; MASTODON; HAIR; COLLAGEN; REMAINS	Background: The classification of ancient animal corpses at the species level remains a challenging task for forensic scientists and anthropologists. Severe damage and mixed, tiny pieces originating from several skeletons may render morphological classification virtually impossible. Standard approaches are based on sequencing mitochondrial and nuclear targets. Methodology/Principal Findings: We present a method that can accurately classify mammalian species using dental pulp and mass spectrometry peptide profiling. Our work was organized into three successive steps. First, after extracting proteins from the dental pulp collected from 37 modern individuals representing 13 mammalian species, trypsin-digested peptides were used for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. The resulting peptide profiles accurately classified every individual at the species level in agreement with parallel cytochrome b gene sequencing gold standard. Second, using a 279-modern spectrum database, we blindly classified 33 of 37 teeth collected in 37 modern individuals (89.1%). Third, we classified 10 of 18 teeth (56%) collected in 15 ancient individuals representing five mammal species including human, from five burial sites dating back 8,500 years. Further comparison with an upgraded database comprising ancient specimen profiles yielded 100% classification in ancient teeth. Peptide sequencing yield 4 and 16 different non-keratin proteins including collagen (alpha-1 type I and alpha-2 type I) in human ancient and modern dental pulp, respectively. Conclusions/Significance: Mass spectrometry peptide profiling of the dental pulp is a new approach that can be added to the arsenal of species classification tools for forensics and anthropology as a complementary method to DNA sequencing. The dental pulp is a new source for collagen and other proteins for the species classification of modern and ancient mammal individuals.	[Tran, Thi-Nguyen-Ny; Aboudharam, Gerard; Flaudrops, Christophe; Raoult, Didier; Drancourt, Michel] Univ Aix Marseille 2, CNRS,Fac Med,IFR48, Unite Rech Malad Infect & Trop Emergentes URMITE, UMR 6236,IRD 198, Marseille, France; [Gardeisen, Armelle] Univ Montpellier 3, CNRS, UMR 5140, F-34032 Montpellier, France; [Davoust, Bernard] Direct Reg Serv Sante Armees Toulon, Toulon, France; [Bocquet-Appel, Jean-Pierre] Ecole Prat Hautes Etud, Paris, France; [Bocquet-Appel, Jean-Pierre] CNRS, UPR 2147, Paris, France; [Belghazi, Maya] Univ Aix Marseille 2, Fac Med Secteur Nord, IFR Jean Roche, CAPM, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Montpellier; Universite Paul-Valery; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Tran, TNN (corresponding author), Univ Aix Marseille 2, CNRS,Fac Med,IFR48, Unite Rech Malad Infect & Trop Emergentes URMITE, UMR 6236,IRD 198, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x; Bellis C, 2003, FORENSIC SCI INT, V134, P99, DOI 10.1016/S0379-0738(03)00128-2; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Catusse J, 2008, P NATL ACAD SCI USA, V105, P10262, DOI 10.1073/pnas.0800585105; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Garcia JMQ, 2003, INT ENDOD J, V36, P404, DOI 10.1046/j.1365-2591.2003.00669.x; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; HALDI J, 1963, J DENT RES, V42, P1217, DOI 10.1177/00220345630420051601; Harlamb SC, 1996, ARCH ORAL BIOL, V41, P1097, DOI 10.1016/S0003-9969(96)00036-2; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hollemeyer K, 2002, ANAL CHEM, V74, P5960, DOI 10.1021/ac020347f; Hollemeyer K, 2008, RAPID COMMUN MASS SP, V22, P2751, DOI 10.1002/rcm.3679; HONJO H, 1970, J DENT RES, V49, P888, DOI 10.1177/00220345700490043101; Humpula JF, 2007, GEOCHIM COSMOCHIM AC, V71, P5956, DOI 10.1016/j.gca.2007.09.003; Karger A, 2010, J VIROL METHODS, V164, P116, DOI 10.1016/j.jviromet.2009.11.022; Kempson IM, 2003, EUR J MASS SPECTROM, V9, P589, DOI 10.1255/ejms.584; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Myers SL, 1999, J FORENSIC SCI, V44, P805; Okiji T, 2002, SELTZER AND BENDER'S DENTAL PULP, P95; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Ouedraogo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013691; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007	34	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17319	10.1371/journal.pone.0017319	http://dx.doi.org/10.1371/journal.pone.0017319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364886	Green Published, gold			2022-12-27	WOS:000287764100046
J	Zhang, L; Li, DY; Luo, SQ				Zhang, Lu; Li, Dongyue; Luo, Shuqian			Non-Invasive Microstructure and Morphology Investigation of the Mouse Lung: Qualitative Description and Quantitative Measurement	PLOS ONE			English	Article							CONTRAST; RESOLUTION; CT; VISUALIZATION; BIOPSY; MICE	Background: Early detection of lung cancer is known to improve the chances of successful treatment. However, lungs are soft tissues with complex three-dimensional configuration. Conventional X-ray imaging is based purely on absorption resulting in very low contrast when imaging soft tissues without contrast agents. It is difficult to obtain adequate information of lung lesions from conventional X-ray imaging. Methods: In this study, a recently emerged imaging technique, in-line X-ray phase contrast imaging (IL-XPCI) was used. This powerful technique enabled high-resolution investigations of soft tissues without contrast agents. We applied IL-XPCI to observe the lungs in an intact mouse for the purpose of defining quantitatively the micro-structures in lung. Findings: The three-dimensional model of the lung was successfully established, which provided an excellent view of lung airways. We highlighted the use of IL-XPCI in the visualization and assessment of alveoli which had rarely been studied in three dimensions (3D). The precise view of individual alveolus was achieved. The morphological parameters, such as diameter and alveolar surface area were measured. These parameters were of great importance in the diagnosis of diseases related to alveolus and alveolar scar. Conclusion: Our results indicated that IL-XPCI had the ability to represent complex anatomical structures in lung. This offered a new perspective on the diagnosis of respiratory disease and may guide future work in the study of respiratory mechanism on the alveoli level.	[Zhang, Lu; Li, Dongyue; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University	Zhang, L (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	sqluo@ieee.org			Natural Science Foundation of China [60532090, 30770593]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the Natural Science Foundation of China, Grant No. 60532090 and 30770593. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigelman-Aubry C, 2002, RADIOLOGY, V223, P181, DOI 10.1148/radiol.2231010779; Biederer J, 2003, RADIOLOGY, V226, P242, DOI 10.1148/radiol.2261011974; Burdett CL, 2010, J HEART LUNG TRANSPL, V29, P759, DOI 10.1016/j.healun.2010.03.002; CARO JJ, 1991, AM J ROENTGENOL, V156, P825, DOI 10.2214/ajr.156.4.1825900; Hausmann Roland, 2004, Leg Med (Tokyo), V6, P61, DOI 10.1016/j.legalmed.2003.08.007; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Itoh H, 2001, EUR J RADIOL, V37, P143, DOI 10.1016/S0720-048X(00)00301-6; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kitchen MJ, 2005, BRIT J RADIOL, V78, P1018, DOI 10.1259/bjr/13024611; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029; Litzlbauer HD, 2006, AM J PHYSIOL-LUNG C, V291, pL535, DOI 10.1152/ajplung.00088.2005; LOWDER ML, 2007, THESIS GEORGIA I TEC; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Momose A, 2009, OPT EXPRESS, V17, P12540, DOI 10.1364/OE.17.012540; Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194; Sen S, 2001, LUNG CANCER, V33, P41, DOI 10.1016/S0169-5002(01)00193-3; Sera T, 2008, EUR J RADIOL, V68, pS54, DOI 10.1016/j.ejrad.2008.04.030; Sera T, 2008, PHYS MED BIOL, V53, P4285, DOI 10.1088/0031-9155/53/16/005; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Suzuki Y, 2002, J SYNCHROTRON RADIAT, V9, P160, DOI 10.1107/S090904950200554X; Watz H, 2005, RADIOLOGY, V236, P1053, DOI 10.1148/radiol.2363041142; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836	30	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17400	10.1371/journal.pone.0017400	http://dx.doi.org/10.1371/journal.pone.0017400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364899	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100054
J	Vyas, AK; Yang, KC; Woo, D; Tzekov, A; Kovacs, A; Jay, PY; Hruz, PW				Vyas, Arpita Kalla; Yang, Kai-Chien; Woo, Dennis; Tzekov, Anatoly; Kovacs, Attila; Jay, Patrick Y.; Hruz, Paul W.			Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MYOCARDIAL SUBSTRATE METABOLISM; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; UP-REGULATION; INSULIN; RAT; DOGS; REPERFUSION; EXPRESSION	Background: There is growing awareness of secondary insulin resistance and alterations in myocardial glucose utilization in congestive heart failure. Whether therapies that directly target these changes would be beneficial is unclear. We previously demonstrated that acute blockade of the insulin responsive facilitative glucose transporter GLUT4 precipitates acute decompensated heart failure in mice with advanced dilated cardiomyopathy. Our current objective was to determine whether pharmacologic enhancement of insulin sensitivity and myocardial glucose uptake preserves cardiac function and survival in the setting of primary heart failure. Methodology/Principal Findings: The GLP-1 agonist exenatide was administered twice daily to a murine model of dilated cardiomyopathy (TG9) starting at 56 days of life. TG9 mice develop congestive heart failure and secondary insulin resistance in a highly predictable manner with death by 12 weeks of age. Glucose homeostasis was assessed by measuring glucose tolerance at 8 and 10 weeks and tissue 2-deoxyglucose uptake at 75 days. Exenatide treatment improved glucose tolerance, myocardial GLUT4 expression and 2-deoxyglucose uptake, cardiac contractility, and survival over control vehicle-treated TG9 mice. Phosphorylation of AMP kinase and AKT was also increased in exenatide-treated animals. Total myocardial GLUT1 levels were not different between groups. Exenatide also abrogated the detrimental effect of the GLUT4 antagonist ritonavir on survival in TG9 mice. Conclusion/Significance: In heart failure secondary insulin resistance is maladaptive and myocardial glucose uptake is suboptimal. An incretin-based therapy, which addresses these changes, appears beneficial.	[Vyas, Arpita Kalla; Yang, Kai-Chien; Woo, Dennis; Tzekov, Anatoly; Jay, Patrick Y.; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Kovacs, Attila] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Jay, Patrick Y.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Vyas, AK (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu	Yang, Kai-Chien/AAO-6991-2021	Hruz, Paul/0000-0002-1478-3355; Yang, Kai-Chien/0000-0002-9128-9166	National Institutes of Health [P30DK056341 (NORC), DK064572, HL092798, DK 020579]; Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK064572, P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by research grants P30DK056341 (NORC), DK064572 and HL092798 from the National Institutes of Health and the Children's Discovery Institute. Insulin assays were performed in the Diabetes Research and Training Center core laboratory funded by NIH grant DK 020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Asmar M, 2010, CURR OPIN ENDOCRINOL, V17, P57, DOI 10.1097/MED.0b013e3283339051; Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Denissen JF, 1997, DRUG METAB DISPOS, V25, P489; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Hausenloy DJ, 2008, CIRC-HEART FAIL, V1, P147, DOI 10.1161/CIRCHEARTFAILURE.108.810887; HOM FG, 1984, DIABETES, V33, P141, DOI 10.2337/diabetes.33.2.141; Hruz PW, 2008, FASEB J, V22, P2161, DOI 10.1096/fj.07-102269; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Liang GY, 2008, EXP BIOL MED, V233, P1142, DOI 10.3181/0801-RM-33; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; Morissette MR, 2003, J MOL CELL CARDIOL, V35, P1217, DOI 10.1016/S0022-2828(03)00212-8; Mulder P, 2006, ADV CARDIOL, V43, P97, DOI 10.1159/000095431; Peterson LR, 2008, DIABETES, V57, P32, DOI 10.2337/db07-1199; Poornima I, 2008, CIRC-HEART FAIL, V1, P153, DOI 10.1161/CIRCHEARTFAILURE.108.766402; RODRIGUES B, 1995, J MOL CELL CARDIOL, V27, P169, DOI 10.1016/S0022-2828(08)80016-8; Rosenblatt-Velin N, 2001, CARDIOVASC RES, V52, P407, DOI 10.1016/S0008-6363(01)00393-5; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Schwenk RW, 2008, CARDIOVASC RES, V79, P249, DOI 10.1093/cvr/cvn116; Sen P, 2003, MOL CELL BIOCHEM, V253, P241, DOI 10.1023/A:1026020101379; Shah Ankur, 2003, Rev Cardiovasc Med, V4 Suppl 6, pS50; SMITH SA, 1986, BIOCHEM J, V237, P789, DOI 10.1042/bj2370789; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021	27	50	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17178	10.1371/journal.pone.0017178	http://dx.doi.org/10.1371/journal.pone.0017178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359201	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300033
J	Womack, JA; Goulet, JL; Gibert, C; Brandt, C; Chang, CC; Gulanski, B; Fraenkel, L; Mattocks, K; Rimland, D; Rodriguez-Barradas, MC; Tate, J; Yin, MT; Justice, AC				Womack, Julie A.; Goulet, Joseph L.; Gibert, Cynthia; Brandt, Cynthia; Chang, Chung Chou; Gulanski, Barbara; Fraenkel, Liana; Mattocks, Kristin; Rimland, David; Rodriguez-Barradas, Maria C.; Tate, Janet; Yin, Michael T.; Justice, Amy C.		Vet Aging Cohort Study Project	Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HUMAN-IMMUNODEFICIENCY-VIRUS; OSTEOPOROSIS CARE GAP; ANTIRETROVIRAL THERAPY; ELDERLY-MEN; WOMEN; OSTEOPENIA; PREVALENCE; CORTICOSTEROIDS; EPIDEMIOLOGY	Background: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors. Methodology/Principal Findings: Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m(2); p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)]. Conclusions/Significance: HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.	[Womack, Julie A.; Goulet, Joseph L.; Brandt, Cynthia; Gulanski, Barbara; Fraenkel, Liana; Mattocks, Kristin; Tate, Janet; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Gibert, Cynthia] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA; [Gibert, Cynthia] George Washington Univ, Dept Med, Washington, DC USA; [Brandt, Cynthia] Yale Univ, Yale Ctr Med Informat, New Haven, CT USA; [Chang, Chung Chou] Univ Pittsburgh, Sch Med, Sect Decis Sci & Clin Syst Modeling, Pittsburgh, PA USA; [Gulanski, Barbara; Mattocks, Kristin; Justice, Amy C.] Yale Univ, Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Fraenkel, Liana] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA; [Rimland, David] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA; [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Med Serv, Michael E De Bakey Vet Affairs VA Med Ctr, Houston, TX 77030 USA; [Yin, Michael T.] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Baylor College of Medicine; Baylor College of Medicine; Columbia University	Womack, JA (corresponding author), VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.	julie.womack@va.gov		Yin, Michael T/0000-0002-9346-9056; Goulet, Joseph Lucien/0000-0002-0842-804X	VA Office, Academic Affiliations, Information Research & Development Medical Informatics; National Institute on Alcohol Abuse and Alcoholism [U10 AA 13566]; VHA Public Health Strategic Health Core Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI059884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K01NR013437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA013566] Funding Source: NIH RePORTER	VA Office, Academic Affiliations, Information Research & Development Medical Informatics; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); VHA Public Health Strategic Health Core Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding: Dr. Womack is funded by the VA Office, Academic Affiliations, Information Research & Development Medical Informatics Fellowship Program. Veterans Aging Cohort Study funded by the National Institute on Alcohol Abuse and Alcoholism (U10 AA 13566) and VHA Public Health Strategic Health Core Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; [Anonymous], 2001, MISSING DATA; Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015; Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Bolland MJ, 2007, CLIN ENDOCRINOL, V67, P270, DOI 10.1111/j.1365-2265.2007.02875.x; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; BUHR AJ, 1959, LANCET, V1, P531; Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; *CDC, 2004, HIV AIDS SURV REP; Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468; Collin F, 2009, AIDS, V23, P1021, DOI 10.1097/QAD.0b013e3283292195; Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993; CRAWFORD SL, 1995, J CLIN EPIDEMIOL, V48, P209, DOI 10.1016/0895-4356(94)00124-9; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74; Gallant JE, 1998, CHEST, V114, P1258, DOI 10.1378/chest.114.5.1258; Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Hoffmann M, 2000, J NEUROVIROL, V6, P229, DOI 10.3109/13550280009015825; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lindau TR, 1999, ACTA ORTHOP SCAND, V70, P124, DOI 10.3109/17453679909011248; McComsey Grace A, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P86, DOI 10.1177/154510970400300303; McQueen MM, 2003, CURR ORTHOPAED, V17, P360, DOI 10.1016/S0268-0890(03)00097-5; Nguyen TV, 2001, AM J EPIDEMIOL, V153, P587, DOI 10.1093/aje/153.6.587; Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0; Papaioannou A, 2008, OSTEOPOROSIS INT, V19, P581, DOI 10.1007/s00198-007-0483-0; Pasco JA, 2006, OSTEOPOROSIS INT, V17, P1404, DOI 10.1007/s00198-006-0135-9; Piliero PJ, 2002, AIDS, V16, P1565, DOI 10.1097/00002030-200207260-00019; Prior J, 2007, OSTEOPOROSIS INT, V18, P1345, DOI 10.1007/s00198-007-0428-7; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Siris ES, 2004, ARCH INTERN MED, V164, P1108, DOI 10.1001/archinte.164.10.1108; Sornay-Rendu E, 2005, J BONE MINER RES, V20, P1813, DOI 10.1359/JBMR.050609; Steinke DT, 2002, GUT, V50, P100, DOI 10.1136/gut.50.1.100; STELLBRINK H, 2009, ASSESSMENT SAFETY EF; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Szulc P, 2005, OSTEOPOROSIS INT, V16, P1184, DOI 10.1007/s00198-005-1970-9; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; van Diepen S, 2008, CIRCULATION, V118, P1946, DOI 10.1161/CIRCULATIONAHA.108.784009; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; WARRINER AH, CURR RHEUMATOL REP, V12, P163; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	59	199	200	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17217	10.1371/journal.pone.0017217	http://dx.doi.org/10.1371/journal.pone.0017217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359191	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000287392700061
J	Ah-Fong, AMV; Judelson, HS				Ah-Fong, Audrey M. V.; Judelson, Howard S.			New Role for Cdc14 Phosphatase: Localization to Basal Bodies in the Oomycete Phytophthora and Its Evolutionary Coinheritance with Eukaryotic Flagella	PLOS ONE			English	Article							CELL-DIVISION; CHROMOSOME SEGREGATION; C-ELEGANS; INFESTANS; CYCLE; CHLAMYDOMONAS; PROTEINS; GENE; STABILIZATION; MICROTUBULES	Cdc14 protein phosphatases are well known for regulating the eukaryotic cell cycle, particularly during mitosis. Here we reveal a distinctly new role for Cdc14 based on studies of the microbial eukaryote Phytophthora infestans, the Irish potato famine agent. While Cdc14 is transcribed constitutively in yeast and animal cells, the P. infestans ortholog is expressed exclusively in spore stages of the life cycle and not in vegetative hyphae where the bulk of mitosis takes place. PiCdc14 expression is first detected in nuclei at sporulation, and during zoospore formation the protein accumulates at the basal body, which is the site from which flagella develop. The association of PiCdc14 with basal bodies was supported by co-localization studies with the DIP13 basal body protein and flagellar beta-tubulin, and by demonstrating the enrichment of PiCdc14 in purified flagella-basal body complexes. Overexpressing PiCdc14 did not cause defects in growth or mitosis in hyphae, but interfered with cytoplasmic partitioning during zoosporogenesis. This cytokinetic defect might relate to its ability to bind microtubules, which was shown using an in vitro cosedimentation assay. The use of gene silencing to reveal the precise function of PiCdc14 in flagella is not possible since we showed previously that silencing prevents the formation of the precursor stage, sporangia. Nevertheless, the association of Cdc14 with flagella and basal bodies is consistent with their phylogenetic distribution in eukaryotes, as species that lack the ability to produce flagella generally also lack Cdc14. An ancestral role of Cdc14 in the flagellar stage of eukaryotes is thereby proposed.	[Ah-Fong, Audrey M. V.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ah-Fong, AMV (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			National Institute of Food and Agriculture, United States Department of Agriculture [2008-35319-04536, 2008-35600-04686]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Institute of Food and Agriculture, United States Department of Agriculture, under agreement numbers 2008-35319-04536 and 2008-35600-04686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Clifford DM, 2008, BIOCHEM SOC T, V36, P436, DOI 10.1042/BST0360436; Cueille N, 2001, J CELL SCI, V114, P2649; Debec A, 2010, CELL MOL LIFE SCI, V67, P2173, DOI 10.1007/s00018-010-0323-9; Dulev S, 2009, P NATL ACAD SCI USA, V106, P14466, DOI 10.1073/pnas.0900190106; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Grandien K, 2001, GENE DEV, V15, P2161, DOI 10.1101/gad.200601; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Hardham AR, 2001, MOL CELL BIOL FILAME, P127; HARPER JDI, 1995, PROTOPLASMA, V188, P225, DOI 10.1007/BF01280374; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; HYDE GJ, 1993, EUR J CELL BIOL, V62, P75; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Krasinska L, 2007, EXP CELL RES, V313, P1225, DOI 10.1016/j.yexcr.2006.12.022; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; MALTESE CE, 1995, MYCOL RES, V99, P1175, DOI 10.1016/S0953-7562(09)80273-6; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MARKS GE, 1965, CHROMOSOMA, V16, P681, DOI 10.1007/BF00285117; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; MCKEEN W E, 1984, Canadian Journal of Plant Pathology, V6, P40; Mitchell DR, 2007, ADV EXP MED BIOL, V607, P130; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Schindler K, 2009, CELL CYCLE, V8, P1090, DOI 10.4161/cc.8.7.8144; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Trautmann S, 2005, CURR BIOL, V15, P1384, DOI 10.1016/j.cub.2005.06.039; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Vitulo N, 2007, EVOL BIOINFORM, V3, P121; WHITTAKER SL, 1992, MYCOL RES, V96, P355, DOI 10.1016/S0953-7562(09)80950-7; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16725	10.1371/journal.pone.0016725	http://dx.doi.org/10.1371/journal.pone.0016725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340037	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600017
J	Opota, O; Gauthier, NC; Doye, A; Berry, C; Gounon, P; Lemichez, E; Pauron, D				Opota, Onya; Gauthier, Nils C.; Doye, Anne; Berry, Colin; Gounon, Pierre; Lemichez, Emmanuel; Pauron, David			Bacillus sphaericus Binary Toxin Elicits Host Cell Autophagy as a Response to Intoxication	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS LARVAE; PORE-FORMING TOXINS; VACUOLATING CYTOTOXIN; ANCHORED PROTEINS; PINOCYTIC PATHWAY; EPITHELIAL-CELLS; PIPIENS DIPTERA; TARGET RECEPTOR; ENDOSOMES; CULICIDAE	Bacillus sphaericus strains that produce the binary toxin (Bin) are highly toxic to Culex and Anopheles mosquitoes, and have been used since the late 1980s as a biopesticide for the control of these vectors of infectious disease agents. The Bin toxin produced by these strains targets mosquito larval midgut epithelial cells where it binds to Cpm1 (Culex pipiens maltase 1) a digestive enzyme, and causes severe intracellular damage, including a dramatic cytoplasmic vacuolation. The intoxication of mammalian epithelial MDCK cells engineered to express Cpm1 mimics the cytopathologies observed in mosquito enterocytes following Bin ingestion: pore formation and vacuolation. In this study we demonstrate that Bin-induced vacuolisation is a transient phenomenon that affects autolysosomes. In addition, we show that this vacuolisation is associated with induction of autophagy in intoxicated cells. Furthermore, we report that after internalization, Bin reaches the recycling endosomes but is not localized either within the vacuolating autolysosomes or within any other degradative compartment. Our observations reveal that Bin elicits autophagy as the cell's response to intoxication while protecting itself from degradation through trafficking towards the recycling pathways.	[Opota, Onya; Pauron, David] Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale, INRA 1301,CNRS 6243, Sophia Antipolis, France; [Gauthier, Nils C.; Doye, Anne; Lemichez, Emmanuel] UNSA, INSERM, U895, Ctr Mediterraneen Med Mol, Nice, France; [Berry, Colin] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Gounon, Pierre] Univ Nice Sophia Antipolis, Fac Sci, Ctr Commun Microscopie Elect Appl, Nice, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Cardiff University; UDICE-French Research Universities; Universite Cote d'Azur	Opota, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland.	onya.opota@epfl.ch; David.Pauron@sophia.inra.fr	Opota, Onya/K-5851-2017; Berry, Colin/A-4338-2010; Lemichez, Emmanuel/G-3559-2013	Opota, Onya/0000-0002-5421-0607; Berry, Colin/0000-0002-9943-548X; Lemichez, Emmanuel/0000-0001-9080-7761; Plummer, Beverley/0000-0002-6559-7237	Institut National de la Recherche Agronomique (Inra); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministere de la Education et de la Recherche	Institut National de la Recherche Agronomique (Inra); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministere de la Education et de la Recherche	The work depicted in this paper has been granted by two French governmental agencies, the Institut National de la Recherche Agronomique (Inra) and the Institut National de la Sante et de la Recherche Medicale (INSERM). Moreover, this work represents a substantial part of Dr. Onya Opota's PhD for which he received a fellowship from the French Ministere de la Education et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; CHARLES JF, 1987, ANN INST PASTEUR MIC, V138, P471, DOI 10.1016/0769-2609(87)90064-0; Cokmus C, 1997, J INVERTEBR PATHOL, V69, P197, DOI 10.1006/jipa.1997.4660; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Darboux I, 2002, P NATL ACAD SCI USA, V99, P5830, DOI 10.1073/pnas.092615399; Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; de Melo JV, 2009, APPL ENVIRON MICROB, V75, P4782, DOI 10.1128/AEM.00811-09; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Gauthier NC, 2004, J BIOL CHEM, V279, P9481, DOI 10.1074/jbc.M312040200; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; NARASU ML, 1988, INDIAN J BIOCHEM BIO, V25, P253; OEI C, 1992, J GEN MICROBIOL, V138, P1515, DOI 10.1099/00221287-138-7-1515; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; OPOTA O, 2007, COMP BIOCH PHYSL B; Pauchet Y, 2005, CELL MICROBIOL, V7, P1335, DOI 10.1111/j.1462-5822.2005.00560.x; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 2001, J MEMBRANE BIOL, V184, P171, DOI 10.1007/s00232-001-0086-1; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Silva-Filha MH, 1999, INSECT BIOCHEM MOLEC, V29, P711, DOI 10.1016/S0965-1748(99)00047-8; Silva-Filha MHNL, 2003, PESTIC BIOCHEM PHYS, V77, P138, DOI 10.1016/j.pestbp.2003.07.002; SINGH GJP, 1988, J INVERTEBR PATHOL, V52, P237, DOI 10.1016/0022-2011(88)90131-0; Soberon M, 2007, TOXICON, V49, P597, DOI 10.1016/j.toxicon.2006.11.008; Tan YK, 2009, AUTOPHAGY, V5, P734, DOI 10.4161/auto.5.5.8567; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	49	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14682	10.1371/journal.pone.0014682	http://dx.doi.org/10.1371/journal.pone.0014682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339824	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000287367600008
J	Nichols, FC; Yao, XD; Bajrami, B; Downes, J; Finegold, SM; Knee, E; Gallagher, JJ; Housley, WJ; Clark, RB				Nichols, Frank C.; Yao, Xudong; Bajrami, Bekim; Downes, Julia; Finegold, Sydney M.; Knee, Erica; Gallagher, James J.; Housley, William J.; Clark, Robert B.			Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS LIPIDS; SYSTEMIC INNATE IMMUNITY; RHEUMATOID-ARTHRITIS; MICROBIOTA; PERIODONTITIS; ASSOCIATION; DISEASE	Novel phosphorylated dihydroceramide (PDHC) lipids produced by the periodontal pathogen Porphyromonas gingivalis include phosphoethanolamine (PE DHC) and phosphoglycerol dihydroceramides (PG DHC) lipids. These PDHC lipids mediate cellular effects through Toll-like receptor 2 (TLR2) including promotion of IL-6 secretion from dendritic cells and inhibition of osteoblast differentiation and function in vitro and in vivo. The PE DHC lipids also enhance (TLR2)-dependent murine experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. The unique non-mammalian structures of these lipids allows for their specific quantification in bacteria and human tissues using multiple reaction monitoring (MRM)-mass spectrometry (MS). Synthesis of these lipids by other common human bacteria and the presence of these lipids in human tissues have not yet been determined. We now report that synthesis of these lipids can be attributed to a small number of intestinal and oral organisms within the Bacteroides, Parabacteroides, Prevotella, Tannerella and Porphyromonas genera. Additionally, the PDHCs are not only present in gingival tissues, but are also present in human blood, vasculature tissues and brain. Finally, the distribution of these TLR2-activating lipids in human tissues varies with both the tissue site and disease status of the tissue suggesting a role for PDHCs in human disease.	[Nichols, Frank C.; Knee, Erica] Univ Connecticut, Sch Dent Med, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA; [Yao, Xudong; Bajrami, Bekim] Univ Connecticut, Dept Chem, Storrs, CT USA; [Downes, Julia; Finegold, Sydney M.] VA Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Gallagher, James J.] Univ Connecticut, Sch Med, Dept Surg, Farmington, CT 06032 USA; [Gallagher, James J.] Connecticut Vasc Inst, Hartford, CT USA; [Housley, William J.; Clark, Robert B.] Univ Connecticut, Sch Med, Dept Immunol, Farmington, CT 06032 USA; [Housley, William J.; Clark, Robert B.] Univ Connecticut, Sch Med, Dept Med, Farmington, CT 06032 USA	University of Connecticut; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Connecticut; University of Connecticut; University of Connecticut	Nichols, FC (corresponding author), Univ Connecticut, Sch Dent Med, Dept Oral Hlth & Diagnost Sci, Farmington, CT 06032 USA.	nichols@nso.uchc			National Multiple Sclerosis Society [RG4070-A-6]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by a grant from the National Multiple Sclerosis Society (RG4070-A-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKEMA EV, 2010, J RHEUMATOL; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; de Pablo P, 2008, J RHEUMATOL, V35, P70; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; FUKAMI H, 2010, J LIPID RES; GARBUS J, 1963, J BIOL CHEM, V238, P59; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MIKULS TR, 2008, INT IMMUNOPHARMACOL; Nichols FC, 2006, ORAL MICROBIOL IMMUN, V21, P84, DOI 10.1111/j.1399-302X.2006.00264.x; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Nichols FC, 2009, AM J PATHOL, V175, P2430, DOI 10.2353/ajpath.2009.090544; Philpott DJ, 2010, NAT MED, V16, P160, DOI 10.1038/nm0210-160; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Wang YH, 2010, INFECT IMMUN, V78, P3726, DOI 10.1128/IAI.00225-10; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zahlten J, 2007, J DENT RES, V86, P635, DOI 10.1177/154405910708600710	21	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16771	10.1371/journal.pone.0016771	http://dx.doi.org/10.1371/journal.pone.0016771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347306	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500005
J	Karageorgopoulos, DE; Lamnatou, V; Sardi, TA; Gkegkes, ID; Falagas, ME				Karageorgopoulos, Drosos E.; Lamnatou, Vasiliki; Sardi, Thalia A.; Gkegkes, Ioannis D.; Falagas, Matthew E.			Temporal Trends in the Impact Factor of European versus USA Biomedical Journals	PLOS ONE			English	Article							PUBLICATION	Background: The impact factors of biomedical journals tend to rise over time. We sought to assess the trend in the impact factor, during the past decade, of journals published on behalf of United States (US) and European scientific societies, in four select biomedical subject categories (Biology, Cell Biology, Critical Care Medicine, and Infectious Diseases). Methods: We identified all journals included in the above-mentioned subject categories of Thomson Reuters Journal Citation Reports (R) for the years 1999, 2002, 2005, and 2008. We selected those that were published on behalf of US or European scientific societies, as documented in journal websites. Results: We included 167 journals (35 in the subject category of Biology, 79 in Cell Biology, 27 in Critical Care Medicine, and 26 in Infectious Diseases). Between 1999 and 2008, the percentage increase in the impact factor of the European journals was higher than for the US journals (73.7 +/- 110.0% compared with 39.7 +/- 70.0%, p = 0.049). Regarding specific subject categories, the percentage change in the factor of the European journals tended to be higher than the respective US journals for Cell Biology (61.7% versus 16.3%), Critical Care Medicine (212.4% versus 65.4%), Infectious Diseases (88.3% versus 48.7%), whereas the opposite was observed for journals in Biology (41.0% versus 62.5%). Conclusion: Journals published on behalf of European scientific societies, in select biomedical fields, may tend to close the "gap" in impact factor compared with those of US societies. What's Already Known About This Topic? The impact factors of biomedical journals tend to rise through years. The leading positions in productivity in biomedical research are held by developed countries, including those from North America and Western Europe. What Does This Article Add? The journals from European biomedical scientific societies tended, over the past decade, to increase their impact factor more than the respective US journals.	[Karageorgopoulos, Drosos E.; Lamnatou, Vasiliki; Sardi, Thalia A.; Gkegkes, Ioannis D.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Alfa Institute Of Biomedical Sciences; Henry Dunant Hospital; Tufts University	Karageorgopoulos, DE (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Andersen Julia, 2006, Journal of Microbiology Immunology and Infection, V39, P436; Dinkel A, 2004, EXP PSYCHOL, V51, P319, DOI 10.1027/1618-3169.51.4.319; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Falagas ME, 2006, CAN MED ASSOC J, V175, P1389, DOI 10.1503/cmaj.060361; Falagas ME, 2006, MAYO CLIN PROC, V81, P1401, DOI 10.4065/81.10.1401; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Lopez-Abente G, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-24; Neroth P, 2005, LANCET, V365, P1455, DOI 10.1016/S0140-6736(05)66402-1; Opthof T, 1997, CARDIOVASC RES, V33, P1, DOI 10.1016/S0008-6363(96)00215-5; Rahman M, 2003, PUBLIC HEALTH, V117, P274, DOI 10.1016/S0033-3506(03)00068-4; Rizkallah J, PLOS ONE, V5; Valkimadi PE, 2009, SCIENTOMETRICS, V81, P219, DOI 10.1007/s11192-008-2139-z	15	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16300	10.1371/journal.pone.0016300	http://dx.doi.org/10.1371/journal.pone.0016300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347409	Green Submitted, Green Published, gold			2022-12-27	WOS:000287361700014
J	Putters, J; Almeida, ACD; van Kerkhof, P; van Rossum, AGSH; Gracanin, A; Strous, GJ				Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Gracanin, Ana; Strous, Ger J.			Jak2 Is a Negative Regulator of Ubiquitin-Dependent Endocytosis of the Growth Hormone Receptor	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; ERYTHROPOIETIN RECEPTOR; FERM DOMAIN; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; DOWN-REGULATION; JANUS KINASE; DEGRADATION; SYSTEM	Background: Length and intensity of signal transduction via cytokine receptors is precisely regulated. Degradation of certain cytokine receptors is mediated by the ubiquitin ligase SCF(beta TrCP). In several instances, Janus kinase (Jak) family members can stabilise their cognate cytokine receptors at the cell surface. Principal Findings: In this study we show in Hek293 cells that Jak2 binding to the growth hormone receptor prevents endocytosis in a non-catalytic manner. Following receptor activation, the detachment of phosphorylated Jak2 induces down-regulation of the growth hormone receptor by SCF(beta TrCP). Using gamma 2A human fibroblast cells we show that both growth hormone-induced and constitutive growth hormone receptor endocytosis depend on the same factors, strongly suggesting that the modes of endocytosis are identical. Different Jak2 RNA levels in HepG2, IM9 and Hek293 cells indicate the importance of cellular concentration on growth hormone receptor function. Both Jak2 and bTrCP bind to neighbouring linear motifs in the growth hormone receptor tail without the requirement of modifications, indicating that growth hormone sensitivity is regulated by the cellular level of non-committed Jak2. Conclusions/Significance: As signal transduction of many cytokine receptors depends on Jak2, the study suggests an integrative role of Jak2 in cytokine responses based on its enzyme activity as well as its stabilising properties towards the receptors.	[Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Strous, Ger J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Putters, Joyce; Almeida, Ana C. da Silva; van Kerkhof, Peter; van Rossum, Agnes G. S. H.; Strous, Ger J.] Univ Med Ctr Utrecht, Inst Biomembranes, Utrecht, Netherlands; [Almeida, Ana C. da Silva; van Rossum, Agnes G. S. H.] Drug Discovery Factory BV, Bussum, Netherlands; [Gracanin, Ana] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Putters, J (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	gstrous@umcutrecht.nl		van Kerkhof, Peter/0000-0002-8954-2230	The Netherlands Organisation for Scientific Research [NWO-ALW 814-02-011]; The European Network of Excellence, Rubicon [LSHG-CT-2005-018683]; The Marie Curie network, UbiRegulators [MRTN-CT-2006-034555]	The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); The European Network of Excellence, Rubicon; The Marie Curie network, UbiRegulators	This research was supported by The Netherlands Organisation for Scientific Research Grant NWO-ALW 814-02-011, to JP. The European Network of Excellence, Rubicon funded Agnes G.S.H. v R. (Grant LSHG-CT-2005-018683, Role of ubiquitin and ubiquitin-like modifiers in cellular regulation). The Marie Curie network, UbiRegulators, funded da Silva Almeida AC (Grant MRTN-CT-2006-034555). The funders, including the commercial company Drug Discovery Factory BV (DDF), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit T, 2000, J CLIN ENDOCR METAB, V85, P927, DOI 10.1210/jc.85.3.927; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Behrmann I, 2004, J BIOL CHEM, V279, P35486, DOI 10.1074/jbc.M404202200; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; dos Santos CMA, 2001, J BIOL CHEM, V276, P10839, DOI 10.1074/jbc.M003635200; dos Santos GMA, 2001, J BIOL CHEM, V276, P32635, DOI 10.1074/jbc.M103583200; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Goldsmith JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE932, DOI 10.1152/ajpendo.1997.273.5.E932; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He K, 2005, ENDOCRINOLOGY, V146, P4755, DOI 10.1210/en.2005-0514; He K, 2003, MOL ENDOCRINOL, V17, P2211, DOI 10.1210/me.2003-0256; Hilkens CMU, 2001, FEBS LETT, V505, P87, DOI 10.1016/S0014-5793(01)02783-1; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kumar KGS, 2003, EMBO J, V22, P5480; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Loesch K, 2007, ENDOCRINOLOGY, V148, P5955, DOI 10.1210/en.2007-0455; Meenhuis A, 2009, BIOCHEM J, V417, P737, DOI 10.1042/BJ20081153; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfaffl MW, 2002, DOMEST ANIM ENDOCRIN, V22, P91, DOI 10.1016/S0739-7240(01)00128-X; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Strous GJ, 1997, J BIOL CHEM, V272, P40; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933	51	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14676	10.1371/journal.pone.0014676	http://dx.doi.org/10.1371/journal.pone.0014676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347402	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700008
J	Phipps, MC; Clem, WC; Catledge, SA; Xu, Y; Hennessy, KM; Thomas, V; Jablonsky, MJ; Chowdhury, S; Stanishevsky, AV; Vohra, YK; Bellis, SL				Phipps, Matthew C.; Clem, William C.; Catledge, Shane A.; Xu, Yuanyuan; Hennessy, Kristin M.; Thomas, Vinoy; Jablonsky, Michael J.; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.; Bellis, Susan L.			Mesenchymal Stem Cell Responses to Bone-Mimetic Electrospun Matrices Composed of Polycaprolactone, Collagen I and Nanoparticulate Hydroxyapatite	PLOS ONE			English	Article							FOCAL ADHESION KINASE; OSTEOGENIC DIFFERENTIATION; ILIAC CREST; TISSUE; SCAFFOLDS; NANOFIBERS; VITRO; VITRONECTIN; FIBERS; GRAFT	The performance of biomaterials designed for bone repair depends, in part, on the ability of the material to support the adhesion and survival of mesenchymal stem cells (MSCs). In this study, a nanofibrous bone-mimicking scaffold was electrospun from a mixture of polycaprolactone (PCL), collagen I, and hydroxyapatite (HA) nanoparticles with a dry weight ratio of 50/30/20 respectively (PCL/col/HA). The cytocompatibility of this tri-component scaffold was compared with three other scaffold formulations: 100% PCL (PCL), 100% collagen I (col), and a bi-component scaffold containing 80% PCL/20% HA (PCL/HA). Scanning electron microscopy, fluorescent live cell imaging, and MTS assays showed that MSCs adhered to the PCL, PCL/HA and PCL/col/HA scaffolds, however more rapid cell spreading and significantly greater cell proliferation was observed for MSCs on the tri-component bone-mimetic scaffolds. In contrast, the col scaffolds did not support cell spreading or survival, possibly due to the low tensile modulus of this material. PCL/col/HA scaffolds adsorbed a substantially greater quantity of the adhesive proteins, fibronectin and vitronectin, than PCL or PCL/HA following in vitro exposure to serum, or placement into rat tibiae, which may have contributed to the favorable cell responses to the tri-component substrates. In addition, cells seeded onto PCL/col/HA scaffolds showed markedly increased levels of phosphorylated FAK, a marker of integrin activation and a signaling molecule known to be important for directing cell survival and osteoblastic differentiation. Collectively these results suggest that electrospun bone-mimetic matrices serve as promising degradable substrates for bone regenerative applications.	[Phipps, Matthew C.; Xu, Yuanyuan; Hennessy, Kristin M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Clem, William C.; Catledge, Shane A.; Thomas, Vinoy; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.; Bellis, Susan L.] Univ Alabama Birmingham, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA; [Clem, William C.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Catledge, Shane A.; Thomas, Vinoy; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.] Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; [Jablonsky, Michael J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Phipps, MC (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	ykvohra@uab.edu; bellis@uab.edu	THOMAS, VINOY/A-8016-2009	THOMAS, VINOY/0000-0002-1191-3353; Catledge, Shane/0000-0003-3202-3234	National Institute of Dental and Craniofacial Research (NIDCR) [R01DE013952]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR51539]; National Science Foundation (NSF) [CMS-0555778]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB004312]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB004312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013952] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support was provided by: (1) National Institute of Dental and Craniofacial Research (NIDCR) under grant # R01DE013952 (YKV) http://www.nidcr.nih.gov/. (2) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under grant # R01AR51539 (SLB) http://www.niams.nih.gov/. (3) National Science Foundation (NSF) Award # CMS-0555778 (AVS) http://www.nsf.gov/div/index.jsp?div=PHY. (4) WC Clem was supported by the NIH training Grant # T32EB004312 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) http://www.nibib.nih.gov/. (5) MC Phipps was supported by a Howard Hughes Med to Grad Fellowship http://www.hhmi.org/grants/institutions/medintograd.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292; BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z; Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313; BRIGHTON CT, 1995, CLIN ORTHOP RELAT R, P223; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013; Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657; DARNEY PD, 1989, AM J OBSTET GYNECOL, V160, P1292, DOI 10.1016/S0002-9378(89)80015-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006; FREISS W, 1996, PHARM DEV TECHNOL, V1, P185; GEBB C, 1986, J BIOL CHEM, V261, P6698; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Goulet JA, 1997, CLIN ORTHOP RELAT R, P76; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905; Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043; Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z; Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006; Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030; Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Moursi AM, 1997, J CELL SCI, V110, P2187; Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104; Thomas V, 2006, J NANOSCI NANOTECHNO, V6, P487, DOI 10.1166/jnn.2006.097; Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w; Tzaphlidou M, 2005, BONE, V36, pS198; VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310; Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu YQ, 2004, J AM CERAM SOC, V87, P1988; Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150; Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870	54	82	85	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16813	10.1371/journal.pone.0016813	http://dx.doi.org/10.1371/journal.pone.0016813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346817	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600030
J	Althaus, CL; De Boer, RJ				Althaus, Christian L.; De Boer, Rob J.			Implications of CTL-Mediated Killing of HIV-Infected Cells during the Non-Productive Stage of Infection	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; COMPLEX CLASS-I; DOWN-REGULATION; EXPRESSION KINETICS; VIRAL REPLICATION; TYPE-1 INFECTION; IMMUNE CONTROL; NEF PROTEIN; PLASMA	Patients infected with HIV exhibit orders of magnitude differences in their set-point levels of the plasma viral load. As to what extent this variation is due to differences in the efficacy of the cytotoxic T lymphocyte (CTL) response in these patients is unclear. Several studies have shown that HIV-infected CD4(+) T cells also present viral epitopes that are recognized by CTLs before the productive stage of infection, i.e., during the intracellular eclipse phase before the infected cell starts to produce new viral particles. Here, we use mathematical modeling to investigate the potential impact of early killing of HIV-infected cells on viral replication. We suggest that the majority of CTL-mediated killing could occur during the viral eclipse phase, and that the killing of virus-producing cells could be substantially lower at later stages due to MHC-I-down-regulation. Such a mechanism is in agreement with several experimental observations that include CD8(+) T cell depletion and antiretroviral drug treatment. This indicates a potentially important role of CTL-mediated killing during the non-productive stage of HIV-infected cells.	[Althaus, Christian L.; De Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands	Utrecht University	Althaus, CL (corresponding author), Univ Utrecht, Utrecht, Netherlands.	christian.althaus@alumni.ethz.ch	de Boer, Rob/B-6050-2011; Althaus, Christian L./F-6008-2015	de Boer, Rob/0000-0002-2130-691X; Althaus, Christian L./0000-0002-5230-6760	Netherlands Organisation for Scientific Research [016.048.603]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	CLA and RJDB gratefully acknowledge financial support by the Netherlands Organisation for Scientific Research (VICI grant 016.048.603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2004, J VIROL, V78, P561, DOI 10.1128/JVI.78.2.561-567.2004; Althaus CL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.4; Althaus CL, 2009, J VIROL, V83, P7659, DOI 10.1128/JVI.01799-08; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; BALAMURALI M, 2010, J IMMUNOL; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Borghans JAM, 1996, B MATH BIOL, V58, P43, DOI 10.1016/0092-8240(95)00306-1; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Dixit NM, 2004, ANTIVIR THER, V9, P237; FISCHER W, 2010, PLOS ONE, V5; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Ganusov VV, 2003, P ROY SOC B-BIOL SCI, V270, P1513, DOI 10.1098/rspb.2003.2401; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gruters RA, 2002, VACCINE, V20, P2011, DOI 10.1016/S0264-410X(02)00089-0; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kesmir C, 2003, IMMUNOGENETICS, V55, P437, DOI 10.1007/s00251-003-0585-6; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kim EY, 2008, J VIROL, V82, P5631, DOI 10.1128/JVI.02749-07; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Klenerman P, 1996, P NATL ACAD SCI USA, V93, P15323, DOI 10.1073/pnas.93.26.15323; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Muller V, 2001, P ROY SOC B-BIOL SCI, V268, P235, DOI 10.1098/rspb.2000.1358; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nowak MA., 2000, VIRUS DYNAMICS MATH; Pandrea I, 2008, J VIROL, V82, P3713, DOI 10.1128/JVI.02402-07; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Sacha JB, 2008, J VIROL, V82, P9293, DOI 10.1128/JVI.00749-08; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Sacha JB, 2010, J VIROL, V84, P10907, DOI 10.1128/JVI.01357-10; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sergeev RA, 2010, J THEOR BIOL, V263, P369, DOI 10.1016/j.jtbi.2009.11.003; Swigut T, 2004, J VIROL, V78, P13335, DOI 10.1128/JVI.78.23.13335-13344.2004; van Baalen CA, 2002, EUR J IMMUNOL, V32, P2644, DOI 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R; Vojnov L, 2010, J VIROL, V84, P753, DOI 10.1128/JVI.01596-09; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wick WD, 2009, J VIROL, V83, P2349, DOI 10.1128/JVI.00821-08; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yang OO, 1997, ADV IMMUNOL, V66, P273, DOI 10.1016/S0065-2776(08)60600-8	63	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16468	10.1371/journal.pone.0016468	http://dx.doi.org/10.1371/journal.pone.0016468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326882	gold, Green Published			2022-12-27	WOS:000287037100009
J	Rakowski, LA; Lehotzky, EA; Chiang, MY				Rakowski, Lesley A.; Lehotzky, Erica A.; Chiang, Mark Y.			Transient Responses to NOTCH and TLX1/HOX11 Inhibition in T-Cell Acute Lymphoblastic Leukemia/Lymphoma	PLOS ONE			English	Article							GENE-EXPRESSION; HOMEOBOX GENE; C-MYC; HOX11; MUTATIONS; LEUKEMIA; ACTIVATION; RESISTANCE; ONCOGENE; PATHWAY	To improve the treatment strategies of T-cell acute lymphoblastic leukemia/lymphoma (T-ALL), further efforts are needed to identify therapeutic targets. Dysregulated expression of HOX-type transcription factors occurs in 30-40% of cases of T-ALL. TLX1/HOX11 is the prototypical HOX-type transcription factor. TLX1 may be an attractive therapeutic target because mice that are deficient in TLX1 are healthy. To test this possibility, we developed a conditional doxycycline-regulated mouse model of TLX1-initiated T-ALL. TLX1 induced T-ALL after similar to 5-7 months with penetrance of 15-60%. Similar to human TLX1-type T-ALLs, the TLX1-induced tumors were arrested at the cortical stage of T-cell development and acquired activating NOTCH1 mutations. Inhibition of NOTCH signaling abrogated growth of cell lines derived from the TLX1-induced tumors. NOTCH inhibition also transiently delayed leukemia progression in vivo. Suppression of TLX1 expression slowed the growth of TLX1 tumor cell lines. Suppression of TLX1 in vivo also transiently delayed leukemia progression. We have shown that TLX1 functions as a T-cell oncogene that is active during both the induction and the maintenance phases of leukemia. However, the effect of suppressing NOTCH or TLX1 was transient. The tumors eventually "escaped" from inhibition. These data imply that the biological pathways and gene sets impacted by TLX1 and NOTCH have largely lost their importance in the fully established tumor. They have been supplanted by stronger oncogenic pathways. Although TLX1 or NOTCH inhibitors may not be effective as single agents, they may still contribute to combination therapy for TLX1-driven acute leukemia.	[Rakowski, Lesley A.; Lehotzky, Erica A.; Chiang, Mark Y.] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Rakowski, Lesley A.; Lehotzky, Erica A.; Chiang, Mark Y.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rakowski, LA (corresponding author), Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	markchia@umich.edu		Chiang, Mark/0000-0003-2099-0956	University of Michigan Division of Hematology/Oncology; University of Michigan Comprehensive Cancer Center; University of Michigan's Cancer Center [3 P30 CA46592-22S3]; NCI [5K08 CA120544-02]; V Foundation	University of Michigan Division of Hematology/Oncology; University of Michigan Comprehensive Cancer Center; University of Michigan's Cancer Center(University of Michigan System); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation	This work was supported by the University of Michigan Division of Hematology/Oncology, the University of Michigan Comprehensive Cancer Center, and an American Recovery and Reinvestment Act Supplement of the University of Michigan's Cancer Center Support Grant (3 P30 CA46592-22S3). M.Y.C. was supported by a career development award from the NCI (5K08 CA120544-02) and a V Foundation Scholar grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnafi V, 2009, BLOOD, V113, P3918, DOI 10.1182/blood-2008-10-184069; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bergeron J, 2007, BLOOD, V110, P2324, DOI 10.1182/blood-2007-04-079988; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; CHIANG MY, 2009, BLOOD, V114; Cullion K, 2009, BLOOD, V113, P6172, DOI 10.1182/blood-2008-02-136762; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; De Keersmaecker K, 2009, BLOOD, V114, P65; DEAR TN, 1993, P NATL ACAD SCI USA, V90, P4431, DOI 10.1073/pnas.90.10.4431; DELLAGATTA G, 2009, BLOOD, V114; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; DUBE ID, 1991, BLOOD, V78, P2996; Dudley DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006678; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Greene WK, 1998, MOL CELL BIOL, V18, P7030, DOI 10.1128/MCB.18.12.7030; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Hawley RG, 1997, CANCER RES, V57, P337; Hough MR, 1998, P NATL ACAD SCI USA, V95, P13853, DOI 10.1073/pnas.95.23.13853; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Owens BM, 2006, BRIT J HAEMATOL, V132, P216, DOI 10.1111/j.1365-2141.2005.05850.x; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; RIZ I, MOL CANC, V9, P181; Riz I, 2009, BRIT J HAEMATOL, V145, P140, DOI 10.1111/j.1365-2141.2008.07556.x; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; Su X, 2006, GENE CHROMOSOME CANC, V45, P846, DOI 10.1002/gcc.20348; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024	51	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16761	10.1371/journal.pone.0016761	http://dx.doi.org/10.1371/journal.pone.0016761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326611	gold, Green Submitted, Green Published			2022-12-27	WOS:000287037000019
J	Sun, ZF; Asmann, YW; Kalari, KR; Bot, B; Eckel-Passow, JE; Baker, TR; Carr, JM; Khrebtukova, I; Luo, SJ; Zhang, L; Schroth, GP; Perez, EA; Thompson, EA				Sun, Zhifu; Asmann, Yan W.; Kalari, Krishna R.; Bot, Brian; Eckel-Passow, Jeanette E.; Baker, Tiffany R.; Carr, Jennifer M.; Khrebtukova, Irina; Luo, Shujun; Zhang, Lu; Schroth, Gary P.; Perez, Edith A.; Thompson, E. Aubrey			Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR STATUS; ESTROGEN; PATTERNS; SUSCEPTIBILITY; TRANSCRIPTION; PROFILES; TUMORS; RNF4	We used deep sequencing technology to profile the transcriptome, gene copy number, and CpG island methylation status simultaneously in eight commonly used breast cell lines to develop a model for how these genomic features are integrated in estrogen receptor positive (ER+) and negative breast cancer. Total mRNA sequence, gene copy number, and genomic CpG island methylation were carried out using the Illumina Genome Analyzer. Sequences were mapped to the human genome to obtain digitized gene expression data, DNA copy number in reference to the non-tumor cell line (MCF10A), and methylation status of 21,570 CpG islands to identify differentially expressed genes that were correlated with methylation or copy number changes. These were evaluated in a dataset from 129 primary breast tumors. Gene expression in cell lines was dominated by ER-associated genes. ER+ and ER- cell lines formed two distinct, stable clusters, and 1,873 genes were differentially expressed in the two groups. Part of chromosome 8 was deleted in all ER- cells and part of chromosome 17 amplified in all ER+ cells. These loci encoded 30 genes that were overexpressed in ER+ cells; 9 of these genes were overexpressed in ER+ tumors. We identified 149 differentially expressed genes that exhibited differential methylation of one or more CpG islands within 5 kb of the 5' end of the gene and for which mRNA abundance was inversely correlated with CpG island methylation status. In primary tumors we identified 84 genes that appear to be robust components of the methylation signature that we identified in ER+ cell lines. Our analyses reveal a global pattern of differential CpG island methylation that contributes to the transcriptome landscape of ER+ and ER- breast cancer cells and tumors. The role of gene amplification/deletion appears to more modest, although several potentially significant genes appear to be regulated by copy number aberrations.	[Sun, Zhifu; Asmann, Yan W.; Kalari, Krishna R.; Bot, Brian; Eckel-Passow, Jeanette E.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Kalari, Krishna R.; Baker, Tiffany R.; Carr, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Khrebtukova, Irina; Luo, Shujun; Zhang, Lu; Schroth, Gary P.] Illumina Inc, Hayward, CA USA; [Perez, Edith A.] Mayo Clin, Dept Med, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Illumina; Mayo Clinic	Sun, ZF (corresponding author), Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.	thompson.aubrey@mayo.edu		Sun, Zhifu/0000-0001-8461-7523; Bot, Brian/0000-0002-2412-6826; Kalari, Krishna/0000-0001-8944-8378	26.2 with Donna Foundation; Florida Department of Health [1BG12-34201]; Mayo Foundation	26.2 with Donna Foundation; Florida Department of Health; Mayo Foundation	This work was supported by grants from the 26.2 with Donna Foundation (to EAP) and the Florida Department of Health Bankhead/Coley grant program (1BG12-34201 to EAT) and by the Mayo Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sequencing was carried out in Illumina, Inc and the co-authors from the company had direct roles in study design, data collection, data analysis, decision to publish, and preparation of the manuscript.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Gruvberger S, 2001, CANCER RES, V61, P5979; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Heinrich C, 2010, ONCOGENE, V29, P1598, DOI 10.1038/onc.2009.456; Ho SM, 2008, NEOPLASIA, V10, P20, DOI 10.1593/neo.07889; La M, 2004, BIOCHEM BIOPH RES CO, V320, P760, DOI 10.1016/j.bbrc.2004.06.022; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LA, 2010, HUM MOL GENET, V19, P4273, DOI 10.1093/hmg/ddq351; Liu ET, 2002, BREAST CANCER RES, V4, P141, DOI 10.1186/bcr438; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; NIELSEN TO, 2010, CLIN CANC RES; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Salonen J, 2009, MOL CELL ENDOCRINOL, V307, P205, DOI 10.1016/j.mce.2009.03.015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song HL, 2009, HUM MOL GENET, V18, P2297, DOI 10.1093/hmg/ddp138; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Warnat P, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-89; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	34	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17490	10.1371/journal.pone.0017490	http://dx.doi.org/10.1371/journal.pone.0017490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364760	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100066
J	Bedhomme, S; Elena, SF				Bedhomme, Stephanie; Elena, Santiago F.			Virus Infection Suppresses Nicotiana benthamiana Adaptive Phenotypic Plasticity	PLOS ONE			English	Article							COMPETITIVE ABILITY; NATURAL-SELECTION; VIRULENCE; DENSITY; POLYMORPHISM; POPULATIONS; FITNESS; GROWTH	Competition and parasitism are two important selective forces that shape life-histories, migration rates and population dynamics. Recently, it has been shown in various pathosystems that parasites can modify intraspecific competition, thus generating an indirect cost of parasitism. Here, we investigated if this phenomenon was present in a plant-potyvirus system using two viruses of different virulence (Tobacco etch virus and Turnip mosaic virus). Moreover, we asked if parasitism interacted with the shade avoidance syndrome, the plant-specific phenotypic plasticity in response to intraspecific competition. Our results indicate that the modification of intraspecific competition by parasitism is not present in the Nicotiana benthamiana - potyvirus system and suggests that this phenomenon is not universal but depends on the peculiarities of each pathosystem. However, whereas the healthy N. benthamiana presented a clear shade avoidance syndrome, this phenotypic plasticity totally disappeared when the plants were infected with TEV and TuMV, very likely resulting in a fitness loss and being another form of indirect cost of parasitism. This result suggests that the suppression or the alteration of adaptive phenotypic plasticity might be a component of virulence that is often overlooked.	[Bedhomme, Stephanie; Elena, Santiago F.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Consejo Super Invest Cient, E-46071 Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Bedhomme, S (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Consejo Super Invest Cient, E-46071 Valencia, Spain.	stebed@upvnet.upv.es	bedhomme, stéphanie/C-8912-2014; Elena, Santiago F./A-4191-2011	Elena, Santiago F./0000-0001-8249-5593; Bedhomme, Stephanie/0000-0001-8075-0968	Ministerio de Ciencia e Innovacion, Spain [BFU2009-06993]; Generalitat Valenciana [PROMETEO2010-019]; CSIC JAE	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); CSIC JAE	This work has been supported by grants BFU2009-06993 (Ministerio de Ciencia e Innovacion, Spain) and PROMETEO2010-019 (Generalitat Valenciana) (S.F.E.) and a CSIC JAE-Doc contract (S.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, POTYVIRIDAE; Bedhomme S, 2005, PLOS BIOL, V3, P1403, DOI 10.1371/journal.pbio.0030262; Bedhomme S, 2004, P ROY SOC B-BIOL SCI, V271, P739, DOI 10.1098/rspb.2003.2657; Borash DJ, 1998, AM NAT, V151, P148, DOI 10.1086/286108; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; BURDON JJ, 1984, OECOLOGIA, V64, P199, DOI 10.1007/BF00376871; Carrasco P, 2007, J VIROL, V81, P12979, DOI 10.1128/JVI.00524-07; Damgaard C, 2002, OIKOS, V98, P459, DOI 10.1034/j.1600-0706.2002.980310.x; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Ferguson HM, 2002, P ROY SOC B-BIOL SCI, V269, P1217, DOI 10.1098/rspb.2002.2023; Finckh MR, 1996, J APPL ECOL, V33, P1041, DOI 10.2307/2404684; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Jokela J, 2005, OIKOS, V108, P156, DOI 10.1111/j.0030-1299.2005.13185.x; Jokela J, 1999, OECOLOGIA, V119, P320, DOI 10.1007/s004420050792; KLECZKOWSKI A, 1949, ANN APPL BIOL, V36, P139, DOI 10.1111/j.1744-7348.1949.tb06404.x; Koprivnikar J, 2008, OECOLOGIA, V155, P641, DOI 10.1007/s00442-007-0937-2; Pagan I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000531; PAUL ND, 1986, NEW PHYTOL, V104, P257, DOI 10.1111/j.1469-8137.1986.tb00650.x; Rivero A, 2007, PARASITOLOGY, V134, P1355, DOI 10.1017/S0031182007002703; Santos M, 1997, EVOLUTION, V51, P420, DOI 10.2307/2411114; Schmitt J, 1999, AM NAT, V154, pS43, DOI 10.1086/303282; Sisterson MS, 2003, OECOLOGIA, V135, P362, DOI 10.1007/s00442-003-1205-8; Stearns S.C., 1992, pi; Vale PF, 2008, J EVOLUTION BIOL, V21, P1418, DOI 10.1111/j.1420-9101.2008.01555.x	26	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17275	10.1371/journal.pone.0017275	http://dx.doi.org/10.1371/journal.pone.0017275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359142	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300044
J	Bello, SM; Parfitt, SA; Stringer, CB				Bello, Silvia M.; Parfitt, Simon A.; Stringer, Chris B.			Earliest Directly-Dated Human Skull-Cups	PLOS ONE			English	Article							GOUGHS CAVE; ANTERIOR TEETH; TROPHY-TAKING; LBK ENCLOSURE; HUMAN REMAINS; CUT-MARKS; CANNIBALISM; CUTMARKS; HOMINID; ATAPUERCA	Background: The use of human braincases as drinking cups and containers has extensive historic and ethnographic documentation, but archaeological examples are extremely rare. In the Upper Palaeolithic of western Europe, cut-marked and broken human bones are widespread in the Magdalenian (similar to 15 to 12,000 years BP) and skull-cup preparation is an element of this tradition. Principal Findings: Here we describe the post-mortem processing of human heads at the Upper Palaeolithic site of Gough's Cave (Somerset, England) and identify a range of modifications associated with the production of skull-cups. New analyses of human remains from Gough's Cave demonstrate the skilled post-mortem manipulation of human bodies. Results of the research suggest the processing of cadavers for the consumption of body tissues (bone marrow), accompanied by meticulous shaping of cranial vaults. The distribution of cut-marks and percussion features indicates that the skulls were scrupulously 'cleaned' of any soft tissues, and subsequently modified by controlled removal of the facial region and breakage of the cranial base along a sub-horizontal plane. The vaults were also 'retouched', possibly to make the broken edges more regular. This manipulation suggests the shaping of skulls to produce skull-cups. Conclusions: Three skull-cups have been identified amongst the human bones from Gough's Cave. New ultrafiltered radiocarbon determinations provide direct dates of about 14,700 cal BP, making these the oldest directly dated skull-cups and the only examples known from the British Isles.	[Bello, Silvia M.; Parfitt, Simon A.; Stringer, Chris B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Parfitt, Simon A.] UCL, Inst Archaeol, London, England	Natural History Museum London; University of London; University College London	Bello, SM (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	s.bello@nhm.ac.uk	Bello, Silvia/ABW-5535-2022; Bello, Silvia/GZK-9069-2022		Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	The research is part of the "Ancient Human Occupation of Britain" project funded by the Leverhulme Trust. The trustees had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 2003, B NATURAL HIST MUSEU, V58, P59, DOI DOI 10.1017/5096804620300010X; Andrushko VA, 2005, AM J PHYS ANTHROPOL, V127, P375, DOI 10.1002/ajpa.20044; Andrushko VA, 2010, AM J PHYS ANTHROPOL, V141, P83, DOI 10.1002/ajpa.21117; [Anonymous], 1994, HUMAN EVOLUTION, DOI DOI 10.1007/BF02437262; Balch H. E., 1947, MENDIP CHEDDAR ITS G; Balfour H, 1897, J ROYAL ANTHROP I GR, V26, P340; Barton RNE, 2003, J QUATERNARY SCI, V18, P631, DOI 10.1002/jqs.772; BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Belcastro MG, 2010, J HUM EVOL, V58, P522, DOI 10.1016/j.jhevol.2010.03.011; Bello S.M., 2011, ANCIENT HUMAN OCCUPA, P227; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2010, AM J PHYS ANTHROPOL, P65; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; Binford L.R., 1981, BONES ANCIENT MEN MO; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Boulestin B., 1999, BRIT ARCHAEOLOGICAL, V776; Boulestin B, 2009, ANTIQUITY, V83, P968, DOI 10.1017/S0003598X00099282; Breuil H., 1909, ANTHROPOLOGIE, VXX, P523; Bueschgen WD, 1996, INT J OSTEOARCHAEOL, V6, P230; Buisson D., 1991, B SOC PREHIST FR, V88, P174; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Carbonell E, 2010, CURR ANTHROPOL, V51, P539, DOI 10.1086/653807; Cauwe N, 1996, B SOC PREHIST FR, V93, P342; Chaco RJ, 2007, TAKING DISPLAYING HU; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Cook J., 1986, P U BRISTOL SPELAEOL, V17, P275; Cook J., 1991, LATE GLACIAL N W EUR, P160; CURRANT AP, 1989, ANTIQUITY, V63, P131, DOI 10.1017/S0003598X00075645; De Castro JMB, 2004, EVOL ANTHROPOL, V13, P25, DOI 10.1002/evan.10130; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Dewbury AG, 2007, J ARCHAEOL SCI, V34, P354, DOI 10.1016/j.jas.2006.05.009; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; Finucane BC, 2008, AM J PHYS ANTHROPOL, V135, P75, DOI 10.1002/ajpa.20710; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Glory A., 1947, B MEM SOC ANTHRO PAR, V8, P114; Haglund WD, 1991, THESIS WASHINGTON U; Haverkort CM, 1999, INT J OSTEOARCHAEOL, V9, P147, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<147::AID-OA466>3.0.CO;2-W; Hawkey D. E., 2003, B NATURAL HIST MUS S, V58, P23; Hillson SW, 2010, J HUM EVOL, V59, P493, DOI 10.1016/j.jhevol.2010.06.004; HOCART CH, 1993, RAPID COMMUN MASS SP, V7, P219, DOI 10.1002/rcm.1290070311; Humphrey L. T., 2002, B NAT HIST MUS LOND, V58, P135; Jacobi R., 2004, P PREHIST SOC, V70, P1, DOI [10.1017/S0079497X00001110, DOI 10.1017/S0079497X00001110]; Jacobi RM, 2009, QUATERNARY SCI REV, V28, P1895, DOI 10.1016/j.quascirev.2009.03.006; Keith A., 1929, P SOMERSET ARCHAEOLO, V74, P118; Laufer B, 1923, USE HUMAN SKULLS BON; Le Mort F., 1991, ANTHROPOLOGIE, V29, P189; Le Mort F, 1981, DEGRADATION ARTIFICI; Le Mort F., 1992, PEUPLEMENT MAGDALENI, P29; Le Mort F., 2003, REV ARCHEOL PICARDIE, V21, P117; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; MACPHAIL RI, 2003, B NATURAL HIST MUS S, V58, P51; Massola A., 1961, MANKIND, V5, P415; Meehan B, 1971, FORM DISTRIBUTION AN; Micozzi Marc S., 1997, P171; Orschiedt J, 2003, INT J OSTEOARCHAEOL, V13, P375, DOI 10.1002/oa.704; ORSCHIEDT J, 2002, PALEO, V14, P239; Orschiedt J, 2006, J CONFL ARCHAEOL, V2, P153, DOI 10.1163/157407706778942330; Pettit P., 2011, PALAEOLITHIC ORIGINS; Pickering TR, 2000, AM J PHYS ANTHROPOL, V111, P579, DOI 10.1002/(SICI)1096-8644(200004)111:4<579::AID-AJPA12>3.0.CO;2-Y; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Scott JE, 2009, J HUM EVOL, V57, P248, DOI 10.1016/j.jhevol.2009.05.012; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Street M, 2006, J HUM EVOL, V51, P551, DOI 10.1016/j.jhevol.2006.04.014; Stringer C. B., 2007, HOMO BRITANNICUS INC; Tubbs RS, 2008, CHILD NERV SYST, V24, P417, DOI 10.1007/s00381-007-0509-0; Turner C.G., 1999, MAN CORN CANNIBALISM; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; White T.D., 1992, PREHISTORIC CANNIBAL; WHITE TD, 1986, AM J PHYS ANTHROPOL, V69, P503, DOI 10.1002/ajpa.1330690410	72	52	54	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17026	10.1371/journal.pone.0017026	http://dx.doi.org/10.1371/journal.pone.0017026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359211	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700036
J	Danjo, R; Kawasaki, F; Ordway, RW				Danjo, Rie; Kawasaki, Fumiko; Ordway, Richard W.			A Tripartite Synapse Model in Drosophila	PLOS ONE			English	Article							SYNAPTICALLY RELEASED GLUTAMATE; CLIMBING FIBER; GLIA INTERACTIONS; PERIPHERAL GLIA; CALCIUM WAVES; TRANSPORTERS; ROLES; TRANSMISSION; DEPRESSION; NSF	Tripartite (three-part) synapses are defined by physical and functional interactions of glia with pre- and post-synaptic elements. Although tripartite synapses are thought to be of widespread importance in neurological health and disease, we are only beginning to develop an understanding of glial contributions to synaptic function. In contrast to studies of neuronal mechanisms, a significant limitation has been the lack of an invertebrate genetic model system in which conserved mechanisms of tripartite synapse function may be examined through large-scale application of forward genetics and genome-wide genetic tools. Here we report a Drosophila tripartite synapse model which exhibits morphological and functional properties similar to those of mammalian synapses, including glial regulation of extracellular glutamate, synaptically-induced glial calcium transients and glial coupling of synapses with tracheal structures mediating gas exchange. In combination with classical and cell-type specific genetic approaches in Drosophila, this model is expected to provide new insights into the molecular and cellular mechanisms of tripartite synapse function.	[Danjo, Rie] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol & Cellular Neurosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Danjo, R (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	rwo4@psu.edu			National Institutes of Health (NIH) [R01 NS065983-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by National Institutes of Health (NIH) R01 NS065983-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2010, J NEUROSCI, V30, P5776, DOI 10.1523/JNEUROSCI.3957-09.2010; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beierlein M, 2006, J NEUROSCI, V26, P6958, DOI 10.1523/JNEUROSCI.0613-06.2006; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Besson MT, 2000, CURR BIOL, V10, P207, DOI 10.1016/S0960-9822(00)00339-0; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; BRAND AH, 1993, DEVELOPMENT, V118, P401; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Deitmer JW, 2010, BRAIN RES REV, V63, P113, DOI 10.1016/j.brainresrev.2009.10.006; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dittman JS, 1998, J NEUROSCI, V18, P6147; Feng ZH, 2007, CURR OPIN PHARMACOL, V7, P316, DOI 10.1016/j.coph.2006.12.003; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Haydon PG, 2009, NEUROPHARMACOLOGY, V56, P83, DOI 10.1016/j.neuropharm.2008.06.050; Hoogland TM, 2009, P NATL ACAD SCI USA, V106, P3496, DOI 10.1073/pnas.0809269106; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jackson FR, 2008, NEURON GLIA BIOL, V4, P11, DOI 10.1017/S1740925X09000027; Kawasaki F, 1998, J NEUROSCI, V18, P10241; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kawasaki F, 1999, J NEUROPHYSIOL, V82, P123, DOI 10.1152/jn.1999.82.1.123; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Kurth-Nelson ZL, 2009, J NEUROSCI, V29, P11339, DOI 10.1523/JNEUROSCI.2493-09.2009; Metea MR, 2007, EXP PHYSIOL, V92, P635, DOI 10.1113/expphysiol.2006.036376; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nedergaard M, 2010, CELL CALCIUM, V47, P140, DOI 10.1016/j.ceca.2009.11.010; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Ohtsuki G, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.004.2009; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Rival T, 2006, J NEUROBIOL, V66, P1061, DOI 10.1002/neu.20270; Rochon D, 2001, J NEUROSCI, V21, P3819, DOI 10.1523/JNEUROSCI.21-11-03819.2001; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Seal RP, 1998, RECEPTOR CHANNEL, V6, P51; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Silies M, 2010, CURRENT OPINION NEUR, V21, P1; Soustelle L, 2002, DEV BIOL, V248, P294, DOI 10.1006/dbio.2002.0742; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Takatsuru Y, 2006, NEUROSCI RES, V54, P140, DOI 10.1016/j.neures.2005.11.002; Takatsuru Y, 2007, NEUROSCI LETT, V420, P85, DOI 10.1016/j.neulet.2007.04.062; Takayasu Y, 2004, EUR J NEUROSCI, V19, P1285, DOI 10.1111/j.1460-9568.2004.03224.x; Takayasu Y, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02019.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	61	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17131	10.1371/journal.pone.0017131	http://dx.doi.org/10.1371/journal.pone.0017131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359186	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700052
J	Guimaraes, AJ; Nakayasu, ES; Sobreira, TJP; Cordero, RJB; Nimrichter, L; Almeida, IC; Nosanchuk, JD				Guimaraes, Allan Jefferson; Nakayasu, Ernesto S.; Sobreira, Tiago J. P.; Cordero, Radames J. B.; Nimrichter, Leonardo; Almeida, Igor C.; Nosanchuk, Joshua Daniel			Histoplasma capsulatum Heat-Shock 60 Orchestrates the Adaptation of the Fungus to Temperature Stress	PLOS ONE			English	Article							CELL-WALL; PULMONARY HISTOPLASMOSIS; SACCHAROMYCES-CEREVISIAE; PATHOGENIC FUNGUS; INTRACELLULAR-DISTRIBUTION; MITOCHONDRIAL ACTIVITY; IMMUNE-RESPONSES; PROTEIN; HEAT-SHOCK-PROTEIN-60; MORPHOGENESIS	Heat shock proteins (Hsps) are among the most widely distributed and evolutionary conserved proteins. Hsps are essential regulators of diverse constitutive metabolic processes and are markedly upregulated during stress. A 62 kDa Hsp (Hsp60) of Histoplasma capsulatum (Hc) is an immunodominant antigen and the major surface ligand to CR3 receptors on macrophages. However little is known about the function of this protein within the fungus. We characterized Hc Hsp60-protein interactions under different temperature to gain insights of its additional functions oncell wall dynamism, heat stress and pathogenesis. We conducted co-immunoprecipitations with antibodies to Hc Hsp60 using cytoplasmic and cell wall extracts. Interacting proteins were identified by shotgun proteomics. For the cell wall, 84 common interactions were identified among the 3 growth conditions, including proteins involved in heat-shock response, sugar and amino acid/protein metabolism and cell signaling. Unique interactions were found at each temperature [30 degrees C (81 proteins), 37 degrees C (14) and 37/40 degrees C (47)]. There were fewer unique interactions in cytoplasm [30 degrees C (6), 37 degrees C (25) and 37/40 degrees C (39)] and four common interactions, including additional Hsps and other known virulence factors. These results show the complexity of Hsp60 function and provide insights into Hc biology, which may lead to new avenues for the management of histoplasmosis.	[Guimaraes, Allan Jefferson; Nosanchuk, Joshua Daniel] Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY USA; [Guimaraes, Allan Jefferson; Cordero, Radames J. B.; Nosanchuk, Joshua Daniel] Yeshiva Univ, Dept Microbiol & Immunol, Albert Einstein Coll Med, Bronx, NY USA; [Nakayasu, Ernesto S.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Sobreira, Tiago J. P.] Heart Inst InCor, Lab Genet & Mol Cardiol, Grp Computat Biol, Sao Paulo, Brazil; [Nimrichter, Leonardo] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas El Paso	Guimaraes, AJ (corresponding author), Yeshiva Univ, Dept Med, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY USA.	josh.nosanchuk@einstein.yu.edu	Almeida, Igor C./AAF-9409-2019; Nimrichter, Leonardo/L-3545-2014; Nosanchuk, Joshua/AAS-7801-2021; Guimaraes, Allan J/E-2160-2014; Nakayasu, Ernesto S./AAJ-8374-2020; Guimaraes, Allan/AAQ-2343-2020; Cordero, Radamés JB/F-6912-2011; Sobreira, Tiago/C-1276-2008	Almeida, Igor C./0000-0002-2443-8213; Nimrichter, Leonardo/0000-0001-9281-6856; Guimaraes, Allan J/0000-0002-2856-9667; Nakayasu, Ernesto S./0000-0002-4056-2695; Guimaraes, Allan/0000-0002-2856-9667; Cordero, Radamés JB/0000-0002-3026-7094; Sobreira, Tiago/0000-0002-0217-0084	Fogarty International Center (NIH ) [D43-TW007129]; NIH [AI52733, 5G12RR008124-16A1]; Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center [NIH AI-51519]; Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, R01AI052733] Funding Source: NIH RePORTER	Fogarty International Center (NIH )(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center; Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.J.G. and L.N. were supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). A.J.G and J.D.N. are supported in part by NIH AI52733 and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center (NIH AI-51519). L.N. is supported by grants from Conselho Nacional de Desenvolvimento Tecnologico (CNPq, Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil). ICA is funded by NIH grant # 5G12RR008124-16A1. The authors thank the Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El Paso (NIH grants # 5G12RR008124-16A1 and 5G12RR008124-16A1S1), for the access to the LC-MS/MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Allendoerfer R, 1997, J INFECT DIS, V175, P905, DOI 10.1086/513989; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; BORGIA G, 1990, MYCOSES, V33, P405, DOI 10.1111/myc.1990.33.7-8.405; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; CARUSO M, 1987, MOL MICROBIOL, V1, P151, DOI 10.1111/j.1365-2958.1987.tb00507.x; Davies EL, 2006, CLIN EXP IMMUNOL, V145, P183, DOI 10.1111/j.1365-2249.2006.03109.x; EISSENBERG LG, 1987, INFECT IMMUN, V55, P29, DOI 10.1128/IAI.55.1.29-34.1987; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Gomez BL, 1997, J CLIN MICROBIOL, V35, P2618, DOI 10.1128/JCM.35.10.2618-2622.1997; GOMEZ FJ, 1995, INFECT IMMUN, V63, P2587, DOI 10.1128/IAI.63.7.2587-2595.1995; GOMEZ FJ, 1991, INFECT IMMUN, V59, P4459, DOI 10.1128/IAI.59.12.4459-4464.1991; GOMEZ FJ, 1992, INFECT IMMUN, V60, P2565, DOI 10.1128/IAI.60.7.2565-2571.1992; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; GUIMARAES AJ, 2010, MICROBIOLOGY RES, V2; GUIMARAES AJ, 2010, INFECT IMMUN; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Guimaraes AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003449; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2006, FEBS LETT, V580, P115, DOI 10.1016/j.febslet.2005.11.060; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jethmalani SM, 1997, J CELL BIOCHEM, V66, P98; Jethmalani SM, 1997, BIOCHEM BIOPH RES CO, V237, P382, DOI 10.1006/bbrc.1997.7127; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; KAMEI K, 1992, J MED VET MYCOL, V30, P385; KAUFMANN SHE, 1990, MED MICROBIOL IMMUN, V179, P61; KEATH EJ, 1989, INFECT IMMUN, V57, P1384, DOI 10.1128/IAI.57.5.1384-1390.1989; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAMBOWITZ AM, 1983, NATURE, V303, P806, DOI 10.1038/303806a0; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Long KH, 2003, J IMMUNOL, V170, P487, DOI 10.4049/jimmunol.170.1.487; Lopes LCL, 2010, CLIN VACCINE IMMUNOL, V17, P1155, DOI 10.1128/CVI.00033-10; Lundgren DH, 2005, CURR PROTOC BIOINFOR, VChapter 13, pUnit 13 3; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; MARESCA B, 1981, P NATL ACAD SCI-BIOL, V78, P4596, DOI 10.1073/pnas.78.7.4596; Maresca B, 1993, Arch Med Res, V24, P247; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; MINCHIOTTI G, 1992, BIOCHIM BIOPHYS ACTA, V1131, P103, DOI 10.1016/0167-4781(92)90106-A; Mrsa V, 1997, YEAST, V13, P1145; Nosanchuk JD, 2003, J CLIN INVEST, V112, P1164, DOI [10.1172/JCI200319361, 10.1172/JCI19361]; PATRIARCA EJ, 1992, BIOCHEM CELL BIOL, V70, P207, DOI 10.1139/o92-031; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Pizzini CV, 1999, CLIN DIAGN LAB IMMUN, V6, P20, DOI 10.1128/CDLI.6.1.20-23.1999; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shaner L, 2008, CURR GENET, V54, P1, DOI 10.1007/s00294-008-0193-y; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; SHAPIRO RS, 1990, VIRULENCE, V1, P45; SHEARER G, 1987, J GEN MICROBIOL, V133, P3375; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Srivastava P., 2004, CURR PROTOC IMMUNOL; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stone K., 1996, ENZYMATIC DIGESTION; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; TAPLEY TL, P NATL ACAD SCI US, V107, P1071; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003; Wolf A M, 1987, J Vet Intern Med, V1, P158, DOI 10.1111/j.1939-1676.1987.tb02008.x; WOLF JE, 1987, J IMMUNOL, V138, P582; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441	67	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14660	10.1371/journal.pone.0014660	http://dx.doi.org/10.1371/journal.pone.0014660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347364	Green Submitted, gold, Green Published			2022-12-27	WOS:000287363000003
J	Hu, YH; Li, ZF; Wu, XH; Lu, QL				Hu, Yihong; Li, Zhi-fang; Wu, Xiaohua; Lu, Qilong			Large Induces Functional Glycans in an O-Mannosylation Dependent Manner and Targets GlcNAc Terminals on Alpha-Dystroglycan	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; RABBIT SKELETAL-MUSCLE; HAMSTER OVARY CELLS; HUMAN LARGE GENE; LAMININ-BINDING; ABNORMAL GLYCOSYLATION; MUTATIONS; PROTEIN; GLYCOPROTEIN	Alpha-dystroglycan (alpha-DG) is a ubiquitously expressed receptor for extracellular matrix proteins and some viruses, and plays a pivotal role in a number of pathological events, including cancer progression, muscular dystrophies, and viral infection. The O-glycans on alpha-DG are essential for its ligand binding, but the biosynthesis of the functional O-glycans remains obscure. The fact that transient overexpression of LARGE, a putative glycosyltransferase, up-regulates the functional glycans on alpha-DG to mediate its ligand binding implied that overexpression of LARGE may be a novel strategy to treat disorders with hypoglycosylation of alpha-DG. In this study, we focus on the effects of stable overexpression of Large on alpha-DG glycosylation in Chinese hamster ovary (CHO) cell and its glycosylation deficient mutants. Surprisingly, stable overexpression of Large in an O-mannosylation null deficient Lec15.2 CHO cells failed to induce the functional glycans on alpha-DG. Introducing the wild-type DPM2 cDNA, the deficient gene in the Lec15.2 cells, fully restored the Large-induced functional glycosylation, suggesting that Large induces the functional glycans in a DPM2/O-mannosylation dependent manner. Furthermore, stable overexpression of Large can effectively induce functional glycans on N-linked glycans in the Lec8 cells and ldlD cells growing in Gal deficient media, in both of which circumstances galactosylation are deficient. In addition, supplement of Gal to the ldlD cell culture media significantly reduces the amount of functional glycans induced by Large, suggested that galactosylation suppresses Large to induce the functional glycans. Thus our results revealed a mechanism by which Large competes with galactosyltransferase to target GlcNAc terminals to induce the functional glycans on alpha-DG.	[Hu, Yihong; Li, Zhi-fang; Wu, Xiaohua; Lu, Qilong] Carolinas Med Ctr, Cannon Res Ctr, Dept Neurol, McColl Lockwood Lab Muscular Dystrophy Res, Charlotte, NC 28203 USA	Carolinas Medical Center	Hu, YH (corresponding author), Carolinas Med Ctr, Cannon Res Ctr, Dept Neurol, McColl Lockwood Lab Muscular Dystrophy Res, Charlotte, NC 28203 USA.	xiaohua.wu@carolinashealthcare.org	lu, qi/HHS-2115-2022		Carolinas Muscular Dystrophy foundation	Carolinas Muscular Dystrophy foundation	This work is supported by Carolinas Muscular Dystrophy foundation (http://www.givechf.org/index.php?option = com_content&task = view&id = 28&Itemid = 44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAN JT, 2009, GLYCOBIOLOGY; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Chiba A, 1997, J BIOL CHEM, V272, P2156; DEBERNABE DBV, 2009, J BIOL CHEM; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GORECKI DC, 1994, HUM MOL GENET, V3, P1589; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KRIEGER M, 1989, METHOD CELL BIOL, V32, P57; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McDearmon EL, 2003, J BIOL CHEM, V278, P44868, DOI 10.1074/jbc.M307026200; McDearmon EL, 2006, FEBS LETT, V580, P3381, DOI 10.1016/j.febslet.2006.05.010; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Rojek JA, 2007, J VIROL, V81, P5685, DOI 10.1128/JVI.02574-06; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Sgambato A, 2004, CANCER BIOL THER, V3, P967, DOI 10.4161/cbt.3.10.1132; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; STOLL J, 1982, P NATL ACAD SCI-BIOL, V79, P2296, DOI 10.1073/pnas.79.7.2296; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Ware FE, 1996, J BIOL CHEM, V271, P13935, DOI 10.1074/jbc.271.24.13935; Yamamoto T, 2008, INT J EXP PATHOL, V89, P332, DOI 10.1111/j.1365-2613.2008.00599.x; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; YOSHIDAMORIGUCH.T, SCIENCE, V327, P88	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16866	10.1371/journal.pone.0016866	http://dx.doi.org/10.1371/journal.pone.0016866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347376	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700046
J	Leo, C; Sala, V; Morello, M; Chiribiri, A; Riess, I; Mancardi, D; Schiaffino, S; Ponzetto, C; Crepaldi, T				Leo, Christian; Sala, Valentina; Morello, Mara; Chiribiri, Amedeo; Riess, Ilan; Mancardi, Daniele; Schiaffino, Stefano; Ponzetto, Carola; Crepaldi, Tiziana			Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MYOSIN GENE-EXPRESSION; GAP-JUNCTIONS; INTERCALATED DISC; INVASIVE GROWTH; STEM-CELLS; MYOCARDIUM; RECEPTOR; MICE; PHOSPHORYLATION	Background: The Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine involved in many physiological processes, including skeletal muscle, placenta and liver development. Little is known about its role and that of Met tyrosine kinase receptor in cardiac development. Methodology/Principal Findings: In this study, we generated two transgenic mice with cardiac-specific, tetracycline-suppressible expression of either Hepatocyte Growth Factor (HGF) or the constitutively activated Tpr-Met kinase to explore: i) the effect of stimulation of the endogenous Met receptor by autocrine production of HGF and ii) the consequence of sustained activation of Met signalling in the heart. We first showed that Met is present in the neonatal cardiomyocytes and is responsive to exogenous HGF. Exogenous HGF starting from prenatal stage enhanced cardiac proliferation and reduced sarcomeric proteins and Connexin43 (Cx43) in newborn mice. As adults, these transgenics developed systolic contractile dysfunction. Conversely, prenatal Tpr-Met expression was lethal after birth. Inducing Tpr-Met expression during postnatal life caused early-onset heart failure, characterized by decreased Cx43, upregulation of fetal genes and hypertrophy. Conclusions/Significance: Taken together, our data show that excessive activation of the HGF/Met system in development may result in cardiac damage and suggest that Met signalling may be implicated in the pathogenesis of cardiac disease.	[Leo, Christian; Sala, Valentina; Riess, Ilan; Ponzetto, Carola; Crepaldi, Tiziana] Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy; [Morello, Mara; Chiribiri, Amedeo] Univ Turin, Dept Internal Med, Turin, Italy; [Mancardi, Daniele] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Schiaffino, Stefano] VIMM, Padua, Italy	University of Turin; University of Turin; University of Turin; Veneto Institute Molecular Medicine	Leo, C (corresponding author), Univ Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy.	tiziana.crepaldi@unito.it	Sala, Valentina/K-4042-2012; crepaldi, tiziana/AAY-7207-2020; Chiribiri, Amedeo/T-2771-2019	Sala, Valentina/0000-0002-2283-2807; crepaldi, tiziana/0000-0003-3410-947X; Schiaffino, Stefano/0000-0002-5607-6421; MANCARDI, Daniele/0000-0003-3809-6047; Chiribiri, Amedeo/0000-0003-3394-4289	Compagnia di San Paolo; Fondazione CRT; Ministero dell'Istruzione dell'Universita e della Ricerca; Association Francaise contre les Myopathies (AFM); Regione Piemonte	Compagnia di San Paolo(Compagnia di San Paolo); Fondazione CRT(Fondazione CRT); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Regione Piemonte(Regione Piemonte)	This work was supported by funds from the Compagnia di San Paolo, Fondazione CRT, Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN), Association Francaise contre les Myopathies (AFM). V.S. is a Fellow of Universita Italo Francese. D.M. was supported by Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, LANCET, V2, P577; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Crepaldi T, 2007, J BIOL CHEM, V282, P6812, DOI 10.1074/jbc.M610916200; Doble BW, 2004, J CELL SCI, V117, P507, DOI 10.1242/jcs.00889; Feigenbaum H, 2005, ECHOCARDIOGRAPHY, V6th; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; Giacobini P, 2007, J NEUROSCI, V27, P431, DOI 10.1523/JNEUROSCI.4979-06.2007; Gutstein DE, 2003, J CELL SCI, V116, P875, DOI 10.1242/jcs.00258; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; IKEJIMA K, 1995, BIOCHEM BIOPH RES CO, V214, P440, DOI 10.1006/bbrc.1995.2306; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Kardami E, 1998, TRENDS CARDIOVAS MED, V8, P180, DOI 10.1016/S1050-1738(98)00007-3; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; MOORBY CD, 1995, EXP CELL RES, V219, P657, DOI 10.1006/excr.1995.1276; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Rappolee DA, 1996, CIRC RES, V78, P1028, DOI 10.1161/01.RES.78.6.1028; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; SCHIAFFINO S, 1993, TRENDS CARDIOVAS MED, V3, P12, DOI 10.1016/1050-1738(93)90022-X; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Song WM, 1999, DEV DYNAM, V214, P92, DOI 10.1002/(SICI)1097-0177(199901)214:1<92::AID-DVDY9>3.3.CO;2-O; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zammit PS, 2000, DEV DYNAM, V217, P75, DOI 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L	37	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14675	10.1371/journal.pone.0014675	http://dx.doi.org/10.1371/journal.pone.0014675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347410	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700007
J	Rodda, GH; Jarnevich, CS; Reed, RN				Rodda, Gordon H.; Jarnevich, Catherine S.; Reed, Robert N.			Challenges in Identifying Sites Climatically Matched to the Native Ranges of Animal Invaders	PLOS ONE			English	Article							SAMPLE SELECTION BIAS; SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; SPATIAL AUTOCORRELATION; POTENTIAL DISTRIBUTION; NICHE SHIFT; CONSERVATISM; HABITAT; TRANSFERABILITY; INVASIONS	Background: Species distribution models are often used to characterize a species' native range climate, so as to identify sites elsewhere in the world that may be climatically similar and therefore at risk of invasion by the species. This endeavor provoked intense public controversy over recent attempts to model areas at risk of invasion by the Indian Python (Python molurus). We evaluated a number of MaxEnt models on this species to assess MaxEnt's utility for vertebrate climate matching. Methodology/Principal Findings: Overall, we found MaxEnt models to be very sensitive to modeling choices and selection of input localities and background regions. As used, MaxEnt invoked minimal protections against data dredging, multi-collinearity of explanatory axes, and overfitting. As used, MaxEnt endeavored to identify a single ideal climate, whereas different climatic considerations may determine range boundaries in different parts of the native range. MaxEnt was extremely sensitive to both the choice of background locations for the python, and to selection of presence points: inclusion of just four erroneous localities was responsible for Pyron et al.'s conclusion that no additional portions of the U. S. mainland were at risk of python invasion. When used with default settings, MaxEnt overfit the realized climate space, identifying models with about 60 parameters, about five times the number of parameters justifiable when optimized on the basis of Akaike's Information Criterion. Conclusions/Significance: When used with default settings, MaxEnt may not be an appropriate vehicle for identifying all sites at risk of colonization. Model instability and dearth of protections against overfitting, multi-collinearity, and data dredging may combine with a failure to distinguish fundamental from realized climate envelopes to produce models of limited utility. A priori identification of biologically realistic model structure, combined with computational protections against these statistical problems, may produce more robust models of invasion risk.	[Rodda, Gordon H.; Jarnevich, Catherine S.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA	United States Department of the Interior; United States Geological Survey	Rodda, GH (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA.	catherine_jarnevich@usgs.gov			U.S. government	U.S. government	This work was funded the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, though the USGS did review the manuscript to ensure conformance with USGS scientific standards.	Anderson DR, 2001, WILDLIFE SOC B, V29, P311; [Anonymous], 1877, DIFFERENT FORMS FLOW; [Anonymous], P 21 INT C MACH LEAR; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; DEYANG L, 1986, ACTA HERPETOL SIN, V5, P198; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; ELITH J, 2010, METHODS ECOLOGY EVOL, DOI DOI 10.1111/J.2041-210X.2010.00036.X; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; FREEDMAN DA, 1983, AM STAT, V37, P152, DOI 10.2307/2685877; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Khan MS., 2006, AMPHIBIANS REPTILES; Khan MS, 2002, GUIDE SNAKES PAKISTA; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Martin WK, 1996, EMU, V96, P166, DOI 10.1071/MU9960166; Mertens R., 1969, STUTTGARTER BEITR GE, V197, P1; Minton S. A., 1966, B AM MUS NAT HIST, V134, P29; NABHITABHATA J, 2005, STATUS MAMMALS REPTI; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips BL, 2008, WILDLIFE RES, V35, P222, DOI 10.1071/WR07101; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pyron RA, 2009, MOL ECOL, V18, P3443, DOI 10.1111/j.1365-294X.2009.04292.x; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; REED RN, 2009, 20091202 US GEOL SUR, P1; REXSTAD EA, 1988, J WILDLIFE MANAGE, V52, P794, DOI 10.2307/3800948; Rodda Gordon H., 2007, P138; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Rodder D, 2010, PAC SCI, V64, P11, DOI 10.2984/64.1.011; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rodder D, 2008, NORTH-WEST J ZOOL, V4, P236; Segurado P, 2006, J APPL ECOL, V43, P433, DOI 10.1111/j.1365-2664.2006.01162.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; WARREN DL, 2010, ECOL APPL IN PRESS; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; 2008, FED REG, V73, P5784	68	101	103	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14670	10.1371/journal.pone.0014670	http://dx.doi.org/10.1371/journal.pone.0014670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347411	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700004
J	Avril, M; Hathaway, MJ; Srivastava, A; Dechavanne, S; Hommel, M; Beeson, JG; Smith, JD; Gamain, B				Avril, Marion; Hathaway, Marianne J.; Srivastava, Anand; Dechavanne, Sebastien; Hommel, Mirja; Beeson, James G.; Smith, Joseph D.; Gamain, Benoit			Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; PREGNANCY-ASSOCIATED MALARIA; FALCIPARUM-INFECTED ERYTHROCYTES; VACCINE CANDIDATE VAR2CSA; CSA-BINDING PARASITES; PLASMODIUM-FALCIPARUM; REACTIVE ANTIBODIES; VAR GENES; ANTIGENIC PROPERTIES; MEMBRANE PROTEIN-1	The high molecular weight, multidomain VAR2CSA protein mediating adhesion of Plasmodium falciparum-infected erythrocytes in the placenta is the leading candidate for a pregnancy malaria vaccine. However, it has been difficult so far to generate strong and consistent adhesion blocking antibody responses against most single-domain VAR2CSA immunogens. Recent advances in expression of the full-length recombinant protein showed it binds with much greater specificity and affinity to chondroitin sulphate A (CSA) than individual VAR2CSA domains. This raises the possibility that a specific CSA binding pocket(s) is formed in the full length antigen and could be an important target for vaccine development. In this study, we compared the immunogenicity of a full-length VAR2CSA recombinant protein containing all six Duffy binding-like (DBL) domains to that of a three-domain construct (DBL4-6) in mice and rabbits. Animals immunized with either immunogen acquired antibodies reacting with several VAR2CSA individual domains by ELISA, but antibody responses against the highly conserved DBL4 domain were weaker in animals immunized with full-length DBL1-6 recombinant protein compared to DBL4-6 recombinant protein. Both immunogens induced cross-reactive antibodies to several heterologous CSA-binding parasite lines expressing different VAR2CSA orthologues. However, antibodies that inhibited adhesion of parasites to CSA were only elicited in rabbits immunized with full-length immunogen and inhibition was restricted to the homologous CSA-binding parasite. These findings demonstrate that partial and full-length VAR2CSA immunogens induce cross-reactive antibodies, but inhibitory antibody responses to full-length immunogen were highly allele-specific and variable between animal species.	[Avril, Marion; Hathaway, Marianne J.; Smith, Joseph D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Srivastava, Anand; Dechavanne, Sebastien; Gamain, Benoit] Inst Pasteur, Unite Biol Interact Hote Parasite, CNRS, URA 2581, Paris, France; [Hommel, Mirja; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Smith, Joseph D.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Gamain, Benoit] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Gamain, Benoit] INSERM, UMRS 665, Paris, France; [Gamain, Benoit] Univ Paris 07, Paris, France	Center for Infectious Disease Research; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Avril, M (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	joe.smith@seattlebiomed.org; benoit.gamain@inserm.fr	Hommel, Mirja/C-9791-2019; Srivastava, Anand/AFY-2073-2022; Srivastava, Anand/AAD-2166-2019; SRIVASTAVA, ANAND/C-9609-2012; Gamain, Benoit/N-9985-2017; Dechavanne, Sebastien/AAL-8108-2021	Hommel, Mirja/0000-0002-4788-6932; Srivastava, Anand/0000-0002-2031-4643; SRIVASTAVA, ANAND/0000-0002-2031-4643; Gamain, Benoit/0000-0002-8255-2145; Dechavanne, Sebastien/0000-0001-9400-1976	Bill and Melinda Gates Foundation; Institut National de la Sante et de la Recherche Medicale and Sanofi-Aventis; National Health and Medical Research Council of Australia; Australian Research Council; European Community [201222]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Institut National de la Sante et de la Recherche Medicale and Sanofi-Aventis; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); European Community(European Commission)	This work was supported by a grant from the Bill and Melinda Gates Foundation (JDS) and an ATIP-AVENIR grant from the Institut National de la Sante et de la Recherche Medicale and Sanofi-Aventis (BG). JGB and MH are supported by the National Health and Medical Research Council of Australia, and the Australian Research Council. The research leading to these results has received funding from the European Community's Seventh Framework Programme Grant ([FP7/2007-2013]) (BG) under Grant agreement 201222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Avril M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-143; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Czajkowsky DM, 2010, J IMMUNOL, V184, P4597, DOI 10.4049/jimmunol.1000203; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Elliott SR, 2005, INFECT IMMUN, V73, P2848, DOI 10.1128/IAI.73.5.2848-2856.2005; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; MAGISTRADO PA, 2010, VACCINE; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SEMBLAT JP, MOL BIOCH P IN PRESS; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08	54	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16622	10.1371/journal.pone.0016622	http://dx.doi.org/10.1371/journal.pone.0016622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326877	Green Published, gold			2022-12-27	WOS:000287037100010
J	Carre, A; Rachdi, L; Tron, E; Richard, B; Castanet, M; Schlumberger, M; Bidart, JM; Szinnai, G; Polak, M				Carre, Aurore; Rachdi, Latif; Tron, Elodie; Richard, Benedicte; Castanet, Mireille; Schlumberger, Martin; Bidart, Jean-Michel; Szinnai, Gabor; Polak, Michel			Hes1 Is Required for Appropriate Morphogenesis and Differentiation during Mouse Thyroid Gland Development	PLOS ONE			English	Article							CELL-PROLIFERATION; PROGENITOR CELLS; C-CELLS; EXPRESSION; THYMUS; GROWTH; NOTCH1; ONSET	Notch signalling plays an important role in endocrine development, through its target gene Hes1. Hes1, a bHLH transcriptional repressor, influences progenitor cell proliferation and differentiation. Recently, Hes1 was shown to be expressed in the thyroid and regulate expression of the sodium iodide symporter (Nis). To investigate the role of Hes1 for thyroid development, we studied thyroid morphology and function in mice lacking Hes1. During normal mouse thyroid development, Hes1 was detected from E9.5 onwards in the median anlage, and at E11.5 in the ultimobranchial bodies. Hes1(-/-) mouse embryos had a significantly lower number of Nkx2-1-positive progenitor cells (p < 0.05) at E9.5 and at E11.5. Moreover, Hes1(-/-) mouse embryos showed a significantly smaller total thyroid surface area (-40 to -60%) compared to wild type mice at all study time points (E9.5-E16.5). In both Hes1(-/-) and wild type mouse embryos, most Nkx2-1-positive thyroid cells expressed the cell cycle inhibitor p57 at E9.5 in correlation with low proliferation index. In Hes1(-/-) mouse embryos, fusion of the median anlage with the ultimobranchial bodies was delayed by 3 days (E16.5 vs. E13.5 in wild type mice). After fusion of thyroid anlages, hypoplastic Hes1(-/-) thyroids revealed a significantly decreased labelling area for T4 (-78%) and calcitonin (-65%) normalized to Nkx2-1 positive cells. Decreased T4-synthesis might be due to reduced Nis labelling area (-69%). These findings suggest a dual role of Hes1 during thyroid development: first, control of the number of both thyrocyte and C-cell progenitors, via a p57-independent mechanism; second, adequate differentiation and endocrine function of thyrocytes and C-cells.	[Carre, Aurore; Rachdi, Latif; Tron, Elodie; Richard, Benedicte; Castanet, Mireille; Polak, Michel] Univ Paris 05, INSERM, U845, Paris, France; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med, Villejuif, France; [Bidart, Jean-Michel] Inst Gustave Roussy, Dept Biol Clin, F-94805 Villejuif, France; [Szinnai, Gabor] Univ Childrens Hosp Basel, Basel, Switzerland; [Szinnai, Gabor] Univ Basel, Dept Biomed, Basel, Switzerland; [Polak, Michel] Necker Enfants Malades Hosp, Paediat Endocrine Unit, Paris, France; [Polak, Michel] AP HP, Ctr Malad Endocriniennes Rares Croissance, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; University of Basel; University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Carre, A (corresponding author), Univ Paris 05, INSERM, U845, Paris, France.	michel.polak@nck.aphp.fr	Carre, Aurore/L-1021-2013; Rachdi, Latif/I-1988-2017	Carre, Aurore/0000-0002-6795-3629; Rachdi, Latif/0000-0002-1089-2837; Szinnai, Gabor/0000-0003-0559-2597	CIFRE; Ministere de l'Education Nationale et de la Recherche; European Society for Paediatric Endocrinology (ESPE); University Children's Hospital Basel, Basel, Switzerland; Electricite de France [RB 200605]; Sandoz France; Fondation Princesse Grace de la Principaute de Monaco	CIFRE; Ministere de l'Education Nationale et de la Recherche; European Society for Paediatric Endocrinology (ESPE); University Children's Hospital Basel, Basel, Switzerland; Electricite de France; Sandoz France(Novartis); Fondation Princesse Grace de la Principaute de Monaco	AC was supported by CIFRE in collaboration with HRA Pharma and by the Ministere de l'Education Nationale et de la Recherche. GS and MP received the Collaborative Research Unit Grant from the European Society for Paediatric Endocrinology (ESPE). GS received a Research Grant from the University Children's Hospital Basel, Basel, Switzerland. This study was supported in part by a grant from Electricite de France (RB 200605), by Sandoz France and by the Fondation Princesse Grace de la Principaute de Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Brown RS, 2000, ENDOCRINOLOGY, V141, P340, DOI 10.1210/en.141.1.340; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Fagman H, 2006, DEV DYNAM, V235, P444, DOI 10.1002/dvdy.20653; Ferretti E, 2008, J CLIN ENDOCR METAB, V93, P4080, DOI 10.1210/jc.2008-0528; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kameda Y, 2007, J HISTOCHEM CYTOCHEM, V55, P1075, DOI 10.1369/jhc.7A7179.2007; Kameda Y, 2007, DEV DYNAM, V236, P262, DOI 10.1002/dvdy.21018; Kunnimalaiyaan M, 2006, J BIOL CHEM, V281, P39819, DOI 10.1074/jbc.M603578200; Lania G, 2009, DEV BIOL, V328, P109, DOI 10.1016/j.ydbio.2009.01.014; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Milenkovic M, 2007, J ENDOCRINOL, V192, P615, DOI 10.1677/JOE-06-0003; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Raetzman LT, 2007, DEV BIOL, V304, P455, DOI 10.1016/j.ydbio.2006.11.010; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Szinnai G, 2007, J CLIN ENDOCR METAB, V92, P70, DOI 10.1210/jc.2006-1450; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Xu PX, 2002, DEVELOPMENT, V129, P3033	26	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16752	10.1371/journal.pone.0016752	http://dx.doi.org/10.1371/journal.pone.0016752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364918	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100009
J	Radtke, C; Allmeling, C; Waldmann, KH; Reimers, K; Thies, K; Schenk, HC; Hillmer, A; Guggenheim, M; Brandes, G; Vogt, PM				Radtke, Christine; Allmeling, Christina; Waldmann, Karl-Heinz; Reimers, Kerstin; Thies, Kerstin; Schenk, Henning C.; Hillmer, Anja; Guggenheim, Merlin; Brandes, Gudrun; Vogt, Peter M.			Spider Silk Constructs Enhance Axonal Regeneration and Remyelination in Long Nerve Defects in Sheep	PLOS ONE			English	Article							PERIPHERAL-NERVE; SCHWANN-CELLS; SPINAL-CORD; CONDUITS; FIBERS; REPAIR; RAT; RECONSTRUCTION; GRAFT; TUBES	Background: Surgical reapposition of peripheral nerve results in some axonal regeneration and functional recovery, but the clinical outcome in long distance nerve defects is disappointing and research continues to utilize further interventional approaches to optimize functional recovery. We describe the use of nerve constructs consisting of decellularized vein grafts filled with spider silk fibers as a guiding material to bridge a 6.0 cm tibial nerve defect in adult sheep. Methodology/Principal Findings: The nerve constructs were compared to autologous nerve grafts. Regeneration was evaluated for clinical, electrophysiological and histological outcome. Electrophysiological recordings were obtained at 6 months and 10 months post surgery in each group. Ten months later, the nerves were removed and prepared for immunostaining, electrophysiological and electron microscopy. Immunostaining for sodium channel (NaV 1.6) was used to define nodes of Ranvier on regenerated axons in combination with anti-S100 and neurofilament. Anti-S100 was used to identify Schwann cells. Axons regenerated through the constructs and were myelinated indicating migration of Schwann cells into the constructs. Nodes of Ranvier between myelin segments were observed and identified by intense sodium channel (NaV 1.6) staining on the regenerated axons. There was no significant difference in electrophysiological results between control autologous experimental and construct implantation indicating that our construct are an effective alternative to autologous nerve transplantation. Conclusions/Significance: This study demonstrates that spider silk enhances Schwann cell migration, axonal regrowth and remyelination including electrophysiological recovery in a long-distance peripheral nerve gap model resulting in functional recovery. This improvement in nerve regeneration could have significant clinical implications for reconstructive nerve surgery.	[Radtke, Christine; Allmeling, Christina; Reimers, Kerstin; Hillmer, Anja; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Waldmann, Karl-Heinz; Thies, Kerstin] Univ Vet Med Hannover, Clin Pigs Small Ruminants Forens Med & Ambulatory, Hannover, Germany; [Schenk, Henning C.] Univ Vet Med Hanover, Dept Small Anim Med & Surg, Hannover, Germany; [Guggenheim, Merlin] Univ Zurich Hosp, Dept Surg, Dept Plast & Reconstruct Surg, CH-8091 Zurich, Switzerland; [Brandes, Gudrun] Hannover Med Sch, Inst Cell Biol, Ctr Anat, D-3000 Hannover, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Zurich; University Zurich Hospital; Hannover Medical School	Radtke, C (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	radtke.christine@mh-hannover.de	Radtke, Christine/M-2927-2013; Vogt, Peter M./AAL-1332-2020; Messier, Claude/A-2322-2008; Radtke, Christine/B-8491-2018	Messier, Claude/0000-0002-4791-1763; Radtke, Christine/0000-0001-6877-5038	Neurobionik Foundation Hannover, Germany; German Research Foundation [FOR 1103: Ra 1901/1-1, Ti 309/4-1]	Neurobionik Foundation Hannover, Germany; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Neurobionik Foundation Hannover, Germany and the German Research Foundation (FOR 1103: Ra 1901/1-1; Ti 309/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Arai T, 2000, SCAND J PLAST RECONS, V34, P101; Battiston B, 2009, INT REV NEUROBIOL, V87, P227, DOI 10.1016/S0074-7742(09)87011-6; CHIONO V, 2009, BIOMED MICRODEVICES; Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8; Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9; FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1; Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y; Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x; Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003; KEELEY R, 1993, J RECONSTR MICROSURG, V9, P349, DOI 10.1055/s-2007-1006742; Lankford KL, 2002, J COMP NEUROL, V443, P259, DOI 10.1002/cne.10117; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P100, DOI 10.1016/j.jhsb.2003.09.018; LUTSCHG J, 1981, J NEUROL, V225, P25, DOI 10.1007/BF00313458; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; Radtke C, 2005, NEUROSCI LETT, V387, P85, DOI 10.1016/j.neulet.2005.06.073; Radtke C, 2009, BRAIN RES, V1254, P10, DOI 10.1016/j.brainres.2008.11.036; Rivlin M, 2010, HAND CLIN, V26, P435, DOI 10.1016/j.hcl.2010.04.010; Sasaki M, 2006, J NEUROSCI, V26, P1803, DOI 10.1523/JNEUROSCI.3611-05.2006; STEISS JE, 1987, VET RES COMMUN, V11, P243, DOI 10.1007/BF00570922; Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034; Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168; Vollrath F, 2000, J Biotechnol, V74, P67; WANG CY, 2010, ACTA BIOMATER; Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001; Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798	34	93	98	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16990	10.1371/journal.pone.0016990	http://dx.doi.org/10.1371/journal.pone.0016990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364921	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000287764100016
J	Yang, J; Yang, X; Chu, YW; Li, M				Yang, Ji; Yang, Xue; Chu, Yiwei; Li, Ming			Identification of Baicalin as an Immunoregulatory Compound by Controlling T(H)17 Cell Differentiation	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-HELPER-CELLS; ROR-GAMMA-T; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ARYL-HYDROCARBON RECEPTOR; TH17 CELLS; TGF-BETA; ANTIINFLAMMATORY ACTIVITY; TISSUE INFLAMMATION; IL-23 RECEPTOR	T(H)17 cells have been implicated in a growing list of inflammatory disorders. Antagonism of T(H)17 cells can be used for the treatment of inflammatory injury. Currently, very little is known about the natural compound controlling the differentiation of T(H)17 cells. Here, we showed that Baicalin, a compound isolated from a Chinese herb, inhibited T(H)17 cell differentiation both in vitro and in vivo. Baicalin might inhibit newly generated T(H)17 cells via reducing ROR gamma t expression, and together with up-regulating Foxp3 expression to suppress ROR gamma t-mediated IL-17 expression in established T(H)17 cells. In vivo treatment with Baicalin could inhibit T(H)17 cell differentiation, restrain T(H)17 cells infiltration into kidney, and protect MRL/lpr mice against nephritis. Our findings not only demonstrate that Baicalin could control T(H)17 cell differentiation but also suggest that Baicalin might be a promising therapeutic agent for the treatment of T(H)17 cells-mediated inflammatory diseases.	[Yang, Ji; Li, Ming] Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Yang, Xue] Fudan Univ, Div Rheumatol, Huashan Hosp, Shanghai 200433, Peoples R China; [Chu, Yiwei] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yang, J (corresponding author), Fudan Univ, Dept Dermatol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	li.ming@zs-hospital.sh.cn			National Natural Science Foundation of China [81000693]; Institutes of Biomedical Sciences of Fudan University [2009068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institutes of Biomedical Sciences of Fudan University	Funding: This work was supported by the National Natural Science Foundation of China (81000693), Institutes of Biomedical Sciences of Fudan University (2009068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2007, J IMMUNOL, V178, P7849, DOI 10.4049/jimmunol.178.12.7849; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Kasai A, 2008, BIOL PHARM BULL, V31, P838, DOI 10.1248/bpb.31.838; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7; Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McHale JF, 1999, J IMMUNOL, V163, P3993; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ouyang WJ, 2009, EUR J IMMUNOL, V39, P670, DOI 10.1002/eji.200839105; Pan HF, 2008, NAT CLIN PRACT RHEUM, V4, P352, DOI 10.1038/ncprheum0815; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Wan JY, 2008, EUR J PHARMACOL, V587, P302, DOI 10.1016/j.ejphar.2008.02.081; Wang YG, 2008, MOD RHEUMATOL, V18, P385, DOI 10.1007/s10165-008-0074-8; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zeng Y, 2007, BRAZ J MED BIOL RES, V40, P1003, DOI 10.1590/S0100-879X2006005000115; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17164	10.1371/journal.pone.0017164	http://dx.doi.org/10.1371/journal.pone.0017164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359178	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700056
J	Bengali, Z; Satheshkumar, PS; Yang, ZL; Weisberg, AS; Paran, N; Moss, B				Bengali, Zain; Satheshkumar, P. S.; Yang, Zhilong; Weisberg, Andrea S.; Paran, Nir; Moss, Bernard			Drosophila S2 Cells Are Non-Permissive for Vaccinia Virus DNA Replication Following Entry via Low pH-Dependent Endocytosis and Early Transcription	PLOS ONE			English	Article							INTRACELLULAR MATURE VIRION; MEMBRANE-PROTEIN; ESSENTIAL COMPONENT; INTERMEDIATE STAGE; A27L PROTEIN; IN-VITRO; GENE; EXPRESSION; FUSION; INFECTION	Vaccinia virus (VACV), a member of the chordopox subfamily of the Poxviridae, abortively infects insect cells. We have investigated VACV infection of Drosophila S2 cells, which are useful for protein expression and genome-wide RNAi screening. Biochemical and electron microscopic analyses indicated that VACV entry into Drosophila S2 cells depended on the VACV multiprotein entry-fusion complex but appeared to occur exclusively by a low pH-dependent endocytic mechanism, in contrast to both neutral and low pH entry pathways used in mammalian cells. Deep RNA sequencing revealed that the entire VACV early transcriptome, comprising 118 open reading frames, was robustly expressed but neither intermediate nor late mRNAs were made. Nor was viral late protein synthesis or inhibition of host protein synthesis detected by pulse-labeling with radioactive amino acids. Some reduction in viral early proteins was noted by Western blotting. Nevertheless, synthesis of the multitude of early proteins needed for intermediate gene expression was demonstrated by transfection of a plasmid containing a reporter gene regulated by an intermediate promoter. In addition, expression of a reporter gene with a late promoter was achieved by cotransfection of intermediate genes encoding the late transcription factors. The requirement for transfection of DNA templates for intermediate and late gene expression indicated a defect in viral genome replication in VACV-infected S2 cells, which was confirmed by direct analysis. Furthermore, VACV-infected S2 cells did not support the replication of a transfected plasmid, which occurs in mammalian cells and is dependent on all known viral replication proteins, indicating a primary restriction of DNA synthesis.	[Bengali, Zain; Satheshkumar, P. S.; Yang, Zhilong; Weisberg, Andrea S.; Paran, Nir; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bengali, Z (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	bmoss@nih.gov	Yang, Zhilong/E-8967-2010; Paran, Nir/AAC-1036-2020	Yang, Zhilong/0000-0001-8995-2654; Moss, Bernard/0000-0002-2154-8564	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000307, ZIAAI000539, ZIAAI001075] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012; Bisht H, 2008, J VIROL, V82, P8687, DOI 10.1128/JVI.00852-08; Brown E, 2006, J VIROL, V80, P9455, DOI 10.1128/JVI.01149-06; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Cherry S, 2008, CURR OPIN MICROBIOL, V11, P262, DOI 10.1016/j.mib.2008.05.007; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; DELANGE AM, 1986, P NATL ACAD SCI USA, V83, P614, DOI 10.1073/pnas.83.3.614; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Earl PL, 1998, CURRENT PROTOCOLS MO; Foo CH, 2009, VIROLOGY, V385, P368, DOI 10.1016/j.virol.2008.12.019; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; Izmailyan RA, 2006, J VIROL, V80, P8402, DOI 10.1128/JVI.00624-06; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; LANGRIDGE WHR, 1983, J INVERTEBR PATHOL, V42, P77, DOI 10.1016/0022-2011(83)90204-5; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; LEECHEN GJ, 1988, VIROLOGY, V163, P52, DOI 10.1016/0042-6822(88)90233-4; Li Y, 1997, J VIROL, V71, P9557, DOI 10.1128/JVI.71.12.9557-9562.1997; Li Y, 1998, VIROLOGY, V248, P74, DOI 10.1006/viro.1998.9241; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin YCJ, 2008, J VIROL, V82, P5922, DOI 10.1128/JVI.02723-07; Magee WC, 2009, J VIROL METHODS, V161, P44, DOI 10.1016/j.jviromet.2009.05.012; MCDONALD WF, 1992, J VIROL, V66, P534, DOI 10.1128/JVI.66.1.534-547.1992; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; MERCHLINSKY M, 1988, CANCER CELL, V6, P87; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Moss B, 2007, FIELDS VIROLOGY; Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08; Ojeda S, 2006, J VIROL, V80, P51, DOI 10.1128/JVI.80.1.51-61.2006; Ojeda S, 2006, J VIROL, V80, P9822, DOI 10.1128/JVI.00987-06; Paran N, 2009, CELL HOST MICROBE, V6, P563, DOI 10.1016/j.chom.2009.11.005; Sanz P, 1999, P NATL ACAD SCI USA, V96, P2692, DOI 10.1073/pnas.96.6.2692; Satheshkumar PS, 2009, J VIROL, V83, P12822, DOI 10.1128/JVI.01744-09; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Senkevich TG, 2005, J VIROL, V79, P4744, DOI 10.1128/JVI.79.8.4744-4754.2005; Senkevich TG, 2004, J VIROL, V78, P2357, DOI 10.1128/JVI.78.5.2357-2366.2004; Senkevich TG, 2004, J VIROL, V78, P2348, DOI 10.1128/JVI.78.5.2348-2356.2004; Shatzer AN, 2008, VIROLOGY, V375, P236, DOI 10.1016/j.virol.2008.01.028; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Townsley AC, 2005, J VIROL, V79, P10988, DOI 10.1128/JVI.79.17.10988-10998.2005; Townsley AC, 2005, J VIROL, V79, P9458, DOI 10.1128/JVI.79.15.9458-9469.2005; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; WINOKUR PL, 1992, EMBO J, V11, P4111, DOI 10.1002/j.1460-2075.1992.tb05504.x; Wright CF, 2001, J BIOL CHEM, V276, P40680, DOI 10.1074/jbc.M102399200; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17248	10.1371/journal.pone.0017248	http://dx.doi.org/10.1371/journal.pone.0017248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347205	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200030
J	Katz, E; Dubois-Marshall, S; Sims, AH; Gautier, P; Caldwell, H; Meehan, RR; Harrison, DJ				Katz, Elad; Dubois-Marshall, Sylvie; Sims, Andrew H.; Gautier, Philippe; Caldwell, Helen; Meehan, Richard R.; Harrison, David J.			An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer	PLOS ONE			English	Article							TUMOR PROGRESSION; CLAUDIN-LOW; N-CADHERIN; CELLS; INVASION; METASTASIS; EXPRESSION; GENE; MOTILITY; SUBTYPES	The epithelial to mesenchymal transition (EMT) is a developmental program in which epithelial cells down-regulate their cell-cell junctions, acquire spindle cell morphology and exhibit cellular motility. In human breast cancer, invasion into surrounding tissue is the first step in metastatic progression. Here, we devised an in vitro model using selected cell lines, which recapitulates many features of EMT as observed in human breast cancer. By comparing the gene expression profiles of claudin-low breast cancers with the experimental model, we identified a 9-gene signature characteristic of EMT. This signature was found to distinguish a series of breast cancer cell lines that have demonstrable, classical EMT hallmarks, including loss of E-cadherin protein and acquisition of N-cadherin and vimentin expression. We subsequently developed a three-dimensional model to recapitulate the process of EMT with these cell lines. The cells maintain epithelial morphology when encapsulated in a reconstituted basement membrane, but undergo spontaneous EMT and invade into surrounding collagen in the absence of exogenous cues. Collectively, this model of EMT in vitro reveals the behaviour of breast cancer cells beyond the basement membrane breach and recapitulates the in vivo context for further investigation into EMT and drugs that may interfere with it.	[Katz, Elad; Dubois-Marshall, Sylvie; Sims, Andrew H.; Caldwell, Helen; Meehan, Richard R.; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland; [Katz, Elad; Dubois-Marshall, Sylvie; Caldwell, Helen; Harrison, David J.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland; [Gautier, Philippe; Meehan, Richard R.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Katz, E (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Breakthrough Breast Canc Res Unit, Edinburgh, Midlothian, Scotland.	elad.katz@ed.ac.uk	Sims, Andrew/E-4819-2012; Gautier, Philippe/D-4067-2011	Sims, Andrew/0000-0001-9082-3665; harrison, david/0000-0001-9041-9988; Meehan, Richard/0000-0001-6471-6882	Edinburgh Experimental Cancer Medicine Centre; Breakthrough Breast Cancer; Scottish Funding Council; MRC [MC_U127574433] Funding Source: UKRI; Medical Research Council [MC_U127574433] Funding Source: researchfish	Edinburgh Experimental Cancer Medicine Centre; Breakthrough Breast Cancer; Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Clinical materials were obtained through the auspices of the Edinburgh Experimental Cancer Medicine Centre. This work was supported by Breakthrough Breast Cancer and the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt LM, 2010, SEMIN CELL DEV BIOL, V21, P11, DOI 10.1016/j.semcdb.2009.10.003; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fanayan S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-7; Fernandez Y, 2010, CANCER TREAT REV, V36, P33, DOI 10.1016/j.ctrv.2009.10.001; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Parr C, 2006, INT J CANCER, V119, P1176, DOI 10.1002/ijc.21881; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiercinska E, 2010, BREAST CANC RES TREA; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	42	45	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17083	10.1371/journal.pone.0017083	http://dx.doi.org/10.1371/journal.pone.0017083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347235	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200020
J	Wu, CC; Bossaerts, P; Knutson, B				Wu, Charlene C.; Bossaerts, Peter; Knutson, Brian			The Affective Impact of Financial Skewness on Neural Activity and Choice	PLOS ONE			English	Article							DECISION-MAKING; PROSPECT-THEORY; PREFRONTAL CORTEX; RISK-TAKING; REWARD; ACTIVATION; PREFERENCE; VARIANCE; REPRESENTATION; UNCERTAINTY	Few finance theories consider the influence of "skewness'' (or large and asymmetric but unlikely outcomes) on financial choice. We investigated the impact of skewed gambles on subjects' neural activity, self-reported affective responses, and subsequent preferences using functional magnetic resonance imaging (FMRI). Neurally, skewed gambles elicited more anterior insula activation than symmetric gambles equated for expected value and variance, and positively skewed gambles also specifically elicited more nucleus accumbens (NAcc) activation than negatively skewed gambles. Affectively, positively skewed gambles elicited more positive arousal and negatively skewed gambles elicited more negative arousal than symmetric gambles equated for expected value and variance. Subjects also preferred positively skewed gambles more, but negatively skewed gambles less than symmetric gambles of equal expected value. Individual differences in both NAcc activity and positive arousal predicted preferences for positively skewed gambles. These findings support an anticipatory affect account in which statistical properties of gambles-including skewness-can influence neural activity, affective responses, and ultimately, choice.	[Wu, Charlene C.; Knutson, Brian] Stanford Univ, Stanford, CA 94305 USA; [Bossaerts, Peter] CALTECH, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology	Wu, CC (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	charlene.wu@stanford.edu	Bossaerts, Peter/AAZ-9851-2020; Bossaerts, Peter/O-9964-2015	Bossaerts, Peter/0000-0003-2308-2603; Knutson, Brian/0000-0002-7669-426X	National Science Foundation [0748915]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was supported by National Science Foundation Grant 0748915 to BK and National Science Foundation Graduate Research Fellowship to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERFER CP, 1970, J BUS, V43, P341, DOI 10.1086/295286; Ang A, 2006, REV FINANC STUD, V19, P1191, DOI 10.1093/rfs/hhj035; ARDITTI FD, 1975, J FINANC, V30, P797, DOI 10.2307/2326859; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Chiu WH, 2005, MANAGE SCI, V51, P1816, DOI 10.1287/mnsc.1050.0431; COOMBS CH, 1981, J EXP PSYCHOL HUMAN, V7, P1110, DOI 10.1037/0096-1523.7.5.1110; COOMBS CH, 1960, J EXP PSYCHOL, V60, P265, DOI 10.1037/h0041444; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; EDWARDS W, 1954, AM J PSYCHOL, V67, P441, DOI 10.2307/1417935; EDWARDS W, 1953, AM J PSYCHOL, V66, P349, DOI 10.2307/1418231; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Gneezy U, 2003, J FINANC, V58, P821, DOI 10.1111/1540-6261.00547; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; KRAUS A, 1976, J FINANC, V31, P1085, DOI 10.2307/2326275; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Levy H, 2004, REV FINANC STUD, V17, P1015, DOI 10.1093/rfs/hhg062; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lovallo D, 2000, J BEHAV DECIS MAKING, V13, P179, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<179::AID-BDM332>3.0.CO;2-J; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MENEZES C, 1980, AM ECON REV, V70, P921; Mitton T, 2007, REV FINANC STUD, V20, P1255, DOI 10.1093/revfin/hhm011; Miyamoto JM, 1996, OPER RES, V44, P313, DOI 10.1287/opre.44.2.313; Nielsen L, 2008, EMOTION, V8, P318, DOI 10.1037/1528-3542.8.3.318; Patton A. J., 2004, J FINANCIAL ECONOMET, V2, P130, DOI DOI 10.1093/JJFINEC/NBH006; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; QUIGGIN J, 1982, J ECON BEHAV ORGAN, V3, P323, DOI 10.1016/0167-2681(82)90008-7; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Symmonds M, 2010, J NEUROSCI, V30, P14380, DOI 10.1523/JNEUROSCI.1459-10.2010; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	42	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16838	10.1371/journal.pone.0016838	http://dx.doi.org/10.1371/journal.pone.0016838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721QH	21347239	Green Accepted, gold, Green Published			2022-12-27	WOS:000287369200010
J	Chow, BWY; Ho, CSH; Wong, SWL; Waye, MMY; Bishop, DVM				Chow, Bonnie Wing-Yin; Ho, Connie Suk-Han; Wong, Simpson Wai-Lap; Waye, Mary M. Y.; Bishop, Dorothy V. M.			Genetic and Environmental Influences on Chinese Language and Reading Abilities	PLOS ONE			English	Article							GENERAL COGNITIVE-ABILITY; PHONOLOGICAL AWARENESS; ORTHOGRAPHIC KNOWLEDGE; LONGITUDINAL TWIN; PREREADING SKILLS; UNITED-STATES; CHILDREN; ACQUISITION; PERFORMANCE; RECOGNITION	This study investigated the etiology of individual differences in Chinese language and reading skills in 312 typically developing Chinese twin pairs aged from 3 to 11 years (228 pairs of monozygotic twins and 84 pairs of dizygotic twins; 166 male pairs and 146 female pairs). Children were individually given tasks of Chinese word reading, receptive vocabulary, phonological memory, tone awareness, syllable and rhyme awareness, rapid automatized naming, morphological awareness and orthographic skills, and Raven's Coloured Progressive Matrices. All analyses controlled for the effects of age. There were moderate to substantial genetic influences on word reading, tone awareness, phonological memory, morphological awareness and rapid automatized naming (estimates ranged from .42 to .73), while shared environment exerted moderate to strong effects on receptive vocabulary, syllable and rhyme awareness and orthographic skills (estimates ranged from .35 to .63). Results were largely unchanged when scores were adjusted for nonverbal reasoning as well as age. Findings of this study are mostly similar to those found for English, a language with very different characteristics, and suggest the universality of genetic and environmental influences across languages.	[Chow, Bonnie Wing-Yin; Wong, Simpson Wai-Lap; Bishop, Dorothy V. M.] Univ Oxford, Oxford, England; [Chow, Bonnie Wing-Yin] City Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ho, Connie Suk-Han] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Wong, Simpson Wai-Lap] Hong Kong Inst Educ, Hong Kong, Hong Kong, Peoples R China; [Waye, Mary M. Y.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Oxford; City University of Hong Kong; University of Hong Kong; Education University of Hong Kong (EdUHK); Chinese University of Hong Kong	Chow, BWY (corresponding author), Univ Oxford, Oxford, England.	wybchow@gmail.com	韋妙宜教授, Mary Miu Yee Waye/A-9674-2008	韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Wong, Simpson W.L./0000-0002-6606-6382; CHOW, Wing Yin/0000-0002-3995-7358; Bishop, Dorothy/0000-0002-2448-4033	Research Grants Council of the Hong Kong Special Administrative Region [HKU743907H]; Wellcome Trust of the United Kingdom [082498/z/07]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Wellcome Trust of the United Kingdom(Wellcome Trust)	This research was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (HKU743907H) and the Wellcome Trust of the United Kingdom (082498/z/07). Funders' website: http://www.ugc.edu.hk/eng/rgc/index.htm,http://www/wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates Elizabeth, 1995, HDB CHILD LANGUAGE; Braun W.J., 2007, 1 COURSE STAT PROGRA; BROOKS A, 1990, PERS INDIV DIFFER, V11, P141, DOI 10.1016/0191-8869(90)90006-D; Byrne B, 2005, SCI STUD READ, V9, P219, DOI 10.1207/s1532799xssr0903_3; Byrne B, 2002, ANN DYSLEXIA, V52, P49; Byrne B, 2009, J NEUROLINGUIST, V22, P219, DOI 10.1016/j.jneuroling.2008.09.003; Castles A, 2003, Q J EXP PSYCHOL-A, V56, P445, DOI 10.1080/02724980244000486; Chen X, 2009, READ WRIT, V22, P615, DOI 10.1007/s11145-008-9127-9; Cheung H, 2007, LANG LEARN, V57, P469, DOI 10.1111/j.1467-9922.2007.00423.x; Chia KS, 2004, ANN ACAD MED SINGAP, V33, P195; Chow BWY, 2005, J EDUC PSYCHOL, V97, P81, DOI 10.1037/0022-0663.97.1.81; Cunningham AE, 2001, READ WRIT, V14, P549, DOI 10.1023/A:1011100226798; Davis CJ, 2001, ANN DYSLEXIA, V51, P231, DOI 10.1007/s11881-001-0012-3; Dionne G, 2003, CHILD DEV, V74, P394, DOI 10.1111/1467-8624.7402005; Doi L. M., 1999, SCI STUD READ, V3, P129, DOI [10.1207/s1532799xssr0302_3, DOI 10.1207/S1532799XSSR0302_]; Dunn L.M., 2007, PEABODY PICTURE VOCA, DOI [DOI 10.1037/T15144-000, 10.1037/t15144-000]; GATHERCOLE SE, 1991, BRIT J PSYCHOL, V82, P387, DOI 10.1111/j.2044-8295.1991.tb02407.x; Gayan J, 2003, J EXP CHILD PSYCHOL, V84, P97, DOI 10.1016/S0022-0965(02)00181-9; Hart SA, 2009, J EDUC PSYCHOL, V101, P388, DOI 10.1037/a0015115; Ho C.S.-H., 2000, HONG KONG TEST SPECI; Hohnen B, 1999, DEV PSYCHOL, V35, P590, DOI 10.1037/0012-1649.35.2.590; Hu C.F., 1998, SCI STUD READ, V2, P55, DOI [10.1207/s1532799xssr0201_3, DOI 10.1207/S1532799XSSR0201_3]; Hulme C, 2002, J EXP CHILD PSYCHOL, V82, P2, DOI 10.1006/jecp.2002.2670; Imaizumi Y, 2003, J BIOSOC SCI, V35, P287, DOI 10.1017/S0021932003002876; Kovas Y, 2005, CHILD DEV, V76, P632, DOI 10.1111/j.1467-8624.2005.00868.x; KU YM, 2003, READING WRITING INTE, V16, P399, DOI DOI 10.1023/A:1024227231216; Li H, 2005, INT J EARLY YEARS ED, V13, P235, DOI 10.1080/09669760500295870; Liu I. M., 1975, FREQUENCY COUNT 4000; Mahony D, 2000, READ WRIT, V12, P191, DOI 10.1023/A:1008136012492; McBride-Chang C, 2000, J EDUC PSYCHOL, V92, P50, DOI 10.1037/0022-0663.92.1.50; McBride-Chang C, 2003, J EDUC PSYCHOL, V95, P743, DOI 10.1037/0022-0663.95.4.743; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Petrill SA, 2006, J LEARN DISABIL-US, V39, P48, DOI 10.1177/00222194060390010501; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Raven JC., 1995, RAVENS COLOURED PROG; Rutter M, 2002, J SCHOOL PSYCHOL, V40, P451, DOI 10.1016/S0022-4405(02)00124-3; Samuelsson S, 2005, J EDUC PSYCHOL, V97, P705, DOI 10.1037/0022-0663.97.4.705; Samuelsson S, 2007, READ WRIT, V20, P51, DOI 10.1007/s11145-006-9018-x; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; Snow C.E., 1998, PREVENTING READING D, DOI DOI 10.1002/PITS.10011; TORGESEN JK, 1992, J EDUC PSYCHOL, V84, P364, DOI DOI 10.1037/0022-0663.84.3.364; TUNMER WE, 1985, J EDUC PSYCHOL, V77, P417, DOI 10.1037/0022-0663.77.4.417; WADSWORTH SJ, 1995, INTELLIGENCE, V20, P145, DOI 10.1016/0160-2896(95)90030-6; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468	47	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16640	10.1371/journal.pone.0016640	http://dx.doi.org/10.1371/journal.pone.0016640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NZ	21347359	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000012
J	Izaks, GJ; Joosten, H; Koerts, J; Gansevoort, RT; Slaets, JP				Izaks, Gerbrand J.; Joosten, Hanneke; Koerts, Janneke; Gansevoort, Ron T.; Slaets, Joris P.			Reference Data for the Ruff Figural Fluency Test Stratified by Age and Educational Level	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LESIONS; RELIABILITY; PERFORMANCE; ADULTS	The Ruff Figural Fluency Test (RFFT) was developed to avoid the difficulties that were encountered in earlier tests of figural fluency. Although the test characteristics of the RFFT seem to be good and it is a valuable addition to neuropsychological assessments, reference data are still scarce. To this aim, we required 2,404 community dwelling persons in Groningen, the Netherlands to perform the RFFT. All 1,651 persons with a complete RFFT and known educational level formed the reference sample. Their age ranged from 35 to 82 years and their educational level from primary school to university grade. Ninety-six percent of the persons were of Western European descent. All tests were analyzed by two independent examiners and subsequently three measures were calculated: number of unique designs, number of perseverative errors and error ratio. The main finding was that performance on the RFFT was dependent on age and educational level. This was not only observed in older persons but also in young and middle-aged persons. Reference data for the three RFFT measures are presented in groups of five years of age ranging from 35-39 years to 75 years or older.	[Izaks, Gerbrand J.; Joosten, Hanneke; Slaets, Joris P.] Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands; [Izaks, Gerbrand J.; Slaets, Joris P.] Univ Med Ctr Groningen, Alzheimer Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Joosten, Hanneke; Gansevoort, Ron T.] Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [Koerts, Janneke] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Izaks, Gerbrand J.; Joosten, Hanneke; Gansevoort, Ron T.; Slaets, Joris P.] Univ Groningen, Grad Sch Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Izaks, GJ (corresponding author), Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands.	g.j.izaks@int.umcg.nl	Izaks, Gerbrand/F-5089-2014	Izaks, Gerbrand/0000-0003-3213-7637	Dutch Alzheimer Foundation; Dutch Kidney Foundation [E.033]	Dutch Alzheimer Foundation; Dutch Kidney Foundation	This study was partly funded by the Dutch Alzheimer Foundation (www.alzheimer-nederland.nl). The PREVEND study in general was funded by the Dutch Kidney Foundation (www.nierstichting.nl; grant E.033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berning LC, 1998, ASSESSMENT, V5, P181, DOI 10.1177/107319119800500208; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Fama R, 1998, CLIN NEUROPSYCHOL, V12, P487, DOI 10.1076/clin.12.4.487.7235; Fama R, 2000, NEUROPSYCHOLOGY, V14, P29, DOI 10.1037/0894-4105.14.1.29; Foster PS, 2005, ARCH CLIN NEUROPSYCH, V20, P427, DOI 10.1016/j.acn.2004.09.010; Goebel S, 2009, CLIN NEUROPSYCHOL, V23, P675, DOI 10.1080/13854040802389185; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KHALIL MS, 2010, J CLIN EXP NEUR 0603; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P879, DOI 10.1016/S0887-6177(02)00163-4; Rosselli N, 2003, BRAIN COGNITION, V52, P326, DOI 10.1016/S0278-2626(03)00170-2; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Ruff R. M., 1996, RUFF FIGURAL FLUENCY; RUFF RM, 1994, ARCH CLIN NEUROPSYCH, V9, P41, DOI 10.1016/0887-6177(94)90013-2; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tucha O, 1999, J CLIN EXP NEUROPSYC, V21, P229, DOI 10.1076/jcen.21.2.229.928; United Nations, 2006, INT STAND CLASS ED I; Weiner DE, 2009, AM J KIDNEY DIS, V53, P438, DOI 10.1053/j.ajkd.2008.08.022; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62	24	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17045	10.1371/journal.pone.0017045	http://dx.doi.org/10.1371/journal.pone.0017045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NZ	21347325	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000034
J	Choy, HA; Kelley, MM; Croda, J; Matsunaga, J; Babbitt, JT; Ko, AI; Picardeau, M; Haake, DA				Choy, Henry A.; Kelley, Melissa M.; Croda, Julio; Matsunaga, James; Babbitt, Jane T.; Ko, Albert I.; Picardeau, Mathieu; Haake, David A.			The Multifunctional LigB Adhesin Binds Homeostatic Proteins with Potential Roles in Cutaneous Infection by Pathogenic Leptospira interrogans	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEINS; STAPHYLOCOCCUS-AUREUS; MUCOSAL IMMUNOLOGY; CRYSTAL-STRUCTURE; HUMAN-FIBRINOGEN; GENE-EXPRESSION; TISSUE-REPAIR; MSCRAMM; REGION; MODEL	Leptospirosis is a potentially fatal zoonotic disease in humans and animals caused by pathogenic spirochetes, such as Leptospira interrogans. The mode of transmission is commonly limited to the exposure of mucous membrane or damaged skin to water contaminated by leptospires shed in the urine of carriers, such as rats. Infection occurs during seasonal flooding of impoverished tropical urban habitats with large rat populations, but also during recreational activity in open water, suggesting it is very efficient. LigA and LigB are surface localized proteins in pathogenic Leptospira strains with properties that could facilitate the infection of damaged skin. Their expression is rapidly induced by the increase in osmolarity encountered by leptospires upon transition from water to host. In addition, the immunoglobulin-like repeats of the Lig proteins bind proteins that mediate attachment to host tissue, such as fibronectin, fibrinogen, collagens, laminin, and elastin, some of which are important in cutaneous wound healing and repair. Hemostasis is critical in a fresh injury, where fibrinogen from damaged vasculature mediates coagulation. We show that fibrinogen binding by recombinant LigB inhibits fibrin formation, which could aid leptospiral entry into the circulation, dissemination, and further infection by impairing healing. LigB also binds fibroblast fibronectin and type III collagen, two proteins prevalent in wound repair, thus potentially enhancing leptospiral adhesion to skin openings. LigA or LigB expression by transformation of a nonpathogenic saprophyte, L. biflexa, enhances bacterial adhesion to fibrinogen. Our results suggest that by binding homeostatic proteins found in cutaneous wounds, LigB could facilitate leptospirosis transmission. Both fibronectin and fibrinogen binding have been mapped to an overlapping domain in LigB comprising repeats 9-11, with repeat 11 possibly enhancing binding by a conformational effect. Leptospirosis patient antibodies react with the LigB domain, suggesting applications in diagnosis and vaccines that are currently limited by the strain-specific leptospiral lipopolysaccharide coats.	[Choy, Henry A.; Matsunaga, James; Babbitt, Jane T.; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Choy, Henry A.; Kelley, Melissa M.; Matsunaga, James; Babbitt, Jane T.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Croda, Julio; Ko, Albert I.] Brasilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil; [Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France; [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA; [Haake, David A.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Haake, David A.] Univ Calif Los Angeles, Dept Mol Genet Microbiol & Immunol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Fundacao Oswaldo Cruz; Universidade Federal da Grande Dourados; Yale University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Choy, HA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	hachoy@ucla.edu	Ko, Albert/P-2343-2015; Croda, Julio/I-5172-2013	Ko, Albert/0000-0001-9023-2339; Croda, Julio/0000-0002-6665-6825	National Institutes of Health [R01 AI34431, U01 AI088752, D43 TW00919, R01 AI052473]; VA Medical Research Funds; Institut Pasteur, Paris, France; French Ministry of Research [ANR-08-MIE-018]; Oswaldo Cruz Foundation [PDTIS RVR05]; FOGARTY INTERNATIONAL CENTER [D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034431, R01AI052473, U01AI088752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Medical Research Funds(US Department of Veterans Affairs); Institut Pasteur, Paris, France; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Oswaldo Cruz Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (R01 AI34431, U01 AI088752, D43 TW00919, and R01 AI052473), VA Medical Research Funds (to D. A. H.), the Institut Pasteur, Paris, France, the French Ministry of Research (ANR-08-MIE-018), and the Fiocruz-Pasteur Scientific Cooperation Agreement, Oswaldo Cruz Foundation (PDTIS RVR05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum CL, 2005, DERMATOL SURG, V31, P674; BERNSTEIN JM, 1992, RESPIRATION, V59, P3; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047; Ito T, 1987, Nihon Juigaku Zasshi, V49, P875; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu CZ, 2005, THROMB HAEMOSTASIS, V94, P286, DOI 10.1160/TH05-03-0205; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560; Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652; Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; QUAGLINO D, 1991, J INVEST DERMATOL, V97, P34; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Thibeault SL, 2009, MUCOSAL IMMUNOL, V2, P122, DOI 10.1038/mi.2008.82; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	51	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16879	10.1371/journal.pone.0016879	http://dx.doi.org/10.1371/journal.pone.0016879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347378	Green Submitted, Green Published, gold			2022-12-27	WOS:000287361700049
J	Lundgren, O; Jodal, M; Jansson, M; Ryberg, AT; Svensson, L				Lundgren, Ove; Jodal, Mats; Jansson, Madeleine; Ryberg, Anders T.; Svensson, Lennart			Intestinal Epithelial Stem/Progenitor Cells Are Controlled by Mucosal Afferent Nerves	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CLOSTRIDIUM-DIFFICILE TOXIN; STEM-CELLS; SUBSTANCE-P; ELECTROLYTE SECRETION; INDUCED PROLIFERATION; MOLECULAR-MECHANISMS; SMOOTH-MUSCLE; COLON	Background: The maintenance of the intestinal epithelium is of great importance for the survival of the organism. A possible nervous control of epithelial cell renewal was studied in rats and mice. Methods: Mucosal afferent nerves were stimulated by exposing the intestinal mucosa to capsaicin (1.6 mM), which stimulates intestinal external axons. Epithelial cell renewal was investigated in the jejunum by measuring intestinal thymidine kinase (TK) activity, intestinal H-3-thymidine incorporation into DNA, and the number of crypt cells labeled with BrdU. The influence of the external gut innervation was minimized by severing the periarterial nerves. Principal Findings: Luminal capsaicin increased all the studied variables, an effect nervously mediated to judge from inhibitory effects on TK activity or H-3-thymidine incorporation into DNA by exposing the mucosa to lidocaine (a local anesthetic) or by giving four different neurotransmitter receptor antagonists i.v. (muscarinic, nicotinic, neurokinin1 (NK1) or calcitonin gene related peptide (CGRP) receptors). After degeneration of the intestinal external nerves capsaicin did not increase TK activity, suggesting the involvement of an axon reflex. Intra-arterial infusion of Substance P (SP) or CGRP increased intestinal TK activity, a response abolished by muscarinic receptor blockade. Immunohistochemistry suggested presence of M3 and M5 muscarinic receptors on the intestinal stem/progenitor cells. We propose that the stem/progenitor cells are controlled by cholinergic nerves, which, in turn, are influenced by mucosal afferent neuron(s) releasing acetylcholine and/or SP and/or CGRP. In mice lacking the capsaicin receptor, thymidine incorporation into DNA and number of crypt cells labeled with BrdU was lower than in wild type animals suggesting that nerves are important also in the absence of luminal capsaicin, a conclusion also supported by the observation that atropine lowered thymidine incorporation into DNA by 60% in control rat segments. Conclusion: Enteric nerves are of importance in maintaining the intestinal epithelial barrier.	[Lundgren, Ove; Jodal, Mats; Jansson, Madeleine] Univ Gothenburg, Physiol Sect, Sahlgrenska Acad, Gothenburg, Sweden; [Ryberg, Anders T.] Univ Gothenburg, Pharmacol Sect, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Svensson, Lennart] Linkoping Univ, Dept Mol Virol, Linkoping, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University	Lundgren, O (corresponding author), Univ Gothenburg, Physiol Sect, Sahlgrenska Acad, Gothenburg, Sweden.	ove.lundgren@fysiologi.gu.se	svensson, lennart/K-6163-2019		Swedish Scientific Council [2855, 5951, 8266]; Royal Society of Arts and Sciences in Gothenburg; Magnus Bergvall's and Adlerberth Research foundations	Swedish Scientific Council; Royal Society of Arts and Sciences in Gothenburg; Magnus Bergvall's and Adlerberth Research foundations	This research was supported by the Swedish Scientific Council (2855, 5951, 8266), the Royal Society of Arts and Sciences in Gothenburg and the Magnus Bergvall's and Adlerberth Research foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Banks MR, 2005, BRIT J PHARMACOL, V144, P994, DOI 10.1038/sj.bjp.0706128; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; BREIMER ME, 1981, EXP CELL RES, V135, P1, DOI 10.1016/0014-4827(81)90293-7; Bueno L, 2002, GUT, V51, pI19, DOI 10.1136/gut.51.suppl_1.i19; CASSUTO J, 1981, GUT, V22, P958, DOI 10.1136/gut.22.11.958; CASSUTO J, 1981, SCAND J GASTROENTERO, V16, P377, DOI 10.3109/00365528109181984; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheng KR, 2003, CANCER RES, V63, P6744; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; Day DW, 2003, MORSON DAWSONS GASTR; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; Frucht H, 1999, CLIN CANCER RES, V5, P2532; Fujisawa H, 2005, BIOCHEM BIOPH RES CO, V338, P271, DOI 10.1016/j.bbrc.2005.07.183; Furness J.B., 2006, ENTERIC NERVOUS SYST; HOLLE GE, 1991, GASTROENTEROLOGY, V101, P1264, DOI 10.1016/0016-5085(91)90076-W; Holzer P, 2004, EUR J PHARMACOL, V500, P231, DOI 10.1016/j.ejphar.2004.07.028; Houghton SG, 2006, J SURG RES, V131, P53, DOI 10.1016/j.jss.2005.07.029; HUGHES CA, 1980, CLIN SCI, V59, P317, DOI 10.1042/cs0590317; IMONDI AR, 1969, EXP CELL RES, V58, P323, DOI 10.1016/0014-4827(69)90512-6; JODAL M, 1986, GASTROENTEROLOGY, V91, P225, DOI 10.1016/0016-5085(86)90463-4; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kagnoff MF, 2006, ANN NY ACAD SCI, V1072, P313, DOI 10.1196/annals.1326.038; Kaunitz JD, 2001, LIFE SCI, V69, P3073, DOI 10.1016/S0024-3205(01)01413-8; Keates AC, 1998, AM J PHYSIOL-GASTR L, V274, pG196, DOI 10.1152/ajpgi.1998.274.1.G196; KENNEDY MFG, 1983, CLIN EXP PHARMACOL P, V10, P577, DOI 10.1111/j.1440-1681.1983.tb00226.x; KLEMPERER HG, 1968, BIOCHEM J, V108, P541, DOI 10.1042/bj1080541; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Kordasti S, 2004, GUT, V53, P952, DOI 10.1136/gut.2003.033563; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LIPKIN M, 1974, CANCER, V34, P878, DOI 10.1002/1097-0142(197409)34:3+<878::AID-CNCR2820340715>3.0.CO;2-R; LUCK MS, 1993, CELL TISSUE RES, V271, P363, DOI 10.1007/BF00318623; Lundgren O, 2004, GASTROENTEROLOGY, V126, pA425; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Lundgren O, 2002, PHARMACOL TOXICOL, V90, P109, DOI 10.1034/j.1600-0773.2002.900301.x; MacNaughton WK, 2005, MEM I OSWALDO CRUZ, V100, P211, DOI 10.1590/S0074-02762005000900036; Magami Y, 2002, J GASTROEN HEPATOL, V17, P262, DOI 10.1046/j.1440-1746.2002.02683.x; MANN R, 1989, HISTOCHEMISTRY, V92, P219, DOI 10.1007/BF00500921; Mantyh CR, 1996, GASTROENTEROLOGY, V111, P1272, DOI 10.1053/gast.1996.v111.pm8898641; MATHIAS JR, 1989, HDB PHYSL GASTROINTE, V1, P1153; McVey DC, 2001, PEPTIDES, V22, P1439, DOI 10.1016/S0196-9781(01)00463-6; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mourad FH, 2000, GUT, V47, P382, DOI 10.1136/gut.47.3.382; Nguyen C, 2003, CAN J PHYSIOL PHARM, V81, P920, DOI 10.1139/Y03-080; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pfaar O, 2009, SWISS MED WKLY, V139, P35, DOI smw-12468; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; RUCHTI C, 1983, CELL TISSUE RES, V232, P625, DOI 10.1007/BF00216434; SALSER JS, 1973, CANCER RES, V33, P1889; Sambrook J, 2001, MOL CLONING LAB MANU; SANN H, 1995, NEUROSCI LETT, V198, P17, DOI 10.1016/0304-3940(95)11951-R; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHEVING LA, 1989, J BIOL CHEM, V264, P1735; SEE NA, 1990, J AUTONOM NERV SYST, V31, P219, DOI 10.1016/0165-1838(90)90188-O; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; SJOQVIST A, 1991, ACTA PHYSIOL SCAND, V142, P127, DOI 10.1111/j.1748-1716.1991.tb09137.x; Slack BE, 2000, BIOCHEM J, V348, P381, DOI 10.1042/0264-6021:3480381; Tamura CS, 1997, BRAIN RES, V770, P248, DOI 10.1016/S0006-8993(97)00855-X; Tobin G, 2006, J APPL PHYSIOL, V100, P1215, DOI 10.1152/japplphysiol.00779.2005; Turvill JL, 2000, GASTROENTEROLOGY, V119, P1037, DOI 10.1053/gast.2000.18147; TUTTON PJM, 1980, CANCER, V45, P1172, DOI 10.1002/1097-0142(19800315)45:5+<1172::AID-CNCR2820451322>3.0.CO;2-B; TUTTON PJM, 1975, CLIN EXP PHARMACOL P, V2, P269, DOI 10.1111/j.1440-1681.1975.tb03032.x; Ukegawa JI, 2003, J CANCER RES CLIN, V129, P272, DOI 10.1007/s00432-003-0433-y; VANNER S, 1994, AM J PHYSIOL-GASTR L, V267, pG650, DOI 10.1152/ajpgi.1994.267.4.G650; Vidrich A, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P307; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zucoloto S, 1997, RES EXP MED, V197, P117, DOI 10.1007/s004330050061; ZUCOLOTO S, 1988, CELL TISSUE KINET, V21, P213, DOI 10.1111/j.1365-2184.1988.tb00780.x	81	53	53	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16295	10.1371/journal.pone.0016295	http://dx.doi.org/10.1371/journal.pone.0016295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347406	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700013
J	Deng, YP; Meyer, SA; Guan, X; Escalon, BL; Ai, JM; Wilbanks, MS; Welti, R; Garcia-Reyero, N; Perkins, EJ				Deng, Youping; Meyer, Sharon A.; Guan, Xin; Escalon, Barbara Lynn; Ai, Junmei; Wilbanks, Mitchell S.; Welti, Ruth; Garcia-Reyero, Natalia; Perkins, Edward J.			Analysis of Common and Specific Mechanisms of Liver Function Affected by Nitrotoluene Compounds	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; HEMOGLOBIN ADDUCTS; 2,4,6-TRINITROTOLUENE TNT; PEROXISOME PROLIFERATOR; LIPID-METABOLISM; RETINOIC ACID; RAT-LIVER; PHASE-I; TOXICITY; STRESS	Background: Nitrotoluenes are widely used chemical manufacturing and munitions applications. This group of chemicals has been shown to cause a range of effects from anemia and hypercholesterolemia to testicular atrophy. We have examined the molecular and functional effects of five different, but structurally related, nitrotoluenes on using an integrative systems biology approach to gain insight into common and disparate mechanisms underlying effects caused by these chemicals. Methodology/Principal Findings: Sprague-Dawley female rats were exposed via gavage to one of five concentrations of one of five nitrotoluenes [2,4,6-trinitrotoluene (TNT), 2-amino-4,6-dinitrotoluene (2ADNT) 4-amino-2,6-dinitrotoulene (4ADNT), 2,4-dinitrotoluene (2,4DNT) and 2,6-dinitrotoluene (2,6DNT)] with necropsy and tissue collection at 24 or 48 h. Gene expression profile results correlated well with clinical data and liver histopathology that lead to the concept that hematotoxicity was followed by hepatotoxicity. Overall, 2,4DNT, 2,6DNT and TNT had stronger effects than 2ADNT and 4ADNT. Common functional terms, gene expression patterns, pathways and networks were regulated across all nitrotoluenes. These pathways included NRF2-mediated oxidative stress response, aryl hydrocarbon receptor signaling, LPS/IL-1 mediated inhibition of RXR function, xenobiotic metabolism signaling and metabolism of xenobiotics by cytochrome P450. One biological process common to all compounds, lipid metabolism, was found to be impacted both at the transcriptional and lipid production level. Conclusions/Significance: A systems biology strategy was used to identify biochemical pathways affected by five nitroaromatic compounds and to integrate data that tie biochemical alterations to pathological changes. An integrative graphical network model was constructed by combining genomic, gene pathway, lipidomic, and physiological endpoint results to better understand mechanisms of liver toxicity and physiological endpoints affected by these compounds.	[Deng, Youping] Rush Univ, Dept Internal Med, Ctr Canc, Med Ctr, Chicago, IL 60612 USA; [Meyer, Sharon A.] Univ Louisiana Monroe, Monroe, LA USA; [Guan, Xin] SpecProc Inc, Vicksburg, MS USA; [Escalon, Barbara Lynn; Wilbanks, Mitchell S.; Perkins, Edward J.] USA, Engn Res & Dev Ctr, Vicksburg, MS USA; [Ai, Junmei] Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA; [Welti, Ruth] Kansas State Univ, Div Biol Sci, Manhattan, KS 66506 USA; [Garcia-Reyero, Natalia] Jackson State Univ, Jackson, MS USA	Rush University; University of Louisiana System; University of Louisiana Monroe; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); University of Southern Mississippi; Kansas State University; Jackson State University	Deng, YP (corresponding author), Rush Univ, Dept Internal Med, Ctr Canc, Med Ctr, Chicago, IL 60612 USA.	youping_deng@rush.edu		Welti, Ruth/0000-0003-4373-2538	US Army [W912HZ-05-P-0145]; SpecPro Inc.	US Army(United States Department of DefenseUnited States Army); SpecPro Inc.	This project was supported by US Army Environmental Quality Program (contract #W912HZ-05-P-0145) and SpecPro Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2001, COMP BIOCHEM PHYS B, V129, P703, DOI 10.1016/S1096-4959(01)00389-X; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASHBY J, 1985, ARCH TOXICOL, V58, P14, DOI 10.1007/BF00292610; ASSINK HA, 1984, J CLIN CHEM CLIN BIO, V22, P685; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Beigneux AP, 2003, AM J PHYSIOL-ENDOC M, V284, pE228, DOI 10.1152/ajpendo.00155.2002; BERMUDEZ E, 1979, ENVIRON MUTAGEN, V1, P391, DOI 10.1002/em.2860010412; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; ELLIS HV, 1980, MAMMALIAN TOXICITY M; ELLIS HV, 1978, MAMMALIAN TOXICITY M; Fairbanks VF, 1986, TXB CLIN CHEM, P1532; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Foreman JE, 2009, TOXICOL SCI, V110, P204, DOI 10.1093/toxsci/kfp077; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Glass Konsuela Y, 2005, Int J Environ Res Public Health, V2, P355, DOI 10.3390/ijerph2005020022; Gong PF, 2006, HEPATOLOGY, V43, P144, DOI 10.1002/hep.21004; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091; HALL RL, 2008, PRINCIPLES METHODS T, P1317; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hickey NJ, 2009, TOXICOL SCI, V111, P311, DOI 10.1093/toxsci/kfp160; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Homma-Takeda S, 2002, FREE RADICAL RES, V36, P555, DOI 10.1080/10715760290025933; Honeycutt ME, 1996, ECOTOX ENVIRON SAFE, V35, P282, DOI 10.1006/eesa.1996.0112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins TF, 2006, CHEMOSPHERE, V63, P1280, DOI 10.1016/j.chemosphere.2005.09.066; Johnson MS, 2007, ENVIRON TOXICOL CHEM, V26, P1481, DOI 10.1897/06-525.1; Jones CR, 2005, CARCINOGENESIS, V26, P133, DOI 10.1093/carcin/bgh286; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; KOLLER BH, 1988, J IMMUNOL, V141, P897; LA DK, 1992, ARCH TOXICOL, V66, P633, DOI 10.1007/BF01981502; LA DK, 1992, CHEM-BIOL INTERACT, V83, P121, DOI 10.1016/0009-2797(92)90041-I; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEVINE BS, 1990, FUND APPL TOXICOL, V15, P373, DOI 10.1016/0272-0590(90)90062-O; Luebker DJ, 2002, TOXICOLOGY, V176, P175, DOI 10.1016/S0300-483X(02)00081-1; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Patel AA, 2009, J CLIN GASTROENTEROL, V43, P970, DOI 10.1097/MCG.0b013e3181b57475; Pirooznia M, 2008, BIOINFORMATICS, V24, P2561, DOI 10.1093/bioinformatics/btn441; POPP J A, 1991, P279; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; RAWAT A, 2010, PHYSL GENOMICS; Reddy G, 2000, INT J TOXICOL, V19, P169, DOI 10.1080/10915810050074937; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Rotondi M, 2007, EUR J ENDOCRINOL, V156, P409, DOI 10.1530/EJE-06-0735; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Sabbioni A, 2006, CANCER EPIDEM BIOMAR, V15, P559, DOI 10.1158/1055-9965.EPI-05-0677; Sabbioni G, 2005, CARCINOGENESIS, V26, P1272, DOI 10.1093/carcin/bgi078; Sabbioni G, 1996, J CHROMATOGR B, V682, P243, DOI 10.1016/0378-4347(96)00083-7; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharp P.E., 1998, LAB RAT; Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020; SPANGGORD RJ, 1990, CHEM RES TOXICOL, V3, P551, DOI 10.1021/tx00018a010; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tchounwou PB, 2001, ENVIRON TOXICOL, V16, P209, DOI 10.1002/tox.1026; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N; Vacca LL., 1985, LAB MANUAL HISTOCHEM; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wintz H, 2006, TOXICOL SCI, V94, P71, DOI 10.1093/toxsci/kfl080; Yang XH, 2001, CANCER RES, V61, P348; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	76	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14662	10.1371/journal.pone.0014662	http://dx.doi.org/10.1371/journal.pone.0014662			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346803	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600001
J	Simpson, SD; Radford, AN; Tickle, EJ; Meekan, MG; Jeffs, AG				Simpson, Stephen D.; Radford, Andrew N.; Tickle, Edward J.; Meekan, Mark G.; Jeffs, Andrew G.			Adaptive Avoidance of Reef Noise	PLOS ONE			English	Article							UNDERWATER SOUND; LARVAL FISHES; ORIENTATION; SETTLEMENT; HABITATS; ATTRACTION; AUSTRALIA; PATTERNS; CUE	Auditory information is widely used throughout the animal kingdom in both terrestrial and aquatic environments. Some marine species are dependent on reefs for adult survival and reproduction, and are known to use reef noise to guide orientation towards suitable habitat. Many others that forage in food-rich inshore waters would, however, benefit from avoiding the high density of predators resident on reefs, but nothing is known about whether acoustic cues are used in this context. By analysing a sample of nearly 700,000 crustaceans, caught during experimental playbacks in light traps in the Great Barrier Reef lagoon, we demonstrate an auditory capability in a broad suite of previously neglected taxa, and provide the first evidence in any marine organisms that reef noise can act as a deterrent. In contrast to the larvae of species that require reef habitat for future success, which showed an attraction to broadcasted reef noise, taxa with a pelagic or nocturnally emergent lifestyle actively avoided it. Our results suggest that a far greater range of invertebrate taxa than previously thought can respond to acoustic cues, emphasising yet further the potential negative impact of globally increasing levels of underwater anthropogenic noise.	[Simpson, Stephen D.; Radford, Andrew N.; Tickle, Edward J.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Jeffs, Andrew G.] Univ Auckland, Dept Marine Sci, Auckland 1, New Zealand; [Meekan, Mark G.] UWA Oceans Inst, Australian Inst Marine Sci, Crawley, Australia	University of Bristol; University of Auckland; Australian Institute of Marine Science; University of Western Australia	Simpson, SD (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Stephen.Simpson@bristol.ac.uk	Jeffs, Andrew G/D-9474-2012	Radford, Andrew N/0000-0001-5470-3463; Meekan, Mark/0000-0002-3067-9427; Simpson, Stephen/0000-0002-4856-6164; Jeffs, Andrew/0000-0002-8504-1949	Natural Environment Research Council UK; Biotechnology and Biological Sciences Research Council UK; Australian Institute of Marine Science; Marsden Fund NZ	Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian Institute of Marine Science; Marsden Fund NZ(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by the Natural Environment Research Council UK (SDS), the Biotechnology and Biological Sciences Research Council UK (ANR), the Australian Institute of Marine Science (MGM), and the Marsden Fund NZ (AGJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annese DM, 2005, ENVIRON BIOL FISH, V72, P161, DOI 10.1007/s10641-004-0774-7; Au W.W.L., 2008, PRINCIPLES MARINE BI; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; DOHERTY PJ, 1987, B MAR SCI, V41, P423; HAMNER WM, 1988, B MAR SCI, V42, P459; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; Lovell JM, 2005, COMP BIOCHEM PHYS A, V140, P89, DOI 10.1016/j.cbpb.2004.11.003; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Meekan MG, 2001, MAR BIOL, V139, P373; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; RADFORD CA, 2011, CORAL REEFS IN PRESS; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660	25	63	64	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16625	10.1371/journal.pone.0016625	http://dx.doi.org/10.1371/journal.pone.0016625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326604	Green Published, gold			2022-12-27	WOS:000287037000013
J	Zhang, DG; Jiang, MY; Miao, DS				Zhang, DingGuo; Jiang, MinYue; Miao, DengShun			Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; HEPATIC-FIBROSIS; CLINICAL-TRIALS; SENESCENCE; DIFFERENTIATION; ASSOCIATION; ACTIVATION; EXPRESSION; MORTALITY; PROTEIN	Background: Human amniotic membrane-derived mesenchymal stem cells (hAMCs) have the potential to reduce heart and lung fibrosis, but whether could reduce liver fibrosis remains largely unknown. Methodology/Principal Findings: Hepatic cirrhosis model was established by infusion of CCl4 (1 ml/kg body weight twice a week for 8 weeks) in immunocompetent C57Bl/6J mice. hAMCs, isolated from term delivered placenta, were infused into the spleen at 4 weeks after mice were challenged with CCl4. Control mice received only saline infusion. Animals were sacrificed at 4 weeks post-transplantation. Blood analysis was performed to evaluate alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Histological analysis of the livers for fibrosis, hepatic stellate cells activation, hepatocyte apoptosis, proliferation and senescence were performed. The donor cell engraftment was assessed using immunofluorescence and polymerase chain reaction. The areas of hepatic fibrosis were reduced (6.2%+/- 2.1 vs. control 9.6%+/- 1.7, p<0.05) and liver function parameters (ALT 539.6 +/- 545.1 U/dl, AST 589.7 +/- 342.8 U/dl, vs. control ALT 139.1 +/- 138.3 U/dl, p<0.05 and AST 212.3 +/- 110.7 U/dl, p<0.01) were markedly ameliorated in the hAMCs group compared to control group. The transplantation of hAMCs into liver-fibrotic mice suppressed activation of hepatic stellate cells, decreased hepatocyte apoptosis and promoted liver regeneration. More interesting, hepatocyte senescence was depressed significantly in hAMCs group compared to control group. Immunofluorescence and polymerase chain reaction revealed that hAMCs engraftment into host livers and expressed the hepatocyte-specific markers, human albumin and alpha-fetoproteinran. Conclusions/Significance: The transplantation of hAMCs significantly decreased the fibrosis formation and progression of CCl4-induced cirrhosis, providing a new approach for the treatment of fibrotic liver disease.	[Zhang, DingGuo; Jiang, MinYue; Miao, DengShun] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China	Nanjing Medical University	Zhang, DG (corresponding author), Nanjing Med Univ, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; dingguo, zhang/0000-0003-0041-6180	National Natural Science Foundation of China [81000058, 30830103]; Postdoctoral Science Foundation of China [20100471352]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (Grant No. 81000058 to DGZ, 30830103 to DSM) and the Postdoctoral Science Foundation of China (Grant No. 20100471352 to DGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006226; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Cai J, 2002, HEPATOLOGY, V36, P386, DOI 10.1053/jhep.2002.34614; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436; Chernykh ER, 2007, B EXP BIOL MED+, V144, P640, DOI 10.1007/s10517-007-0393-3; Gao F, 2007, CAN J CARDIOL, V23, P891; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; HUANG YW, 2010, HEPATOLOGY; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241; Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87; Kisseleva T, 2010, CURR OPIN GASTROEN, V26, P395, DOI 10.1097/MOG.0b013e32833a6bec; Lefkowitch JH, 2008, CURR OPIN GASTROEN, V24, P269, DOI 10.1097/MOG.0b013e3282f8e28f; Marcus AJ, 2008, DIFFERENTIATION, V76, P130, DOI 10.1111/j.1432-0436.2007.00194.x; Mohamadnejad M, 2007, WORLD J GASTROENTERO, V13, P3359, DOI 10.3748/wjg.v13.i24.3359; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; Moriya K, 2007, WORLD J GASTROENTERO, V13, P866, DOI 10.3748/wjg.v13.i6.866; Morrison DS, 2006, LANCET, V367, P1899, DOI 10.1016/S0140-6736(06)68836-3; MUHANNA N, 2010, GUT; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; Nieto N, 2005, J BIOL CHEM, V280, P30963, DOI 10.1074/jbc.M503569200; Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; SALAMA H, 2010, CELL TRANSPLANT; Scalera F, 2009, BIOCHEM BIOPH RES CO, V390, P703, DOI 10.1016/j.bbrc.2009.10.033; Silveira MG, 2010, HEPATOLOGY, V52, P349, DOI 10.1002/hep.23637; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tamagawa T, 2007, HUM CELL, V20, P77, DOI 10.1111/j.1749-0774.2007.00032.x; Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9; Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Vizzutti F, 2009, ANN HEPATOL, V8, P89; Watanabe A, 2007, HEPATOLOGY, V46, p870A; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wu J, 1999, Expert Opin Investig Drugs, V8, P585, DOI 10.1517/13543784.8.5.585; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; YOKOI Y, 1988, LIVER, V8, P48; Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248; Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39	48	61	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16789	10.1371/journal.pone.0016789	http://dx.doi.org/10.1371/journal.pone.0016789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326862	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037000021
J	Barone, MV; Zanzi, D; Maglio, M; Nanayakkara, M; Santagata, S; Lania, G; Miele, E; Ribecco, MTS; Maurano, F; Auricchio, R; Gianfrani, C; Ferrini, S; Troncone, R; Auricchio, S				Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Maurano, Francesco; Auricchio, Renata; Gianfrani, Carmen; Ferrini, Silvano; Troncone, Riccardo; Auricchio, Salvatore			Gliadin-Mediated Proliferation and Innate Immune Activation in Celiac Disease Are Due to Alterations in Vesicular Trafficking	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; CELL-DEATH; IL-15; INTERLEUKIN-15; RECEPTOR; CYTOKINE; JUXTACRINE; EXPRESSION; SECRETION; RESPONSES	Background and Objectives: Damage to intestinal mucosa in celiac disease (CD) is mediated both by inflammation due to adaptive and innate immune responses, with IL-15 as a major mediator of the innate immune response, and by proliferation of crypt enterocytes as an early alteration of CD mucosa causing crypts hyperplasia. We have previously shown that gliadin peptide P31-43 induces proliferation of cell lines and celiac enterocytes by delaying degradation of the active epidermal growth factor receptor (EGFR) due to delayed maturation of endocytic vesicles. IL-15 is increased in the intestine of patients affected by CD and has pleiotropic activity that ultimately results in immunoregulatory cross-talk between cells belonging to the innate and adaptive branches of the immune response. Aims of this study were to investigate the role of P31-43 in the induction of cellular proliferation and innate immune activation. Methods/Principal Findings: Cell proliferation was evaluated by bromodeoxyuridine (BrdU) incorporation both in CaCo-2 cells and in biopsies from active CD cases and controls. We used real-time PCR to evaluate IL-15 mRNA levels and FACS as well as ELISA and Western Blot (WB) analysis to measure protein levels and distribution in CaCo-2 cells. Gliadin and P31-43 induce a proliferation of both CaCo-2 cells and CD crypt enterocytes that is dependent on both EGFR and IL-15 activity. In CaCo-2 cells, P31-43 increased IL-15 levels on the cell surface by altering intracellular trafficking. The increased IL-15 protein was bound to IL15 receptor (IL-15R) alpha, did not require new protein synthesis and functioned as a growth factor. Conclusion: In this study, we have shown that P31-43 induces both increase of the trans-presented IL-15/IL5R alpha complex on cell surfaces by altering the trafficking of the vesicular compartments as well as proliferation of crypt enterocytes with consequent remodelling of CD mucosa due to a cooperation of IL-15 and EGFR.	[Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Barone, M. Vittoria; Zanzi, Delia; Maglio, Mariantonia; Nanayakkara, Merlin; Santagata, Sara; Lania, Giuliana; Miele, Erasmo; Ribecco, Maria Teresa Silvia; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Maurano, Francesco; Gianfrani, Carmen] CNR Avellino, Ist Sci Alimentaz, Avellino, Italy; [Ferrini, Silvano] Ist Nazl Ric Canc, Lab Immunol Therapy, I-16132 Genoa, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Genoa; IRCCS AOU San Martino IST	Barone, MV (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	mv.barone@unina.it	santagata, sara/AAA-5225-2020; Maurano, Francesco/H-6487-2013; AURICCHIO, RENATA/AAC-7718-2022	santagata, sara/0000-0001-8680-084X; Maurano, Francesco/0000-0002-6780-8325; Ferrini, Silvano/0000-0001-7254-2616; Ribecco, Maria Teresa Silvia/0000-0003-3278-9221; NANAYAKKARA, MERLIN/0000-0002-2569-4606; BARONE, Maria Vittoria/0000-0001-6190-4917	Regione Campania	Regione Campania(Regione Campania)	This work was supported by funds from Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElela S, 1997, NUCLEIC ACIDS RES, V25, P1788, DOI 10.1093/nar/25.9.1788; Bamford RN, 1996, J LEUKOCYTE BIOL, V59, P476, DOI 10.1002/jlb.59.4.476; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Barzegar C, 1998, ONCOGENE, V16, P2503, DOI 10.1038/sj.onc.1201775; Bernardo D, 2008, CLIN EXP IMMUNOL, V154, P64, DOI 10.1111/j.1365-2249.2008.03743.x; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulfone-Paus S, 2006, BIOESSAYS, V28, P362, DOI 10.1002/bies.20380; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Ebert EC, 2005, IMMUNOLOGY, V115, P118, DOI 10.1111/j.1365-2567.2005.02132.x; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gaggero A, 1999, EUR J IMMUNOL, V29, P1265, DOI 10.1002/(SICI)1521-4141(199904)29:04<1265::AID-IMMU1265>3.0.CO;2-V; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Kinoshita N, 2002, J IMMUNOL, V169, P6187, DOI 10.4049/jimmunol.169.11.6187; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2001, AM J GASTROENTEROL, V96, P150; MARSH MN, 1992, EUR J GASTROEN HEPAT, V4, P667; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Meazza R, 1997, EUR J IMMUNOL, V27, P1049, DOI 10.1002/eji.1830270502; Meazza R, 1996, ONCOGENE, V12, P2187; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; MULDER CJJ, 1993, GUT, V34, P1740, DOI 10.1136/gut.34.12.1740; PAXTON RJ, 2001, CURR PROTOC IMMUNOL, pCH6; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; SCITA G, NATURE, V28, P464; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Yano S, 2003, BIOCHEM BIOPH RES CO, V301, P841, DOI 10.1016/S0006-291X(03)00060-3; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656	41	48	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17039	10.1371/journal.pone.0017039	http://dx.doi.org/10.1371/journal.pone.0017039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364874	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100021
J	Lyons, E; Freeling, M; Kustu, S; Inwood, W				Lyons, Eric; Freeling, Michael; Kustu, Sydney; Inwood, William			Using Genomic Sequencing for Classical Genetics in E. coli K12	PLOS ONE			English	Article							EXTRAGENIC PALINDROMIC SEQUENCES; B STRAINS REL606; ESCHERICHIA-COLI; SALMONELLA; EXPRESSION; K-12; IDENTIFICATION; REARRANGEMENTS; DUPLICATIONS; REPLICATION	We here develop computational methods to facilitate use of 454 whole genome shotgun sequencing to identify mutations in Escherichia coli K12. We had Roche sequence eight related strains derived as spontaneous mutants in a background without a whole genome sequence. They provided difference tables based on assembling each genome to reference strain E. coli MG1655 (NC_000913). Due to the evolutionary distance to MG1655, these contained a large number of both false negatives and positives. By manual analysis of the dataset, we detected all the known mutations (24 at nine locations) and identified and genetically confirmed new mutations necessary and sufficient for the phenotypes we had selected in four strains. We then had Roche assemble contigs de novo, which we further assembled to full-length pseudomolecules based on synteny with MG1655. This hybrid method facilitated detection of insertion mutations and allowed annotation from MG1655. After removing one genome with less than the optimal 20- to 30-fold sequence coverage, we identified 544 putative polymorphisms that included all of the known and selected mutations apart from insertions. Finally, we detected seven new mutations in a total of only 41 candidates by comparing single genomes to composite data for the remaining six and using a ranking system to penalize homopolymer sequencing and misassembly errors. An additional benefit of the analysis is a table of differences between MG1655 and a physiologically robust E. coli wild-type strain NCM3722. Both projects were greatly facilitated by use of comparative genomics tools in the CoGe software package (http://genomevolution.org/).	[Lyons, Eric; Freeling, Michael; Kustu, Sydney; Inwood, William] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lyons, E (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	wbinwood@berkeley.edu		Lyons, Eric/0000-0002-3348-8845	NIH [G738361]; NSF [MCB-0820821]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported by NIH grant G738361 to S. K. and NSF grant MCB-0820821 to M. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beckwith J, 2009, J BIOL CHEM, V284, P12585, DOI 10.1074/jbc.X800017200; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DONCH J, 1968, J BACTERIOL, V95, P1555, DOI 10.1128/JB.95.5.1555-1559.1968; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; HARTMAN PE, 1986, ENVIRON MOL MUTAGEN, V8, P631, DOI 10.1002/em.2860080414; HIGGINS CF, 1988, GENE, V72, P3, DOI 10.1016/0378-1119(88)90122-9; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Hughes D, 2000, GENOME BIOL, V1; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inwood WB, 2009, GENETICS, V183, P1341, DOI 10.1534/genetics.109.109579; Inwood WB, 2009, GENETICS, V183, P1327, DOI 10.1534/genetics.109.103747; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; JIMENEZSANCHEZ A, 1975, MUTAT RES, V28, P337; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; LIN RJ, 1984, J MOL BIOL, V177, P1, DOI 10.1016/0022-2836(84)90054-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; MIESEL L, 1994, GENETICS, V137, P919; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Richter DC, 2007, BIOINFORMATICS, V23, P1573, DOI 10.1093/bioinformatics/btm153; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; SaiSree L, 2001, J BACTERIOL, V183, P6943, DOI 10.1128/JB.183.23.6943-6946.2001; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; STERN MJ, 1984, CELL, V37, P1015, DOI 10.1016/0092-8674(84)90436-7; Studier FW, 2009, J MOL BIOL, V394, P653, DOI 10.1016/j.jmb.2009.09.021; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103	46	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e16717	10.1371/journal.pone.0016717	http://dx.doi.org/10.1371/journal.pone.0016717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364914	Green Published, gold			2022-12-27	WOS:000287764100008
J	Niu, WQ; Qi, Y				Niu, Wenquan; Qi, Yue			Association of alpha-Adducin and G-Protein beta 3 Genetic Polymorphisms with Hypertension: A Meta-Analysis of Chinese Populations	PLOS ONE			English	Article							BLOOD-PRESSURE; I/D POLYMORPHISMS; SALT SENSITIVITY; POINT MUTATIONS; SUBUNIT VARIANT; INCREASES; TRANSPORT; C825T	Background: Mounting evidence has suggested that alpha-adducin and G-protein beta 3 (GNB3) genes are logical candidates for salt-sensitive hypertension. Some, but not all, studies have reported that alpha-adducin G460T and GNB3 C825T polymorphisms may influence the risk of the disease. To comprehensively address this issue, we performed a meta-analysis to evaluate the influence of these two polymorphisms on hypertension and potential biases in Chinese. Methods: Data were analyzed using Stata (v11.0) and random-effects model was applied irrespective of between-studies heterogeneity, which was evaluated via subgroup and meta-regression analyses. Study quality was assessed in duplicate. Publication bias was weighed using Egger's test and funnel plot. Results: 36 study populations totaling 9042 hypertensive patients and 8399 controls were finally identified. Overall, in allelic/genotypic/dominant/recessive models, no significant association was identified for both G460T and C825T polymorphisms (P > 0.05) and there was possible heterogeneity (I-2 > 25%). Subgroup analyses by study design indicated that the magnitude of association in population-based studies was marginally significantly strengthened for alpha-adducin G460T allelic model (OR = 1.12; 95% CI: 1:00-1.25; P = 0.043). Moreover, subgroup analyses by geographic distribution indicated comparison of 825T with 825C yielded a marginally significant increased risk in southern Chinese only (OR = 1.48; 95% CI: 1.01-2.16; P = 0.045). Further meta-regression analyses showed that geographic regions were a significant source of between-study heterogeneity for both polymorphisms. There was a possibility of publication bias for G460T, but not for C825T. Conclusions: Our overall results suggest null association of alpha-adducin G460T and GNB3 C825T polymorphisms with hypertension in Chinese but indicate local marginal significance of C825T, as a putative salt-sensitive switch, in southern Chinese.	[Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Key Lab Vasc Biol,Ruijin Hosp, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hypertens, Sch Med, Shanghai 200030, Peoples R China; [Niu, Wenquan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Vasc Biol, Shanghai, Peoples R China; [Niu, Wenquan] Shanghai Res Inst Hypertens, Shanghai, Peoples R China; [Qi, Yue] Capital Med Univ, Affiliated Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Capital Medical University	Niu, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Key Lab Vasc Biol,Ruijin Hosp, Shanghai 200030, Peoples R China.	niuwenquan@yahoo.cn	Qi, Yue/HGT-8175-2022		Seed Foundation of Development on Science and Technology by President of Capital Medical University Affiliated Beijing Anzhen Hospital [2010Z10]; Shanghai "Chen Guang'' Project [09CG12]; Natural Science Foundation of Shanghai [09ZR1426200]; Ruijin Hospital; Shanghai City; Shanghai Jiaotong University School of Medicine [09XJ21019]; National Science Foundation for Young Scientists of China [30900808]	Seed Foundation of Development on Science and Technology by President of Capital Medical University Affiliated Beijing Anzhen Hospital; Shanghai "Chen Guang'' Project; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Ruijin Hospital; Shanghai City; Shanghai Jiaotong University School of Medicine; National Science Foundation for Young Scientists of China	This work was financially supported by the Seed Foundation of Development on Science and Technology by President of Capital Medical University Affiliated Beijing Anzhen Hospital (2010Z10), the Shanghai "Chen Guang'' Project (09CG12), the Natural Science Foundation of Shanghai (09ZR1426200), two Excellent Young Teachers Programs, one from Ruijin Hospital and the other from Shanghai City, the Science Fund of Shanghai Jiaotong University School of Medicine (09XJ21019), and the National Science Foundation for Young Scientists of China (Grant Number: 30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlassina C, 1997, J HYPERTENS, V15, P1567, DOI 10.1097/00004872-199715120-00057; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Borenstein M, 2009, INTRO META ANAL; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; DiPietro NA, 2010, PHARMACOTHERAPY, V30, P973, DOI 10.1592/phco.30.10.973; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; He X, 2001, CLIN EXP HYPERTENS, V23, P579, DOI 10.1081/CEH-100106828; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang XH, 2003, J MOL MED, V81, P729, DOI 10.1007/s00109-003-0482-3; Ishikawa K, 2000, AM J HYPERTENS, V13, P140, DOI 10.1016/S0895-7061(99)00118-1; Ju ZY, 2003, J HYPERTENS, V21, P1861, DOI 10.1097/00004872-200310000-00013; Katsuya T, 2003, HYPERTENS RES, V26, P521, DOI 10.1291/hypres.26.521; Kedzierska K, 2006, ARCH MED RES, V37, P150, DOI 10.1016/j.arcmed.2005.05.012; Kelly TN, 2009, AM J HYPERTENS, V22, P985, DOI 10.1038/ajh.2009.118; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013057; Manunta P, 2008, HYPERTENSION, V52, P366, DOI 10.1161/HYPERTENSIONAHA.108.113977; Niu WQ, 2010, J HUM HYPERTENS, V24, P467, DOI 10.1038/jhh.2009.88; Pamies-Andreu E, 2003, J HUM HYPERTENS, V17, P187, DOI 10.1038/sj.jhh.1001534; Ruano-Ravina A, 2008, GAC SANIT, V22, P609, DOI 10.1016/S0213-9111(08)75363-9; Ruixing Yin, 2008, Am J Hypertens, V21, P382, DOI 10.1038/ajh.2008.1; SIFFERT W, 1995, J CLIN INVEST, V96, P759, DOI 10.1172/JCI118120; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Stenstrom K, 2009, J HYPERTENS, V27, P2452, DOI 10.1097/HJH.0b013e328330cf15; Sun C, 2009, J HUM HYPERTENS, V23, P578, DOI 10.1038/jhh.2008.168; Torielli L, 2008, AM J PHYSIOL-RENAL, V295, pF478, DOI 10.1152/ajprenal.90226.2008; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Wang X, 2004, J HUM HYPERTENS, V18, P663, DOI 10.1038/sj.jhh.1001700; WILLIAMS RR, 1991, HYPERTENSION, V18, P29, DOI 10.1161/01.HYP.18.3_Suppl.I29; Yu K, 2010, EUR J HUM GENET, V18, P370, DOI 10.1038/ejhg.2009.131; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	31	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17052	10.1371/journal.pone.0017052	http://dx.doi.org/10.1371/journal.pone.0017052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364877	Green Submitted, gold, Green Published			2022-12-27	WOS:000287764100023
J	Pezzementi, L; Nachon, F; Chatonnet, A				Pezzementi, Leo; Nachon, Florian; Chatonnet, Arnaud			Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; COLLAGEN-TAILED FORMS; ACTIVE-SITE; TORPEDO ACETYLCHOLINESTERASE; SUBSTRATE-INHIBITION; MAMMALIAN-CELLS; SKELETAL-MUSCLE; AMINO-ACIDS; IN-VIVO; CHOLINESTERASES	Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are thought to be the result of a gene duplication event early in vertebrate evolution. To learn more about the evolution of these enzymes, we expressed in vitro, characterized, and modeled a recombinant cholinesterase (ChE) from a teleost, the medaka Oryzias latipes. In addition to AChE, O. latipes has a ChE that is different from either vertebrate AChE or BChE, which we are classifying as an atypical BChE, and which may resemble a transitional form between the two. Of the fourteen aromatic amino acids in the catalytic gorge of vertebrate AChE, ten are conserved in the atypical BChE of O. latipes; by contrast, only eight are conserved in vertebrate BChE. Notably, the atypical BChE has one phenylalanine in its acyl pocket, while AChE has two and BChE none. These substitutions could account for the intermediate nature of this atypical BChE. Molecular modeling supports this proposal. The atypical BChE hydrolyzes acetylthiocholine (ATCh) and propionylthiocholine (PTCh) preferentially but butyrylthiocholine (BTCh) to a considerable extent, which is different from the substrate specificity of AChE or BChE. The enzyme shows substrate inhibition with the two smaller substrates but not with the larger substrate BTCh. In comparison, AChE exhibits substrate inhibition, while BChE does not, but may instead show substrate activation. The atypical BChE from O. latipes also shows a mixed pattern of inhibition. It is effectively inhibited by physostigmine, typical of all ChEs. However, although the atypical BChE is efficiently inhibited by the BChE-specific inhibitor ethopropazine, it is not by another BChE inhibitor, iso-OMPA, nor by the AChE-specific inhibitor BW284c51. The atypical BChE is found as a glycophosphatidylinositol-anchored (GPI-anchored) amphiphilic dimer (G(2)(a)), which is unusual for any BChE. We classify the enzyme as an atypical BChE and discuss its implications for the evolution of AChE and BChE and for ecotoxicology.	[Pezzementi, Leo] Birmingham So Coll, Dept Biol, Birmingham, AL 35254 USA; [Nachon, Florian] Inst Rech Biomed Armees, Dept Toxicol, La Tronche, France; [Chatonnet, Arnaud] INRA, Unite Mixte Rech 866, F-34060 Montpellier, France; [Chatonnet, Arnaud] Univ Montpellier I, Montpellier, France; [Chatonnet, Arnaud] Univ Montpellier 2, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Pezzementi, L (corresponding author), Birmingham So Coll, Dept Biol, Birmingham, AL 35254 USA.	lpezzeme@bsc.edu; chatonne@ensam.inra.fr	Chatonnet, Arnaud/E-2190-2017; Chatonnet, Arnaud/AAM-5569-2021	Chatonnet, Arnaud/0000-0002-4057-3896; 	National Institutes of Heath [R15 GM072510-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM072510] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Institutes of Heath (http://www.nih.gov/) Academic Research Enhancement Award R15 GM072510-01 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to the authors and are not necessarily the official views of the funders.	Altamirano CV, 1999, CHEM-BIOL INTERACT, V119, P53, DOI 10.1016/S0009-2797(99)00013-7; Ariel N, 1998, BIOCHEM J, V335, P95, DOI 10.1042/bj3350095; AUSTIN L, 1953, BIOCHEM J, V54, P695, DOI 10.1042/bj0540695; Barak D, 2002, BIOCHEMISTRY-US, V41, P8245, DOI 10.1021/bi020143t; BARAK D, 1994, J BIOL CHEM, V269, P6296; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bosco K. H., 2008, BMC STRUCT BIOL, V8, P49; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Chuiko GM, 2005, CHEM-BIOL INTERACT, V157, P365, DOI 10.1016/j.cbi.2005.10.053; Chuiko GM, 2003, COMP BIOCHEM PHYS B, V135, P55, DOI 10.1016/S1096-4959(03)00048-4; Chuiko GM, 2000, COMP BIOCHEM PHYS C, V127, P233, DOI 10.1016/S0742-8413(00)00150-X; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; DAVIES RO, 1960, CAN J BIOCHEM PHYS, V38, P545; Delano W.L, 2002, PYMOL USERS MANUAL; DOCTOR BP, 1987, ANAL BIOCHEM, V166, P399, DOI 10.1016/0003-2697(87)90590-2; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; El-Alfy A, 1998, TOXICOL APPL PHARM, V152, P175, DOI 10.1006/taap.1998.8479; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FLUCK RA, 1982, COMP BIOCHEM PHYS C, V72, P59, DOI 10.1016/0306-4492(82)90205-2; Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020&lt;0037:AIIEFA&gt;2.0.CO;2, 10.1002/etc.5620200104]; FUTERMAN AH, 1985, J NEUROCHEM, V45, P1487, DOI 10.1111/j.1471-4159.1985.tb07217.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBNEY G, 1990, J BIOL CHEM, V265, P12576; GINDI T, 1979, J EMBRYOL EXP MORPH, V51, P209; GNATT A, 1994, J NEUROCHEM, V62, P749; HAREL M, 1992, P NATL ACAD SCI USA, V89, P10827, DOI 10.1073/pnas.89.22.10827; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOLLAND PWH, 1994, DEVELOPMENT, P125; INESTROSA NC, 1988, NEUROSCI LETT, V90, P186, DOI 10.1016/0304-3940(88)90809-9; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; JBILO O, 1994, TOXICON, V32, P1445, DOI 10.1016/0041-0101(94)90416-2; Kaplan D, 2001, BIOCHEMISTRY-US, V40, P7433, DOI 10.1021/bi010181x; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KASHIWAGI K, EXP ANIM, V59, P395; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; LAPPIN RI, 1985, DEV BIOL, V110, P269, DOI 10.1016/0012-1606(85)90086-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; LEIBEL WS, 1988, J EXP ZOOL, V247, P209, DOI 10.1002/jez.1402470304; LEIBEL WS, 1988, J EXP ZOOL, V247, P198, DOI 10.1002/jez.1402470303; LEVY D, 1986, BIOCHEM PHARMACOL, V35, P1079, DOI 10.1016/0006-2952(86)90142-5; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; LI Y, 1993, J BIOL CHEM, V268, P5790; Liu MY, 2004, TRENDS GENET, V20, P399, DOI 10.1016/j.tig.2004.06.013; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; LoewensteinLichtenstein Y, 1996, MOL PHARMACOL, V50, P1423; LUNDIN SJ, 1968, ACTA CHEM SCAND, V22, P2183, DOI 10.3891/acta.chem.scand.22-2183; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; Massiah MA, 2001, BIOCHEMISTRY-US, V40, P5682, DOI 10.1021/bi010243j; Masson P, 1996, EUR J BIOCHEM, V235, P36, DOI 10.1111/j.1432-1033.1996.00036.x; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MIKALSEN A, 1986, COMP BIOCHEM PHYS C, V83, P447, DOI 10.1016/0742-8413(86)90152-0; MORALEV SN, 2007, COMP ENZYMOLOGY CHOL, P484; MOYA MA, 1991, COMP BIOCHEM PHYS C, V98, P299, DOI 10.1016/0742-8413(91)90209-C; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Nillos MG, 2007, ENVIRON TOXICOL CHEM, V26, P1949, DOI 10.1897/07-001R.1; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Ordentlich A, 1996, J BIOL CHEM, V271, P11953, DOI 10.1074/jbc.271.20.11953; ORDENTLICH A, 1995, J BIOL CHEM, V270, P2082, DOI 10.1074/jbc.270.5.2082; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Pezzementi L, 2003, COMP BIOCHEM PHYS B, V136, P813, DOI 10.1016/S1096-4959(03)00259-8; PEZZEMENTI L, 1987, J NEUROCHEM, V48, P1753, DOI 10.1111/j.1471-4159.1987.tb05733.x; Pezzementi L, 2010, CHEM-BIOL INTERACT, V187, P27, DOI 10.1016/j.cbi.2010.03.043; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; Rosenberry TL, 1999, CHEM-BIOL INTERACT, V119, P85, DOI 10.1016/S0009-2797(99)00017-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders M, 1996, COMP BIOCHEM PHYS B, V115, P97, DOI 10.1016/0305-0491(96)00088-0; Saxena A, 1997, BIOCHEMISTRY-US, V36, P14642, DOI 10.1021/bi971425+; Schmidt EE, 2007, BIOESSAYS, V29, P262, DOI 10.1002/bies.20546; Scholz NL, 2006, ENVIRON TOXICOL CHEM, V25, P1185, DOI 10.1897/05-699.1; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; Shapira M, 1998, TOXICOL LETT, V103, P205, DOI 10.1016/S0378-4274(98)00308-7; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Silver A., 1974, BIOL CHOLINESTERASES; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; STIEGER S, 1989, EUR J BIOCHEM, V181, P633, DOI 10.1111/j.1432-1033.1989.tb14770.x; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Sutherland D, 1997, J EXP ZOOL, V277, P213, DOI 10.1002/(SICI)1097-010X(19970215)277:3<213::AID-JEZ3>3.0.CO;2-R; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; TOUTANT JP, 1985, J NEUROCHEM, V44, P580, DOI 10.1111/j.1471-4159.1985.tb05452.x; Ucar G, 2005, NEUROSCI LETT, V382, P327, DOI 10.1016/j.neulet.2005.03.028; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Walker C.H., 1991, Chemicals in Agriculture, V2, P1; Wheelock CE, 2005, AQUAT TOXICOL, V74, P172, DOI 10.1016/j.aquatox.2005.05.009; Whittaker VP, 2010, CHEM-BIOL INTERACT, V187, P23, DOI 10.1016/j.cbi.2010.02.041; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	104	47	47	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17396	10.1371/journal.pone.0017396	http://dx.doi.org/10.1371/journal.pone.0017396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364766	Green Published, gold			2022-12-27	WOS:000287764100052
J	Song, M; Du, HJ; Wu, N; Hou, B; Wu, GC; Wang, JA; Feng, H; Jiang, TZ				Song, Ming; Du, Hanjian; Wu, Nan; Hou, Bing; Wu, Guocai; Wang, Jian; Feng, Hua; Jiang, Tianzi			Impaired Resting-State Functional Integrations within Default Mode Network of Generalized Tonic-Clonic Seizures Epilepsy	PLOS ONE			English	Article							BRAIN; CONNECTIVITY; ARCHITECTURE; DISCHARGES; FMRI	Generalized tonic-clonic seizures (GTCS) are characterized by unresponsiveness and convulsions, which cause complete loss of consciousness. Many recent studies have found that the ictal alterations in brain activity of the GTCS epilepsy patients are focally involved in some brain regions, including thalamus, upper brainstem, medial prefrontal cortex, posterior midbrain regions, and lateral parietal cortex. Notably, many of these affected brain regions are the same and overlap considerably with the components of the so-called default mode network (DMN). Here, we hypothesize that the brain activity of the DMN of the GTCS epilepsy patients are different from normal controls, even in the resting state. To test this hypothesis, we compared the DMN of the GTCS epilepsy patients and the controls using the resting state functional magnetic resonance imaging. Thirteen brain areas in the DMN were extracted, and a complete undirected weighted graph was used to model the DMN for each participant. When directly comparing the edges of the graph, we found significant decreased functional connectivities within the DMN of the GTCS epilepsy patients comparing to the controls. As for the nodes of the graph, we found that the degree of some brain areas within the DMN was significantly reduced in the GTCS epilepsy patients, including the anterior medial prefrontal cortex, the bilateral superior frontal cortex, and the posterior cingulate cortex. Then we investigated into possible mechanisms of how GTCS epilepsy could cause the reduction of the functional integrations of DMN. We suggested the damaged functional integrations of the DMN in the GTCS epilepsy patients even during the resting state, which could help to understand the neural correlations of the impaired consciousness of GTCS epilepsy patients.	[Song, Ming; Hou, Bing; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Du, Hanjian; Wu, Nan; Wu, Guocai; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; Army Medical University; Army Medical University	Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	fenghua8888@yahoo.com.cn; jiangtz@nlpr.ia.ac.cn	wang, jian/GVS-0711-2022; Hou, Bing/B-6241-2011; Feng, Hua/AAX-4121-2021; Jiang, Tianzi/I-4256-2012	Hou, Bing/0000-0002-4268-8144; Feng, Hua/0000-0003-4489-9217; Jiang, Tianzi/0000-0001-9531-291X; Du, Hanjian/0000-0002-2353-8802	National Key Basic Research and Development Program (973) [2011CB707800]; Natural Science Foundation of China [30730035, 30872660]; NSFC [60723005]; China Postdoctoral Science Foundation [20100470614]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was partially supported by the National Key Basic Research and Development Program (973) (Grant No. 2011CB707800 to TJ); the Natural Science Foundation of China (Grant No. 30730035 to TJ and Grant No. 30872660 to HF, HD, NW, GW, JW); the Excellent State Key Laboratory Project of NSFC (Grant No. 60723005 to MS); China Postdoctoral Science Foundation (Grant No. 20100470614 to BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2009, NAT REV NEUROL, V5, P267, DOI 10.1038/nrneurol.2009.38; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Elger CE, 1998, NEUROPSYCHOBIOLOGY, V38, P145, DOI 10.1159/000026530; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Li QF, 2009, EPILEPSY RES, V87, P160, DOI 10.1016/j.eplepsyres.2009.08.018; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Song M, 2009, IEEE T AUTON MENT DE, V1, P101, DOI 10.1109/TAMD.2009.2029312; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042	37	53	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17294	10.1371/journal.pone.0017294	http://dx.doi.org/10.1371/journal.pone.0017294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364890	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100041
J	Mair, N; Benetti, C; Andratsch, M; Leitner, MG; Constantin, CE; Camprubi-Robles, M; Quarta, S; Biasio, W; Kuner, R; Gibbins, IL; Kress, M; Haberberger, RV				Mair, Norbert; Benetti, Camilla; Andratsch, Manfred; Leitner, Michael G.; Constantin, Cristina E.; Camprubi-Robles, Maria; Quarta, Serena; Biasio, Wolfgang; Kuner, Rohini; Gibbins, Ian L.; Kress, Michaela; Haberberger, Rainer V.			Genetic Evidence for Involvement of Neuronally Expressed S1P(1) Receptor in Nociceptor Sensitization and Inflammatory Pain	PLOS ONE			English	Article							RAT SENSORY NEURONS; PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; RHEUMATOID-ARTHRITIS; VASCULAR MATURATION; NEUROTROPHIC FACTOR; SPHINGOSINE-1-PHOSPHATE; CELLS; KINASE; ROLES	Sphingosine-1-phosphate (S1P) is a key regulator of immune response. Immune cells, epithelia and blood cells generate high levels of S1P in inflamed tissue. However, it is not known if S1P acts on the endings of nociceptive neurons, thereby contributing to the generation of inflammatory pain. We found that the S1P(1) receptor for S1P is expressed in subpopulations of sensory neurons including nociceptors. Both S1P and agonists at the S1P(1) receptor induced hypersensitivity to noxious thermal stimulation in vitro and in vivo. S1P-induced hypersensitivity was strongly attenuated in mice lacking TRPV1 channels. S1P and inflammation-induced hypersensitivity was significantly reduced in mice with a conditional nociceptor-specific deletion of the S1P(1) receptor. Our data show that neuronally expressed S1P(1) receptors play a significant role in regulating nociceptor function and that S1P/S1P(1) signaling may be a key player in the onset of thermal hypersensitivity and hyperalgesia associated with inflammation.	[Mair, Norbert; Benetti, Camilla; Andratsch, Manfred; Leitner, Michael G.; Constantin, Cristina E.; Camprubi-Robles, Maria; Quarta, Serena; Biasio, Wolfgang; Kress, Michaela] Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Innsbruck, Austria; [Kuner, Rohini] Univ Heidelberg, Dept Pharmacol, D-6900 Heidelberg, Germany; [Gibbins, Ian L.; Haberberger, Rainer V.] Flinders Univ S Australia, Flinders Med Sci & Technol, Ctr Neurosci, Adelaide, SA 5001, Australia	Medical University of Innsbruck; Ruprecht Karls University Heidelberg; Flinders University South Australia	Mair, N (corresponding author), Innsbruck Med Univ, Div Physiol, Dept Physiol & Med Phys, Innsbruck, Austria.	norbert.mair@i-med.ac.at	Leitner, Michael/N-8793-2019; Kuner, Rohini/AGU-0204-2022; Leitner, Michael G./D-7887-2014; Quarta, Serena/H-1037-2011	Leitner, Michael/0000-0002-3259-6481; Leitner, Michael G./0000-0002-3259-6481; Kress, Michaela/0000-0002-8921-7470; Haberberger, Rainer Viktor/0000-0001-8043-3786	Austrian Research Funding Agency FWF [P205620]; Australian National Health and Medical Research Council [535055]; International Association for the Study of Pain (IASP)	Austrian Research Funding Agency FWF(Austrian Science Fund (FWF)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); International Association for the Study of Pain (IASP)	This work was supported by the Austrian Research Funding Agency FWF (grant P205620 to M.K.), the Australian National Health and Medical Research Council (project grant 535055), and the International Association for the Study of Pain (IASP)(collaborative research grant to MK and RVH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Deng QL, 2007, MOL PHARMACOL, V71, P724, DOI 10.1124/mol.106.029223; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Dittert I, 1998, J NEUROSCI METH, V82, P195, DOI 10.1016/S0165-0270(98)00051-X; FORSTER C, 1990, J NEUROSCI METH, V31, P109, DOI 10.1016/0165-0270(90)90155-9; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Hagen KB, 1997, J RHEUMATOL, V24, P1703; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; LE SH, 2004, J CELL BIOCHEM, V92, P882; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Meng H, 2009, DEV DYNAM, V238, P487, DOI 10.1002/dvdy.21852; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, FASEB J, V16, P1497, DOI 10.1096/fj.02-0101com; Ohkawa R, 2008, ANN CLIN BIOCHEM, V45, P356, DOI 10.1258/acb.2007.007189; Park KA, 2005, TRENDS PHARMACOL SCI, V26, P571, DOI 10.1016/j.tips.2005.09.010; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Saravanan Vadivelu, 2002, Expert Opin Pharmacother, V3, P845; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Siehler S, 2002, BBA-MOL CELL BIOL L, V1582, P94, DOI 10.1016/S1388-1981(02)00142-7; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tsunemi S, 2010, CLIN IMMUNOL, V136, P197, DOI 10.1016/j.clim.2010.03.428; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	63	56	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17268	10.1371/journal.pone.0017268	http://dx.doi.org/10.1371/journal.pone.0017268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359147	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300043
J	Tan, T; Tang, XH; Zhang, J; Niu, YY; Chen, HW; Li, B; Wei, QA; Ji, WZ				Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi			Generation of Trophoblast Stem Cells from Rabbit Embryonic Stem Cells with BMP4	PLOS ONE			English	Article							PLACENTAL DEVELOPMENT; UTERINE EPITHELIUM; MOUSE EMBRYOS; IN-VITRO; TROPHECTODERM DIFFERENTIATION; CYTOTROPHOBLAST CELLS; GIANT-CELLS; IMPLANTATION; PROLIFERATION; EXPRESSION	Trophoblast stem (TS) cells are ideal models to investigate trophectoderm differentiation and placental development. Herein, we describe the derivation of rabbit trophoblast stem cells from embryonic stem (ES) cells. Rabbit ES cells generated in our laboratory were induced to differentiate in the presence of BMP4 and TS-like cell colonies were isolated and expanded. These cells expressed the molecular markers of mouse TS cells, were able to invade, give rise to derivatives of TS cells, and chimerize placental tissues when injected into blastocysts. The rabbit TS-like cells maintained self-renewal in culture medium with serum but without growth factors or feeder cells, whilst their proliferation and identity were compromised by inhibitors of FGFs and TGF-beta receptors. Taken together, our study demonstrated the derivation of rabbit TS cells and suggested the essential roles of FGF and TGF-beta signalings in maintenance of rabbit TS cell self-renewal.	[Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Tan, Tao; Zhang, Jing; Chen, Hongwei; Li, Bin; Wei, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tan, Tao; Tang, Xianghui; Zhang, Jing; Niu, Yuyu; Chen, Hongwei; Li, Bin; Wei, Qiang; Ji, Weizhi] Yunnan Key Lab Anim Reprod Biol, Kunming, Yunnan, Peoples R China; [Ji, Weizhi] Kunming Biomed Int, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tan, T (corresponding author), Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	wji@mail.kiz.ac.cn		Chen, Hongwei/0000-0002-9400-6053; tan, tao/0000-0002-7589-602X; Ji, Weizhi/0000-0003-2550-4224	Major State Research Development Program [2006CB701505, 2007CB947701]; National Basic Research Program [2006AA02A116]; Chinese Academy of Sciences [KSCX2-YW-R-47]; Chinese National Science Foundation [30570906, 30700159]	Major State Research Development Program; National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Major State Research Development Program 2006CB701505, 2007CB947701; National Basic Research Program 2006AA02A116; Chinese Academy of Sciences KSCX2-YW-R-47; and Chinese National Science Foundation 30570906 and 30700159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2009, MOL CELL BIOL, V29, P2748, DOI 10.1128/MCB.01391-08; Chuykin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009794; Denker H W, 1977, Adv Anat Embryol Cell Biol, V53, P3; Douglas GC, 2009, ENDOCR REV, V30, P228, DOI 10.1210/er.2009-0001; ENDERS AC, 1971, AM J ANAT, V132, P219, DOI 10.1002/aja.1001320208; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Grigor'eva EV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007161; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hemberger M, 2004, DEV BIOL, V271, P362, DOI 10.1016/j.ydbio.2004.03.040; Hoffman LH, 1998, ENDOCRINOLOGY, V139, P266, DOI 10.1210/en.139.1.266; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; LEE VH, 1995, BIOL REPROD, V52, P868, DOI 10.1095/biolreprod52.4.868; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Reyes A, 2000, MOL BIOL EVOL, V17, P979, DOI 10.1093/oxfordjournals.molbev.a026379; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; Wang Y, 2006, MOL HUM REPROD, V12, P451, DOI 10.1093/molehr/gal054; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WINTERHAGER E, 1994, ANAT EMBRYOL, V189, P71; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761	38	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17124	10.1371/journal.pone.0017124	http://dx.doi.org/10.1371/journal.pone.0017124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359200	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300031
J	Jennes, W; Verheyden, S; Demanet, C; Menten, J; Vuylsteke, B; Nkengasong, JN; Kestens, L				Jennes, Wim; Verheyden, Sonja; Demanet, Christian; Menten, Joris; Vuylsteke, Bea; Nkengasong, John N.; Kestens, Luc			Low CD4+T Cell Counts among African HIV-1 Infected Subjects with Group B KIR Haplotypes in the Absence of Specific Inhibitory KIR Ligands	PLOS ONE			English	Article							MHC CLASS-I; NATURAL-KILLER-CELLS; VIRUS TYPE-1 INFECTION; HLA CLASS-I; EXPOSED UNINFECTED INDIVIDUALS; IMMUNOGLOBULIN-LIKE RECEPTORS; HIV-1 INFECTION; NK CELLS; CUTTING EDGE; DISEASE PROGRESSION	Natural killer (NK) cells are regulated by interactions between polymorphic killer immunoglobulin-like receptors (KIR) and human leukocyte antigens (HLA). Genotypic combinations of KIR3DS1/L1 and HLA Bw4-80I were previously shown to influence HIV-1 disease progression, however other KIR genes have not been well studied. In this study, we analyzed the influence of all activating and inhibitory KIR, in association with the known HLA inhibitory KIR ligands, on markers of disease progression in a West African population of therapy-naive HIV-1 infected subjects. We observed a significant association between carriage of a group B KIR haplotype and lower CD4+ T cell counts, with an additional effect for KIR3DS1 within the frame of this haplotype. In contrast, we found that individuals carrying genes for the inhibitory KIR ligands HLA-Bw4 as well as HLA-C1 showed significantly higher CD4+ T cell counts. These associations were independent from the viral load and from individual HIV-1 protective HLA alleles. Our data suggest that group B KIR haplotypes and lack of specific inhibitory KIR ligand genes, genotypes considered to favor NK cell activation, are predictive of HIV-1 disease progression.	[Jennes, Wim; Vuylsteke, Bea; Kestens, Luc] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Verheyden, Sonja; Demanet, Christian] Univ Ziekenhuis Brussel, HLA, Brussels, Belgium; [Verheyden, Sonja; Demanet, Christian] Univ Ziekenhuis Brussel, Mol Hematol Lab, Brussels, Belgium; [Menten, Joris] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Vuylsteke, Bea; Nkengasong, John N.] Projet RETRO CI, Abidjan, Cote Ivoire; [Nkengasong, John N.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	Institute of Tropical Medicine (ITM); University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Jennes, W (corresponding author), Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium.	wjennes@itg.be	Jennes, Wim/M-2523-2013	Jennes, Wim/0000-0002-3125-6389	Belgian Fund for Scientific Research (FWO-Vlaanderen) [G.0660.06]	Belgian Fund for Scientific Research (FWO-Vlaanderen)(FWO)	This work was supported by the Belgian Fund for Scientific Research (FWO-Vlaanderen), grant number G.0660.06. Website: www.fwo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Flores-Villanueva PO, 2003, J IMMUNOL, V170, P1925, DOI 10.4049/jimmunol.170.4.1925; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Korbel DS, 2009, J IMMUNOL, V182, P6426, DOI 10.4049/jimmunol.0804224; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lazaryan A, 2006, J VIROL, V80, P6056, DOI 10.1128/JVI.02119-05; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Marsh SGE, 2003, HUM IMMUNOL, V64, P648, DOI 10.1016/S0198-8859(03)00067-3; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moesta AK, 2010, J IMMUNOL, V185, P4233, DOI 10.4049/jimmunol.1001951; MORETTA A, 1993, J EXP MED, V178, P597, DOI 10.1084/jem.178.2.597; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Nelson GW, 2004, J IMMUNOL, V173, P4273, DOI 10.4049/jimmunol.173.7.4273; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; R Core Team, 2018, R LANG ENV STAT COMP; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Verheyden S, 2004, LEUKEMIA, V18, P2002, DOI 10.1038/sj.leu.2403525; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Ward Jeffrey, 2008, Curr HIV/AIDS Rep, V5, P44, DOI 10.1007/s11904-008-0008-2	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17043	10.1371/journal.pone.0017043	http://dx.doi.org/10.1371/journal.pone.0017043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347267	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600033
J	Plasencia, I; Survery, S; Ibragimova, S; Hansen, JS; Kjellbom, P; Helix-Nielsen, C; Johanson, U; Mouritsen, OG				Plasencia, Ines; Survery, Sabeen; Ibragimova, Sania; Hansen, Jesper S.; Kjellbom, Per; Helix-Nielsen, Claus; Johanson, Urban; Mouritsen, Ole G.			Structure and Stability of the Spinach Aquaporin SoPIP2;1 in Detergent Micelles and Lipid Membranes	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; WATER CHANNEL PROTEIN; LENS FIBER MEMBRANES; ESCHERICHIA-COLI; MIP FAMILY; GLYCEROL FACILITATOR; ELECTRON-MICROSCOPY; SECONDARY STRUCTURE; BILAYER MEMBRANES; FREEZE-FRACTURE	Background: SoPIP2;1 constitutes one of the major integral proteins in spinach leaf plasma membranes and belongs to the aquaporin family. SoPIP2;1 is a highly permeable and selective water channel that has been successfully overexpressed and purified with high yields. In order to optimize reconstitution of the purified protein into biomimetic systems, we have here for the first time characterized the structural stability of SoPIP2;1. Methodology/Principal Finding: We have characterized the protein structural stability after purification and after reconstitution into detergent micelles and proteoliposomes using circular dichroism and fluorescence spectroscopy techniques. The structure of SoPIP2;1 was analyzed either with the protein solubilized with octyl-beta-D-glucopyranoside (OG) or reconstituted into lipid membranes formed by E. coli lipids, diphytanoylphosphatidylcholine (DPhPC), or reconstituted into lipid membranes formed from mixtures of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPE), 1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE), 1-palmitoyl-2-oleoyl-phosphatidylserine (POPS), and ergosterol. Generally, SoPIP2;1 secondary structure was found to be predominantly a-helical in accordance with crystallographic data. The protein has a high thermal structural stability in detergent solutions, with an irreversible thermal unfolding occurring at a melting temperature of 58 degrees C. Incorporation of the protein into lipid membranes increases the structural stability as evidenced by an increased melting temperature of up to 70 degrees C. Conclusion/Significance: The results of this study provide insights into SoPIP2;1 stability in various host membranes and suggest suitable choices of detergent and lipid composition for reconstitution of SoPIP2;1 into biomimetic membranes for biotechnological applications.	[Plasencia, Ines; Mouritsen, Ole G.] Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Survery, Sabeen; Kjellbom, Per; Johanson, Urban] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Ibragimova, Sania; Helix-Nielsen, Claus] Tech Univ Denmark, DTU Phys, DK-2800 Lyngby, Denmark; [Hansen, Jesper S.] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Ibragimova, Sania; Hansen, Jesper S.; Helix-Nielsen, Claus] Aquaporin AS, Copenhagen, Denmark	University of Southern Denmark; Lund University; Technical University of Denmark; Technical University of Denmark	Plasencia, I (corresponding author), Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	miplsen@memphys.sdu.dk	Helix-Nielsen, Claus/A-5979-2011; Johanson, Urban/D-4344-2015; Hélix-Nielsen, Claus/N-1054-2019; Johanson, Urban/AHE-8231-2022	Johanson, Urban/0000-0001-8862-128X; Hélix-Nielsen, Claus/0000-0002-9392-7133; Johanson, Urban/0000-0001-8862-128X; Survery, Sabeen/0000-0001-6740-5430; Mouritsen, Ole G./0000-0002-4258-8960; Hansen, Jesper Soendergaard/0000-0003-1638-1285	Sixth European Research Framework Programme [NMP4-CT-2006-033234]; Danish National Advanced Technology Foundation (Industrial biomimetic water membranes) [023-2007-1]; Danish National Research Foundation; Formas and the Swedish Research Council (VR)	Sixth European Research Framework Programme; Danish National Advanced Technology Foundation (Industrial biomimetic water membranes); Danish National Research Foundation(Danmarks Grundforskningsfond); Formas and the Swedish Research Council (VR)(Swedish Research Council)	This study has been undertaken in the MEMBAQ project ( Incorporation of Aquaporins in Membranes for Industrial Applications) supported by the Sixth European Research Framework Programme under contract [NMP4-CT-2006-033234] and the Danish National Advanced Technology Foundation (Industrial biomimetic water membranes) under contract [023-2007-1]. MEMPHYS-Center for Biomembrane Physics is supported by the Danish National Research Foundation. Financial support was also provided by Formas and the Swedish Research Council (VR). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AERTS T, 1990, J BIOL CHEM, V265, P8675; Baba T, 1999, BBA-BIOMEMBRANES, V1421, P91, DOI 10.1016/S0005-2736(99)00114-5; BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Engel A, 2002, INT REV CYTOL, V215, P75; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Fraysse LC, 2005, BIOL CELL, V97, P519, DOI 10.1042/BC20040122; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Gaspar M, 2003, PLANT SCI, V165, P21, DOI 10.1016/S0168-9452(03)00117-1; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JANKO K, 1977, BIOCHIM BIOPHYS ACTA, V470, P8, DOI 10.1016/0005-2736(77)90057-8; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Konig N, 1997, J MOL BIOL, V265, P590, DOI 10.1006/jmbi.1996.0763; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSEY H, 1979, BIOCHIM BIOPHYS ACTA, V555, P147, DOI 10.1016/0005-2736(79)90079-8; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nielsen CH, 2009, ANAL BIOANAL CHEM, V395, P697, DOI 10.1007/s00216-009-2960-0; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1994, J BIOL CHEM, V269, P1668; RAND RP, 1986, ANNU REV PHYSIOL, V48, P201; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sehgal P, 2005, BBA-BIOMEMBRANES, V1716, P59, DOI 10.1016/j.bbamem.2005.08.006; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Woodbury D J, 1999, Methods Enzymol, V294, P319; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	50	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14674	10.1371/journal.pone.0014674	http://dx.doi.org/10.1371/journal.pone.0014674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339815	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600005
J	Ummanni, R; Mundt, F; Pospisil, H; Venz, S; Scharf, C; Barett, C; Falth, M; Kollermann, J; Walther, R; Schlomm, T; Sauter, G; Bokemeyer, C; Sultmann, H; Schuppert, A; Brummendorf, TH; Balabanov, S				Ummanni, Ramesh; Mundt, Frederike; Pospisil, Heike; Venz, Simone; Scharf, Christian; Barett, Christine; Faelth, Maria; Koellermann, Jens; Walther, Reinhard; Schlomm, Thorsten; Sauter, Guido; Bokemeyer, Carsten; Sueltmann, Holger; Schuppert, A.; Bruemmendorf, Tim H.; Balabanov, Stefan			Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ANDROGEN RECEPTOR; ARGINASE-II; EXPRESSION; PEROXIREDOXINS; PROGRESSION; BIOMARKERS; PROGNOSIS; STATISTICS; PRINCIPLE	Prostate cancer (PCa) is the most common type of cancer found in men and among the leading causes of cancer death in the western world. In the present study, we compared the individual protein expression patterns from histologically characterized PCa and the surrounding benign tissue obtained by manual micro dissection using highly sensitive two-dimensional differential gel electrophoresis (2D-DIGE) coupled with mass spectrometry. Proteomic data revealed 118 protein spots to be differentially expressed in cancer (n = 24) compared to benign (n = 21) prostate tissue. These spots were analysed by MALDI-TOF-MS/MS and 79 different proteins were identified. Using principal component analysis we could clearly separate tumor and normal tissue and two distinct tumor groups based on the protein expression pattern. By using a systems biology approach, we could map many of these proteins both into major pathways involved in PCa progression as well as into a group of potential diagnostic and/or prognostic markers. Due to complexity of the highly interconnected shortest pathway network, the functional sub networks revealed some of the potential candidate biomarker proteins for further validation. By using a systems biology approach, our study revealed novel proteins and molecular networks with altered expression in PCa. Further functional validation of individual proteins is ongoing and might provide new insights in PCa progression potentially leading to the design of novel diagnostic and therapeutic strategies.	[Ummanni, Ramesh; Mundt, Frederike; Barett, Christine; Bokemeyer, Carsten; Bruemmendorf, Tim H.; Balabanov, Stefan] Univ Hosp Eppendorf, Hubertus Wald Tumor Zentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Venz, Simone; Walther, Reinhard] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Greifswald, Germany; [Venz, Simone; Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Interfacultary Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Ernst Moritz Arndt Univ Greifswald, Dept Otorhinolaryngol Head & Neck Surg, Greifswald, Germany; [Faelth, Maria; Sueltmann, Holger] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Koellermann, Jens; Sauter, Guido] Univ Hosp Eppendorf, Dept Pathol, Hamburg, Germany; [Schlomm, Thorsten] Univ Hosp Eppendorf, Prostate Canc Ctr, Hamburg, Germany; Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, Med Klin Hamatol & Onkol 4, Aachen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Applied Sciences Wildau; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; RWTH Aachen University; RWTH Aachen University	Ummanni, R (corresponding author), Univ Hosp Eppendorf, Hubertus Wald Tumor Zentrum, Dept Oncol Haematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany.	s.balabanov@uke.uni-hamburg.de	Sültmann, Holger/E-4534-2013; Pospisil, Heike/G-7377-2016; Balabanov, Stefan/E-9765-2014; Scharf, Christian/A-7931-2011	Sültmann, Holger/0000-0002-5257-8600; Scharf, Christian/0000-0001-6806-6450; Schuppert, Andreas/0000-0003-3783-6605	German Federal Ministry for Education and Research [01GS0890, 01GS0892, 01GS0189]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry for Education and Research in the framework of the Program for Medical Genome Research (Grants: 01GS0890, 01GS0892, 01GS0189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandro Riccardo, 2005, Clin Colorectal Cancer, V4, P396, DOI 10.3816/CCC.2005.n.012; AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Eschrich S, 2009, INT J RADIAT ONCOL, V75, P497, DOI 10.1016/j.ijrobp.2009.05.056; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Gao X, 1997, ADV EXP MED BIOL, V407, P41; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hessels D, 2004, EXPERT REV MOL DIAGN, V4, P513, DOI 10.1586/14737159.4.4.513; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; KILLIAN CS, 1986, J NATL CANCER I, V76, P179; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kumar-Sinha C, 2003, EXPERT REV MOL DIAGN, V3, P459, DOI 10.1586/14737159.3.4.459; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee S, 2002, CANCER LETT, V184, P197, DOI 10.1016/S0304-3835(02)00197-0; Lexander H, 2005, ANAL QUANT CYTOL, V27, P263; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; MELLINGER GT, 1967, J UROLOGY, V97, P331, DOI 10.1016/S0022-5347(17)63039-8; Mumenthaler SM, 2008, PROSTATE, V68, P1561, DOI 10.1002/pros.20816; Mumenthaler SM, 2008, INT J ONCOL, V32, P357; Nagy B, 2009, PATHOL ONCOL RES, V15, P279, DOI 10.1007/s12253-008-9077-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Russell D H, 1981, Prog Clin Biol Res, V75A, P207; SCARDINO PT, 1989, UROL CLIN N AM, V16, P635; Sciavolino PJ, 1998, ANN MED, V30, P357, DOI 10.3109/07853899809029935; Solassol K, 2005, ANAL BIOCHEM, V338, P26, DOI 10.1016/j.ab.2004.11.031; Tabib A, 1999, INT J BIOCHEM CELL B, V31, P1289, DOI 10.1016/S1357-2725(99)00098-9; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047	46	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16833	10.1371/journal.pone.0016833	http://dx.doi.org/10.1371/journal.pone.0016833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347291	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500008
J	Zhang, HQ; Cao, HJ; Kimelberg, HK; Zhou, M				Zhang, Huaqiu; Cao, H. James; Kimelberg, Harold K.; Zhou, Min			Volume Regulated Anion Channel Currents of Rat Hippocampal Neurons and Their Contribution to Oxygen-and-Glucose Deprivation Induced Neuronal Death	PLOS ONE			English	Article							SENSITIVE CHLORIDE CHANNELS; EXCITATORY AMINO-ACIDS; SIMULATED ISCHEMIA; CEREBRAL-ISCHEMIA; AREA CA1; RELEASE; TAMOXIFEN; GLUTAMATE; GABA; NEUROPROTECTION	Volume-regulated anion channels (VRAC) are widely expressed chloride channels that are critical for the cell volume regulation. In the mammalian central nervous system, the physiological expression of neuronal VRAC and its role in cerebral ischemia are issues largely unknown. We show that hypoosmotic medium induce an outwardly rectifying chloride conductance in CA1 pyramidal neurons in rat hippocampal slices. The induced chloride conductance was sensitive to some of the VRAC inhibitors, namely, IAA-94 (300 mu M) and NPPB (100 mu M), but not to tamoxifen (10 mu M). Using oxygen-andglucose deprivation (OGD) to simulate ischemic conditions in slices, VRAC activation appeared after OGD induced anoxic depolarization (AD) that showed a progressive increase in current amplitude over the period of post-OGD reperfusion. The OGD induced VRAC currents were significantly inhibited by inhibitors for glutamate AMPA (30 mu M NBQX) and NMDA (40 mu M AP-5) receptors in the OGD solution, supporting the view that induction of AD requires an excessive Na+-loading via these receptors that in turn to activate neuronal VRAC. In the presence of NPPB and DCPIB in the post-OGD reperfusion solution, the OGD induced CA1 pyramidal neuron death, as measured by TO-PRO-3-I staining, was significantly reduced, although DCPIB did not appear to be an effective neuronal VRAC blocker. Altogether, we show that rat hippocampal pyramidal neurons express functional VRAC, and ischemic conditions can initial neuronal VRAC activation that may contribute to ischemic neuronal damage.	[Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China; [Cao, H. James; Kimelberg, Harold K.; Zhou, Min] Ordway Res Inst, Albany, NY USA	Huazhong University of Science & Technology; Ordway Research Institute	Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430074, Peoples R China.	zhanghq_04@yahoo.com; mzhou@ordwayresearch.org		Zhou, Min/0000-0001-6249-2977	Charitable Leadership Foundation, Latham; National Science Foundation [ISO-0641828]; National Institutes of Health [RO1NS35205]; National Natural Science Foundation of China for Young Scholars [3090049]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035205] Funding Source: NIH RePORTER	Charitable Leadership Foundation, Latham; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an endowment created at Ordway Research Institute by M. Frank and Margaret Domiter Rudy, grants from Charitable Leadership Foundation, Latham (to HKK and MZ), National Science Foundation (ISO-0641828 to MZ), National Institutes of Health RO1NS35205 (to HKK) and National Natural Science Foundation of China for Young Scholars (3090049 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Britton FC, 2000, AM J PHYSIOL-HEART C, V279, pH2225, DOI 10.1152/ajpheart.2000.279.5.H2225; Churchwell KB, 1996, J NEUROSCI, V16, P7447; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Eggermont J, 2001, CELL BIOCHEM BIOPHYS, V35, P263, DOI 10.1385/CBB:35:3:263; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; Haskew-Layton RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003543; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Inoue H, 2007, J NEUROSCI RES, V85, P1427, DOI 10.1002/jnr.21279; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kimelberg HK, 2006, GLIA, V54, P747, DOI 10.1002/glia.20423; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Leaney JL, 1997, J PHYSIOL-LONDON, V501, P555, DOI 10.1111/j.1469-7793.1997.555bm.x; Li GZ, 2004, NEUROCHEM RES, V29, P239, DOI 10.1023/B:NERE.0000010452.26022.a7; MCGILL JM, 1992, AM J PHYSIOL, V262, pG703, DOI 10.1152/ajpgi.1992.262.4.G703; Nilius B, 1998, PFLUG ARCH EUR J PHY, V436, P742, DOI 10.1007/s004240050697; Nilius B, 2000, CELL PHYSIOL BIOCHEM, V10, P313, DOI 10.1159/000016364; Nilius B, 1996, GEN PHARMACOL-VASC S, V27, P1131, DOI 10.1016/S0306-3623(96)00061-4; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Patel AJ, 1998, J NEUROSCI, V18, P3117; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Phillis JW, 1997, BRAIN RES, V758, P9, DOI 10.1016/S0006-8993(97)00155-8; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Rasband W, IMAGEJ; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; VANHOOIJDONK CAEM, 1994, CYTOMETRY, V17, P185, DOI 10.1002/cyto.990170212; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Xie MJ, 2008, J CEREBR BLOOD F MET, V28, P456, DOI 10.1038/sj.jcbfm.9600545; Zhang HQ, 2008, EXP NEUROL, V212, P44, DOI 10.1016/j.expneurol.2008.03.006; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	52	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16803	10.1371/journal.pone.0016803	http://dx.doi.org/10.1371/journal.pone.0016803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347298	gold, Green Submitted, Green Published			2022-12-27	WOS:000287364500007
J	Zhou, L; Bokhari, SA; Dong, CJ; Liu, JY				Zhou, Lu; Bokhari, Saleem A.; Dong, Chun-Juan; Liu, Jin-Yuan			Comparative Proteomics Analysis of the Root Apoplasts of Rice Seedlings in Response to Hydrogen Peroxide	PLOS ONE			English	Article							CELL-WALL PROTEOME; LEAF APOPLAST; EXTRACELLULAR-MATRIX; MALATE-DEHYDROGENASE; GENE-EXPRESSION; STRESS-RESPONSE; IMPORTANT ROLES; PROTEINS; TOLERANCE; PLANTS	Background: Plant apoplast is the prime site for signal perception and defense response, and of great importance in responding to environmental stresses. Hydrogen peroxide (H2O2) plays a pivotal role in determining the responsiveness of cells to stress. However, how the apoplast proteome changes under oxidative condition is largely unknown. In this study, we initiated a comparative proteomic analysis to explore H2O2-responsive proteins in the apoplast of rice seedling roots. Methodology/Principal Findings: 14-day-old rice seedlings were treated with low concentrations (300 and 600 mM) of H2O2 for 6 h and the levels of relative electrolyte leakage, malondialdehyde and H2O2 were assayed in roots. The modified vacuum infiltration method was used to extract apoplast proteins of rice seedling roots, and then two-dimensional electrophoresis gel analysis revealed 58 differentially expressed protein spots under low H2O2 conditions. Of these, 54 were successfully identified by PMF or MS/MS as matches to 35 different proteins including known and novel H2O2-responsive proteins. Almost all of these identities (98%) were indeed apoplast proteins confirmed either by previous experiments or through publicly available prediction programs. These proteins identified are involved in a variety of processes, including redox homeostasis, cell wall modification, signal transduction, cell defense and carbohydrate metabolism, indicating a complex regulative network in the apoplast of seedling roots under H2O2 stress. Conclusions/Significance: The present study is the first apoplast proteome investigation of plant seedlings in response to H2O2 and may be of paramount importance for the understanding of the plant network to environmental stresses. Based on the abundant changes in these proteins, together with their putative functions, we proposed a possible protein network that provides new insights into oxidative stress response in the rice root apoplast and clues for the further functional research of target proteins associated with H2O2 response.	[Zhou, Lu] Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, MOE Lab Prot Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Zhou, L (corresponding author), Tsinghua Univ, Sch Life Sci, Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua.edu.cn	Bokhari, Saleem A./C-7471-2012		National Transgenic Animals & Plants Research Project [2009ZX08009-069B]; State Key Basic Research and Development Plan [2006CB101706, 2010CB126003]; National Natural Science Foundation of China [30870197]	National Transgenic Animals & Plants Research Project; State Key Basic Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Transgenic Animals & Plants Research Project [2009ZX08009-069B]; the State Key Basic Research and Development Plan [2006CB101706 and 2010CB126003]; and the National Natural Science Foundation of China [30870197]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2006, PLANT SOIL, V279, P1, DOI 10.1007/s11104-005-3154-y; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bhushan D, 2007, MOL CELL PROTEOMICS, V6, P1868, DOI 10.1074/mcp.M700015-MCP200; Chang CJ, 1998, PLANT GROWTH REGUL, V25, P11, DOI 10.1023/A:1005903403926; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; Chen ZX, 2001, PLANT PHYSIOL, V126, P473, DOI 10.1104/pp.126.2.473; Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11&lt;1754::AID-ELPS1754&gt;3.0.CO;2-E; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Edwards SR, 1999, FEMS MICROBIOL LETT, V177, P211, DOI 10.1111/j.1574-6968.1999.tb13734.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Goulet C, 2010, PROTEOMICS, V10, P2536, DOI 10.1002/pmic.200900382; GREEN R, 1995, PLANT CELL, V7, P203, DOI 10.1105/tpc.7.2.203; GROSS GG, 1977, PHYTOCHEMISTRY, V16, P319, DOI 10.1016/0031-9422(77)80055-1; GROSS GG, 1977, PLANTA, V136, P271, DOI 10.1007/BF00385995; Haslam RP, 2003, ANN APPL BIOL, V143, P81, DOI 10.1111/j.1744-7348.2003.tb00272.x; Hoson T, 1998, J PLANT RES, V111, P167, DOI 10.1007/BF02507163; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Jeffery CJ, 2005, MASS SPECTROM REV, V24, P772, DOI 10.1002/mas.20041; Kleczkowski LA, 2004, PLANT PHYSIOL, V134, P912, DOI 10.1104/pp.103.036053; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; Lee SJ, 2004, PLANT PHYSIOL BIOCH, V42, P979, DOI 10.1016/j.plaphy.2004.10.014; Lee TM, 1997, PLANT SCI, V126, P1, DOI 10.1016/S0168-9452(97)00076-9; Li T, 2009, BMB REP, V42, P648, DOI 10.5483/BMBRep.2009.42.10.648; MADER M, 1979, PLANT SCI LETT, V17, P75, DOI 10.1016/0304-4211(79)90164-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Natera SHA, 2008, J PROTEOME RES, V7, P1159, DOI 10.1021/pr070255c; Negri AS, 2008, J PLANT PHYSIOL, V165, P1379, DOI 10.1016/j.jplph.2007.10.011; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Pacoda D, 2004, J PLANT PHYSIOL, V161, P1143, DOI 10.1016/j.jplph.2004.01.012; Pandey A, 2010, J PROTEOME RES, V9, P3443, DOI 10.1021/pr901098p; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pennycooke JC, 2003, PLANT PHYSIOL, V133, P901, DOI 10.1104/pp.103.024554; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Sagi G, 2005, PLANT CELL, V17, P1788, DOI 10.1105/tpc.105.031823; SAMUEL MA, 2006, INT REV CYTOL, V253, P1, DOI DOI 10.1016/S0074-7696(06)53001-3; Sasaki C, 2006, GLYCOBIOLOGY, V16, P1242, DOI 10.1093/glycob/cwl043; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Slabas AR, 2004, BIOCHEM SOC T, V32, P524, DOI 10.1042/BST0320524; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Soares NC, 2009, J PROTEOME RES, V8, P2298, DOI 10.1021/pr8009353; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Vanacker H, 1998, PLANT PHYSIOL, V117, P1103, DOI 10.1104/pp.117.3.1103; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; Watson BS, 2004, PHYTOCHEMISTRY, V65, P1709, DOI 10.1016/j.phytochem.2004.04.026; Weeks ME, 2006, PROTEOMICS, V6, P2772, DOI 10.1002/pmic.200500741; WEIMAR M, 1987, PHYSIOL PLANTARUM, V69, P692, DOI 10.1111/j.1399-3054.1987.tb01986.x; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yao Y, 2006, ELECTROPHORESIS, V27, P4559, DOI 10.1002/elps.200600111; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhang L, 2009, PLANT PHYSIOL, V149, P916, DOI 10.1104/pp.108.131144; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250	70	49	53	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16723	10.1371/journal.pone.0016723	http://dx.doi.org/10.1371/journal.pone.0016723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347307	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000014
J	Bekhouche, I; Finetti, P; Adelaide, J; Ferrari, A; Tarpin, C; Charafe-Jauffret, E; Charpin, C; Houvenaeghel, G; Jacquemier, J; Bidaut, G; Birnbaum, D; Viens, P; Chaffanet, M; Bertucci, F				Bekhouche, Ismahane; Finetti, Pascal; Adelaide, Jose; Ferrari, Anthony; Tarpin, Carole; Charafe-Jauffret, Emmanuelle; Charpin, Colette; Houvenaeghel, Gilles; Jacquemier, Jocelyne; Bidaut, Ghislain; Birnbaum, Daniel; Viens, Patrice; Chaffanet, Max; Bertucci, Francois			High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; COPY NUMBER ALTERATION; RHOC-GTPASE; EXPRESSION PATTERNS; E-CADHERIN; MOLECULAR CHARACTERIZATION; MICROARRAY ANALYSIS; EPITHELIAL-CELLS; TUMOR EMBOLI; PHENOTYPE	Background: Inflammatory breast cancer (IBC) is an aggressive form of BC poorly defined at the molecular level. We compared the molecular portraits of 63 IBC and 134 non-IBC (nIBC) clinical samples. Methodology/Findings: Genomic imbalances of 49 IBCs and 124 nIBCs were determined using high-resolution array-comparative genomic hybridization, and mRNA expression profiles of 197 samples using whole-genome microarrays. Genomic profiles of IBCs were as heterogeneous as those of nIBCs, and globally relatively close. However, IBCs showed more frequent "complex'' patterns and a higher percentage of genes with CNAs per sample. The number of altered regions was similar in both types, although some regions were altered more frequently and/or with higher amplitude in IBCs. Many genes were similarly altered in both types; however, more genes displayed recurrent amplifications in IBCs. The percentage of genes whose mRNA expression correlated with CNAs was similar in both types for the gained genes, but similar to 7-fold lower in IBCs for the lost genes. Integrated analysis identified 24 potential candidate IBC-specific genes. Their combined expression accurately distinguished IBCs and nIBCS in an independent validation set, and retained an independent prognostic value in a series of 1,781 nIBCs, reinforcing the hypothesis for a link with IBC aggressiveness. Consistent with the hyperproliferative and invasive phenotype of IBC these genes are notably involved in protein translation, cell cycle, RNA processing and transcription, metabolism, and cell migration. Conclusions: Our results suggest a higher genomic instability of IBC. We established the first repertory of DNA copy number alterations in this tumor, and provided a list of genes that may contribute to its aggressiveness and represent novel therapeutic targets.	[Bekhouche, Ismahane; Finetti, Pascal; Adelaide, Jose; Ferrari, Anthony; Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne; Birnbaum, Daniel; Chaffanet, Max; Bertucci, Francois] CRCM, UMR891, INSERM, IPC,Dept Mol Oncol, Marseille, France; [Tarpin, Carole; Viens, Patrice; Bertucci, Francois] Inst J Paoli I Calmettes, Dept Med Oncol, F-13009 Marseille, France; [Charafe-Jauffret, Emmanuelle; Charpin, Colette; Viens, Patrice; Bertucci, Francois] Univ Mediterrane, Marseille, France; [Charafe-Jauffret, Emmanuelle; Jacquemier, Jocelyne] Inst J Paoli I Calmettes, Dept BioPathol, F-13009 Marseille, France; [Charpin, Colette] Hop Nord Marseille, Dept Pathol, Marseille, France; [Houvenaeghel, Gilles] Inst J Paoli I Calmettes, Dept Surg, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Institut Paoli-Calmette (IPC)	Bekhouche, I (corresponding author), CRCM, UMR891, INSERM, IPC,Dept Mol Oncol, Marseille, France.	bertuccif@marseille.fnclcc.fr	ADELAIDE, José JA/O-4390-2017; Viens, Patrice/Q-8499-2018; CHAFFANET, Max/AAU-5743-2020; Finetti, Pascal/O-8669-2017; Charafe-Jauffret, emmanuelle/P-6009-2017	ADELAIDE, José JA/0000-0003-4364-9857; Viens, Patrice/0000-0003-1511-1048; Finetti, Pascal/0000-0002-2674-3123; Bertucci, Francois/0000-0002-0157-0959; CHAFFANET, Max/0000-0002-2344-1488; Bidaut, Ghislain/0000-0001-8502-2361; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299	Inserm; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (Label DB); Institut National du Cancer [ACI2007, AO2008, AO translationnelle 2007 IBC07]; Algerian Government	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer (Label DB); Institut National du Cancer(Institut National du Cancer (INCA) France); Algerian Government	This work was supported by Inserm, Institut Paoli-Calmettes, and grants from Ligue Nationale Contre le Cancer (Label DB) and Institut National du Cancer (ACI2007, AO2008, AO translationnelle 2007 IBC07). IB has been supported by a fellowship from the Algerian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Ahomadegbe JC, 2000, ONCOGENE, V19, P5413, DOI 10.1038/sj.onc.1203914; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Atienza JM, 2005, MOL CANCER THER, V4, P361; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bernstein KA, 2004, MOL BIOL CELL, V15, P5038, DOI 10.1091/mbc.E04-06-0515; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bertucci F, 2005, CANCER RES, V65, P2170, DOI 10.1158/0008-5472.CAN-04-4115; Bertucci F, 2004, CANCER RES, V64, P8558, DOI 10.1158/0008-5472.CAN-04-2696; Blanquart C, 2010, BIOCHEM BIOPH RES CO, V392, P83, DOI 10.1016/j.bbrc.2009.12.176; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Charafe-Lauffret E, 2008, SEMIN ONCOL, V35, P41, DOI 10.1053/j.seminoncol.2007.11.015; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dawood S, 2008, SEMIN ONCOL, V35, P64, DOI 10.1053/j.seminoncol.2007.11.012; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Geyer FC, 2009, PATHOLOGY, V41, P77, DOI 10.1080/00313020802563536; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Houchens NW, 2008, ONCOLOGY-NY, V22, P1556; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang W, 2008, AM J PATHOL, V172, P893, DOI 10.2353/ajpath.2008.070899; Hwang KT, 2008, INT J CANCER, V123, P1807, DOI 10.1002/ijc.23672; Hyman E, 2002, CANCER RES, V62, P6240; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto T, 2010, BREAST CANC RES TREA; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2002, ONCOGENE, V21, P3172, DOI 10.1038/sj.onc.1205462; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lerebours F, 2003, CLIN CANCER RES, V9, P4184; Lerebours F, 2002, INT J CANCER, V102, P618, DOI 10.1002/ijc.10729; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Martin J, 1999, MOL CELL BIOL, V19, P5548; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nguyen DM, 2006, CLIN CANCER RES, V12, P5047, DOI 10.1158/1078-0432.CCR-05-2248; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Resetkova E, 2008, SEMIN ONCOL, V35, P25, DOI 10.1053/j.seminoncol.2007.11.013; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, CELL CYCLE, V8, P3091, DOI 10.4161/cc.8.19.9637; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Singletary SE, 2008, SEMIN ONCOL, V35, P7, DOI 10.1053/j.seminoncol.2007.11.010; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spradling KD, 2001, J BIOL CHEM, V276, P29257, DOI 10.1074/jbc.M101663200; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van den Eynden GG, 2004, BREAST CANCER RES TR, V85, P13, DOI 10.1023/B:BREA.0000021028.33926.a8; van Golen KL, 1999, CLIN CANCER RES, V5, P2511; van Golen KL, 2000, CANCER RES, V60, P5832; van Golen KL, 2002, MOL CANCER THER, V1, P575; van Golen KL, 2002, CLIN EXP METASTAS, V19, P301, DOI 10.1023/A:1015518114931; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Van Laere S, 2007, BRIT J CANCER, V97, P1165, DOI 10.1038/sj.bjc.6603967; Van Laere S, 2005, BREAST CANCER RES TR, V93, P237, DOI 10.1007/s10549-005-5157-z; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDERAUWERA I, 2010, BR J CANC, V27; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WICKNER RB, 1988, P NATL ACAD SCI USA, V85, P6007, DOI 10.1073/pnas.85.16.6007; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P256, DOI 10.1016/j.semradonc.2009.05.008; Wu M, 2004, BREAST CANCER RES TR, V84, P3, DOI 10.1023/B:BREA.0000018426.76893.21; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zhang YH, 2005, BREAST CANCER RES, V7, pR1080, DOI 10.1186/bcr1351; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	84	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16950	10.1371/journal.pone.0016950	http://dx.doi.org/10.1371/journal.pone.0016950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21339811	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700056
J	Powell, ML; Leigh, KE; Poyry, TAA; Jackson, RJ; Brown, TDK; Brierley, I				Powell, Michael L.; Leigh, Kendra E.; Poeyry, Tuija A. A.; Jackson, Richard J.; Brown, T. David K.; Brierley, Ian			Further Characterisation of the Translational Termination-Reinitiation Signal of the Influenza B Virus Segment 7 RNA	PLOS ONE			English	Article							OPEN READING FRAME; 18S RIBOSOMAL-RNA; MESSENGER-RNA; INITIATION; SEQUENCE; EXPRESSION; MECHANISM; PROTEIN; CALICIVIRUS; EFFICIENCY	Termination-dependent reinitiation is used to co-ordinately regulate expression of the M1 and BM2 open-reading frames (ORFs) of the dicistronic influenza B segment 7 RNA. The start codon of the BM2 ORF overlaps the stop codon of the M1 ORF in the pentanucleotide UAAUG and similar to 10% of ribosomes terminating at the M1 stop codon reinitiate translation at the overlapping AUG. BM2 synthesis requires the presence of, and translation through, 45 nt of RNA immediately upstream of the UAAUG, known as the 'termination upstream ribosome binding site' (TURBS). This region may tether ribosomal 40S subunits to the mRNA following termination and a short region of the TURBS, motif 1, with complementarity to helix 26 of 18S rRNA has been implicated in this process. Here, we provide further evidence for a direct interaction between mRNA and rRNA using antisense oligonucleotide targeting and functional analysis in yeast cells. The TURBS also binds initiation factor eIF3 and we show here that this protein stimulates reinitiation from both wild-type and defective TURBS when added exogenously, perhaps by stabilising ribosome-mRNA interactions. Further, we show that the position of the TURBS with respect to the UAAUG overlap is crucial, and that termination too far downstream of the 18S complementary sequence inhibits the process, probably due to reduced 40S tethering. However, in reporter mRNAs where the restart codon alone is moved downstream, termination-reinitiation is inhibited but not abolished, thus the site of reinitiation is somewhat flexible. Reinitiation on distant AUGs is not inhibited in eIF4G-depleted RRL, suggesting that the tethered 40S subunit can move some distance without a requirement for linear scanning.	[Powell, Michael L.; Leigh, Kendra E.; Brown, T. David K.; Brierley, Ian] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Poeyry, Tuija A. A.; Jackson, Richard J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Powell, ML (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	mlp34@cam.ac.uk		Leigh, Kendra/0000-0002-6467-3330	Biotechnology and Biological Sciences Research Council [BB/C007034/1]; Biotechnology and Biological Sciences Research Council [BB/D008190/1] Funding Source: researchfish; BBSRC [BB/C007034/1, BB/D008190/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) grant BB/C007034/1 awarded to RJJ, TDKB, and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; Baranov PV, 2006, TRENDS GENET, V22, P174, DOI 10.1016/j.tig.2006.01.005; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; BRIEDIS DJ, 1982, VIROLOGY, V116, P581, DOI 10.1016/0042-6822(82)90150-7; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Girnary R, 2007, J GEN VIROL, V88, P226, DOI 10.1099/vir.0.82064-0; Grentzmann G, 1998, RNA, V4, P479; HIEBERT SW, 1986, VIROLOGY, V155, P747, DOI 10.1016/0042-6822(86)90237-0; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Hu MCY, 1999, P NATL ACAD SCI USA, V96, P1339, DOI 10.1073/pnas.96.4.1339; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; NYGARD O, 1982, NUCLEIC ACIDS RES, V10, P1327, DOI 10.1093/nar/10.4.1327; Panopoulos P, 2008, J BIOL CHEM, V283, P33087, DOI 10.1074/jbc.M804904200; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAVLAKIS G N, 1990, New Biologist, V2, P20; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000	41	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16822	10.1371/journal.pone.0016822	http://dx.doi.org/10.1371/journal.pone.0016822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347434	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600031
J	Zappettini, S; Grilli, M; Lagomarsino, F; Cavallero, A; Fedele, E; Marchi, M				Zappettini, Stefania; Grilli, Massimo; Lagomarsino, Federica; Cavallero, Anna; Fedele, Ernesto; Marchi, Mario			Presynaptic Nicotinic alpha 7 and Non-alpha 7 Receptors Stimulate Endogenous GABA Release from Rat Hippocampal Synaptosomes through Two Mechanisms of Action	PLOS ONE			English	Article							SUBUNIT MESSENGER-RNAS; MOUSE-BRAIN SYNAPTOSOMES; CENTRAL-NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; STRIATAL SYNAPTOSOMES; DOPAMINE RELEASE; SELECTIVE LIGAND; ACH RECEPTORS; ACID RELEASE	Background: Although converging evidence has suggested that nicotinic acetylcholine receptors (nAChR) play a role in the modulation of GABA release in rat hippocampus, the specific involvement of different nAChR subtypes at presynaptic level is still a matter of debate. In the present work we investigated, using selective alpha 7 and alpha 4 beta 2 nAChR agonists, the presence of different nAChR subtypes on hippocampal GABA nerve endings to assess to what extent and through which mechanisms they stimulate endogenous GABA release. Methodology/Findings: All agonists elicited GABA overflow. Choline (Ch)-evoked GABA overflow was dependent to external Ca2+, but unaltered in the presence of Cd2+, tetrodotoxin (TTX), dihydro-b-erythroidine (DH beta E) and 1-(4,4-Diphenyl-3- butenyl)-3-piperidinecarboxylic acid hydrochloride SKF 89976A. The effect of Ch was blocked by methyllycaconitine (MLA), alpha-bungarotoxin (alpha-BTX), dantrolene, thapsigargin and xestospongin C, suggesting that GABA release might be triggered by Ca2+ entry into synaptosomes through the alpha 7 nAChR channel with the involvement of calcium from intracellular stores. Additionally, 5-Iodo-A-85380 dihydrochloride (5IA85380) elicited GABA overflow, which was Ca2+ dependent, blocked by Cd2+, and significantly inhibited by TTX and DH beta E, but unaffected by MLA, SKF 89976A, thapsigargin and xestospongin C and dantrolene. These findings confirm the involvement of alpha 4 beta 2 nAChR in 5IA85380-induced GABA release that seems to occur following membrane depolarization and opening calcium channels. Conclusions/Significance: Rat hippocampal synaptosomes possess both alpha 7 and alpha 4 beta 2 nAChR subtypes, which can modulate GABA release via two distinct mechanisms of action. The finding that GABA release evoked by the mixture of sub-maximal concentration of 5IA85380 plus sub-threshold concentrations of Ch was significantly larger than that elicited by the sum of the effects of the two agonists is compatible with the possibility that they coexist on the same nerve terminals. These findings would provide the basis for possible selective pharmacological strategies to treat neuronal disorders that involve the dysfunction of hippocampal cholinergic system.	[Zappettini, Stefania; Grilli, Massimo; Lagomarsino, Federica; Cavallero, Anna; Fedele, Ernesto; Marchi, Mario] Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy; [Fedele, Ernesto; Marchi, Mario] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Marchi, Mario] Natl Inst Neurosci, Genoa, Italy	University of Genoa; University of Genoa	Zappettini, S (corresponding author), Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy.	marchi@pharmatox.unige.it	marchi, mario/C-4237-2008; Grilli, Massimo/C-4217-2008; Fedele, Ernesto/K-4839-2015	Grilli, Massimo/0000-0003-1046-7897; Fedele, Ernesto/0000-0002-0386-0925; mario, marchi/0000-0003-0263-9070; Zappettini, PharmD, PhD, PMP, Stefania/0000-0002-1238-9573	Italian Ministero Universita Ricerca [Nu 20072BTSR2_002]; Compagnia di San Paolo; University of Genoa [ALCOTRA 2007-2013]	Italian Ministero Universita Ricerca(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo); University of Genoa	This work was supported by the Italian Ministero Universita Ricerca to Prof. Mario Marchi (prot. Nu 20072BTSR2_002), by Compagnia di San Paolo, and by University of Genoa 'Progetto Ricerca Ateneo'; project AROMA (ALCOTRA 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2000, BEHAV BRAIN RES, V113, P131, DOI 10.1016/S0166-4328(00)00208-4; Alkondon M, 2000, EUR J PHARMACOL, V393, P59, DOI 10.1016/S0014-2999(00)00006-6; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Arnaiz-Cot JJ, 2008, EUR J NEUROSCI, V27, P1097, DOI 10.1111/j.1460-9568.2008.06077.x; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Bancila V, 2009, J NEUROCHEM, V110, P570, DOI 10.1111/j.1471-4159.2009.06169.x; Bencherif M, 1998, J PHARMACOL EXP THER, V284, P886; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Fisher JL, 1998, J PHYSIOLOGY-PARIS, V92, P209, DOI 10.1016/S0928-4257(98)80012-0; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Grilli M, 2008, J NEUROCHEM, V105, P2205, DOI 10.1111/j.1471-4159.2008.05307.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo JZ, 2002, NEUROSCIENCE, V110, P505, DOI 10.1016/S0306-4522(01)00579-6; Henderson Z, 2005, J PHYSIOL-LONDON, V562, P165, DOI 10.1113/jphysiol.2004.070300; Kanno T, 2005, BIOCHEM BIOPH RES CO, V338, P742, DOI 10.1016/j.bbrc.2005.10.044; KHIROUGH SS, 2002, J PHYSL, P425; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Lendvai B, 2008, PHYSIOL REV, V88, P333, DOI 10.1152/physrev.00040.2006; Lu Y, 1998, J PHARMACOL EXP THER, V287, P648; Marchi M, 2010, PROG NEUROBIOL, V92, P105, DOI 10.1016/j.pneurobio.2010.06.004; MARKS MJ, 1995, J PHARMACOL EXP THER, V274, P833; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Marshall D, 1996, NEUROPHARMACOLOGY, V35, P1531, DOI 10.1016/S0028-3908(96)00117-7; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Mogg AJ, 2004, NEUROPHARMACOLOGY, V47, P848, DOI 10.1016/j.neuropharm.2004.06.013; Mukhin AG, 2000, MOL PHARMACOL, V57, P642, DOI 10.1124/mol.57.3.642; NAKAMURA Y, 1993, GLIA, V9, P48, DOI 10.1002/glia.440090107; Parodi M, 2006, NEUROCHEM INT, V48, P138, DOI 10.1016/j.neuint.2005.08.010; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sershen H, 1997, NEUROSCIENCE, V77, P121, DOI 10.1016/S0306-4522(96)00425-3; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Soliakov L, 1996, J NEUROCHEM, V67, P163; SOLIAKOV L, 1995, NEUROPHARMACOLOGY, V34, P1535, DOI 10.1016/0028-3908(95)00122-M; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Vizi ES, 1999, BRAIN RES REV, V30, P219, DOI 10.1016/S0165-0173(99)00016-8; VIZI ES, 1995, ANN NY ACAD SCI, V757, P84, DOI 10.1111/j.1749-6632.1995.tb17466.x; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; WONNACOTT S, 1989, PROG BRAIN RES, V79, P157	50	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16911	10.1371/journal.pone.0016911	http://dx.doi.org/10.1371/journal.pone.0016911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346795	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600033
J	Akiyama, H; Misawa, T; Ono, M; Uchida, C; Uchida, T				Akiyama, Hirotada; Misawa, Takuma; Ono, Masao; Uchida, Chiyoko; Uchida, Takafumi			Prolyl Isomerase Pin1 Protects Mice from Endotoxin Shock	PLOS ONE			English	Article							EXPRESSION; BINDING; GENE; PHOSPHORYLATION; MACROPHAGES; MECHANISMS; DISEASE; STAT3	Background: Prolyl isomerase Pin1 may be involved in innate immunity against microbial infection, but the mechanism how Pin1 controls the innate immunity is poorly understood. Methodology/Principal Findings: Injection of lipopolysaccharide (LPS) into the mice induces inflammatory pulmonary disorder and sometimes the serious damages lead to death. Comparing to the wild-type (WT) mice, the Pin1(-/-) mice showed more serious damages in lung and the lower survival rate after the LPS injection. We compared the levels of typical inflammatory cytokines. Pin1(-/-) mice overreacted to the LPS injection to produce inflammatory cytokines, especially IL-6 more than WT mice. We showed that Pin1 binds phosphorylated PU. 1 and they localize together in a nucleus. These results suggest that Pin1 controls the transcriptional activity of PU. 1 and suppresses overreaction of macrophage that causes serious damages in lung. Conclusions/Significance: Pin1 may protect the mice from serious inflammation by LPS injection by attenuating the increase of IL-6 transcription of the mouse macrophages.	[Akiyama, Hirotada; Misawa, Takuma; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan; [Ono, Masao] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Uchida, Chiyoko; Uchida, Takafumi] Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Akiyama, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan.	uchidat@biochem.tohoku.ac.jp		Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science and Technology of Japan [20228006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Kiban S, No 20228006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; FREUNDLICH B, 1983, J IMMUNOL METHODS, V62, P31, DOI 10.1016/0022-1759(83)90107-2; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Liu TZ, 2008, AM J PHYSIOL-CELL PH, V295, pC819, DOI 10.1152/ajpcell.00366.2007; Liu TZ, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-20; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1	18	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14656	10.1371/journal.pone.0014656	http://dx.doi.org/10.1371/journal.pone.0014656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326608	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000005
J	Al Safadi, R; Mereghetti, L; Salloum, M; Lartigue, MF; Virlogeux-Payant, I; Quentin, R; Rosenau, A				Al Safadi, Rim; Mereghetti, Laurent; Salloum, Mazen; Lartigue, Marie-Frederique; Virlogeux-Payant, Isabelle; Quentin, Roland; Rosenau, Agnes			Two-Component System RgfA/C Activates the fbsB Gene Encoding Major Fibrinogen-Binding Protein in Highly Virulent CC17 Clone Group B Streptococcus	PLOS ONE			English	Article							INVASIVE NEONATAL DISEASE; GRAM-POSITIVE BACTERIA; HUMAN EPITHELIAL-CELLS; AGALACTIAE STRAINS; STAPHYLOCOCCUS-AUREUS; ENHANCED INVASIVENESS; POPULATION-STRUCTURE; SURFACE PROTEIN; EXPRESSION; SEQUENCE	Group B streptococcus (GBS) strains with the highest ability to bind to human fibrinogen belong to the highly invasive clonal complex (CC) 17. To investigate the fibrinogen-binding mechanisms of CC17 strains, we determined the prevalence of fibrinogen-binding genes (fbsA and fbsB), and fbs regulator genes (rogB encoding an fbsA activator, rovS encoding an fbsA repressor and rgf encoding a two-component system [TCS] whose role on fbs genes was not determined yet) in a collection of 134 strains representing the major CCs of the species. We showed that specific gene combinations were related to particular CCs; only CC17 strains contained the fbsA, fbsB, and rgf genes combination. Non polar rgfAC deletion mutants of three CC17 serotype III strains were constructed. They showed a 3.2- to 5.1-fold increase of fbsA transcripts, a 4.8- to 6.7-fold decrease of fbsB transcripts, and a 52% to 68% decreased fibrinogen-binding ability, demonstrating that the RgfA/RgfC TCS inhibits the fbsA gene and activates the fbsB gene. The relative contribution of the two fbs genes in fibrinogen-binding ability was determined by constructing isogenic fbsA, fbsB, deletion mutants of the three CC17 strains. The ability to bind to fibrinogen was reduced by 49% to 57% in Lambda fbsA mutants, and by 78% to 80% in Lambda fbsB mutants, suggesting that FbsB protein plays a greater role in the fibrinogen-binding ability of CC17 strains. Moreover, the relative transcription level of fbsB gene was 9.2- to 12.7-fold higher than that of fbsA gene for the three wild type strains. Fibrinogen-binding ability could be restored by plasmid-mediated expression of rgfAC, fbsA, and fbsB genes in the corresponding deletion mutants. Thus, our results demonstrate that a specific combination of fbs genes and fbs regulator genes account for the high fibrinogen-binding ability of CC17 strains that may participate to their enhanced invasiveness for neonates as compared to strains of other CCs.	[Al Safadi, Rim; Mereghetti, Laurent; Salloum, Mazen; Lartigue, Marie-Frederique; Quentin, Roland; Rosenau, Agnes] Univ Tours, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Feratif Rech Agents Transmissibles & Infecti, UFR Med, Tours, France; [Virlogeux-Payant, Isabelle] INRA, Infectiol Anim & Sante Publ UR1282, Nouzilly, France; [Mereghetti, Laurent] CHRU Tours, Hop Bretonneau, Serv Bacteriol Virol, Tours, France; [Lartigue, Marie-Frederique; Quentin, Roland; Rosenau, Agnes] CHRU Tours, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; INRAE; CHU Tours; CHU Tours	Al Safadi, R (corresponding author), Univ Tours, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Feratif Rech Agents Transmissibles & Infecti, UFR Med, Tours, France.	rosenau@univ-tours.fr	Virlogeux-Payant, Isabelle/H-5800-2013; Lartigue, Marie-Frédérique/AAC-6060-2020; Lartigue, Marie-Frédérique/E-8444-2011	Lartigue, Marie-Frédérique/0000-0003-4948-7959; Lartigue, Marie-Frédérique/0000-0003-4948-7959; Virlogeux-Payant, Isabelle/0000-0003-4149-0168	Region Centre, France [200700025461]	Region Centre, France(Region Centre-Val de Loire)	This work was supported by grant no 200700025461 from the Region Centre, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Safadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010794; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Chatellier S, 1997, J CLIN MICROBIOL, V35, P2573, DOI 10.1128/JCM.35.10.2573-2579.1997; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Jacobsson K, 2003, VET MICROBIOL, V96, P103, DOI 10.1016/S0378-1135(03)00206-2; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Li S, 1997, FEMS MICROBIOL LETT, V152, P155, DOI 10.1016/S0378-1097(97)00195-X; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200	45	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14658	10.1371/journal.pone.0014658	http://dx.doi.org/10.1371/journal.pone.0014658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326613	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037000006
J	Lupton, MK; Proitsi, P; Danillidou, M; Tsolaki, M; Hamilton, G; Wroe, R; Pritchard, M; Lord, K; Martin, BM; Kloszewska, I; Soininen, H; Mecocci, P; Vellas, B; Harold, D; Hollingworth, P; Lovestone, S; Powell, JF				Lupton, Michelle K.; Proitsi, Petroula; Danillidou, Makrina; Tsolaki, Magda; Hamilton, Gillian; Wroe, Richard; Pritchard, Megan; Lord, Kathryn; Martin, Belinda M.; Kloszewska, Iwona; Soininen, Hilkka; Mecocci, Patrizia; Vellas, Bruno; Harold, Denise; Hollingworth, Paul; Lovestone, Simon; Powell, John F.			Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; POLYMORPHISMS; POPULATION; MUTATIONS; CLU	Nicastrin is an obligatory component of the c-secretase; the enzyme complex that leads to the production of Ab fragments critically central to the pathogenesis of Alzheimer's disease (AD). Analyses of the effects of common variation in this gene on risk for late onset AD have been inconclusive. We investigated the effect of rare variation in the coding regions of the Nicastrin gene in a cohort of AD patients and matched controls using an innovative pooling approach and next generation sequencing. Five SNPs were identified and validated by individual genotyping from 311 cases and 360 controls. Association analysis identified a non-synonymous rare SNP (N417Y) with a statistically higher frequency in cases compared to controls in the Greek population (OR 3.994, CI 1.105-14.439, p = 0.035). This finding warrants further investigation in a larger cohort and adds weight to the hypothesis that rare variation explains some of genetic heritability still to be identified in Alzheimer's disease.	[Lupton, Michelle K.; Proitsi, Petroula; Wroe, Richard; Pritchard, Megan; Lord, Kathryn; Martin, Belinda M.; Lovestone, Simon; Powell, John F.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England; [Harold, Denise; Hollingworth, Paul] Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, MRC Ctr Neuropsychiatr Genet & Genom, Cardiff, S Glam, Wales; [Hamilton, Gillian] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Danillidou, Makrina; Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Mecocci, Patrizia] Univ Perugia, Dept Clin & Expt Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Vellas, Bruno] Hop Toulouse, Dept Internal & Geriatr Med, Toulouse, France	University of London; King's College London; Cardiff University; University of Edinburgh; Aristotle University of Thessaloniki; Medical University Lodz; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Perugia; CHU de Toulouse	Lupton, MK (corresponding author), Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London WC2R 2LS, England.	michelle.lupton@kcl.ac.uk	Powell, John F/G-4412-2011; Hunter, Gillian/A-1952-2015; Mecocci, Patrizia/W-2116-2019	Powell, John F/0000-0001-6124-439X; Mecocci, Patrizia/0000-0003-0729-5246; Tsolaki, Magda/0000-0002-2072-8010; Proitsi, Petroula/0000-0002-2553-6974; Williams, Julie/0000-0002-4069-0259; Pritchard, Megan Ruth/0000-0001-8872-3614; Lovestone, Simon/0000-0003-0473-4565; Harold, Denise/0000-0001-5195-0143; Lupton, Michelle/0000-0002-7274-7299	NIHR Biomedical Research Centre for Mental Health at SLAM; KCL; Medical Research Council; Alzheimer's Research Trust; European Union [HEALTH-F4-2009-242257]; Alzheimers Research UK [ART-RF2007-3] Funding Source: researchfish; Medical Research Council [G0801418B] Funding Source: researchfish	NIHR Biomedical Research Centre for Mental Health at SLAM; KCL; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; European Union(European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the NIHR Biomedical Research Centre for Mental Health at SLAM and KCL (http://www.slam.nhs.uk/about-us/biomedical-research-centre/brc-home.aspx). It is also supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) through the PhD Studentship funding and the Alzheimer's Research Trust (http://www.alzheimers-research.org.uk/). This work was also supported by the 7th framework programme of the European Union (ADAMS project, http://www.adams-consortium.eu/, HEALTH-F4-2009-242257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Confaloni A, 2003, NEUROSCI LETT, V353, P61, DOI 10.1016/j.neulet.2003.09.007; Cousin E, 2003, NEUROSCI LETT, V353, P153, DOI 10.1016/S0304-3940(03)01105-4; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Deary IJ, 2005, NEUROSCI LETT, V373, P110, DOI 10.1016/j.neulet.2004.09.073; Dermaut B, 2002, AM J HUM GENET, V70, P1568, DOI 10.1086/340732; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Helisalmi S, 2004, NEUROLOGY, V63, P173, DOI 10.1212/01.WNL.0000133153.98139.4E; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li Z, 2009, EUR J NEUROSCI, V30, P1831, DOI 10.1111/j.1460-9568.2009.06942.x; LOVESTONE S, ANN N Y ACAD SCI, V1180, P36; Ma ZH, 2009, NEUROSCI LETT, V458, P136, DOI 10.1016/j.neulet.2009.04.048; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitsui J, 2010, J HUM GENET, V55, P448, DOI 10.1038/jhg.2010.46; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Orlacchio A, 2004, NEUROSCI LETT, V363, P49, DOI 10.1016/j.neulet.2004.03.044; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Prabhu S, 2009, GENOME RES, V19, P1254, DOI 10.1101/gr.088559.108; PROITSI P, 2009, NEUROBIOL AGING; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	36	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17298	10.1371/journal.pone.0017298	http://dx.doi.org/10.1371/journal.pone.0017298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364883	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287764100042
J	Su, YN; Hung, CC; Lin, SY; Chen, FY; Chern, JPS; Tsai, C; Chang, TS; Yang, CC; Li, H; Ho, HN; Lee, CN				Su, Yi-Ning; Hung, Chia-Cheng; Lin, Shin-Yu; Chen, Fang-Yi; Chern, Jimmy P. S.; Tsai, Chris; Chang, Tai-Sheng; Yang, Chih-Chao; Li, Hung; Ho, Hong-Nerng; Lee, Chien-Nan			Carrier Screening for Spinal Muscular Atrophy (SMA) in 107,611 Pregnant Women during the Period 2005-2009: A Prospective Population-Based Cohort Study	PLOS ONE			English	Article							TAY-SACHS-DISEASE; QUANTITATIVE-ANALYSIS; SMN1 GENE; GAUCHER-DISEASE; RISK ASSESSMENT; COPY NUMBER; PHENOTYPE; IDENTIFICATION; FREQUENCY; DIAGNOSTICS	Background: Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The American College of Medical Genetics has recently recommended routine carrier screening for SMA because of the high carrier frequency (1 in 25-50) as well as the severity of that genetic disease. Large studies are needed to determine the feasibility, benefits, and costs of such a program. Methods and Findings: This is a prospective population-based cohort study of 107,611 pregnant women from 25 counties in Taiwan conducted during the period January 2005 to June 2009. A three-stage screening program was used: (1) pregnant women were tested for SMA heterozygosity; (2) if the mother was determined to be heterozygous for SMA (carrier status), the paternal partner was then tested; (3) if both partners were SMA carriers, prenatal diagnostic testing was performed. During the study period, a total of 2,262 SMA carriers with one copy of the SMN1 gene were identified among the 107,611 pregnant women that were screened. The carrier rate was approximately 1 in 48 (2.10%). The negative predictive value of DHPLC coupled with MLPA was 99.87%. The combined method could detect approximately 94% of carriers because most of the cases resulted from a common single deletion event. In addition, 2,038 spouses were determined to be SMA carriers. Among those individuals, 47 couples were determined to be at high risk for having offspring with SMA. Prenatal diagnostic testing was performed in 43 pregnant women (91.49%) and SMA was diagnosed in 12 (27.91%) fetuses. The prevalence of SMA in our population was 1 in 8,968. Conclusion: The main benefit of SMA carrier screening is to reduce the burden associated with giving birth to an affected child. In this study, we determined the carrier frequency and genetic risk and provided carrier couples with genetic services, knowledge, and genetic counseling.	[Su, Yi-Ning; Hung, Chia-Cheng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Genom, Taipei 10764, Taiwan; [Su, Yi-Ning; Hung, Chia-Cheng] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Su, Yi-Ning; Lin, Shin-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lin, Shin-Yu; Ho, Hong-Nerng; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Fang-Yi] Taiwan Adventist Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chern, Jimmy P. S.] Tao Yuan Gen Hosp, Dept Hlth, Dept Family Med, Tao Yuan, Taiwan; [Tsai, Chris; Chang, Tai-Sheng] Bionet Cooperat Inc, Taipei, Taiwan; [Yang, Chih-Chao] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Li, Hung] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Su, YN (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Genom, Taipei 10764, Taiwan.	leecn@ntu.edu.tw	NTU, Ref07/AAX-7890-2021	Lee, Chien-Nan/0000-0002-1725-0407; LIN, SHIN-YU/0000-0002-0753-2793; Ho, Hong-Nerng/0000-0002-7207-0089; Yang, Chih-Chao/0000-0002-0352-3144	Taiwan National Science Council [95-2314-B-002-280-MY3, 96-2628-B-002-063-MY3]; National Taiwan University Hospital [97S913]; Bionet Cooperation (Taiwan) Inc.	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Bionet Cooperation (Taiwan) Inc.	This study was supported by grants 95-2314-B-002-280-MY3 and 96-2628-B-002-063-MY3 from the Taiwan National Science Council, and by grant 97S913 from National Taiwan University Hospital. Chris Tsai and Tai-Sheng Chang are employees of Bionet Cooperation (Taiwan) Inc., who also supported the carrier screening program by way of a grant. These studies were performed in the laboratory of YNS at National Taiwan University College of Medicine/National Taiwan University Hospital, Taiwan, and at Bionet Cooperation (Taiwan) Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P1194; Anhuf D, 2003, HUM MUTAT, V22, P74, DOI 10.1002/humu.10221; ARKBLAD E, 2009, ACTA PAEDIAT; Arkblad EL, 2006, NEUROMUSCULAR DISORD, V16, P830, DOI 10.1016/j.nmd.2006.08.011; Basel-Vanagaite L, 2008, GENET TEST, V12, P53, DOI 10.1089/gte.2007.0030; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chan V, 2004, J NEUROL, V251, P1089, DOI 10.1007/s00415-004-0487-z; Cusco I, 2002, HUM MUTAT, V20, P452, DOI 10.1002/humu.10144; Cusin V, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e39; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Hendrickson BC, 2009, J MED GENET, V46, P641, DOI 10.1136/jmg.2009.066969; Hung CC, 2005, ANAL CHEM, V77, P6960, DOI 10.1021/ac0512047; Jedrzejowska M, 2008, EUR J HUM GENET, V16, P930, DOI 10.1038/ejhg.2008.41; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Lee TM, 2004, J KOREAN MED SCI, V19, P870, DOI 10.3346/jkms.2004.19.6.870; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Norton ME, 2008, CURR OPIN OBSTET GYN, V20, P157, DOI 10.1097/GCO.0b013e3282f73230; Ogino S, 2004, EUR J HUM GENET, V12, P1015, DOI 10.1038/sj.ejhg.5201288; Ogino S, 2004, EXPERT REV MOL DIAGN, V4, P15, DOI 10.1586/14737159.4.1.15; Ogino S, 2002, HUM GENET, V111, P477, DOI 10.1007/s00439-002-0828-x; Ogino S, 2002, AM J MED GENET, V110, P301, DOI 10.1002/ajmg.10425; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN J, 1980, LANCET, V1, P919; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Prior TW, 2010, OBSTET GYN CLIN N AM, V37, P23, DOI 10.1016/j.ogc.2010.03.001; Prior TW, 2008, GENET MED, V10, P340, DOI 10.1097/GIM.0b013e318188d069; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Roe AM, 2007, AM J MED GENET C, V145C, P77, DOI 10.1002/ajmg.c.30121; Smith M, 2007, EUR J HUM GENET, V15, P759, DOI 10.1038/sj.ejhg.5201821; Su YN, 2005, HUM MUTAT, V25, P460, DOI 10.1002/humu.20160; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Wirth B, 1997, AM J HUM GENET, V61, P1102, DOI 10.1086/301608; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281	42	53	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17067	10.1371/journal.pone.0017067	http://dx.doi.org/10.1371/journal.pone.0017067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364876	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100026
J	Suzuki, SW; Onodera, J; Ohsumi, Y				Suzuki, Sho W.; Onodera, Jun; Ohsumi, Yoshinori			Starvation Induced Cell Death in Autophagy-Defective Yeast Mutants Is Caused by Mitochondria Dysfunction	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; PROTEIN; DEGRADATION; MAINTENANCE; MITOPHAGY; RESPIRATION; VACUOLE; ATG32; GENE	Autophagy is a highly-conserved cellular degradation and recycling system that is essential for cell survival during nutrient starvation. The loss of viability had been used as an initial screen to identify autophagy-defective (atg) mutants of the yeast Saccharomyces cerevisiae, but the mechanism of cell death in these mutants has remained unclear. When cells grown in a rich medium were transferred to a synthetic nitrogen starvation media, secreted metabolites lowered the extracellular pH below 3.0 and autophagy-defective mutants mostly died. We found that buffering of the starvation medium dramatically restored the viability of atg mutants. In response to starvation, wild-type (WT) cells were able to upregulate components of the respiratory pathway and ROS (reactive oxygen species) scavenging enzymes, but atg mutants lacked this synthetic capacity. Consequently, autophagy-defective mutants accumulated the high level of ROS, leading to deficient respiratory function, resulting in the loss of mitochondria DNA (mtDNA). We also showed that mtDNA deficient cells are subject to cell death under low pH starvation conditions. Taken together, under starvation conditions non-selective autophagy, rather than mitophagy, plays an essential role in preventing ROS accumulation, and thus in maintaining mitochondria function. The failure of response to starvation is the major cause of cell death in atg mutants.	[Suzuki, Sho W.; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan; [Suzuki, Sho W.] Tokyo Inst Technol, Grad Sch Biosci, Yokohama, Kanagawa 227, Japan; [Onodera, Jun; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Cell Biol, Mol Cell Biol Div, Okazaki, Aichi 444, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Suzuki, SW (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 227, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166; Suzuki, Sho/0000-0002-6563-5387	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Epple UD, 2001, J BACTERIOL, V183, P5942, DOI 10.1128/JB.183.20.5942-5955.2001; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; HALL RM, 1977, MOL BIOL REP, V3, P443, DOI 10.1007/BF00808386; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	28	114	126	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17412	10.1371/journal.pone.0017412	http://dx.doi.org/10.1371/journal.pone.0017412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364763	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100058
J	Vernon, AC; Crum, WR; Johansson, SM; Modo, M				Vernon, Anthony C.; Crum, William R.; Johansson, Saga M.; Modo, Michel			Evolution of Extra-Nigral Damage Predicts Behavioural Deficits in a Rat Proteasome Inhibitor Model of Parkinson's Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; NEURON DEGENERATION; ALPHA-SYNUCLEIN; BRAIN ATROPHY; MOUSE MODEL; MESENCEPHALIC CULTURES; COGNITIVE IMPAIRMENT; INTRALAMINAR NUCLEI; HUNTINGTONS-DISEASE; ALZHEIMER-DISEASE	Establishing the neurological basis of behavioural dysfunction is key to provide a better understanding of Parkinson's disease (PD) and facilitate development of effective novel therapies. For this, the relationships between longitudinal structural brain changes associated with motor behaviour were determined in a rat model of PD and validated by postmortem immunohistochemistry. Rats bearing a nigrostriatal lesion induced by infusion of the proteasome inhibitor lactacystin into the left-medial forebrain bundle and saline-injected controls underwent magnetic resonance imaging (MRI) at baseline (prior to surgery) and 1, 3 and 5 weeks post-surgery with concomitant motor assessments consisting of forelimb grip strength, accelerating rotarod, and apormorphine-induced rotation. Lactacystin-injected rats developed early motor deficits alongside decreased ipsilateral cortical volumes, specifically thinning of the primary motor (M1) and somatosensory cortices and lateral ventricle hypertrophy (as determined by manual segmentation and deformation-based morphometry). Although sustained, motor dysfunction and nigrostriatal damage were maximal by 1 week post-surgery. Additional volume decreases in the ipsilateral ventral midbrain; corpus striatum and thalamus were only evident by week 3 and 5. Whilst cortical MRI volume changes best predicted the degree of motor impairment, post-mortem tyrosine hydroxylase immunoreactivity in the striatum was a better predictor of motor behaviour overall, with the notable exception of performance in the accelerating rotarod, in which, M1 cortical thickness remained the best predictor. These results highlight the importance of identifying extra-nigral regions of damage that impact on behavioural dysfunction from damage to the nigrostriatal system.	[Vernon, Anthony C.; Johansson, Saga M.; Modo, Michel] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England; [Crum, William R.] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Vernon, AC (corresponding author), Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, Dept Neurosci, London WC2R 2LS, England.	mike.modo@kcl.ac.uk	Crum, William R/C-4891-2008; Modo, Mike/A-5995-2011; Modo, Michel/E-5170-2012	Crum, William R/0000-0001-9369-2197; Modo, Michel/0000-0003-4436-735X; Vernon, Anthony/0000-0001-7305-1069	Edmund J. Safra Foundation; NIHR Biomedical Research Centre for Mental Health at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Wellcome Trust; EPSRC [WT 088641/Z/09/Z]	Edmund J. Safra Foundation; NIHR Biomedical Research Centre for Mental Health at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Edmund J. Safra Foundation funded this study (www.edmondjsafra.org/). W.R. Crum acknowledges support from the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, and the King's College London Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (WT 088641/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUTHNOTT G, 1971, BRAIN RES, V27, P406, DOI 10.1016/0006-8993(71)90272-1; Aymerich MS, 2006, EUR J NEUROSCI, V23, P2099, DOI 10.1111/j.1460-9568.2006.04741.x; Bacci JJ, 2004, J NEUROPATH EXP NEUR, V63, P20, DOI 10.1093/jnen/63.1.20; BAGLIO F, 2009, NEUROBIOL AGING; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks D, 2009, BRAIN RES BULL, V78, P97, DOI 10.1016/j.brainresbull.2008.08.014; Brownell AL, 2003, NEUROIMAGE, V20, P1064, DOI 10.1016/S1053-8119(03)00348-3; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; CENCI MA, 1993, EUR J NEUROSCI, V5, P1062, DOI 10.1111/j.1460-9568.1993.tb00959.x; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; Dalaker TO, 2010, MOVEMENT DISORD, V25, P629, DOI 10.1002/mds.22867; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Debeir T, 2005, EXP NEUROL, V193, P444, DOI 10.1016/j.expneurol.2005.01.007; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Deutch AY, 2006, J NEURAL TRANSM-SUPP, P67; Dunnett SB, 1998, EXP NEUROL, V154, P31, DOI 10.1006/exnr.1998.6926; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Guzman R, 2000, J NEUROSCI METH, V97, P77, DOI 10.1016/S0165-0270(00)00172-2; Halliday GM, 2005, BRAIN, V128, P2272, DOI 10.1093/brain/awh596; Henderson JM, 2000, ANN NEUROL, V47, P345, DOI 10.1002/1531-8249(200003)47:3<345::AID-ANA10>3.3.CO;2-M; Henderson JM, 2000, BRAIN, V123, P1410, DOI 10.1093/brain/123.7.1410; Hou ZY, 2010, J CLIN NEUROSCI, V17, P628, DOI 10.1016/j.jocn.2009.07.101; Ibarretxe-Bilbao N, 2010, J NEUROL NEUROSUR PS, V81, P650, DOI 10.1136/jnnp.2009.179655; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jenkins BG, 2004, J NEUROSCI, V24, P9553, DOI 10.1523/JNEUROSCI.1558-04.2004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Junque C, 2005, MOVEMENT DISORD, V20, P540, DOI 10.1002/mds.20371; Kassubek J, 2002, NEUROSCI LETT, V323, P29, DOI 10.1016/S0304-3940(02)00111-8; Kondoh T, 2005, EXP NEUROL, V192, P194, DOI 10.1016/j.expneurol.2004.12.016; Kostic VS, 2010, NEUROLOGY, V75, P857, DOI 10.1212/WNL.0b013e3181f11c1d; Lauwers E, 2007, NEUROBIOL AGING, V28, P248, DOI 10.1016/j.neurobiolaging.2005.12.005; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; MacInnes N, 2008, J NEURAL TRANSM, V115, P869, DOI 10.1007/s00702-008-0027-6; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Miwa H, 2005, NEUROSCI LETT, V380, P93, DOI 10.1016/j.neulet.2005.01.024; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Orieux G, 2000, NEUROSCIENCE, V97, P79, DOI 10.1016/S0306-4522(00)00011-7; Pavese N, 2009, BBA-MOL BASIS DIS, V1792, P722, DOI 10.1016/j.bbadis.2008.10.003; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pedersen KM, 2005, MOVEMENT DISORD, V20, P164, DOI 10.1002/mds.20289; Pelled G, 2002, EUR J NEUROSCI, V15, P389, DOI 10.1046/j.0953-816x.2001.01866.x; Pelled G, 2005, EUR J NEUROSCI, V21, P2227, DOI 10.1111/j.1460-9568.2005.04035.x; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Peran P, 2010, BRAIN; PRODOEHL J, 2010, MOV DISORD; Reaney SH, 2006, EXP NEUROL, V202, P434, DOI 10.1016/j.expneurol.2006.07.010; Recchia A, 2008, NEUROBIOL DIS, V30, P8, DOI 10.1016/j.nbd.2007.11.002; REIJNDERS JS, 2010, MOV DISORD; Ren QG, 2009, J MOL NEUROSCI, V38, P57, DOI 10.1007/s12031-008-9161-8; Ren QG, 2009, NEUROCHEM RES, V34, P859, DOI 10.1007/s11064-008-9830-6; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P12, DOI 10.1016/j.nbd.2008.09.017; Saywell W, 2006, BIOCHEM BIOPH RES CO, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Sedahat K, 2009, BRAIN RES, V1271, P83, DOI 10.1016/j.brainres.2009.03.026; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Summerfield C, 2005, ARCH NEUROL-CHICAGO, V62, P281, DOI 10.1001/archneur.62.2.281; Tam CWC, 2005, NEUROLOGY, V64, P861, DOI 10.1212/01.WNL.0000153070.82309.D4; Tessa C, 2010, EXP NEUROL, V224, P299, DOI 10.1016/j.expneurol.2010.04.005; Van Camp N, 2010, MAGN RESON MATER PHY, V23, P65, DOI 10.1007/s10334-010-0198-7; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Wang HD, 2008, NEUROPSYCHOPHARMACOL, V33, P1276, DOI 10.1038/sj.npp.1301521; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Zhang X, 2005, BIOCHEM BIOPH RES CO, V333, P544, DOI 10.1016/j.bbrc.2005.05.150; Zhang ZM, 2006, NEUROIMAGE, V33, P636, DOI 10.1016/j.neuroimage.2006.07.004; Zhu W, 2007, FASEB J, V21, P3835, DOI 10.1096/fj.07-8386com	87	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17269	10.1371/journal.pone.0017269	http://dx.doi.org/10.1371/journal.pone.0017269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364887	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100038
J	Bonilla, C; Hooker, S; Mason, T; Bock, CH; Kittles, RA				Bonilla, Carolina; Hooker, Stanley; Mason, Tshela; Bock, Cathryn H.; Kittles, Rick A.			Prostate Cancer Susceptibility Loci Identified on Chromosome 12 in African Americans	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GENE POLYMORPHISMS; RISK; ASSOCIATION; VARIANTS; LINKAGE; EXPRESSION; CYP27B1; CYP24A1; PAR-4	Prostate cancer (PCa) is a complex disease that disproportionately affects African Americans and other individuals of African descent. A number of regions across the genome have been associated to PCa, most of them with moderate effects. A few studies have reported chromosomal changes on 12p and 12q that occur during the onset and development of PCa but to date no consistent association of the disease with chromosome 12 polymorphic variation has been identified. In order to unravel genetic risk factors that underlie PCa health disparities we investigated chromosome 12 using ancestry informative markers (AIMs), which allow us to distinguish genomic regions of European or West African origin, and tested them for association with PCa. Additional SNPs were genotyped in those areas where significant signals of association were detected. The strongest signal was discovered at the SNP rs12827748, located upstream of the PAWR gene, a tumor suppressor, which is amply expressed in the prostate. The most frequent allele in Europeans was the risk allele among African Americans. We also examined vitamin D related genes, VDR and CYP27B1, and found a significant association of PCa with the TaqI polymorphism (rs731236) in the former. Although our results warrant further investigation we have uncovered a genetic susceptibility factor for PCa in a likely candidate by means of an approach that takes advantage of the differential contribution of parental groups to an admixed population.	[Bonilla, Carolina] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hooker, Stanley; Kittles, Rick A.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Mason, Tshela] Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; [Bock, Cathryn H.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA	University of Bristol; University of Chicago; Howard University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Bonilla, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	C.Bonilla@bristol.ac.uk	Bonilla, Carolina/U-9263-2018	Bonilla, Carolina/0000-0002-9972-6383; Bock, Cathryn/0000-0002-8696-768X; Kittles, Rick/0000-0002-5004-4437	US Department of Defense [W81XWH-06-1-0066]	US Department of Defense(United States Department of Defense)	CB was a recipient of US Department of Defense-Congressionally Directed Medical Research Program grant no. W81XWH-06-1-0066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Andersson P, 2006, EUR J CANCER, V42, P2833, DOI 10.1016/j.ejca.2006.06.030; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berndt SI, 2006, J UROLOGY, V175, P1613, DOI 10.1016/S0022-5347(05)00958-4; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; Gsur A, 2002, PROSTATE, V51, P30, DOI 10.1002/pros.10064; Hawkins GA, 2002, PROSTATE, V53, P175, DOI 10.1002/pros.10144; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Holick CN, 2007, CANCER EPIDEM BIOMAR, V16, P1990, DOI 10.1158/1055-9965.EPI-07-0487; Ingles SA, 1998, CANCER RES, V58, P1620; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy S, 2003, CANCER METAST REV, V22, P83, DOI 10.1023/A:1022216119066; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Schaid DJ, 2007, HUM GENET, V121, P729, DOI 10.1007/s00439-007-0368-5; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Taylor JA, 1996, CANCER RES, V56, P4108; Whitman EJ, 2010, CANCER EPIDEM BIOMAR, V19, P1, DOI 10.1158/1055-9965.EPI-08-1111; Yin M, 2009, INT J CLIN EXP MED, V2, P159; Zapata-Benavides P, 2009, ARCH MED RES, V40, P595, DOI 10.1016/j.arcmed.2009.08.007	27	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16044	10.1371/journal.pone.0016044	http://dx.doi.org/10.1371/journal.pone.0016044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358824	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700015
J	Pena, SDJ; Di Pietro, G; Fuchshuber-Moraes, M; Genro, JP; Hutz, MH; Kehdy, FDG; Kohlrausch, F; Magno, LAV; Montenegro, RC; Moraes, MO; de Moraes, MEA; de Moraes, MR; Ojopi, EB; Perini, JA; Racciopi, C; Ribeiro-dos-Santos, AKC; Rios-Santos, F; Romano-Silva, MA; Sortica, VA; Suarez-Kurtz, G				Pena, Sergio D. J.; Di Pietro, Giuliano; Fuchshuber-Moraes, Mateus; Genro, Julia Pasqualini; Hutz, Mara H.; Gomes Kehdy, Fernanda de Souza; Kohlrausch, Fabiana; Viana Magno, Luiz Alexandre; Montenegro, Raquel Carvalho; Moraes, Manoel Odorico; Amaral de Moraes, Maria Elisabete; de Moraes, Milene Raiol; Ojopi, Elida B.; Perini, Jamila A.; Racciopi, Clarice; Campos Ribeiro-dos-Santos, Andrea Kely; Rios-Santos, Fabricio; Romano-Silva, Marco A.; Sortica, Vinicius A.; Suarez-Kurtz, Guilherme			The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected	PLOS ONE			English	Article							COLOR; POLYMORPHISMS; DIVERSITY; VKORC1; WARFARIN; IMPACT	Based on pre-DNA racial/color methodology, clinical and pharmacological trials have traditionally considered the different geographical regions of Brazil as being very heterogeneous. We wished to ascertain how such diversity of regional color categories correlated with ancestry. Using a panel of 40 validated ancestry-informative insertion-deletion DNA polymorphisms we estimated individually the European, African and Amerindian ancestry components of 934 self-categorized White, Brown or Black Brazilians from the four most populous regions of the Country. We unraveled great ancestral diversity between and within the different regions. Especially, color categories in the northern part of Brazil diverged significantly in their ancestry proportions from their counterparts in the southern part of the Country, indicating that diverse regional semantics were being used in the self-classification as White, Brown or Black. To circumvent these regional subjective differences in color perception, we estimated the general ancestry proportions of each of the four regions in a form independent of color considerations. For that, we multiplied the proportions of a given ancestry in a given color category by the official census information about the proportion of that color category in the specific region, to arrive at a "total ancestry" estimate. Once such a calculation was performed, there emerged a much higher level of uniformity than previously expected. In all regions studied, the European ancestry was predominant, with proportions ranging from 60.6% in the Northeast to 77.7% in the South. We propose that the immigration of six million Europeans to Brazil in the 19(th) and 20(th) centuries - a phenomenon described and intended as the "whitening of Brazil" -is in large part responsible for dissipating previous ancestry dissimilarities that reflected region-specific population histories. These findings, of both clinical and sociological importance for Brazil, should also be relevant to other countries with ancestrally admixed populations.	[Pena, Sergio D. J.; Gomes Kehdy, Fernanda de Souza; Racciopi, Clarice] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Di Pietro, Giuliano; Rios-Santos, Fabricio] Univ Estadual Santa Cruz, Dept Ciencias Saude, Ilheus, Brazil; [Fuchshuber-Moraes, Mateus; Kohlrausch, Fabiana; Perini, Jamila A.; Suarez-Kurtz, Guilherme] Inst Nacl Canc, Coordenacao Pesquisa Div Farmacol, Rio De Janeiro, Brazil; [Genro, Julia Pasqualini; Hutz, Mara H.; Sortica, Vinicius A.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Viana Magno, Luiz Alexandre; Romano-Silva, Marco A.] Univ Fed Minas Gerais, INCT MM, Lab Neurociencia, Fac Med, Belo Horizonte, MG, Brazil; [Montenegro, Raquel Carvalho; Moraes, Manoel Odorico; Amaral de Moraes, Maria Elisabete] Univ Fed Ceara, Unidade Farmacol Clin, Dept Fisiol & Farmacol, Fac Med, Fortaleza, Ceara, Brazil; [Amaral de Moraes, Maria Elisabete; Campos Ribeiro-dos-Santos, Andrea Kely] Fed Univ Para, Lab Genet Humana & Med, Guama, Brazil; [Ojopi, Elida B.] Univ Sao Paulo, Fac Med, Lab Neurociencias, Inst Psiquiatria, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual de Santa Cruz; National Cancer Institute (Inca); Universidade Federal do Rio Grande do Sul; Universidade Federal de Minas Gerais; Universidade Federal do Ceara; Universidade Federal do Para; Universidade de Sao Paulo	Pena, SDJ (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	spena@dcc.ufmg.br	Ojopi, Elida Benquique/A-6773-2012; Genro, Julia/J-4795-2015; Sortica, Vinicius A/G-5772-2017; Romano-Silva, Marco Aurelio/A-1790-2008; Magno, Alexandre/B-1552-2010; Kohlrausch, Fabiana/AEQ-7448-2022; Rios-Santos, Fabricio/E-5930-2011; Hutz, Mara H/I-4070-2012; Magno, Luiz Alexandre V./AAJ-9839-2021; Suarez-Kurtz, Guilherme/J-6648-2012; Romano-Silva, Marco Aurelio/T-8321-2019; Santos, Ândrea Ribeiro dos/B-6061-2013; Montenegro, Raquel/I-1260-2013; Kohlrausch, Fabiana/H-1989-2012; Suarez-Kurtz, Guilherme/P-4620-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019	Ojopi, Elida Benquique/0000-0001-5824-5199; Sortica, Vinicius A/0000-0001-6185-0832; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Magno, Alexandre/0000-0003-3693-1897; Kohlrausch, Fabiana/0000-0001-5992-2905; Rios-Santos, Fabricio/0000-0001-7151-1631; Magno, Luiz Alexandre V./0000-0003-3693-1897; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Montenegro, Raquel/0000-0002-3861-293X; Kohlrausch, Fabiana/0000-0001-5992-2905; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Hutz, Mara/0000-0002-9146-1229; Di Pietro, Giuliano/0000-0001-9753-222X; Kehdy, Fernanda/0000-0001-8964-9049	Financiadora de Estudos e Projetos (FINEP) of Brazil [01.08.0123.00]	Financiadora de Estudos e Projetos (FINEP) of Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by the Financiadora de Estudos e Projetos (FINEP) of Brazil, by contract 01.08.0123.00 to the Rede Nacional de Farmacogenetica/-genomica - REFARGEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; [Anonymous], 1999, NOVOS ESTUD-CEBRAP; Bastos JL, 2009, CAD SAUDE PUBLICA, V25, P2111, DOI 10.1590/S0102-311X2009001000003; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Cann HM, 2002, SCIENCE, V296, P261; Carvalho-Silva DR, 2006, GENETICA, V126, P251, DOI 10.1007/s10709-005-1454-z; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Costa S, 2006, EST AFRO ASIAT, V28, P47; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; dos Santos SA, 2002, LAT AM PERSPECT, V29, P61, DOI 10.1177/0094582X0202900104; Graham DJ, 2000, EARTH SURF PROC LAND, V25, P1473, DOI 10.1002/1096-9837(200012)25:13&lt;1473::AID-ESP158&gt;3.0.CO;2-C; Harris Marvin., 1980, PATTERNS RACE AM; Harris Marvin, 1963, SOCIOLOGIA, V25, P203; IBGE, 2012, BRAS 500 AN POV; IBGE, 2003, EST SEC 20; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jonas DE, 2009, TRENDS PHARMACOL SCI, V30, P375, DOI 10.1016/j.tips.2009.05.001; KLEIN HS, 1992, J SOC HIST, V25, P505, DOI 10.1353/jsh/25.3.505; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Manly BFJ, 1997, RANDOMIZATION BOOTST; Nobles M, 2000, AM J PUBLIC HEALTH, V90, P1738, DOI 10.2105/AJPH.90.11.1738; Osorio R.G, 2003, SISTEMA CLASSIFICATO; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026; Petruccelli JL, 2001, EST AFRO ASIAT, V23, P5; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; PRADO Paulo, 1981, RETRATO BRASIL ENSAI; Pritchard JK, 2000, GENETICS, V155, P945; Ribeiro D., 1995, POVO BRASILEIRO FORM; Salzano FM, 1970, STUDY BRAZILIAN POPU; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Seyferth G, 1986, CIENCIA HOJE, P54; Seyferth Giralda, 1985, REV MUS PAULISTA, V30, P81; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Suarez-Kurtz G, 2006, CURR DRUG TARGETS, V7, P1649, DOI 10.2174/138945006779025392; Suarez-Kurtz G, 2007, PHARMACOGENOMICS, V8, P1299, DOI 10.2217/14622416.8.10.1299; Suarez-Kurtz G, 2010, PHARMACOGENOMICS, V11, P1257, DOI [10.2217/pgs.10.89, 10.2217/PGS.10.89]; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Takahashi H, 2006, PHARMACOGENET GENOM, V16, P101, DOI 10.1097/01.fpc.0000184955.08453.a8; Talbot J, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-87; Telles EE, 2002, ETHNIC RACIAL STUD, V25, P415, DOI 10.1080/01419870252932133; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727	43	406	423	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17063	10.1371/journal.pone.0017063	http://dx.doi.org/10.1371/journal.pone.0017063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359226	gold, Green Published, Green Submitted			2022-12-27	WOS:000287392700041
J	Kakutani, H; Takahashi, A; Kondoh, M; Saito, Y; Yamaura, T; Sakihama, T; Hamakubo, T; Yagi, K				Kakutani, Hideki; Takahashi, Azusa; Kondoh, Masuo; Saito, Yumiko; Yamaura, Toshiaki; Sakihama, Toshiko; Hamakubo, Takao; Yagi, Kiyohito			A Novel Screening System for Claudin Binder Using Baculoviral Display	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; PROTEIN-COUPLED RECEPTOR; TIGHT JUNCTION STRANDS; C-TERMINAL FRAGMENT; BUDDED BACULOVIRUS; CANCER; BARRIER; RECONSTITUTION; THERAPY; COMPLEX	Recent progress in cell biology has provided new insight into the claudin (CL) family of integral membrane proteins, which contains more than 20 members, as a target for pharmaceutical therapy. Few ligands for CL have been identified because it is difficult to prepare CL in an intact form. In the present study, we developed a method to screen for CL binders by using the budded baculovirus (BV) display system. CL4-displaying BV interacted with a CL4 binder, the C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE), but it did not interact with C-CPE that was mutated in its CL4-binding region. C-CPE did not interact with BV and CL1-displaying BV. We used CL4-displaying BV to select CL4-binding phage in a mixture of a scFv-phage and C-CPE-phage. The percentage of C-CPE-phage in the phage mixture increased from 16.7% before selection to 92% after selection, indicating that CL-displaying BV may be useful for the selection of CL binders. We prepared a C-CPE phage library by mutating the functional amino acids. We screened the library for CL4 binders by affinity to CL4-displaying BV, and we found that the novel CL4 binders modulated the tight-junction barrier. These findings indicate that the CL-displaying BV system may be a promising method to produce a novel CL binder and modulator.	[Kakutani, Hideki; Takahashi, Azusa; Kondoh, Masuo; Saito, Yumiko; Yamaura, Toshiaki; Yagi, Kiyohito] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Osaka, Japan; [Sakihama, Toshiko; Hamakubo, Takao] Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	Osaka University; University of Tokyo	Kakutani, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Osaka, Japan.	masuo@phs.osaka-u.ac.jp; yagi@phs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21689006]; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; Suzuken Memorial Foundation; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21689006), by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, by Takeda Science Foundation, by a Suzuken Memorial Foundation, by a grant from Kansai Biomedical Cluster project in Saito, which is promoted by the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a Research Grant for Promoting Technological Seeds from Japan Science and Technology Agency. A.T. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Balda MS, 1998, J CELL SCI, V111, P541; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Loisel TP, 1997, NAT BIOTECHNOL, V15, P1300, DOI 10.1038/nbt1197-1300; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; MCCLANE BA, 1994, TOXICOLOGY, V87, P43, DOI 10.1016/0300-483X(94)90154-6; MEUNIER V, 1995, CELL BIOL TOXICOL, V11, P187, DOI 10.1007/BF00756522; Michl P, 2001, GASTROENTEROLOGY, V121, P678, DOI 10.1053/gast.2001.27124; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Offner S, 2005, CANCER IMMUNOL IMMUN, V54, P431, DOI 10.1007/s00262-004-0613-x; Romani C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.010; Saeki R, 2009, MOL PHARMACOL, V76, P918, DOI 10.1124/mol.109.058412; Sakihama T, 2008, J BIOTECHNOL, V135, P28, DOI 10.1016/j.jbiotec.2008.02.022; Sakihama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004024; Santin AD, 2005, CANCER RES, V65, P4334, DOI 10.1158/0008-5472.CAN-04-3472; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suzuki M, 2009, CANCER SCI, V100, P1623, DOI 10.1111/j.1349-7006.2009.01239.x; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16611	10.1371/journal.pone.0016611	http://dx.doi.org/10.1371/journal.pone.0016611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339813	Green Published, gold			2022-12-27	WOS:000287367600014
J	Weinstock-Guttman, B; Zivadinov, R; Cutter, G; Tamano-Blanco, M; Marr, K; Badgett, D; Carl, E; Elfadil, M; Kennedy, C; Benedict, RHB; Ramanathan, M				Weinstock-Guttman, Bianca; Zivadinov, Robert; Cutter, Gary; Tamano-Blanco, Miriam; Marr, Karen; Badgett, Darlene; Carl, Ellen; Elfadil, Makki; Kennedy, Cheryl; Benedict, Ralph H. B.; Ramanathan, Murali			Chronic Cerebrospinal Vascular Insufficiency Is Not Associated with HLA DRB1*1501 Status in Multiple Sclerosis Patients	PLOS ONE			English	Article							VENOUS INSUFFICIENCY; DIAGNOSIS; HLA-DRB1; GENETICS; ALLELES; DISEASE; RISK; FLOW	Background: Chronic cerebrospinal venous insufficiency (CCSVI) was described as a vascular condition characterized by anomalies of veins outside the skull was reported to be associated with multiple sclerosis (MS). The objective was to assess the associations between HLA DRB1*1501 status and the occurrence of CCSVI in MS patients. Methodology/Principal Findings: This study included 423 of 499 subjects enrolled in the Combined Transcranial and Extracranial Venous Doppler Evaluation (CTEVD) study. The HLA DRB1*1501 status was obtained in 268 MS patients and 155 controls by genotyping rs3135005, a SNP associated with DRB1*1501 status. All subjects underwent a clinical examination and Doppler scan of the head and neck. The frequency of CCSVI was higher (OR = 4.52, P < 0.001) in the MS group 56.0% vs. 21.9% in the controls group and also higher in the progressive MS group 69.8% vs. 49.5% in the non-progressive MS group. The 51.9% frequency of HLA DRB1*1501 positivity (HLA(+)) in MS was higher compared (OR = 2.33, P < 0.001) to 31.6% to controls. The HLA+ frequency in the non-progressive (51.6%) and progressive MS groups (52.3%) was similar. The frequency of HLA(+) CCSVI+ was 40.7% in progressive MS, 27.5% in non-progressive MS and 8.4% in controls. The presence of CCSVI was independent of HLA DRB1*1501 status in MS patients. Conclusions/Significance: The lack of strong associations of CCSVI with HLA DRB1*1501 suggests that the role of the underlying associations of CCSVI in MS should be interpreted with caution. Further longitudinal studies should determine whether interactions between these factors can contribute to disease progression in MS.	[Weinstock-Guttman, Bianca; Zivadinov, Robert; Marr, Karen; Carl, Ellen; Elfadil, Makki; Kennedy, Cheryl] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Cutter, Gary] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Tamano-Blanco, Miriam; Badgett, Darlene; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Weinstock-Guttman, B (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	Murali@Buffalo.Edu	Zivadinov, Robert/Q-2054-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Cutter, Gary/AAY-5392-2021; Carl, Ellen/AAC-9162-2020	Zivadinov, Robert/0000-0002-7799-1485; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Cutter, Gary/0000-0002-8455-980X; Carl, Ellen/0000-0002-0930-8285	Buffalo Neuroimaging Analysis Center and Baird MS Center; Jacobs Neurological Institute; University of Buffalo; Direct MS Foundation; Jacquemin Family Foundation; Estee Lauder Companies	Buffalo Neuroimaging Analysis Center and Baird MS Center; Jacobs Neurological Institute; University of Buffalo; Direct MS Foundation; Jacquemin Family Foundation; Estee Lauder Companies	This study was funded by internal resources of the Buffalo Neuroimaging Analysis Center and Baird MS Center, the Jacobs Neurological Institute, and the University of Buffalo. In addition, the authors received support from the Direct MS Foundation, the Jacquemin Family Foundation, Suzanne Brown, Estee Lauder Companies, Greg Gibb, Roland Kurman, Carmen and Suzzanne Linderman, Liliana Macreanu, Jill and Larry Nolan, Tactical Technologies, The Flowers4MS Foundation, and The Pink Door. Suzanne Brown, Greg Gibb, Roland Kurman, Carmen and Suzzanne Linderman, Liliana Macreanu, and Jill and Larry Nolan donated as private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Brouillard P, 2007, HUM MOL GENET, V16, pR140, DOI 10.1093/hmg/ddm211; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Ferlini A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-64; Vasconcelos CCF, 2009, J NEUROIMMUNOL, V214, P101, DOI 10.1016/j.jneuroim.2009.06.009; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hojnacki D, 2010, INT ANGIOL, V29, P127; Hu HT, 2008, J INVEST DERMATOL, V128, P2325, DOI 10.1038/jid.2008.89; Kantarci OH, 2008, SEMIN NEUROL, V28, P7, DOI 10.1055/s-2007-1019125; Khatri VP, 2001, ANN SURG, V233, P282, DOI 10.1097/00000658-200102000-00019; Koc Z, 2007, EUR J RADIOL, V61, P267, DOI 10.1016/j.ejrad.2006.09.008; Limaye N, 2009, HUM MOL GENET, V18, pR65, DOI 10.1093/hmg/ddp002; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Singh AV, 2009, J CEREBR BLOOD F MET, V29, P1867, DOI 10.1038/jcbfm.2009.180; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Weatherby SJM, 2001, J NEUROL, V248, P304, DOI 10.1007/s004150170205; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2010, RADIOLOGY IN PRESS; Zivadinov R, 2010, NEUROLOGY IN PRESS; Zivadinov R, 2010, AM J NEUROR IN PRESS	29	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16802	10.1371/journal.pone.0016802	http://dx.doi.org/10.1371/journal.pone.0016802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340025	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600020
J	Gutierrez, O; Berciano, MT; Lafarga, M; Fernandez-Luna, JL				Gutierrez, Olga; Berciano, Maria T.; Lafarga, Miguel; Fernandez-Luna, Jose L.			A Novel Pathway of TEF Regulation Mediated by MicroRNA-125b Contributes to the Control of Actin Distribution and Cell Shape in Fibroblasts	PLOS ONE			English	Article							RHO-GTPASES; P53; APOPTOSIS; LEUKEMIA; GENES; DIFFERENTIATION; EXPRESSION; PROTEINS; DYNAMICS; LINES	Background: Thyrotroph embryonic factor (TEF), a member of the PAR bZIP family of transcriptional regulators, has been involved in neurotransmitter homeostasis, amino acid metabolism, and regulation of apoptotic proteins. In spite of its relevance, nothing is known about the regulation of TEF. Principal Findings: p53-dependent genotoxic agents have been shown to be much more harmful for PAR bZIP-deficient mice as compared to wild type animals. Here we demonstrate that TEF expression is controlled by p53 through upregulation of microRNA-125b, as determined by both regulating the activity of p53 and transfecting cells with microRNA-125b precursors. We also describe a novel role for TEF in controlling actin distribution and cell shape in mouse fibroblasts. Lack of TEF is accompanied by dramatic increase of cell area and decrease of elongation (bipolarity) and dispersion (multipolarity). Staining of actin cytoskeleton also showed that TEF (-/-) cells are characterized by appearance of circumferential actin bundles and disappearance of straight fibers. Interestingly, transfection of TEF (-/-) fibroblasts with TEF induced a wild type-like phenotype. Consistent with our previous findings, transfection of wild type fibroblasts with miR-125b promoted a TEF (-/-)-like phenotype, and a similar but weaker effect was observed following exogenous expression of p53. Conclusions/Significance: These findings provide the first evidence of TEF regulation, through a miR-125b-mediated pathway, and describes a novel role of TEF in the maintenance of cell shape in fibroblasts.	[Gutierrez, Olga; Fernandez-Luna, Jose L.] Hosp Univ Marques de Valdecilla, Unidad Genet Mol, Inst Formac & Invest Marques de Valdecilla, Serv Cantabro Salud, Santander, Spain; [Berciano, Maria T.; Lafarga, Miguel] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Gutierrez, O (corresponding author), Hosp Univ Marques de Valdecilla, Unidad Genet Mol, Inst Formac & Invest Marques de Valdecilla, Serv Cantabro Salud, Santander, Spain.	fluna@humv.es	Xie, Huangming/B-2260-2012	Lafarga, Miguel/0000-0003-3402-1152; Berciano, Maria T./0000-0002-8225-6995	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) [RD06/0020/0074, PI070196]; Fundacion Marques de Valdecilla [API08/01]	Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III)	Funding: This work was supported by Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) grant RD06/0020/0074 (Red Tematica de Investigacion Cooperativa en Cancer), PI070196, and Accion Transversal del Cancer 2008, and grant API08/01 from Fundacion Marques de Valdecilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Benito A, 1996, BLOOD, V87, P3837, DOI 10.1182/blood.V87.9.3837.bloodjournal8793837; Benito A, 2006, J BIOL CHEM, V281, P38351, DOI 10.1074/jbc.M607004200; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; GEFEN N, LEUKEMIA, V24, P89; Gloushankova N, 1997, ONCOGENE, V15, P2985, DOI 10.1038/sj.onc.1201483; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hong M, 1999, CANCER RES, V59, P2847; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; KHATIB ZA, 1994, GENOMICS, V23, P344, DOI 10.1006/geno.1994.1510; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEUNG AK, MOL CELL, V40, P205; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Rizzo MG, 1998, BRIT J CANCER, V77, P1429, DOI 10.1038/bjc.1998.236; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Wang PY, 2010, MOL CELL BIOCHEM, V339, P163, DOI 10.1007/s11010-009-0380-2; Wittmann T, 2001, J CELL SCI, V114, P3795; Xie SY, 2010, ONCOL REP, V23, P1693, DOI 10.3892/or_00000813; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17169	10.1371/journal.pone.0017169	http://dx.doi.org/10.1371/journal.pone.0017169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347262	gold, Green Published			2022-12-27	WOS:000287364500037
J	Sultana, R; Tanneeru, K; Guruprasad, L				Sultana, Rafiya; Tanneeru, Karunakar; Guruprasad, Lalitha			The PE-PPE Domain in Mycobacterium Reveals a Serine alpha/beta Hydrolase Fold and Function: An In-Silico Analysis	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; GAP PENALTIES; TUBERCULOSIS; PURIFICATION; SEQUENCE; TRIACYLGLYCEROL; EXPRESSION; FAMILY; LIPASE; IDENTIFICATION	The PE and PPE proteins first reported in the genome sequence of Mycobacterium tuberculosis strain H37Rv are now identified in all mycobacterial species. The PE-PPE domain (Pfam ID: PF08237) is a 225 amino acid residue conserved region located towards the C-terminus of some PE and PPE proteins and hypothetical proteins. Our in-silico sequence analysis revealed that this domain is present in all Mycobacteria, some Rhodococcus and Nocardia farcinica genomes. This domain comprises a pentapeptide sequence motif GxSxG/S at the N-terminus and conserved amino acid residues Ser, Asp and His that constitute a catalytic triad characteristic of lipase, esterase and cutinase activity. The fold prediction and comparative modeling of the 3-D structure of the PE-PPE domain revealed a "serine alpha/beta hydrolase'' structure with a central beta-sheet flanked by alpha-helices on either side. The structure comprises a lid insertion with a closed structure conformation and has a solvent inaccessible active site. The oxyanion hole that stabilizes the negative charge on the tetrahedral intermediate has been identified. Our findings add to the growing list of serine hydrolases in mycobacterium, which are essential for the maintenance of their impermeable cell wall and virulence. These results provide the directions for the design of experiments to establish the function of PE and PPE proteins.	[Sultana, Rafiya; Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Sultana, R (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in	Tanneeru, Karunakar/C-8200-2019; Tanneeru, Karunakar/C-8946-2016	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	CSIR, New Delhi India; Council of Scientific and Industrial Research	CSIR, New Delhi India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The students Ms. Rafiya Sultana and Mr. Karunakar Tanneeru received fellowships from CSIR, New Delhi India. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RS and KT thank Council of Scientific and Industrial Research for providing research fellowship. The authors thank CMSD, University of Hyderabad for the computational facility.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brod FCA, 2010, MOL BIOTECHNOL, V44, P242, DOI 10.1007/s12033-009-9232-2; Brod FCA, 2010, MOL BIOTECHNOL, V44, P110, DOI 10.1007/s12033-009-9218-0; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; du Plessis EM, 2010, CURR MICROBIOL, V60, P248, DOI 10.1007/s00284-009-9533-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fett WF, 1999, J APPL MICROBIOL, V86, P561, DOI 10.1046/j.1365-2672.1999.00690.x; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Ilinkin I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-71; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN TS, 1980, PHYSIOL PLANT PATHOL, V17, P1, DOI 10.1016/0048-4059(80)90002-8; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Park IH, 2009, J MICROBIOL BIOTECHN, V19, P128, DOI 10.4014/jmb.0802.130; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; SEBASTIAN J, 1988, ARCH BIOCHEM BIOPHYS, V263, P77, DOI 10.1016/0003-9861(88)90615-7; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SIMONE GD, 2004, J BIOL CHEM, V279, P6815; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421	43	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16745	10.1371/journal.pone.0016745	http://dx.doi.org/10.1371/journal.pone.0016745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347309	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000016
J	Sriwilaijaroen, N; Kondo, S; Yagi, H; Takemae, N; Saito, T; Hiramatsu, H; Kato, K; Suzuki, Y				Sriwilaijaroen, Nongluk; Kondo, Sachiko; Yagi, Hirokazu; Takemae, Nobuhiro; Saito, Takehiko; Hiramatsu, Hiroaki; Kato, Koichi; Suzuki, Yasuo			N-Glycans from Porcine Trachea and Lung: Predominant NeuAc alpha 2-6Gal Could Be a Selective Pressure for Influenza Variants in Favor of Human-Type Receptor	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; GLYCOLYLNEURAMINIC ACID; BINDING PROPERTIES; VIRUS-INFECTION; MOLECULAR-BASIS; H5N1 INFLUENZA; HOST-RANGE; A VIRUSES; ORIGIN; CELLS	It is known that pigs acted as "mixing vessels" for genesis of a new reassortant influenza strain responsible for pandemic H1N1 2009. However, the host factors driving the evolution of a reassorted virus in pigs to 'jump species' resulting in a human outbreak remain unclear. N-glycans derived from the porcine respiratory tract were enzymatically released, fluorescent labeled with 2-aminopyridine, separated according to charge, size and hydrophobicity, and structurally identified by a two-dimensional (size and hydrophobicity) HPLC mapping technique and MALDI-TOF mass spectrometry before and after exo-glycosidase digestion. We found a 3-, 5-, and 13-fold increases in NeuAc alpha 2-6, a preferable human influenza receptor, over NeuAc alpha 2-3, an avian influenza receptor, from upper and lower parts of the porcine trachea towards the porcine lung, a major target organ for swine virus replication. The large proportion of NeuAc alpha 2-6 may exert selective pressure for selection of influenza variants with altered receptor preference for this human-type alpha 2-6 receptor, a crucial first step for generating a human pandemic.	[Sriwilaijaroen, Nongluk] Thammasat Univ, Fac Med, Pathum Thani, Thailand; [Sriwilaijaroen, Nongluk; Hiramatsu, Hiroaki; Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Aichi, Japan; [Kondo, Sachiko; Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Aichi, Japan; [Kondo, Sachiko; Kato, Koichi] GLYENCE Co Ltd, Aichi, Japan; [Takemae, Nobuhiro; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborat Ctr, Bangkok, Thailand; [Takemae, Nobuhiro; Saito, Takehiko] Natl Agr & Food Res Org NARO, Res Team Zoonot Dis, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan; [Kato, Koichi] Inst Mol Sci, Aichi, Japan; [Kato, Koichi] Natl Inst Natl Sci, Okazaki Inst Integrat Biosci, Aichi, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Tokyo 112, Japan; [Suzuki, Yasuo] Univ Shizuoka, Sch Pharmaceut Sci, Global COE Program Innovat Human Sci, Shizuoka 4228526, Japan	Thammasat University; Chubu University; Nagoya City University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Ochanomizu University; University of Shizuoka	Sriwilaijaroen, N (corresponding author), Thammasat Univ, Fac Med, Rangsit Campus, Pathum Thani, Thailand.	suzukiy@isc.chubu.ac.jp	Saito, Takehiko/AFM-3038-2022; Yagi, Hirokazu/ABH-6151-2020	Yasuo, Suzuki/0000-0003-3518-5642; Sriwilaijaroen, Nongluk/0000-0001-7351-6102; Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	Ministry of Education, Culture, Sports, Science and Technology, Japan [20390028]; Health and Labor Science Research Grants, Japan; Grants-in-Aid for Scientific Research [22790076] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Science Research Grants, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grant-in-aid (20390028) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by Health and Labor Science Research Grants, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although GLYENCE Co., Ltd., did not provide direct financial support, it can be considered as an indirect funder for this study. SK and KK are an employee and an advisory director, respectively, of GLYENCE Co., Ltd., Therefore GLYENCE Co., Ltd., played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bewley CA, 2008, NAT BIOTECHNOL, V26, P60, DOI 10.1038/nbt0108-60; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Choi YK, 2005, J VIROL, V79, P10821, DOI 10.1128/JVI.79.16.10821-10825.2005; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; FABLET C, 2010, VET MICROBI IN PRESS; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs MJ, 2006, NATURE, V440, pE8, DOI 10.1038/nature04823; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; HUSSEINI RH, 1983, J GEN VIROL, V64, P589, DOI 10.1099/0022-1317-64-3-589; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Olsen CW, 2006, DIS SWINE, V9, P469; Roberts Bryan, 2008, P3, DOI 10.1007/978-0-387-75722-3_1; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Sriwilaijaroen N, 2009, GLYCOCONJUGATE J, V26, P433, DOI 10.1007/s10719-008-9193-x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Takahashi N, 2008, EXPT GLYCOSCIENCE GL, P7, DOI DOI 10.1007/978-4-431-77924-72; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Yagi H, 2005, GLYCOBIOLOGY, V15, P1051, DOI 10.1093/glycob/cwi092; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034	39	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16302	10.1371/journal.pone.0016302	http://dx.doi.org/10.1371/journal.pone.0016302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347401	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700015
J	Valero, J; Espana, J; Parra-Damas, A; Martin, E; Rodriguez-Alvarez, J; Saura, CA				Valero, Jorge; Espana, Judit; Parra-Damas, Arnaldo; Martin, Elsa; Rodriguez-Alvarez, Jose; Saura, Carlos A.			Short-Term Environmental Enrichment Rescues Adult Neurogenesis and Memory Deficits in APP(Sw,Ind) Transgenic Mice	PLOS ONE			English	Article							DENTATE GRANULE CELLS; AMYLOID-BETA PROTEIN; ALZHEIMERS-DISEASE; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; NEUROPSYCHOLOGICAL REHABILITATION; PHYSICAL-ACTIVITY; OLFACTORY-BULB; SHOLL ANALYSIS; NEURONS	Epidemiological studies indicate that intellectual activity prevents or delays the onset of Alzheimer's disease (AD). Similarly, cognitive stimulation using environmental enrichment (EE), which increases adult neurogenesis and functional integration of newborn neurons into neural circuits of the hippocampus, protects against memory decline in transgenic mouse models of AD, but the mechanisms involved are poorly understood. To study the therapeutic benefits of cognitive stimulation in AD we examined the effects of EE in hippocampal neurogenesis and memory in a transgenic mouse model of AD expressing the human mutant beta-amyloid (A beta) precursor protein (APP(Sw,Ind)). By using molecular markers of new generated neurons (bromodeoxiuridine, NeuN and doublecortin), we found reduced neurogenesis and decreased dendritic length and projections of doublecortin-expressing cells of the dentate gyrus in young APP(Sw,Ind) transgenic mice. Moreover, we detected a lower number of mature neurons (NeuN positive) in the granular cell layer and a reduced volume of the dentate gyrus that could be due to a sustained decrease in the incorporation of new generated neurons. We found that short-term EE for 7 weeks efficiently ameliorates early hippocampal-dependent spatial learning and memory deficits in APP(Sw,Ind) transgenic mice. The cognitive benefits of enrichment in APP(Sw,Ind) transgenic mice were associated with increased number, dendritic length and projections to the CA3 region of the most mature adult newborn neurons. By contrast, A beta levels and the total number of neurons in the dentate gyrus were unchanged by EE in APP(Sw,Ind) mice. These results suggest that promoting the survival and maturation of adult generated newborn neurons in the hippocampus may contribute to cognitive benefits in AD mouse models.	[Valero, Jorge; Espana, Judit; Parra-Damas, Arnaldo; Martin, Elsa; Rodriguez-Alvarez, Jose; Saura, Carlos A.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain	Autonomous University of Barcelona; CIBERNED	Valero, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08193 Barcelona, Spain.	carlos.saura@uab.es	Valero, Jorge/I-4478-2013; Rodriguez-Alvarez, Jose/F-8403-2011; Valero, Jorge/AAG-8053-2019; Saura, Carlos A/AFM-9239-2022; Saura, Carlos A/D-2727-2011; Parra-Damas, Arnaldo/A-8629-2018	Valero, Jorge/0000-0001-6072-3313; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Valero, Jorge/0000-0001-6072-3313; Saura, Carlos A/0000-0003-3692-5657; Parra-Damas, Arnaldo/0000-0001-5683-060X	Ministerio de Ciencia e Innovacion [SAF2007-64115, SAF2010-20925, CB06/05/0042]; European Commission [200611]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2007-64115, SAF2010-20925 and CIBERNED CB06/05/0042) and the 7th Framework Programme of the European Commission (MEMOSAD project, Grant 200611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrisqueta-Gomez J, 2004, ARQ NEURO-PSIQUIAT, V62, P778, DOI 10.1590/S0004-282X2004000500007; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Anderton BH, 1998, PROG NEUROBIOL, V55, P595, DOI 10.1016/S0301-0082(98)00022-7; Avila R, 2004, BRAZ J MED BIOL RES, V37, P1721, DOI 10.1590/S0100-879X2004001100018; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Berardi N, 2007, J ALZHEIMERS DIS, V11, P359; CABALKA LM, 1992, NEUROBIOL AGING, V13, P283, DOI 10.1016/0197-4580(92)90041-U; Catlow BJ, 2009, BRAIN RES, V1256, P173, DOI 10.1016/j.brainres.2008.12.028; Clare L, 2002, NEUROPSYCHOLOGY, V16, P538, DOI 10.1037//0894-4105.16.4.538; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; Cotel MC, 2012, NEUROBIOL AGING, V33, P96, DOI 10.1016/j.neurobiolaging.2010.02.012; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dong SZ, 2007, EUR J NEUROSCI, V26, P101, DOI 10.1111/j.1460-9568.2007.05641.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FRIEDLAND RP, 1993, NEUROLOGY, V43, P246, DOI 10.1212/WNL.43.2.246; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gomez C, 2005, J CHEM NEUROANAT, V29, P238, DOI 10.1016/j.jchemneu.2005.01.005; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hastings NB, 2001, CLIN NEUROSCI RES, V1, P175, DOI 10.1016/S1566-2772(01)00003-2; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Ide Y, 2008, EUR J NEUROSCI, V28, P2381, DOI 10.1111/j.1460-9568.2008.06548.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; JURASKA JM, 1985, BRAIN RES, V333, P73, DOI 10.1016/0006-8993(85)90125-8; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LAZAROV O, 2009, EXP NEUROL; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li S, 2008, LIFE SCI, V82, P934, DOI 10.1016/j.lfs.2008.02.010; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Milosevic NT, 2007, J THEOR BIOL, V245, P130, DOI 10.1016/j.jtbi.2006.09.022; MIROCHNIC S, 2009, HIPPOCAMPUS; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Petreanu L, 2002, J NEUROSCI, V22, P6106; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Ristanovic D, 2006, J NEUROSCI METH, V158, P212, DOI 10.1016/j.jneumeth.2006.05.030; SCHAEFFER EL, 2009, PROG NEUROPSYCHOPHAR; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Su Y, 1998, J NEUROSCI RES, V53, P177, DOI 10.1002/(SICI)1097-4547(19980715)53:2<177::AID-JNR6>3.0.CO;2-4; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Valero J, 2007, DEV NEUROBIOL, V67, P839, DOI 10.1002/dneu.20352; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Wu CC, 2004, P NATL ACAD SCI USA, V101, P7141, DOI 10.1073/pnas.0402147101; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	84	69	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16832	10.1371/journal.pone.0016832	http://dx.doi.org/10.1371/journal.pone.0016832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347380	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700040
J	Geis, C; Weishaupt, A; Grunewald, B; Wultsch, T; Reif, A; Gerlach, M; Dirkx, R; Solimena, M; Perani, D; Heckmann, M; Toyka, KV; Folli, F; Sommer, C				Geis, Christian; Weishaupt, Andreas; Gruenewald, Benedikt; Wultsch, Thomas; Reif, Andreas; Gerlach, Manfred; Dirkx, Ron; Solimena, Michele; Perani, Daniela; Heckmann, Manfred; Toyka, Klaus V.; Folli, Franco; Sommer, Claudia			Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; SPINAL-CORD-INJURY; 65-KDA ISOFORM; ANXIETY; ANTIBODIES; AUTOANTIBODIES; ENCEPHALITIS; CIRCUITS; DISORDER; EPILEPSY	Background: Anxiety is a heterogeneous behavioral domain playing a role in a variety of neuropsychiatric diseases. While anxiety is the cardinal symptom in disorders such as panic disorder, co-morbid anxious behavior can occur in a variety of diseases. Stiff person syndrome (SPS) is a CNS disorder characterized by increased muscle tone and prominent agoraphobia and anxiety. Most patients have high-titer antibodies against glutamate decarboxylase (GAD) 65. The pathogenic role of these autoantibodies is unclear. Methodology/Principal Findings: We re-investigated a 53 year old woman with SPS and profound anxiety for GABA-A receptor binding in the amygdala with (11) C-flumazenil PET scan and studied the potential pathogenic role of purified IgG from her plasma filtrates containing high-titer antibodies against GAD 65. We passively transferred the IgG fraction intrathecally into rats and analyzed the effects using behavioral and in vivo electrophysiological methods. In cell culture, we measured the effect of patient IgG on GABA release from hippocampal neurons. Repetitive intrathecal application of purified patient IgG in rats resulted in an anxious phenotype resembling the core symptoms of the patient. Patient IgG selectively bound to rat amygdala, hippocampus, and frontal cortical areas. In cultured rat hippocampal neurons, patient IgG inhibited GABA release. In line with these experimental results, the GABA-A receptor binding potential was reduced in the patient's amygdala/hippocampus complex. No motor abnormalities were found in recipient rats. Conclusion/Significance: The observations in rats after passive transfer lead us to propose that anxiety-like behavior can be induced in rats by passive transfer of IgG from a SPS patient positive for anti-GAD 65 antibodies. Anxiety, in this case, thus may be an antibody-mediated phenomenon with consecutive disturbance of GABAergic signaling in the amygdala region.	[Geis, Christian; Weishaupt, Andreas; Gruenewald, Benedikt; Toyka, Klaus V.; Sommer, Claudia] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Wultsch, Thomas; Reif, Andreas] Univ Wurzburg, Dept Psychiat, D-8700 Wurzburg, Germany; [Dirkx, Ron] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Inst Physiol, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-8700 Wurzburg, Germany; [Dirkx, Ron; Solimena, Michele] Tech Univ Dresden, Carl Gustav Carus Med Sch, D-8027 Dresden, Germany; [Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, Dept Nucl Med, I-20132 Milan, Italy; [Perani, Daniela] Univ Vita Salute San Raffaele, Div Neurosci, Milan, Italy; [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, Dept Med, San Antonio, TX 78229 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; Technische Universitat Dresden; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Texas System; University of Texas Health San Antonio	Geis, C (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	Geis_C@klinik.uni-wuerzburg.de	Solimena, Michele/GVS-5990-2022; Perani, Daniela/AAN-3221-2020; Sommer, Claudia/A-9820-2010; folli, franco/J-2795-2018; Solimena, Michele/E-1275-2011	Sommer, Claudia/0000-0002-7064-5002; folli, franco/0000-0001-9824-5222; Heckmann, Manfred/0000-0002-4874-1735	Deutsche Forschungsgemeinschaft [SFB 581, TP A7]; IZKF; University of Wurzburg;  [SFB TRR 58];  [TP Z2];  [KFO 125];  [TP 4];  [RE 1632/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF; University of Wurzburg; ; ; ; ; 	The work was supported by Deutsche Forschungsgemeinschaft SFB 581, TP A7; SFB TRR 58, TP Z2; KFO 125, TP 4; RE 1632/5; IZKF, and University Research Funds of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli R, 2005, NEUROLOGY, V64, P1961, DOI 10.1212/01.WNL.0000163984.71993.FE; Anagnostaras SG, 1999, NAT NEUROSCI, V2, P780, DOI 10.1038/12146; Aroniadou-Anderjaska V, 2007, AMINO ACIDS, V32, P305, DOI 10.1007/s00726-006-0415-x; Barron DH, 1938, J PHYSIOL-LONDON, V92, P276, DOI 10.1113/jphysiol.1938.sp003603; Bergado-Acosta JR, 2008, LEARN MEMORY, V15, P163, DOI 10.1101/lm.705408; Black JL, 1998, PSYCHOSOMATICS, V39, P38, DOI 10.1016/S0033-3182(98)71379-9; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dalakas MC, 2008, CURR NEUROL NEUROSCI, V8, P48, DOI 10.1007/s11910-008-0009-y; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Davis KM, 2000, BIOCHEM BIOPH RES CO, V267, P777, DOI 10.1006/bbrc.1999.2038; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Floeter MK, 1998, NEUROLOGY, V51, P85, DOI 10.1212/WNL.51.1.85; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geis C, 2010, BRAIN, V133, P3166, DOI 10.1093/brain/awq253; Gerlach M, 1996, BRAIN RES, V741, P142, DOI 10.1016/S0006-8993(96)00915-8; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Henningsen P, 2003, J NEUROL NEUROSUR PS, V74, P462, DOI 10.1136/jnnp.74.4.462; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018; Levy LM, 2005, ARCH NEUROL-CHICAGO, V62, P970, DOI 10.1001/archneur.62.6.970; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; MEINCK HM, 1994, J NEUROL, V241, P157; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; Murinson B B, 2001, CNS Spectr, V6, P427; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perani D, 2007, MOVEMENT DISORD, V22, P1030, DOI 10.1002/mds.21441; Raju R, 2006, BRAIN, V129, P3270, DOI 10.1093/brain/awl245; Rakocevic G, 2004, ARCH NEUROL-CHICAGO, V61, P902, DOI 10.1001/archneur.61.6.902; SCHMIDT RF, 1971, ERG PHYSIOL BIOL CH, V63, P20, DOI 10.1007/BFb0047741; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3; Wultsch T, 2007, J NEURAL TRANSM-SUPP, P69; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9	45	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16775	10.1371/journal.pone.0016775	http://dx.doi.org/10.1371/journal.pone.0016775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346811	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600025
J	Koch, CM; Suschek, CV; Lin, QO; Bork, S; Goergens, M; Joussen, S; Pallua, N; Ho, AD; Zenke, M; Wagner, W				Koch, Carmen M.; Suschek, Christoph V.; Lin, Qiong; Bork, Simone; Goergens, Maria; Joussen, Sylvia; Pallua, Norbert; Ho, Anthony D.; Zenke, Martin; Wagner, Wolfgang			Specific Age-Associated DNA Methylation Changes in Human Dermal Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; CULTURE; SKIN; INK4/ARF; CANCER; TISSUE; SITE	Epigenetic modifications of cytosine residues in the DNA play a critical role for cellular differentiation and potentially also for aging. In mesenchymal stromal cells (MSC) from human bone marrow we have previously demonstrated age-associated methylation changes at specific CpG-sites of developmental genes. In continuation of this work, we have now isolated human dermal fibroblasts from young (<23 years) and elderly donors (>60 years) for comparison of their DNA methylation profiles using the Infinium HumanMethylation27 assay. In contrast to MSC, fibroblasts could not be induced towards adipogenic, osteogenic and chondrogenic lineage and this is reflected by highly significant differences between the two cell types: 766 CpG sites were hyper-methylated and 752 CpG sites were hypo-methylated in fibroblasts in comparison to MSC. Strikingly, global DNA methylation profiles of fibroblasts from the same dermal region clustered closely together indicating that fibroblasts maintain positional memory even after in vitro culture. 75 CpG sites were more than 15% differentially methylated in fibroblasts upon aging. Very high hyper-methylation was observed in the aged group within the INK4A/ARF/INK4b locus and this was validated by pyrosequencing. Age-associated DNA methylation changes were related in fibroblasts and MSC but they were often regulated in opposite directions between the two cell types. In contrast, long-term culture associated changes were very consistent in fibroblasts and MSC. Epigenetic modifications at specific CpG sites support the notion that aging represents a coordinated developmental mechanism that seems to be regulated in a cell type specific manner.	[Koch, Carmen M.; Lin, Qiong; Joussen, Sylvia; Zenke, Martin; Wagner, Wolfgang] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Sch Med, Aachen, Germany; [Suschek, Christoph V.; Goergens, Maria; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Burn Ctr, Sch Med, Aachen, Germany; [Bork, Simone; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Bork, Simone] Heidelberg Acad Sci & Humanities, Heidelberg, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University; Ruprecht Karls University Heidelberg	Koch, CM (corresponding author), Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Sch Med, Aachen, Germany.	wwagner@ukaachen.de	Lin, Qiong/J-6880-2015	Lin, Qiong/0000-0002-7964-6191; Wagner, Wolfgang/0000-0002-1971-3217; Ho, Anthony D./0000-0002-1656-0833	Heidelberg Academy of Sciences (WIN-Kolleg); German Ministry of Education and Research (BMBF); German federal and state governments; Faculty of Medicine, RWTH Aachen; Stem Cell Network North Rhine Westphalia	Heidelberg Academy of Sciences (WIN-Kolleg); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German federal and state governments; Faculty of Medicine, RWTH Aachen; Stem Cell Network North Rhine Westphalia	This work was supported by the Heidelberg Academy of Sciences (WIN-Kolleg), by the German Ministry of Education and Research (BMBF) within the supporting program "cell based regenerative medicine" (CB-HERMES), by the excellence initiative of the German federal and state governments, by the START-Program of the Faculty of Medicine, RWTH Aachen and by the Stem Cell Network North Rhine Westphalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2010, AGING-US, V2, P93, DOI 10.18632/aging.100121; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Boukamp P, 2005, CURR MOL MED, V5, P171, DOI 10.2174/1566524053586644; BROTMAN HF, 1977, J EXP ZOOL, V200, P243, DOI 10.1002/jez.1402000206; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HORN P, 2010, CYTOTHERAPY IN PRESS; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; JINTARIDTH P, 2010, PHYSL GENOMICS; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; KUAN PF, 2010, BIOINFORMAT IN PRESS; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lorenz K, 2008, EXP DERMATOL, V17, P925, DOI 10.1111/j.1600-0625.2008.00724.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; MUNOZNAJAR UM, 2010, EPIGENETIC CONTROL A; Murgatroyd C, 2010, AGING-US, V2, P107; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; So KJ, 2006, CANCER SCI, V97, P1155, DOI 10.1111/j.1349-7006.2006.00302.x; TABIN CJ, 1992, DEVELOPMENT, V116, P289; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; WILSON VL, 1987, J BIOL CHEM, V262, P9948; WILSON VL, 1983, SCIENCE, V220, P1054; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	62	98	102	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16679	10.1371/journal.pone.0016679	http://dx.doi.org/10.1371/journal.pone.0016679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347436	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600015
J	Montgomery, AL; Morris, SK; Kumar, R; Jotkar, R; Mony, P; Bassani, DG; Jha, P				Montgomery, Ann L.; Morris, Shaun K.; Kumar, Rajesh; Jotkar, Raju; Mony, Prem; Bassani, Diego G.; Jha, Prabhat			Capturing the Context of Maternal Deaths from Verbal Autopsies: A Reliability Study of the Maternal Data Extraction Tool (M-DET)	PLOS ONE			English	Article							MORTALITY; INDIA	Background: The availability of quality data to inform policy is essential to reduce maternal deaths. To characterize maternal deaths in settings without complete vital registration systems, we designed and assessed the inter-rater reliability of a tool to systematically extract data and characterize the events that precede a nationally representative sample of maternal deaths in India. Method/Principal Findings: Of 1017 nationally representative pregnancy-related deaths, which occurred between 2001 and 2003, we randomly selected 105 reports. Two independent coders used the maternal data extraction tool (questions with coding guidelines) to collect information on antenatal care access, final pregnancy outcome; planned place of birth and care provider; community consultation, transport, admission, hospital referral; and verification of cause of death assignment. Kappa estimated inter-rater agreement was calculated and classified as poor (K <= 0.4), moderate (K = 0.4-<= 0.6), substantial (K = 0.6-<= 0.8) and high (K>0.8) using the criteria from Landis & Koch. The data extraction tool had high agreement for gestational age, pregnancy outcome, transport, death en route and admission to hospital; substantial agreement for receipt of antenatal care, planned place of birth, readmission and referral to higher level hospital, and whether or not death occurred in the intrapartum period; moderate to substantial agreement for classification of deaths as direct or indirect obstetric deaths or incidental deaths; moderate agreement for classification of community healthcare consultation and total number of healthcare contacts; and poor agreement for the classification of deaths as sudden deaths and other/unknown cause of death. The ability of the tool to identify the most-responsible-person in labour varied from moderate agreement to high agreement. Conclusions: This data extraction tool achieved good inter-rater reliability and can be used to collect data on events surrounding maternal deaths and for verification/improvement of underlying cause of death.	[Montgomery, Ann L.; Morris, Shaun K.; Jotkar, Raju; Bassani, Diego G.; Jha, Prabhat] St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Kumar, Rajesh] Post Grad Inst Med Educ Chandigarh, Sch Publ Hlth, Chandigarh, India; [Mony, Prem] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Bangalore, Karnataka, India; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1X8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Toronto	Montgomery, AL (corresponding author), St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cghr@smh.toronto.on.ca	Bassani, Diego/G-2827-2015; Mony, Prem K./GRF-4752-2022	Bassani, Diego/0000-0001-6704-3820; Mony, Prem K./0000-0002-1399-0520	Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes; Canada Research Chair; United States Fund for the United Nations Children's Fund (UNICEF) [50140]; International Research Development Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto	Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes(March of Dimes); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); United States Fund for the United Nations Children's Fund (UNICEF); International Research Development Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto	Shaun K. Morris is a fellow of the Pediatric Scientist Development Program. The project described was supported by grants Sick Kids Foundation, Paediatric Chairs of Canada, and the March of Dimes. Prabhat Jha is supported by the Canada Research Chair. External funding is from the United States Fund for the United Nations Children's Fund (UNICEF) sub-grant 50140; International Research Development Centre (Grant 102172), and Li Ka Shing Knowledge Institute and Keenan Research Centre at St. Michael's Hospital, University of Toronto (Centre for Global Health Research support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Fillippi V., 2004, NUMBERS REV MATERNAL, P103; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Graham WJ, 2007, AM J PUBLIC HEALTH, V97, P978, DOI 10.2105/AJPH.2005.073692; Graham WJ, 2002, LANCET, V359, P701, DOI 10.1016/S0140-6736(02)07817-0; *IMMPACT INT, 2007, IMMPACT WEB TOOL VER; *INT I POP SCI MAC, 2007, NAT FAM HLTH SURV NF; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; KUMAR R, 2006, INDIAN J PUBLIC HLTH, V1, P26; Kumar V, 2004, LANCET, V364, P18, DOI 10.1016/S0140-6736(04)17625-3; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; RGI CGHR, 2005, PROSP STUD SRS VERB; Shiffman J, 2007, AM J PUBLIC HEALTH, V97, P796, DOI 10.2105/AJPH.2006.095455; Singh S., 2009, BARRIERS SAFE MOTHER; *SRS COLL RGI CGHR, 2006, PROSP STUD ON MILL D; WHO, 2010, TRENDS MAT MORT 1990; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14637	10.1371/journal.pone.0014637	http://dx.doi.org/10.1371/journal.pone.0014637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326873	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037100001
J	Wong, YF; Kopp, JB; Roberts, C; Scambler, PJ; Abe, Y; Rankin, AC; Dutt, N; Hendry, BM; Xu, QH				Wong, Yuen Fei; Kopp, Jeffrey B.; Roberts, Catherine; Scambler, Peter J.; Abe, Yoshifusa; Rankin, Alexandra C.; Dutt, Neelanjana; Hendry, Bruce M.; Xu, Qihe			Endogenous Retinoic Acid Activity in Principal Cells and Intercalated Cells of Mouse Collecting Duct System	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; VACUOLAR H+-ATPASE; DEPENDENT ACTIVATION; NEPHRON DEVELOPMENT; MOLECULAR-CLONING; GENE-EXPRESSION; KIDNEY; RECEPTORS; RATS; ORGANOGENESIS	Background: Retinoic acid is the bioactive derivative of vitamin A, which plays an indispensible role in kidney development by activating retinoic acid receptors. Although the location, concentration and roles of endogenous retinoic acid in postnatal kidneys are poorly defined, there is accumulating evidence linking post-natal vitamin A deficiency to impaired renal concentrating and acidifying capacity associated with increased susceptibility to urolithiasis, renal inflammation and scarring. The aim of this study is to examine the presence and the detailed localization of endogenous retinoic acid activity in neonatal, young and adult mouse kidneys, to establish a fundamental ground for further research into potential target genes, as well as physiological and pathophysiological roles of endogenous retinoic acid in the post-natal kidneys. Methodology/Principal Findings: RARE-hsp68-lacZ transgenic mice were employed as a reporter for endogenous retinoic acid activity that was determined by X-gal assay and immunostaining of the reporter gene product, beta-galactosidase. Double immunostaining was performed for beta-galactosidase and markers of kidney tubules to localize retinoic acid activity. Distinct pattern of retinoic acid activity was observed in kidneys, which is higher in neonatal and 1- to 3-week-old mice than that in 5- and 8-week-old mice. The activity was present specifically in the principal cells and the intercalated cells of the collecting duct system in all age groups, but was absent from the glomeruli, proximal tubules, thin limbs of Henle's loop and distal tubules. Conclusions/Significance: Endogenous retinoic acid activity exists in principal cells and intercalated cells of the mouse collecting duct system after birth and persists into adulthood. This observation provides novel insights into potential roles for endogenous retinoic acid beyond nephrogenesis and warrants further studies to investigate target genes and functions of endogenous retinoic acid in the kidney after birth, particularly in the collecting duct system.	[Wong, Yuen Fei; Rankin, Alexandra C.; Hendry, Bruce M.; Xu, Qihe] Kings Coll London, Dept Renal Med, London WC2R 2LS, England; [Dutt, Neelanjana] Kings Coll Hosp London, Dept Histopathol, London, England; [Kopp, Jeffrey B.; Abe, Yoshifusa] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Roberts, Catherine; Scambler, Peter J.] Inst Child Hlth, Mol Med Unit, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of London; University College London	Wong, YF (corresponding author), Kings Coll London, Dept Renal Med, London WC2R 2LS, England.	qihe.xu@kcl.ac.uk	Wong, Yuen Fei/N-2615-2017; Yoshifusa, Abe/AAX-5923-2021; Kopp, Jeffrey B/O-2681-2015; Wong, Yuen Fei/AAE-2086-2020; Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Wong, Yuen Fei/0000-0002-8761-2848; Kopp, Jeffrey B/0000-0001-9052-186X; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628	Kidney Research United Kingdom project [RP29/2/06]; National Institutes of Health [Z01 DK043308]; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Kidney Research UK [IN1/2010] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043412, Z01DK043308] Funding Source: NIH RePORTER	Kidney Research United Kingdom project(Kidney Research UK (KRUK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Kidney Research United Kingdom project grant (RP29/2/06) awarded to QX and BMH and a National Institutes of Health Intramural Program grant (Z01 DK043308) to JBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bhat PV, 1998, J HISTOCHEM CYTOCHEM, V46, P1025, DOI 10.1177/002215549804600906; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Finberg KE, 2003, GENE, V318, P25, DOI 10.1016/S0378-1119(03)00790-X; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; GIJBELS MJJ, 1992, CELL TISSUE RES, V268, P197, DOI 10.1007/BF00338069; Grases F, 1998, CLIN CHIM ACTA, V269, P147, DOI 10.1016/S0009-8981(97)00198-8; Higgins CC, 1935, J AMER MED ASSOC, V104, P1296, DOI 10.1001/jama.1935.02760150008002; Islam MR, 2008, AM J PHYSIOL-RENAL, V295, pF1845, DOI 10.1152/ajprenal.90355.2008; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kavukcu S, 2001, PEDIATR NEPHROL, V16, P689, DOI 10.1007/s004670100606; Kovacikova J, 2006, KIDNEY INT, V70, P1706, DOI 10.1038/sj.ki.5001851; Liebler S, 2004, AM J PHYSIOL-RENAL, V286, pF458, DOI 10.1152/ajprenal.00173.2003; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; Ma WB, 2002, J HISTOCHEM CYTOCHEM, V50, P1421, DOI 10.1177/002215540205001015; Marin MP, 2005, J NUTR, V135, P695, DOI 10.1093/jn/135.4.695; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Quinlan J, 2007, AM J PHYSIOL-RENAL, V293, pF987, DOI 10.1152/ajprenal.00098.2007; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Schmidt CK, 2003, ANAL BIOCHEM, V315, P36, DOI 10.1016/S0003-2697(02)00662-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Vilar J, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133668; Wagner J, 2001, NEPHROL DIAL TRANSPL, V16, P441, DOI 10.1093/ndt/16.3.441; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2010, NEPHRON EXP NEPHROL, V114, pE127, DOI 10.1159/000276587; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; ZILE M, 1972, J NUTR, V102, P1255, DOI 10.1093/jn/102.10.1255	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16770	10.1371/journal.pone.0016770	http://dx.doi.org/10.1371/journal.pone.0016770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326615	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000020
J	Dierssen, M; Arque, G; McDonald, J; Andreu, N; Martinez-Cue, C; Florez, J; Fillat, C				Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Martinez-Cue, Carmen; Florez, Jesus; Fillat, Cristina			Behavioral Characterization of a Mouse Model Overexpressing DSCR1/RCAN1	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOWN-SYNDROME; TS65DN MICE; B-CHAIN; CALCINEURIN; MEMORY; INHIBITOR; RCAN1; DSCR1; EXPRESSION	DSCR1/RCAN1 is a chromosome 21 gene found to be overexpressed in the brains of Down syndrome (DS) and postulated as a good candidate to contribute to mental disability. However, even though Rcan1 knockout mice have pronounced spatial learning and memory deficits, the possible deleterious effects of its overexpression in DS are not well understood. We have generated a transgenic mouse model overexpressing DSCR1/RCAN1 in the brain and analyzed the effect of RCAN1 overexpression on cognitive function. TgRCAN1 mice present a marked disruption of the learning process in a visuo-spatial learning task. However, no significant differences were observed in the performance of the memory phase of the test (removal session) nor in a step-down passive avoidance task, thus suggesting that once learning has been established, the animals are able to consolidate the information in the longer term.	[Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Fillat, Cristina] Barcelona Biomed Res Pk PRBB, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Catalonia, Spain; [Dierssen, Mara; Arque, Gloria; McDonald, Jerome; Andreu, Nuria; Fillat, Cristina] CIBER Enfermedades Raras CIBERER, Barcelona, Catalonia, Spain; [Martinez-Cue, Carmen; Florez, Jesus] Univ Cantabria, Fac Med, Dept Physiol & Pharmacol, E-39005 Santander, Spain; [Florez, Jesus] Fdn Iberoamer Down21, Fdn Sindrome Down Cantabria, Santander, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Cantabria	Dierssen, M (corresponding author), Barcelona Biomed Res Pk PRBB, Ctr Genom Regulat CRG, Genes & Dis Program, Barcelona, Catalonia, Spain.	mara.dierssen@crg.es	Arque, Gloria/AHD-3561-2022; Arque, Gloria/AAT-7266-2020; Dierssen, Mara/G-3552-2015; Fillat, Cristina/ABH-1674-2020; Andreu, Nuria/H-2576-2015; Cue, Carmen Martinez/AAA-2850-2019	Arque, Gloria/0000-0002-8039-3726; Dierssen, Mara/0000-0003-0853-6865; Andreu, Nuria/0000-0003-1999-8483; Fillat, Cristina/0000-0002-0801-3338; Martinez-Cue, Carmen/0000-0002-2137-1156	DURSI [09 2009SGR1313, SGR091527]; FIS [PI 082038, PI041559]; Marato TV3; Jerome Lejeune; Reina Sofia; Areces Foundations; EU [LSHG-CT-2006-037627, CureFXS E-Rare: EU/FIS PS09102673];  [FCT-08-0782];  [SAF2007-60827];  [SAF2010-16427];  [SAF2007-31093-E]	DURSI; FIS(Instituto de Salud Carlos III); Marato TV3; Jerome Lejeune; Reina Sofia; Areces Foundations; EU(European Commission); ; ; ; 	The laboratories of MD and CF are supported by DURSI (Grups consolidats 09 2009SGR1313, SGR091527). This work was supported by FCT-08-0782, SAF2007-60827, SAF2010-16427, SAF2007-31093-E, FIS (PI 082038, PI041559), Marato TV3, Jerome Lejeune, Reina Sofia and Areces Foundations and EU (LSHG-CT-2006-037627; CureFXS E-Rare: EU/FIS PS09102673). The CIBER of Enfermedades Raras is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Casas C, 2001, MECH DEVELOP, V101, P289, DOI 10.1016/S0925-4773(00)00583-9; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; de Lagran MM, 2004, NEUROBIOL DIS, V15, P132, DOI 10.1016/j.nbd.2003.10.002; DIERSSEN M, 1992, BRAIN RES, V586, P117, DOI 10.1016/0006-8993(92)91379-S; Dierssen M, 2002, PHARMACOL BIOCHEM BE, V73, P19, DOI 10.1016/S0091-3057(02)00792-X; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Guimera J, 1997, GENOMICS, V45, P59, DOI 10.1006/geno.1997.4861; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mitchell AN, 2007, ARCH BIOCHEM BIOPHYS, V467, P185, DOI 10.1016/j.abb.2007.08.030; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; SUN X, J BIOL CHEM; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445	24	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17010	10.1371/journal.pone.0017010	http://dx.doi.org/10.1371/journal.pone.0017010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364922	Green Published, gold			2022-12-27	WOS:000287764100017
J	Harrington, DL; Castillo, GN; Greenberg, PA; Song, DD; Lessig, S; Lee, RR; Rao, SM				Harrington, Deborah L.; Castillo, Gabriel N.; Greenberg, Paul A.; Song, David D.; Lessig, Stephanie; Lee, Roland R.; Rao, Stephen M.			Neurobehavioral Mechanisms of Temporal Processing Deficits in Parkinson's Disease	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINERGIC MODULATION; GEOMETRICALLY ACCURATE; TIME PERCEPTION; CEREBELLUM; MEMORY; REPRESENTATION; REPRODUCTION; INFORMATION; NETWORK	Background: Parkinson's disease (PD) disrupts temporal processing, but the neuronal sources of deficits and their response to dopamine (DA) therapy are not understood. Though the striatum and DA transmission are thought to be essential for timekeeping, potential working memory (WM) and executive problems could also disrupt timing. Methodology/Findings: The present study addressed these issues by testing controls and PD volunteers 'on' and 'off' DA therapy as they underwent fMRI while performing a time-perception task. To distinguish systems associated with abnormalities in temporal and non-temporal processes, we separated brain activity during encoding and decision-making phases of a trial. Whereas both phases involved timekeeping, the encoding and decision phases emphasized WM and executive processes, respectively. The methods enabled exploration of both the amplitude and temporal dynamics of neural activity. First, we found that time-perception deficits were associated with striatal, cortical, and cerebellar dysfunction. Unlike studies of timed movement, our results could not be attributed to traditional roles of the striatum and cerebellum in movement. Second, for the first time we identified temporal and non-temporal sources of impaired time perception. Striatal dysfunction was found during both phases consistent with its role in timekeeping. Activation was also abnormal in a WM network (middle-frontal and parietal cortex, lateral cerebellum) during encoding and a network that modulates executive and memory functions (parahippocampus, posterior cingulate) during decision making. Third, hypoactivation typified neuronal dysfunction in PD, but was sometimes characterized by abnormal temporal dynamics (e.g., lagged, prolonged) that were not due to longer response times. Finally, DA therapy did not alleviate timing deficits. Conclusions/Significance: Our findings indicate that impaired timing in PD arises from nigrostriatal and mesocortical dysfunction in systems that mediate temporal and non-temporal control-processes. However, time perception impairments were not improved by DA treatment, likely due to inadequate restoration of neuronal activity and perhaps corticostriatal effective-connectivity.	[Harrington, Deborah L.; Song, David D.; Lessig, Stephanie; Lee, Roland R.] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Harrington, Deborah L.; Song, David D.; Lessig, Stephanie; Lee, Roland R.] Vet Affairs San Diego Healthcare Syst, Neurol Serv, San Diego, CA USA; [Harrington, Deborah L.; Song, David D.; Lessig, Stephanie; Lee, Roland R.] Vet Affairs San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Harrington, Deborah L.; Castillo, Gabriel N.; Greenberg, Paul A.; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Song, David D.; Lessig, Stephanie] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Rao, Stephen M.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Cleveland Clinic Foundation	Harrington, DL (corresponding author), Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.	dharrington@ucsd.edu	Rao, Stephen M/A-2460-2010	Rao, Stephen M/0000-0002-6463-7460; Harrington, Deborah/0000-0001-9658-9080	Department of Veterans Affairs [1IOICX000146-01, B5015R]; NIH [NS040068]; Office of Naval Research [N00141010072]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040068] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Department of Veterans Affairs (1IOICX000146-01 and B5015R), the NIH (NS040068), and the Office of Naval Research (N00141010072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Elsinger CL, 2003, J INT NEUROPSYCH SOC, V9, P1088, DOI 10.1017/S1355617703970123; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Graham S, 2009, NEUROIMAGE, V45, P1359, DOI 10.1016/j.neuroimage.2008.12.040; Guehl D, 2008, NEUROPSYCHOLOGIA, V46, P2326, DOI 10.1016/j.neuropsychologia.2008.03.007; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 2004, COGNITIVE BRAIN RES, V21, P193, DOI 10.1016/j.cogbrainres.2004.01.010; Harrington DL, 2004, BRAIN, V127, P561, DOI 10.1093/brain/awh065; HELMICH RC, 2009, CEREB CORTEX; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; JONES CR, 2008, BRAIN COGN; Kelland DZ, 1996, ARCH CLIN NEUROPSYCH, V11, P339, DOI 10.1016/0887-6177(95)00032-1; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Kosillo P, 2010, BRAIN STRUCT FUNCT, V214, P623, DOI 10.1007/s00429-010-0267-8; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Malapani C, 2002, J COGNITIVE NEUROSCI, V14, P311, DOI 10.1162/089892902317236920; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Melgire M, 2005, BRAIN COGNITION, V58, P119, DOI 10.1016/j.bandc.2004.09.013; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Perbal S, 2005, BRAIN COGNITION, V58, P35, DOI 10.1016/j.bandc.2005.02.003; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Ramsey JD, 2010, NEUROIMAGE, V49, P1545, DOI 10.1016/j.neuroimage.2009.08.065; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Razmy A, 2004, ARCH NEUROL-CHICAGO, V61, P97, DOI 10.1001/archneur.61.1.97; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith JG, 2007, BRAIN COGNITION, V64, P130, DOI 10.1016/j.bandc.2007.01.005; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wittmann M, 2010, NEUROPSYCHOLOGIA, V48, P3110, DOI 10.1016/j.neuropsychologia.2010.06.023; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	61	59	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17461	10.1371/journal.pone.0017461	http://dx.doi.org/10.1371/journal.pone.0017461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364772	gold, Green Submitted, Green Published			2022-12-27	WOS:000287764100063
J	Mostowy, R; Kouyos, RD; Fouchet, D; Bonhoeffer, S				Mostowy, Rafal; Kouyos, Roger D.; Fouchet, David; Bonhoeffer, Sebastian			The Role of Recombination for the Coevolutionary Dynamics of HIV and the Immune Response	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; IN-VIVO; ANTIRETROVIRAL THERAPY; GENETIC-RECOMBINATION; PERIPHERAL-BLOOD; ESCAPE MUTATIONS; DRUG-RESISTANCE; CELL RESPONSES; DECAY KINETICS	The evolutionary implications of recombination in HIV remain not fully understood. A plausible effect could be an enhancement of immune escape from cytotoxic T lymphocytes (CTLs). In order to test this hypothesis, we constructed a population dynamic model of immune escape in HIV and examined the viral-immune dynamics with and without recombination. Our model shows that recombination (i) increases the genetic diversity of the viral population, (ii) accelerates the emergence of escape mutations with and without compensatory mutations, and (iii) accelerates the acquisition of immune escape mutations in the early stage of viral infection. We see a particularly strong impact of recombination in systems with broad, non-immunodominant CTL responses. Overall, our study argues for the importance of recombination in HIV in allowing the virus to adapt to changing selective pressures as imposed by the immune system and shows that the effect of recombination depends on the immunodominance pattern of effector T cell responses.	[Mostowy, Rafal; Kouyos, Roger D.; Bonhoeffer, Sebastian] ETH, Inst Integrat Biol, Zurich, Switzerland; [Fouchet, David] Univ Lyon, Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mostowy, R (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	rafal.mostowy@env.ethz.ch	Bonhoeffer, Sebastian/A-2735-2008; Kouyos, Roger/G-6226-2014; Kouyos, Roger/ABB-2291-2021	Bonhoeffer, Sebastian/0000-0001-8052-3925; Kouyos, Roger/0000-0002-9220-8348; Kouyos, Roger/0000-0002-9220-8348	Swiss National Foundation [3100A0-116408]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Funding: This work was supported by Swiss National Foundation grant number 3100A0-116408 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Althaus CL, 2005, J VIROL, V79, P13572, DOI 10.1128/JVI.79.21.13572-13578.2005; An Wenfeng, 2002, AIDS Reviews, V4, P195; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; BELL G, 1982, MASTERPIECE NATUE EV; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Bonhoeffer S, 1997, J VIROL, V71, P3275, DOI 10.1128/JVI.71.4.3275-3278.1997; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bretscher MT, 2004, BIOESSAYS, V26, P180, DOI 10.1002/bies.10386; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Charpentier C, 2006, J VIROL, V80, P2472, DOI 10.1128/JVI.80.5.2472-2482.2006; Chen JB, 2006, J VIROL, V80, P9651, DOI 10.1128/JVI.00936-06; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Fraser C, 2005, J ROY SOC INTERFACE, V2, P489, DOI 10.1098/rsif.2005.0064; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HAMILTON WD, 1976, Q REV BIOL, V51, P407; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Josefsson L, 2010, ANTIVIR THER, V15, pA41; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kouyos RD, 2009, EPIDEMICS-NETH, V1, P58, DOI 10.1016/j.epidem.2008.11.001; Kuwata T, 1997, J VIROL, V71, P7088, DOI 10.1128/JVI.71.9.7088-7091.1997; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Lopez M, 2007, CURR MOL MED, V7, P446; Mandl JN, 2007, J VIROL, V81, P11982, DOI 10.1128/JVI.00946-07; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; Mohri H, 1998, SCIENCE, V279, P1223, DOI 10.1126/science.279.5354.1223; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Muller V, 2001, P ROY SOC B-BIOL SCI, V268, P235, DOI 10.1098/rspb.2000.1358; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; QUINONESMATEU M, 1999, AIDS REV, V1, P89; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salathe M, 2008, TRENDS ECOL EVOL, V23, P439, DOI 10.1016/j.tree.2008.04.010; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Vijay NNV, 2008, J GEN VIROL, V89, P1467, DOI 10.1099/vir.0.83668-0; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wooley DP, 1997, J VIROL, V71, P9650, DOI 10.1128/JVI.71.12.9650-9653.1997; Yates A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001301	71	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16052	10.1371/journal.pone.0016052	http://dx.doi.org/10.1371/journal.pone.0016052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364750	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800004
J	Speybroeck, N; Praet, N; Claes, F; Nguyen, VH; Torres, K; Mao, S; Van den Eede, P; Ta, TT; Gamboa, D; Sochantha, T; Ngo, DT; Coosemans, M; Buscher, P; D'Alessandro, U; Berkvens, D; Erhart, A				Speybroeck, Niko; Praet, Nicolas; Claes, Filip; Nguyen Van Hong; Torres, Kathy; Mao, Sokny; Van den Eede, Peter; Ta Thi Thinh; Gamboa, Dioni; Sochantha, Tho; Ngo Duc Thang; Coosemans, Marc; Buescher, Philippe; D'Alessandro, Umberto; Berkvens, Dirk; Erhart, Annette			True versus Apparent Malaria Infection Prevalence: The Contribution of a Bayesian Approach	PLOS ONE			English	Article							DIAGNOSTIC-TECHNIQUES; DISEASE PREVALENCE; ACRIDINE-ORANGE; SENSITIVITY; SPECIFICITY; RELIABILITY; COMBINATION; FRAMEWORK; ABSENCE; TESTS	Aims: To present a new approach for estimating the "true prevalence'' of malaria and apply it to datasets from Peru, Vietnam, and Cambodia. Methods: Bayesian models were developed for estimating both the malaria prevalence using different diagnostic tests (microscopy, PCR & ELISA), without the need of a gold standard, and the tests' characteristics. Several sources of information, i.e. data, expert opinions and other sources of knowledge can be integrated into the model. This approach resulting in an optimal and harmonized estimate of malaria infection prevalence, with no conflict between the different sources of information, was tested on data from Peru, Vietnam and Cambodia. Results: Malaria sero-prevalence was relatively low in all sites, with ELISA showing the highest estimates. The sensitivity of microscopy and ELISA were statistically lower in Vietnam than in the other sites. Similarly, the specificities of microscopy, ELISA and PCR were significantly lower in Vietnam than in the other sites. In Vietnam and Peru, microscopy was closer to the "true'' estimate than the other 2 tests while as expected ELISA, with its lower specificity, usually overestimated the prevalence. Conclusions: Bayesian methods are useful for analyzing prevalence results when no gold standard diagnostic test is available. Though some results are expected, e.g. PCR more sensitive than microscopy, a standardized and context-independent quantification of the diagnostic tests' characteristics (sensitivity and specificity) and the underlying malaria prevalence may be useful for comparing different sites. Indeed, the use of a single diagnostic technique could strongly bias the prevalence estimation. This limitation can be circumvented by using a Bayesian framework taking into account the imperfect characteristics of the currently available diagnostic tests. As discussed in the paper, this approach may further support global malaria burden estimation initiatives.	[Speybroeck, Niko; Coosemans, Marc] Univ Catholique Louvain Neuve, Res Inst Hlth & Soc IRSS, Brussels, Belgium; [Praet, Nicolas; Claes, Filip; Van den Eede, Peter; Buescher, Philippe; D'Alessandro, Umberto; Berkvens, Dirk; Erhart, Annette] Inst Trop Med, B-2000 Antwerp, Belgium; [Nguyen Van Hong; Ta Thi Thinh] NIMPE, Hanoi, Vietnam; [Torres, Kathy; Gamboa, Dioni] Univ Peruana Cayetano Heredia, IMT, AvH, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Mao, Sokny; Sochantha, Tho; Ngo Duc Thang] CNM, Phnom Penh, Cambodia; [Gamboa, Dioni] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Bioquim Biol Mol & Farmacol, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; National Center Parasitology, Entomology & Malaria Control; Universidad Peruana Cayetano Heredia	Speybroeck, N (corresponding author), Univ Catholique Louvain Neuve, Res Inst Hlth & Soc IRSS, Brussels, Belgium.	nspeybroeck@itg.be	Gamboa, Dionicia/CAF-2097-2022; D'Alessandro, Umberto/D-3457-2015; Büscher, Philippe/B-9956-2012	Gamboa, Dionicia/0000-0002-1420-7729; D'Alessandro, Umberto/0000-0001-6341-5009; Büscher, Philippe/0000-0002-1926-7472; Speybroeck, Niko/0000-0003-3322-3502; Torres, Katherine/0000-0003-0414-7547				[Anonymous], 2008, WORLD MAL REP 2008; Arora Sandeep, 2003, Braz J Infect Dis, V7, P332, DOI 10.1590/S1413-86702003000500008; Attaran A, 2005, PLOS MED, V2, P955, DOI 10.1371/journal.pmed.0020318; Basanez MG, 2004, TRENDS PARASITOL, V20, P85, DOI 10.1016/j.pt.2003.11.008; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Berkvens D, 2006, EPIDEMIOLOGY, V17, P145, DOI 10.1097/01.ede.0000198422.64801.8d; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Billiouw M, 2005, VET PARASITOL, V127, P189, DOI 10.1016/j.vetpar.2004.09.028; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; COLLIER JAB, 1983, ANN TROP MED PARASIT, V77, P113, DOI 10.1080/00034983.1983.11811683; Craig MH, 1997, T ROY SOC TROP MED H, V91, P279, DOI 10.1016/S0035-9203(97)90074-2; Craig MH, 2002, T ROY SOC TROP MED H, V96, P258, DOI 10.1016/S0035-9203(02)90092-1; Cruciani M, 2004, MED SCI MONITOR, V10, pMT81; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gelman A, 2003, INT STAT REV, V71, P369; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Habib I, 2008, J APPL MICROBIOL, V105, P2002, DOI 10.1111/j.1365-2672.2008.03902.x; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; Keiser J, 2002, ANN TROP MED PARASIT, V96, P643, DOI 10.1179/000349802125001834; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Ngo DT, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-3; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; RICKMAN LS, 1989, LANCET, V1, P68; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Saegerman C, 2004, VET MICROBIOL, V100, P91, DOI 10.1016/j.vetmic.2004.02.003; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Wongsrichanalai C, 2001, TRENDS PARASITOL, V17, P307, DOI 10.1016/S1471-4922(01)01925-0	35	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16705	10.1371/journal.pone.0016705	http://dx.doi.org/10.1371/journal.pone.0016705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364745	Green Published, Green Accepted, gold			2022-12-27	WOS:000287482800013
J	Li, YW; Huang, DQ; Xia, X; Wang, ZY; Luo, LY; Wen, R				Li, Yiwen; Huang, Deqiang; Xia, Xin; Wang, Zhengying; Luo, Lingyu; Wen, Rong			CCR3 and Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; P70 S6 KINASE; MACULAR DEGENERATION; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSE; RAPAMYCIN; RECEPTORS; DISEASE; VEGF; ANGIOGENESIS	Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the elderly in industrialized countries. The "wet'' AMD, characterized by the development of choroidal neovacularization (CNV), could result in rapid and severe loss of central vision. The critical role of vascular endothelial growth factor A (VEGF-A) in CNV development has been established and VEGF-A neutralization has become the standard care for wet AMD. Recently, CCR3 was reported to play an important role in CNV development and that CCR3 targeting was reported to be superior to VEGF-A targeting in CNV suppression. We investigated the role of CCR3 in CNV development using the Matrigel induced CNV and found that in both rats and mice, CNV was well-developed in the control eyes as well as in eyes treated with CCR3 antagonist SB328437 or CCR3 neutralizing antibodies. No statistically significant difference in CNV areas was found between the control and SB328437 or CCR3-ab treated eyes. Immunostaining showed no specific expression of CCR3 in or near CNV. In contrast, both VEGF-A neutralizing antibodies and rapamycin significantly suppressed CNV. These results indicate that CCR3 plays no significant role in CNV development and question the therapeutic approach of CCR3 targeting to suppress CNV. On the other hand, our data support the therapeutic strategies of VEGF-A and mTOR (mammalian target of rapamycin) targeting for CNV.	[Li, Yiwen; Huang, Deqiang; Xia, Xin; Wang, Zhengying; Luo, Lingyu; Wen, Rong] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Wen, Rong] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami	Li, YW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	rwen@med.miami.edu			National Institutes of Health [R01EY015289, R01EY018586, P30EY14801]; Hope for Vision; State of Florida; Department of Defense [W81XWH-09-1-0674]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018586, P30EY014801, R01EY015289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; State of Florida; Department of Defense(United States Department of Defense); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health (R01EY015289 and R01EY018586 to RW, and P30EY14801), Hope for Vision (RW), the James and Esther King Biomedical Research Program of the State of Florida (YL), and the Department of Defense (W81XWH-09-1-0674 to RW). It was also supported by an unrestricted grant from Research to Prevent Blindness to Bascom Palmer Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; CAO J, 2010, INVEST OPHTHALMOL VI; CHANG JY, 1991, TRENDS PHARMACOL SCI, V12, P218, DOI 10.1016/0165-6147(91)90555-7; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Das A, 2003, PROG RETIN EYE RES, V22, P721, DOI 10.1016/j.preteyeres.2003.08.001; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dejneka NS, 2004, MOL VIS, V10, P964; Emerson MV, 2007, BIODRUGS, V21, P245, DOI 10.2165/00063030-200721040-00005; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hartford CM, 2007, CLIN PHARMACOL THER, V82, P381, DOI 10.1038/sj.clpt.6100317; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kozawa O, 2001, J CELL BIOCHEM, V81, P430, DOI 10.1002/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; LANE WS, 1991, J PROTEIN CHEM, V10, P151, DOI 10.1007/BF01024778; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lin Richard C., 2007, International Ophthalmology Clinics, V47, P117, DOI 10.1097/IIO.0b013e31802bd873; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; Mason AB, 2009, J MOL CELL BIOL, V1, P17, DOI 10.1093/jmcb/mjp011; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Owen C, 2001, PULM PHARMACOL THER, V14, P193, DOI 10.1006/pupt.2001.0281; Pease JE, 2006, J ALLERGY CLIN IMMUN, V118, P305, DOI 10.1016/j.jaci.2006.06.010; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qiu G, 2006, EXP EYE RES, V83, P141, DOI 10.1016/j.exer.2005.11.014; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2005, OPHTHALMOLOGY, V112, P1048, DOI 10.1016/j.ophtha.2005.01.043; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Willems LI, 2010, MED RES REV, V30, P778, DOI 10.1002/med.20181; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Zhao L, 2007, MOL VIS, V13, P873	38	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17106	10.1371/journal.pone.0017106	http://dx.doi.org/10.1371/journal.pone.0017106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21358803	Green Submitted, gold, Green Published			2022-12-27	WOS:000287369200022
J	Horby, P; Pham, QT; Hens, N; Nguyen, TTY; Le, QM; Dang, DT; Nguyen, ML; Nguyen, TH; Alexander, N; Edmunds, WJ; Tran, ND; Fox, A; Nguyen, TH				Horby, Peter; Pham Quang Thai; Hens, Niel; Nguyen Thi Thu Yen; Le Quynh Mai; Dang Dinh Thoang; Nguyen Manh Linh; Nguyen Thu Huong; Alexander, Neal; Edmunds, W. John; Tran Nhu Duong; Fox, Annette; Nguyen Tran Hien			Social Contact Patterns in Vietnam and Implications for the Control of Infectious Diseases	PLOS ONE			English	Article							INFLUENZA-A; TRANSMISSION; SPREAD; MODEL; PARAMETERS; AGENTS	Background: The spread of infectious diseases from person to person is determined by the frequency and nature of contacts between infected and susceptible members of the population. Although there is a long history of using mathematical models to understand these transmission dynamics, there are still remarkably little empirical data on contact behaviors with which to parameterize these models. Even starker is the almost complete absence of data from developing countries. We sought to address this knowledge gap by conducting a household based social contact diary in rural Vietnam. Methods and Findings: A diary based survey of social contact patterns was conducted in a household-structured community cohort in North Vietnam in 2007. We used generalized estimating equations to model the number of contacts while taking into account the household sampling design, and used weighting to balance the household size and age distribution towards the Vietnamese population. We recorded 6675 contacts from 865 participants in 264 different households and found that mixing patterns were assortative by age but were more homogenous than observed in a recent European study. We also observed that physical contacts were more concentrated in the home setting in Vietnam than in Europe but the overall level of physical contact was lower. A model of individual versus household vaccination strategies revealed no difference between strategies in the impact on R(0). Conclusions and Significance: This work is the first to estimate contact patterns relevant to the spread of infections transmitted from person to person by non-sexual routes in a developing country setting. The results show interesting similarities and differences from European data and demonstrate the importance of context specific data.	[Horby, Peter; Fox, Annette] Oxford Univ Clin Res Unit, Hanoi, Vietnam; [Horby, Peter; Fox, Annette] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Pham Quang Thai; Nguyen Thi Thu Yen; Le Quynh Mai; Nguyen Manh Linh; Nguyen Thu Huong; Tran Nhu Duong; Nguyen Tran Hien] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Hens, Niel] Hasselt Univ, Diepenbeek, Belgium; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modeling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Dang Dinh Thoang] Ha Nam Ctr Prevent Med, Ha Nam, Vietnam; [Alexander, Neal; Edmunds, W. John] London Sch Hyg & Epidemiol, London, England	University of Oxford; National Institute of Hygiene & Epidemiology (NIHE); Hasselt University; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine	Horby, P (corresponding author), Oxford Univ Clin Res Unit, Hanoi, Vietnam.	peter.horby@gmail.com	Hens, Niel/M-4445-2017; Horby, Peter/D-1585-2013; Quang, Thai Pham/Z-2770-2019	Hens, Niel/0000-0003-1881-0637; Quang, Thai Pham/0000-0002-3796-6162; Nguyen, Thi Thu Huong/0000-0002-9441-3660; Fox, Annette/0000-0002-0565-7146; Horby, Peter/0000-0002-9822-1586	Wellcome Trust UK [081613/Z/06/Z, 077078/Z/05/Z]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [060081]; IAP research network of the Belgian Government (Belgian Science Policy) [P6/03]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust UK(Wellcome Trust); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IAP research network of the Belgian Government (Belgian Science Policy)(Belgian Federal Science Policy Office); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust UK (grants 081613/Z/06/Z and 077078/Z/05/Z). NH gratefully acknowledges financial support from "SIMID", a strategic basic research project funded by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT), project number 060081 and by the IAP research network number P6/03 of the Belgian Government (Belgian Science Policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Ball F, 2008, MATH BIOSCI, V212, P69, DOI 10.1016/j.mbs.2008.01.001; BECKER NG, 1995, MATH BIOSCI, V127, P207, DOI 10.1016/0025-5564(94)00055-5; BERGLUND B, 1967, ACTA PAEDIATR SCAND, V56, P395, DOI 10.1111/j.1651-2227.1967.tb15398.x; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; CPHCSC, 2010, 2009 VIETNAM POPULAT; Diekmann O, 2000, MATH METHODOLOGY INF; Duerr HP, 2007, EPIDEMIOL INFECT, V135, P1124, DOI 10.1017/S0950268807007959; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Goeyvaerts N, 2011, BIOSTATISTICS, V12, P283, DOI 10.1093/biostatistics/kxq059; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lowen A., 2009, PLOS CURR; MCCAW JM, BMC INFECT DIS, V10, P166; MONTO AS, 1971, AM J EPIDEMIOL, V94, P280, DOI 10.1093/oxfordjournals.aje.a121321; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	25	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16965	10.1371/journal.pone.0016965	http://dx.doi.org/10.1371/journal.pone.0016965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347264	Green Published, gold, Green Accepted			2022-12-27	WOS:000287367600026
J	Perry, CN; Huang, CQ; Liu, W; Magee, N; Carreira, RS; Gottlieb, RA				Perry, Cynthia N.; Huang, Chengqun; Liu, Wayne; Magee, Najib; Carreira, Raquel Sousa; Gottlieb, Roberta A.			Xenotransplantation of Mitochondrial Electron Transfer Enzyme, Ndi1, in Myocardial Reperfusion Injury	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; INSENSITIVE INTERNAL NADH; COMPLEX-I DEFECTS; SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; MEDIATED PROTEIN TRANSDUCTION; BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; SUPEROXIDE-PRODUCTION; SUBSARCOLEMMAL MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION	A significant consequence of ischemia/reperfusion (I/R) is mitochondrial respiratory dysfunction, leading to energetic deficits and cellular toxicity from reactive oxygen species (ROS). Mammalian complex I, a NADH-quinone oxidoreductase enzyme, is a multiple subunit enzyme that oxidizes NADH and pumps protons across the inner membrane. Damage to complex I leads to superoxide production which further damages complex I as well as other proteins, lipids and mtDNA. The yeast, S. cerevisiae, expresses internal rotenone insensitive NADH-quinone oxidoreductase (Ndi1); a single 56kDa polypeptide which, like the multi-subunit mammalian complex I, serves as the entry site of electrons to the respiratory chain, but without proton pumping. Heterologous expression of Ndi1 in mammalian cells results in protein localization to the inner mitochondrial membrane which can function in parallel with endogenous complex I to oxidize NADH and pass electrons to ubiquinone. Expression of Ndi1 in HL-1 cardiomyocytes and in neonatal rat ventricular myocytes protected the cells from simulated ischemia/reperfusion (sI/R), accompanied by lower ROS production, and preservation of ATP levels and NAD+/NADH ratios. We next generated a fusion protein of Ndi1 and the 11aa protein transduction domain from HIV TAT. TAT-Ndi1 entered cardiomyocytes and localized to mitochondrial membranes. Furthermore, TAT-Ndi1 introduced into Langendorff-perfused rat hearts also localized to mitochondria. Perfusion of TAT-Ndi1 before 30 min no-flow ischemia and up to 2 hr reperfusion suppressed ROS production and preserved ATP stores. Importantly, TAT-Ndi1 infused before ischemia reduced infarct size by 62%; TAT-Ndi1 infused at the onset of reperfusion was equally cardioprotective. These results indicate that restoring NADH oxidation and electron flow at reperfusion can profoundly ameliorate reperfusion injury.	[Perry, Cynthia N.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Perry, Cynthia N.; Huang, Chengqun; Liu, Wayne; Magee, Najib; Carreira, Raquel Sousa; Gottlieb, Roberta A.] SDSU Biosci Ctr, San Diego, CA USA	University of California System; University of California San Diego	Perry, CN (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.	robbieg@sciences.sdsu.edu		Gottlieb, Roberta/0000-0002-1432-006X	NIH [R01-HL060590 0, F31 HL091723]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060590, F31HL091723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH R01-HL060590 0 and NIH F31 HL091723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1991, J MOL CELL CARDIOL, V23, P1359, DOI 10.1016/0022-2828(91)90183-M; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Becker-Hapak M, 2003, CURR PROTOC CELL BIO; Bright R, 2007, BRAIN RES, V1144, P146, DOI 10.1016/j.brainres.2007.01.113; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Das DK, 1994, ANN NY ACAD SCI, V723, pXIII; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; DEVRIES S, 1992, EUR J BIOCHEM, V203, P587; Fang J, 2003, FREE RADICAL BIO MED, V34, P478, DOI 10.1016/S0891-5849(02)01328-X; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; Gustafsson AB, 2005, METH MOLEC MED, V112, P81; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Kim CH, 2007, IMMUNOLOGY, V122, P615, DOI 10.1111/j.1365-2567.2007.02680.x; Kitajima-Ihara T, 1998, FEBS LETT, V421, P37, DOI 10.1016/S0014-5793(97)01533-0; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; MA H, 2010, EUR HEART J; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; MARRES CAM, 1991, EUR J BIOCHEM, V195, P857, DOI 10.1111/j.1432-1033.1991.tb15775.x; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Pain T, 2000, CIRC RES, V87, P460; Paradies G, 1999, FREE RADICAL BIO MED, V27, P42, DOI 10.1016/S0891-5849(99)00032-5; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; SIEGEL C, 2010, ACTA PHYSL; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	42	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16288	10.1371/journal.pone.0016288	http://dx.doi.org/10.1371/journal.pone.0016288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339825	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600011
J	Ribisl, KM; Williams, RS; Gizlice, Z; Herring, AH				Ribisl, Kurt M.; Williams, Rebecca S.; Gizlice, Ziya; Herring, Amy H.			Effectiveness of State and Federal Government Agreements with Major Credit Card and Shipping Companies to Block Illegal Internet Cigarette Sales	PLOS ONE			English	Article							AVAILABILITY; TOBACCO	Most Internet vendors offer tax-free cigarettes making them cheaper than those sold at stores. This undermines the impact that higher prices have upon reducing consumption. Most Internet tobacco sales have violated taxation and youth access laws, which led to landmark voluntary agreements in 2005 with the major credit card companies and major private shippers to ban payment transactions and shipments for all Internet cigarette sales. Objective: To assess whether these bans increased the rate of Internet Cigarette Vendors (ICVs) ceasing online sales, decreased the proportion of vendors offering banned payment and shipping options, and decreased consumer traffic to the most popular ICVs. Design: Websites in a longitudinal study of ICVs were visited in 2003 (n = 338), 2004 (n = 775), 2005 (n = 664), 2006 (n = 762), and 2007 (n = 497) to assess whether they were in business and monitor their advertised sales practices. The number of unique monthly visitors to the 50 most popular ICVs at baseline was examined for the period one year before and two years after the bans to determine whether the bans altered traffic. Results: Following the bans, the rate of ICVs ceasing online sales year to year increased, but due to an influx of new vendors, there was a net increase in ICVs. The proportion of vendors accepting banned payment options dropped from 99.2% to 37.4% after the bans, and the proportion offering banned shipping options dropped from 32.2% to 5.6%, but there was a corresponding increase in vendors offering non-banned payment options (e. g., personal checks) and shipping options (e.g., US Postal Service). Following the bans, there was a 3.5 fold decline in traffic to the most popular ICV websites. Conclusions: This promising approach to controlling the sale of restricted goods online has implications for regulating other products such as alcohol, firearms, quack cures, and medicines sold without a prescription.	[Ribisl, Kurt M.; Herring, Amy H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Ribisl, Kurt M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Williams, Rebecca S.; Gizlice, Ziya] Univ N Carolina, Ctr Hlth Promot & Dis Prevent, Chapel Hill, NC USA; [Herring, Amy H.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ribisl, KM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	kurt_ribisl@unc.edu	Ribisl, Kurt M/C-4867-2015	Ribisl, Kurt M/0000-0003-3318-8524; Herring, Amy/0000-0003-1552-8871	Robert Wood Johnson Foundation; NIH/NIEHS [P30 ES10126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by research funding from a grant from the Robert Wood Johnson Foundation to the School of Public Health at the University of North Carolina at Chapel Hill ("Effectiveness of state and federal government agreements with major credit card and shipping companies to block Internet cigarette sales'' - Kurt M. Ribisl, Principal Investigator). We also acknowledge the support of NIH/NIEHS P30 ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt Powell E., 2005, DEAL AIMS PREVENT WE; [Anonymous], 2005, UPS AGR NOT SHIP CIG; Carroll TE, 2002, DRUG ALCOHOL REV, V21, P83, DOI 10.1080/0959230220119381; Chaloupka F J, 1999, Nicotine Tob Res, V1 Suppl 1, pS105; Cohen JE, 2001, TOB CONTROL, V10, P364, DOI 10.1136/tc.10.4.364; Davis K., 2006, CIGARETTE PURCHASING; Federal Express, 2003, FED EXPR TERMS COND; Forman RF, 2006, AM J PSYCHIAT, V163, P1233, DOI 10.1176/appi.ajp.163.7.1233; Forman Robert F, 2006, Curr Psychiatry Rep, V8, P377, DOI 10.1007/s11920-006-0039-6; General Accounting Office, 2002, INT CIG SAL GIV ATF; Gollust SE, 2003, GENET MED, V5, P332, DOI 10.1097/01.GIM.0000076972.83711.48; Goolsbee A, 2007, WORKING PAPER SERIES; Hyland A, 2005, AM J PUBLIC HEALTH, V95, P994, DOI 10.2105/AJPH.2004.057687; *I MED, 2007, END TOB PROBL BLUEPR; Jensen JA, 2004, JAMA-J AM MED ASSOC, V291, P1837, DOI 10.1001/jama.291.15.1837; Ribisl KM, 2003, JAMA-J AM MED ASSOC, V290, P1356, DOI 10.1001/jama.290.10.1356; Ribisl KM, 2001, TOB CONTROL, V10, P352, DOI 10.1136/tc.10.4.352; Ribisl KM, 2007, ENDING TOBACCO PROBL; US Department of Health and Human Services, 2000, RED TOB US REP SURG	19	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16754	10.1371/journal.pone.0016754	http://dx.doi.org/10.1371/journal.pone.0016754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721PR	21340032	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600018
J	Caetano-Lopes, J; Lopes, A; Rodrigues, A; Fernandes, D; Perpetuo, IP; Monjardino, T; Lucas, R; Monteiro, J; Konttinen, YT; Canhao, H; Fonseca, JE				Caetano-Lopes, Joana; Lopes, Ana; Rodrigues, Ana; Fernandes, Diana; Perpetuo, Ines P.; Monjardino, Teresa; Lucas, Raquel; Monteiro, Jacinto; Konttinen, Yrjo T.; Canhao, Helena; Fonseca, Joao E.			Upregulation of Inflammatory Genes and Downregulation of Sclerostin Gene Expression Are Key Elements in the Early Phase of Fragility Fracture Healing	PLOS ONE			English	Article							BONE-FORMATION; INCREASES; REPAIR; ADULT; RATS; AGE	Background: Fracture healing is orchestrated by a specific set of events that culminates in the repair of bone and reachievement of its biomechanical properties. The aim of our work was to study the sequence of gene expression events involved in inflammation and bone remodeling occurring in the early phases of callus formation in osteoporotic patients. Methodology/Principal Findings: Fifty-six patients submitted to hip replacement surgery after a low-energy hip fracture were enrolled in this study. The patients were grouped according to the time interval between fracture and surgery: bone collected within 3 days after fracture (n = 13); between the 4(th) and 7(th) day (n = 33); and after one week from the fracture (n = 10). Inflammation- and bone metabolism-related genes were assessed at the fracture site. The expression of pro-inflammatory cytokines was increased in the first days after fracture. The genes responsible for bone formation and resorption were upregulated one week after fracture. The increase in RANKL expression occurred just before that, between the 4(th)-7(th) days after fracture. Sclerostin expression diminished during the first days after fracture. Conclusions: The expression of inflammation-related genes, especially IL-6, is highest at the very first days after fracture but from day 4 onwards there is a shift towards bone remodeling genes, suggesting that the inflammatory phase triggers bone healing. We propose that an initial inflammatory stimulus and a decrease in sclerostin-related effects are the key components in fracture healing. In osteoporotic patients, cellular machinery seems to adequately react to the inflammatory stimulus, therefore local promotion of these events might constitute a promising medical intervention to accelerate fracture healing.	[Caetano-Lopes, Joana; Lopes, Ana; Rodrigues, Ana; Fernandes, Diana; Perpetuo, Ines P.; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Rheumatol Res Unit, Inst Mol Med, P-1699 Lisbon, Portugal; [Rodrigues, Ana; Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, Serv Reumatol & Doencas Osseas Metab, Lisbon, Portugal; [Monjardino, Teresa; Lucas, Raquel] Univ Porto, Sch Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal; [Monjardino, Teresa; Lucas, Raquel] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal; [Monteiro, Jacinto] Hosp Santa Maria, Dept Orthopaed, Lisbon, Portugal; [Konttinen, Yrjo T.] Univ Helsinki, Dept Med, Helsinki, Finland; [Konttinen, Yrjo T.] ORTON Orthopaed Hosp, Invalid Fdn, Helsinki, Finland; [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade do Porto; Universidade do Porto; Universidade de Lisboa; Hospital Santa Maria; University of Helsinki; Coxa Hospital for Joint Replacement	Caetano-Lopes, J (corresponding author), Univ Lisbon, Fac Med, Rheumatol Res Unit, Inst Mol Med, P-1699 Lisbon, Portugal.	jefonseca@netcabo.pt	Monjardino, Teresa/H-5399-2019; Canhao, Helena/C-9611-2018; Fernandes, Diana/D-5916-2011; Rodrigues, Ana/GYQ-6273-2022; IP, Perpétuo/F-3643-2011; Caetano-Lopes, Joana/J-9345-2012	Monjardino, Teresa/0000-0003-4944-3366; Canhao, Helena/0000-0003-1894-4870; Fernandes, Diana/0000-0002-1015-3946; IP, Perpétuo/0000-0001-7671-2539; Caetano-Lopes, Joana/0000-0003-0310-4641; Canhao, Helena/0000-0002-3239-2809; Fonseca, Joao/0000-0003-1432-3671; Lucas, Raquel/0000-0002-4408-8134; Rodrigues, Ana Maria/0000-0003-2046-8017; Monteiro, Jacinto Manuel de Melo Oliveira/0000-0002-4067-200X	Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia) [PTDC/SAU-BEB/65992/2006, SFRH/BD/36825/2007]	Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by two grants from the Portuguese Foundation of Science and Technology (Fundacao para a Ciencia e Tecnologia)(PTDC/SAU-BEB/65992/2006, SFRH/BD/36825/2007). (www.fct.mctes.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Dean DB, 2010, J ANAT IN PRESS; Desai BJ, 2003, J ORTHOP TRAUMA, V17, P689, DOI 10.1097/00005131-200311000-00005; Egyhazi S, 2004, CLIN CHEM, V50, P975, DOI 10.1373/clinchem.2003.027102; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014; Giannoudis PV, 2007, INJURY, V38, pS1, DOI 10.1016/j.injury.2007.02.004; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ikegami Shota, 2009, Orthop Rev (Pavia), V1, pe21, DOI 10.4081/or.2009.e21; Ireland D, 2003, METH MOLEC MED, V80, P433; Ivaska KK, 2007, J BONE MINER RES, V22, P1155, DOI 10.1359/JBMR.070505; Khan Safdar N, 2008, HSS J, V4, P149, DOI 10.1007/s11420-008-9087-2; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; LYRITIS G, 1976, ACTA ORTHOP SCAND, V47, P264, DOI 10.3109/17453677608991988; Marzona L, 2009, CLIN CASES MINER BON, V6, P159; Meyer RA, 2006, J ORTHOP RES, V24, P1933, DOI 10.1002/jor.20124; Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	29	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16947	10.1371/journal.pone.0016947	http://dx.doi.org/10.1371/journal.pone.0016947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347301	Green Published, Green Submitted, gold			2022-12-27	WOS:000287364500014
J	Davis, JL; Dumont, ER; Strait, DS; Grosse, IR				Davis, Julian L.; Dumont, Elizabeth R.; Strait, David S.; Grosse, Ian R.			An Efficient Method of Modeling Material Properties Using a Thermal Diffusion Analogy: An Example Based on Craniofacial Bone	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; ELASTIC PROPERTIES; CRANIAL MECHANICS; CORTICAL BONE; LIZARD SKULL; BIOMECHANICS; MORPHOLOGY; PERFORMANCE; ALLOMETRY; EVOLUTION	The ability to incorporate detailed geometry into finite element models has allowed researchers to investigate the influence of morphology on performance aspects of skeletal components. This advance has also allowed researchers to explore the effect of different material models, ranging from simple (e.g., isotropic) to complex (e.g., orthotropic), on the response of bone. However, bone's complicated geometry makes it difficult to incorporate complex material models into finite element models of bone. This difficulty is due to variation in the spatial orientation of material properties throughout bone. Our analysis addresses this problem by taking full advantage of a finite element program's ability to solve thermal-structural problems. Using a linear relationship between temperature and modulus, we seeded specific nodes of the finite element model with temperatures. We then used thermal diffusion to propagate the modulus throughout the finite element model. Finally, we solved for the mechanical response of the finite element model to the applied loads and constraints. We found that using the thermal diffusion analogy to control the modulus of bone throughout its structure provides a simple and effective method of spatially varying modulus. Results compare favorably against both experimental data and results from an FE model that incorporated a complex (orthotropic) material model. This method presented will allow researchers the ability to easily incorporate more material property data into their finite element models in an effort to improve the model's accuracy.	[Davis, Julian L.] Univ So Indiana, Dept Engn, Evansville, IN 47712 USA; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Strait, David S.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Grosse, Ian R.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA	University Southern Indiana; University of Massachusetts System; University of Massachusetts Amherst; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Massachusetts System; University of Massachusetts Amherst	Davis, JL (corresponding author), Univ So Indiana, Dept Engn, 8600 Univ Blvd, Evansville, IN 47712 USA.	jldavis2@usi.edu	D, Betsy/ABD-1855-2020	Davis, Julian/0000-0003-4109-3904	National Science Foundation [NSF-DBI 0743460, NSF-BCS 0725078, NSF-BCS 0725126]; Div Of Biological Infrastructure [0743460] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (www.nsf.gov) grants NSF-DBI 0743460 to ERD and IRG, NSF-BCS 0725078 to IRG, and NSF-BCS 0725126 to DSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; CLATTENBURG R, 1975, J BIOMED MATER RES, V9, P169; Currey J.D., 2002, BONES STRUCTURE MECH; Currey J, 2009, CLIN ORTHOP RELAT R, V467, P1948, DOI 10.1007/s11999-009-0784-z; Davidson SRH, 2000, MED ENG PHYS, V22, P741, DOI 10.1016/S1350-4533(01)00003-0; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; El-Brawany M. A., 2009, Journal of Medical Engineering & Technology, V33, P249, DOI 10.1080/03091900802451265; Helgason B, 2008, MED ENG PHYS, V30, P444, DOI 10.1016/j.medengphy.2007.05.006; INCROPERA FP, 1996, INTRO HEAT TRANSFER, P801; Kim H. D., 1992, Biomimetics, V1, P293; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moazen M, 2008, J BIOMECH, V41, P1274, DOI 10.1016/j.jbiomech.2008.01.012; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Rapoff AJ, 2008, AM J PHYS ANTHROPOL, V135, P100, DOI 10.1002/ajpa.20714; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Strait DS, 2007, J HUM EVOL, V52, P585, DOI 10.1016/j.jhevol.2006.11.019; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait David S., 2008, P173, DOI 10.1007/978-0-387-76585-3_9; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Wachter NJ, 2002, BONE, V31, P90, DOI 10.1016/S8756-3282(02)00779-2; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594	42	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17004	10.1371/journal.pone.0017004	http://dx.doi.org/10.1371/journal.pone.0017004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347288	gold, Green Published			2022-12-27	WOS:000287364500020
J	Gervasi, MG; Osycka-Salut, C; Caballero, J; Vazquez-Levin, M; Pereyra, E; Billi, S; Franchi, A; Perez-Martinez, S				Gracia Gervasi, Maria; Osycka-Salut, Claudia; Caballero, Julieta; Vazquez-Levin, Monica; Pereyra, Elba; Billi, Silvia; Franchi, Ana; Perez-Martinez, Silvina			Anandamide Capacitates Bull Spermatozoa through CB1 and TRPV1 Activation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BOVINE SPERM; ACROSOME REACTION; MOUSE SPERMATOZOA; ENDOCANNABINOID SYSTEM; SELECTIVE ANTAGONIST; OVIDUCT; RECEPTOR; RELEASE; HEPARIN	Anandamide (AEA), a major endocannabinoid, binds to cannabinoid and vanilloid receptors (CB1, CB2 and TRPV1) and affects many reproductive functions. Nanomolar levels of anandamide are found in reproductive fluids including mid-cycle oviductal fluid. Previously, we found that R(+)-methanandamide, an anandamide analogue, induces sperm releasing from bovine oviductal epithelium and the CB1 antagonist, SR141716A, reversed this effect. Since sperm detachment may be due to surface remodeling brought about by capacitation, the aim of this paper was to investigate whether anandamide at physiological concentrations could act as a capacitating agent in bull spermatozoa. We demonstrated that at nanomolar concentrations R(+)-methanandamide or anandamide induced bull sperm capacitation, whereas SR141716A and capsazepine (a TRPV1 antagonist) inhibited this induction. Previous studies indicate that mammalian spermatozoa possess the enzymatic machinery to produce and degrade their own AEA via the actions of the AEA-synthesizing phospholipase D and the fatty acid amide hydrolase (FAAH) respectively. Our results indicated that, URB597, a potent inhibitor of the FAAH, produced effects on bovine sperm capacitation similar to those elicited by exogenous AEA suggesting that this process is normally regulated by an endogenous tone. We also investigated whether anandamide is involved in bovine heparin-capacitated spermatozoa, since heparin is a known capacitating agent of bovine sperm. When the spermatozoa were incubated in the presence of R(+)-methanandamide and heparin, the percentage of capacitated spermatozoa was similar to that in the presence of R(+)-methanandamide alone. The pre-incubation with CB1 or TRPV1 antagonists inhibited heparin-induced sperm capacitation; moreover the activity of FAAH was 30% lower in heparin-capacitated spermatozoa as compared to control conditions. This suggests that heparin may increase endogenous anandamide levels. Our findings indicate that anandamide induces sperm capacitation through the activation of CB1 and TRPV1 receptors and could be involved in the same molecular pathway as heparin in bovines.	[Gracia Gervasi, Maria; Osycka-Salut, Claudia; Pereyra, Elba; Franchi, Ana; Perez-Martinez, Silvina] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina; [Caballero, Julieta; Vazquez-Levin, Monica] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Billi, Silvia] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Gervasi, MG (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina.	perezms@fmed.uba.ar	osycka-salut, claudia elena/AAG-3441-2020	osycka-salut, claudia elena/0000-0002-8033-5155; Caballero, Julieta/0000-0002-5466-3614; Gervasi, Maria Gracia/0000-0002-5468-2700	National Research Council (CONICET)-Argentina [PIP 112-200801-02204]; FONCyT-Argentina [BID 1728 OC/AR PICT2004-20207]	National Research Council (CONICET)-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT-Argentina(FONCyT)	This work was supported by National Research Council (CONICET)-Argentina (PIP 112-200801-02204) to AF and SPM and by FONCyT-Argentina (BID 1728 OC/AR PICT2004-20207) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirregoitia E, 2010, FERTIL STERIL, V93, P1378, DOI 10.1016/j.fertnstert.2009.01.153; ANDERSON SH, 1994, BIOL REPROD, V51, P795, DOI 10.1095/biolreprod51.4.795; Aquila S, 2009, J CELL PHYSIOL, V221, P147, DOI 10.1002/jcp.21837; Battista N, 2008, MOL CELL ENDOCRINOL, V286, pS17, DOI 10.1016/j.mce.2008.01.010; Bergqvist AS, 2007, ZYGOTE, V15, P225, DOI 10.1017/S0967199407004182; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALVO L, 1989, FERTIL STERIL, V52, P1048; CHIAN RC, 1995, BIOL REPROD, V52, P156, DOI 10.1095/biolreprod52.1.156; CHIAN RC, 1995, MOL REPROD DEV, V42, P318, DOI 10.1002/mrd.1080420309; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; FRASER LR, 1995, MOL REPROD DEV, V40, P233, DOI 10.1002/mrd.1080400213; FUKUI Y, 1990, THERIOGENOLOGY, V34, P579, DOI 10.1016/0093-691X(90)90013-J; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; HANDROW RR, 1989, J EXP ZOOL, V252, P174, DOI 10.1002/jez.1402520209; Harper M. J. K., 1994, PHYSL REPROD, V1, P123; Herrero MB, 1999, BIOL REPROD, V61, P575, DOI 10.1095/biolreprod61.3.575; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; KALAB P, 1994, J BIOL CHEM, V269, P3810; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MA, 1987, FERTIL STERIL, V48, P649; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; O'Flaherty C, 2004, BBA-GEN SUBJECTS, V1674, P215, DOI 10.1016/j.bbagen.2004.06.020; Palmer SL, 2002, CHEM PHYS LIPIDS, V121, P3, DOI 10.1016/S0009-3084(02)00143-3; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Rinaldi-Carmona M, 1998, J PHARMACOL EXP THER, V284, P644; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rodriguez PC, 2005, ANIM REPROD SCI, V85, P231, DOI 10.1016/j.anireprosci.2004.05.018; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Sun XF, 2009, BIOL REPROD, V80, P235, DOI 10.1095/biolreprod.108.072736; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Talevi R, 2007, BIOL REPROD, V76, P728, DOI 10.1095/biolreprod.106.056028; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang H, 2006, J CLIN INVEST, V116, P2122, DOI 10.1172/JCI28621; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; Yanagimachi R., 1994, P189	58	50	52	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16993	10.1371/journal.pone.0016993	http://dx.doi.org/10.1371/journal.pone.0016993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347292	gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500018
J	Hii, YL; Rocklov, J; Ng, N				Hii, Yien Ling; Rocklov, Joacim; Ng, Nawi			Short Term Effects of Weather on Hand, Foot and Mouth Disease	PLOS ONE			English	Article							ENTEROVIRUS-71; HERPANGINA; SINGAPORE; SURVIVAL; EPIDEMIC; TAIWAN	Background: Hand, foot, and mouth disease (HFMD) outbreaks leading to clinical and fatal complications have increased since late 1990s; especially in the Asia Pacific Region. Outbreaks of HFMD peaks in the warmer season of the year, but the underlying factors for this annual pattern and the reasons to the recent upsurge trend have not yet been established. This study analyzed the effect of short-term changes in weather on the incidence of HFMD in Singapore. Methods: The relative risks between weekly HFMD cases and temperature and rainfall were estimated for the period 20012008 using time series Poisson regression models allowing for over-dispersion. Smoothing was used to allow non-linear relationship between weather and weekly HFMD cases, and to adjust for seasonality and long-term time trend. Additionally, autocorrelation was controlled and weather was allowed to have a lagged effect on HFMD incidence up to 2 weeks. Results: Weekly temperature and rainfall showed statistically significant association with HFMD incidence at time lag of 1-2 weeks. Every 1 degrees C increases in maximum temperature above 32 degrees C elevated the risk of HFMD incidence by 36% (95% CI = 1.341-1.389). Simultaneously, one mm increase of weekly cumulative rainfall below 75 mm increased the risk of HFMD by 0.3% (CI = 1.002-1.003). While above 75 mm the effect was opposite and each mm increases of rainfall decreased the incidence by 0.5% (CI = 0.995-0.996). We also found that a difference between minimum and maximum temperature greater than 7 degrees C elevated the risk of HFMD by 41% (CI = 1.388-1.439). Conclusion: Our findings suggest a strong association between HFMD and weather. However, the exact reason for the association is yet to be studied. Information on maximum temperature above 32 degrees C and moderate rainfall precede HFMD incidence could help to control and curb the up-surging trend of HFMD.	[Hii, Yien Ling; Rocklov, Joacim; Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden	Umea University	Hii, YL (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Umea, Sweden.	yienling.hii@epiph.umu.se	Ng, Nawi/F-8373-2011	Ng, Nawi/0000-0003-0556-1483; Lai, Shengjie/0000-0001-9781-8148; Rocklov, Joacim/0000-0003-4030-0449	FAS; Swedish Council for Working Life and Social Research [2006-1512]	FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was undertaken within the Umea Centre for Global Health Research at Umea University, with support from FAS, the Swedish Council for Working Life and Social Research (grant no: 2006-1512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2009, KEY ANN IND; CDC, 2008, HAND FOOT MOUTH DIS; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chan KP, 2003, EMERG INFECT DIS, V9, P78; GOH KT, 2004, GUIDE INFECT DIS PUB; HAGIWARA A, 1983, J GEN VIROL, V64, P491, DOI 10.1099/0022-1317-64-2-499; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Khetsuriani N, 2006, ENTEROVIRUS SURVEILL, P1; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Malaysia MoH, 2009, INC NOT COMM DIS MAL; MCGEADY ML, 1979, APPL ENVIRON MICROB, V37, P972, DOI 10.1128/AEM.37.5.972-977.1979; Ministry of Health Singapore, 2008, EPIDEMIOL NEWS B, V34, P63; NICD, 2008, HAND FOOT MOUTH DIS; NOAA, 2008, NNDC CLIM DAT ONL; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; RDCT, 2009, R LANG ENV STAT COMP; Salo RJ, 1976, EFFECT ACID PH SALTS; Singapore MoH, 2004, GUID INF DIS PUBL HL; Singapore MoH, 2009, WEEKL INF DIS B; Urashima M, 2003, JPN J INFECT DIS, V56, P48; [WHO WPRO], 2010, COMM DIS SURV RESP M; [WHO WPRO], 2010, OV HAND FOOT MOUTH D; WHO/WPRO, 2010, COMM DIS SURV RESP R; WHO/ WPRO, 2010, TRENDS STAT COMM DIS; WPRO/WHO, 2009, HAND FOOT MOUTH DIS; YEAGER JG, 1979, APPL ENVIRON MICROB, V38, P694, DOI 10.1128/AEM.38.4.694-701.1979	29	154	168	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16796	10.1371/journal.pone.0016796	http://dx.doi.org/10.1371/journal.pone.0016796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347303	Green Submitted, gold, Green Published			2022-12-27	WOS:000287364500006
J	Preyer, M; Vigneri, P; Wang, JYJ				Preyer, Martin; Vigneri, Paolo; Wang, Jean Y. J.			Interplay between Kinase Domain Autophosphorylation and F-Actin Binding Domain in Regulating Imatinib Sensitivity and Nuclear Import of BCR-ABL	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COIL OLIGOMERIZATION DOMAIN; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; C-ABL; PHOSPHORYLATION PATHWAYS; PHILADELPHIA-CHROMOSOME; INHIBITOR STI571; STRUCTURAL BASIS; POSITIVE CELLS	Background: The constitutively activated BCR-ABL tyrosine kinase of chronic myeloid leukemia (CML) is localized exclusively to the cytoplasm despite the three nuclear localization signals (NLS) in the ABL portion of this fusion protein. The NLS function of BCR-ABL is re-activated by a kinase inhibitor, imatinib, and in a kinase-defective BCR-ABL mutant. The mechanism of this kinase-dependent inhibition of the NLS function is not understood. Methodology/Principal Findings: By examining the subcellular localization of mutant BCR-ABL proteins under conditions of imatinib and/or leptomycin B treatment to inhibit nuclear export, we have found that mutations of three specific tyrosines (Y232, Y253, Y257, according to ABL-1a numbering) in the kinase domain can inhibit the NLS function of kinase-proficient and kinase-defective BCR-ABL. Interestingly, binding of imatinib to the kinase-defective tyrosine-mutant restored the NLS function, suggesting that the kinase domain conformation induced by imatinib-binding is critical to the re-activation of the NLS function. The C-terminal region of ABL contains an F-actin binding domain (FABD). We examined the subcellular localization of several FABD-mutants and found that this domain is also required for the activated kinase to inhibit the NLS function; however, the binding to F-actin per se is not important. Furthermore, we found that some of the C-terminal deletions reduced the kinase sensitivity to imatinib. Conclusions/Significance: Results from this study suggest that an autophosphorylation-dependent kinase conformation together with the C-terminal region including the FABD imposes a blockade of the BCR-ABL NLS function. Conversely, conformation of the C-terminal region including the FABD can influence the binding affinity of imatinib for the kinase domain. Elucidating the structural interactions among the kinase domain, the NLS region and the FABD may therefore provide insights on the design of next generation BCR-ABL inhibitors for the treatment of CML.	Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Preyer, M (corresponding author), Salk Inst Biol Studies, Genet Lab, La Jolla, CA USA.	jywang@ucsd.edu	Vigneri, Paolo G/K-8504-2016	Vigneri, Paolo G/0000-0002-5943-6066	National Institutes of Health, USA [CA-043054]; NATIONAL CANCER INSTITUTE [R01CA043054, R37CA043054] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the National Institutes of Health, USA, CA-043054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; DALEY GQ, 1992, MOL CELL BIOL, V12, P1864, DOI 10.1128/MCB.12.4.1864; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2005, MOL CELL, V19, P461, DOI 10.1016/j.molcel.2005.06.030; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; LINDGREN V, 1977, NATURE, V266, P744, DOI 10.1038/266744a0; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Steen H, 2003, MOL CELL PROTEOMICS, V2, P138, DOI 10.1074/mcp.M300001-MCP200; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Taylor CM, 2005, BIOCHEMISTRY-US, V44, P16246, DOI 10.1021/bi051493t; Van Etten RA, 2003, CURR BIOL, V13, pR608, DOI 10.1016/S0960-9822(03)00528-1; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; Vella V, 2003, J BIOL CHEM, V278, P25151, DOI 10.1074/jbc.M301962200; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; WETZLER M, 1993, J CLIN INVEST, V92, P1925, DOI 10.1172/JCI116786; Wiesner S, 2005, J BIOMOL NMR, V32, P335, DOI 10.1007/s10858-005-8868-x; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Zhang XW, 2001, MOL CELL BIOL, V21, P840, DOI 10.1128/MCB.21.3.840-853.2001; Zhao X, 2002, NAT STRUCT BIOL, V9, P117	43	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17020	10.1371/journal.pone.0017020	http://dx.doi.org/10.1371/journal.pone.0017020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347248	gold, Green Published			2022-12-27	WOS:000287364500023
J	Jin, ZB; Okamoto, S; Osakada, F; Homma, K; Assawachananont, J; Hirami, Y; Iwata, T; Takahashi, M				Jin, Zi-Bing; Okamoto, Satoshi; Osakada, Fumitaka; Homma, Kohei; Assawachananont, Juthaporn; Hirami, Yasuhiko; Iwata, Takeshi; Takahashi, Masayo			Modeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; GENERATION; MOUSE	Retinitis pigmentosa (RP) is the most common inherited human eye disease resulting in night blindness and visual defects. It is well known that the disease is caused by rod photoreceptor degeneration; however, it remains incurable, due to the unavailability of disease-specific human photoreceptor cells for use in mechanistic studies and drug screening. We obtained fibroblast cells from five RP patients with distinct mutations in the RP1, RP9, PRPH2 or RHO gene, and generated patient-specific induced pluripotent stem (iPS) cells by ectopic expression of four key reprogramming factors. We differentiated the iPS cells into rod photoreceptor cells, which had been lost in the patients, and found that they exhibited suitable immunocytochemical features and electrophysiological properties. Interestingly, the number of the patient-derived rod cells with distinct mutations decreased in vitro; cells derived from patients with a specific mutation expressed markers for oxidation or endoplasmic reticulum stress, and exhibited different responses to vitamin E than had been observed in clinical trials. Overall, patient-derived rod cells recapitulated the disease phenotype and expressed markers of cellular stresses. Our results demonstrate that the use of patient-derived iPS cells will help to elucidate the pathogenic mechanisms caused by genetic mutations in RP.	[Jin, Zi-Bing; Okamoto, Satoshi; Homma, Kohei; Assawachananont, Juthaporn; Hirami, Yasuhiko; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Jin, Zi-Bing] Hosp Eye, Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [Osakada, Fumitaka] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Takahashi, Masayo] Kyoto Univ, Ctr iPS Res & Applicat, Kyoto, Japan	RIKEN; Wenzhou Medical University; Salk Institute; Kyoto University	Jin, ZB (corresponding author), RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan.	mretina@cdb.riken.jp	Okamoto, Satoshi/F-7309-2013; Homma, Kohei/AAF-6716-2021; Jin, Zi-Bing/AAE-4106-2019; Jin, Zi-Bing/J-6810-2014	Okamoto, Satoshi/0000-0003-4071-9696; Homma, Kohei/0000-0002-6253-8047; Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Osakada, Fumitaka/0000-0002-9078-1458	Ministry of Health, Labour and Welfare, Japan [H21-Nanchi-Ippan-216]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the grant from the Ministry of Health, Labour and Welfare, Japan (#H21-Nanchi-Ippan-216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; Weleber R.G., 2006, RETINA, P395; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	15	171	184	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e17084	10.1371/journal.pone.0017084	http://dx.doi.org/10.1371/journal.pone.0017084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347327	Green Published, gold, Green Submitted			2022-12-27	WOS:000287363000037
J	Chaves, SR; Rosenblum, JS				Chaves, Susana R.; Rosenblum, Jonathan S.			Efficient Nuclear Transport of Structurally Disturbed Cargo: Mutations in a Cargo Protein Switch Its Cognate Karyopherin	PLOS ONE			English	Article							TRANSFER-RNA MATURATION; LA PROTEIN; IMPORT PATHWAY; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-PROTEINS; BINDING-PROTEINS; YEAST; CHAPERONES; LOCALIZATION; AUTOANTIGEN	The Karyopherin (Kap) family of nuclear transport receptors enables trafficking of proteins to and from the nucleus in a precise, regulated manner. Individual members function in overlapping pathways, while simultaneously being very specific for their main cargoes. The details of this apparent contradiction and rules governing pathway preference remain to be further elucidated. S. cerevisiae Lhp1 is an abundant protein that functions as an RNA chaperone in a variety of biologically important processes. It localizes almost exclusively to the nucleus and is imported by Kap108. We show that mutation of 3 of the 275 residues in Lhp1 alters its import pathway to a Kap121-dependent process. This mutant does not retain wild-type function and is bound by several chaperones. We propose that Kap121 also acts as a chaperone, one that can act as a genetic buffer by transporting mutated proteins to the nucleus.	[Chaves, Susana R.] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Braga, Portugal; [Rosenblum, Jonathan S.] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Universidade do Minho; Howard Hughes Medical Institute; Rockefeller University	Chaves, SR (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal.	suchaves@bio.uminho.pt	Chaves, Susana R/H-8786-2013	Chaves, Susana R/0000-0002-6004-9872; Rosenblum, Jonathan/0000-0002-7318-0896	PRAXIS XXI, Portugal	PRAXIS XXI, Portugal	S.R. Chaves was supported in part by PRAXIS XXI, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; ALSPAUGH MA, 1975, J CLIN INVEST, V55, P1067, DOI 10.1172/JCI108007; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, V2; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chaves SR, 2001, J BIOL CHEM, V276, P17712, DOI 10.1074/jbc.M010760200; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Delahodde A, 2001, MOL MICROBIOL, V39, P304, DOI 10.1046/j.1365-2958.2001.02182.x; Gharahdaghi F, 1996, ANAL BIOCHEM, V233, P94, DOI 10.1006/abio.1996.0012; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HOFFMAN DW, 1991, P NATL ACAD SCI USA, V88, P2495, DOI 10.1073/pnas.88.6.2495; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marchetti MA, 2000, J CELL SCI, V113, P899; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; MUKAI H, 1993, GENE, V132, P57; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rosenblum JS, 1998, J CELL BIOL, V143, P887, DOI 10.1083/jcb.143.4.887; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Simons FHM, 1996, EXP CELL RES, V224, P224, DOI 10.1006/excr.1996.0132; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Van Horn DJ, 1997, RNA, V3, P1434; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16846	10.1371/journal.pone.0016846	http://dx.doi.org/10.1371/journal.pone.0016846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347375	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700043
J	Legendre, CM; Charpentier-Cote, C; Drouin, R; Bouffard, C				Legendre, Claire-Marie; Charpentier-Cote, Catherine; Drouin, Regen; Bouffard, Chantal			Neurofibromatosis Type 1 and the "Elephant Man's" Disease: The Confusion Persists: An Ethnographic Study	PLOS ONE			English	Article							PROTEUS-SYNDROME; CHILDREN; ADOLESCENTS; CHALLENGES; GUIDELINES; MANAGEMENT; SELF; CARE	Background: During informal interviews in the course of an ethnographic study on intergenerational dialogue between individuals with neurofibromatosis and their parents, many members of Canadian neurofibromatosis associations stated they continue to be told the condition that afflicts them or their children is the "elephant man's" disease. Today, even though well established clinical criteria make it possible to diagnose and differentiate the two diseases, the confusion between NF1 and the disease of Joseph Merrick, the "elephant man", persists in both media representations and those of physicians. The objective of this article is to document the persistence of this confusion, to identify the factors that contribute to it, and to identify its impact on the well being of individuals with NF1. Methodology: Preliminary stages of an ethnographic study. Principal Findings: Our findings show that some reference sources, past medical training, and print and online news media have all contributed to the persistence of the association between NF1 and the disease of Joseph Merrick, the "elephant man". Our observations suggest that this misconception can have negative medical, social, and psychological impacts on patients and their families and thus increase the burden of the disease. Conclusions: Changes of attitude regarding medical teaching and the media could lead to definitively clearing up the confusion.	[Legendre, Claire-Marie; Charpentier-Cote, Catherine; Drouin, Regen; Bouffard, Chantal] Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Legendre, CM (corresponding author), Univ Sherbrooke, Div Genet, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	claire-marie.legendre@usherbrooke.ca			Association de la Neurofibromatose du Quebec (ANFQ); Foundation of Stars Children's Health Research; Fonds de Recherche en Sante du Quebec (FRSQ) [16378]	Association de la Neurofibromatose du Quebec (ANFQ); Foundation of Stars Children's Health Research; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The work underlying this article was supported by the Association de la Neurofibromatose du Quebec (ANFQ) (http://www.anfq.org/), the Foundation of Stars Children's Health Research, and the Fonds de Recherche en Sante du Quebec (FRSQ) (file number: 16378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLON J, 1995, SOC SCI MED, V40, P1481, DOI 10.1016/0277-9536(94)00356-X; Ablon J, 2000, AM J MED GENET, V93, P136, DOI 10.1002/1096-8628(20000717)93:2<136::AID-AJMG11>3.0.CO;2-L; ALLEN P, 2009, SEVERELY BURNED MAN, V30; Barton B, 2007, CHILD CARE HLTH DEV, V33, P401, DOI 10.1111/j.1365-2214.2006.00717.x; Barton B, 2004, DEV MED CHILD NEUROL, V46, P553, DOI 10.1017/S0012162204000921; Belzeaux R, 2006, PRESSE MED, V35, P277, DOI 10.1016/S0755-4982(06)74570-5; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 2001, JAMA-J AM MED ASSOC, V285, P2240, DOI 10.1001/jama.285.17.2240; BIESECKER LG, 2005, MANAGEMENT GENETIC S, P449; CAREY J, 1988, NEUROFIBROMATOSIS NE, V10, P1; CASSIDY SB, 2005, MANAGEMENT GENETIC S, V17; CASTLENAU B, 2009, WORLDS 1 HANDS FACE; CHILDS D, 2007, 3 FACE TRANSPLANT SI; COHEN MJ, 1987, P GREENWOOD GENET, V6, P6; COHEN MM, 1993, AM J MED GENET, V47, P645, DOI 10.1002/ajmg.1320470514; COHEN MM, 1988, NEUROFIBROMATOSIS, V1, P21; CUTTING L, 2004, LDRP, V19, P11; Descheemaeker MJ, 2005, J INTELL DISABIL RES, V49, P33, DOI 10.1111/j.1365-2788.2005.00660.x; Dupuis A, 2005, J PEDIATR-US, V147, P312, DOI 10.1016/j.jpeds.2005.06.043; DURAND M, 2007, GREFFE TOUTE IMAGE D; ECHKENAZI A, 2007, DEUXIEME GREFFE VISA; Eichenfield LF, 1997, J AM ACAD DERMATOL, V37, P625, DOI 10.1016/S0190-9622(97)70182-8; ENGEL J, 1989, NY TIMES; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Fisch GS, 2007, AM J MED GENET A, V143A, P2478, DOI 10.1002/ajmg.a.31915; FLOYD A, 1987, ELEPHANT WOMAN SOC B, V69, P3; FRIEND T, 1990, US TODAY; FRIEND T, 1989, US TODAY; GAGNERFRENETTE L, 2001, NEUROFIBROMATOSIS EL; Goldberg Y, 1996, CLIN PEDIATR, V35, P545, DOI 10.1177/000992289603501101; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hammersley M, 1994, ETHNOGRAPHY PRINCIPL; Hart L, 2005, NURSE PRACT, V30, P38, DOI 10.1097/00006205-200506000-00007; HOSTAMISLIGIL G, 1989, NEUROFIBROMATOSIS, V2, P2; Krab LC, 2008, J CHILD NEUROL, V23, P1002, DOI 10.1177/0883073808316366; MERRICK J, 1988, WHAT ELEPHANT MAN RE; MONTAGU A, 1979, ELEPHANT MAN STUDY H; Morse RP, 1999, ARCH NEUROL-CHICAGO, V56, P364, DOI 10.1001/archneur.56.3.364; *NIH CONS DEV C ST, 1988, ARCH NEUROL-CHICAGO, V45, P4; Parkes W. F., 1909, BRIT J DERMATOL, V21, P3; Patenaude AF, 2003, J PEDIATR PSYCHOL, V28, P135, DOI 10.1093/jpepsy/28.2.135; PELE L, 2009, TROISIEME GREFFE VIS; Pinson S, 2002, ARCH PEDIATRIE, V9, P49, DOI 10.1016/S0929-693X(01)00695-9; Radtke Heather B, 2007, J Genet Couns, V16, P387, DOI 10.1007/s10897-007-9101-8; RAI GS, 1981, J AM GERIATR SOC, V29, P45, DOI 10.1111/j.1532-5415.1981.tb02395.x; Redmann Carolyn, 2007, J Fam Health Care, V17, P95; ROBERTGNANSIA E, 2005, SYNDROME PROTEE ORPH; ROSENFELD A, 1988, INSIDE ELEPHANT MAN; SAUVEUR CD, 2008, MAINTENANT JE VIS CO; SEASHORE MR, 1995, PEDIATRICS, V96, P368; SEWARD G, 1986, BMJ-BRIT MED J, V293, P1; TIBBLES JAR, 1986, BRIT MED J, V293, P683, DOI 10.1136/bmj.293.6548.683; Turner J, 2007, AM J MED GENET A, V143A, P2089, DOI 10.1002/ajmg.a.31904; WATT N, 2008, TRANSFORMED FACE TRA; Weber FP, 1909, BRIT J DERMATOL, V21, P49; Williams PG, 1998, J AUTISM DEV DISORD, V28, P567, DOI 10.1023/A:1026012414193; WILLIAMSON D, 1991, TELEGRAM GAZETTE; Wolkenstein P, 2003, ARCH DERMATOL, V139, P103, DOI 10.1001/archderm.139.1.103; Wolkenstein P, 2001, ARCH DERMATOL, V137, P1421, DOI 10.1001/archderm.137.11.1421; Zaroff CM, 2005, EPILEPSY BEHAV, V7, P133, DOI 10.1016/j.yebeh.2005.05.012; 1990, SCI NEWS, V138, P1	61	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16409	10.1371/journal.pone.0016409	http://dx.doi.org/10.1371/journal.pone.0016409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347399	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700016
J	Ruggiero, D; Dalmasso, C; Nutile, T; Sorice, R; Dionisi, L; Aversano, M; Broet, P; Leutenegger, AL; Bourgain, C; Ciullo, M				Ruggiero, Daniela; Dalmasso, Cyril; Nutile, Teresa; Sorice, Rossella; Dionisi, Laura; Aversano, Mario; Broeet, Philippe; Leutenegger, Anne-Louise; Bourgain, Catherine; Ciullo, Marina			Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF Polymorphisms	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRAIT LINKAGE ANALYSIS; GENERAL PEDIGREES; CANCER; DISEQUILIBRIUM; EXPRESSION; LOCUS; SUSCEPTIBILITY; IDENTIFICATION; ANGIOGENESIS	Vascular Endothelial Growth Factor (VEGF) is the main player in angiogenesis. Because of its crucial role in this process, the study of the genetic factors controlling VEGF variability may be of particular interest for many angiogenesis-associated diseases. Although some polymorphisms in the VEGF gene have been associated with a susceptibility to several disorders, no genome-wide search on VEGF serum levels has been reported so far. We carried out a genome-wide linkage analysis in three isolated populations and we detected a strong linkage between VEGF serum levels and the 6p21.1 VEGF region in all samples. A new locus on chromosome 3p26.3 significantly linked to VEGF serum levels was also detected in a combined population sample. A sequencing of the gene followed by an association study identified three common single nucleotide polymorphisms (SNPs) influencing VEGF serum levels in one population (Campora), two already reported in the literature (rs3025039, rs25648) and one new signal (rs3025020). A fourth SNP (rs41282644) was found to affect VEGF serum levels in another population (Cardile). All the identified SNPs contribute to the related population linkages (35% of the linkage explained in Campora and 15% in Cardile). Interestingly, none of the SNPs influencing VEGF serum levels in one population was found to be associated in the two other populations. These results allow us to exclude the hypothesis that the common variants located in the exons, intron-exon junctions, promoter and regulative regions of the VEGF gene may have a causal effect on the VEGF variation. The data support the alternative hypothesis of a multiple rare variant model, possibly consisting in distinct variants in different populations, influencing VEGF serum levels.	[Ruggiero, Daniela; Nutile, Teresa; Sorice, Rossella; Dionisi, Laura; Aversano, Mario; Ciullo, Marina] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Dalmasso, Cyril; Broeet, Philippe; Bourgain, Catherine] Univ Paris 11, INSERM, U669, Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, UMR S946, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Ruggiero, D (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	ciullo@igb.cnr.it	ruggiero, daniela/K-5638-2016; Ciullo, Marina/AAE-3041-2020; Leutenegger, Anne-Louise/B-5597-2009; Bourgain, Catherine/L-1505-2017	ruggiero, daniela/0000-0003-3898-7827; Ciullo, Marina/0000-0002-9621-9984; Leutenegger, Anne-Louise/0000-0002-1302-4357; Bourgain, Catherine/0000-0002-6761-0140; BROET, PHILIPPE/0000-0001-9122-2810; NUTILE, TERESA/0000-0001-7062-8352	EU [Vasoplus-037254]; Italian Ministry of Universities [FIRB -RBIN064YAT]; Assessorato Ricerca Regione Campania; Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	EU(European Commission); Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Assessorato Ricerca Regione Campania(Regione Campania); Ente Parco Nazionale del Cilento e Vallo di Diano; Fondazione Banco di Napoli	This work was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano and the Fondazione Banco di Napoli to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Balasubramanian SP, 2007, INT J CANCER, V121, P1009, DOI 10.1002/ijc.22772; Bellenguez C, 2009, GENET EPIDEMIOL, V33, P207, DOI 10.1002/gepi.20371; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Ciullo M, 2008, DIABETES, V57, P783, DOI 10.2337/db07-0970; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Colonna V, 2009, EUR J HUM GENET, V17, P1635, DOI 10.1038/ejhg.2009.97; Dalmasso Cyril, 2007, BMC Proc, V1 Suppl 1, pS141; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Falchi M, 2004, AM J HUM GENET, V75, P1015, DOI 10.1086/426155; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Goddard KAB, 1999, GENET EPIDEMIOL, V17, pS575; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Hansen TF, 2010, J CANCER RES CLIN, V136, P751, DOI 10.1007/s00432-009-0714-1; Jain L, 2009, MOL CANCER THER, V8, P2496, DOI 10.1158/1535-7163.MCT-09-0302; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Krippl P, 2003, INT J CANCER, V106, P468, DOI 10.1002/ijc.11238; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin CC, 2003, UROLOGY, V62, P374, DOI 10.1016/S0090-4295(03)00268-1; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pantsulaia I, 2004, CYTOKINE, V27, P152, DOI 10.1016/j.cyto.2004.04.005; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; SIERVO M, 2010, J INTERNAL MED  0623; SPIEGELHALTER D, WINBUGS USER MANUAL; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710	34	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16982	10.1371/journal.pone.0016982	http://dx.doi.org/10.1371/journal.pone.0016982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347390	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700060
J	Zhang, JX; Xu, XY; Rao, NV; Argyle, B; McCoard, L; Rusho, WJ; Kennedy, TP; Prestwich, GD; Krueger, G				Zhang, Jianxing; Xu, Xiaoyu; Rao, Narayanam V.; Argyle, Brian; McCoard, Lindsi; Rusho, William J.; Kennedy, Thomas P.; Prestwich, Glenn D.; Krueger, Gerald			Novel Sulfated Polysaccharides Disrupt Cathelicidins, Inhibit RAGE and Reduce Cutaneous Inflammation in a Mouse Model of Rosacea	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; GLYCATION END-PRODUCTS; HUMAN-SKIN; TRANSDERMAL DELIVERY; CELL RECRUITMENT; RECEPTOR RAGE; IN-VITRO; PENETRATION; PERMEATION; ABSORPTION	Background: Rosacea is a common disfiguring skin disease of primarily Caucasians characterized by central erythema of the face, with telangiectatic blood vessels, papules and pustules, and can produce skin thickening, especially on the nose of men, creating rhinophyma. Rosacea can also produce dry, itchy eyes with irritation of the lids, keratitis and corneal scarring. The cause of rosacea has been proposed as over-production of the cationic cathelicidin peptide LL-37. Methodology/Principal Findings: We tested a new class of non-anticoagulant sulfated anionic polysaccharides, semisynthetic glycosaminoglycan ethers (SAGEs) on key elements of the pathogenic pathway leading to rosacea. SAGEs were anti-inflammatory at ng/ml, including inhibition of polymorphonuclear leukocyte (PMN) proteases, P-selectin, and interaction of the receptor for advanced glycation end-products (RAGE) with four representative ligands. SAGEs bound LL-37 and inhibited interleukin-8 production induced by LL-37 in cultured human keratinocytes. When mixed with LL-37 before injection, SAGEs prevented the erythema and PMN infiltration produced by direct intradermal injection of LL-37 into mouse skin. Topical application of a 1% (w/w) SAGE emollient to overlying injected skin also reduced erythema and PMN infiltration from intradermal LL-37. Conclusions: Anionic polysaccharides, exemplified by SAGEs, offer potential as novel mechanism-based therapies for rosacea and by extension other LL-37-mediated and RAGE-ligand driven skin diseases.	[Zhang, Jianxing; Xu, Xiaoyu; Argyle, Brian; McCoard, Lindsi; Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84112 USA; [Zhang, Jianxing; Xu, Xiaoyu; Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Rao, Narayanam V.; Kennedy, Thomas P.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Rusho, William J.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Krueger, Gerald] Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zhang, JX (corresponding author), Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84112 USA.	tkennedy@mail.mcg.edu			State of Utah to GlycoMira LLC; Center for Therapeutic Biomaterials; Utah Center of Excellence; NIH [R43 AR057281]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR057281] Funding Source: NIH RePORTER	State of Utah to GlycoMira LLC; Center for Therapeutic Biomaterials; Utah Center of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Centers of Excellence grant from the State of Utah to GlycoMira LLC, by the Center for Therapeutic Biomaterials, also a Utah Center of Excellence, and by NIH grant R43 AR057281 to Drs. Zhang, Prestwich and Kennedy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; BARKER RL, 1991, J CLIN INVEST, V88, P798, DOI 10.1172/JCI115379; Betz G, 2001, INT J PHARM, V228, P147, DOI 10.1016/S0378-5173(01)00832-8; Bevins CL, 2007, NAT MED, V13, P904, DOI 10.1038/nm0807-904; BONINA FP, 1994, INT J PHARMACEUT, V102, P19, DOI 10.1016/0378-5173(94)90035-3; BOSSHARD E, 1985, FOOD CHEM TOXICOL, V23, P149, DOI 10.1016/0278-6915(85)90007-9; Bralley EE, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-1; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; DEMOERLOOSE P, 1992, BLOOD COAGUL FIBRIN, V3, P827, DOI 10.1097/00001721-199212000-00040; Elewski BE, 2011, J EUR ACAD DERMATOL, V25, P188, DOI 10.1111/j.1468-3083.2010.03751.x; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; Fuellen G, 2003, TRENDS IMMUNOL, V24, P622, DOI 10.1016/j.it.2003.10.004; Karande P, 2004, NAT BIOTECHNOL, V22, P192, DOI 10.1038/nbt928; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lanke SSS, 2009, INT J PHARMACEUT, V365, P26, DOI 10.1016/j.ijpharm.2008.08.028; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; Meingassner JG, 2005, EXP DERMATOL, V14, P752, DOI 10.1111/j.1600-0625.2005.00354.x; Mitragotri S, 2001, PHARMACEUT RES, V18, P1151, DOI 10.1023/A:1010979010907; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ogata M, 1997, INFECT IMMUN, V65, P2160, DOI 10.1128/IAI.65.6.2160-2167.1997; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pacini S, 2006, PHARM RES-DORDR, V23, P114, DOI 10.1007/s11095-005-8923-z; Parisel C, 2003, J BIOMED MATER RES A, V67A, P517, DOI 10.1002/jbm.a.10085; PARK H, 2010, J BIOL CHEM, DOI DOI 10.1074/JBC.M110/169276; Powell FC, 2005, NEW ENGL J MED, V352, P793, DOI 10.1056/NEJMcp042829; PRESTWICH G, 2010, Patent No. 7855187; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; SCHAEFER H, 1976, PHARMAZIE, V31, P251; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; SCHRAVEN E, 1973, ARZNEIMITTEL-FORSCH, V23, P274; SILVERBERG M, 1980, J BIOL CHEM, V255, P7281; Song YK, 2006, BIOMATERIALS, V27, P271, DOI 10.1016/j.biomaterials.2005.05.097; STUTTGEN G, 1990, ARZNEIMITTEL-FORSCH, V40-1, P484; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yamasaki K, 2008, EUR J DERMATOL, V18, P11; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; YOUNG JM, 1984, J INVEST DERMATOL, V82, P367, DOI 10.1111/1523-1747.ep12260709; ZESCH A, 1976, ARZNEIMITTEL-FORSCH, V26, P1365; ZIMMERMANN RE, 1982, THERAPIEWOCHE, V32, P6157	50	51	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16658	10.1371/journal.pone.0016658	http://dx.doi.org/10.1371/journal.pone.0016658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347371	Green Submitted, Green Published, gold			2022-12-27	WOS:000287361700025
J	Conway, MJ; Cruz, L; Alam, S; Christensen, ND; Meyers, C				Conway, Michael J.; Cruz, Linda; Alam, Samina; Christensen, Neil David; Meyers, Craig			Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes	PLOS ONE			English	Article							HPV INFECTION; PROPAGATION; FEATURES; PROTEIN; SURFACE; DNA	Background: Human papillomavirus (HPV) capsids are composed of 72 pentamers of the major capsid protein L1, and an unknown number of L2 minor capsid proteins. An N-terminal "external loop" of L2 contains cross-neutralizing epitopes, and native HPV16 virions extracted from 20-day-old organotypic tissues are neutralized by anti-HPV16 L2 antibodies but virus from 10-day-old cultures are not, suggesting that L2 epitopes are more exposed in mature, 20-day virions. This current study was undertaken to determine whether cross-neutralization of other HPV types is similarly dependent on time of harvest and to screen for the most effective cross-neutralizing epitope in native virions. Methodology and Principal Findings: Neutralization assays support that although HPV16 L2 epitopes were only exposed in 20-day virions, HPV31 or HPV18 epitopes behaved differently. Instead, HPV31 and HPV18 L2 epitopes were exposed in 10-day virions and remained so in 20-day virions. In contrast, presumably due to sequence divergence, HPV45 was not cross-neutralized by any of the anti-HPV16 L2 antibodies. We found that the most effective cross-neutralizing antibody was a polyclonal antibody named anti-P56/75 #1, which was raised against a peptide consisting of highly conserved HPV16 L2 amino acids 56 to 75. Conclusions and Significance: This is the first study to determine the susceptibility of multiple, native high-risk HPV types to neutralization by L2 antibodies. Multiple anti-L2 antibodies were able to cross-neutralize HPV16, HPV31, and HPV18. Only neutralization of HPV16 depended on the time of tissue harvest. These data should inform attempts to produce a second-generation, L2-based vaccine.	[Conway, Michael J.; Cruz, Linda; Alam, Samina; Meyers, Craig] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Christensen, Neil David] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Conway, MJ (corresponding author), Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA.	cmm10@psu.edu	alam, samina/V-1599-2018		NIAID [R01AI57988]; Pennsylvania Commonwealth Department of Health [410005094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Commonwealth Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a PHS Grant from the NIAID (R01AI57988), and MJC was supported by TSF GRSA SAP#410005094 from the Pennsylvania Commonwealth Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Culp TD, 2003, J VIROL METHODS, V111, P135, DOI 10.1016/S0166-0934(03)00170-8; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Liu WJ, 1997, VIROLOGY, V227, P474, DOI 10.1006/viro.1996.8348; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; SMITH LH, 1995, J INVEST DERMATOL, V105, P438, DOI 10.1111/1523-1747.ep12321173; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	21	32	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16405	10.1371/journal.pone.0016405	http://dx.doi.org/10.1371/journal.pone.0016405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346798	Green Published, gold, Green Submitted			2022-12-27	WOS:000287077600006
J	Ryu, S; Joshi, N; McDonnell, K; Woo, J; Choi, H; Gao, DC; McCombie, WR; Mittal, V				Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Woo, Jongchan; Choi, Hyejin; Gao, Dingcheng; McCombie, William R.; Mittal, Vivek			Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing Data by Analysis of Pri-MicroRNA Secondary Structures	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MESENCHYMAL TRANSITION; TUMOR INVASION; METASTASIS; EXPRESSION; IDENTIFICATION; DEREGULATION; GENOMICS; FAMILY; CELLS	MicroRNAs (miRNAs) are key regulators of gene expression and contribute to a variety of biological processes. Abnormal miRNA expression has been reported in various diseases including pathophysiology of breast cancer, where they regulate protumorigenic processes including vascular invasiveness, estrogen receptor status, chemotherapy resistance, invasion and metastasis. The miRBase sequence database, a public repository for newly discovered miRNAs, has grown rapidly with approximately > 10,000 entries to date. Despite this rapid growth, many miRNAs have not yet been validated, and several others are yet to be identified. A lack of a full complement of miRNAs has imposed limitations on recognizing their important roles in cancer, including breast cancer. Using deep sequencing technology, we have identified 189 candidate novel microRNAs in human breast cancer cell lines with diverse tumorigenic potential. We further show that analysis of 500-nucleotide pri-microRNA secondary structure constitutes a reliable method to predict bona fide miRNAs as judged by experimental validation. Candidate novel breast cancer miRNAs with stem lengths of greater than 30 bp resulted in the generation of precursor and mature sequences in vivo. On the other hand, candidates with stem length less than 30 bp were less efficient in producing mature miRNA. This approach may be used to predict which candidate novel miRNA would qualify as bona fide miRNAs from deep sequencing data with approximately 90% accuracy.	[Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA; [Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Cornell Univ, New York, NY 10021 USA; [Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Woo, Jongchan] Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; [McCombie, William R.] Cold Spring Harbor Lab, New York, NY USA	Cornell University; Cornell University; Cornell University; Rockefeller University; Cold Spring Harbor Laboratory	Ryu, S (corresponding author), Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA.	vim2010@med.cornell.edu	Gao, Dingcheng/P-5889-2019; Choi, Hyejin/ABC-5099-2020	Choi, Hyejin/0000-0002-4884-2747; McCombie, W. Richard/0000-0003-1899-0682	Neuberger Berman Lung Cancer laboratory; The Robert I. Goldman Foundation	Neuberger Berman Lung Cancer laboratory; The Robert I. Goldman Foundation	This work was supported by funding from the Neuberger Berman Lung Cancer laboratory and The Robert I. Goldman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hager G, 2009, NAT METHODS, V6, P254, DOI 10.1038/nmeth0409-254; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Ritchie W, 2007, RNA, V13, P457, DOI 10.1261/rna.366507; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	35	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16403	10.1371/journal.pone.0016403	http://dx.doi.org/10.1371/journal.pone.0016403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346806	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600005
J	Trauner, A; Bennett, MH; Williams, HD				Trauner, Andrej; Bennett, Mark H.; Williams, Huw D.			Isolation of Bacterial Ribosomes with Monolith Chromatography	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE RIBOSOMES; PURIFICATION; SEPARATION; SUPPORTS; SUBUNITS; COLUMNS; RNA	We report the development of a rapid chromatographic method for the isolation of bacterial ribosomes from crude cell lysates in less than ten minutes. Our separation is based on the use of strong anion exchange monolithic columns. Using a simple stepwise elution program we were able to purify ribosomes whose composition is comparable to those isolated by sucrose gradient ultracentrifugation, as confirmed by quantitative proteomic analysis (iTRAQ). The speed and simplicity of this approach could accelerate the study of many different aspects of ribosomal biology.	[Trauner, Andrej; Bennett, Mark H.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London	Trauner, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Trauner, Andrej/0000-0002-6260-9829	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencina M, 2004, J SEP SCI, V27, P801, DOI 10.1002/jssc.200401784; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Bousquet Jean, 2006, Paediatr Drugs, V8, P235, DOI 10.2165/00148581-200608040-00003; Brne P, 2007, J CHROMATOGR A, V1144, P120, DOI 10.1016/j.chroma.2006.12.044; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; FABRY M, 1981, BIOCHIM BIOPHYS ACTA, V652, P139, DOI 10.1016/0005-2787(81)90217-3; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; JELENC PC, 1980, ANAL BIOCHEM, V105, P369, DOI 10.1016/0003-2697(80)90472-8; Josic D, 2007, J CHROMATOGR A, V1144, P2, DOI 10.1016/j.chroma.2006.11.082; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KIRILLOV SV, 1978, NUCLEIC ACIDS RES, V5, P4305, DOI 10.1093/nar/5.11.4305; Kramberger P, 2007, J CHROMATOGR A, V1144, P143, DOI 10.1016/j.chroma.2006.10.055; LEGOFFIC F, 1974, FEBS LETT, V41, P69, DOI 10.1016/0014-5793(74)80956-7; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lost Isabelle, 2008, V432, P321, DOI 10.1007/978-1-59745-028-7_22; Maguire BA, 2008, RNA, V14, P188, DOI 10.1261/rna.692408; Miyazaki C, 1999, VACCINE, V17, P245, DOI 10.1016/S0264-410X(98)00191-1; SARUYAMA H, 1986, ANAL BIOCHEM, V159, P12, DOI 10.1016/0003-2697(86)90300-3; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Simons SP, 2009, ANAL BIOCHEM, V395, P77, DOI 10.1016/j.ab.2009.07.042; Smrekar F, 2008, J CHROMATOGR B, V861, P177, DOI 10.1016/j.jchromb.2007.05.048; Strancar Ales, 2002, Adv Biochem Eng Biotechnol, V76, P49	22	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16273	10.1371/journal.pone.0016273	http://dx.doi.org/10.1371/journal.pone.0016273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326610	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000008
J	Monaco, DC; Rodriguez, AM; Pascutti, MF; Carobene, M; Falivene, J; Gomez, A; Maeto, C; Turk, G; Najera, JL; Esteban, M; Gherardi, MM				Monaco, Daniela C.; Rodriguez, Ana M.; Pascutti, Maria F.; Carobene, Mauricio; Falivene, Juliana; Gomez, Alejandro; Maeto, Cynthia; Turk, Gabriela; Najera, Jose L.; Esteban, Mariano; Gherardi, M. Magdalena			T-Cell Immune Responses Against Env from CRF12_BF and Subtype B HIV-1 Show High Clade-Specificity that Can Be Overridden by Multiclade Immunizations	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; CROSS-REACTIVITY; BUENOS-AIRES; RECOMBINANTS; INFECTION; GAG; INDIVIDUALS; VACCINATION; PREVALENCE	Background: The extreme genetic diversity of the human immunodeficiency virus type 1 (HIV-1) poses a daunting challenge to the generation of an effective AIDS vaccine. In Argentina, the epidemic is characterized by the high prevalence of infections caused by subtype B and BF variants. The aim of this study was to characterize in mice the immunogenic and antigenic properties of the Env protein from CRF12_BF in comparison with clade B, employing prime-boost schemes with the combination of recombinant DNA and vaccinia virus (VV) vectors. Methodology/Principal Findings: As determined by ELISPOT from splenocytes of animals immunized with either EnvBF or EnvB antigens, the majority of the cellular responses to Env were found to be clade-specific. A detailed peptide mapping of the responses reveal that when there is cross-reactivity, there are no amino acid changes in the peptide sequence or were minimal and located at the peptide ends. In those cases, analysis of T cell polifunctionality and affinity indicated no differences with respect to the cellular responses found against the original homologous sequence. Significantly, application of a mixed immunization combining both clades (B and BF) induced a broader cellular response, in which the majority of the peptides targeted after the single clade vaccinations generated a positive response. In this group we could also find significant cellular and humoral responses against the whole gp120 protein from subtype B. Conclusions/Significance: This work has characterized for the first time the immunogenic peptides of certain EnvBF regions, involved in T cell responses. It provides evidence that to improve immune responses to HIV there is a need to combine Env antigens from different clades, highlighting the convenience of the inclusion of BF antigens in future vaccines for geographic regions where these HIV variants circulate.	[Monaco, Daniela C.; Rodriguez, Ana M.; Pascutti, Maria F.; Carobene, Mauricio; Falivene, Juliana; Gomez, Alejandro; Maeto, Cynthia; Turk, Gabriela; Gherardi, M. Magdalena] Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina; [Najera, Jose L.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain	University of Buenos Aires; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Monaco, DC (corresponding author), Univ Buenos Aires, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina.	mgherardi@fmed.uba.ar	NAJERA, Jose Luis/W-8177-2019; Esteban, Mariano/ABG-5375-2020	Esteban, Mariano/0000-0003-0846-2827; Falivene, Juliana/0000-0003-3437-4863; Najera, jose Luis/0000-0001-7798-3330; Gomez, Alejandro Martin/0000-0001-6955-5977; Pascutti, Maria Fernanda/0000-0003-3212-780X	Argentinean Agency for the Promotion of Science and Technology (ANPCYT) [34410]; CONICET (PIP) [6122]; AECID-PCI of Spain [A/025293/09]; CONICET-CSIC [579/06]	Argentinean Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); AECID-PCI of Spain; CONICET-CSIC(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	D. C. Monaco was supported by the Argentinean Agency for the Promotion of Science and Technology. This research has been funded by the Argentinean Agency for the Promotion of Science and Technology (ANPCYT, Grant N<SUP>o</SUP> 34410), by the CONICET (PIP Grant No 6122 and CONICET-CSIC Grant No 579/06) and by the AECID-PCI of Spain (Grant No A/025293/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Aguayo N, 2008, REV SOC BRAS MED TRO, V41, P225, DOI 10.1590/S0037-86822008000300001; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andre S, 1998, J VIROL, V72, P1497; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Battig P, 2005, MICROBES INFECT, V7, P729, DOI 10.1016/j.micinf.2005.01.014; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; BERGMANN C, 1993, EUR J IMMUNOL, V23, P2777, DOI 10.1002/eji.1830231109; Betts MR, 1997, J VIROL, V71, P8908, DOI 10.1128/JVI.71.11.8908-8911.1997; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Butler IF, 2007, CURR HIV RES, V5, P23, DOI 10.2174/157016207779316297; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carrillo MG, 2002, AIDS RES HUM RETROV, V18, P477, DOI 10.1089/088922202317406619; Castro E, 2003, JAIDS-J ACQ IMM DEF, V32, P338, DOI 10.1097/00126334-200303010-00015; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; DALLO S, 1987, VIROLOGY, V159, P408, DOI 10.1016/0042-6822(87)90480-6; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Dorrell L, 2001, EUR J IMMUNOL, V31, P1747, DOI 10.1002/1521-4141(200106)31:6<1747::AID-IMMU1747>3.3.CO;2-C; Earl P L, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1617s43; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Gherardi MM, 2004, J IMMUNOL, V172, P6209, DOI 10.4049/jimmunol.172.10.6209; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gherardi MM, 2000, J VIROL, V74, P6278, DOI 10.1128/JVI.74.14.6278-6286.2000; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Larke N, 2007, EUR J IMMUNOL, V37, P566, DOI 10.1002/eji.200636711; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pando MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-58; Quarleri JF, 2004, AIDS RES HUM RETROV, V20, P1100, DOI 10.1089/aid.2004.20.1100; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Risco C, 1999, VIROLOGY, V265, P375, DOI 10.1006/viro.1999.0046; Rodriguez AM, 2009, VIRUS RES, V146, P1, DOI 10.1016/j.virusres.2009.08.004; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17185	10.1371/journal.pone.0017185	http://dx.doi.org/10.1371/journal.pone.0017185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364754	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800031
J	Rapanelli, M; Frick, LR; Zanutto, BS				Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio			Learning an Operant Conditioning Task Differentially Induces Gliogenesis in the Medial Prefrontal Cortex and Neurogenesis in the Hippocampus	PLOS ONE			English	Article							GENERATED GRANULE CELLS; ENHANCED SYNAPTIC PLASTICITY; RAT DENTATE GYRUS; ADULT NEUROGENESIS; SPATIAL MEMORY; VOLUNTARY EXERCISE; NEURAL-NETWORKS; AGED RATS; NEURONS; PROLIFERATION	Circuit modification associated with learning and memory involves multiple events, including the addition and remotion of newborn cells trough adulthood. Adult neurogenesis and gliogenesis were mainly described in models of voluntary exercise, enriched environments, spatial learning and memory task; nevertheless, it is unknown whether it is a common mechanism among different learning paradigms, like reward dependent tasks. Therefore, we evaluated cell proliferation, neurogenesis, astrogliogenesis, survival and neuronal maturation in the medial prefrontal cortex (mPFC) and the hippocampus (HIPP) during learning an operant conditioning task. This was performed by using endogenous markers of cell proliferation, and a bromodeoxiuridine (BrdU) injection schedule in two different phases of learning. Learning an operant conditioning is divided in two phases: a first phase when animals were considered incompletely trained (IT, animals that were learning the task) when they performed between 50% and 65% of the responses, and a second phase when animals were considered trained (Tr, animals that completely learned the task) when they reached 100% of the responses with a latency time lower than 5 seconds. We found that learning an operant conditioning task promoted cell proliferation in both phases of learning in the mPFC and HIPP. Additionally, the results presented showed that astrogliogenesis was induced in the medial prefrontal cortex (mPFC) in both phases, however, the first phase promoted survival of these new born astrocytes. On the other hand, an increased number of new born immature neurons was observed in the HIPP only in the first phase of learning, whereas, decreased values were observed in the second phase. Finally, we found that neuronal maturation was induced only during the first phase. This study shows for the first time that learning a reward-dependent task, like the operant conditioning, promotes neurogenesis, astrogliogenesis, survival and neuronal maturation depending on the learning phase in the mPFC-HIPP circuit.	[Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio] IBYME CONICET, Lab Biol Comportamiento, Buenos Aires, DF, Argentina; [Silvano Zanutto, Bonifacio] Univ Buenos Aires, Fac Ingn, Inst Ingn Biomed, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rapanelli, M (corresponding author), IBYME CONICET, Lab Biol Comportamiento, Buenos Aires, DF, Argentina.	mrapanelli@ibyme.conicet.gov.ar	rapanelli, maximiliano/P-3141-2016	rapanelli, maximiliano/0000-0001-7329-2364	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2006 2485]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-02851]; Universidad de Buenos Aires [I027]; Sigma Xi [G200803150637]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); Sigma Xi	Funding: This study was funded by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2006 2485), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-02851), Universidad de Buenos Aires (I027) and Sigma Xi (G200803150637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez PJ, 2006, LEARN MEMORY, V13, P599, DOI 10.1101/lm.335006; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kelly MP, 2003, J NEUROSCI, V23, P6443; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rapanelli M, 2009, NEUROSCIENCE, V163, P1031, DOI 10.1016/j.neuroscience.2009.07.037; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Rapanelli M, 2010, J NEUROCHEM, V113, P725, DOI 10.1111/j.1471-4159.2010.06640.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Van Kampen JM, 2004, EUR J NEUROSCI, V19, P2377, DOI 10.1111/j.0953-816X.2004.03342.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e14713	10.1371/journal.pone.0014713	http://dx.doi.org/10.1371/journal.pone.0014713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723CC	21364751	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800003
J	Delputte, PL; Van Gorp, H; Favoreel, HW; Hoebeke, I; Delrue, I; Dewerchin, H; Verdonck, F; Verhasselt, B; Cox, E; Nauwynck, HJ				Delputte, Peter L.; Van Gorp, Hanne; Favoreel, Herman W.; Hoebeke, Inge; Delrue, Iris; Dewerchin, Hannah; Verdonck, Frank; Verhasselt, Bruno; Cox, Eric; Nauwynck, Hans J.			Porcine Sialoadhesin (CD169/Siglec-1) Is an Endocytic Receptor that Allows Targeted Delivery of Toxins and Antigens to Macrophages	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ACID-BINDING-RECEPTOR; LIPID RAFT ASSOCIATION; SIALIC-ACID; PSEUDORABIES VIRUS; ALVEOLAR MACROPHAGES; MEDIATED ENDOCYTOSIS; B-CELL; MONOCLONAL-ANTIBODIES; TISSUE MACROPHAGES	Sialoadhesin is exclusively expressed on specific subpopulations of macrophages. Since sialoadhesin-positive macrophages are involved in inflammatory autoimmune diseases, such as multiple sclerosis, and potentially in the generation of immune responses, targeted delivery of drugs, toxins or antigens via sialoadhesin-specific immunoconjugates may prove a useful therapeutic strategy. Originally, sialoadhesin was characterized as a lymphocyte adhesion molecule, though recently its involvement in internalization of sialic acid carrying pathogens was shown, suggesting that sialoadhesin is an endocytic receptor. In this report, we show that porcine sialoadhesin-specific antibodies and F(ab')(2) fragments trigger sialoadhesin internalization, both in primary porcine macrophages and in cells expressing recombinant porcine sialoadhesin. Using chemical inhibitors, double immunofluorescence stainings and dominant-negative constructs, porcine sialoadhesin internalization was shown to be clathrin-and Eps15-dependent and to result in targeting to early endosomes but not lysosomes. Besides characterizing the sialoadhesin endocytosis mechanism, two sialoadhesin-specific immunoconjugates were evaluated. We observed that porcine sialoadhesin-specific immunotoxins efficiently kill sialoadhesin-expressing macrophages. Furthermore, porcine sialoadhesin-specific albumin immunoconjugates were shown to be internalized in macrophages and immunization with these immunoconjugates resulted in a rapid and robust induction of albumin-specific antibodies, this compared to immunization with albumin alone. Together, these data expand sialoadhesin functionality and show that it can function as an endocytic receptor, a feature that cannot only be misused by sialic acid carrying pathogens, but that may also be used for specific targeting of toxins or antigens to sialoadhesin-expressing macrophages.	[Delputte, Peter L.; Van Gorp, Hanne; Favoreel, Herman W.; Hoebeke, Inge; Delrue, Iris; Dewerchin, Hannah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Favoreel, Herman W.; Verdonck, Frank; Cox, Eric] Univ Ghent, Fac Vet Med, Immunol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Verhasselt, Bruno] Univ Ghent, Fac Med & Hlth Sci, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Delputte, PL (corresponding author), Ablynx NV, Zwijnaarde, Belgium.	Peter.Delputte@Ugent.be; Hanne.VanGorp@Ugent.be; Hans.Nauwynck@Ugent.be	Delputte, Peter/A-1062-2008; Favoreel, Herman W/H-8712-2013	Delputte, Peter/0000-0003-3972-616X; Favoreel, Herman W/0000-0003-4993-6857; Verhasselt, Bruno/0000-0002-4645-1144; Dewerchin, Hannah/0000-0002-0059-6751; Nauwynck, Hans/0000-0001-5470-0713; Cox, Eric/0000-0003-4281-2990	fund for scientific research (FWO Vlaanderen); Ghent University; Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO) [80046]	fund for scientific research (FWO Vlaanderen)(FWO); Ghent University(Ghent University); Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	L. Delputte was supported with a post-doctoral fellowship of the fund for scientific research (FWO Vlaanderen) (www.fwo.be). H. Van Gorp was financially supported by a post-doctoral grant from the Special Research Fund of Ghent University. This research was further supported by the Industrial Research Fund (IOF) of Ghent University (www.techtransfer.ugent.be) and the Flemish Institute for the Promotion of Innovation by Science and Technology (IWT - SBO 80046) (www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audran R, 1995, J IMMUNOL METHODS, V188, P147, DOI 10.1016/0022-1759(95)00213-8; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bernstein ID, 2002, CLIN LYMPHOMA, V2, pS9, DOI 10.3816/CLM.2002.s.002; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Chan CHT, 1998, J BIOL CHEM, V273, P27809, DOI 10.1074/jbc.273.43.27809; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1995, J CLIN INVEST, V95, P635, DOI 10.1172/JCI117708; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Delputte PL, 2007, J VIROL, V81, P9546, DOI 10.1128/JVI.00569-07; Delputte PL, 2005, J GEN VIROL, V86, P1441, DOI 10.1099/vir.0.80675-0; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Deputte PL, 2006, ADV EXP MED BIOL, V581, P247; DesplanqueS AS, 2007, VIROLOGY, V362, P60, DOI 10.1016/j.virol.2006.12.018; Dewerchin HL, 2008, J GEN VIROL, V89, P2731, DOI 10.1099/vir.0.2008/002212-0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Duan XB, 1998, J VIROL, V72, P4520, DOI 10.1128/JVI.72.5.4520-4523.1998; Ducreux J, 2009, BIOCONJUGATE CHEM, V20, P295, DOI 10.1021/bc800390g; Favoreel HW, 2004, J VIROL, V78, P5279, DOI 10.1128/JVI.78.10.5279-5287.2004; Foussias G, 2000, BIOCHEM BIOPH RES CO, V278, P775, DOI 10.1006/bbrc.2000.3866; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Herrera L, 2000, LEUKEMIA, V14, P853, DOI 10.1038/sj.leu.2401779; Ikezumi Y, 2005, NEPHROL DIAL TRANSPL, V20, P2704, DOI 10.1093/ndt/gfi105; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jiang HR, 2006, J IMMUNOL, V177, P2258, DOI 10.4049/jimmunol.177.4.2258; John BJ, 2003, J IMMUNOL, V170, P3534, DOI 10.4049/jimmunol.170.7.3534; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Keler T, 2007, ONCOGENE, V26, P3758, DOI 10.1038/sj.onc.1210375; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Kratzer R, 2010, J IMMUNOL, V184, P6855, DOI 10.4049/jimmunol.0902555; Mansfield E, 1997, BLOOD, V90, P2020, DOI 10.1182/blood.V90.5.2020; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nath D, 1999, IMMUNOLOGY, V98, P213; NAUWYNCK HJ, 1995, ARCH VIROL, V140, P1137, DOI 10.1007/BF01315422; Newton DL, 2001, BLOOD, V97, P528, DOI 10.1182/blood.V97.2.528; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Perry DG, 1999, J IMMUNOL, V162, P380; PESCOVITZ MD, 1984, J IMMUNOL, V133, P368; PHONPHOK Y, 1991, FEBS LETT, V281, P188, DOI 10.1016/0014-5793(91)80390-O; Raveh D, 1998, J LEUKOCYTE BIOL, V64, P108, DOI 10.1002/jlb.64.1.108; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Revilla C, 2009, VET RES, V40, DOI 10.1051/vetres:2008052; Schadee-Eestermans IL, 2000, IMMUNOBIOLOGY, V202, P309, DOI 10.1016/S0171-2985(00)80036-4; SHAN DM, 1995, J IMMUNOL, V154, P4466; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; Thrush GR, 1996, ANNU REV IMMUNOL, V14, P49, DOI 10.1146/annurev.immunol.14.1.49; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Van der Stede Y, 2001, VACCINE, V19, P1870, DOI 10.1016/S0264-410X(00)00440-0; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; Verdonck F, 2005, J CONTROL RELEASE, V104, P243, DOI 10.1016/j.jconrel.2005.02.007; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wilson DS, 2002, J IMMUNOL METHODS, V260, P29, DOI 10.1016/S0022-1759(01)00514-2; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	72	63	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16827	10.1371/journal.pone.0016827	http://dx.doi.org/10.1371/journal.pone.0016827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359217	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700025
J	Martinez, M; Brezun, JM; Xerri, C				Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian			Sensorimotor Experience Influences Recovery of Forelimb Abilities but Not Tissue Loss after Focal Cortical Compression in Adult Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PRIMARY SOMATOSENSORY CORTEX; ENRICHED ENVIRONMENT; SPINAL-CORD; CEREBRAL-CORTEX; VESTIBULAR COMPENSATION; BEHAVIORAL RECOVERY; CUTANEOUS INPUTS; MOTOR; LOCOMOTION	Sensorimotor activity has been shown to play a key role in functional outcome after extensive brain damage. This study was aimed at assessing the influence of sensorimotor experience through subject-environment interactions on the time course of both lesion and gliosis volumes as well as on the recovery of forelimb sensorimotor abilities following focal cortical injury. The lesion consisted of a cortical compression targeting the forepaw representational area within the primary somatosensory cortex of adult rats. After the cortical lesion, rats were randomly subjected to various postlesion conditions: unilateral C5-C6 dorsal root transection depriving the contralateral cortex from forepaw somatosensory inputs, standard housing or an enriched environment promoting sensorimotor experience and social interactions. Behavioral tests were used to assess forelimb placement during locomotion, forelimb-use asymmetry, and forepaw tactile sensitivity. For each group, the time course of tissue loss was described and the gliosis volume over the first postoperative month was evaluated using an unbiased stereological method. Consistent with previous studies, recovery of behavioral abilities was found to depend on post-injury experience. Indeed, increased sensorimotor activity initiated early in an enriched environment induced a rapid and more complete behavioral recovery compared with standard housing. In contrast, severe deprivation of peripheral sensory inputs led to a delayed and only partial sensorimotor recovery. The dorsal rhizotomy was found to increase the perilesional gliosis in comparison to standard or enriched environments. These findings provide further evidence that early sensory experience has a beneficial influence on the onset and time course of functional recovery after focal brain injury.	[Martinez, Marina; Brezun, Jean-Michel; Xerri, Christian] Univ Provence, CNRS, UMR 6149, IFR 131, Marseilles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Martinez, M (corresponding author), Univ Provence, CNRS, UMR 6149, IFR 131, Pole 3 C, Marseilles, France.	christian.xerri@univ-provence.fr	Martínez Filgueira, Marina/GZG-8145-2022	Martinez, Marina/0000-0002-3294-3017	Ministere de l'Enseignement Superieur et de la Recherche; CNRS	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from Ministere de l'Enseignement Superieur et de la Recherche and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriat AM, 2006, BRAIN RES, V1109, P183, DOI 10.1016/j.brainres.2006.06.035; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; CASTRO AJ, 1977, PHYSIOL BEHAV, V18, P605, DOI 10.1016/0031-9384(77)90059-2; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Coq JO, 1999, EXP BRAIN RES, V129, P518, DOI 10.1007/s002210050922; Coyle DE, 1998, GLIA, V23, P75; DOETSCH GS, 1990, EXP NEUROL, V108, P162, DOI 10.1016/0014-4886(90)90024-M; Frigon A, 2006, BIOL CYBERN, V95, P607, DOI 10.1007/s00422-006-0129-x; GOLDBERGER ME, 1974, J COMP NEUROL, V158, P37, DOI 10.1002/cne.901580104; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ibrahim AG, 2009, EXP NEUROL, V215, P142, DOI 10.1016/j.expneurol.2008.09.023; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Jenkins WM, 1987, PROG BRAIN RES <D>, V71, P249; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; Keiner S, 2008, GLIA, V56, P516, DOI 10.1002/glia.20632; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kundrotiene J, 2002, J NEUROTRAUM, V19, P69, DOI 10.1089/089771502753460259; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Martinez M, 2010, EXP NEUROL, V221, P186, DOI 10.1016/j.expneurol.2009.10.022; Martinez M, 2009, EUR J NEUROSCI, V30, P2356, DOI 10.1111/j.1460-9568.2009.07019.x; Martinez M, 2009, J NEUROTRAUM, V26, P1043, DOI 10.1089/neu.2008.0717; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Napieralski JA, 1998, EXP NEUROL, V154, P80, DOI 10.1006/exnr.1998.6893; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Webb AA, 2003, EUR J NEUROSCI, V18, P412, DOI 10.1046/j.1460-9568.2003.02768.x; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; ZennouAzogui Y, 1996, BEHAV BRAIN RES, V74, P65, DOI 10.1016/0166-4328(95)00142-5; ZENNOUAZOGUI Y, 1995, RESTOR NEUROL NEUROS, V7, P235, DOI 10.3233/RNN-1994-7406	56	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16726	10.1371/journal.pone.0016726	http://dx.doi.org/10.1371/journal.pone.0016726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359230	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700022
J	Sarachana, T; Xu, MY; Wu, RC; Hu, VW				Sarachana, Tewarit; Xu, Minyi; Wu, Ray-Chang; Hu, Valerie W.			Sex Hormones in Autism: Androgens and Estrogens Differentially and Reciprocally Regulate RORA, a Novel Candidate Gene for Autism	PLOS ONE			English	Article							FETAL TESTOSTERONE; EXPRESSION; ALPHA; EXPLORATION; PATTERNS; PROMO	Autism, a pervasive neurodevelopmental disorder manifested by deficits in social behavior and interpersonal communication, and by stereotyped, repetitive behaviors, is inexplicably biased towards males by a ratio of,4: 1, with no clear understanding of whether or how the sex hormones may play a role in autism susceptibility. Here, we show that male and female hormones differentially regulate the expression of a novel autism candidate gene, retinoic acid-related orphan receptor-alpha (RORA) in a neuronal cell line, SH-SY5Y. In addition, we demonstrate that RORA transcriptionally regulates aromatase, an enzyme that converts testosterone to estrogen. We further show that aromatase protein is significantly reduced in the frontal cortex of autistic subjects relative to sex-and age-matched controls, and is strongly correlated with RORA protein levels in the brain. These results indicate that RORA has the potential to be under both negative and positive feedback regulation by male and female hormones, respectively, through one of its transcriptional targets, aromatase, and further suggest a mechanism for introducing sex bias in autism.	[Sarachana, Tewarit; Xu, Minyi; Wu, Ray-Chang; Hu, Valerie W.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Sarachana, T (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmvwh@gwumc.edu	Wu, Ray-chang/X-2018-2019	Hu, Valerie/0000-0002-3357-0777	Autism Speaks [2381]; National Center for Research Resources [S10RR025565]; Office of the Commission on Higher Education of the Royal Thai Government, Thailand; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER	Autism Speaks; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Commission on Higher Education of the Royal Thai Government, Thailand(Office of Higher Education Commission (OHEC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: The project described was supported in part by a grant from Autism Speaks Grant # 2381 (VWH), by a joint intramural GWU and Clinical and Translational Science Institute-Children's National Award for development of Novel Clinical and Translational Methodologies (VWH), and by Award Number S10RR025565 from the National Center for Research Resources (P.I.: Anastas Popratiloff, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. TS is a predoctoral student in the Institute for Biomedical Sciences at The George Washington University, who is supported by a Higher Educational Strategic Scholarship for Frontier Research from the Office of the Commission on Higher Education of the Royal Thai Government, Thailand. This work is part of his dissertation research to be presented in partial fulfillment of the requirements for the Ph.D. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, BRIT J PSYCHOL, V100, P1, DOI 10.1348/000712608X311731; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Doulazmi M, 1999, J COMP NEUROL, V411, P267; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; GOODALL G, 1987, BEHAV NEURAL BIOL, V47, P307, DOI 10.1016/S0163-1047(87)90422-5; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Harding HP, 1997, MOL ENDOCRINOL, V11, P1737, DOI 10.1210/me.11.11.1737; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Hu VW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005775; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Lalonde R, 2008, NEUROBIOL LEARN MEM, V90, P472, DOI 10.1016/j.nlm.2008.05.004; LALONDE R, 1987, PHYSIOL BEHAV, V41, P115, DOI 10.1016/0031-9384(87)90139-9; LALONDE R, 1987, J NEUROGENET, V4, P285, DOI 10.3109/01677068709102349; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361	26	143	145	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17116	10.1371/journal.pone.0017116	http://dx.doi.org/10.1371/journal.pone.0017116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359227	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700051
J	Watanabe, K; Matsuda, T; Nishioka, T; Namatame, M				Watanabe, Katsumi; Matsuda, Tetsuya; Nishioka, Tomoyuki; Namatame, Miki			Eye Gaze during Observation of Static Faces in Deaf People	PLOS ONE			English	Article							FACIAL EXPRESSIONS; RECOGNIZE EMOTIONS; VISUAL-ATTENTION; SIGN-LANGUAGE; PERCEPTION; SEX; INDIVIDUALS; MOVEMENTS; CUES	Knowing where people look when viewing faces provides an objective measure into the part of information entering the visual system as well as into the cognitive strategy involved in facial perception. In the present study, we recorded the eye movements of 20 congenitally deaf (10 male and 10 female) and 23 (11 male and 12 female) normal-hearing Japanese participants while they evaluated the emotional valence of static face stimuli. While no difference was found in the evaluation scores, the eye movements during facial observations differed among participant groups. The deaf group looked at the eyes more frequently and for longer duration than the nose whereas the hearing group focused on the nose (or the central region of face) more than the eyes. These results suggest that the strategy employed to extract visual information when viewing static faces may differ between deaf and hearing people.	[Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Watanabe, Katsumi] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Watanabe, Katsumi] Japan Sci & Technol Agcy, Saitama, Japan; [Matsuda, Tetsuya] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Nishioka, Tomoyuki; Namatame, Miki] Tsukuba Univ Technol, Dept Synthet Design, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Tsukuba University of Technology	Watanabe, K (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan.	kw@fennel.rcast.u-tokyo.ac.jp		Lauwereyns, Jan/0000-0003-0551-2550; Watanabe, Katsumi/0000-0003-1282-9994	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21300301]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Japan Science and Technology Agency and Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (21300301) and the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2006, CURR DIR PSYCHOL SCI, V15, P222, DOI 10.1111/j.1467-8721.2006.00440.x; Argyle M., 1976, GAZE MUTUAL GAZE; Armann R, 2009, ATTEN PERCEPT PSYCHO, V71, P1107, DOI 10.3758/APP.71.5.1107; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; BERRY DS, 1990, J PERS SOC PSYCHOL, V58, P1004, DOI 10.1037/0022-3514.58.6.1004; Bettger J, 1997, J Deaf Stud Deaf Educ, V2, P223; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bruce V., 1988, PRACTICAL ASPECTS ME, P169; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; De Filippo CL, 2006, EAR HEARING, V27, P331, DOI 10.1097/01.aud.0000226248.45263.ad; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; Dye MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005640; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 2003, UNMASKING FACE GUIDE; Emmorey K, 2009, J DEAF STUD DEAF EDU, V14, P237, DOI 10.1093/deafed/enn037; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Frijda NH, 1953, ACTA PSYCHOL, V9, P294, DOI 10.1016/0001-6918(53)90021-3; Groner R, 1984, THEORETICAL APPL ASP, P523; Hall J. A., 1984, NONVERBAL SEX DIFFER; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Hanawalt NG, 1944, J GEN PSYCHOL, V31, P23, DOI 10.1080/00221309.1944.10545217; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Koda T, 2010, LECT NOTES COMPUT SC, V6259, P16; Kubota Y, 2003, SCHIZOPHR RES, V61, P265, DOI 10.1016/S0920-9964(02)00298-0; Lander K, 1999, MEM COGNITION, V27, P974, DOI 10.3758/BF03201228; Liddell S, 1980, AM LANGUAGE SYNTAX; McCullough S, 1997, J Deaf Stud Deaf Educ, V2, P212; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; Mindess Anna., 2006, READING SIGNS INTERC, V2nd ed.; Muir LJ, 2005, J DEAF STUD DEAF EDU, V10, P390, DOI 10.1093/deafed/eni037; Nakamura K, 2006, DEAF JAPAN SIGNING P; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; Roy C, 2010, J VIS, V10, P531, DOI DOI 10.1167/10.7.531; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Sullivan LA, 1996, GENET SOC GEN PSYCH, V122, P389; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; Tharpe AM, 2008, J AM ACAD AUDIOL, V19, P741, DOI 10.3766/jaaa.19.10.2; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	61	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16919	10.1371/journal.pone.0016919	http://dx.doi.org/10.1371/journal.pone.0016919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721YC	21359223	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700031
J	Coriat, R; Gouya, H; Mir, O; Ropert, S; Vignaux, O; Chaussade, S; Sogni, P; Pol, S; Blanchet, B; Legmann, P; Goldwasser, F				Coriat, Romain; Gouya, Herve; Mir, Olivier; Ropert, Stanislas; Vignaux, Olivier; Chaussade, Stanislas; Sogni, Philippe; Pol, Stanislas; Blanchet, Benoit; Legmann, Paul; Goldwasser, Francois			Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib	PLOS ONE			English	Article							HYPERDYNAMIC SPLANCHNIC CIRCULATION; AZYGOS BLOOD-FLOW; VARICEAL HEMORRHAGE; RAF/MEK/ERK PATHWAY; GROWTH-FACTOR; PHASE-II; HYPERTENSION; MANAGEMENT; INHIBITOR; THERAPY	Portal hypertension, the most important complication with cirrhosis of the liver, is a serious disease. Sorafenib, a tyrosine kinase inhibitor is validated in advanced hepatocellular carcinoma. Because angiogenesis is a pathological hallmark of portal hypertension, the goal of our study was to determine the effect of sorafenib on portal venous flow and portosystemic collateral circulation in patients receiving sorafenib therapy for advanced hepatocellular carcinoma. Porto-collateral circulations were evaluated using a magnetic resonance technique prior sorafenib therapy, and at day 30. All patients under sorafenib therapy had a decrease in portal venous flow of at least 36%. In contrast, no specific change was observed in the azygos vein or the abdominal aorta. No portal venous flow modification was observed in the control group. Sorafenib is the first anti-angiogenic therapy to demonstrate a beneficial and reversible decrease of portal venous flow among cirrhotic patients.	[Coriat, Romain; Mir, Olivier; Ropert, Stanislas; Goldwasser, Francois] Hop Cochin, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, F-75674 Paris, France; [Coriat, Romain; Mir, Olivier; Ropert, Stanislas; Goldwasser, Francois] Teaching Hosp Cochin, Dept Med Oncol, Paris, France; [Coriat, Romain; Gouya, Herve; Mir, Olivier; Ropert, Stanislas; Vignaux, Olivier; Chaussade, Stanislas; Sogni, Philippe; Pol, Stanislas; Blanchet, Benoit; Legmann, Paul; Goldwasser, Francois] Univ Paris 05, Paris, France; [Gouya, Herve; Vignaux, Olivier; Legmann, Paul] Teaching Hosp Cochin, Dept Radiol, Paris, France; [Chaussade, Stanislas] Teaching Hosp Cochin, Gastroenterol Unit, Paris, France; [Sogni, Philippe; Pol, Stanislas] Hop Cochin, AP HP, Liver Unit, F-75674 Paris, France; [Sogni, Philippe; Pol, Stanislas] Hop Cochin, AP HP, INSERM, U567, F-75674 Paris, France; [Blanchet, Benoit] Hop Cochin, AP HP, Pharmacol Lab, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Coriat, R (corresponding author), Hop Cochin, AP HP, Ctr Res Angiogenesis Inhibitors CERIA, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	romain.coriat@cch.aphp.fr	Coriat, Romain/O-7902-2017; Goldwasser, François/P-4861-2017; Mir, Olivier/GNP-7828-2022	Mir, Olivier/0000-0002-6761-4002				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Angermayr B, 2007, GUT, V56, P560, DOI 10.1136/gut.2005.088013; Angermayr B, 2006, J HEPATOL, V44, P1033, DOI 10.1016/j.jhep.2005.09.021; BOSCH J, 1992, GASTROENTEROL CLIN N, V21, P1; BURKART DJ, 1993, RADIOLOGY, V188, P643, DOI 10.1148/radiology.188.3.8351326; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; Debatin JF, 1996, HEPATOLOGY, V24, P1109; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; EVANS AJ, 1993, INVEST RADIOL, V28, P109, DOI 10.1097/00004424-199302000-00004; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Kayacetin E, 2004, J GASTROENTEROL, V39, P661, DOI 10.1007/s00535-003-1362-x; KONDO C, 1991, AM J ROENTGENOL, V157, P9, DOI 10.2214/ajr.157.1.2048544; Lam ET, 2010, J CLIN ONCOL, V28, P2323, DOI 10.1200/JCO.2009.25.0068; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Mejias M, 2009, HEPATOLOGY, V49, P1245, DOI 10.1002/hep.22758; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reiberger T, 2009, J HEPATOL, V51, P865, DOI 10.1016/j.jhep.2009.06.024; Rosmorduc O, 2010, GASTROEN CLIN BIOL, V34, P446, DOI 10.1016/j.gcb.2010.05.007; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.1321; Semela D, 2008, GASTROENTEROLOGY, V135, P671, DOI 10.1053/j.gastro.2008.04.010; Shah VH, 2009, HEPATOLOGY, V49, P1066, DOI 10.1002/hep.22872; Thalheimer U, 2007, GASTROENTEROLOGY, V133, P2029, DOI 10.1053/j.gastro.2007.10.028; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu MT, 1996, RADIOLOGY, V198, P457, DOI 10.1148/radiology.198.2.8596849	34	48	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16978	10.1371/journal.pone.0016978	http://dx.doi.org/10.1371/journal.pone.0016978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340026	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600029
J	Geremia, C; White, PJ; Wallen, RL; Watson, FGR; Treanor, JJ; Borkowski, J; Potter, CS; Crabtree, RL				Geremia, Chris; White, P. J.; Wallen, Rick L.; Watson, Fred G. R.; Treanor, John J.; Borkowski, John; Potter, Christopher S.; Crabtree, Robert L.			Predicting Bison Migration out of Yellowstone National Park Using Bayesian Models	PLOS ONE			English	Article							POPULATION REGULATION; RATES; WILD	Long distance migrations by ungulate species often surpass the boundaries of preservation areas where conflicts with various publics lead to management actions that can threaten populations. We chose the partially migratory bison ( Bison bison) population in Yellowstone National Park as an example of integrating science into management policies to better conserve migratory ungulates. Approximately 60% of these bison have been exposed to bovine brucellosis and thousands of migrants exiting the park boundary have been culled during the past two decades to reduce the risk of disease transmission to cattle. Data were assimilated using models representing competing hypotheses of bison migration during 1990-2009 in a hierarchal Bayesian framework. Migration differed at the scale of herds, but a single unifying logistic model was useful for predicting migrations by both herds. Migration beyond the northern park boundary was affected by herd size, accumulated snow water equivalent, and aboveground dried biomass. Migration beyond the western park boundary was less influenced by these predictors and process model performance suggested an important control on recent migrations was excluded. Simulations of migrations over the next decade suggest that allowing increased numbers of bison beyond park boundaries during severe climate conditions may be the only means of avoiding episodic, large-scale reductions to the Yellowstone bison population in the foreseeable future. This research is an example of how long distance migration dynamics can be incorporated into improved management policies.	[Geremia, Chris; White, P. J.; Wallen, Rick L.; Treanor, John J.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA; [Geremia, Chris] Colorado State Univ, Nat Resource & Ecol Lab, Ft Collins, CO 80523 USA; [Watson, Fred G. R.] Calif State Univ Monterey Bay, Watershed Inst, Seaside, CA USA; [Borkowski, John] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA; [Potter, Christopher S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Crabtree, Robert L.] Yellowstone Ecol Res Ctr, Bozeman, MT USA	United States Department of the Interior; Colorado State University; California State University System; California State University Monterey Bay; Montana State University System; Montana State University Bozeman; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Geremia, C (corresponding author), Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Natl Pk, WY 82190 USA.	Chris_Geremia@nps.gov			National Park Service	National Park Service	This research was funded by the National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aune KE, 1998, INT S BIS EC MAN N A, P61; Becker MS, 2008, ECOLOGY LARGE MAMMAL, P305; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bjornlie DD, 2001, J WILDLIFE MANAGE, V65, P560, DOI 10.2307/3803109; Bruggeman JE, 2008, ECOLOGY LARGE MAMMAL, P217; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cheville NF, 1998, BRUCELLOSIS GREATER; Clark J. S, 2007, MODELS ECOLOGICAL DA; CLUTTONBROCK TH, 1985, J ANIM ECOL, V54, P831, DOI 10.2307/4381; Coughenour M.B., 2008, FRAGMENTATION SEMIAR; Crabtree R, 2009, REMOTE SENS ENVIRON, V113, P1486, DOI 10.1016/j.rse.2008.12.014; Freese CH, 2007, BIOL CONSERV, V136, P175, DOI 10.1016/j.biocon.2006.11.019; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P2365, DOI 10.2193/2006-201; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Garrott RA, 2003, CAN J ZOOL, V81, P33, DOI 10.1139/Z02-218; Gates CC, 2005, ECOLOGY BISON MOVEME; Geremia C, 2008, ECOLOGY LARGE MAMMAL, P255; Halbert N, 2003, THESIS TEXAS A M U; Hess S. C., 2002, THESIS MONTANA STATE; Hobbs NT, 2010, DYNAMICS LA IN PRESS; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Huang S, 2010, EMOTE SENSI IN PRESS; Kilpatrick AM, 2009, J APPL ECOL, V46, P476, DOI 10.1111/j.1365-2664.2008.01602.x; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Meagher M., 1973, NATL PARK SERV SCI M, V1, P1; MESSIER F, 1988, ARCTIC, V41, P279; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Olexa EM, 2007, J WILDLIFE MANAGE, V71, P1531, DOI 10.2193/2005-735; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Potter C, 2007, EARTH INTERACT, V11, DOI 10.1175/EI228.1; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Rhyan JC, 2009, J WILDLIFE DIS, V45, P729, DOI 10.7589/0090-3558-45.3.729; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Sanderson EW, 2008, CONSERV BIOL, V22, P252, DOI 10.1111/j.1523-1739.2008.00899.x; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Watson FGR, 2006, J HYDROL, V328, P728; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	24	25	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16848	10.1371/journal.pone.0016848	http://dx.doi.org/10.1371/journal.pone.0016848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340035	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600021
J	Hammelmann, V; Zong, XG; Hofmann, F; Michalakis, S; Biel, M				Hammelmann, Verena; Zong, Xiangang; Hofmann, Franz; Michalakis, Stylianos; Biel, Martin			The cGMP-Dependent Protein Kinase II Is an Inhibitory Modulator of the Hyperpolarization-Activated HCN2 Channel	PLOS ONE			English	Article							PYRAMIDAL NEURONS; CATION CHANNELS; PHYSIOLOGICAL-FUNCTION; INTEGRATIVE PROPERTIES; PACEMAKER CHANNELS; CYCLIC-NUCLEOTIDES; NITRIC-OXIDE; MICE LACKING; MOUSE-BRAIN; LOCALIZATION	Opening of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels is facilitated by direct binding of cyclic nucleotides to a cyclic nucleotide-binding domain (CNBD) in the C-terminus. Here, we show for the first time that in the HCN2 channel cGMP can also exert an inhibitory effect on gating via cGMP-dependent protein kinase II (cGKII)-mediated phosphorylation. Using coimmunoprecipitation and immunohistochemistry we demonstrate that cGKII and HCN2 interact and colocalize with each other upon heterologous expression as well as in native mouse brain. We identify the proximal C-terminus of HCN2 as binding region of cGKII and show that cGKII phosphorylates HCN2 at a specific serine residue (S641) in the C-terminal end of the CNBD. The cGKII shifts the voltage-dependence of HCN2 activation to 2-5 mV more negative voltages and, hence, counteracts the stimulatory effect of cGMP on gating. The inhibitory cGMP effect can be either abolished by mutation of the phosphorylation site in HCN2 or by impairing the catalytic domain of cGKII. By contrast, the inhibitory effect is preserved in a HCN2 mutant carrying a CNBD deficient for cGMP binding. Our data suggest that bidirectional regulation of HCN2 gating by cGMP contributes to cellular fine-tuning of HCN channel activity.	[Hammelmann, Verena; Zong, Xiangang; Michalakis, Stylianos; Biel, Martin] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Hammelmann, Verena; Zong, Xiangang; Michalakis, Stylianos; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Hofmann, Franz] Tech Univ Munich, Forschergrp Carvas 923, Munich, Germany	University of Munich; University of Munich; Technical University of Munich	Hammelmann, V (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany.	mbiel@cup.uni-muenchen.de	Michalakis, Stylianos/W-2094-2018; Biel, Martin/G-1175-2014; Michalakis, Stylianos/M-4677-2019	Michalakis, Stylianos/0000-0001-5092-9238; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238	Deutsche Forschungsgemeinschaft (DFG); Sonderforschungsbereich 870 [SFB 870]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sonderforschungsbereich 870	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Sonderforschungsbereich 870 (SFB 870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; DEHOOP MJ, 1994, CELL BIOL LAB HDB, P154; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Magee JC, 1998, J NEUROSCI, V18, P7613; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Musialek P, 1997, CIRC RES, V81, P60, DOI 10.1161/01.RES.81.1.60; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Taylor MK, 2000, J BIOL CHEM, V275, P28053; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Werner C, 2004, EUR J NEUROSCI, V20, P3498, DOI 10.1111/j.1460-9568.2004.03793.x; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; XU X, 2010, J BIOL CHEM; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	40	9	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17078	10.1371/journal.pone.0017078	http://dx.doi.org/10.1371/journal.pone.0017078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347269	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600035
J	Li, B; Zheng, YW; Sano, Y; Taniguchi, H				Li, Bin; Zheng, Yun-Wen; Sano, Yuuki; Taniguchi, Hideki			Evidence for Mesenchymal-Epithelial Transition Associated with Mouse Hepatic Stem Cell Differentiation	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; PROGENITOR CELLS; PRECURSOR CELLS; LIVER FIBROSIS; VIMENTIN; CARCINOMA; EXPRESSION; GROWTH; HEPATOCYTES; CANCER	Mesenchymal-epithelial transition events are related to embryonic development, tissue construction, and wound healing. Stem cells are involved in all of these processes, at least in part. However, the direct evidence of mesenchymal-epithelial transition associated with stem cells is unclear. To determine whether mesenchymal-epithelial transition occurs in liver development and/or the differentiation process of hepatic stem cells in vitro, we analyzed a variety of murine liver tissues from embryonic day 11.5 to adults and the colonies derived from hepatic stem/progenitor cells isolated with flow cytometry. The results of gene expression, immunohistochemistry and Western blot showed that as liver develops, the expression of epithelial markers such as Cytokeratin18 and E-cadherin increase, while expression of mesenchymal markers such as vimentin and N-cadherin decreased. On the other hand, in freshly isolated hepatic stem cells, the majority of cells (65.0%) co-express epithelial and mesenchymal markers; this proportion is significantly higher than observed in hematopoietic cells, non-hematopoietic cells and non-stem cell fractions. Likewise, in stem cell-derived colonies cultured over time, upregulation of epithelial genes (Cytokeratin-18 and E-cadherin) occurred simultaneously with downregulation of mesenchymal genes (vimentin and Snail1). Furthermore, in the fetal liver, vimentin-positive cells in the non-hematopoietic fraction had distinct proliferative activity and expressed early the hepatic lineage marker alpha-fetoprotein. Conclusion: Hepatic stem cells co-express mesenchymal and epithelial markers; the mesenchymal-epithelial transition occurred in both liver development and differentiation of hepatic stem/progenitor cells in vitro. Besides as a mesenchymal marker, vimentin is a novel indicator for cell proliferative activity and undifferentiated status in liver cells.	[Li, Bin; Zheng, Yun-Wen; Sano, Yuuki; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan	Yokohama City University	Li, B (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan.	rtanigu@med.yokohama-cu.ac.jp	Li, Bin/P-8992-2015; Zheng, Yun-Wen/R-2874-2019	Li, Bin/0000-0002-4884-6967; Zheng, Yun-Wen/0000-0001-9002-3190	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Japan Science and Technology Agency (JST) [62890004];  [18591421];  [19390340];  [20591531];  [21249071]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); ; ; ; 	Supported by Grants-in-Aid (18591421, 19390340, 20591531 and 21249071) and the 21st Century Center of Excellence (COE) program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan and the grants from Strategic Promotion of Innovative Research and Development (S-innovation, 62890004) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brabletz S, 2009, J PATHOL, V217, P307, DOI 10.1002/path.2475; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Eckes B, 2000, J CELL SCI, V113, P2455; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; KONG D, PLOS ONE, V5; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MENDEZ MG, 1838, FASEB J, V24, P1838; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morton RA, 2007, MOL CELL ENDOCRINOL, V270, P87, DOI 10.1016/j.mce.2007.02.005; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Park MY, 2007, INT J ONCOL, V31, P1309; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Price J, 2001, CURR OPIN NEUROBIOL, V11, P564, DOI 10.1016/S0959-4388(00)00250-6; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seeberger KL, 2009, LAB INVEST, V89, P110, DOI 10.1038/labinvest.2008.122; Spaderna S, 2007, Verh Dtsch Ges Pathol, V91, P21; STENGER AM, 1992, MOL BRAIN RES, V13, P273, DOI 10.1016/0169-328X(92)90036-B; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; VENETIANER A, 1983, NATURE, V305, P730, DOI 10.1038/305730a0; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zheng YW, 2000, TRANSPLANT P, V32, P2372, DOI 10.1016/S0041-1345(00)01704-8	52	50	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17092	10.1371/journal.pone.0017092	http://dx.doi.org/10.1371/journal.pone.0017092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347296	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500025
J	Chang, TC; Yang, Y; Yasue, H; Bharti, AK; Retzel, EF; Liu, WS				Chang, Ti-Cheng; Yang, Yang; Yasue, Hiroshi; Bharti, Arvind K.; Retzel, Ernest F.; Liu, Wan-Sheng			The Expansion of the PRAME Gene Family in Eutheria	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; MULTIPLE ALIGNMENTS; ANTIGEN; EVOLUTIONARY; EXPRESSION; SOFTWARE; MELANOMA; SEQUENCE; TSPY; CHROMOSOME	The PRAME gene family belongs to the group of cancer/testis genes whose expression is restricted primarily to the testis and a variety of cancers. The expansion of this gene family as a result of gene duplication has been observed in primates and rodents. We analyzed the PRAME gene family in Eutheria and discovered a novel Y-linked PRAME gene family in bovine, PRAMEY, which underwent amplification after a lineage-specific, autosome-to-Y transposition. Phylogenetic analyses revealed two major evolutionary clades. Clade I containing the amplified PRAMEYs and the unamplified autosomal homologs in cattle and other eutherians is under stronger functional constraints; whereas, Clade II containing the amplified autosomal PRAMEs is under positive selection. Deep-sequencing analysis indicated that eight of the identified 16 PRAMEY loci are active transcriptionally. Compared to the bovine autosomal PRAME that is expressed predominantly in testis, the PRAMEY gene family is expressed exclusively in testis and is up-regulated during testicular maturation. Furthermore, the sense RNA of PRAMEY is expressed specifically whereas the antisense RNA is expressed predominantly in spermatids. This study revealed that the expansion of the PRAME family occurred in both autosomes and sex chromosomes in a lineage-dependent manner. Differential selection forces have shaped the evolution and function of the PRAME family. The positive selection observed on the autosomal PRAMEs (Clade II) may result in their functional diversification in immunity and reproduction. Conversely, selective constraints have operated on the expanded PRAMEYs to preserve their essential function in spermatogenesis.	[Chang, Ti-Cheng; Yang, Yang; Liu, Wan-Sheng] Penn State Univ, Coll Agr Sci, Ctr Reprod Biol & Hlth, Dept Dairy & Anim Sci, University Pk, PA 16802 USA; [Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Integrat Biosci Program, Huck Inst Life Sci, University Pk, PA 16802 USA; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Bharti, Arvind K.; Retzel, Ernest F.] Natl Ctr Genome Resources, Santa Fe, NM USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Agrobiological Sciences - Japan; National Center for Genome Resources (NCGR)	Chang, TC (corresponding author), Penn State Univ, Coll Agr Sci, Ctr Reprod Biol & Hlth, Dept Dairy & Anim Sci, University Pk, PA 16802 USA.	wul12@psu.edu	Chang, Ti-Cheng/HHS-7370-2022; Chang, Ti-Cheng/N-3252-2018; Yang, Yang/M-3310-2015		USDA-CSREES [2005-35205-18653, 2010-65205-20362]; Pennsylvania State University	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Pennsylvania State University	This work was supported by grants from USDA-CSREES (No. 2005-35205-18653 and No. 2010-65205-20362) and start-up funds from the Pennsylvania State University to Liu, W-S. http://www.csrees.usda.gov/fo/funding.cfm, http://www.psu.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Bronson RA, 1999, J REPROD IMMUNOL, V45, P159; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Del Mastro R G, 1997, Methods Mol Biol, V68, P183; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Epping MT, 2006, CANCER RES, V66, P10639, DOI 10.1158/0008-5472.CAN-06-2522; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gunn SR, 2009, LEUKEMIA RES, V33, P1276, DOI 10.1016/j.leukres.2008.10.010; HUGHES JF, 2010, NATURE; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; ISAHAKIA MA, 1988, BIOL REPROD, V39, P889, DOI 10.1095/biolreprod39.4.889; JAKUBICZKA S, 1993, GENOMICS, V17, P732, DOI 10.1006/geno.1993.1394; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kawano R, 2009, J CLIN EXP HEMATOP, V49, P1, DOI 10.3960/jslrt.49.1; Kiuchi S, 2006, CYTOGENET GENOME RES, V115, P51, DOI 10.1159/000094801; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu WS, 2009, CYTOGENET GENOME RES, V126, P318, DOI 10.1159/000266168; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lu JC, 2008, EXPERT REV CLIN IMMU, V4, P113, DOI 10.1586/1744666X.4.1.113; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McCarthy N, 2005, NAT REV CANCER, V5, P839, DOI 10.1038/nrc1747; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; Nelson Peter T, 2007, Cancer Immun, V7, P1; Ono T, 2001, P NATL ACAD SCI USA, V98, P3282, DOI 10.1073/pnas.041625098; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J., 2001, MOL CLONING; Sawyer S, 1999, GENECONV COMPUTER PA; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Vodicka R, 2007, REPROD BIOMED ONLINE, V14, P579, DOI 10.1016/S1472-6483(10)61049-8; Wang A, 2008, ANIM GENET, V39, P207, DOI 10.1111/j.1365-2052.2008.01706.x; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; TAXONOMY COMMON TREE	60	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16867	10.1371/journal.pone.0016867	http://dx.doi.org/10.1371/journal.pone.0016867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347312	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000021
J	Poyatos, JF				Poyatos, Juan F.			The Balance of Weak and Strong Interactions in Genetic Networks	PLOS ONE			English	Article							EPISTASIS; RECONSTRUCTION; CONSERVATION	Genetic interactions are being quantitatively characterized in a comprehensive way in several model organisms. These data are then globally represented in terms of genetic networks. How are interaction strengths distributed in these networks? And what type of functional organization of the underlying genomic systems is revealed by such distribution patterns? Here, I found that weak interactions are important for the structure of genetic buffering between signaling pathways in Caenorhabditis elegans, and that the strength of the association between two genes correlates with the number of common interactors they exhibit. I also determined that this network includes genetic cascades balancing weak and strong links, and that its hubs act as particularly strong genetic modifiers; both patterns also identified in Saccharomyces cerevisae networks. In yeast, I further showed a relation, although weak, between interaction strengths and some phenotypic/evolutionary features of the corresponding target genes. Overall, this work demonstrates a non-random organization of interaction strengths in genetic networks, a feature common to other complex networks, and that could reflect in this context how genetic variation is eventually influencing the phenotype.	[Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain; [Poyatos, Juan F.] Univ Oslo, CEES, Dept Biol, Oslo, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); University of Oslo	Poyatos, JF (corresponding author), CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain.	jpoyatos@cnb.csic.es			Ministerio de Ciencia, Tecnologia e Innovacion (Spain) [BFU2008-03632/BMC]; Research Mobility Programme; Abel Extraordinary Chair	Ministerio de Ciencia, Tecnologia e Innovacion (Spain); Research Mobility Programme; Abel Extraordinary Chair	This work was partially supported by Ministerio de Ciencia, Tecnologia e Innovacion (Spain) Grant BFU2008-03632/BMC and Research Mobility Programme, and also by the Abel Extraordinary Chair under the NILS Mobility Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Carter GW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000347; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Csermely P, 2004, TRENDS BIOCHEM SCI, V29, P331, DOI 10.1016/j.tibs.2004.05.004; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Gao H, 2010, GENETICS, V184, P827, DOI 10.1534/genetics.109.111120; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e14598	10.1371/journal.pone.0014598	http://dx.doi.org/10.1371/journal.pone.0014598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347355	gold, Green Published, Green Submitted			2022-12-27	WOS:000287363000001
J	Nudds, RL; Kaiser, GW; Dyke, GJ				Nudds, Robert L.; Kaiser, Gary W.; Dyke, Gareth J.			Scaling of Avian Primary Feather Length	PLOS ONE			English	Article							FLIGHT; KINEMATICS; ANATOMY; BIRDS	The evolution of the avian wing has long fascinated biologists, yet almost no work includes the length of primary feathers in consideration of overall wing length variation. Here we show that the length of the longest primary feather (f(prim)) contributing to overall wing length scales with negative allometry against total arm (ta = humerus+ulna+manus). The scaling exponent varied slightly, although not significantly so, depending on whether a species level analysis was used or phylogeny was controlled for using independent contrasts: f(prim) proportional to ta(0.78-0.82). The scaling exponent was not significantly different from that predicted (0.86) by earlier work. It appears that there is a general trend for the primary feathers of birds to contribute proportionally less, and ta proportionally more, to overall wingspan as this dimension increases. Wingspan in birds is constrained close to mass (M-1/3) because of optimisation for lift production, which limits opportunities for exterior morphological change. Within the wing, variations in underlying bone and feather lengths nevertheless may, in altering the joint positions, permit a range of different flight styles by facilitating variation in upstroke kinematics.	[Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Kaiser, Gary W.] Royal British Columbia Museum, Victoria, BC, Canada; [Dyke, Gareth J.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University of Manchester; University College Dublin	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Robert.Nudds@manchester.ac.uk	Bond, Alexander L/A-3786-2010; Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				DIAL KP, 1991, J MORPHOL, V207, P327, DOI 10.1002/jmor.1052070309; Greenewalt C.H., 1975, Transactions of the American Philosophical Society, V65, P1, DOI 10.2307/1006161; Greenewalt C. H., 1962, Smithsonian Miscellaneous Collections, V144, P1; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Norberg U., 1990, VERTEBRATE FLIGHT ME; Nudds RL, 2007, J ZOOL, V272, P218, DOI 10.1111/j.1469-7998.2006.00261.x; Nudds RL, 2007, J AVIAN BIOL, V38, P515, DOI 10.1111/j.0908-8857.2007.03913.x; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Rayner Jeremy M. V., 1988, V5, P1; RAYNER JMV, 1985, J ZOOL, V206, P415; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sokal R.R., 2012, BIOMETRY; Tobalske BW, 2007, J EXP BIOL, V210, P2368, DOI 10.1242/jeb.005686; Worcester SE, 1996, J ZOOL, V239, P609, DOI 10.1111/j.1469-7998.1996.tb05947.x	18	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15665	10.1371/journal.pone.0015665	http://dx.doi.org/10.1371/journal.pone.0015665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347413	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287361700009
J	Schmidt, PM; Attwood, RM; Mohr, PG; Barrett, SA; McKimm-Breschkin, JL				Schmidt, Peter M.; Attwood, Rebecca M.; Mohr, Peter G.; Barrett, Susan A.; McKimm-Breschkin, Jennifer L.			A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase	PLOS ONE			English	Article							COILED-COIL TETRAMER; VIRUS NEURAMINIDASE; A-VIRUS; INSECT CELLS; OSELTAMIVIR RESISTANCE; H1N1 NEURAMINIDASE; SIALIDASE ACTIVITY; LETHAL INFLUENZA; STRUCTURAL BASIS; STALK LENGTH	The influenza surface glycoprotein neuraminidase (NA) is essential for the efficient spread of the virus. Antiviral drugs such as Tamiflu (oseltamivir) and Relenza (zanamivir) that inhibit NA enzyme activity have been shown to be effective in the treatment of influenza infections. The recent 'swine flu' pandemic and world-wide emergence of Tamiflu-resistant seasonal human influenza A(H1N1) H(274)Y have highlighted the need for the ongoing development of new anti-virals, efficient production of vaccine proteins and novel diagnostic tools. Each of these goals could benefit from the production of large quantities of highly pure and stable NA. This publication describes a generic expression system for NAs in a baculovirus Expression Vector System (BEVS) that is capable of expressing milligram amounts of recombinant NA. To construct NAs with increased stability, the natural influenza NA stalk was replaced by two different artificial tetramerization domains that drive the formation of catalytically active NA homotetramers: GCN4-pLI from yeast or the Tetrabrachion tetramerization domain from Staphylothermus marinus. Both recombinant NAs are secreted as FLAG-tagged proteins to allow for rapid and simple purification. The Tetrabrachion-based NA showed good solubility, increased stability and biochemical properties closer to the original viral NA than the GCN4-pLI based construct. The expressed quantities and high quality of the purified recombinant NA suggest that this expression system is capable of producing recombinant NA for a broad range of applications including high-throughput drug screening, protein crystallisation, or vaccine development.	[Schmidt, Peter M.; Attwood, Rebecca M.; Barrett, Susan A.; McKimm-Breschkin, Jennifer L.] CSIRO, Div Mat Sci & Engn, Parkville, Vic, Australia; [Mohr, Peter G.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schmidt, PM (corresponding author), CSIRO, Div Mat Sci & Engn, Parkville, Vic, Australia.	Peter.Schmidt@CSIRO.au	Schmidt, Peter/V-3882-2019; McKimm-Breschkin, Jennifer L/D-1880-2013	Schmidt, Peter/0000-0003-1340-9086; Barrett, Susan/0000-0003-1132-5268; McKimm-Breschkin, Jennifer/0000-0002-2345-6786	National Institutes of Health (NIH) [5R01AI62721]; National Health and Medical Research Council (NHMRC) [595625]; GlaxoSmithKline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062721] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health (NIH) grant 5R01AI62721 'Mechanisms of influenza NA drug resistance' (http://www.nih.gov/), the National Health and Medical Research Council (NHMRC) grant 595625 'Impact of resistance mutations on sensitivity of A (H1N1) swine flu neuraminidase (NA) to current and novel NA-inhibitors' (http://www.nhmrc.gov.au/), and GlaxoSmithKline (http://www.gsk.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors are employees of the Commonwealth Scientific Industrial Research Organisation (CSIRO). JLM is receiving funding from GSK and the NIH. JLM and PMS receive funding from the NHMRC. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NHMRC or GSK. The authors also confirm that the above mentioned competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AEED PA, 1994, BIOCHEMISTRY-US, V33, P8793, DOI 10.1021/bi00195a022; Becker EM, 2000, J CARDIOVASC PHARM, V35, P390, DOI 10.1097/00005344-200003000-00007; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; CASTRUCCI MR, 1992, J VIROL, V66, P4647, DOI 10.1128/JVI.66.8.4647-4653.1992; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Conne P, 1997, VACCINE, V15, P1675, DOI 10.1016/S0264-410X(97)00087-X; Dalakouras T, 2006, J CHROMATOGR A, V1136, P48, DOI 10.1016/j.chroma.2006.09.067; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; FERNLEY RT, 1988, BIOCHEMISTRY-US, V27, P2815, DOI 10.1021/bi00408a023; Fiers W, 2001, PHILOS T ROY SOC B, V356, P1961, DOI 10.1098/rstb.2001.0980; Goto H, 1997, VIROLOGY, V238, P265, DOI 10.1006/viro.1997.8810; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Johnson GD, 2005, ARCH BIOCHEM BIOPHYS, V444, P7, DOI 10.1016/j.abb.2005.09.011; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; KURODA K, 1990, VIROLOGY, V174, P418, DOI 10.1016/0042-6822(90)90095-9; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; MATHER KA, 1992, VIRUS RES, V26, P127, DOI 10.1016/0168-1702(92)90152-Y; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; MCKIMMBRESCHKIN JL, 1990, J IMMUNOL METHODS, V135, P277, DOI 10.1016/0022-1759(90)90282-Z; MCKIMMBRESCHKIN JL, 1991, J VIROL METHODS, V32, P121, DOI 10.1016/0166-0934(91)90192-3; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; OAKLEY AJ, 2010, J MED CHEM IN PRESS; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sahasrabudhe A, 1998, VIROLOGY, V247, P14, DOI 10.1006/viro.1998.9222; Sales M, 2007, PROTEIN SCI, V16, P2224, DOI 10.1110/ps.062702907; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Waterman MJF, 1996, CANCER RES, V56, P158; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Yano T, 2008, MICROBIOL IMMUNOL, V52, P216, DOI 10.1111/j.1348-0421.2008.00034.x; Yongkiettrakul S, 2009, J VIROL METHODS, V156, P44, DOI 10.1016/j.jviromet.2008.10.025; Zhu XY, 2008, ACTA CRYSTALLOGR D, V64, P843, DOI 10.1107/S0907444908016648; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	51	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16284	10.1371/journal.pone.0016284	http://dx.doi.org/10.1371/journal.pone.0016284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326879	Green Submitted, Green Published, gold			2022-12-27	WOS:000287037100007
J	Jin, GL; Reitman, ZJ; Spasojevic, I; Batinic-Haberle, I; Yang, JA; Schmidt-Kittler, O; Bigner, DD; Yan, H				Jin, Genglin; Reitman, Zachary J.; Spasojevic, Ivan; Batinic-Haberle, Ines; Yang, Jian; Schmidt-Kittler, Oleg; Bigner, Darell D.; Yan, Hai			2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP(+)-Dependent Isocitrate Dehydrogenase Mutations	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH1 MUTATIONS; GLIOBLASTOMA; LEUKEMIA; CANCERS	Background: Gliomas frequently contain mutations in the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase (IDH1) or the mitochondrial NADP(+)-dependent isocitrate dehydrogenase (IDH2). Several different amino acid substitutions recur at either IDH1 R132 or IDH2 R172 in glioma patients. Genetic evidence indicates that these mutations share a common gain of function, but it is unclear whether the shared function is dominant negative activity, neomorphic production of (R)-2-hydroxyglutarate (2HG), or both. Methodology/Principal Findings: We show by coprecipitation that five cancer-derived IDH1 R132 mutants bind IDH1-WT but that three cancer-derived IDH2 R172 mutants exert minimal binding to IDH2-WT. None of the mutants dominant-negatively lower isocitrate dehydrogenase activity at physiological (40 mu M) isocitrate concentrations in mammalian cell lysates. In contrast to this, all of these mutants confer 10- to 100-fold higher 2HG production to cells, and glioma tissues containing IDH1 R132 or IDH2 R172 mutations contain high levels of 2HG compared to glioma tissues without IDH mutations (54.4 vs. 0.1 mg 2HG/g protein). Conclusions: Binding to, or dominant inhibition of, WT IDH1 or IDH2 is not a shared feature of the IDH1 and IDH2 mutations, and thus is not likely to be important in cancer. The fact that the gain of the enzymatic activity to produce 2HG is a shared feature of the IDH1 and IDH2 mutations suggests that this is an important function for these mutants in driving cancer pathogenesis.	[Jin, Genglin; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA; [Jin, Genglin; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Clin Pharmacol Lab, Dept Med,Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; [Yang, Jian; Schmidt-Kittler, Oleg] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine	Jin, GL (corresponding author), Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA.	yan00002@mc.duke.edu	Jin, Genglin/F-6868-2011; Yang, Jian/B-9451-2012	Reitman, Zachary/0000-0002-9122-9550	American Cancer Society [10-126-01-CCE]; Pediatric Brain Tumor Foundation Institute;  [1R01CA140316]; NATIONAL CANCER INSTITUTE [R01CA140316] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Pediatric Brain Tumor Foundation Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by American Cancer Society Research Scholar Grant 10-126-01-CCE (www.cancer.org), The Pediatric Brain Tumor Foundation Institute Grant (http://www.pbtfus.org/), and 1R01CA140316 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frezza C, 2010, CANCER CELL, V17, P7, DOI 10.1016/j.ccr.2009.12.031; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Lopez GY, 2010, BIOCHEM BIOPH RES CO, V398, P585, DOI 10.1016/j.bbrc.2010.06.125; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; REITMAN ZJ, 2010, J NATL CANCER I, V127, P245; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yan H, 2009, CANCER RES, V69, P9157, DOI 10.1158/0008-5472.CAN-09-2650; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	21	84	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16812	10.1371/journal.pone.0016812	http://dx.doi.org/10.1371/journal.pone.0016812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326614	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000024
J	Caceda, R; James, GA; Ely, TD; Snarey, J; Kilts, CD				Caceda, Ricardo; James, G. Andrew; Ely, Timothy D.; Snarey, John; Kilts, Clinton D.			Mode of Effective Connectivity within a Putative Neural Network Differentiates Moral Cognitions Related to Care and Justice Ethics	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; FUNCTIONAL CONNECTIVITY; SOCIAL-PERCEPTION; RHESUS-MONKEY; JUDGMENT; FMRI; BRAIN; SENSITIVITY	Background: Moral sensitivity refers to the interpretive awareness of moral conflict and can be justice or care oriented. Justice ethics is associated primarily with human rights and the application of moral rules, whereas care ethics is related to human needs and a situational approach involving social emotions. Among the core brain regions involved in moral issue processing are: medial prefrontal cortex, anterior (ACC) and posterior (PCC) cingulate cortex, posterior superior temporal sulcus (pSTS), insula and amygdala. This study sought to inform the long standing debate of whether care and justice moral ethics represent one or two different forms of cognition. Methodology/Principal Findings: Model-free and model-based connectivity analysis were used to identify functional neural networks underlying care and justice ethics for a moral sensitivity task. In addition to modest differences in patterns of associated neural activity, distinct modes of functional and effective connectivity were observed for moral sensitivity for care and justice issues that were modulated by individual variation in moral ability. Conclusions/Significance: These results support a neurobiological differentiation between care and justice ethics and suggest that human moral behavior reflects the outcome of integrating opposing rule-based, self-other perspectives, and emotional responses.	[Caceda, Ricardo; Ely, Timothy D.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [James, G. Andrew; Kilts, Clinton D.] Univ Arkansas Med Sci, Brain Imaging Res Ctr, Inst Psychiat Res, Little Rock, AR 72205 USA; [Snarey, John] Emory Univ, Candler Sch Theol, Atlanta, GA 30322 USA	Emory University; University of Arkansas System; University of Arkansas Medical Sciences; Emory University	Caceda, R (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	CDKilts@uams.edu	James, George Andrew/J-6903-2015; snarey, john r/D-3306-2013; Caceda, Ricardo/K-5054-2015	James, George Andrew/0000-0002-2940-2746; Caceda, Ricardo/0000-0001-6434-488X; Ely, Timothy/0000-0002-5690-5234	Goizueta Business School at Emory University	Goizueta Business School at Emory University	This study was performed with funds from the Goizueta Business School at Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amin Z, 2006, NEUROIMAGE, V32, P457, DOI 10.1016/j.neuroimage.2006.03.013; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2006, THEORY MORAL SENTIME; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Casebeer WD, 2003, NAT REV NEUROSCI, V4, P840, DOI 10.1038/nrn1223; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; COLBY A, 1987, MEASREMENT MORAL JUD; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Funk CM, 2009, CURR OPIN NEUROBIOL, V19, P678, DOI 10.1016/j.conb.2009.09.011; GILLIGAN C, 1982, AM J ORTHOPSYCHIAT, V52, P199, DOI 10.1111/j.1939-0025.1982.tb02682.x; Goodenough OR, 2004, PHILOS T R SOC B, V359, P1709, DOI 10.1098/rstb.2004.1552; Greene J, 2003, NAT REV NEUROSCI, V4, P846, DOI 10.1038/nrn1224; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Herholz K, 2007, BRIT J RADIOL, V80, pS160, DOI 10.1259/bjr/97295129; Immordino-Yang MH, 2009, P NATL ACAD SCI USA, V106, P8021, DOI 10.1073/pnas.0810363106; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Kahneman D., 1979, ECONOMETRICA, V47, P313, DOI DOI 10.2307/1914185; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kohlberg L, 1984, ESSAYS MORAL DEV, VI; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Mohanty A, 2007, PSYCHOPHYSIOLOGY, V44, P343, DOI 10.1111/j.1469-8986.2007.00515.x; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Prehn K, 2008, SOC COGN AFFECT NEUR, V3, P33, DOI 10.1093/scan/nsm037; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schlosser RGM, 2006, NEUROSCIENCE, V139, P91, DOI 10.1016/j.neuroscience.2005.06.037; Schultz J, 2004, J COGNITIVE NEUROSCI, V16, P1695, DOI 10.1162/0898929042947874; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; SNAREY JR, 1985, PSYCHOL BULL, V97, P202, DOI 10.1037/0033-2909.97.2.202; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Summerfield JJ, 2009, NEUROIMAGE, V44, P1188, DOI 10.1016/j.neuroimage.2008.09.033; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; TORGESEN J, 1999, TEST WORD EFFICIENCY; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Van Horn JD, 2009, INT J PSYCHOPHYSIOL, V73, P3, DOI 10.1016/j.ijpsycho.2008.11.003; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137; Young L, 2009, NEUROPSYCHOLOGIA, V47, P2065, DOI 10.1016/j.neuropsychologia.2009.03.020; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zhuang JC, 2005, NEUROIMAGE, V25, P462, DOI 10.1016/j.neuroimage.2004.11.007; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	68	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14730	10.1371/journal.pone.0014730	http://dx.doi.org/10.1371/journal.pone.0014730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726YS	21364916	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100002
J	Grant, WF; Gillingham, MB; Batra, AK; Fewkes, NM; Comstock, SM; Takahashi, D; Braun, TP; Grove, KL; Friedman, JE; Marks, DL				Grant, Wilmon F.; Gillingham, Melanie B.; Batra, Ayesha K.; Fewkes, Natasha M.; Comstock, Sarah M.; Takahashi, Diana; Braun, Theodore P.; Grove, Kevin L.; Friedman, Jacob E.; Marks, Daniel L.			Maternal High Fat Diet Is Associated with Decreased Plasma n-3 Fatty Acids and Fetal Hepatic Apoptosis in Nonhuman Primates	PLOS ONE			English	Article							LONG-TERM CONSEQUENCES; EXPERIMENTAL DIABETES-MELLITUS; ADIPOSE-TISSUE DEVELOPMENT; HYPOTHALAMIC VMN NEURONS; POSTNATALLY OVERFED RATS; NEUROPEPTIDE-Y SYSTEM; FAMINE BIRTH COHORT; NUTRIENT RESTRICTION; DUTCH FAMINE; DOCOSAHEXAENOIC ACIDS	To begin to understand the contributions of maternal obesity and over-nutrition to human development and the early origins of obesity, we utilized a non-human primate model to investigate the effects of maternal high-fat feeding and obesity on breast milk, maternal and fetal plasma fatty acid composition and fetal hepatic development. While the high-fat diet (HFD) contained equivalent levels of n-3 fatty acids (FA's) and higher levels of n-6 FA's than the control diet (CTR), we found significant decreases in docosahexaenoic acid (DHA) and total n-3 FA's in HFD maternal and fetal plasma. Furthermore, the HFD fetal plasma n-6: n-3 ratio was elevated and was significantly correlated to the maternal plasma n-6: n-3 ratio and maternal hyperinsulinemia. Hepatic apoptosis was also increased in the HFD fetal liver. Switching HFD females to a CTR diet during a subsequent pregnancy normalized fetal DHA, n-3 FA's and fetal hepatic apoptosis to CTR levels. Breast milk from HFD dams contained lower levels of eicosopentanoic acid (EPA) and DHA and lower levels of total protein than CTR breast milk. This study links chronic maternal consumption of a HFD with fetal hepatic apoptosis and suggests that a potentially pathological maternal fatty acid milieu is replicated in the developing fetal circulation in the nonhuman primate.	[Grant, Wilmon F.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA; [Grant, Wilmon F.; Fewkes, Natasha M.; Braun, Theodore P.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Grant, Wilmon F.] Oregon Hlth & Sci Univ, Human Invest Program, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Gillingham, Melanie B.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Batra, Ayesha K.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Ctr Study Weight Regulat, Portland, OR 97201 USA; [Comstock, Sarah M.; Takahashi, Diana; Grove, Kevin L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Friedman, Jacob E.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Grant, WF (corresponding author), Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009	Braun, Theodore/0000-0002-6248-2143; Gillingham, Melanie/0000-0003-0897-8268	National Institutes of Health (NIH) [DK-79194, RR00163, DK-062155, DK-078590]; Burroughs-Wellcome Trust [RR024140, HD046420 T32]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024140]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000163, P51RR000163, UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062155, R01DK079194, R24DK090964, R01DK078590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Trust(Wellcome Trust); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health (NIH) grants DK-79194 (to K.L. Grove), RR00163 (to K.L. Grove and ONPRC), DK-062155 (to J.E. Friedman), DK-078590 and the Burroughs-Wellcome Trust Translational Research Award (to D.L. Marks), RR024140 and HD046420 T32 (to W.F. Grant). In addition, support was also received from the Oregon Clinical and Translational Research Institute (OCTRI); grant number UL1 RR024140 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; *ABI, 2006, AMPL EFF TAQM EXPR A; Aid S, 2003, J LIPID RES, V44, P1545, DOI 10.1194/jlr.M300079-JLR200; ANGUITA RM, 1993, J NUTR, V123, P1421; BECKMANN CRB, 2006, OBSTET GYNECOLOGY, pR17; Bispham J, 2005, ENDOCRINOLOGY, V146, P3943, DOI 10.1210/en.2005-0246; BLOCK G, 1985, AM J EPIDEMIOL, V122, P27, DOI 10.1093/oxfordjournals.aje.a114084; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6; Budge Helen, 2005, Birth Defects Research, V75, P193, DOI 10.1002/bdrc.20044; CARLSON SE, 1992, J PEDIATR-US, V120, pS159, DOI 10.1016/S0022-3476(05)81251-X; Carrapato MRG, 2003, J PERINAT MED, V31, P5, DOI 10.1515/JPM.2003.001; CASTUMA JC, 1972, J LIPID RES, V13, P783; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; Cox LA, 2006, J PHYSIOL-LONDON, V572, P67, DOI 10.1113/jphysiol.2006.106872; Crabtree JT, 1998, MOL CELL BIOCHEM, V185, P191, DOI 10.1023/A:1006852230337; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Davidowa H, 2003, EUR J NEUROSCI, V18, P613, DOI 10.1046/j.1460-9568.2003.02789.x; Davidowa H, 2000, NEUROSCI LETT, V293, P21, DOI 10.1016/S0304-3940(00)01475-0; Davidowa H, 2000, NEUROREPORT, V11, P2795, DOI 10.1097/00001756-200008210-00037; Davidowa H, 2002, NUTR NEUROSCI, V5, P27, DOI 10.1080/10284150290007056; Davidowa H, 2004, NEUROSCI LETT, V371, P64, DOI 10.1016/j.neulet.2004.08.042; Davidowa H, 2002, REGUL PEPTIDES, V108, P103, DOI 10.1016/S0167-0115(02)00153-2; Davidowa H, 2001, NEUROREPORT, V12, P3201, DOI 10.1097/00001756-200110290-00012; DIAMANT YZ, 1982, AM J OBSTET GYNECOL, V144, P5, DOI 10.1016/0002-9378(82)90385-4; ECK MG, 1979, DIABETES, V28, P479, DOI 10.2337/diabetes.28.5.479; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grayson BE, 2006, NEUROSCIENCE, V143, P975, DOI 10.1016/j.neuroscience.2006.08.055; GRAYSON BE, 2007, CHANGES MELANO UNPUB; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Grove KL, 2003, NEUROSCIENCE, V116, P393, DOI 10.1016/S0306-4522(02)00668-1; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; HUDSON DG, 1977, BIOL NEONATE, V32, P290; INKPEN CA, 1969, J LIPID RES, V10, P277; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Ishii H, 2003, ALCOHOL CLIN EXP RES, V27, P1207, DOI 10.1097/01.alc.0000086766.46408.bf; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kodas E, 2002, J LIPID RES, V43, P1209, DOI 10.1194/jlr.M200132-JLR200; Koutcherov Y, 2002, J COMP NEUROL, V446, P301, DOI 10.1002/cne.10175; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Li C, 2007, PLACENTA, V28, P1200, DOI 10.1016/j.placenta.2007.06.011; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Painter RC, 2007, J HYPERTENS, V25, P533, DOI 10.1097/HJH.0b013e328012135b; Peters JC, 2003, LIPIDS, V38, P123, DOI 10.1007/s11745-003-1041-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792; ROSENTHAL MD, 1987, BIOCHIM BIOPHYS ACTA, V917, P279, DOI 10.1016/0005-2760(87)90132-9; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; RUYLE M, 1990, P NATL ACAD SCI USA, V87, P7902, DOI 10.1073/pnas.87.20.7902; Schlabritz-Loutsevitch N, 2007, PLACENTA, V28, P783, DOI 10.1016/j.placenta.2006.11.012; Schlabritz-Loutsevitch NE, 2007, BRIT J NUTR, V98, P276, DOI 10.1017/S0007114507700727; Siega-Riz AM, 2002, AM J OBSTET GYNECOL, V186, P480, DOI 10.1067/mob.2002.121078; SILVERMAN BL, 1993, ANN NY ACAD SCI, V699, P36, DOI 10.1111/j.1749-6632.1993.tb18835.x; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V290, pE129, DOI 10.1152/ajpendo.00248.2005; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; STEIN AD, 1995, HUM BIOL, V67, P135; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; STEIN Z, 1975, PEDIATR RES, V9, P76, DOI 10.1203/00006450-197509020-00004; Stocker CJ, 2005, P NUTR SOC, V64, P143, DOI 10.1079/PNS2005417; Su HM, 1999, PEDIATR RES, V45, P87, DOI 10.1203/00006450-199901000-00015; Su HM, 1999, J LIPID RES, V40, P1304; Su HM, 2001, J LIPID RES, V42, P581; Subar AF, 1998, PEDIATRICS, V102, P913, DOI 10.1542/peds.102.4.913; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; SUTER M, FASEB J; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; VAHRATIAN A, 2008, MATERN CHILD HLTH J; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whitaker RC, 2004, PEDIATRICS, V114, pE29, DOI 10.1542/peds.114.1.e29; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616; Yogev Y, 2008, EUR J OBSTET GYN R B, V137, P21, DOI 10.1016/j.ejogrb.2007.03.022	104	76	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17261	10.1371/journal.pone.0017261	http://dx.doi.org/10.1371/journal.pone.0017261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364873	Green Submitted, gold, Green Published			2022-12-27	WOS:000287764100037
J	Zheng, JT; Xing, DH; Wu, XH; Shen, YJ; Kroll, DM; Ji, GL; Li, QSQ				Zheng, Jianti; Xing, Denghui; Wu, Xiaohui; Shen, Yingjia; Kroll, Diana M.; Ji, Guoli; Li, Qingshun Quinn			Ratio-Based Analysis of Differential mRNA Processing and Expression of a Polyadenylation Factor Mutant pcfs4 Using Arabidopsis Tiling Microarray	PLOS ONE			English	Article							FLOWERING TIME; ALTERNATIVE POLYADENYLATION; POLYMERASE-II; TERMINATION FACTOR; TRANSCRIPTION; THALIANA; PCF11; GAMETOPHYTE; RESPONSES; SIGNALS	Background: Alternative polyadenylation as a mechanism in gene expression regulation has been widely recognized in recent years. Arabidopsis polyadenylation factor PCFS4 was shown to function in leaf development and in flowering time control. The function of PCFS4 in controlling flowering time was correlated with the alternative polyadenylation of FCA, a flowering time regulator. However, genetic evidence suggested additional targets of PCFS4 that may mediate its function in both flowering time and leaf development. Methodology/Principal Findings: To identify further targets, we investigated the whole transcriptome of a PCFS4 mutant using Affymetrix Arabidopsis genomic tiling 1.0R array and developed a data analysis pipeline, termed RADPRE (Ratio-based Analysis of Differential mRNA Processing and Expression). In RADPRE, ratios of normalized probe intensities between wild type Columbia and a pcfs4 mutant were first generated. By doing so, one of the major problems of tiling array data-variations caused by differential probe affinity-was significantly alleviated. With the probe ratios as inputs, a hierarchy of statistical tests was carried out to identify differentially processed genes (DPG) and differentially expressed genes (DEG). The false discovery rate (FDR) of this analysis was estimated by using the balanced random combinations of Col/pcfs4 and pcfs4/Col ratios as inputs. Gene Ontology (GO) analysis of the DPGs and DEGs revealed potential new roles of PCFS4 in stress responses besides flowering time regulation. Conclusion/Significance: We identified 68 DPGs and 114 DEGs with FDR at 1% and 2%, respectively. Most of the 68 DPGs were subjected to alternative polyadenylation, splicing or transcription initiation. Quantitative PCR analysis of a set of DPGs confirmed that most of these genes were truly differentially processed in pcfs4 mutant plants. The enriched GO term "regulation of flower development'' among PCFS4 targets further indicated the efficacy of the RADPRE pipeline. This simple but effective program is available upon request.	[Zheng, Jianti; Wu, Xiaohui; Ji, Guoli; Li, Qingshun Quinn] Xiamen Univ, Dept Automat, Xiamen, Fujian, Peoples R China; [Zheng, Jianti; Xing, Denghui; Wu, Xiaohui; Shen, Yingjia; Kroll, Diana M.; Li, Qingshun Quinn] Miami Univ, Dept Bot, Oxford, OH 45056 USA	Xiamen University; Miami University	Zheng, JT (corresponding author), Xiamen Univ, Dept Automat, Xiamen, Fujian, Peoples R China.	glji@xmu.edu.cn; liq@muohio.edu	Wu, Xiaohui/C-8290-2011; Ji, GL/G-3355-2010; Li, Qingshun/C-5603-2009	Li, Qingshun/0000-0003-4105-1480; Wu, Xiaohui/0000-0003-0356-7785	US National Institutes of Health [1R15GM07719201A1]; US National Science Foundation [IOS-0817818]; Ohio Plant Biotech Consortium; National Natural Science Foundation of China [60774033]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20070384003, 20090121110022]; Xiamen University [0630-E62000]; China Scholarship Council [2008631054]; Direct For Biological Sciences [0817818, 0817829] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Ohio Plant Biotech Consortium; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Xiamen University(Xiamen University); China Scholarship Council(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by US National Institutes of Health (1R15GM07719201A1 to QQL), US National Science Foundation (IOS-0817818 to QQL), and a grant from the Ohio Plant Biotech Consortium (to QQL and DX). It was also supported by grants from the National Natural Science Foundation of China (No. 60774033), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20070384003 and No. 20090121110022), and Xiamen University National 211 3rd Period Project of China (No. 0630-E62000) (all to GJ). JZ and XW were doctoral students from Xiamen University and visiting scholars at Miami University. JZ was an awardee of China Scholarship Council (File No. 2008631054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ares M, 2005, CELL, V120, P163, DOI 10.1016/j.cell.2005.01.002; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Box J. F., 1987, STAT SCI, V2, P45, DOI [10.1214/ss/1177013437, DOI 10.1214/SS/1177013437]; Chung HR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-204; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Ghosh S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-359; Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Judy JT, 2009, BIOINFORMATICS, V25, P2369, DOI 10.1093/bioinformatics/btp425; Kaneko S, 2005, MOL CELL, V20, P91, DOI 10.1016/j.molcel.2005.08.033; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim SG, 2007, PLANT SIGNAL BEHAV, V2, P517, DOI 10.4161/psb.2.6.4645; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Kurihara Y, 2009, PLANT CELL PHYSIOL, V50, P1715, DOI 10.1093/pcp/pcp109; Laubinger S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r112; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000294; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; Mas P, 2009, CURR OPIN PLANT BIOL, V12, P574, DOI 10.1016/j.pbi.2009.07.010; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Naouar N, 2009, PLANT J, V57, P184, DOI 10.1111/j.1365-313X.2008.03662.x; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Shen YJ, 2008, NUCLEIC ACIDS RES, V36, P3150, DOI 10.1093/nar/gkn158; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Thomas B, 2006, J EXP BOT, V57, P3387, DOI 10.1093/jxb/erl071; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Toyoda T, 2005, PLANT J, V43, P611, DOI 10.1111/j.1365-313X.2005.02470.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; XING D, 2010, WILEY INTERDISCIPLIN, V1, P59; Xing DH, 2008, PLANT J, V54, P899, DOI 10.1111/j.1365-313X.2008.03455.x; Xing DH, 2009, PLANT SIGNAL BEHAV, V4, P440, DOI [10.1104/pp.108.129817, 10.4161/psb.4.5.8345]; Xing DH, 2008, PLANT PHYSIOL, V148, P2059, DOI 10.1104/pp.108.129817; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhang ZD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r81; Zhang ZQ, 2007, GENE DEV, V21, P1609, DOI 10.1101/gad.1542707; Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zheng SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp282	59	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e14719	10.1371/journal.pone.0014719	http://dx.doi.org/10.1371/journal.pone.0014719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364912	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100001
J	Stohl, EA; Gruenig, MC; Cox, MM; Seifert, HS				Stohl, Elizabeth A.; Gruenig, Marielle C.; Cox, Michael M.; Seifert, H. Steven			Purification and Characterization of the RecA Protein from Neisseria gonorrhoeae	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; PILIN-ANTIGENIC-VARIATION; ESCHERICHIA-COLI; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; DEINOCOCCUS-RADIODURANS; ATP HYDROLYSIS; ERROR-PRONE; STABLE COMPLEXES; BRANCH MIGRATION	The strict human pathogen Neisseria gonorrhoeae is the only causative agent of the sexually transmitted infection gonorrhea. The recA gene from N. gonorrhoeae is essential for DNA repair, natural DNA transformation, and pilin antigenic variation, all processes that are important for the pathogenesis and persistence of N. gonorrhoeae in the human population. To understand the biochemical features of N. gonorrhoeae RecA (RecA(Ng)), we overexpressed and purified the RecA(Ng) and SSBNg proteins and compared their activities to those of the well-characterized E. coli RecA and SSB proteins in vitro. We observed that RecA(Ng) promoted more strand exchange at early time points than RecA(Ec) through DNA homologous substrates, and exhibited the highest ATPase activity of any RecA protein characterized to date. Further analysis of this robust ATPase activity revealed that RecA(Ng) is more efficient at displacing SSB from ssDNA and that RecA(Ng) shows higher ATPase activity during strand exchange than RecA(Ec). Using substrates created to mimic the cellular processes of DNA transformation and pilin antigenic variation we observed that RecA(Ec) catalyzed more strand exchange through a 100 bp heterologous insert, but that RecA(Ng) catalyzed more strand exchange through regions of microheterology. Together, these data suggest that the processes of ATP hydrolysis and DNA strand exchange may be coupled differently in RecA(Ng) than in RecA(Ec). This difference may explain the unusually high ATPase activity observed for RecA(Ng) with the strand exchange activity between RecA(Ng) and RecA(Ec) being more similar.	[Stohl, Elizabeth A.; Seifert, H. Steven] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Gruenig, Marielle C.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Stohl, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	e-stohl@northwestern.edu			National Institutes of Health [GM32335, U19 AI01448-16]; Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship;  [R01 AI044239];  [R01 AI033493]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001448, R01AI044239, R01AI033493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (http://www.nih.gov). Work in the Seifert lab was supported by R01 AI044239 and R01 AI033493 to H.S.S. Work in the Cox lab was supported by NIH grant GM32335 to M.M.C. Additionally, EAS was partially supported by NIH grant U19 AI01448-16, and M.C.G. was partially supported by the Dr. James Chieh-Hsia Mao and the William R. & Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Baitin DM, 2003, J MOL BIOL, V328, P1, DOI 10.1016/S0022-2836(03)00242-0; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; CAMPBELL LA, 1984, J BACTERIOL, V160, P288, DOI 10.1128/JB.160.1.288-293.1984; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FYFE JAM, 1990, GENE, V93, P151, DOI 10.1016/0378-1119(90)90151-G; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN SD, 1991, J BACTERIOL, V173, P5921, DOI 10.1128/jb.173.18.5921-5923.1991; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Gruenig MC, 2010, J BIOL CHEM, V285, P37188, DOI 10.1074/jbc.M110.171967; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Helm RA, 2009, J BACTERIOL, V191, P5613, DOI 10.1128/JB.00535-09; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; JAIN SK, 1994, J BIOL CHEM, V269, P20653; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KATO R, 1993, J BIOCHEM-TOKYO, V114, P926, DOI 10.1093/oxfordjournals.jbchem.a124278; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kline KA, 2005, J BACTERIOL, V187, P5347, DOI 10.1128/JB.187.15.5347-5355.2005; Kline KA, 2005, J BACTERIOL, V187, P2903, DOI 10.1128/JB.187.8.2903-2907.2005; Kline KA, 2003, MOL MICROBIOL, V50, P3, DOI 10.1046/j.1365-2958.2003.03679.x; KOOMEY JM, 1987, J BACTERIOL, V169, P790, DOI 10.1128/jb.169.2.790-795.1987; KOOMEY M, 1987, GENETICS, V117, P391; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; Mehr IJ, 2000, GENETICS, V154, P523; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER RV, 1990, ANNU REV MICROBIOL, V44, P365; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Pham P, 2001, P NATL ACAD SCI USA, V98, P8350, DOI 10.1073/pnas.111007198; PIERRE A, 1983, J BIOL CHEM, V258, P2870; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SCHOOK POP, 2010, MOL MICROBIOL; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seifert HS, 1997, GENE, V188, P215, DOI 10.1016/S0378-1119(96)00810-4; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; Steffen SE, 2000, ARCH BIOCHEM BIOPHYS, V382, P303, DOI 10.1006/abbi.2000.2029; Steffen SE, 2001, ARCH BIOCHEM BIOPHYS, V388, P165, DOI 10.1006/abbi.2001.2286; Stohl EA, 2002, MICROBIOL-SGM, V148, P1821, DOI 10.1099/00221287-148-6-1821; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06	76	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17101	10.1371/journal.pone.0017101	http://dx.doi.org/10.1371/journal.pone.0017101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359151	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482300029
J	Mathes, RW; Ito, K; Matte, T				Mathes, Robert W.; Ito, Kazuhiko; Matte, Thomas			Assessing Syndromic Surveillance of Cardiovascular Outcomes from Emergency Department Chief Complaint Data in New York City	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; AIR-POLLUTION; HOSPITAL ADMISSIONS; TIME-SERIES; SMOKING BAN; MORTALITY; POPULATION; ILLNESS; CLASSIFICATION	Background: Prospective syndromic surveillance of emergency department visits has been used for near-real time tracking of communicable diseases to detect outbreaks or other unexpected disease clusters. The utility of syndromic surveillance for tracking cardiovascular events, which may be influenced by environmental factors and influenza, has not been evaluated. We developed and evaluated a method for tracking cardiovascular events using emergency department free-text chief complaints. Methodology/Principal Findings: There were three phases to our analysis. First we applied text processing algorithms based on sensitivity, specificity, and positive predictive value to chief complaint data reported by 11 New York City emergency departments for which ICD-9 discharge diagnosis codes were available. Second, the same algorithms were applied to data reported by a larger sample of 50 New York City emergency departments for which discharge diagnosis was unavailable. From this more complete data, we evaluated the consistency of temporal variation of cardiovascular syndromic events and hospitalizations from 76 New York City hospitals. Finally, we examined associations between particulate matter <= 2.5 mu m (PM2.5), syndromic events, and hospitalizations. Sensitivity and positive predictive value were low for syndromic events, while specificity was high. Utilizing the larger sample of emergency departments, a strong day of week pattern and weak seasonal trend were observed for syndromic events and hospitalizations. These time-series were highly correlated after removing the day-of-week, holiday, and seasonal trends. The estimated percent excess risks in the cold season (October to March) were 1.9% (95% confidence interval (CI): 0.6, 3.2), 2.1% (95% CI: 0.9, 3.3), and 1.8% (95% CI: 0.5, 3.0) per same-day 10 mu g/m(3) increase in PM2.5 for cardiac-only syndromic data, cardiovascular syndromic data, and hospitalizations, respectively. Conclusions/Significance: Near real-time emergency department chief complaint data may be useful for timely surveillance of cardiovascular morbidity related to ambient air pollution and other environmental events.	[Mathes, Robert W.] Bur Environm Surveillance & Policy, New York City Dept Hlth & Mental Hyg, New York, NY USA; [Ito, Kazuhiko] NYU, Sch Med, Tuxedo Pk, NY USA; [Matte, Thomas] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	New York City Department of Health & Mental Hygiene; New York University; City University of New York (CUNY) System; Hunter College (CUNY)	Mathes, RW (corresponding author), Bur Environm Surveillance & Policy, New York City Dept Hlth & Mental Hyg, New York, NY USA.	rmathes@health.nyc.gov			Environmental Protection Agency [R833623010]; National Institute of Environmental Health Sciences (NIEHS) Center [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences (NIEHS) Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Environmental Protection Agency, STAR Grant R833623010 and National Institute of Environmental Health Sciences (NIEHS) Center grant ES00260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Bassil KL, 2008, CAN J PUBLIC HEALTH, V99, P339, DOI 10.1007/BF03403768; Bassil KL, 2009, ENVIRON RES, V109, P600, DOI 10.1016/j.envres.2009.03.011; Bell ML, 2008, AM J EPIDEMIOL, V168, P1301, DOI 10.1093/aje/kwn252; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brown DL, 1999, AM HEART J, V137, P830, DOI 10.1016/S0002-8703(99)70406-0; Chapman WW, 2005, ANN EMERG MED, V46, P445, DOI 10.1016/j.annemergmed.2005.04.012; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Espino JU, 2001, J AM MED INFORM ASSN, P164; Feng JW, 2006, CLIN CARDIOL, V29, P13, DOI 10.1002/clc.4960290105; Fischer T, 2004, INT J CARDIOL, V97, P425, DOI 10.1016/j.ijcard.2003.10.026; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Gruska M, 2005, CHRONOBIOL INT, V22, P107, DOI 10.1081/CBI-200041046; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Jansen AGSC, 2007, EUR RESPIR J, V30, P1158, DOI 10.1183/09031936.00034407; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kinjo H, 2003, HEART, V89, P398, DOI 10.1136/heart.89.4.398; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kriszbacher I, 2008, INT J CARDIOL, V129, P251, DOI 10.1016/j.ijcard.2007.07.095; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Marx MA, 2006, AM J PUBLIC HEALTH, V96, P547, DOI 10.2105/AJPH.2004.061358; Mocny M, 2003, ACAD EMERG MED, V10, P513; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Sayer JW, 1997, HEART, V77, P325, DOI 10.1136/hrt.77.4.325; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Shedd OL, 2004, J AM COLL CARDIOL, V44, P1265, DOI 10.1016/j.jacc.2004.04.058; Spencer FA, 1998, J AM COLL CARDIOL, V31, p309A, DOI 10.1016/S0735-1097(97)85055-3; Touloumi G, 2006, STAT MED, V25, P4164, DOI 10.1002/sim.2681; Turner RM, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-37; VANDERPALEN J, 1995, NEW ZEAL MED J, V108, P332; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87	36	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14677	10.1371/journal.pone.0014677	http://dx.doi.org/10.1371/journal.pone.0014677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721PR	21339818	Green Published, gold			2022-12-27	WOS:000287367600006
J	Lehen'kyi, V; Raphael, M; Oulidi, A; Flourakis, M; Khalimonchyk, S; Kondratskyi, A; Gordienko, DV; Mauroy, B; Bonnal, JL; Skryma, R; Prevarskaya, N				Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Gordienko, Dmitri V.; Mauroy, Brigitte; Bonnal, Jean-Lois; Skryma, Roman; Prevarskaya, Natalia			TRPV6 Determines the Effect of Vitamin D3 on Prostate Cancer Cell Growth	PLOS ONE			English	Article							1 ALPHA,25-DIHYDROXYVITAMIN D-3; OPERATED CA2+ CHANNELS; 1,25-DIHYDROXYVITAMIN D-3; ANDROGEN RECEPTOR; LNCAP CELLS; SIGNALING PATHWAY; EPITHELIAL-CELLS; MESSENGER-RNA; MUSCLE-CELLS; PROLIFERATION	Despite remarkable advances in the therapy and prevention of prostate cancer it is still the second cause of death from cancer in industrialized countries. Many therapies initially shown to be beneficial for the patients were abandoned due to the high drug resistance and the evolution rate of the tumors. One of the prospective therapeutical agents even used in the first stage clinical trials, 1,25-dihydroxyvitamin D3, was shown to be either unpredictable or inefficient in many cases. We have already shown that TRPV6 calcium channel, which is the direct target of 1,25-dihydroxyvitamin D3 receptor, positively controls prostate cancer proliferation and apoptosis resistance (Lehen'kyi et al., Oncogene, 2007). However, how the known 1,25-dihydroxyvitamin D3 antiproliferative effects may be compatible with the upregulation of pro-oncogenic TRPV6 channel remains a mystery. Here we demonstrate that in low steroid conditions 1,25-dihydroxyvitamin D3 upregulates the expression of TRPV6, enchances the proliferation by increasing the number of cells entering into S-phase. We show that these pro-proliferative effects of 1,25-dihydroxyvitamin D3 are directly mediated via the overexpression of TRPV6 channel which increases calcium uptake into LNCaP cells. The apoptosis resistance of androgen-dependent LNCaP cells conferred by TRPV6 channel is drastically inversed when 1,25-dihydroxyvitamin D3 effects were combined with the successful TRPV6 knockdown. In addition, the use of androgen-deficient DU-145 and androgen-insensitive LNCaP C4-2 cell lines allowed to suggest that the ability of 1,25-dihydroxyvitamin D3 to induce the expression of TRPV6 channel is a crucial determinant of the success or failure of 1,25-dihydroxyvitamin D3-based therapies.	[Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Skryma, Roman; Prevarskaya, Natalia] Equipe Labellise Ligue Natl Canc, INSERM, U1003, Villeneuve Dascq, France; [Lehen'kyi, V'yacheslav; Raphael, Maylis; Oulidi, Agathe; Flourakis, Matthieu; Khalimonchyk, Sergii; Kondratskyi, Artem; Skryma, Roman; Prevarskaya, Natalia] Univ Sci & Technol Lille, Villeneuve Dascq, France; [Gordienko, Dmitri V.] St Georges Univ London, Div Basic Med Sci, London, England; [Mauroy, Brigitte; Bonnal, Jean-Lois] Univ Catholique Lille, Serv Urol, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; St Georges University London; Universite Catholique de Lille	Lehen'kyi, V (corresponding author), Equipe Labellise Ligue Natl Canc, INSERM, U1003, Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Bonnal, Jean-Louis JLB/U-9025-2018; LEHEN'KYI, V'yacheslav/AAJ-6008-2020	LEHEN'KYI, V'yacheslav/0000-0003-0806-8766; Prevarskaya, natacha/0000-0003-0316-197X; Flourakis, Matthieu/0000-0002-5366-9125; Kondratskyi, Artem/0000-0003-3290-0524; Gordienko, Dmitri (Dmytro)/0000-0002-4118-9976	Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer	Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Ministere de l'Education Nationale et Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; Bodding M, 2003, J BIOL CHEM, V278, P50872, DOI 10.1074/jbc.M308800200; Buitrago CG, 2003, J BIOL CHEM, V278, P2199, DOI 10.1074/jbc.M205732200; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHESKIS B, 1995, MOL ENDOCRINOL, V9, P1814, DOI 10.1210/me.9.12.1814; Cooperberg MR, 2005, J CLIN ONCOL, V23, P8146, DOI 10.1200/JCO.2005.02.9751; Eelen G, 2004, J BONE MINER RES, V19, P133, DOI 10.1359/JBMR.0301204; Fixemer T, 2003, ONCOGENE, V22, P7858, DOI 10.1038/sj.onc.1206895; Gache C, 1999, BREAST CANCER RES TR, V55, P29, DOI 10.1023/A:1006163418479; Gavrilov V, 2005, ANTICANCER RES, V25, P3425; Gniadecki R, 1996, J INVEST DERMATOL, V106, P1212, DOI 10.1111/1523-1747.ep12348498; Gniadecki R, 1996, J INVEST DERMATOL, V106, P510, DOI 10.1111/1523-1747.ep12343866; GRAUER A, 1995, BIOCHEM BIOPH RES CO, V213, P922, DOI 10.1006/bbrc.1995.2217; Haverstick DM, 2000, CANCER RES, V60, P1002; Hsieh TC, 1996, BIOCHEM BIOPH RES CO, V223, P141, DOI 10.1006/bbrc.1996.0859; Hsieh TC, 1997, BIOCHEM BIOPH RES CO, V235, P539, DOI 10.1006/bbrc.1997.6838; KOH E, 1988, LIFE SCI, V42, P215, DOI 10.1016/0024-3205(88)90685-6; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; Krohn K, 2003, CALCIFIED TISSUE INT, V73, P400, DOI 10.1007/s00223-002-2160-9; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lou YR, 2004, J STEROID BIOCHEM, V92, P317, DOI 10.1016/j.jsbmb.2004.10.007; Martin JL, 2000, ENDOCRINOLOGY, V141, P2401, DOI 10.1210/en.141.7.2401; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Peehl DM, 2004, J STEROID BIOCHEM, V92, P307, DOI 10.1016/j.jsbmb.2004.10.006; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Rashid SF, 2001, STEROIDS, V66, P433, DOI 10.1016/S0039-128X(00)00203-8; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Swami S, 2005, MOL CELL ENDOCRINOL, V241, P49, DOI 10.1016/j.mce.2005.05.001; Tischler AS, 1996, TOXICOL APPL PHARM, V140, P115, DOI 10.1006/taap.1996.0204; van Abel M, 2003, AM J PHYSIOL-GASTR L, V285, pG78, DOI 10.1152/ajpgi.00036.2003; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wiers KM, 1997, CANCER IMMUNOL IMMUN, V44, P97, DOI 10.1007/s002620050361; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Yamauchi D, 2005, BIOCHEM BIOPH RES CO, V331, P1353, DOI 10.1016/j.bbrc.2005.04.053; Zhao XY, 1997, ENDOCRINOLOGY, V138, P3290, DOI 10.1210/en.138.8.3290	43	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16856	10.1371/journal.pone.0016856	http://dx.doi.org/10.1371/journal.pone.0016856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347289	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287364500010
J	Zhao, TN; De Graaff, E; Breedveld, GJ; Loda, A; Severijnen, LA; Wouters, CH; Verheijen, FW; Dekker, MCJ; Montagna, P; Willemsen, R; Oostra, BA; Bonifati, V				Zhao, Tianna; De Graaff, Esther; Breedveld, Guido J.; Loda, Agnese; Severijnen, Lies-Anne; Wouters, Cokkie H.; Verheijen, Frans W.; Dekker, Marieke C. J.; Montagna, Pasquale; Willemsen, Rob; Oostra, Ben A.; Bonifati, Vincenzo			Loss of Nuclear Activity of the FBXO7 Protein in Patients with Parkinsonian-Pyramidal Syndrome (PARK15)	PLOS ONE			English	Article							F-BOX PROTEINS; FUNCTIONAL DOMAINS; DISEASE; FAMILY; IDENTIFICATION; INHIBITOR; MUTATIONS	Mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, an autosomal recessive neurodegenerative disease presenting with severe levodopa-responsive parkinsonism and pyramidal disturbances. Understanding the PARK15 pathogenesis might thus provide clues on the mechanisms of maintenance of brain dopaminergic neurons, the same which are lost in Parkinson's disease. The protein(s) encoded by FBXO7 remain very poorly characterized. Here, we show that two protein isoforms are expressed from the FBXO7 gene in normal human cells. The isoform 1 is more abundant, particularly in primary skin fibroblasts. Both isoforms are undetectable in cell lines from the PARK15 patient of an Italian family; the isoform 1 is undetectable and the isoform 2 is severely decreased in the patients from a Dutch PARK15 family. In human cell lines and mouse primary neurons, the endogenous or over-expressed, wild type FBXO7 isoform 1 displays mostly a diffuse nuclear localization. An intact N-terminus is needed for the nuclear FBXO7 localization, as N-terminal modification by PARK15-linked missense mutation, or N-terminus tag leads to cytoplasmic mislocalization. Furthermore, the N-terminus of wild type FBXO7 (but not of mutant FBXO7) is able to confer nuclear localization to profilin (a cytoplasmic protein). Our data also suggest that overexpressed mutant FBXO7 proteins (T22M, R378G and R498X) have decreased stability compared to their wild type counterpart. In human brain, FBXO7 immunoreactivity was highest in the nuclei of neurons throughout the cerebral cortex, intermediate in the globus pallidum and the substantia nigra, and lowest in the hippocampus and cerebellum. In conclusion, the common cellular abnormality found in the PARK15 patients from the Dutch and Italian families is the depletion of the FBXO7 isoform 1, which normally localizes in the cell nucleus. The activity of FBXO7 in the nucleus appears therefore crucial for the maintenance of brain neurons and the pathogenesis of PARK15.	[Zhao, Tianna; De Graaff, Esther; Breedveld, Guido J.; Loda, Agnese; Severijnen, Lies-Anne; Wouters, Cokkie H.; Verheijen, Frans W.; Willemsen, Rob; Oostra, Ben A.; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Dekker, Marieke C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Montagna, Pasquale] Univ Bologna, Dept Neurol, Bologna, Italy	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Bologna	Zhao, TN (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl	de Graaff, Esther/D-3287-2011	Loda, Agnese/0000-0001-8109-128X; Wouters, Carine/0000-0002-6426-8845	Erasmus MC Rotterdam (Erasmus Fellowship); Netherlands Organization for Scientific Research (NWO)	Erasmus MC Rotterdam (Erasmus Fellowship); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Erasmus MC Rotterdam (Erasmus Fellowship), and the Netherlands Organization for Scientific Research (NWO, VIDI grant) to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2009, PARKINSONISM RELAT D, V15, P721, DOI 10.1016/j.parkreldis.2009.09.010; Bonifati V, 2010, ENCY MOVEMENT DISORD, V3, P392; Bonifati V, 2007, PARKINSONISM RELAT D, V13, pS233, DOI 10.1016/S1353-8020(08)70008-7; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; French CA, 2003, J BIOL CHEM, V278, P45445, DOI 10.1074/jbc.M308621200; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Kirk R, 2008, J BIOL CHEM, V283, P22325, DOI 10.1074/jbc.M709900200; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Levenga J, 2009, NEUROBIOL DIS, V35, P241, DOI 10.1016/j.nbd.2009.05.004; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	23	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16983	10.1371/journal.pone.0016983	http://dx.doi.org/10.1371/journal.pone.0016983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347293	Green Submitted, Green Published, gold			2022-12-27	WOS:000287364500017
J	Piganeau, G; Eyre-Walker, A; Grimsley, N; Moreau, H				Piganeau, Gwenael; Eyre-Walker, Adam; Grimsley, Nigel; Moreau, Herve			How and Why DNA Barcodes Underestimate the Diversity of Microbial Eukaryotes	PLOS ONE			English	Article							18S RDNA SEQUENCES; MOLECULAR EVOLUTION; POLYMORPHISM; PLANKTON; ECOLOGY	Background: Because many picoplanktonic eukaryotic species cannot currently be maintained in culture, direct sequencing of PCR-amplified 18S ribosomal gene DNA fragments from filtered sea-water has been successfully used to investigate the astounding diversity of these organisms. The recognition of many novel planktonic organisms is thus based solely on their 18S rDNA sequence. However, a species delimited by its 18S rDNA sequence might contain many cryptic species, which are highly differentiated in their protein coding sequences. Principal Findings: Here, we investigate the issue of species identification from one gene to the whole genome sequence. Using 52 whole genome DNA sequences, we estimated the global genetic divergence in protein coding genes between organisms from different lineages and compared this to their ribosomal gene sequence divergences. We show that this relationship between proteome divergence and 18S divergence is lineage dependant. Unicellular lineages have especially low 18S divergences relative to their protein sequence divergences, suggesting that 18S ribosomal genes are too conservative to assess planktonic eukaryotic diversity. We provide an explanation for this lineage dependency, which suggests that most species with large effective population sizes will show far less divergence in 18S than protein coding sequences. Conclusions: There is therefore a trade-off between using genes that are easy to amplify in all species, but which by their nature are highly conserved and underestimate the true number of species, and using genes that give a better description of the number of species, but which are more difficult to amplify. We have shown that this trade-off differs between unicellular and multicellular organisms as a likely consequence of differences in effective population sizes. We anticipate that biodiversity of microbial eukaryotic species is underestimated and that numerous "cryptic species'' will become discernable with the future acquisition of genomic and metagenomic sequences.	[Piganeau, Gwenael; Grimsley, Nigel; Moreau, Herve] Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Piganeau, Gwenael; Grimsley, Nigel; Moreau, Herve] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Sussex	Piganeau, G (corresponding author), Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr	Grimsley, Nigel/O-1359-2015; Piganeau, Gwenael V/C-7600-2011; Eyre-Walker, Adam/G-6216-2011	Grimsley, Nigel/0000-0001-9323-417X; Piganeau, Gwenael V/0000-0002-9992-4187; Eyre-Walker, Adam/0000-0001-5527-8729	European Community [254619];  [AAP-FRB2009-PICOPOP]	European Community(European Commission); 	This study was funded by the European Community's 7th Framework program FP7 under grant agreement no254619 and the AAP-FRB2009-PICOPOP (http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; COYNE J, 2010, SPECIATION; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Jancek S, 2008, MOL BIOL EVOL, V25, P2293, DOI 10.1093/molbev/msn168; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; Welch JJ, 2008, J MOL EVOL, V67, P418, DOI 10.1007/s00239-008-9146-9; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	25	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16342	10.1371/journal.pone.0016342	http://dx.doi.org/10.1371/journal.pone.0016342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347361	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000287363000008
J	Sawyer, I; Smillie, SJ; Bodkin, JV; Fernandes, E; O'Byrne, KT; Brain, SD				Sawyer, Iain; Smillie, Sarah-Jane; Bodkin, Jennifer V.; Fernandes, Elizabeth; O'Byrne, Kevin T.; Brain, Susan D.			The Vasoactive Potential of Kisspeptin-10 in the Peripheral Vasculature	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HORMONE; KISS-1; GENE; RAT; DECAPEPTIDE; ACTIVATION; MECHANISMS; PREGNANCY; HISTAMINE	Splice products of the Kiss1 protein (kisspeptins) have been shown to be involved in a diverse range of functions, including puberty, metastasis and vasoconstriction in large human arteries. Circulating Kisspeptin-10 (Kp-10) plasma levels are low in normal individuals but are elevated during various disease states as well as pregnancy. Here, we investigated the potential of Kp-10, the shortest biologically active kisspeptin, to influence microvascular effects, concentrating on the cutaneous vasculature. Kp-10 caused a dose-dependent increase in oedema formation (0.3-10nmol/injection site), assessed by Evans Blue albumin dye extravasation, in the dorsal skin of CD1 mice. Oedema formation was shown to be inhibited by the histamine H-1 receptor antagonist mepyramine. The response was characterised by a ring of pallor at the injection site in keeping with vasoconstrictor activity. Therefore, changes in dorsal skin blood flow were assessed by clearance of intradermally injected (99m)technetium. Kp-10 was found to significantly reduce clearance, in keeping with decreased blood flow and providing further evidence for vasoconstrictor activity. The decreased clearance was partially inhibited by co-treatment with the cyclo-oxygenase inhibitor indomethacin. Finally evidence for the kisspeptin receptor gene (Kiss1R), but not the kisspeptin peptide gene (Kiss1), mRNA expression was observed in heart, aorta and kidney samples from normal and angiotensin II induced hypertensive mice, with similar mRNA levels observed in each. We have evidence for two peripheral vasoactive roles for kisspeptin-10. Firstly, plasma extravasation indicative of ability to induce oedema formation and secondly decreased peripheral blood flow, indicating microvascular constriction. Thus Kp-10 has vasoactive properties in the peripheral microvasculature.	[Sawyer, Iain; Smillie, Sarah-Jane; Bodkin, Jennifer V.; Fernandes, Elizabeth; Brain, Susan D.] Kings Coll London, British Heart Fdn Ctr, Vasc Biol Sect, Div Cardiovasc, London WC2R 2LS, England; [O'Byrne, Kevin T.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Sawyer, I (corresponding author), Kings Coll London, Sch Med, Dept Cardiol, London WC2R 2LS, England.	sue.brain@kcl.ac.uk	Brain, Susan/L-3681-2013; Fernandes, Elizabeth S./Q-7276-2019; Fernandes, Elizabeth S/J-9397-2012	Fernandes, Elizabeth S./0000-0002-0567-2514; Brain, Susan/0000-0002-9684-8342	British Heart Foundation; Biotechnology and Biological Sciences Research Council; British Pharmacological Society; Higher Education Funding Council for England; Knowledge Transfer Network; Medical Research Council; Scottish Funding Council; Biotechnology and Biological Sciences Research Council [BB/F007396/1, BB/E527098/1] Funding Source: researchfish; BBSRC [BB/F007396/1, BB/E527098/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Knowledge Transfer Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	These studies were supported by the British Heart Foundation and a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council, British Pharmacological Society, Higher Education Funding Council for England, Knowledge Transfer Network, Medical Research Council, and Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2009, PRENATAL DIAG, V29, P982, DOI 10.1002/pd.2328; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; BRAIN SD, 1988, BRIT J PHARMACOL, V95, P1005, DOI 10.1111/j.1476-5381.1988.tb11731.x; BRAIN SD, 1985, BRIT J PHARMACOL, V86, P855, DOI 10.1111/j.1476-5381.1985.tb11107.x; BRAIN SD, 2005, BRIT J PHARMACOL, V147, pS202; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bytautiene E, 2008, REPROD SCI, V15, P26, DOI 10.1177/1933719107309645; Cao T, 1999, AM J PHYSIOL-REG I, V277, pR476, DOI 10.1152/ajpregu.1999.277.2.R476; CAROLE AO, 2005, J ALLERGY CLIN IMMUN, V115, P1162; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Cho SG, 2009, J CELL BIOCHEM, V107, P1139, DOI 10.1002/jcb.22216; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Kim S, 2000, PHARMACOL REV, V52, P11; Kobayashi T, 2010, BIOORGAN MED CHEM, V18, P3841, DOI 10.1016/j.bmc.2010.04.036; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Liang LH, 2009, HYPERTENSION, V54, P1254, DOI 10.1161/HYPERTENSIONAHA.109.129783; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nijher GMK, 2010, BRIT J CLIN PHARMACO, V70, P674, DOI 10.1111/j.1365-2125.2010.03746.x; OWEN DAA, 1984, AGENTS ACTIONS, V14, P39, DOI 10.1007/BF01966830; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; REPKE H, 1987, J PHARMACOL EXP THER, V243, P317; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Santic R, 2007, P NATL ACAD SCI USA, V104, P10217, DOI 10.1073/pnas.0608585104; Schmidhuber SM, 2007, J INVEST DERMATOL, V127, P716, DOI 10.1038/sj.jid.5700569; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; Wei JF, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-21; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	42	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e14671	10.1371/journal.pone.0014671	http://dx.doi.org/10.1371/journal.pone.0014671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347414	Green Submitted, Green Published, gold			2022-12-27	WOS:000287361700005
J	Cristea, S; Gregory, PD; Urnov, FD; Cost, GJ				Cristea, Sandra; Gregory, Philip D.; Urnov, Fyodor D.; Cost, Gregory J.			Dissection of Splicing Regulation at an Endogenous Locus by Zinc-Finger Nuclease-Mediated Gene Editing	PLOS ONE			English	Article							II TRANSCRIPTION; MUTATIONS; CELLS; SITE	Sequences governing RNA splicing are difficult to study in situ due to the great difficulty of traditional targeted mutagenesis. Zinc-finger nuclease (ZFN) technology allows for the rapid and efficient introduction of site-specific mutations into mammalian chromosomes. Using a ZFN pair along with a donor plasmid to manipulate the outcomes of DNA repair, we introduced several discrete, targeted mutations into the fourth intron of the endogenous BAX gene in Chinese hamster ovary cells. Putative lariat branch points, the polypyrimidine tract, and the splice acceptor site were targeted. We recovered numerous otherwise isogenic clones carrying the intended mutations and analyzed the effect of each on BAX pre-mRNA splicing. Mutation of one of three possible branch points, the polypyrimidine tract, and the splice acceptor site all caused exclusion of exon five from BAX mRNA. Interestingly, these exon-skipping mutations allowed usage of cryptic splice acceptor sites within intron four. These data demonstrate that ZFN-mediated gene editing is a highly effective tool for dissection of pre-mRNA splicing regulatory sequences in their endogenous context.	[Cristea, Sandra; Gregory, Philip D.; Urnov, Fyodor D.; Cost, Gregory J.] Sangamo BioSci, Richmond, CA 94804 USA	Sangamo Therapeutics, Inc.	Cristea, S (corresponding author), Sangamo BioSci, Richmond, CA 94804 USA.	gcost@sangamo.com		Gregory, Philip/0000-0001-9249-2468; Cost, Gregory/0000-0002-8509-4653	Sangamo BioSciences	Sangamo BioSciences	This work was funded by Sangamo BioSciences. As the authors are employees of Sangamo BioSciences, the funders designed the study, collected and analyzed the data, decided to publish it, and prepared the manuscript.	Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHEN IT, 1993, MOL CELL BIOL, V13, P289, DOI 10.1128/MCB.13.1.289; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; DEKELVER RC, 2010, GENOME RES; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; HORNIG H, 1986, NATURE, V324, P589, DOI 10.1038/324589a0; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Malphettes L, 2010, BIOTECHNOL BIOENG, V106, P774, DOI 10.1002/bit.22751; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556	34	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16961	10.1371/journal.pone.0016961	http://dx.doi.org/10.1371/journal.pone.0016961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347446	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600036
J	Ke, Z; Yip, SP; Li, L; Zheng, XX; Tong, KY				Ke, Zheng; Yip, Shea Ping; Li, Le; Zheng, Xiao-Xiang; Tong, Kai-Yu			The Effects of Voluntary, Involuntary, and Forced Exercises on Brain-Derived Neurotrophic Factor and Motor Function Recovery: A Rat Brain Ischemia Model	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ELECTRICAL-STIMULATION; STROKE; BDNF; HIPPOCAMPUS; TREADMILL; INJURY; PLASTICITY; MOVEMENT; DEFICITS	Background: Stroke rehabilitation with different exercise paradigms has been investigated, but which one is more effective in facilitating motor recovery and up-regulating brain neurotrophic factor (BDNF) after brain ischemia would be interesting to clinicians and patients. Voluntary exercise, forced exercise, and involuntary muscle movement caused by functional electrical stimulation (FES) have been individually demonstrated effective as stroke rehabilitation intervention. The aim of this study was to investigate the effects of these three common interventions on brain BDNF changes and motor recovery levels using a rat ischemic stroke model. Methodology/Principal Findings: One hundred and seventeen Sprague-Dawley rats were randomly distributed into four groups: Control (Con), Voluntary exercise of wheel running (V-Ex), Forced exercise of treadmill running (F-Ex), and Involuntary exercise of FES (I-Ex) with implanted electrodes placed in two hind limb muscles on the affected side to mimic gait-like walking pattern during stimulation. Ischemic stroke was induced in all rats with the middle cerebral artery occlusion/reperfusion model and fifty-seven rats had motor deficits after stroke. Twenty-four hours after reperfusion, rats were arranged to their intervention programs. De Ryck's behavioral test was conducted daily during the 7-day intervention as an evaluation tool of motor recovery. Serum corticosterone concentration and BDNF levels in the hippocampus, striatum, and cortex were measured after the rats were sacrificed. V-Ex had significantly better motor recovery in the behavioral test. V-Ex also had significantly higher hippocampal BDNF concentration than F-Ex and Con. F-Ex had significantly higher serum corticosterone level than other groups. Conclusion/Significance: Voluntary exercise is the most effective intervention in upregulating the hippocampal BDNF level, and facilitating motor recovery. Rats that exercised voluntarily also showed less corticosterone stress response than other groups. The results also suggested that the forced exercise group was the least preferred intervention with high stress, low brain BDNF levels and less motor recovery.	[Ke, Zheng; Yip, Shea Ping; Li, Le; Tong, Kai-Yu] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Zheng, Xiao-Xiang] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China	Hong Kong Polytechnic University; Zhejiang University	Ke, Z (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.	k.y.tong@polyu.edu.hk	Li, Le/N-1841-2019; Yip, Shea Ping/A-1185-2016; Tong, Raymond Kai-yu/C-3546-2009	Li, Le/0000-0002-9340-9061; Yip, Shea Ping/0000-0002-2170-8185; Tong, Raymond Kai-yu/0000-0003-4375-653X	Research Grants Council of the Hong Kong Special Administrative Region, China [PolyU5633/07M]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region, China (grant no. PolyU5633/07M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Carro E, 2000, J NEUROSCI, V20, P2926; Cechetti F, 2008, BRAIN RES, V1188, P182, DOI 10.1016/j.brainres.2007.10.012; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Hayes K, 2008, ACTA NEUROPATHOL, V115, P289, DOI 10.1007/s00401-008-0340-z; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Johnston ANB, 2001, MOL BRAIN RES, V88, P26, DOI 10.1016/S0169-328X(01)00016-X; Leung LY, 2006, NEUROSCI LETT, V397, P135, DOI 10.1016/j.neulet.2005.12.006; Li DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006673; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Park BR, 2004, NEUROSCI RES COMMUN, V34, P10, DOI 10.1002/nrc.10101; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; Yang YR, 2003, CAN J NEUROL SCI, V30, P252, DOI 10.1017/S0317167100002687	32	188	209	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16643	10.1371/journal.pone.0016643	http://dx.doi.org/10.1371/journal.pone.0016643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347437	Green Submitted, gold, Green Published			2022-12-27	WOS:000287077600011
J	Luciano, AA; Yu, HY; Jackson, LW; Wolfe, LA; Bernstein, HB				Luciano, Angel A.; Yu, Haiyan; Jackson, Leila W.; Wolfe, Lisa A.; Bernstein, Helene B.			Preterm Labor and Chorioamnionitis Are Associated with Neonatal T Cell Activation	PLOS ONE			English	Article							MICROBIAL INVASION; INFECTION; FETAL; PARTURITION; TERM; MEMBRANES; INFANTS; RUPTURE	Background: Preterm parturition is characterized by innate immune activation and increased proinflammatory cytokine levels. This well established association leads us to hypothesize that preterm delivery is also associated with neonatal T lymphocyte activation and maturation. Methodology/Principal Findings: Cord blood samples were obtained following term, preterm, and deliveries complicated by clinical chorioamnionitis. Activation marker expression was quantitated by flow cytometric analysis. Infants born following preterm delivery demonstrated enhanced CD4(+) T lymphocyte activation, as determined by CD25 (Term 9.72% vs. Preterm 17.67%, p = 0.0001), HLA-DR (Term 0.91% vs. Preterm 1.92%, p = 0.0012), and CD69 expression (Term 0.38% vs. Preterm 1.20%, p = 0.0003). Neonates delivered following clinical chorioamnionitis also demonstrated increased T cell activation. Preterm neonates had an increased frequency of CD45RO(+) T cells. Conclusion/Significance: Preterm parturition is associated with neonatal CD4(+) T cell activation, and an increased frequency of CD45RO(+) T cells. These findings support the concept that activation of the fetal adaptive immune system in utero is closely associated with preterm labor.	[Luciano, Angel A.] Univ S Florida, Coll Med, Dept Pediat, Div Neonatol, Tampa, FL 33612 USA; [Luciano, Angel A.] USF Childrens Res Inst, St Petersburg, FL USA; [Yu, Haiyan; Wolfe, Lisa A.; Bernstein, Helene B.] Case Western Reserve Univ, Sch Med, Dept Reprod Biol,Med Ctr, Dept Obstet & Gynecol,MacDonald Womens Hosp,Univ, Cleveland, OH 44106 USA; [Yu, Haiyan] Sichuan Univ, Dept Obstet & Gynecol, W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Jackson, Leila W.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	State University System of Florida; University of South Florida; Case Western Reserve University; Sichuan University; Case Western Reserve University	Luciano, AA (corresponding author), Univ S Florida, Coll Med, Dept Pediat, Div Neonatol, Tampa, FL 33612 USA.	hbb22@case.edu			American Cancer Society [RSG-07-070-01-LIB]	American Cancer Society(American Cancer Society)	This study was supported by the American Cancer Society Grant #RSG-07-070-01-LIB. The American Cancer Society had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, Int J Gynaecol Obstet, V63, P75; Athayde N, 2000, AM J OBSTET GYNECOL, V182, P135, DOI 10.1016/S0002-9378(00)70502-3; Bernstein HB, 2002, AM J OBSTET GYNECOL, V187, P1283, DOI 10.1067/mob.2002.126978; BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Bruning T, 1997, CLIN EXP IMMUNOL, V107, P306, DOI 10.1111/j.1365-2249.1997.268-ce1165.x; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Esplin MS, 2005, J MATERN-FETAL NEO M, V17, P365, DOI 10.1080/14767050500141329; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GRAVETT MG, 1994, AM J OBSTET GYNECOL, V171, P1660, DOI 10.1016/0002-9378(94)90418-9; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Kenyon S, 2004, OBSTET GYNECOL, V104, P1051, DOI 10.1097/01.AOG.0000143268.36682.21; Kim SK, 2009, J PERINAT MED, V37, P543, DOI 10.1515/JPM.2009.106; Matsuda Y, 2010, MICROBIOL IMMUNOL, V54, P38, DOI 10.1111/j.1348-0421.2009.00181.x; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1988, SEMIN PERINATOL, V12, P262; ROMERO R, 1994, AM J REPROD IMMUNOL, V32, P108, DOI 10.1111/j.1600-0897.1994.tb01101.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; Stavitsky AB, 2007, MOL IMMUNOL, V44, P2787, DOI 10.1016/j.molimm.2007.01.011; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85	25	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16698	10.1371/journal.pone.0016698	http://dx.doi.org/10.1371/journal.pone.0016698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347427	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600019
J	Sagili, RR; Pankiw, T; Metz, BN				Sagili, Ramesh R.; Pankiw, Tanya; Metz, Bradley N.			Division of Labor Associated with Brood Rearing in the Honey Bee: How Does It Translate to Colony Fitness?	PLOS ONE			English	Article							PHEROMONE; HYMENOPTERA; GROWTH; APIDAE	Division of labor is a striking feature observed in honey bees and many other social insects. Division of labor has been claimed to benefit fitness. In honey bees, the adult work force may be viewed as divided between non-foraging hive bees that rear brood and maintain the nest, and foragers that collect food outside the nest. Honey bee brood pheromone is a larval pheromone that serves as an excellent empirical tool to manipulate foraging behaviors and thus division of labor in the honey bee. Here we use two different doses of brood pheromone to alter the foraging stimulus environment, thus changing demographics of colony division of labor, to demonstrate how division of labor associated with brood rearing affects colony growth rate. We examine the effects of these different doses of brood pheromone on individual foraging ontogeny and specialization, colony level foraging behavior, and individual glandular protein synthesis. Low brood pheromone treatment colonies exhibited significantly higher foraging population, decreased age of first foraging and greater foraging effort, resulting in greater colony growth compared to other treatments. This study demonstrates how division of labor associated with brood rearing affects honey bee colony growth rate, a token of fitness.	[Sagili, Ramesh R.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Pankiw, Tanya; Metz, Bradley N.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Oregon State University; Texas A&M University System; Texas A&M University College Station	Sagili, RR (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	sagilir@hort.oregonstate.edu			USDA/NRI [2004-35302-15031]; Texas Honey Bee Legislative Initiative	USDA/NRI(United States Department of Agriculture (USDA)); Texas Honey Bee Legislative Initiative	This research was supported by grants from the USDA/NRI 2004-35302-15031 to T. Pankiw, as well as support from the Texas Honey Bee Legislative Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1998, SURVIVAL ANAL USING, P111; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; ECKERT CD, 1994, OECOLOGIA, V97, P248, DOI 10.1007/BF00323157; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; GARY NE, 1987, ANN ENTOMOL SOC AM, V80, P664, DOI 10.1093/aesa/80.5.664; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; LE CONTE Y, 1994, NATURWISSENSCHAFTEN, V81, P462, DOI 10.1007/BF01136651; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Oster G.F., 1978, Monographs in Population Biology, pi; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P575, DOI 10.1007/s00114-004-0568-y; Pankiw T, 2001, BEHAV ECOL SOCIOBIOL, V49, P206, DOI 10.1007/s002650000282; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P178, DOI 10.1007/s00114-004-0506-z; Pankiw T, 2002, ANN ENTOMOL SOC AM, V95, P761, DOI 10.1603/0013-8746(2002)095[0761:PFRTBP]2.0.CO;2; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pankiw T, 2008, J ECON ENTOMOL, V101, P1749, DOI 10.1603/0022-0493-101.6.1749; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sagili RR, 2009, J INSECT BEHAV, V22, P339, DOI 10.1007/s10905-009-9176-1; Sagili RR, 2005, J INSECT PHYSIOL, V51, P953, DOI 10.1016/j.jinsphys.2005.04.003; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; SEELEY TD, 1991, ETHOLOGY, V87, P284; Sokal R.R., 2012, BIOMETRY; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; WILSON EO, 1987, J ANIM ECOL, V56, P1, DOI 10.2307/4795; WINSTON ML, 1987, BIOL HONEY BEE, P48	30	27	27	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16785	10.1371/journal.pone.0016785	http://dx.doi.org/10.1371/journal.pone.0016785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347428	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600027
J	Alard, JE; Hillion, S; Guillevin, L; Saraux, A; Pers, JO; Youinou, P; Jamin, C				Alard, Jean-Eric; Hillion, Sophie; Guillevin, Loic; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe			Autoantibodies to Endothelial Cell Surface ATP Synthase, the Endogenous Receptor for Hsp60, Might Play a Pathogenic Role in Vasculatides	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SYSTEMIC AUTOIMMUNE-DISEASES; RENAL TUBULAR-ACIDOSIS; SJOGRENS-SYNDROME; INTRACELLULAR PH; FLOW-CYTOMETRY; ANTIBODIES; VASCULITIS; HEAT-SHOCK-PROTEIN-60; APOPTOSIS	Background: Heat shock protein (hsp) 60 that provides "danger signal" binds to the surface of resting endothelial cells (EC) but its receptor has not yet been characterized. In mitochondria, hsp60 specifically associates with adenosine triphosphate (ATP) synthase. We therefore examined the possible interaction between hsp60 and ATP synthase on EC surface. Methodology/Principal Findings: Using Far Western blot approach, co-immunoprecipitation studies and surface plasmon resonance analyses, we demonstrated that hsp60 binds to the beta-subunit of ATP synthase. As a cell surface-expressed molecule, ATP synthase is potentially targeted by anti-EC-antibodies (AECAs) found in the sera of patients suffering vasculitides. Based on enzyme-linked immunosorbent assay and Western blotting techniques with F1-ATP synthase as substrate, we established the presence of anti-ATP synthase antibodies at higher frequency in patients with primary vasculitides (group I) compared with secondary vasculitides (group II). Anti-ATP synthase reactivity from group I patients was restricted to the beta-subunit of ATP synthase, whereas those from group II was directed to the alpha-, beta- and gamma-subunits. Cell surface ATP synthase regulates intracellular pH (pHi). In low extracellular pH medium, we detected abnormal decreased of EC pHi in the presence of anti-ATP synthase antibodies, irrespective of their fine reactivities. Interestingly, soluble hsp60 abrogated the anti-ATP synthase-induced pHi down-regulation. Conclusions/Significance: Our results indicate that ATP synthase is targeted by AECAs on the surface of EC that induce intracellular acidification. Such pathogenic effect in vasculitides can be modulated by hsp60 binding on ATP synthase which preserves ATP synthase activity.	[Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Brest, EA2216 Immunol & Pathol, Brest, France; [Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Brest, IFR SclnBioS 148, Brest, France; [Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Europeenne Bretagne, Brest, France; [Guillevin, Loic] Hop Cochin, Dept Internal Med, F-75674 Paris, France; [Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Ctr Hosp Univ, Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Universite de Bretagne Occidentale	Alard, JE (corresponding author), Univ Brest, EA2216 Immunol & Pathol, Brest, France.	youinou@univ-brest.fr	HILLION, Sophie/I-9747-2019; Pers, Jacques-Olivier/AGG-7221-2022	Hillion, Sophie/0000-0002-3354-0981	Conseil regional de Bretagne	Conseil regional de Bretagne(Region Bretagne)	Jean-Eric Alard was supported by the "Conseil regional de Bretagne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard JE, 2008, CLIN REV ALLERG IMMU, V35, P66, DOI 10.1007/s12016-007-8062-x; Alard JE, 2007, AUTOIMMUN REV, V6, P438, DOI 10.1016/j.autrev.2007.01.012; Alard JE, 2009, FASEB J, V23, P2772, DOI 10.1096/fj.08-128785; Alessandri C, 2006, ADV CLIN CHEM, V42, P297, DOI 10.1016/S0065-2423(06)42008-4; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BREEDVELD FC, 1986, ARCH INTERN MED, V146, P1009, DOI 10.1001/archinte.146.5.1009; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chi SL, 2007, CANCER RES, V67, P4716, DOI 10.1158/0008-5472.CAN-06-1094; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Domiciano DS, 2009, LUPUS, V18, P1233, DOI 10.1177/0961203309346654; Dubaniewicz A, 2010, AUTOIMMUN REV, V9, P419, DOI 10.1016/j.autrev.2009.11.015; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; George J, 1999, ARTERIOSCL THROM VAS, V19, P505, DOI 10.1161/01.ATV.19.3.505; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Guilpain P, 2008, CLIN REV ALLERG IMMU, V35, P59, DOI 10.1007/s12016-007-8069-3; GUR H, 1987, ANN RHEUM DIS, V46, P617, DOI 10.1136/ard.46.8.617; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Jamin C, 2005, ARTHRITIS RHEUM-US, V52, P4028, DOI 10.1002/art.21401; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; KALDI K, 1994, BIOCHEM J, V301, P329, DOI 10.1042/bj3010329; Marches R, 2001, P NATL ACAD SCI USA, V98, P3434, DOI 10.1073/pnas.061028998; Mavragani CP, 2006, NAT CLIN PRACT RHEUM, V2, P252, DOI 10.1038/ncprheum0165; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; PRASAD TK, 1990, MOL CELL BIOL, V10, P3979, DOI 10.1128/MCB.10.8.3979; Radojkovic C, 2009, ARTERIOSCL THROM VAS, V29, P1125, DOI 10.1161/ATVBAHA.109.187997; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Revelen R, 2002, CLIN EXP RHEUMATOL, V20, P19; Revelen R, 2000, CLIN CHEM, V46, P273; Ronda N, 2007, AUTOANTIBODIES, 2ND EDITION, P725, DOI 10.1016/B978-044452763-9/50094-9; Savage COS, 2000, BRIT MED J, V320, P1325, DOI 10.1136/bmj.320.7245.1325; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Soy M, 2005, RHEUMATOL INT, V26, P86, DOI 10.1007/s00296-005-0587-9; Sprenger RR, 2004, ELECTROPHORESIS, V25, P156, DOI 10.1002/elps.200305675; STATER EC, 1967, METHOD ENZYMOL, V10, P48; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; VACIRCA D, 2010, AUTOANTIBODIES ADENO, DOI DOI 10.1016/J.NEUROBIOLAGING.2010.05.013; Wahl ML, 2002, ENDOTHELIUM-J ENDOTH, V9, P205, DOI 10.1080/10623320213633; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Wick MC, 2008, CELL STRESS CHAPERON, V13, P275, DOI 10.1007/s12192-008-0044-2; XU QB, 1992, ARTERIOSCLER THROMB, V12, P789, DOI 10.1161/01.ATV.12.7.789; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Zheng JB, 1999, BIOCHEM BIOPH RES CO, V261, P499, DOI 10.1006/bbrc.1999.1063	45	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14654	10.1371/journal.pone.0014654	http://dx.doi.org/10.1371/journal.pone.0014654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326874	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037100002
J	Stepien, M; Gaudichon, C; Fromentin, G; Even, P; Tome, D; Azzout-Marniche, D				Stepien, Magdalena; Gaudichon, Claire; Fromentin, Gilles; Even, Patrick; Tome, Daniel; Azzout-Marniche, Dalila			Increasing Protein at the Expense of Carbohydrate in the Diet Down-Regulates Glucose Utilization as Glucose Sparing Effect in Rats	PLOS ONE			English	Article							UREA CYCLE ENZYMES; WEIGHT-LOSS; ADIPOSE-TISSUE; BODY-COMPOSITION; GLYCEMIC CONTROL; GENE-EXPRESSION; ENERGY-INTAKE; OBESE WOMEN; SUBSTRATE OXIDATION; RESPIRATION CHAMBER	High protein (HP) diet could serve as a good strategy against obesity, provoking the changes in energy metabolic pathways. However, those modifications differ during a dietary adaptation. To better understand the mechanisms involved in effect of high protein diet (HP) on limiting adiposity in rats we studied in parallel the gene expression of enzymes involved in protein and energy metabolism and the profiles of nutrients oxidation. Eighty male Wistar rats were fed a normal protein diet (NP, 14% of protein) for one week, then either maintained on NP diet or assigned to a HP diet (50% of protein) for 1, 3, 6 and 14 days. mRNA levels of genes involved in carbohydrate and lipid metabolism were measured in liver, adipose tissues, kidney and muscles by real time PCR. Energy expenditure (EE) and substrate oxidation were measured by indirect calorimetry. Liver glycogen and plasma glucose and hormones were assayed. In liver, HP feeding 1) decreased mRNA encoding glycolysis enzymes (GK, L-PK) and lipogenesis enzymes(ACC, FAS), 2) increased mRNA encoding gluconeogenesis enzymes (PEPCK), 3) first lowered, then restored mRNA encoding glycogen synthesis enzyme (GS), 4) did not change mRNA encoding beta-oxidation enzymes (CPT1, ACOX1, beta HAD). Few changes were seen in other organs. In parallel, indirect calorimetry confirmed that following HP feeding, glucose oxidation was reduced and fat oxidation was stable, except during the 1(st) day of adaptation where lipid oxidation was increased. Finally, this study showed that plasma insulin was lowered and hepatic glucose uptake was decreased. Taken together, these results demonstrate that following HP feeding, CHO utilization was increased above the increase in carbohydrate intake while lipogenesis was decreased thus giving a potential explanation for the fat lowering effect of HP diets.	[Stepien, Magdalena; Gaudichon, Claire; Fromentin, Gilles; Even, Patrick; Tome, Daniel; Azzout-Marniche, Dalila] INRA AgroParisTech, CNRH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Stepien, Magdalena; Gaudichon, Claire; Fromentin, Gilles; Even, Patrick; Tome, Daniel; Azzout-Marniche, Dalila] INRA, CNRH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Stepien, M (corresponding author), INRA AgroParisTech, CNRH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	dalila.azzout@agroparistech.fr		Even, Patrick/0000-0001-5733-3023; Azzout-Marniche, Dalila/0000-0001-8397-9143; GAUDICHON, Claire/0000-0002-0983-4760	European Commission [MEST-CT-20058-020494]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The research that led to these results received funding from the European Commissions Sixth Framework Programme (FP6) under NuSISCO Contract No. MEST-CT-20058-020494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WGH, 1988, AM J PHYSIOL, V255, pE332, DOI 10.1152/ajpendo.1988.255.3.E332; Azzout-Marniche D, 2007, AM J PHYSIOL-REG I, V292, pR1400, DOI 10.1152/ajpregu.00566.2006; Baum JI, 2006, J NUTR, V136, P1855, DOI 10.1093/jn/136.7.1855; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Brito SMRC, 2005, CAN J PHYSIOL PHARM, V83, P477, DOI 10.1139/Y05-035; Chevalier L, 2009, NUTRITION, V25, P932, DOI 10.1016/j.nut.2009.01.013; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; COLOMBO JP, 1990, BIOCHEM BIOPH RES CO, V172, P1239, DOI 10.1016/0006-291X(90)91582-D; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; GANNON MC, 1987, DIABETES, V36, P52, DOI 10.2337/diabetes.36.1.52; GANNON MC, 1995, J NUTR, V125, P1159; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gordon MM, 2008, J NUTR HEALTH AGING, V12, P505, DOI 10.1007/BF02983202; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Hochstenbach-Waelen A, 2009, AM J CLIN NUTR, V89, P831, DOI 10.3945/ajcn.2008.26917; Jackson AA, 1999, EUR J CLIN NUTR, V53, pS44, DOI 10.1038/sj.ejcn.1600743; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kahn A, 1997, BIOCHIMIE, V79, P113, DOI 10.1016/S0300-9084(97)81501-5; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Labayen Idoia, 2003, Forum Nutr, V56, P168; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Layman DK, 2004, J NUTR, V134, p968S, DOI 10.1093/jn/134.4.968S; Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440; Leidy HJ, 2007, OBESITY, V15, P421, DOI 10.1038/oby.2007.531; Lejeune MPGM, 2006, AM J CLIN NUTR, V83, P89; Lobley GE, 2007, BRIT J NUTR, V97, P1099, DOI 10.1017/S0007114507691934; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Morens C, 2003, J NUTR, V133, P2733, DOI 10.1093/jn/133.9.2733; Morens C, 2001, AM J PHYSIOL-ENDOC M, V281, pE826, DOI 10.1152/ajpendo.2001.281.4.E826; NICOLAIDIS S, 1974, PHARMACOL BIOCHEM BE, V2, P131, DOI 10.1016/0091-3057(74)90147-6; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Palou M, 2008, PFLUG ARCH EUR J PHY, V456, P825, DOI 10.1007/s00424-008-0461-1; Petzke KJ, 2005, EUR J NUTR, V44, P414, DOI 10.1007/s00394-004-0545-4; Petzke KJ, 2007, J NUTR BIOCHEM, V18, P400, DOI 10.1016/j.jnutbio.2006.07.005; Pichon L, 2006, J NUTR, V136, P1256, DOI 10.1093/jn/136.5.1256; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROEHRIG KL, 1974, ANAL BIOCHEM, V58, P414, DOI 10.1016/0003-2697(74)90210-3; SCHIMKE RT, 1961, COLD SPRING HARB SYM, V26, P363, DOI 10.1101/SQB.1961.026.01.044; Sim KG, 2002, CLIN CHIM ACTA, V323, P37, DOI 10.1016/S0009-8981(02)00182-1; SNODGRASS PJ, 1978, J BIOL CHEM, V253, P2748; Tentolouris N, 2008, METABOLISM, V57, P313, DOI 10.1016/j.metabol.2007.10.004; Treyzon L, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-23; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp-Plantenga MS, 2009, PHYSIOL BEHAV, V97, P414, DOI 10.1016/j.physbeh.2009.03.010; Zang Y, 2005, OBES RES, V13, P1530, DOI 10.1038/oby.2005.188	54	41	42	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14664	10.1371/journal.pone.0014664	http://dx.doi.org/10.1371/journal.pone.0014664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326875	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037100004
J	Banasik, K; Justesen, JM; Hornbak, M; Krarup, NT; Gjesing, AP; Sandholt, CH; Jensen, TS; Grarup, N; Andersson, A; Jorgensen, T; Witte, DR; Sandbaek, A; Lauritzen, T; Thorens, B; Brunak, S; Sorensen, TIA; Pedersen, O; Hansen, T				Banasik, Karina; Justesen, Johanne M.; Hornbak, Malene; Krarup, Nikolaj T.; Gjesing, Anette P.; Sandholt, Camilla H.; Jensen, Thomas S.; Grarup, Niels; Andersson, Asa; Jorgensen, Torben; Witte, Daniel R.; Sandbaek, Annelli; Lauritzen, Torsten; Thorens, Bernard; Brunak, Soren; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben			Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; HEPATIC STEATOSIS; INSULIN-RESISTANCE; STEATOHEPATITIS; EXPRESSION; ASSOCIATION; POPULATION; PREVALENCE; METABOLISM; COMPLEXES	Objective: Candidate genes for non-alcoholic fatty liver disease (NAFLD) identified by a bioinformatics approach were examined for variant associations to quantitative traits of NAFLD-related phenotypes. Research Design and Methods: By integrating public database text mining, trans-organism protein-protein interaction transferal, and information on liver protein expression a protein-protein interaction network was constructed and from this a smaller isolated interactome was identified. Five genes from this interactome were selected for genetic analysis. Twenty-one tag single-nucleotide polymorphisms (SNPs) which captured all common variation in these genes were genotyped in 10,196 Danes, and analyzed for association with NAFLD-related quantitative traits, type 2 diabetes (T2D), central obesity, and WHO-defined metabolic syndrome (MetS). Results: 273 genes were included in the protein-protein interaction analysis and EHHADH, ECHS1, HADHA, HADHB, and ACADL were selected for further examination. A total of 10 nominal statistical significant associations (P < 0.05) to quantitative metabolic traits were identified. Also, the case-control study showed associations between variation in the five genes and T2D, central obesity, and MetS, respectively. Bonferroni adjustments for multiple testing negated all associations. Conclusions: Using a bioinformatics approach we identified five candidate genes for NAFLD. However, we failed to provide evidence of associations with major effects between SNPs in these five genes and NAFLD-related quantitative traits, T2D, central obesity, and MetS.	[Banasik, Karina; Justesen, Johanne M.; Hornbak, Malene; Krarup, Nikolaj T.; Gjesing, Anette P.; Sandholt, Camilla H.; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Hagedorn Res Inst, Gentofte, Denmark; [Banasik, Karina; Jorgensen, Torben; Sorensen, Thorkild I. A.; Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Jensen, Thomas S.; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Hornbak, Malene; Andersson, Asa] Univ Copenhagen, Fac Pharmaceut Sci, Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Thorens, Bernard] Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Sorensen, Thorkild I. A.] Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Technical University of Denmark; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; Aarhus University; University of Lausanne; Aarhus University; University of Southern Denmark	Banasik, K (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	kabs@hagedorn.dk	Justesen, Johanne Marie/AAY-4210-2021; Pedersen, Oluf/AAG-8015-2020; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Banasik, Karina/G-1728-2013; Banasik, Karina/S-3475-2019; Justesen, Johanne Marie/L-6023-2015; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018; Grarup, Niels/K-2807-2015; Gjesing, Anette/ACC-7521-2022; Brunak, Soren/O-6621-2016	Justesen, Johanne Marie/0000-0002-0484-8522; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Banasik, Karina/0000-0003-2489-2499; Justesen, Johanne Marie/0000-0002-0484-8522; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Gjesing, Anette/0000-0003-4580-1576; Krarup, Nikolaj/0000-0002-1660-4832; Krarup, Nikolaj Thure/0000-0001-6526-8663; Hansen, Torben/0000-0001-8748-3831; /0000-0003-4360-7710; Jorgensen, Torben/0000-0001-9453-2830; Brunak, Soren/0000-0003-0316-5866	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Danish Health Research Council; European Commission [LSHM-CT-2005-018734]; Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences); Danish Research Council; Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Danish Health Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP, www.lucamp.org), the Danish Health Research Council, "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP http://www.hepadip.org), which is supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734), the Danish Diabetes Association, the Danish Council for Independent Research (Medical Sciences). The Inter99 was initiated by T. Jorgensen (Principal Investigator), K. Borch-Johnsen (co-Principal Investigator), H. Ibsen and T. F. Thomsen. The steering committee comprises the former two and C. Pisinger. The study was financially supported by research grants from the Danish Research Council, the Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation and the Danish Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albrechtsen A, 2007, GENETICS, V176, P1197, DOI 10.1534/genetics.107.071696; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; de Alwis NMW, 2008, CURR DIABETES REP, V8, P156, DOI 10.1007/s11892-008-0027-9; Duvnjak M, 2009, WORLD J GASTROENTERO, V15, P6023, DOI 10.3748/wjg.15.6023; Eaton S, 1996, CLIN SCI, V90, P307, DOI 10.1042/cs0900307; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juge-Aubry CE, 2001, BIOCHEM J, V353, P253, DOI 10.1042/0264-6021:3530253; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kohjima M, 2007, INT J MOL MED, V20, P351; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Leonard JF, 2006, PROTEOMICS, V6, P1915, DOI 10.1002/pmic.200500251; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki M, 2010, J TOXICOL SCI, V35, P131, DOI 10.2131/jts.35.131; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Neuschwander-Tetri BA, 2007, CURR OPIN GASTROEN, V23, P193, DOI 10.1097/MOG.0b013e32801421a9; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sparso T, 2007, MOL GENET METAB, V90, P205, DOI 10.1016/j.ymgme.2006.10.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsuneto A, 2010, HYPERTENS RES, V33, P638, DOI 10.1038/hr.2010.45; Willner IR, 2001, AM J GASTROENTEROL, V96, P2957; World Health Organization Study G, 1999, TECH REP SER WHO NCD; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541; Zhang X, 2009, HEPATOLOGY	38	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16542	10.1371/journal.pone.0016542	http://dx.doi.org/10.1371/journal.pone.0016542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21339799	gold, Green Published, Green Submitted			2022-12-27	WOS:000286663900066
J	King, C; Sarvetnick, N				King, Cecile; Sarvetnick, Nora			The Incidence of Type-1 Diabetes in NOD Mice Is Modulated by Restricted Flora Not Germ-Free Conditions	PLOS ONE			English	Article							VIRUS-INFECTION; MELLITUS IDDM; T-CELLS; PREVENTION; MOUSE; ADJUVANT; BACTERIA; INSULIN; AUTOIMMUNITY; MATURATION	In the NOD mouse, the incidence of type-1 diabetes is thought to be influenced by the degree of cleanliness of the mouse colony. Studies collectively demonstrate that exposure to bacterial antigen or infection in the neonatal period prevents diabetes [1,2,3,4,5,6,7,8,9,10], supporting the notion that immunostimulation can benefit the maturation of the postnatal immune system [11]. A widely accepted extrapolation from this data has been the notion that NOD mice maintained under germ-free conditions have an increased incidence of diabetes. However, evidence supporting this influential concept is surprisingly limited [12]. In this study, we demonstrate that the incidence of diabetes in female NOD mice remained unchanged under germ-free conditions. By contrast, a spontaneous monoculture with a gram-positive aerobic spore-forming rod delayed the onset and reduced the incidence of diabetes. These findings challenge the view that germ-free NOD mice have increased diabetes incidence and demonstrate that modulation of intestinal microbiota can prevent the development of type-1 diabetes.	[King, Cecile; Sarvetnick, Nora] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	King, C (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW 2010, Australia.	c.king@garvan.org.au	King, Cecile/Q-9794-2019	King, Cecile/0000-0003-2193-2563	NIH [DK54063]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH/DK54063 and Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2010, DIABETES, V59, P2237, DOI 10.2337/db10-0147; Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; CRABBE PA, 1970, LAB INVEST, V22, P448; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; ELLIOTT RB, 1988, DIABETOLOGIA, V31, P62; GLAISTER JR, 1973, INT ARCH ALLER A IMM, V45, P719, DOI 10.1159/000231071; Gombert JM, 1996, CR ACAD SCI III-VIE, V319, P125; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P59, DOI 10.1111/j.1399-3038.1995.tb00261.x; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; HUDSON JA, 1964, P SOC EXP BIOL MED, V116, P628; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; MACLAREN N, 1989, DIABETES, V38, P534, DOI 10.2337/diabetes.38.4.534; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martins TC, 1996, J AUTOIMMUN, V9, P501, DOI 10.1006/jaut.1996.0067; Martins TC, 1999, CLIN EXP IMMUNOL, V115, P248, DOI 10.1046/j.1365-2249.1999.00781.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Mueller DB, 2009, ANN NUTR METAB, V54, P208, DOI 10.1159/000220416; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; Ramiya VK, 1996, J AUTOIMMUN, V9, P349, DOI 10.1006/jaut.1996.0047; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Sai P, 1996, DIABETES METAB, V22, P341; SATOH J, 1988, DIABETES, V37, P1188, DOI 10.2337/diabetes.37.9.1188; SHEHADEH NN, 1993, J AUTOIMMUN, V6, P291, DOI 10.1006/jaut.1993.1025; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; WILBERZ S, 1991, DIABETOLOGIA, V34, P2, DOI 10.1007/BF00404016	30	114	123	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17049	10.1371/journal.pone.0017049	http://dx.doi.org/10.1371/journal.pone.0017049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364875	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100022
J	Kimura, RH; Jones, DS; Jiang, L; Miao, Z; Cheng, Z; Cochran, JR				Kimura, Richard H.; Jones, Douglas S.; Jiang, Lei; Miao, Zheng; Cheng, Zhen; Cochran, Jennifer R.			Functional Mutation of Multiple Solvent-Exposed Loops in the Ecballium elaterium Trypsin Inhibitor-II Cystine Knot Miniprotein	PLOS ONE			English	Article							CANCER ALPHA(V)-INTEGRIN EXPRESSION; SMALL-ANIMAL PET; INTEGRIN ALPHA(V)BETA(3); STRUCTURAL SCAFFOLD; TUMOR ANGIOGENESIS; SURFACE DISPLAY; RGD PEPTIDES; IN-VIVO; BINDING; ALPHA-V-BETA-3	Background: The Ecballium elaterium trypsin inhibitor (EETI-II), a 28-amino acid member of the knottin family of peptides, contains three interwoven disulfide bonds that form multiple solvent-exposed loops. Previously, the trypsin binding loop of EETI-II has been engineered to confer binding to several alternative molecular targets. Here, EETI-II was further explored as a molecular scaffold for polypeptide engineering by evaluating the ability to mutate two of its structurally adjacent loops. Methodology/Principal Findings: Yeast surface display was used to engineer an EETI-II mutant containing two separate integrin binding epitopes. The resulting knottin peptide was comprised of 38 amino acids, and contained 11- and 10-residue loops compared to wild-type EETI-II, which naturally contains 6- and 5-residue loops, respectively. This knottin peptide bound to alpha(v)beta(5) and alpha(v)beta(5) integrins with affinities in the low nanomolar range, but bound weakly to the related integrins alpha(5)beta(1) and alpha(iib)beta(3). In addition, the engineered knottin peptide inhibited tumor cell adhesion to vitronectin, an extracellular matrix protein that binds to alpha(v)beta(3) and alpha(v)beta(5) integrins. A Cu-64 radiolabeled version of this knottin peptide demonstrated moderate serum stability and excellent tumor-to-muscle and tumor-to-blood ratios by positron emission tomography imaging in human tumor xenograft models. Tumor uptake was similar to 3-5% injected dose per gram (%ID/g) at one hour post injection, with rapid clearance of probe through the kidneys. Conclusions/Significance: We demonstrated that multiple loops of EETI-II can be mutated to bind with high affinity to tumor-associated integrin receptors. The resulting knottin peptide contained 21 (>50%) non-native amino acids within two mutated loops, indicating that extended loop lengths and sequence diversity were well tolerated within the EETI-II scaffold. A radiolabeled version of this knottin peptide showed promise for non-invasive imaging of integrin expression in living subjects. However, reduced serum and metabolic stability were observed compared to an engineered integrin-binding EETI-II knottin peptide containing only one mutated loop.	[Kimura, Richard H.; Jiang, Lei; Miao, Zheng; Cheng, Zhen] Stanford Univ, Dept Radiol, MIPS, Canc Ctr,Bio X Program, Stanford, CA 94305 USA; [Jones, Douglas S.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Ctr Canc, Bio X Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Kimura, RH (corresponding author), Stanford Univ, Dept Radiol, MIPS, Canc Ctr,Bio X Program, Stanford, CA 94305 USA.	zcheng@stanford.edu; jennifer.cochran@stanford.edu	miao, zheng/A-8851-2012; Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463; Jones, Douglas/0000-0002-8456-6073	Stanford Molecular Imaging Scholars postdoctoral fellowship [R25 CA118681]; National Cancer Institute (NCI) [5R01 CA119053]; NCI In Vivo Cellular and Molecular Imaging Center (ICMIC) [P50 CA114747]; Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE [R25CA118681, P50CA114747, R01CA119053] Funding Source: NIH RePORTER	Stanford Molecular Imaging Scholars postdoctoral fellowship; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI In Vivo Cellular and Molecular Imaging Center (ICMIC); Edward Mallinckrodt Jr. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported, in part, by a Stanford Molecular Imaging Scholars postdoctoral fellowship R25 CA118681 (to R.H.K), the National Cancer Institute (NCI) 5R01 CA119053 (to Z.C.), NCI In Vivo Cellular and Molecular Imaging Center (ICMIC) P50 CA114747, and a Faculty Scholar Award from the Edward Mallinckrodt Jr. Foundation (J.R.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Beer AJ, 2008, CANCER METAST REV, V27, P631, DOI 10.1007/s10555-008-9158-3; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Bruning A, 2003, GENE THER, V10, P198, DOI 10.1038/sj.gt.3301887; Cai W, 2005, BIOTECHNIQUES, V39, pS6, DOI DOI 10.2144/000112091; Cai WB, 2008, CURR PHARM DESIGN, V14, P2943, DOI 10.2174/138161208786404308; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403; Chen XY, 2004, MOL IMAGING BIOL, V6, P350, DOI 10.1016/j.mibio.2004.06.004; Cheng Z, 2005, BIOCONJUGATE CHEM, V16, P1433, DOI 10.1021/bc0501698; Cheng Z, 2008, J NUCL MED, V49, P804, DOI 10.2967/jnumed.107.047381; Cheng Z, 2010, MOL IMAGING BIOL, V12, P316, DOI 10.1007/s11307-009-0256-6; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Cochran JR, 2000, CHEM BIOL, V7, P683, DOI 10.1016/S1074-5521(00)00019-3; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; FAVEL A, 1989, INT J PEPT PROT RES, V33, P202; HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4; Haubner R, 1997, ANGEW CHEM INT EDIT, V36, P1375; Haubner R, 2006, EUR J NUCL MED MOL I, V33, pS54, DOI 10.1007/s00259-006-0136-0; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hilpert K, 2003, J BIOL CHEM, V278, P24986, DOI 10.1074/jbc.M212152200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jiang L, 2010, J NUCL MED, V51, P251, DOI 10.2967/jnumed.109.069831; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kimura RH, 2010, BIOCONJUGATE CHEM, V21, P436, DOI 10.1021/bc9003102; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kolmar H, 2010, EXPERT REV MOL DIAGN, V10, P361, DOI 10.1586/ERM.10.15; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Krause S, 2007, FEBS J, V274, P86, DOI 10.1111/j.1742-4658.2006.05567.x; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; Lee S, 2010, BIOCHEMISTRY-US, V49, P1364, DOI 10.1021/bi901135x; Li ZB, 2007, J NUCL MED, V48, P1162, DOI 10.2967/jnumed.107.039859; Liu S, 2006, MOL PHARMACEUT, V3, P472, DOI 10.1021/mp060049x; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Miao Z., 2010, AMINO ACIDS; Miao Z, 2009, BIOCONJUGATE CHEM, V20, P2342, DOI 10.1021/bc900361g; Nielsen CH, 2010, CANCER RES, V70, P9022, DOI 10.1158/0008-5472.CAN-10-1338; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Richards J, 2003, J MOL BIOL, V326, P1475, DOI 10.1016/S0022-2836(03)00082-2; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schottelius M, 2009, ACCOUNTS CHEM RES, V42, P969, DOI 10.1021/ar800243b; Shi JY, 2009, BIOCONJUGATE CHEM, V20, P750, DOI 10.1021/bc800455p; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Silverman AP, 2009, J MOL BIOL, V385, P1064, DOI 10.1016/j.jmb.2008.11.004; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tolmachev V, 2009, EUR J NUCL MED MOL I, V36, P692, DOI 10.1007/s00259-008-1003-y; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Wu Y, 2005, J NUCL MED, V46, P1707; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang XZ, 2006, J NUCL MED, V47, P113	62	34	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16112	10.1371/journal.pone.0016112	http://dx.doi.org/10.1371/journal.pone.0016112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364742	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482800005
J	Petravic, J; Davenport, MP				Petravic, Janka; Davenport, Miles P.			Simian-Human Immunodeficiency Infection - Is the Course Set in the Acute Phase?	PLOS ONE			English	Article							T-CELL RESPONSES; CD8-T-CELL MEMORY; VIRAL REPLICATION; VIRUS-INFECTIONS; CD4-T-CELL HELP; RHESUS-MONKEYS; HIV-INFECTION; VACCINATION; DYNAMICS; LOAD	Identifying early predictors of infection outcome is important for the clinical management of HIV infection, and both viral load and CD4+ T cell level have been found to be useful predictors of subsequent disease progression. Very high viral load or extensively depleted CD4+ T cells in the acute phase often result in failure of immune control, and a fast progression to AIDS. It is usually assumed that extensive loss of CD4+ T cells in the acute phase of HIV infection prevents the establishment of robust T cell help required for virus control in the chronic phase. We tested this hypothesis using viral load and CD4+ T cell number of SHIV-infected rhesus macaques. In acute infection, the lowest level of CD4+ T cells was a good predictor of later survival; animals having less than 3.3% of baseline CD4+ T cells progressed to severe disease, while animals with more than 3.3% of baseline CD4+ T cells experienced CD4+ T cell recovery. However, it is unclear if the disease progression was caused by early depletion, or was simply a result of a higher susceptibility of an animal to infection. We derived a simple relationship between the expected number of CD4+ T cells in the acute and chronic phases for a constant level of host susceptibility or resistance. We found that in most cases, the depletion of CD4+ T cells in chronic infection was consistent with the prediction from the acute CD4+ T cell loss. However, the animals with less than 3.3% of baseline CD4 T cells in the acute phase were approximately 20% more depleted late in the infection than expected based on constant level of virus control. This suggests that severe acute CD4 depletion indeed impairs the immune response.	[Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Sydney, NSW, Australia	University of New South Wales Sydney	Petravic, J (corresponding author), Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Sydney, NSW, Australia.	m.davenport@unsw.edu.au	Petravic, Janka/AAD-9192-2020	Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC)	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Davenport MP, 2007, IMMUNOL REV, V216, P164; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Horton H, 2002, J VIROL, V76, P7187, DOI 10.1128/JVI.76.14.7187-7202.2002; Igarashi T, 2003, J VIROL, V77, P10829, DOI 10.1128/JVI.77.20.10829-10840.2003; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Motulski H, 1995, INTUITIVE BIOSTATIST; Nowak MA., 2000, VIRUS DYNAMICS MATH; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Petravic J, 2008, J VIROL, V82, P11589, DOI 10.1128/JVI.01596-08; Regoes RR, 2002, J VIROL, V76, P2573, DOI 10.1128/jvi.76.5.2573-2578.2002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Zhang L, 2004, J VIROL, V78, P5520, DOI 10.1128/JVI.78.10.5520-5522.2004; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17180	10.1371/journal.pone.0017180	http://dx.doi.org/10.1371/journal.pone.0017180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359149	Green Submitted, gold, Green Published			2022-12-27	WOS:000287482300034
J	Liew, SL; Ma, YN; Han, SH; Aziz-Zadeh, L				Liew, Sook-Lei; Ma, Yina; Han, Shihui; Aziz-Zadeh, Lisa			Who's Afraid of the Boss: Cultural Differences in Social Hierarchies Modulate Self-Face Recognition in Chinese and Americans	PLOS ONE			English	Article							RIGHT-HEMISPHERE; INDIVIDUALISM-COLLECTIVISM; NEURAL BASIS; COMMUNICATION; CONSEQUENCES; PSYCHOLOGY; ADVANTAGE; IMPACT; OTHERS; VALUES	Human adults typically respond faster to their own face than to the faces of others. However, in Chinese participants, this self-face advantage is lost in the presence of one's supervisor, and they respond faster to their supervisor's face than to their own. While this "boss effect" suggests a strong modulation of self-processing in the presence of influential social superiors, the current study examined whether this effect was true across cultures. Given the wealth of literature on cultural differences between collectivist, interdependent versus individualistic, independent self-construals, we hypothesized that the boss effect might be weaker in independent than interdependent cultures. Twenty European American college students were asked to identify orientations of their own face or their supervisors' face. We found that European Americans, unlike Chinese participants, did not show a "boss effect" and maintained the self-face advantage even in the presence of their supervisor's face. Interestingly, however, their self-face advantage decreased as their ratings of their boss's perceived social status increased, suggesting that self-processing in Americans is influenced more by one's social status than by one's hierarchical position as a social superior. In addition, when their boss's face was presented with a labmate's face, American participants responded faster to the boss's face, indicating that the boss may represent general social dominance rather than a direct negative threat to oneself, in more independent cultures. Altogether, these results demonstrate a strong cultural modulation of self-processing in social contexts and suggest that the very concept of social positions, such as a boss, may hold markedly different meanings to the self across Western and East Asian cultures.	[Liew, Sook-Lei; Aziz-Zadeh, Lisa] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Liew, Sook-Lei; Aziz-Zadeh, Lisa] Univ So Calif, Div Occupat Sci & Occupat Therapy, Los Angeles, CA USA; [Ma, Yina; Han, Shihui] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	University of Southern California; University of Southern California; Peking University	Liew, SL (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	sliew@usc.edu; shan@pku.edu.cn	URDEA, PETRU/P-4393-2016; Ma, Yina/H-6203-2017; Ma, Yina/AAI-4307-2020; Onaca, Alexandru L/C-2247-2018	Ma, Yina/0000-0002-5457-0354; 	National Basic Research Program of China (973) [2010CB833903]; National Natural Science Foundation of China [30630025, 30828012, 30910103901]; Fundamental Research Funds for the Central Universities of China; National Science Foundation; National Science Foundation East Asia Institute; National Science Foundation Pacific Summer Institute; University of Southern California; Brain and Creativity Institute at the University of Southern California; Division of Occupational Science and Occupational Therapy at the School of Dentistry, USC	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Science Foundation(National Science Foundation (NSF)); National Science Foundation East Asia Institute; National Science Foundation Pacific Summer Institute; University of Southern California; Brain and Creativity Institute at the University of Southern California; Division of Occupational Science and Occupational Therapy at the School of Dentistry, USC	This work is supported by National Basic Research Program of China (973 Program 2010CB833903), National Natural Science Foundation of China (Project 30630025, 30828012, 30910103901), the Fundamental Research Funds for the Central Universities of China, the National Science Foundation Graduate Research Fellowship, the National Science Foundation East Asia and Pacific Summer Institutes, the University of Southern California Provost's PhD Fellowship, the Brain and Creativity Institute at the University of Southern California, and the Division of Occupational Science and Occupational Therapy at the School of Dentistry, USC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLONDER LX, 1991, BRAIN, V114, P1115, DOI 10.1093/brain/114.3.1115; BOCHNER S, 1994, J CROSS CULT PSYCHOL, V25, P273, DOI 10.1177/0022022194252007; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Brockner J, 1996, J PERS SOC PSYCHOL, V71, P603, DOI 10.1037/0022-3514.71.3.603; Chen G, 1994, COMMUNICATION Q, V42, P93, DOI DOI 10.1080/01463379409369919; Chiao JY, 2010, J COGNITIVE NEUROSCI, V22, P1, DOI 10.1162/jocn.2009.21192; Chiao JY, 2009, HUM BRAIN MAPP, V30, P2813, DOI 10.1002/hbm.20707; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Devinsky O, 2000, EPILEPSY BEHAV, V1, P60, DOI 10.1006/ebeh.2000.0025; Fiske A. P., 1998, HDB SOCIAL PSYCHOL, V2, P915; Freeman JB, 2009, NEUROIMAGE, V47, P353, DOI 10.1016/j.neuroimage.2009.04.038; Han SH, 2009, PROG BRAIN RES, V178, P203, DOI 10.1016/S0079-6123(09)17814-7; Hofstede G., 1980, CULTURES CONSEQUENCE; Ikeda K, 2001, POLIT BEHAV, V23, P23, DOI 10.1023/A:1017617630744; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kirkman BL, 2001, J CROSS CULT PSYCHOL, V32, P597, DOI 10.1177/0022022101032005005; Leary MR, 1983, PERSONALITY SOCIAL P, V9, P518; Leong FTL, 2010, J CAREER DEV, V37, P465, DOI 10.1177/0894845310363808; Loh J, 2010, J CROSS CULT PSYCHOL, V41, P236, DOI 10.1177/0022022109354641; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Ma YN, 2009, J EXP SOC PSYCHOL, V45, P1048, DOI 10.1016/j.jesp.2009.05.008; Markus HR, 1998, J CROSS CULT PSYCHOL, V29, P63, DOI 10.1177/0022022198291004; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; MOSKOWITZ DS, 1994, J PERS SOC PSYCHOL, V66, P753, DOI 10.1037/0022-3514.66.4.753; Mychack P, 2001, NEUROLOGY, V56, pS11, DOI 10.1212/WNL.56.suppl_4.S11; Ng SH, 2010, ASIAN J SOC PSYCHOL, V13, P83, DOI 10.1111/j.1467-839X.2010.01303.x; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Oetzel JG, 1998, HUM COMMUN RES, V25, P202, DOI 10.1111/j.1468-2958.1998.tb00443.x; Offermann LR, 1997, J CROSS CULT PSYCHOL, V28, P342, DOI 10.1177/0022022197283008; Power D, 2010, J OPER MANAG, V28, P206, DOI 10.1016/j.jom.2009.11.002; Sanchez-Burks J, 2003, J PERS SOC PSYCHOL, V85, P363, DOI 10.1037/0022-3514.85.2.363; SINGELIS TM, 1995, J CROSS CULT PSYCHOL, V26, P622, DOI 10.1177/002202219502600607; Sui J, 2007, PSYCHOL SCI, V18, P861, DOI 10.1111/j.1467-9280.2007.01992.x; Sui J, 2009, SOC NEUROSCI, V4, P402, DOI 10.1080/17470910802674825; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; WEISZ JR, 1984, AM PSYCHOL, V39, P955, DOI 10.1037/0003-066X.39.9.955; YUM JO, 1988, COMMUN MONOGR, V55, P374, DOI 10.1080/03637758809376178; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	45	28	32	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16901	10.1371/journal.pone.0016901	http://dx.doi.org/10.1371/journal.pone.0016901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721YC	21359209	Green Published, gold			2022-12-27	WOS:000287392700028
J	Psychogios, N; Hau, DD; Peng, J; Guo, AC; Mandal, R; Bouatra, S; Sinelnikov, I; Krishnamurthy, R; Eisner, R; Gautam, B; Young, N; Xia, JG; Knox, C; Dong, E; Huang, P; Hollander, Z; Pedersen, TL; Smith, SR; Bamforth, F; Greiner, R; McManus, B; Newman, JW; Goodfriend, T; Wishart, DS				Psychogios, Nikolaos; Hau, David D.; Peng, Jun; Guo, An Chi; Mandal, Rupasri; Bouatra, Souhaila; Sinelnikov, Igor; Krishnamurthy, Ramanarayan; Eisner, Roman; Gautam, Bijaya; Young, Nelson; Xia, Jianguo; Knox, Craig; Dong, Edison; Huang, Paul; Hollander, Zsuzsanna; Pedersen, Theresa L.; Smith, Steven R.; Bamforth, Fiona; Greiner, Russ; McManus, Bruce; Newman, John W.; Goodfriend, Theodore; Wishart, David S.			The Human Serum Metabolome	PLOS ONE			English	Article							MASS-SPECTROMETRY; HUMAN-PLASMA; AMINO-ACIDS; QUANTITATIVE METABOLOMICS; MONOAMINE METABOLITES; GAS-CHROMATOGRAPHY; FATTY-ACIDS; ESI-MS; IDENTIFICATION; LIPIDOMICS	Continuing improvements in analytical technology along with an increased interest in performing comprehensive, quantitative metabolic profiling, is leading to increased interest pressures within the metabolomics community to develop centralized metabolite reference resources for certain clinically important biofluids, such as cerebrospinal fluid, urine and blood. As part of an ongoing effort to systematically characterize the human metabolome through the Human Metabolome Project, we have undertaken the task of characterizing the human serum metabolome. In doing so, we have combined targeted and non-targeted NMR, GC-MS and LC-MS methods with computer-aided literature mining to identify and quantify a comprehensive, if not absolutely complete, set of metabolites commonly detected and quantified (with today's technology) in the human serum metabolome. Our use of multiple metabolomics platforms and technologies allowed us to substantially enhance the level of metabolome coverage while critically assessing the relative strengths and weaknesses of these platforms or technologies. Tables containing the complete set of 4229 confirmed and highly probable human serum compounds, their concentrations, related literature references and links to their known disease associations are freely available at http://www.serummetabolome.ca.	[Psychogios, Nikolaos; Hau, David D.; Guo, An Chi; Mandal, Rupasri; Bouatra, Souhaila; Sinelnikov, Igor; Krishnamurthy, Ramanarayan; Eisner, Roman; Gautam, Bijaya; Young, Nelson; Knox, Craig; Dong, Edison; Huang, Paul; Greiner, Russ; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Peng, Jun] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Bamforth, Fiona] Univ Alberta, Dept Clin Lab Med, Edmonton, AB, Canada; [Xia, Jianguo; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Hollander, Zsuzsanna; McManus, Bruce] James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Vancouver, BC, Canada; [Hollander, Zsuzsanna; McManus, Bruce] NCE CECR Ctr Excellence Prevent Organ Failure, PROOF Ctr, Vancouver, BC, Canada; [Pedersen, Theresa L.; Newman, John W.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Smith, Steven R.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Goodfriend, Theodore] Vet Adm Hosp, Madison, WI USA; [Goodfriend, Theodore] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; National Research Council Canada; United States Department of Agriculture (USDA); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Wisconsin System; University of Wisconsin Madison	Psychogios, N (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Xia, Jianguo/Z-1935-2019; Smith, Steven/HDM-9496-2022; Knox, Craig/AAG-1019-2022; Psychogios, Nikolaos/B-6867-2011; Wishart, David Scott/ABI-3181-2020; Knox, Craig/AFK-2712-2022; Peng, Jun/L-3755-2013; Greiner, Russell/AAQ-4502-2020	Xia, Jianguo/0000-0003-2040-2624; Greiner, Russell/0000-0001-8327-934X; Hollander, Zsuzsanna/0000-0003-4889-996X; Wishart, David S/0000-0002-3207-2434; Smith, Steven/0000-0002-5098-8147; Newman, John/0000-0001-9632-6571; Psychogios, Nikolaos/0000-0002-2747-6012	Canadian Institutes for Health Research (CIHR); Alberta Advanced Education and Technology (AAET); Genome Alberta; Genome BC; Alberta Ingenuity Fund (AIF); University of Alberta; United States Department of Agriculture Agricultural Research Service [5306-51530-019-00D]; National Institutes of Health [HL076238]; Medical Research Service, Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076238] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Advanced Education and Technology (AAET); Genome Alberta; Genome BC; Alberta Ingenuity Fund (AIF); University of Alberta(University of Alberta); United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service, Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Canadian Institutes for Health Research (CIHR), Alberta Advanced Education and Technology (AAET), Genome Alberta, Genome BC, the Alberta Ingenuity Fund (AIF) and the University of Alberta. Additional support for JWN and TLP was derived from United States Department of Agriculture Agricultural Research Service Project# 5306-51530-019-00D. SS and TG are supported by National Institutes of Health grant HL076238, and the Medical Research Service, Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Ackermann Bradley L., 2002, Current Topics in Medicinal Chemistry, V2, P53, DOI 10.2174/1568026023394605; Akoto L, 2008, J CHROMATOGR A, V1186, P365, DOI 10.1016/j.chroma.2007.08.080; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BEHESHTI I, 1994, CLIN CHEM, V40, P2088; Bezuglov VV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P22; Bicalho B, 2008, J CHROMATOGR A, V1211, P120, DOI 10.1016/j.chroma.2008.09.066; BJERKENSTEDT L, 1985, BRIT J PSYCHIAT, V147, P276, DOI 10.1192/bjp.147.3.276; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Bradshaw HB, 2009, PROSTAG OTH LIPID M, V89, P131, DOI 10.1016/j.prostaglandins.2009.04.006; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Burtis CA., 1999, TIETZ TEXBOOK CLIN C; Burtis CA, 2008, TIETZ FUNDAMENTALS C, p[xx, 952]; Caraceni P, 2009, CIRCULATING HEPATIC; Carlson EE, 2007, J AM CHEM SOC, V129, P15780, DOI 10.1021/ja0779506; Carr TP, 2008, NUTR RES, V28, P641, DOI 10.1016/j.nutres.2008.08.003; Chen P, 2005, MICROVASC RES, V69, P28, DOI 10.1016/j.mvr.2005.02.001; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; CORSO G, 1993, BIOL MASS SPECTROM, V22, P698, DOI 10.1002/bms.1200221205; Cottingham Katie, 2008, J Proteome Res, V7, P4213, DOI [10.1021/pr800626d, 10.1021/pr8006073]; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Daykin CA, 2002, ANAL BIOCHEM, V304, P220, DOI 10.1006/abio.2002.5637; de Graaf RA, 2003, ANAL CHEM, V75, P2100, DOI 10.1021/ac020782+; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; DeLong CJ, 2001, J LIPID RES, V42, P1959; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; FISCHER S, 1986, CHROMATOGRAPHIA, V22, P416, DOI 10.1007/BF02268802; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox S.I., 1999, HUMAN PHYSL, P364; FOXALL PJD, 1993, J PHARMACEUT BIOMED, V11, P267, DOI 10.1016/0731-7085(93)80017-U; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Grant G H, 1970, Adv Clin Chem, V13, P383, DOI 10.1016/S0065-2423(08)60390-X; Grasbeck R, 1981, REFERENCE VALUES LAB, p[xiv, 413]; Guo K, 2007, ANAL CHEM, V79, P8631, DOI 10.1021/ac0704356; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Hagan SO, 2007, ANAL CHEM, V79, P464, DOI 10.1021/ac061443+; HAGENFELDT L, 1984, J NEUROCHEM, V42, P833, DOI 10.1111/j.1471-4159.1984.tb02756.x; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P587, DOI 10.1016/S1044-0305(99)00035-5; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Ivanova PT, 2009, CURR OPIN CHEM BIOL, V13, P526, DOI 10.1016/j.cbpa.2009.08.011; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kekwick RA, 1939, BIOCHEM J, V33, P1122, DOI 10.1042/bj0331122; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; Koivusalo M, 2001, J LIPID RES, V42, P663; Kuriki K, 2003, J NUTR, V133, P3643, DOI 10.1093/jn/133.11.3643; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lentner C, 1981, PHYS CHEM COMPOSITIO, P165; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Martin H, 1981, REFERENCE VALUES LAB; Martini F, 2006, FUNDAMENTALS ANATOMY, P640; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Mueller GP, 2007, J BIOL CHEM, V282, P22364, DOI 10.1074/jbc.M701801200; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; PACEASCIAK CR, 1989, J LIPID RES, V30, P451; Perwaiz S, 2001, J LIPID RES, V42, P114; Pillarisetti S, 2009, DRUG DISCOV TODAY, V14, P1098, DOI 10.1016/j.drudis.2009.08.002; Pratico Domenico, 2009, Expert Rev Cardiovasc Ther, V7, P1079, DOI 10.1586/erc.09.91; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rossi F, 2009, BONE, V44, P476, DOI 10.1016/j.bone.2008.10.056; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; Shurubor YI, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-9; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smith ML, 2008, BIOCH LIPIDS LIPOPRO, p[xii, 631]; Solberg H., 1989, ADV CLIN CHEM, V27, P1, DOI 10.1016/s0065-2423(08)60181-x; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sugiura T, 2009, BIOFACTORS, V35, P88, DOI 10.1002/biof.18; Tan B, 2006, AAPS J, V8, pE461, DOI 10.1208/aapsj080354; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; VIINIKKA L, 1980, PROSTAGLANDINS, V20, P759, DOI 10.1016/0090-6980(80)90114-8; Walker JM, 2005, PROSTAG OTH LIPID M, V77, P35, DOI 10.1016/j.prostaglandins.2004.09.017; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Watkins S, 2004, Generating, viewing, interpreting and utilizing a quantitative database of metabolites, Patent No. [US20040143461, 20040143641]; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; West J.B., 1985, BEST TAILORS PHYSL B, P334; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Whitehead SN, 2007, ANAL CHEM, V79, P8539, DOI 10.1021/ac0712291; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; WOO KL, 1995, J CHROMATOGR B, V665, P15, DOI 10.1016/0378-4347(94)00515-7; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Ye X, 2008, TALANTA, V76, P865, DOI 10.1016/j.talanta.2008.04.034; Zelena E, 2009, ANAL CHEM, V81, P1357, DOI 10.1021/ac8019366; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052; ZLATKIS A, 1974, J CHROMATOGR, V91, P379, DOI 10.1016/S0021-9673(01)97916-6	104	1085	1118	15	408	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16957	10.1371/journal.pone.0016957	http://dx.doi.org/10.1371/journal.pone.0016957			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359215	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700033
J	Rao, MV; Mohan, PS; Kumar, A; Yuan, AD; Montagna, L; Campbell, J; Veeranna; Espreafico, EM; Julien, JP; Nixon, RA				Rao, Mala V.; Mohan, Panaiyur S.; Kumar, Asok; Yuan, Aidong; Montagna, Lee; Campbell, Jabbar; Veeranna; Espreafico, Enilza M.; Julien, Jean P.; Nixon, Ralph A.			The Myosin Va Head Domain Binds to the Neurofilament-L Rod and Modulates Endoplasmic Reticulum (ER) Content and Distribution within Axons	PLOS ONE			English	Article							IN-VIVO; INTERMEDIATE-FILAMENTS; TRANSPORT; ACTIN; CALMODULIN; MOTOR; LOCALIZATION; CYTOSKELETON; MELANOSOMES; PROTEINS	The neurofilament light subunit (NF-L) binds to myosin Va (Myo Va) in neurons but the sites of interaction and functional significance are not clear. We show by deletion analysis that motor domain of Myo Va binds to the NF-L rod domain that forms the NF backbone. Loss of NF-L and Myo Va binding from axons significantly reduces the axonal content of ER, and redistributes ER to the periphery of axon. Our data are consistent with a novel function for NFs as a scaffold in axons for maintaining the content and proper distribution of vesicular organelles, mediated in part by Myo Va. Based on observations that the Myo Va motor domain binds to intermediate filament (IF) proteins of several classes, Myo Va interactions with IFs may serve similar roles in organizing organelle topography in different cell types.	[Rao, Mala V.; Mohan, Panaiyur S.; Kumar, Asok; Yuan, Aidong; Montagna, Lee; Campbell, Jabbar; Veeranna; Nixon, Ralph A.] NYU, Nathan Kline Inst, Sch Med, Orangeburg, NY 10962 USA; [Rao, Mala V.; Mohan, Panaiyur S.; Yuan, Aidong; Veeranna; Nixon, Ralph A.] NYU, Dept Psychiat, Sch Med, Orangeburg, NY USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, Sch Med, Orangeburg, NY USA; [Espreafico, Enilza M.] Dept Cellular & Mol Biol, Sao Paulo, Brazil; [Espreafico, Enilza M.] Dept Pathogenic Bioagents, Sao Paulo, Brazil; [Julien, Jean P.] Univ Laval, Mol Endocrinol Lab, Dept Anat & Physiol, CHU Laval,Ctr Rech, Quebec City, PQ, Canada	Nathan Kline Institute for Psychiatric Research; New York University; New York University; New York University; Laval University	Rao, MV (corresponding author), NYU, Nathan Kline Inst, Sch Med, Orangeburg, NY 10962 USA.	nixon@nki.rfmh.org	Espreafico, Enilza/O-3053-2016; Espreafico, Enilza/AAW-4658-2021	Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234; Rao, Mala/0000-0001-7985-2414	NIH/NIA [A605604]; NATIONAL INSTITUTE ON AGING [R01AG005604] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is funded by the grant from NIH/NIA A605604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; DZANDU JK, 1988, ANAL BIOCHEM, V174, P157, DOI 10.1016/0003-2697(88)90531-3; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans LL, 1998, J CELL SCI, V111, P2055; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; Jung CH, 2004, J NEUROSCI, V24, P9486, DOI 10.1523/JNEUROSCI.1665-04.2004; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; LEWIS SA, 1986, MOL CELL BIOL, V6, P1529, DOI 10.1128/MCB.6.5.1529; Libby RT, 2004, J CELL SCI, V117, P4509, DOI 10.1242/jcs.01316; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; Oliver TN, 1999, CELL MOL LIFE SCI, V56, P243, DOI 10.1007/s000180050426; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Perkins GA, 2008, J STRUCT BIOL, V161, P469, DOI 10.1016/j.jsb.2007.10.005; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rao MV, 2002, J CELL BIOL, V159, P279, DOI 10.1083/JCB.200205062; Rodriguez OC, 2002, J CELL SCI, V115, P991; Schmidt Stephen D., 2004, V299, P267; Slepchenko BM, 2007, J CELL BIOL, V179, P635, DOI 10.1083/jcb.200705146; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; TIMAR J, 1993, CELL MOTIL CYTOSKEL, V26, P49, DOI 10.1002/cm.970260106; TOKUTAKE S, 1983, ANAL BIOCHEM, V135, P102, DOI 10.1016/0003-2697(83)90736-4; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Wu XF, 1997, J CELL SCI, V110, P847; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Yuan AD, 2003, J NEUROSCI, V23, P9452; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	52	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17087	10.1371/journal.pone.0017087	http://dx.doi.org/10.1371/journal.pone.0017087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359212	gold, Green Published			2022-12-27	WOS:000287392700047
J	Gess, B; Sevimli, S; Strecker, JK; Young, P; Schabitz, WR				Gess, Burkhard; Sevimli, Sevgi; Strecker, Jan-Kolja; Young, Peter; Schaebitz, Wolf-Ruediger			Sodium-Dependent Vitamin C Transporter 2 (SVCT2) Expression and Activity in Brain Capillary Endothelial Cells after Transient Ischemia in Mice	PLOS ONE			English	Article							ASCORBIC-ACID TRANSPORT; CEREBRAL-ARTERY OCCLUSION; DEHYDROASCORBIC ACID; OXIDATIVE STRESS; RAT-BRAIN; GLUCOSE TRANSPORTERS; INFLAMMATORY CELLS; HUMAN-NEUTROPHILS; OXIDIZED FORM; STROKE	Expression and transport activity of Sodium-dependent Vitamin C Transporter 2 (SVCT2) was shown in various tissues and organs. Vitamin C was shown to be cerebroprotective in several animal models of stroke. Data on expression, localization and transport activity of SVCT2 after cerebral ischemia, however, has been scarce so far. Thus, we studied the expression of SVCT2 after middle cerebral artery occlusion (MCAO) in mice by immunohistochemistry. We found an upregulation of SVCT2 after stroke. Co-stainings with Occludin, Von-Willebrand Factor and CD34 demonstrated localization of SVCT2 in brain capillary endothelial cells in the ischemic area after stroke. Time-course analyses of SVCT2 expression by immunohistochemistry and western blots showed upregulation in the subacute phase of 2-5 days. Radioactive uptake assays using 14 C-labelled ascorbic acid showed a significant increase of ascorbic acid uptake into the brain after stroke. Taken together, these results provide evidence for the expression and transport activity of SVCT2 in brain capillary endothelial cells after transient ischemia in mice. These results may lead to the development of novel neuroprotective strategies in stroke therapy.	[Gess, Burkhard; Sevimli, Sevgi; Strecker, Jan-Kolja; Young, Peter; Schaebitz, Wolf-Ruediger] Univ Clin Muenster, Dept Neurol, Munster, Germany; [Schaebitz, Wolf-Ruediger] Evangel Klinikum Bethel, Bielefeld, Germany	University of Munster; Evangelical Hospital Bethel (EvKB) - House Gilead I	Gess, B (corresponding author), Univ Clin Muenster, Dept Neurol, Munster, Germany.	gess@uni-muenster.de			Innovative Medizinische Forschung (IMF), Munster (IMF) [I-GE 111002]; Deutsche Forschungsgemeinschaft (DFG) [GE 2249/1-1]	Innovative Medizinische Forschung (IMF), Munster (IMF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was funded by Innovative Medizinische Forschung (IMF), Munster (IMF grant nr.: I-GE 111002; http://campus.uni-muenster.de/imf_start.html) and Deutsche Forschungsgemeinschaft (DFG, grant nr.: GE 2249/1-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Angelow S, 2003, BRAIN RES, V988, P105, DOI 10.1016/S0006-8993(03)03350-X; Avshalumov MV, 2004, NEURON GLIA BIOL, V1, P365, DOI 10.1017/S1740925X05000311; Berger UV, 2003, J NEUROCHEM, V86, P896, DOI 10.1046/j.1471-4159.2003.01891.x; BIGLEY R, 1983, DIABETES, V32, P545, DOI 10.2337/diabetes.32.6.545; Caprile T, 2009, J NEUROCHEM, V108, P563, DOI 10.1111/j.1471-4159.2008.05788.x; Castro M, 2001, J NEUROCHEM, V78, P815, DOI 10.1046/j.1471-4159.2001.00461.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Gess B, 2010, GLIA, V58, P287, DOI 10.1002/glia.20923; Gieseg SP, 2009, FRONT BIOSCI-LANDMRK, V14, P1230, DOI 10.2741/3305; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Henry PT, 1998, ACTA NEUROCHIR, V140, P977, DOI 10.1007/s007010050201; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hosoya K, 2004, INVEST OPHTH VIS SCI, V45, P1232, DOI 10.1167/iovs.03-0505; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Ishida H, 2006, AM J HYPERTENS, V19, P33, DOI 10.1016/j.amjhyper.2005.06.023; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kuroda S, 1997, CLIN NEUROSCI, V4, P199; Mack WJ, 2006, NEUROSURGERY, V59, P383, DOI 10.1227/01.NEU.0000223496.96945.A7; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Miller AA, 2010, CLIN SCI, V119, P1, DOI 10.1042/CS20090649; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; Qiao H, 2008, BRAIN RES, V1208, P79, DOI 10.1016/j.brainres.2008.02.102; Qiao H, 2009, BIOFACTORS, V35, P306, DOI 10.1002/biof.43; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015; Rogalewski A, 2008, NERVENARZT, V79, P218, DOI 10.1007/s00115-007-2386-x; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Rutkowski M, 2004, Z NATURFORSCH C, V59, P762; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Schorah CJ, 1996, AM J CLIN NUTR, V63, P760, DOI 10.1093/ajcn/63.5.760; Sevimli S, 2009, EXP NEUROL, V217, P328, DOI 10.1016/j.expneurol.2009.03.018; Smith AR, 2002, FASEB J, V16, P1102, DOI 10.1096/fj.01-0825fje; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Spector R, 2009, J NEUROCHEM, V111, P315, DOI 10.1111/j.1471-4159.2009.06326.x; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; Takanaga H, 2004, PFLUG ARCH EUR J PHY, V447, P677, DOI 10.1007/s00424-003-1104-1; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; van Gijn J, 1998, LANCET, V352, pSIII23; WAGNER GC, 1986, NEUROPHARMACOLOGY, V25, P559, DOI 10.1016/0028-3908(86)90184-X; WASHKO P, 1989, J BIOL CHEM, V264, P18996; WELCH RW, 1995, J BIOL CHEM, V270, P12584, DOI 10.1074/jbc.270.21.12584; Wong CHY, 2008, CURR MED CHEM, V15, P1; Zhang WW, 2009, CHINESE MED J-PEKING, V122, P1996, DOI 10.3760/cma.j.issn.0366-6999.2009.17.007; Ziylan YZ, 2006, INT J NEUROSCI, V116, P25, DOI 10.1080/00207450690962262	50	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17139	10.1371/journal.pone.0017139	http://dx.doi.org/10.1371/journal.pone.0017139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347255	gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500033
J	Liuzza, MT; Candidi, M; Aglioti, SM				Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria			Do Not Resonate with Actions: Sentence Polarity Modulates Cortico-Spinal Excitability during Action-Related Sentence Reading	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; PARKINSONS-DISEASE; NEURON DISEASE; ACTION WORDS; TIME-COURSE; LANGUAGE; VERB; FACILITATION; BRAIN	Background: Theories of embodied language suggest that the motor system is differentially called into action when processing motor-related versus abstract content words or sentences. It has been recently shown that processing negative polarity action-related sentences modulates neural activity of premotor and motor cortices. Methods and Findings: We sought to determine whether reading negative polarity sentences brought about differential modulation of cortico-spinal motor excitability depending on processing hand-action related or abstract sentences. Facilitatory paired-pulses Transcranial Magnetic Stimulation (pp-TMS) was applied to the primary motor representation of the right-hand and the recorded amplitude of induced motor-evoked potentials (MEP) was used to index M1 activity during passive reading of either hand-action related or abstract content sentences presented in both negative and affirmative polarity. Results showed that the cortico-spinal excitability was affected by sentence polarity only in the hand-action related condition. Indeed, in keeping with previous TMS studies, reading positive polarity, hand action-related sentences suppressed cortico-spinal reactivity. This effect was absent when reading hand action-related negative polarity sentences. Moreover, no modulation of cortico-spinal reactivity was associated with either negative or positive polarity abstract sentences. Conclusions: Our results indicate that grammatical cues prompting motor negation reduce the cortico-spinal suppression associated with affirmative action sentences reading and thus suggest that motor simulative processes underlying the embodiment may involve even syntactic features of language.	[Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Liuzza, Marco Tullio; Candidi, Matteo; Aglioti, Salvatore Maria] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Liuzza, MT (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	matteo.candidi@uniroma1.it	Liuzza, Marco Tullio/A-9967-2012; Aglioti, Salvatore M/E-9829-2012; Candidi, Matteo/K-9245-2016	Liuzza, Marco Tullio/0000-0001-6708-1253; CANDIDI, MATTEO/0000-0001-8201-7954; Aglioti, Salvatore Maria/0000-0001-8175-7563	Istituto Italiano di Tecnologia (IIT) SEED [21538]; European FP7 grant Tango; European Commission [249858]	Istituto Italiano di Tecnologia (IIT) SEED; European FP7 grant Tango; European Commission(European CommissionEuropean Commission Joint Research Centre)	S.M.A. was funded by the Istituto Italiano di Tecnologia (IIT) SEED (Prot. Num. 21538) and the European FP7 grant Tango. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 249858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Barsalou LW, 1999, BEHAV BRAIN SCI, V22; Bergen B, 2010, BRAIN LANG, V112, P150, DOI 10.1016/j.bandl.2009.07.002; Borghi AM, 2004, MEM COGNITION, V32, P863, DOI 10.3758/BF03196865; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; BRIGGS G G, 1975, Cortex, V11, P230; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Bufalari I, 2010, BIOL PSYCHOL, V85, P283, DOI 10.1016/j.biopsycho.2010.07.015; Candidi M, 2010, CEREB CORTEX, V20, P2832, DOI 10.1093/cercor/bhq033; Candidi M, 2010, EUR J NEUROSCI, V32, P677, DOI 10.1111/j.1460-9568.2010.07305.x; Carpenter PA, 1999, NEUROIMAGE, V10, P216, DOI 10.1006/nimg.1999.0465; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; Davis C, 2010, NEUROCASE, V16, P259, DOI 10.1080/13554790903456183; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fodor J, 1983, MODULARITY MIND; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Kaup B., 2005, P ANN M COGN SCI SOC, V27, P1114; Kaup B, 2007, Q J EXP PSYCHOL, V60, P976, DOI 10.1080/17470210600823512; Kaup B, 2006, J PRAGMATICS, V38, P1033, DOI 10.1016/j.pragma.2005.09.012; KERTESZ A, 1984, NEUROLOGY, V34, P40, DOI 10.1212/WNL.34.1.40; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lakoff George., 1999, PHILOS FLESH EMBODIE; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; PAPAGNO C, 1993, J NEUROL NEUROSUR PS, V56, P286, DOI 10.1136/jnnp.56.3.286; Papeo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004508; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Pecher D., 2005, GROUNDING COGNITION; Peran P, 2009, CORTEX, V45, P960, DOI 10.1016/j.cortex.2009.02.019; Pulvermuller F, 1999, CEREB CORTEX, V9, P497, DOI 10.1093/cercor/9.5.497; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P307, DOI 10.1017/S0140525X99511825; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodriguez-Ferreiro J, 2009, NEUROPSYCHOLOGIA, V47, P3271, DOI 10.1016/j.neuropsychologia.2009.07.007; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Silveri MC, 2007, NEUROPSYCHOLOGIA, V45, P2570, DOI 10.1016/j.neuropsychologia.2007.03.014; Taylor LJ, 2008, Q J EXP PSYCHOL, V61, P896, DOI 10.1080/17470210701625519; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tettamanti M, 2008, NEUROIMAGE, V43, P358, DOI 10.1016/j.neuroimage.2008.08.004; Tomasino B, 2010, NEUROSCIENCE, V169, P246, DOI 10.1016/j.neuroscience.2010.04.039; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 2010, BRAIN LANG, V112, P143, DOI 10.1016/j.bandl.2008.11.004	65	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16855	10.1371/journal.pone.0016855	http://dx.doi.org/10.1371/journal.pone.0016855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721OO	21347305	Green Published, Green Submitted, gold			2022-12-27	WOS:000287364500009
J	Deng, MY; Lam, S; Meyer, U; Feldon, J; Li, Q; Wei, R; Luk, L; Chua, SE; Sham, P; Wang, Y; McAlonan, GM				Deng, Michelle Y.; Lam, Sylvia; Meyer, Urs; Feldon, Joram; Li, Qi; Wei, Ran; Luk, Lawrence; Chua, Siew Eng; Sham, Pak; Wang, Yu; McAlonan, Grainne Mary			Frontal-Subcortical Protein Expression following Prenatal Exposure to Maternal Inflammation	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; AUTISM SPECTRUM DISORDERS; PREFRONTAL CORTEX; WHITE-MATTER; INFLUENZA EPIDEMICS; SIGNALING PATHWAYS; MOLECULAR EVIDENCE; SCHIZOPHRENIA; BRAIN; INFECTION	Background: Maternal immune activation (MIA) during prenatal life is a risk factor for neurodevelopmental disorders including schizophrenia and autism. Such conditions are associated with alterations in fronto-subcortical circuits, but their molecular basis is far from clear. Methodology/Principal Findings: Using two-dimensional differential in-gel electrophoresis (2D-DIGE) and mass spectrometry, with targeted western blot analyses for confirmation, we investigated the impact of MIA on the prefrontal and striatal proteome from an established MIA mouse model generated in C57B6 mice, by administering the viral analogue PolyI:C or saline vehicle (control) intravenously on gestation day (GD) 9. In striatum, 11 proteins were up-regulated and 4 proteins were down-regulated in the PolyI: C mice, while 10 proteins were up-regulated and 7 proteins down-regulated in prefrontal cortex (PFC). These were proteins involved in the mitogen-activated protein kinase (MAPK) signaling pathway, oxidation and auto-immune targets, including dual specificity mitogen-activated protein kinase kinase 1 (MEK), eukaryotic initiation factor (eIF) 4A-II, creatine kinase (CK)-B, L-lactate dehydrogenase (LDH)-B, WD repeat-containing protein and NADH dehydrogenase in the striatum; and guanine nucleotide-binding protein (G-protein), 14-3-3 protein, alpha-enolase, olfactory maker protein and heat shock proteins (HSP) 60, and 90-beta in the PFC. Conclusions/Significance: This data fits with emerging evidence for disruption of critical converging intracellular pathways involving MAPK pathways in neurodevelopmental conditions and it shows considerable overlap with protein pathways identified by genetic modeling and clinical post-mortem studies. This has implications for understanding causality and may offer potential biomarkers and novel treatment targets for neurodevelopmental conditions.	[Deng, Michelle Y.; Lam, Sylvia; Li, Qi; Wei, Ran; Chua, Siew Eng; Sham, Pak; McAlonan, Grainne Mary] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Meyer, Urs; Feldon, Joram] Swiss Fed Inst Technol Zurich ETH, Neurobiol & Behav Lab, Schwerzenbach, Switzerland; [Luk, Lawrence] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Chua, Siew Eng; Sham, Pak; McAlonan, Grainne Mary] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu] Univ Hong Kong, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Deng, MY (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	wei, wei/HHR-8613-2022; Meyer, Urs/C-4602-2016; Wei, ran/GXF-3452-2022; McAlonan, Grainne/G-1541-2011	Meyer, Urs/0000-0001-7244-0345; wang, yu/0000-0001-8697-2940; McAlonan, Grainne/0000-0002-4466-2343	Swiss Federal Institute of Technology (ETH) Zurich [1107/03]; Swiss National Science Foundation [3100AO-100309, 3100A0-116719]; NARSAD Distinguished Investigator Award; University of Hong Kong; Hong Kong Research Grants Council	Swiss Federal Institute of Technology (ETH) Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NARSAD Distinguished Investigator Award(NARSAD); University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	JF and UM received financial support from the Swiss Federal Institute of Technology (ETH) Zurich (grant-1107/03) and the Swiss National Science Foundation (grant 3100AO-100309 and grant 3100A0-116719). JF holds a 2009 NARSAD Distinguished Investigator Award. GMA was funded by a University of Hong Kong Award and holds a General Research Fund from the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; BEHAN A, 2008, MOL PSYCHIAT; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Berry-Kravis E, 2004, MENT RETARD DEV D R, V10, P42, DOI 10.1002/mrdd.20007; Bronchud MH, 2008, PRINCIPLES MOL ONCOL; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Clark D, 2006, MOL PSYCHIATR, V11, P459, DOI 10.1038/sj.mp.4001806; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Fountoulakis M, 2005, J CHROMATOGR B, V819, P115, DOI 10.1016/j.jchromb.2005.01.037; Fumagalli F, 2006, MOL PHARMACOL, V69, P1366, DOI 10.1124/mol.105.019828; Hans A, 2004, FASEB J, V18, P863, DOI 10.1096/fj.03-0764fje; Hazlett EA, 2008, NEUROIMAGE, V42, P1164, DOI 10.1016/j.neuroimage.2008.05.039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iwazaki T, 2007, PROTEOMICS, V7, P1131, DOI 10.1002/pmic.200600595; Iwazaki T, 2006, BRAIN RES, V1097, P19, DOI 10.1016/j.brainres.2006.04.052; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; Kim JJ, 2001, SCHIZOPHR RES, V52, P127, DOI 10.1016/S0920-9964(00)00091-8; Kumari V, 2003, PSYCHIAT RES-NEUROIM, V122, P99, DOI 10.1016/s0925-4927(02)00123-3; Kyosseva SV, 1999, BIOL PSYCHIAT, V46, P689, DOI 10.1016/S0006-3223(99)00104-3; LEUNG M, 2009, SCHIZOPHR B; Li Q, 2010, NEUROIMAGE, V52, P1, DOI 10.1016/j.neuroimage.2010.04.015; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Martins-De-Souza D, 2009, EUR ARCH PSY CLIN N, V259, P151, DOI 10.1007/s00406-008-0847-2; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MEYER U, 2009, NEUROSCI BIOBEHAV RE; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Meyer U, 2010, PROG NEUROBIOL, V90, P285, DOI 10.1016/j.pneurobio.2009.10.018; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Muller N, 2006, NEUROTOX RES, V10, P131; Nesvaderani M, 2009, AUST NZ J PSYCHIAT, V43, P310, DOI 10.1080/00048670902721103; NEVESPEREIRA M, 2009, J MED GENET; Novikova SI, 2006, NEUROBIOL DIS, V23, P61, DOI 10.1016/j.nbd.2006.02.002; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Paulson L, 2004, PROTEOMICS, V4, P819, DOI 10.1002/pmic.200300622; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prabakaran S, 2007, J PROTEOME RES, V6, P141, DOI 10.1021/pr060308a; Roncada P, 2009, J NEUROCHEM, V108, P611, DOI 10.1111/j.1471-4159.2008.05806.x; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith Stephen E. P., 2009, P111, DOI 10.1007/978-0-387-84851-8_7; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Suginta W, 2001, BIOCHEM J, V359, P55, DOI 10.1042/0264-6021:3590055; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; To MD, 2005, CELL CYCLE, V4, P1185, DOI 10.4161/cc.4.9.2039; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Vercauteren FGG, 2007, PROTEOMICS, V7, P3569, DOI 10.1002/pmic.200700379; Wang XF, 2003, BIOL PSYCHIAT, V53, P361, DOI 10.1016/S0006-3223(02)01972-8; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I	74	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16638	10.1371/journal.pone.0016638	http://dx.doi.org/10.1371/journal.pone.0016638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347362	Green Submitted, Green Published, gold			2022-12-27	WOS:000287363000011
J	Drini, M; Wong, NC; Scott, HS; Craig, JM; Dobrovic, A; Hewitt, CA; Dow, C; Young, JP; Jenkins, MA; Saffery, R; Macrae, FA				Drini, Musa; Wong, Nicholas C.; Scott, Hamish S.; Craig, Jeffrey M.; Dobrovic, Alexander; Hewitt, Chelsee A.; Dow, Christofer; Young, Joanne P.; Jenkins, Mark A.; Saffery, Richard; Macrae, Finlay A.			Investigating the Potential Role of Genetic and Epigenetic Variation of DNA Methyltransferase Genes in Hyperplastic Polyposis Syndrome	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENOME-WIDE ASSOCIATION; DE-NOVO METHYLATION; COLORECTAL-CANCER; SERRATED POLYPS; INITIAL-CHARACTERIZATION; KRAS MUTATIONS; BRAF MUTATION; BREAST-CANCER; DNMT3B	Background: Hyperplastic Polyposis Syndrome (HPS) is a condition associated with multiple serrated polyps, and an increased risk of colorectal cancer (CRC). At least half of CRCs arising in HPS show a CpG island methylator phenotype (CIMP), potentially linked to aberrant DNA methyltransferase (DNMT) activity. CIMP is associated with methylation of tumor suppressor genes including regulators of DNA mismatch repair (such as MLH1, MGMT), and negative regulators of Wnt signaling (such as WIF1). In this study, we investigated the potential for interaction of genetic and epigenetic variation in DNMT genes, in the aetiology of HPS. Methods: We utilized high resolution melting (HRM) analysis to screen 45 cases with HPS for novel sequence variants in DNMT1, DNMT3A, DNMT3B, and DNMT3L. 21 polyps from 13 patients were screened for BRAF and KRAS mutations, with assessment of promoter methylation in the DNMT1, DNMT3A, DNMT3B, DNMT3L MLH1, MGMT, and WIF1 gene promoters. Results: No pathologic germline mutations were observed in any DNA-methyltransferase gene. However, the T allele of rs62106244 (intron 10 of DNMT1 gene) was over-represented in cases with HPS (p<0.01) compared with population controls. The DNMT1, DNMT3A and DNMT3B promoters were unmethylated in all instances. Interestingly, the DNMT3L promoter showed low levels of methylation in polyps and normal colonic mucosa relative to matched disease free cells with methylation level negatively correlated to expression level in normal colonic tissue. DNMT3L promoter hypomethylation was more often found in polyps harbouring KRAS mutations (p = 0.0053). BRAF mutations were common (11 out of 21 polyps), whilst KRAS mutations were identified in 4 of 21 polyps. Conclusions: Genetic or epigenetic alterations in DNMT genes do not appear to be associated with HPS, but further investigation of genetic variation at rs62106244 is justified given the high frequency of the minor allele in this case series.	[Drini, Musa; Macrae, Finlay A.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Drini, Musa] Canberra Hosp, Dept Gastroenterol & Hepatol, Garran, ACT, Australia; [Wong, Nicholas C.; Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Scott, Hamish S.] Inst Med & Vet Sci, Adelaide, SA 5000, Australia; [Dobrovic, Alexander; Hewitt, Chelsee A.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Dobrovic, Alexander] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Young, Joanne P.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Jenkins, Mark A.] Univ Melbourne, Sch Populat Hlth, MEGA Epidemiol, Carlton, Vic 3053, Australia	Royal Melbourne Hospital; University of Melbourne; Australian National University; Canberra Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Institute Medical & Veterinary Science Australia; Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Melbourne	Drini, M (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3052, Australia.	musa.drini@act.gov.au	Young, Joanne P/B-9981-2011; Scott, Hamish/B-2122-2009; Wong, Nick Wong/AAF-8627-2021; Craig, Jeffrey M/B-3484-2012; Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Saffery, Richard/GLS-1976-2022	Scott, Hamish/0000-0002-5813-631X; Wong, Nick Wong/0000-0003-4393-7541; Craig, Jeffrey M/0000-0003-3979-7849; Jenkins, Mark/0000-0002-8964-6160; Saffery, Richard/0000-0002-9510-4181; Young, Joanne/0000-0002-1514-1522; Dobrovic, Alexander/0000-0003-3414-112X; Hewitt, Chelsee/0000-0001-7472-6128	Hicks Foundation	Hicks Foundation	Hicks Foundation supported MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Aapola U, 2001, CYTOGENET CELL GENET, V92, P122, DOI 10.1159/000056881; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; BENHATTAR J, 1993, GASTROENTEROLOGY, V104, P1044, DOI 10.1016/0016-5085(93)90272-E; Bestor TH, 1998, AM J HUM GENET, V62, P1269, DOI 10.1086/301891; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Burt R, 2000, WHO INT CLASSIFICATI, P135; Carvajal-Carmona LG, 2007, J PATHOL, V212, P378, DOI 10.1002/path.2187; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chan AOO, 2002, AM J PATHOL, V160, P529, DOI 10.1016/S0002-9440(10)64872-9; Chan TL, 2003, CANCER RES, V63, P4878; Chow E, 2006, GASTROENTEROLOGY, V131, P30, DOI 10.1053/j.gastro.2006.03.046; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Ehrich M., 2006, INTRO EPITYPER QUANT; ELMAARRI O, 2009, HUM MOL GENET, V26, P26; Flynn J, 1996, BIOCHEMISTRY-US, V35, P7308, DOI 10.1021/bi9600512; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gokul G, 2007, EPIGENETICS-US, V2, P80, DOI 10.4161/epi.2.2.3692; Gokul G, 2009, EPIGENETICS-US, V4, P322, DOI 10.4161/epi.4.5.9239; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; IBRAHIM AE, 2010, GUT; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Issa JPJ, 2005, GASTROENTEROLOGY, V129, P1121, DOI 10.1053/j.gastro.2005.07.040; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kanai Y, 1996, JPN J CANCER RES, V87, P1210, DOI 10.1111/j.1349-7006.1996.tb03135.x; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Minoo P, 2006, GUT, V55, DOI 10.1136/gut.2005.082859; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Montgomery KG, 2004, BREAST CANCER RES, V6, pR390, DOI 10.1186/bcr807; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; O'Brien MJ, 2004, AM J SURG PATHOL, V28, P423, DOI 10.1097/00000478-200404000-00001; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Park BL, 2004, J HUM GENET, V49, P642, DOI 10.1007/s10038-004-0192-x; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wong NC, 2008, BIOTECHNIQUES, V45, P423, DOI 10.2144/000112945; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Yang S, 2004, AM J SURG PATHOL, V28, P1452, DOI 10.1097/01.pas.0000141404.56839.6a	66	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16831	10.1371/journal.pone.0016831	http://dx.doi.org/10.1371/journal.pone.0016831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347319	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000287363000019
J	Dunstan, AJ; Ward, PD; Marshall, NJ				Dunstan, Andrew J.; Ward, Peter D.; Marshall, N. Justin			Nautilus pompilius Life History and Demographics at the Osprey Reef Seamount, Coral Sea, Australia	PLOS ONE			English	Article							CHAMBER FORMATION; GROWTH; FIJI; MACROMPHALUS; CEPHALOPODA; PHILIPPINES; BELAUENSIS; LONGEVITY; BIOLOGY; HABITAT	Nautiloids are the subject of speculation as to their threatened status arising from the impacts of targeted fishing for the ornamental shell market. Life history knowledge is essential to understand the susceptibility of this group to overfishing and to the instigation of management frameworks. This study provides a comprehensive insight into the life of Nautilus in the wild. At Osprey Reef from 1998-2008, trapping for Nautilus was conducted on 354 occasions, with 2460 individuals of one species, Nautilus pompilius, captured and 247 individuals recaptured. Baited remote underwater video systems (BRUVS) were deployed on 15 occasions and six remotely operated vehicle (ROV) dives from 100-800 m were conducted to record Nautilus presence and behavior. Maturity, sex and size data were recorded, while measurements of recaptured individuals allowed estimation of growth rates to maturity, and longevity beyond maturity. We found sexual dimorphism in size at maturity (males: 131.9 +/- SD = 2.6 mm; females: 118.9 +/- 7.5 mm shell diameter) in a population dominated by mature individuals (58%). Mean growth rates of 15 immature recaptured animals were 0.061 +/- 0.023 mm day(-1) resulting in an estimate of around 15.5 years to maturation. Recaptures of mature animals after five years provide evidence of a lifespan exceeding 20 years. Juvenile Nautilus pompilius feeding behavior was recorded for the first time within the same depth range (200-610 m) as adults. Our results provide strong evidence of a K-selected life history for Nautilus from a detailed study of a 'closed' wild population. In conjunction with population size and density estimates established for the Osprey Reef Nautilus, this work allows calculations for sustainable catch and provides mechanisms to extrapolate these findings to other extant nautiloid populations (Nautilus and Allonautilus spp.) throughout the Indo-Pacific.	[Dunstan, Andrew J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Washington; University of Washington Seattle; University of Queensland	Dunstan, AJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com		Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; Australian Research Council [ID LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); Australian Research Council(Australian Research Council)	This work was funded by Undersea Explorer, University of Queensland and Australian Research Council Linkage Projects: Project ID LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J. M., 2010, NAUTILUS BIOL PALEOB, P373; Arnold JM, 1990, J CEPHALOPOD BIOL, V2, P1; COCHRAN JK, 1984, NATURE, V308, P725, DOI 10.1038/308725a0; Commission ISS, 2001, IUCN RED LIST CAT CR; DAVIS RA, 1973, J PALEONTOL, V47, P925; DENTON EJ, 1966, J MAR BIOL ASSOC UK, V46, P723, DOI 10.1017/S0025315400033440; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; EICHLER R, 1966, SCIENCE, V153, P734, DOI 10.1126/science.153.3737.734; Hamada T., 1987, NAUTILUS BIOL PALEOB, P579; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; Hayasaka S, 1983, 1 KAG U RES CTR S PA; KANIE Y, 1979, Venus the Japanese Journal of Malacology, V38, P129; Landman N.H., 2010, NAUTILUS BIOL PALEOB, P401, DOI DOI 10.1007/978-90-481-3299-7_28; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; LANDMAN NH, 1989, MAR BIOL, V102, P65, DOI 10.1007/BF00391324; Landman NH, 2001, VELIGER, V44, P333; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Martin A.W., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P207; OBA T, 1992, MAR BIOL, V113, P211; OKUBO S, 1995, VELIGER, V38, P192; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; SAUNDERS WB, 1989, NAUTILUS, V103, P99; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1987, NAUTILUS, V101, P188; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; TANABE K, 1990, MALACOLOGIA, V31, P297; Tanabe K., 1985, KAGOSHIMA U RES CTR, V4, P38; Ward P.D., 1987, NATURAL HIST NAUTILU, P267; WARD PD, 1983, NATURE, V304, P57, DOI 10.1038/304057a0; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1985, PALEOBIOLOGY, V11, P438, DOI 10.1017/S0094837300011726; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; WOODRUFF DS, 2010, NAUTILUS PALEOBIOLOG; WRAY CG, 1995, PALEOBIOLOGY, V21, P220, DOI 10.1017/S009483730001321X	36	21	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16312	10.1371/journal.pone.0016312	http://dx.doi.org/10.1371/journal.pone.0016312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347356	gold, Green Published, Green Submitted			2022-12-27	WOS:000287363000007
J	Akunuru, S; Palumbo, J; Zhai, QJ; Zheng, Y				Akunuru, Shailaja; Palumbo, Joseph; Zhai, Qihui James; Zheng, Yi			Rac1 Targeting Suppresses Human Non-Small Cell Lung Adenocarcinoma Cancer Stem Cell Activity	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SIDE POPULATION; PROSPECTIVE IDENTIFICATION; MICROENVIRONMENT; RESISTANCE; KINASE; GROWTH; TUMORS	The cancer stem cell (CSC) theory predicts that a small fraction of cancer cells possess unique self-renewal activity and mediate tumor initiation and propagation. However, the molecular mechanisms involved in CSC regulation remains unclear, impinging on effective targeting of CSCs in cancer therapy. Here we have investigated the hypothesis that Rac1, a Rho GTPase implicated in cancer cell proliferation and invasion, is critical for tumor initiation and metastasis of human non-small cell lung adenocarcinoma (NSCLA). Rac1 knockdown by shRNA suppressed the tumorigenic activities of human NSCLA cell lines and primary patient NSCLA specimens, including effects on invasion, proliferation, anchorage-independent growth, sphere formation and lung colonization. Isolated side population (SP) cells representing putative CSCs from human NSCLA cells contained elevated levels of Rac1-GTP, enhanced in vitro migration, invasion, increased in vivo tumor initiating and lung colonizing activities in xenografted mice. However, CSC activity was also detected within the non-SP population, suggesting the importance of therapeutic targeting of all cells within a tumor. Further, pharmacological or shRNA targeting of Rac1 inhibited the tumorigenic activities of both SP and non-SP NSCLA cells. These studies indicate that Rac1 represents a useful target in NSCLA, and its blockade may have therapeutic value in suppressing CSC proliferation and metastasis.	[Akunuru, Shailaja; Zheng, Yi] Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati, OH 45221 USA; [Akunuru, Shailaja; Zheng, Yi] Univ Cincinnati, Mol Dev Biol Program, Cincinnati, OH USA; [Palumbo, Joseph] Univ Cincinnati, Childrens Hosp Res Fdn, Div Hematol & Oncol, Cincinnati, OH USA; [Zhai, Qihui James] Univ Cincinnati, Dept Pathol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati, OH 45221 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIH [R01 CA141341, T32 HL091805]; NATIONAL CANCER INSTITUTE [R01CA141341, T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH R01 CA141341 and T32 HL091805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dirks P, 2010, NATURE, V466, P40, DOI 10.1038/466040a; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A., 2010, ONCOGENE; FUCHS O, 2010, CURR MOL PHARM; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	37	47	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16951	10.1371/journal.pone.0016951	http://dx.doi.org/10.1371/journal.pone.0016951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347385	Green Published, Green Submitted, gold			2022-12-27	WOS:000287361700057
J	Pakhomova, ON; Gregory, BW; Khorokhorina, VA; Bowman, AM; Xiao, S; Pakhomov, AG				Pakhomova, Olga N.; Gregory, Betsy W.; Khorokhorina, Vera A.; Bowman, Angela M.; Xiao, Shu; Pakhomov, Andrei G.			Electroporation-Induced Electrosensitization	PLOS ONE			English	Article							ELECTRIC-FIELD THERAPY; PLASMA-MEMBRANE; IRREVERSIBLE ELECTROPORATION; REPETITION FREQUENCY; HIGH-INTENSITY; GENE-TRANSFER; ELECTROCHEMOTHERAPY; CELLS; PULSES; TUMORS	Background: Electroporation is a method of disrupting the integrity of cell membrane by electric pulses (EPs). Electrical modeling is widely employed to explain and study electroporation, but even most advanced models show limited predictive power. No studies have accounted for the biological consequences of electroporation as a factor that alters the cell's susceptibility to forthcoming EPs. Methodology/Principal Findings: We focused first on the role of EP rate for membrane permeabilization and lethal effects in mammalian cells. The rate was varied from 0.001 to 2,000 Hz while keeping other parameters constant (2 to 3,750 pulses of 60-ns to 9-mu s duration, 1.8 to 13.3 kV/cm). The efficiency of all EP treatments was minimal at high rates and started to increase gradually when the rate decreased below a certain value. Although this value ranged widely (0.1-500 Hz), it always corresponded to the overall treatment duration near 10 s. We further found that longer exposures were more efficient irrespective of the EP rate, and that splitting a high-rate EP train in two fractions with 1-5 min delay enhanced the effects severalfold. Conclusions/Significance: For varied experimental conditions, EPs triggered a delayed and gradual sensitization to EPs. When a portion of a multi-pulse exposure was delivered to already sensitized cells, the overall effect markedly increased. Because of the sensitization, the lethality in EP-treated cells could be increased from 0 to 90% simply by increasing the exposure duration, or the exposure dose could be reduced twofold without reducing the effect. Many applications of electroporation can benefit from accounting for sensitization, by organizing the exposure either to maximize sensitization (e.g., for sterilization) or, for other applications, to completely or partially avoid it. In particular, harmful side effects of electroporation-based therapies (electrochemotherapy, gene therapies, tumor ablation) include convulsions, pain, heart fibrillation, and thermal damage. Sensitization can potentially be employed to reduce these side effects while preserving or increasing therapeutic efficiency.	[Pakhomova, Olga N.; Gregory, Betsy W.; Khorokhorina, Vera A.; Bowman, Angela M.; Xiao, Shu; Pakhomov, Andrei G.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Old Dominion University; Old Dominion University	Pakhomova, ON (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	andrei@pakhomov.net		Pakhomov, Andrei/0000-0003-3816-3860	National Cancer Institute [R01CA125482]; National Institute of General Medical Sciences [R01GM088303]; NATIONAL CANCER INSTITUTE [R01CA125482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088303] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by R01CA125482 from the National Cancer Institute and R01GM088303 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Andre FM, 2008, HUM GENE THER, V19, P1261, DOI [10.1089/hum.2008.060, 10.1089/hgt.2008.060]; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Bilska AO, 2000, BIOELECTROCHEMISTRY, V51, P133, DOI 10.1016/S0302-4598(00)00066-0; Bonnafous P, 1999, BBA-BIOMEMBRANES, V1461, P123, DOI 10.1016/S0005-2736(99)00154-6; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; El-Hag AH, 2006, IEEE T PLASMA SCI, V34, P1412, DOI 10.1109/TPS.2006.878382; Escoffre JM, 2009, MOL BIOTECHNOL, V41, P286, DOI 10.1007/s12033-008-9121-0; Esser AT, 2010, BIOPHYS J, V98, P2506, DOI 10.1016/j.bpj.2010.02.035; Faurie C, 2010, J GENE MED, V12, P117, DOI 10.1002/jgm.1414; Heller LC, 2010, CURR GENE THER, V10, P312; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jayaram SH, 2004, IEEE T IND APPL, V40, P1489, DOI 10.1109/TIA.2004.836134; JIANG N, 2010, BIOELECTROMAGNETICS; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; KINOSITA K, 1977, NATURE, V268, P438, DOI 10.1038/268438a0; Lebar Alenka Macek, 2002, IEEE Trans Nanobioscience, V1, P116, DOI 10.1109/TNB.2003.809464; Lebovka N., 2010, ADV ELECTROPORATION, P463; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2005, BIOELECTROCHEMISTRY, V65, P121, DOI 10.1016/j.bioelechem.2004.07.004; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; Mir LM, 2009, MOL BIOTECHNOL, V43, P167, DOI 10.1007/s12033-009-9192-6; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Neumann E., 1989, ELECTROPORATION ELEC; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov A.G., 2010, ADV ELECTROPORATION, P178; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2010, ADV ELECTROPORATION; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pucihar G, 2002, BIOELECTROCHEMISTRY, V57, P167, DOI 10.1016/S1567-5394(02)00116-0; Raeisi E, 2010, J MEMBRANE BIOL, V236, P163, DOI 10.1007/s00232-010-9288-8; Rubinsky B, 2010, SER BIOMED ENG, P1, DOI 10.1007/978-3-642-05420-4; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Sack M, 2010, IEEE T PLASMA SCI, V38, P1928, DOI 10.1109/TPS.2010.2050073; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2009, IEEE T DIELECT EL IN, V16, P1224, DOI 10.1109/TDEI.2009.5293932; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2010, J MEMBRANE BIOL, V236, P155, DOI 10.1007/s00232-010-9268-z; Teissie J, 2002, BIOELECTROCHEMISTRY, V55, P107, DOI 10.1016/S1567-5394(01)00138-4; Terpitz U, 2008, BBA-BIOMEMBRANES, V1778, P1493, DOI 10.1016/j.bbamem.2008.03.015; Tiwari JK, 2010, PLANT CELL TISS ORG, V103, P175, DOI 10.1007/s11240-010-9765-x; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Vernhes MC, 1999, BIOELECTROCH BIOENER, V48, P17, DOI 10.1016/S0302-4598(98)00239-6; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007966; Walker K, 2006, BIOELECTROMAGNETICS, V27, P221, DOI 10.1002/bem.20200; Yang XJ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-53; Zupanic A, 2007, NEOPLASMA, V54, P246	53	72	73	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e17100	10.1371/journal.pone.0017100	http://dx.doi.org/10.1371/journal.pone.0017100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347394	Green Submitted, gold, Green Published			2022-12-27	WOS:000287361700066
J	Mate, G; Neda, Z; Benedek, J				Mate, Gabriell; Neda, Zoltan; Benedek, Jozsef			Spring-Block Model Reveals Region-Like Structures	PLOS ONE			English	Article							FUNCTIONAL REGIONS; ECONOMIC-GEOGRAPHY; GRAVITY	A mechanical spring-block model is used for realizing an objective space partition of settlements from a geographic territory in region-like structures. The method is based on the relaxation-dynamics of the spring-block system and reveals in a hierarchical manner region-like entities at different spatial scales. It takes into account in an elegant manner both the spatiality of the elements and the connectivity relations among them. Spatiality is taken into account by using the geographic coordinates of the settlements, and by detecting the neighbors with the help of a Delaunay triangulation. Connectivity between neighboring settlements are quantified using a Pearson-like correlation for the relative variation of a relevant socio-economic parameter (population size, GDP, tax payed per inhabitant, etc.). The method is implemented in an interactive JAVA application and it is applied with success for an artificially generated society and for the case of USA, Hungary and Transylvania.	[Mate, Gabriell; Neda, Zoltan] Univ Babes Bolyai, Dept Theoret & Computat Phys, R-3400 Cluj Napoca, Romania; [Mate, Gabriell] Heidelberg Univ, Inst Theoret Phys, D-6900 Heidelberg, Germany; [Benedek, Jozsef] Univ Babes Bolyai, Dept Human Geog, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; Ruprecht Karls University Heidelberg; Babes Bolyai University from Cluj	Mate, G (corresponding author), Univ Babes Bolyai, Dept Theoret & Computat Phys, R-3400 Cluj Napoca, Romania.	g.mate@tphys.uni-heidelberg.de	Néda, Zoltán/C-3754-2011	Jozsef, Benedek/0000-0003-2561-5848	IDEI/PN2 [2369]	IDEI/PN2	This work was performed in the framework of the IDEI/PN2 nr. 2369 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amin A, 1999, INT J URBAN REGIONAL, V23, P365, DOI 10.1111/1468-2427.00201; Anderson TR, 1956, PAPERS REGIONAL SCI, V2, P175, DOI DOI 10.1111/J.1435-5597.1956.TB01563.X; [Anonymous], HIST CENS BROWS; *ASTR, COORD ROM SETTL; BARNES TJ, 1991, GEOGR ANN B, V73, P111, DOI DOI 10.1080/0435684.1991.11879617; BAUMANN HJ, 1983, PAPERS REGIONAL SCI, V52, P53; BENEDEK J, 2007, GEOGRAPHISCHEN GESEL, V149, P81; BROWN LA, 1971, J REGIONAL SCI, V11, P57, DOI 10.1111/j.1467-9787.1971.tb00240.x; BURRIDGE R, 1967, B SEISMOL SOC AM, V57, P341; CARROTHERS GAP, 1956, J AM I PLANNERS, V22, P94, DOI 10.1080/01944365608979229; GABRIEL KR, 1974, J REGIONAL SCI, V14, P89, DOI 10.1111/j.1467-9787.1974.tb00432.x; GOLD CM, 1992, LECT NOTES COMPUT SC, V639, P220; GRIESINGER DW, 1979, REG STUD, V19, P291; ISOPLATOV S, 1998, EUROPEAN PHYS J B, V2, P267; Jarai-Szabo F, 2005, CHEM PHYS LETT, V408, P241, DOI 10.1016/j.cplett.2005.04.051; Jordan P., 2005, ACTA U CAROLINAE GEO, VXXXVIII, P141; Karlsson C, 2006, ANN REGIONAL SCI, V40, P1, DOI 10.1007/s00168-005-0019-5; Kovacs K, 2005, MODEL SIMUL MATER SC, V13, P1341, DOI 10.1088/0965-0393/13/8/010; LEBYODKIN MA, 1995, PHYS REV LETT, V74, P4758, DOI 10.1103/PhysRevLett.74.4758; Leung K, 2000, PHYS REV LETT, V85, P662, DOI 10.1103/PhysRevLett.85.662; Leung KT, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046118; LEWIS TG, 2009, HOBOKEN; LUKERMANN F, 1960, ANN ASSOC AM GEOGR, V50, P493, DOI 10.1111/j.1467-8306.1960.tb00364.x; LUKERMANN F, 1958, PROF GEOGR, V10, P2, DOI 10.1111/j.0033-0124.1958.104_2.x; MANTEGA RN, 1999, INTRO ECONOPHYSICS C; MATE G, 2009, REGION DETECTION HOM; MITCHELL W, 2007, 0706 CTR FULL EMPL, P1; *NAT GEOPH DAT CTR, COASTL EXTR; Neda Z, 2009, CONTROL ENG APPL INF, V11, P3; NORONHA VT, 1992, ANN ASSOC AM GEOGR, V82, P86, DOI 10.1111/j.1467-8306.1992.tb01899.x; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; OLAMI Z, 1992, PHYS REV LETT, V68, P1244, DOI 10.1103/PhysRevLett.68.1244; QUETELET A, 1835, HOMME DEV FACULTES E; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; RICH DC, 1980, GEO ABSTR; RIGBY LD, 2000, COMPANION EC GEOGRAP, P202; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; STEWART JQ, 1950, AM J PHYS, V18, P239, DOI 10.1119/1.1932559; Sunley P., 2000, COMPANION EC GEOGRAP, P187; Thiemann C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015422; VARGA EA, ETHNICAL DENOMINATIO	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16518	10.1371/journal.pone.0016518	http://dx.doi.org/10.1371/journal.pone.0016518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	717WH	21346819	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600008
J	Garrido-Urbani, S; Jemelin, S; Deffert, C; Carnesecchi, S; Basset, O; Szyndralewiez, C; Heitz, F; Page, P; Montet, X; Michalik, L; Arbiser, J; Ruegg, C; Krause, KH; Imhof, B				Garrido-Urbani, Sarah; Jemelin, Stephane; Deffert, Christine; Carnesecchi, Stephanie; Basset, Olivier; Szyndralewiez, Cedric; Heitz, Freddy; Page, Patrick; Montet, Xavier; Michalik, Liliane; Arbiser, Jack; Rueegg, Curzio; Krause, Karl Heinz; Imhof, Beat			Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPAR alpha Mediated Mechanism	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; CELL-PROLIFERATION; NAD(P)H OXIDASE; ANGIOTENSIN-II; NOX1; EXPRESSION; CANCER; ROLES; ADENOCARCINOMA	Reactive oxygen species, ROS, are regulators of endothelial cell migration, proliferation and survival, events critically involved in angiogenesis. Different isoforms of ROS-generating NOX enzymes are expressed in the vasculature and provide distinct signaling cues through differential localization and activation. We show that mice deficient in NOX1, but not NOX2 or NOX4, have impaired angiogenesis. NOX1 expression and activity is increased in primary mouse and human endothelial cells upon angiogenic stimulation. NOX1 silencing decreases endothelial cell migration and tube-like structure formation, through the inhibition of PPAR alpha, a regulator of NF-kappa B. Administration of a novel NOX-specific inhibitor reduced angiogenesis and tumor growth in vivo in a PPAR alpha dependent manner. In conclusion, vascular NOX1 is a critical mediator of angiogenesis and an attractive target for anti-angiogenic therapies.	[Garrido-Urbani, Sarah; Jemelin, Stephane; Deffert, Christine; Carnesecchi, Stephanie; Basset, Olivier; Krause, Karl Heinz; Imhof, Beat] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Geneva, Switzerland; [Carnesecchi, Stephanie] Univ Geneva, Dept Pediat, Ctr Med Univ, Geneva, Switzerland; [Szyndralewiez, Cedric; Heitz, Freddy; Page, Patrick] GenKyoTex SA, Geneva, Switzerland; [Montet, Xavier] Univ Geneva, Dept Physiol & Metab, Ctr Med Univ, Geneva, Switzerland; [Michalik, Liliane] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Arbiser, Jack] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Rueegg, Curzio] Univ Fribourg, Dept Med, Fac Sci, CH-1700 Fribourg, Switzerland	University of Geneva; University of Geneva; Genkyotex; University of Geneva; University of Lausanne; Emory University; University of Fribourg	Garrido-Urbani, S (corresponding author), Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Geneva, Switzerland.	beat.imhof@unige.ch	Krause, Karl-Heinz/E-8030-2011; Montet, Xavier/GMW-9003-2022	Krause, Karl-Heinz/0000-0002-9033-6768; Montet, Xavier/0000-0003-2442-5866; Garrido-Urbani, Sarah/0000-0002-7309-0137; Michalik, Liliane/0000-0003-2963-2100	Swiss Cancer League [KPS-OCS 01812-12-2005]; Swiss National Science Foundation [FNS-310030-120184]; GenKyoTex S.A.	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GenKyoTex S.A.	This work was supported by the Swiss Cancer League, KPS-OCS 01812-12-2005 and by the Swiss National Science Foundation, FNS-310030-120184. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by GenKyoTex S.A. as employer of some of the authors. This funder was implicated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ago T, 2005, STROKE, V36, P1040, DOI 10.1161/01.STR.0000163111.05825.0b; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Aurrand-Lions M, 2004, J PATHOL, V203, P700, DOI 10.1002/path.1571; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Blann AD, 2001, AM J CARDIOL, V87, P1160, DOI 10.1016/S0002-9149(01)01486-2; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Carnesecchi S, 2009, AM J RESP CRIT CARE, V179; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; DIEBOLD I, MOL BIOL CELL; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kang SI, 2008, BIOCHEM BIOPH RES CO, V369, P1209, DOI 10.1016/j.bbrc.2008.03.037; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kobayashi S, 2004, EXP CELL RES, V300, P455, DOI 10.1016/j.yexcr.2004.07.023; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; LIOU GY, FREE RADIC RES, V44, P479; LIU RM, J BIOL CHEM; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Luczak K, 2004, CELL BIOL INT, V28, P483, DOI 10.1016/j.cellbi.2004.03.004; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Manea A, 2005, BIOL CELL, V97, P723, DOI 10.1042/BC20040107; Maraldi T, 2010, INT J ONCOL, V36, P1581, DOI 10.3892/ijo_00000645; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; MILJKOVICLICINA M, 2009, FASEB J; Montet X, 2007, INVEST RADIOL, V42, P652, DOI 10.1097/RLI.0b013e31805f445b; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PAGE P, 2008, Patent No. 2008113856; Palicz A, 2001, J BIOL CHEM, V276, P3090, DOI 10.1074/jbc.M007759200; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Pozzi A, 2007, J BIOL CHEM, V282, P17685, DOI 10.1074/jbc.M701429200; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shono T, 1996, MOL CELL BIOL, V16, P4231; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8	73	124	131	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14665	10.1371/journal.pone.0014665	http://dx.doi.org/10.1371/journal.pone.0014665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326871	Green Published, gold, Green Submitted			2022-12-27	WOS:000287037100005
J	Devigne, C; Broly, P; Deneubourg, JL				Devigne, Cedric; Broly, Pierre; Deneubourg, Jean-Louis			Individual Preferences and Social Interactions Determine the Aggregation of Woodlice	PLOS ONE			English	Article							ANT LASIUS-NIGER; TERRESTRIAL ISOPODS ISOPODA; COLLECTIVE DECISION-MAKING; PORCELLIO-SCABER; ANIMAL AGGREGATIONS; FOOD RECRUITMENT; BEHAVIOR; WATER; ONISCIDEA; PATTERNS	Background: The aggregation of woodlice in dark and moist places is considered an adaptation to land life and most studies are focused on its functionality or on the behavioural mechanisms related to the individual's response to abiotic factors. Until now, no clear experimental demonstration was available about aggregation resulting from inter-attraction between conspecifics. Methodology/Main Findings: We present the dynamics of aggregation, not previously described in detail in literature, as being independent of the experimental conditions: homogeneous and heterogeneous environments with identical or different shelters. Indeed whatever these conditions, the aggregation is very quick. In less than 10 minutes more than 50% of woodlice were aggregated in several small groups in the homogeneous environment or under shelters in the heterogeneous environment. After this fast aggregation, woodlice progressively moved into a single aggregate or under one shelter. Conclusions/Significance: Here we show for the first time that aggregation in woodlice implies a strong social component and results from a trade-off between individual preferences and inter-attraction between individuals. Moreover, our results reveal that the response to the heterogeneities affects only the location of the aggregates and not the level of aggregation, and demonstrate the strong inter-attraction between conspecifics which can outweigh individual preferences. This inter-attraction can lead to situations that could seem sub-optimal.	[Devigne, Cedric; Broly, Pierre] Univ Lille Nord France, Lille, France; [Devigne, Cedric; Broly, Pierre] UCLille, FLST, Lab Environm & Sante, Lille, France; [Deneubourg, Jean-Louis] Univ Libre Bruxelles, Brussels, Belgium	Universite de Lille - ISITE; Universite de Lille; Universite Libre de Bruxelles	Devigne, C (corresponding author), Univ Lille Nord France, Lille, France.	cedric.devigne@icl-lille.fr	Devigne, Cedric/C-2438-2016	Devigne, Cedric/0000-0002-3168-6207	Catholic University of Lille	Catholic University of Lille	This study has been carried out with support from the Catholic University of Lille in the framework of the fund-raising campaign "Ensemble Innovons". This financial help generally allows the authors to buy small materials and pay students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CH, 1918, J EXP ZOOL, V27, P193, DOI 10.1002/jez.1400270204; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALIKHAN M, 1995, TERRESTRIAL ISOPOD B; Allee W.C, 1931, ANIMAL AGGREGATION S; Allee WC, 1926, J EXP ZOOL, V45, P255, DOI 10.1002/jez.1400450108; Allee WC, 1929, ECOLOGY, V10, P14, DOI 10.2307/1940510; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; [Anonymous], 1993, EVOLUTIONARY BIOL LA; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; Bell W. J., 2007, COCKROACHES ECOLOGY; Brockett BFT, 2005, EUR J SOIL BIOL, V41, P123, DOI 10.1016/j.ejsobi.2005.09.004; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; CAREFOOT TH, 1993, COMP BIOCHEM PHYS A, V106, P413, DOI 10.1016/0300-9629(93)90235-V; Colasurdo N, 2005, J INSECT BEHAV, V18, P77, DOI 10.1007/s10905-005-9348-6; Costa J., 2006, OTHER INSECT SOC; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Deneubourg JL, 2002, BIOL BULL-US, V202, P262, DOI 10.2307/1543477; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; DENEUBOURG JL, 1987, EUR J OPER RES, V30, P168, DOI 10.1016/0377-2217(87)90093-2; Depickere S, 2008, J INSECT PHYSIOL, V54, P1349, DOI 10.1016/j.jinsphys.2008.07.013; Devigne C, 2006, INSECT SOC, V53, P46, DOI 10.1007/s00040-005-0834-9; Devigne C, 2004, ANIM BEHAV, V67, P1023, DOI 10.1016/j.anbehav.2003.09.012; Devigne Cedric, 2005, Acta Zoologica Sinica, V51, P161; Duffy J. E., 2007, EVOLUTIONARY ECOLOGY; Dugatkin L.A., 1997, COOPERATION ANIMALS; EBISUNO T, 1982, APPL ENTOMOL ZOOL, V17, P584, DOI 10.1303/aez.17.584; EDNEY EB, 1968, AM ZOOL, V8, P309; FARR JA, 1978, B MAR SCI, V28, P659; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; FRIEDLANDER CP, 1965, ANIM BEHAV, V13, P342, DOI 10.1016/0003-3472(65)90054-0; FRIEDLANDER CP, 1964, ANIM BEHAV, V12, P164, DOI 10.1016/0003-3472(64)90118-6; Fryxell JM, 2007, NATURE, V449, P1041, DOI 10.1038/nature06177; GANTER PF, 1984, ECOLOGY, V65, P438, DOI 10.2307/1941406; Giraldeau L.A., 2000, MG BEH ECOL; Giraldeau Luc-Alain, 1997, P42; Glass EV, 1998, EXP APPL ACAROL, V22, P31, DOI 10.1023/A:1006081323887; Greenaway P, 1998, ISR J ZOOL, V44, P473; Gunn DL, 1937, J EXP BIOL, V14, P178; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HAMNER WM, 1986, LIMNOL OCEANOGR, V31, P171, DOI 10.4319/lo.1986.31.1.0171; Hartline HK, 1923, J GEN PHYSIOL, V6, P137, DOI 10.1085/jgp.6.2.137; Hassall M, 2010, BEHAVIOUR, V147, P151, DOI 10.1163/000579509X12512861455834; Hendrickx F, 2003, ENVIRON POLLUT, V121, P87, DOI 10.1016/S0269-7491(02)00203-8; Holldobler B., 2009, SUPERORGANISM; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Jeanson R, 2007, AM NAT, V170, P47, DOI 10.1086/518570; Jeanson Raphael, 2009, P460; Kaufman BZ, 1996, ZOOL ZH, V75, P188; Krebs JR., 1997, BEHAV ECOLOGY EVOLUT; KUENEN D. J., 1963, ENTOMOL EXPTL ET APPL, V6, P133; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Linsenmair Karl Eduard, 2007, P339; Linsenmair KE, 1984, S ZOOL SOC LONDON, V53, P423; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Nicolis SC, 2008, J THEOR BIOL, V254, P580, DOI 10.1016/j.jtbi.2008.06.028; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Paoletti MG, 1999, AGR ECOSYST ENVIRON, V74, P157, DOI 10.1016/S0167-8809(99)00035-3; Peters MI, 2006, ETHOLOGY, V112, P521, DOI 10.1111/j.1439-0310.2005.01197.x; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; RABAUD ETIENNE, 1929, BULL BIOL FRANCE ET BELGIQUE, V63, P377; Scherkenbeck J, 1999, J CHEM ECOL, V25, P1105, DOI 10.1023/A:1020885926578; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; Sorensen FF, 1997, ENVIRON TOXICOL CHEM, V16, P685, DOI [10.1897/1551-5028(1997)016&lt;0685:ALBIWO&gt;2.3.CO;2, 10.1002/etc.5620160412]; Stocker S, 1999, MATH BIOSCI, V156, P167, DOI 10.1016/S0025-5564(98)10065-2; STYRON CE, 1967, AM MIDL NAT, V78, P389, DOI 10.2307/2485238; STYRON CE, 1968, ECOLOGY, V49, P629, DOI 10.2307/1935528; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sutton S., 1972, WOODLICE; TAKEDA N, 1984, S ZOOL SOC LOND, V53, P381; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Thiel Martin, 2007, P3; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; WARBURG MR, 1964, ANIM BEHAV, V12, P175, DOI 10.1016/0003-3472(64)90119-8; WARBURG MR, 1968, AM ZOOL, V8, P545; WIESER W, 1969, OECOLOGIA, V3, P390, DOI 10.1007/BF00390384; WRIGHT JC, 1990, J EXP BIOL, V154, P13; Yoder JA, 1997, PHYSIOL ENTOMOL, V22, P79, DOI 10.1111/j.1365-3032.1997.tb01143.x; Yoder Jay A., 2002, Journal of Cave and Karst Studies, V64, P140; Zimmer M, 2005, J CHEM ECOL, V31, P1933, DOI 10.1007/s10886-005-5935-4; Zimmer M, 1996, EUR J SOIL BIOL, V32, P141; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912; Zimmer M, 2002, FUNCT ECOL, V16, P596, DOI 10.1046/j.1365-2435.2002.00669.x; [No title captured]; [No title captured]	88	48	48	17	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17389	10.1371/journal.pone.0017389	http://dx.doi.org/10.1371/journal.pone.0017389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364761	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100051
J	Diesing, AK; Nossol, C; Danicke, S; Walk, N; Post, A; Kahlert, S; Rothkotter, HJ; Kluess, J				Diesing, Anne-Kathrin; Nossol, Constanze; Daenicke, Sven; Walk, Nicole; Post, Andreas; Kahlert, Stefan; Rothkoetter, Hermann-Josef; Kluess, Jeannette			Vulnerability of Polarised Intestinal Porcine Epithelial Cells to Mycotoxin Deoxynivalenol Depends on the Route of Application	PLOS ONE			English	Article							FUSARIUM-TOXIN DEOXYNIVALENOL; NATURALLY CONTAMINATED WHEAT; PROTEIN-SYNTHESIS; CACO-2 CELLS; CYCLE ARREST; HUMAN HEALTH; IN-VITRO; TRICHOTHECENES; TRANSPORT; APOPTOSIS	Background and Aims: Deoxynivalenol (DON) is a Fusarium derived mycotoxin, often occurring on cereals used for human and animal nutrition. The intestine, as prominent barrier for nutritional toxins, has to handle the mycotoxin from the mucosa protected luminal side (apical exposure), as well as already absorbed toxin, reaching the cells from basolateral side via the blood stream. In the present study, the impact of the direction of DON exposure on epithelial cell behaviour and intestinal barrier integrity was elucidated. Methods: A non-transformed intestinal porcine epithelial cell line (IPEC-J2), cultured in membrane inserts, serving as a polarised in vitro model to determine the effects of deoxynivalenol (DON) on cellular viability and tight junction integrity. Results: Application of DON in concentrations up to 4000 ng/mL for 24, 48 and 72 hours on the basolateral side of membrane cultured polarised IPEC-J2 cells resulted in a breakdown of the integrity of cell connections measured by transepithelial electrical resistance (TEER), as well as a reduced expression of the tight junction proteins ZO-1 and claudin 3. Epithelial cell number decreased and nuclei size was enlarged after 72 h incubation of 4000 ng/mL DON from basolateral. Although necrosis or caspase 3 mediated apoptosis was not detectable after basolateral DON application, cell cycle analysis revealed a significant increase in DNA fragmentation, decrease in G0/G1 phase and slight increase in G2/M phase after 72 hours incubation with DON 2000 ng/mL. Conclusions: Severity of impact of the mycotoxin deoxynivalenol on the intestinal epithelial barrier is dependent on route of application. The epithelium appears to be rather resistant towards apical (luminal) DON application whereas the same toxin dose from basolateral severely undermines barrier integrity.	[Diesing, Anne-Kathrin; Nossol, Constanze; Walk, Nicole; Post, Andreas; Kahlert, Stefan; Rothkoetter, Hermann-Josef; Kluess, Jeannette] Otto Von Guericke Univ, Inst Anat, Fac Med, Magdeburg, Germany; [Daenicke, Sven] Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany	Otto von Guericke University	Diesing, AK (corresponding author), Otto Von Guericke Univ, Inst Anat, Fac Med, Magdeburg, Germany.	jeannette.kluess@med.ovgu.de			European Union [227549]; Deutsche Forschungsgemeinschaft (DFG) [RO 743/3-2]	European Union(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was financially supported by the European Union in the frame of the project "INTERPLAY" (grant agreement-no. 227549, http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=50&CAT=PROJ&QUERY=012ba9fde3b3:22de:58a7a82c&RCN=92294) and the Deutsche Forschungsgemeinschaft (DFG RO 743/3-2, http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Awad WA, 2007, POULTRY SCI, V86, P15, DOI 10.1093/ps/86.1.15; Baltriukiene D, 2007, ATLA-ALTERN LAB ANIM, V35, P53, DOI 10.1177/026119290703500101; BARRETT KE, 1989, AM J PHYSIOL, V256, pC197; Bensassi F, 2009, TOXICOLOGY, V264, P104, DOI 10.1016/j.tox.2009.07.020; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; Chen AC, 2004, J NUTR, V134, P1303, DOI 10.1093/jn/134.6.1303; Danicke S, 2006, TOXICOL LETT, V165, P297, DOI 10.1016/j.toxlet.2006.05.006; Danicke S, 2004, ARCH ANIM NUTR, V58, P1, DOI 10.1080/0003942031000161045; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; FAO/WHO Expert Committee on Food Additives, 2001, WHO TECHN REP SER, V906, P35; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Goyarts T, 2006, TOXICOL LETT, V163, P171, DOI 10.1016/j.toxlet.2005.10.007; Goyarts T, 2006, FOOD CHEM TOXICOL, V44, P1953, DOI 10.1016/j.fct.2006.06.017; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Koenigs M, 2007, TOXICOLOGY, V240, P48, DOI 10.1016/j.tox.2007.07.016; Kouadio JH, 2007, TOXICON, V49, P306, DOI 10.1016/j.toxicon.2006.09.029; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Larsen JC, 2004, TOXICOL LETT, V153, P1, DOI 10.1016/j.toxlet.2004.04.020; Maresca M, 2002, J NUTR, V132, P2723, DOI 10.1093/jn/132.9.2723; Maresca M, 2008, TOXICOL APPL PHARM, V228, P84, DOI 10.1016/j.taap.2007.11.013; Moss MO, 2003, VET J, V165, P184, DOI 10.1016/S1090-0233(02)00246-0; OHTSUBO K, 1968, JPN J MED SCI BIOL, V21, P185, DOI 10.7883/yoken1952.21.185; Pestka JJ, 2008, FOOD ADDIT CONTAM A, V25, P1128, DOI 10.1080/02652030802056626; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; RODRIGUEZBOULAN E, 1989, ANNU REV PHYSIOL, V51, P741, DOI 10.1146/annurev.physiol.51.1.741; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; SCHOENTAL R, 1985, ADV CANCER RES, V45, P217, DOI 10.1016/S0065-230X(08)60270-5; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Shen L, 2009, CURR TOP MICROBIOL, V337, P1, DOI 10.1007/978-3-642-01846-6_1; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Sudakin DL, 2003, TOXICOL LETT, V143, P97, DOI 10.1016/S0378-4274(03)00116-4; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tep J, 2007, TOXICOL LETT, V170, P248, DOI 10.1016/j.toxlet.2007.03.012; Tiemann U, 2003, REPROD TOXICOL, V17, P209, DOI 10.1016/S0890-6238(02)00141-7; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; Wannemacher R, 1997, MED ASPECTS CHEM BIO, V6, P655; Wu XN, 2007, FOOD CHEM TOXICOL, V45, P1846, DOI 10.1016/j.fct.2007.03.018; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; YOUNG LG, 1983, J ANIM SCI, V57, P655, DOI 10.2527/jas1983.573655x	50	92	99	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17472	10.1371/journal.pone.0017472	http://dx.doi.org/10.1371/journal.pone.0017472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364771	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100065
J	Iwamori, T; Lin, YN; Ma, L; Iwamori, N; Matzuk, MM				Iwamori, Tokuko; Lin, Yi-Nan; Ma, Lang; Iwamori, Naoki; Matzuk, Martin M.			Identification and Characterization of RBM44 as a Novel Intercellular Bridge Protein	PLOS ONE			English	Article							GERM-CELL DEVELOPMENT; GENE-EXPRESSION; ESCRT MACHINERY; MICE DEFICIENT; CYTOKINESIS; FERTILITY; SPERMATOGENESIS; DIFFERENTIATION; COMPLEX; ABSENCE	Intercellular bridges are evolutionarily conserved structures that connect differentiating germ cells. We previously reported the identification of TEX14 as the first essential intercellular bridge protein, the demonstration that intercellular bridges are required for male fertility, and the finding that intercellular bridges utilize components of the cytokinesis machinery to form. Herein, we report the identification of RNA binding motif protein 44 ( RBM44) as a novel germ cell intercellular bridge protein. RBM44 was identified by proteomic analysis after intercellular bridge enrichment using TEX14 as a marker protein. RBM44 is highly conserved between mouse and human and contains an RNA recognition motif of unknown function. RBM44 mRNA is enriched in testis, and immunofluorescence confirms that RBM44 is an intercellular bridge component. However, RBM44 only partially localizes to TEX14-positive intercellular bridges. RBM44 is expressed most highly in pachytene and secondary spermatocytes, but disappears abruptly in spermatids. We discovered that RBM44 interacts with itself and TEX14 using yeast two-hybrid, mammalian two-hybrid, and immunoprecipitation. To define the in vivo function of RBM44, we generated a targeted deletion of Rbm44 in mice. Rbm44 null male mice produce somewhat increased sperm, and show enhanced fertility of unknown etiology. Thus, although RBM44 localizes to intercellular bridges during meiosis, RBM44 is not required for fertility in contrast to TEX14.	[Iwamori, Tokuko; Lin, Yi-Nan; Ma, Lang; Iwamori, Naoki; Matzuk, Martin M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Lin, Yi-Nan; Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Iwamori, T (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.tmc.edu			National Institutes of Health [R01HD057880, U01HD060496]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060496] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work has been supported in part by National Institutes of Health grants R01HD057880 and U01HD060496 (to M. M. M.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chennathukuzhi V, 2003, MOL CELL BIOL, V23, P6419, DOI 10.1128/MCB.23.18.6419-6434.2003; Dev A, 2007, MOL REPROD DEV, V74, P1456, DOI 10.1002/mrd.20742; DREYFUSS G, 1988, J CELL BIOL, V106, P1419, DOI 10.1083/jcb.106.5.1419; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; ERICKSON RP, 1973, NATURE-NEW BIOL, V243, P210, DOI 10.1038/newbio243210a0; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; HUCKINS C, 1978, ANAT REC, V192, P529, DOI 10.1002/ar.1091920407; IWAMORI T, 2010, MOL CELL BIOL; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; REN HP, 1991, AM J ANAT, V192, P121, DOI 10.1002/aja.1001920203; Roy A, 2007, FASEB J, V21, P1013, DOI 10.1096/fj.06-7035com; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	30	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17066	10.1371/journal.pone.0017066	http://dx.doi.org/10.1371/journal.pone.0017066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364893	gold, Green Submitted, Green Published			2022-12-27	WOS:000287764100025
J	Tian, YH; Hou, Y; Zhou, XA; Cheng, HH; Zhou, RJ				Tian, Yihao; Hou, Yu; Zhou, Xiang; Cheng, Hanhua; Zhou, Rongjia			Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation	PLOS ONE			English	Article							MICROTUBULE STABILITY; PROTEIN; TUMORIGENESIS; PROGRESSION; APOPTOSIS; ISOFORM; GROWTH	Oncogenes and tumor suppressors work in concert to regulate cell growth or death, which is a pair of antagonist factors for regulation of tumorigenesis. Here we show promoter characteristic of tumor suppressor RASSF1A, which revealed a p53 binding site in the distal and a GC-rich region in the proximal promoter region of RASSF1A, in despite of TATA box-less. The GC-rich region, which is similar to 300 bp upstream from the RASSF1A ATG, showed the strongest promoter activity in an assay of RASSF1A-driving GFP expression. Methylation analysis of the CpG island showed that 78.57% of the GC sties were methylated in testis tumor samples compared with methylation-less in normal testis. Hypermethylation of the GC-rich region is associated with RASSF1A silencing in human testis tumors. In addition, electrophoretic mobility shift assay indicated that p53 protein bound to the RASSF1A promoter. Further chromatin immunoprecipitation confirmed p53 binding to the RASSF1A. Moreover, p53 binding to the promoter down-regulated RASSF1A expression. These results suggest that p53 protein specifically binds to the RASSF1A promoter and inhibits its expression. Our results provide new insight into the mechanism of action of tumor suppressors and may be a starting point for development of new approaches to cancer treatment.	[Tian, Yihao] Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China; Wuhan Univ, Ctr Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Tian, YH (corresponding author), Wuhan Univ, Dept Genet, Coll Life Sci, Wuhan 430072, Peoples R China.	hhcheng@whu.edu.cn; rjzhou@whu.edu.cn	Zhou, Rongjia/G-4660-2013; Zhou, Rongjia/N-9739-2019	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project [2006CB102103]; Key Transgenic New Organism Project [2009ZX08009-148B]; Program of Wuhan Subject Chief Scientist; 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project(National Basic Research Program of China); Key Transgenic New Organism Project; Program of Wuhan Subject Chief Scientist; 111 project(Ministry of Education, China - 111 Project)	Funding was provided by the National Natural Science Foundation of China, the National Key Basic Research project (2006CB102103), the Key Transgenic New Organism Project (2009ZX08009-148B), Program of Wuhan Subject Chief Scientist, and the 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRUCH J, 2008, J BIOL CHEM; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Lusher ME, 2002, CANCER RES, V62, P5906; OKOROKOV AL, 2009, CURR OPIN STRUCT BIO; RICHTER AM, 2009, BIOCH BIOPHYS ACTA; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tommasi S, 2005, CANCER RES, V65, P92; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	32	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17017	10.1371/journal.pone.0017017	http://dx.doi.org/10.1371/journal.pone.0017017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364923	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100019
J	Behnisch, T; YuanXiang, P; Bethge, P; Parvez, S; Chen, Y; Yu, J; Karpova, A; Frey, JU; Mikhaylova, M; Kreutz, MR				Behnisch, Thomas; YuanXiang, PingAn; Bethge, Philipp; Parvez, Suhel; Chen, Ying; Yu, Jin; Karpova, Anna; Frey, Julietta U.; Mikhaylova, Marina; Kreutz, Michael R.			Nuclear Translocation of Jacob in Hippocampal Neurons after Stimuli Inducing Long-Term Potentiation but Not Long-Term Depression	PLOS ONE			English	Article							NMDA RECEPTORS; SUBUNIT COMPOSITION; IMPORTIN-ALPHA; CREB SHUTOFF; LTP; SYNAPSE; EXPRESSION; PLASTICITY; ACTIVATION; INHIBITOR	Background: In recent years a number of potential synapto-nuclear protein messengers have been characterized that are thought to be involved in plasticity-related gene expression, and that have the capacity of importin-mediated and activity-dependent nuclear import. However, there is a surprising paucity of data showing the nuclear import of such proteins in cellular models of learning and memory. Only recently it was found that the transcription factor cyclic AMP response element binding protein 2 (CREB2) transits to the nucleus during long-term depression (LTD), but not during long-term potentiation (LTP) of synaptic transmission in hippocampal primary neurons. Jacob is another messenger that couples NMDA-receptor-activity to nuclear gene expression. We therefore aimed to study whether Jacob accumulates in the nucleus in physiological relevant models of activity-dependent synaptic plasticity. Methodology/Principal Findings: We have analyzed the dynamics of Jacob's nuclear import following induction of NMDA-receptor dependent LTP or LTD at Schaffer collateral-CA1 synapses in rat hippocampal slices. Using time-lapse imaging of neurons expressing a Jacob-Green-Fluorescent-Protein we found that Jacob rapidly translocates from dendrites to the nucleus already during the tetanization period of LTP, but not after induction of LTD. Immunocytochemical stainings confirmed the nuclear accumulation of endogenous Jacob in comparison to apical dendrites after induction of LTP but not LTD. Complementary findings were obtained after induction of NMDA-receptor dependent chemical LTP and LTD in hippocampal primary neurons. However, in accordance with previous studies, high concentrations of NMDA and glycine as well as specific activation of extrasynaptic NMDA-receptors resembling pathological conditions induce an even more profound increase of nuclear Jacob levels. Conclusions/Significance: Taken together, these findings suggest that the two major forms of NMDA-receptor dependent synaptic plasticity, LTP and LTD, elicit the transition of different synapto-nuclear messengers albeit in both cases importin-mediated retrograde transport and NMDA-receptor activation is required.	[Behnisch, Thomas; YuanXiang, PingAn; Chen, Ying; Yu, Jin] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Behnisch, Thomas] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Bethge, Philipp; Karpova, Anna; Mikhaylova, Marina; Kreutz, Michael R.] Leibniz Inst Neurobiol, Project Grp Neuroplast, Magdeburg, Germany; [Parvez, Suhel; Frey, Julietta U.] Leibniz Inst Neurobiol, Dept Neurophysiol, Magdeburg, Germany; [Parvez, Suhel] Hamdard Univ, Dept Toxicol, New Delhi, India	Fudan University; Fudan University; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Jamia Hamdard University	Behnisch, T (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	behnish@fudan.edu.cn	YUANXIANG, PingAn/AAF-1662-2019; Mikhaylova, Marina/AAM-4368-2020; Behnisch, Thomas/G-3688-2018; Parvez, Suhel/E-6778-2010	YUANXIANG, PingAn/0000-0002-3746-3282; Mikhaylova, Marina/0000-0001-7646-1346; Behnisch, Thomas/0000-0002-7842-3252; Parvez, Suhel/0000-0002-6318-6506	NSFC [30870795, 30970920]; DFG [SFB779, TPB8]; CBBS/Land Saxony-Anhalt/EU [C1-TP4]; DIP grant; DZNE; Schram Foundation	NSFC(National Natural Science Foundation of China (NSFC)); DFG(German Research Foundation (DFG)); CBBS/Land Saxony-Anhalt/EU(European Commission); DIP grant; DZNE; Schram Foundation	This work was supported by NSFC grants (30870795, 30970920) to T. B. and by the DFG (SFB779, TPB8 to M. R. K.), the CBBS/Land Saxony-Anhalt/EU (C1-TP4 to M. R. K.), DIP grant, the DZNE (to M. R. K.), and the Schram Foundation (to M. R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; Cai F, 2010, NEUROSCIENCE, V169, P1520, DOI 10.1016/j.neuroscience.2010.06.032; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frey S, 2008, PROG BRAIN RES, V169, P117, DOI 10.1016/S0079-6123(07)00007-6; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Goslin K., 1991, CULTURING NERVE CELL, P251; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kindler S, 2009, J BIOL CHEM, V284, P25431, DOI 10.1074/jbc.M109.022137; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kollen M, 2008, NEUROSCIENCE, V154, P1308, DOI 10.1016/j.neuroscience.2008.04.045; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; Leutgeb JK, 2003, J NEUROSCI METH, V130, P19, DOI 10.1016/S0165-0270(03)00228-0; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; RONICKE R, 2010, NEUROBIOL AGING 0202; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	39	37	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17276	10.1371/journal.pone.0017276	http://dx.doi.org/10.1371/journal.pone.0017276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364755	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482800042
J	Gillis, J; Pavlidis, P				Gillis, Jesse; Pavlidis, Paul			The Impact of Multifunctional Genes on "Guilt by Association" Analysis	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SYSTEMATIC METAANALYSES; COEXPRESSION NETWORKS; HIGH-THROUGHPUT; BY-ASSOCIATION; SCALE; MODULARITY; EVOLUTION; COST; RESOURCE	Many previous studies have shown that by using variants of "guilt-by-association", gene function predictions can be made with very high statistical confidence. In these studies, it is assumed that the "associations" in the data (e. g., protein interaction partners) of a gene are necessary in establishing "guilt". In this paper we show that multifunctionality, rather than association, is a primary driver of gene function prediction. We first show that knowledge of the degree of multifunctionality alone can produce astonishingly strong performance when used as a predictor of gene function. We then demonstrate how multifunctionality is encoded in gene interaction data (such as protein interactions and coexpression networks) and how this can feed forward into gene function prediction algorithms. We find that high-quality gene function predictions can be made using data that possesses no information on which gene interacts with which. By examining a wide range of networks from mouse, human and yeast, as well as multiple prediction methods and evaluation metrics, we provide evidence that this problem is pervasive and does not reflect the failings of any particular algorithm or data type. We propose computational controls that can be used to provide more meaningful control when estimating gene function prediction performance. We suggest that this source of bias due to multifunctionality is important to control for, with widespread implications for the interpretation of genomics studies.	[Gillis, Jesse; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Ctr High Throughput Biol, Vancouver, BC, Canada; [Gillis, Jesse; Pavlidis, Paul] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Gillis, J (corresponding author), Univ British Columbia, Dept Psychiat, Ctr High Throughput Biol, Vancouver, BC, Canada.	paul@chibi.ubc.ca	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Gillis, Jesse/0000-0002-0936-9774	NIH [GM076990]; Michael Smith Foundation for Health Research; Canadian Institutes for Health Research; CIHR; MIND Foundation of British Columbia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); MIND Foundation of British Columbia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH Grant GM076990, salary awards to PP from the Michael Smith Foundation for Health Research (http://www.msfhr.org/) and the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/), and postdoctoral fellowships to JG from CIHR and the MIND Foundation of British Columbia (http://mindbc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268702; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Casci T, 2006, NAT REV GENET, V7, P664, DOI 10.1038/nrg1949; Cesareni G, 2008, CURR PROTOC BIOINFOR; Chen GR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-75; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Griswold CK, 2006, EVOL DEV, V8, P81, DOI 10.1111/j.1525-142X.2006.05077.x; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Ivanic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005815; Ivanic J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-11; Janitz M, 2007, REV PHYSIOL BIOCH P, V159, P115, DOI 10.1007/112_2007_0703; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koonin EV, 2006, CURR OPIN BIOTECH, V17, P481, DOI 10.1016/j.copbio.2006.08.003; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee MW, 2007, YEAST, V24, P145, DOI 10.1002/yea.1446; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Martin S, 2005, BIOINFORMATICS, V21, P218, DOI 10.1093/bioinformatics/bth483; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McQueen M, PDGENE DATABASE; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; NEWTON I, 1687, EVOLUTION, V54, P510; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; PENACASTILLO L, 2008, GENOME BIOL S1, V9, pIL7; Pu SY, 2008, BIOINFORMATICS, V24, P2376, DOI 10.1093/bioinformatics/btn440; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Salathe M, 2006, MOL BIOL EVOL, V23, P721, DOI 10.1093/molbev/msj086; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van de Peppel J, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100006; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Young PJ, 2002, J BIOL CHEM, V277, P2852, DOI 10.1074/jbc.M108769200; ZENG Y, BIOL DIRECT, V5, P37; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	73	126	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17258	10.1371/journal.pone.0017258	http://dx.doi.org/10.1371/journal.pone.0017258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364756	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000287482800038
J	Campbell-Smith, G; Campbell-Smith, M; Singleton, I; Linkie, M				Campbell-Smith, Gail; Campbell-Smith, Miran; Singleton, Ian; Linkie, Matthew			Apes in Space: Saving an Imperilled Orangutan Population in Sumatra	PLOS ONE			English	Article							KIBALE NATIONAL-PARK; RANGING BEHAVIOR; FOREST EDGE; CROP; CONFLICT; ELEPHANT; PEOPLE; CONSTRAINTS; PERCEPTIONS; ATTITUDES	Deforestation rates in Sumatra are amongst the highest in the tropics. Lowland forests, which support the highest densities of orangutans, are particularly vulnerable to clearance and fragmentation because they are highly accessible. Consequently, many orangutans will, in the future, live in strictly or partially isolated populations. Whilst orangutans have been extensively studied in primary forests, their response to living in human-dominated landscapes remains poorly known, despite it being essential for their future management. Here, we focus on an isolated group of critically endangered Sumatran orangutans (Pongo abelii) that co-exist with farmers in a mixed agroforest system consisting of degraded natural forest, smallholder (predominantly rubber) farms and oil palm plantations. Over 24 months we conducted the first ever spatial assessment of orangutan habitat use in the human-transformed landscape of Batang Serangan, North Sumatra. From 1,204 independent crop-raiding incidents recorded, orangutans showed strong foraging preference for mixed farmland/degraded forest habitat over oil palm patches. The core home range areas of the eight adult orangutans encompassed only 14% of the available study area. Monthly home range sizes averaged 423 ha (+/- 139, SD) for males, and 131 +/- 46 ha for females, and were positively influenced by wild and cultivated fruit presence, and by crop consumption. The average daily distance travelled was similar for both adult males (868 m +/- 350, SD) and females (866 m +/- 195), but increased when orangutans raided crops. These findings show that orangutans can survive, demographically, in certain types of degraded landscapes, foraging on a mixture of crops and wild fruits. However, the poor quality habitat offered to orangutans by oil palm plantations, in terms of low food availability and as a barrier to female movements, is cause for concern since this is the land use type that is most rapidly replacing the preferred forest habitat across both Sumatran and Bornean orangutan ranges.	[Campbell-Smith, Gail; Linkie, Matthew] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Campbell-Smith, Miran] Orangutan Informat Ctr, Human Orangutan Conflict & Mitigat Programme, Medan, North Sumatra, Indonesia; [Singleton, Ian] PanEco Fdn, Sumatran Orangutan Conservat Programme, Medan, North Sumatra, Indonesia; [Linkie, Matthew] Fauna & Flora Int, Cambridge, England	University of Kent	Campbell-Smith, G (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	primatelass@gmail.com			United States Fish and Wildlife Service [31221208, 31221435]; G Campbell-Smith by Born Free Foundation; Humane Society International; PanEco; People's Trust for Endangered Species; Orangutan Republik Education Initiative; Orangutan Foundation; Primate Society of Great Britain; Borneo Orangutan Society-Canada; SeaWorld and Bush Gardens Conservation Fund	United States Fish and Wildlife Service(US Fish & Wildlife Service); G Campbell-Smith by Born Free Foundation; Humane Society International; PanEco; People's Trust for Endangered Species; Orangutan Republik Education Initiative; Orangutan Foundation; Primate Society of Great Britain; Borneo Orangutan Society-Canada; SeaWorld and Bush Gardens Conservation Fund	Funding: This specific study was supported by the United States Fish and Wildlife Service Great Ape Conservation Fund through grants # 31221208 and # 31221435 held by N Leader-Williams at the Durrell Institute of Conservation and Ecology, University of Kent, and by funds awarded to G Campbell-Smith by Born Free Foundation, Humane Society International, SeaWorld and Bush Gardens Conservation Fund, PanEco, People's Trust for Endangered Species, Orangutan Republik Education Initiative, Orangutan Foundation, Primate Society of Great Britain and Borneo Orangutan Society-Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Atmoko Sri Suci Utami, 2009, P225; Buij R, 2002, BIOL CONSERV, V107, P83, DOI 10.1016/S0006-3207(02)00048-4; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; Ganas J, 2005, BEHAV ECOL SOCIOBIOL, V58, P277, DOI 10.1007/s00265-005-0920-z; Grueter CC, 2009, PRIMATES, V50, P81, DOI 10.1007/s10329-008-0113-2; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; HARRISON ME, 2008, AM J PRIMATOL, V70, P1; Heiduck S, 2002, ORYX, V36, P133, DOI 10.1017/S0030605302000200; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hoare, 1999, STANDARDISED DATA CO; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2009, AM J PRIMATOL, V71, P636, DOI 10.1002/ajp.20698; Husson Simon J., 2009, P77; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Lahm S., 1996, PACHYDERM, V21, P69; Lee P. C., 2005, COMMENSALISM CONFLIC, V4, P1, DOI DOI 10.1002/047001539X.CH1; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Marchal V., 2009, PRIMATE CONSERVATION, V24, P107; Marshall Andrew J., 2009, P311; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; MORROGHBERNARD HC, 2002, ORANGUTAN DATA COLLE; Nantha HS, 2009, BIODIVERS CONSERV, V18, P487, DOI 10.1007/s10531-008-9512-3; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Nyhus PJ, 2000, ORYX, V34, P262, DOI 10.1017/S0030605300031331; Ostro LET, 1999, J WILDLIFE MANAGE, V63, P748, DOI 10.2307/3802665; Parker GE, 2006, ORYX, V40, P343, DOI 10.1017/S0030605306000822; Reynolds V, 2006, BUDONGO FOREST PROJE, V7, P4; Saj TL, 2001, AFR J ECOL, V39, P195, DOI 10.1046/j.0141-6707.2000.00299.x; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Singleton I, 2000, THESIS U KENT CANTER THESIS U KENT CANTER; Singleton Ian, 2009, P205; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Stephens D.W., 1986, pi; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Thouless Chris R., 1994, Oryx, V28, P119; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wartmann FM, 2010, PRIMATES, V51, P119, DOI 10.1007/s10329-009-0186-6; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	52	47	47	5	217	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17210	10.1371/journal.pone.0017210	http://dx.doi.org/10.1371/journal.pone.0017210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21364732	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700059
J	Jones, A; Osmond, C; Godfrey, KM; Phillips, DIW				Jones, Alexander; Osmond, Clive; Godfrey, Keith M.; Phillips, David I. W.			Evidence for Developmental Programming of Cerebral Laterality in Humans	PLOS ONE			English	Article							RESTRICTED MATERNAL NUTRITION; TYMPANIC MEMBRANE THERMOMETRY; PSYCHOLOGICAL STRESS; HEMISPHERIC ACTIVATION; ADULT LIFE; BLOOD-FLOW; DEPRESSION; BRAIN; PREGNANCY; FETAL	Adverse fetal environments are associated with depression, reduced cognitive ability and increased stress responsiveness in later life, but underlying mechanisms are unknown. Environmental pressures on the fetus, resulting from variations in placental function and maternal nutrition, health and stress might alter neurodevelopment, promoting the development of some brain regions over others. As asymmetry of cerebral activity, with greater right hemisphere activity, has been associated with psychopathology, we hypothesized that regional specialization during fetal life might be reflected persistently in the relative activity of the cerebral hemispheres. We tested this hypothesis in 140 healthy 8-9 year-old children, using tympanic membrane temperature to assess relative blood flow to the cerebral hemispheres at rest and following psychosocial stress (Trier Social Stress Test for Children). Their birth weight and placental weight had already been measured when their mothers took part in a previous study of pregnancy outcomes. We found that children who had a smaller weight at birth had evidence of greater blood flow to the right hemisphere than to the left hemisphere (r = -.09, P = .29 at rest; r = -.18, P = .04 following stress). This finding was strengthened if the children had a relatively low birth weight for their placental weight (r = -.17, P = .05 at rest; r = -.31, P = .0005 following stress). Our findings suggest that lateralization of cerebral activity is influenced persistently by early developmental experiences, with possible consequences for long-term neurocognitive function.	[Jones, Alexander] UCL, Ctr Cardiovasc Imaging, Inst Child Hlth, London, England; [Osmond, Clive; Godfrey, Keith M.; Phillips, David I. W.] MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, Diet & Lifestyle Biomed Res Unit, Southampton Natl Inst Hlth Res Nutr, Southampton, Hants, England	University of London; University College London; University of Southampton	Jones, A (corresponding author), UCL, Ctr Cardiovasc Imaging, Inst Child Hlth, London, England.	alexander.jones@ich.ucl.ac.uk		Osmond, Clive/0000-0002-9054-4655; Godfrey, Keith/0000-0002-4643-0618	National Institute for Health Research (UK) Specialist Biomedical Research Centre [09CC04]; National Institute of Child Health and Human Development (NICHD) [1 R01 HD41107-01]; Medical Research Council [U1475000004, MC_UP_A620_1017] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041107] Funding Source: NIH RePORTER; MRC [MC_UP_A620_1017] Funding Source: UKRI	National Institute for Health Research (UK) Specialist Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a National Institute for Health Research (UK) Specialist Biomedical Research Centre grant (09CC04 to A.J.) and a National Institute of Child Health and Human Development (NICHD) grant (1 R01 HD41107-01 to D.I.W.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Belkacemi L, 2009, PLACENTA, V30, P739, DOI 10.1016/j.placenta.2009.06.003; BELYI BI, 1987, INT J NEUROSCI, V32, P799, DOI 10.3109/00207458709043334; Braun CMJ, 1999, NEUROPSY NEUROPSY BE, V12, P35; Broekman BFP, 2009, PEDIATRICS, V123, pE1011, DOI 10.1542/peds.2008-3344; BuskeKirschbaum A, 1997, PSYCHOSOM MED, V59, P419, DOI 10.1097/00006842-199707000-00012; Campbell DM, 1996, BRIT J OBSTET GYNAEC, V103, P273, DOI 10.1111/j.1471-0528.1996.tb09718.x; CARMON A, 1972, BEHAV BIOL, V7, P853, DOI 10.1016/S0091-6773(72)80177-9; Carran MA, 2003, NEUROLOGY, V61, P770, DOI 10.1212/01.WNL.0000086378.74539.85; Cherbuin N, 2004, BRAIN COGNITION, V54, P228, DOI 10.1016/j.bandc.2004.02.014; Cherbuin N, 2007, LATERALITY, V12, P239, DOI 10.1080/13576500701218345; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Godfrey KM, 1997, BRIT J OBSTET GYNAEC, V104, P663, DOI 10.1111/j.1471-0528.1997.tb11975.x; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Heasman L, 1998, PEDIATR RES, V44, P546, DOI 10.1203/00006450-199810000-00013; Heasman L, 1999, P NUTR SOC, V58, P283, DOI 10.1017/S0029665199000397; Hecht D, 2010, NEUROSCI RES; Hopkins WD, 1998, BEHAV NEUROSCI, V112, P83, DOI 10.1037/0735-7044.112.1.83; Janocha A, 2009, NEUROENDOCRINOL LETT, V30, P119; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; Jones A, 2008, EUROPEAN HEART J; Jones A, 2007, HYPERTENSION, V49, P548, DOI 10.1161/01.HYP.0000257196.13485.9b; Lumey LH, 1998, PLACENTA, V19, P105; MEINERS ML, 1977, B PSYCHONOMIC SOC, V10, P194; OGAWA T, 1993, EUR J APPL PHYSIOL, V67, P354, DOI 10.1007/BF00357635; PERINI GI, 1986, PSYCHOTHER PSYCHOSOM, V45, P141, DOI 10.1159/000287940; REGARD M, 1994, BRAIN, V117, P91, DOI 10.1093/brain/117.1.91; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; ROGERS LJ, 1990, BEHAV BRAIN RES, V38, P211, DOI 10.1016/0166-4328(90)90176-F; Tegethoff M, 2010, PLOS ONE IN PRESS; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Whitfield J B, 2001, Twin Res, V4, P365, DOI 10.1375/twin.4.5.365; Wisniewski AB, 1998, PSYCHONEUROENDOCRINO, V23, P519, DOI 10.1016/S0306-4530(98)00019-5; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V; WITTLING W, 1990, BRAIN COGNITION, V14, P243, DOI 10.1016/0278-2626(90)90032-J; Wittling W, 1997, ACTA PHYSIOL SCAND, V161, P55; Yablonskiy DA, 2000, P NATL ACAD SCI USA, V97, P7603, DOI 10.1073/pnas.97.13.7603	44	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17071	10.1371/journal.pone.0017071	http://dx.doi.org/10.1371/journal.pone.0017071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359174	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287392700044
J	Swanston, T; Haakensen, M; Deneer, H; Walker, EG				Swanston, Treena; Haakensen, Monique; Deneer, Harry; Walker, Ernest G.			The Characterization of Helicobacter pylori DNA Associated with Ancient Human Remains Recovered from a Canadian Glacier	PLOS ONE			English	Article							VACUOLATING CYTOTOXIN ALLELES; MOLECULAR ANALYSIS; VACA GENOTYPES; STRAINS; CAGA; PATHOGENESIS; PERSISTENCE; DIVERSITY; EVOLUTION; REGION	Helicobacter pylori is a gram-negative bacterium that colonizes the stomach of nearly half of the world's population. Genotypic characterization of H. pylori strains involves the analysis of virulence-associated genes, such as vacA, which has multiple alleles. Previous phylogenetic analyses have revealed a connection between modern H. pylori strains and the movement of ancient human populations. In this study, H. pylori DNA was amplified from the stomach tissue of the Kwaday Dan Ts'inchi individual. This ancient individual was recovered from the Samuel Glacier in Tatshenshini-Alsek Park, British Columbia, Canada on the traditional territory of the Champagne and Aishihik First Nations and radiocarbon dated to a timeframe of approximately AD 1670 to 1850. This is the first ancient H. pylori strain to be characterized with vacA sequence data. The Tatshenshini H. pylori strain has a potential hybrid vacA m2a/m1d middle (m) region allele and a vacA s2 signal (s) region allele. A vacA s2 allele is more commonly identified with Western strains, and this suggests that European strains were present in northwestern Canada during the ancient individual's time. Phylogenetic analysis indicated that the vacA m1d region of the ancient strain clusters with previously published novel Native American strains that are closely related to Asian strains. This indicates a past connection between the Kwaday Dan Ts'inchi individual and the ancestors who arrived in the New World thousands of years ago.	[Swanston, Treena; Walker, Ernest G.] Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK, Canada; [Haakensen, Monique; Deneer, Harry] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Swanston, T (corresponding author), Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK, Canada.	treena.swanston@usask.ca			University of Saskatchewan	University of Saskatchewan	This study was funded by the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Allison MJ, 1999, AM J CLIN PATHOL, V112, P605; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1999, J CLIN MICROBIOL, V37, P2979, DOI 10.1128/JCM.37.9.2979-2982.1999; Atherton JC, 1999, CURR MICROBIOL, V39, P211, DOI 10.1007/s002849900447; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Aviles-Jimenez F, 2004, J BACTERIOL, V186, P5182, DOI 10.1128/jb.186.15.5182-5185.2004; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Beattie O., 2000, CANADIAN J ARCHAEOLO, V24, P129; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser Martin J, 2005, Trans Am Clin Climatol Assoc, V116, P65; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Castillo-Rojas G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-119; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; De Gusmao VR, 2000, J CLIN MICROBIOL, V38, P2853; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Goodman KJ, 2008, CAN J GASTROENTEROL, V22, P289, DOI 10.1155/2008/258610; Ji XH, 2000, INFECT IMMUN, V68, P3754, DOI 10.1128/IAI.68.6.3754-3757.2000; Ji XH, 2002, FEMS MICROBIOL LETT, V206, P253, DOI 10.1016/S0378-1097(01)00543-2; Kim YS, 2009, EUR J GASTROEN HEPAT, V21, P522, DOI 10.1097/MEG.0b013e3283196af0; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Letley DP, 2003, J BIOL CHEM, V278, P26734, DOI 10.1074/jbc.M304071200; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Monsalve MV, 2002, AM J PHYS ANTHROPOL, V119, P288, DOI 10.1002/ajpa.10116; Morales-Espinosa R, 1999, J CLIN MICROBIOL, V37, P3001, DOI 10.1128/JCM.37.9.3001-3004.1999; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Nicholas K.B., 1997, GENEDOC ANAL VISUALI; Owen RJ, 2007, MICROBIOL-SGM, V153, P1176, DOI 10.1099/mic.0.2006/002923-0; Pan ZJ, 1998, J INFECT DIS, V178, P220, DOI 10.1086/515601; Reyrat JM, 1999, MOL MICROBIOL, V34, P197, DOI 10.1046/j.1365-2958.1999.01592.x; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Richards MP, 2007, AM ANTIQUITY, V72, P719, DOI 10.2307/25470442; Rollo F, 2007, J ARCHAEOL SCI, V34, P1294, DOI 10.1016/j.jas.2006.10.019; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P2597, DOI 10.1128/JCM.36.9.2597-2603.1998; van Doorn LJ, 1998, J CLIN MICROBIOL, V36, P1271, DOI 10.1128/JCM.36.5.1271-1276.1998; Wang HJ, 1998, J INFECT DIS, V178, P207, DOI 10.1086/515600; Weyermann M, 2006, EPIDEMIOLOGY, V17, P332, DOI 10.1097/01.ede.0000201257.31155.a0; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005	46	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16864	10.1371/journal.pone.0016864	http://dx.doi.org/10.1371/journal.pone.0016864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359221	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700026
J	Wuchty, S; Arjona, D; Li, AG; Kotliarov, Y; Walling, J; Ahn, S; Zhang, A; Maric, D; Anolik, R; Zenklusen, JC; Fine, HA				Wuchty, Stefan; Arjona, Dolores; Li, Aiguo; Kotliarov, Yuri; Walling, Jennifer; Ahn, Susie; Zhang, Alice; Maric, Dragan; Anolik, Rachel; Zenklusen, Jean Claude; Fine, Howard A.			Prediction of Associations between microRNAs and Gene Expression in Glioma Biology	PLOS ONE			English	Article							MESSENGER-RNAS; REVEALS; AMPLIFICATION; GLIOBLASTOMA; REGIONS; MIRNAS; TUMORS; SITES; WEE1; SET	Despite progress in the determination of miR interactions, their regulatory role in cancer is only beginning to be unraveled. Utilizing gene expression data from 27 glioblastoma samples we found that the mere knowledge of physical interactions between specific mRNAs and miRs can be used to determine associated regulatory interactions, allowing us to identify 626 associated interactions, involving 128 miRs that putatively modulate the expression of 246 mRNAs. Experimentally determining the expression of miRs, we found an over-representation of over(under)-expressed miRs with various predicted mRNA target sequences. Such significantly associated miRs that putatively bind over-expressed genes strongly tend to have binding sites nearby the 3'UTR of the corresponding mRNAs, suggesting that the presence of the miRs near the translation stop site may be a factor in their regulatory ability. Our analysis predicted a significant association between miR-128 and the protein kinase WEE1, which we subsequently validated experimentally by showing that the over-expression of the naturally under-expressed miR-128 in glioma cells resulted in the inhibition of WEE1 in glioblastoma cells.	[Wuchty, Stefan] NINDS, Neurooncol Branch, NCI, Natl Ctr Biotechnol Informat,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wuchty, S (corresponding author), NINDS, Neurooncol Branch, NCI, Natl Ctr Biotechnol Informat,NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hfine@mail.nih.gov	Kotliarov, Yuri/B-6938-2017	Kotliarov, Yuri/0000-0002-6558-8883	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010840, ZIABC011101, ZIABC010839, ZIABC011099, ZIABC011100, ZICBC011086, ZIABC011102, ZIASC010100] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjona D, 2005, NEUROPATH APPL NEURO, V31, P384, DOI 10.1111/j.1365-2990.2005.00653.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI, 1995, J ROY STAT SOC, V57, P89; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Gonzalez-Gomez P, 2003, INT J ONCOL, V22, P601; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	53	59	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14681	10.1371/journal.pone.0014681	http://dx.doi.org/10.1371/journal.pone.0014681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358821	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700003
J	Blahnik, KR; Dou, L; Echipare, L; Iyengar, S; O'Geen, H; Sanchez, E; Zhao, YJ; Marra, MA; Hirst, M; Costello, JF; Korf, I; Farnham, PJ				Blahnik, Kimberly R.; Dou, Lei; Echipare, Lorigail; Iyengar, Sushma; O'Geen, Henriette; Sanchez, Erica; Zhao, Yongjun; Marra, Marco A.; Hirst, Martin; Costello, Joseph F.; Korf, Ian; Farnham, Peggy J.			Characterization of the Contradictory Chromatin Signatures at the 3 ' Exons of Zinc Finger Genes	PLOS ONE			English	Article							METHYLATION; EPIGENETICS; GENOME; HETEROCHROMATIN; POLYCOMB; REGIONS; BINDING	The H3K9me3 histone modification is often found at promoter regions, where it functions to repress transcription. However, we have previously shown that 3' exons of zinc finger genes (ZNFs) are marked by high levels of H3K9me3. We have now further investigated this unusual location for H3K9me3 in ZNF genes. Neither bioinformatic nor experimental approaches support the hypothesis that the 3' exons of ZNFs are promoters. We further characterized the histone modifications at the 3' ZNF exons and found that these regions also contain H3K36me3, a mark of transcriptional elongation. A genome-wide analysis of ChIP-seq data revealed that ZNFs constitute the majority of genes that have high levels of both H3K9me3 and H3K36me3. These results suggested the possibility that the ZNF genes may be imprinted, with one allele transcribed and one allele repressed. To test the hypothesis that the contradictory modifications are due to imprinting, we used a SNP analysis of RNA-seq data to demonstrate that both alleles of certain ZNF genes having H3K9me3 and H3K36me3 are transcribed. We next analyzed isolated ZNF 3' exons using stably integrated episomes. We found that although the H3K36me3 mark was lost when the 3' ZNF exon was removed from its natural genomic location, the isolated ZNF 3' exons retained the H3K9me3 mark. Thus, the H3K9me3 mark at ZNF 3' exons does not impede transcription and it is regulated independently of the H3K36me3 mark. Finally, we demonstrate a strong relationship between the number of tandemly repeated domains in the 3' exons and the H3K9me3 mark. We suggest that the H3K9me3 at ZNF 3' exons may function to protect the genome from inappropriate recombination rather than to regulate transcription.	[Blahnik, Kimberly R.; Iyengar, Sushma] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Dou, Lei; Echipare, Lorigail; O'Geen, Henriette; Sanchez, Erica; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Dou, Lei] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Zhao, Yongjun; Marra, Marco A.; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Costello, Joseph F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurosurg, San Francisco, CA 94143 USA; [Korf, Ian] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Farnham, Peggy J.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; British Columbia Cancer Agency; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California Davis; University of Southern California	Blahnik, KR (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	pfarnham@usc.edu	Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Farnham, Peggy/0000-0003-4469-7914	National Institutes of Health [R01CA45250, U54HG004558, NIH R01HG004348, U01ES017154]; George and Dorothy Zolk Fellowship; National Science Foundation [IIS-0612326]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004348, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Dorothy Zolk Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health [R01CA45250, U54HG004558, NIH R01HG004348, and U01ES017154]; the George and Dorothy Zolk Fellowship; and the National Science Foundation [IIS-0612326]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Crews D, 2010, HORM-INT J ENDOCRINO, V9, P41, DOI 10.14310/horm.2002.1251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; FRIETZE S, ZNF274 RECR IN PRESS; Grayson DR, 2009, EPIGENETICS-US, V4, P144, DOI 10.4161/epi.4.3.8534; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; HARRIS RA, 2010, NATURE BIOT IN PRESS; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwamoto K, 2009, NEUROPSYCHOBIOLOGY, V60, P5, DOI 10.1159/000234811; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; WIENCKE JK, 2007, ONCOGENE; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	31	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17121	10.1371/journal.pone.0017121	http://dx.doi.org/10.1371/journal.pone.0017121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347206	Green Submitted, gold, Green Published			2022-12-27	WOS:000287369200024
J	Lamppa, JW; Ackerman, ME; Lai, JI; Scanlon, TC; Griswold, KE				Lamppa, John W.; Ackerman, Margaret E.; Lai, Jennifer I.; Scanlon, Thomas C.; Griswold, Karl E.			Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity	PLOS ONE			English	Article							MUCOID EXOPOLYSACCHARIDE ALGINATE; PSEUDOMONAS-AERUGINOSA; IN-VITRO; INFECTIONS	Alginate lyase enzymes represent prospective biotherapeutic agents for treating bacterial infections, particularly in the cystic fibrosis airway. To effectively deimmunize one therapeutic candidate while maintaining high level catalytic proficiency, a combined genetic engineering-PEGylation strategy was implemented. Rationally designed, site-specific PEGylation variants were constructed by orthogonal maleimide-thiol coupling chemistry. In contrast to random PEGylation of the enzyme by NHS-ester mediated chemistry, controlled mono-PEGylation of A1-III alginate lyase produced a conjugate that maintained wild type levels of activity towards a model substrate. Significantly, the PEGylated variant exhibited enhanced solution phase kinetics with bacterial alginate, the ultimate therapeutic target. The immunoreactivity of the PEGylated enzyme was compared to a wild type control using in vitro binding studies with both enzyme-specific antibodies, from immunized New Zealand white rabbits, and a single chain antibody library, derived from a human volunteer. In both cases, the PEGylated enzyme was found to be substantially less immunoreactive. Underscoring the enzyme's potential for practical utility, > 90% of adherent, mucoid, Pseudomonas aeruginosa biofilms were removed from abiotic surfaces following a one hour treatment with the PEGylated variant, whereas the wild type enzyme removed only 75% of biofilms in parallel studies. In aggregate, these results demonstrate that site-specific mono-PEGylation of genetically engineered A1-III alginate lyase yielded an enzyme with enhanced performance relative to therapeutically relevant metrics.	[Lamppa, John W.; Ackerman, Margaret E.; Scanlon, Thomas C.; Griswold, Karl E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Lai, Jennifer I.] MIT, Dept Biol Engn, Boston, MA USA; [Griswold, Karl E.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Griswold, Karl E.] Dartmouth Coll, Program Mol & Cellular Biol, Hanover, NH 03755 USA	Dartmouth College; Massachusetts Institute of Technology (MIT); Dartmouth College; Dartmouth College	Lamppa, JW (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	karl.e.griswold@dartmouth.edu	Ackerman, Margaret/B-5944-2012; Griswold, Karl/B-3449-2012	Griswold, Karl/0000-0002-9835-3394	Cystic Fibrosis Foundation at Dartmouth Medical School; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P20RR018787-06]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation at Dartmouth Medical School; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Pilot and Feasibility Grant from the Cystic Fibrosis Foundation's Research Development Program at Dartmouth Medical School and by P20RR018787-06 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Alipour M, 2009, J ANTIMICROB CHEMOTH, V64, P317, DOI 10.1093/jac/dkp165; Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; BAYER AS, 1991, INFECT IMMUN, V59, P302, DOI 10.1128/IAI.59.1.302-308.1991; BAYER AS, 1992, INFECT IMMUN, V60, P3979, DOI 10.1128/IAI.60.10.3979-3985.1992; EFTEKHAR F, 1988, INFECT IMMUN, V56, P2788, DOI 10.1128/IAI.56.11.2788-2793.1988; Elkin Sarah, 2003, Expert Rev Anti Infect Ther, V1, P609, DOI 10.1586/14787210.1.4.609; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Hashimoto W, 1999, J BIOSCI BIOENG, V87, P123, DOI 10.1016/S1389-1723(99)89001-X; Hatch RA, 1998, ANTIMICROB AGENTS CH, V42, P974, DOI 10.1128/AAC.42.4.974; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Kodera Y, 1998, PROG POLYM SCI, V23, P1233, DOI 10.1016/S0079-6700(97)00033-6; MAI GT, 1993, INFECT IMMUN, V61, P559, DOI 10.1128/IAI.61.2.559-564.1993; MAY TB, 1991, CLIN MICROBIOL REV, V4, P191, DOI 10.1128/CMR.4.2.191-206.1991; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; MRSNY RJ, 1994, PULM PHARMACOL, V7, P357, DOI 10.1006/pulp.1994.1042; MURATA K, 1993, J FERMENT BIOENG, V76, P427, DOI 10.1016/0922-338X(93)90040-F; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Sakakibara H, 2002, J PHARM SCI, V91, P1191, DOI 10.1002/jps.10110; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Shire S J, 1996, Pharm Biotechnol, V9, P393; SIMPSON JA, 1993, BIOCHEM MOL BIOL INT, V30, P1021; SKJAKBRAEK G, 1989, CARBOHYD RES, V185, P131, DOI 10.1016/0008-6215(89)84028-5; Smedley YM, 1986, J PHARM PHARM S, V38, P54; Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Wingender J, 2001, METHOD ENZYMOL, V336, P302, DOI 10.1016/S0076-6879(01)36597-7; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	34	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17042	10.1371/journal.pone.0017042	http://dx.doi.org/10.1371/journal.pone.0017042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340021	Green Published, Green Submitted, gold			2022-12-27	WOS:000287367600032
J	Wang, P; Holst, C; Andersen, MR; Astrup, A; Bouwman, FG; van Otterdijk, S; Wodzig, WKWH; van Baak, MA; Larsen, TM; Jebb, SA; Kafatos, A; Pfeiffer, AFH; Martinez, JA; Handjieva-Darlenska, T; Kunesova, M; Saris, WHM; Mariman, ECM				Wang, Ping; Holst, Claus; Andersen, Malene R.; Astrup, Arne; Bouwman, Freek G.; van Otterdijk, Sanne; Wodzig, Will K. W. H.; van Baak, Marleen A.; Larsen, Thomas M.; Jebb, Susan A.; Kafatos, Anthony; Pfeiffer, Andreas F. H.; Alfredo Martinez, J.; Handjieva-Darlenska, Teodora; Kunesova, Marie; Saris, Wim H. M.; Mariman, Edwin C. M.			Blood Profile of Proteins and Steroid Hormones Predicts Weight Change after Weight Loss with Interactions of Dietary Protein Level and Glycemic Index	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; I-CONVERTING-ENZYME; LOSS MAINTENANCE; OBESITY; POLYMORPHISMS; INFLAMMATION; DISEASE; ADULTS	Background: Weight regain after weight loss is common. In the Diogenes dietary intervention study, high protein and low glycemic index (GI) diet improved weight maintenance. Objective: To identify blood predictors for weight change after weight loss following the dietary intervention within the Diogenes study. Design: Blood samples were collected at baseline and after 8-week low caloric diet-induced weight loss from 48 women who continued to lose weight and 48 women who regained weight during subsequent 6-month dietary intervention period with 4 diets varying in protein and GI levels. Thirty-one proteins and 3 steroid hormones were measured. Results: Angiotensin I converting enzyme (ACE) was the most important predictor. Its greater reduction during the 8-week weight loss was related to continued weight loss during the subsequent 6 months, identified by both Logistic Regression and Random Forests analyses. The prediction power of ACE was influenced by immunoproteins, particularly fibrinogen. Leptin, luteinizing hormone and some immunoproteins showed interactions with dietary protein level, while interleukin 8 showed interaction with GI level on the prediction of weight maintenance. A predictor panel of 15 variables enabled an optimal classification by Random Forests with an error rate of 24 +/- 1%. A logistic regression model with independent variables from 9 blood analytes had a prediction accuracy of 92%. Conclusions: A selected panel of blood proteins/steroids can predict the weight change after weight loss. ACE may play an important role in weight maintenance. The interactions of blood factors with dietary components are important for personalized dietary advice after weight loss.	[Wang, Ping; Bouwman, Freek G.; van Otterdijk, Sanne; van Baak, Marleen A.; Saris, Wim H. M.; Mariman, Edwin C. M.] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Holst, Claus] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Andersen, Malene R.] Copenhagen Univ Hosp, Dept Clin Biochem, Gentofte, Denmark; [Astrup, Arne; Larsen, Thomas M.] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Copenhagen, Denmark; [Wodzig, Will K. W. H.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Jebb, Susan A.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Kafatos, Anthony] Univ Crete, Dept Social Med, Prevent Med & Nutr Clin, Iraklion, Greece; [Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany; [Pfeiffer, Andreas F. H.] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Alfredo Martinez, J.] Univ Navarra, Dept Physiol & Nutr, E-31080 Pamplona, Spain; [Handjieva-Darlenska, Teodora] Natl Multiprofile Transport Hosp, Dept Nutr Dietet & Metab Dis, Sofia, Bulgaria; [Kunesova, Marie] Inst Endocrinol, Obes Management Ctr, Prague, Czech Republic	Maastricht University; Maastricht University Medical Centre (MUMC); University of Copenhagen; University of Copenhagen; University of Copenhagen; Maastricht University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Crete; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Navarra; Institute of Endocrinology - Prague	Wang, P (corresponding author), Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	e.mariman@maastrichtuniversity.nl	Pfeiffer, Andreas F.H./AAJ-2311-2020; Martinez Hernandez, J Alfredo/K-8709-2014; Meinert Larsen, Thomas/D-4818-2015; Astrup, Arne/B-1407-2015	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Wang, Ping/0000-0002-8876-4210; Martinez Hernandez, J Alfredo/0000-0001-5218-6941; van Baak, Marleen/0000-0003-2592-6363; Meinert Larsen, Thomas/0000-0001-7621-3131; Astrup, Arne/0000-0001-8968-8996; Jebb, Susan/0000-0001-9190-2920	European Community [FOOD-CT-2005-513946]; MRC [MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_U105960389] Funding Source: researchfish	European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Diogenes project. Diogenes is the acronym of the project "Diet, Obesity and Genes'' supported by the European Community (contract No. FOOD-CT-2005-513946), http://www.diogenes-eu.org/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwman FG, 2009, J PROTEOME RES, V8, P5532, DOI 10.1021/pr900606m; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Eriksson U, 2002, CURR BIOL, V12, pR745, DOI 10.1016/S0960-9822(02)01255-1; Fabricatore AN, 2009, BEHAV RES THER, V47, P685, DOI 10.1016/j.brat.2009.05.004; Festa A, 2001, INT J OBESITY, V25, P1407, DOI 10.1038/sj.ijo.0801792; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goossens G H, 2003, Obes Rev, V4, P43; Goyenechea E, 2009, ANN NUTR METAB, V54, P43, DOI 10.1159/000205319; Harp JB, 2002, OBES RES, V10, P985, DOI 10.1038/oby.2002.134; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Larsen TM, 2010, OBES REV, V11, P76, DOI 10.1111/j.1467-789X.2009.00603.x; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Maubaret CG, 2009, ATHEROSCLEROSIS, V207, pE10, DOI 10.1016/j.atherosclerosis.2009.09.055; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; Mobbs CV, 2007, CELL METAB, V5, P1, DOI 10.1016/j.cmet.2006.12.005; Moore CS, 2010, OBES REV, V11, P67, DOI 10.1111/j.1467-789X.2009.00602.x; Pasman WJ, 1999, OBES RES, V7, P43, DOI 10.1002/j.1550-8528.1999.tb00389.x; Phillips CM, 2009, J NUTR, V139, P2011, DOI 10.3945/jn.109.110635; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; R Core Team, 2018, R LANG ENV STAT COMP; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; SKIDGEL RA, 1985, P NATL ACAD SCI USA, V82, P1025, DOI 10.1073/pnas.82.4.1025; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Vogels N, 2005, AM J CLIN NUTR, V82, P740, DOI 10.1093/ajcn/82.4.740; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; WULFF BS, 1993, J BIOL CHEM, V268, P13327; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	35	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16773	10.1371/journal.pone.0016773	http://dx.doi.org/10.1371/journal.pone.0016773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340022	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600019
J	Ohta, H; Arai, S; Akita, K; Ohta, T; Fukuda, S				Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu			Neurotrophic Effects of a Cyanine Dye via the PI3K-Akt Pathway: Attenuation of Motor Discoordination and Neurodegeneration in an Ataxic Animal Model	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PC12 CELLS; NEURITE OUTGROWTH; CEREBRAL-ISCHEMIA; PURKINJE-CELLS; PROTEIN-KINASE; FACTOR-I; BRAIN; RECEPTOR; NEURONS	Background: Neurotrophic factors may be future therapeutic agents for neurodegenerative disease. In the screening of biologically active molecules for neurotrophic potency, we found that a photosensitizing cyanine dye, NK-4, had remarkable neurotrophic activities and was a potent radical scavenger. Methodology/Principal Findings: In this study, we evaluated the effect of NK-4 on the protection of neurons against oxidative damage and investigated the associated intracellular signaling pathways. Subsequently, we evaluated the effect of NK-4 in an animal model of neurodegeneration. In vitro, NK-4 showed dose-dependent protection of PC12 cells from toxicity induced by oxidative stress caused by hydrogen peroxide (H2O2) or 6-hydroxydopamine (6-OHDA). Comparison of extracellular signal-regulated kinase signaling pathways between treatment with NK-4 and nerve growth factor (NGF) using K252a, an inhibitor of the NGF receptor TrkA, revealed that NK-4 activity occurs independently of NGF receptors. LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor, blocked the protective effect of NK-4, and NK-4 caused activation of Akt/protein kinase B, a downstream effector of PI3K. These results suggest that the neuroprotective effects of NK-4 are mediated by the PI3K-Akt signaling pathway. NK-4 treatment also attenuated stress-induced activation of SAPK/JNK, which suggests that NK-4 activates a survival signaling pathway and inhibits stress-activated apoptotic pathways independently of the TrkA receptor in neuronal cells. In vivo, administration of NK-4 improved motor coordination in genetic ataxic hamsters, as assessed by rota-rod testing. Histological analysis showed that cerebellar atrophy was significantly attenuated by NK-4 treatment. Notably, the Purkinje cell count in the treated group was threefold higher than that in the vehicle group. Conclusions/Significance: These results suggest that NK-4 is a potential agent for therapy for neurodegenerative disorders based on the activation of survival signaling pathways.	[Ohta, Hitomi; Arai, Shigeyuki; Akita, Kenji; Ohta, Tsunetaka; Fukuda, Shigeharu] Hayashibara Biochem Labs Inc, Res Ctr, Inst Biomed, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.	Ohta, H (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Inst Biomed, Okayama, Japan.	htmohta@hayashibara.co.jp			Hayashibara Biochemical Laboratories Inc.	Hayashibara Biochemical Laboratories Inc.	Funding: Funding for this study was provided by Hayashibara Biochemical Laboratories Inc. The authors are employees of Hayashibara Biochemical Laboratories Inc., and they participated in study design, data collection, decision to publish and preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akita K, 2007, J NEUROGENET, V21, P19, DOI 10.1080/01677060600843316; Akita K, 2009, CEREBELLUM, V8, P202, DOI 10.1007/s12311-009-0113-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Barski JJ, 2003, J NEUROSCI, V23, P3469; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BERG MM, 1992, J BIOL CHEM, V267, P13; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Carrascosa C, 2004, BIOMATERIALS, V25, P707, DOI 10.1016/S0142-9612(03)00562-3; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; Dago L, 2002, J NEUROCHEM, V81, P17, DOI 10.1046/j.1471-4159.2002.00803.x; de Warrenburg BPC, 2005, MOVEMENT DISORD, V20, P497, DOI 10.1002/mds.20375; Fernandez AM, 1998, P NATL ACAD SCI USA, V95, P1253, DOI 10.1073/pnas.95.3.1253; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; FISHER M, 1995, J CEREBR BLOOD F MET, V15, P953, DOI 10.1038/jcbfm.1995.121; Florez-McClure ML, 2004, J NEUROSCI, V24, P4498, DOI 10.1523/JNEUROSCI.5744-03.2004; Fonnum F, 2004, J NEUROCHEM, V88, P513, DOI 10.1046/j.1471-4159.2003.02211.x; Fonnum F, 2000, TOXICOL LETT, V112, P9, DOI 10.1016/S0378-4274(99)00246-5; GIAVAZZI R, 1986, CANCER RES, V46, P1928; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Halliwell B, 1999, FREE RADIC BIOL MED, V3, P146; Halliwell B, 1999, FREE RADIC BIOL MED, V3, P170; Halliwell B., 1999, FREE RADICALS BIOL M, V3, P140; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ishihara M, 2007, IN VIVO, V21, P163; Kim Y, 2004, MOL CELLS, V18, P353; Koya-Miyata S, 2010, BIOL PHARM BULL, V33, P1872, DOI 10.1248/bpb.33.1872; Kunikata T, 2002, BIOL PHARM BULL, V25, P1018, DOI 10.1248/bpb.25.1018; LEVI A, 1988, MOL NEUROBIOL, V2, P201, DOI 10.1007/BF02935346; Li JX, 2010, NEURON, V68, P45, DOI 10.1016/j.neuron.2010.08.013; Malek RL, 1999, J BIOL CHEM, V274, P35499, DOI 10.1074/jbc.274.50.35499; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; MENDEZ JS, 1975, J NEUROSURG, V42, P166, DOI 10.3171/jns.1975.42.2.0166; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Mito K, 1996, J MED ENG TECHNOL, V20, P121, DOI 10.3109/03091909609008390; Mito Keiichiro, 1996, Frontiers of Medical and Biological Engineering, V7, P81; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; Spedding M, 2008, NOVART FDN SYMP, V289, P222, DOI [DOI 10.1002/9780470751251.CH18, DOI 10.1002/SERIES1767]; Ushio C, 2009, BIOMED RES-TOKYO, V30, P365, DOI 10.2220/biomedres.30.365; Weeks BS, 2007, MED SCI MONITOR, V13, pBR51; Welsh JP, 2002, ADV NEUROL, V89, P331; Yoo Young Mi, 2003, Neurosurg Focus, V15, pECP1; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9; Zhou XH, 2003, BIOL PHARM BULL, V26, P341	56	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17137	10.1371/journal.pone.0017137	http://dx.doi.org/10.1371/journal.pone.0017137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347252	gold, Green Submitted, Green Published			2022-12-27	WOS:000287364500032
J	Tanturli, M; Giuntoli, S; Barbetti, V; Rovida, E; Dello Sbarba, P				Tanturli, Michele; Giuntoli, Serena; Barbetti, Valentina; Rovida, Elisabetta; Dello Sbarba, Persio			Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia	PLOS ONE			English	Article							BONE-MARROW-CELLS; APOPTOSIS; PROGENITORS	We previously demonstrated that severe hypoxia inhibits growth of Chronic Myeloid Leukemia (CML) cells and selects stem cells where BCR/Abl(protein) is suppressed, although mRNA is not, so that hypoxia-selected stem cells, while remaining leukemic, are independent of BCR/Abl signaling and thereby refractory to Imatinib-mesylate. The main target of this study was to address the effects of the proteasome inhibitor Bortezomib (BZ) on the maintenance of stem or progenitor cells in hypoxic primary cultures (LC1), by determining the capacity of LC1 cells to repopulate normoxic secondary cultures (LC2) and the kinetics of this repopulation. Unselected K562 cells from day-2 hypoxic LC1 repopulated LC2 with rapid, progenitor-type kinetics; this repopulation was suppressed by BZ addition to LC1 at time 0, but completely resistant to day-1 BZ, indicating that progenitors require some time to adapt to stand hypoxia. K562 cells selected in hypoxic day-7 LC1 repopulated LC2 with stem-type kinetics, which was largely resistant to BZ added at either time 0 or day 1, indicating that hypoxia-selectable stem cells are BZ-resistant per se, i.e. before their selection. Furthermore, these cells were completely resistant to day-6 BZ, i.e. after selection. On the other hand, hypoxia-selected stem cells from CD34-positive cells of blast-crisis CML patients appeared completely resistant to either time-0 or day-1 BZ. To exploit in vitro the capacity of CML cells to adapt to hypoxia enabled to detect a subset of BZ-resistant leukemia stem cells, a finding of particular relevance in light of the fact that our experimental system mimics the physiologically hypoxic environment of bone marrow niches where leukemia stem cells most likely home and sustain minimal residual disease in vivo. This suggests the use of BZ as an enhanced strategy to control CML. in particular to prevent relapse of disease, to be considered with caution and to need further deepening.	[Tanturli, Michele] Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy; Ist Toscano Tumori, Florence, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Tanturli, M (corresponding author), Univ Florence, Dipartimento Patol & Oncol Sperimentali, Florence, Italy.	persio@unifi.it	Rovida, Elisabetta/F-3565-2015; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Tanturli, Michele/0000-0002-2642-1706	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG5220]; Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra; Federazione Italiana per la Ricerca sul Cancro (FIRC); Istituto Toscano Tumori (ITT)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori (ITT)	This work was supported by grants from Istituto Toscano Tumori (ITT), Associazione Italiana per la Ricerca sul Cancro (AIRC; contract # IG5220) and Associazione Italiana per la lotta contro le Leucemie e i Linfomi (AIL, sezione di Prato), Fondazione Cassa di Risparmio di Volterra. VB was supported by Federazione Italiana per la Ricerca sul Cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albero MP, 2010, ONCOGENE, V29, P3276, DOI 10.1038/onc.2010.81; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Cipolleschi MG, 2000, LEUKEMIA, V14, P735, DOI 10.1038/sj.leu.2401744; DELLOSBARBA P, 1987, EXP HEMATOL, V15, P137; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Giuntoli S, 2006, LEUKEMIA, V20, P1291, DOI 10.1038/sj.leu.2404224; Giuntoli S, 2007, STEM CELLS, V25, P1119, DOI 10.1634/stemcells.2006-0637; Giuntoli S, 2011, HAEMATOL-HEMATOL J, V96, P204, DOI 10.3324/haematol.2010.029082; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Ivanovic Z, 2002, EXP HEMATOL, V30, P67, DOI 10.1016/S0301-472X(01)00765-2; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Olivotto M, 2008, CELL CYCLE, V7, P176, DOI 10.4161/cc.7.2.5315; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104	13	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17008	10.1371/journal.pone.0017008	http://dx.doi.org/10.1371/journal.pone.0017008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347297	Green Published, Green Submitted, gold			2022-12-27	WOS:000287364500021
J	Vuohelainen, T; Ojala, R; Virtanen, A; Korhonen, P; Luukkaala, T; Holm, P; Tammela, O				Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Luukkaala, Tiina; Holm, Paivi; Tammela, Outi			Decreased Free Water Clearance Is Associated with Worse Respiratory Outcomes in Premature Infants	PLOS ONE			English	Article							ANTI-DIURETIC HORMONE; ATRIAL-NATRIURETIC-PEPTIDE; BRONCHOPULMONARY DYSPLASIA; MECHANICAL VENTILATION; DISTRESS SYNDROME; NEONATAL-PERIOD; VASOPRESSIN; HOMEOSTASIS; EXCRETION; PRESSURE	Objective: The goal was to elucidate predictors of decreased free water clearance (DFWC) in very low birth weight (VLBW) infants. We hypothesized that DFWC and fluid retention are linked to the severity of pulmonary problems and prolonged respiratory support, especially to nCPAP treatment. Methods: The investigation was carried out at Tampere University Hospital between 2001 and 2006. The study population comprised 74 VLBW infants born at 29.21 (24.57-34.14) weeks of gestation. Median birth weight was 1175 (575-1490) grams. We measured plasma and urine osmolality and 24-hour urine volume to calculate free water clearance (FWC) for each infant. If FWC was less than 30 ml/kg/day the infant was classified as having DFWC. Results: There were 38 (51.4%) infants with DFWC in the study population. The median duration of the observed DFT period was 14 (4-44) days. The gestational age at birth was lower for DFWC infants compared to infants with normal FWC (NFWC), 28.29 (24.57-32.86) vs. 30.00 (25.57-34.14) weeks (p = 0.001). DFWC infants also needed longer ventilator treatment, 2 (0-23) vs. 0.50 (0-23) days (p = 0.046), nCPAP treatment 30 (0-100) vs. 3 (0-41) days (p < 0.0001) and longer oxygen supplementation 47 (0-163) vs. 22 (0-74) days (p = 0.011) than NFWC infants. All values presented here are medians with ranges. Conclusions: DFWC appears to be frequently connected with exacerbation and prolongation of pulmonary problems in VLBW infants. Cautious fluid administration seems to be indicated in VLBW infants with prolonged respiratory problems and DFWC.	[Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Tammela, Outi] Univ Tampere, Paediat Res Ctr, FIN-33101 Tampere, Finland; [Vuohelainen, Tuomo; Ojala, Riitta; Virtanen, Anita; Korhonen, Paivi; Tammela, Outi] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Vuohelainen, Tuomo; Ojala, Riitta; Korhonen, Paivi; Tammela, Outi] Tampere Univ Hosp, Dept Paediat, Tampere, Finland; [Luukkaala, Tiina] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland; [Holm, Paivi] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital	Vuohelainen, T (corresponding author), Univ Tampere, Paediat Res Ctr, FIN-33101 Tampere, Finland.	tuomo.vuohelainen@fimnet.fi		Luukkaala, Tiina/0000-0003-4636-9586; Korhonen, Paivi/0000-0002-1747-5526	Tampere University Hospital [9K130, 9L102]	Tampere University Hospital	This study was financially supported by the Competitive Research Funding of the Tampere University Hospital (Grants 9K130 and 9L102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell EF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000503.pub2; BENFIELD GFA, 1982, THORAX, V37, P147, DOI 10.1136/thx.37.2.147; Das Bibhuti B., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P43; DAWSON KP, 1983, THORAX, V38, P589, DOI 10.1136/thx.38.8.589; FRASS M, 1993, CRIT CARE MED, V21, P343, DOI 10.1097/00003246-199303000-00009; HAZINSKI TA, 1988, PEDIATR RES, V23, P86, DOI 10.1203/00006450-198801000-00019; HEMMER M, 1980, ANESTHESIOLOGY, V52, P395, DOI 10.1097/00000542-198005000-00004; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kobr J, 2010, PHYSIOL RES, V59, P545, DOI 10.33549/physiolres.931752; KOJIMA T, 1990, PEDIATR RES, V27, P260, DOI 10.1203/00006450-199003000-00011; Laughon MM, 2009, SEMIN FETAL NEONAT M, V14, P374, DOI 10.1016/j.siny.2009.08.002; MANNING PT, 1985, SCIENCE, V229, P395, DOI 10.1126/science.2990050; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pihkala J, 1989, Duodecim, V105, P1540; RAO M, 1986, AM J DIS CHILD, V140, P825, DOI 10.1001/archpedi.1986.02140220107045; RONCONI M, 1995, J PERINAT MED, V23, P307, DOI 10.1515/jpme.1995.23.4.307; ROSSAINT R, 1993, J APPL PHYSIOL, V75, P2484, DOI 10.1152/jappl.1993.75.6.2484; SHENNAN AT, 1988, PEDIATRICS, V82, P527; SPITZER AR, 1981, J PEDIATR-US, V98, P476, DOI 10.1016/S0022-3476(81)80728-7; Swischuk LE, 1996, PEDIATR RADIOL, V26, P508, DOI 10.1007/BF01372230; TAMMELA OKT, 1992, ACTA PAEDIATR, V81, P207, DOI 10.1111/j.1651-2227.1992.tb12205.x; TAMMELA OKT, 1995, EUR J PEDIATR, V154, pS15, DOI 10.1007/BF02155106; Tkacova R, 1997, J AM COLL CARDIOL, V30, P739, DOI 10.1016/S0735-1097(97)00199-X; Vuohelainen T, 2008, ACTA PAEDIATR, V97, P904, DOI 10.1111/j.1651-2227.2008.00809.x; Vuohelainen T, 2007, PEDIATR RES, V62, P106, DOI 10.1203/PDR.0b013e3180674d92; VUORI A, 1982, INT J CLIN PHARM TH, V20, P488; WIRIYATHIAN S, 1986, PEDIATR RES, V20, P103, DOI 10.1203/00006450-198602000-00001	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16995	10.1371/journal.pone.0016995	http://dx.doi.org/10.1371/journal.pone.0016995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347330	gold, Green Published, Green Submitted			2022-12-27	WOS:000287363000029
J	Brenner, K; Arnold, FH				Brenner, Katie; Arnold, Frances H.			Self-Organization, Layered Structure, and Aggregation Enhance Persistence of a Synthetic Biofilm Consortium	PLOS ONE			English	Article							EVOLUTIONARY PERSPECTIVE; SPATIAL STRUCTURE; COMMUNICATION; COMMUNITY; SELECTION; BACTERIA; MICROORGANISMS; POPULATIONS; COMPETITION; BEHAVIOR	Microbial consortia constitute a majority of the earth's biomass, but little is known about how these cooperating communities persist despite competition among community members. Theory suggests that non-random spatial structures contribute to the persistence of mixed communities; when particular structures form, they may provide associated community members with a growth advantage over unassociated members. If true, this has implications for the rise and persistence of multi-cellular organisms. However, this theory is difficult to study because we rarely observe initial instances of non-random physical structure in natural populations. Using two engineered strains of Escherichia coli that constitute a synthetic symbiotic microbial consortium, we fortuitously observed such spatial self-organization. This consortium forms a biofilm and, after several days, adopts a defined layered structure that is associated with two unexpected, measurable growth advantages. First, the consortium cannot successfully colonize a new, downstream environment until it self-organizes in the initial environment; in other words, the structure enhances the ability of the consortium to survive environmental disruptions. Second, when the layered structure forms in downstream environments the consortium accumulates significantly more biomass than it did in the initial environment; in other words, the structure enhances the global productivity of the consortium. We also observed that the layered structure only assembles in downstream environments that are colonized by aggregates from a previous, structured community. These results demonstrate roles for self-organization and aggregation in persistence of multi-cellular communities, and also illustrate a role for the techniques of synthetic biology in elucidating fundamental biological principles.	[Brenner, Katie; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Brenner, K (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X	National Institutes of Health [1-R01-CA118486]; NATIONAL CANCER INSTITUTE [R01CA118486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institutes of Health grant 1-R01-CA118486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Johnson CR, 2002, TRENDS ECOL EVOL, V17, P83, DOI 10.1016/S0169-5347(01)02385-0; Johnson CR, 2002, P ROY SOC B-BIOL SCI, V269, P655, DOI 10.1098/rspb.2001.1948; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Lion S, 2008, ECOL LETT, V11, P277, DOI 10.1111/j.1461-0248.2007.01132.x; Millstein RL, 2006, BRIT J PHILOS SCI, V57, P627, DOI 10.1093/bjps/axl025; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Pesci EC, 1997, TRENDS MICROBIOL, V5, P132, DOI 10.1016/S0966-842X(97)01008-1; RICHAUD C, 1984, J BIOL CHEM, V259, P4824; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wingreen NS, 2006, PLOS BIOL, V4, P1486, DOI 10.1371/journal.pbio.0040299	35	52	54	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16791	10.1371/journal.pone.0016791	http://dx.doi.org/10.1371/journal.pone.0016791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347422	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000287361700033
J	Saraiva, VB; Silva, LD; Ferreira-DaSilva, CT; da Silva, JL; Teixeira-Ferreira, A; Perales, J; Souza, MC; Henriques, MD; Caruso-Neves, C; Pinheiro, AAD				Saraiva, Victor Barbosa; Silva, Leandro de Souza; Ferreira-DaSilva, Claudio Teixeira; da Silva-Filho, Joao Luiz; Teixeira-Ferreira, Andre; Perales, Jonas; Souza, Mariana Conceicao; Henriques, Maria das Gracas; Caruso-Neves, Celso; de Sa Pinheiro, Ana Acacia			Impairment of the Plasmodium falciparum Erythrocytic Cycle Induced by Angiotensin Peptides	PLOS ONE			English	Article							MALARIAL INFECTION; NA+-ATPASE; RECEPTOR; PARASITES; SYSTEM; CELLS; INVASION; KINASES; CULTURE; BLOOD	Plasmodium falciparum causes the most serious complications of malaria and is a public health problem worldwide with over 2 million deaths each year. The erythrocyte invasion mechanisms by Plasmodium sp. have been well described, however the physiological aspects involving host components in this process are still poorly understood. Here, we provide evidence for the role of renin-angiotensin system (RAS) components in reducing erythrocyte invasion by P. falciparum. Angiotensin II (Ang II) reduced erythrocyte invasion in an enriched schizont culture of P. falciparum in a dose-dependent manner. Using mass spectroscopy, we showed that Ang II was metabolized by erythrocytes to Ang IV and Ang-(1-7). Parasite infection decreased Ang-(1-7) and completely abolished Ang IV formation. Similar to Ang II, Ang-(1-7) decreased the level of infection in an A779 (specific antagonist of Ang-(1-7) receptor, MAS)-sensitive manner. 10(-7) M PD123319, an AT(2) receptor antagonist, partially reversed the effects of Ang-(1-7) and Ang II. However, 10(-6) M losartan, an antagonist of the AT(1) receptor, had no effect. Gs protein is a crucial player in the Plasmodium falciparum blood cycle and angiotensin peptides can modulate protein kinase A (PKA) activity; 10(-8) M Ang II or 10(-8) M Ang-(1-7) inhibited this activity in erythrocytes by 60% and this effect was reversed by 10(-7) M A779. 10(-6) M dibutyryl-cAMP increased the level of infection and 10(-7) M PKA inhibitor decreased the level of infection by 30%. These results indicate that the effect of Ang-(1-7) on P. falciparum blood stage involves a MAS-mediated PKA inhibition. Our results indicate a crucial role for Ang II conversion into Ang-(1-7) in controlling the erythrocytic cycle of the malaria parasite, adding new functions to peptides initially described to be involved in the regulation of vascular tonus.	[Saraiva, Victor Barbosa] Inst Fed Educ Ciencia & Tecnol Fluminense, Cabo Frio, Brazil; [Silva, Leandro de Souza; Ferreira-DaSilva, Claudio Teixeira; da Silva-Filho, Joao Luiz; Caruso-Neves, Celso; de Sa Pinheiro, Ana Acacia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Teixeira-Ferreira, Andre; Perales, Jonas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Teixeira-Ferreira, Andre; Perales, Jonas] Rede Proteom Rio de Janeiro, Rio De Janeiro, Brazil; [Souza, Mariana Conceicao; Henriques, Maria das Gracas] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, Brazil; [de Sa Pinheiro, Ana Acacia] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, Brazil	Instituto Federal Fluminense; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Saraiva, VB (corresponding author), Inst Fed Educ Ciencia & Tecnol Fluminense, Cabo Frio, Brazil.	acacia@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Souza, Mariana/GQQ-6648-2022; Henriques, Maria das Graças M O/G-2998-2013; Silva-Filho, João Luiz/I-5704-2016; Fisiologia, Ciencias Biologicas/C-2407-2012; Sila, Leandro/B-1381-2018; Souza, Mariana/C-1677-2015	Caruso-Neves, Celso/0000-0002-2415-7753; Henriques, Maria das Graças M O/0000-0003-3065-0541; Silva-Filho, João Luiz/0000-0003-4762-2205; Sila, Leandro/0000-0001-8720-0088; Barbosa, Victor/0000-0002-9130-8902; Souza, Mariana/0000-0002-6933-9227; Pinheiro, Ana Acacia/0000-0002-3894-1645	World Health Organization [A51005]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010]	World Health Organization(World Health Organization); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by World Health Organization grant (ID. A51005) and by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Pronex/FAPERJ E-26/110.562/2010, Pronex/FAPERJ E-26/110.551/2010, APQ1/FAPERJ E-26/110.792/2009, JCNE/FAPERJ E-26/101.450/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SP, 2010, AM J PHYSIOL-HEART C, V298, pH587, DOI 10.1152/ajpheart.00975.2009; Al-Qattan KK, 2006, ANAT HISTOL EMBRYOL, V35, P130, DOI 10.1111/j.1439-0264.2005.00649.x; Cerutti C, 1999, MEM I OSWALDO CRUZ, V94, P803, DOI 10.1590/S0074-02761999000600017; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; De Souza AM, 2004, REGUL PEPTIDES, V120, P167, DOI 10.1016/j.regpep.2004.03.005; Dhangadamajhi G, 2010, INFECT GENET EVOL, V10, P337, DOI 10.1016/j.meegid.2010.01.009; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Filtz TM, 2004, EUR J PHARMACOL, V502, P11, DOI 10.1016/j.ejphar.2004.08.030; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Haldar K, 2001, CURR OPIN HEMATOL, V8, P92, DOI 10.1097/00062752-200103000-00006; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; KNIGHT A, 1982, T ROY SOC TROP MED H, V76, P503, DOI 10.1016/0035-9203(82)90150-X; Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.tem.2007.05.001; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lara LD, 2006, BIOCHEM J, V395, P183, DOI 10.1042/BJ20051455; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maciel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003296; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Maia J.C., 1983, GENES ANTIGENS PARAS, P144; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nussberger J, 2001, CLIN CHEM, V47, P726; Rega A., 1979, CATION FLUX BIOMEMBR, P67; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Suganuma T, 2005, CLIN CANCER RES, V11, P2686, DOI 10.1158/1078-0432.CCR-04-1946; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vlahakos DV, 2010, AM J KIDNEY DIS, V56, P558, DOI 10.1053/j.ajkd.2009.12.042	38	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17174	10.1371/journal.pone.0017174	http://dx.doi.org/10.1371/journal.pone.0017174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364758	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000287482800030
J	Croitoru-Lamoury, J; Lamoury, FMJ; Caristo, M; Suzuki, K; Walker, D; Takikawa, O; Taylor, R; Brew, BJ				Croitoru-Lamoury, Juliana; Lamoury, Francois M. J.; Caristo, Michael; Suzuki, Kazuo; Walker, David; Takikawa, Osamu; Taylor, Rosanne; Brew, Bruce J.			Interferon-gamma Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEURAL PRECURSOR CELLS; L-TRYPTOPHAN TRANSPORT; MARROW STROMAL CELLS; CD4(+) T-CELLS; IMMUNE-RESPONSE; DENDRITIC CELLS; 2,3-DIOXYGENASE ACTIVITY; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS	The kynurenine pathway (KP) of tryptophan metabolism is linked to antimicrobial activity and modulation of immune responses but its role in stem cell biology is unknown. We show that human and mouse mesenchymal and neural stem cells (MSCs and NSCs) express the complete KP, including indoleamine 2,3 dioxygenase 1 (IDO) and IDO2, that it is highly regulated by type I (IFN-beta) and II interferons (IFN-gamma), and that its transcriptional modulation depends on the type of interferon, cell type and species. IFN-gamma inhibited proliferation and altered human and mouse MSC neural, adipocytic and osteocytic differentiation via the activation of IDO. A functional KP present in MSCs, NSCs and perhaps other stem cell types offers novel therapeutic opportunities for optimisation of stem cell proliferation and differentiation.	[Croitoru-Lamoury, Juliana; Lamoury, Francois M. J.; Caristo, Michael; Suzuki, Kazuo; Brew, Bruce J.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Walker, David] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Takikawa, Osamu] Natl Ctr Geriatr & Gerontol, Lab Radiat Safety, Natl Inst Longev Sci, Morioka, Iwate, Japan; [Taylor, Rosanne] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; Monash University; National Center for Geriatrics & Gerontology; University of Sydney	Croitoru-Lamoury, J (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	j.lamoury@amr.org.au	McLean, Emma/F-4616-2012; Brew, Bruce/J-6513-2012	Suzuki, Kazuo/0000-0002-2531-794X; brew, bruce/0000-0003-0622-1392	National and Health Medical Research Council (NHMRC); St. Vincent's Clinic Foundation, Sydney; University of New South Wales, Sydney, Australia	National and Health Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); St. Vincent's Clinic Foundation, Sydney; University of New South Wales, Sydney, Australia	This work was supported by National and Health Medical Research Council (NHMRC), St. Vincent's Clinic Foundation, Sydney, University of New South Wales, Sydney, Australia and MS Research Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhani A, 2005, EUR J NEUROL, V12, P625, DOI 10.1111/j.1468-1331.2005.01041.x; Austin C, 2009, AMINO ACIDS, V36, P99, DOI 10.1007/s00726-008-0037-6; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; BARISH ME, 1991, DEV BIOL, V144, P412, DOI 10.1016/0012-1606(91)90433-4; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Costantino G, 2009, EXPERT OPIN THER TAR, V13, P247, DOI [10.1517/14728220802665734, 10.1517/14728220802665734 ]; Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485; Di Pucchio T, 2010, EXPERT OPIN THER PAT, V20, P229, DOI 10.1517/13543770903512974; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Grohmann U, 2010, IMMUNOL REV, V236, P243, DOI 10.1111/j.1600-065X.2010.00915.x; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kahler David J, 2009, Handb Exp Pharmacol, P165, DOI 10.1007/978-3-540-71029-5_8; Kanai M, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-8; Kaper T, 2007, PLOS BIOL, V5, P2201, DOI 10.1371/journal.pbio.0050257; Kudo Y, 2001, J PHYSIOL-LONDON, V531, P417, DOI 10.1111/j.1469-7793.2001.0417i.x; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Kwidzinski E, 2007, J MOL MED, V85, P1351, DOI 10.1007/s00109-007-0229-7; Lamoury FMJ, 2006, CYTOTHERAPY, V8, P228, DOI 10.1080/14653240600735875; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Manuelpillai U, 2005, AM J OBSTET GYNECOL, V192, P280, DOI 10.1016/j.ajog.2004.06.090; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Puccetti P, 2007, EUR J IMMUNOL, V37, P876, DOI 10.1002/eji.200737184; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Song SJ, 2007, STEM CELLS DEV, V16, P747, DOI 10.1089/scd.2007.0027; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Travers MT, 2004, BBA-BIOMEMBRANES, V1661, P106, DOI 10.1016/j.bbamem.2003.12.004; Tyndall A, 2009, CURR OPIN HEMATOL, V16, P285, DOI 10.1097/MOH.0b013e32832aacb3; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vamos E, 2009, J NEUROL SCI; Walker DW, 1999, PEDIATR RES, V45, P820, DOI 10.1203/00006450-199906000-00007; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	63	158	168	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14698	10.1371/journal.pone.0014698	http://dx.doi.org/10.1371/journal.pone.0014698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359206	gold, Green Submitted, Green Published			2022-12-27	WOS:000287392700011
J	Folkers, ME; Delker, DA; Maxwell, CI; Nelson, CA; Schwartz, JJ; Nix, DA; Hagedorn, CH				Folkers, Milan E.; Delker, Don A.; Maxwell, Christopher I.; Nelson, Cassie A.; Schwartz, Jason J.; Nix, David A.; Hagedorn, Curt H.			ENCODE Tiling Array Analysis Identifies Differentially Expressed Annotated and Novel 5 ' Capped RNAs in Hepatitis C Infected Liver	PLOS ONE			English	Article							SIGNALING PATHWAYS; GENETIC-VARIATION; INTERFERON-ALPHA; MESSENGER-RNA; IN-VIVO; VIRUS; PREDICTION; SIGNATURE; AFFINITY; FIBROSIS	Microarray studies of chronic hepatitis C infection have provided valuable information regarding the host response to viral infection. However, recent studies of the human transcriptome indicate pervasive transcription in previously unannotated regions of the genome and that many RNA transcripts have short or lack 3' poly(A) ends. We hypothesized that using ENCODE tiling arrays (1% of the genome) in combination with affinity purifying Pol II RNAs by their unique 5' m(7) GpppN cap would identify previously undescribed annotated and unannotated genes that are differentially expressed in liver during hepatitis C virus (HCV) infection. Both 5'-capped and poly(A)+ populations of RNA were analyzed using ENCODE tiling arrays. Sixty-four annotated genes were significantly increased in HCV cirrhotic as compared to control liver; twenty-seven (42%) of these genes were identified only by analyzing 5' capped RNA. Thirty-one annotated genes were significantly decreased; sixteen (50%) of these were identified only by analyzing 5' capped RNA. Bioinformatic analysis showed that capped RNA produced more consistent results, provided a more extensive expression profile of intronic regions and identified upregulated Pol II transcriptionally active regions in unannotated areas of the genome in HCV cirrhotic liver. Two of these regions were verified by PCR and RACE analysis. qPCR analysis of liver biopsy specimens demonstrated that these unannotated transcripts, as well as IRF1, TRIM22 and MET, were also upregulated in hepatitis C with mild inflammation and no fibrosis. The analysis of 5' capped RNA in combination with ENCODE tiling arrays provides additional gene expression information and identifies novel upregulated Pol II transcripts not previously described in HCV infected liver. This approach, particularly when combined with new RNA sequencing technologies, should also be useful in further defining Pol II transcripts differentially regulated in specific disease states and in studying RNAs regulated by changes in pre-mRNA splicing or 3' polyadenylation status.	[Folkers, Milan E.; Delker, Don A.; Maxwell, Christopher I.; Nelson, Cassie A.; Hagedorn, Curt H.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Delker, Don A.; Maxwell, Christopher I.; Nix, David A.; Hagedorn, Curt H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Schwartz, Jason J.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Hagedorn, Curt H.] Univ Utah, Dept Expt Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Folkers, ME (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	curt.hagedorn@hsc.utah.edu			National Institutes of Healths [CA063640, T32CA093247]; NATIONAL CANCER INSTITUTE [R55CA063640, R01CA063640, T32CA093247] Funding Source: NIH RePORTER	National Institutes of Healths(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Healths grant CA063640 (CHH). C. Maxwell was supported by a NIH Multidisciplinary Cancer Research Training Program T32CA093247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bajak Edyta Z., 2008, V419, P147, DOI 10.1007/978-1-59745-033-1_10; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Choi YH, 2003, P NATL ACAD SCI USA, V100, P7033, DOI 10.1073/pnas.1232347100; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dill MT, 2010, GASTROENTEROLOGY; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Gao Bo, 2009, HEPATOLOGY NA, V9999; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hayashida K, 2005, CLIN GASTROENTEROL H, V3, P1253, DOI 10.1016/S1542-3565(05)00412-X; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Helt GA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-266; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kikuchi K, 2009, NUCLEIC ACIDS RES, V37, P4987, DOI 10.1093/nar/gkp426; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Lederer SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-98; Li Ke, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P351; Mas VR, 2010, MOL MED, V16, P287, DOI 10.2119/molmed.2009.00165; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Peng J, 2005, RNA, V11, P1131, DOI 10.1261/rna.2470905; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Richter JD, 2008, CELL, V132, P335, DOI 10.1016/j.cell.2008.01.024; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Smith MW, 2006, GASTROENTEROLOGY, V130, P179, DOI 10.1053/j.gastro.2005.08.015; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI [10.1016/jhep.2003.09.024, 10.1053/jhep.2003.09024]; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Spivak-Kroizman T, 2002, FEBS LETT, V516, P9, DOI 10.1016/S0014-5793(02)02445-6; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Sumpter R, 2004, J VIROL, V78, P11591, DOI 10.1128/JVI.78.21.11591-11604.2004; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vlad G, 2003, HUM IMMUNOL, V64, P483, DOI 10.1016/S0198-8859(03)00040-5; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Wietzke-Braun P, 2006, EUR J GASTROEN HEPAT, V18, P991, DOI 10.1097/01.meg.0000224478.89545.76; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	69	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14697	10.1371/journal.pone.0014697	http://dx.doi.org/10.1371/journal.pone.0014697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359205	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700010
J	Chui, KKH; Wenger, JB; Cohen, SA; Naumova, EN				Chui, Kenneth K. H.; Wenger, Julia B.; Cohen, Steven A.; Naumova, Elena N.			Visual Analytics for Epidemiologists: Understanding the Interactions Between Age, Time, and Disease with Multi-Panel Graphs	PLOS ONE			English	Article							SEASONALITY; SURVEILLANCE; MORTALITY; INFLUENZA; POPULATION; PNEUMONIA; PATTERNS; PERIOD	Background: Visual analytics, a technique aiding data analysis and decision making, is a novel tool that allows for a better understanding of the context of complex systems. Public health professionals can greatly benefit from this technique since context is integral in disease monitoring and biosurveillance. We propose a graphical tool that can reveal the distribution of an outcome by time and age simultaneously. Methodology/Principal Findings: We introduce and demonstrate multi-panel (MP) graphs applied in four different settings: U.S. national influenza-associated and salmonellosis-associated hospitalizations among the older adult population (>= 65 years old), 1991-2004; confirmed salmonellosis cases reported to the Massachusetts Department of Public Health for the general population, 2004-2005; and asthma-associated hospital visits for children aged 0-18 at Milwaukee Children's Hospital of Wisconsin, 1997-2006. We illustrate trends and anomalies that otherwise would be obscured by traditional visualization techniques such as case pyramids and time-series plots. Conclusion/Significance: MP graphs can weave together two vital dynamics-temporality and demographics-that play important roles in the distribution and spread of diseases, making these graphs a powerful tool for public health and disease biosurveillance efforts.	[Chui, Kenneth K. H.; Cohen, Steven A.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Wenger, Julia B.] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Medford, MA 02155 USA	Massachusetts Department of Public Health; Tufts University; Harvard University; Massachusetts General Hospital; Tufts University	Chui, KKH (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	kenneth.chui@tufts.edu	Naumova, Elena N/C-5954-2011; Chui, Kenneth/AFT-2074-2022; Naumova, Elena/AAP-3395-2020	Chui, Kenneth/0000-0002-8063-8631; Naumova, Elena/0000-0002-9562-4734	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI062627, N01 AI-50032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627, N01AI050032] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grants U19 AI062627 and N01 AI-50032. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 1996, J FOOD PROTECT, V59, P287, DOI 10.4315/0362-028X-59.3.287; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Amin OM, 2002, AM J TROP MED HYG, V66, P799, DOI 10.4269/ajtmh.2002.66.799; Barwick R S, 2000, MMWR CDC Surveill Summ, V49, P1; Bean Nancy H., 1996, Morbidity and Mortality Weekly Report, V45, P1; Bisset K, 2009, CYBER ENV SUPPORT PA; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Castronovo DA, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-61; CHOI K, 1981, AM J EPIDEMIOL, V113, P215, DOI 10.1093/oxfordjournals.aje.a113090; Chui KKH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-447; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Cleveland WS., 1993, VISUALIZING DATA; Cohen SA, 2010, EPIDEMIOL INFECT, V138, P1135, DOI 10.1017/S0950268809991506; COHEN SA, 2009, INTELLIGENCE SECURIT, P47; DOSHI M, 2007, ADV DIS SURVEILLANCE, V2, P49; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Guo D, 2007, INT J GEOGR INF SCI, V21, P859, DOI 10.1080/13658810701349037; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Maciejewski R, 2010, IEEE T VIS COMPUT GR, V16, P205, DOI 10.1109/TVCG.2009.100; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Naumova EN, 2006, J PUBLIC HEALTH POL, V27, P2, DOI 10.1057/palgrave.jphp.3200061; Naumova EN, 2000, PUBLIC HEALTH REP, V115, P436, DOI 10.1093/phr/115.5.436; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Petridou ET, 2007, SCAND J PUBLIC HEALT, V35, P278, DOI 10.1080/14034940600996662; Rivera F, 2002, NEPHROL DIAL TRANSPL, V17, P1594, DOI 10.1093/ndt/17.9.1594; Simental L, 2008, APPL ENVIRON MICROB, V74, P5918, DOI 10.1128/AEM.01139-08; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TAYLOR JO, 1991, AM J EPIDEMIOL, V134, P489, DOI 10.1093/oxfordjournals.aje.a116121; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Thomas JD, 2005, ILLUMINATING PATH RE, P3; Tufte ER, 2001, VISUAL DISPLAY QUANT; Vugia D., 2004, Morbidity and Mortality Weekly Report, V53, P340; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Wharton M, 1990, MMWR Recomm Rep, V39, P1; Wilkinson L., 1999, GRAMMAR GRAPHICS	41	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e14683	10.1371/journal.pone.0014683	http://dx.doi.org/10.1371/journal.pone.0014683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721QH	21347221	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200002
J	Whalen, CC; Zalwango, S; Chiunda, A; Malone, L; Eisenach, K; Joloba, M; Boom, WH; Mugerwa, R				Whalen, Christopher C.; Zalwango, Sarah; Chiunda, Allan; Malone, LaShaunda; Eisenach, Kathleen; Joloba, Moses; Boom, W. Henry; Mugerwa, Roy			Secondary Attack Rate of Tuberculosis in Urban Households in Kampala, Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; SKIN-TEST; CONTACTS; EPIDEMIOLOGY; INFECTION; RISK; DISEASES; CHILDREN; ERROR	Background: Tuberculosis is an ancient disease that continues to threaten individual and public health today, especially in sub-Saharan Africa. Current surveillance systems describe general risk of tuberculosis in a population but do not characterize the risk to an individual following exposure to an infectious case. Methods: In a study of household contacts of infectious tuberculosis cases (n = 1918) and a community survey of tuberculosis infection (N = 1179) in Kampala, Uganda, we estimated the secondary attack rate for tuberculosis disease and tuberculosis infection. The ratio of these rates is the likelihood of progressive primary disease after recent household infection. Results: The secondary attack rate for tuberculosis disease was 3.0% (95% confidence interval: 2.2, 3.8). The overall secondary attack rate for tuberculosis infection was 47.4 (95% confidence interval: 44.3, 50.6) and did not vary widely with age, HIV status or BCG vaccination. The risk for progressive primary disease was highest among the young or HIV infected and was reduced by BCG vaccination. Conclusions: Early case detection and treatment may limit household transmission of M. tuberculosis. Household members at high risk for disease should be protected through vaccination or treatment of latent tuberculosis infection.	[Whalen, Christopher C.; Chiunda, Allan] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Zalwango, Sarah; Joloba, Moses] Makerere Univ, TB Res Unit, Kampala, Uganda; [Malone, LaShaunda; Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Malone, LaShaunda; Boom, W. Henry] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Eisenach, Kathleen] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Mugerwa, Roy] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda	University System of Georgia; University of Georgia; Makerere University; Case Western Reserve University; University Hospitals of Cleveland; University of Arkansas System; University of Arkansas Medical Sciences; Makerere University	Whalen, CC (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	ccwhalen@uga.edu		Joloba, Moses/0000-0002-0334-9983	Tuberculosis Research Unit, United States National Institutes of Allergy and Infectious Diseases (NIAID); United States National Institutes of Health and Human Services [NO1-AI-95383, HHSN266200700022C/NO1-AI-7002]; Fogarty International Center [TW-00011]; Center for AIDS Research at the NIAID [AI 36219]; National Institutes of Health; FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383, P30AI036219] Funding Source: NIH RePORTER	Tuberculosis Research Unit, United States National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in whole or in part by the Tuberculosis Research Unit, established with federal funds from the United States National Institutes of Allergy and Infectious Diseases (NIAID) and the United States National Institutes of Health and Human Services, under contract nos. NO1-AI-95383 and HHSN266200700022C/NO1-AI-7002, the AIDS International Training and Research Program of the Fogarty International Center (TW-00011), and the Center for AIDS Research (AI 36219) at the NIAID, the National Institutes of Health. The sponsor of the project reviewed and approved the study design and made periodic reviews of progress, but the sponsor did not participate in data collection, data analysis, the decision to publish, or preparation of the manuscript.	Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; CHECKOWAY H, 1988, INT J EPIDEMIOL, V17, P666, DOI 10.1093/ije/17.3.666; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; EGSMOSE T, 1961, B WLD HLTH ORG, V25, P831; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FINE PEM, 1988, INT J EPIDEMIOL, V17, P635, DOI 10.1093/ije/17.3.635; Frost WH, 1933, AM J PUBLIC HEALTH N, V23, P426, DOI 10.2105/AJPH.23.5.426; Frost WH, 1938, AM J PUBLIC HEALTH N, V28, P7, DOI 10.2105/AJPH.28.1.7; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Halloran M. E., 2001, EPIDEMIOL METHODS ST, P56; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Joloba ML, 2000, E AFR MED J, V77, P111; KEMPER JT, 1980, AM J EPIDEMIOL, V112, P457, DOI 10.1093/oxfordjournals.aje.a113013; LESKE MC, 1981, AM J EPIDEMIOL, V113, P606, DOI 10.1093/oxfordjournals.aje.a113138; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sutherland I, 1971, Bull Int Union Tuberc, V45, P80; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; WALTER SD, 1983, AM J EPIDEMIOL, V117, P598, DOI 10.1093/oxfordjournals.aje.a113582; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55	28	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16137	10.1371/journal.pone.0016137	http://dx.doi.org/10.1371/journal.pone.0016137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339819	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600010
J	Skovgaard, D; Kjaer, A; Heinemeier, KM; Brandt-Larsen, M; Madsen, J; Kjaer, M				Skovgaard, Dorthe; Kjaer, Andreas; Heinemeier, Katja Maria; Brandt-Larsen, Malene; Madsen, Jacob; Kjaer, Michael			Use of Cis-[F-18]Fluoro-Proline for Assessment of Exercise-Related Collagen Synthesis in Musculoskeletal Connective Tissue	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; POSITRON-EMISSION-TOMOGRAPHY; SKELETAL-MUSCLE; GROWTH-FACTORS; RAT MUSCLE; TENDON; BONE; PET; METABOLISM; EXPRESSION	Protein turnover in collagen rich tissue is influenced by exercise, but can only with difficulty be studied in vivo due to use of invasive procedure. The present study was done to investigate the possibility of applying the PET-tracer, cis-[F-18]fluoro-proline (cis-Fpro), for non-invasive assessment of collagen synthesis in rat musculoskeletal tissues at rest and following short-term (3 days) treadmill running. Musculoskeletal collagen synthesis was studied in rats at rest and 24 h post-exercise. At each session, rats were PET scanned at two time points following injection of cis-FPro: (60 and 240 min p.i). SUV were calculated for Achilles tendon, calf muscle and tibial bone. The PET-derived results were compared to mRNA expression of collagen type I and III. Tibial bone had the highest SUV that increased significantly (p<0.001) from the early (60 min) to the late (240 min) PET scan, while SUV in tendon and muscle decreased (p<0.001). Exercise had no influence on SUV, which was contradicted by an increased gene expression of collagen type I and III in muscle and tendon. The clearly, visible uptake of cis-Fpro in the collagen-rich musculoskeletal tissues is promising for multi-tissue studies in vivo. The tissue-specific differences with the highest basal uptake in bone are in accordance with earlier studies relying on tissue incorporation of isotopic-labelled proline. A possible explanation of the failure to demonstrate enhanced collagen synthesis following exercise, despite augmented collagen type I and III transcription, is that SUV calculations are not sensitive enough to detect minor changes in collagen synthesis. Further studies including kinetic compartment modeling must be performed to establish whether cis-Fpro can be used for non-invasive in-vivo assessment of exercise-induced changes in musculoskeletal collagen synthesis.	[Skovgaard, Dorthe; Heinemeier, Katja Maria; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark; [Skovgaard, Dorthe; Kjaer, Andreas; Heinemeier, Katja Maria; Kjaer, Michael] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Skovgaard, Dorthe; Brandt-Larsen, Malene; Madsen, Jacob] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen	Skovgaard, D (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med Copenhagen, Copenhagen, Denmark.	dskovgaard@dadlnet.dk	Kjaer, Michael/W-6842-2019; Kjaer, Andreas/E-8932-2015	Kjaer, Michael/0000-0002-4582-8755; Kjaer, Andreas/0000-0002-2706-5547	Danish Medical Research Council; Danish National Advanced Technology Foundation; Novo Nordisk Foundation, Danish Rheumatism Association, Team Denmark [R38-A270, 33241979-06]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Advanced Technology Foundation; Novo Nordisk Foundation, Danish Rheumatism Association, Team Denmark(Novo Nordisk Foundation)	This work was supported by the Danish Medical Research Council, the Danish National Advanced Technology Foundation, the Novo Nordisk Foundation, Danish Rheumatism Association: R38-A270, Team Denmark: 33241979-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asola M, 2008, KIDNEY INT, V73, pS131, DOI 10.1038/sj.ki.5002614; Asola MR, 2002, EUR J NUCL MED MOL I, V29, P1485, DOI 10.1007/s00259-002-0921-3; Babraj J, 2002, BIOCHEM SOC T, V30, P61, DOI 10.1042/bst0300061; Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; Babraj JA, 2005, J BONE MINER RES, V20, P930, DOI 10.1359/JBMR.050201; BOOTH FW, 1972, MED SCI SPORT EXER, V4, P230; Carter EA, 1999, J TRAUMA, V47, P341, DOI 10.1097/00005373-199908000-00021; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de Boer JR, 2003, J NUCL MED, V44, P341; Fischman AJ, 1998, P NATL ACAD SCI USA, V95, P12793, DOI 10.1073/pnas.95.22.12793; Haaparanta M, 2003, LIFE SCI, V73, P1437, DOI 10.1016/S0024-3205(03)00470-3; Hamacher K, 1999, J LABELLED COMPD RAD, V42, P1135; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hsu HB, 1996, P NATL ACAD SCI USA, V93, P1841, DOI 10.1073/pnas.93.5.1841; Jones Hazel A, 2005, Toxicol Appl Pharmacol, V207, P230, DOI 10.1016/j.taap.2005.02.027; Kim J, 2006, J NUCL MED, V47, P330; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Lavalaye J, 2008, MOL IMAGING BIOL; Mackey AL, 2008, CONNECT TISSUE RES, V49, P165, DOI 10.1080/03008200802151672; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; Meyer PT, 2006, EUR J NUCL MED MOL I, V33, P948, DOI 10.1007/s00259-006-0121-7; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; REDDY GK, 1992, CALCIFIED TISSUE INT, V50, P320, DOI 10.1007/BF00301629; SKOVGAARD D, 2010, MOL IMAGING BIOL, P52235; Smith K, 2007, CURR OPIN CLIN NUTR, V10, P582, DOI 10.1097/MCO.0b013e328285d858; Stoffels G, 2008, NUCL MED BIOL, V35, P895, DOI 10.1016/j.nucmedbio.2008.08.003; SUOMINEN H, 1980, ACTA PHYSIOL SCAND, V108, P17, DOI 10.1111/j.1748-1716.1980.tb06495.x; TAKEUCHI T, 1969, BIOCHIM BIOPHYS ACTA, V175, P142, DOI 10.1016/0005-2795(69)90153-6; UITTO J, 1977, ARCH BIOCHEM BIOPHYS, V181, P293, DOI 10.1016/0003-9861(77)90507-0; VIDEMAN T, 1981, BIOCHEM J, V200, P435, DOI 10.1042/bj2000435; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wackerhage H, 2006, J ANAT, V208, P451, DOI 10.1111/j.1469-7580.2006.00544.x; Wallace WE, 2002, J NUCL MED, V43, P413; Warner SE, 2006, CALCIFIED TISSUE INT, V79, P395, DOI 10.1007/s00223-005-0293-3; Wester HJ, 1999, NUCL MED BIOL, V26, P259, DOI 10.1016/S0969-8051(98)00107-3; Zimny M, 2002, NUCL MED COMMUN, V23, P695, DOI 10.1097/00006231-200207000-00015	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e16678	10.1371/journal.pone.0016678	http://dx.doi.org/10.1371/journal.pone.0016678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347251	gold, Green Published, Green Submitted			2022-12-27	WOS:000287364500003
J	Srichai, MB; Colleta, H; Gewin, L; Matrisian, L; Abel, TW; Koshikawa, N; Seiki, M; Pozzi, A; Harris, RC; Zent, R				Srichai, Manakan B.; Colleta, Heloisa; Gewin, Leslie; Matrisian, Linsey; Abel, Ty W.; Koshikawa, Naohiko; Seiki, Motoharu; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy			Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) Modulates Water Homeostasis in Mice	PLOS ONE			English	Article							RENAL DEVELOPMENT; TRANSGENIC MICE; KIDNEY-DISEASE; EXPRESSION; CANCER; CELLS	MT4-MMP is a membrane-type metalloproteinase (MMP) anchored to the membrane by a glycosyl-phosphatidylinositol (GPI) motif. GPI-type MT-MMPs (MT4- and MT6-MMP) are related to other MT-MMPs, but their physiological substrates and functions in vivo have yet to be identified. In this manuscript we show that MT4-MMP is expressed early in kidney development, as well as in the adult kidney, where the highest levels of expression are found in the papilla. MT4-MMP null mice had minimal renal developmental abnormalities, with a minor branching morphogenesis defect in early embryonic kidney development and slightly dysmorphic collecting ducts in adult mice. Interestingly, MT4-MMP null mice had higher baseline urine osmolarities relative to wild type controls, but these animals were able to concentrate and dilute their urines normally. However, MT4-MMP-null mice had decreased daily water intake and daily urine output, consistent with primary hypodipsia. MT4-MMP was shown to be expressed in areas of the hypothalamus considered important for regulating thirst. Thus, our results show that although MT4-MMP is expressed in the kidney, this metalloproteinase does not play a major role in renal development or function; however it does appear to modify the neural stimuli that modulate thirst.	[Srichai, Manakan B.; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy] Vet Adm Hosp, Dept Med, Nashville, TN USA; [Srichai, Manakan B.; Colleta, Heloisa; Gewin, Leslie; Matrisian, Linsey; Pozzi, Ambra; Harris, Raymond C.; Zent, Roy] Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, Nashville, TN USA; [Abel, Ty W.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Dept Canc Biol, Med Ctr, Nashville, TN USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Koshikawa, Naohiko; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tokyo	Srichai, MB (corresponding author), Vet Adm Hosp, Dept Med, Nashville, TN USA.	roy.zent@vanderbilt.edu	Seiki, Motoharu/K-9443-2015; Koshikawa, Naohiko/S-7306-2017	Koshikawa, Naohiko/0000-0002-4539-888X	NIH [DK075594, DK083187, DK62794]; NIDDK; AHA; Veterans Affairs; National Kidney Foundation; Grants-in-Aid for Scientific Research [22591762] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062794, R01DK083187, P30DK079341, R01DK075594] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); Veterans Affairs(US Department of Veterans Affairs); National Kidney Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The work was funded by NIH Grants DK075594, DK083187, DK62794 and the George O'Brien Center Grant from NIDDK. The studies were performed from funds from these three RO1 grants to RZ and RCH. In addition much of the phenotyping was done by the renal physiology core of the George O'Brien Center Grant; American Heart Association, established investigator award (RZ). RZ has a career award from the AHA. Funding also came from Veterans Affairs, Career Development Award (MBS) and Merit awards (RZ, AP, RCH). All these investigators hold positions at the VA and thus were partially funded by the VA to do these studies; funding also came from the National Kidney Foundation Fellowship Award (LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle S, 2007, DEV DYNAM, V236, P2321, DOI 10.1002/dvdy.21242; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chabottaux V, 2006, CANCER RES, V66, P5165, DOI 10.1158/0008-5472.CAN-05-3012; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Ermolli M, 2003, TRANSPL IMMUNOL, V11, P137, DOI 10.1016/S0966-3274(02)00150-8; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Godley LA, 1996, GENE DEV, V10, P836, DOI 10.1101/gad.10.7.836; Haas CS, 2004, CONNECT TISSUE RES, V45, P73, DOI 10.1080/03008200490442644; HUSTED RF, 1988, AM J PHYSIOL, V255, pF1160, DOI 10.1152/ajprenal.1988.255.6.F1160; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lelongt B, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_9.28; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Puente XS, 1996, CANCER RES, V56, P944; Riggins KS, 2010, EXP CELL RES, V316, P2993, DOI 10.1016/j.yexcr.2010.08.003; Rikimaru A, 2007, GENES CELLS, V12, P1091, DOI 10.1111/j.1365-2443.2007.01110.x; ROBERTSON GL, 1982, AM J MED, V72, P339, DOI 10.1016/0002-9343(82)90825-7; Ronco P, 2007, SEMIN NEPHROL, V27, P352, DOI 10.1016/j.semnephrol.2007.02.006; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Srichai MB, 2008, J AM SOC NEPHROL, V19, P1538, DOI 10.1681/ASN.2007101101; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	26	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17099	10.1371/journal.pone.0017099	http://dx.doi.org/10.1371/journal.pone.0017099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347258	Green Published, gold, Green Submitted			2022-12-27	WOS:000287364500028
J	Buchheim, MA; Keller, A; Koetschan, C; Forster, F; Merget, B; Wolf, M				Buchheim, Mark A.; Keller, Alexander; Koetschan, Christian; Foerster, Frank; Merget, Benjamin; Wolf, Matthias			Internal Transcribed Spacer 2 (nu ITS2 rRNA) Sequence-Structure Phylogenetics: Towards an Automated Reconstruction of the Green Algal Tree of Life	PLOS ONE			English	Article							COLONIAL VOLVOCALES CHLOROPHYTA; SECONDARY STRUCTURE; NUCLEAR RDNA; DNA BARCODES; DASYCLADALES CHLOROPHYTA; MOLECULAR SYSTEMATICS; GENE-SEQUENCES; LAND PLANTS; 18S RDNA; EVOLUTION	Background: Chloroplast-encoded genes (matK and rbcL) have been formally proposed for use in DNA barcoding efforts targeting embryophytes. Extending such a protocol to chlorophytan green algae, though, is fraught with problems including non homology (matK) and heterogeneity that prevents the creation of a universal PCR toolkit (rbcL). Some have advocated the use of the nuclear-encoded, internal transcribed spacer two (ITS2) as an alternative to the traditional chloroplast markers. However, the ITS2 is broadly perceived to be insufficiently conserved or to be confounded by introgression or biparental inheritance patterns, precluding its broad use in phylogenetic reconstruction or as a DNA barcode. A growing body of evidence has shown that simultaneous analysis of nucleotide data with secondary structure information can overcome at least some of the limitations of ITS2. The goal of this investigation was to assess the feasibility of an automated, sequence-structure approach for analysis of IT2 data from a large sampling of phylum Chlorophyta. Methodology/Principal Findings: Sequences and secondary structures from 591 chlorophycean, 741 trebouxiophycean and 938 ulvophycean algae, all obtained from the ITS2 Database, were aligned using a sequence structure-specific scoring matrix. Phylogenetic relationships were reconstructed by Profile Neighbor-Joining coupled with a sequence structure-specific, general time reversible substitution model. Results from analyses of the ITS2 data were robust at multiple nodes and showed considerable congruence with results from published phylogenetic analyses. Conclusions/Significance: Our observations on the power of automated, sequence-structure analyses of ITS2 to reconstruct phylum-level phylogenies of the green algae validate this approach to assessing diversity for large sets of chlorophytan taxa. Moreover, our results indicate that objections to the use of ITS2 for DNA barcoding should be weighed against the utility of an automated, data analysis approach with demonstrated power to reconstruct evolutionary patterns for highly divergent lineages.	[Buchheim, Mark A.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Buchheim, Mark A.] Univ Tulsa, Mervin Bovaird Inst Mol Biol & Biotechnol, Tulsa, OK 74104 USA; [Keller, Alexander; Koetschan, Christian; Foerster, Frank; Merget, Benjamin; Wolf, Matthias] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany	University of Tulsa; University of Tulsa; University of Wurzburg	Buchheim, MA (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	mark-buchheim@utulsa.edu	Wolf, Matthias/A-5580-2008; Keller, Alexander/D-1221-2009; Förster, Frank/A-2181-2010	Wolf, Matthias/0000-0003-2004-1806; Keller, Alexander/0000-0001-5716-3634; Förster, Frank/0000-0003-4166-5423	Deutsche Forschungsgemeinschaft [Mu-2831/1-1]; National Science Foundation [MCB-0132083, DEB-0129030]; BIGGS Graduate School, Bavaria, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); BIGGS Graduate School, Bavaria, Germany	Financial support for this study was provided by the Deutsche Forschungsgemeinschaft (Mu-2831/1-1 to MW) and the National Science Foundation (MCB-0132083 and DEB-0129030 to MAB). AK was supported by the BIGGS Graduate School, Bavaria, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 1999, PLANT BIOLOGY, V1, P418, DOI 10.1111/j.1438-8677.1999.tb00724.x; Angeler DG, 1999, J PHYCOL, V35, P815, DOI 10.1046/j.1529-8817.1999.3540815.x; Angeler DG, 1998, BIOLOGIA, V53, P567; Arnheim N., 1983, P38; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Buchheim M, 2005, J PHYCOL, V41, P1039, DOI 10.1111/j.1529-8817.2005.00129.x; BUCHHEIM MA, 1992, J PHYCOL, V28, P362, DOI 10.1111/j.0022-3646.1992.00362.x; Buchheim MA, 2002, J PHYCOL, V38, P376, DOI 10.1046/j.1529-8817.2002.01145.x; BUCHHEIM MA, 1991, BIOSYSTEMS, V25, P85, DOI 10.1016/0303-2647(91)90015-D; Buchheim MA, 1997, J PHYCOL, V33, P1024, DOI 10.1111/j.0022-3646.1997.01024.x; Buchheim MA, 1997, J PHYCOL, V33, P286, DOI 10.1111/j.0022-3646.1997.00286.x; Buchheim MA, 2001, J PHYCOL, V37, P819, DOI 10.1046/j.1529-8817.2001.00162.x; Buchheim MA, 1996, MOL PHYLOGENET EVOL, V5, P391, DOI 10.1006/mpev.1996.0034; Buchheim MA, 2010, J PHYCOL, V46, P1038, DOI 10.1111/j.1529-8817.2010.00886.x; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; CHASE MW, 2009, SCI ONLINE; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coat G, 1998, EUR J PHYCOL, V33, P81, DOI 10.1017/S0967026297001455; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Coleman AW, 2001, J PHYCOL, V37, P836, DOI 10.1046/j.1529-8817.2001.01043.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Durand C, 2002, J EVOLUTION BIOL, V15, P122, DOI 10.1046/j.1420-9101.2002.00370.x; Ebach MC, 2005, BIOSCIENCE, V55, P822; EDLIND TD, 1990, GENE, V96, P289, DOI 10.1016/0378-1119(90)90266-T; Engelmann JC, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2008.02199.x; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Friedl T, 1996, PHYCOLOGIA, V35, P456, DOI 10.2216/i0031-8884-35-5-456.1; Friedrich J, 2005, BIOINFORMATICS, V21, P2108, DOI 10.1093/bioinformatics/bti289; Gile GH, 2010, J PHYCOL, V46, P743, DOI 10.1111/j.1529-8817.2010.00851.x; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Harpke D, 2006, MOL PHYLOGENET EVOL, V41, P579, DOI 10.1016/j.ympev.2006.05.036; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hegewald E, 2003, PLANT SYST EVOL, V241, P185, DOI 10.1007/s00606-003-0061-7; Hegewald E., 2000, ALGOL STUD, V100, P29, DOI DOI 10.1127/algol_stud/100/2000/29; Hegewald E, 2010, PHYCOLOGIA, V49, P325, DOI 10.2216/09-61.1; Hepperle D, 2000, J PHYCOL, V36, P590, DOI 10.1046/j.1529-8817.2000.99184.x; Hershkovitz MA, 1996, MOL BIOL EVOL, V13, P1276, DOI 10.1093/oxfordjournals.molbev.a025693; Holdrege C, 2006, BIOSCIENCE, V56, P93; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Jakupciak JP, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2009.02632.x; Kapraun DF, 1998, PHYCOLOGIA, V37, P176, DOI 10.2216/i0031-8884-37-3-176.1; KAPRAUN DF, 1993, PHYCOLOGIA, V32, P1, DOI 10.2216/i0031-8884-32-1-1.1; Kapraun Donald F., 1994, Cryptogamic Botany, V4, P410; Keller A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-4; Keller A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-218; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2003, BIOLOGIA, V58, P437; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledford H, 2008, NATURE, V451, P616, DOI 10.1038/451616b; Leliaert F, 2003, EUR J PHYCOL, V38, P233, DOI 10.1080/1364253031000136376; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lewis LA, 2004, J PHYCOL, V40, P1127, DOI 10.1111/j.1529-8817.2004.03235.x; Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/PH07-61.1; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; McManus HA, 2005, PHYCOLOGIA, V44, P582, DOI 10.2216/0031-8884(2005)44[582:MPMVAC]2.0.CO;2; Mei Hong, 2007, Acta Hydrobiologica Sinica, V31, P492; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Muller T, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-20; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakazawa AS, 2004, PHYCOLOGIA, V43, P711, DOI 10.2216/i0031-8884-43-6-711.1; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Nozaki H, 1999, J PHYCOL, V35, P104, DOI 10.1046/j.1529-8817.1999.3510104.x; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, BIOLOGIA, V58, P425; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; Nozaki H, 2003, MOL PHYLOGENET EVOL, V29, P58, DOI 10.1016/S1055-7903(03)00089-7; Nozaki Hisayoshi, 2001, Phycologia, V40, P37; Pillmann A, 1997, EUR J PHYCOL, V32, P379, DOI 10.1017/S0967026297001352; Pocock T, 2004, J PHYCOL, V40, P1138, DOI 10.1111/j.1529-8817.2004.04060.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Rahmann S, 2006, ADV DATA MINING TECH, P104; Rambaut A, 2009, FIGTREE V1 2 3; Sanders ER, 2003, AM J BOT, V90, P628, DOI 10.3732/ajb.90.4.628; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; Smith VS, 2005, SYST BIOL, V54, P841, DOI 10.1080/10635150500354894; TURMEL M, 2002, COMPLETE CHLOROPLAST; van Hannen EJ, 2002, EUR J PHYCOL, V37, P203, DOI 10.1017/S096702620200361X; Verbruggen H, 2005, MOL PHYLOGENET EVOL, V37, P789, DOI 10.1016/j.ympev.2005.06.015; Wheeler QD, 2005, CLADISTICS, V21, P405, DOI 10.1111/j.1096-0031.2005.00075.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; WILL KW, 2005, SYSTEMATIC BIOL, V54; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2003, BIOLOGIA, V58, P433; Wolf M, 2003, BIOLOGIA, V58, P759; Wolf M, 2002, PLANT SYST EVOL, V230, P161, DOI 10.1007/s006060200002; WOLF M, 2009, SCIENCE         1210; Wolf M., 2002, ARCH HYDROBIOL S, V104, P59; Wolf M, 2008, BIOINFORMATICS, V24, P2401, DOI 10.1093/bioinformatics/btn453; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Zechman FW, 2003, J PHYCOL, V39, P819, DOI 10.1046/j.1529-8817.2003.02183.x; Zimmer EA, 1980, P NATL ACAD SCI USA, V77, P2518	115	67	72	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16931	10.1371/journal.pone.0016931	http://dx.doi.org/10.1371/journal.pone.0016931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347329	Green Published, gold			2022-12-27	WOS:000287363000023
J	Momozawa, Y; Deffontaine, V; Louis, E; Medrano, JF				Momozawa, Yukihide; Deffontaine, Valerie; Louis, Edouard; Medrano, Juan F.			Characterization of Bacteria in Biopsies of Colon and Stools by High Throughput Sequencing of the V2 Region of Bacterial 16S rRNA Gene in Human	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; MICROBIOME	Background: The characterization of the human intestinal microflora and their interactions with the host have been identified as key components in the study of intestinal disorders such as inflammatory bowel diseases. High-throughput sequencing has enabled culture-independent studies to deeply analyze bacteria in the gut. It is possible with this technology to systematically analyze links between microbes and the genetic constitution of the host, such as DNA polymorphisms and methylation, and gene expression. Methods and Findings: In this study the V2 region of the bacterial 16S ribosomal RNA (rRNA) gene using 454 pyrosequencing from seven anatomic regions of human colon and two types of stool specimens were analyzed. The study examined the number of reads needed to ascertain differences between samples, the effect of DNA extraction procedures and PCR reproducibility, and differences between biopsies and stools in order to design a large scale systematic analysis of gut microbes. It was shown (1) that sequence coverage lower than 1,000 reads influenced quantitative and qualitative differences between samples measured by UniFrac distances. Distances between samples became stable after 1,000 reads. (2) Difference of extracted bacteria was observed between the two DNA extraction methods. In particular, Firmicutes Bacilli were not extracted well by one method. (3) Quantitative and qualitative difference in bacteria from ileum to rectum colon were not observed, but there was a significant positive trend between distances within colon and quantitative differences. Between sample type, biopsies or stools, quantitative and qualitative differences were observed. Conclusions: Results of human colonic bacteria analyzed using high-throughput sequencing were highly dependent on the experimental design, especially the number of sequence reads, DNA extraction method, and sample type.	[Momozawa, Yukihide; Deffontaine, Valerie] Univ Liege, GIGA Res, Unit Anim Genom, Liege, Belgium; [Momozawa, Yukihide; Deffontaine, Valerie] Univ Liege, Fac Vet Med, Liege, Belgium; [Louis, Edouard] Univ Liege, GIGA Res, Unit Hepatol & Gastroenterol, Dept Clin Sci, Liege, Belgium; [Louis, Edouard] Univ Liege, Fac Med, Liege, Belgium; [Louis, Edouard] Univ Liege, CHU Liege, Liege, Belgium; [Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of California System; University of California Davis	Momozawa, Y (corresponding author), Univ Liege, GIGA Res, Unit Anim Genom, Liege, Belgium.	Yukihide.Momozawa@guest.ulg.ac.be	Momozawa, Yukihide/N-6453-2015		Fonds National de la Recherche Scientifique (FNRS) [830107]; GIGA-Crohn [315422]; Walloon region; Forem Formations program	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); GIGA-Crohn; Walloon region; Forem Formations program	This project was supported by the Fonds National de la Recherche Scientifique (FNRS) - Region Wallonne program IP-SEQ-Groupe Interdisciplinaire de Genoproteomique Appliquee (GIGA) (Convention no830107) and by the Region Wallonne program GIGA-Crohn (Convention no315422). VD is supported by the Walloon region and Forem Formations program (Portefeuille GIGA2 BioIndustry Support - Volet IP-SEQ). EL is a senior research associate from the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varaljay VA, 2010, APPL ENVIRON MICROB, V76, P609, DOI 10.1128/AEM.01258-09; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	19	78	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16952	10.1371/journal.pone.0016952	http://dx.doi.org/10.1371/journal.pone.0016952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21347324	Green Published, Green Submitted, gold			2022-12-27	WOS:000287363000024
J	Gafos, M; Mzimela, M; Ndlovu, H; Mhlongo, N; Hoogland, Y; Mutemwa, R				Gafos, Mitzy; Mzimela, Misiwe; Ndlovu, Hlengiwe; Mhlongo, Nkosinathi; Hoogland, Yael; Mutemwa, Richard			"One Teabag Is Better than Four": Participants Response to the Discontinuation of 2% PRO2000/5 Microbicide Gel in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							CLINICAL-TRIAL; ACCEPTABILITY	Introduction: The Microbicides Development Programme evaluated the safety and effectiveness of 0.5% and 2% PRO2000/5 microbicide gels in reducing the risk of vaginally acquired HIV. In February 2008 the Independent Data Monitoring Committee recommended that evaluation of 2% PRO2000/5 gel be discontinued due to futility. The Africa Centre site systematically collected participant responses to this discontinuation. Methods: Clinic and field staff completed field reports using ethnographic participant observation techniques. In-depth-interviews and focus group discussions were conducted with participants discontinued from 2% gel. A total of 72 field reports, 12 in-depth-interviews and 3 focus groups with 250 women were completed for this analysis. Retention of discontinued participants was also analysed. Qualitative data was analysed using NVivo 2 and quantitative data using STATA 10.0. Results: Participants responded initially with fear that discontinuation was due to harm, followed by acceptance after effective messaging, and finally with disappointment. Participants reported that their initial fear was exacerbated by being contacted and advised to visit the clinic for information about the closure. Operational changes were subsequently made to the contact procedures. By incorporating feedback from participants, messages were continuously revised to ensure that information was comprehensible and misconceptions were addressed quickly thereby enabling participants to accept the discontinuation. Participants were disappointed that 2% PRO2000/5 was being excluded as a HIV prevention option, but also that they would no longer have access to gel that improved their sexual relationships with their partners and assisted condom negotiations. In total 238 women were discontinued from gel and 185 (78%) went on to complete their scheduled follow-up period. Discussion: The use of qualitative social science techniques allowed the site team to amend operational procedures and messaging throughout the discontinuation period. This proved instrumental in ensuring that the discontinuation was successfully completed in a manner that was both understandable and acceptable to participants.	[Gafos, Mitzy; Mzimela, Misiwe; Ndlovu, Hlengiwe; Mhlongo, Nkosinathi; Hoogland, Yael] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Mutemwa, Richard] London Sch Hyg & Trop Med, London WC1, England; [Gafos, Mitzy] City Univ London, London EC1V 0HB, England; [Mutemwa, Richard] MRC, Clin Trials Unit, Microbicides Dev Programme, Microbicides Dev Programme Team, London, England	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; City University London; Medical Research Council Clinical Trials Unit	Gafos, M (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.	mgafos@africacentre.ac.za		Gafos, Mitzy/0000-0002-7894-1498	United Kingdom Department for International Development and Medical Research Council; MRC [G0100137] Funding Source: UKRI; Medical Research Council [G0100137] Funding Source: researchfish	United Kingdom Department for International Development and Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MDP 301 clinical trial was funded by the United Kingdom Department for International Development and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Vaccine Advocacy Coalition, 2010, ONG PLANN CLIN TRIAL; *FAM HLTH INT, 2005, JOINT STAT SAVVY PHA; Family Health International, 2006, PHAS 3 TRIAL NIG EV; Gafos M, 2010, CULT HEALTH SEX, V12, P929, DOI 10.1080/13691058.2010.507876; Grant A, 2004, BRIT MED J, V329, P525, DOI 10.1136/bmj.329.7465.525; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; HEISE L, 2009, MAPPING STANDARDS CA; HLONGWA W, 2007, MED RES TRIAL GUINEA; *INT PARTN MICR, 2007, GEL PROD ATTR STUD R; *JOINT UN PROGR HI, 2010, UNAIDS10EJC1853E JOI; KUTIKUPPALA SR, 2000, INT C AIDS 2000 JUL, V13, P40; Lievre M, 2001, BRIT MED J, V322, P603, DOI 10.1136/bmj.322.7286.603; MARTIN S, 2008, ACCEPTABILITY VAGINA; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; *MICR DEV PROGR, 2008, MICR DEV PROGR MDP U; Montgomery CM, 2010, CULT HEALTH SEX, V12, P649, DOI 10.1080/13691051003736261; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; MWANZA B, 2006, DRY SEX ACCEPTABILIT; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; RAMJEE G, 2007, AIDS RES THERAPY, V4; Ramjee G, 2007, PLOS MED, V4, P1167, DOI 10.1371/journal.pmed.0040235; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Vallely A, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-17; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; WHITEHEAD SJ, 2008, WILL MICROBICIDES FE	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2011	6	1							e14577	10.1371/journal.pone.0014577	http://dx.doi.org/10.1371/journal.pone.0014577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OY	21344002	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000286522300011
J	Nishimura, M; Yamamoto, H; Yoshida, T; Seimiya, M; Sawabe, Y; Matsushita, K; Umemura, H; Sogawa, K; Takizawa, H; Yokosuka, O; Nomura, F				Nishimura, Motoi; Yamamoto, Haruna; Yoshida, Toshihiko; Seimiya, Masanori; Sawabe, Yuji; Matsushita, Kazuyuki; Umemura, Hiroshi; Sogawa, Kazuyuki; Takizawa, Hirotaka; Yokosuka, Osamu; Nomura, Fumio			Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels	PLOS ONE			English	Article							LIPASE DEFICIENCY; DENSITY-LIPOPROTEIN; LIVER-DISEASE; VIRUS; METABOLISM; STEATOSIS; DIAGNOSIS; ABNORMALITIES; ASSAY	Background: The liver secretes very-low-density lipoproteins (VLDLs) and plays a key role in lipid metabolism. Plasma total triglyceride (TG) level variations have been studied in patients with hepatitis C virus (HCV)-related chronic hepatitis (CH-C). However, the results of these studies are variable. A homogenous assay protocol was recently proposed to directly measure the TG content in VLDL (VLDL-TG) and VLDL remnants. Methodology/Principal Findings: Using the assay protocol, we determined serum VLDL-TG levels in 69 fasting patients with biopsy-proven HCV-related chronic liver disease and 50 healthy subjects. Patients were classified into stages F0-F4 using the 5-point Desmet scale. Serum total TG levels in patients with non-cirrhotic (F1-F3) CH-C did not demonstrate significant differences compared with healthy subjects, but serum VLDL-TG levels did demonstrate significant differences. Mean serum VLDL-TG levels tended to decrease with disease progression from F1 to F4 (cirrhosis). Compared with healthy subjects, serum non-VLDL-TG levels significantly increased in patients with stages F2 and F3 CH-C; however, we observed no significant difference in patients with liver cirrhosis. Furthermore, the serum VLDL-TG/non-VLDL-TG ratio, when taken, demonstrated a significant decrease in patients with CH-C from the mildest stage F1 onward. Conclusions/Significance: The decrease in serum VLDL-TG levels was attenuated by increase in non-VLDL-TG levels in patients with non-cirrhotic CH-C, resulting in comparable total TG levels. Results of previous studies though variable, were confirmed to have a logical basis. The decrease in the serum VLDL-TG/non-VLDL-TG ratio as early as stage F1 demonstrated TG metabolic alterations in early stages of CH-C for the first time. The involvement of TG metabolism in CH-C pathogenesis has been established in experimental animals, while conventional TG measurements are generally considered as poor indicators of CH-C progression in clinical practice. The serum VLDL-TG/non-VLDL-TG ratio, which focuses on TG metabolic alterations, may be an early indicator of CH-C.	[Nishimura, Motoi; Yamamoto, Haruna; Matsushita, Kazuyuki; Umemura, Hiroshi; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Nishimura, Motoi; Yamamoto, Haruna; Yoshida, Toshihiko; Seimiya, Masanori; Sawabe, Yuji; Matsushita, Kazuyuki; Umemura, Hiroshi; Nomura, Fumio] Chiba Univ Hosp, Div Lab Med, Chiba, Japan; [Nishimura, Motoi; Matsushita, Kazuyuki; Sogawa, Kazuyuki; Nomura, Fumio] Chiba Univ Hosp, Clin Prote Res Ctr, Chiba, Japan; [Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Takizawa, Hirotaka] Kashiwado Mem Fdn, Kashiwado Clin, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University	Nishimura, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan.	ZXA03460@nifty.ne.jp	Matsushita, Kazuyuki/AAJ-5380-2020	Matsushita, Kazuyuki/0000-0001-6742-0761	Japanese government [KAKENHI 21790531]	Japanese government	This work was supported by Grant-in-Aid for Scientific Research of Japanese government (KAKENHI 21790531, http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; CONNELLY PW, 1990, ARTERIOSCLEROSIS, V10, P40, DOI 10.1161/01.ATV.10.1.40; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fujiwara K, 2006, LIVER INT, V26, P520, DOI 10.1111/j.1478-3231.2006.01263.x; Fujiwara K, 2008, J GASTROENTEROL, V43, P951, DOI 10.1007/s00535-008-2254-x; GOLDBERG IJ, 1985, METABOLISM, V34, P832, DOI 10.1016/0026-0495(85)90107-6; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HIRAOKA H, 1993, HEPATOLOGY, V18, P103, DOI 10.1016/0270-9139(93)90513-M; Hsu CS, 2008, HEPATOL INT, V2, P250, DOI 10.1007/s12072-008-9064-3; KLOSE G, 1977, EUR J CLIN INVEST, V7, P557, DOI 10.1111/j.1365-2362.1977.tb01651.x; MCINTYRE N, 1978, GUT, V19, P526, DOI 10.1136/gut.19.6.526; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; OHNO O, 1997, J CLIN MICROBIOL, V35, P201; Okada M, 2005, CLIN CHEM, V51, P1804, DOI 10.1373/clinchem.2005.049304; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Ruel IL, 2003, J LIPID RES, V44, P1508, DOI 10.1194/jlr.M200479-JLR200; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; SHIRAI K, 1981, BIOCHEM BIOPH RES CO, V100, P591, DOI 10.1016/S0006-291X(81)80217-3; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; SIMMONDS P, 1993, J GEN VIROL, V74, P661, DOI 10.1099/0022-1317-74-4-661; Takase H, 2005, ATHEROSCLEROSIS, V180, P197, DOI 10.1016/j.atherosclerosis.2004.11.020; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17309	10.1371/journal.pone.0017309	http://dx.doi.org/10.1371/journal.pone.0017309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364889	gold, Green Published, Green Submitted			2022-12-27	WOS:000287764100043
J	Tricker, E; Arvand, A; Kwan, R; Chen, GY; Gallagher, E; Cheng, G				Tricker, Erin; Arvand, Afsane; Kwan, Raymond; Chen, Gordon Y.; Gallagher, Ewen; Cheng, Genhong			Apoptosis Induced by Cytoskeletal Disruption Requires Distinct Domains of MEKK1	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; E3 UBIQUITIN LIGASE; INDUCED CELL-DEATH; JNK ACTIVATION; GENE DISRUPTION; UBIQUITYLATION; VINBLASTINE; PATHWAYS; BINDING; PROLIFERATION	MEKK1 is a mitogen-activated protein kinase kinase kinase (MAP3K) that activates the MAPK JNK and is required for microtubule inhibitor-induced apoptosis in B cells. Here, we find that apoptosis induced by actin disruption via cytochalasin D and by the protein phosphatase 1/2A inhibitor okadaic acid also requires MEKK1 activation. To elucidate the functional requirements for activation of the MEKK1-dependent apoptotic pathway, we created mutations within MEKK1. MEKK1-deficient cells were complemented with MEKK1 containing mutations in either the ubiquitin interacting motif (UIM), plant homeodomain (PHD), caspase cleavage site or the kinase domain at near endogenous levels of expression and tested for their sensitivity to each drug. We found that both the kinase activity and the PHD domain of MEKK1 are required for JNK activation and efficient induction of apoptosis by drugs causing cytoskeletal disruption. Furthermore, we discovered that modification of MEKK1 and its localization depends on the integrity of the PHD.	[Tricker, Erin; Arvand, Afsane; Kwan, Raymond; Chen, Gordon Y.; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Gallagher, Ewen] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Arvand, Afsane] Mt St Marys Coll, Dept Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; Imperial College London	Tricker, E (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	gcheng@mednet.ucla.edu			National Institutes of Health [R01 CA100210]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant R01 CA100210 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudreau RM, 2007, CELL SIGNAL, V19, P139, DOI 10.1016/j.cellsig.2006.05.030; BOUDREAU RT, 2007, EXP MOL PATHOL; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chao JI, 2006, MOL PHARMACOL, V69, P154, DOI 10.1124/mol.105.015503; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chu R, 2009, BIOCHEM PHARMACOL, V78, P241, DOI 10.1016/j.bcp.2009.04.005; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Giannini AL, 2008, BIOCHEM J, V410, P101, DOI 10.1042/BJ20070995; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; KAN Z, NATURE, V466, P869; Kolomeichuk SN, 2008, FEBS J, V275, P1889, DOI 10.1111/j.1742-4658.2008.06349.x; Kolomeichuk SN, 2008, MOL PHARMACOL, V73, P128, DOI 10.1124/mol.108.039750; Kwan R, 2001, MOL CELL BIOL, V21, P7183, DOI 10.1128/MCB.21.21.7183-7190.2001; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ROWINSKY EK, 1991, PHARMACOL THERAPEUT, V52, P35, DOI 10.1016/0163-7258(91)90086-2; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Schlesinger TK, 2002, J BIOL CHEM, V277, P10283, DOI 10.1074/jbc.M106885200; Strnad P, 2001, CELL TISSUE RES, V306, P277, DOI 10.1007/s004410100455; Suria H, 1999, LIFE SCI, V65, P2697, DOI 10.1016/S0024-3205(99)00538-X; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; White SR, 2001, AM J RESP CELL MOL, V24, P282, DOI 10.1165/ajrcmb.24.3.3995; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; XIA Y, 2006, MOL CELL BIOL; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZHAO B, 2007, PP2A REGULATES UPSTR	39	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17310	10.1371/journal.pone.0017310	http://dx.doi.org/10.1371/journal.pone.0017310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364884	Green Submitted, Green Published, gold			2022-12-27	WOS:000287764100044
J	Gromova, P; Rubin, BP; An, T; Erneux, C; Vanderwinden, JM				Gromova, Petra; Rubin, Brian P.; An Thys; Erneux, Christophe; Vanderwinden, Jean-Marie			Neurotensin Receptor 1 Is Expressed in Gastrointestinal Stromal Tumors but Not in Interstitial Cells of Cajal	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; KINASE-C-THETA; IMATINIB MESYLATE; POTENTIAL ROLE; HUMAN-PLASMA; KIT K641E; IN-VITRO; GENE; CANCER; ACTIVATION	Gastrointestinal stromal tumors (GIST) are thought to derive from the interstitial cells of Cajal (ICC) or an ICC precursor. Oncogenic mutations of the KIT or PDGFRA receptor tyrosine kinases are present in the majority of GIST, leading to ligand-independent activation of the intracellular signal transduction pathways. We previously investigated the gene expression profile in the murine Kit(K641E) GIST model and identified Ntsr1 mRNA, encoding the Neurotensin receptor 1, amongst the upregulated genes. Here we characterized Ntsr1 mRNA and protein expression in the murine Kit(K641E) GIST model and in tissue microarrays of human GIST. Ntsr1 mRNA upregulation in Kit(K641E) animals was confirmed by quantitative PCR. Ntsr1 immunoreactivity was not detected in the Kit positive ICC of WT mice, but was present in the Kit positive hyperplasia of Kit(K641E) mice. In the normal human gut, NTSR1 immunoreactivity was detected in myenteric neurons but not in KIT positive ICC. Two independent tissue microarrays, including a total of 97 GIST, revealed NTSR1 immunoreactivity in all specimens, including the KIT negative GIST with PDGFRA mutation. NTSR1 immunoreactivity exhibited nuclear, cytoplasmic or mixed patterns, which might relate to variable levels of NTSR1 activation. As studies using radio-labeled NTSR1 ligand analogues for whole body tumor imaging and for targeted therapeutic interventions have already been reported, this study opens new perspectives for similar approaches in GIST.	[Gromova, Petra; An Thys; Vanderwinden, Jean-Marie] Univ Libre Brussels, Fac Med, Neurophysiol Lab, Brussels, Belgium; [Rubin, Brian P.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Rubin, Brian P.] Taussig Canc Ctr, Cleveland, OH USA; [Erneux, Christophe] Univ Libre Brussels, Fac Med, IRIBHM, Brussels, Belgium	Universite Libre de Bruxelles; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Universite Libre de Bruxelles	Gromova, P (corresponding author), Univ Libre Brussels, Fac Med, Neurophysiol Lab, Brussels, Belgium.	jmvdwin@ulb.ac.be	Gener, Petra/AAD-5770-2019	Thys, An/0000-0002-6838-312X; Gener, Petra/0000-0002-2250-570X	National Fund for Scientific Research (Belgium) [7.4.558.07.F, 7.4.529.08.F]; Fonds de la Recherche Scientifique Medicale [3.4.571.07.F]; Belgian State Policy; Life Raft Group	National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Belgian State Policy; Life Raft Group	Funding: National Fund for Scientific Research (Belgium) http://www2.frs-fnrs.be/, Televie grant 7.4.558.07.F, jointly to JMV and CE. National Fund for Scientific Research (Belgium), Fonds de la Recherche Scientifique Medicale grant 3.4.571.07.F to JMV. National Fund for Scientific Research (Belgium), Grant 7.4.529.08.F and Belgian State Policy http://www.belspo.be/belspo/home/port_en.stm PAIP (P6/28) to CE. BPR is funded by a generous grant from The Life Raft Group http://www.liferaftgroup.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; BLACKBURN AM, 1979, J ENDOCRINOL, V83, P175, DOI 10.1677/joe.0.0830175; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; Buchegger F, 2003, J NUCL MED, V44, P1649; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Demetri GD, 2007, J NATL COMPR CANC S2, V5, pS30; Dong ZZ, 1998, AM J PHYSIOL-GASTR L, V274, pG535, DOI 10.1152/ajpgi.1998.274.3.G535; Duensing A, 2004, CANCER RES, V64, P5127, DOI 10.1158/0008-5472.CAN-04-0559; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Fletcher CDM, 2002, INT J SURG PATHOL, V10, P81, DOI 10.1177/106689690201000201; Garcia-Garayoa E, 2009, EUR J NUCL MED MOL I, V36, P37, DOI 10.1007/s00259-008-0894-y; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Gonzalez-Barrios JA, 2006, MOL THER, V14, P857, DOI 10.1016/j.ymthe.2006.09.001; Gromova P, 2009, J CELL MOL MED, V13, P1536, DOI 10.1111/j.1582-4934.2009.00768.x; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jager PL, 2004, NUCL MED COMMUN, V25, P433, DOI 10.1097/00006231-200405000-00002; Kitamura Y, 2008, J GASTROENTEROL, V43, P499, DOI 10.1007/s00535-008-2200-y; LEONG MTM, 2004, J BIOL CHEM, V279, P12636; LEONG MTM, 2004, J HISTOCHEM CYTOCHEM, V52, P335; Liegl-Atzwanger B, 2010, VIRCHOWS ARCH, V456, P111, DOI 10.1007/s00428-010-0891-y; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Medeiros F, 2004, AM J SURG PATHOL, V28, P889, DOI 10.1097/00000478-200407000-00007; Meggiato T, 1996, TUMORI, V82, P592, DOI 10.1177/030089169608200616; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Parkkila S, 2010, MODERN PATHOL, V23, P743, DOI 10.1038/modpathol.2009.189; Prior JO, 2009, J CLIN ONCOL, V27, P439, DOI 10.1200/JCO.2008.17.2742; Reubi JC, 1999, INT J CANCER, V82, P213, DOI 10.1002/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Shankar S, 2005, RADIOLOGY, V235, P892, DOI 10.1148/radiol.2353040332; SHAW C, 1983, REGUL PEPTIDES, V7, P145, DOI 10.1016/0167-0115(83)90306-3; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; THEODORSSONNORHEIM E, 1983, GASTROENTEROLOGY, V85, P881; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8	40	14	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e14710	10.1371/journal.pone.0014710	http://dx.doi.org/10.1371/journal.pone.0014710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364741	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800002
J	Han, B; Guo, J; Abrahaley, T; Qin, LJ; Wang, L; Zheng, YD; Li, B; Liu, DD; Yao, HC; Yang, JW; Li, CM; Xi, ZG; Yang, X				Han, Bing; Guo, Jing; Abrahaley, Tesfamariam; Qin, Longjuan; Wang, Li; Zheng, Yuduo; Li, Bing; Liu, Dandan; Yao, Hanchao; Yang, Jiwen; Li, Changming; Xi, Zhuge; Yang, Xu			Adverse Effect of Nano-Silicon Dioxide on Lung Function of Rats with or without Ovalbumin Immunization	PLOS ONE			English	Article							INDUCED AIRWAY INFLAMMATION; DIESEL EXHAUST PARTICLES; ANIMAL-MODELS; OXIDATIVE STRESS; ASTHMA; POLLUTION; TOXICITY; EXPOSURE; DISEASES; INJURY	Background: The great advances of nanomaterials have brought out broad important applications, but their possible nanotoxicity and risks have not been fully understood. It is confirmed that exposure of environmental particulate matter (PM), especially ultrafine PM, are responsible for many lung function impairment and exacerbation of pre-existing lung diseases. However, the adverse effect of nanoparticles on allergic asthma is seldom investigated and the mechanism remains undefined. For the first time, this work investigates the relationship between allergic asthma and nanosized silicon dioxide (nano-SiO2). Methodology/Principal Findings: Ovalbumin (OVA)-treated and saline-treated control rats were daily intratracheally administered 0.1 ml of 0, 40 and 80 mg/ml nano-SiO2 solutions, respectively for 30 days. Increased nano-SiO2 exposure results in adverse changes on inspiratory and expiratory resistance (Ri and Re), but shows insignificant effect on rat lung dynamic compliance (Cldyn). Lung histological observation reveals obvious airway remodeling in 80 mg/ml nano-SiO2-introduced saline and OVA groups, but the latter is worse. Additionally, increased nano-SiO2 exposure also leads to more severe inflammation. With increasing nano-SiO2 exposure, IL-4 in lung homogenate increases and IFN-gamma shows a reverse but insignificant change. Moreover, at a same nano-SiO2 exposure concentration, OVA-treated rats exhibit higher (significant) IL4 and lower (not significant) IFN-gamma compared with the saline-treated rats. The percentages of eosinophil display an unexpected result, in which higher exposure results lower eosinophil percentages. Conclusions/Significance: This was a preliminary study which for the first time involved the effect of nano-SiO2 to OVA induced rat asthma model. The results suggested that intratracheal administration of nano-SiO2 could lead to the airway hyperresponsiveness (AHR) and the airway remolding with or without OVA immunization. This occurrence may be due to the Th1/Th2 cytokine imbalance accelerated by the nano-SiO2 through increasing the tissue IL-4 production.	[Han, Bing; Guo, Jing; Abrahaley, Tesfamariam; Qin, Longjuan; Wang, Li; Zheng, Yuduo; Li, Bing; Liu, Dandan; Yao, Hanchao; Yang, Jiwen; Yang, Xu] Huazhong Normal Univ, Lab Environm Sci, Wuhan, Peoples R China; [Han, Bing; Guo, Jing; Abrahaley, Tesfamariam; Qin, Longjuan; Wang, Li; Zheng, Yuduo; Li, Bing; Liu, Dandan; Yao, Hanchao; Yang, Jiwen; Yang, Xu] Huazhong Normal Univ, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Xi, Zhuge] Tianjin Inst Hlth, Tianjin, Peoples R China; [Li, Changming] Nanyang Technol Univ, Div Bioengn, Singapore, Singapore; [Xi, Zhuge] Tianjin Inst Environm Med, Tianjin, Peoples R China	Central China Normal University; Central China Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Han, B (corresponding author), Huazhong Normal Univ, Lab Environm Sci, Wuhan, Peoples R China.	zhugexi2003@sina.com; yangxu@mail.ccnu.edu.cn	Li, Chang Ming/G-6192-2010; Li, Chang Ming/F-9340-2017; Li, Chang Ming/N-8811-2019	Li, Chang Ming/0000-0002-4041-2574; Li, Chang Ming/0000-0002-4041-2574	Chinese National Program for High Technology Research and Development [2006AA03Z330]; Key Project of Chinese National Program for Fundamental Research and Development [2010CB933904]	Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China); Key Project of Chinese National Program for Fundamental Research and Development	This work was supported by the projects of the Chinese National Program for High Technology Research and Development (863 program) No. 2006AA03Z330 and Key Project of Chinese National Program for Fundamental Research and Development (973 program) No. 2010CB933904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIOH, 2009, AIOH POS PAP RESP CR; Brusasco V, 2001, ALLERGY, V56, P1114, DOI 10.1034/j.1398-9995.2001.00148.x; Carvalho C, 1999, EXP LUNG RES, V25, P303; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; Ding M, 2002, INT IMMUNOPHARMACOL, V2, P173, DOI 10.1016/S1567-5769(01)00170-9; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Elias JA, 2000, AM J RESP CRIT CARE, V161, pS168, DOI 10.1164/ajrccm.161.supplement_2.a1q4-4; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Herz U, 2004, METHODS, V32, P271, DOI 10.1016/j.ymeth.2003.08.013; Hoyt VW, 2008, J CHEM HEALTH SAF, V15, P10, DOI 10.1016/j.jchas.2007.07.015; Hylkema MN, 2002, CLIN EXP IMMUNOL, V129, P390, DOI 10.1046/j.1365-2249.2002.01938.x; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; KAROL MH, 1994, EUR RESPIR J, V7, P555, DOI 10.1183/09031936.94.07030555; Kobayashi N, 2009, TOXICOLOGY, V264, P110, DOI 10.1016/j.tox.2009.08.002; Kucharewicz I, 2008, FOLIA HISTOCHEM CYTO, V46, P199, DOI 10.2478/v10042-008-0030-7; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Liu S, 2005, INFLAMM RES, V54, P221, DOI 10.1007/s00011-005-1346-9; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; *NIOSH, 2002, PUBL NIOSH; Nishimori H, 2009, EUR J PHARM BIOPHARM, V72, P626, DOI 10.1016/j.ejpb.2009.03.007; *OSHA, 2009, 336204 OSHA US DEP L; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Park R, 2002, OCCUP ENVIRON MED, V59, P36, DOI 10.1136/oem.59.1.36; Pereira CEL, 2007, BRAZ J MED BIOL RES, V40, P1353, DOI 10.1590/S0100-879X2006005000164; Qiao Y, 2009, INHAL TOXICOL, V21, P1200, DOI 10.3109/08958370902806159; Samuelsen M, 2008, TOXICOLOGY, V246, P124, DOI 10.1016/j.tox.2008.01.001; Savolainen K, 2010, TOXICOLOGY, V269, P92, DOI 10.1016/j.tox.2010.01.013; SCENIHR, 2007, APPR RISK ASS METH A; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Su YY, 2010, TOXICOLOGY, V269, P155, DOI 10.1016/j.tox.2009.11.015; Suh WH, 2009, PROG NEUROBIOL, V87, P133, DOI 10.1016/j.pneurobio.2008.09.009; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yamauchi K, 2006, TOHOKU J EXP MED, V209, P75, DOI 10.1620/tjem.209.75; Yanagisawa R, 2003, THORAX, V58, P605, DOI 10.1136/thorax.58.7.605; Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x; 2000, NAT BIOTECHNOL S, V18, pIT10	42	41	47	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17236	10.1371/journal.pone.0017236	http://dx.doi.org/10.1371/journal.pone.0017236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21359146	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482300042
J	Dong, GH; Lu, QL; Zhou, H; Zhao, XA				Dong, Guangheng; Lu, Qilin; Zhou, Hui; Zhao, Xuan			Precursor or Sequela: Pathological Disorders in People with Internet Addiction Disorder	PLOS ONE			English	Article							DEPRESSION; ABUSE; PREDICTORS; HOSTILITY; USAGE	Background: This study aimed to evaluate the roles of pathological disorders in Internet addiction disorder and identify the pathological problems in IAD, as well as explore the mental status of Internet addicts prior to addiction, including the pathological traits that may trigger Internet addiction disorder. Methods and Findings: 59 students were measured by Symptom CheckList-90 before and after they became addicted to the Internet. A comparison of collected data from Symptom Checklist-90 before Internet addiction and the data collected after Internet addiction illustrated the roles of pathological disorders among people with Internet addiction disorder. The obsessive-compulsive dimension was found abnormal before they became addicted to the Internet. After their addiction, significantly higher scores were observed for dimensions on depression, anxiety, hostility, interpersonal sensitivity, and psychoticism, suggesting that these were outcomes of Internet addiction disorder. Dimensions on somatisation, paranoid ideation, and phobic anxiety did not change during the study period, signifying that these dimensions are not related to Internet addiction disorder. Conclusions: We can not find a solid pathological predictor for Internet addiction disorder. Internet addiction disorder may bring some pathological problems to the addicts in some ways.	[Dong, Guangheng; Zhou, Hui; Zhao, Xuan] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Lu, Qilin] Dalian Univ Technol, Inst Neuroinformat, Dalian, Peoples R China	Zhejiang Normal University; Dalian University of Technology	Dong, GH (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China.	dongguangheng@gmail.com			National Science Foundation of China [30900405]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Science Foundation of China (30900405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, CHIN J MENTAL HLTH; Armstrong L, 2000, INT J HUM-COMPUT ST, V53, P537, DOI 10.1006/ijhc.2000.0400; Barnes GA, 2005, PSYCHOL ADDICT BEHAV, V19, P165, DOI 10.1037/0893-164X.19.2.165; BEUTEL ME, CYBERPSYCHO IN PRESS; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; China Internet Network Information Center (CNNIC), 2010, 26 CNNIC; Chou C, 2000, COMPUT EDUC, V35, P65, DOI 10.1016/S0360-1315(00)00019-1; Christensen M H, 2001, J Psychosoc Nurs Ment Health Serv, V39, P40; Davis C, 2009, APPETITE, V53, P1, DOI 10.1016/j.appet.2009.05.018; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Dell'Osso B, 2006, EUR ARCH PSY CLIN N, V256, P464, DOI 10.1007/s00406-006-0668-0; DEROGATIS LR, 1975, USE SYMPTOM CHECKLIS; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Douglas AC, 2008, COMPUT HUM BEHAV, V24, P3027, DOI 10.1016/j.chb.2008.05.009; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Hsu SH, 2009, COMPUT EDUC, V53, P990, DOI 10.1016/j.compedu.2009.05.016; Huang C, 2010, CYBERPSYCH BEH SOC N, V13, P241, DOI 10.1089/cyber.2009.0217; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; MCCORMICK RA, 1995, ADDICT BEHAV, V20, P555, DOI 10.1016/0306-4603(95)00015-5; Morahan-Martin J, 2005, SOC SCI COMPUT REV, V23, P39, DOI 10.1177/0894439304271533; Peng W, 2010, CYBERPSYCH BEH SOC N, V13, P329, DOI 10.1089/cyber.2009.0082; Rierdan J, 1999, AM PSYCHOL, V54, P781, DOI 10.1037/0003-066X.54.9.781; Shapira NA, 2003, DEPRESS ANXIETY, V17, P207, DOI 10.1002/da.10094; Spinella M, 2005, ADDICT BEHAV, V30, P183, DOI 10.1016/j.addbeh.2004.04.011; Thatcher A., 2005, S AFRICAN J PSYCHOL, V35, P766, DOI DOI 10.1177/008124630503500409; Volkow ND, 2004, BIOL PSYCHIAT, V56, P714, DOI 10.1016/j.biopsych.2004.07.007; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; WU HR, 2004, CHINESE J PUBLIC HLT, V20, P1363; Yen JY, 2007, J ADOLESCENT HEALTH, V41, P93, DOI 10.1016/j.jadohealth.2007.02.002; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K.S., 2009, INTERNET ADDICTION T; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]	33	107	109	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14703	10.1371/journal.pone.0014703	http://dx.doi.org/10.1371/journal.pone.0014703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721YC	21358822	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700013
J	Kusano, M; Redestig, H; Hirai, T; Oikawa, A; Matsuda, F; Fukushima, A; Arita, M; Watanabe, S; Yano, M; Hiwasa-Tanase, K; Ezura, H; Saito, K				Kusano, Miyako; Redestig, Henning; Hirai, Tadayoshi; Oikawa, Akira; Matsuda, Fumio; Fukushima, Atsushi; Arita, Masanori; Watanabe, Shin; Yano, Megumu; Hiwasa-Tanase, Kyoko; Ezura, Hiroshi; Saito, Kazuki			Covering Chemical Diversity of Genetically-Modified Tomatoes Using Metabolomics for Objective Substantial Equivalence Assessment	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; MIRACULIN; METABOLITE; EXPRESSION; FRUIT; SPECTROSCOPY; PROTEOMICS; TOLERANT; REVEALS; STRESS	As metabolomics can provide a biochemical snapshot of an organism's phenotype it is a promising approach for charting the unintended effects of genetic modification. A critical obstacle for this application is the inherently limited metabolomic coverage of any single analytical platform. We propose using multiple analytical platforms for the direct acquisition of an interpretable data set of estimable chemical diversity. As an example, we report an application of our multi-platform approach that assesses the substantial equivalence of tomatoes over-expressing the taste-modifying protein miraculin. In combination, the chosen platforms detected compounds that represent 86% of the estimated chemical diversity of the metabolites listed in the LycoCyc database. Following a proof-of-safety approach, we show that > 92% had an acceptable range of variation while simultaneously indicating a reproducible transformation-related metabolic signature. We conclude that multi-platform metabolomics is an approach that is both sensitive and robust and that it constitutes a good starting point for characterizing genetically modified organisms.	[Kusano, Miyako; Redestig, Henning; Oikawa, Akira; Matsuda, Fumio; Fukushima, Atsushi; Arita, Masanori; Saito, Kazuki] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Hirai, Tadayoshi; Watanabe, Shin; Yano, Megumu; Hiwasa-Tanase, Kyoko; Ezura, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ctr Gene Res, Tsukuba, Ibaraki, Japan; [Arita, Masanori] Univ Tokyo, Dept Biophys & Biochem, Tokyo, Japan; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	RIKEN; University of Tsukuba; University of Tokyo; Chiba University	Kusano, M (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan.	ksaito@psc.riken.jp	Kusano, Miyako/A-3879-2012; Oikawa, Akira/D-2715-2017; Redestig, Henning/B-1060-2010; Ezura, H/AAO-8184-2021; Fukushima, Atsushi/C-9279-2017; Saito, Kazuki/D-2670-2009	Kusano, Miyako/0000-0002-0052-6155; Fukushima, Atsushi/0000-0001-9015-1694; Saito, Kazuki/0000-0001-6310-5342; Watanabe, Shin/0000-0002-8529-7485; Hiwasa-Tanase, Kyoko/0000-0003-1142-491X; Redestig, Henning/0000-0003-2130-9288	RIKEN; Gene Research Center, the University of Tsukuba	RIKEN; Gene Research Center, the University of Tsukuba	This study was supported by a house-keeping grant from RIKEN. This study was supported, in part, by Cooperative Research Grant of the Gene Research Center, the University of Tsukuba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Boggio SB, 2000, PLANT SCI, V159, P125, DOI 10.1016/S0168-9452(00)00342-3; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Catchpole GS, 2005, P NATL ACAD SCI USA, V102, P14458, DOI 10.1073/pnas.0503955102; Colquhoun IJ, 2006, TRENDS GENET, V22, P525, DOI 10.1016/j.tig.2006.08.002; Corpillo D, 2004, PROTEOMICS, V4, P193, DOI 10.1002/pmic.200300540; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; GROSS KC, 1983, PHYTOCHEMISTRY, V22, P1137, DOI 10.1016/0031-9422(83)80207-6; Harrigan GG, 2010, NAT BIOTECHNOL, V28, P402, DOI 10.1038/nbt0510-402; Hirai T, 2010, J PLANT PHYSIOL, V167, P209, DOI 10.1016/j.jplph.2009.08.001; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Hothorn LA, 2006, REGUL TOXICOL PHARM, V44, P125, DOI 10.1016/j.yrtph.2005.10.001; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kim YW, 2010, J AGR FOOD CHEM, V58, P282, DOI 10.1021/jf9030663; Kok EJ, 2008, REGUL TOXICOL PHARM, V50, P98, DOI 10.1016/j.yrtph.2007.09.007; Kok EJ, 2007, J PLANT PHYSIOL, V164, P337, DOI 10.1016/j.jplph.2006.02.013; Krizova K, 2009, PLANT PHYSIOL, V149, P1493, DOI 10.1104/pp.108.133165; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Kurihara Y., 1997, FFI J JPN, V174, P67; Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Le Gall G, 2003, J AGR FOOD CHEM, V51, P2447, DOI 10.1021/jf0259967; Levandi T, 2008, ANAL CHEM, V80, P6329, DOI 10.1021/ac8006329; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Mattoo AK, 2006, PLANT PHYSIOL, V142, P1759, DOI 10.1104/pp.106.084400; Mazourek M, 2009, PLANT PHYSIOL, V150, P1806, DOI 10.1104/pp.109.136549; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Obert JC, 2004, J AGR FOOD CHEM, V52, P1375, DOI 10.1021/jf035218u; OECD, 2006, SER SAF NOV FOODS FE, V14, P10; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Redestig H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-214; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soniya EV, 2001, CURR SCI INDIA, V80, P1213; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Sun HJ, 2006, FEBS LETT, V580, P620, DOI 10.1016/j.febslet.2005.12.080; Sun HJ, 2007, PLANT BIOTECHNOL J, V5, P768, DOI 10.1111/j.1467-7652.2007.00283.x; Wang J, 2009, J AGR FOOD CHEM, V57, P2392, DOI 10.1021/jf803363g; Ward JL, 2003, PHYTOCHEMISTRY, V62, P949, DOI 10.1016/S0031-9422(02)00705-7; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Yano M, 2010, PLANT SCI, V178, P469, DOI 10.1016/j.plantsci.2010.02.016	50	77	83	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16989	10.1371/journal.pone.0016989	http://dx.doi.org/10.1371/journal.pone.0016989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359231	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700034
J	Messaoud, Y; Chen, HYH				Messaoud, Yassine; Chen, Han Y. H.			The Influence of Recent Climate Change on Tree Height Growth Differs with Species and Spatial Environment	PLOS ONE			English	Article							TREMBLING ASPEN; BLACK SPRUCE; SITE INDEX; BRITISH-COLUMBIA; FAGUS-SYLVATICA; RADIAL GROWTH; WHITE SPRUCE; ATMOSPHERIC CO2; CARBON-DIOXIDE; DOUGLAS-FIR	Tree growth has been reported to increase in response to recent global climate change in controlled and semi-controlled experiments, but few studies have reported response of tree growth to increased temperature and atmospheric carbon dioxide (CO2) concentration in natural environments. This study addresses how recent global climate change has affected height growth of trembling aspen (Populus tremuloides Michx) and black spruce (Picea mariana Mill B. S.) in their natural environments. We sampled 145 stands dominated by aspen and 82 dominated by spruce over the entire range of their distributions in British Columbia, Canada. These stands were established naturally after fire between the 19(th) and 20(th) centuries. Height growth was quantified as total heights of sampled dominant and co-dominant trees at breast-height age of 50 years. We assessed the relationships between 50-year height growth and environmental factors at both spatial and temporal scales. We also tested whether the tree growth associated with global climate change differed with spatial environment (latitude, longitude and elevation). As expected, height growth of both species was positively related to temperature variables at the regional scale and with soil moisture and nutrient availability at the local scale. While height growth of trembling aspen was not significantly related to any of the temporal variables we examined, that of black spruce increased significantly with stand establishment date, the anomaly of the average maximum summer temperature between May-August, and atmospheric CO2 concentration, but not with the Palmer Drought Severity Index. Furthermore, the increase of spruce height growth associated with recent climate change was higher in the western than in eastern part of British Columbia. This study demonstrates that the response of height growth to recent climate change, i.e., increasing temperature and atmospheric CO2 concentration, did not only differ with tree species, but also their growing spatial environment.	[Messaoud, Yassine; Chen, Han Y. H.] Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada	Lakehead University	Messaoud, Y (corresponding author), Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada.	hchen1@lakeheadu.ca	Chen, Han YH/A-1359-2008	Chen, Han YH/0000-0001-9477-5541	Natural Sciences and Engineering Research Council of Canada [DG283336-09]; Ontario Early Researcher Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	Natural Sciences and Engineering Research Council of Canada (DG283336-09) and an Ontario Early Researcher Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, SPECIAL REPORT SERIE; Asshoff R, 2006, GLOBAL CHANGE BIOL, V12, P848, DOI 10.1111/j.1365-2486.2006.01133.x; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bradley KL, 2007, TRENDS ECOL EVOL, V22, P538, DOI 10.1016/j.tree.2007.08.005; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Chen HYH, 2002, CAN J FOREST RES, V32, P112, DOI 10.1139/x01-179; Chen HYH, 1998, FOREST ECOL MANAG, V102, P157, DOI 10.1016/S0378-1127(97)00154-0; Chen HYH, 1998, CAN J FOREST RES, V28, P1743, DOI 10.1139/cjfr-28-12-1743; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dai A, 1999, J CLIMATE, V12, P2451, DOI [10.1175/1520-0442(1999)012<2451:EOCSMP>2.0.CO;2, 10.1175/1520-0442(1999)012&lt;2451:EOCSMP&gt;2.0.CO;2]; DYER ME, 1987, FOREST SCI, V33, P3; Fantin N, 2002, CAN J FOREST RES, V32, P1478, DOI [10.1139/x02-053, 10.1139/X02-053]; Fries A, 1998, SCAND J FOREST RES, V13, P128, DOI 10.1080/02827589809382969; Gifford RM, 2004, NEW PHYTOL, V163, P221, DOI 10.1111/j.1469-8137.2004.01133.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GRAUMLICH LJ, 1991, ECOLOGY, V72, P1, DOI 10.2307/1938895; Green RN, 1994, HDB MINISTRY FORESTS; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hamel B, 2004, FOREST ECOL MANAG, V191, P239, DOI 10.1016/j.foreco.2003.12.004; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Howell CD, 2007, STAT METHODS PSYCHOL; KELLOMAKI S, 1994, FOREST ECOL MANAG, V65, P201, DOI 10.1016/0378-1127(94)90171-6; Klinka K, 2003, FOREST ECOL MANAG, V175, P521, DOI 10.1016/S0378-1127(02)00184-6; Klinka K, 1996, FOREST CHRON, V72, P193, DOI 10.5558/tfc72193-2; Klinka K., 2000, DISTRIBUTION SYNOPSI; Koutavas A, 2008, DENDROCHRONOLOGIA, V26, P13, DOI 10.1016/j.dendro.2007.06.001; Kozlowski TT., 1997, GROWTH CONTROL WOODY; LAMARCHE VC, 1984, SCIENCE, V225, P1019, DOI 10.1126/science.225.4666.1019; Lapointe-Garant MP, 2010, GLOBAL CHANGE BIOL, V16, P2039, DOI 10.1111/j.1365-2486.2009.02048.x; Leonelli G, 2008, CAN J FOREST RES, V38, P1211, DOI 10.1139/X07-227; Loehle C, 2000, CAN J FOREST RES, V30, P1632, DOI 10.1139/cjfr-30-10-1632; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Luttmerding H. A., 1990, DESCRIBING ECOSYSTEM; Miller J.H., 1990, SILVICS N AM, P461; Miyamoto Y, 2010, FOREST ECOL MANAG, V259, P514, DOI 10.1016/j.foreco.2009.11.008; MONSERUD RA, 1984, FOREST SCI, V30, P943; Moore DJP, 2006, GLOBAL CHANGE BIOL, V12, P1367, DOI 10.1111/j.1365-2486.2006.01189.x; Nigh GD, 2004, FOREST SCI, V50, P659; Nigh GD, 2002, FOREST CHRON, V78, P306, DOI 10.5558/tfc78306-2; Nigh GD, 2006, CLIMATIC CHANGE, V76, P321, DOI 10.1007/s10584-005-9041-y; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Pinno BD, 2009, FOREST ECOL MANAG, V257, P782, DOI 10.1016/j.foreco.2008.09.058; Pinto PE, 2008, FOREST ECOL MANAG, V255, P619, DOI 10.1016/j.foreco.2007.09.031; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Seynave I, 2008, J BIOGEOGR, V35, P1851, DOI 10.1111/j.1365-2699.2008.01930.x; Soule PT, 2006, NEW PHYTOL, V171, P379, DOI 10.1111/j.1469-8137.2006.01746.x; Srur AM, 2008, REV CHIL HIST NAT, V81, P239; SYSTAT, 2007, SYST 12 WIND; Viereck L. A., 2007, ALASKA TREES SHRUBS, V2nd; Voelker SL, 2006, ECOL MONOGR, V76, P549, DOI 10.1890/0012-9615(2006)076[0549:HCGEDW]2.0.CO;2; Wang GG, 2006, GLOBAL CHANGE BIOL, V12, P601, DOI 10.1111/j.1365-2486.2006.01098.x; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wirth C, 2008, ECOL MONOGR, V78, P489, DOI 10.1890/07-0074.1	57	36	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e14691	10.1371/journal.pone.0014691	http://dx.doi.org/10.1371/journal.pone.0014691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358817	gold, Green Submitted, Green Published			2022-12-27	WOS:000287392700006
J	Miyagi, M; Wan, Q; Ahmad, MF; Gokulrangan, G; Tomechko, SE; Bennett, B; Dealwis, C				Miyagi, Masaru; Wan, Qun; Ahmad, Md. Faiz; Gokulrangan, Giridharan; Tomechko, Sara E.; Bennett, Brad; Dealwis, Chris			Histidine Hydrogen-Deuterium Exchange Mass Spectrometry for Probing the Microenvironment of Histidine Residues in Dihydrofolate Reductase	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CRYSTAL-STRUCTURE; PK(A) VALUES; METHOTREXATE; CATALYSIS; PROTEINS; KINETICS; NETWORK; MOTIONS; PROTONS	Background: Histidine Hydrogen-Deuterium Exchange Mass Spectrometry (His-HDX-MS) determines the HDX rates at the imidazole C(2)-hydrogen of histidine residues. This method provides not only the HDX rates but also the pK(a) values of histidine imidazole rings. His-HDX-MS was used to probe the microenvironment of histidine residues of E. coli dihydrofolate reductase (DHFR), an enzyme proposed to undergo multiple conformational changes during catalysis. Methodology/Principal Findings: Using His-HDX-MS, the pK(a) values and the half-lives (t(1/2)) of HDX reactions of five histidine residues of apo-DHFR, DHFR in complex with methotrexate (DHFR-MTX), DHFR in complex with MTX and NADPH (DHFR-MTX-NADPH), and DHFR in complex with folate and NADP(+) (DHFR-folate-NADP+) were determined. The results showed that the two parameters (pK(a) and t(1/2)) are sensitive to the changes of the microenvironment around the histidine residues. Although four of the five histidine residues are located far from the active site, ligand binding affected their pK(a), t(1/)2 or both. This is consistent with previous observations of ligand binding-induced distal conformational changes on DHFR. Most of the observed pK(a) and t(1/2) changes could be rationalized using the X-ray structures of apo-DHFR, DHFR-MTX-NADPH, and DHFR-folate-NADP+. The availability of the neutron diffraction structure of DHFR-MTX enabled us to compare the protonation states of histidine imidazole rings. Conclusions/Significance: Our results demonstrate the usefulness of His-HDX-MS in probing the microenvironments of histidine residues within proteins.	[Miyagi, Masaru; Gokulrangan, Giridharan; Tomechko, Sara E.; Dealwis, Chris] Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Miyagi, Masaru; Wan, Qun; Ahmad, Md. Faiz; Bennett, Brad; Dealwis, Chris] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Miyagi, M (corresponding author), Case Western Reserve Univ, Case Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	masaru.miyagi@case.edu; chris.dealwis@case.edu		Wan, Qun/0000-0002-8309-0341	National Institutes of Health (NIH) [P30EY-11373]; Case Western Reserve University; Cleveland Foundation; Department of Defense (DOD) Laboratory Directed Research and Development [20070131ER]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; Cleveland Foundation; Department of Defense (DOD) Laboratory Directed Research and Development(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) grant P30EY-11373 (Visual Sciences Research Center of Case Western Reserve University) and funds from Case Western Reserve University and the Cleveland Foundation. QW and CD were funded by a Department of Defense (DOD) Laboratory Directed Research and Development award (20070131ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Amyes TL, 2004, J AM CHEM SOC, V126, P4366, DOI 10.1021/ja039890j; Barlin G. B., 1972, ELUCIDATION ORGANI 1, P611; Bennett B, 2006, P NATL ACAD SCI USA, V103, P18493, DOI 10.1073/pnas.0604977103; Bennett BC, 2008, ACTA CRYSTALLOGR D, V64, P764, DOI 10.1107/S0907444908012845; Bennett BC, 2007, J MED CHEM, V50, P4374, DOI 10.1021/jm070319v; Bennett BC, 2009, J STRUCT BIOL, V166, P162, DOI 10.1016/j.jsb.2009.01.001; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Harris T M, 1965, Chem Ind, V41, P1728; Horiuchi Y, 2010, BBA-PROTEINS PROTEOM, V1804, P846, DOI 10.1016/j.bbapap.2009.12.011; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LODOWSKI DT, 2010, BIOCHEMISTRY; Markley J. L., 1973, P INT C STABLE ISOT, V1st, P103; MARTIN RB, 1963, SCIENCE, V139, P1198, DOI 10.1126/science.139.3560.1198; MATTHEWS DA, 1977, SCIENCE, V197, P452, DOI 10.1126/science.17920; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Niimura N, 2004, CELL BIOCHEM BIOPHYS, V40, P351, DOI 10.1385/CBB:40:3:351; POE M, 1979, J BIOL CHEM, V254, P8143; Rajagopalan PTR, 2002, P NATL ACAD SCI USA, V99, P13481, DOI 10.1073/pnas.172501499; SACHS DH, 1971, J BIOL CHEM, V246, P6576; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; VAUGHAN JD, 1970, J ORG CHEM, V35, P1141, DOI 10.1021/jo00829a062; Wimalasena DS, 2010, BIOCHEMISTRY-US, V49, P6973, DOI 10.1021/bi100647z; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; WYETH P, 1980, BIOCHEMISTRY-US, V19, P2608, DOI 10.1021/bi00553a012; Yamamoto T, 2004, J BIOCHEM, V135, P663, DOI 10.1093/jb/mvh080; Yamamoto T, 2004, J BIOCHEM, V135, P17, DOI 10.1093/jb/mvh002	31	25	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17055	10.1371/journal.pone.0017055	http://dx.doi.org/10.1371/journal.pone.0017055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359214	gold, Green Submitted, Green Published			2022-12-27	WOS:000287392700040
J	Xu, XL; Xie, CZ; Edwards, H; Zhou, H; Buck, SA; Ge, YB				Xu, Xuelian; Xie, Chengzhi; Edwards, Holly; Zhou, Hui; Buck, Steven A.; Ge, Yubin			Inhibition of Histone Deacetylases 1 and 6 Enhances Cytarabine-Induced Apoptosis in Pediatric Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							REFRACTORY SOLID TUMORS; SUBEROYLANILIDE HYDROXAMIC ACID; ACUTE MEGAKARYOCYTIC LEUKEMIA; PHASE-I; HEMATOLOGIC MALIGNANCIES; VALPROIC ACID; DOWN-SYNDROME; CHEMOTHERAPY SENSITIVITY; CYTOSINE-ARABINOSIDE; TARGETED THERAPY	Background: Pediatric acute myeloid leukemia (AML) remains a challenging disease to treat even with intensified cytarabine-based chemotherapy. Histone deacetylases (HDACs) have been reported to be promising therapeutic targets for treating AML. However, HDAC family members that are involved in chemotherapy sensitivities remain unknown. In this study, we sought to identify members of the HDAC family that are involved in cytarabine sensitivities, and to select the optimal HDACI that is most efficacious when combined with cytarabine for treating children with AML. Methodology: Expression profiles of classes I, II, and IV HDACs in 4 pediatric AML cell lines were determined by Western blotting. Inhibition of class I HDACs by different HDACIs was measured post immnunoprecipitation. Individual down-regulation of HDACs in pediatric AML cells was performed with lentiviral shRNA. The effects of cytarabine and HDACIs on apoptosis were determined by flow cytometry analysis. Results: Treatments with structurally diverse HDACIs and HDAC shRNA knockdown experiments revealed that down-regulation of both HDACs 1 and 6 is critical in enhancing cytarabine-induced apoptosis in pediatric AML, at least partly mediated by Bim. However, down-regulation of HDAC2 may negatively impact cytarabine sensitivities in the disease. At clinically achievable concentrations, HDACIs that simultaneously inhibited both HDACs 1 and 6 showed the best anti-leukemic activities and significantly enhanced cytarabine-induced apoptosis. Conclusion: Our results further confirm that HDACs are bona fide therapeutic targets for treating pediatric AML and suggest that pan-HDACIs may be more beneficial than isoform-specific drugs.	[Xu, Xuelian; Xie, Chengzhi; Edwards, Holly; Ge, Yubin] Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Xu, Xuelian; Xie, Chengzhi; Edwards, Holly; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Xu, Xuelian; Xie, Chengzhi; Zhou, Hui; Ge, Yubin] Jilin Univ, State Engn Lab AIDS Vaccine, Coll Life Sci, Changchun 130023, Peoples R China; [Buck, Steven A.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Ge, Yubin] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Jilin University; Children's Hospital of Michigan; Wayne State University	Xu, XL (corresponding author), Wayne State Univ, Sch Med, Dev Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA.	gey@karmanos.org	xie, chengzhi/F-9615-2012; qiao, zhixin/I-3408-2012	Ge, Yubin/0000-0002-8748-716X; Zhou, Hui/0000-0001-5858-5636	Karmanos Cancer Institute; Children's Research Center of Michigan, Leukemia Research Life; Herrick Foundation; Children's Leukemia Foundation of Michigan	Karmanos Cancer Institute; Children's Research Center of Michigan, Leukemia Research Life; Herrick Foundation; Children's Leukemia Foundation of Michigan	Funding: This work was supported by the Karmanos Cancer Institute Start-up Fund, the Children's Research Center of Michigan, Leukemia Research Life, the Herrick Foundation, and the Children's Leukemia Foundation of Michigan.	Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chen S, 2009, MOL CELL BIOL, V29, P6149, DOI 10.1128/MCB.01481-08; DAMON LE, 1991, CANCER RES, V51, P4141; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DEANGELIS LM, 1992, CANCER CHEMOTH PHARM, V29, P173, DOI 10.1007/BF00686248; Edwards H, 2009, BLOOD, V114, P2744, DOI 10.1182/blood-2008-09-179812; Fujiwara Y, 2009, CANCER SCI, V100, P1728, DOI 10.1111/j.1349-7006.2009.01237.x; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Ge YB, 2006, BLOOD, V107, P1570, DOI 10.1182/blood-2005-06-2219; Ge YB, 2005, JNCI-J NATL CANCER I, V97, P226, DOI 10.1093/jnci/dji026; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Gore L, 2008, CLIN CANCER RES, V14, P4517, DOI 10.1158/1078-0432.CCR-07-1461; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Karagiannis TC, 2007, LEUKEMIA, V21, P61, DOI 10.1038/sj.leu.2404464; Kaspers GJL, 2007, HAEMATOLOGICA, V92, P1519, DOI 10.3324/haematol.11203; Kummar S, 2007, CLIN CANCER RES, V13, P5411, DOI 10.1158/1078-0432.CCR-07-0791; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Ledent V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-24; Letai A, 2005, TRENDS MOL MED, V11, P442, DOI 10.1016/j.molmed.2005.08.007; LILIEMARK JO, 1985, CANCER RES, V45, P2373; Mariadason JM, 2000, CANCER RES, V60, P4561; Melnick A, 2002, CURR OPIN HEMATOL, V9, P322, DOI 10.1097/00062752-200207000-00010; Meshinchi S, 2007, ONCOLOGIST, V12, P341, DOI 10.1634/theoncologist.12-3-341; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Siu LL, 2008, J CLIN ONCOL, V26, P1940, DOI 10.1200/JCO.2007.14.5730; Soriano AO, 2007, BLOOD, V110, P2302, DOI 10.1182/blood-2007-03-078576; Steele NL, 2008, CLIN CANCER RES, V14, P804, DOI 10.1158/1078-0432.CCR-07-1786; Taub JW, 1999, BLOOD, V94, P1393; ten Cate B, 2007, LEUKEMIA, V21, P248, DOI 10.1038/sj.leu.2404477; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Xie CZ, 2009, BLOOD, V114, P823; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zwaan CM, 2004, BRIT J HAEMATOL, V127, P264, DOI 10.1111/j.1365-2141.2004.05167.x	45	4	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17138	10.1371/journal.pone.0017138	http://dx.doi.org/10.1371/journal.pone.0017138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359182	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700054
J	Chai, CC; Jiang, JF				Chai, Caichun; Jiang, Jifa			Competitive Exclusion and Coexistence of Pathogens in a Homosexually-Transmitted Disease Model	PLOS ONE			English	Article							DYNAMICS; CLASSIFICATION; COEVOLUTION	A sexually-transmitted disease model for two strains of pathogen in a one-sex, heterogeneously-mixing population has been studied completely by Jiang and Chai in (J Math Biol 56:373-390, 2008). In this paper, we give a analysis for a SIS STD with two competing strains, where populations are divided into three differential groups based on their susceptibility to two distinct pathogenic strains. We investigate the existence and stability of the boundary equilibria that characterizes competitive exclusion of the two competing strains; we also investigate the existence and stability of the positive coexistence equilibrium, which characterizes the possibility of coexistence of the two strains. We obtain sufficient and necessary conditions for the existence and global stability about these equilibria under some assumptions. We verify that there is a strong connection between the stability of the boundary equilibria and the existence of the coexistence equilibrium, that is, there exists a unique coexistence equilibrium if and only if the boundary equilibria both exist and have the same stability, the coexistence equilibrium is globally stable or unstable if and only if the two boundary equilibria are both unstable or both stable.	[Chai, Caichun] Anhui Univ Finance & Econ, Caichun Chai Coll Stat & Appl Math, Bengbu, Anhui, Peoples R China; [Chai, Caichun] Anhui Univ Finance & Econ, Inst Appl Math, Bengbu, Anhui, Peoples R China; [Jiang, Jifa] Shanghai Normal Univ, Jifa Jiang Math & Sci Coll, Shanghai, Peoples R China	Anhui University of Finance & Economics; Anhui University of Finance & Economics; Shanghai Normal University	Chai, CC (corresponding author), Anhui Univ Finance & Econ, Caichun Chai Coll Stat & Appl Math, Bengbu, Anhui, Peoples R China.	ccspring@ustc.edu			Youth Foundation of Anhui University of Finance and Economics [ACKYQ1065ZC]; Chinese NSF [10671143, 10531030]	Youth Foundation of Anhui University of Finance and Economics(Anhui University); Chinese NSF(National Natural Science Foundation of China (NSFC))	Supported by the Youth Foundation of Anhui University of Finance and Economics No. ACKYQ1065ZC, Chinese NSF grants 10671143 and 10531030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; BECK K, 1984, J MATH BIOL, V19, P63, DOI 10.1007/BF00275931; BERMAN A, 1989, NONNEGATIVE MARTICES; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; BUTLER GJ, 1983, J MATH BIOL, V17, P133, DOI 10.1007/BF00305755; Castillo-Chavez C, 1999, SIAM J APPL MATH, V59, P1790, DOI 10.1137/S0036139997325862; Castillo-Chavez C, 1988, MATH ECOLOGY, P303; Castillo-Chavez C., 1995, DIFF EQUAT+, P289; CastilloChavez C, 1997, J MATH BIOL, V35, P503, DOI 10.1007/s002850050063; CastilloChavez C, 1996, SIAM J APPL MATH, V56, P494, DOI 10.1137/S003613999325419X; [柴彩春 CHAI Cai-chun], 2009, [中国科学技术大学学报, Journal of University of Science and Technology of China], V39, P570; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; EWALD W, 1994, EVOLUTION INFECT DIS; Hethcote H.W., 1984, LECT NOTES BIOMATH, V56; Jiang J, 2008, J MATH BIOL, V56, P373, DOI 10.1007/s00285-007-0119-1; Levin S.A., 1983, COEVOLUTION, P21; Levin S.A., 1983, LECT NOTES BIOMATH, V52, P328, DOI DOI 10.1007/978-3-642-87893-0_41; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Li J, 2003, J MATH BIOL, V47, P547, DOI 10.1007/s00285-003-0235-5; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; MAY RM, 1983, PHILOS T R SOC LON B, V219, P282; MAYNARD JS, 1978, EVOLUTION SEX; Qiu ZP, 2010, APPL MATH COMPUT, V216, P1553, DOI 10.1016/j.amc.2010.03.006; SMITH HL, 1986, SIAM J APPL MATH, V46, P856, DOI 10.1137/0146052; SMITH HL, 1986, NONLINEAR ANAL-THEOR, V10, P1037, DOI 10.1016/0362-546X(86)90087-8	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16467	10.1371/journal.pone.0016467	http://dx.doi.org/10.1371/journal.pone.0016467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347222	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200004
J	Kilpelainen, M; Nurminen, L; Donner, K				Kilpelainen, Markku; Nurminen, Lauri; Donner, Kristian			Effects of Mean Luminance Changes on Human Contrast Perception: Contrast Dependence, Time-Course and Spatial Specificity	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; PRIMARY VISUAL-CORTEX; NATURAL IMAGES; LIGHT-ADAPTATION; BACKGROUND LUMINANCE; EYE-MOVEMENTS; CONE VISION; RESPONSES; BRIGHTNESS; DYNAMICS	Background: When we are viewing natural scenes, every saccade abruptly changes both the mean luminance and the contrast structure falling on any given retinal location. Thus it would be useful if the two were independently encoded by the visual system, even when they change simultaneously. Recordings from single neurons in the cat visual system have suggested that contrast information may be quite independently represented in neural responses to simultaneous changes in contrast and luminance. Here we test to what extent this is true in human perception. Methodology/Principal Findings: Small contrast stimuli were presented together with a 7-fold upward or downward step of mean luminance (between 185 and 1295 Td, corresponding to 14 and 98 cd/m(2)), either simultaneously or with various delays (50-800 ms). The perceived contrast of the target under the different conditions was measured with an adaptive staircase method. Over the contrast range 0.1-0.45, mainly subtractive attenuation was found. Perceived contrast decreased by 0.052 +/- 0.021 (N = 3) when target onset was simultaneous with the luminance increase. The attenuation subsided within 400 ms, and even faster after luminance decreases, where the effect was also smaller. The main results were robust against differences in target types and the size of the field over which luminance changed. Conclusions/Significance: Perceived contrast is attenuated mainly by a subtractive term when coincident with a luminance change. The effect is of ecologically relevant magnitude and duration; in other words, strict contrast constancy must often fail during normal human visual behaviour. Still, the relative robustness of the contrast signal is remarkable in view of the limited dynamic response range of retinal cones. We propose a conceptual model for how early retinal signalling may allow this.	[Kilpelainen, Markku] Univ Helsinki, Dept Behav Sci, Helsinki, Finland; [Nurminen, Lauri] Aalto Univ, Sch Sci & Technol, Brain Res Unit, Low Temp Lab, Espoo, Finland; [Donner, Kristian] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; Aalto University; University of Helsinki	Kilpelainen, M (corresponding author), Univ Helsinki, Dept Behav Sci, Helsinki, Finland.	markku.kilpelainen@helsinki.fi	Kilpeläinen, Markku/C-7613-2011; Kilpeläinen, Markku/AAF-3420-2021	Kilpeläinen, Markku/0000-0002-4112-7548; Kilpeläinen, Markku/0000-0002-4112-7548; Donner, Kristian/0000-0001-7833-4236; Nurminen, Lauri/0000-0001-7480-7059	Finnish Graduate School of Psychology; Finnish Graduate School of Neuroscience; Academy of Finland [128081]	Finnish Graduate School of Psychology; Finnish Graduate School of Neuroscience; Academy of Finland(Academy of Finland)	Markku Kilpelainen was funded by the Finnish Graduate School of Psychology (www.gspsy.fi). Lauri Nurminen was funded by the Finnish Graduate School of Neuroscience (www.brain-mind.fi). Kristian Donner was supported by a research grant 128081 from the Academy of Finland (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Baker DH, 2009, P NATL ACAD SCI USA, V106, P5436, DOI 10.1073/pnas.0812860106; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; BOWEN RW, 1989, VISION RES, V29, P1501, DOI 10.1016/0042-6989(89)90134-X; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; DeMarco PJ, 2000, VISION RES, V40, P1907, DOI 10.1016/S0042-6989(00)00033-X; Djupsund K, 1996, VISION RES, V36, P3253, DOI 10.1016/0042-6989(96)00021-1; DONNER K, 1989, VISUAL NEUROSCI, V3, P39, DOI 10.1017/S0952523800012499; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; Frazor RA, 2006, VISION RES, V46, P1585, DOI 10.1016/j.visres.2005.06.038; Freeman DK, 2010, J NEUROPHYSIOL, V104, P704, DOI 10.1152/jn.00767.2009; Friedburg C, 2001, J PHYSIOL-LONDON, V534, P217, DOI 10.1111/j.1469-7793.2001.t01-1-00217.x; Garcia-Perez MA, 2010, J SENS STUD, V25, P876, DOI 10.1111/j.1745-459X.2010.00310.x; Geisler WS, 2007, J NEUROSCI, V27, P5063, DOI 10.1523/JNEUROSCI.0835-07.2007; GEISLER WS, 1978, VISION RES, V18, P279, DOI 10.1016/0042-6989(78)90162-1; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Heikkinen H, 2009, VISION RES, V49, P1717, DOI 10.1016/j.visres.2009.03.024; HOOD DC, 1993, VISUAL NEUROSCI, V10, P857, DOI 10.1017/S0952523800006076; KAERNBACH C, 1990, J ACOUST SOC AM, V88, P2645, DOI 10.1121/1.399985; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Kilpelainen M, 2007, VISION RES, V47, P3298, DOI 10.1016/j.visres.2007.09.008; KRAUSKOPF J, 1980, VISION RES, V20, P671, DOI 10.1016/0042-6989(80)90091-7; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lee B, 1996, VISION RES, V36, P2159, DOI 10.1016/0042-6989(95)00271-5; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; Lindgren JT, 2008, J VISION, V8, DOI 10.1167/8.12.6; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; PELI E, 1995, J OPT SOC AM A, V12, P817, DOI 10.1364/JOSAA.12.000817; PELI E, 1991, J OPT SOC AM A, V8, P1352, DOI 10.1364/JOSAA.8.001352; PELLI DG, 1985, J OPT SOC AM A, V2, pP89; Poot L, 1997, J OPT SOC AM A, V14, P2499, DOI 10.1364/JOSAA.14.002499; Rieke F, 2009, NEURON, V64, P605, DOI 10.1016/j.neuron.2009.11.028; Saarela TP, 2008, J VISION, V8, DOI 10.1167/8.3.23; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; STEVENS JC, 1963, J OPT SOC AM, V53, P375, DOI 10.1364/JOSA.53.000375; Stevenson IH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009206; Summers RJ, 2009, VISION RES, V49, P1894, DOI 10.1016/j.visres.2009.04.027; Tse PU, 2010, NEUROIMAGE, V49, P805, DOI 10.1016/j.neuroimage.2009.07.052; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Webb BS, 2005, J NEUROSCI, V25, P11666, DOI 10.1523/JNEUROSCI.3414-05.2005; WESTHEIMER G, 1967, J PHYSIOL-LONDON, V190, P139, DOI 10.1113/jphysiol.1967.sp008198; WHITTLE P, 1969, VISION RES, V9, P1095, DOI 10.1016/0042-6989(69)90050-9; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17200	10.1371/journal.pone.0017200	http://dx.doi.org/10.1371/journal.pone.0017200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347246	Green Submitted, Green Published, gold			2022-12-27	WOS:000287369200027
J	Fernandez-Mazuecos, M; Vargas, P				Fernandez-Mazuecos, Mario; Vargas, Pablo			Genetically Depauperate in the Continent but Rich in Oceanic Islands: Cistus monspeliensis (Cistaceae) in the Canary Islands	PLOS ONE			English	Article							TROPICAL WETLAND TREE; OLEA-EUROPAEA L.; DNA POLYMORPHISM; POPULATIONS; DIVERSITY; EVOLUTION; PHYLOGEOGRAPHY; COLONIZATION; MAINLAND; PATTERNS	Background: Population genetic theory holds that oceanic island populations are expected to have lower levels of genetic variation than their mainland counterparts, due to founder effect after island colonization from the continent. Cistus monspeliensis (Cistaceae) is distributed in both the Canary Islands and the Mediterranean region. Numerous phylogenetic results obtained in the last years allow performing further phylogeographic analyses in Cistus. Methodology/Principal Findings: We analyzed sequences from multiple plastid DNA regions in 47 populations of Cistus monspeliensis from the Canary Islands (21 populations) and the Mediterranean basin (26 populations). The time-calibrated phylogeny and phylogeographic analyses yielded the following results: (1) a single, ancestral haplotype is distributed across the Mediterranean, whereas 10 haplotypes in the Canary Islands; (2) four haplotype lineages are present in the Canarian Islands; (3) multiple colonization events across the archipelago are inferred; (4) the earliest split of intraspecific lineages occurred in the Early to Middle Pleistocene (< 930,000 years BP). Conclusions/Significance: The contrasting pattern of cpDNA variation is best explained by genetic bottlenecks in the Mediterranean during Quaternary glaciations, while the Canarian archipelago acted as a refugium of high levels of genetic diversity. Active colonization across the Canarian islands is supported not only by the distribution of C. monspeliensis in five of the seven islands, but also by our phylogeographic reconstruction in which unrelated haplotypes are present on the same island. Widespread distribution of thermophilous habitats on every island, as those found throughout the Mediterranean, has likely been responsible for the successful colonization of C. monspeliensis, despite the absence of a long-distance dispersal mechanism. This is the first example of a plant species with higher genetic variation among oceanic island populations than among those of the continent.	[Fernandez-Mazuecos, Mario; Vargas, Pablo] CSIC, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Fernandez-Mazuecos, M (corresponding author), CSIC, Real Jardin Bot, Madrid, Spain.	mfmazuecos@rjb.csic.es	Fernández-Mazuecos, Mario/F-9699-2011	Fernández-Mazuecos, Mario/0000-0003-4027-6477	Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [CGL2005-06017-C02]	Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research on continental plants has been supported by the Spanish Direccion General de Investigacion Cientifica y Tecnica (DGICYT) through project CGL2005-06017-C02 and a PhD scholarship to M.F.-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; Baldwin B. G., 1998, MOL SYSTEMATICS PLAN, P410, DOI DOI 10.1007/978-1-4615-5419-6_14; Bloomquist EW, 2010, TRENDS ECOL EVOL, V25, P626, DOI 10.1016/j.tree.2010.08.010; Bramwell D., 1976, Monographiae Biologicae, V30, P207; Bramwell D., 2001, FLORES SILVESTRES IS, V4; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; Chiang YC, 2006, MOL ECOL, V15, P765, DOI 10.1111/j.1365-294X.2005.02833.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cox C.B., 2010, BIOGEOGRAPHY ECOLOGI; CRONK QCB, 1992, BIOL J LINN SOC, V46, P91, DOI 10.1111/j.1095-8312.1992.tb00852.x; Del Arco M, 2004, LISTA ESPECIES SILVE, P99; DeWalt SJ, 2004, AM J BOT, V91, P1155, DOI 10.3732/ajb.91.8.1155; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Drummond A. J., 2010, GENEIOUS V4 8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fernandez-Mazuecos M, 2010, MOL ECOL, V19, P1381, DOI 10.1111/j.1365-294X.2010.04549.x; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Garcia-Verdugo C, 2009, MOL ECOL, V18, P454, DOI 10.1111/j.1365-294X.2008.04027.x; Garcia-Verdugo C, 2010, BOT J LINN SOC, V162, P54, DOI 10.1111/j.1095-8339.2009.01013.x; Gomez A, 2003, THEOR APPL GENET, V107, P1123, DOI 10.1007/s00122-003-1320-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guzman B, 2005, MOL PHYLOGENET EVOL, V37, P644, DOI 10.1016/j.ympev.2005.04.026; Guzman B, 2010, PERSPECT PLANT ECOL, V12, P163, DOI 10.1016/j.ppees.2009.09.002; Guzman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006362; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Hansen A, 1993, FLORA MACARONESIA CH; Hedderson TA, 2006, J BRYOL, V28, P283, DOI 10.1179/174328206X136287; Hess J, 2000, MOL ECOL, V9, P857, DOI 10.1046/j.1365-294x.2000.00942.x; Hudson RR, 2000, GENETICS, V155, P2011; INOUE K, 1990, AM J BOT, V77, P1440, DOI 10.2307/2444754; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marrero A, 2008, BOT MACARONESICA, V27, P73; Matsumura S, 2009, MOL PHYLOGENET EVOL, V53, P1032, DOI 10.1016/j.ympev.2009.06.011; Medail F, 1999, PLANT ECOL, V140, P221, DOI 10.1023/A:1009775327616; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Nei M., 1987, MOL EVOLUTIONARY GEN; Nepokroeff M, 2003, SYST BIOL, V52, P820, DOI 10.1080/10635150390251072; Nielsen R, 2009, MOL ECOL, V18, P1034, DOI 10.1111/j.1365-294X.2008.04059.x; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER VER 1 4; Richardson JE, 2003, EVOLUTION, V57, P816; Rivera-Ocasio E, 2002, MOL ECOL, V11, P675, DOI 10.1046/j.1365-294X.2002.01476.x; Rivera-Ocasio E, 2006, CONSERV GENET, V7, P251, DOI 10.1007/s10592-005-9022-8; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Shepherd LD, 2009, J BIOGEOGR, V36, P1972, DOI 10.1111/j.1365-2699.2009.02120.x; Short MJ, 1994, FLORA MADEIRA, P226; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Sunding P., 1979, PLANTS ISLANDS, P13; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takayama K, 2005, MOL ECOL, V14, P1059, DOI 10.1111/j.1365-294X.2005.02462.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TSUMURA Y, 1993, CAN J FOREST RES, V23, P859, DOI 10.1139/x93-112; Vargas P, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P297, DOI 10.1007/1-4020-4904-8_11; Vendramin GG, 2008, EVOLUTION, V62, P680, DOI 10.1111/j.1558-5646.2007.00294.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY	68	46	47	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17172	10.1371/journal.pone.0017172	http://dx.doi.org/10.1371/journal.pone.0017172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21347265	Green Published, gold, Green Submitted			2022-12-27	WOS:000287367600040
J	Romero, A; Estevez-Calvar, N; Dios, S; Figueras, A; Novoa, B				Romero, Alejandro; Estevez-Calvar, Noelia; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz			New Insights into the Apoptotic Process in Mollusks: Characterization of Caspase Genes in Mytilus galloprovincialis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VIRUS-INFECTION; BIVALVE MOLLUSKS; CYTOCHROME-C; ACTIVATION; MUSSELS; OYSTER; MECHANISMS; EXPRESSION; RECEPTORS	Apoptosis is an essential biological process in the development and maintenance of immune system homeostasis. Caspase proteins constitute the core of the apoptotic machinery and can be categorized as either initiators or effectors of apoptosis. Although the genes encoding caspase proteins have been described in vertebrates and in almost all invertebrate phyla, there are few reports describing the initiator and executioner caspases or the modulation of their expression by different stimuli in different apoptotic pathways in bivalves. In the present work, we characterized two initiator and four executioner caspases in the mussel Mytilus galloprovincialis. Both initiators and executioners showed structural features that make them different from other caspase proteins already described. Evaluation of the genes' tissue expression patterns revealed extremely high expression levels within the gland and gills, where the apoptotic process is highly active due to the clearance of damaged cells. Hemocytes also showed high expression values, probably due to of the role of apoptosis in the defense against pathogens. To understand the mechanisms of caspase gene regulation, hemocytes were treated with UV-light, environmental pollutants and pathogen-associated molecular patterns (PAMPs) and apoptosis was evaluated by microscopy, flow cytometry and qPCR techniques. Our results suggest that the apoptotic process could be tightly regulated in bivalve mollusks by overexpression/suppression of caspase genes; additionally, there is evidence of caspase-specific responses to pathogens and pollutants. The apoptotic process in mollusks has a similar complexity to that of vertebrates, but presents unique features that may be related to recurrent exposure to environmental changes, pollutants and pathogens imposed by their sedentary nature.	[Romero, Alejandro; Estevez-Calvar, Noelia; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Romero, A (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	virus@iim.csic.es	Dios, Sonia/M-4201-2018; Figueras, Antonio/B-5133-2015; Novoa, Beatriz/K-3785-2014; Romero, Alejandro/R-4565-2019; Figueras, Antonio/AAB-8921-2019	Dios, Sonia/0000-0002-2126-991X; Figueras, Antonio/0000-0002-0617-0030; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Novoa, Beatriz/0000-0003-4888-8419	EU from the Spanish Ministerio de Ciencia e Innovacion [FOOD-CT-2005-007103, AGL2008-05111/ACU]	EU from the Spanish Ministerio de Ciencia e Innovacion	This work was funded by the EU Integrated Project FOOD-CT-2005-007103 and AGL2008-05111/ACU from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen HL, 2005, J CLIN INVEST, V115, P2875, DOI 10.1172/JCI25365; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Baccarani E. M., 1998, DIS AQUAT ORGAN, V32, P145; Baier-Anderson C, 2000, ENVIRON RES, V83, P72, DOI 10.1006/enrs.1999.4033; Barsiene Janina, 2008, Ekologija, V54, P44; Best SM, 2004, VIROLOGY, V320, P191, DOI 10.1016/j.virol.2003.11.025; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bridgham JT, 2003, CELL DEATH DIFFER, V10, P19, DOI 10.1038/sj.cdd.4401174; Buckland-Nicks J, 2005, J EXP ZOOL PART A, V303A, P723, DOI 10.1002/jez.a.207; Chang CC, 2008, FISH SHELLFISH IMMUN, V25, P672, DOI 10.1016/j.fsi.2008.09.004; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COLES JA, 1995, DIS AQUAT ORGAN, V22, P59, DOI 10.3354/dao022059; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Dyrynda EA, 2000, MAR ECOL PROG SER, V206, P155, DOI 10.3354/meps206155; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Farris J. L, 2006, FRESHWATER BIVALVE E; FIGUERAS AJ, 1991, AQUACULTURE, V99, P17, DOI 10.1016/0044-8486(91)90285-F; Gagnaire B, 2006, CELL BIOL TOXICOL, V22, P1, DOI 10.1007/s10565-006-0011-6; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gifondorwa DJ, 2006, BIOL BULL-US, V210, P109, DOI 10.2307/4134600; HALE J, 1996, EUR J BIOCHEM, V236, P1; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; Huang WB, 2010, FISH SHELLFISH IMMUN, V28, P587, DOI 10.1016/j.fsi.2009.12.016; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koyama AH, 2003, INT REV IMMUNOL, V22, P341, DOI 10.1080/08830180305210; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lancellotti Marcelo, 2006, Brazilian Journal of Morphological Sciences, V23, P75; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lynch M, 1999, EVOLUTION, V53, P319, DOI [10.2307/2640769, 10.1111/j.1558-5646.1999.tb03768.x]; MOORE MN, 1978, J CONSEIL, V38, P6; Muzio M, 1998, INT J CLIN LAB RES, V28, P141, DOI 10.1007/s005990050035; NAIMO TJ, 1995, ECOTOXICOLOGY, V4, P341, DOI 10.1007/BF00118870; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; PIPE RK, 1995, FISH SHELLFISH IMMUN, V5, P581, DOI 10.1016/S1050-4648(95)80043-3; PROTA G, 1994, EUR J CANCER, V30A, P553, DOI 10.1016/0959-8049(94)90438-3; Reis MIR, 2007, MOL IMMUNOL, V44, P774, DOI 10.1016/j.molimm.2006.04.028; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robertson AJ, 2006, DEV BIOL, V300, P321, DOI 10.1016/j.ydbio.2006.08.053; ROBLEDO JAF, 1994, DIS AQUAT ORGAN, V18, P203, DOI 10.3354/dao018203; Sakata S, 2007, GENE, V396, P134, DOI 10.1016/j.gene.2007.03.010; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Terahara K, 2008, CURR PHARM DESIGN, V14, P131, DOI 10.2174/138161208783378725; Tittel JN, 2000, GENOME BIOL, V1, P1; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; Villalba A, 1997, DIS AQUAT ORGAN, V31, P127, DOI 10.3354/dao031127; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Wiens M, 2003, BBA-MOL CELL RES, V1593, P179, DOI 10.1016/S0167-4889(02)00388-9; Williams Trevor, 2009, Virologica Sinica, V24, P295, DOI 10.1007/s12250-009-3060-1; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Wolbers F, 2004, APOPTOSIS, V9, P385, DOI 10.1023/B:APPT.0000025816.16399.7a; Wootton EC, 2003, AQUAT TOXICOL, V65, P13, DOI 10.1016/S0166-445X(03)00098-5; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191; Zorita I, 2007, ENVIRON POLLUT, V148, P236, DOI 10.1016/j.envpol.2006.10.022	64	82	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2011	6	2							e17003	10.1371/journal.pone.0017003	http://dx.doi.org/10.1371/journal.pone.0017003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721OO	21347300	Green Published, gold			2022-12-27	WOS:000287364500019
J	Anchelin, M; Murcia, L; Alcaraz-Perez, F; Garcia-Navarro, EM; Cayuela, ML				Anchelin, Monique; Murcia, Laura; Alcaraz-Perez, Francisca; Garcia-Navarro, Esther M.; Cayuela, Maria L.			Behaviour of Telomere and Telomerase during Aging and Regeneration in Zebrafish	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE GENE; REPEAT AMPLIFICATION PROTOCOL; STEM-CELL BEHAVIOR; GRADUAL SENESCENCE; CATALYTIC SUBUNIT; TERMINAL TRANSFERASE; ADULT ZEBRAFISH; HUMAN-DISEASE; C-MYC; LENGTH	Telomere length and telomerase activity are important factors in the pathobiology of human diseases. Age-related diseases and premature aging syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase. The zebrafish (Danio rerio) offers multiple experimental manipulation advantages over other vertebrate models and, therefore, it has been recently considered as a potential model for aging, cancer, and regeneration studies. However, it has only partially been exploited to shed light on these fundamental biological processes. The aim of this study was, therefore, to investigate telomere length and telomerase expression and activity in different strains of zebrafish obtained from different stock centres to determine whether they undergo any changes during aging and regeneration. We found that although both telomerase expression and telomere length increased from embryo to adulthood stages, they drastically declined in aged fish despite telomerase activity was detected in different tissues of old fish. In addition, we observed a weaker upregulation of telomerase expression in regenerating fins of old fish, which well correlates with their impaired regeneration capacity. Strikingly, telomeres were elongated or maintained during the fin regeneration process at all ages and after repeated amputations, likely to support high cell proliferation rates. We conclude that the expression of telomerase and telomere length are closely related during the entire life cycle of the fish and that these two parameters can be used as biomarkers of aging in zebrafish. Our results also reveal a direct relationship between the expression of telomerase, telomere length and the efficiency of tissue regeneration.	[Anchelin, Monique; Murcia, Laura; Alcaraz-Perez, Francisca; Garcia-Navarro, Esther M.; Cayuela, Maria L.] Univ Hosp Virgen de la Arrixaca, CIBERehd, Dept Surg, Telomerase Aging & Canc Grp,Res Unit, Murcia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Clinico Universitario Virgen de la Arrixaca	Anchelin, M (corresponding author), Univ Hosp Virgen de la Arrixaca, CIBERehd, Dept Surg, Telomerase Aging & Canc Grp,Res Unit, Murcia, Spain.	marial.cayuela@carm.es	Murcia, Laura/AAD-7100-2021	Murcia, Laura/0000-0001-7768-0989; Alcaraz Perez, Francisca/0000-0003-1802-4943	Spanish Ministry of Science and Innovation [05/0087, PIO6/00369]; Regional Government of Murcia, Spain (CARM) [08760/PI/08]; University of Murcia; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain; RED RTICC [RD07/0020/0023]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Murcia, Spain (CARM); University of Murcia; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain; RED RTICC	This work was supported by the Spanish Ministry of Science and Innovation (grants 05/0087 and PIO6/00369), Fundacion Seneca from the Regional Government of Murcia, Spain (CARM, grant 08760/PI/08), University of Murcia (fellowships to FA-P), Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Spain (short-fellowships to MA) and RED RTICC (RD07/0020/0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCARAZPEREZ F, 2008, BMC BIOTECHNOL, P8; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Canela Andres, 2007, Methods Mol Biol, V371, P45; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Cayuela ML, 2005, EMBO REP, V6, P268, DOI 10.1038/sj.embor.7400359; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Du HY, 2007, AGING CELL, V6, P689, DOI 10.1111/j.1474-9726.2007.00324.x; Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007; Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249; HIYAMA K, 1995, ONCOGENE, V10, P937; Horikawa I, 1999, CANCER RES, V59, P826; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lau BWM, 2008, J MOL NEUROSCI, V34, P63, DOI 10.1007/s12031-007-0072-x; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu JP, 2006, CELL RES, V16, P809, DOI 10.1038/sj.cr.7310098; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; Mason PJ, 2004, CELL CYCLE, V3, P1127; McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349; PERICUESTA E, 2006, REPROD BIOL ENDOCRIN, V3; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Reimschuessel R, 2001, ILAR J, V42, P285; Rowlerson A, 1997, CELL TISSUE RES, V289, P311, DOI 10.1007/s004410050878; Takakura M, 1999, CANCER RES, V59, P551; TSAI SB, AGING CELL, V6, P209; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wright WE, 1996, DEV GENET, V18, P173; Yu LL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000014; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	63	101	104	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16955	10.1371/journal.pone.0016955	http://dx.doi.org/10.1371/journal.pone.0016955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347393	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700058
J	Ruz, M; Moser, A; Webster, K				Ruz, Maria; Moser, Anna; Webster, Kristin			Social Expectations Bias Decision-Making in Uncertain Inter-Personal Situations	PLOS ONE			English	Article							ULTIMATUM GAME; NEURAL SYSTEMS; AUTOMATICITY; INFORMATION; BEHAVIOR; WORDS; TRUST; NORMS; FACE	Understanding the role that social cues have on interpersonal choice, and their susceptibility to contextual effects, is of core importance to models of social decision-making. Language, on the other hand, is one of the main means of communication during social interactions in our culture. The present experiments tested whether positive and negative linguistic descriptions of alleged partners in a modified Ultimatum Game biased decisions made to the same set of offers, and whether the contextual uncertainty of the game modulated this biasing effect. The results showed that in an uncertain context, the same offers were accepted with higher probability when they were preceded by positive rather than by negative valenced trait-words. Participants also accepted fair offers with higher probability than unfair offers, but this effect did not interact with the valence of the social descriptive words. In addition, the speed of the decision was affected by valence: acceptance choices were faster when they followed a positive adjective, whereas rejection responses were faster after a negative-valenced word. However, these effects were highly reduced when the uncertainty was eliminated from the game. This suggests that positive and negative relevant social information can bias decisions made to the same pieces of evidence during interpersonal interactions, but that this mainly takes place when the uncertainty associated with the choices is high.	[Ruz, Maria; Moser, Anna] Univ Granada, Dept Expt Psychol, Granada, Spain; [Webster, Kristin] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Granada; Brown University	Ruz, M (corresponding author), Univ Granada, Dept Expt Psychol, Granada, Spain.	mruz@ugr.es	Ruz, Maria/G-1668-2016	Ruz, Maria/0000-0003-1733-5715	Spanish Ministry of Science and Innovation (MICINN) [RYC-2008-03008]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Research presented in this paper was supported by the Spanish Ministry of Science and Innovation (MICINN) through a Ramon y Cajal Research Fellowship granted to MR (ref. RYC-2008-03008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade EB, 2007, PSYCHOL SCI, V18, P668, DOI 10.1111/j.1467-9280.2007.01956.x; [Anonymous], 1999, C1 CTR RES PSYCH, DOI DOI 10.1002/PER.2410010304; Asch S.E., 1951, ORG INFLUENCE PROCES, V58, P295; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Damasio A.R., 2005, DESCARTES ERROR EMOT; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DEDREU CKW, 2007, HDB BASIC PRINCIPLES, P608; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Grieve PG, 1999, PERS SOC PSYCHOL B, V25, P926, DOI 10.1177/01461672992511002; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Hewstone M., 1996, STEREOTYPES STEREOTY; Higgins E. T., 1989, UNINTENDED THOUGHT; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kucera F., 1967, COMPUTATIONAL ANAL P; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; OLSON JM, 1996, EXPENTANCIES; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Reid SA, 2005, PERS SOC PSYCHOL B, V31, P804, DOI 10.1177/0146167204271708; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Ruz M, 2005, J COGNITIVE NEUROSCI, V17, P768, DOI 10.1162/0898929053747685; Ruz M, 2011, NEUROIMAGE, V54, P1685, DOI 10.1016/j.neuroimage.2010.08.039; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; SCHACHTER S, 1985, J ECON BEHAV ORGAN, V6, P339, DOI 10.1016/0167-2681(85)90003-4; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; SEMIN GR, 1991, EUROPEAN REV SOCIAL, P1; Smith JR, 2007, BRIT J SOC PSYCHOL, V46, P769, DOI 10.1348/014466606X164439; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Van Kleef GA, 2010, ADV EXP SOC PSYCHOL, V42, P45, DOI 10.1016/S0065-2601(10)42002-X; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x	43	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e15762	10.1371/journal.pone.0015762	http://dx.doi.org/10.1371/journal.pone.0015762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721NN	21347404	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700010
J	Fonseca-Silva, F; Inacio, JDF; Canto-Cavalheiro, MM; Almeida-Amaral, EE				Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo			Reactive Oxygen Species Production and Mitochondrial Dysfunction Contribute to Quercetin Induced Death in Leishmania amazonensis	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; TRYPANOSOMA-CRUZI; IN-VIVO; DONOVANI PROMASTIGOTES; APOPTOSIS; FLAVONOIDS; DRUGS; CELLS; PARASITE; ANALOGS	Background: Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishmania, affects more than 12 million people worldwide. Quercetin has generated considerable interest as a pharmaceutical compound with a wide range of therapeutic activities. One such activity is exhibited against the bloodstream parasite Trypanosoma brucei and amastigotes of Leishmania donovani. However, the mechanism of protozoan action of quercetin has not been studied. Methodology/Principal Findings: In the present study, we report here the mechanism for the antileishmanial activity of quercetin against Leishmania amazonensis promastigotes. Quercetin inhibited L. amazonensis promastigote growth in a dose- and time-dependent manner beginning at 48 hours of treatment and with maximum growth inhibition observed at 96 hours. The IC(50) for quercetin at 48 hours was 31.4 mu M. Quercetin increased ROS generation in a dose-dependent manner after 48 hours of treatment. The antioxidant GSH and NAC each significantly reduced quercetin-induced cell death. In addition, quercetin caused mitochondrial dysfunction due to collapse of mitochondrial membrane potential. Conclusions/Significance: The effects of several drugs that interfere directly with mitochondrial physiology in parasites such as Leishmania have been described. The unique mitochondrial features of Leishmania make this organelle an ideal drug target while minimizing toxicity. Quercetin has been described as a pro-oxidant, generating ROS which are responsible for cell death in some cancer cells. Mitochondrial membrane potential loss can be brought about by ROS added directly in vitro or induced by chemical agents. Taken together, our results demonstrate that quercetin eventually exerts its antileishmanial effect on L. amazonensis promastigotes due to the generation of ROS and disrupted parasite mitochondrial function.	[Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo] Fundacao Oswaldo Cruz FIOCRUZ, Lab Bioquim Tripanosomatideos, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Fonseca-Silva, F (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Lab Bioquim Tripanosomatideos, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.	elmo@ioc.fiocruz.br	Almeida-Amaral, Elmo Eduardo/AAD-2834-2019; Inacio, Job Domingos/AAK-5961-2021		Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz (FIOCRUZ)	Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1985, MOL BIOCHEM PARASIT, V16, P289, DOI 10.1016/0166-6851(85)90071-4; Banki K, 1999, J IMMUNOL, V162, P1466; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Castro-Pinto DB, 2007, J ENZYM INHIB MED CH, V22, P71, DOI 10.1080/14756360600920180; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; De Marchi U, 2009, BBA-BIOENERGETICS, V1787, P1425, DOI 10.1016/j.bbabio.2009.06.002; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dvorakova K, 2001, BLOOD, V97, P3544, DOI 10.1182/blood.V97.11.3544; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Guida MC, 2007, EXP PARASITOL, V117, P188, DOI 10.1016/j.exppara.2007.04.015; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3; Lapidot TM, 2002, J AGR FOOD CHEM, V50, P7220, DOI 10.1021/jf020615a; Leite MS, 2009, EXP PARASITOL, V121, P137, DOI 10.1016/j.exppara.2008.10.018; Luque-Ortega JR, 2001, ANTIMICROB AGENTS CH, V45, P1121, DOI 10.1128/AAC.45.4.1121-1125.2001; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Mittra B, 2000, MOL MED, V6, P527, DOI 10.1007/BF03401792; Miura YH, 1998, BIOL PHARM BULL, V21, P93, DOI 10.1248/bpb.21.93; Mukherjee P, 2009, INT J ANTIMICROB AG, V34, P596, DOI 10.1016/j.ijantimicag.2009.08.007; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Muzitano MF, 2006, PHYTOCHEMISTRY, V67, P2071, DOI 10.1016/j.phytochem.2006.06.027; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; ROY A, 2008, MOL PHARM; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sen N, 2008, CURR PHARM DESIGN, V14, P839, DOI 10.2174/138161208784041024; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Tasdemir D, 2006, ANTIMICROB AGENTS CH, V50, P1352, DOI 10.1128/AAC.50.4.1352-1364.2006; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013	39	120	121	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14666	10.1371/journal.pone.0014666	http://dx.doi.org/10.1371/journal.pone.0014666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346801	Green Published, Green Submitted, gold			2022-12-27	WOS:000287077600002
J	Rodriguez, LAG; Gonzalez-Perez, A; Bueno, H; Hwa, J				Garcia Rodriguez, Luis Alberto; Gonzalez-Perez, Antonio; Bueno, Hector; Hwa, John			NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR OUTCOMES; EVENTS; PREVENTION; INHIBITORS; ROFECOXIB; CELECOXIB; CYCLOOXYGENASE; IBUPROFEN; NAPROXEN	Background: Recent clinical trials and observational studies have reported increased coronary events associated with non steroidal anti-inflammatory drugs (NSAIDs). There appeared to be a disproportionate increase in non-fatal versus fatal events, however, numbers of fatal events in individual studies were too small, and event rates too low, to be meaningful. Objectives: We undertook a pooled analysis to investigate the effect of NSAIDs on myocardial infarction (MI) risk with the specific aim to differentiate non-fatal from fatal events. Methods: We searched Pubmed (January, 1990 to March, 2010) for observational studies and randomised controlled trials that assessed the effect of NSAIDs (traditional or selective COX-2 inhibitors [coxibs]) on MI incidence separately for fatal and non-fatal events. Summary estimates of relative risk (RR) for non-fatal and fatal MIs were calculated with a random effects model. Results: NSAID therapy carried a RR of 1.30 (95% CI, 1.20-1.41) for non-fatal MI with no effect on fatal MI (RR 1.02, 95% CI, 0.89-1.17) in six observational studies. Overall, the risk increase for non-fatal MI was 25% higher (95% CI, 11%-42%) than for fatal MI. The two studies that included only individuals with prior cardiovascular disease presented risk estimates for non-fatal MI on average 58% greater (95% CI, 26%-98%) than those for fatal MI. In nine randomised controlled trials, all investigating coxibs, the pooled RR estimate for non-fatal MI was 1.61 (95% CI, 1.04-2.50) and 0.86 (95% CI 0.51-1.47) for fatal MIs. Conclusions: NSAID use increases the risk of non-fatal MI with no substantial effect on fatal events. Such differential effects, with potentially distinct underlying pathology may provide insights into NSAID-induced coronary pathology. We studied the association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of myocardial infarction (MI), separating non-fatal from fatal events, summarizing the evidence from both observational studies and randomised controlled trials. An increased risk of non-fatal MI was clearly found in both types of studies while use of NSAID did not confer an increased risk of fatal MI. Our findings provide support for the concept that thrombi generated under NSAID treatment could be different from spontaneous thrombi.	[Garcia Rodriguez, Luis Alberto; Gonzalez-Perez, Antonio] Ctr Espanol Invest Farmacoepidemiol CEIFE, Madrid, Spain; [Gonzalez-Perez, Antonio] Neocodex SL, Dept Genom Estruct, Seville, Spain; [Bueno, Hector] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Hwa, John] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA	General University Gregorio Maranon Hospital; Yale University	Rodriguez, LAG (corresponding author), Ctr Espanol Invest Farmacoepidemiol CEIFE, Madrid, Spain.	lagarcia@ceife.es	González-Pérez, Antonio/AAY-4179-2021; Bueno, Hector/I-3910-2015; rodriguez, luis a garcia/B-1980-2010; Gonzalez-Perez, Antonio/A-5247-2010	González-Pérez, Antonio/0000-0001-9771-5982; Bueno, Hector/0000-0003-0277-7596; Gonzalez-Perez, Antonio/0000-0001-9771-5982	NIH [RO1 HL074190]; American Heart Association [0740059N]; Bayer; Pfizer; Almirall; BMS; Sanofi-Aventis; Astra-Zeneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Bayer(Bayer AG); Pfizer(Pfizer); Almirall(Almirall); BMS(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Astra-Zeneca(AstraZeneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by grants from NIH RO1 HL074190 (JH) and a Established Investigator Award from the American Heart Association 0740059N (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflicts: CEIFE has received unrestricted research grants from Bayer and Pfizer in the last five years. Dr. Bueno reports having received consulting fees from Almirall, Bayer, BMS, and Sanofi-Aventis, and research grants from Astra-Zeneca, BMS, and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bennett JS, 2005, CIRCULATION, V111, P1713, DOI 10.1161/01.CIR.0000160005.90598.41; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Bueno H, 2010, AM J CARDIOL, V105, P1102, DOI 10.1016/j.amjcard.2009.12.008; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; CANNON CP, 2008, BRAUNWALDS HEART DIS, P1319; Chan AT, 2006, CIRCULATION, V113, P1578, DOI 10.1161/CIRCULATIONAHA.105.595793; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Rodriguez LAG, 2009, CIRCULATION, V120, pS405; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hernandez-Diaz S, 2006, BASIC CLIN PHARMACOL, V98, P266, DOI 10.1111/j.1742-7843.2006.pto_302.x; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kerr DJ, 2007, NEW ENGL J MED, V357, P360, DOI 10.1056/NEJMoa071841; Martin BK, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010033; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Patrono C, 2004, CHEST, V126, p234S, DOI 10.1378/chest.126.3_suppl.234S; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Rodriguez LAG, 2004, CIRCULATION, V109, P3000, DOI 10.1161/01.CIR.0000132491.96623.04; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; White WB, 2002, AM J CARDIOL, V89, P425, DOI 10.1016/S0002-9149(01)02265-2	30	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16780	10.1371/journal.pone.0016780	http://dx.doi.org/10.1371/journal.pone.0016780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347435	Green Submitted, Green Published, gold			2022-12-27	WOS:000287077600026
J	Wang, MY; Spinetti, G; Monticone, RE; Zhang, J; Wu, J; Jiang, LQ; Khazan, B; Telljohann, R; Lakatta, EG				Wang, Mingyi; Spinetti, Gaia; Monticone, Robert E.; Zhang, Jing; Wu, James; Jiang, Liqun; Khazan, Benjamin; Telljohann, Richard; Lakatta, Edward G.			A Local Proinflammatory Signalling Loop Facilitates Adverse Age-Associated Arterial Remodeling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MATRIX-METALLOPROTEINASE; ANGIOTENSIN-II; TGF-BETA; INVASION; EXPRESSION; DISEASE; MCP-1; ATHEROSCLEROSIS	Background: The coincidence of vascular smooth muscle cells (VSMC) infiltration and collagen deposition within a diffusely thickened intima is a salient feature of central arterial wall inflammation that accompanies advancing age. However, the molecular mechanisms involved remain undefined. Methodology/Principal Findings: Immunostaining and immunoblotting of rat aortae demonstrate that a triad of proinflammatory molecules, MCP-1, TGF-beta 1, and MMP-2 increases within the aortic wall with aging. Exposure of VSMC isolated from 8-mo-old rats (young) to MCP-1 effects, via CCR-2 signaling, both an increase in TGF-beta 1 activity, up to levels of untreated VSMC from 30-mo-old (old) rats, and a concurrent increase in MMP-2 activation. Furthermore, exposure of young VSMC to TGF-beta 1 increases levels of MCP-1, and MMP-2 activation, to levels of untreated VSMC from old rats. This autocatalytic signaling loop that enhances collagen production and invasiveness of VSMC is effectively suppressed by si-MCP-1, a CCR2 antagonist, or MMP-2 inhibition. Conclusions/Significance: Threshold levels of MCP-1, MMP-2, or TGF-beta 1 activity trigger a feed-forward signaling mechanism that is implicated in the initiation and progression of adverse age-associated arterial wall remodeling. Intervention that suppressed this signaling loop may potentially retard age-associated adverse arterial remodeling.	[Wang, Mingyi; Spinetti, Gaia; Monticone, Robert E.; Zhang, Jing; Wu, James; Jiang, Liqun; Khazan, Benjamin; Telljohann, Richard; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Spinetti, Gaia] MultiMed IRCCS, Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS Multimedica	Wang, MY (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	mingyiw@grc.nia.nih.gov	Wang, Mingyi/L-8370-2017; Telljohann, Richard/ABF-1207-2021; Spinetti, Gaia/T-8245-2018; Lakatta, Edward G/AAL-1447-2020	Wang, Mingyi/0000-0001-6412-369X; Spinetti, Gaia/0000-0001-7996-6809; Lakatta, Edward/0000-0002-4772-0035	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000240] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gressner OA, 2008, J CELL MOL MED, V12, P2717, DOI 10.1111/j.1582-4934.2008.00260.x; Inagaki Y, 2008, GASTROENTEROLOGY, V134, P1180, DOI 10.1053/j.gastro.2008.01.014; Jenkins GM, 1998, CIRCULATION, V97, P82, DOI 10.1161/01.CIR.97.1.82; Jiang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002231; Joner M, 2007, ARTERIOSCL THROM VAS, V27, P182, DOI 10.1161/01.ATV.0000251021.28725.e8; Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Palumbo R, 2000, CIRCULATION, V102, P225, DOI 10.1161/01.CIR.102.2.225; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Raymond J, 2005, J VASC INTERV RADIOL, V16, P1355, DOI 10.1097/01.RVI.0000171693.68581.96; Redondo S, 2007, CYTOKINE GROWTH F R, V18, P279, DOI 10.1016/j.cytogfr.2007.04.005; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roth-Eichhorn S, 1998, HEPATOLOGY, V28, P1588, DOI 10.1002/hep.510280619; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; STARY HC, 1991, EUR HEART J SUPPL, P3; VIRMANI R, 1991, AM J PATHOL, V139, P1119; Virmani R, 1998, Semin Interv Cardiol, V3, P163; Wang M, 2006, ARTERIOSCL THROM VAS, V26, pE83; Wang M, 2002, HYPERTENSION, V39, P865, DOI 10.1161/01.HYP.0000014506.13322.66; WANG M, 2006, HDB HYPERTENSION, V23, P137; Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409; Wang MY, 2010, CURR OPIN NEPHROL HY, V19, P201, DOI 10.1097/MNH.0b013e3283361c0b; Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45	30	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16653	10.1371/journal.pone.0016653	http://dx.doi.org/10.1371/journal.pone.0016653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347430	gold, Green Published, Green Submitted			2022-12-27	WOS:000287077600012
J	Dagliyan, O; Uney-Yuksektepe, F; Kavakli, IH; Turkay, M				Dagliyan, Onur; Uney-Yuksektepe, Fadime; Kavakli, I. Halil; Turkay, Metin			Optimization Based Tumor Classification from Microarray Gene Expression Data	PLOS ONE			English	Article							BAYESIAN VARIABLE SELECTION; PARTIAL LEAST-SQUARES; B-CELL LYMPHOMAS; PROSTATE-CANCER; LOGISTIC-REGRESSION; PREDICTION; LEUKEMIA; BINDING; IDENTIFICATION; ORGANIZATION	Background: An important use of data obtained from microarray measurements is the classification of tumor types with respect to genes that are either up or down regulated in specific cancer types. A number of algorithms have been proposed to obtain such classifications. These algorithms usually require parameter optimization to obtain accurate results depending on the type of data. Additionally, it is highly critical to find an optimal set of markers among those up or down regulated genes that can be clinically utilized to build assays for the diagnosis or to follow progression of specific cancer types. In this paper, we employ a mixed integer programming based classification algorithm named hyper-box enclosure method (HBE) for the classification of some cancer types with a minimal set of predictor genes. This optimization based method which is a user friendly and efficient classifier may allow the clinicians to diagnose and follow progression of certain cancer types. Methodology/Principal Findings: We apply HBE algorithm to some well known data sets such as leukemia, prostate cancer, diffuse large B-cell lymphoma (DLBCL), small round blue cell tumors (SRBCT) to find some predictor genes that can be utilized for diagnosis and prognosis in a robust manner with a high accuracy. Our approach does not require any modification or parameter optimization for each data set. Additionally, information gain attribute evaluator, relief attribute evaluator and correlation-based feature selection methods are employed for the gene selection. The results are compared with those from other studies and biological roles of selected genes in corresponding cancer type are described. Conclusions/Significance: The performance of our algorithm overall was better than the other algorithms reported in the literature and classifiers found in WEKA data-mining package. Since it does not require a parameter optimization and it performs consistently very high prediction rate on different type of data sets, HBE method is an effective and consistent tool for cancer type prediction with a small number of gene markers.	[Dagliyan, Onur; Kavakli, I. Halil] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Uney-Yuksektepe, Fadime] Istanbul Kultur Univ, Dept Ind Engn, Istanbul, Turkey; [Turkay, Metin] Koc Univ, Dept Ind Engn, Istanbul, Turkey	Koc University; Istanbul Kultur University; Koc University	Dagliyan, O (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	mturkay@ku.edu.tr	Üney-Yüksektepe, Fadime/A-4293-2014; Turkay, Metin/F-9769-2011; Dagliyan, Onur/N-5683-2019; Kavakli, Ibrahim/AAF-5468-2020	Üney-Yüksektepe, Fadime/0000-0002-8068-5235; Turkay, Metin/0000-0003-4769-6714; Dagliyan, Onur/0000-0003-1825-1011; Kavakli, Ibrahim/0000-0001-6624-3505	Turkish National Academy of Science of Turkey; IBM SUR Award	Turkish National Academy of Science of Turkey(Turkish Academy of Sciences); IBM SUR Award(International Business Machines (IBM))	The computing hardware support from the IBM SUR Award is gratefully acknowledged. I. H. K is thankful for the support of the Turkish National Academy of Science of Turkey for the young investigator program.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Antonov AV, 2004, BIOINFORMATICS, V20, P644, DOI 10.1093/bioinformatics/btg462; Armutlu P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-411; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bicciato S, 2003, BIOTECHNOL BIOENG, V81, P594, DOI 10.1002/bit.10505; Brambillasca F, 1999, LEUKEMIA, V13, P369, DOI 10.1038/sj.leu.2401338; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Chen PC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-44; Chu W, 2005, BIOINFORMATICS, V21, P3385, DOI 10.1093/bioinformatics/bti526; CHUNG FZ, 1985, BIOCHEM J, V231, P537, DOI 10.1042/bj2310537; Dagliyan O, 2009, J CHEM INF MODEL, V49, P2403, DOI 10.1021/ci900247t; Dettling M, 2002, GENOME BIOL, V3; Deutsch JM, 2003, BIOINFORMATICS, V19, P45, DOI 10.1093/bioinformatics/19.1.45; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; ELLIMS PH, 1984, LEUKEMIA RES, V8, P123, DOI 10.1016/0145-2126(84)90040-7; Estey EH, 2002, BLOOD, V99, P4222, DOI 10.1182/blood-2001-12-0174; Fort G, 2005, BIOINFORMATICS, V21, P1104, DOI 10.1093/bioinformatics/bti114; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hall MA., 1999, CORRELATION BASED FE; Hashimoto M, 2008, MUTAT RES-GEN TOX EN, V657, P63, DOI 10.1016/j.mrgentox.2008.09.001; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Hewett R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S21; Hokaiwado N, 2008, CARCINOGENESIS, V29, P1134, DOI 10.1093/carcin/bgn097; Jin RJ, 2008, CANCER RES, V68, P3601, DOI 10.1158/0008-5472.CAN-08-0073; Kahraman P, 2007, IND ENG CHEM RES, V46, P4921, DOI 10.1021/ie0614327; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; KOHAVI G, 1997, ARTIF INTELL, V97, P273; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Lee Y, 2003, BIOINFORMATICS, V19, P1132, DOI 10.1093/bioinformatics/btg102; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Okuya M, 2010, J BIOL CHEM, V285, P1850, DOI 10.1074/jbc.M109.023762; Ornitz DM, 2001, GENOME BIOL, V2; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sakhinia E, 2006, J CLIN PATHOL, V59, P1059, DOI 10.1136/jcp.2005.031161; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sepp-Lorenzino L, 2001, PROSTATE CANCER P D, V4, P33, DOI 10.1038/sj.pcan.4500491; Sha NJ, 2004, BIOMETRICS, V60, P812, DOI 10.1111/j.0006-341X.2004.00233.x; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tan Aik Choon, 2003, Appl Bioinformatics, V2, pS75; Tedoldl S, 2006, J PATHOL, V209, P454, DOI 10.1002/path.2002; Trevino V, 2007, MOL MED, V13, P527, DOI 10.2119/2006-00107.Trevino; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Uney F, 2006, EUR J OPER RES, V173, P910, DOI 10.1016/j.ejor.2005.04.049; UNEYYUKSEKTEPE F, 2008, COMPUT CHEM ENG, V32, P78; UNEYYUKSEKTEPE F, 2009, THESIS KOC U ISTANBU; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Wong ETL, 1999, BLOOD, V94, P3730, DOI 10.1182/blood.V94.11.3730.423a15_3730_3736; Xiong HL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-299; Yang AJ, 2010, BIOINFORMATICS, V26, P215, DOI 10.1093/bioinformatics/btp638; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Zhang JG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-370; Zhou XB, 2004, J BIOMED INFORM, V37, P249, DOI 10.1016/j.jbi.2004.07.009; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	68	65	68	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14579	10.1371/journal.pone.0014579	http://dx.doi.org/10.1371/journal.pone.0014579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326602	Green Submitted, Green Published, gold			2022-12-27	WOS:000287037000002
J	Dancause, KN; Vilar, MG; Steffy, R; Lum, JK				Dancause, Kelsey Needham; Vilar, Miguel G.; Steffy, Rlene; Lum, J. Koji			Characterizing Genetic Diversity of Contemporary Pacific Chickens Using Mitochondrial DNA Analyses	PLOS ONE			English	Article							ORIGINS; MTDNA; DISPERSAL; VANUATU; ISLAND	Background: Mitochondrial DNA (mtDNA) hypervariable region (HVR) sequences of prehistoric Polynesian chicken samples reflect dispersal of two haplogroups-D and E-by the settlers of the Pacific. The distribution of these chicken haplogroups has been used as an indicator of human movement. Recent analyses suggested similarities between prehistoric Pacific and South American chicken samples, perhaps reflecting prehistoric Polynesian introduction of the chicken into South America. These analyses have been heavily debated. The current distribution of the D and E lineages among contemporary chicken populations in the Western Pacific is unclear, but might ultimately help to inform debates about the movements of humans that carried them. Objectives: We sought to characterize contemporary mtDNA diversity among chickens in two of the earliest settled archipelagoes of Remote Oceania, the Marianas and Vanuatu. Methods: We generated HVR sequences for 43 chickens from four islands in Vanuatu, and for 5 chickens from Guam in the Marianas. Results: Forty samples from Vanuatu and three from Guam were assigned to haplogroup D, supporting this as a Pacific chicken haplogroup that persists in the Western Pacific. Two haplogroup E lineages were observed in Guam and two in Vanuatu. Of the E lineages in Vanuatu, one was identical to prehistoric Vanuatu and Polynesian samples and the other differed by one polymorphism. Contrary to our expectations, we observed few globally distributed domesticate lineages not associated with Pacific chicken dispersal. This might suggest less European introgression of chickens into Vanuatu than expected. If so, the E lineages might represent lineages maintained from ancient Pacific chicken introductions. The Vanuatu sample might thus provide an opportunity to distinguish between maintained ancestral Pacific chicken lineages and replacement by global domesticates through genomic analyses, which could resolve questions of contemporary haplogroup E chicken relationships and inform interpretations of debated sequences from archaeological samples.	[Dancause, Kelsey Needham] McGill Univ, Douglas Hosp Res Ctr, Montreal, PQ, Canada; [Vilar, Miguel G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Steffy, Rlene] Univ Guam, Micronesian Area Res Ctr, Hagatna, GU USA; [Lum, J. Koji] Binghamton Univ, Dept Anthropol, Binghamton, NY USA	McGill University; University of Pennsylvania; University of Guam; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Dancause, KN (corresponding author), McGill Univ, Douglas Hosp Res Ctr, Montreal, PQ, Canada.	kelseydancause@gmail.com		Dancause, Kelsey/0000-0002-8677-9953				ALLEN JS, 1996, ARCHAEOL NZ, V39, P291; Fu Yan, 2001, Acta Genetica Sinica, V28, P411; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Gongora J, 2008, P NATL ACAD SCI USA, V105, P10308, DOI 10.1073/pnas.0801991105; Gongora J, 2008, P NATL ACAD SCI USA, V105, pE100, DOI 10.1073/pnas.0809681105; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Komiyama T, 2004, MOL PHYLOGENET EVOL, V33, P16, DOI 10.1016/j.ympev.2004.04.019; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; LIU ZG, 2004, GENETIC VARIABILITY; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; MACCLANCY J, 2002, KILL BIRD 2 STONES S; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Miyake T, 1997, GALLUS GALLUS MITOCH; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; Oliver D, 1989, OCEANIA NATIVE CULTU; PIRANY N, 2009, DIRECT SUBMISSION GE; Qu LJ, 2004, HIGH POLYMORPHISM RA; REINMAN FRED R, 1977, ARCHAEOLOGICAL SURVE; Rogers R., 1995, DESTINYS LANDFALL HI; Silva P, 2009, ANIM GENET, V40, P1, DOI 10.1111/j.1365-2052.2008.01783.x; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; Storey AA, 2010, J ARCHAEOL SCI, V37, P2459, DOI 10.1016/j.jas.2010.05.006; Storey AA, 2008, P NATL ACAD SCI USA, V105, pE99, DOI 10.1073/pnas.0807625105	27	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16843	10.1371/journal.pone.0016843	http://dx.doi.org/10.1371/journal.pone.0016843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326866	gold, Green Accepted, Green Published			2022-12-27	WOS:000287037000026
J	Harrison, F; Buckling, A				Harrison, Freya; Buckling, Angus			Wider Access to Genotypic Space Facilitates Loss of Cooperation in a Bacterial Mutator	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PATHOGENIC BACTERIA; SIDEROPHORE PRODUCTION; EVOLUTION; VIRULENCE; RATES; ADAPTATION; HYPERMUTABILITY	Understanding the ecological, evolutionary and genetic factors that affect the expression of cooperative behaviours is a topic of wide biological significance. On a practical level, this field of research is useful because many pathogenic microbes rely on the cooperative production of public goods (such as nutrient scavenging molecules, toxins and biofilm matrix components) in order to exploit their hosts. Understanding the evolutionary dynamics of cooperation is particularly relevant when considering long-term, chronic infections where there is significant potential for intra-host evolution. The impact of responses to non-social selection pressures on social evolution is arguably an under-examined area. In this paper, we consider how the evolution of a non-social trait - hypermutability - affects the cooperative production of iron-scavenging siderophores by the opportunistic human pathogen Pseudomonas aeruginosa. We confirm an earlier prediction that hypermutability accelerates the breakdown of cooperation due to increased sampling of genotypic space, allowing mutator lineages to generate non-cooperative genotypes with the ability to persist at high frequency and dominate populations. This may represent a novel cost of hypermutability.	[Harrison, Freya; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Harrison, F (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	freya.harrison@zoo.ox.ac.uk		Buckling, Angus/0000-0003-1170-4604	Royal Society; University of Oxford; Magdalen College, Oxford	Royal Society(Royal Society of London); University of Oxford; Magdalen College, Oxford	This work was funded by the Royal Society (grant awarded to AB) and by the University of Oxford (Newton-Abraham studentship awarded to FH). FH is currently supported by a Fellowship by Examination at Magdalen College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedau MA, 2003, BIOSYSTEMS, V69, P143, DOI 10.1016/S0303-2647(02)00137-5; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; CORNELIS P, 2002, ENV MICROBIOL, V4; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; Funchain P, 2000, GENETICS, V154, P959; Giraud A, 2002, ANTIMICROB AGENTS CH, V46, P863, DOI 10.1128/AAC.46.3.863-865.2002; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harrison F, 2005, CURR BIOL, V15, P1968, DOI 10.1016/j.cub.2005.09.048; HARRISON F, 2009, FRONT BIOSCI S, V1, P250; Harrison F, 2007, P ROY SOC B-BIOL SCI, V274, P1341, DOI 10.1098/rspb.2006.0408; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Harrison F, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-21; Harrison F, 2009, ISME J, V3, P632, DOI 10.1038/ismej.2009.9; HAUSER AR, SEVERE INFECT CAUSED; Jiricny N, 2010, J EVOLUTION BIOL, V23, P738, DOI 10.1111/j.1420-9101.2010.01939.x; Kummerli R, 2009, P ROY SOC B-BIOL SCI, V276, P3531, DOI 10.1098/rspb.2009.0861; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Nyilasi Ildiko, 2005, Acta Microbiologica et Immunologica Hungarica, V52, P185, DOI 10.1556/AMicr.52.2005.2.4; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Racey D, 2010, EVOLUTION, V64, P515, DOI 10.1111/j.1558-5646.2009.00821.x; Rainey PB, 1999, CURR BIOL, V9, pR371, DOI 10.1016/S0960-9822(99)80230-9; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Schaaff F, 2002, ANTIMICROB AGENTS CH, V46, P3540, DOI 10.1128/AAC.46.11.3540-3548.2002; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, TRENDS MICROBIOL, V5, P427, DOI 10.1016/S0966-842X(97)01157-8; Tenaillon O, 1999, GENETICS, V152, P485; TROBNER W, 1984, MOL GEN GENET, V198, P177, DOI 10.1007/BF00328720; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; WANDERSMAN C, 2004, ANN REV MICROBIOL, V58; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	42	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17254	10.1371/journal.pone.0017254	http://dx.doi.org/10.1371/journal.pone.0017254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364773	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100036
J	Leduc, F; Faucher, D; Nkoma, GB; Gregoire, MC; Arguin, M; Wellinger, RJ; Boissonneault, G				Leduc, Frederic; Faucher, David; Nkoma, Genevieve Bikond; Gregoire, Marie-Chantal; Arguin, Melina; Wellinger, Raymund J.; Boissonneault, Guylain			Genome-Wide Mapping of DNA Strand Breaks	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; CHROMATIN; REPAIR; YEAST; ACTIVATION; ORIGIN; DAMAGE; ASSAY; H2AX	Determination of cellular DNA damage has so far been limited to global assessment of genome integrity whereas nucleotide-level mapping has been restricted to specific loci by the use of specific primers. Therefore, only limited DNA sequences can be studied and novel regions of genomic instability can hardly be discovered. Using a well-characterized yeast model, we describe a straightforward strategy to map genome-wide DNA strand breaks without compromising nucleotide-level resolution. This technique, termed "damaged DNA immunoprecipitation'' (dDIP), uses immunoprecipitation and the terminal deoxynucleotidyl transferase-mediated dUTP-biotin end-labeling (TUNEL) to capture DNA at break sites. When used in combination with microarray or next-generation sequencing technologies, dDIP will allow researchers to map genome-wide DNA strand breaks as well as other types of DNA damage and to establish a clear profiling of altered genes and/or intergenic sequences in various experimental conditions. This mapping technique could find several applications for instance in the study of aging, genotoxic drug screening, cancer, meiosis, radiation and oxidative DNA damage.	[Leduc, Frederic; Nkoma, Genevieve Bikond; Gregoire, Marie-Chantal; Arguin, Melina; Boissonneault, Guylain] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada; [Faucher, David; Wellinger, Raymund J.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Leduc, F (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	guylain.boissonneault@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Gregoire, Marie-Chantal/0000-0002-2478-1716; Boissonneault, Guylain/0000-0003-4755-3473	Canadian Institutes of Health Research [MOP-93781]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research (grant #MOP-93781) to G.B. (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brachmann CB, 1998, YEAST, V14, P115; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Conconi A, 2005, MOL CELL BIOL, V25, P9773, DOI 10.1128/MCB.25.22.9773-9783.2005; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Gradzka I, 2005, DNA REPAIR, V4, P1129, DOI 10.1016/j.dnarep.2005.06.001; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Leduc F, 2008, BIOL REPROD, V78, P324, DOI 10.1095/biolreprod.107.064162; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Maniatis T., 1982, MOL CLONING LAB MANU; Pfeifer GP, 1998, TOXICOL LETT, V103, P447, DOI 10.1016/S0378-4274(98)00337-3; RAGHURAMAN MK, 1994, GENE DEV, V8, P554, DOI 10.1101/gad.8.5.554; SCHMITZ GG, 1991, ANAL BIOCHEM, V192, P222, DOI 10.1016/0003-2697(91)90212-C; SHIBATA Y, 2009, MAPPING REGULATORY E; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057	22	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17353	10.1371/journal.pone.0017353	http://dx.doi.org/10.1371/journal.pone.0017353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364894	Green Submitted, gold, Green Published			2022-12-27	WOS:000287764100049
J	Yamanoue, Y; Miya, M; Doi, H; Mabuchi, K; Sakai, H; Nishida, M				Yamanoue, Yusuke; Miya, Masaki; Doi, Hiroyuki; Mabuchi, Kohji; Sakai, Harumi; Nishida, Mutsumi			Multiple Invasions into Freshwater by Pufferfishes (Teleostei: Tetraodontidae): A Mitogenomic Perspective	PLOS ONE			English	Article							PHYLOGENETIC TREE SELECTION; MITOCHONDRIAL-DNA SEQUENCES; MIDDLE MAGDALENA VALLEY; GONDWANA LIFE RAFTS; MARINE INCURSIONS; DIVERGENCE TIME; NORTHWESTERN AMAZONIA; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; EASTERN CORDILLERA	Pufferfishes of the Family Tetraodontidae are the most speciose group in the Order Tetraodontiformes and mainly inhabit coastal waters along continents. Although no members of other tetraodontiform families have fully discarded their marine lives, approximately 30 tetraodontid species spend their entire lives in freshwaters in disjunct tropical regions of South America, Central Africa, and Southeast Asia. To investigate the interrelationships of tetraodontid pufferfishes and thereby elucidate the evolutionary origins of their freshwater habitats, we performed phylogenetic analysis based on whole mitochondrial genome sequences from 50 tetraodontid species and closely related species (including 31 newly determined sequences). The resulting phylogenies reveal that the family is composed of four major lineages and that freshwater species from the different continents are independently nested in two of the four lineages. A monophyletic origin of the use of freshwater habitats was statistically rejected, and ancestral habitat reconstruction on the resulting tree demonstrates that tetraodontids independently entered freshwater habitats in different continents at least three times. Relaxed molecular-clock Bayesian divergence time estimation suggests that the timing of these invasions differs between continents, occurring at 0-10 million years ago (MA) in South America, 17-38 MA in Central Africa, and 48-78 MA in Southeast Asia. These timings are congruent with geological events that could facilitate adaptation to freshwater habitats in each continent.	[Yamanoue, Yusuke; Mabuchi, Kohji; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Chiba, Japan; [Doi, Hiroyuki] Shimonoseki Marine Sci Museum Kaikyokan, Yamaguchi, Japan; [Sakai, Harumi] Natl Fisheries Univ, Dept Appl Aquabiol, Yamaguchi, Japan	University of Tokyo; Japan Fisheries Research & Education Agency (FRA)	Yamanoue, Y (corresponding author), Univ Tokyo, Fisheries Lab, Shizuoka, Japan.	yamanouey@yahoo.co.jp	Miya, Masaki/O-2664-2019	Miya, Masaki/0000-0002-9791-9886	Japan Society for the Promotion of Science [19207007, 22370035, 22770079]; Nippon Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nippon Foundation(Nippon Foundation)	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (19207007, 22370035, 22770079), and the Nippon Foundation-Hadal Environmental Science Education Program (HADEEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], 2007, FRESHWATER FISH DIST; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Beadle LC., 1974, INLAND WATERS AFRICA; BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; Benton M.J., 1993, FOSSIL RECORD; Benton M.J., 2005, VERTEBRATE PALAEONTO; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Cazier EC, 1997, AAPG BULL, V81, P1332; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; COOPER MA, 1995, AAPG BULL, V79, P1421; CrnogoracJurcevic T, 1997, GENOMICS, V41, P177, DOI 10.1006/geno.1997.4646; DEKKERS W J, 1975, Bijdragen tot de Dierkunde, V45, P87; Ebert K., 2001, PUFFERS FRESH BRACKI; Fraser-Brunner A., 1943, Annals & Magazine of Natural History Series 11, V10, P1; Froese R, 2010, FISHBASE VERSION 03; Giresse P, 2005, J AFR EARTH SCI, V43, P301, DOI 10.1016/j.jafrearsci.2005.07.009; GRAY J, 1988, PALAEOGEOGR PALAEOCL, V62, P1, DOI 10.1016/0031-0182(88)90054-5; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Holcroft NI, 2005, MOL PHYLOGENET EVOL, V34, P525, DOI 10.1016/j.ympev.2004.11.003; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2006, PALAIOS, V21, P197, DOI 10.2110/palo.2005.p05-131; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Horton BK, 2002, GEOL SOC AM BULL, V114, P771, DOI 10.1130/0016-7606(2002)114<0771:PESSIN>2.0.CO;2; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kato Akira, 2005, BMC Physiol, V5, P18, DOI 10.1186/1472-6793-5-18; Kullander SO, 2003, CHECK LIST FRESHWATE; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Kumazawa Y, 2004, ENDOCYT CELL RES, V15, P136; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; Little C, 1990, TERRESTRIAL INVASION; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Maddison W., 2018, MESQUITE MODULAR SYS; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Monks N., 2006, BRACKISH WATER FISHE, P252; Monsch KA, 1998, PALAEOGEOGR PALAEOCL, V143, P31, DOI 10.1016/S0031-0182(98)00064-9; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Remane A, 1971, BIOL BRACKISH WATER; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SENOU H, 1989, FRESHWATER FISHES JA, P674; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Sparks JS, 2004, MOL PHYLOGENET EVOL, V30, P599, DOI 10.1016/S1055-7903(03)00225-2; Stamatakis A, 2010, BIOINFORMATICS, V26, pi132, DOI 10.1093/bioinformatics/btq205; Stiassny M.L.J., 1991, CICHLID FISHES BEHAV, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tyler James C., 2002, Studi e Ricerche sui Giacimenti Terziari di Bolca, V9, P47; TYLER JAMES C., 1964, PROC ACAD NATUR SCI PHILADELPHIA, V116, P119; TYLER JC, 1992, P BIOL SOC WASH, V105, P462; Tyler JC, 1996, SMITHSONIAN CONTRIBU, V82, P1, DOI DOI 10.5479/SI.00810266.82.1; Tyler JC, 1980, NOAA TECHNICAL REPOR, V434, P1, DOI DOI 10.5962/BHL.TITLE.63022; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vonhof HB, 2003, GEOL SOC AM BULL, V115, P983, DOI 10.1130/B25058.1; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wilson AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001979; Winterbottom R., 1974, Smithsonian Contributions to Zoology, VNo. 155, P1; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yamanoue Y, 2009, MOL BIOL EVOL, V26, P623, DOI 10.1093/molbev/msn283; Yamanoue Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-212; Yang Z, 2008, J APPL ICHTHYOL, V24, P569, DOI 10.1111/j.1439-0426.2008.01071.x; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YUAN CM, 1986, FRESHWATER FISHES JI, P255; Zhang KJ, 2002, GEOL J, V37, P217, DOI 10.1002/gj.911; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	95	62	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17410	10.1371/journal.pone.0017410	http://dx.doi.org/10.1371/journal.pone.0017410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364898	Green Published, gold, Green Submitted			2022-12-27	WOS:000287764100056
J	Zeng, L; Das, S; Burne, RA				Zeng, Lin; Das, Satarupa; Burne, Robert A.			Genetic Analysis of the Functions and Interactions of Components of the LevQRST Signal Transduction Complex of Streptococcus mutans	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; FRUCTAN HYDROLASE GENE; GRAM-POSITIVE BACTERIA; BETA-D-FRUCTOSIDASE; PHOSPHOTRANSFERASE SYSTEM; HISTIDINE KINASES; MULTIPLE SUGAR; EXPRESSION; MUTAGENESIS; METABOLISM	Transcription of the genes for a fructan hydrolase (fruA) and a fructose/mannose sugar: phosphotransferase permease (levDEFG) in Streptococcus mutans is activated by a four-component regulatory system consisting of a histidine kinase (LevS), a response regulator (LevR) and two carbohydrate-binding proteins (LevQT). The expression of the fruA and levD operons was at baseline in a levQ mutant and substantially decreased in a levT null mutant, with lower expression with the cognate inducers fructose or mannose, but slightly higher expression in glucose or galactose. A strain expressing levQ with two point mutations (E170A/F292S) did not require inducers to activate gene expression and displayed altered levD expression when growing on various carbohydrates, including cellobiose. Linker-scanning (LS) mutagenesis was used to generate three libraries of mutants of levQ, levS and levT that displayed various levels of altered substrate specificity and of fruA/levD gene expression. The data support that LevQ and LevT are intimately involved in the sensing of carbohydrate signals, and that LevQ appears to be required for the integrity of the signal transduction complex, apparently by interacting with the sensor kinase LevS.	[Zeng, Lin; Das, Satarupa; Burne, Robert A.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Zeng, L (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	lzeng@dental.ufl.edu	Zeng, Lin/L-5931-2019	Zeng, Lin/0000-0002-9269-2707; Burne, Robert/0000-0002-4234-0316	National Institute of Dental and Craniofacial Research, United States of America [RO1 DE12236]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012236] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant RO1 DE12236 from the National Institute of Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Burne RA, 1996, J DENT RES, V75, P1572, DOI 10.1177/00220345960750080801; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; BURNE RA, 1987, J BACTERIOL, V169, P4507, DOI 10.1128/jb.169.10.4507-4517.1987; BURNE RA, 1992, INFECT IMMUN, V60, P4621, DOI 10.1128/IAI.60.11.4621-4632.1992; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cha R S, 1992, PCR Methods Appl, V2, P14; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Faustoferri RC, 1998, PLASMID, V40, P247, DOI 10.1006/plas.1998.1371; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; MUNRO C, 1991, INFECT IMMUN, V59, P2316, DOI 10.1128/IAI.59.7.2316-2323.1991; Poquet I, 1998, J BACTERIOL, V180, P1904, DOI 10.1128/JB.180.7.1904-1912.1998; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; ROSEY EL, 1992, J BACTERIOL, V174, P6159, DOI 10.1128/JB.174.19.6159-6170.1992; Rozen R, 2001, FEMS MICROBIOL LETT, V195, P205, DOI 10.1016/S0378-1097(01)00009-X; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Sambrook J, 2001, MOL CLONING LAB MANU; Shaw W V, 1975, Methods Enzymol, V43, P737; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; VANHOUTE J, 1994, J DENT RES, V73, P1727, DOI 10.1177/00220345940730110801; Wen ZT, 2001, FEMS MICROBIOL LETT, V205, P337, DOI 10.1111/j.1574-6968.2001.tb10969.x; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x; Zeng L, 2010, J BACTERIOL, V192, P2434, DOI 10.1128/JB.01624-09; Zeng L, 2010, MOL MICROBIOL, V75, P1145, DOI 10.1111/j.1365-2958.2009.07029.x; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08; Zuobi-Hasona Kheir, 2008, V425, P287, DOI 10.1007/978-1-60327-210-0_23	34	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17335	10.1371/journal.pone.0017335	http://dx.doi.org/10.1371/journal.pone.0017335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364902	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600040
J	Jessen, F; Wiese, B; Bickel, H; Eifflander-Gorfer, S; Fuchs, A; Kaduszkiewicz, H; Kohler, M; Luck, T; Mosch, E; Pentzek, M; Riedel-Heller, SG; Wagner, M; Weyerer, S; Maier, W; van den Bussche, H				Jessen, Frank; Wiese, Birgitt; Bickel, Horst; Eifflaender-Gorfer, Sandra; Fuchs, Angela; Kaduszkiewicz, Hanna; Koehler, Mirjam; Luck, Tobias; Moesch, Edelgard; Pentzek, Michael; Riedel-Heller, Steffi G.; Wagner, Michael; Weyerer, Siegfried; Maier, Wolfgang; van den Bussche, Hendrik		AgeCoDe Study Grp	Prediction of Dementia in Primary Care Patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SUBJECTIVE MEMORY IMPAIRMENT; ALZHEIMERS-DISEASE; RISK; ASSOCIATION; PROGRESSION; PREVALENCE; BIOMARKERS; DIAGNOSIS; CRITERIA	Background: Current approaches for AD prediction are based on biomarkers, which are however of restricted availability in primary care. AD prediction tools for primary care are therefore needed. We present a prediction score based on information that can be obtained in the primary care setting. Methodology/Principal Findings: We performed a longitudinal cohort study in 3.055 non-demented individuals above 75 years recruited via primary care chart registries (Study on Aging, Cognition and Dementia, AgeCoDe). After the baseline investigation we performed three follow-up investigations at 18 months intervals with incident dementia as the primary outcome. The best set of predictors was extracted from the baseline variables in one randomly selected half of the sample. This set included age, subjective memory impairment, performance on delayed verbal recall and verbal fluency, on the Mini-Mental- State-Examination, and on an instrumental activities of daily living scale. These variables were aggregated to a prediction score, which achieved a prediction accuracy of 0.84 for AD. The score was applied to the second half of the sample (test cohort). Here, the prediction accuracy was 0.79. With a cut-off of at least 80% sensitivity in the first cohort, 79.6% sensitivity, 66.4% specificity, 14.7% positive predictive value (PPV) and 97.8% negative predictive value of (NPV) for AD were achieved in the test cohort. At a cut-off for a high risk population (5% of individuals with the highest risk score in the first cohort) the PPV for AD was 39.1% (52% for any dementia) in the test cohort. Conclusions: The prediction score has useful prediction accuracy. It can define individuals (1) sensitively for low cost-low risk interventions, or (2) more specific and with increased PPV for measures of prevention with greater costs or risks. As it is independent of technical aids, it may be used within large scale prevention programs.	[Jessen, Frank; Wagner, Michael; Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Wiese, Birgitt] Hannover Med Sch, Inst Biometr, D-3000 Hannover, Germany; [Bickel, Horst; Moesch, Edelgard] Tech Univ Munich, Dept Psychiat, Munich, Germany; [Eifflaender-Gorfer, Sandra; Weyerer, Siegfried] Cent Inst Mental Hlth, D-6800 Mannheim, Germany; [Fuchs, Angela; Pentzek, Michael] Univ Hosp, Dept Gen Practice, Dusseldorf, Germany; [Kaduszkiewicz, Hanna; Koehler, Mirjam; van den Bussche, Hendrik] Univ Med Ctr, Dept Primary Med Care, Hamburg, Germany; [Luck, Tobias; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med & Occupat Hlth, Leipzig, Germany; [Jessen, Frank; Maier, Wolfgang] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Bonn; Hannover Medical School; Technical University of Munich; University of Munich; Central Institute of Mental Health; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jessen, F (corresponding author), Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany.	frank.jessen@ukb.uni-bonn.de	Wagner, Michael/E-2325-2011; Jessen, Frank/AAK-6170-2020; Riedel-Heller, Steffi/ABG-1537-2021; Jessen, Frank/E-7655-2012	Wagner, Michael/0000-0003-2589-6440; Dichgans, Martin/0000-0002-0654-387X; Pentzek, Michael/0000-0001-6538-0241; Luck, Tobias/0000-0001-7551-4397	German Federal Ministry for Education and Research [O1 GI 0102, 01 GI 0710, 01 GI 0711, 01 GI 0712, 01 GI 0713, 01 GI 0714, 01 GI 0715, 01 GI 0716, 01 GI 0717]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Funding: This work was supported by the German Federal Ministry for Education and Research grants O1 GI 0102, 01 GI 0710, 01 GI 0711, 01 GI 0712, 01 GI 0713, 01 GI 0714, 01 GI 0715, 01 GI 0716, 01 GI 0717. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Artero S, 2008, J NEUROL NEUROSUR PS, V79, P979, DOI 10.1136/jnnp.2007.136903; Auriacombe S, 2010, NEUROLOGY, V74, P1760, DOI 10.1212/WNL.0b013e3181df0959; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Harrell FE, 2001, REGRESSION MODELING; Heun R, 2001, ARCH GEN PSYCHIAT, V58, P190, DOI 10.1001/archpsyc.58.2.190; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jessen F, 2007, PSYCHOL MED, V37, P1753, DOI 10.1017/S0033291707001122; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jungwirth S, 2009, J NEURAL TRANSM, V116, P1513, DOI 10.1007/s00702-009-0318-6; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Konig W., 1988, 12 CASMIN U MANNH; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Luck T, 2007, DEMENT GERIATR COGN, V24, P307, DOI 10.1159/000108099; Luck T, 2007, GEROPSYCH, V20, P31, DOI 10.1024/1011-6877.20.1.31; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Palmer K, 2003, BRIT MED J, V326, P245, DOI 10.1136/bmj.326.7383.245; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Purser JL, 2005, J AM GERIATR SOC, V53, P1966, DOI 10.1111/j.1532-5415.2005.53566.x; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sauerbrei W, 1999, J ROY STAT SOC C-APP, V48, P313, DOI 10.1111/1467-9876.00155; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; Vincze G, 2007, INT J GERIATR PSYCH, V22, P1208, DOI 10.1002/gps.1815; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; ZAUDIG M, 1996, SIDAM HDB STRUKTURIE	45	95	102	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16852	10.1371/journal.pone.0016852	http://dx.doi.org/10.1371/journal.pone.0016852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364746	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800017
J	Bibi, F				Bibi, Faysal			Mio-Pliocene Faunal Exchanges and African Biogeography: The Record of Fossil Bovids	PLOS ONE			English	Article							LATE-MIOCENE; MIDDLE AWASH; ARABIAN PENINSULA; MAMMALIA; ARTIODACTYLA; BIOSTRATIGRAPHY; SYSTEMATICS; PHYLOGENY; EVOLUTION; HOMINIDS	The development of the Ethiopian biogeographic realm since the late Miocene is here explored with the presentation and review of fossil evidence from eastern Africa. Prostrepsiceros cf. vinayaki and an unknown species of possible caprin affinity are described from the hominid-bearing Asa Koma and Kuseralee Members (similar to 5.7 and similar to 5.2 Ma) of the Middle Awash, Ethiopia. The Middle Awash Prostrepsiceros cf. vinayaki constitutes the first record of this taxon from Africa, previously known from the Siwaliks and Arabia. The possible caprin joins a number of isolated records of caprin or caprin-like taxa recorded, but poorly understood, from the late Neogene of Africa. The identification of these two taxa from the Middle Awash prompts an overdue review of fossil bovids from the sub-Saharan African record that demonstrate Eurasian affinities, including the reduncin Kobus porrecticornis, and species of Tragoportax. The fossil bovid record provides evidence for greater biological continuity between Africa and Eurasia in the late Miocene and earliest Pliocene than is found later in time. In contrast, the early Pliocene (after 5 Ma) saw the loss of any significant proportions of Eurasian-related taxa, and the continental dominance of African-endemic taxa and lineages, a pattern that continues today.	Univ Poitiers, CNRS, UMR 6046, Inst Paleoprimatol & Paleontol Humaine Evolut & P, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Bibi, F (corresponding author), Univ Poitiers, CNRS, UMR 6046, Inst Paleoprimatol & Paleontol Humaine Evolut & P, Poitiers, France.	faysal.bibi@univ-poitiers.fr	Self, Casey J/B-6871-2011; Bibi, Faysal/AAZ-9917-2021	Bibi, Faysal/0000-0002-9414-5547	National Science Foundation [0852975]; Institute International de Paleoprimatologie et Paleontologie Humaine; Agence Nationale de la Recherche [ANR-09-BLAN-0238]; Revealing Hominid Origins Initiative; Geological Society of America; Yale University; Yale Institute for Biospheric Studies Center for Field Ecology; Yale ECOSAVE Center; Abu Dhabi Authority for Culture and Heritage; Rimo Ramses Nakhle Foundation	National Science Foundation(National Science Foundation (NSF)); Institute International de Paleoprimatologie et Paleontologie Humaine; Agence Nationale de la Recherche(French National Research Agency (ANR)); Revealing Hominid Origins Initiative; Geological Society of America; Yale University; Yale Institute for Biospheric Studies Center for Field Ecology; Yale ECOSAVE Center; Abu Dhabi Authority for Culture and Heritage; Rimo Ramses Nakhle Foundation	This study was supported by a National Science Foundation Graduate Research Fellowship, a National Science Foundation International Research Fellowship Award (#0852975), the Institute International de Paleoprimatologie et Paleontologie Humaine (I. P. H. E. P.), the Agence Nationale de la Recherche (ANR-09-BLAN-0238), the Revealing Hominid Origins Initiative (R.H.O.I.), a Geological Society of America Ross Research Award, a Yale University Enders Grant, a Yale Institute for Biospheric Studies Center for Field Ecology grant, a Yale ECOSAVE Center grant, the Abu Dhabi Authority for Culture and Heritage, and the Rimo Ramses Nakhle Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; Bernor Raymond L., 2009, P549; Bibi F, 2006, PALAEONTOL ELECTRON, V9; BIBI F, NEOGENE TE IN PRESS; Bibi F., 2009, THESIS YALE U; Bibi F, 2009, PALAEONTOL ELECTRON, V12; BOUVRAIN G, 1986, GEOBIOS-LYON, V19, P661, DOI 10.1016/S0016-6995(86)80063-8; Bouvrain G, 2007, ANN PALEONTOL, V93, P121, DOI 10.1016/j.annpal.2007.03.001; Brink J.S., 1999, Archaeozoologia, V10, P11; BRUNET M, 1984, GEOL MIJNBOUW, V63, P31; Cheylan G., 1991, P227; CLUTTONBROCK J, 1970, J ZOOL, V162, P19; Cooke H.B.S., 1970, Fossil Vertebr Afr, V2, P107; ERDBRINK DPB, 1988, P K NED AKAD B PHYS, V91, P101; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; Ferretti MP, 2003, J VERTEBR PALEONTOL, V23, P659, DOI 10.1671/2353; Franz-Odendaal TA, 2003, S AFR J SCI, V99, P453; Gentry A. W., 2006, Transactions of the Royal Society of South Africa, V61, P41; Gentry A. W., 1971, Bull Br Mus nat Hist (Geol), V20, P229; Gentry A.W., 1996, P571; Gentry A.W., 1970, Fossil Vertebr Afr, V2, P243; Gentry A.W., 1978, Bulletin of the British Museum (Natural History) Geology, V29, P289; Gentry A.W., 1987, P378; GENTRY A W, 1980, Annals of the South African Museum, V79, P213; Gentry A.W., 1985, CAHIERS PALEONTOLOGI, V1, P119; Gentry Alan W., 2000, P65; Gentry AW, 1999, FOSSIL VERTEBRATES OF ARABIA, P290; GERAADS D, 1989, GEOBIOS-LYON, V22, P777, DOI 10.1016/S0016-6995(89)80072-5; Geraads D, 2008, J VERTEBR PALEONTOL, V28, P231, DOI 10.1671/0272-4634(2008)28[231:NHBMFT]2.0.CO;2; Geraads D, 2010, QUATERN INT, V212, P159, DOI 10.1016/j.quaint.2009.06.002; Geraads D, 2009, J VERTEBR PALEONTOL, V29, P923, DOI 10.1671/039.029.0311; Geraads Denis, 2006, Transactions of the Royal Society of South Africa, V61, P97; Gilbert WH, 2008, MID AWASH SER, V1, P45; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Yohannes, 2009, P565; Haile-Selassie Yohannes, 2009, P277; Harris J.M., 1988, CONTRIBUTIONS SCI, V399, P1; HARRIS JM, 1991, KOOBI FORA, V3, P139; Harris John M., 2003, Contributions in Science (Los Angeles), V498, P39; Harris John M., 2003, P531; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; Hassanin Alexandre, 1998, Journal of Mammalian Evolution, V5, P217, DOI 10.1023/A:1020560412929; Kostopoulos Dimitris S., 2009, Beitraege zur Palaeontologie, V31, P345; Kostopoulos DS, 2009, GEODIVERSITAS, V31, P879, DOI 10.5252/g2009n4a879; KOSTOPOULOS DS, GEODIVERSIT IN PRESS; Lehmann Ulrich, 1987, P323; Lihoreau F, 2006, P NATL ACAD SCI USA, V103, P8763, DOI 10.1073/pnas.0603126103; Mallon D.P., 2001, ANTELOPES 4, P231; Moyûß-Solûß S., 1983, PUBLICACIONES GEOLOG, V18, P1; NAKATA H, 1994, AUTOMATIC CONTROL - WORLD CONGRESS 1993, VOL 5, P1; Nakaya H., 1984, AFR STUDY MONOGR S, V2, P87; Nakaya Hideo, 1987, African Study Monographs Supplementary Issue, V5, P79; PICKFORD M, 1994, PALAEOGEOGR PALAEOCL, V112, P297, DOI 10.1016/0031-0182(94)90078-7; Pilgrim G. E., 1939, Palaeontologia Indica, V16, pUnpaginated; PILGRIM GE, 1937, B AM MUS NAT HIST, V72, P729; RAYMOND LB, 2008, GARYOUNIS SCI B, V5, P283; RENNE P. R., 2009, ARDIPITHECUS KADABBA, V2, P93; Ropiquet A, 2005, J ZOOL SYST EVOL RES, V43, P49, DOI 10.1111/j.1439-0469.2004.00290.x; Sawada Y, 1998, CR ACAD SCI II A, V326, P445, DOI 10.1016/S1251-8050(98)80069-4; Sclater P. L., 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI [10.1111/j.1096-3642, DOI 10.1111/J.1096-3642.1858.TB02549.X]; Sen S, 1998, GEOBIOS-LYON, V31, P385, DOI 10.1016/S0016-6995(98)80021-1; Spassov N, 2004, GEODIVERSITAS, V26, P339; Stromer E., 1928, Abhandlungen der Bayerischen Akademie der Wissenschaften, V32, P1; THOMAS H, 1981, P K NED AKAD B PHYS, V84, P335; Thomas H., 1979, Geobios (Villeurbanne), V12, P267, DOI 10.1016/S0016-6995(79)80082-0; THOMAS H, 1984, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V6, P81; Thomas H, 1998, CR ACAD SCI II A, V326, P145, DOI 10.1016/S1251-8050(97)87459-9; THOMAS H, 1982, Geobios (Villeurbanne), V15, P283, DOI 10.1016/S0016-6995(82)80082-X; THOMAS H, 1984, PALAEOGEOGR PALAEOCL, V45, P251, DOI 10.1016/0031-0182(84)90009-9; THOMAS H, 1980, P 8 PAN C PREH QUAT, P82; Thomas H., 1979, ARCHEOLOGIA, V134, P61; Thomas H, 1984, MEMOIRES SOC GEOLOGI, V145, P1; Tsujikawa Hiroshi, 2005, African Study Monographs Supplementary Issue, V32, P1; Vrba E. S., 1997, Palaeontologia Africana, V34, P127; Vrba E. S., 1994, Palaeontologia Africana, V31, P55; Vrba Elisabeth S., 2006, Transactions of the Royal Society of South Africa, V61, P63; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; WELLS L. H., 1956, PALAEONTOL AFRICANA, V4, P1; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Werdelin Lars, 2003, Contributions in Science (Los Angeles), V498, P115; Wesselman H.B., 2009, ARDIPITHECUS KADDABA; White TD, 2009, SCIENCE, V326, P50; Whybrow Peter, 1999, FOSSIL VERTEBRATES A; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058	87	51	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16688	10.1371/journal.pone.0016688	http://dx.doi.org/10.1371/journal.pone.0016688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21358825	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700021
J	Nacke, H; Thurmer, A; Wollherr, A; Will, C; Hodac, L; Herold, N; Schoning, I; Schrumpf, M; Daniel, R				Nacke, Heiko; Thuermer, Andrea; Wollherr, Antje; Will, Christiane; Hodac, Ladislav; Herold, Nadine; Schoening, Ingo; Schrumpf, Marion; Daniel, Rolf			Pyrosequencing-Based Assessment of Bacterial Community Structure Along Different Management Types in German Forest and Grassland Soils	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; FUNGAL COMMUNITIES; PH GRADIENT; GEN.-NOV.; DIVERSITY; ACTINOBACTERIA; SEQUENCES; MEMBERS; PHYLUM	Background: Soil bacteria are important drivers for nearly all biogeochemical cycles in terrestrial ecosystems and participate in most nutrient transformations in soil. In contrast to the importance of soil bacteria for ecosystem functioning, we understand little how different management types affect the soil bacterial community composition. Methodology/Principal Findings: We used pyrosequencing-based analysis of the V2-V3 16S rRNA gene region to identify changes in bacterial diversity and community structure in nine forest and nine grassland soils from the Schwabische Alb that covered six different management types. The dataset comprised 598,962 sequences that were affiliated to the domain Bacteria. The number of classified sequences per sample ranged from 23,515 to 39,259. Bacterial diversity was more phylum rich in grassland soils than in forest soils. The dominant taxonomic groups across all samples (>1% of all sequences) were Acidobacteria, Alphaproteobacteria, Actinobacteria, Betaproteobacteria, Deltaproteobacteria, Gammaproteobacteria, and Firmicutes. Significant variations in relative abundances of bacterial phyla and proteobacterial classes, including Actinobacteria, Firmicutes, Verrucomicrobia, Cyanobacteria, Gemmatimonadetes and Alphaproteobacteria, between the land use types forest and grassland were observed. At the genus level, significant differences were also recorded for the dominant genera Phenylobacter, Bacillus, Kribbella, Streptomyces, Agromyces, and Defluviicoccus. In addition, soil bacterial community structure showed significant differences between beech and spruce forest soils. The relative abundances of bacterial groups at different taxonomic levels correlated with soil pH, but little or no relationships to management type and other soil properties were found. Conclusions/Significance: Soil bacterial community composition and diversity of the six analyzed management types showed significant differences between the land use types grassland and forest. Furthermore, bacterial community structure was largely driven by tree species and soil pH.	[Nacke, Heiko; Will, Christiane; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany; [Thuermer, Andrea; Wollherr, Antje; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany; [Herold, Nadine; Schrumpf, Marion] Max Planck Inst Biogeochem, Jena, Germany; [Schoening, Ingo] Univ Jena, Inst Ecol, Jena, Germany	University of Gottingen; University of Gottingen; Max Planck Society; Friedrich Schiller University of Jena	Nacke, H (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany.	rdaniel@gwdg.de	Schrumpf, Marion/C-1671-2013; Hodac, Ladislav/AAP-7284-2021; Hodac, Ladislav/A-4072-2014; Daniel, Rolf/AAQ-5933-2021; Schöning, Ingo/D-3341-2009; Herold, Nadine/I-7996-2013	Hodac, Ladislav/0000-0002-6885-1317; Daniel, Rolf/0000-0002-8646-7925; Schöning, Ingo/0000-0002-9830-5026; Schrumpf, Marion/0000-0003-4219-4125; Nacke, Heiko/0000-0001-6169-6169	DFG [1374, DA 374/4-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DA 374/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anandham R, 2011, INT J SYST EVOL MICR, V61, P392, DOI 10.1099/ijs.0.022012-0; Anderson RC, 2000, INT J SYST EVOL MICR, V50, P633, DOI 10.1099/00207713-50-2-633; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Brady N. C., 2007, NATURE PROPERTIES SO; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2007, VET MICROBIOL, V121, P299, DOI 10.1016/j.vetmic.2006.12.006; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; FAO, 2006, GUID SOIL DESCR; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Hackl E, 2004, APPL ENVIRON MICROB, V70, P5057, DOI 10.1128/AEM.70.9.5057-5065.2004; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; JimenezSalgado T, 1997, APPL ENVIRON MICROB, V63, P3676, DOI 10.1128/AEM.63.9.3676-3683.1997; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; McCaig AE, 2001, APPL ENVIRON MICROB, V67, P4554, DOI 10.1128/AEM.67.10.4554-4559.2001; Morales SE, 2009, APPL ENVIRON MICROB, V75, P668, DOI 10.1128/AEM.01757-08; Newton RJ, 2007, APPL ENVIRON MICROB, V73, P7169, DOI 10.1128/AEM.00794-07; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sait M, 2006, APPL ENVIRON MICROB, V72, P1852, DOI 10.1128/AEM.72.3.1852-1857.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmalenberger A, 2001, APPL ENVIRON MICROB, V67, P3557, DOI 10.1128/AEM.67.8.3557-3563.2001; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Shannon CE, 1949, MD COMPUT, V14, P306; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1685, DOI 10.1099/ijs.0.004838-0; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Xie CH, 2005, INT J SYST EVOL MICR, V55, P753, DOI 10.1099/ijs.0.63377-0	54	390	442	5	282	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17000	10.1371/journal.pone.0017000	http://dx.doi.org/10.1371/journal.pone.0017000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21359220	Green Published, gold, Green Submitted			2022-12-27	WOS:000287392700035
J	Jiang, WQ; Nguyen, A; Cao, Y; Chang, ACM; Reddel, RR				Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.			HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA BODIES; FRAUMENI SYNDROME FIBROBLASTS; NUCLEOSOME ASSEMBLY PATHWAY; PRIMARY HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; HETEROCHROMATIN FOCI; DNA-SYNTHESIS; HP1 PROTEINS; MRE11/RAD50/NBS1 COMPLEX	Approximately 10% of cancers use recombination-mediated Alternative Lengthening of Telomeres (ALT) instead of telomerase to prevent telomere shortening. A characteristic of cells that utilize ALT is the presence of ALT-associated PML nuclear bodies (APBs) containing (TTAGGG)n DNA, telomere binding proteins, DNA recombination proteins, and heterochromatin protein 1 (HP1). The function of APBs is unknown and it is possible that they are functionally heterogeneous. Most ALT cells lack functional p53, and restoration of the p53/p21 pathway in these cells results in growth arrest/senescence and a substantial increase in the number of large APBs that is dependent on two HP1 isoforms, HP1 alpha and HP1 gamma. Here we investigated the mechanism of HP1-mediated APB formation, and found that histone chaperones, HIRA and ASF1a, are present in APBs following activation of the p53/p21 pathway in ALT cells. HIRA and ASF1a were also found to colocalize inside PML bodies in normal fibroblasts approaching senescence, providing evidence for the existence of a senescence-associated ASF1a/HIRA complex inside PML bodies, consistent with a role for these proteins in induction of senescence in both normal and ALT cells. Moreover, knockdown of HIRA but not ASF1a significantly reduced p53-mediated induction of large APBs, with a concomitant reduction of large HP1 foci. We conclude that HIRA, in addition to its physical and functional association with ASF1a, plays a unique, ASF1a-independent role, which is required for the localization of HP1 to PML bodies and thus for APB formation.	[Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Jiang, Wei-Qin; Nguyen, Akira; Cao, Ying; Chang, Andy C. -M.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Jiang, WQ (corresponding author), Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia.	rreddel@cmri.org.au	Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107	Cancer Council New South Wales [PG 06-04]; National Health and Medical Research Council of Australia [633265]	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Program Grant PG 06-04 from Cancer Council New South Wales (www.cancercouncil.com.au) and project grant ID 633265 from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brachner A, 2006, CANCER RES, V66, P3584, DOI 10.1158/0008-5472.CAN-05-2839; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Grobelny JV, 2000, J CELL SCI, V113, P4577; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Harborth J, 2001, J CELL SCI, V114, P4557; Henson JD, 2005, CLIN CANCER RES, V11, P217; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Jiang WQ, 2007, ONCOGENE, V26, P4635, DOI 10.1038/sj.onc.1210260; Jiang WQ, 2009, J CELL BIOL, V185, P797, DOI 10.1083/jcb.200810084; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; MACLEAN K, 1994, ONCOGENE, V9, P719; Marciniak RA, 2005, CANCER RES, V65, P2730, DOI 10.1158/0008-5472.CAN-04-2888; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633; Moran-Jones K, 2005, NUCLEIC ACIDS RES, V33, P486, DOI 10.1093/nar/gki203; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Singer MS, 1998, GENETICS, V150, P613; Slatter T, 2010, AM J PATHOL, V177, P2694, DOI 10.2353/ajpath.2010.100468; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Toouli CD, 2002, ONCOGENE, V21, P128, DOI 10.1038/sj.onc.1205014; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu GK, 2003, CANCER RES, V63, P2589; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079; Zhang RG, 2007, MOL CELL BIOL, V27, P949, DOI 10.1128/MCB.01639-06; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	69	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17036	10.1371/journal.pone.0017036	http://dx.doi.org/10.1371/journal.pone.0017036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347226	Green Published, Green Submitted, gold			2022-12-27	WOS:000287369200014
J	McDermott, JE; Archuleta, M; Thrall, BD; Adkins, JN; Waters, KM				McDermott, Jason E.; Archuleta, Michelle; Thrall, Brian D.; Adkins, Joshua N.; Waters, Katrina M.			Controlling the Response: Predictive Modeling of a Highly Central, Pathogen-Targeted Core Response Module in Macrophage Activation	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; NETWORKS; CHOLESTEROL; VARIANCE	We have investigated macrophage activation using computational analyses of a compendium of transcriptomic data covering responses to agonists of the TLR pathway, Salmonella infection, and manufactured amorphous silica nanoparticle exposure. We inferred regulatory relationship networks using this compendium and discovered that genes with high betweenness centrality, so-called bottlenecks, code for proteins targeted by pathogens. Furthermore, combining a novel set of bioinformatics tools, topological analysis with analysis of differentially expressed genes under the different stimuli, we identified a conserved core response module that is differentially expressed in response to all studied conditions. This module occupies a highly central position in the inferred network and is also enriched in genes preferentially targeted by pathogens. The module includes cytokines, interferon induced genes such as Ifit1 and 2, effectors of inflammation, Cox1 and Oas1 and OasI2, and transcription factors including AP1, Egr1 and 2 and Mafb. Predictive modeling using a reverse-engineering approach reveals dynamic differences between the responses to each stimulus and predicts the regulatory influences directing this module. We speculate that this module may be an early checkpoint for progression to apoptosis and/or inflammation during macrophage activation.	[McDermott, Jason E.; Thrall, Brian D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	McDermott, JE (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	Jason.McDermott@pnl.gov	Adkins, Joshua/B-9881-2013	Adkins, Joshua/0000-0003-0399-0700; Waters, Katrina/0000-0003-4696-5396; McDermott, Jason/0000-0003-2961-2572	National Institute of Allergy and Infectious Diseases NIH/DHHS [Y1-AI-8401, NIH/NIEHS R01ES016212]; Environmental Biomarkers Initiative and Biological Systems Initiative; Battelle Memorial Institute [DE-AC05-76RLO-1830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008401, R22AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016212] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Environmental Biomarkers Initiative and Biological Systems Initiative; Battelle Memorial Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded, in part, by the National Institute of Allergy and Infectious Diseases NIH/DHHS through Interagency agreement Y1-AI-8401, NIH/NIEHS R01ES016212, and the Environmental Biomarkers Initiative and Biological Systems Initiative through the Laboratory Directed Research and Development program at Pacific Northwest National Laboratory (PNNL). PNNL is operated by Battelle Memorial Institute under contract DE-AC05-76RLO-1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Catron DM, 2002, CELL MICROBIOL, V4, P315, DOI 10.1046/j.1462-5822.2002.00198.x; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; El Chartouni C, IMMUNOBIOLOGY; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Gong J, 2010, J MOL MODEL, V16, P1283, DOI 10.1007/s00894-009-0640-9; Heffron F, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P187; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jefferies CA, 2005, TRENDS MOL MED, V11, P403, DOI 10.1016/j.molmed.2005.07.006; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McDermott JE, 2010, DIS MARKERS, V28, P253, DOI [10.1155/2010/708932, 10.3233/DMA-2010-0695]; McDermott JE, 2009, J COMPUT BIOL, V16, P169, DOI 10.1089/cmb.2008.04TT; McDermott JE, 2010, DIS MARKERS IN PRESS; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Pajarinen J, 2010, J BIOMED MATER RES A, V92A, P1528, DOI 10.1002/jbm.a.32495; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Raza S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-63; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Schmid S, 2010, J BIOL CHEM; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Suhir H, 2010, CLIN REV ALLERG IMMU, V38, P11, DOI 10.1007/s12016-009-8135-0; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Waters KM, 2009, TOXICOL SCI, V107, P553, DOI 10.1093/toxsci/kfn250; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059	45	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14673	10.1371/journal.pone.0014673	http://dx.doi.org/10.1371/journal.pone.0014673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339814	gold, Green Published, Green Submitted			2022-12-27	WOS:000287367600004
J	Rosenthal, GG; Fitzsimmons, JN; Woods, KU; Gerlach, G; Fisher, HS				Rosenthal, Gil G.; Fitzsimmons, Jessica N.; Woods, Kristina U.; Gerlach, Gabriele; Fisher, Heidi S.			Tactical Release of a Sexually-Selected Pheromone in a Swordtail Fish	PLOS ONE			English	Article							OLFACTORY CUES; SIGNALS; RECOGNITION; PREFERENCE; DOMINANCE; EVOLUTION; AUDIENCE; FEMALES; URINE	Background: Chemical communication plays a critical role in sexual selection and speciation in fishes; however, it is generally assumed that most fish pheromones are passively released since most fishes lack specialized scent glands or scent-marking behavior. Swordtails (genus Xiphophorus) are widely used in studies of female mate choice, and female response to male chemical cues is important to sexual selection, reproductive isolation, and hybridization. However, it is unclear whether females are attending to passively produced cues, or to pheromones produced in the context of communication. Methodology/Principal Findings: We used fluorescein dye injections to visualize pulsed urine release in male sheepshead swordtails, Xiphophorus birchmanni. Simultaneous-choice assays of mating preference showed that females attend to species-and sex-specific chemical cues emitted in male urine. Males urinated more frequently in the presence and proximity of an audience (conspecific females). In the wild, males preferentially courted upstream of females, facilitating transmission of pheromone cues. Conclusions/Significance: Males in a teleost fish have evolved sophisticated temporal and spatial control of pheromone release, comparable to that found in terrestrial animals. Pheromones are released specifically in a communicative context, and the timing and positioning of release favors efficient signal transmission.	[Rosenthal, Gil G.; Fisher, Heidi S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico; [Fitzsimmons, Jessica N.; Woods, Kristina U.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Gerlach, Gabriele] Marine Biol Lab, Woods Hole, MA 02543 USA	Texas A&M University System; Texas A&M University College Station; Boston University; Marine Biological Laboratory - Woods Hole	Rosenthal, GG (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	grosenthal@bio.tamu.edu	Fitzsimmons, Jessica/G-1343-2011; Gerlach, Gabriele/K-5919-2012; Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024; Fisher, Heidi S./0000-0001-5622-4335	National Science Foundation [IOB-0447665]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (www.nsf.gov), IOB-0447665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Appelt CW, 2007, ANIM BEHAV, V74, P1329, DOI 10.1016/j.anbehav.2007.02.032; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; Barata EN, 2008, J CHEM ECOL, V34, P438, DOI 10.1007/s10886-008-9458-7; Barata EN, 2008, ANIM BEHAV, V75, P379, DOI 10.1016/j.anbehav.2007.05.018; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; Bergman DA, 2005, ANIM BEHAV, V70, P485, DOI 10.1016/j.anbehav.2004.11.021; Bradbury JW, 2000, ANIM BEHAV, V59, P259, DOI 10.1006/anbe.1999.1330; Breithaupt T, 2000, BEHAV ECOL SOCIOBIOL, V49, P67, DOI 10.1007/s002650000271; CULUMBER ZW, MOL ECOLOGY; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; DECAPRONA MDC, 1990, ANIM BEHAV, V39, P290; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Fisher HS, 2006, ANIM BEHAV, V72, P721, DOI 10.1016/j.anbehav.2006.02.009; Fisher HS, 2006, BEHAV ECOL, V17, P979, DOI 10.1093/beheco/arl038; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; Fisher HS, 2009, ANIM BEHAV, V78, P265, DOI 10.1016/j.anbehav.2009.02.029; GYGER M, 1986, ANIM BEHAV, V34, P1570, DOI 10.1016/S0003-3472(86)80229-9; Hankison SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P140; Holldobler B., 1990, pi; Jobling M., 1995, ENVIRON BIOL FISH; Marler P., 1991, P187; McLennan DA, 1997, ANIM BEHAV, V54, P1077, DOI 10.1006/anbe.1997.0504; McLennan DA, 1999, EVOLUTION, V53, P880, DOI 10.1111/j.1558-5646.1999.tb05382.x; McLennan DA, 2008, ANIM BEHAV, V75, P1731, DOI 10.1016/j.anbehav.2007.10.030; Miller GL, 2007, J CHEM ECOL, V33, P541, DOI 10.1007/s10886-006-9243-4; Morris MR, 1996, ANIM BEHAV, V52, P1193, DOI 10.1006/anbe.1996.0267; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; ROSENTHAL GG, 2006, BEHAV PHYSL FISH, P39; Rosenthal GG, 2006, ZEBRAFISH, V3, P85, DOI 10.1089/zeb.2006.3.85; Ryan MJ, 2001, MG BEH ECOL, P133; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Stacey N. E., 2005, BEHAV INTERACTIONS F; Wong BBM, 2005, BEHAV ECOL, V16, P818, DOI 10.1093/beheco/ari058; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	39	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16994	10.1371/journal.pone.0016994	http://dx.doi.org/10.1371/journal.pone.0016994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21339807	Green Published, gold, Green Submitted			2022-12-27	WOS:000287361700063
J	Hagemann, G; Ugur, T; Schleussner, E; Mentzel, HJ; Fitzek, C; Witte, OW; Gaser, C				Hagemann, Georg; Ugur, Tarik; Schleussner, Ekkehard; Mentzel, Hans-Joachim; Fitzek, Clemens; Witte, Otto W.; Gaser, Christian			Changes in Brain Size during the Menstrual Cycle	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; SYNAPTIC CONNECTIVITY; GENDER-DIFFERENCES; SEX-DIFFERENCES; ESTROGEN; ADULT; ESTRADIOL; HORMONE; PLASTICITY; RECEPTORS	Background: There is increasing evidence for hormone-dependent modification of function and behavior during the menstrual cycle, but little is known about associated short-term structural alterations of the brain. Preliminary studies suggest that a hormone-dependent decline in brain volume occurs in postmenopausal, or women receiving antiestrogens, long term. Advances in serial MR-volumetry have allowed for the accurate detection of small volume changes of the brain. Recently, activity-induced short-term structural plasticity of the brain was demonstrated, challenging the view that the brain is as rigid as formerly believed. Methodology/Principal Findings: We used MR-volumetry to investigate short-term brain volume changes across the menstrual cycle in women or a parallel 4 week period in men, respectively. We found a significant grey matter volume peak and CSF loss at the time of ovulation in females. This volume peak did not correlate with estradiol or progesterone hormone levels. Men did not show any significant brain volume alterations. Conclusions/Significance: These data give evidence of short-term hormone-dependent structural brain changes during the menstrual cycle, which need to be correlated with functional states and have to be considered in structure-associated functional brain research.	[Hagemann, Georg; Ugur, Tarik; Witte, Otto W.] Univ Hosp Jena, Hans Berger Clin Neurol, Jena, Germany; [Hagemann, Georg] HELIOS Klin, Dept Neurol, Berlin, Germany; [Ugur, Tarik] Univ Duisburg Essen, Rhein Kliniken Essen, Dept Psychiat & Psychotherapy, Essen, Germany; [Schleussner, Ekkehard] Univ Jena, Dept Obstet, Jena, Germany; [Mentzel, Hans-Joachim; Fitzek, Clemens] Univ Jena, Inst Diagnost & Intervent Radiol, Jena, Germany; [Fitzek, Clemens] Asklepios Fachklinikum Brandenburg, Inst Radiol & Neuroradiol, Brandenburg, Germany; [Gaser, Christian] Univ Jena, Dept Psychiat, Jena, Germany	Friedrich Schiller University of Jena; Helios Kliniken; University of Duisburg Essen; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Hagemann, G (corresponding author), Univ Hosp Jena, Hans Berger Clin Neurol, Jena, Germany.	georg.hagemann@helios-kliniken.de	Gaser, Christian/F-5103-2010; Witte, Otto/P-4127-2018	Gaser, Christian/0000-0002-9940-099X; Witte, Otto/0000-0003-2101-4105				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; BENTSON J, 1978, J COMPUT ASSIST TOMO, V2, P16, DOI 10.1097/00004728-197801000-00003; Berman KF, 1997, P NATL ACAD SCI USA, V94, P8836, DOI 10.1073/pnas.94.16.8836; Bixo M, 1995, J STEROID BIOCHEM, V55, P297, DOI 10.1016/0960-0760(95)00179-4; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Breedlove SM, 2001, P NATL ACAD SCI USA, V98, P2956, DOI 10.1073/pnas.071054098; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chakraborty TR, 2004, EXP BIOL MED, V229, P977, DOI 10.1177/153537020422901001; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; DawsonBasoa ME, 1996, PAIN, V64, P607, DOI 10.1016/0304-3959(96)87175-2; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duning T, 2005, NEUROLOGY, V64, P548, DOI 10.1212/01.WNL.0000150542.16969.CC; Eberling JL, 2003, NEUROBIOL AGING, V24, P725, DOI 10.1016/S0197-4580(02)00056-8; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Erickson KI, 2005, NEUROBIOL AGING, V26, P1205, DOI 10.1016/j.neurobiolaging.2004.11.009; Fernandez G, 2003, J NEUROSCI, V23, P3790; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Good M, 1999, EUR J NEUROSCI, V11, P4476, DOI 10.1046/j.1460-9568.1999.00920.x; HATTON GI, 1992, ANN NY ACAD SCI, V652, P142, DOI 10.1111/j.1749-6632.1992.tb34351.x; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Hosli E, 2001, INT J DEV NEUROSCI, V19, P11, DOI 10.1016/S0736-5748(00)00082-4; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; LINDSEY BW, 2007, PROG NEUROBIOL; LUI KJ, 1992, STAT MED, V11, P633, DOI 10.1002/sim.4780110508; Mackiewicz KL, 2006, P NATL ACAD SCI USA, V103, P14200, DOI 10.1073/pnas.0601648103; Madeira MD, 2001, J COMP NEUROL, V432, P329; Maki PM, 2001, NEUROIMAGE, V14, P789, DOI 10.1006/nimg.2001.0887; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; McEwen BS, 1998, PSYCHOPHARMACOL BULL, V34, P251; MCEWEN BS, 1994, EXP GERONTOL, V29, P431, DOI 10.1016/0531-5565(94)90022-1; Melcangi RC, 2006, NEUROSCIENCE, V138, P733, DOI 10.1016/j.neuroscience.2005.10.066; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mhyre AJ, 2006, NEUROSCIENCE, V138, P851, DOI 10.1016/j.neuroscience.2005.10.019; Miranda P, 1999, J NEUROSCI, V19, P3316; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; N-Wihlback AC, 2006, PSYCHOPHARMACOLOGY, V186, P388, DOI 10.1007/s00213-005-0185-2; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Oatridge A, 2002, AM J NEURORADIOL, V23, P19; Osterlund MK, 2001, PROG NEUROBIOL, V64, P251, DOI 10.1016/S0301-0082(00)00059-9; Palmon SC, 1998, J CEREBR BLOOD F MET, V18, P1248, DOI 10.1097/00004647-199811000-00011; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P497, DOI 10.1016/0306-4530(92)90008-U; Rubinow DR, 2006, FRONT NEUROENDOCRIN, V27, P210, DOI 10.1016/j.yfrne.2006.02.003; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Segal M, 2001, HORM BEHAV, V40, P156, DOI 10.1006/hbeh.2001.1688; Sherwin BB, 2006, NEUROSCIENCE, V138, P1021, DOI 10.1016/j.neuroscience.2005.07.051; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6; Vickers Andrew J, 2003, BMC Med Res Methodol, V3, P22, DOI 10.1186/1471-2288-3-22; Wong M, 1996, CRIT REV NEUROBIOL, V10, P189, DOI 10.1615/CritRevNeurobiol.v10.i2.30; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598	61	66	66	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14655	10.1371/journal.pone.0014655	http://dx.doi.org/10.1371/journal.pone.0014655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326603	Green Published, Green Submitted, gold			2022-12-27	WOS:000287037000004
J	Lee, J; Romero, R; Xu, Y; Kim, JS; Topping, V; Yoo, W; Kusanovic, JP; Chaiworapongsa, T; Hassan, SS; Yoon, BH; Kim, CJ				Lee, JoonHo; Romero, Roberto; Xu, Yi; Kim, Jung-Sun; Topping, Vanessa; Yoo, Wonsuk; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yoon, Bo Hyun; Kim, Chong Jai			A Signature of Maternal Anti-Fetal Rejection in Spontaneous Preterm Birth: Chronic Chorioamnionitis, Anti-Human Leukocyte Antigen Antibodies, and C4d	PLOS ONE			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; CLINICAL-SIGNIFICANCE; ALLOGRAFT-REJECTION; RECURRENT ABORTION; MEDIATED REJECTION; HUMORAL IMMUNITY; UNKNOWN ETIOLOGY; HLA ANTIBODIES; PREGNANCY; MECHANISMS	Background: Chronic chorioamnionitis is found in more than one-third of spontaneous preterm births. Chronic chorioamnionitis and villitis of unknown etiology represent maternal anti-fetal cellular rejection. Antibody-mediated rejection is another type of transplantation rejection. We investigated whether there was evidence for antibody-mediated rejection against the fetus in spontaneous preterm birth. Methods and Findings: This cross-sectional study included women with (1) normal pregnancy and term delivery (n = 140) and (2) spontaneous preterm delivery (n = 140). We analyzed maternal and fetal sera for panel-reactive anti-HLA class I and class II antibodies, and determined C4d deposition on umbilical vein endothelium by immunohistochemistry. Maternal anti-HLA class I seropositivity in spontaneous preterm births was higher than in normal term births (48.6% vs. 32.1%, p = 0.005). Chronic chorioamnionitis was associated with a higher maternal anti-HLA class I seropositivity (p<0.01), significant in preterm and term birth. Villitis of unknown etiology was associated with increased maternal and fetal anti-HLA class I and II seropositivity (p<0.05, for each). Fetal anti-HLA seropositivity was closely related to maternal anti-HLA seropositivity in both groups (p<0.01, for each). C4d deposition on umbilical vein endothelium was more frequent in preterm labor than term labor (77.1% vs. 11.4%, p<0.001). Logistic regression analysis revealed that chronic chorioamnionitis (OR = 6.10, 95% CI 1.29-28.83), maternal anti-HLA class I seropositivity (OR = 5.90, 95% CI 1.60-21.83), and C4d deposition on umbilical vein endothelium (OR = 36.19, 95% CI 11.42-114.66) were associated with preterm labor and delivery. Conclusions: A major subset of spontaneous preterm births has a signature of maternal anti-fetal cellular and antibody-mediated rejections with links to fetal graft-versus-host disease and alloimmune reactions.	[Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Detroit, MI USA; [Romero, Roberto; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kim, Jung-Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Yoo, Wonsuk] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Pedro Kusanovic, Juan] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Santiago, Chile; [Pedro Kusanovic, Juan] Pontificia Univ Catolica Chile, Sch Med, Dept Obstet & Gynecol, Santiago, Chile; [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Sungkyunkwan University (SKKU); Samsung Medical Center; Wayne State University; Universidad de Chile; Pontificia Universidad Catolica de Chile; Seoul National University (SNU); Wayne State University	Lee, J (corresponding author), NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA.	prbchiefstaff@med.wayne.edu; cjkim@med.wayne.edu	Kusanovic, Juan Pedro/R-8616-2019; Yoon, Bo Hyun/H-6344-2011; Kusanovic, Juan Pedro/AAM-5782-2020; YOO, WONSUK/HHN-9044-2022; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Lee, John Tayu/0000-0002-1551-4923; Millett, Christopher/0000-0002-0793-9884; YOO, WONSUK/0000-0003-2414-2399; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIYIJONES SCA, 1987, J IMMUNOL, V138, P1408; Agrawal Suraksha, 2002, BMC Pregnancy Childbirth, V2, P6, DOI 10.1186/1471-2393-2-6; AKSEL S, 1992, JAMA-J AM MED ASSOC, V268, P2930, DOI 10.1001/jama.268.20.2930; Althaus J, 2005, AM J OBSTET GYNECOL, V193, P1100, DOI 10.1016/j.ajog.2005.06.043; Ball B, 2000, TRANSPLANT P, V32, P353, DOI 10.1016/S0041-1345(99)00976-8; Bartel G, 2007, TRANSPLANTATION, V83, P727, DOI 10.1097/01.tp.0000256337.18347.aa; Bartel G, 2011, HUM IMMUNOL, V72, P187, DOI 10.1016/j.humimm.2010.11.005; Betkowski AS, 2002, J HEART LUNG TRANSPL, V21, P644, DOI 10.1016/S1053-2498(01)00422-3; COHEN F, 1964, BLOOD, V23, P621, DOI 10.1182/blood.V23.5.621.621; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; DUNN MJ, 1992, LANCET, V339, P1566, DOI 10.1016/0140-6736(92)91832-S; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gu DS, 2010, HUM IMMUNOL, V71, P586, DOI 10.1016/j.humimm.2010.02.010; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Howell WM, 2010, J CLIN PATHOL, V63, P387, DOI 10.1136/jcp.2009.072371; Ionescu DN, 2005, TRANSPL IMMUNOL, V15, P63, DOI 10.1016/j.trim.2005.05.001; Jacques SM, 1998, HUM PATHOL, V29, P1457, DOI 10.1016/S0046-8177(98)90016-8; KILPATRICK DC, 1987, LANCET, V2, P1460; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim IK, 2008, TRANSPLANTATION, V86, P889, DOI 10.1097/TP.0b013e318186ac4a; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; Makrigiannakis A, 2008, AM J REPROD IMMUNOL, V60, P482, DOI 10.1111/j.1600-0897.2008.00655.x; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moncharmont P, 2004, ACTA HAEMATOL-BASEL, V111, P215, DOI 10.1159/000077569; Nielsen HS, 2007, J REPROD IMMUNOL, V75, P63, DOI 10.1016/j.jri.2007.03.003; Nielsen HS, 2010, J REPROD IMMUNOL, V87, P67, DOI 10.1016/j.jri.2010.05.006; Pandey Manoj Kumar, 2004, Archives of Gynecology and Obstetrics, V269, P161, DOI 10.1007/s00404-003-0560-3; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Porter TF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000112.pub2; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; REDLINE RW, 1993, AM J PATHOL, V143, P473; REDMAN CWG, 1983, AM J REPROD IMMUNOL, V4, P179, DOI 10.1111/j.1600-0897.1983.tb00274.x; REGAN L, 1991, HUM REPROD, V6, P294, DOI 10.1093/oxfordjournals.humrep.a137325; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Rowshani AT, 2008, CLIN TRANSPLANT, V22, P689, DOI 10.1111/j.1399-0012.2008.00872.x; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Saito S, 2003, TRANSFUSION, V43, P908, DOI 10.1046/j.1537-2995.2003.00429.x; SARGENT IL, 1988, LANCET, V2, P1099; Schild RL, 1999, ULTRASOUND OBST GYN, V14, P64, DOI 10.1046/j.1469-0705.1999.14010064.x; SEBRING ES, 1990, TRANSFUSION, V30, P344, DOI 10.1046/j.1537-2995.1990.30490273444.x; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Taglauer ES, 2010, INT J DEV BIOL, V54, P421, DOI 10.1387/ijdb.082800et; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thude H, 2006, TRANSFUSION MED, V16, P143, DOI 10.1111/j.1365-3148.2006.00634.x; Tilburgs T, 2010, J REPROD IMMUNOL, V85, P58, DOI 10.1016/j.jri.2010.01.005; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Wilczynski JR, 2006, HUM IMMUNOL, V67, P492, DOI 10.1016/j.humimm.2006.04.007; Zeevi A, 2006, IMMUNOL RES, V36, P255, DOI 10.1385/IR:36:1:255	58	175	177	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16806	10.1371/journal.pone.0016806	http://dx.doi.org/10.1371/journal.pone.0016806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326865	gold, Green Published, Green Submitted			2022-12-27	WOS:000287037000022
J	Charland, KM; Brownstein, JS; Verma, A; Brien, S; Buckeridge, DL				Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.			Socio-Economic Disparities in the Burden of Seasonal Influenza: The Effect of Social and Material Deprivation on Rates of Influenza Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; HOSPITAL ADMISSION; HEALTH; CHILDREN; DISEASE; SURVEILLANCE; MORTALITY; SYSTEM; AGE	Background: There is little empirical evidence in support of a relationship between rates of influenza infection and level of material deprivation (i.e., lack of access to goods and services) and social deprivation (i.e. lack of social cohesion and support). Method: Using validated population-level indices of material and social deprivation and medical billing claims for outpatient clinic and emergency department visits for influenza from 1996 to 2006, we assessed the relationship between neighbourhood rates of influenza and neighbourhood levels of deprivation using Bayesian ecological regression models. Then, by pooling data from neighbourhoods in the top decile (i.e., most deprived) and the bottom decile, we compared rates in the most deprived populations to the least deprived populations using age-and sex-standardized rate ratios. Results: Deprivation scores ranged from one to five with five representing the highest level of deprivation. We found a 21% reduction in rates for every 1 unit increase in social deprivation score (rate ratio [RR] 0.79, 95% Credible Interval [CrI] 0.66, 0.97). There was little evidence of a meaningful linear relationship with material deprivation (RR 1.06, 95% CrI 0.93, 1.24). However, relative to neighbourhoods with deprivation scores in the bottom decile, those in the top decile (i. e., most materially deprived) had substantially higher rates (RR 2.02, 95% Confidence Interval 1.99, 2.05). Conclusion: Though it is hypothesized that social and material deprivation increase risk of acute respiratory infection, we found decreasing healthcare utilization rates for influenza with increasing social deprivation. This finding may be explained by the fewer social contacts and, thus, fewer influenza exposure opportunities of the socially deprived. Though there was no evidence of a linear relationship with material deprivation, when comparing the least to the most materially deprived populations, we observed higher rates in the most materially deprived populations.	[Charland, Katia M.; Brownstein, John S.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Buckeridge, David L.] Montreal Publ Hlth Dept, Off Surveillance & Epidemiol, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; McGill University	Charland, KM (corresponding author), Childrens Hosp, Childrens Hosp Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	katia.charland@mcgill.ca	Verma, Aman/D-5550-2014; Thompson, Ross/D-7996-2013; Austin, Jeremy/F-8729-2010; Owen, Kylie/K-9400-2015; Gershwin, Lisa-ann/N-6392-2015	Verma, Aman/0000-0001-7436-1325; Thompson, Ross/0000-0002-5287-2455; Robb, Kate/0000-0002-7038-3612; Austin, Jeremy/0000-0003-4244-2942; Owen, Kylie/0000-0002-8986-482X; Gershwin, Lisa-ann/0000-0003-1254-725X	National Institute of Allergy and Infectious Diseases [R21AI073591-01]; National Library of Medicine, National Institutes of Health [R21LM009263-01]; Canadian Institutes of Health Research [PAN-83152, CAT 86857]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM009263] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Allergy and Infectious Diseases [R21AI073591-01], the National Library of Medicine, National Institutes of Health [R21LM009263-01], and the Canadian Institutes of Health Research [PAN-83152, CAT 86857]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2008, SOC SCI MED, V66, P691, DOI 10.1016/j.socscimed.2007.10.011; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cadieux G, 2008, HEALTH SERV RES, V43, P2223, DOI 10.1111/j.1475-6773.2008.00873.x; Cardoso MRA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-19; Carpenter KM, 2010, ANN BEHAV MED, V39, P79, DOI 10.1007/s12160-010-9160-1; Christakis N. A., 2010, PLOS ONE, V5; Cohen F, 2007, PSYCHOSOM MED, V69, P225, DOI 10.1097/PSY.0b013e31803139a6; Crighton EJ, 2007, SOC SCI MED, V64, P1636, DOI 10.1016/j.socscimed.2006.12.001; Feldman PJ, 2004, ANN BEHAV MED, V27, P91, DOI 10.1207/s15324796abm2702_3; Glynn AN, 2008, J ROY STAT SOC A STA, V171, P179; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Hawker JI, 2003, RESP MED, V97, P1219, DOI 10.1016/S0954-6111(03)00252-X; Jackson C, 2006, STAT MED, V25, P2136, DOI 10.1002/sim.2370; Jackson CH, 2008, SOC SCI MED, V67, P1995, DOI 10.1016/j.socscimed.2008.09.041; Jordan R, 2006, RESP MED, V100, P1282, DOI 10.1016/j.rmed.2005.10.014; Jordan RE, 2008, BRIT J GEN PRACT, V58, P400, DOI 10.3399/bjgp08X302682; Kaler SG, 2008, ANN NY ACAD SCI, V1136, P28, DOI 10.1196/annals.1425.035; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Pampalon R, 2000, Chronic Dis Can, V21, P104; Philibert MD, 2007, SOC SCI MED, V64, P1651, DOI 10.1016/j.socscimed.2006.12.010; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SPIEGELHELTER DJ, 2002, WINBUGS BAYESIAN INF; STONE AA, ARCH INTERN MED, V170, P570; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008	28	40	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17207	10.1371/journal.pone.0017207	http://dx.doi.org/10.1371/journal.pone.0017207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21359150	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300040
J	Wei, GX; Zhang, YC; Jiang, TZ; Luo, J				Wei, Gaoxia; Zhang, Yuanchao; Jiang, Tianzi; Luo, Jing			Increased Cortical Thickness in Sports Experts: A Comparison of Diving Players with the Controls	PLOS ONE			English	Article							SPATIAL MEMORY DEFICITS; SURFACE-BASED ANALYSIS; GRAY-MATTER DENSITY; BRAIN; CORTEX; MEDITATION; PLASTICITY; NAVIGATION; INTERVENTION; HIPPOCAMPUS	Sports experts represent a population of people who have acquired expertise in sports training and competition. Recently, the number of studies on sports experts has increased; however, neuroanatomical changes following extensive training are not fully understood. In this study, we used cortical thickness measurement to investigate the brain anatomical characteristics of professional divers with extensive training experience. A comparison of the brain anatomical characteristics of the non-athlete group with those of the athlete group revealed three regions with significantly increased cortical thickness in the athlete group. These regions included the left superior temporal sulcus, the right orbitofrontal cortex and the right parahippocampal gyrus. Moreover, a significant positive correlation between the mean cortical thickness of the right parahippocampal gyrus and the training experience was detected, which might indicate the effect of extensive training on diving players' brain structure.	[Wei, Gaoxia; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Yuanchao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhang, Yuanchao; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Automation, CAS	Wei, GX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	jiangtz@nlpr.ia.ac.cn; luoj@psych.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; Wei, Gao-Xia/0000-0002-6350-9096; Peng, Tao/0000-0001-5260-7128	Institute of Psychology [YOCX111S01]; National Basic Research Program of China [2010CB833904]; National Natural Science Foundation of China [30970890, 30770708]; National Hi-Tech Research and Development Program of China [2008AA022604]; Chinese Academy of Sciences [KSCX2-EW-J-8]	Institute of Psychology; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by Young Scientists Fund of Institute of Psychology (Grant NO.: YOCX111S01), National Basic Research Program of China (Grant NO.: 2010CB833904), National Natural Science Foundation of China (Grant NO.: 30970890 and 30770708), National Hi-Tech Research and Development Program of China (Grant NO.: 2008AA022604) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant NO.: KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davids K., 2006, MOVEMENT SYSTEM VARI; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gaser C, 2003, J NEUROSCI, V23, P9240; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lay BS, 2002, HUM MOVEMENT SCI, V21, P807, DOI 10.1016/S0167-9457(02)00166-5; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Park IS, 2006, J KOREAN MED SCI, V21, P342, DOI 10.3346/jkms.2006.21.2.342; Park IS, 2010, HUMAN MOVEM IN PRESS; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Starkes JL, 2003, ADV RES SPORT EXPERT, P371; Starkes JL, 2003, RECENT ADV RES SPORT, P49; Ste-Marie DM, 1999, APPL COGNITIVE PSYCH, V13, P269, DOI 10.1002/(SICI)1099-0720(199906)13:3<269::AID-ACP567>3.3.CO;2-P; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wei GX, 2009, PROG NAT SCI-MATER, V19, P1397, DOI 10.1016/j.pnsc.2008.12.009; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	55	60	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17112	10.1371/journal.pone.0017112	http://dx.doi.org/10.1371/journal.pone.0017112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22164266	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700050
J	Li, W; Zhu, S; Li, JH; Huang, Y; Zhou, RR; Fan, XG; Yang, HA; Gong, X; Eissa, NT; Jahnen-Dechent, W; Wang, P; Tracey, KJ; Sama, AE; Wang, HC				Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Fan, Xuegong; Yang, Huan; Gong, Xing; Eissa, N. Tony; Jahnen-Dechent, Willi; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao			A Hepatic Protein, Fetuin-A, Occupies a Protective Role in Lethal Systemic Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; HUMAN ALPHA-2-HS GLYCOPROTEIN; ACUTE-PHASE PROTEIN; IFN-GAMMA; EXPERIMENTAL SEPSIS; BOVINE FETUIN; APOPTOTIC CELLS; TYROSINE KINASE; HMGB1 RELEASE; BACTERIAL-DNA	Background: A liver-derived protein, fetuin-A, was first purified from calf fetal serum in 1944, but its potential role in lethal systemic inflammation was previously unknown. This study aims to delineate the molecular mechanisms underlying the regulation of hepatic fetuin-A expression during lethal systemic inflammation (LSI), and investigated whether alterations of fetuin-A levels affect animal survival, and influence systemic accumulation of a late mediator, HMGB1. Methods and Findings: LSI was induced by endotoxemia or cecal ligation and puncture (CLP) in fetuin-A knock-out or wildtype mice, and animal survival rates were compared. Murine peritoneal macrophages were challenged with exogenous (endotoxin) or endogenous (IFN-gamma) stimuli in the absence or presence of fetuin-A, and HMGB1 expression and release was assessed. Circulating fetuin-A levels were decreased in a time-dependent manner, starting between 26 h, reaching a nadir around 24-48 h, and returning towards base-line approximately 72 h post onset of endotoxemia or sepsis. These dynamic changes were mirrored by an early cytokine IFN-gamma-mediated inhibition (up to 50-70%) of hepatic fetuin-A expression. Disruption of fetuin-A expression rendered animals more susceptible to LSI, whereas supplementation of fetuin-A (20100 mg/kg) dose-dependently increased animal survival rates. The protection was associated with a significant reduction in systemic HMGB1 accumulation in vivo, and parallel inhibition of IFN-gamma or LPS-induced HMGB1 release in vitro. Conclusions: These experimental data suggest that fetuin-A is protective against lethal systemic inflammation partly by inhibiting active HMGB1 release.	[Li, Wei; Zhu, Shu; Li, Jianhua; Huang, Yan; Zhou, Rongrong; Yang, Huan; Wang, Ping; Tracey, Kevin J.; Sama, Andrew E.; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Li, Wei; Zhu, Shu; Sama, Andrew E.; Wang, Haichao] N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY USA; [Huang, Yan; Zhou, Rongrong; Fan, Xuegong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China; [Gong, Xing; Eissa, N. Tony] Baylor Coll Med, Pulm Crit Care & Sleep Med Sect, Houston, TX 77030 USA; [Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Dept Biomed Engn, Biointerface Lab, Aachen, Germany	Northwell Health; Northwell Health; North Shore University Hospital; Central South University; Baylor College of Medicine; RWTH Aachen University; RWTH Aachen University Hospital	Li, W (corresponding author), Feinstein Inst Med Res, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Jahnen-Dechent, Willi/A-7608-2011	Wang, Haichao/0000-0002-0211-9000; Wang, Ping/0000-0002-1557-0394; Jahnen-Dechent, Willi/0000-0003-1315-4407; Li, Wei/0000-0002-7941-7022; Tracey, Kevin J/0000-0003-1884-6314	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; National Center for Complementary & Integrative Health [R01AT005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062508, R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM063075 and R01GM070817 to HW.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chmiela M, 1997, GUT, V40, P20, DOI 10.1136/gut.40.1.20; CHRISTIE DL, 1987, FEBS LETT, V214, P45, DOI 10.1016/0014-5793(87)80010-8; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Deriy LV, 2002, SHOCK, V17, P312, DOI 10.1097/00024382-200204000-00013; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; DZIEGIELEWSKA KM, 1992, J COMP PHYSIOL B, V162, P168, DOI 10.1007/BF00398343; Dziegielewska KM, 1998, IMMUNOL LETT, V60, P31, DOI 10.1016/S0165-2478(97)00126-0; Dziegielewska KM, 1995, FETUIN, P1; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; HAASEMANN M, 1991, BIOCHEM J, V274, P899, DOI 10.1042/bj2740899; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Li W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001153; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Lord JM, 2003, CLIN SCI, V105, P267, DOI 10.1042/CS20030177; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; OHNISHI T, 1993, J BONE MINER RES, V8, P367; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(05)62030-2; Wang HC, 2004, NAT MED, V10, P124, DOI 10.1038/nm0204-124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang SL, 2002, ANN SURG, V236, P625, DOI 10.1097/00000658-200211000-00013; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	57	262	275	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16945	10.1371/journal.pone.0016945	http://dx.doi.org/10.1371/journal.pone.0016945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21347455	gold, Green Submitted, Green Published			2022-12-27	WOS:000287077600035
J	Hofherr, SE; Adams, KE; Chen, CY; May, S; Weaver, EA; Barry, MA				Hofherr, Sean E.; Adams, Kristen E.; Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.			Real-Time Dynamic Imaging of Virus Distribution In Vivo	PLOS ONE			English	Article							GENE DELIVERY; ADENOVIRUS; TOXICITY; VECTORS; THERAPY	The distribution of viruses and gene therapy vectors is difficult to assess in a living organism. For instance, trafficking in murine models can usually only be assessed after sacrificing the animal for tissue sectioning or extraction. These assays are laborious requiring whole animal sectioning to ascertain tissue localization. They also obviate the ability to perform longitudinal or kinetic studies in one animal. To track viruses after systemic infection, we have labeled adenoviruses with a near-infrared (NIR) fluorophore and imaged these after intravenous injection in mice. Imaging was able to track and quantitate virus particles entering the jugular vein simultaneous with injection, appearing in the heart within 500 milliseconds, distributing in the bloodstream and throughout the animal within 7 seconds, and that the bulk of virus distribution was essentially complete within 3 minutes. These data provide the first in vivo real-time tracking of the rapid initial events of systemic virus infection.	[Hofherr, Sean E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Div Infect Dis, Translat Immunovirol & Biodef Program, Dept Internal Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Mayo Grad Sch, Dept Mol Med, Dept Immunol, Rochester, MN USA; [Adams, Kristen E.] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston	Hofherr, SE (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	mab@mayo.edu	Chen, Christopher/B-8141-2012	Chen, Christopher/0000-0003-2726-3989; Davies, Benjamin/0000-0003-3623-600X	Muscular Dystrophy Association; N.I.H. [R01-CA136945]; NATIONAL CANCER INSTITUTE [R01CA136945] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to M.A.B. from the Muscular Dystrophy Association and the N.I.H. (R01-CA136945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barry MA, 2009, CURR OPIN MOL THER, V11, P411; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Dubensky TW, 2002, CANCER CELL, V1, P307, DOI 10.1016/S1535-6108(02)00062-4; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Ottobrini L, 2008, EUR J NUCL MED MOL I, V35, P365, DOI 10.1007/s00259-007-0578-z; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Ray P, 2003, CANCER RES, V63, P1160; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	13	202	206	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17076	10.1371/journal.pone.0017076	http://dx.doi.org/10.1371/journal.pone.0017076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347236	gold, Green Published, Green Submitted			2022-12-27	WOS:000287369200018
J	Vandevenne, P; Lebrun, M; El Mjiyad, N; Ote, I; Di Valentin, E; Habraken, Y; Dortu, E; Piette, J; Sadzot-Delvaux, C				Vandevenne, Patricia; Lebrun, Marielle; El Mjiyad, Nadia; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Dortu, Estelle; Piette, Jacques; Sadzot-Delvaux, Catherine			The Varicella-Zoster Virus ORF47 Kinase Interferes with Host Innate Immune Response by Inhibiting the Activation of IRF3	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; DOUBLE-STRANDED-RNA; TRANSCRIPTIONAL REGULATORY PROTEIN; ANTIVIRAL RESPONSE; GENE-EXPRESSION; I INTERFERON; VIRAL REPLICATION; STIMULATED GENES; SERINE KINASE	The innate immune response constitutes the first line of host defence that limits viral spread and plays an important role in the activation of adaptive immune response. Viral components are recognized by specific host pathogen recognition receptors triggering the activation of IRF3. IRF3, along with NF-kappa B, is a key regulator of IFN-beta expression. Until now, the role of IRF3 in the activation of the innate immune response during Varicella-Zoster Virus (VZV) infection has been poorly studied. In this work, we demonstrated for the first time that VZV rapidly induces an atypical phosphorylation of IRF3 that is inhibitory since it prevents subsequent IRF3 homodimerization and induction of target genes. Using a mutant virus unable to express the viral kinase ORF47p, we demonstrated that (i) IRF3 slower-migrating form disappears; (ii) IRF3 is phosphorylated on serine 396 again and recovers the ability to form homodimers; (iii) amounts of IRF3 target genes such as IFN-beta and ISG15 mRNA are greater than in cells infected with the wild-type virus; and (iv) IRF3 physically interacts with ORF47p. These data led us to hypothesize that the viral kinase ORF47p is involved in the atypical phosphorylation of IRF3 during VZV infection, which prevents its homodimerization and subsequent induction of target genes such as IFN-beta and ISG15.	[Vandevenne, Patricia; Lebrun, Marielle; Ote, Isabelle; Di Valentin, Emmanuel; Habraken, Yvette; Piette, Jacques; Sadzot-Delvaux, Catherine] Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium; [El Mjiyad, Nadia] Inst Invest Biomed Bellvitge IDIBELL, Lab Mol Oncol LOM, Barcelona, Spain; [Dortu, Estelle] Univ Liege, Dept Pathol, Liege, Belgium	University of Liege; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Liege	Vandevenne, P (corresponding author), Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium.	csadzot@ulg.ac.be	Lebrun, Marielle/GVT-8895-2022	Di Valentin, Emmanuel/0000-0002-5287-7950; Lobsiger, Christian/0000-0002-4313-010X; Cleveland, Don/0000-0002-1934-3682	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS); Interuniversity Attraction Poles (IAP) Programme [IAP6/18]	Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium); "Fonds National pour la Recherche Scientifique" (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles (IAP) Programme(Belgian Federal Science Policy Office)	The work was supported by the "Fonds pour la Recherche dans l'Agriculture et l'Industrie" (FRIA, Brussels, Belgium), and The "Fonds National pour la Recherche Scientifique" (FNRS). This paper also presents research results of the IAP6/18, funded by the Interuniversity Attraction Poles (IAP) Programme, initiated by the Belgian State, Science Policy Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Abendroth A, 2001, J VIROL, V75, P4878, DOI 10.1128/JVI.75.10.4878-4888.2001; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Boehme KW, 2004, J VIROL, V78, P1202, DOI 10.1128/JVI.78.3.1202-1211.2004; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Eisfeld AJ, 2006, J VIROL, V80, P1710, DOI 10.1128/JVI.80.4.1710-1723.2006; El Mjiyad N, 2007, J VIROL, V81, P13092, DOI 10.1128/JVI.01378-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; HEINEMAN TC, 1995, J VIROL, V69, P7367, DOI 10.1128/JVI.69.11.7367-7370.1995; Heineman TC, 1996, J VIROL, V70, P7312, DOI 10.1128/JVI.70.10.7312-7317.1996; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hu HL, 2005, VIROLOGY, V337, P304, DOI 10.1016/j.virol.2005.04.024; Hwang SM, 2009, CELL HOST MICROBE, V5, P166, DOI 10.1016/j.chom.2008.12.013; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jones JO, 2006, J VIROL, V80, P5113, DOI 10.1128/JVI.01956-05; Kennedy PGE, 2001, VIROLOGY, V289, P218, DOI 10.1006/viro.2001.1173; Kenyon T. K., 2003, Journal of Medical Virology, V70, pS95, DOI 10.1002/jmv.10329; Kenyon TK, 2002, J VIROL, V76, P10980, DOI 10.1128/JVI.76.21.10980-10993.2002; Kenyon TK, 2001, J VIROL, V75, P8854, DOI 10.1128/JVI.75.18.8854-8858.2001; Kinchington PR, 2000, J VIROL, V74, P2265, DOI 10.1128/JVI.74.5.2265-2277.2000; KINCHINGTON PR, 1999, FRONTIERS BIOSCIENCE, V4; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Moffat JF, 1998, P NATL ACAD SCI USA, V95, P11969, DOI 10.1073/pnas.95.20.11969; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; NG TI, 1994, J VIROL, V68, P1350, DOI 10.1128/JVI.68.3.1350-1359.1994; NIKKELS AF, 1993, VIRCHOWS ARCH A, V422, P121, DOI 10.1007/BF01607163; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reddy SM, 1998, J VIROL, V72, P8083, DOI 10.1128/JVI.72.10.8083-8088.1998; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schaap A, 2005, J VIROL, V79, P12921, DOI 10.1128/JVI.79.20.12921-12933.2005; Sen N, 2010, J VIROL, V84, P9240, DOI 10.1128/JVI.01147-10; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2002, BIOCHEM PHARMACOL, V64, P985, DOI 10.1016/S0006-2952(02)01165-6; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shibaki T, 2001, J INTERF CYTOK RES, V21, P279, DOI 10.1089/107999001300177466; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Spengler M, 2001, ARCH VIR S, V17, P71; STEVENSON D, 1994, J GEN VIROL, V75, P317, DOI 10.1099/0022-1317-75-2-317; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; Taylor RT, 2005, J VIROL, V79, P3873, DOI 10.1128/JVI.79.6.3873-3877.2005; VANDEVENNE P, 2010, BIOCH PHARM; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304	65	95	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16870	10.1371/journal.pone.0016870	http://dx.doi.org/10.1371/journal.pone.0016870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21347389	gold, Green Published, Green Submitted			2022-12-27	WOS:000287361700047
J	Yu, DX; Yu, ZJ; Sun, Q; Sun, LA; Li, HX; Song, J; Mi, M; Wu, HY; Lu, L; Liu, C; Zhang, G; Hu, FB; Lin, X				Yu, Danxia; Yu, Zhijie; Sun, Qi; Sun, Liang; Li, Huaixing; Song, Jun; Mi, Ming; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Hu, Frank B.; Lin, Xu			Effects of Body Fat on the Associations of High-Molecular-Weight Adiponectin, Leptin and Soluble Leptin Receptor with Metabolic Syndrome in Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK-FACTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; OBESITY; WOMEN; SENSITIVITY; HEALTH; ADIPOCYTOKINES	Background: Little is known regarding the associations between high-molecular-weight (HMW-) adiponectin, leptin and soluble leptin receptor (sOB-R) and metabolic syndrome (MetS) in Chinese. Also few studies elucidate the effects of inflammation and body fat mass on the relations. Methods: Plasma HMW-adiponectin, leptin and sOB-R were measured among 1055 Chinese men and women (35 similar to 54 yrs). Whole body and trunk fat mass were determined by Dual-energy X-ray absorptiometry. MetS was defined by the updated NCEP/ATPIII criterion for Asian-Americans. Results: HMW-adiponectin was inversely associated with MetS in multivariate model including fat mass index (FMI), inflammatory markers, leptin and sOB-R (OR in the highest quartile =0.30, 95%CI 0.18 similar to 0.50, P<.0001). Plasma sOB-R was also inversely associated with MetS independent of body fatness and inflammatory markers, whereas the association was somewhat attenuated after adjusting HMW-adiponectin (OR for the highest quartile =0.78, 95%CI 0.47 similar to 1.32, P = 0.15). In contrast, leptin was associated with increased odds of MetS independent of inflammatory markers, HMW-adiponectin, and sOB-R (OR for the highest quartile =2.64, 95%CI 1.35 similar to 5.18, P = 0.006), although further adjustment for FMI abolished this association. Conclusions: HMW-adiponectin exhibited strong inverse associations with MetS independent of body composition, inflammation, leptin and sOB-R; while the associations of leptin and sOB-R were largely explained by fat mass or HMW-adiponectin, respectively.	[Yu, Danxia; Yu, Zhijie; Sun, Liang; Li, Huaixing; Wu, Hongyu; Lu, Ling; Liu, Chen; Zhang, Geng; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Song, Jun; Mi, Ming] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health	Yu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	xlin@sibs.ac.cn		Sun, Xinli/0000-0002-6592-6168; Yu, Danxia/0000-0002-1710-9382; Wang, Guo-Liang/0000-0001-8877-3064	Chinese Academy of Sciences [KSCX2-YW-R-116, KSCX2-EW-R-10]; Ministry of Science and Technology of China [2008DFA31960, 2009AA022704, 2011CB504002]; National Natural Science Foundation of China [30930081, 81021002]; Shanghai Institutes [SIBS2008006]; Unilever Corporate Research	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes; Unilever Corporate Research(Unilever)	This study was supported by grant from the Chinese Academy of Sciences (KSCX2-YW-R-116, KSCX2-EW-R-10); the Ministry of Science and Technology of China (2008DFA31960, 863 Program 2009AA022704, 973 program 2011CB504002); the National Natural Science Foundation of China (30930081, 81021002); the Chief Scientist Program of Shanghai Institutes and (SIBS2008006). Dr. Qi Sun was supported by a postdoctoral fellowship from the Unilever Corporate Research before September 2010. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; *COMM IR, 2009, GUID DAT PROC AN INT; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Franks PW, 2005, OBES RES, V13, P1476, DOI 10.1038/oby.2005.178; Furler SM, 2006, OBESITY, V14, P228, DOI 10.1038/oby.2006.29; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Ingelsson E, 2008, J CLIN ENDOCR METAB, V93, P3149, DOI 10.1210/jc.2008-0207; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koska J, 2008, AM J CLIN NUTR, V87, P295, DOI 10.1093/ajcn/87.2.295; Lammert A, 2001, BIOCHEM BIOPH RES CO, V283, P982, DOI 10.1006/bbrc.2001.4885; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh DK, 2007, DIABETES OBES METAB, V9, P282, DOI 10.1111/j.1463-1326.2006.00610.x; Sepilian VP, 2006, FERTIL STERIL, V85, P1441, DOI 10.1016/j.fertnstert.2005.10.038; Shimamura M, 2004, BIOCHEM BIOPH RES CO, V322, P1080, DOI 10.1016/j.bbrc.2004.08.024; Soderberg S, 2007, INT J OBESITY, V31, P1126, DOI 10.1038/sj.ijo.0803561; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; SUN Q, 2009, LEPTIN SOLUBLE LEPTI, V59, P611; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ukkola O, 2007, METABOLISM, V56, P1221, DOI 10.1016/j.metabol.2007.04.019; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Wang J, 2008, OBESITY, V16, P172, DOI 10.1038/oby.2007.42; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zhai F, 2006, NUTR HLTH STATUS CHI; Zhuo Q, 2009, DIABETES RES CLIN PR, V84, P27, DOI 10.1016/j.diabres.2008.12.019	41	66	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16818	10.1371/journal.pone.0016818	http://dx.doi.org/10.1371/journal.pone.0016818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347230	gold, Green Submitted, Green Published			2022-12-27	WOS:000287369200008
J	Schmeier, S; Schaefer, U; MacPherson, CR; Bajic, VB				Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.			dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; DATABASE; CANCER; IDENTIFICATION; DISEASES; UPDATE; ROLES; SITES; SNP	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules that act as post-transcriptional regulators and affect the regulation of protein-coding genes. Mostly transcribed by PolII, miRNA genes are regulated at the transcriptional level similarly to protein-coding genes. In this study we focus on human miRNAs. These miRNAs are involved in a variety of pathways and can affect many diseases. Our interest is on possible deregulation of the transcription initiation of the miRNA encoding genes, which is facilitated by variations in the genomic sequence of transcriptional control regions (promoters). Methodology: Our aim is to provide an online resource to facilitate the investigation of the potential effects of single nucleotide polymorphisms (SNPs) on miRNA gene regulation. We analyzed SNPs overlapped with predicted transcription factor binding sites (TFBSs) in promoters of miRNA genes. We also accounted for the creation of novel TFBSs due to polymorphisms not present in the reference genome. The resulting changes in the original TFBSs and potential creation of new TFBSs were incorporated into the Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA). Conclusions: The dPORE-miRNA database enables researchers to explore potential effects of SNPs on the regulation of miRNAs. dPORE-miRNA can be interrogated with regards to: a/miRNAs (their targets, or involvement in diseases, or biological pathways), b/SNPs, or c/transcription factors. dPORE-miRNA can be accessed at http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. Its use is free for academic and non-profit users.	[Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia	King Abdullah University of Science & Technology	Schmeier, S (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Schmeier, Sebastian/D-4731-2011; Bajic, Vladimir/D-2810-2009	Schmeier, Sebastian/0000-0002-3947-8226; MacPherson, Cameron/0000-0002-8945-9736; Bajic, Vladimir/0000-0001-5435-4750; Jankovic, Boris/0000-0003-1868-6007				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim BC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schmeier S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-595; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	50	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16657	10.1371/journal.pone.0016657	http://dx.doi.org/10.1371/journal.pone.0016657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21750739	gold, Green Submitted, Green Published			2022-12-27	WOS:000287037000016
J	Taylor, AM; Reby, D; McComb, K				Taylor, Anna M.; Reby, David; McComb, Karen			Cross Modal Perception of Body Size in Domestic Dogs (Canis familiaris)	PLOS ONE			English	Article							VOCAL-TRACT RESONANCES; RED DEER; INDIVIDUAL RECOGNITION; PHONETIC INFORMATION; RHESUS MACAQUES; MONKEYS; VOICE; CHIMPANZEE; MACACA; DISCRIMINATION	While the perception of size-related acoustic variation in animal vocalisations is well documented, little attention has been given to how this information might be integrated with corresponding visual information. Using a cross-modal design, we tested the ability of domestic dogs to match growls resynthesised to be typical of either a large or a small dog to size-matched models. Subjects looked at the size-matched model significantly more often and for a significantly longer duration than at the incorrect model, showing that they have the ability to relate information about body size from the acoustic domain to the appropriate visual category. Our study suggests that the perceptual and cognitive mechanisms at the basis of size assessment in mammals have a multisensory nature, and calls for further investigations of the multimodal processing of size information across animal species.	[Taylor, Anna M.; Reby, David; McComb, Karen] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	Taylor, AM (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	anna.magdalena.taylor@gmail.com	reby, david/A-4227-2013	Goldingay, Ross/0000-0002-6684-9299; Reby, David/0000-0001-9261-1711; Walker, Faith/0000-0001-8435-4452	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was entirely funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to author AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adachi I, 2007, BEHAV PROCESS, V74, P27, DOI 10.1016/j.beproc.2006.09.004; [Anonymous], SPORTST VERS 5 4 48; BAUER HR, 1983, PSYCHOL REC, V33, P161, DOI 10.1007/BF03394834; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Evans TA, 2005, J EXP PSYCHOL ANIM B, V31, P399, DOI 10.1037/0097-7403.31.4.399; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Izumi A, 2004, ANIM COGN, V7, P179, DOI 10.1007/s10071-004-0212-4; Johnston RE, 2008, J COMP PSYCHOL, V122, P121, DOI 10.1037/0735-7036.122.2.121; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; Miller E.H., 1991, P128; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Riede T, 1999, J EXP BIOL, V202, P2859; SCHMIDTNIELSEN K, 1975, J EXP ZOOL, V194, P287, DOI 10.1002/jez.1401940120; SINNOTT JM, 1991, J ACOUST SOC AM, V89, P2421, DOI 10.1121/1.400974; SINNOTT JM, 1989, J ACOUST SOC AM, V86, P557, DOI 10.1121/1.398235; SOMMERS MS, 1992, J ACOUST SOC AM, V91, P3499, DOI 10.1121/1.402839; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; WILSON EO, 1972, SCI AM, V227, P52, DOI 10.1038/scientificamerican0972-52	36	54	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17069	10.1371/journal.pone.0017069	http://dx.doi.org/10.1371/journal.pone.0017069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22053200	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000287392700043
